PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Giedd, JN; Rapoport, JL				Giedd, Jay N.; Rapoport, Judith L.			Structural MRI of Pediatric Brain Development: What Have We Learned and Where Are We Going?	NEURON			English	Review							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILDHOOD-ONSET SCHIZOPHRENIA; QUANTITATIVE MORPHOLOGY; CORTICAL DEVELOPMENT; CHILDREN; ADOLESCENTS; CORTEX; ABNORMALITIES; CEREBELLUM	Magnetic resonance imaging (MRI) allows unprecedented access to the anatomy and physiology of the developing brain without the use of ionizing radiation. Over the past two decades, thousands of brain MRI scans from healthy youth and those with neuropsychiatric illness have been acquired and analyzed with respect to diagnosis, sex, genetics, and/or psychological variables such as IQ. Initial reports comparing size differences of various brain components averaged across large age spans have given rise to longitudinal studies examining trajectories of development over time and evaluations of neural circuitry as opposed to structures in isolation. Although MRI is still not of routine diagnostic utility for evaluation of pediatric neuropsychiatric disorders, patterns of typical versus atypical development have emerged that may elucidate pathologic mechanisms and suggest targets for intervention. In this review we summarize general contributions of structural MRI to our understanding of neurodevelopment in health and illness.	[Giedd, Jay N.; Rapoport, Judith L.] NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Giedd, JN (corresponding author), NIMH, Child Psychiat Branch, Bldg 10, Bethesda, MD 20892 USA.	jg@nih.gov	Giedd, Jay/J-9644-2015; Giedd, Jay N./A-3080-2008; Giedd, Jay N/B-7302-2012; Hassan, Randa/AAW-3624-2021	Giedd, Jay/0000-0003-2002-8978; Giedd, Jay N/0000-0003-0827-3460; 	Intramural NIH HHS [Z99 MH999999, ZIA MH002581-21] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002794, ZIAMH002581] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BASSETT AS, 2010, J PSYCHIAT IN PRESS, DOI DOI 10.1016/J.JPSY-CHIRES.2010.06.013; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; Casey BJ, 2010, NEURON, V67, P749, DOI 10.1016/j.neuron.2010.08.033; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; CASTELLANOS FX, 1994, BIOL PSYCHIAT, V35, P725, DOI 10.1016/0006-3223(94)91052-9; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Darlington RB, 1999, J COMP NEUROL, V411, P359; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Fishell G, 1997, CURR OPIN NEUROBIOL, V7, P62, DOI 10.1016/S0959-4388(97)80121-3; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Giedd JN, 2007, PEDIATRICS, V119, pE232, DOI 10.1542/peds.2005-2969; Giedd Jay N, 2008, Novartis Found Symp, V289, P101; GIEDD JN, 1994, AM J PSYCHIAT, V151, P665; Giedd JN, 2001, ANN NY ACAD SCI, V931, P33; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gogtay N, 2004, NEUROPSYCHOPHARMACOL, V29, pS82; Gogtay N, 2008, P NATL ACAD SCI USA, V105, P15979, DOI 10.1073/pnas.0806485105; Gogtay N, 2008, J AM ACAD CHILD PSY, V47, P1120, DOI 10.1097/CHI.0b013e31817eed7a; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lange N, 1997, PSYCHIAT RES-NEUROIM, V74, P1, DOI 10.1016/S0925-4927(96)03054-5; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2009, HUM BRAIN MAPP, V30, P163, DOI 10.1002/hbm.20494; Logvinov S V, 2009, Morfologiia, V136, P42; Mackie S, 2007, AM J PSYCHIAT, V164, P647, DOI 10.1176/appi.ajp.164.4.647; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Merke DP, 2005, J CLIN ENDOCR METAB, V90, P2531, DOI 10.1210/jc.2004-2488; Merke DP, 2003, J CLIN ENDOCR METAB, V88, P1760, DOI 10.1210/jc.2002-021730; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; Ofen N, 2007, NAT NEUROSCI, V10, P1198, DOI 10.1038/nn1950; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmitt JE, 2007, NEUROIMAGE, V35, P70, DOI 10.1016/j.neuroimage.2006.04.232; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2007, ARCH GEN PSYCHIAT, V64, P921, DOI 10.1001/archpsyc.64.8.921; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Shaw P, 2009, AM J PSYCHIAT, V166, P58, DOI 10.1176/appi.ajp.2008.08050781; Sobel LJ, 2010, AM J PSYCHIAT, V167, P977, DOI 10.1176/appi.ajp.2010.09091259; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Wallace GL, 2006, J CHILD PSYCHOL PSYC, V47, P987, DOI 10.1111/j.1469-7610.2006.01676.x; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012	58	554	559	2	74	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 9	2010	67	5					728	734		10.1016/j.neuron.2010.08.040	http://dx.doi.org/10.1016/j.neuron.2010.08.040			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826305	Green Accepted, Bronze			2022-12-17	WOS:000281938900008
J	Liu, C; Weaver, DR; Jin, XW; Shearman, LP; Pieschl, RL; Gribkoff, VK; Reppert, SM				Liu, C; Weaver, DR; Jin, XW; Shearman, LP; Pieschl, RL; Gribkoff, VK; Reppert, SM			Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock	NEURON			English	Article							2-<I-125>IODOMELATONIN BINDING-SITES; BIOLOGICAL CLOCK; NUCLEUS NEURONS; SYRIAN-HAMSTERS; PHASE ADVANCES; K+ CHANNEL; G-PROTEINS; JET-LAG; RAT; INVITRO	The pineal hormone melatonin elicits two effects on the suprachiasmatic nuclei (SCN): acute neuronal inhibition and phase-shifting. Melatonin evokes its biological effects through G protein-coupled receptors. Since the Mel(1a) melatonin receptor may transduce the major neurobiological actions of melatonin in mammals, we examined whether it mediates both melatonin effects on SCN function by using mice with targeted disruption of the Mel(1a) receptor. The Mel(1a) receptor accounts for all detectable, high affinity melatonin binding in mouse brain. Functionally, this receptor is necessary for the acute inhibitory action of melatonin on the SCN. Melatonin-induced phase shifts, however, are only modestly altered in the receptor-deficient mice; pertussis toxin still blocks melatonin-induced phase shifts in Mel(1a) receptor-deficient mice. The other melatonin receptor subtype, the Mel(1b) receptor, is expressed in mouse SCN, implicating it in the phase-shifting response. The results provide a molecular basis for two distinct, mechanistically separable effects of melatonin on SCN physiology.	MASSACHUSETTS GEN HOSP,SERV PEDIAT,LAB DEV CHRONOBIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114; BRISTOL MYERS SQUIBB CO,PHARMACEUT RES INST,CNS ELECTROPHYSIOL,WALLINGFORD,CT 06492	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Bristol-Myers Squibb			Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Weaver, David/0000-0001-7941-6719	NICHD NIH HHS [R37 HD14427] Funding Source: Medline; NIDDK NIH HHS [DK42125] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042125] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARENDT J, 1987, ERGONOMICS, V30, P1379, DOI 10.1080/00140138708966031; Benloucif S, 1996, J BIOL RHYTHM, V11, P113, DOI 10.1177/074873049601100204; BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; BOUSKILA Y, 1995, J PHYSIOL-LONDON, V488, P339, DOI 10.1113/jphysiol.1995.sp020970; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; CARLSON LL, 1989, ENDOCRINOLOGY, V125, P2670, DOI 10.1210/endo-125-5-2670; CASSONE VM, 1990, TRENDS NEUROSCI, V13, P457, DOI 10.1016/0166-2236(90)90099-V; DAVIS FC, 1988, AM J PHYSIOL, V255, pR439, DOI 10.1152/ajpregu.1988.255.3.R439; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dubocovich ML, 1996, BEHAV BRAIN RES, V73, P141; DUNCAN MJ, 1993, DEV BRAIN RES, V73, P205, DOI 10.1016/0165-3806(93)90140-6; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Grosse J, 1996, AM J PHYSIOL-REG I, V270, pR533, DOI 10.1152/ajpregu.1996.270.3.R533; HAAS HL, 1979, J NEUROSCI METH, V1, P323, DOI 10.1016/0165-0270(79)90021-9; HASTINGS MH, 1992, BRAIN RES, V591, P20, DOI 10.1016/0006-8993(92)90973-D; JIANG ZG, 1995, BRAIN RES, V687, P125, DOI 10.1016/0006-8993(95)00478-9; KARSCHIN C, 1994, FEBS LETT, V348, P139, DOI 10.1016/0014-5793(94)00590-7; KELLEY MR, 1993, ALCOHOL, V10, P185, DOI 10.1016/0741-8329(93)90033-K; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KLEIN DC, 1993, LIGHT BIOL RHYTHMS M, P55; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu C, 1996, J NEUROSCI, V16, P744; MASON R, 1988, NEUROSCI LETT, V95, P296, DOI 10.1016/0304-3940(88)90674-X; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MORGAN PJ, 1990, J NEUROENDOCRINOL, V2, P773, DOI 10.1111/j.1365-2826.1990.tb00639.x; Nelson CS, 1996, NEUROREPORT, V7, P717, DOI 10.1097/00001756-199602290-00009; PALM L, 1991, ANN NEUROL, V29, P336, DOI 10.1002/ana.410290318; PETRIE K, 1989, BRIT MED J, V298, P705, DOI 10.1136/bmj.298.6675.705; PROSSER RA, 1994, BRAIN RES, V644, P67, DOI 10.1016/0006-8993(94)90348-4; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Reppert SM, 1995, CELL, V83, P1059, DOI 10.1016/0092-8674(95)90131-0; REPPERT SM, 1988, SCIENCE, V242, P78, DOI 10.1126/science.2845576; Roca AL, 1996, ENDOCRINOLOGY, V137, P3469, DOI 10.1210/en.137.8.3469; ROCA AL, 1996, THESIS HARVARD U CAM; SACK RL, 1991, J BIOL RHYTHM, V6, P249, DOI 10.1177/074873049100600305; SHIBATA S, 1989, NEUROSCI LETT, V97, P140, DOI 10.1016/0304-3940(89)90153-5; SIUCIAK JA, 1990, EUR J PHARMACOL, V180, P387, DOI 10.1016/0014-2999(90)90328-4; STARKEY SJ, 1995, NEUROREPORT, V6, P1947, DOI 10.1097/00001756-199510020-00029; Starkey SJ, 1996, NEUROSCI LETT, V211, P199, DOI 10.1016/0304-3940(96)12756-7; STEHLE J, 1989, J NEURAL TRANSM-GEN, V78, P173, DOI 10.1007/BF01252503; VANECEK J, 1992, ENDOCRINOLOGY, V130, P701, DOI 10.1210/en.130.2.701; VANREETH O, 1989, NATURE, V339, P49, DOI 10.1038/339049a0; Weaver DR, 1996, NEUROREPORT, V8, P109, DOI 10.1097/00001756-199612200-00022; Weaver DR, 1996, MOL ENDOCRINOL, V10, P1478, DOI 10.1210/me.10.11.1478; WEAVER DR, 1991, SUPRACHIASMATIC NUCL, P289; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865	51	554	574	2	34	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					91	102		10.1016/S0896-6273(00)80350-5	http://dx.doi.org/10.1016/S0896-6273(00)80350-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247266	Bronze			2022-12-17	WOS:A1997XN39400009
J	Nir, Y; Staba, RJ; Andrillon, T; Vyazovskiy, VV; Cirelli, C; Fried, I; Tononi, G				Nir, Yuval; Staba, Richard J.; Andrillon, Thomas; Vyazovskiy, Vladyslav V.; Cirelli, Chiara; Fried, Itzhak; Tononi, Giulio			Regional Slow Waves and Spindles in Human Sleep	NEURON			English	Article							INTERHEMISPHERIC EEG ASYMMETRY; LESS-THAN-1 HZ OSCILLATION; MEMORY CONSOLIDATION; NEOCORTICAL NEURONS; CEREBRAL-CORTEX; WAKE CYCLE; K-COMPLEX; HIPPOCAMPAL; STATES; SYNCHRONIZATION	The most prominent EEG events in sleep are slow waves, reflecting a slow (< 1 Hz) oscillation between up and down states in cortical neurons. It is unknown whether slow oscillations are synchronous across the majority or the minority of brain regions-are they a global or local phenomenon? To examine this, we recorded simultaneously scalp EEG, intracerebral EEG, and unit firing in multiple brain regions of neurosurgical patients. We find that most sleep slow waves and the underlying active and inactive neuronal states occur locally. Thus, especially in late sleep, some regions can be active while others are silent. We also find that slow waves can propagate, usually from medial prefrontal cortex to the medial temporal lobe and hippocampus. Sleep spindles, the other hallmark of NREM sleep EEG, are likewise predominantly local. Thus, intracerebral communication during sleep is constrained because slow and spindle oscillations often occur out-of-phase in different brain regions.	[Nir, Yuval; Andrillon, Thomas; Vyazovskiy, Vladyslav V.; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Staba, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Behav Neurosci, Los Angeles, CA 90095 USA; [Andrillon, Thomas] Ecole Normale Super, Dept Cognit Studies, F-75005 Paris, France; [Fried, Itzhak] Tel Aviv Univ, Funct Neurosurg Unit, Tel Aviv Med Ctr, IL-64239 Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Sch Med, IL-64239 Tel Aviv, Israel	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	gtononi@wisc.edu	Andrillon, Thomas/P-6440-2019	Andrillon, Thomas/0000-0003-2794-8494; Nir, Yuval/0000-0002-5433-6349; Vyazovskiy, Vladyslav/0000-0002-4336-6681	European Molecular Biology Organization; Human Frontier Science Program Organization; Brainpower for Israel Fund; National Institute of Health [P20 MH077967, R01 NS055185]; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH077967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033221, R01NS055185, R01NS071048] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Organization(Human Frontier Science Program); Brainpower for Israel Fund; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the patients for their cooperation; E. Behnke, T. Fields, V. Isiaka, D. Pourshaban, R. Mukamel, A. Tankus, N. Suthana, and K. Shattuck for assistance with data acquisition; B. Salaz and I. Wainwright for administrative help; B. Riedner for slow wave detection algorithms and valuable input; and M. Murphy and F. Ferrarelli for discussions and comments. This work was supported by the European Molecular Biology Organization and Human Frontier Science Program Organization long-term fellowships (support to Y.N.), the Brainpower for Israel Fund (support to Y.N.), National Institute of Health Director's Pioneer Award (support to G.T.), NIH (grants P20 MH077967 and R01 NS055185 to G.T.), and National Institute of Neurological Disorders and Stroke (grants to R.S. and I.F.).	Achermann P, 1998, J SLEEP RES, V7, P36, DOI 10.1046/j.1365-2869.7.s1.6.x; Aeschbach D, 2008, J NEUROSCI, V28, P2766, DOI 10.1523/JNEUROSCI.5548-07.2008; AMARAL D G, 1992, P1; Amzica F, 1998, NEUROSCIENCE, V82, P671; AMZICA F, 1995, J NEUROSCI, V15, P4658; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; CADERAS M, 1982, CLIN ELECTROENCEPHAL, V13, P216, DOI 10.1177/155005948201300402; Campbell Ian G, 2009, Curr Protoc Neurosci, VChapter 10, DOI 10.1002/0471142301.ns1002s49; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Contreras D, 1997, NEUROSCIENCE, V77, P933; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; Dang-Vu TT, 2005, NEUROIMAGE, V28, P14, DOI 10.1016/j.neuroimage.2005.05.028; Dehghani N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011454; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DINNER DS, 2001, EPILEPSY SLEEP PHYSL; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Gottselig JM, 2002, BRAIN, V125, P373, DOI 10.1093/brain/awf021; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Iber C., 2007, AASM MANUAL SCORING; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; KRISTIANSEN K, 1949, ELECTROEN CLIN NEURO, V1, P265, DOI 10.1016/0013-4694(49)90191-1; Landsness EC, 2009, SLEEP, V32, P1273; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LOOMIS ALFRED L., 1935, SCIENCE, V81, P597, DOI 10.1126/science.81.2111.597; Magnin M, 2010, P NATL ACAD SCI USA, V107, P3829, DOI 10.1073/pnas.0909710107; Mahowald MW, 2005, NATURE, V437, P1279, DOI 10.1038/nature04287; Maquet P, 2000, J SLEEP RES, V9, P207; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Molle M, 2002, J NEUROSCI, V22, P10941; MUKHAMETOV LM, 1977, BRAIN RES, V134, P581, DOI 10.1016/0006-8993(77)90835-6; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Nir Y, 2010, TRENDS COGN SCI, V14, P88, DOI 10.1016/j.tics.2009.12.001; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; NODA H, 1970, J NEUROPHYSIOL, V33, P672, DOI 10.1152/jn.1970.33.5.672; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Rattenborg NC, 2001, BRAIN BEHAV EVOLUT, V58, P323, DOI 10.1159/000057573; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sirota Anton, 2005, Thalamus & Related Systems, V3, P245, DOI 10.1017/S1472928807000258; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Steriade M., 2003, NEURONAL SUBSTRATES; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2006, NEURON, V52, P748, DOI 10.1016/j.neuron.2006.11.014; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; VYAZOVSKIY VV, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10009; Wagner T, 2010, CORTEX, V46, P256, DOI 10.1016/j.cortex.2009.05.012; Werth E, 1997, J SLEEP RES, V6, P102, DOI 10.1046/j.1365-2869.1997.d01-36.x; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; WYLER AR, 1982, ANN NEUROL, V11, P301, DOI 10.1002/ana.410110311; Zikopoulos B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000848	102	553	556	6	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 14	2011	70	1					153	169		10.1016/j.neuron.2011.02.043	http://dx.doi.org/10.1016/j.neuron.2011.02.043			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	755JJ	21482364	Bronze, Green Accepted			2022-12-17	WOS:000289925600016
J	Benchenane, K; Peyrache, A; Khamassi, M; Tierney, PL; Gioanni, Y; Battaglia, FP; Wiener, SI				Benchenane, Karim; Peyrache, Adrien; Khamassi, Mehdi; Tierney, Patrick L.; Gioanni, Yves; Battaglia, Francesco P.; Wiener, Sidney I.			Coherent Theta Oscillations and Reorganization of Spike Timing in the Hippocampal-Prefrontal Network upon Learning	NEURON			English	Article							CORTICAL-NEURONS; SPATIAL MEMORY; IN-VIVO; DOPAMINERGIC MODULATION; CELL ASSEMBLIES; CORTEX; RAT; INTERNEURONS; SYNCHRONIZATION; NEOCORTEX	To study the interplay between hippocampus and medial prefrontal cortex (Pfc) and its importance for learning and memory consolidation, we measured the coherence in theta oscillations between these two structures in rats learning new rules on a Y maze. Coherence peaked at the choice point, most strongly after task rule acquisition. Simultaneously, Pfc pyramidal neurons reorganized their phase, concentrating at hippocampal theta trough, and synchronous cell assemblies emerged. This synchronous state may result from increased inhibition exerted by interneurons on pyramidal cells, as measured by cross-correlation, and could be modulated by dopamine: we found similar hippocampal-Pfc theta coherence increases and neuronal phase shifts following local administration of dopamine in Pfc of anesthetized rats. Pfc cell assemblies emerging during high coherence were preferentially replayed during subsequent sleep, concurrent with hippocampal sharp waves. Thus, hippocampal/prefrontal coherence could lead to synchronization of reward predicting activity in prefrontal networks, tagging it for subsequent memory consolidation.	[Benchenane, Karim; Peyrache, Adrien; Khamassi, Mehdi; Battaglia, Francesco P.; Wiener, Sidney I.] CNRS, Lab Physiol Percept & Act, Coll France, F-75231 Paris 05, France; [Khamassi, Mehdi] Univ Paris 06, CNRS FRE 2507, Inst Syst Intelligents & Robot, F-75252 Paris, France; [Tierney, Patrick L.; Gioanni, Yves] INSERM, U667, Coll France, F-75231 Paris 05, France; [Tierney, Patrick L.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Battaglia, Francesco P.] Univ Amsterdam, SILS Ctr Neurosci, NL-1098 XH Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Massachusetts Institute of Technology (MIT); University of Amsterdam	Benchenane, K (corresponding author), Univ Paris 06, ENMVI Team, CNRS, UMR 7102, 12 Rue Cuvier, F-75005 Paris, France.	karim.benchenane@snv.jussieu.fr; f.p.battaglia@uva.nl	Khamassi, Mehdi/B-2425-2012; Tierney, Patrick/E-5860-2010; Battaglia, Francesco F.P./F-2543-2011; benchenane, karim/D-8023-2015	Khamassi, Mehdi/0000-0002-2515-1046; Battaglia, Francesco F.P./0000-0003-3715-8875; benchenane, karim/0000-0001-7118-0748; Peyrache, Adrien/0000-0001-9708-309X; Wiener, Sidney/0000-0002-5819-1319	Fondation Fyssen; Fondation pour la Recherche Medicale; EC [FP6-IST 027819, FP6-IST-027140, FP6-IST-027017]	Fondation Fyssen; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EC(European CommissionEuropean Commission Joint Research Centre)	We thank Prof. J.-M. Deniau, Drs. A.-M. Thierry and M.B. Zugaro for interesting discussions, S. Doutremer for histology, Prof. D. Hopkins and N. Quenech'du for the anatomical reconstructions, V. Douchamps for help with the experiments, and Prof. A. Berthoz for support throughout the project. This work was supported by Fondation Fyssen (F.P.B.), Fondation pour la Recherche Medicale (A.P.), and EC contracts FP6-IST 027819 (ICEA), FP6-IST-027140 (BAGS), and FP6-IST-027017 (NeuroProbes).	[Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Baeg EH, 2007, J NEUROSCI, V27, P909, DOI 10.1523/JNEUROSCI.4759-06.2007; Bandyopadhyay S, 2007, J NEUROPHYSIOL, V97, P4120, DOI 10.1152/jn.00898.2006; Birrell JM, 2000, J NEUROSCI, V20, P4320; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; Delatour B, 2000, BEHAV BRAIN RES, V109, P113, DOI 10.1016/S0166-4328(99)00168-0; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fisher NI., 1995, STAT ANAL CIRCULAR D; Floresco SB, 1997, J NEUROSCI, V17, P1880; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shastri L, 2002, TRENDS COGN SCI, V6, P162, DOI 10.1016/S1364-6613(02)01868-5; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Tierney PL, 2008, CEREB CORTEX, V18, P2251, DOI 10.1093/cercor/bhm252; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; van der Meulen JAJ, 2007, CEREB CORTEX, V17, P1444, DOI 10.1093/cercor/bhl057; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	64	553	565	2	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					921	936		10.1016/j.neuron.2010.05.013	http://dx.doi.org/10.1016/j.neuron.2010.05.013			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620877	Green Published, Bronze, Green Submitted			2022-12-17	WOS:000279420800014
J	Kable, JW; Glimcher, PW				Kable, Joseph W.; Glimcher, Paul W.			The Neurobiology of Decision: Consensus and Controversy	NEURON			English	Review							DOPAMINE NEURONS ENCODE; DORSOLATERAL PREFRONTAL CORTEX; POSTERIOR PARIETAL CORTEX; ORBITOFRONTAL CORTEX; NEURAL BASIS; CINGULATE CORTEX; PERCEPTUAL DECISION; PREDICTION ERRORS; REWARD PREDICTION; BASAL GANGLIA	We review and synthesize recent neurophysiological studies of decision making in humans and nonhuman primates. From these studies, the basic outline of the neurobiological mechanism for primate choice is beginning to emerge. The identified mechanism is now known to include a multicomponent valuation stage, implemented in ventromedial prefrontal cortex and associated parts of striatum, and a choice stage, implemented in lateral prefrontal and parietal areas. Neurobiological studies of decision making are beginning to enhance our understanding of economic and social behavior as well as our understanding of significant health disorders where people's behavior plays a key role.	[Kable, Joseph W.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Glimcher, Paul W.] NYU, Ctr Neuroecon, New York, NY 10003 USA	University of Pennsylvania; New York University	Kable, JW (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	kable@psych.upenn.edu; glimcher@cns.nyu.edu		Glimcher, Paul/0000-0001-7872-3856	National Institutes of Health [R01-EY010536, R01-NS054775]; NATIONAL EYE INSTITUTE [R01EY010536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Senecal and J. Stump for their comments on a previous version of this manuscript. P.W.G. is supported by grants from the National Institutes of Health (R01-EY010536 and R01-NS054775).	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Basso MA, 1998, J NEUROSCI, V18, P7519; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bernheim BD, 2004, AM ECON REV, V94, P1558, DOI 10.1257/0002828043052222; Bossaerts P, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P353, DOI 10.1016/B978-0-12-374176-9.00023-3; Cardinal RN, 2002, NEURAL NETWORKS, V15, P617, DOI 10.1016/S0893-6080(02)00053-9; Chiu PH, 2008, NAT NEUROSCI, V11, P514, DOI 10.1038/nn2067; Chiu PH, 2008, NEURON, V57, P463, DOI 10.1016/j.neuron.2007.12.020; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Cohen JD, 2002, NEURON, V36, P193, DOI 10.1016/S0896-6273(02)00973-X; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Fox CR, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P145, DOI 10.1016/B978-0-12-374176-9.00011-7; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Friedman M., 1953, ESSAYS POSITIVE EC, P3; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gul F., 2010, FDN POSITIVE NORMATI, P3, DOI DOI 10.1093/ACPROF:OSO/9780195328318.003.0001; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Houthakker HS, 1950, ECONOMICA-NEW SER, V17, P159, DOI 10.2307/2549382; Isa T, 2004, METH NE FRO NEUROSCI, P159; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Koszegi B, 2006, Q J ECON, V121, P1133, DOI 10.1093/qje/121.4.1133; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Lee P, 2006, J NEUROSCI, V26, P4763, DOI 10.1523/JNEUROSCI.0724-06.2006; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; LEVY I, 2007, 37 ANN SOC NEUR M SA; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Marr D., 1982, VISION COMPUTATIONAL; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McFadden D., 1974, FRONTIERS ECONOMETRI, P105, DOI [10.1108/eb028592, DOI 10.1108/EB028592]; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Niv Y, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P331, DOI 10.1016/B978-0-12-374176-9.00022-1; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Samuelson PA, 1936, REV ECON STUD, V4, P155; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SELTEN R, 1975, INT J GAME THEORY, V4, P819; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Singer T, 2005, AM ECON REV, V95, P340, DOI 10.1257/000282805774670103; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tobler PN, 2003, J NEUROSCI, V23, P10402; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Zaghloul KA, 2009, SCIENCE, V323, P1496, DOI 10.1126/science.1167342	121	553	564	3	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					733	745		10.1016/j.neuron.2009.09.003	http://dx.doi.org/10.1016/j.neuron.2009.09.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778504	Green Submitted, Green Accepted, Bronze			2022-12-17	WOS:000270569700008
J	Logan, JM; Sanders, AL; Snyder, AZ; Morris, JC; Buckner, RL				Logan, JM; Sanders, AL; Snyder, AZ; Morris, JC; Buckner, RL			Under-recruitment and nonselective recruitment: Dissociable neural mechanisms associated with aging	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INFERIOR PREFRONTAL CORTEX; EPISODIC MEMORY; FRONTAL-CORTEX; RECOGNITION MEMORY; FUNCTIONAL MRI; BRAIN ACTIVITY; DIVIDED ATTENTION; AGE-DIFFERENCES; WORKING-MEMORY	Frontal contributions to cognitive decline in aging were explored using functional MRI. Frontal regions active in younger adults during self-initiated (intentional) memory encoding were under-recruited in older adults. Older adults showed less activity in anterior-ventral regions associated with controlled use of semantic information. Under-recruitment was reversed by requiring semantic elaboration suggesting it stemmed from difficulty in spontaneous recruitment of available frontal resources. In addition, older adults recruited multiple frontal regions in a nonselective manner for both verbal and nonverbal materials. Lack of selectivity was not reversed during semantically directed encoding even when under-recruitment was diminished. These findings suggest two separate forms of age-associated change in frontal cortex: under-recruitment and nonselective recruitment. The former is reversible and potentially amenable to cognitive training; the latter may reflect a less malleable change associated with cognitive decline in advanced aging.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Buckner, RL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.		Kennedy, Kristen M/B-4699-2008; Morris, John C/A-1686-2012	Kennedy, Kristen M/0000-0001-5373-9026; 	NIA NIH HHS [AG05681, AG03991] Funding Source: Medline; NIMH NIH HHS [MH57506] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, P01AG003991] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Backman L, 1997, J COGNITIVE NEUROSCI, V9, P378, DOI 10.1162/jocn.1997.9.3.378; Baker JT, 2001, NEUROREPORT, V12, P1251, DOI 10.1097/00001756-200105080-00039; Balota D., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; BUCKNER RL, 2002, COGNITIVE NEUROSCIEN; Cabeza R, 1997, J NEUROSCI, V17, P391; CABEZA R, 2002, IN PRESS PSYCHOL AGI; Camp C., 2000, COGNITIVE REHABILITA, P224; Cao Y, 1999, STROKE, V30, P2331, DOI 10.1161/01.STR.30.11.2331; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Craik F.I., 1982, AGING COGNITIVE PROC, P51, DOI DOI 10.1007/978-1-4684-4178-9_11; Craik F.I.M., 1977, HDB PSYCHOL AGING, P384; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Craik FIM, 1980, P GEORG TALL MEM C N; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P168; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; Dixit N.K., 2000, NEUROIMAGE, V11, pS94; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Gold BT, 2000, BRAIN LANG, V73, P456, DOI 10.1006/brln.2000.2317; GOODGLASS H, 1983, BOSTON NAMING TEST S; Grady CL, 1999, CEREB CORTEX, V9, P805, DOI 10.1093/cercor/9.8.805; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Hasher L, 1999, ATTENTION PERFORM, V17, P653; Hasher L., 1988, WORKING MEMORY COMPR, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; HULICKA IM, 1966, J GENET PSYCHOL, V109, P135, DOI 10.1080/00221325.1966.10533690; Iidaka T, 2000, J COGNITIVE NEUROSCI, V12, P267, DOI 10.1162/089892900562093; Iidaka T, 2001, COGNITIVE BRAIN RES, V11, P1, DOI 10.1016/S0926-6410(00)00058-6; Kapur S, 1996, COGNITIVE BRAIN RES, V4, P243, DOI 10.1016/S0926-6410(96)00058-4; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; KAUSLER DH, 1988, AM J PSYCHOL, V101, P207, DOI 10.2307/1422835; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knoke D, 1998, BRAIN COGNITION, V38, P261, DOI 10.1006/brcg.1998.1042; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Kuera H., 1967, COMPUTATIONAL ANAL P; Madden DJ, 1999, HUM BRAIN MAPP, V7, P115, DOI 10.1002/(SICI)1097-0193(1999)7:2<115::AID-HBM5>3.0.CO;2-N; Madden DJ, 1999, J COGNITIVE NEUROSCI, V11, P511, DOI 10.1162/089892999563571; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; McIntosh AR, 1999, CURR BIOL, V9, P1275, DOI 10.1016/S0960-9822(99)80512-0; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; MYERSON J, 1990, PSYCHOL REV, V97, P475, DOI 10.1037/0033-295X.97.4.475; NIELSON KA, 2002, IN PRESS PSYCHOL AGI; Nyberg L., 1996, J GERONTOL B-PSYCHOL, V51, P234; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Ohyama M, 1996, STROKE, V27, P897, DOI 10.1161/01.STR.27.5.897; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; PARK DC, 1990, J GERONTOL B-PSYCHOL, V45, P52; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2000, HDB AGING COGNITION, P1; Reuter-Lorenz PA, 2001, EUR J COGN PSYCHOL, V13, P257, DOI 10.1080/09541440125972; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Sohlberg MM, 2001, COGNITIVE REHABILITA; Stuss DT, 1996, PSYCHOL AGING, V11, P387, DOI 10.1037/0882-7974.11.3.387; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Talairach J., 1988, COPLANAR STEREOTAXIC; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Thurstone L., 1949, EXAMINER MANUAL SRT; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wechsler D, 1973, MANUAL WECHSLER MEMO; Wechsler D, 1955, WAIS MANUAL; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; ZAGAR R, 1984, J CLIN PSYCHOL, V40, P1466, DOI 10.1002/1097-4679(198411)40:6<1466::AID-JCLP2270400635>3.0.CO;2-5	91	553	560	0	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					827	840		10.1016/S0896-6273(02)00612-8	http://dx.doi.org/10.1016/S0896-6273(02)00612-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	529EC	11879658	Bronze			2022-12-17	WOS:000174286200017
J	Gross, RE; Mehler, MF; Mabie, PC; Zang, ZY; Santschi, L; Kessler, JA				Gross, RE; Mehler, MF; Mabie, PC; Zang, ZY; Santschi, L; Kessler, JA			Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; OLIGODENDROCYTES IN-VITRO; FIBRILLARY ACIDIC PROTEIN; RAT CEREBRAL-CORTEX; GROWTH-FACTOR; PRECURSOR CELLS; NEURAL CREST; STEM-CELLS; NEURONAL DIFFERENTIATION; ASTROCYTE DEVELOPMENT	The epigenetic signals that regulate lineage development in the embryonic mammalian brain are poorly understood. Here we demonstrate that a specific subclass of the transforming growth factor beta superfamily, the bone morphogenetic proteins (BMPs), cause the selective, dose-dependent elaboration of the astroglial lineage from murine embryonic subventricular zone (SVZ) multipotent progenitor cells. The astroglial inductive effect is characterized by enhanced morphological complexity and expression of glial fibrillary acidic protein, with concurrent suppression of neuronal and oligodendroglial cell fates. SVZ progenitor cells express transcripts for the appropriate BMP-specific type I and II receptor subunits and selective BMP ligands, suggesting the presence of paracrine or autocrine developmental signaling pathways (or both). These observations suggest that the BMPs have a selective role in determining the cell fate of SVZ multipotent progenitor cells or their more developmentally restricted progeny.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSURG,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,ROSE F KENNEDY CTR RES MENTAL RETARDAT & HUMAN DE,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine					NINDS NIH HHS [NS-34758, NS-20778, NS-20013] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034758, R01NS020013, R01NS020778] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED S, 1995, J NEUROSCI, V15, P5765; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; Anderson DJ, 1995, NEURON, V15, P1219, DOI 10.1016/0896-6273(95)90001-2; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; CAMMER W, 1992, J COMP NEUROL, V321, P33, DOI 10.1002/cne.903210104; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Craig CG, 1996, J NEUROSCI, V16, P2649; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P45, DOI 10.3109/08977199409015050; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FANN MJ, 1994, J NEUROCHEM, V63, P2074; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; GODSAVE SF, 1991, DEVELOPMENT, V111, P523; GREEN JBA, 1994, CELL, V77, P317, DOI 10.1016/0092-8674(94)90145-7; GRUNZ H, 1989, CELL DIFFER DEV, V28, P211, DOI 10.1016/0922-3371(89)90006-3; Heitzler P, 1996, DEVELOPMENT, V122, P161; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; JONES CM, 1991, DEVELOPMENT, V111, P531; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LIU F, 1995, MOL CELL BIOL, V15, P3479; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MAYER M, 1994, DEVELOPMENT, V120, P143; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MEHLER MF, 1995, INT J DEV NEUROSCI, V13, P213, DOI 10.1016/0736-5748(94)00060-G; MEHLER MF, 1994, DEV NEUROSCI-BASEL, V16, P180, DOI 10.1159/000112105; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; NAKAFUKU M, 1995, J NEUROSCI RES, V41, P153, DOI 10.1002/jnr.490410203; PATTERSON PH, 1993, CELL, V72, P123, DOI 10.1016/S0092-8674(05)80032-7; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; PERIDES G, 1992, P NATL ACAD SCI USA, V89, P10326, DOI 10.1073/pnas.89.21.10326; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Pourquie O, 1996, CELL, V84, P461, DOI 10.1016/S0092-8674(00)81291-X; PRIVAT A, 1972, J COMP NEUROL, V146, P277, DOI 10.1002/cne.901460302; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SAKAI Y, 1990, P NATL ACAD SCI USA, V87, P8378, DOI 10.1073/pnas.87.21.8378; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SIMPSON P, 1995, NEURON, V15, P739, DOI 10.1016/0896-6273(95)90163-9; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TOMIZAWA K, 1995, MOL BRAIN RES, V28, P122, DOI 10.1016/0169-328X(94)00199-O; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; WALL NA, 1994, CURR OPIN GENET DEV, V4, P517, DOI 10.1016/0959-437X(94)90066-C; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; YOSHIDA T, 1993, DEV BRAIN RES, V76, P147, DOI 10.1016/0165-3806(93)90132-T; YOSHIDA T, 1993, J NEUROSCI RES, V35, P129, DOI 10.1002/jnr.490350203	83	553	575	4	30	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					595	606		10.1016/S0896-6273(00)80193-2	http://dx.doi.org/10.1016/S0896-6273(00)80193-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893018	Bronze			2022-12-17	WOS:A1996VP74300006
J	HOLLMANN, M; BOULTER, J; MARON, C; BEASLEY, L; SULLIVAN, J; PECHT, G; HEINEMANN, S				HOLLMANN, M; BOULTER, J; MARON, C; BEASLEY, L; SULLIVAN, J; PECHT, G; HEINEMANN, S			ZINC POTENTIATES AGONIST-INDUCED CURRENTS AT CERTAIN SPLICE VARIANTS OF THE NMDA RECEPTOR	NEURON			English	Article							GLUTAMATE-OPERATED CHANNELS; DEPENDENT CHLORIDE CURRENT; AMINO-ACID RECEPTORS; METHYL-D-ASPARTATE; XENOPUS OOCYTES; HIPPOCAMPAL-NEURONS; RAT-BRAIN; ACETYLCHOLINE-RECEPTOR; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING	We have determined the gene structure for the NMDA receptor subunit gene NMDAR1. We found eight splice variants that arise from different combinations of a single 5' terminal exon insertion and three different 3' terminal exon deletions, relative to NMDAR1. We analyzed the modulation by Zn2+ of currents through homomeric receptors assembled from these splice variants and found that, in addition to its well-known inhibitory effect at high concentrations, Zn2+ potentiates agonist-induced currents at submicromolar concentrations (EC50 = 0.50 muM). This potentiation is observed only with a subset of NMDAR1 splice variants that show additional differences in pharmacological properties. Zn2+ potentiation is rapidly reversible, non-competitive with either glutamate or glycine, and voltage independent. Zn2+ potentiation is mimicked by Cd2+, Cu2+, and Ni2+, but not by Mn2+, Co2+, Fe3+, Sn2+, or Hg2+. Our results suggest a possible role for Zn2+ as a positive modulator of NMDA receptors in certain regions of the brain.			HOLLMANN, M (corresponding author), SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA.			Hollmann, Michael/0000-0001-8000-7787	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011549, R01NS012961, R01NS028709] Funding Source: NIH RePORTER; NINDS NIH HHS [NS11549, 5 R01 NS12961, NS28709] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANANTHARAM V, 1992, FEBS LETT, V305, P27, DOI 10.1016/0014-5793(92)80648-Z; ANIKSZTEJN L, 1987, BRAIN RES, V404, P58, DOI 10.1016/0006-8993(87)91355-2; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BISSWAGNNER H, 1979, THEORIE METHODEN ENZ; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOULTER J, 1986, J NEUROSCI RES, V16, P37, DOI 10.1002/jnr.490160106; BOULTER J, 1989, METHODS NEUROSCIENCE, P328; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BREWER GJ, 1980, AM J HEMATOL, V8, P231, DOI 10.1002/ajh.2830080215; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CHARTON G, 1985, EXP BRAIN RES, V58, P202; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; CRAWFORD IL, 1972, J NEUROCHEM, V19, P1451, DOI 10.1111/j.1471-4159.1972.tb05088.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONALDSON J, 1973, CAN J BIOCHEM CELL B, V51, P87, DOI 10.1139/o73-010; DREOSTI IE, 1984, NEUROBIOLOGY ZINC, P1; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; GALLO V, 1992, J NEUROSCI, V12, P1010; GEOFFROY M, 1991, MOL PHARMACOL, V39, P587; GOLDMAN D, 1985, J NEUROSCI, V5, P2553; GOLDMAND, 1907, CELL, V48, P965; GRAMACCIOLI CM, 1966, ACTA CRYSTALLOGR, V21, P600, DOI 10.1107/S0365110X66003529; HASKINS KM, 1980, BIOCHEM BIOPH RES CO, V95, P1703, DOI 10.1016/S0006-291X(80)80095-7; HAUG FMS, 1967, HISTOCHEMISTRY, V8, P355, DOI 10.1007/BF00401978; HESKETH JE, 1984, FEBS LETT, V169, P313, DOI 10.1016/0014-5793(84)80341-5; HESKETH JE, 1984, INT J BIOCHEM, V16, P1331, DOI 10.1016/0020-711X(84)90236-2; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; IBATA Y, 1969, J HISTOCHEM CYTOCHEM, V17, P171, DOI 10.1177/17.3.171; KHULUSI SS, 1986, BRAIN RES, V363, P152, DOI 10.1016/0006-8993(86)90669-4; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MCGONIGLE P, 1989, BASIC NEUROCHEMISTRY, P183; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; MONAGHAN DT, 1989, NMDA RECEPTOR, P53; MONAGHAN DT, 1991, FID RES FDN, V5, P203; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; RASSENDREN FA, 1990, NEURON, V4, P733, DOI 10.1016/0896-6273(90)90199-P; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; SEKIGUCHI M, 1990, J NEUROSCI, V10, P2148; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; UMBACH JA, 1989, MOL PHARMACOL, V36, P582; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I; ZORUMSKI CF, 1990, NEURON, V5, P61, DOI 10.1016/0896-6273(90)90033-C	65	553	574	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1993	10	5					943	954		10.1016/0896-6273(93)90209-A	http://dx.doi.org/10.1016/0896-6273(93)90209-A			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	7684237				2022-12-17	WOS:A1993LD32200016
J	Adlard, PA; Cherny, RA; Finkelstein, DI; Gautier, E; Robb, E; Cortes, M; Volitakis, I; Liu, X; Smith, JP; Perez, K; Laughton, K; Li, QX; Charman, SA; Nicolazzo, JA; Wilkins, S; Deleva, K; Lynch, T; Kok, G; Ritchie, CW; Tanzi, RE; Cappai, R; Masters, CL; Barnham, KJ; Bush, AI				Adlard, Paul A.; Cherny, Robert A.; Finkelstein, David I.; Gautier, Elisabeth; Robb, Elysia; Cortes, Mikhalina; Volitakis, Irene; Liu, Xiang; Smith, Jeffrey P.; Perez, Keyla; Laughton, Katrina; Li, Qiao-Xin; Charman, Susan A.; Nicolazzo, Joseph A.; Wilkins, Simon; Deleva, Karolina; Lynch, Toni; Kok, Gaik; Ritchie, Craig W.; Tanzi, Rudolph E.; Cappai, Roberto; Masters, Colin L.; Barnham, Kevin J.; Bush, Ashley I.			Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial A beta	NEURON			English	Article							AMYLOID-BETA; IN-VIVO; DISEASE; PROTEIN; ZINC; TAU; OLIGOMERS; PATHOLOGY; MODEL; SYNAPTOPHYSIN	As a disease-modifying approach for Alzheimer's disease (AD), clioquinol (CQ) targets beta-amyloid (A beta) reactions with synaptic Zn and Cu yet promotes metal uptake. Here we characterize the second-generation 8-hydroxy quinoline analog PBT2, which also targets metal-induced aggregation of AB, but is more effective as a Zn/Cu ionophore and has greater blood-brain barrier permeability. Given orally to two types of amyloid-bearing transgenic mouse models of AD, PBT2 outperformed CQ by markedly decreasing soluble interstitial brain AB within hours and improving cognitive performance to exceed that of normal littermate controls within days. Nontransgenic mice were unaffected by PBT2. The current data demonstrate that ionophore activity, inhibition of in vitro metal-mediated AB reactions, and blood-brain barrier permeability are indices that predict a potential disease-modifying drug for AD. The speed of recovery of the animals underscores the acutely reversible nature of the cognitive deficits associated with transgenic models of AD.	[Adlard, Paul A.; Cherny, Robert A.; Finkelstein, David I.; Robb, Elysia; Cortes, Mikhalina; Volitakis, Irene; Liu, Xiang; Smith, Jeffrey P.; Perez, Keyla; Laughton, Katrina; Li, Qiao-Xin; Wilkins, Simon; Deleva, Karolina; Lynch, Toni; Cappai, Roberto; Masters, Colin L.; Barnham, Kevin J.; Bush, Ashley I.] Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic 3052, Australia; [Adlard, Paul A.; Cherny, Robert A.; Laughton, Katrina; Li, Qiao-Xin; Cappai, Roberto; Barnham, Kevin J.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Finkelstein, David I.; Wilkins, Simon; Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Cappai, Roberto; Barnham, Kevin J.] Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Melbourne, Vic 3010, Australia; [Cherny, Robert A.; Gautier, Elisabeth; Kok, Gaik] Prana Biotechnol Ltd, Parkville, Vic 3052, Australia; [Charman, Susan A.; Nicolazzo, Joseph A.] Monash Univ, Monash Inst Pharmaceut Sci, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia; [Ritchie, Craig W.] UCL Royal Free & Univ Coll Med Sch, Dept Mental Hlth Sci, Metab & Clin Trials Unit, London WC1E 6BT, England; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; Monash University; University of London; University College London; UCL Medical School; Harvard University; Massachusetts General Hospital	Bush, AI (corresponding author), Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic 3052, Australia.	abush@mhri.edu.au	Bush, Ashley I/A-1186-2007; Finkelstein, David/B-9617-2009; Charman, Susan A/E-2221-2011; Bush, Ashley/Y-2457-2019; Tanzi, Rudolph/AAE-9622-2019; Wilkins, Simon/D-1174-2009; Cappai, Roberto/B-3347-2010	Bush, Ashley I/0000-0001-8259-9069; Finkelstein, David/0000-0002-8167-4917; Charman, Susan A/0000-0003-1753-8213; Bush, Ashley/0000-0001-8259-9069; Tanzi, Rudolph/0000-0002-7032-1454; Wilkins, Simon/0000-0001-7712-4114; Cappai, Roberto/0000-0002-9505-8496				Abraha A, 2000, J CELL SCI, V113, P3737; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Ballard C, 2001, INT J GERIATR PSYCH, V16, P494, DOI 10.1002/gps.368; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Callahan LM, 1999, J NEUROPATH EXP NEUR, V58, P275, DOI 10.1097/00005072-199903000-00007; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Eikelenboom P, 1999, DEMENT GERIATR COGN, V10, P319, DOI 10.1159/000017162; Frederickson CJ, 2006, J NEUROSCI METH, V154, P19, DOI 10.1016/j.jneumeth.2005.11.014; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; LANNFELT L, 2008, LANCET NEUR IN PRESS; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lee JY, 2004, NEUROBIOL AGING, V25, P1315, DOI 10.1016/j.neurobiolaging.2004.01.005; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Opazo C, 2006, AGING CELL, V5, P69, DOI 10.1111/j.1474-9726.2006.00196.x; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Puglielli L, 2005, J CLIN INVEST, V115, P2556, DOI 10.1172/JCI23610; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Zhang B, 2008, J BIOL CHEM, V283, P11866, DOI 10.1074/jbc.M800199200	45	552	568	1	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2008	59	1					43	55		10.1016/j.neuron.2008.06.018	http://dx.doi.org/10.1016/j.neuron.2008.06.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614028	Bronze			2022-12-17	WOS:000257728800007
J	Hauser, SL; Oksenberg, JR				Hauser, Stephen L.; Oksenberg, Jorge R.			The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration	NEURON			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PROGENITOR CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; NITRIC-OXIDE SYNTHASE; REGULATORY T-CELLS; SPINAL-CORD; AFRICAN-AMERICANS; AXONAL DAMAGE; CEREBROSPINAL-FLUID	The autoimmune model of multiple sclerosis (MS) pathogenesis provided for many years a useful but incomplete conceptual framework for understanding the complex array of factors that lead to the loss of immune homeostasis, myelin and axonal injury, and progressive neurological symptoms. The availability of novel tools in molecular neurogenetics and increasingly sophisticated neuroimaging technologies, together with the revitalization of MS neuropathology, has created a new paradigm for the multidisciplinary study of this disease. This is reflected by the growing resolution of the MS genomic map, discovery of delicate inflammatory networks that are perturbed in MS, identification of mediators of demyelination, and recognition that cumulative axonal loss and neuronal injury are the histological correlates of neurological disability. Together, these advances have set the stage for the development of therapeutic approaches designed to target the demyelinating and neurodegenerative components of the disease and promote repair.	Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Oksenberg, JR (corresponding author), Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA.	jorge.oksenberg@ucsf.edu	Hauser, Stephen L/J-2978-2016					Acar G, 2003, J NEUROL, V250, P588, DOI 10.1007/s00415-003-1041-0; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; ASCHERIO A, 2001, JAMA-J AM MED ASSOC, V386, P3083; Bachelin C, 2005, BRAIN, V128, P540, DOI 10.1093/brain/awh406; Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Barcellos LF, 2002, BRAIN, V125, P150; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bechtold DA, 2004, ANN NEUROL, V55, P607, DOI 10.1002/ana.20045; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Brassat D, 1999, NEUROLOGY, V52, P1632, DOI 10.1212/WNL.52.8.1632; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; Cader S, 2006, BRAIN, V129, P527, DOI 10.1093/brain/awh670; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Cid C, 2002, J NEUROL SCI, V193, P103, DOI 10.1016/S0022-510X(01)00650-5; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Colombo M, 2000, J IMMUNOL, V164, P2782, DOI 10.4049/jimmunol.164.5.2782; COMPSTON A, 2006, MCALPINES MULTIPLE; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Craner MJ, 2004, BRAIN, V127, P294, DOI 10.1093/brain/awh032; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Cross AH, 2005, IMMUNOL RES, V32, P85, DOI 10.1385/IR:32:1-3:085; CROSS AH, 1994, J CLIN INVEST, V93, P2684, DOI 10.1172/JCI117282; Diemel LT, 2004, GLIA, V45, P278, DOI 10.1002/glia.10335; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Farina C, 2005, LANCET NEUROL, V4, P567, DOI 10.1016/S1474-4422(05)70167-8; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FILIPPI M, 2005, MULTIPLE SCLEROSIS N, P215; Firth D., 1948, CASE AUGUSTUS DESTE; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Frost EE, 2003, J NEUROBIOL, V54, P457, DOI 10.1002/neu.10158; Gadea M, 2004, BRAIN, V127, P89, DOI 10.1093/brain/awh002; Garbern JY, 2002, BRAIN, V125, P551, DOI 10.1093/brain/awf043; GENAIN CP, 1994, J CLIN INVEST, V94, P1339, DOI 10.1172/JCI117454; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Goodin DS, 2006, ANN NEUROL, V59, P597, DOI 10.1002/ana.20832; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; HAUSER SL, 2005, HARRISONS PRINCIPLES, P2461; Hoftberger R, 2004, BRAIN PATHOL, V14, P43; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Hohlfeld R, 2000, J NEUROIMMUNOL, V107, P161, DOI 10.1016/S0165-5728(00)00233-2; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kantarci OH, 2002, J NEUROIMMUNOL, V123, P144, DOI 10.1016/S0165-5728(01)00481-7; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kornek B, 1999, BRAIN PATHOL, V9, P651; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; KURTZKE JF, 1979, NEUROLOGY, V29, P1228, DOI 10.1212/WNL.29.9_Part_1.1228; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lassmann H, 2003, LANCET, V361, P1317, DOI 10.1016/S0140-6736(03)13088-7; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Leppert D, 1996, ANN NEUROL, V40, P846, DOI 10.1002/ana.410400606; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; LINDSTROM AB, 1994, J EXPO ANAL ENV EPID, V4, P183; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; Lucchinetti CF, 2004, ANN NEUROL, V56, P308, DOI 10.1002/ana.20182; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; MEDAER R, 1979, ACTA NEUROL SCAND, V60, P189; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Mummert SK, 2005, GENE CHROMOSOME CANC, V43, P155, DOI 10.1002/gcc.20176; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Newman TA, 2001, BRAIN, V124, P2203, DOI 10.1093/brain/124.11.2203; Noseworthy JH, 2003, CURR OPIN NEUROL, V16, P289, DOI 10.1097/00019052-200306000-00007; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; O'Connor PW, 2004, NEUROLOGY, V62, P2038, DOI 10.1212/01.WNL.0000128136.79044.D6; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Oksenberg JR, 2005, GENES IMMUN, V6, P375, DOI 10.1038/sj.gene.6364237; Owens GP, 1998, ANN NEUROL, V43, P236, DOI 10.1002/ana.410430214; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Platten M, 2005, NAT MED, V11, P252, DOI 10.1038/nm0305-252; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; POSER CM, 1994, ANN NEUROL, V36, pS231, DOI 10.1002/ana.410360810; Ransohoff RM, 2005, NAT NEUROSCI, V8, P1275, DOI 10.1038/nn1005-1275; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; RIDICK RA, 2006, IN PRESS ANN NEUROL; RISCH N, 1990, AM J HUM GENET, V46, P222; Rivers TM, 1935, J EXP MED, V61, P689, DOI 10.1084/jem.61.5.689; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sahrbacher UC, 1998, EUR J IMMUNOL, V28, P1332, DOI 10.1002/(SICI)1521-4141(199804)28:04<1332::AID-IMMU1332>3.3.CO;2-7; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sawcer S, 2005, AM J HUM GENET, V77, P454; Schneider A, 2004, J BIOL CHEM, V279, P55833, DOI 10.1074/jbc.M409954200; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seifert T, 2002, MULT SCLER, V8, P447, DOI 10.1191/1352458502ms830oa; Seldin MF, 2004, GENOME RES, V14, P1076, DOI 10.1101/gr.2165904; Setzu A, 2006, GLIA, V54, P297, DOI 10.1002/glia.20371; Sheridan C, 2005, NAT BIOTECHNOL, V23, P397, DOI 10.1038/nbt0405-397; Smith KJ, 2001, ANN NEUROL, V49, P470; SMITH KJ, 2005, MULTIPLE SCLEROSIS N, P255; Smith-Jensen T, 2000, NEUROLOGY, V54, P1227, DOI 10.1212/WNL.54.6.1227; Stefano S, 2003, AUTOIMMUNITY, V36, P257, DOI 10.1080/0891693031000151607; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Stern JNH, 2005, P NATL ACAD SCI USA, V102, P1620, DOI 10.1073/pnas.0409022102; Stratmann T, 2003, J CLIN INVEST, V112, P902, DOI 10.1172/JCI200318337; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wallin MT, 2004, ANN NEUROL, V55, P65, DOI 10.1002/ana.10788; Waxman S, 2005, MULTIPLE SCLEROSIS N; Waxman SG., 2005, MULTIPLE SCLEROSIS N, P165; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wucherpfennig KW, 2005, CURR TOP MICROBIOL, V296, P19; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhang YP, 2005, J NEUROIMMUNOL, V167, P120, DOI 10.1016/j.jneuroim.2005.05.006; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	158	552	567	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					61	76		10.1016/j.neuron.2006.09.011	http://dx.doi.org/10.1016/j.neuron.2006.09.011			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015227	Bronze			2022-12-17	WOS:000241408100005
J	Machold, R; Hayashi, S; Rutlin, M; Muzumdar, MD; Nery, S; Corbin, JG; Gritli-Linde, A; Dellovade, T; Porter, JA; Rubin, LL; Dudek, H; McMahon, AP; Fishell, G				Machold, R; Hayashi, S; Rutlin, M; Muzumdar, MD; Nery, S; Corbin, JG; Gritli-Linde, A; Dellovade, T; Porter, JA; Rubin, LL; Dudek, H; McMahon, AP; Fishell, G			Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches	NEURON			English	Article							SUBVENTRICULAR ZONE CELLS; CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; OLIGODENDROCYTE DEVELOPMENT; MAMMALIAN TELENCEPHALON; VENTRAL FOREBRAIN; DROSOPHILA OVARY; MICE LACKING; GENE; PROLIFERATION	To directly test the requirement for hedgehog signaling in the telencephalon from early neurogenesis, we examined conditional null alleles of both the Sonic hedgehog and Smoothened genes. While the removal of Shh signaling in these animals resulted in only minor patterning abnormalities, the number of neural progenitors in both the postnatal subventricular zone and hippocampus was dramatically reduced. In the subventricular zone, this was partially attributable to a marked increase in programmed cell death. Consistent with Hedgehog signaling being required for the maintenance of stem cell niches in the adult brain, progenitors from the subventricular zone of floxed Smo animals formed significantly fewer neurospheres. The loss of hedgehog signaling also resulted in abnormalities in the dentate gyrus and olfactory bulb. Furthermore, stimulation of the hedgehog pathway in the mature brain resulted in elevated proliferation in telencephalic progenitors. These results suggest that hedgehog signaling is required to maintain progenitor cells in the postnatal telencephalon.	NYU, Ctr Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Ctr Med, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Gothenburg, Sahlgrenska Acad, Dept Oral Biochem, SE-40530 Gothenburg, Sweden; Curis Inc, Cambridge, MA 02138 USA	New York University; New York University; Harvard University; University of Gothenburg	McMahon, AP (corresponding author), NYU, Ctr Med, Skirball Inst Biomol Med, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.		Nery, Susana Vaz/P-4518-2014; McMahon, Andrew P/ABE-7520-2020	Vaz Nery, Susana/0000-0002-2399-7785; Fishell, Gordon/0000-0002-9640-9278; Rubin, Lee/0000-0002-8658-841X; Muzumdar, Mandar/0000-0001-7424-7223	NINDS NIH HHS [1F32NS42525-01, NS 33642, NS10962-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, F32NS042525, R01NS033642] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bai CB, 2002, DEVELOPMENT, V129, P4753; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; BRAUN PE, 1988, J NEUROSCI, V8, P3057; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Frank-Kamenetsky M., 2002, J BIOL UDAYANA, V1, P1; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; GOLDMAN JE, 1995, J NEURO-ONCOL, V24, P61, DOI 10.1007/BF01052660; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gorski JA, 2002, J NEUROSCI, V22, P6309; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Gunhaga L, 2000, DEVELOPMENT, V127, P3283; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Ingham PW, 1998, CURR OPIN GENET DEV, V8, P88, DOI 10.1016/S0959-437X(98)80067-1; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Long FX, 2001, DEVELOPMENT, V128, P5099; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; MERCOLA M, 1990, DEV BIOL, V138, P114, DOI 10.1016/0012-1606(90)90181-H; Nery S, 2001, DEVELOPMENT, V128, P527; Parisi M J, 1998, Cell Res, V8, P15; Rallu M, 2002, DEVELOPMENT, V129, P4963; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roth KA, 2001, MENT RETARD DEV D R, V7, P261, DOI 10.1002/mrdd.1036; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Sussel L, 1998, DEVELOPMENT, V125, P2213; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tworoger M, 1999, GENETICS, V151, P739; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wichterle H, 2001, DEVELOPMENT, V128, P3759; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yun K, 2001, DEVELOPMENT, V128, P193; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang Y, 2000, DEVELOPMENT, V127, P2165; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	73	551	582	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 11	2003	39	6					937	950		10.1016/S0896-6273(03)00561-0	http://dx.doi.org/10.1016/S0896-6273(03)00561-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721BA	12971894	Bronze			2022-12-17	WOS:000185296100008
J	Luscher, C; Xia, HH; Beattie, EC; Carroll, RC; von Zastrow, M; Malenka, RC; Nicoll, RA				Luscher, C; Xia, HH; Beattie, EC; Carroll, RC; von Zastrow, M; Malenka, RC; Nicoll, RA			Role of AMPA receptor cycling in synaptic transmission and plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; GLUR2; PROTEINS; DYNAMIN; ENDOCYTOSIS; CLATHRIN; BINDING	Compounds known to disrupt exocytosis or endocytosis were introduced into CA1 pyramidal cells while monitoring excitatory postsynaptic currents (EPSCs). Disrupting exocytosis or the interaction of GluR2 with NSF caused a gradual reduction in the AMPAR EPSC, while inhibition of endocytosis caused a gradual increase in the AMPAR EPSC. These manipulations had no effect on the NMDAR EPSC but prevented the subsequent induction of LTD. These results suggest that AMPARs, but not NMDARs, cycle into and out of the synaptic membrane at a rapid rate and that certain forms of synaptic plasticity may utilize this dynamic process.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@phy.ucsf.edu	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596				Allison DW, 1998, J NEUROSCI, V18, P2423; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gasman S, 1997, J BIOL CHEM, V272, P20564, DOI 10.1074/jbc.272.33.20564; He Y, 1998, EXP NEUROL, V150, P1, DOI 10.1006/exnr.1997.6720; HUTTNER WB, 1993, NATURE, V365, P104, DOI 10.1038/365104a0; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1999, J NEUROSCI, V19, P1263; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schmierer K, 1998, NEUROLOGY, V51, P250, DOI 10.1212/WNL.51.1.250; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sheng M, 1997, NATURE, V386, P221, DOI 10.1038/386221a0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8	39	550	569	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					649	658		10.1016/S0896-6273(00)81119-8	http://dx.doi.org/10.1016/S0896-6273(00)81119-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595516	Bronze			2022-12-17	WOS:000083913000020
J	Paresce, DM; Ghosh, RN; Maxfield, FR				Paresce, DM; Ghosh, RN; Maxfield, FR			Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor	NEURON			English	Article							HAMSTER OVARY CELLS; LOW-DENSITY-LIPOPROTEIN; PRECURSOR PROTEIN; IMMUNOHISTOCHEMICAL LOCALIZATION; NEUROLOGICAL DISEASE; BINDING-PROPERTIES; AMEBOID MICROGLIA; APOLIPOPROTEIN-E; BRAIN-TISSUE; A-BETA	Microglia are immune system cells associated with Alzheimer's disease plaques containing beta-amyloid (A beta). Murine microglia internalize microaggregates of fluorescently labeled or radioiodinated A beta peptide 1-42. Uptake was confirmed using aggregates of unlabeled A beta detected by immunofluorescence. Uptake of A beta was reduced by coincubation with excess acetyl-low density lipoprotein (Ac-LDL) or other scavenger receptor (SR) ligands, and Dil-labeled Ac-LDL uptake by microglia was blocked by excess A beta. CHO cells transfected with class A or B SRs showed significantly enhanced uptake of A beta. These results show that microglia express SRs that may play a significant role in the clearance of A beta plaques. Binding to SRs could activate inflammation responses that contribute to the pathology of Alzheimer's disease.	COLUMBIA UNIV, DEPT BIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV, ALZHEIMERS DIS RES CTR, NEW YORK, NY 10032 USA; COLUMBIA UNIV, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA; CORNELL UNIV, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA	Columbia University; Columbia University; Columbia University; Cornell University	Paresce, DM (corresponding author), COLUMBIA UNIV, DEPT PATHOL, NEW YORK, NY 10032 USA.		Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866	NIDDK NIH HHS [DK27083] Funding Source: Medline; NINDS NIH HHS [NS34761] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027083, R37DK027083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034761] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; ARAUJO DM, 1992, BRAIN RES, V569, P141, DOI 10.1016/0006-8993(92)90380-R; ASHKENAS J, 1993, J LIPID RES, V34, P983; BELL MD, 1994, J NEUROCYTOL, V23, P605, DOI 10.1007/BF01191555; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; Christie RH, 1996, AM J PATHOL, V148, P399; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; COTMAN CW, 1992, NEUROBIOL AGING, V13, P587, DOI 10.1016/0197-4580(92)90060-B; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Elkabes S, 1996, J NEUROSCI, V16, P2508; FRACKOWIAK J, 1992, ACTA NEUROPATHOL, V84, P225; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1993, ANN NY ACAD SCI, V695, P103, DOI 10.1111/j.1749-6632.1993.tb23036.x; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GOREVIC PD, 1987, BIOCHEM BIOPH RES CO, V147, P854, DOI 10.1016/0006-291X(87)91008-4; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1991, J NEUROSCI, V11, P3783; HERZ J, 1991, J BIOL CHEM, V266, P21232; JOHNSON WJ, 1982, SCIENCE, V218, P574, DOI 10.1126/science.6289443; JOHNSTON PA, 1987, J IMMUNOL, V138, P1551; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KRIEGER M, 1992, TRENDS BIOCHEM SCI, V17, P141, DOI 10.1016/0968-0004(92)90322-Z; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MAXFIELD FR, 1989, METHOD CELL BIOL, V29, P13; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; MCGEER PL, 1992, J NEUROSCI RES, V31, P428, DOI 10.1002/jnr.490310305; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; NAKAJIMA K, 1989, BIOMED RES-TOKYO, V10, P411; PALKAMA T, 1991, IMMUNOLOGY, V74, P432; PENMAN M, 1991, J BIOL CHEM, V266, P23985; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; QUERFURTH HW, 1995, MOL BRAIN RES, V28, P319, DOI 10.1016/0169-328X(94)00224-3; REBECK GW, 1993, NEURON, V11, P575; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J NEUROCHEM, V61, P1916, DOI 10.1111/j.1471-4159.1993.tb09834.x; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; SALZMAN NH, 1988, J CELL BIOL, V106, P1083, DOI 10.1083/jcb.106.4.1083; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHACKELFORD RE, 1995, J BIOL CHEM, V270, P3475, DOI 10.1074/jbc.270.8.3475; SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; WEGIEL J, 1990, ACTA NEUROPATHOL, V81, P116, DOI 10.1007/BF00334499; WISNIEWSKI HM, 1990, AM J MED GENET, P287, DOI 10.1002/ajmg.1320370757; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8	66	550	577	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					553	565		10.1016/S0896-6273(00)80187-7	http://dx.doi.org/10.1016/S0896-6273(00)80187-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816718	hybrid			2022-12-17	WOS:A1996VJ44000021
J	Masland, RH				Masland, Richard H.			The Neuronal Organization of the Retina	NEURON			English	Review							RESTORES VISUAL RESPONSES; INNER PLEXIFORM LAYER; BIPOLAR CELL PATHWAYS; LOCAL EDGE DETECTORS; GANGLION-CELLS; AMACRINE CELLS; RECEPTIVE-FIELD; DIRECTION-SELECTIVITY; SYNAPTIC-TRANSMISSION; CROSSOVER INHIBITION	The mammalian retina consists of neurons of >60 distinct types, each playing a specific role in processing visual images. They are arranged in three main stages. The first decomposes the outputs of the rod and cone photoreceptors into similar to 12 parallel information streams. The second connects these streams to specific types of retinal ganglion cells. The third combines bipolar and amacrine cell activity to create the diverse encodings of the visual world-roughly 20 of them-that the retina transmits to the brain. New transformations of the visual input continue to be found: at least half of the encodings sent to the brain (ganglion cell response selectivities) remain to be discovered. This diversity of the retina's outputs has yet to be incorporated into our understanding of higher visual function.	[Masland, Richard H.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; [Masland, Richard H.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Masland, RH (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.	richard_masland@meei.harvard.edu			NIH [EY13399]; Harvard Neurodiscovery Center; NATIONAL EYE INSTITUTE [R01EY013399, R01EY017169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Neurodiscovery Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	I thank Dr. Steven DeVries for the electrophysiological traces shown in Figure 3 and for reading the section on bipolar cells. Members of the Jakobs/Masland lab made helpful comments. The figures were made by Michael Becker. Susan Cardoza copyedited and helped with the references. The author is supported by NIH grant EY13399 and the Harvard Neurodiscovery Center.	AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; Bieda MC, 2000, VISUAL NEUROSCI, V17, P243, DOI 10.1017/S0952523800172062; Lin B, 2006, J COMP NEUROL, V499, P797, DOI 10.1002/cne.21126; Breuninger T, 2011, J NEUROSCI, V31, P6504, DOI 10.1523/JNEUROSCI.0616-11.2011; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Buldyrev I, 2012, J NEUROPHYSIOL, V107, P1795, DOI 10.1152/jn.00924.2011; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cao Y, 2012, P NATL ACAD SCI USA, V109, P7905, DOI 10.1073/pnas.1202332109; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; Chen S, 2012, NAT NEUROSCI, V15, P954, DOI 10.1038/nn.3128; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; Collin SP, 2008, CLIN EXP OPTOM, V91, P85, DOI 10.1111/j.1444-0938.2007.00228.x; Cook JE, 1996, VISUAL NEUROSCI, V13, P15, DOI 10.1017/S0952523800007094; Crook JD, 2008, J NEUROSCI, V28, P11277, DOI 10.1523/JNEUROSCI.2982-08.2008; Crook JD, 2009, J NEUROSCI, V29, P8372, DOI 10.1523/JNEUROSCI.1218-09.2009; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Demb JB, 2012, VISUAL NEUROSCI, V29, P51, DOI 10.1017/S0952523811000368; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Eggers ED, 2011, VISUAL NEUROSCI, V28, P95, DOI 10.1017/S0952523810000209; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; FAMIGLIETTI EV, 1977, SCIENCE, V198, P1267, DOI 10.1126/science.73223; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Freed MA, 2000, J NEUROSCI, V20, P3956; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Greenberg KP, 2011, NEURON, V69, P713, DOI 10.1016/j.neuron.2011.01.024; Grimes WN, 2011, VISUAL NEUROSCI, V28, P381, DOI 10.1017/S0952523811000290; Grimes WN, 2010, NEURON, V65, P873, DOI 10.1016/j.neuron.2010.02.028; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; Herrmann R, 2011, NEURON, V72, P101, DOI 10.1016/j.neuron.2011.07.030; Hirano AA, 2005, J COMP NEUROL, V488, P70, DOI 10.1002/cne.20577; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Ichinose T, 2005, J NEUROSCI, V25, P1856, DOI 10.1523/jneurosci.5208-04.2005; Ichinose T, 2007, J NEUROSCI, V27, P4756, DOI 10.1523/JNEUROSCI.0183-07.2007; Jackman SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001057; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jusuf PR, 2005, J COMP NEUROL, V488, P113, DOI 10.1002/cne.20555; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Klaassen LJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001107; Kleinfeld D, 2011, J NEUROSCI, V31, P16125, DOI 10.1523/JNEUROSCI.4077-11.2011; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Li W, 2006, NAT NEUROSCI, V9, P669, DOI 10.1038/nn1686; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lin B, 2000, EUR J NEUROSCI, V12, P4155, DOI 10.1111/j.1460-9568.2000.01311.x; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Ma YP, 2005, VISUAL NEUROSCI, V22, P119, DOI 10.1017/S0952523805222010; MacNeil MA, 2004, J COMP NEUROL, V472, P73, DOI 10.1002/cne.20063; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Maddox DM, 2008, J PHYSIOL-LONDON, V586, P4409, DOI 10.1113/jphysiol.2008.157289; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P121, DOI 10.1098/rspb.1984.0086; Masland RH, 2003, NATURE, V423, P387, DOI 10.1038/423387a; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Masland RH, 2007, CURR BIOL, V17, pR577, DOI 10.1016/j.cub.2007.05.040; Matsui K, 1998, J NEUROSCI, V18, P4500; MATURANA HUMBERTO R., 1960, JOUR GEN PHYSIOL, V43, P129, DOI 10.1085/jgp.43.6.129; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Molnar A, 2009, J COMPUT NEUROSCI, V27, P569, DOI 10.1007/s10827-009-0170-6; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; MULLER B, 1993, J NEUROSCI, V13, P3628; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; NELSON R, 1985, J NEUROPHYSIOL, V54, P592, DOI 10.1152/jn.1985.54.3.592; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; NELSON R, 1982, J NEUROPHYSIOL, V47, P928, DOI 10.1152/jn.1982.47.5.928; Nobles RD, 2012, J NEUROSCI, V32, P3321, DOI 10.1523/JNEUROSCI.5341-11.2012; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X; Peichl L., 1998, DEV ORG RET MOL FUNC; Polosukhina A, 2012, NEURON, V75, P271, DOI 10.1016/j.neuron.2012.05.022; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; Reese BE, 2011, DEV NEUROBIOL, V71, P1273, DOI 10.1002/dneu.20903; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Roska B, 2003, NAT NEUROSCI, V6, P600, DOI 10.1038/nn1061; SANDELL JH, 1989, J COMP NEUROL, V283, P303, DOI 10.1002/cne.902830210; Saszik S, 2012, J NEUROSCI, V32, P297, DOI 10.1523/JNEUROSCI.2739-08.2012; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Schwartz G, 2007, NEURON, V55, P958, DOI 10.1016/j.neuron.2007.07.042; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sivyer B, 2011, J COMP NEUROL, V519, P3128, DOI 10.1002/cne.22720; Sivyer B, 2010, P NATL ACAD SCI USA, V107, P5628, DOI 10.1073/pnas.0909621107; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; STRETTOI E, 1994, J COMP NEUROL, V347, P139, DOI 10.1002/cne.903470111; Taylor WR, 2011, CURR OPIN NEUROBIOL, V21, P672, DOI 10.1016/j.conb.2011.07.001; Van Essen D.C., 2004, VISUAL NEUROSCIENCES; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; van Wyk M, 2006, J NEUROSCI, V26, P13250, DOI 10.1523/JNEUROSCI.1991-06.2006; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; Venkataramani S, 2010, J NEUROSCI, V30, P15664, DOI 10.1523/JNEUROSCI.2081-10.2010; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Werblin FS, 2010, VISUAL NEUROSCI, V27, P1, DOI 10.1017/S0952523810000076; Wright L L, 2000, Vis Neurosci, V17, p1145R; Wu S M, 2001, Prog Brain Res, V131, P125; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320; Zeck GM, 2005, EUR J NEUROSCI, V22, P2016, DOI 10.1111/j.1460-9568.2005.04390.x; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109	132	548	569	20	211	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 18	2012	76	2					266	280		10.1016/j.neuron.2012.10.002	http://dx.doi.org/10.1016/j.neuron.2012.10.002			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LV	23083731	Green Accepted, Bronze			2022-12-17	WOS:000310424700004
J	MATSUO, ES; SHIN, RW; BILLINGSLEY, ML; VANDEVOORDE, A; OCONNOR, M; TROJANOWSKI, JQ; LEE, VMY				MATSUO, ES; SHIN, RW; BILLINGSLEY, ML; VANDEVOORDE, A; OCONNOR, M; TROJANOWSKI, JQ; LEE, VMY			BIOPSY-DERIVED ADULT HUMAN BRAIN TAU IS PHOSPHORYLATED AT MANY OF THE SAME SITES AS ALZHEIMERS-DISEASE PAIRED HELICAL FILAMENT-TAU	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PROTEIN-TAU; NERVOUS-SYSTEM; OKADAIC ACID; NEUROFIBRILLARY PATHOLOGY; ABNORMAL PHOSPHORYLATION; MONOCLONAL-ANTIBODIES; RAT-BRAIN; MICROTUBULE; EPITOPES	Tau from Alzheimer's disease (AD) paired helical filaments (PHF-tau) is phosphorylated at sites not found in autopsy-derived adult tau from normal human brains, and this suggested that PHF-tau is abnormally phosphorylated. To explore this hypothesis, we examined human adult tau from brain biopsies and demonstrated that biopsy-derived tau is phosphorylated at most sites thought to be abnormally phosphorylated in PHF-tau. These sites also were phosphorylated in autopsy-derived human fetal tau and rapidly processed rat tau. The hypophosphorylation of autopsy-derived adult human tau is due to rapid dephosphorylation postmortem, and protein phosphatases 2A (PP2A) and 2B(PP2B) in human brain biopsies dephosphorylate tau in a site-specific manner. The down-regulation of phosphatases (i.e., PP2A and PP2B) in the AD brain could lead to the generation of maximally phosphorylated PHF-tau that does not bind microtubules and aggregates as PHFs in neurofibrillary tangles and dystrophic neurites.	PENN STATE UNIV,COLL MED,DEPT PHARMACOL,HERSHEY,PA 17033; INNOGENET SA,B-9052 GHENT,BELGIUM	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Innogenetics NV	MATSUO, ES (corresponding author), UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,DIV ANAT PATHOL,PHILADELPHIA,PA 19104, USA.							ARRIAGADA PA, 1992, NEUROLOGY, V42, P63; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DICKSON DW, 1991, NEUROBIOL AGING, V13, P179; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1147; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; GOEDERT M, 1991, NEUROSCI LETT, V126, P149, DOI 10.1016/0304-3940(91)90541-Z; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HARRIS KA, 1993, ANN NEUROL, V33, P77, DOI 10.1002/ana.410330113; HASAGAWA M, 1992, J BIOL CHEM, V267, P17047; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; INGERBRITSEN TS, 1983, EUR J BIOCHEM, V123, P297; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KOBAYASHI S, 1993, FEBS LETT, V335, P171, DOI 10.1016/0014-5793(93)80723-8; KOSIK KS, 1992, SCIENCE, V256, P780, DOI 10.1126/science.1589757; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; LEDESMA MD, 1992, FEBS LETT, V308, P218, DOI 10.1016/0014-5793(92)81278-T; LEE JH, 1993, EXP NEUROL, V121, P93, DOI 10.1006/exnr.1993.1074; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LINWALL G, 1984, J BIOL CHEM, V259, P7384; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MERCKEN M, 1992, ACTA NEUROPATHOL, V84, P265, DOI 10.1007/BF00227819; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; POLLI JW, 1991, DEV BRAIN RES, V63, P105, DOI 10.1016/0165-3806(91)90071-P; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TROJANOWSKI JQ, 1989, J NEUROSCI METH, V29, P171, DOI 10.1016/0165-0270(89)90030-7; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; TROJANOWSKI JQ, 1993, CLIN NEUROSCI, V1, P184; TSUYAMA S, 1987, J BIOL CHEM, V262, P10886; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WATANABE A, 1993, J BIOL CHEM, V268, P25712; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; YAMAMOTO H, 1990, J NEUROCHEM, V55, P683, DOI 10.1111/j.1471-4159.1990.tb04187.x; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	50	548	565	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					989	1002		10.1016/0896-6273(94)90264-X	http://dx.doi.org/10.1016/0896-6273(94)90264-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946342				2022-12-17	WOS:A1994PP53300021
J	ERNFORS, P; BENGZON, J; KOKAIA, Z; PERSSON, H; LINVALL, O				ERNFORS, P; BENGZON, J; KOKAIA, Z; PERSSON, H; LINVALL, O			INCREASED LEVELS OF MESSENGER-RNAS FOR NEUROTROPHIC FACTORS IN THE BRAIN DURING KINDLING EPILEPTOGENESIS	NEURON			English	Article							NERVE GROWTH-FACTOR; CHOLINE-ACETYLTRANSFERASE ACTIVITY; RAT HIPPOCAMPAL-FORMATION; PREVENTS NEURONAL DEATH; AMINO-ACID RECEPTORS; METHYL-D-ASPARTATE; BASAL FOREBRAIN; SYNAPTIC REORGANIZATION; REGIONAL DISTRIBUTION; MOLECULAR-CLONING	Kindling, induced by repeated subconvulsive electrical or chemical stimulations leads to progressive and permanent amplification of seizure activity, culminating in generalized seizures. We report that kindling induced by electrical stimulation in the ventral hippocampus leads to a marked and transient increase of mRNA for NGF and BDNF in the dentate gyrus, the parietal cortex, and the piriform cortex. BDNF mRNA increased also in the pyramidal layer of hippocampus and in the amygdaloid complex. No change was seen in the level of HDNF/NT-3 mRNA. The increased expression of NGF and BDNF mRNAs was not influenced by pretreatment with the NMDA receptor antagonist MK801, but was partially blocked by the quisqualate, AMPA receptor antagonist NBQX. The presumed subsequent increase of the trophic factors themselves may be important for kindling-associated plasticity in specific neuronal systems in the hippocampus, which could promote hyperexcitability and contribute to the development of epileptic syndromes.	UNIV LUND HOSP, DEPT NEUROL, RESTORAT NEUROL UNIT, S-22185 LUND, SWEDEN	Lund University; Skane University Hospital	ERNFORS, P (corresponding author), KAROLINSKA INST, DEPT MED BIOCHEM, MOLEC NEUROBIOL LAB, S-10401 STOCKHOLM 60, SWEDEN.		Kokaia, Zaal/AAL-6009-2020	Kokaia, Zaal/0000-0003-2296-2449; Bengzon, Johan/0000-0001-6536-2107	NIA NIH HHS [AG 04418] Funding Source: Medline; NINDS NIH HHS [NS 09199] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS009199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BALLERIN M, 1991, IN PESS EXP NEUROL; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; CAIN DP, 1983, BRAIN RES, V260, P135, DOI 10.1016/0006-8993(83)90774-6; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COLLINS F, 1985, J NEUROSCI, V5, P2809; CROUCHER MJ, 1989, BRAIN RES, V501, P58, DOI 10.1016/0006-8993(89)91026-3; CRUTCHER KA, 1987, BRAIN RES REV, V12, P203, DOI 10.1016/0165-0173(87)90013-0; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; Ebendal T, 1989, Prog Growth Factor Res, V1, P143, DOI 10.1016/0955-2235(89)90008-2; ERNFORS P, 1989, P NATL ACAD SCI USA, V86, P4756, DOI 10.1073/pnas.86.12.4756; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FRIEDMAN WJ, 1991, IN PRESS J NEUROSCI; FRIEDMAN WJ, 1991, IN PRESS EUR J NEURO; FUNABASHI T, 1988, BRAIN RES, V458, P132, DOI 10.1016/0006-8993(88)90504-5; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GASTAUT H, 1975, EPILEPSIA, V16, P457, DOI 10.1111/j.1528-1157.1975.tb06073.x; GEINISMAN Y, 1988, P NATL ACAD SCI USA, V85, P3260, DOI 10.1073/pnas.85.9.3260; GILBERT ME, 1988, BRAIN RES, V463, P90, DOI 10.1016/0006-8993(88)90530-6; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; HAGG T, 1990, J NEUROSCI, V10, P3087; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1984, BRAIN RES, V293, P305, DOI 10.1016/0006-8993(84)91237-X; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HONEGGER P, 1982, DEV BRAIN RES, V3, P229, DOI 10.1016/0165-3806(82)90023-2; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IBANEZ C, 1991, IN PRESS EMBO J; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KOKAIA M, 1989, BRAIN RES, V491, P398, DOI 10.1016/0006-8993(89)90079-6; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LOTHMAN EW, 1985, BRAIN RES, V360, P83, DOI 10.1016/0006-8993(85)91223-5; LU B, 1989, EXP NEUROL, V104, P191, DOI 10.1016/0014-4886(89)90029-0; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARTINEZ HJ, 1987, BRAIN RES, V412, P295, DOI 10.1016/0006-8993(87)91136-X; MCNAMARA JO, 1988, NEUROPHARMACOLOGY, V27, P563, DOI 10.1016/0028-3908(88)90176-1; MCNAMARA JO, 1984, ANN NEUROL, V16, pS72, DOI 10.1002/ana.410160712; MESSENHEIMER JA, 1979, EXP NEUROL, V64, P469, DOI 10.1016/0014-4886(79)90225-5; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; MOBLEY WC, 1989, NEURON, V3, P655, DOI 10.1016/0896-6273(89)90276-6; MORRELL F, 1986, KINDLING, V3, P17; MORRISETT RA, 1989, BRAIN RES, V496, P25, DOI 10.1016/0006-8993(89)91048-2; PETERSON DW, 1983, BRAIN RES, V275, P169, DOI 10.1016/0006-8993(83)90431-6; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; REPRESA A, 1989, NEUROSCI LETT, V99, P345, DOI 10.1016/0304-3940(89)90471-0; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SATO K, 1988, BRAIN RES, V463, P12, DOI 10.1016/0006-8993(88)90521-5; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; WESTERBERG V, 1987, EXP NEUROL, V95, P194, DOI 10.1016/0014-4886(87)90017-3; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; YEH GC, 1989, P NATL ACAD SCI USA, V86, P8157, DOI 10.1073/pnas.86.20.8157; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; [No title captured]	75	548	560	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1991	7	1					165	176		10.1016/0896-6273(91)90084-D	http://dx.doi.org/10.1016/0896-6273(91)90084-D			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1829904				2022-12-17	WOS:A1991FY48100016
J	He, BYJ; Zempel, JM; Snyder, AZ; Raichle, ME				He, Biyu J.; Zempel, John M.; Snyder, Abraham Z.; Raichle, Marcus E.			The Temporal Structures and Functional Significance of Scale-free Brain Activity	NEURON			English	Article							SELF-ORGANIZED CRITICALITY; CONTINGENT NEGATIVE-VARIATION; PRIMARY VISUAL-CORTEX; 1/F NOISE; POWER SPECTRA; NEURONAL OSCILLATIONS; SENSORY RESPONSES; FIELD POTENTIALS; SINGLE-NEURON; FREE DYNAMICS	Scale-free dynamics, with a power spectrum following P alpha f(-beta), are an intrinsic feature of many complex processes in nature. In neural systems, scale-free activity is often neglected in electrophysiological research. Here, we investigate scale-free dynamics in human brain and show that it contains extensive nested frequencies, with the phase of lower frequencies modulating the amplitude of higher frequencies in an upward progression across the frequency spectrum. The functional significance of scale-free brain activity is indicated by task performance modulation and regional variation, with 13 being larger in default network and visual cortex and smaller in hippocampus and cerebellum. The precise patterns of nested frequencies in the brain differ from other scale-free dynamics in nature, such as earth seismic waves and stock market fluctuations, suggesting system-specific generative mechanisms. Our findings reveal robust temporal structures and behavioral significance of scale-free brain activity and should motivate future study on its physiological mechanisms and cognitive implications.	[He, Biyu J.; Snyder, Abraham Z.; Raichle, Marcus E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Zempel, John M.; Snyder, Abraham Z.; Raichle, Marcus E.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	He, BYJ (corresponding author), Washington Univ, Sch Med, Dept Radiol, 4525 Scott Ave, St Louis, MO 63110 USA.	biyu.jade.he@gmail.com		He, Biyu/0000-0003-1549-1351	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833, P01NS006833] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS006833, P50 NS006833-430032] Funding Source: Medline; PHS HHS [06833] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bak P, 1996, NATURE WORKS; Balboa RM, 2003, VISION RES, V43, P2527, DOI 10.1016/S0042-6989(03)00471-1; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Bok S. T., 1959, HISTONOMY CEREBRAL C; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Buiatti M, 2007, NEUROSCIENCE, V146, P1400, DOI 10.1016/j.neuroscience.2007.02.048; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; BULLOCK TH, 1995, P NATL ACAD SCI USA, V92, P11568, DOI 10.1073/pnas.92.25.11568; Bullock TH, 2003, NEUROSCIENCE, V121, P233, DOI 10.1016/S0306-4522(03)00208-2; BULLOCK TH, 1988, BRAIN RES REV, V13, P57, DOI 10.1016/0165-0173(88)90005-7; Buzsaki G., 2006, RHYTHMS BRAIN, P119; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; CHAFER N, 1999, COGNITION, V69, pB17; Chklovskii DB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-18; Cho A, 2009, SCIENCE, V325, P408, DOI 10.1126/science.325_408; de Arcangelis L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028107; De Los Rios P, 1999, PHYS REV LETT, V82, P472, DOI 10.1103/PhysRevLett.82.472; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; ELBERT T, 1991, PSYCHOPHYSIOLOGY, V28, P648, DOI 10.1111/j.1469-8986.1991.tb01009.x; Erland S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031114; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frank SA, 2009, J EVOLUTION BIOL, V22, P1563, DOI 10.1111/j.1420-9101.2009.01775.x; Freeman WJ, 2009, COGN NEURODYNAMICS, V3, P97, DOI 10.1007/s11571-008-9064-y; Freeman WJ, 2007, SCHOLARPEDIA, V2, P1357, DOI DOI 10.4249/SCHOLARPEDIA.1357; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; GRANGER CWJ, 1980, J ECONOMETRICS, V14, P227, DOI 10.1016/0304-4076(80)90092-5; GRUNEIS F, 1989, BIOL CYBERN, V60, P161, DOI 10.1007/BF00207284; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; HSU KJ, 1991, P NATL ACAD SCI USA, V88, P3507, DOI 10.1073/pnas.88.8.3507; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Khader P, 2008, INT J PSYCHOPHYSIOL, V67, P252, DOI 10.1016/j.ijpsycho.2007.05.018; Koch C, 1997, NATURE, V385, P207, DOI 10.1038/385207a0; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kramer MA, 2008, J NEUROSCI METH, V170, P352, DOI 10.1016/j.jneumeth.2008.01.020; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Lin M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016133; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Lowen SB, 1997, J NEUROSCI, V17, P5666; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Mandelbrot B., 1999, MULTIFRACTALS 1 F NO; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Maylor EA, 2001, PSYCHON B REV, V8, P162, DOI 10.3758/BF03196153; Melloni L, 2009, TRENDS COGN SCI, V13, P239, DOI 10.1016/j.tics.2009.03.007; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Onton J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.061.2009; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; ROCKSTROH B, 1989, SLOW BRAIN POTENTIAL, V2; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shin CW, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.045101; Siegel M, 2003, J NEUROSCI, V23, P4251; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Takahashi K, 2004, NEUROSCI RES, V48, P203, DOI 10.1016/j.neures.2003.10.015; Thivierge JP, 2008, J NEUROSCI, V28, P7968, DOI 10.1523/JNEUROSCI.0870-08.2008; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Ward L. M., 2007, SCHOLARPEDIA, V2, P1537, DOI [DOI 10.4249/SCH0LARPEDIA.1537, 10.4249/scholarpedia.1537, DOI 10.4249/SCHOLARPEDIA.1537]; Ward L. M., 2002, DYNAMICAL COGNITIVE; WEISSMAN MB, 1988, REV MOD PHYS, V60, P537, DOI 10.1103/RevModPhys.60.537; YAMAMOTO M, 1991, Frontiers of Medical and Biological Engineering, V3, P135; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1143, DOI 10.1152/jappl.1991.71.3.1143; YOUNG MP, 1992, J NEUROPHYSIOL, V67, P1464, DOI 10.1152/jn.1992.67.6.1464; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	97	547	553	2	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 13	2010	66	3					353	369		10.1016/j.neuron.2010.04.020	http://dx.doi.org/10.1016/j.neuron.2010.04.020			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471349	Bronze, Green Accepted			2022-12-17	WOS:000277825200005
J	Edbauer, D; Neilson, JR; Foster, KA; Wang, CF; Seeburg, DP; Batterton, MN; Tada, T; Dolan, BM; Sharp, PA; Sheng, M				Edbauer, Dieter; Neilson, Joel R.; Foster, Kelly A.; Wang, Chi-Fong; Seeburg, Daniel P.; Batterton, Matthew N.; Tada, Tomoko; Dolan, Bridget M.; Sharp, Phillip A.; Sheng, Morgan			Regulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132	NEURON			English	Article							X MENTAL-RETARDATION; DENDRITIC SPINE MORPHOGENESIS; GTPASE-ACTIVATING-PROTEIN; NMDA RECEPTORS; KNOCKOUT MICE; MOUSE MODEL; SUBUNIT COMPOSITION; NONCODING RNAS; MESSENGER-RNAS; AMPA RECEPTOR	MicroRNAs (miRNAs) are noncoding RNAs that suppress translation of specific mRNAs. The miRNA machinery interacts with fragile X mental retardation protein (FMRP), which functions as translational repressor. We show that miR-125b and miR-1 32, as well as several other miRNAs, are associated with FMRP in mouse brain. miR-125b and miR-132 had largely opposing effects on dendritic spine morphology and synaptic physiology in hippocampal neurons. FMRP knockdown ameliorates the effect of miRNA overexpression on spine morphology. We identified NMDA receptor subunit NR2A as a target of miR-125b and show that NR2A mRNA is specifically associated with FMRP in brain. In hippocampal neurons, NR2A expression is negatively regulated through its 3' UTR by FMRP, miR-125b, and Argonaute 1. Regulation of NR2A 3'UTR by FMRP depends in part on miR-125b. Because NMDA receptor subunit composition profoundly affects synaptic plasticity, these observations have implications for the pathophysiology of fragile X syndrome, in which plasticity is altered.	[Edbauer, Dieter; Foster, Kelly A.; Wang, Chi-Fong; Seeburg, Daniel P.; Batterton, Matthew N.; Tada, Tomoko; Dolan, Bridget M.; Sharp, Phillip A.; Sheng, Morgan] MIT, Dept Biol, Cambridge, MA 02319 USA; [Neilson, Joel R.; Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02319 USA; [Edbauer, Dieter; Foster, Kelly A.; Wang, Chi-Fong; Seeburg, Daniel P.; Batterton, Matthew N.; Tada, Tomoko; Dolan, Bridget M.; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02319 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health	Edbauer, D (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany.	dieter.edbauer@med.uni-muenchen.de; msheng@mit.edu	Xie, Huangming/B-2260-2012; Edbauer, Dieter/M-9906-2019; Huang, H/E-9490-2010	Edbauer, Dieter/0000-0002-7186-4653; Sheng, Morgan/0000-0002-8703-5366; Neilson, Joel R./0000-0002-3408-608X	Deutsche Forschungsgemeinschaft [ED157/1]; NCI [PO1-CA42063, P30-CA14051, K99-CA131474]; Investigator of the Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA042063, K99CA131474, P30CA014051] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for brain tissue from FMR1 KO mice provided by S. Tonegawa. We thank G. Bassell, J. Jaworski, T. Nakazawa, R. Tsien, and T. Yamamoto for reagents. We thank B. Bingol, Y. Chen, Y. Hayashi, H. Hsin, C. Nelson, and L.-H. Tsai for critical reading of the manuscript, D.E. received a postdoctoral fellowship from Deutsche Forschungsgemeinschaft (ED157/1) J.R.N. and P.A.S. were supported by NCI PO1-CA42063 to P.A.S. and partially by NCI P30-CA14051 Cancer Center Support (Core) Grant. J.R.N. was additionally supported by NCI K99-CA131474. M.S. was Investigator of the Howard Hughes Medical Institute.	Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cheever A, 2009, RNA, V15, P362, DOI 10.1261/rna.1500809; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Lu JI, 2005, BIOCHEM BIOPH RES CO, V334, P319, DOI 10.1016/j.bbrc.2005.05.206; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nakagawa T, 2006, J NEUROSCI METH, V152, P1, DOI 10.1016/j.jneumeth.2005.08.001; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Yang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000444; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zeng Y, 2005, METHOD ENZYMOL, V392, P371, DOI 10.1016/S0076-6879(04)92022-8; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	68	547	572	0	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 11	2010	65	3					373	384		10.1016/j.neuron.2010.01.005	http://dx.doi.org/10.1016/j.neuron.2010.01.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159450	Green Accepted, Bronze, Green Published			2022-12-17	WOS:000275185200010
J	BUSCIGLIO, J; LORENZO, A; YEH, J; YANKNER, BA				BUSCIGLIO, J; LORENZO, A; YEH, J; YANKNER, BA			BETA-AMYLOID FIBRILS INDUCE TAU-PHOSPHORYLATION AND LOSS OF MICROTUBULE-BINDING	NEURON			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; PRECURSOR PROTEIN; CORTICAL-NEURONS; ALZ-50 EPITOPE; KINASE-I; NEUROTOXICITY	A central issue in the pathogenesis of Alzheimer's disease (AD) is the relationship between amyloid deposition and neurofibrillary tangle formation. To determine whether amyloid fibril formation affects the phosphorylation state of tau, primary cultures of fetal rat hippocampal and human cortical neurons were treated with beta-amyloid (beta A) in a soluble, amorphous-aggregated, or fibrillar form. Fibrillar beta A, but not soluble or amorphous-aggregated beta A, markedly induces the phosphorylation of tau at Ser-202 and Ser-396/Ser-404, resulting in a shift in the tau M(r) in human cortical neurons. Hyperphosphorylated tau accumulates in the somatodendritic compartment of fibrillar beta A-treated neurons in a soluble form that is not associated with microtubules and is incapable of binding to microtubules in vitro. Dephosphorylation of beta A-induced tau restores its capacity to bind to microtubules. Thus, amyloid fibril formation alters the phosphorylation state of tau, resulting in the loss of microtubule binding capacity and somatodendritic accumulation, properties also exhibited by tau in the AD brain. Amyloid fibril formation may therefore be a cause of abnormal tau phosphorylation in AD.	HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT OBSTET & GYNECOL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard Medical School	BUSCIGLIO, J (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG009229] Funding Source: NIH RePORTER; NIA NIH HHS [AG09229] Funding Source: Medline; NINDS NIH HHS [NS30352] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUSCIGLIO J, 1992, NEUROBIOL AGING, V13, P609, DOI 10.1016/0197-4580(92)90065-6; BUSCIGLIO J, 1993, J NEUROCHEM, V61, P1565, DOI 10.1111/j.1471-4159.1993.tb13658.x; CACERES A, 1986, J NEUROSCI, V6, P714; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHAUHAN A, 1991, LIFE SCI, V49, P1555, DOI 10.1016/0024-3205(91)90328-9; CHAUHAN A, 1993, BRAIN RES, V629, P47, DOI 10.1016/0006-8993(93)90479-7; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DELACOURTE A, 1990, ACTA NEUROPATHOL, V80, P111, DOI 10.1007/BF00308912; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GOEDERT M, 1991, NEUROSCI LETT, V126, P149, DOI 10.1016/0304-3940(91)90541-Z; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KENESSEY A, 1963, BRAIN RES, V629, P40; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; KSIEZAKREDING H, 1990, J NEUROSCI RES, V25, P412, DOI 10.1002/jnr.490250319; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; LU Q, 1993, J NEUROSCI, V13, P508; MANDELKOW EM, 1993, TRENDS BIOCHEM SCI, V18, P480, DOI 10.1016/0968-0004(93)90011-B; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MAY PC, 1993, J NEUROCHEM, V61, P2330, DOI 10.1111/j.1471-4159.1993.tb07480.x; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1992, NEUROREPORT, V3, P769, DOI 10.1097/00001756-199209000-00012; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHIN RW, 1993, P NATL ACAD SCI USA, V90, P6825, DOI 10.1073/pnas.90.14.6825; SHOJI M, 1992, SCIENCE, V25, P126; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; WATANABE A, 1993, J BIOL CHEM, V268, P25712; WILLIAMS RC, 1979, BIOCHEMISTRY-US, V18, P2499, DOI 10.1021/bi00579a010; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YANKNER BA, 1991, NEW ENGL J MED, V325, P1849; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	64	547	572	1	28	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					879	888		10.1016/0896-6273(95)90232-5	http://dx.doi.org/10.1016/0896-6273(95)90232-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718249	Bronze			2022-12-17	WOS:A1995QU82600022
J	Blaesse, P; Airaksinen, MS; Rivera, C; Kaila, K				Blaesse, Peter; Airaksinen, Matti S.; Rivera, Claudio; Kaila, Kai			Cation-Chloride Cotransporters and Neuronal Function	NEURON			English	Review							K-CL COTRANSPORTER; RAT NEOCORTICAL NEURONS; TEMPORAL-LOBE EPILEPSY; SECRETORY NA+-K+-2CL(-) COTRANSPORTER; DEVELOPMENTAL UP-REGULATION; REDUCED SEIZURE THRESHOLD; FOCAL CEREBRAL-ISCHEMIA; HIPPOCAMPAL AREA CA3; AUDITORY BRAIN-STEM; INTRACELLULAR CHLORIDE	Recent years have witnessed a steep increase in studies on the diverse roles of neuronal cation-chloride co-transporters (CCCs). The versatility of CCC gene transcription, posttranslational modification, and trafficking are on par with what is known about ion channels. The cell-specific and subcellular expression patterns of different CCC isoforms have a key role in modifying a neuron's electrophysiological phenotype during development, synaptic plasticity, and disease. While having a major role in controlling responses mediated by GABA(A) and glycine receptors, CCCs also show close interactions with glutamatergic signaling. A crosstalk among CCCs and trophic factors is important in short-term and long-term modification of neuronal properties. CCCs appear to be multifunctional proteins that are also involved in shaping neuronal structure at various stages of development, from stem cells to synaptogenesis. The rapidly expanding work on CCCs promotes our understanding of fundamental mechanisms that control brain development and functions under normal and pathophysiological conditions.	[Blaesse, Peter; Kaila, Kai] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Airaksinen, Matti S.; Kaila, Kai] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Rivera, Claudio] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Kaila, K (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Viikinkaari 1, FIN-00014 Helsinki, Finland.	kai.kaila@helsinki.fi	Rivera, Claudio/ABE-2499-2021; Kaila, Kai K/R-8528-2016	Rivera, Claudio/0000-0003-2462-6561; Kaila, Kai K/0000-0003-0668-5955; Airaksinen, Matti/0000-0002-7199-4984	Academy of Finland; Sigrid Juselius Foundation; European Integrated [EFP6-037315]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Integrated	The original research work by the authors was supported by grants from the Academy of Finland, from the Sigrid Juselius Foundation, and from the European Integrated Project "EPICURE" EFP6-037315. M.S.A., C.R., and K.K. are members of the Finnish CoE of Molecular and Integrative Neuroscience, and K.K. is a member of the Nordic CoE "WIRED." P.B. is a postdoctoral fellow of the German Academic Exchange Service (DAAD). We thank Drs. Eric Delpire, Christian A. Hubner, John A. Payne, and Theodore J. Price for constructive comments on the manuscript.	Achilles K, 2007, J NEUROSCI, V27, P8616, DOI 10.1523/JNEUROSCI.5041-06.2007; AICKIN CC, 1982, J PHYSIOL-LONDON, V329, P319, DOI 10.1113/jphysiol.1982.sp014305; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Auger AP, 2001, P NATL ACAD SCI USA, V98, P8059, DOI 10.1073/pnas.131016298; Avoli M, 2005, PROG NEUROBIOL, V77, P166, DOI 10.1016/j.pneurobio.2005.09.006; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Banke TG, 2008, J PHYSIOL-LONDON, V586, P4925, DOI 10.1113/jphysiol.2008.157024; Bartho P, 2004, EUR J NEUROSCI, V20, P965, DOI 10.1111/j.1460-9568.2004.03562.x; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Becker M, 2003, CELL TISSUE RES, V312, P155, DOI 10.1007/s00441-003-0713-5; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Berglund K, 2006, BRAIN CELL BIOL, V35, P207, DOI 10.1007/s11068-008-9019-6; Blackburn-Munro G, 2005, CURR PHARM DESIGN, V11, P2961, DOI 10.2174/1381612054865000; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Brumback AC, 2008, J NEUROSCI, V28, P1301, DOI 10.1523/JNEUROSCI.3378-07.2008; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Byun N, 2007, NEUROBIOL DIS, V28, P39, DOI 10.1016/j.nbd.2007.06.014; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chudotvorova I, 2005, J PHYSIOL-LONDON, V566, P671, DOI 10.1113/jphysiol.2005.089821; Clarkson J, 2006, MOL CELL ENDOCRINOL, V254, P32, DOI 10.1016/j.mce.2006.04.036; Clayton GH, 1998, DEV BRAIN RES, V109, P281, DOI 10.1016/S0165-3806(98)00078-9; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Dixon MJ, 1999, HUM MOL GENET, V8, P1579, DOI 10.1093/hmg/8.8.1579; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Flatman PW, 2008, CURR OPIN NEPHROL HY, V17, P186, DOI 10.1097/MNH.0b013e3282f5244e; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; FLUMELLI H, 2007, CURR OPIN NEUROBIOL, V17, P81; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fukuda A, 1998, J NEUROPHYSIOL, V79, P439, DOI 10.1152/jn.1998.79.1.439; Galanopoulou AS, 2008, J NEUROSCI, V28, P1557, DOI 10.1523/JNEUROSCI.5180-07.2008; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gao XB, 1998, J NEUROPHYSIOL, V79, P716, DOI 10.1152/jn.1998.79.2.716; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Gonzalez-Islas C, 2009, J NEUROPHYSIOL, V101, P507, DOI 10.1152/jn.90986.2008; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; Haglund MM, 2005, J NEUROPHYSIOL, V94, P907, DOI 10.1152/jn.00944.2004; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006; Hennou S, 2002, EUR J NEUROSCI, V16, P197, DOI 10.1046/j.1460-9568.2002.02073.x; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, MECH DEVELOP, V102, P267, DOI 10.1016/S0925-4773(01)00309-4; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Jang IS, 2006, NEUROSCIENCE, V138, P25, DOI 10.1016/j.neuroscience.2005.11.001; Jang IS, 2001, J NEUROSCI, V21, P5962, DOI 10.1523/JNEUROSCI.21-16-05962.2001; Jarolimek W, 1999, J NEUROSCI, V19, P4695; Jean-Xavier C, 2007, P NATL ACAD SCI USA, V104, P11477, DOI 10.1073/pnas.0704832104; Jensen TS, 2002, EUR J PAIN, V6, P61, DOI 10.1053/eujp.2001.0324; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Jin YS, 1999, J NEUROSCI, V19, P539; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; Kaila K, 1997, J NEUROSCI, V17, P7662; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kanold PO, 2006, NEURON, V51, P627, DOI 10.1016/j.neuron.2006.07.008; Karadsheh MF, 2001, J NEUROPHYSIOL, V85, P995, DOI 10.1152/jn.2001.85.2.995; KATCHMAN AN, 1994, J NEUROPHYSIOL, V71, P1128, DOI 10.1152/jn.1994.71.3.1128; Katz B., 1966, NERVE MUSCLE SYNAPSE; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khalilov I, 1999, DEV NEUROSCI-BASEL, V21, P310, DOI 10.1159/000017380; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kilb W, 2007, NEUROPHARMACOLOGY, V53, P524, DOI 10.1016/j.neuropharm.2007.06.015; Kilb W, 2002, NEUROSCIENCE, V112, P299, DOI 10.1016/S0306-4522(02)00071-4; Kohling R, 1998, BRAIN, V121, P1073, DOI 10.1093/brain/121.6.1073; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lamsa K, 2000, J NEUROPHYSIOL, V83, P359, DOI 10.1152/jn.2000.83.1.359; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Le Rouzic P, 2006, BRAIN RES, V1110, P39, DOI 10.1016/j.brainres.2006.06.055; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Leitch E, 2005, J NEUROSCI, V25, P4801, DOI 10.1523/JNEUROSCI.0172-05.2005; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li BQ, 2008, VISUAL NEUROSCI, V25, P109, DOI 10.1017/S0952523808080164; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Liu ZP, 2006, SCIENCE, V314, P1610, DOI 10.1126/science.1134246; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; Marty A, 2005, TRENDS NEUROSCI, V28, P284, DOI 10.1016/j.tins.2005.04.003; Marty S, 2000, J NEUROSCI, V20, P8087; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Mercado A, 2004, NEUROCHEM RES, V29, P17, DOI 10.1023/B:NERE.0000010432.44566.21; Mikawa S, 2002, DEV BRAIN RES, V136, P93, DOI 10.1016/S0165-3806(02)00345-0; Minlebaev M, 2007, J NEUROPHYSIOL, V97, P692, DOI 10.1152/jn.00759.2006; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Mulley JC, 2005, HUM MOL GENET, V14, pR243, DOI 10.1093/hmg/ddi355; Mulley JC, 2003, CURR OPIN NEUROL, V16, P171, DOI 10.1097/00019052-200304000-00009; Munoz A, 2007, EPILEPSIA, V48, P663, DOI 10.1111/j.1528-1167.2007.00986.x; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; OBATA K, 1978, BRAIN RES, V144, P179, DOI 10.1016/0006-8993(78)90447-X; Owens DF, 1999, J NEUROPHYSIOL, V82, P570, DOI 10.1152/jn.1999.82.2.570; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; PAYNE JA, 1997, AM J PHYSIOL, V516, pC1525; Pearson MM, 2001, NEUROSCIENCE, V103, P481, DOI 10.1016/S0306-4522(00)00567-4; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Pedersen SF, 2006, AM J PHYSIOL-REG I, V291, pR1, DOI 10.1152/ajpregu.00782.2005; Perrot-Sinal TS, 2007, J NEUROENDOCRINOL, V19, P302, DOI 10.1111/j.1365-2826.2007.01530.x; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Praetorius J, 2007, PFLUG ARCH EUR J PHY, V454, P1, DOI 10.1007/s00424-006-0170-6; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; PYLOVA SI, 1989, BRAIN RES, V490, P170, DOI 10.1016/0006-8993(89)90446-0; Randall J, 1997, AM J PHYSIOL-CELL PH, V273, pC1267, DOI 10.1152/ajpcell.1997.273.4.C1267; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Rennie J, 2007, ARCH DIS CHILD-FETAL, V92, pF148, DOI 10.1136/adc.2004.068551; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Reynolds A, 2008, J NEUROSCI, V28, P1588, DOI 10.1523/JNEUROSCI.3791-07.2008; Rheims S, 2008, J NEUROPHYSIOL, V100, P609, DOI 10.1152/jn.90402.2008; Riekki R, 2008, J NEUROPHYSIOL, V99, P3075, DOI 10.1152/jn.00606.2007; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Rocha-Gonzalez HI, 2008, J NEUROPHYSIOL, V100, P169, DOI 10.1152/jn.01007.2007; Rogawski MA, 2004, NAT MED, V10, P685, DOI 10.1038/nm1074; Rohrbough J, 1996, J NEUROSCI, V16, P82; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Romo-Parra H, 2008, J NEUROPHYSIOL, V99, P1523, DOI 10.1152/jn.01074.2007; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Rust MB, 2007, J CLIN INVEST, V117, P1708, DOI 10.1172/JCI30630; Rust MB, 2006, CIRC RES, V98, P549, DOI 10.1161/01.RES.0000204449.83861.22; Saier MH, 2003, MOL MICROBIOL, V48, P1145, DOI 10.1046/j.1365-2958.2003.03499.x; Salin-Cantegrel A, 2008, HUM MOL GENET, V17, P2703, DOI 10.1093/hmg/ddn172; SERAFINI R, 1995, J PHYSIOL-LONDON, V488, P371, DOI 10.1113/jphysiol.1995.sp020973; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Simat M, 2007, EUR J NEUROSCI, V26, P2239, DOI 10.1111/j.1460-9568.2007.05846.x; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Staley Kevin J., 2002, Epilepsy Curr, V2, P35, DOI 10.1046/j.1535-7597.2002.00018.x; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Titz S, 2003, J PHYSIOL-LONDON, V550, P719, DOI 10.1113/jphysiol.2003.041863; TOMBERG J, 2005, EUR J NEUROSCI, V21, P1327; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Trevino M, 2005, J PHYSIOL-LONDON, V567, P939, DOI 10.1113/jphysiol.2005.092064; Tyzio R, 2008, EUR J NEUROSCI, V27, P2515, DOI 10.1111/j.1460-9568.2008.06234.x; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Uvarov P, 2005, J NEUROCHEM, V95, P1144, DOI 10.1111/j.1471-4159.2005.03434.x; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Uvarov P, 2006, J NEUROSCI, V26, P13463, DOI 10.1523/JNEUROSCI.4731-06.2006; Vale C, 2005, HEARING RES, V206, P107, DOI 10.1016/j.heares.2005.03.012; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Vardi N, 2000, J NEUROSCI, V20, P7657; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; Vibat CRT, 2001, ANAL BIOCHEM, V298, P218, DOI 10.1006/abio.2001.5398; Vinay L, 2008, BRAIN RES REV, V57, P103, DOI 10.1016/j.brainresrev.2007.09.003; Voipio J, 2000, PROG BRAIN RES, V125, P329; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; WANG DD, 2009, J PHYSL IN PRESS; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Wardle RA, 2003, J NEUROSCI, V23, P8722; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Williams JR, 2004, AM J PHYSIOL-CELL PH, V287, pC919, DOI 10.1152/ajpcell.00005.2004; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Yan YP, 2001, BRAIN RES, V911, P43, DOI 10.1016/S0006-8993(01)02649-X; Yan YP, 2001, J CEREBR BLOOD F MET, V21, P711, DOI 10.1097/00004647-200106000-00009; Zhang LL, 2007, J NEUROPHYSIOL, V98, P266, DOI 10.1152/jn.00288.2007; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zhu L, 2005, J NEUROPHYSIOL, V93, P1557, DOI 10.1152/jn.00616.2004	235	546	563	1	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 26	2009	61	6					820	838		10.1016/j.neuron.2009.03.003	http://dx.doi.org/10.1016/j.neuron.2009.03.003			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	426XJ	19323993	Bronze			2022-12-17	WOS:000264741400005
J	CHARLES, AC; MERRILL, JE; DIRKSEN, ER; SANDERSON, MJ				CHARLES, AC; MERRILL, JE; DIRKSEN, ER; SANDERSON, MJ			INTERCELLULAR SIGNALING IN GLIAL-CELLS - CALCIUM WAVES AND OSCILLATIONS IN RESPONSE TO MECHANICAL STIMULATION AND GLUTAMATE	NEURON			English	Article							EXCITATORY AMINO-ACIDS; SPREADING DEPRESSION; INTRACELLULAR CA-2+; NERVOUS-SYSTEM; ASTROCYTES; CULTURES; PROLIFERATION; BRAIN; OLIGODENDROCYTES; COMMUNICATION	Intercellular Ca2+ signaling in primary cultures of glial cells was investigated with digital fluorescence video imaging. Mechanical stimulation of a single cell induced a wave of increased [Ca2+]i that was communicated to surrounding cells. This was followed by asynchronous Ca2+ oscillations in some cells. Similar communicated Ca2+ responses occurred in the absence of extracellular Ca2+, despite an initial decrease in [Ca2+]i in the stimulated cell. Mechanical stimulation in the presence of glutamate induced a typical communicated Ca2+ wave through cells undergoing asynchronous Ca2+ oscillations in response to glutamate. The coexistence of communicated Ca2+ waves and asynchronous Ca2+ oscilaltions suggests distinct mechanisms for intra- and intercellular Ca2+ signaling. This intercellular signaling may coordinate cooperative glial function.	UNIV CALIF LOS ANGELES,SCH MED,DEPT ANAT & CELL BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	CHARLES, AC (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT NEUROL,LOS ANGELES,CA 90024, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026983] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26983] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED Z, 1990, BRAIN RES, V516, P165, DOI 10.1016/0006-8993(90)90914-W; ANDERS JJ, 1988, GLIA, V1, P371, DOI 10.1002/glia.440010604; BARRES BA, 1989, NATURE, V339, P343, DOI 10.1038/339343a0; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; DUDEK FE, 1988, BRAIN RES, V439, P275; ENKVIST MOK, 1989, GLIA, V2, P397, DOI 10.1002/glia.440020602; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTNICK MJ, 1981, BRAIN RES, V213, P486, DOI 10.1016/0006-8993(81)90259-6; HASELGROVE JC, 1990, BRAIN RES, V506, P109, DOI 10.1016/0006-8993(90)91205-U; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; JENSEN AM, 1990, J NEUROSCI, V10, P1165; KETTENMANN H, 1988, GLIA, V1, P64, DOI 10.1002/glia.440010108; KETTENMANN H, 1983, J NEUROSCI, V3, P506; KETTENMANN H, 1988, GLIAL CELL RECEPTORS, P95; KIMELBERG HK, 1986, ASTROCYTES, V3, P129; LAURITZEN M, 1988, BRAIN RES, V475, P317, DOI 10.1016/0006-8993(88)90620-8; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; MARRERO H, 1989, NATURE, V339, P378, DOI 10.1038/339378a0; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MERRILL JE, 1984, SCIENCE, V224, P1428, DOI 10.1126/science.6610212; MONCK JR, 1988, J BIOL CHEM, V263, P4569; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5; SACHS F, 1988, CRIT REV BIOMED ENG, V16, P141; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SANDERSON MJ, 1986, P NATL ACAD SCI USA, V83, P7302, DOI 10.1073/pnas.83.19.7302; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0	37	546	557	0	50	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					983	992		10.1016/0896-6273(91)90238-U	http://dx.doi.org/10.1016/0896-6273(91)90238-U			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1675864				2022-12-17	WOS:A1991FT94900013
J	Krakauer, JW; Ghazanfar, AA; Gomez-Marin, A; MacIver, MA; Poeppel, D				Krakauer, John W.; Ghazanfar, Asif A.; Gomez-Marin, Alex; MacIver, Malcolm A.; Poeppel, David			Neuroscience Needs Behavior: Correcting a Reductionist Bias	NEURON			English	Review							PREY-CAPTURE; ELECTRIC FISH; NEURAL BASIS; ADAPTATION; EVOLUTION; DYNAMICS; SYSTEM; BRIDGE; BRAIN; LEVEL	There are ever more compelling tools available for neuroscience research, ranging from selective genetic targeting to optogenetic circuit control to mapping whole connectomes. These approaches are coupled with a deep-seated, often tacit, belief in the reductionist program for understanding the link between the brain and behavior. The aim of this program is causal explanation through neural manipulations that allow testing of necessity and sufficiency claims. We argue, however, that another equally important approach seeks an alternative form of understanding through careful theoretical and experimental decomposition of behavior. Specifically, the detailed analysis of tasks and of the behavior they elicit is best suited for discovering component processes and their underlying algorithms. In most cases, we argue that study of the neural implementation of behavior is best investigated after such behavioral work. Thus, we advocate a more pluralistic notion of neuroscience when it comes to the brain-behavior relationship: behavioral work provides understanding, whereas neural interventions test causality.	[Krakauer, John W.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; [Krakauer, John W.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA; [Ghazanfar, Asif A.] Princeton Univ, Princeton Neurosci Inst, Dept Psychol, Princeton, NJ 08540 USA; [Ghazanfar, Asif A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Gomez-Marin, Alex] CSIC, Inst Neurociencias, Alicante 03550, Spain; [Gomez-Marin, Alex] Univ Miguel Hernandez, Alicante 03550, Spain; [MacIver, Malcolm A.] Northwestern Univ, Dept Neurobiol, Dept Mech Engn, Neurosci & Robot Lab, Evanston, IL 60208 USA; [Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA; [Poeppel, David] Max Planck Inst Empir Aesthet, Dept Neurosci, D-60322 Frankfurt, Germany	Johns Hopkins University; Johns Hopkins University; Princeton University; Princeton University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Northwestern University; New York University	Krakauer, JW (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA.; Krakauer, JW (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA.	jkrakau1@jhmi.edu	MacIver, Malcolm/ABA-6758-2020; MacIver, Malcolm A/E-3005-2013; Gomez Marin, Alejandro/M-6408-2015	MacIver, Malcolm A/0000-0002-3711-8235; Gomez Marin, Alejandro/0000-0003-2764-2583	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; [Anonymous], 1987, INTENTIONAL STANCE; [Anonymous], 2012, IS WATER H2O EVIDENC; Badre D, 2015, NEURON, V88, P855, DOI 10.1016/j.neuron.2015.10.021; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bass AH, 2012, P NATL ACAD SCI USA, V109, P10677, DOI 10.1073/pnas.1201886109; Benichov JI, 2016, CURR BIOL, V26, P309, DOI 10.1016/j.cub.2015.12.037; Borjon JI, 2014, BRAIN BEHAV EVOLUT, V84, P93, DOI 10.1159/000365346; Carandini M, 2012, NAT NEUROSCI, V15, P507, DOI 10.1038/nn.3043; Cooper RP, 2015, TOP COGN SCI, V7, P243, DOI 10.1111/tops.12132; Dawkins R., 1976, GROWING POINTS ETHOL, V7, P54; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dombeck DA, 2012, CURR OPIN NEUROBIOL, V22, P3, DOI 10.1016/j.conb.2011.10.015; Fetsch CR, 2016, CURR OPIN NEUROBIOL, V37, P16, DOI 10.1016/j.conb.2015.12.002; Fortune ES, 2006, CURR OPIN NEUROBIOL, V16, P474, DOI 10.1016/j.conb.2006.06.006; Frank MJ, 2015, COGNITION, V135, P14, DOI 10.1016/j.cognition.2014.11.009; Gomez-Marin A, 2014, NAT NEUROSCI, V17, P1455, DOI 10.1038/nn.3812; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Heiligenberg W., 1991, NEURAL NETS ELECT FI; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Huberdeau DM, 2015, CURR OPIN NEUROBIOL, V33, P71, DOI 10.1016/j.conb.2015.03.003; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Jonas E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005268; Kahneman D., 2011, THINKING; Katz PS, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0057; Kay L. E., 1996, MOL VISION LIFE CALT; Kendler KS, 2008, PSYCHOL MED, V38, P899, DOI 10.1017/S0033291708002973; Leininger EC, 2015, CYTOGENET GENOME RES, V145, P302, DOI 10.1159/000433483; Levitis DA, 2009, ANIM BEHAV, V78, P103, DOI 10.1016/j.anbehav.2009.03.018; LONGUETH.HC, 1972, PROC R SOC SER B-BIO, V182, P255, DOI 10.1098/rspb.1972.0079; MacIver M.A., 2009, CAMBRIDGE HDB SITUAT, P480; MacIver MA, 2001, J EXP BIOL, V204, P543; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marom S, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.005.2009; Marr D., 1982, VISION COMPUTATIONAL; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Nelson ME, 1999, J EXP BIOL, V202, P1195; Noble D, 2012, INTERFACE FOCUS, V2, P55, DOI 10.1098/rsfs.2011.0067; Oatley K., 1978, PERCEPTIONS REPRESEN; Panigrahi B, 2015, CELL, V162, P1418, DOI 10.1016/j.cell.2015.08.014; Patterson BW, 2013, J EXP BIOL, V216, P3071, DOI 10.1242/jeb.087742; Poeppel D, 2005, TWENTY-FIRST CENTURY PSYCHOLINGUISTICS: FOUR CORNERSTONES, P103; Reynolds C.W., 1987, SIGGRAPH COMPUTER GR, V21, P25, DOI [10.1145/37402.37406, DOI 10.1145/37402.37406]; Schall JD, 2004, ANNU REV PSYCHOL, V55, P23, DOI 10.1146/annurev.psych.55.090902.141907; SELVERSTON AI, 1980, BEHAV BRAIN SCI, V3, P535, DOI 10.1017/S0140525X00006580; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smit H, 2014, ERKENNTNIS, V79, P1077, DOI 10.1007/s10670-013-9594-5; Snyder JB, 2007, PLOS BIOL, V5, P2671, DOI 10.1371/journal.pbio.0050301; Sober E, 1999, PHILOS SCI, V66, P542, DOI 10.1086/392754; Sternberg S, 2011, COGN NEUROPSYCHOL, V28, P156, DOI 10.1080/02643294.2011.557231; Takahashi DY, 2015, SCIENCE, V349, P734, DOI 10.1126/science.aab1058; Takahashi DY, 2012, J IEEE I C DEVELOP L; Takahashi DY, 2013, CURR BIOL, V23, P2162, DOI 10.1016/j.cub.2013.09.005; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Therrien AS, 2015, CURR OPIN NEUROBIOL, V33, P127, DOI 10.1016/j.conb.2015.03.013; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Tinbergen N., 1955, STUDY INSTINCT; VONUEXKULL J, 1992, SEMIOTICA, V89, P319, DOI 10.1515/semi.1992.89.4.319; WATANABE A, 1963, J EXP BIOL, V40, P57; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004; Yuste R, 2015, NAT REV NEUROSCI, V16, P487, DOI 10.1038/nrn3962	64	545	547	3	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 8	2017	93	3					480	490		10.1016/j.neuron.2016.12.041	http://dx.doi.org/10.1016/j.neuron.2016.12.041			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EO1AB	28182904	Bronze			2022-12-17	WOS:000396428800006
J	Shepherd, JD; Rumbaugh, G; Wu, J; Chowdhury, S; Plath, N; Kuhl, D; Huganir, RL; Worley, PF				Shepherd, Jason D.; Rumbaugh, Gavin; Wu, Jing; Chowdhury, Shoalb; Plath, Niels; Kuhl, Dietmar; Huganir, Richard L.; Worley, Paul F.			Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors	NEURON			English	Article							LONG-TERM POTENTIATION; ARC MESSENGER-RNA; HIPPOCAMPAL-NEURONS; PROTEIN EXPRESSION; CULTURED NEURONS; TRANSGENIC MICE; VISUAL-CORTEX; PLASTICITY; ACTIVATION; GENE	Homeostatic plasticity may compensate for Hebbian forms of synaptic plasticity, such as long-term potentiation (LTP) and depression (LTD), by scaling neuronal output without changing the relative strength of individual synapses. This delicate balance between neuronal output and distributed synaptic weight may be necessary for maintaining efficient encoding of information across neuronal networks. Here, we demonstrate that Arc/Arg3.1, an immediate-early gene (IEG) that is rapidly induced by neuronal activity associated with information encoding in the brain, mediates homeostatic synaptic scaling of AMPA type glutamate receptors (AMPARs) via its ability to activate a novel and selective AMPAR endocytic pathway. High levels of Arc/Arg3.1 block the homeostatic increases in AMPAR function induced by chronic neuronal inactivity. Conversely, loss of Arc/Arg3.1 results in increased AMPAR function and abolishes homeostatic scaling of AMPARs. These observations, together with evidence that Arc/Arg3.1 is required for memory consolidation, reveal the importance of Arc/Arg3.1's dynamic expression as it exerts continuous and precise control over synaptic strength and cellular excitability.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Free University of Berlin	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	Kuhl, Dietmar/A-4689-2009; Shepherd, Jason/N-8555-2018	Kuhl, Dietmar/0000-0002-4772-6701; Shepherd, Jason/0000-0001-7384-8289	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830, R01MH053608] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH053608, P50 MH068830] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARIK T, 2002, PCR CLONING PROTOCOL, V192; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Dickey CA, 2003, J NEUROSCI, V23, P5219; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nguyen PV, 1996, J NEUROSCI, V16, P3189; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OTANI S, 1989, NEUROSCI LETT, V106, P175, DOI 10.1016/0304-3940(89)90222-X; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yeung LC, 2004, P NATL ACAD SCI USA, V101, P14943, DOI 10.1073/pnas.0405555101; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	49	545	555	1	41	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					475	484		10.1016/j.neuron.2006.08.034	http://dx.doi.org/10.1016/j.neuron.2006.08.034			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088213	Green Accepted, Bronze			2022-12-17	WOS:000242269700010
J	Debiec, J; LeDoux, JE; Nader, K				Debiec, J; LeDoux, JE; Nader, K			Cellular and systems reconsolidation in the hippocampus	NEURON			English	Article							LONG-TERM-MEMORY; RETROGRADE-AMNESIA; PROTEIN-SYNTHESIS; CONTEXTUAL FEAR; CONSOLIDATION; RETRIEVAL; EXTINCTION; AMYGDALA; CORTEX; ACTIVATION	Cellular theories of memory consolidation posit that new memories require new protein synthesis in order to be stored. Systems consolidation theories posit that the hippocampus has a time-limited role in memory storage, after which the memory is independent of the hippocampus. Here, we show that intra-hippocampal infusions of the protein synthesis inhibitor anisomycin caused amnesia for a consolidated hippocampal-dependent contextual fear memory, but only if the memory was reactivated prior to infusion. The effect occurred even if reactivation was delayed for 45 days after training, a time when contextual memory is independent of the hippocampus. Indeed, reactivation of a hippocampus-independent memory caused the trace to again become hippocampus dependent, but only for 2 days rather than for weeks. Thus, hippocampal memories can undergo reconsolidation at both the cellular and systems levels.	McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA; Jagiellonian Univ, Coll Med, Dept Psychiat, PL-31501 Krakow, Poland	McGill University; New York University; Jagiellonian University; Collegium Medicum Jagiellonian University	Nader, K (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Debiec, Jacek/B-6820-2008	Debiec, Jacek/0000-0002-8473-1534	NIMH NIH HHS [K02 MH00956, P50 MH 58911, R37 MH38774] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038774, P50MH058911, K02MH000956] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Bartlett F. C., 1932, REMEMBERING; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; CHERKIN A, 1972, PHYSIOL BEHAV, V8, P949, DOI 10.1016/0031-9384(72)90309-5; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS HP, 1978, PHARMACOL BIOCHEM BE, V8, P701, DOI 10.1016/0091-3057(78)90269-1; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; Ebbinghaus M, 1885, GEDACHTNIS; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FLEXNER LB, 1965, EXP NEUROL, V13, P264, DOI 10.1016/0014-4886(65)90114-7; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOLD PE, 1974, PSYCHOL REV, V81, P465, DOI 10.1037/h0036949; GOLD PE, 1973, SCIENCE, V180, P1199, DOI 10.1126/science.180.4091.1199; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Land C, 2000, PSYCHOBIOLOGY, V28, P476; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; LOFTUS EF, 1984, MEMORY CONSOLIDATION, P163; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayes AR, 2001, PHILOS T ROY SOC B, V356, P1395, DOI 10.1098/rstb.2001.0941; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McNish KA, 1997, J NEUROSCI, V17, P9353; MILLER RR, 1974, PSYCHOL REV, V81, P470, DOI 10.1037/h0036951; Miller RR, 2000, NAT REV NEUROSCI, V1, P214, DOI 10.1038/35044578; Millin PM, 2001, NAT REV NEUROSCI, V2, P68, DOI 10.1038/35049075; Misanin JR, 1968, SCIENCE, V160, P203; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MULLER GE, 1900, Z PSYCHOL S, V1; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; QUARTERM.D, 1970, NATURE, V228, P677, DOI 10.1038/228677a0; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; Rolls E.T., 1989, NEURAL MODELS PLASTI, P240; Rosenblum K, 1997, J NEUROSCI, V17, P5129; Ryan L, 2001, HIPPOCAMPUS, V11, P707, DOI 10.1002/hipo.1086; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; SCHNEIDER AM, 1968, SCIENCE, V159, P219, DOI 10.1126/science.159.3811.219; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; ZINKIN S, 1967, SCIENCE, V155, P102, DOI 10.1126/science.155.3758.102	73	545	555	1	64	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					527	538		10.1016/S0896-6273(02)01001-2	http://dx.doi.org/10.1016/S0896-6273(02)01001-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408854	Bronze			2022-12-17	WOS:000178877700020
J	Deverman, BE; Patterson, PH				Deverman, Benjamin E.; Patterson, Paul H.			Cytokines and CNS Development	NEURON			English	Review							LEUKEMIA INHIBITORY FACTOR; COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; CILIARY NEUROTROPHIC FACTOR; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; NEURAL STEM-CELLS; OSTEOPETROTIC OP/OP MICE; CAJAL-RETZIUS CELLS; NEURONS IN-VITRO	Cytokines are pleotrophic proteins that coordinate the host response to infection as well as mediate normal, ongoing signaling between cells of nonimmune tissues, including the nervous system. As a consequence of this dual role, cytokines induced in response to maternal infection or prenatal hypoxia can profoundly impact fetal neurodevelopment. The neurodevelopmental roles of individual cytokine signaling pathways are being elucidated through gain- and loss-of-function studies in cell culture and model organisms. We review this work with a particular emphasis on studies where cytokines, their receptors, or components of their signaling pathways have been altered in vivo. The extensive and diverse requirements for properly regulated cytokine signaling during normal nervous system development revealed by these studies sets the foundation for ongoing and future work aimed at understanding how cytokines induced normally and pathologically during critical stages of fetal development alter nervous system function and behavior later in life.	[Deverman, Benjamin E.; Patterson, Paul H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Patterson, PH (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd,M-C 216-76, Pasadena, CA 91125 USA.	php@caltech.edu			NINDS; McGrath Foundation; California Institute for Regenerative Medicine	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McGrath Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	Experiments described from the authors' laboratory were funded by the NINDS and the McGrath Foundation. B.E.D. is supported by a fellowship from the California Institute for Regenerative Medicine.	Adachi T, 2005, J NEUROSCI RES, V79, P608, DOI 10.1002/jnr.20373; AKIYAMA H, 1994, BRAIN RES, V635, P257, DOI 10.1016/0006-8993(94)91447-8; Alfonsi F, 2008, DEV BIOL, V313, P267, DOI 10.1016/j.ydbio.2007.10.020; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Andrews T, 1998, J NEUROSCI RES, V54, P574, DOI 10.1002/(SICI)1097-4547(19981201)54:5<574::AID-JNR2>3.3.CO;2-S; Anthony TE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-30; ASHWELL K, 1991, DEV BRAIN RES, V58, P1, DOI 10.1016/0165-3806(91)90231-7; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Baerwald KD, 1998, J NEUROSCI RES, V52, P230, DOI 10.1002/(SICI)1097-4547(19980415)52:2<230::AID-JNR11>3.3.CO;2-P; Bagri A, 2002, DEVELOPMENT, V129, P4249; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Barres BA, 1996, MOL CELL NEUROSCI, V8, P146, DOI 10.1006/mcne.1996.0053; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, DEVELOPMENT, V118, P283; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BLEVINS G, 1995, J NEUROSCI RES, V40, P535, DOI 10.1002/jnr.490400412; Bodeutsch N, 2000, GLIA, V32, P91, DOI 10.1002/1098-1136(200010)32:1<91::AID-GLIA90>3.0.CO;2-X; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brown AS, 2004, AM J PSYCHIAT, V161, P889, DOI 10.1176/appi.ajp.161.5.889; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Buka SL, 2001, BRAIN BEHAV IMMUN, V15, P411, DOI 10.1006/brbi.2001.0644; BURNS TM, 1993, GROWTH FACTORS, V9, P253, DOI 10.3109/08977199308991585; Campos C, 2001, WA SCI TECHNOL, V1, P13, DOI 10.2166/ws.2001.0095; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Chalasani SH, 2007, J NEUROSCI, V27, P973, DOI 10.1523/JNEUROSCI.4132-06.2007; CHAMAK B, 1994, J NEUROSCI RES, V38, P221, DOI 10.1002/jnr.490380213; Chang MY, 2004, CELL DEATH DIFFER, V11, P985, DOI 10.1038/sj.cdd.4401426; CHANG Y, 1994, J NEUROIMMUNOL, V52, P9; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Cockle JV, 2007, REPROD SCI, V14, P629, DOI 10.1177/1933719107304563; CONSTAM DB, 1994, EUR J NEUROSCI, V6, P766, DOI 10.1111/j.1460-9568.1994.tb00988.x; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; de la Mano A, 2007, CYTOKINE, V37, P128, DOI 10.1016/j.cyto.2007.03.004; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Deng WB, 2008, ARCH NEUROL-CHICAGO, V65, P1291, DOI 10.1001/archneur.65.10.1291; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Ellman LM, 2009, NEURON, V64, P25, DOI 10.1016/j.neuron.2009.09.024; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; Falsig J, 2008, J NEUROSCI RES, V86, P1434, DOI 10.1002/jnr.21590; Farkas LM, 2003, J NEUROSCI, V23, P5178; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; FERRER I, 1990, NEUROSCI RES, V8, P60, DOI 10.1016/0168-0102(90)90058-M; Fontaine RH, 2008, CELL DEATH DIFFER, V15, P1542, DOI 10.1038/cdd.2008.79; Forger NG, 2003, J NEUROSCI, V23, P8854; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Gaulden J, 2008, HUM MOL GENET, V17, pR60, DOI 10.1093/hmg/ddn119; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; GIULIAN D, 1988, J NEUROSCI, V8, P709; Gregg C, 2005, DEVELOPMENT, V132, P565, DOI 10.1242/dev.01592; HARRIS AJ, 1984, J NEUROSCI, V4, P13; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatta T, 2002, J NEUROSCI, V22, P5516; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Holtmann B, 2005, J NEUROSCI, V25, P1778, DOI 10.1523/JNEUROSCI.4249-04.2005; Holzschuh J, 2003, J NEUROSCI, V23, P5507; Horuk R, 1997, J IMMUNOL, V158, P2882; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kim IJ, 2002, J NEUROSCI, V22, P4530, DOI 10.1523/JNEUROSCI.22-11-04530.2002; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kirsch F, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-32; Klein RS, 2001, DEVELOPMENT, V128, P1971; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kondo Y, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-31; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; LaFerla FM, 2000, J MOL NEUROSCI, V15, P45, DOI 10.1385/JMN:15:1:45; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Lodge DJ, 2008, NEUROTOX RES, V14, P97, DOI 10.1007/BF03033801; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; MAYER M, 1994, DEVELOPMENT, V120, P143; Maysami S, 2006, J NEUROIMMUNOL, V178, P17, DOI 10.1016/j.jneuroim.2006.05.021; Mehler MF, 1995, CRIT REV NEUROBIOL, V9, P419; Meng SZ, 1999, BRAIN DEV-JPN, V21, P30; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Meyer U, 2008, MOL PSYCHIATR, V13, P208, DOI 10.1038/sj.mp.4002042; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; Miyasaka N, 2007, DEVELOPMENT, V134, P2459, DOI 10.1242/dev.001958; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; NAITO M, 1991, AM J PATHOL, V139, P657; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Penner Justin D, 2007, Expert Rev Neurother, V7, P797, DOI 10.1586/14737175.7.7.797; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pitman M, 2004, MOL CELL NEUROSCI, V27, P255, DOI 10.1016/j.mcn.2004.07.004; Pollard JW, 1997, MOL REPROD DEV, V46, P54, DOI 10.1002/(SICI)1098-2795(199701)46:1&lt;54::AID-MRD9&gt;3.0.CO;2-Q; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Robinson S, 1998, J NEUROSCI, V18, P10457; Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7; Sasaki A, 2000, NEUROPATHOLOGY, V20, P134, DOI 10.1046/j.1440-1789.2000.00286.x; Schwarting GA, 2006, J NEUROSCI, V26, P6834, DOI 10.1523/JNEUROSCI.1728-06.2006; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Stumm RK, 2003, J NEUROSCI, V23, P5123; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; TSENG CY, 1983, J ANAT, V136, P837; TURNLEY AM, 1991, NATURE, V353, P566, DOI 10.1038/353566a0; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Viti J, 2003, J NEUROSCI, V23, P3385; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang CC, 2002, DEV BRAIN RES, V139, P337, DOI 10.1016/S0165-3806(02)00584-9; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Zhang YT, 2006, J NEUROSCI, V26, P12174, DOI 10.1523/JNEUROSCI.2289-06.2006; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zhu Y, 2009, DEVELOPMENT, V136, P1919, DOI 10.1242/dev.032276; Zou X, 2009, VET PATHOL, V46, P514, DOI 10.1354/vp.08-VP-0239-B-BC; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	170	544	554	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 15	2009	64	1					61	78		10.1016/j.neuron.2009.09.002	http://dx.doi.org/10.1016/j.neuron.2009.09.002			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840550	Bronze			2022-12-17	WOS:000271454400012
J	VERDOORN, TA; DRAGUHN, A; YMER, S; SEEBURG, PH; SAKMANN, B				VERDOORN, TA; DRAGUHN, A; YMER, S; SEEBURG, PH; SAKMANN, B			FUNCTIONAL-PROPERTIES OF RECOMBINANT RAT GABA-A RECEPTORS DEPEND UPON SUBUNIT COMPOSITION	NEURON			English	Article									UNIV HEIDELBERG,CTR MOLEC BIOL,MOLEC NEUROENDOCRINOL LAB,W-6900 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg	VERDOORN, TA (corresponding author), MAX PLANCK INST MED RES,ZELLPHYSIOL ABT,W-6900 HEIDELBERG 1,GERMANY.							ALLEN CN, 1987, BRAIN RES, V410, P159, DOI 10.1016/S0006-8993(87)80039-2; BERNASCONI CF, 1976, RELAXATION KINETICS, P20; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; BORMANN J, 1983, J PHYSIOL-LONDON, V341, pP9; BORMANN J, 1985, P NATL ACAD SCI USA, V82, P2168, DOI 10.1073/pnas.82.7.2168; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GRAY R, 1985, J NEUROPHYSIOL, V54, P134, DOI 10.1152/jn.1985.54.1.134; HAMILL OP, 1983, NATURE, V305, P805, DOI 10.1038/305805a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LEVITAN ES, 1988, NEURON, V1, P773, DOI 10.1016/0896-6273(88)90125-0; LOLAIT SJ, 1989, FEBS LETT, V246, P145, DOI 10.1016/0014-5793(89)80271-6; MACDONALD RL, 1989, J PHYSL, V410, P4796; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MOSS SJ, 1990, IN PRESS EUR J PHARM; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; NIELSEN M, 1980, NATURE, V286, P606, DOI 10.1038/286606a0; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SCHOFIELD PR, 1989, TRENDS PHARMACOL SCI, V10, P476, DOI 10.1016/0165-6147(89)90041-2; SEQUIER JM, 1988, P NATL ACAD SCI USA, V85, P7815, DOI 10.1073/pnas.85.20.7815; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGHART W, 1980, NATURE, V286, P285, DOI 10.1038/286285a0; SMITH SM, 1989, J MEMBRANE BIOL, V180, P45; STEINBACH JH, 1989, TRENDS NEUROSCI, V12, P3, DOI 10.1016/0166-2236(89)90145-8; WISDEN W, 1988, NEURON, V1, P937, DOI 10.1016/0896-6273(88)90151-1; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x	36	544	559	1	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1990	4	6					919	928		10.1016/0896-6273(90)90145-6	http://dx.doi.org/10.1016/0896-6273(90)90145-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK185	1694446				2022-12-17	WOS:A1990DK18500012
J	Man, HY; Lin, JW; Ju, WH; Ahmadian, G; Liu, LD; Becker, LE; Sheng, M; Wang, YT				Man, HY; Lin, JW; Ju, WH; Ahmadian, G; Liu, LD; Becker, LE; Sheng, M; Wang, YT			Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization	NEURON			English	Article							LONG-TERM POTENTIATION; COATED VESICLE FORMATION; SILENT SYNAPSES; INSULIN; INDUCTION; PROTEIN; CELLS; LTP; HIPPOCAMPUS; ENDOCYTOSIS	Redistribution of postsynaptic AMPA- (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-) subtype glutamate receptors may regulate synaptic strength at glutamatergic synapses, but the mediation of the redistribution is poorly understood. We show that AMPA receptors underwent clathrin-dependent endocytosis, which was accelerated by insulin in a GluR2 subunit-dependent manner. Insulin-stimulated endocytosis rapidly decreased AMPA receptor numbers in the plasma membrane, resulting in long-term depression (LTD) of AMPA receptor-mediated synaptic transmission in hippocampal CA1 neurons. Moreover, insulin-induced LTD and low-frequency stimulation-(LFS-) induced homosynaptic CA1 LTD were found to be mutually occlusive and were both blocked by inhibiting postsynaptic clathrin-mediated endocytosis. Thus, controlling postsynaptic receptor numbers through endocytosis may be an important mechanism underlying synaptic plasticity in the mammalian CNS.	Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wang, YT (corresponding author), Hosp Sick Children, Programme Brain & Behav, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	y.t.wang@utoronto.ca	Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008	Sheng, Morgan/0000-0002-8703-5366; Liu, Lidong/0000-0002-7026-690X	NINDS NIH HHS [NS35050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Karoor V, 1998, J BIOL CHEM, V273, P33035, DOI 10.1074/jbc.273.49.33035; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; Lissin DV, 1999, J NEUROSCI, V19, P1263; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 1998, NEURON, V21, P1226, DOI 10.1016/S0896-6273(00)80640-6; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; MORGAN DO, 1987, P NATL ACAD SCI USA, V84, P41, DOI 10.1073/pnas.84.1.41; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; WOZNIAK M, 1993, NEUROCHEM INT, V22, P1, DOI 10.1016/0197-0186(93)90062-A; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	44	543	554	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2000	25	3					649	662		10.1016/S0896-6273(00)81067-3	http://dx.doi.org/10.1016/S0896-6273(00)81067-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301CY	10774732	Bronze			2022-12-17	WOS:000086291700017
J	WILLIAMS, EJ; FURNESS, J; WALSH, FS; DOHERTY, P				WILLIAMS, EJ; FURNESS, J; WALSH, FS; DOHERTY, P			ACTIVATION OF THE FGF RECEPTOR UNDERLIES NEURITE OUTGROWTH STIMULATED BY L1, N-CAM, AND N-CADHERIN	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; CELL-ADHESION MOLECULES; 2ND MESSENGER SYSTEMS; NEURONAL RESPONSIVENESS; VENTRICULAR MYOCYTES; IMMUNOGLOBULIN-LIKE; TYROSINE KINASES; XENOPUS EMBRYOS; NEURAL ADHESION; NERVOUS-SYSTEM	Cell contact-dependent neurite outgrowth stimulated by CAMs requires activation of a second messenger pathway that requires the function of a tyrosine kinase upstream from calcium influx into neurons. In the present study, we present evidence that implicates activation of the fibroblast growth factor receptor (FGFR) in the pathway underlying neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. We have identified a CAM homology domain in the FGF family of receptors and show that antibodies which bind to this domain specifically inhibit neurite outgrowth stimulated by the above CAMs. We also show that synthetic peptides derived from this domain can differentially and specifically inhibit neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. In addition, a soluble L1-Fc chimera is shown to stimulate an increase in phosphotyrosine on the same set of neuronal proteins that are phosphorylated following activation of the FGFR with basic FGF.			WILLIAMS, EJ (corresponding author), UNITED MED & DENT SCH,GUYS HOSP,DEPT EXPTL PATHOL,LONDON BRIDGE,LONDON SE1 9RT,ENGLAND.		Doherty, Patrick/A-8752-2008		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; ASAI T, 1993, MOL BRAIN RES, V17, P174, DOI 10.1016/0169-328X(93)90088-7; BIXBY JL, 1992, J NEUROBIOL, V23, P468, DOI 10.1002/neu.480230503; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BYERS S, 1992, DEV BIOL, V152, P411, DOI 10.1016/0012-1606(92)90149-B; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; Doherty P, 1992, Curr Opin Neurobiol, V2, P595, DOI 10.1016/0959-4388(92)90024-F; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; Doherty P, 1989, CURR OPIN CELL BIOL, V1, P1102, DOI 10.1016/S0955-0674(89)80057-2; DOHERTY P, 1992, DEVELOPMENT, V115, P885; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; DONALIES M, 1991, P NATL ACAD SCI USA, V88, P8024, DOI 10.1073/pnas.88.18.8024; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FRIESEL R, 1992, DEVELOPMENT, V116, P1051; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HOLLENBAUGH D, 1992, CURR OPIN IMMUNOL, V4, P216, DOI 10.1016/0952-7915(92)90017-9; HUANG J, 1990, CIRCULATION, V82, P525; HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KATER SB, 1991, J NEUROSCI, V11, P891; LEBEAU JM, 1991, J NEUROSCI RES, V28, P299, DOI 10.1002/jnr.490280217; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LIU L, 1993, J NEUROSCI RES, V35, P327, DOI 10.1002/jnr.490350313; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MUSCI TJ, 1990, P NATL ACAD SCI USA, V87, P8365, DOI 10.1073/pnas.87.21.8365; REDIES C, 1993, GLIA, V8, P161, DOI 10.1002/glia.440080304; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; SAFFELL JL, 1994, J CELL BIOL, V125, P427, DOI 10.1083/jcb.125.2.427; SAFFELL JL, 1992, J CELL BIOL, V118, P663, DOI 10.1083/jcb.118.3.663; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; SIMMONS DL, 1993, CELLULAR INTERACTION, P93; SMALL SJ, 1988, NEURON, V1, P1007, DOI 10.1016/0896-6273(88)90158-4; VONBOHLEN F, 1992, EUR J NEUROSCI, V4, P896; WILLIAMS EJ, 1994, DEVELOPMENT, V120, P1685; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P1231; WILLIAMS EJ, 1994, J CELL BIOL, V124, P1029, DOI 10.1083/jcb.124.6.1029; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; YAYON A, 1993, P NATL ACAD SCI USA, V90, P10643, DOI 10.1073/pnas.90.22.10643; YAZAKI T, 1991, BIOMED RES-TOKYO, V12, P223, DOI 10.2220/biomedres.12.223; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	52	543	563	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					583	594		10.1016/0896-6273(94)90027-2	http://dx.doi.org/10.1016/0896-6273(94)90027-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917292				2022-12-17	WOS:A1994PJ28400007
J	Dawson, TM; Ko, HS; Dawson, VL				Dawson, Ted M.; Ko, Han Seok; Dawson, Valina L.			Genetic Animal Models of Parkinson's Disease	NEURON			English	Review							HUMAN ALPHA-SYNUCLEIN; DOPAMINERGIC NEURON DEGENERATION; UBIQUITIN-PROTEIN LIGASE; DROSOPHILA DJ-1 MUTANTS; TRANSGENIC MICE; OXIDATIVE STRESS; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; CAENORHABDITIS-ELEGANS; KINASE-ACTIVITY	Parkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized by the degeneration of dopamine (DA) and non-DA neurons, the almost uniform presence of Lewy bodies, and motor deficits. Although the majority of PD is sporadic, specific genetic defects in rare familial cases have provided unique insights into the pathogenesis of PD. Through the creation of animal and cellular models of mutations in LRRK2 and a-synuclein, which are linked to autosomal-dominant PD, and mutations in parkin, DJ-1, and PINK1, which are responsible for autosomal-recessive PD, insight into the molecular mechanisms of this disorder are leading to new ideas about the pathogenesis of PD. In this review, we discuss the animal models for these genetic causes of PD, their limitations, and value. Moreover, we discuss future directions and potential strategies for optimization of the genetic models.	[Dawson, Ted M.; Ko, Han Seok; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, NeuroRegenerat Program, Baltimore, MD 21205 USA; [Dawson, Ted M.; Ko, Han Seok; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Programs, Baltimore, MD 21205 USA; [Dawson, Ted M.; Ko, Han Seok; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, NeuroRegenerat Program, Baltimore, MD 21205 USA.	tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970	Morris K. Udall Parkinson's Disease Research Center of Excellence NIH/NINDS [NS38377, NS04826]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R01NS048206] Funding Source: NIH RePORTER	Morris K. Udall Parkinson's Disease Research Center of Excellence NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Morris K. Udall Parkinson's Disease Research Center of Excellence NIH/NINDS (NS38377) and NS04826. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. T.M.D. is a paid consultant to Merck KGAA. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. We would like to thank Yunjong Lee and Mingyao Ying for critical comments and insights. Due to the nature of this review, we apologize to all of the authors we were not able to cite regarding animal and cellular models of PD.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Albrecht M, 2005, LANCET, V365, P1230, DOI 10.1016/S0140-6736(05)74810-8; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Bedford L, 2008, BBA-MOL BASIS DIS, V1782, P683, DOI 10.1016/j.bbadis.2008.10.009; Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Chesselet Marie-Francoise, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS84, DOI 10.1016/j.parkreldis.2008.04.004; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Clark LN, 2009, ARCH NEUROL-CHICAGO, V66, P578, DOI 10.1001/archneurol.2009.54; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2008, LANCET NEUROL, V7, P474, DOI 10.1016/S1474-4422(08)70099-1; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Dawson TM, 2002, NEURON, V35, P219, DOI 10.1016/S0896-6273(02)00780-8; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Forman MS, 2005, NEURON, V47, P479, DOI 10.1016/j.neuron.2005.07.021; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamre K, 1999, BRAIN RES, V828, P91, DOI 10.1016/S0006-8993(99)01273-1; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Heutink P, 2006, J NEURAL TRANSM-SUPP, P215; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jain S, 2006, J NEUROSCI, V26, P11230, DOI 10.1523/JNEUROSCI.1876-06.2006; Jellinger KA, 2009, BBA-MOL BASIS DIS, V1792, P730, DOI 10.1016/j.bbadis.2008.07.006; Joyce JN, 1996, NEUROSCI BIOBEHAV R, V20, P453, DOI 10.1016/0149-7634(95)00025-9; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Kokjohn TA, 2009, ALZHEIMERS DEMENT, V5, P340, DOI 10.1016/j.jalz.2009.03.002; Komatsu M, 2006, AUTOPHAGY, V2, P315, DOI 10.4161/auto.2974; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kuwahara T, 2006, J BIOL CHEM, V281, P334, DOI 10.1074/jbc.M504860200; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Liberatore GT, 1999, NAT MED, V5, P1403; Lim KL, 2009, BBA-MOL BASIS DIS, V1792, P604, DOI 10.1016/j.bbadis.2008.10.005; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; MOORE DJ, 2006, SCI AGING KNOWLEDGE, pPE2; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Nuber S, 2008, J NEUROSCI, V28, P2471, DOI 10.1523/JNEUROSCI.3040-07.2008; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; PALLANCK LJ, 2007, PARKINSONS DIS GENET, P287; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pesah Y, 2005, GENESIS, V41, P154, DOI 10.1002/gene.20106; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramsey CP, 2010, HUM MOL GENET, V19, P1425, DOI 10.1093/hmg/ddq017; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Singleton AB, 2005, TRENDS NEUROSCI, V28, P416, DOI 10.1016/j.tins.2005.05.009; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Sutherland GT, 2009, MOVEMENT DISORD, V24, P833, DOI 10.1002/mds.22214; Tanaka K, 2001, J MOL MED, V79, P482, DOI 10.1007/s001090100242; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Thomas B, 2007, NEUROBIOL DIS, V26, P312, DOI 10.1016/j.nbd.2006.12.021; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; von Coelln R, 2006, J NEUROSCI, V26, P3685, DOI 10.1523/JNEUROSCI.0414-06.2006; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Wang C, 2007, J NEUROSCI, V27, P8563, DOI 10.1523/JNEUROSCI.0218-07.2007; Wang DL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-3; Wang LX, 2008, NEUROREPORT, V19, P873, DOI 10.1097/WNR.0b013e3282ffda5e; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West A.B., 2007, PARK DIS GENET PATHO, V25, P199, DOI [10.3109/9781420019223-17, DOI 10.3109/9781420019223-17]; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4; WONG G, 2007, PARKINSONS DIS GENET, P311; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	161	542	562	6	173	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 10	2010	66	5					646	661		10.1016/j.neuron.2010.04.034	http://dx.doi.org/10.1016/j.neuron.2010.04.034			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	612YL	20547124	Green Accepted, Bronze			2022-12-17	WOS:000278941900006
J	LIN, DM; GOODMAN, CS				LIN, DM; GOODMAN, CS			ECTOPIC AND INCREASED EXPRESSION OF FASCICLIN-II ALTERS MOTONEURON GROWTH CONE GUIDANCE	NEURON			English	Article							CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; GENE FUSHI-TARAZU; IMMUNOGLOBULIN SUPERFAMILY; DROSOPHILA-MELANOGASTER; NEURONAL RECOGNITION; PATHWAY SELECTION; MOTO-NEURONS; CHICK-EMBRYO; SPECIFICITY	We used the enhancer detection/GAL4 system in Drosophila to direct increased levels of Fasciclin II (Fas II) expression on motoneuron growth cones and axons and to direct ectopic Fas II expression on other cells they encounter. Four classes of abnormal phenotypes are observed: ''bypass'' phenotypes, in which axons fail to defasciculate at the choice point where they would normally enter their muscle target region and instead extend past their target; ''detour'' phenotypes, in which these bypass growth cones enter their muscle target region at a different location; ''stall'' phenotypes, in which axons that enter their muscle target region fail to defasciculate from one another to probe their muscle targets; and ''misroute'' phenotypes, in which growth cones are diverted onto abnormal pathways by contact with Fas II-positive cells. These phenotypes show that changes in the pattern and level of Fas II expression can alter growth cone guidance, apparently in part by modulating the ability of these growth cones to respond to other guidance cues.			LIN, DM (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07232] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1993, DEVELOPMENT, P227; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; EDELMAN GM, 1983, COLD SPRING HARB SYM, V48, P515, DOI 10.1101/SQB.1983.048.01.056; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HARTENSTEIN V, 1992, ROUX ARCH DEV BIOL, V201, P194, DOI 10.1007/BF00188752; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manning Gerards, 1993, P609; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PETER N, 1994, J NEUROSCI, V14, P1413, DOI 10.1523/JNEUROSCI.14-03-01413.1994; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rutishauser U, 1993, Curr Opin Neurobiol, V3, P709, DOI 10.1016/0959-4388(93)90142-L; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Tessier-Lavigne M, 1992, Curr Opin Neurobiol, V2, P60, DOI 10.1016/0959-4388(92)90163-F; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TOSNEY KW, 1984, J NEUROSCI, V4, P2518; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5	44	542	545	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					507	523		10.1016/0896-6273(94)90022-1	http://dx.doi.org/10.1016/0896-6273(94)90022-1			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917288				2022-12-17	WOS:A1994PJ28400002
J	KOSIK, KS; ORECCHIO, LD; BAKALIS, S; NEVE, RL				KOSIK, KS; ORECCHIO, LD; BAKALIS, S; NEVE, RL			DEVELOPMENTALLY REGULATED EXPRESSION OF SPECIFIC TAU SEQUENCES	NEURON			English	Article									BRIGHAM & WOMENS HOSP,DEPT MED,DIV NEUROL,CTR NEUROL DIS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DIV GENET,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	KOSIK, KS (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROL NEUROSCI,BOSTON,MA 02115, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006601, R01AG006172] Funding Source: NIH RePORTER; NIA NIH HHS [AG06172, AG06601] Funding Source: Medline; NICHD NIH HHS [P30-HD18655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AIZAWA H, 1988, J BIOL CHEM, V263, P7703; ARENDT T, 1986, NEUROSCIENCE, V19, P1265, DOI 10.1016/0306-4522(86)90141-7; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; BAUDIER J, 1987, J BIOL CHEM, V262, P17577; BENGUR AR, 1987, J BIOL CHEM, V262, P7613; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; DRUBIN DG, 1984, J CELL BIOL, V98, P1090, DOI 10.1083/jcb.98.3.1090; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRER I, 1983, ACTA NEUROPATHOL, V59, P167, DOI 10.1007/BF00703200; FRANCON J, 1982, EUR J BIOCHEM, V129, P465, DOI 10.1111/j.1432-1033.1982.tb07072.x; GEDDES JW, 1985, SCIENCE, V230, P1179, DOI 10.1126/science.4071042; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; JAMESON L, 1980, BIOCHEMISTRY-US, V19, P2472, DOI 10.1021/bi00552a027; JAMESON L, 1981, P NATL ACAD SCI-BIOL, V78, P3413, DOI 10.1073/pnas.78.6.3413; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1987, J NEUROSCI, V7, P3142; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KOSIK KS, 1988, NEURON, V1, P127, DOI 10.1016/0896-6273(88)90196-1; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; MCKEE AC, 1989, IN PRESS ANN NEUROL; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; ORDAHL CP, 1983, NATURE, V303, P348, DOI 10.1038/303348a0; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; PROBST A, 1983, BRAIN RES, V268, P249, DOI 10.1016/0006-8993(83)90490-0; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHEIBEL AB, 1978, EXP NEUROL, V60, P1, DOI 10.1016/0014-4886(78)90164-4; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TYTELL M, 1984, P NATL ACAD SCI-BIOL, V81, P1570, DOI 10.1073/pnas.81.5.1570; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; YAMAMOTO H, 1983, J NEUROCHEM, V41, P1119, DOI 10.1111/j.1471-4159.1983.tb09060.x; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	40	542	557	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1989	2	4					1389	1397		10.1016/0896-6273(89)90077-9	http://dx.doi.org/10.1016/0896-6273(89)90077-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	U2744	2560640				2022-12-17	WOS:A1989U274400012
J	Critchley, HD; Harrison, NA				Critchley, Hugo D.; Harrison, Neil A.			Visceral Influences on Brain and Behavior	NEURON			English	Review							AUTONOMIC NERVOUS-SYSTEM; CEREBRAL-BLOOD-FLOW; AREA POSTREMA; PHYSIOLOGICAL CONDITION; EMOTIONAL APPRAISAL; DECLARATIVE MEMORY; SYMPATHETIC-NERVES; CENTRAL MECHANISMS; PREFRONTAL CORTEX; LAMINA TERMINALIS	Mental processes and their neural substrates are intimately linked to the homeostatic control of internal bodily state. There are a set of distinct interoceptive pathways that directly and indirectly influence brain functions. The anatomical organization of these pathways and the psychological/behavioral expressions of their influence appear along discrete, evolutionarily conserved dimensions that are tractable to a mechanistic understanding. Here, we review the role of these pathways as sources of biases to perception, cognition, emotion, and behavior and arguably the dynamic basis to the concept of self.	[Critchley, Hugo D.; Harrison, Neil A.] Brighton & Sussex Med Sch, Brighton BN1 9RR, E Sussex, England; [Critchley, Hugo D.; Harrison, Neil A.] Millview Hosp, Sussex Educ Ctr, Sussex Partnership NHS Fdn Trust, Hove BN3 7HZ, England; [Critchley, Hugo D.; Harrison, Neil A.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton BN1 9PX, E Sussex, England	University of Brighton; University of Sussex; University of Sussex	Critchley, HD (corresponding author), Brighton & Sussex Med Sch, Brighton BN1 9RR, E Sussex, England.	h.critchley@bsms.ac.uk	critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Harrison, Neil/0000-0002-9584-3769	Wellcome Trust; Dr. Mortimer and Theresa Sackler Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Dr. Mortimer and Theresa Sackler Foundation	N.A.H. is funded by the Wellcome Trust. N.A.H. and H.D.C. are faculty within the Sackler Centre for Consciousness Science, University of Sussex, supported by the Dr. Mortimer and Theresa Sackler Foundation. Help with the manuscript and figures from Dr. S. Garfinkel and with earlier drafts from Dr. M. Gray is gratefully acknowledged.	ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; Benedict C, 2009, FASEB J, V23, P3629, DOI 10.1096/fj.08-122853; Beyak MJ, 2010, AUTON NEUROSCI-BASIC, V153, P69, DOI 10.1016/j.autneu.2009.07.019; Blessing WW, 1997, LOWER BRAINSTEM BODI; BORISON HL, 1953, PHARMACOL REV, V5, P193; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Bryclon L, 2008, BIOL PSYCHIAT, V63, P1022, DOI 10.1016/j.biopsych.2007.12.007; BUSIJA DW, 1984, AM J PHYSIOL, V247, pH446, DOI 10.1152/ajpheart.1984.247.3.H446; BUTLER G, 1983, ADV BEHAV RES THER, V5, P51, DOI 10.1016/0146-6402(83)90015-2; Cacioppo JT, 2000, HDB EMOTIONS, V2, P173, DOI DOI 10.1017/CBO9780511546396.025; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cannon W.B., 1927, BODILY CHANGES PAIN; Cantril H, 1932, AM J PSYCHOL, V44, P300, DOI 10.2307/1414829; Chauhan B, 2008, AUTON NEUROSCI-BASIC, V140, P96, DOI 10.1016/j.autneu.2008.03.005; Ciura S, 2011, J NEUROSCI, V31, P14669, DOI 10.1523/JNEUROSCI.1420-11.2011; Corfield DR, 1995, ADV EXP MED BIOL, V393, P331; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Critchley HD, 2007, PSYCHOSOM MED, V69, P17, DOI 10.1097/PSY.0b013e31802e106d; Critchley HD, 2011, AUTON NEUROSCI-BASIC, V161, P34, DOI 10.1016/j.autneu.2010.09.005; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; CUNNINGHAM ET, 1994, NEUROSCIENCE, V58, P635, DOI 10.1016/0306-4522(94)90087-6; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A.R., 1999, FEELING WHAT HAPPENS; Damasio A.R., 2010, SELF COMES MIND CONS; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMPNEY RAL, 2001, P AUST PHYSL PHARM S, V32, P1; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Darwin C., 1872, P374; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Loarte MD, 2009, J NEUROL, V256, P127, DOI 10.1007/s00415-009-0821-6; DEPABLO ALL, 1982, J APPL PHYSIOL, V53, P873, DOI 10.1152/jappl.1982.53.4.873; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Donadio V, 2002, J PHYSIOL-LONDON, V544, P285, DOI 10.1113/jphysiol.2002.019596; Donadio V, 2007, BRAIN, V130, P1653, DOI 10.1093/brain/awm037; DUNN LT, 1988, BEHAV NEUROSCI, V102, P3, DOI 10.1037/0735-7044.102.1.3; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Edwards L, 2003, PSYCHOPHYSIOLOGY, V40, P762, DOI 10.1111/1469-8986.00076; Eickhoff SB, 2006, NEUROIMAGE, V31, P1004, DOI 10.1016/j.neuroimage.2006.01.023; Eisenberger NI, 2010, BIOL PSYCHIAT, V68, P748, DOI 10.1016/j.biopsych.2010.06.010; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; ELAM M, 1984, BRAIN RES, V290, P281, DOI 10.1016/0006-8993(84)90945-4; Evrard HC, 2012, NEURON, V74, P482, DOI 10.1016/j.neuron.2012.03.003; Frith C, 2012, CONSCIOUS COGN, V21, P52, DOI 10.1016/j.concog.2011.06.010; Fukushima H, 2011, INT J PSYCHOPHYSIOL, V79, P259, DOI 10.1016/j.ijpsycho.2010.10.015; Gendron M, 2009, EMOT REV, V1, P316, DOI 10.1177/1754073909338877; Gianaros PJ, 2012, HUM BRAIN MAPP, V33, P1700, DOI 10.1002/hbm.21315; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Golanov EV, 2001, J NEUROSCI, V21, P4032, DOI 10.1523/JNEUROSCI.21-11-04032.2001; Gray MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000546; Gray MA, 2012, EMOTION, V12, P180, DOI 10.1037/a0025083; Gray MA, 2009, J NEUROSCI, V29, P1817, DOI 10.1523/JNEUROSCI.3363-08.2009; Griffin MG, 1997, AM J PSYCHIAT, V154, P1081; Gross C., 1995, NEUROSCIENTIST, V1, P245, DOI [10.1177/107385849500100408, DOI 10.1177/107385849500100408]; GROSS PM, 1991, CAN J PHYSIOL PHARM, V69, P1010, DOI 10.1139/y91-152; Harrison NA, 2007, EMOTION, V7, P724, DOI 10.1037/1528-3542.7.4.724; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Harrison NA, 2009, BIOL PSYCHIAT, V66, P415, DOI 10.1016/j.biopsych.2009.03.007; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Heaver B, 2011, MEMORY, V19, P398, DOI 10.1080/09658211.2011.575788; Heims HC, 2006, CLIN AUTON RES, V16, P113, DOI 10.1007/s10286-006-0318-7; Het S, 2005, PSYCHONEUROENDOCRINO, V30, P771, DOI 10.1016/j.psyneuen.2005.03.005; Hindmarch CCT, 2011, EXP PHYSIOL, V96, P495, DOI 10.1113/expphysiol.2010.056515; Hobday DI, 2001, BRAIN, V124, P361, DOI 10.1093/brain/124.2.361; Hollis JH, 2008, AM J PHYSIOL-REG I, V294, pR1390, DOI 10.1152/ajpregu.00869.2007; James W., 1890, EMOTIONS; James W, 1894, PSYCHOL REV, V1, P516, DOI [10.1037/h0065078, DOI 10.1037/H0065078]; KAADA B R, 1951, Acta Physiol Scand Suppl, V24, P1; Kanoski SE, 2010, J EXP PSYCHOL-ANIM B, V36, P313, DOI 10.1037/a0017228; Karnani M, 2011, AM J PHYSIOL-REG I, V300, pR47, DOI 10.1152/ajpregu.00527.2010; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; King AB, 1999, J COMP NEUROL, V413, P572; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Lange C, 1885, EMOTIONS; Latalova K, 2010, NEUROENDOCRINOL LETT, V31, P829; Luheshi GN, 2000, AUTON NEUROSCI-BASIC, V85, P127, DOI 10.1016/S1566-0702(00)00231-9; MANDLER G, 1958, J ABNORM SOC PSYCH, V56, P367, DOI 10.1037/h0048083; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; Mazda T, 2004, AM J PHYSIOL-GASTR L, V287, pG228, DOI 10.1152/ajpgi.00373.2003; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Morgan HL, 2011, BIOL PSYCHIAT, V69, P35, DOI 10.1016/j.biopsych.2010.07.032; Morris AL, 2008, CONSCIOUS COGN, V17, P1378, DOI 10.1016/j.concog.2008.04.005; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Nicotra A, 2006, BRAIN, V129, P718, DOI 10.1093/brain/awh699; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson HW, 2008, NEUROSCI LETT, V436, P128, DOI 10.1016/j.neulet.2008.03.015; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; Panksepp J, 2004, AFFECTIVE NEUROSCIEN; Paton JFR, 1999, NEUROSCIENCE, V93, P143, DOI 10.1016/S0306-4522(99)00098-6; Paton JFR, 2001, J PHYSIOL-LONDON, V531, P445, DOI 10.1111/j.1469-7793.2001.0445i.x; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Peled A, 2000, BIOL PSYCHIAT, V48, P1105, DOI 10.1016/S0006-3223(00)00947-1; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2008, COGNITION EMOTION, V22, P272, DOI 10.1080/02699930701357535; Powley TL, 2004, PHYSIOL BEHAV, V82, P69, DOI 10.1016/j.physbeh.2004.04.037; Price CJ, 2008, NEUROSCIENTIST, V14, P182, DOI 10.1177/1073858407311100; Rabchevsky AG, 2006, PROG BRAIN RES, V152, P265, DOI 10.1016/S0079-6123(05)52017-X; Ramirez JM, 2003, ANN NY ACAD SCI, V1000, P293, DOI 10.1196/annals.1280.028; REID IA, 1992, AM J PHYSIOL, V262, pE763, DOI 10.1152/ajpendo.1992.262.6.E763; Reis D.J., 2006, ANN NY ACAD SCI, V835, P168; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; Ritter RC, 2004, PHYSIOL BEHAV, V81, P249, DOI 10.1016/j.physbeh.2004.02.012; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; RODGERS W, 1966, J COMP PHYSIOL PSYCH, V61, P1, DOI 10.1037/h0022864; Rolls ET, 2011, INT J OBESITY, V35, P550, DOI 10.1038/ijo.2010.155; Ryan JP, 2012, PSYCHOSOM MED, V74, P476, DOI 10.1097/PSY.0b013e31824d0865; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; SATO A, 1992, NEUROSCI RES, V14, P242, DOI 10.1016/0168-0102(92)90071-J; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Schultz W., 2010, F1000 BIOL REP; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; SHAPIRO RE, 1985, J COMP NEUROL, V234, P344, DOI 10.1002/cne.902340306; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Smith PM, 2010, AM J PHYSIOL-REG I, V299, pR405, DOI 10.1152/ajpregu.00103.2010; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Tindell AJ, 2009, J NEUROSCI, V29, P12220, DOI 10.1523/JNEUROSCI.2499-09.2009; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; TSUBOKAWA T, 1980, BRAIN RES, V190, P51, DOI 10.1016/0006-8993(80)91159-2; van Stegeren AH, 1998, PSYCHOPHARMACOLOGY, V138, P305, DOI 10.1007/s002130050675; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; Wallin BG, 2007, ACTA PHYSIOL, V190, P265, DOI 10.1111/j.1748-1716.2007.01730.x; Weinreich D, 1997, J NEUROSCI, V17, P7683; Werner NS, 2010, BIOL PSYCHOL, V85, P370, DOI 10.1016/j.biopsycho.2010.08.008; WHITEHEAD WE, 1977, BIOFEEDBACK SELF-REG, V2, P371, DOI 10.1007/BF00998623; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	142	541	542	3	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2013	77	4					624	638		10.1016/j.neuron.2013.02.008	http://dx.doi.org/10.1016/j.neuron.2013.02.008			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439117	Bronze			2022-12-17	WOS:000315561300006
J	Peineau, S; Taghibiglou, C; Bradley, C; Wong, TP; Liu, LD; Lu, J; Lo, E; Wu, DC; Saule, E; Bouschet, T; Matthews, P; Isaac, JTR; Bortolotto, ZA; Wang, YT; Collingridge, GL				Peineau, Stephane; Taghibiglou, Changiz; Bradley, Clarrisa; Wong, Tak Pan; Liu, Lidong; Lu, Jie; Lo, Edmond; Wu, Dongchuan; Saule, Emilia; Bouschet, Tristan; Matthews, Paul; Isaac, John T. R.; Bortolotto, Zuner A.; Wang, Yu Tian; Collingridge, Graham L.			UP inhibits LTD in the hippocampus via regulation of GSK3 beta	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3; LONG-TERM DEPRESSION; PROTEIN-KINASE; TAU-PROTEIN; RECEPTOR TRAFFICKING; NMDA RECEPTORS; AREA CA1; EXPRESSION; INDUCTION; PHOSPHORYLATION	Glycogen synthase kinase-3 (GSK3) has been implicated in major neurological disorders, but its role in normal neuronal function is largely unknown. Here we show that GSK3 beta mediates an interaction between two major forms of synaptic plasticity in the brain, N-methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) and NMDA receptor-dependent long-term depression (LTD). In rat hippocampal slices, GSK3 beta inhibitors block the induction of LTD. Furthermore, the activity of GSK3 beta is enhanced during LTD via activation of PP1. Conversely, following the induction of LTP, there is inhibition of GSK3 beta activity. This regulation of GSK3 beta during LTP involves activation of NMDA receptors and the PI3K-Akt pathway and disrupts the ability of synapses to undergo LTD for up to 1 hr. We conclude that the regulation of GSK3 beta activity provides a powerful mechanism to preserve information encoded during LTP from erasure by subsequent LTD, perhaps thereby permitting the initial consolidation of learnt information.	MRC, Ctr Synapt Plast, Dept Anat, Sch Med Sci, Bristol BS8 1TD, Avon, England; Univ British Columbia, Brain Res Ctr, UBC Hosp, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, UBC Hosp, Vancouver, BC V6T 1Z3, Canada; NINDS, NIH, Bethesda, MD 20892 USA	University of Bristol; University of British Columbia; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Collingridge, GL (corresponding author), MRC, Ctr Synapt Plast, Dept Anat, Sch Med Sci, Univ Walk, Bristol BS8 1TD, Avon, England.	g.l.collingridge@bristol.ac.uk	Bouschet, Tristan/C-8265-2019; Wang, Yu Tian/A-4729-2008; Wu, Dong Chuan/O-3909-2015; Taghibiglou, Changiz/H-4590-2019; Wang, Yu Tian/J-8255-2015; Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020	Bouschet, Tristan/0000-0002-7858-6115; Collingridge, Graham L/0000-0002-9572-5359; WU, DONG CHUAN/0000-0002-9539-5935; Peineau, Stephane/0000-0002-4721-6795; Liu, Lidong/0000-0002-7026-690X; Matthews, Paul M/0000-0002-1619-8328; Wong, Tak Pan/0000-0001-8611-4911	Medical Research Council [G9532377] Funding Source: Medline; MRC [G9532377] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Anderton BH, 1999, CURR BIOL, V9, pR106, DOI 10.1016/S0960-9822(99)80062-1; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beasley C, 2001, NEUROSCI LETT, V302, P117, DOI 10.1016/S0304-3940(01)01688-3; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kirschenbaum F, 2001, J BIOL CHEM, V276, P30701, DOI 10.1074/jbc.M102849200; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kozlovsky N, 2002, EUR NEUROPSYCHOPHARM, V12, P13, DOI 10.1016/S0924-977X(01)00131-6; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li BL, 2003, J CELL BIOCHEM, V90, P1224, DOI 10.1002/jcb.10674; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Takahashi M, 2000, BRAIN RES, V857, P193, DOI 10.1016/S0006-8993(99)02424-5; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	65	541	558	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					703	717		10.1016/j.neuron.2007.01.029	http://dx.doi.org/10.1016/j.neuron.2007.01.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329210	Bronze, Green Submitted			2022-12-17	WOS:000245127100011
J	Tootell, RBH; Hadjikhani, N; Hall, EK; Marrett, S; Vanduffel, W; Vaughan, JT; Dale, AM				Tootell, RBH; Hadjikhani, N; Hall, EK; Marrett, S; Vanduffel, W; Vaughan, JT; Dale, AM			The retinotopy of visual spatial attention	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; SELECTIVE ATTENTION; NEURAL MECHANISMS; CEREBRAL-CORTEX; HUMAN BRAIN; VISUOSPATIAL ATTENTION; EXTRASTRIATE CORTEX; FUNCTIONAL-ANALYSIS; BLOOD-FLOW; AREAS V1	We used high-field (3T) functional magnetic resonance imaging (fMRI) to label cortical activity due to visual spatial attention, relative to flattened cortical maps of the retinotopy and visual areas from the same human subjects. In the main task, the visual stimulus remained constant, but covert visual spatial attention was varied in both location and load. In each of the extrastriate retinotopic areas, we found MR increases at the representations of the attended target. Similar but smaller increases were found in V1. Decreased MR levels were found in the same cortical locations when attention was directed at retinotopically different locations. In and surrounding area MT+, MR increases were lateralized but not otherwise retinotopic. At the representation of eccentricities central to that of the attended targets, prominent MR decreases occurred during spatial attention.	Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tootell, RBH (corresponding author), Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA.	tootell@nmr.mgh.harvard.edu	Hadjikhani, Nouchine/C-2018-2008; Dale, Anders M/A-5180-2010	Hadjikhani, Nouchine/0000-0003-4075-3106; Marrett, Sean/0000-0001-8179-6511	NATIONAL EYE INSTITUTE [R01EY007980] Funding Source: NIH RePORTER; NEI NIH HHS [EY07980] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aine C J, 1995, Int J Neurosci, V80, P79, DOI 10.3109/00207459508986095; ANDERSEN RA, 1985, J COMP NEUROL, V232, P443, DOI 10.1002/cne.902320403; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; COLBY CL, 1991, J CHILD NEUROL, V6, pS90, DOI 10.1177/0883073891006001S11; Conner CE, 1997, J NEUROSCI, V17, P3201; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DREVETS WC, 1995, NATURE, V373, P249, DOI 10.1038/373249a0; DUFFY FH, 1975, BRAIN RES, V89, P121; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; ERIKSEN CW, 1973, PERCEPT PSYCHOPHYS, V14, P155, DOI 10.3758/BF03198630; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GATTASS R, 1988, J NEUROSCI, V8, P1831; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MAY JG, 1986, EXP BRAIN RES, V63, P265; McCarthy G., 1994, HUM BRAIN MAPP, V2, P234, DOI [10.1002/hbm.460020405, DOI 10.1002/HBM.460020405]; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; PAUS T, 1995, J NEUROPHYSIOL, V74, P2179, DOI 10.1152/jn.1995.74.5.2179; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; POSNER MI, 1988, MASTER LECT CLIN NEU, P00173; ROELFSEMA PR, 1998, IN PRESS NATURE; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I; WURTZ RH, 1980, PSYCHOBIOL PHYSL PSY, V9, P42; ZEKI S, 1991, J NEUROSCI, V11, P641	64	541	548	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1409	1422		10.1016/S0896-6273(00)80659-5	http://dx.doi.org/10.1016/S0896-6273(00)80659-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883733	Bronze, Green Published			2022-12-17	WOS:000077910600022
J	Nelson, SB; Valakh, V				Nelson, Sacha B.; Valakh, Vera			Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders	NEURON			English	Review							LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT REGULATION; MOUSE MODEL; FRAGILE-X; RETT-SYNDROME; SYNAPTIC PLASTICITY; ANGELMAN-SYNDROME; CORTICAL INTERNEURONS; BDNF TRANSCRIPTION; INHIBITORY INTERNEURONS	Autism spectrum disorders (ASDs) and related neurological disorders are associated with mutations in many genes affecting the ratio between neuronal excitation and inhibition. However, understanding the impact of these mutations on network activity is complicated by the plasticity of these networks, making it difficult in many cases to separate initial deficits from homeostatic compensation. Here we explore the contrasting evidence for primary defects in inhibition or excitation in ASDs and attempt to integrate the findings in terms of the brain's ability to maintain functional homeostasis.	[Nelson, Sacha B.; Valakh, Vera] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Nelson, Sacha B.; Valakh, Vera] Brandeis Univ, Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Nelson, SB (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA.	nelson@brandeis.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS079419, T32NS007292] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS079419, T32 NS007292] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; BAKKER CE, 1994, CELL, V78, P23; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Ben-Ari Yehezkel, 2008, Dialogues Clin Neurosci, V10, P17; Bena F, 2013, AM J MED GENET B, V162B, P388, DOI 10.1002/ajmg.b.32148; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Blume WT, 2006, EPILEPSIA, V47, P71, DOI 10.1111/j.1528-1167.2006.00665.x; Bolliger MF, 2008, P NATL ACAD SCI USA, V105, P6421, DOI 10.1073/pnas.0801383105; Boltor PF, 2011, BRIT J PSYCHIAT, V198, P289, DOI 10.1192/bjp.bp.109.076877; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Brennan FX, 2006, GENES BRAIN BEHAV, V5, P467, DOI 10.1111/j.1601-183X.2005.00183.x; Brunklaus A, 2012, BRAIN, V135, P2329, DOI 10.1093/brain/aws151; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Carlsson ML, 1998, J NEURAL TRANSM, V105, P525, DOI 10.1007/s007020050076; Casanova JR, 2013, EUR J NEUROSCI, V38, P3115, DOI 10.1111/ejn.12315; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Channell MM, 2015, J NEURODEV DISORD, V7, DOI 10.1186/1866-1955-7-5; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Cheval H, 2012, HUM MOL GENET, V21, P3806, DOI 10.1093/hmg/dds208; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; Crino PB, 2013, ACTA NEUROPATHOL, V125, P317, DOI 10.1007/s00401-013-1085-x; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dejanovic BL, 2014, NEUROBIOL DIS, V67, P88, DOI 10.1016/j.nbd.2014.02.001; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Dolce A, 2013, PEDIATR NEUROL, V48, P337, DOI 10.1016/j.pediatrneurol.2012.11.001; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Dutton SB, 2013, NEUROBIOL DIS, V49, P211, DOI 10.1016/j.nbd.2012.08.012; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; English CN, 2012, P NATL ACAD SCI USA, V109, P19456, DOI 10.1073/pnas.1206492109; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Evans DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093951; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Fu C, 2012, CEREB CORTEX, V22, P2111, DOI 10.1093/cercor/bhr300; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gilby KL, 2013, EPILEPSY BEHAV, V26, P370, DOI 10.1016/j.yebeh.2012.11.002; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guilmatre A, 2014, DEV NEUROBIOL, V74, P113, DOI 10.1002/dneu.22128; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hanson JE, 2007, J NEUROSCI, V27, P4014, DOI 10.1523/JNEUROSCI.4717-06.2007; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hauser WA, 2002, PROG BRAIN RES, V135, P215; Heard TT, 2014, INT J DEV NEUROSCI, V38, P155, DOI 10.1016/j.ijdevneu.2014.07.002; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; House DRC, 2011, NEURON, V72, P819, DOI 10.1016/j.neuron.2011.09.008; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Hu H, 2011, J NEUROSCI, V31, P3351, DOI 10.1523/JNEUROSCI.4881-10.2011; Ito S, 2013, NEUROBIOL DIS, V49, P29, DOI 10.1016/j.nbd.2012.08.003; Jackman C, 2009, PEDIATR NEUROL, V40, P310, DOI 10.1016/j.pediatrneurol.2008.10.013; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jiang MH, 2013, J NEUROSCI, V33, P19518, DOI 10.1523/JNEUROSCI.1745-13.2013; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; Kaphzan H, 2012, BIOL PSYCHIAT, V72, P182, DOI 10.1016/j.biopsych.2012.01.021; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Kasnauskiene J, 2013, AM J MED GENET A, V161A, P1487, DOI 10.1002/ajmg.a.35911; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kim S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001900; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Laan LAEM, 2005, BRAIN DEV-JPN, V27, P80, DOI 10.1016/j.braindev.2003.09.013; LaSarge CL, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00018, 10.3389/fnmol.2014.00018]; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Leekam SR, 2011, PSYCHOL BULL, V137, P562, DOI 10.1037/a0023341; Lesca G, 2012, EPILEPSIA, V53, P1526, DOI 10.1111/j.1528-1167.2012.03559.x; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li KX, 2012, NAT NEUROSCI, V15, P267, DOI 10.1038/nn.3006; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lionel AC, 2013, HUM MOL GENET, V22, P2055, DOI 10.1093/hmg/ddt056; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lozano R, 2014, NEUROPSYCH DIS TREAT, V10, P1769, DOI 10.2147/NDT.S42919; Lozovaya N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5563; Lux AL, 2006, EPILEPSY RES, V70, pS77, DOI 10.1016/j.eplepsyres.2006.01.017; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Marsh E, 2009, BRAIN, V132, P1563, DOI 10.1093/brain/awp107; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; McNamara J.O., 2012, JASPERS BASIC MECH E; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Na ES, 2012, J NEUROSCI, V32, P3109, DOI 10.1523/JNEUROSCI.6000-11.2012; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Noutel J, 2011, NEURON, V70, P35, DOI 10.1016/j.neuron.2011.03.001; Numis AL, 2011, NEUROLOGY, V76, P981, DOI 10.1212/WNL.0b013e3182104347; Oakley JC, 2011, EPILEPSIA, V52, P59, DOI 10.1111/j.1528-1167.2011.03004.x; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Olivetti PR, 2012, CURR OPIN NEUROBIOL, V22, P859, DOI 10.1016/j.conb.2012.04.006; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Patel AB, 2013, J NEUROSCI, V33, P2593, DOI 10.1523/JNEUROSCI.2447-12.2013; Penagarikano O, 2012, TRENDS MOL MED, V18, P156, DOI 10.1016/j.molmed.2012.01.003; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Petazzi P, 2014, NEUROBIOL DIS, V67, P49, DOI 10.1016/j.nbd.2014.03.009; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Qiu ZL, 2012, J NEUROSCI, V32, P989, DOI 10.1523/JNEUROSCI.0175-11.2012; Rabaneda LG, 2014, CELL REP, V8, P337, DOI 10.1016/j.celrep.2014.06.022; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rico B, 2011, CURR OPIN GENET DEV, V21, P262, DOI 10.1016/j.gde.2010.12.010; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubinstein M, 2015, NEUROBIOL DIS, V73, P106, DOI 10.1016/j.nbd.2014.09.017; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Samaco RC, 2011, J NEUROSCI, V31, P7951, DOI 10.1523/JNEUROSCI.0169-11.2011; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schwartzkroin PA, 2012, EPILEPSIA, V53, P35, DOI 10.1111/j.1528-1167.2012.03473.x; Shoubridge C, 2010, HUM MUTAT, V31, P889, DOI 10.1002/humu.21288; Soden ME, 2010, J NEUROSCI, V30, P16910, DOI 10.1523/JNEUROSCI.3660-10.2010; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tai C, 2014, P NATL ACAD SCI USA, V111, pE3139, DOI 10.1073/pnas.1411131111; Tan GH, 2012, NAT NEUROSCI, V15, P258, DOI 10.1038/nn.3005; Tanaka M., 2012, JASPERS BASIC MECH E; Thalhammer A, 2014, NEUROPHARMACOLOGY, V78, P23, DOI 10.1016/j.neuropharm.2013.03.015; Thibert RL, 2013, PEDIATR NEUROL, V48, P271, DOI 10.1016/j.pediatrneurol.2012.09.015; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; Valente KD, 2006, ARCH NEUROL-CHICAGO, V63, P122, DOI 10.1001/archneur.63.1.122; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Wang GX, 2008, J NEUROSCI, V28, P11959, DOI 10.1523/JNEUROSCI.3296-08.2008; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Wondolowski J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00223; Woo NH, 2006, NEUROSCIENTIST, V12, P43, DOI 10.1177/1073858405284360; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yang JM, 2013, J NEUROSCI, V33, P19724, DOI 10.1523/JNEUROSCI.1584-13.2013; Yang XF, 2014, PROTEIN CELL, V5, P420, DOI 10.1007/s13238-014-0054-z; Zhang W, 2014, J NEUROSCI, V34, P2754, DOI 10.1523/JNEUROSCI.4900-12.2014; Zhong XF, 2012, J NEUROSCI, V32, P12841, DOI 10.1523/JNEUROSCI.2784-12.2012; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	196	540	549	10	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2015	87	4					684	698		10.1016/j.neuron.2015.07.033	http://dx.doi.org/10.1016/j.neuron.2015.07.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR2GW	26291155	Bronze, Green Accepted			2022-12-17	WOS:000361145600005
J	Izuma, K; Saito, DN; Sadato, N				Izuma, Keise; Saito, Daisuke N.; Sadato, Norihiro			Processing of social and monetary rewards in the human striatum	NEURON			English	Article							EVENT-RELATED FMRI; NEURAL BASIS; ORBITOFRONTAL CORTEX; PREDICTION ERRORS; DECISION-MAKING; MUSIC CORRELATE; BRAIN-REGIONS; RESPONSES; DOPAMINE; SELF	Despite an increasing focus on the neural basis of human decision making in neuroscience, relatively little attention has been paid to decision making in social settings. Moreover, although human social decision making has been explored in a social psychology context, few neural explanations for the observed findings have been considered. To bridge this gap and improve models of human social decision making, we investigated whether acquiring a good reputation, which is an important incentive in human social behaviors, activates the same reward circuitry as monetary rewards. In total, 19 subjects participated in functional magnetic resonance imaging (fMRI) experiments involving monetary and social rewards. The acquisition of one's good reputation robustly activated reward-related brain areas, notably the striatum, and these overlapped with the areas activated by monetary rewards. Our findings support the idea of a "common neural currency" for rewards and represent an important first step toward a neural explanation for complex human social behaviors.	[Izuma, Keise; Saito, Daisuke N.; Sadato, Norihiro] Natl Inst Physiol Sci, Dept Cerebral Res, Div Cerebral Integrat, Aichi, Japan; [Izuma, Keise; Sadato, Norihiro] Grad Univ Adv Studies, Dept Physiol Sci, Sch Life Sci, Kanagawa, Japan; [Saito, Daisuke N.; Sadato, Norihiro] Japan Sci & Technol Agcy, Res Inst Sci & Technol Soc RISTEX, Tokyo, Japan; [Sadato, Norihiro] Univ Fukui, BIRC, Fukui 910, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); University of Fukui	Sadato, N (corresponding author), Natl Inst Physiol Sci, Dept Cerebral Res, Div Cerebral Integrat, Aichi, Japan.	sadato@nips.ac.jp	sarinopoulos, isidoros/B-5453-2010	Sadato, Norihiro/0000-0002-9786-3907				Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Bandura A., 1977, SOCIAL LEARNING THEO; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Costa Jr P. T., 1989, NEO PI FFI MANUAL S; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Hamann S, 2002, NEUROREPORT, V13, P15, DOI 10.1097/00001756-200201210-00008; HOMANS GC, 1958, AM J SOCIOL, V63, P597, DOI 10.1086/222355; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Kwan VSY, 2004, PSYCHOL REV, V111, P94, DOI 10.1037/0033-295X.111.1.94; Lawler EJ, 1999, ANNU REV SOCIOL, V25, P217, DOI 10.1146/annurev.soc.25.1.217; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; ROSENGERG M, 1965, SOC ADOLESCENT SELF; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Thibaut J.W., 1959, SOCIAL PSYCHOL GROUP; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004	76	540	557	2	109	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 24	2008	58	2					284	294		10.1016/j.neuron.2008.03.020	http://dx.doi.org/10.1016/j.neuron.2008.03.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439412	Bronze			2022-12-17	WOS:000255303100015
J	Chowdhury, S; Shepherd, JD; Okuno, H; Lyford, G; Petralia, RS; Plath, N; Kuhl, D; Huganir, RL; Worley, PF				Chowdhury, Shoaib; Shepherd, Jason D.; Okuno, Hiroyuki; Lyford, Gregory; Petralia, Ronald S.; Plath, Niels; Kuhl, Dietmar; Huganir, Richard L.; Worley, Paul F.			Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking	NEURON			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE ENDOCYTOSIS; METABOTROPIC GLUTAMATE RECEPTORS; DOMAIN-CONTAINING PROTEIN; SH3 DOMAIN; DEPENDENT ENDOCYTOSIS; HIPPOCAMPAL-NEURONS; CULTURED NEURONS	Arc/Arg3.1 is an immediate-early gene whose mRNA is rapidly transcribed and targeted to dendrites of neurons as they engage in information processing and storage. Moreover, Arc/Arg3.1 is known to be required for durable forms of synaptic plasticity and learning. Despite these intriguing links to plasticity, Arc/Arg3.1's molecular function remains enigmatic. Here, we demonstrate that Arc/Arg3.1 protein interacts with dynamin and specific isoforms of endophilin to enhance receptor endocytosis. Arc/Arg3.1 selectively modulates trafficking of AMPA-type glutamate receptors (AMPARs) in neurons by accelerating endocytosis and reducing surface expression. The Arc/Arg3.1-endocytosis pathway appears to regulate basal AMPAR levels since Arc/Arg3.1 KO neurons exhibit markedly reduced endocytosis and increased steady-state surface levels. These findings reveal a novel molecular pathway that is regulated by Arc/Arg3.1 and likely contributes to late-phase synaptic plasticity and memory consolidation.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Free University of Berlin	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	Shepherd, Jason/N-8555-2018; Kuhl, Dietmar/A-4689-2009	Shepherd, Jason/0000-0001-7384-8289; Kuhl, Dietmar/0000-0002-4772-6701; OKUNO, HIROYUKI/0000-0001-6237-6503	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830, R01MH053608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIMH NIH HHS [P50 MH068830, R01 MH053608] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barik Sailen, 2002, Methods Mol Biol, V192, P189, DOI 10.1385/1-59259-177-9:189; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bock J, 2005, NEUROSCIENCE, V133, P625, DOI 10.1016/j.neuroscience.2005.02.048; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Darstein M, 2003, J NEUROSCI, V23, P8013; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuoka M, 2003, BRAIN RES, V975, P189, DOI 10.1016/S0006-8993(03)02634-9; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; OTANI S, 1989, NEUROSCI LETT, V106, P175, DOI 10.1016/0304-3940(89)90222-X; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tsui CC, 1996, J NEUROSCI, V16, P2463; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	78	540	564	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					445	459		10.1016/j.neuron.2006.08.033	http://dx.doi.org/10.1016/j.neuron.2006.08.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088211	Green Accepted, Bronze			2022-12-17	WOS:000242269700008
J	Wang, SL; Sdrulla, AD; diSibio, G; Bush, G; Nofziger, D; Hicks, C; Weinmaster, G; Barres, BA				Wang, SL; Sdrulla, AD; diSibio, G; Bush, G; Nofziger, D; Hicks, C; Weinmaster, G; Barres, BA			Notch receptor activation inhibits oligodendrocyte differentiation	NEURON			English	Article							RAT OPTIC-NERVE; GLIAL PROGENITOR-CELL; RETINAL GANGLION-CELLS; DROSOPHILA-MELANOGASTER; MONOCLONAL-ANTIBODY; NEUROGENESIS; PROTEIN; ASTROCYTE; GENE; EXPRESSION	In this study, we show that oligodendrocyte differentiation is powerfully inhibited by activation of the Notch pathway. Oligodendrocytes and their precursors in the developing rat optic nerve express Notch1 receptors and, at the same time, retinal ganglion cells express Jagged1, a ligand of the Notch1 receptor, along their axons. Jagged1 expression is developmentally regulated, decreasing with a time course that parallels myelination in the optic nerve. These results suggest that the timing of oligodendrocyte differentiation and myelination is controlled by the Notch pathway and raise the; question of whether localization of myelination is controlled by this pathway.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.				NEI NIH HHS [R29 EY10257] Funding Source: Medline; NINDS NIH HHS [NS31885] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY010257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031885, R01NS031885] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahlgren SC, 1997, MOL CELL NEUROSCI, V9, P420, DOI 10.1006/mcne.1997.0631; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Bao ZZ, 1997, J NEUROSCI, V17, P1425; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BARTLETT PF, 1981, BRAIN RES, V204, P339, DOI 10.1016/0006-8993(81)90593-X; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; Fitzgerald K, 1995, DEVELOPMENT, V121, P4275; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; FORTINI ME, 1993, CELL, V75, P1245, DOI 10.1016/0092-8674(93)90611-S; FRIEDE RL, 1973, ACTA NEUROPATHOL, V23, P48, DOI 10.1007/BF00689004; FULTON BP, 1991, ANN NY ACAD SCI, V633, P27; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; KONIETZKO U, 1994, HIPPOCAMPUS, V4, P297, DOI 10.1002/hipo.450040313; KOPAN R, 1994, DEVELOPMENT, V120, P2385; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; MATHESON D F, 1970, Brain Research, V24, P257, DOI 10.1016/0006-8993(70)90105-8; MATHESON D F, 1970, Brain Research, V24, P271, DOI 10.1016/0006-8993(70)90106-X; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; Millot C., 1984, GEO-MARINE LETT, V4, P13, DOI DOI 10.1007/BF02237968; Muskavitch M.A.T., 1990, Current Topics in Developmental Biology, V24, P289, DOI 10.1016/S0070-2153(08)60091-5; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; NYE JS, 1994, DEVELOPMENT, V120, P2421; Ono K, 1997, NEURON, V19, P283, DOI 10.1016/S0896-6273(00)80939-3; Peters A, 1991, FINE STRUCTURE NERVO; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAFF MC, 1983, COLD SPRING HARB SYM, V48, P569, DOI 10.1101/SQB.1983.048.01.061; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; Richardson WD, 1990, SEMIN NEUROSCI, V2, P445; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Sanchez I, 1996, J NEUROSCI, V16, P5095; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shi JY, 1998, J NEUROSCI, V18, P4627; SKOFF RP, 1980, J COMP NEUROL, V191, P237, DOI 10.1002/cne.901910207; SKOFF RP, 1990, ANN NY ACAD SCI, V605, P122; SKOFF RP, 1978, NEUROSCI LETT, V7, P191, DOI 10.1016/0304-3940(78)90166-0; SKOFF RP, 1976, J COMP NEUROL, V169, P313, DOI 10.1002/cne.901690304; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387	68	540	560	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					63	75		10.1016/S0896-6273(00)80515-2	http://dx.doi.org/10.1016/S0896-6273(00)80515-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697852	Bronze			2022-12-17	WOS:000075061900007
J	Courchesne, E; Pierce, K; Schumann, CM; Redcay, E; Buckwalter, JA; Kennedy, DP; Morgan, J				Courchesne, Eric; Pierce, Karen; Schumann, Cynthia M.; Redcay, Elizabeth; Buckwalter, Joseph A.; Kennedy, Daniel P.; Morgan, John			Mapping early brain development in autism	NEURON			English	Review							MIRROR NEURON SYSTEM; HIGH-FUNCTIONING AUTISM; CORPUS-CALLOSUM; SPECTRUM DISORDER; HEAD CIRCUMFERENCE; YOUNG-CHILDREN; ASPERGER-SYNDROME; INFANTILE-AUTISM; FRONTAL-CORTEX; SENTENCE COMPREHENSION	Although the neurobiology of autism has been studied for more than two decades, the majority of these studies have examined brain structure 10, 20, or more years after the onset of clinical symptoms. The pathological biology that causes autism remains unknown, but its signature is likely to be most evident during the first years of life when clinical symptoms are emerging. This review highlights neurobiological findings during the first years of life and emphasizes early brain overgrowth as a key factor in the pathobiology of autism. We speculate that excess neuron numbers may be one possible cause of early brain overgrowth and produce defects in neural patterning and wiring, with exuberant local and short-distance cortical interactions impeding the function of large-scale, long-distance interactions between brain regions. Because large-scale networks underlie socio-emotional and communication functions, such alterations in brain architecture could relate to the early clinical manifestations of autism. As such, autism may additionally provide unique insight into genetic and developmental processes that shape early neural wiring patterns and make possible higher-order social, emotional, and communication functions.	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Autism Ctr Excellence, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Courchesne, E (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.	ecourchesne@ucsd.edu	Redcay, Elizabeth/C-7818-2011	Buckwalter, Joseph/0000-0001-9758-7255; Kennedy, Daniel/0000-0002-5915-0893	NIMH NIH HHS [2R01 MH 36840, 1P50 MH 081755-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036840, P50MH081755] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Anderson AW, 2001, MAGN RESON IMAGING, V19, P1, DOI 10.1016/S0730-725X(00)00231-9; Araghi-Niknam M, 2003, CELL MOL NEUROBIOL, V23, P945, DOI 10.1023/B:CEMN.0000005322.27203.73; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Bashat DB, 2007, NEUROIMAGE, V37, P40, DOI 10.1016/j.neuroimage.2007.04.060; Bastuji H, 2002, INT J PSYCHOPHYSIOL, V46, P243, DOI 10.1016/S0167-8760(02)00116-2; BATES E, 2003, CHILD NEUROPSYCHOL 2, P525; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Bloss CS, 2007, J AM ACAD CHILD PSY, V46, P515, DOI 10.1097/chi.0b013e318030e28b; Boger-Megiddo I, 2006, J AUTISM DEV DISORD, V36, P733, DOI 10.1007/s10803-006-0121-2; Buxhoeveden DP, 2006, NEUROPATH APPL NEURO, V32, P483, DOI 10.1111/j.1365-2990.2006.00745.x; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Carver LJ, 2002, MOL PSYCHIATR, V7, pS18, DOI 10.1038/sj.mp.4001168; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Cheour M, 2002, NATURE, V415, P599, DOI 10.1038/415599b; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chung MK, 2004, NEUROIMAGE, V23, P242, DOI 10.1016/j.neuroimage.2004.04.037; Ciesielski KT, 1997, NEUROPSYCHOLOGIA, V35, P643, DOI 10.1016/S0028-3932(96)00119-4; Cody H, 2002, INT J DEV NEUROSCI, V20, P421, DOI 10.1016/S0736-5748(02)00053-9; CONEL J, 1959, POSTNATAL DEV HUMAN, V4; Conel J, 1951, POSTNATAL DEV HUMAN, V4; CONEL JL, 1939, POSTNATAL DEV HUMAN, V1; CONEL JL, 1941, POSTNATAL DEV HUMAN, V2; COURCHESNE E, 1994, AM J ROENTGENOL, V162, P123, DOI 10.2214/ajr.162.1.8273650; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2005, INT J DEV NEUROSCI, V23, P153, DOI 10.1016/j.ijdevneu.2005.01.003; Courchesne E, 2004, CURR OPIN NEUROL, V17, P489, DOI 10.1097/01.wco.0000137542.14610.b4; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Courchesne E, 1999, NEUROLOGY, V52, P1057, DOI 10.1212/WNL.52.5.1057; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; COURCHESNE E, 1993, AM J ROENTGENOL, V160, P387, DOI 10.2214/ajr.160.2.8424359; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2004, DEVELOPMENTAL SCI, V7, P340, DOI 10.1111/j.1467-7687.2004.00352.x; Dawson G, 2007, BIOL PSYCHIAT, V61, P458, DOI 10.1016/j.biopsych.2006.07.016; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; Dementieva YA, 2005, PEDIATR NEUROL, V32, P102, DOI 10.1016/j.pediatrneurol.2004.08.005; Dissanayake C, 2006, DEV PSYCHOPATHOL, V18, P381, DOI 10.1017/S0954579406060202; EGAAS B, 1995, ARCH NEUROL-CHICAGO, V52, P794, DOI 10.1001/archneur.1995.00540320070014; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343; Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190; Gillberg C, 2002, DEV MED CHILD NEUROL, V44, P296; Hadjikhani N, 2004, NEUROREPORT, V15, P267, DOI 10.1097/00001756-200402090-00011; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hardan AY, 2003, J CHILD NEUROL, V18, P317, DOI 10.1177/08830738030180050801; Hardan AY, 2000, NEUROLOGY, V55, P1033, DOI 10.1212/WNL.55.7.1033; Hazlett HC, 2006, BIOL PSYCHIAT, V59, P1, DOI 10.1016/j.biopsych.2005.06.015; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; Haznedar MM, 2000, AM J PSYCHIAT, V157, P1994, DOI 10.1176/appi.ajp.157.12.1994; Herbert MR, 2005, NEUROSCIENTIST, V11, P417, DOI 10.1177/0091270005278866; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; HOSHINO Y, 1984, FOLIA PSYCHIAT NEU J, V38, P33; Huttenlocher P., 2002, NEURAL PLASTICITY EF; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kates WR, 2004, AM J PSYCHIAT, V161, P539, DOI 10.1176/appi.ajp.161.3.539; Kaufmann WE, 2003, J CHILD NEUROL, V18, P463, DOI 10.1177/08830738030180070501; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; Kennedy DP, 2007, BRAIN COGNITION, V64, P124, DOI 10.1016/j.bandc.2007.01.007; KOSHINO H, 2007, IN PRESS CEREB CORTE; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Lainhart JE, 1997, J AM ACAD CHILD PSY, V36, P282, DOI 10.1097/00004583-199702000-00019; Landa R, 2006, J CHILD PSYCHOL PSYC, V47, P629, DOI 10.1111/j.1469-7610.2006.01531.x; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; Levitt JG, 2003, CEREB CORTEX, V13, P728, DOI 10.1093/cercor/13.7.728; Levitt JG, 1999, PROG NEURO-PSYCHOPH, V23, P625, DOI 10.1016/S0278-5846(99)00021-4; LORD C, 2000, AUTISM SPECTRUM DISO, P167; Lotspeich L, 2004, ARCH GEN PSYCHIAT, V61, P291, DOI 10.1001/archpsyc.61.3.291; Manes F, 1999, J NEUROPSYCH CLIN N, V11, P470, DOI 10.1176/jnp.11.4.470; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; MASONBROTHERS A, 1990, PEDIATRICS, V86, P514; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; Munson J, 2006, ARCH GEN PSYCHIAT, V63, P686, DOI 10.1001/archpsyc.63.6.686; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nolte J., 1993, HUMAN BRAIN; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Palmen SJMC, 2005, PSYCHOL MED, V35, P561, DOI 10.1017/S0033291704003496; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; Perrin F, 2002, NEUROREPORT, V13, P1345, DOI 10.1097/00001756-200207190-00026; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; PIVEN J, 1992, BIOL PSYCHIAT, V31, P491, DOI 10.1016/0006-3223(92)90260-7; PIVEN J, 1995, AM J PSYCHIAT, V152, P1145; Piven J, 1997, AM J PSYCHIAT, V154, P1051; PIVEN J, 2004, INT M AUT RES SACR; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; REDCAY E, 2007, IN PRESS DEV SCI; Redcay E, 2007, NEUROIMAGE, V38, P696, DOI 10.1016/j.neuroimage.2007.08.005; Rice SA, 2005, J CHILD NEUROL, V20, P34, DOI 10.1177/08830738050200010601; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; ROGERS SJ, 1990, J AM ACAD CHILD PSY, V29, P863, DOI 10.1097/00004583-199011000-00004; Rojas DC, 2005, J AUTISM DEV DISORD, V35, P479, DOI 10.1007/s10803-005-5038-7; Rojas DC, 2002, NEUROSCI LETT, V328, P237, DOI 10.1016/S0304-3940(02)00521-9; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Schmitz N, 2007, NEUROSCI LETT, V412, P12, DOI 10.1016/j.neulet.2006.07.077; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; SCHULTZ RT, 2005, INT M AUT RES BOST M; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Stevenson RE, 1997, LANCET, V349, P1744, DOI 10.1016/S0140-6736(05)62956-X; Tsatsanis KD, 2003, BIOL PSYCHIAT, V53, P121, DOI 10.1016/S0006-3223(02)01530-5; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; Wetherby AM, 2004, J AUTISM DEV DISORD, V34, P473, DOI 10.1007/s10803-004-2544-y; Wilke M, 2003, AM J NEURORADIOL, V24, P42; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	143	539	553	6	134	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2007	56	2					399	413		10.1016/j.neuron.2007.10.016	http://dx.doi.org/10.1016/j.neuron.2007.10.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	228PA	17964254	Bronze			2022-12-17	WOS:000250740700015
J	Albrecht, U				Albrecht, Urs			Timing to Perfection: The Biology of Central and Peripheral Circadian Clocks	NEURON			English	Review							SOCIAL RHYTHM THERAPY; GENE-EXPRESSION; MAMMALIAN CLOCK; ACID-METABOLISM; DNA-BINDING; TRANSCRIPTION; RECEPTOR; NUCLEUS; SYSTEM; DOPAMINE	The mammalian circadian system, which is comprised of multiple cellular clocks located in the organs and tissues, orchestrates their regulation in a hierarchical manner throughout the 24 hr of the day. At the top of the hierarchy are the suprachiasmatic nuclei, which synchronize subordinate organ and tissue clocks using electrical, endocrine, and metabolic signaling pathways that impact the molecular mechanisms of cellular clocks. The interplay between the central neural and peripheral tissue clocks is not fully understood and remains a major challenge in determining how neurological and metabolic homeostasis is achieved across the sleep-wake cycle. Disturbances in the communication between the plethora of body clocks can desynchronize the circadian system, which is believed to contribute to the development of diseases such as obesity and neuropsychiatric disorders. This review will highlight the relationship between clocks and metabolism, and describe how cues such as light, food, and reward mediate entrainment of the circadian system.	Univ Fribourg, Biochem Unit, Dept Biol, CH-1700 Fribourg, Switzerland	University of Fribourg	Albrecht, U (corresponding author), Univ Fribourg, Biochem Unit, Dept Biol, Chemin Musee 5, CH-1700 Fribourg, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676	Swiss National Science Foundation; State of Fribourg; Swiss International Cooperative Program; Velux Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Fribourg; Swiss International Cooperative Program; Velux Foundation(Velux Fonden)	I apologize for not being able to include all of the relevant studies due to space limitations. I thank Drs. Jean-Luc Dreyer, Jurgen Ripperger, and Gurudutt Pendyala for comments on the manuscript. Funding provided by the Swiss National Science Foundation, the State of Fribourg, the Swiss International Cooperative Program, and the Velux Foundation is gratefully acknowledged.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Antle MC, 2009, REV ENDOCR METAB DIS, V10, P279, DOI 10.1007/s11154-009-9116-6; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boden G, 1999, DIABETES, V48, P2182, DOI 10.2337/diabetes.48.11.2182; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Buijs RM, 1998, PROG BRAIN RES, V119, P365; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/NCHEMBIO.610, 10.1038/nchembio.610]; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cho H, 2012, NATURE; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Dong L, 2011, AM J PSYCHIAT, V168, P1090, DOI 10.1176/appi.ajp.2011.10111579; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; ESKIN A, 1979, FED PROC, V38, P2570; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fox DL, 2008, MOL ENDOCRINOL, V22, P1438, DOI 10.1210/me.2008-0010; Frank E, 2000, BIOL PSYCHIAT, V48, P593, DOI 10.1016/S0006-3223(00)00969-0; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gallou-Kabani C, 2007, EPIGENETICS-US, V2, P137, DOI 10.4161/epi.2.3.4897; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Goel N, 2009, J BIOL RHYTHM, V24, P85, DOI 10.1177/0748730408328914; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hasler BP, 2010, PSYCHIAT RES, V178, P205, DOI 10.1016/j.psychres.2010.04.027; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Hirota T, 2010, GENES CELLS, V15, P111, DOI 10.1111/j.1365-2443.2009.01371.x; Hlastala SA, 2006, DEV PSYCHOPATHOL, V18, P1267, DOI 10.1017/S0954579406060615; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; JOHNSSON A, 1983, International Journal of Chronobiology, V8, P129; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Krugel U, 2003, EUR J PHARMACOL, V482, P185, DOI 10.1016/j.ejphar.2003.09.047; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033292; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lutter M, 2009, J NUTR, V139, P629, DOI 10.3945/jn.108.097618; Magnusson A, 2003, CHRONOBIOL INT, V20, P189, DOI 10.1081/CBI-120019310; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McIntyre Roger S, 2009, J Clin Psychiatry, V70, pe23; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Mountjoy KG, 2010, BIOCHEM J, V428, P305, DOI 10.1042/BJ20091957; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pegoraro M, 2008, J GENET, V87, P505, DOI 10.1007/s12041-008-0073-8; Prasko J, 2008, NEUROENDOCRINOL LETT, V29, P33; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qu TY, 1996, BRAIN RES, V709, P251, DOI 10.1016/0006-8993(95)01306-7; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sahar S, 2011, AGING-US, V3, P794, DOI 10.18632/aging.100368; Sakamaki J, 2009, BIOCHEM BIOPH RES CO, V382, P497, DOI 10.1016/j.bbrc.2009.03.022; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Scott AJ, 2000, PRIMARY CARE, V27, P1057, DOI 10.1016/S0095-4543(05)70189-5; Shi SQ, 2010, CURR BIOL, V20, P316, DOI 10.1016/j.cub.2009.12.034; Simerly R, 2006, NAT MED, V12, P1244, DOI 10.1038/nm1106-1244; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vanselow JT, 2010, PROTEIN REV, V12, P79, DOI 10.1007/978-1-4419-1262-6_3; Wang YJ, 2010, ACS CHEM BIOL, V5, P1029, DOI 10.1021/cb100223d; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yannielli PC, 2007, J NEUROSCI, V27, P2890, DOI 10.1523/JNEUROSCI.3913-06.2007; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zhang SW, 2004, SLEEP, V27, P619, DOI 10.1093/sleep/27.4.619; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	140	538	559	11	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 26	2012	74	2					246	260		10.1016/j.neuron.2012.04.006	http://dx.doi.org/10.1016/j.neuron.2012.04.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	933LA	22542179	Green Submitted, Bronze			2022-12-17	WOS:000303361800007
J	Sala, C; Piech, V; Wilson, NR; Passafaro, M; Liu, GS; Sheng, M				Sala, C; Piech, V; Wilson, NR; Passafaro, M; Liu, GS; Sheng, M			Regulation of dendritic spine morphology and synaptic function by Shank and Homer	NEURON			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; HIPPOCAMPAL-NEURONS; BINDING-PROTEIN; MULTIDOMAIN PROTEINS; EXCITATORY SYNAPSES; DENTATE GYRUS; SMALL GTPASES; FAMILY	The Shank family of proteins interacts with NMDA receptor and metabotropic glutamate receptor complexes in the postsynaptic density (PSD). Targeted to the PSD by a PDZ-dependent mechanism, Shank promotes the maturation of dendritic spines and the enlargement of spine heads via its ability to recruit Homer to postsynaptic sites. Shank and Homer cooperate to induce accumulation of IP3 receptors in dendritic spines and formation of putative multisynapse spines. In addition, postsynaptic expression of Shank enhances presynaptic function, as measured by increased minifrequency and FM4-64 uptake. These data suggest a central role for the Shank scaffold in the structural and functional organization of the dendritic spine and synaptic junction.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; MIT, Dept Brain & Cognit Sci, RIKEN MIT Neurosci Res Ctr, Ctr Learning & Memory, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); RIKEN	Sheng, M (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.		Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 1999, J NEUROSCI, V19, P6506; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; DESMOND NL, 1988, BRAIN RES, V453, P308, DOI 10.1016/0006-8993(88)90171-0; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Ehlers MD, 1999, CURR BIOL, V9, pR848, DOI 10.1016/S0960-9822(00)80043-3; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Harris KM, 1999, P NATL ACAD SCI USA, V96, P12213, DOI 10.1073/pnas.96.22.12213; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HORNER CH, 1993, PROG NEUROBIOL, V41, P281, DOI 10.1016/0301-0082(93)90002-A; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Kreienkamp HJ, 2000, J BIOL CHEM, V275, P32387, DOI 10.1074/jbc.C000490200; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rusakov DA, 1997, HIPPOCAMPUS, V7, P489, DOI 10.1002/(SICI)1098-1063(1997)7:5<489::AID-HIPO5>3.0.CO;2-C; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tobaben S, 2000, J BIOL CHEM, V275, P36204, DOI 10.1074/jbc.M006448200; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Weed SA, 1998, J CELL SCI, V111, P2433; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Zitzer H, 1999, J BIOL CHEM, V274, P18153, DOI 10.1074/jbc.274.26.18153; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	50	538	556	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					115	130		10.1016/S0896-6273(01)00339-7	http://dx.doi.org/10.1016/S0896-6273(01)00339-7			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498055	Bronze			2022-12-17	WOS:000170101100015
J	von Hehn, CA; Baron, R; Woolf, CJ				von Hehn, Christian A.; Baron, Ralf; Woolf, Clifford J.			Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms	NEURON			English	Review							DORSAL-ROOT GANGLION; PERIPHERAL-NERVE INJURY; ACTIVATED PACEMAKER CHANNELS; ROSTRAL VENTROMEDIAL MEDULLA; CHRONIC CONSTRICTION INJURY; VANILLOID RECEPTOR TRPV1; RESISTANT SODIUM-CHANNEL; SPINAL SENSORY NEURONS; LONG-TERM POTENTIATION; CALCIUM-CHANNEL	After nerve injury maladaptive changes can occur in injured sensory neurons and along the entire nociceptive pathway within the CNS, which may lead to spontaneous pain or pain hypersensitivity. The resulting neuropathic pain syndromes present as a complex combination of negative and positive symptoms, which vary enormously from individual to individual. This variation depends on a diversity of underlying pathophysiological changes resulting from the convergence of etiological, genotypic, and environmental factors. The pain phenotype can serve therefore, as a window on underlying pathophysiological neural mechanisms and as a guide for developing personalized pain medicine.	[von Hehn, Christian A.; Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [von Hehn, Christian A.; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Baron, Ralf] Univ Klinikum Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, D-24105 Kiel, Germany	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital	Woolf, CJ (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Woolf, Clifford/A-9784-2010		NIH [NS038253, NS058870]; IMI European collaboration;  [NS747313]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R01NS058870, T32NS007473] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMI European collaboration; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are supported by the NIH NS038253, NS058870 (C.J.W.), IMI European collaboration (R.B.), and NS747313 (C.A.v.H.). Conflict of interest (R.B.): Astra Zeneca, Esteve, Pfizer, Genzyme, Grunenthal, Mundipharma, Allergan, Sanofi Pasteur, Medtronic, Eisai, UCB BioSciences, Lilly, Boehringer Ingelheim, Astellas, Novartis, Bristol-Myers Squibb.	Amir R, 2005, J NEUROSCI, V25, P2576, DOI 10.1523/JNEUROSCI.4118-04.2005; Amir R, 1999, J NEUROSCI, V19, P8589; Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Anand P, 2011, EUR J PAIN, V15, P1040, DOI 10.1016/j.ejpain.2011.04.005; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Asiedu MN, 2011, J NEUROSCI, V31, P6646, DOI 10.1523/JNEUROSCI.6286-10.2011; Attal N, 2004, NEUROLOGY, V62, P218, DOI 10.1212/01.WNL.0000103237.62009.77; Baba H, 2003, MOL CELL NEUROSCI, V24, P818, DOI 10.1016/S1044-7431(03)00236-7; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; Barton ME, 2005, EUR J PHARMACOL, V521, P79, DOI 10.1016/j.ejphar.2005.08.017; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Beggs S, 2010, CURR OPIN NEUROBIOL, V20, P474, DOI 10.1016/j.conb.2010.08.005; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Binder A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017387; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Black JA, 2008, ANN NEUROL, V64, P644, DOI 10.1002/ana.21527; Blackburn-Munro G, 2003, EUR J PHARMACOL, V460, P109, DOI 10.1016/S0014-2999(02)02924-2; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Calvo M, 2012, EXP NEUROL, V234, P271, DOI 10.1016/j.expneurol.2011.08.018; Calvo M, 2011, GLIA, V59, P554, DOI 10.1002/glia.21124; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; Campbell CM, 2009, PAIN, V141, P114, DOI 10.1016/j.pain.2008.10.023; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Cheng LZ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-1; Christoph T, 2006, BIOCHEM BIOPH RES CO, V350, P238, DOI 10.1016/j.bbrc.2006.09.037; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; De Felice M, 2011, PAIN, V152, P2701, DOI 10.1016/j.pain.2011.06.008; Devor M, 2006, J PAIN, V7, pS3, DOI 10.1016/j.jpain.2005.09.006; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dogrul A, 2003, PAIN, V105, P159, DOI 10.1016/S0304-3959(03)00177-5; Dogrul A, 2011, ACTA DIABETOL, V48, P135, DOI 10.1007/s00592-010-0237-x; Edwards RR, 2006, ANESTHESIOLOGY, V104, P1243, DOI 10.1097/00000542-200606000-00020; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Enomoto A, 2007, J NEUROPHYSIOL, V98, P710, DOI 10.1152/jn.00292.2007; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Finnerup NB, 2002, PAIN, V96, P375, DOI 10.1016/S0304-3959(01)00484-5; Fossat P, 2010, J NEUROSCI, V30, P1073, DOI 10.1523/JNEUROSCI.3145-09.2010; Freeman R, 2009, CURR DIABETES REP, V9, P423, DOI 10.1007/s11892-009-0069-7; Friebel U, 2011, NEUROIMAGE, V58, P1070, DOI 10.1016/j.neuroimage.2011.07.022; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Fukuoka T, 2011, NEUROSCI RES, V70, P164, DOI 10.1016/j.neures.2011.01.020; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gold MS, 2003, J NEUROSCI, V23, P158; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016/0304-3959(92)90259-E; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Gwilym SE, 2010, ARTHRITIS RHEUM-US, V62, P2930, DOI 10.1002/art.27585; Hains BC, 2004, J NEUROSCI, V24, P4832, DOI 10.1523/JNEUROSCI.0300-04.2004; Hains BC, 2003, J NEUROSCI, V23, P8881; Hathway GJ, 2009, PAIN, V144, P110, DOI 10.1016/j.pain.2009.03.022; He XH, 2010, PAIN, V151, P266, DOI 10.1016/j.pain.2010.06.005; Herzog RI, 2001, J NEUROPHYSIOL, V86, P1351, DOI 10.1152/jn.2001.86.3.1351; Hoffmann T, 2008, J NEUROSCI, V28, P6281, DOI 10.1523/JNEUROSCI.1627-08.2008; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Hu HJ, 2011, J NEUROPHYSIOL, V105, P3010, DOI 10.1152/jn.01050.2010; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Hudmon A, 2008, J NEUROSCI, V28, P3190, DOI 10.1523/JNEUROSCI.4403-07.2008; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Janssen SP, 2011, NEUROSCIENCE, V184, P183, DOI 10.1016/j.neuroscience.2011.03.060; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Katano T, 2011, NEUROPHARMACOLOGY, V60, P609, DOI 10.1016/j.neuropharm.2010.12.005; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kim CH, 2002, NEUROSCI LETT, V323, P125, DOI 10.1016/S0304-3940(02)00127-1; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; Kim HY, 2011, J NEUROSCI, V31, P12982, DOI 10.1523/JNEUROSCI.3093-11.2011; Kim HY, 2008, J PAIN, V9, P280, DOI 10.1016/j.jpain.2007.11.013; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kovalsky Y, 2009, J NEUROPHYSIOL, V102, P1430, DOI 10.1152/jn.00005.2009; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee DH, 2005, J PAIN, V6, P417, DOI 10.1016/j.jpain.2005.02.002; Leong ML, 2011, J NEUROSCI, V31, P17028, DOI 10.1523/JNEUROSCI.1268-11.2011; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Mahn F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018018; Mantyh PW, 2011, ANESTHESIOLOGY, V115, P189, DOI 10.1097/ALN.0b013e31821b1ac5; Matsumura S, 2010, EUR J NEUROSCI, V32, P798, DOI 10.1111/j.1460-9568.2010.07348.x; Miletic G, 2011, NEUROSCIENCE, V188, P142, DOI 10.1016/j.neuroscience.2011.05.013; Momin A, 2008, J PHYSIOL-LONDON, V586, P5911, DOI 10.1113/jphysiol.2008.163154; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Nassar MA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-33; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Nissenbaum J, 2010, GENOME RES, V20, P1180, DOI 10.1101/gr.104976.110; Nitzan-Luques A, 2011, PAIN, V152, P2413, DOI 10.1016/j.pain.2011.07.012; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Nozaki C, 2011, NAT NEUROSCI, V14, P1017, DOI 10.1038/nn.2844; Ohnami S, 2011, PAIN, V152, P623, DOI 10.1016/j.pain.2010.12.004; Orhan CE, 2010, NEUROSCI LETT, V481, P17, DOI 10.1016/j.neulet.2010.06.039; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; Parks EL, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.12.007; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Ploner M, 2011, CEREB CORTEX, V21, P719, DOI 10.1093/cercor/bhq146; Prescott SA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-32; Ranoux D, 2008, ANN NEUROL, V64, P274, DOI 10.1002/ana.21427; Ren WJ, 2011, NEUROPHARMACOLOGY, V61, P1334, DOI 10.1016/j.neuropharm.2011.08.006; Rose K, 2011, PAIN, V152, P742, DOI 10.1016/j.pain.2010.12.028; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Schafers M, 2003, J NEUROSCI, V23, P3028; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Scholz J, 2008, PAIN, V138, P130, DOI 10.1016/j.pain.2007.11.019; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Schweinhardt P, 2006, NEUROIMAGE, V32, P256, DOI 10.1016/j.neuroimage.2006.03.024; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shinoda M, 2007, J PAIN, V8, P588, DOI 10.1016/j.jpain.2007.03.001; Simpson DM, 2010, NEUROLOGY, V74, P413, DOI 10.1212/WNL.0b013e3181ccc6ef; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Sowa NA, 2010, J NEUROSCI, V30, P2235, DOI 10.1523/JNEUROSCI.5324-09.2010; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Suter MR, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-53; Swanson DM, 2005, J MED CHEM, V48, P1857, DOI 10.1021/jm0495071; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Tan AM, 2011, EXP NEUROL, V232, P222, DOI 10.1016/j.expneurol.2011.08.028; Tegeder I, 2008, EUR J PAIN, V12, P1069, DOI 10.1016/j.ejpain.2008.02.004; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Thakor DK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-14; Toth C, 2009, PAIN MED, V10, P918, DOI 10.1111/j.1526-4637.2009.00655.x; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Tracey I, 2011, NAT REV NEUROL, V7, P173, DOI 10.1038/nrneurol.2011.4; Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; Turk DC, 2010, MAYO CLIN PROC, V85, pS42, DOI 10.4065/mcp.2009.0648; Wang HS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001269; Watabiki T, 2011, J PHARMACOL EXP THER, V336, P743, DOI 10.1124/jpet.110.175570; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Weller K, 2011, NEUROPEPTIDES, V45, P391, DOI 10.1016/j.npep.2011.07.011; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wu G, 2002, J NEUROSCI, V22, P7746; Xiao WH, 2011, NEUROSCIENCE, V199, P461, DOI 10.1016/j.neuroscience.2011.10.010; Xie RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018681; Xu GY, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-60; Yowtak J, 2011, PAIN, V152, P844, DOI 10.1016/j.pain.2010.12.034; Zhang HJ, 2010, J NEUROSCI, V30, P12844, DOI 10.1523/JNEUROSCI.2437-10.2010; Zhang YH, 2012, J NEUROPHYSIOL, V107, P315, DOI 10.1152/jn.00030.2011; Zhao J, 2011, J NEUROPHYSIOL, V106, P608, DOI 10.1152/jn.00107.2011	158	537	548	4	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					638	652		10.1016/j.neuron.2012.02.008	http://dx.doi.org/10.1016/j.neuron.2012.02.008			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365541	Bronze, Green Accepted			2022-12-17	WOS:000300815400006
J	Taveggia, C; Zanazzi, G; Petrylak, A; Yano, H; Rosenbluth, J; Einheber, S; Xu, XR; Esper, RM; Loeb, JA; Shrager, P; Chao, MV; Falls, DL; Role, L; Salzer, JL				Taveggia, C; Zanazzi, G; Petrylak, A; Yano, H; Rosenbluth, J; Einheber, S; Xu, XR; Esper, RM; Loeb, JA; Shrager, P; Chao, MV; Falls, DL; Role, L; Salzer, JL			Neuregulin-1 type III determines the ensheathment fate of axons	NEURON			English	Article							SCHWANN-CELL MYELINATION; NEURON-DERIVED FACTOR; SIGNAL-REGULATED KINASE; PERIPHERAL-NERVE; PLASMA-MEMBRANE; PI 3-KINASE; EXPRESSION; RECEPTOR; GROWTH; HEREGULIN	The signals that determine whether axons are ensheathed or myelinated by Schwann cells have long been elusive. We now report that threshold levels of neuregulin-1 (NRG1) type III on axons determine their ensheathment fate. Ensheathed axons express low levels whereas myelinated fibers express high levels of NRG1 type III. Sensory neurons from NRG1 type III deficient mice are poorly ensheathed and fail to myelinate; lentiviral-mediated expression of NRG1 type III rescues these defects. Expression also converts the normally unmyelinated axons of sympathetic neurons to myelination. Nerve fibers of mice haploinsufficient for NRG1 type III are disproportionately unmyelinated, aberrantly ensheathed, and hypomyelinated, with reduced conduction velocities. Type III is the sole NRG1 isoform retained at the axon surface and activates PI 3-kinase, which is required for Schwann cell myelination. These results indicate that levels of NRG1 type III, independent of axon diameter, provide a key instructive signal that determines the ensheathment fate of axons.	NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Neurosci, New York, NY 10016 USA; NYU, Sch Med, Rusk Inst, New York, NY 10016 USA; CUNY Hunter Coll, Sch Hlth Sci, New York, NY 10010 USA; Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	New York University; New York University; New York University; New York University; New York University; New York University; City University of New York (CUNY) System; Hunter College (CUNY); University of Rochester; University of Rochester; Wayne State University; Wayne State University; Emory University; Columbia University	Salzer, JL (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1St Ave, New York, NY 10016 USA.	salzer@saturn.med.nyu.edu	Taveggia, Carla/AAN-4784-2020; Messier, Claude/A-2322-2008; Role, LW/Q-7371-2018	Messier, Claude/0000-0002-4791-1763; Role, LW/0000-0001-5851-212X; Chao, Moses/0000-0002-6969-3744; Salzer, James/0000-0001-9126-7197; Petrylak, Ashley/0000-0003-2972-7054	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029071, R01NS017965, R01NS051282, R01NS037475, R01NS026001] Funding Source: NIH RePORTER; NINDS NIH HHS [NS051282, R01 NS029071, R01 NS029071-16, NS037475, NS26001, R01 NS051282, R01 NS029071-14, R01 NS029071-13, R01 NS029071-17, R01 NS026001, R01 NS029071-13S1, R01 NS017965, R01 NS029071-15, NS29071, NS17965, R01 NS037475] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; AGUAYO AJ, 1976, J NEUROCYTOL, V5, P565, DOI 10.1007/BF01175570; Auger KR, 2000, BIOCHEM BIOPH RES CO, V272, P822, DOI 10.1006/bbrc.2000.2806; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BRUNDEN KR, 1992, J NEUROSCI RES, V32, P507, DOI 10.1002/jnr.490320406; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Cabedo H, 2002, J BIOL CHEM, V277, P19905, DOI 10.1074/jbc.M201587200; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; ESTRIDGE M, 1978, J CELL BIOL, V79, P138, DOI 10.1083/jcb.79.1.138; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fitzpatrick VD, 1998, FEBS LETT, V431, P102, DOI 10.1016/S0014-5793(98)00737-6; Frenzel KE, 2001, J NEUROCHEM, V77, P1; FRIEDE RL, 1972, J COMP NEUROL, V144, P233, DOI 10.1002/cne.901440207; FRIEDE RL, 1967, J COMP NEUROL, V130, P223, DOI 10.1002/cne.901300304; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; HILLARP NA, 1946, ACTA ANAT, V2, P17; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; Hoke A, 2003, J NEUROSCI, V23, P561; JESSEN KR, 2003, MYELIN BIOL DISORDER, P329; Langley JN, 1903, J PHYSL, V30, P439; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Meyer D, 1997, DEVELOPMENT, V124, P3575; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Murinson BB, 2004, J NEUROPATH EXP NEUR, V63, P246, DOI 10.1093/jnen/63.3.246; Murphy P, 1996, DEVELOPMENT, V122, P2847; MURRAY MA, 1968, ANAT REC, V161, P337; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; OBREMSKI VJ, 1993, J NEUROCYTOL, V22, P102, DOI 10.1007/BF01181574; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Peters A, 1991, FINE STRUCTURE NERVO; Rosenbluth J, 2003, GLIA, V41, P318, DOI 10.1002/glia.10179; ROUFA D, 1986, J NEUROSCI, V6, P790; SCHERER SS, 1994, J NEUROSCI, V14, P1930; Schroering A, 1998, J BIOL CHEM, V273, P30643, DOI 10.1074/jbc.273.46.30643; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SIMPSON SA, 1945, J ANAT, V79, P48; SMITH KJ, 1982, J NEUROL SCI, V55, P231, DOI 10.1016/0022-510X(82)90103-4; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Spencer PS, 1978, PHYSL PATHOBIOLOGY A, P389; Vabnick I, 1999, J NEUROSCI, V19, P747; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; WEINBERG HJ, 1976, BRAIN RES, V113, P363, DOI 10.1016/0006-8993(76)90947-1; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	65	537	556	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					681	694		10.1016/j.neuron.2005.08.017	http://dx.doi.org/10.1016/j.neuron.2005.08.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129398	Bronze, Green Accepted			2022-12-17	WOS:000231782700010
J	Lin, CLG; Bristol, LA; Jin, L; Dykes-Hoberg, M; Crawford, T; Clawson, L; Rothstein, JD				Lin, CLG; Bristol, LA; Jin, L; Dykes-Hoberg, M; Crawford, T; Clawson, L; Rothstein, JD			Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2 a glutamate transporter, in amyotrophic lateral sclerosis	NEURON			English	Article							MOTOR-NEURON DISEASE; SUPEROXIDE-DISMUTASE; CONTROLLED TRIAL; HIGH-AFFINITY; SPINAL-CORD; RAT-BRAIN; RILUZOLE; GENE; ACID; EXCITOTOXICITY	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is characterized by selective upper and lower motor neuron degeneration, the pathogenesis of which is unknown. About 60%-70% of sporadic ALS patients have a 30%-95% loss of the astroglial glutamate transporter EAAT2 (excitatory amino acid transporter 2) protein in motor cortex and spinal cord. Loss of EAAT2 leads to increased extracellular glutamate and excitotoxic neuronal degeneration. Multiple abnormal EAAT2 mRNAs, including intron-retention and exon-skipping, have now been identified from the affected areas of ALS patients. The aberrant mRNAs were highly abundant and were found only in neuropathologically affected areas of ALS patients but not in other brain regions. They were found in 65% of sporadic ALS patients but were not found in nonneurologic disease or other disease controls. They were also detectable in the cerebrospinal fluid (CSF) of living ALS patients, early in the disease. In vitro expression studies suggest that proteins translated from these aberrant mRNAs may undergo rapid degradation and/or produce a dominant negative effect on normal EAAT2 resulting in loss of protein and activity. These findings suggest that the loss of EAAT2 in ALS is due to aberrant mRNA and that these aberrant mRNAs could result from RNA processing errors. Aberrant RNA processing could be important in the pathophysiology of neurodegenerative disease and in excitotoxicity. The presence of these mRNA species in ALS CSF may have diagnostic utility.	Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA.		Lin, Chien-liang G/E-3513-2011; rothstein, jeffrey d/C-9470-2013		NIA NIH HHS [AG12992] Funding Source: Medline; NINDS NIH HHS [NS 33958, NS 36465] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036465, R01NS033958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012992] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AOKI M, 1998, IN PRESS ANN NEUROL, V43; APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brown RH, 1996, ANN NEUROL, V39, P145, DOI 10.1002/ana.410390202; Bruijn LI, 1996, NEUROPATH APPL NEURO, V22, P373, DOI 10.1111/j.1365-2990.1996.tb00907.x; CAMPAGNE MV, 1995, EUR J NEUROSCI, V7, P1627; CARRIEDO SG, 1995, NEUROREPORT, V6, P945, DOI 10.1097/00001756-199504190-00030; COURATIER P, 1993, LANCET, V341, P265, DOI 10.1016/0140-6736(93)92615-Z; COURATIER P, 1994, NEUROREPORT, V5, P1012, DOI 10.1097/00001756-199404000-00040; Didier M, 1996, J NEUROSCI, V16, P2238; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hagiwara T, 1996, GENOMICS, V33, P508, DOI 10.1006/geno.1996.0226; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Ikonomidou C, 1996, J NEUROPATH EXP NEUR, V55, P211, DOI 10.1097/00005072-199602000-00010; INCE P, 1993, NEUROPATH APPL NEURO, V19, P291, DOI 10.1111/j.1365-2990.1993.tb00443.x; Kuivenhoven JA, 1996, J CLIN INVEST, V98, P358, DOI 10.1172/JCI118800; KUNCL RW, 1992, DIS NERV SYST, P1179; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Meyer T, 1997, NEUROREPORT, V8, P775, DOI 10.1097/00001756-199702100-00039; Miller RG, 1996, NEUROLOGY, V47, P1383, DOI 10.1212/WNL.47.6.1383; Morrison M, 1997, P NATL ACAD SCI USA, V94, P9782, DOI 10.1073/pnas.94.18.9782; Rothstein JD, 1996, NEUROLOGY, V47, pS19, DOI 10.1212/WNL.47.4_Suppl_2.19S; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sakai N, 1996, J LIPID RES, V37, P2065; SHAW PJ, 1994, BRAIN RES, V655, P195, DOI 10.1016/0006-8993(94)91614-4; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; SHAW PJ, 1994, J NEUROL SCI, V124, P6, DOI 10.1016/0022-510X(94)90170-8; Siddique T, 1996, HUM MOL GENET, V5, P1465, DOI 10.1093/hmg/5.Supplement_1.1465; SMITH RG, 1992, NEW ENGL J MED, V327, P1721, DOI 10.1056/NEJM199212103272405; Stoffel W, 1996, FEBS LETT, V386, P189, DOI 10.1016/0014-5793(96)00424-3; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Trotti D, 1996, J BIOL CHEM, V271, P5976, DOI 10.1074/jbc.271.11.5976; VOLTERRA A, 1994, MOL PHARMACOL, V46, P986; Wang Q, 1996, J BIOL CHEM, V271, P28617, DOI 10.1074/jbc.271.45.28617; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	55	537	546	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1998	20	3					589	602		10.1016/S0896-6273(00)80997-6	http://dx.doi.org/10.1016/S0896-6273(00)80997-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539131	hybrid			2022-12-17	WOS:000072755600022
J	ARRIZA, JL; SIMERLY, RB; SWANSON, LW; EVANS, RM				ARRIZA, JL; SIMERLY, RB; SWANSON, LW; EVANS, RM			THE NEURONAL MINERALOCORTICOID RECEPTOR AS A MEDIATOR OF GLUCOCORTICOID RESPONSE	NEURON			English	Article									UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,NEURAL SYST LAB,LA JOLLA,CA 92037	University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute	ARRIZA, JL (corresponding author), SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,GENE EXPRESS LAB,LA JOLLA,CA 92037, USA.		Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965				ARMANINI D, 1985, AM J PHYSIOL, V248, pE388, DOI 10.1152/ajpendo.1985.248.3.E388; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BEAUMONT K, 1983, ENDOCRINOLOGY, V113, P2043, DOI 10.1210/endo-113-6-2043; BIRMINGHAM MK, 1984, NEUROCHEM RES, V9, P333, DOI 10.1007/BF00963982; BONVALET JP, 1987, J STEROID BIOCHEM, V27, P953, DOI 10.1016/0022-4731(87)90173-7; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; DEKLOET ER, 1983, BRAIN RES, V264, P323, DOI 10.1016/0006-8993(83)90834-X; DEKLOET ER, 1982, BRAIN RES, V239, P659, DOI 10.1016/0006-8993(82)90546-7; DEKLOET ER, 1987, PSYCHONEUROENDOCRINO, V12, P83, DOI 10.1016/0306-4530(87)90040-0; DEKLOET R, 1975, ENDOCRINOLOGY, V96, P598, DOI 10.1210/endo-96-3-598; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DUVAL D, 1974, ENDOCRINOLOGY, V94, P575, DOI 10.1210/endo-94-2-575; ERMISCH A, 1978, BRAIN RES, V147, P154, DOI 10.1016/0006-8993(78)90780-1; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FARMAN N, 1983, AM J PHYSIOL, V245, pF606, DOI 10.1152/ajprenal.1983.245.5.F606; Faull RLM, 1985, RAT NERVOUS SYSTEM, V1, P129; FUNDER JW, 1987, ANNU REV PHYSIOL, V49, P397; FUXE K, 1985, ENDOCRINOLOGY, V117, P1803, DOI 10.1210/endo-117-5-1803; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GROENEWEGEN HJ, 1986, J COMP NEUROL, V249, P65, DOI 10.1002/cne.902490107; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Jones EG, 1983, CHEM NEUROANATOMY, P257; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; KROZOWSKI ZS, 1983, P NATL ACAD SCI-BIOL, V80, P6056, DOI 10.1073/pnas.80.19.6056; MCEWEN BS, 1969, BRAIN RES, V16, P227, DOI 10.1016/0006-8993(69)90096-1; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; MCEWEN BS, 1986, NEUROENDOCRINOLOGY, V43, P38, DOI 10.1159/000124506; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MEYER JS, 1985, PHYSIOL REV, V65, P946, DOI 10.1152/physrev.1985.65.4.946; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MOGENSON GJ, 1983, J NEUROSCI, V3, P189; MOGUILEWSKY M, 1980, J STEROID BIOCHEM, V12, P309, DOI 10.1016/0022-4731(80)90285-X; NESTLER EJ, 1981, SCIENCE, V212, P1162, DOI 10.1126/science.6785886; NEWMAN DB, 1985, J HIRNFORSCH, V26, P385; NEWMAN DB, 1985, J HIRNFORSCH, V26, P187; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PRICE JL, 1987, HDB CHEM NEUROANATOM, V5, P279; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; ROUSSEAU GG, 1979, GLUCOCORTICOID HORMO, P49; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCALIA F, 1972, J COMP NEUROL, V145, P223, DOI 10.1002/cne.901450208; Steinbusch H. W., 1983, CHEM NEUROANATOMY, P131; STEPHENSON G, 1984, AM J PHYSIOL, V246, pF227, DOI 10.1152/ajprenal.1984.246.2.F227; STEWART PM, 1987, LANCET, V2, P821; Stumpf W.E., 1979, INTERACTION BRAIN PI, P137; STUMPF WE, 1975, ANATOMICAL NEUROENDO, P254; Swanson LW, 1987, HDB CHEM NEUROANATOM, P125; TEUTSCH G, 1981, STEROIDS, V38, P651, DOI 10.1016/0039-128X(81)90084-2; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; WAREMBOURG M, 1975, BRAIN RES, V89, P61, DOI 10.1016/0006-8993(75)90133-X; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WRANGE O, 1983, ENDOCRINOLOGY, V113, P243, DOI 10.1210/endo-113-1-243; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5; [No title captured]	57	537	542	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1988	1	9					887	900		10.1016/0896-6273(88)90136-5	http://dx.doi.org/10.1016/0896-6273(88)90136-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	R1440	2856104				2022-12-17	WOS:A1988R144000013
J	Fertleman, CR; Baker, MD; Parker, KA; Moffatt, S; Elmslie, FV; Abrahamsen, B; Ostman, J; Klugbauer, N; Wood, JN; Gardiner, RM; Rees, M				Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele			SCN9A mutations in paroxysmal extreme pain disorder: Allelic variants underlie distinct channel defects and phenotypes	NEURON			English	Article							FAMILIAL RECTAL PAIN; ALPHA-SUBUNIT; SODIUM-CHANNELS; INACTIVATION; ERYTHERMALGIA; IDENTIFICATION; LINKER; LOOP; PN1	Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing. A genome-wide linkage search followed by mutational analysis of the candidate gene SCN9A, which encodes hNaV(1.7) identified eight missense mutations in 11 families and 2 sporadic cases. Functional analysis in vitro of three of these mutant Na(V)1.7 channels revealed a reduction in fast inactivation, leading to persistent sodium current. Other mutations in SCN9A associated with more negative activation thresholds are known to cause primary erythermalgia (PE). Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current associated with PEPD mutants, but did not affect the negative activation threshold of a PE mutant. PEPD and PE are allelic variants with distinct underlying biophysical mechanisms and represent a separate class of peripheral neuronal sodium channelopathy.	Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, London WC1E 6JJ, England; UCL, Dept Biol, London WC1E 6BT, England; Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England	University of London; University College London; University of London; University College London; University of Freiburg; University of London; Queen Mary University London	Gardiner, RM (corresponding author), Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, 5 Univ St, London WC1E 6JJ, England.	mark.gardiner@ucl.ac.uk	Abrahamsen, Bjarke/ABD-5874-2020	Abrahamsen, Bjarke/0000-0002-6128-8269	Medical Research Council [G9717869, G9706148] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9717869, G9706148] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashcroft FM, 2000, ION CHANNELS DIS; Backonja MM, 2002, NEUROLOGY, V59, pS14, DOI 10.1212/WNL.59.5_suppl_2.S14; Breton H, 2005, J CHROMATOGR B, V828, P80, DOI 10.1016/j.jchromb.2005.09.019; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Carr RW, 2002, J GEN PHYSIOL, V120, P395, DOI 10.1085/jgp.20028628; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Elmslie FV, 1996, J ROY SOC MED, V89, pP290, DOI 10.1177/014107689608900525; Fertleman CR, 2006, J NEUROL NEUROSUR PS, V77, P1294, DOI 10.1136/jnnp.2006.089664; Filatov GN, 1998, J GEN PHYSIOL, V111, P703, DOI 10.1085/jgp.111.6.703; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; HAYDEN R, 1959, AMA J DIS CHILD, V97, P479, DOI 10.1001/archpedi.1959.02070010481013; Kellenberger S, 1997, J GEN PHYSIOL, V109, P589, DOI 10.1085/jgp.109.5.589; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Legroux-Crespel E, 2003, ANN DERMATOL VENER, V130, P429; Lerche H, 1997, J PHYSIOL-LONDON, V505, P345, DOI 10.1111/j.1469-7793.1997.345bb.x; MANN TP, 1972, LANCET, V1, P1016; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Michiels JJ, 2005, ARCH NEUROL-CHICAGO, V62, P1587, DOI 10.1001/archneur.62.10.1587; MOHAMMADI B, 2005, GENOMICS, V15, P235; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; PTACEK LJ, 1991, CELL, V67, P1021; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; SCHUBERT R, 1992, ANN NEUROL, V32, P824, DOI 10.1002/ana.410320620; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Strassman AM, 1999, J NEUROPHYSIOL, V81, P413, DOI 10.1152/jn.1999.81.2.413; Tang LH, 1996, J GEN PHYSIOL, V108, P89, DOI 10.1085/jgp.108.2.89; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Waxman SG, 2005, ANN NEUROL, V57, P785, DOI 10.1002/ana.20511; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wu FF, 2005, J PHYSIOL-LONDON, V565, P371, DOI 10.1113/jphysiol.2005.082909; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	36	536	592	1	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					767	774		10.1016/j.neuron.2006.10.006	http://dx.doi.org/10.1016/j.neuron.2006.10.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145499	Bronze			2022-12-17	WOS:000242856400006
J	Mansvelder, HD; Keath, JR; McGehee, DS				Mansvelder, HD; Keath, JR; McGehee, DS			Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas	NEURON			English	Article							VENTRAL TEGMENTAL AREA; INDUCED DOPAMINE RELEASE; RAT HIPPOCAMPAL INTERNEURONS; FREELY MOVING RATS; ACETYLCHOLINE-RECEPTORS; NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; GABAERGIC NEURONS; CA1 INTERNEURONS; GABA RELEASE	A single nicotine exposure increases dopamine levels in the mesolimbic reward system for hours, but nicotine concentrations experienced by smokers desensitize nAChRs on dopamine neurons in seconds to minutes. Here, we show that persistent modulation of both GABAergic and glutamatergic synaptic transmission by nicotine can contribute to the sustained increase in dopamine neuron excitability. Nicotine enhances GABAergic transmission transiently, which is followed by a persistent depression of these inhibitory inputs due to nAChR desensitization. Simultaneously, nicotine enhances glutamatergic transmission through nAChRs that desensitize less than those on GABA neurons. The net effect is a shift toward excitation of the dopamine reward system. These results suggest that spatial and temporal differences in nicotinic receptor activity on both excitatory and inhibitory neurons in reward areas coordinate to reinforce nicotine self-administration.	Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	McGehee, DS (corresponding author), Univ Chicago, Dept Anesthesia & Crit Care, 5841 S Maryland Ave,MC 4028, Chicago, IL 60637 USA.		Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340	NIDA NIH HHS [DA07255] Funding Source: Medline; NINDS NIH HHS [NS35090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007255] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alkondon M, 2000, NEUROPHARMACOLOGY, V39, P2726, DOI 10.1016/S0028-3908(00)00156-8; Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Alkondon M, 1999, J NEUROSCI, V19, P2693; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; ALKONDON M, 1992, MOL PHARMACOL, V41, P802; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; Blaha CD, 1996, J NEUROSCI, V16, P714; Bonci A, 1999, J NEUROSCI, V19, P3723; Camara AL, 1997, NEUROTOXICOLOGY, V18, P589; Cameron C., 2013, REGRESSION ANAL COUN, DOI 10.1017/CBO9781139013567; Charpantier E, 1998, NEUROREPORT, V9, P3097, DOI 10.1097/00001756-199809140-00033; CORRIGALL WA, 1994, BRAIN RES, V653, P278, DOI 10.1016/0006-8993(94)90401-4; Corringer PJ, 1998, J NEUROSCI, V18, P648; Court JA, 1998, NEUROSCIENCE, V87, P63, DOI 10.1016/S0306-4522(98)00088-8; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; David V, 1997, PSYCHOPHARMACOLOGY, V130, P85, DOI 10.1007/s002130050214; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DiFranza JR, 2000, TOB CONTROL, V9, P313, DOI 10.1136/tc.9.3.313; FELDBERG W, 1945, PHYSIOL REV, V25, P596, DOI 10.1152/physrev.1945.25.4.596; Fenster CP, 1997, J NEUROSCI, V17, P5747; Fiorillo CD, 2000, J NEUROSCI, V20, P7855; Fisher JL, 1998, J PHYSIOLOGY-PARIS, V92, P209, DOI 10.1016/S0928-4257(98)80012-0; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Garzon M, 1999, J COMP NEUROL, V410, P197, DOI 10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Grottick AJ, 2000, J PHARMACOL EXP THER, V294, P1112; Hamid S, 1997, NEUROSCI RES, V29, P81, DOI 10.1016/S0168-0102(97)00074-6; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ikemoto S, 1997, BEHAV NEUROSCI, V111, P369, DOI 10.1037/0735-7044.111.2.369; Ikemoto S, 1997, J NEUROCHEM, V69, P137, DOI 10.1046/j.1471-4159.1997.69010137.x; IMPERATO A, 1986, EUR J PHARMACOL, V132, P337, DOI 10.1016/0014-2999(86)90629-1; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; KALIVAS PW, 1993, NEUROSCIENCE, V57, P1047, DOI 10.1016/0306-4522(93)90048-K; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Lena C, 1997, J NEUROSCI, V17, P576; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Lu Y, 1999, J PHARMACOL EXP THER, V291, P1127; LUETJE CW, 1990, FASEB J, V4, P2753, DOI 10.1096/fasebj.4.10.2197155; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McQuiston AR, 1999, J NEUROSCI, V19, P2887; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; Schilstrom B, 1998, NEUROSCIENCE, V82, P781; SEGUELA P, 1993, J NEUROSCI, V13, P596; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; WALAAS I, 1980, NEUROSCIENCE, V5, P63, DOI 10.1016/0306-4522(80)90071-8; Westerink BHC, 1996, J NEUROSCI, V16, P2605; World Health Organisation, 1999, COMB TOB EP; Yin RY, 2000, BRAIN RES BULL, V51, P507, DOI 10.1016/S0361-9230(00)00237-9	68	536	552	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					905	919		10.1016/S0896-6273(02)00625-6	http://dx.doi.org/10.1016/S0896-6273(02)00625-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906697	Bronze			2022-12-17	WOS:000174389600008
J	MCKINNON, RD; MATSUI, T; DUBOISDALCQ, M; AARONSON, SA				MCKINNON, RD; MATSUI, T; DUBOISDALCQ, M; AARONSON, SA			FGF MODULATES THE PDGF-DRIVEN PATHWAY OF OLIGODENDROCYTE DEVELOPMENT	NEURON			English	Article									NINCDS, CELLULAR & MOLEC BIOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	MCKINNON, RD (corresponding author), NINCDS, VIRAL & MOLEC PATHOGENESIS LAB, BETHESDA, MD 20892 USA.		Messier, Claude/A-2322-2008; Matsui, Toshimitsu/E-8065-2010; McKinnon, Randall D/B-4699-2010	Messier, Claude/0000-0002-4791-1763; Matsui, Toshimitsu/0000-0002-2536-7584; McKinnon, Randall/0000-0002-7539-9613				ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BEHAR T, 1988, J NEUROSCI RES, V21, P168, DOI 10.1002/jnr.490210209; BESNARD F, 1989, INT J DEV NEUROSCI, V7, P401, DOI 10.1016/0736-5748(89)90061-0; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; COUGHLIN SR, 1988, J BIOL CHEM, V263, P988; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; DUBOISDALCQ M, 1987, EMBO J, V6, P2587, DOI 10.1002/j.1460-2075.1987.tb02549.x; DUBOISDALCQ M, 1986, J CELL BIOL, V102, P384, DOI 10.1083/jcb.102.2.384; ECCLESTON PA, 1985, DEV BRAIN RES, V21, P315, DOI 10.1016/0165-3806(85)90221-4; ECCLESTON PA, 1984, DEV BRAIN RES, V16, P1, DOI 10.1016/0165-3806(84)90056-7; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; GARD AL, 1989, DEVELOPMENT, V106, P119; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; HART IK, 1989, DEVELOPMENT, V105, P595; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; KALCHEIM C, 1990, DEVELOPMENT, V109, P203; LATHROP B, 1985, J CELL BIOL, V100, P1540, DOI 10.1083/jcb.100.5.1540; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; LOUGHNAN MS, 1989, NATURE, V340, P76, DOI 10.1038/340076a0; LOWENTHAL JW, 1986, J IMMUNOL, V137, P1226; MARICS I, 1989, ONCOGENE, V4, P335; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1987, MOL CELL BIOL, V7, P2148, DOI 10.1128/MCB.7.6.2148; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MCMORRIS FA, 1986, P NATL ACAD SCI USA, V83, P822, DOI 10.1073/pnas.83.3.822; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; MILNER RJ, 1983, NUCLEIC ACIDS RES, V11, P5497, DOI 10.1093/nar/11.16.5497; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NAVRE M, 1988, J CELL BIOL, V107, P279, DOI 10.1083/jcb.107.1.279; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOBLE M, 1984, EMBO J, V3, P2243, DOI 10.1002/j.1460-2075.1984.tb02122.x; PRINGLE N, 1989, EMBO J, V8, P1049, DOI 10.1002/j.1460-2075.1989.tb03472.x; RAFF MC, 1985, CELL, V42, P61, DOI 10.1016/S0092-8674(85)80101-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1984, DEV BIOL, V106, P53, DOI 10.1016/0012-1606(84)90060-5; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; RISAU W, 1986, P NATL ACAD SCI USA, V83, P3855, DOI 10.1073/pnas.83.11.3855; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; SANETO RP, 1985, P NATL ACAD SCI USA, V82, P3509, DOI 10.1073/pnas.82.10.3509; SHENG HZ, 1989, J NEUROSCI RES, V23, P425, DOI 10.1002/jnr.490230408; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; SOMMER I, 1982, NEUROSCI LETT, V29, P183, DOI 10.1016/0304-3940(82)90351-2; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; TAIRA M, 1987, P NATL ACAD SCI USA, V84, P2980, DOI 10.1073/pnas.84.9.2980; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TROTTER J, 1989, DEV BRAIN RES, V46, P115, DOI 10.1016/0165-3806(89)90148-X; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; ZELLER NK, 1984, P NATL ACAD SCI-BIOL, V81, P18, DOI 10.1073/pnas.81.1.18; ZELLER NK, 1985, J NEUROSCI, V5, P2955; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	77	536	551	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1990	5	5					603	614		10.1016/0896-6273(90)90215-2	http://dx.doi.org/10.1016/0896-6273(90)90215-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	2171589				2022-12-17	WOS:A1990EJ86800005
J	Arenkiel, BR; Peca, J; Davison, IG; Feliciano, C; Deisseroth, K; Augustine, GJ; Ehlers, MD; Feng, GP				Arenkiel, Benjamin R.; Peca, Joao; Davison, Ian G.; Feliciano, Catia; Deisseroth, Karl; Augustine, George J.; Ehlers, Michael D.; Feng, Guoping			In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2	NEURON			English	Article							MAMMALIAN OLFACTORY-BULB; MITRAL CELLS; ODORANT REPRESENTATIONS; CAENORHABDITIS-ELEGANS; BEHAVIORAL-RESPONSES; LATERAL INHIBITION; PIRIFORM CORTEX; REMOTE-CONTROL; SENSORY MAP; NEURONS	Channelrhodopsin-2 (ChR2) is a light-gated, cation-selective ion channel isolated from the green algae Chlamydomonas reinhardtii. Here, we report the generation of transgenic mice that express a ChR2-YFP fusion protein in the CNS for in vivo activation and mapping of neural circuits. Using focal illumination of the cerebral cortex and olfactory bulb, we demonstrate a highly reproducible, light-dependent activation of neurons and precise control of firing frequency in vivo. To test the feasibility of mapping neural circuits, we exploited the circuitry formed between the olfactory bulb and the piriform cortex in anesthetized mice. In the olfactory bulb, individual mitral cells fired action potentials in response to light, and their firing rate was not influenced by costimulated glomeruli. However, in piriform cortex, the activity of target neurons increased as larger areas of the bulb were illuminated to recruit additional glomeruli. These results support a model of olfactory processing that is dependent upon mitral cell convergence and integration onto cortical cells. More broadly, these findings demonstrate a system for precise manipulation of neural activity in the intact mammalian brain with light and illustrate the use of ChR2 mice in exploring functional connectivity of complex neural circuits in vivo.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; Gulbenkian Inst Sci, Gulbenkian PhD Programme Biomed, P-2781901 Oeiras, Portugal; Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Duke University; Howard Hughes Medical Institute; Duke University; Universidade de Coimbra; Stanford University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Feng, Guoping/Y-2827-2019; Oka, Yoshitaka/C-9670-2010; Peça, João/K-7900-2013; Augustine, George James/J-9228-2013	Oka, Yoshitaka/0000-0002-3482-3051; Peça, João/0000-0003-4989-2129; Arenkiel, Benjamin/0000-0001-9047-2420; Feliciano, Catia/0000-0001-7545-6924	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS064171] Funding Source: NIH RePORTER; NINDS NIH HHS [K99 NS064171] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLISON AC, 1953, BIOL REV, V28, P195, DOI 10.1111/j.1469-185X.1953.tb01376.x; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; FENG G, 2004, METHODS MOL MED, V9, P255; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Flusberg BA, 2005, OPT LETT, V30, P2272, DOI 10.1364/OL.30.002272; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hamada S, 1998, MOL BRAIN RES, V54, P199, DOI 10.1016/S0169-328X(97)00322-7; Hardy A, 2005, NEUROSCIENCE, V131, P717, DOI 10.1016/j.neuroscience.2004.10.034; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Kandel ER., 2000, PRINCIPLES NEUROSCIE, V4; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; MCLEAN JH, 1995, J COMP NEUROL, V353, P371, DOI 10.1002/cne.903530305; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Piyawattanametha W, 2006, OPT LETT, V31, P2018, DOI 10.1364/OL.31.002018; Shepherd G.M., 2004, NEUROBIOLOGY; Shepherd GM, 1998, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; WANG H, 2007, IN PRESS P NATL ACAD; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	64	535	584	1	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					205	218		10.1016/j.neuron.2007.03.005	http://dx.doi.org/10.1016/j.neuron.2007.03.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442243	Green Accepted, Bronze			2022-12-17	WOS:000246190600007
J	Colburn, RW; Lubin, ML; Stone, DJ; Wang, Y; Lawrence, D; D'Andrea, MR; Brandt, MR; Liu, Y; Flores, CM; Qin, N				Colburn, Raymond W.; Lubin, Mary Lou; Stone, Dennis J., Jr.; Wang, Yan; Lawrence, Danielle; D'Andrea, Michael R.; Brandt, Michael R.; Liu, Yi; Flores, Christopher M.; Qin, Ning			Attenuated cold sensitivity in TRPM8 null mice	NEURON			English	Article							NEUROPATHIC PAIN; CAPSAICIN RECEPTOR; ION-CHANNEL; MENTHOL; NEURONS; TRPA1; ACTIVATION; ALLODYNIA; NOCICEPTION; MODEL	Thermosensation is an essential sensory function that is subserved by a variety of transducer molecules, including those from the Transient Receptor Potential (TRP) ion channel superfamily. One of its members, TRPM8 (CMR1), a ligand-gated, nonselective cation channel, is activated by both cold and chemical stimuli in vitro. However, its roles in cold thermosensation and pain in vivo have not been fully elucidated. Here, we show that sensory neurons derived from TRPM8 null mice lack detectable levels of TRPM8 mRNA and protein and that the number of these neurons responding to cold (18 degrees C) and menthol (100 mu M) is greatly decreased. Furthermore, compared with WT mice, TRPM8 null mice display deficiencies in certain behaviors, including icilin-induced jumping and cold sensation, as well as a significant reduction in injury-induced responsiveness to acetone cooling. These results suggest that TRPM8 may play an important role in certain types of cold-induced pain in humans.	Johnson & Johnson Pharmaceut Res & Dev LLC, Analgesics Team, Spring House, PA 19477 USA; Johnson & Johnson Pharmaceut Res & Dev LLC, Target Validat Team, E Coast Res & Early Dev, Spring House, PA 19477 USA	Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Johnson & Johnson USA	Qin, N (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, Analgesics Team, Welsh & McKean Rd,POB 776, Spring House, PA 19477 USA.	nqin@prdus.jnj.com						Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Katsura H, 2006, EXP NEUROL, V200, P112, DOI 10.1016/j.expneurol.2006.01.031; Kim SJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-11; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Martinez-Caro L, 2000, NEUROREPORT, V11, P1213, DOI 10.1097/00001756-200004270-00014; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Munns C, 2007, CELL CALCIUM, V41, P331, DOI 10.1016/j.ceca.2006.07.008; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Smith MP, 2004, NEUROREPORT, V15, P1399, DOI 10.1097/01.wnr.0000126559.35631.54; Sommer C, 1998, BRAIN RES, V784, P154, DOI 10.1016/S0006-8993(97)01327-9; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Thut PD, 2003, NEUROSCIENCE, V119, P1071, DOI 10.1016/S0306-4522(03)00225-2; Vissers K, 2005, ANESTH ANALG, V101, P457, DOI 10.1213/01.ANE.0000158471.41575.F0; Voets T., 2007, V179, P329; Walczak JS, 2006, NEUROSCI LETT, V399, P240, DOI 10.1016/j.neulet.2006.01.058; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Werkheiser JL, 2006, AMINO ACIDS, V30, P307, DOI 10.1007/s00726-005-0306-6	32	534	547	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 3	2007	54	3					379	386		10.1016/j.neuron.2007.04.017	http://dx.doi.org/10.1016/j.neuron.2007.04.017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481392	Bronze			2022-12-17	WOS:000246855700009
J	Fukazawa', Y; Saitoh, Y; Ozawa, F; Ohta, Y; Mizuno, K; Inokuchi, K				Fukazawa', Y; Saitoh, Y; Ozawa, F; Ohta, Y; Mizuno, K; Inokuchi, K			Hippocampal LTP is accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP maintenance in vivo	NEURON			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; AMPA RECEPTOR TRAFFICKING; LIM-KINASE; LATE-PHASE; COFILIN PHOSPHORYLATION; PERFORANT PATHWAYS; ENTORHINAL AREA; MESSENGER-RNA; DENTATE GYRUS	The dendritic spine is an important site of neuronal plasticity and contains extremely high levels of cytoskeletal actin. However, the dynamics of the actin cytoskeleton during synaptic plasticity and its in vivo function remain unclear. Here we used an in vivo dentate gyrus LTP model to show that LTP induction is associated with actin cytoskeletal reorganization characterized by a long-lasting increase in F-actin content within dendritic spines. This increase in F-actin content is dependent on NMDA receptor activation and involves the inactivation of actin depolymerizing factor/cofilin. Inhibition of actin polymerization with latrunculin A impaired late phase of LTP without affecting the initial amplitude and early maintenance of LTP. These observations suggest that mechanisms regulating the spine actin cytoskeleton contribute to the persistence of LTP.	Mitsubishi Kaguku Inst Life Sci, Machida, Tokyo 1948511, Japan; Inst Nat Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Tottori Univ, Lab Anim Sci, Tottori 6808553, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tottori University; Tohoku University; Yokohama National University	Inokuchi, K (corresponding author), Mitsubishi Kaguku Inst Life Sci, Machida, Tokyo 1948511, Japan.	kaoru@libra.ls.m-kagaku.co.jp	Mizuno, Kensaku/G-8631-2015; Inokuchi, Kaoru/AAI-9693-2020; Fukazawa, Yugo/H-9899-2012	Inokuchi, Kaoru/0000-0002-5393-3133; Fukazawa, Yugo/0000-0001-7436-8797				ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Cremona O, 2001, J CELL SCI, V114, P1041; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; ERRINGTON ML, 1987, NEUROSCIENCE, V20, P279, DOI 10.1016/0306-4522(87)90019-4; FIFKOVA E, 1985, BRAIN RES REV, V9, P187, DOI 10.1016/0165-0173(85)90012-8; FIFKOVA E, 1992, INT REV CYTOL, V139, P267, DOI 10.1016/S0074-7696(08)61414-X; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Geinisman Y, 1996, J COMP NEUROL, V368, P413; Gomez LL, 2002, J NEUROSCI, V22, P7027; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V144, P215, DOI 10.1002/cne.901440206; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Langford GM, 1998, BRAIN RES REV, V28, P1, DOI 10.1016/S0165-0173(98)00020-4; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Matsuo R, 1998, NEUROSCI LETT, V244, P173, DOI 10.1016/S0304-3940(98)00159-1; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nguyen PV, 1996, J NEUROSCI, V16, P3189; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simone NL, 2000, AM J PATHOL, V156, P445, DOI 10.1016/S0002-9440(10)64749-9; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Takiguchi-Hayashi K, 1998, BRAIN RES, V801, P9, DOI 10.1016/S0006-8993(98)00496-X; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trommald M, 1996, LEARN MEMORY, V3, P218, DOI 10.1101/lm.3.2-3.218; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Weeks ACW, 1998, BRAIN RES, V798, P211, DOI 10.1016/S0006-8993(98)00425-9; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yamazaki M, 2001, J NEUROCHEM, V79, P192, DOI 10.1046/j.1471-4159.2001.00552.x; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	95	534	553	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2003	38	3					447	460		10.1016/S0896-6273(03)00206-X	http://dx.doi.org/10.1016/S0896-6273(03)00206-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741991	Bronze			2022-12-17	WOS:000182800300009
J	Chen, H; Chedotal, A; He, ZG; Goodman, CS; TessierLavigne, M				Chen, H; Chedotal, A; He, ZG; Goodman, CS; TessierLavigne, M			Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III	NEURON			English	Article							GROWTH CONE GUIDANCE; NERVOUS-SYSTEM; CELL-SURFACE; SPINAL-CORD; LUNG-CANCER; RECOGNITION MOLECULE; ALPHA-DYSTROGLYCAN; EXPRESSION; AGRIN; IDENTIFICATION	Semaphorins are a targe family of secreted and transmembrane proteins, several of which are implicated in repulsive axon guidance. Neuropilin (neuropilin-1) was recently identified as a receptor for Collapsin-1/Semaphorin III/D (Sema III). We report the identification of a related protein, neuropilin-2, whose mRNA is expressed by developing neurons in a pattern largely, though not comptetely, nonoverlapping with that of neuropilin-1. Unlike neuropilin-1, which binds with high affinity to the th ree structurally related semaphorins Sema III, Sema E, and Sema IV, neuropilin-2 shows high affinity binding only to Sema E and Sema IV, not Sema III. These results identify neuropilins as a family of receptors (or components of receptors) for at least one semaphorin subfamily. They also suggest that the specificity of action of different members of this subfamily may be determined by the complement of neuropilins expressed by responsive cells.	UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT CELL & MOL BIOL,BERKELEY,CA 94720	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Chen, H (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA.		Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794				Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Campanelli JT, 1996, DEVELOPMENT, V122, P1663; Chedotal A, 1996, J NEUROSCI, V16, P3296; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; OToole JJ, 1996, P NATL ACAD SCI USA, V93, P7369, DOI 10.1073/pnas.93.14.7369; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Roche J, 1996, ONCOGENE, V12, P1289; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VarelaEchavarria A, 1997, GENE DEV, V11, P545, DOI 10.1101/gad.11.5.545; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Xiang RH, 1996, GENOMICS, V32, P39, DOI 10.1006/geno.1996.0074; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	38	534	563	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					547	559		10.1016/S0896-6273(00)80371-2	http://dx.doi.org/10.1016/S0896-6273(00)80371-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331348	Bronze			2022-12-17	WOS:A1997XZ01600011
J	Guo, M; Jan, LY; Jan, YN				Guo, M; Jan, LY; Jan, YN			Control of daughter cell fates during asymmetric division: Interaction of numb and notch	NEURON			English	Article							DROSOPHILA NEUROGENIC GENE; LOOP-HELIX PROTEINS; ORGAN FORMATION; NERVOUS-SYSTEM; FUSHI-TARAZU; MELANOGASTER; LOCUS; EXPRESSION; RECEPTOR; EMBRYOS	During development of the Drosophila peripheral nervous system, a sensory organ precursor (SOP) cell undergoes rounds of asymmetric divisions to generate four distinct cells of a sensory organ. Numb, a membrane-associated protein, is asymmetrically segregated into one daughter cell during SOP division and acts as an inherited determinant of cell fate. Here, we show that Notch, a transmembrane receptor mediating cell-cell communication, functions as a binary switch in cell fate specification during asymmetric divisions of the SOP and its daughter cells in embryogenesis. Moreover, numb negatively regulates Notch, probably through direct protein-protein interaction that requires the phosphotyrosine-binding (PTB) domain of Numb and either the RAM23 region or the very C-terminal end of Notch. Notch then positively regulates a transcription factor encoded by tramtrack (ttk). This leads to Ttk expression in the daughter cell that does not inherit Numb. Thus, the inherited determinant Numb bestows a bias in the machinery for cell-cell communication to allow the specification of distinct daughter cell fates.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Guo, M (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; ASHBURNER M, 1982, GENETICS, V101, P447; Ashburner M., 1989, DROSOPHILA LAB HDB; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; Bartel PL, 1993, CELLULAR INTERACTION, P153; BATE CM, 1978, HDB SENSORY PHYSL, P1; BIER E, 1988, SCIENCE, V240, P913, DOI 10.1126/science.3129785; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; BROWN JL, 1991, EMBO J, V10, P665, DOI 10.1002/j.1460-2075.1991.tb07995.x; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GINIGER E, 1993, DEVELOPMENT, V117, P431; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JAN YN, 1995, NEURON, V14, P1; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KNUST E, 1992, GENETICS, V132, P505; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; Laminet AA, 1996, J BIOL CHEM, V271, P264, DOI 10.1074/jbc.271.1.264; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; LYMAN DF, 1995, GENETICS, V141, P1491; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; READ D, 1992, MECH DEVELOP, V38, P183, DOI 10.1016/0925-4773(92)90052-L; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RHYU MS, 1994, THESIS U CALIFORNIA; RUCHOLA H, 1991, CELL, V66, P433; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VAESSIN H, 1987, EMBO (European Molecular Biology Organization) Journal, V6, P3431; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; XU T, 1992, DEVELOPMENT, V115, P913; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	77	534	548	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					27	41		10.1016/S0896-6273(00)80278-0	http://dx.doi.org/10.1016/S0896-6273(00)80278-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755476	Bronze			2022-12-17	WOS:A1996UY98100005
J	SHIVERS, BD; KILLISCH, I; SPRENGEL, R; SONTHEIMER, H; KOHLER, M; SCHOFIELD, PR; SEEBURG, PH				SHIVERS, BD; KILLISCH, I; SPRENGEL, R; SONTHEIMER, H; KOHLER, M; SCHOFIELD, PR; SEEBURG, PH			2 NOVEL GABAA RECEPTOR SUBUNITS EXIST IN DISTINCT NEURONAL SUBPOPULATIONS	NEURON			English	Article									UNIV HEIDELBERG,INST NEUROBIOL,D-6900 HEIDELBERG,FED REP GER	Ruprecht Karls University Heidelberg	SHIVERS, BD (corresponding author), UNIV HEIDELBERG,CTR MOLEC BIOL,D-6900 HEIDELBERG,FED REP GER.		; Schofield, Peter/C-9669-2011	Sontheimer, Harald/0000-0002-5843-9871; Schofield, Peter/0000-0003-2967-9662				BORMANN J, 1988, P NATL ACAD SCI USA, V85, P9336, DOI 10.1073/pnas.85.23.9336; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DEBLAS AL, 1988, J NEUROSCI, V8, P602; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; ECCLES JC, 1964, CEREBELLUM NEURONAL, P223; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUGANIR RL, 1987, TRENDS PHARMACOL SCI, V8, P472, DOI 10.1016/0165-6147(87)90041-1; JONES EG, 1985, THALAMUS, P176; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Mugnaini E, 1985, HDB CHEM NEUROANATOM, P436; NIEUWENHUYS R, 1985, CHEMOARCHITECTURE BR, P167; Olsen RW, 1986, BENZODIAZEPINE GABA; PALACIOS JM, 1981, BRAIN RES, V222, P285, DOI 10.1016/0006-8993(81)91034-9; PALACIOS JM, 1980, P NATL ACAD SCI-BIOL, V77, P670, DOI 10.1073/pnas.77.1.670; Paxinos G., 2004, J CHEM INF MODEL, V5th; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; RICHARDS JG, 1987, J NEUROSCI, V7, P1866; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOCH P, 1985, NATURE, V314, P168, DOI 10.1038/314168a0; SEQUIER JM, 1988, P NATL ACAD SCI USA, V85, P7815, DOI 10.1073/pnas.85.20.7815; Shivers B D, 1986, Methods Enzymol, V124, P497; SIEGEL RE, 1988, NEURON, V1, P579, DOI 10.1016/0896-6273(88)90107-9; SIEGHART W, 1985, J NEURAL TRANSM, V63, P191, DOI 10.1007/BF01252025; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; STEPHENSON FA, 1988, BIOCHEM J, V249, P21, DOI 10.1042/bj2490021; UNNERSTALL JR, 1981, J PHARMACOL EXP THER, V218, P797; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WISDEN W, 1988, NEURON, V1, P937, DOI 10.1016/0896-6273(88)90151-1; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; YOUNG WS, 1979, NATURE, V280, P393, DOI 10.1038/280393a0	36	534	556	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1989	3	3					327	337		10.1016/0896-6273(89)90257-2	http://dx.doi.org/10.1016/0896-6273(89)90257-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR527	2561970				2022-12-17	WOS:A1989AR52700007
J	Tuch, DS; Reese, TG; Wiegell, MR; Wedeen, VJ				Tuch, DS; Reese, TG; Wiegell, MR; Wedeen, VJ			Diffusion MRI of complex neural architecture	NEURON			English	Article							BRAIN WHITE-MATTER; MAGNETIC-RESONANCE; WATER DIFFUSION; IN-VIVO; AXONAL PROJECTIONS; PROPAGATOR REPRESENTATION; TENSOR; NMR; SPACE; ANISOTROPY	While functional brain imaging methods can locate the cortical regions subserving particular cognitive functions, the connectivity between the functional areas of the human brain remains poorly understood. Recently, investigators have proposed a method to image neural connectivity noninvasively using a magnetic resonance imaging method called diffusion tensor imaging (DTI). DTI measures the molecular diffusion of water along neural pathways. Accurate reconstruction of neural connectivity patterns from DTI has been hindered, however, by the inability of DTI to resolve more than a single axon direction within each imaging voxel. Here, we present a novel magnetic resonance imaging technique that can resolve multiple axon directions within a single voxel. The technique, called q-ball imaging, can resolve intravoxel white matter fiber crossing as well as white matter insertions into cortex. The ability of q-ball imaging to resolve complex intravoxel fiber architecture eliminates a key obstacle to mapping neural connectivity in the human brain noninvasively.	Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University	Tuch, DS (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, 149 13th St,Room 2301, Charlestown, MA 02129 USA.	dtuch@mit.edu			NCRR NIH HHS [RR14075] Funding Source: Medline; NIMH NIH HHS [MH64044] Funding Source: Medline; NINDS NIH HHS [NS46532] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064044, R56MH064044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS046532] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Arfken G.B., 1985, MATH METHODS PHYS, Vthird, P957; Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.0.CO;2-B; Assaf Y, 1999, NMR BIOMED, V12, P335, DOI 10.1002/(SICI)1099-1492(199910)12:6<335::AID-NBM581>3.0.CO;2-A; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Boor C. D., 2001, PRACTICAL GUIDE SPLI; Bracewell R. N, 1999, FOURIER TRANSFORM IT; Callaghan P.T, 1993, PRINCIPLES NUCL MAGN; Callaghan PT, 1999, REP PROG PHYS, V62, P599, DOI 10.1088/0034-4885/62/4/003; CALLAGHAN PT, 1988, J PHYS E SCI INSTRUM, V21, P820, DOI 10.1088/0022-3735/21/8/017; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; Deans S R, 1993, RADON TRANSFORM SOME; DOUEK P, 1991, J COMPUT ASSIST TOMO, V15, P923, DOI 10.1097/00004728-199111000-00003; Fasshauer GE, 1998, INNOV APPL MATH, P117; Fisher NI., 1987, STAT ANAL SPHERICAL, DOI [10.1017/CBO9780511623059, DOI 10.1017/CBO9780511623059]; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Funk P, 1915, MATH ANN, V77, P129, DOI 10.1007/BF01456824; HARDY RL, 1986, GEOPHYS RES LETT, V13, P18, DOI 10.1029/GL013i001p00018; Helgason S, 1999, RADON TRANSFORM, V5; Hoehn-Berlage M, 1999, NMR BIOMED, V12, P45, DOI 10.1002/(SICI)1099-1492(199902)12:1<45::AID-NBM545>3.0.CO;2-6; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; KARGER J, 1983, J MAGN RESON, V51, P1, DOI 10.1016/0022-2364(83)90094-X; KIMMICH R, 1993, PHYS REV B, V47, P11788, DOI 10.1103/PhysRevB.47.11788; King MD, 1997, MAGN RESON MED, V38, P930, DOI 10.1002/mrm.1910380612; KING MD, 1994, MAGNET RESON MED, V32, P707, DOI 10.1002/mrm.1910320605; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kubicki M, 2002, HARVARD REV PSYCHIAT, V10, P324, DOI 10.1093/hrp/10.6.324; Kuchel PW, 2000, J MAGN RESON, V145, P291, DOI 10.1006/jmre.2000.2093; LEBIHAN D, 1993, NEUROREPORT, V4, P887; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Mangin JF, 2002, NMR BIOMED, V15, P481, DOI 10.1002/nbm.780; MARDIA K. V., 2009, DIRECTIONAL STAT; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Niewenhuys R., 1996, HUMAN CENTRAL NERVOU; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; REESE TG, 1995, MAGNET RESON MED, V34, P786, DOI 10.1002/mrm.1910340603; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Thornton JS, 1997, MAGN RESON IMAGING, V15, P433, DOI 10.1016/S0730-725X(96)00378-5; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; TUCH DS, 2002, THESIS HARVARD U MAS; TURNER R, 1990, J MAGN RESON, V86, P445, DOI 10.1016/0022-2364(90)90023-3; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Zavada T, 1999, PHYS REV E, V60, P1292, DOI 10.1103/PhysRevE.60.1292; Zavada T, 1999, PHYS REV E, V59, P5848, DOI 10.1103/PhysRevE.59.5848	61	533	552	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					885	895		10.1016/S0896-6273(03)00758-X	http://dx.doi.org/10.1016/S0896-6273(03)00758-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659088	Bronze			2022-12-17	WOS:000187042200006
J	Kitsukawa, T; Shimizu, M; Sanbo, M; Hirata, T; Taniguchi, M; Bekku, Y; Yagi, T; Fujisawa, H				Kitsukawa, T; Shimizu, M; Sanbo, M; Hirata, T; Taniguchi, M; Bekku, Y; Yagi, T; Fujisawa, H			Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice	NEURON			English	Article							GROWTH CONE GUIDANCE; NEURONAL RECOGNITION MOLECULE; COLLAPSIN-1 MESSENGER-RNA; SPINAL-CORD; CELL-ADHESION; DIFFERENTIAL EXPRESSION; SENSORY INNERVATION; NEURITE OUTGROWTH; MEMBRANE-PROTEIN; CHICK-EMBRYO	Neuropilin is a neuronal cell surface protein and has been shown to function as a receptor for a secreted protein, semaphorin III/D, that can induce neuronal growth cone collapse and repulsion of neurites in vitro. The roles of neuropilin in vivo, however, are unknown. Here, we report that neuropilin-deficient mutant mice produced by targeted disruption of the neuropilin gene show severe abnormalities in the trajectory of efferent fibers of the PNS. We also describe that neuropilin-deprived dorsal root ganglion neurons are perfectly protected from growth cone collapse elicited by semaphorin III/D. Our results indicate that neuropilin-semaphorin III/D-mediated chemorepulsive signals play a major role in guidance of PNS efferents.	NAGOYA UNIV,GRAD SCH SCI,GRP DEV NEUROBIOL,DIV BIOL SCI,CHIKUSA KU,NAGOYA,AICHI 46401,JAPAN; AICHI HUMAN SERV CTR,INST DEV RES,DEPT MORPHOL,KASUGAI,AICHI 48003,JAPAN; NATL INST PHYSIOL SCI,LAB NEUROBIOL & BEHAV GENET,OKAZAKI,AICHI 444,JAPAN	Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)			Bekku, Yoko/AHB-9813-2022; Kitsukawa, Takashi/X-3176-2018	Bekku, Yoko/0000-0003-3206-1396; 				Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fujisawa H, 1995, DEV NEUROSCI-BASEL, V17, P343, DOI 10.1159/000111304; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HIRATA T, 1993, NEUROSCI RES, V17, P159, DOI 10.1016/0168-0102(93)90092-5; Jin Z, 1997, J NEUROSCI, V17, P6256; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANCEJONES C, 1991, DEV BIOL, V143, P93, DOI 10.1016/0012-1606(91)90057-A; LANDMESSER L, 1984, TRENDS NEUROSCI, V7, P336, DOI 10.1016/S0166-2236(84)80083-1; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RAFUSE VF, 1996, J NEUROSCI, V16, P6846; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; SATODA M, 1995, J NEUROSCI, V15, P942; SCOTT SA, 1986, J NEUROBIOL, V17, P649, DOI 10.1002/neu.480170609; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TESSIERLAVIGNE M, 1996, SCIENCE, V274, P1133; TOSNEY KW, 1988, DEV BIOL, V127, P266, DOI 10.1016/0012-1606(88)90314-4; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; WATANABE S, 1995, BIOCHEM BIOPH RES CO, V213, P130, DOI 10.1006/bbrc.1995.2107; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	51	533	546	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					995	1005		10.1016/S0896-6273(00)80392-X	http://dx.doi.org/10.1016/S0896-6273(00)80392-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390514	Bronze			2022-12-17	WOS:A1997YH59400008
J	PEVSNER, J; HSU, SC; BRAUN, JEA; CALAKOS, N; TING, AE; BENNETT, MK; SCHELLER, RH				PEVSNER, J; HSU, SC; BRAUN, JEA; CALAKOS, N; TING, AE; BENNETT, MK; SCHELLER, RH			SPECIFICITY AND REGULATION OF A SYNAPTIC VESICLE DOCKING COMPLEX	NEURON			English	Article							SURFACE-PLASMON RESONANCE; YEAST SECRETORY PATHWAY; PROTEIN; FUSION; SYNTAXIN; IDENTIFICATION; RECEPTORS; CLONING; FAMILY; EVENTS	Synaptic vesicles are proposed to dock at the presynaptic plasma membrane through the interaction of two integral membrane proteins of synaptic vesicles, VAMP and synaptotagmin, and two plasma membrane proteins, syntaxin and SNAP-25. We have characterized the binding properties' of these proteins and observed SNAP-25 potentiation of VAMP 2 binding to syntaxins 1a and 4 but not syntaxins 2 or 3. n-sec1, a neuron-specific syntaxin-binding protein, bound syntaxin with nanomolar affinity, forming a complex that is distinct from the previously identified 7S and 20S syntaxin-containing complexes. This suggests that syntaxin exists in at least three states: bound to n-sec1, in a 7S particle, and in a 20S particle. Recombinant n-sec1 inhibited VAMP or SNAP-25 binding to syntaxin. We propose that the specific associations of VAMP, SNAP-25, and syntaxin mediate vesicle docking and that a syntaxin/n-sec 1 complex precedes and/or regulates formation of these complexes.			PEVSNER, J (corresponding author), STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305, USA.			Ting, Anthony/0000-0002-5058-9576				AALTO MK, 1991, YEAST, V7, P643, DOI 10.1002/yea.320070613; Bennett J., 1985, NEUROTRANSMITTER REC, V2nd, P61; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; INOUE A, 1992, J BIOL CHEM, V267, P10613; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0	29	533	538	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1994	13	2					353	361		10.1016/0896-6273(94)90352-2	http://dx.doi.org/10.1016/0896-6273(94)90352-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060616				2022-12-17	WOS:A1994PD43000008
J	TRIMMER, JS; COOPERMAN, SS; TOMIKO, SA; ZHOU, JY; CREAN, SM; BOYLE, MB; KALLEN, RG; SHENG, ZH; BARCHI, RL; SIGWORTH, FJ; GOODMAN, RH; AGNEW, WS; MANDEL, G				TRIMMER, JS; COOPERMAN, SS; TOMIKO, SA; ZHOU, JY; CREAN, SM; BOYLE, MB; KALLEN, RG; SHENG, ZH; BARCHI, RL; SIGWORTH, FJ; GOODMAN, RH; AGNEW, WS; MANDEL, G			PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION OF A MAMMALIAN SKELETAL-MUSCLE SODIUM-CHANNEL	NEURON			English	Review									UNIV PENN,DAVID MAHONEY INST NEUROL SCI,SCH MED,PHILADELPHIA,PA 19104; TUFTS UNIV,NEW ENGLAND MED CTR,SCH MED,DIV MOLEC MED,BOSTON,MA 02111	University of Pennsylvania; Tufts Medical Center; Tufts University	TRIMMER, JS (corresponding author), YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06510, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022518, R01NS017928] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38156] Funding Source: Medline; NINDS NIH HHS [NS17928, NS22518] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P378; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; BARCHI RL, 1980, P NATL ACAD SCI-BIOL, V77, P1306, DOI 10.1073/pnas.77.3.1306; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; CAMPBELL DT, 1976, J GEN PHYSIOL, V67, P309, DOI 10.1085/jgp.67.3.309; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Colman A., 1984, TRANSCRIPTION TRANSL, P49; COOPERMAN SS, 1987, P NATL ACAD SCI USA, V84, P8721, DOI 10.1073/pnas.84.23.8721; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; GONOI T, 1987, J NEUROSCI, V7, P1728; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P327, DOI 10.1093/nar/14.1.327; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1988, MOL BIOL ION CHANNEL, V33, P289; HARRIS J B, 1973, Nature New Biology, V243, P191; HARRIS JB, 1971, ACTA PHYSIOL SCAND, V83, P382, DOI 10.1111/j.1748-1716.1971.tb05091.x; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Hille B, 1984, IONIC CHANNELS EXCIT, P426; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRANER SD, 1985, J BIOL CHEM, V260, P6341; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; MAIZEL JV, 1981, P NATL ACAD SCI-BIOL, V78, P7665, DOI 10.1073/pnas.78.12.7665; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; Maniatis T., 1982, MOL CLONING; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; OGURA A, 1984, JAP J PHARM, V36, P192; OXFORD GS, 1978, J GEN PHYSIOL, V71, P227, DOI 10.1085/jgp.71.3.227; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPPONE P, 1980, J PHYSIOL-LONDON, V305, P377; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; REDFERN P, 1971, ACTA PHYSIOL SCAND, V82, P70, DOI 10.1111/j.1748-1716.1971.tb04943.x; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; ROGART RB, 1985, BRAIN RES, V329, P314, DOI 10.1016/0006-8993(85)90541-4; ROSENBERG RL, 1984, P NATL ACAD SCI-BIOL, V81, P1239, DOI 10.1073/pnas.81.4.1239; ROSENBERG RL, 1984, P NATL ACAD SCI USA, V81, P5591; ROSSIE S, 1987, J BIOL CHEM, V262, P17530; SALKOFF L, 1987, SCIENCE, V237, P744, DOI 10.1126/science.2441469; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; STADEN R, 1980, NUCLEIC ACIDS RES, V8, P3673, DOI 10.1093/nar/8.16.3673; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; STUHMER W, 1989, IN PRESS NATURE; SUTTON F, 1988, MOL BRAIN RES, V3, P187, DOI 10.1016/0169-328X(88)90065-4; SUZUKI H, 1988, FEBS LETT, V228, P195, DOI 10.1016/0014-5793(88)80615-X; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TOMIKO SA, 1986, BIOCHEMISTRY-US, V25, P2162, DOI 10.1021/bi00356a047; TRIMMER JS, 1989, ANNU REV PHYSIOL, V51, P401, DOI 10.1146/annurev.physiol.51.1.401; WEISS RE, 1986, SCIENCE, V233, P361, DOI 10.1126/science.2425432	73	533	543	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1989	3	1					33	49		10.1016/0896-6273(89)90113-X	http://dx.doi.org/10.1016/0896-6273(89)90113-X			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG992	2559760				2022-12-17	WOS:A1989AG99200004
J	Monory, K; Massa, F; Egertova, M; Eder, M; Blaudzun, H; Westenbroek, R; Kelsch, W; Jacob, W; Marsch, R; Ekker, M; Long, J; Rubenstein, JL; Goebbels, S; Nave, KA; During, M; Klugmann, M; Wolfel, B; Dodt, HU; Zieglgansberger, W; Wotjak, CT; Mackie, K; Elphick, MR; Marsicano, G; Lutz, B				Monory, Krisztina; Massa, Federico; Egertova, Michaela; Eder, Matthias; Blaudzun, Heike; Westenbroek, Ruth; Kelsch, Wolfgang; Jacob, Wolfgang; Marsch, Rudolf; Ekker, Marc; Long, Jason; Rubenstein, John L.; Goebbels, Sandra; Nave, Klaus-Armin; During, Matthew; Klugmann, Matthias; Woelfel, Barbara; Dodt, Hans-Ulrich; Zieglgaensberger, Walter; Wotjak, Carsten T.; Mackie, Ken; Elphick, Maurice R.; Marsicano, Giovanni; Lutz, Beat			The endocannabinoid system controls key epileptogenic circuits in the hippocampus	NEURON			English	Article							CB1 CANNABINOID RECEPTORS; GLUTAMATERGIC SYNAPTIC-TRANSMISSION; ACID-INDUCED SEIZURE; RAT-BRAIN; IMMUNOHISTOCHEMICAL LOCALIZATION; DOUBLE REPORTER; MESSENGER-RNA; GABA RELEASE; EXPRESSION; FOREBRAIN	Balanced control of neuronal activity is central in maintaining function and viability of neuronal circuits. The endocannabinoid system tightly controls neuronal excitability. Here, we show that endocannabinoids directly target hippocampal glutamatergic neurons to provide protection against acute epileptiform seizures in mice. Functional CB1 cannabinoid receptors are present on glutamatergic terminals of the hippocampal formation, colocalizing with vesicular glutamate transporter 1 (VGluT1). Conditional deletion of the CB1 gene either in cortical glutamatergic neurons or in forebrain GABAergic neurons, as well as virally induced deletion of the CB1 gene in the hippocampus, demonstrate that the presence of CB1 receptors in glutamatergic hippocampal neurons is both necessary and sufficient to provide substantial endogenous protection against kainic acid (KA)-induced seizures. The direct endocannabinoid-mediated control of hippocampal glutamatergic neurotransmission may constitute a promising therapeutic target for the treatment of disorders associated with excessive excitatory neuronal activity.	Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany; Max Planck Inst Psychiat, D-80804 Munich, Germany; Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada; Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; Univ Auckland, Sch Med, Dept Mol Med & Pathol, Auckland 92019, New Zealand	Johannes Gutenberg University of Mainz; Max Planck Society; University of London; Queen Mary University London; University of Washington; University of Washington Seattle; University of Ottawa; University of California System; University of California San Francisco; Max Planck Society; University of Auckland	Marsicano, G (corresponding author), INSERM, Inst Francois Magendie, AVENIR, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	giovanni.marsicano@bordeaux.inserm.fr; blutz@uni-mainz.de	Nave, Klaus-Armin/C-8883-2011; During, Matthew/AAC-1388-2020; Massa, Federico/C-5697-2011; Lutz, Beat/AAG-4538-2022; Wotjak, Carsten T./S-3200-2019; Mackie, Kenneth P/B-7358-2011; Marsicano, Giovanni/I-9603-2016; Lutz, Beat/AFK-6229-2022; Mackie, Ken/E-3715-2013	Massa, Federico/0000-0002-9427-3418; Mackie, Ken/0000-0001-8501-6199; Elphick, Maurice/0000-0002-9169-0048; Kelsch, Wolfgang/0000-0002-3470-8125; Marsicano, Giovanni/0000-0003-3804-1951; Eder, Matthias/0000-0002-2579-2628	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH049428, K05MH065670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000286, P01DA015916, R01DA011322] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [S19916] Funding Source: Medline; NIDA NIH HHS [K02 DA000286, DA00286, R01 DA011322, DA15916, P01 DA015916, DA11322] Funding Source: Medline; NIMH NIH HHS [MH065670, MH49428, K05 MH065670, R01 MH049428, R37 MH049428] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Aparicio LC, 2004, J NEUROCHEM, V91, P30, DOI 10.1111/j.1471-4159.2004.02633.x; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2003, BRIT J PHARMACOL, V140, P781, DOI 10.1038/sj.bjp.0705466; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Harkany T, 2003, EUR J NEUROSCI, V18, P1979, DOI 10.1046/j.1460-9568.2003.02898.x; Hoffman AF, 2005, EUR J NEUROSCI, V22, P2387, DOI 10.1111/j.1460-9568.2005.04401.x; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Johnston D., 2004, SYNAPTIC ORG BRAIN, V5th, P455; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kleppisch T, 2003, J NEUROSCI, V23, P6005, DOI 10.1523/JNEUROSCI.23-14-06005.2003; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Lee J, 2002, NEUROSCI LETT, V333, P87, DOI 10.1016/S0304-3940(02)00987-4; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Mohler H, 2002, J PHARMACOL EXP THER, V300, P2, DOI 10.1124/jpet.300.1.2; Morozov A, 2003, BIOL PSYCHIAT, V54, P1125, DOI 10.1016/S0006-3223(03)00467-0; Nomura M, 2000, NEUROENDOCRINOLOGY, V71, P318, DOI 10.1159/000054552; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ong WY, 1999, NEUROSCIENCE, V92, P1177, DOI 10.1016/S0306-4522(99)00025-1; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; Wager-Miller J, 2002, CHEM PHYS LIPIDS, V121, P83, DOI 10.1016/S0009-3084(02)00151-2; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	59	532	546	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					455	466		10.1016/j.neuron.2006.07.006	http://dx.doi.org/10.1016/j.neuron.2006.07.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908411	Green Accepted, Bronze			2022-12-17	WOS:000240504700009
J	Dierks, T; Linden, DEJ; Jandl, M; Formisano, E; Goebel, R; Lanfermann, H; Singer, W				Dierks, T; Linden, DEJ; Jandl, M; Formisano, E; Goebel, R; Lanfermann, H; Singer, W			Activation of Heschl's Gyrus during auditory hallucinations	NEURON			English	Article							FUNCTIONAL NEUROANATOMY; VERBAL IMAGERY; INNER SPEECH; HUMAN BRAIN; CORTEX; SCHIZOPHRENIA; ANATOMY; NOISE; AREA; MRI	Apart from being a common feature of mental illness, auditory hallucinations provide an intriguing model for the study of internally generated sensory perceptions that are attributed to external sources. Until now, the knowledge about the cortical network that supports such hallucinations has been restricted by methodological limitations. Here, we describe an experiment with paranoid schizophrenic patients whose on- and offset of auditory hallucinations could be monitored within one functional magnetic resonance imaging (fMRI) session. We demonstrate an increase of the blood oxygen level-dependent (BOLD) signal in Heschl's gyrus during the patients' hallucinations. Our results provide direct evidence of the involvement of primary auditory areas in auditory verbal hallucinations and establish novel constraints for psychopathological models.	Univ Frankfurt, Div Clin Neurophysiol, Dept Psychiat 1, DE-60528 Frankfurt, Germany; Univ Frankfurt, Dept Neuroradiol, DE-60528 Frankfurt, Germany; Max Planck Inst Hirnforsch, DE-60528 Frankfurt, Germany; Univ Naples Federico II, Dept Elect Engn, I-80138 Naples, Italy	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; University of Naples Federico II	Dierks, T (corresponding author), Univ Frankfurt, Div Clin Neurophysiol, Dept Psychiat 1, DE-60528 Frankfurt, Germany.		Dierks, Thomas/B-7092-2012; Lanfermann, Heinrich/AAR-4069-2021; Linden, David E J/C-7355-2013; Linden, David/S-9948-2019	Dierks, Thomas/0000-0002-4173-5308; Linden, David E J/0000-0002-5638-9292; Linden, David/0000-0002-5638-9292				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Bandettini PA, 1998, MAGNET RESON MED, V39, P410, DOI 10.1002/mrm.1910390311; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; BRAAK H, 1978, ANAT EMBRYOL, V154, P213, DOI 10.1007/BF00304663; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; David AS, 1996, NEUROREPORT, V7, P932, DOI 10.1097/00001756-199603220-00021; Dhankhar A, 1997, J NEUROPHYSIOL, V77, P476, DOI 10.1152/jn.1997.77.1.476; FRITH CD, 1997, HUMAN BRAIN FUNCTION, P329; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; MCCARTHY G, 1993, P NATL ACAD SCI USA, V90, P4952, DOI 10.1073/pnas.90.11.4952; McGuire PK, 1996, PSYCHOL MED, V26, P29, DOI 10.1017/S0033291700033699; McGuire PK, 1996, BRIT J PSYCHIAT, V169, P148, DOI 10.1192/bjp.169.2.148; MCGUIRE PK, 1993, LANCET, V342, P703, DOI 10.1016/0140-6736(93)91707-S; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; Silbersweig D, 1996, MOL PSYCHIATR, V1, P367; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Silbersweig DA, 1998, PHILOS T ROY SOC B, V353, P1883, DOI 10.1098/rstb.1998.0340; Strainer JC, 1997, AM J NEURORADIOL, V18, P601; Talairach J., 1988, COPLANAR STEREOTAXIC; TIIHONEN J, 1992, AM J PSYCHIAT, V149, P255; Ulmer JL, 1998, J COMPUT ASSIST TOMO, V22, P111, DOI 10.1097/00004728-199801000-00021; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Woodruff PWR, 1997, AM J PSYCHIAT, V154, P1676, DOI 10.1176/ajp.154.12.1676	27	532	539	0	46	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					615	621		10.1016/S0896-6273(00)80715-1	http://dx.doi.org/10.1016/S0896-6273(00)80715-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197540	Bronze			2022-12-17	WOS:000079483900024
J	PUIA, G; SANTI, MR; VICINI, S; PRITCHETT, DB; PURDY, RH; PAUL, SM; SEEBURG, PH; COSTA, E				PUIA, G; SANTI, MR; VICINI, S; PRITCHETT, DB; PURDY, RH; PAUL, SM; SEEBURG, PH; COSTA, E			NEUROSTEROIDS ACT ON RECOMBINANT HUMAN GABA-A RECEPTORS	NEURON			English	Article									UNIV HEIDELBERG,CTR MOLEC BIOL,W-6900 HEIDELBERG,GERMANY; SW FDN BIOMED RES,DEPT ORGAN CHEM,SAN ANTONIO,TX 78284; NIMH,CLIN NEUROSCI BRANCH,BETHESDA,MD 20892	Ruprecht Karls University Heidelberg; Texas Biomedical Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	PUIA, G (corresponding author), GEORGETOWN UNIV,FIDIA GEORGETOWN INST NEUROSCI,WASHINGTON,DC 20007, USA.		Paul, Steve/ABE-5400-2020; Puja, Giulia/C-3540-2015	Puja, Giulia/0000-0001-8385-6020; Vicini, Stefano/0000-0001-8671-5194; Ribeiro, Jessyca/0000-0003-0068-0061				BORMANN J, 1985, P NATL ACAD SCI USA, V82, P2168, DOI 10.1073/pnas.82.7.2168; CALLACHAN H, 1987, PROC R SOC SER B-BIO, V231, P359, DOI 10.1098/rspb.1987.0049; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CRAWLEY JN, 1986, BRAIN RES, V398, P382, DOI 10.1016/0006-8993(86)91500-3; GEE KW, 1988, J PHARMACOL EXP THER, V246, P803; HAMILL OP, 1983, NATURE, V305, P805, DOI 10.1038/305805a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; MACDONALD RL, 1989, J PHYSIOL-LONDON, V417, P483, DOI 10.1113/jphysiol.1989.sp017814; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; MATHERS DA, 1987, SYNAPSE, V1, P96, DOI 10.1002/syn.890010113; MATHERS DA, 1985, CAN J PHYSL, V339, P663; MENDELSON WB, 1987, PSYCHOPHARMACOLOGY, V93, P226; MIENVILLE JM, 1989, BRAIN RES, V489, P190, DOI 10.1016/0006-8993(89)90024-3; MIENVILLE JM, 1989, PSYCHOPHARMACOLOGY, V489, P190; MORROW AL, 1987, EUR J PHARMACOL, V142, P483, DOI 10.1016/0014-2999(87)90094-X; MORROW AL, 1990, IN PRESS MOL PHARM; PETERS JA, 1988, BRIT J PHARMACOL, V94, P1257, DOI 10.1111/j.1476-5381.1988.tb11646.x; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; PURDY RH, 1990, IN PRESS J MED CHEM; STUDY RE, 1981, P NATL ACAD SCI-BIOL, V78, P7180, DOI 10.1073/pnas.78.11.7180; TURNER DM, 1989, J PHARMACOL EXP THER, V248, P960; VICINI S, 1985, J NEUROSCI, V5, P2212; VICINI S, 1987, J PHARMACOL EXP THER, V243, P1195	27	532	540	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1990	4	5					759	765		10.1016/0896-6273(90)90202-Q	http://dx.doi.org/10.1016/0896-6273(90)90202-Q			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE975	2160838				2022-12-17	WOS:A1990DE97500011
J	Capela, A; Temple, S				Capela, A; Temple, S			LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC ANTIGEN SSEA-1; PRIMORDIAL GERM-CELLS; RAT CEREBRAL-CORTEX; MAMMALIAN FOREBRAIN; IN-VIVO; SUBEPENDYMAL CELLS; PROGENITOR CELLS; SELF-RENEWAL; SPINAL-CORD	Adult neural stem cells are rare, and little is known about their unique characteristics, leaving their in vivo identity enigmatic. We show that Lewis X (LeX), a carbohydrate expressed by embryonic pluripotent stem cells, is made by adult mouse subventricular zone (SVZ) stem cells and shed into their environment. Only 4% of acutely isolated SVZ cells are LeX(+); this subpopulation, purified by FACS, contains the SVZ stem cells. Ependymal cells are LeX(-), and purified ependymal cells do not make neurospheres, resolving the controversial claim that these are stem cells. Thus, LeX expression by adult CNS stem cells aids their in vivo identification, allows their enrichment, and raises new questions about the role of this unusual carbohydrate in stem cell biology.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	Albany Medical College	Temple, S (corresponding author), Stemcells Inc, 3155 Porter Dr, Palo Alto, CA 94304 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033529] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS33529] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allendoerfer KL, 1999, DEV BIOL, V211, P208, DOI 10.1006/dbio.1999.9308; ALLENDOERFER KL, 1995, MOL CELL NEUROSCI, V6, P381, DOI 10.1006/mcne.1995.1029; Ashwell KWS, 1997, CELL TISSUE RES, V289, P17, DOI 10.1007/s004410050848; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; BARTSCH D, 1991, CELL TISSUE RES, V263, P353, DOI 10.1007/BF00318777; BIRD JM, 1984, DEV BIOL, V104, P449, DOI 10.1016/0012-1606(84)90101-5; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; CAMPOSORTEGA JA, 1995, MOL NEUROBIOL, V10, P75, DOI 10.1007/BF02740668; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DODD J, 1986, J EXP BIOL, V124, P225; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dvorak P, 1998, J CELL SCI, V111, P2945; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gocht A, 1996, HISTOL HISTOPATHOL, V11, P1007; GOMPERTS M, 1994, DEVELOPMENT, V120, P135; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Gritti A, 1996, J NEUROSCI, V16, P1091; HAKOMORI SI, 1992, HISTOCHEM J, V24, P771, DOI 10.1007/BF01046348; JESSELL TM, 1990, ANNU REV NEUROSCI, V13, P227, DOI 10.1146/annurev.ne.13.030190.001303; Jirmanova L, 1999, INT J DEV BIOL, V43, P555; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mai JK, 1998, EUR J NEUROSCI, V10, P746, DOI 10.1046/j.1460-9568.1998.00029.x; MARANI E, 1986, ACTA MORPHOL NEER SC, V24, P103; MARANI E, 1983, HISTOCHEMISTRY, V78, P157, DOI 10.1007/BF00489494; Marmur R, 1998, DEV BIOL, V204, P577, DOI 10.1006/dbio.1998.9099; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Muramatsu T, 1994, Nagoya J Med Sci, V57, P95; Nowakowski R S, 2000, Science, V288, P771; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Reynolds R, 1997, J NEUROSCI RES, V47, P455, DOI 10.1002/(SICI)1097-4547(19970301)47:5<455::AID-JNR1>3.0.CO;2-G; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; TOLE S, 1995, J NEUROSCI, V15, P957; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weiss S, 1996, J NEUROSCI, V16, P7599; Winkler C, 1998, MOL CELL NEUROSCI, V11, P99, DOI 10.1006/mcne.1998.0674; YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3045, DOI 10.1073/pnas.82.9.3045	58	530	570	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					865	875		10.1016/S0896-6273(02)00835-8	http://dx.doi.org/10.1016/S0896-6273(02)00835-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372282	Bronze			2022-12-17	WOS:000177779800010
J	Qiu, J; Cai, CM; Dai, HN; McAtee, M; Hoffman, PN; Bregman, BS; Filbin, MT				Qiu, J; Cai, CM; Dai, HN; McAtee, M; Hoffman, PN; Bregman, BS; Filbin, MT			Spinal axon regeneration induced by elevation of cyclic AMP	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; ADULT NEURONS; CORD INJURY; GROWTH; CNS; SURVIVAL; PROMOTE; CELLS; RATS	Myelin inhibitors, including MAG, are major impediments to CNS regeneration. However, CNS axons of DRGs regenerate if the peripheral branch of these neurons is lesioned first. We show that 1 day post-peripheral-lesion, DRG-cAMP levels triple and MAG/myelin no longer inhibit growth, an effect that is PKA dependent. By 1 week post-lesion, DRG-cAMP returns to control, but growth on MAG/myelin improves and is now PKA independent. Inhibiting PKA in vivo blocks the post-lesion growth on MAG/myelin at 1 day and attenuates it at I week. Alone, injection of db-cAMP into the DRG mimics completely a conditioning lesion as DRGs grow on MAG/myelin, initially, in a PKA-dependent manner that becomes PKA independent. Importantly, DRG injection of db-cAMP results in extensive regeneration of dorsal column axons lesioned 1 week later. These results may be relevant to developing therapies for spinal cord injury.	CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; Georgetown Univ, Sch Med, Dept Neurosci, Washington, DC 20007 USA; Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21218 USA	City University of New York (CUNY) System; Hunter College (CUNY); Georgetown University; Johns Hopkins University	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.			Cai, Dongming/0000-0002-0601-6826	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037060, U54NS041073, R01NS019259, R01NS037060] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41073, NS 37060, NS19259] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Bradbury EJ, 2000, TRENDS PHARMACOL SCI, V21, P389, DOI 10.1016/S0165-6147(00)01536-4; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Filbin MT, 1999, NEURON, V23, P2, DOI 10.1016/S0896-6273(00)80744-8; Fitch MT, 1999, CNS REGENERATION BAS, P55; Hanson MG, 1998, J NEUROSCI, V18, P7361; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; MESULAM MM, 1976, J HISTOCHEM CYTOCHEM, V24, P1273, DOI 10.1177/24.12.63512; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Scherer S.S., 1996, GLIAL CELL DEV, P165; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Smith DS, 1997, J NEUROSCI, V17, P646; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489	26	530	548	4	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					895	903		10.1016/S0896-6273(02)00730-4	http://dx.doi.org/10.1016/S0896-6273(02)00730-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086638	Bronze			2022-12-17	WOS:000176249700008
J	de Bruyne, M; Foster, K; Carlson, JR				de Bruyne, M; Foster, K; Carlson, JR			Odor coding in the Drosophila antenna	NEURON			English	Article							OLFACTORY RECEPTOR NEURONS; 7-TRANSMEMBRANE PROTEINS; CHEMOSENSORY RECEPTORS; SENSORY MAP; WILD-TYPE; MELANOGASTER; ORGANIZATION; EXPRESSION; RESPONSES; PHEROMONE	Odor coding in the Drosophila antenna is examined by a functional analysis of individual olfactory receptor neurons (ORNs) in vivo. Sixteen distinct classes of ORNs, each with a unique response spectrum to a panel of 47 diverse odors, are identified by extracellular recordings. ORNs exhibit multiple modes of response dynamics: an individual neuron can show either excitatory or inhibitory responses, and can exhibit different modes of termination kinetics, when stimulated with different odors. The 16 ORN classes are combined in stereotyped configurations within seven functional types of basiconic sensilla. One sensillum type contains four ORNs and the others contain two neurons, combined according to a strict pairing rule. We provide a functional map of ORNs, showing that each ORN class is restricted to a particular spatial domain on the antennal surface.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.				NIDCD NIH HHS [DC-02174] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Boeckh J., 1981, P86; BOEKHOFF I, 1994, J NEUROSCI, V14, P3304; BORST A, 1984, J INSECT PHYSIOL, V30, P507, DOI 10.1016/0022-1910(84)90032-5; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; DENOTTER CJ, 1992, PHYSIOL ENTOMOL, V17, P33, DOI 10.1111/j.1365-3032.1992.tb00987.x; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Grant AJ, 1998, J COMP PHYSIOL A, V183, P433, DOI 10.1007/s003590050269; Hansson BS, 1999, PHYSIOL ENTOMOL, V24, P121, DOI 10.1046/j.1365-3032.1999.00121.x; HATT H, 1994, P NATL ACAD SCI USA, V91, P6264, DOI 10.1073/pnas.91.14.6264; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hing ALY, 1996, J NEUROBIOL, V30, P454; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; POSTLETHWAIT JH, 1971, DEV BIOL, V24, P477, DOI 10.1016/0012-1606(71)90061-3; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; RIESGOESCOVAR J, 1995, P NATL ACAD SCI USA, V92, P2864, DOI 10.1073/pnas.92.7.2864; RiesgoEscovar JR, 1997, J COMP PHYSIOL A, V180, P151, DOI 10.1007/s003590050036; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Siddiqi O., 1991, CHEM SENSES, P79; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VENKATESH S, 1984, INT J INSECT MORPHOL, V13, P51, DOI 10.1016/0020-7322(84)90032-1; Vickers NJ, 1996, J COMP PHYSIOL A, V178, P831, DOI 10.1007/BF00225831; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278	46	530	542	2	60	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					537	552		10.1016/S0896-6273(01)00289-6	http://dx.doi.org/10.1016/S0896-6273(01)00289-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395013	Bronze			2022-12-17	WOS:000168962000024
J	Xiao, B; Tu, JC; Petralia, RS; Yuan, JP; Doan, A; Breder, CD; Ruggiero, A; Lanahan, AA; Wenthold, RJ; Worley, PF				Xiao, B; Tu, JC; Petralia, RS; Yuan, JP; Doan, A; Breder, CD; Ruggiero, A; Lanahan, AA; Wenthold, RJ; Worley, PF			Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of Homer-related, synaptic proteins	NEURON			English	Article							ALDRICH-SYNDROME PROTEIN; TRANSGENIC MICE; GENE; SEQUENCE; CYTOSKELETON; EXPRESSION; MEMBRANE; VASP	Homer is a neuronal immediate early gene (IEG) that is enriched at excitatory synapses and binds group 1 metabotropic glutamate receptors (mGluRs). Here, we characterize a family of Homer-related proteins derived from three distinct genes. Like Homer IEG (now termed Homer 1a), all new members bind group 1 mGluRs. In contrast to Homer 1a, new members are constitutively expressed and encode a C-terminal coiled-coil (CC) domain that mediates self-multimerization. CC-Horners form natural complexes that cross-link mGluRs and are enriched at the postsynaptic density. Homer 1a does not multimerize and blocks the association of mGluRs with CC-Homer complexes. These observations support a model in which the dynamic expression of Homer 1a competes with constitutively expressed CC-Homers to modify synaptic mGluR properties.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@bs.jhmi.edu		Xiao, Bo/0000-0002-6161-9478	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010309, R01DA010309, R01DA011742] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10309, DA11742] Funding Source: Medline; NIMH NIH HHS [KO2 MH01152] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; GORDON JW, 1987, CELL, V50, P445, DOI 10.1016/0092-8674(87)90498-3; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Lanahan A, 1997, J NEUROSCI, V17, P2876; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; Matsubara A, 1996, J NEUROSCI, V16, P4457; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Park HT, 1997, MOL BRAIN RES, V52, P318, DOI 10.1016/S0169-328X(97)00292-1; Petralia RS, 1997, J CHEM NEUROANAT, V13, P77, DOI 10.1016/S0891-0618(97)00023-9; Ponting CP, 1997, J MOL MED-JMM, V75, P769, DOI 10.1007/s001090050166; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STREHLER EE, 1986, J MOL BIOL, V190, P291, DOI 10.1016/0022-2836(86)90003-3; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Wang YX, 1998, J NEUROSCI, V18, P1148; WORLEY PF, 1990, MOL MECH AGING, P62; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2	27	530	553	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					707	716		10.1016/S0896-6273(00)80588-7	http://dx.doi.org/10.1016/S0896-6273(00)80588-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808458	Bronze			2022-12-17	WOS:000076697300015
J	Micheva, KD; Smith, SJ				Micheva, Kristina D.; Smith, Stephen J.			Array tomography: A new tool for Imaging the molecular architecture and ultrastructure of neural circuits	NEURON			English	Article							FLUORESCENCE MICROSCOPY; SEMITHIN SECTIONS; ELECTRON-MICROSCOPY; ADULT-RAT; LR-WHITE; IMMUNOFLUORESCENCE; PROTEIN; SYNAPSES; ANTIGENS; NEURONS	Many biological functions depend critically upon fine details of tissue molecular architecture that have resisted exploration by existing imaging techniques. This is particularly true for nervous system tissues, where information processing function depends on intricate circuit and synaptic architectures. Here, we describe a new imaging method, called array tomography, which combines and extends superlative features of modern optical fluorescence and electron microscopy methods. Based on methods for constructing and repeatedly staining and imaging ordered arrays of ultrathin (50-200 nm), resin-embedded serial sections on glass microscope slides, array tomography allows for quantitative, high-resolution, large-field volumetric imaging of large numbers of antigens, fluorescent proteins, and ultrastructure in individual tissue specimens. Compared to confocal microscopy, array tomography offers the advantage of better spatial resolution, in particular along the z axis, as well as depth-independent immunofluorescent staining. The application of array tomography can reveal important but previously unseen features of brain molecular architecture.	Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Micheva, KD (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kmicheva@stanford.edu; sjsmith@stanford.edu	Micheva, Kristina/ABH-6913-2020	Micheva, Kristina/0000-0003-1138-3732; Smith, Stephen/0000-0002-2290-8701	NINDS NIH HHS [R01 NS054252-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054252] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRECHT U, 1990, BRAIN RES, V535, P49, DOI 10.1016/0006-8993(90)91823-Y; Blumer MJF, 2002, J NEUROSCI METH, V120, P11, DOI 10.1016/S0165-0270(02)00166-8; BRORSON SH, 1994, MICRON, V25, P453, DOI 10.1016/0968-4328(94)00035-2; Burette A, 2001, J NEUROSCI, V21, P495, DOI 10.1523/JNEUROSCI.21-02-00495.2001; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Frassoni C, 2005, NEUROSCIENCE, V131, P813, DOI 10.1016/j.neuroscience.2004.11.042; Geinisman Y, 1996, J NEUROCYTOL, V25, P805, DOI 10.1007/BF02284843; Haraguchi CM, 2002, HISTOCHEM CELL BIOL, V117, P81, DOI 10.1007/s00418-001-0363-1; HERKEN R, 1988, HISTOCHEM J, V20, P427, DOI 10.1007/BF01002428; KOLODZIEJCZYK E, 1986, J HISTOCHEM CYTOCHEM, V34, P1725, DOI 10.1177/34.12.3023476; Kurth T, 1996, CELL TISSUE RES, V286, P1, DOI 10.1007/s004410050669; Lee LY, 2004, APPL ENVIRON MICROB, V70, P5732, DOI 10.1128/AEM.70.10.5732-5736.2004; Luby-Phelps K, 2003, J HISTOCHEM CYTOCHEM, V51, P271, DOI 10.1177/002215540305100301; Matsunaga W, 2002, NEUROSCIENCE, V111, P151, DOI 10.1016/S0306-4522(01)00607-8; MATUS AI, 1975, J NEUROCYTOL, V4, P733, DOI 10.1007/BF01181633; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Mori M, 2006, J ELECTRON MICROSC, V55, P107, DOI 10.1093/jmicro/dfl011; Newman GR, 1999, HISTOCHEM J, V31, P495, DOI 10.1023/A:1003850921869; NEWMAN GR, 1987, J HISTOCHEM CYTOCHEM, V35, P971, DOI 10.1177/35.9.3302021; NEWMAN GR, 1983, HISTOCHEM J, V15, P543, DOI 10.1007/BF01954145; OJEDA JL, 1989, STAIN TECHNOL, V64, P243, DOI 10.3109/10520298909107009; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; PAWLEY JB, 1995, HDB BIOL CONFOCAL MI; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; SONG LL, 1995, BIOPHYS J, V68, P2588, DOI 10.1016/S0006-3495(95)80442-X; Sukhanova A, 2002, LAB INVEST, V82, P1259, DOI 10.1097/01.LAB.0000027837.13582.E8; Tafoya LCR, 2006, J NEUROSCI, V26, P7826, DOI 10.1523/JNEUROSCI.1866-06.2006; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; TRAMU G, 1978, J HISTOCHEM CYTOCHEM, V26, P322, DOI 10.1177/26.4.207771; Wahlby C, 2002, CYTOMETRY, V47, P32, DOI 10.1002/cyto.10026; Zondervan R, 2004, J PHYS CHEM A, V108, P1657, DOI 10.1021/jp037222e	36	529	549	3	46	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					25	36		10.1016/j.neuron.2007.06.014	http://dx.doi.org/10.1016/j.neuron.2007.06.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610815	Green Accepted, Bronze			2022-12-17	WOS:000248010700006
J	Schwartz, AB; Cui, XT; Weber, DJ; Moran, DW				Schwartz, Andrew B.; Cui, X. Tracy; Weber, Douglas J.; Moran, Daniel W.			Brain-controlled interfaces: Movement restoration with neural prosthetics	NEURON			English	Review							PERIPHERAL-NERVE FIBERS; PRIMATE MOTOR CORTEX; REAL-TIME CONTROL; COMPUTER INTERFACE; SURFACE MODIFICATION; ACTION-POTENTIALS; CORTICAL-NEURONS; SENSORY FEEDBACK; ELECTRODE ARRAY; CELL DISCHARGE	Brain-controlled interfaces are devices that capture brain transmissions involved in a subject's intention to act, with the potential to restore communication and movement to those who are immobilized. Current devices record electrical activity from the scalp, on the surface of the brain, and within the cerebral cortex. These signals are being translated to command signals driving prosthetic limbs and computer displays. Somatosensory feedback is being added to this control as generated behaviors become more complex. New technology to engineer the tissue-electrode interface, electrode design, and extraction algorithms to transform the recorded signal to movement will help translate exciting laboratory demonstrations to patient practice in the near future.	Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Neural Basis Cognit, Dept Neurobiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Neural Basis Cognit, Dept Bioengn, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA; Washington Univ, Dept Biomech Engn, St Louis, MO 63130 USA; Washington Univ, Dept Neurobiol, St Louis, MO 63130 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Washington University (WUSTL)	Schwartz, AB (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Neural Basis Cognit, Dept Neurobiol, Pittsburgh, PA 15213 USA.	abs21@pitt.edu	Weber, Douglas/E-7554-2011; Cui, Tracy/GRF-5659-2022	Cui, Xinyan/0000-0002-0470-2005				Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Bogey RA, 2005, IEEE T NEUR SYS REH, V13, P302, DOI 10.1109/TNSRE.2005.851768; Borisoff JF, 2006, IEEE T BIO-MED ENG, V53, P1715, DOI 10.1109/TBME.2006.877800; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buchko CJ, 2000, J MATER RES, V15, P231, DOI 10.1557/JMR.2000.0038; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; CHARLEY EA, 2005, IMPROVING BRAIN TISS; COOPER R, 1965, ELECTROEN CLIN NEURO, V18, P217, DOI 10.1016/0013-4694(65)90088-X; Crago P E, 1998, IEEE Trans Rehabil Eng, V6, P1, DOI 10.1109/86.662614; Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3; Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I; Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5; Dario P, 1998, IEEE Trans Rehabil Eng, V6, P353, DOI 10.1109/86.736149; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; DONCHIN E, 1970, ELECTROEN CLIN NEURO, V29, P201, DOI 10.1016/0013-4694(70)90124-0; DONOGHUE JP, 1989, J NERUOPHYSIOL, V79, P159; DONOGHUE JP, 2006, NEUR INT WORKSH AUG; Ebersole JS, 1997, J CLIN NEUROPHYSIOL, V14, P470, DOI 10.1097/00004691-199711000-00003; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; EDELMAN GM, 1985, HOW WE CAN SEE, P1; ELBERT T, 1980, ELECTROEN CLIN NEURO, V48, P293, DOI 10.1016/0013-4694(80)90265-5; Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114; Fetz EE, 1999, NAT NEUROSCI, V2, P583, DOI 10.1038/10131; Freeman WJ, 2003, CLIN NEUROPHYSIOL, V114, P1053, DOI 10.1016/S1388-2457(03)00045-2; Georgopoulos AP, 2005, EXP BRAIN RES, V167, P132, DOI 10.1007/s00221-005-0028-8; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; Ghovanloo M, 2004, IEEE J SOLID-ST CIRC, V39, P2457, DOI 10.1109/JSSC.2004.837026; Grill J H, 1998, IEEE Trans Rehabil Eng, V6, P190, DOI 10.1109/86.681185; Haugland M, 1999, Technol Health Care, V7, P393; He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021; HELDMAN A, 2004, LOCAL FIELD POTENTIA; Heldman DA, 2006, IEEE T NEUR SYS REH, V14, P180, DOI 10.1109/TNSRE.2006.875549; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HOFFER JA, 2005, INITIAL RESULTS FULL; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Isaacs RE, 2000, IEEE T REHABIL ENG, V8, P196, DOI 10.1109/86.847814; James CD, 2000, IEEE T BIO-MED ENG, V47, P17, DOI 10.1109/10.817614; JI J, 1991, IEEE T BIO-MED ENG, V38, P75, DOI 10.1109/10.68212; Johnson MD, 2004, P ANN INT IEEE EMBS, V26, P4103; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Kang T, 2005, EXP BRAIN RES, V167, P352, DOI 10.1007/s00221-005-0039-5; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kemere C, 2004, IEEE T BIO-MED ENG, V51, P925, DOI 10.1109/TBME.2004.826675; KENNEDY PR, 1992, NEUROSCI LETT, V142, P89, DOI 10.1016/0304-3940(92)90627-J; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021; Kim SP, 2006, J NEURAL ENG, V3, P145, DOI 10.1088/1741-2560/3/2/009; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; Kirsch RF, 2001, J REHABIL RES DEV, V38, P619; KOVACS GTA, 1992, IEEE T BIO-MED ENG, V39, P893, DOI 10.1109/10.256422; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Kuiken Todd, 2006, Phys Med Rehabil Clin N Am, V17, P1, DOI 10.1016/j.pmr.2005.10.001; Kurosawa K, 2005, IEEE T NEUR SYS REH, V13, P359, DOI 10.1109/TNSRE.2005.847355; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; LEBEDEV MA, 2006, IN PRESS TRENDS NEUR; Leuthardt EC, 2006, NEUROSURGERY, V59, P1, DOI 10.1227/01.NEU.0000221506.06947.AC; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Lin G, 2005, CYTOM PART A, V66A, P9, DOI 10.1002/cyto.a.20149; Lin SM, 1997, NEURAL COMPUT, V9, P607, DOI 10.1162/neco.1997.9.3.607; Liu X, 1999, IEEE Trans Rehabil Eng, V7, P315, DOI 10.1109/86.788468; Loeb GE, 2005, IEEE ENG MED BIOL, V24, P45, DOI 10.1109/MEMB.2005.1511499; LOEB GE, 1977, SCIENCE, V197, P1192, DOI 10.1126/science.897663; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Macefield VG, 2005, CLIN EXP PHARMACOL P, V32, P135, DOI 10.1111/j.1440-1681.2005.04143.x; MALAGODI MS, 1989, ANN BIOMED ENG, V17, P397, DOI 10.1007/BF02368058; MANNARD A, 1974, SCIENCE, V183, P547, DOI 10.1126/science.183.4124.547; Margalit E, 2003, J NEUROSCI METH, V123, P129, DOI 10.1016/S0165-0270(02)00345-X; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0; MENEI P, 1994, J BIOMED MATER RES, V28, P1079, DOI 10.1002/jbm.820280913; Mensinger AF, 2000, J NEUROPHYSIOL, V83, P611, DOI 10.1152/jn.2000.83.1.611; Mofid MM, 1997, PLAST RECONSTR SURG, V100, P14, DOI 10.1097/00006534-199707000-00003; Mohseni P, 2005, IEEE T NEUR SYS REH, V13, P263, DOI 10.1109/TNSRE.2005.853625; Mokry J, 2000, BIOTECHNOL PROGR, V16, P897, DOI 10.1021/bp000113m; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P881, DOI 10.1109/TBME.2004.827465; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P647, DOI 10.1109/TBME.2003.821037; NAJAFI K, 1985, IEEE T ELECTRON DEV, V32, P1206, DOI 10.1109/T-ED.1985.22102; Neihart NM, 2005, IEEE T BIO-MED ENG, V52, P1950, DOI 10.1109/TBME.2005.856247; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Niedermeyer E., 1999, ELECTROENCEPHALOGRAP; Nunez P.L., 2006, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Obeid I, 2004, J NEUROSCI METH, V133, P27, DOI 10.1016/j.jneumeth.2003.09.024; Obeid I, 2003, IEEE T BIO-MED ENG, V50, P255, DOI 10.1109/TBME.2002.807643; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; PROCHAZKA A, 1976, J NEUROPHYSIOL, V39, P1090, DOI 10.1152/jn.1976.39.5.1090; REIER PJ, 1983, SPINAL CORD RECONSTR, P163; Retterer ST, 2004, IEEE T BIO-MED ENG, V51, P2063, DOI 10.1109/TBME.2004.834288; RICHARDSONBURNS S, 2005, NIH NEUR INT WORKSH; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; ROJAS AL, 2005, IMPROVED MODELS ANAL, V815; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Rubinstein Jay T, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P444, DOI 10.1097/01.moo.0000134452.24819.c0; SALCMAN M, 1973, IEEE T BIO-MED ENG, VBM20, P253, DOI 10.1109/TBME.1973.324189; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Santiesteban FMM, 2006, IEEE T BIO-MED ENG, V53, P547, DOI 10.1109/TBME.2005.864497; SCHALK G, 2004, 2 DIMENSIONAL CURSOS; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Schmidt E. M., 1999, CRC METH NEUROSCI S; SCHMIDT EM, 1976, EXP NEUROL, V52, P496, DOI 10.1016/0014-4886(76)90220-X; Schwartz AB, 2000, EUR J NEUROSCI, V12, P1851, DOI 10.1046/j.1460-9568.2000.00097.x; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Schwartz AB, 2001, CURR OPIN NEUROBIOL, V11, P701, DOI 10.1016/S0959-4388(01)00272-0; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shain W, 2003, IEEE T NEUR SYS REH, V11, P186, DOI 10.1109/TNSRE.2003.814800; SOECHTING JF, 1984, NEUROSCIENCE, V13, P595, DOI 10.1016/0306-4522(84)90252-5; SOECHTING JF, 1983, KINEMATICS DYNAMICS, P1; Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037; Stein R B, 1975, Can J Neurol Sci, V2, P235; Stein RB, 2004, CAN J PHYSIOL PHARM, V82, P757, DOI 10.1139/Y04-075; STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766; STENSAAS SS, 1976, ACTA NEUROPATHOL, V35, P187; Strange K D, 1999, IEEE Trans Rehabil Eng, V7, P289, DOI 10.1109/86.788466; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Taylor DM, 2003, IEEE T NEUR SYS REH, V11, P195, DOI 10.1109/TNSRE.2003.814451; TOREBJORK HE, 1987, BRAIN, V110, P1509, DOI 10.1093/brain/110.6.1509; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; VALLBO AB, 1981, BRAIN RES, V215, P359, DOI 10.1016/0006-8993(81)90517-5; Vetter RJ, 2004, IEEE T BIO-MED ENG, V51, P896, DOI 10.1109/TBME.2004.826680; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027; WADHWA R, 2006, J NEURAL ENG, V3, P162; WADHWA R, 2006, ANN M SOC BIOM PITTS; Webb K, 2001, BIOMATERIALS, V22, P1017, DOI 10.1016/S0142-9612(00)00353-7; Weber DJ, 2006, IEEE T NEUR SYS REH, V14, P240, DOI 10.1109/TNSRE.2006.875575; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Williams JC, 1999, NEUROCOMPUTING, V26-7, P1069, DOI 10.1016/S0925-2312(99)00106-X; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3; WILLIAMS JC, 2001, THESIS ARIZONA STATE; Wilson JA, 2006, IEEE T NEUR SYS REH, V14, P246, DOI 10.1109/TNSRE.2006.875570; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Wu W, 2004, IEEE T BIO-MED ENG, V51, P933, DOI 10.1109/TBME.2004.826666; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; YOSHIDA K, 1993, IEEE T BIO-MED ENG, V40, P492, DOI 10.1109/10.243412; YUEN TGH, 1995, BIOMATERIALS, V16, P951, DOI 10.1016/0142-9612(95)93121-S; Zhong YH, 2001, J REHABIL RES DEV, V38, P627	164	529	555	5	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					205	220		10.1016/j.neuron.2006.09.019	http://dx.doi.org/10.1016/j.neuron.2006.09.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015237	Bronze			2022-12-17	WOS:000241408100015
J	Beauchamp, MS; Lee, KE; Argall, BD; Martin, A				Beauchamp, MS; Lee, KE; Argall, BD; Martin, A			Integration of auditory and visual information about objects in superior temporal sulcus	NEURON			English	Article							HUMAN CEREBRAL-CORTEX; HUMAN NEURAL SYSTEMS; MACAQUE MONKEY; HUMAN BRAIN; AUDIOVISUAL INTEGRATION; MANIPULATABLE OBJECTS; HEMISPHERIC LESIONS; CROSSMODAL BINDING; PROCESSING STREAMS; PREFRONTAL CORTEX	Two categories of objects in the environment-animals and man-made manipulable objects (tools)-are easily recognized by either their auditory or visual features. Although these features differ across modalities, the brain integrates them into a coherent percept. In three separate fMRI experiments, posterior superior temporal sulcus and middle temporal gyrus (pSTS/MTG) fulfilled objective criteria for an integration site. pSTS/MTG showed signal increases in response to either auditory or visual stimuli and responded more to auditory or visual objects than to meaningless (but complex) control stimuli. pSTS/MTG showed an enhanced response when auditory and visual object features were presented together, relative to presentation in a single modality. Finally, pSTS/MTG responded more to object identification than to other components of the behavioral task. We suggest that pSTS/MTG is specialized for integrating different types of information both within modalities (e.g., visual form, visual motion) and across modalities (auditory and visual).	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Beauchamp, MS (corresponding author), NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA.	mbeauchamp@nih.gov	martin, alex/B-6176-2009; Argall, Brenna/G-2543-2011; Beauchamp, Michael/AAK-9813-2020	Beauchamp, Michael/0000-0002-7599-9934	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002588] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams RB, 2002, NEUROIMAGE, V16, P361, DOI 10.1006/nimg.2002.1088; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Beauchamp MS, 2003, J COGNITIVE NEUROSCI, V15, P991, DOI 10.1162/089892903770007380; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BELLN P, 2002, BRAIN RES COGN BRAIN, V13, P17; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Devlin JT, 2002, NEUROIMAGE, V15, P675, DOI 10.1006/nimg.2001.1002; Engelien A, 1995, BRAIN, V118, P1395, DOI 10.1093/brain/118.6.1395; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Griffiths TD, 1996, NATURE, V383, P425, DOI 10.1038/383425a0; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Puce A, 2003, NEUROIMAGE, V19, P861, DOI 10.1016/S1053-8119(03)00189-7; Puce A, 1996, J NEUROSCI, V16, P5205; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 1998, J NEUROSCI, V18, P2188; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Saygin AP, 2003, BRAIN, V126, P928, DOI 10.1093/brain/awg082; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SELFRITZ E, 2002, SCIENCE, V297, P1706; Seltzer B, 1996, J COMP NEUROL, V370, P173, DOI 10.1002/(SICI)1096-9861(19960624)370:2<173::AID-CNE4>3.0.CO;2-#; Stein BE., 1993, MERGING SENSES; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tranel D, 2003, NEUROPSYCHOLOGIA, V41, P847, DOI 10.1016/S0028-3932(02)00223-3; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Wagner AD, 1999, PHILOS T R SOC B, V354, P1307, DOI 10.1098/rstb.1999.0481; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	90	528	531	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					809	823		10.1016/S0896-6273(04)00070-4	http://dx.doi.org/10.1016/S0896-6273(04)00070-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003179	Bronze			2022-12-17	WOS:000221458200015
J	Dolan, RJ; Dayan, P				Dolan, Ray J.; Dayan, Peter			Goals and Habits in the Brain	NEURON			English	Review							VENTROMEDIAL PREFRONTAL CORTEX; BASAL GANGLIA; ORBITOFRONTAL CORTEX; MOTIVATIONAL CONTROL; WORKING-MEMORY; MODEL-FREE; INSTRUMENTAL CONTINGENCY; INDIVIDUAL-DIFFERENCES; DORSOLATERAL STRIATUM; DOUBLE DISSOCIATION	An enduring and richly elaborated dichotomy in cognitive neuroscience is that of reflective versus reflexive decision making and choice. Other literatures refer to the two ends of what is likely to be a spectrum with terms such as goal-directed versus habitual, model-based versus model-free or prospective versus retrospective. One of the most rigorous traditions of experimental work in the field started with studies in rodents and graduated via human versions and enrichments of those experiments to a current state in which new paradigms are probing and challenging the very heart of the distinction. We review four generations of work in this tradition and provide pointers to the forefront of the field's fifth generation.	[Dolan, Ray J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1 3BG, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Dolan, RJ (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1 3BG, England.	r.dolan@ucl.ac.uk		Dolan, Ray/0000-0001-9356-761X; Dayan, Peter/0000-0003-3476-1839	Wellcome Trust; R.J.D. Senior Investigator Award [098362/Z/12/Z]; Wellcome Trust [091593/Z/10/Z]; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); R.J.D. Senior Investigator Award; Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation	This work was supported by the Wellcome Trust, R.J.D. Senior Investigator Award 098362/Z/12/Z; the Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. P.D. is supported by the Gatsby Charitable Foundation. We are most grateful for collaborations in these questions over many years, including with Nathaniel Daw, Yael Niv, John O'Doherty, and Ben Seymour, and for the advice on an earlier version of this paper from many colleagues, including Bernard Balleine, Molly Crockett, Amir Dezfouli, Laurence Hunt, Francesco Rigoli, Robb Rutledge, and Peter Smittenaar.	ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; [Anonymous], LEARNING DELAYED REW; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Bellman, 1957, DYNAMIC PROGRAMMING; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Biele G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001089; Blodgett H.C., 1929, U CALIF PUBL PSYCHOL, V4, P113, DOI DOI 10.1101/LM.031336.113; Botvinick MM, 2012, CURR OPIN NEUROBIOL, V22, P956, DOI 10.1016/j.conb.2012.05.008; Bradfield LA, 2013, J EXP PSYCHOL-ANIM B, V39, P2, DOI 10.1037/a0030941; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Chersi F, 2012, COGN PROCESS, V13, pS125, DOI 10.1007/s10339-012-0475-7; Collins AGE, 2012, EUR J NEUROSCI, V35, P1024, DOI 10.1111/j.1460-9568.2011.07980.x; Cools R, 2011, CURR OPIN NEUROBIOL, V21, P402, DOI 10.1016/j.conb.2011.04.002; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; Daw N. D., 2006, RECENT BREAKTHROUGHS, P91; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DAYAN P, 1993, NEURAL COMPUT, V5, P613, DOI 10.1162/neco.1993.5.4.613; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; Dayan P, 2012, CURR OPIN NEUROBIOL, V22, P1068, DOI 10.1016/j.conb.2012.05.011; Dayan P, 2009, NEURAL NETWORKS, V22, P213, DOI 10.1016/j.neunet.2009.03.004; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; de Wit S, 2012, J NEUROSCI, V32, P12066, DOI 10.1523/JNEUROSCI.1088-12.2012; de Wit S, 2012, PSYCHOPHARMACOLOGY, V219, P621, DOI 10.1007/s00213-011-2563-2; de Wit S, 2011, J COGNITIVE NEUROSCI, V23, P1218, DOI 10.1162/jocn.2010.21514; DICKINSON A, 1985, Q J EXP PSYCHOL-B, V37, P397, DOI 10.1080/14640748508401177; DICKINSON A, 1987, Q J EXP PSYCHOL-B, V39, P77; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; DICKINSON A, 1987, Q J EXP PSYCHOL-B, V39, P201; Dickinson A., 2002, STEVENS HDB EXPT PSY, V3, P497, DOI DOI 10.1002/0471214426.PAS0312; Doll BB, 2012, CURR OPIN NEUROBIOL, V22, P1075, DOI 10.1016/j.conb.2012.08.003; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Doll BB, 2009, BRAIN RES, V1299, P74, DOI 10.1016/j.brainres.2009.07.007; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Fellows L. K., 2011, NEUROBIOLOGY SENSATI; Fermin A, 2010, J MOTOR BEHAV, V42, P371, DOI 10.1080/00222895.2010.526467; FitzGerald THB, 2012, J NEUROSCI, V32, P16417, DOI 10.1523/JNEUROSCI.3254-12.2012; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Frank MJ, 2012, CEREB CORTEX, V22, P509, DOI 10.1093/cercor/bhr114; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gallistel CR, 1990, ORG LEARNING; Gershman S.J., 2012, J EXP PSYCHOL GEN; Gillan CM, 2011, AM J PSYCHIAT, V168, P718, DOI 10.1176/appi.ajp.2011.10071062; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; GROENEWEGEN HJ, 1990, PROG BRAIN RES, V85, P95; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hitchcott PK, 2007, CEREB CORTEX, V17, P2820, DOI 10.1093/cercor/bhm010; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; HU D, 1995, P NATL ACAD SCI USA, V92, P5506, DOI 10.1073/pnas.92.12.5506; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; Huys QJM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002410; Isoda M, 2011, EUR J NEUROSCI, V33, P2058, DOI 10.1111/j.1460-9568.2011.07698.x; James W., 1890, PRINCIPLES PSYCHOL, V2; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Johnson A, 2005, NEURAL NETWORKS, V18, P1163, DOI 10.1016/j.neunet.2005.08.009; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kahneman D., 2011, THINKING; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; KIMBLE GA, 1970, PSYCHOL REV, V77, P361, DOI 10.1037/h0029782; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; KRIECKHAUS EE, 1968, J COMP PHYSIOL PSYCH, V65, P197, DOI 10.1037/h0025547; KRUSE JM, 1983, LEARN MOTIV, V14, P165, DOI 10.1016/0023-9690(83)90004-8; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lengyel M., 2008, ADV NEURAL INFORM PR, P889; Li JA, 2011, J NEUROSCI, V31, P5504, DOI 10.1523/JNEUROSCI.6316-10.2011; Liljeholm M, 2011, J NEUROSCI, V31, P2474, DOI 10.1523/JNEUROSCI.3354-10.2011; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Mackintosh N. J, 1983, CONDITIONING ASS LEA; Maia TV, 2008, DEV PSYCHOPATHOL, V20, P1251, DOI 10.1017/S0954579408000606; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Moran RJ, 2011, CURR BIOL, V21, P1320, DOI 10.1016/j.cub.2011.06.053; Muenzinger KF, 1938, PEDAGOG SEMIN J GEN, V53, P75; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; O'Doherty JP, 2011, ANN NY ACAD SCI, V1239, P118, DOI 10.1111/j.1749-6632.2011.06290.x; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Ostlund SB, 2012, NEUROPSYCHOPHARMACOL, V37, P508, DOI 10.1038/npp.2011.217; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pezzulo G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00092; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Prevost C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002918; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Robinson MJF, 2013, CURR BIOL, V23, P282, DOI 10.1016/j.cub.2013.01.016; Ruediger S, 2012, NAT NEUROSCI, V15, P1563, DOI 10.1038/nn.3224; Rummery G. A., 1994, 166 CUEDFINFENGTR U; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Silver D., 2008, P 25 INT C MACH LEAR, P968; Simon DA, 2011, J NEUROSCI, V31, P5526, DOI 10.1523/JNEUROSCI.4647-10.2011; Smith KS, 2013, BRAIN RES, V1511, P102, DOI 10.1016/j.brainres.2013.01.008; Smittenaar P, 2013, NEURON, V80, P914, DOI 10.1016/j.neuron.2013.08.009; Solway A, 2012, PSYCHOL REV, V119, P120, DOI 10.1037/a0026435; Stanovich K. E., 2002, HEURISTICS BIASES PS, P421, DOI DOI 10.1017/CBO9780511808098.026; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Sutton R. S., 1990, Machine Learning: Proceedings of the Seventh International Conference (1990), P216; Sutton R. S., 1991, ACM SIGART B, V2, P160, DOI [10/cd8-9h, 10.1145/122344.122377]; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tanaka SC, 2008, J NEUROSCI, V28, P6750, DOI 10.1523/JNEUROSCI.1808-08.2008; THISTLETHWAITE D, 1951, PSYCHOL BULL, V48, P97, DOI 10.1037/h0055171; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Thorndike EL, 1911, ANIMAL INTELLIGENCE; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tolman E.C., 1930, PUBLICATIONS PSYCHOL, V4, P257; Tolman EC, 1938, PSYCHOL REV, V45, P1, DOI 10.1037/h0062733; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wassum KM, 2009, NEUROSCIENCE, V163, P770, DOI 10.1016/j.neuroscience.2009.06.071; White NM, 1997, CURR OPIN NEUROBIOL, V7, P164, DOI 10.1016/S0959-4388(97)80004-9; WILLIAMS DR, 1969, J EXP ANAL BEHAV, V12, P511, DOI 10.1901/jeab.1969.12-511; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; WIRSIG CR, 1982, J COMP PHYSIOL PSYCH, V96, P615, DOI 10.1037/h0077911; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; YARYURATOBIAS JA, 1970, DIS NERV SYST, V31, P60; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	164	526	530	8	192	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 16	2013	80	2					312	325		10.1016/j.neuron.2013.09.007	http://dx.doi.org/10.1016/j.neuron.2013.09.007			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	241VI	24139036	hybrid, Green Published, Green Submitted			2022-12-17	WOS:000326196400013
J	Hassabis, D; Kumaran, D; Summerfield, C; Botvinick, M				Hassabis, Demis; Kumaran, Dharshan; Summerfield, Christopher; Botvinick, Matthew			Neuroscience-Inspired Artificial Intelligence	NEURON			English	Review							COMPLEMENTARY LEARNING-SYSTEMS; OBJECT RECOGNITION; WORKING-MEMORY; NEURAL-NETWORK; ERROR BACKPROPAGATION; PREFRONTAL CORTEX; VISUAL-ATTENTION; EPISODIC MEMORY; TERM-MEMORY; MODEL	The fields of neuroscience and artificial intelligence (AI) have a long and intertwined history. In more recent times, however, communication and collaboration between the two fields has become less commonplace. In this article, we argue that better understanding biological brains could play a vital role in building intelligent machines. We survey historical interactions between the AI and neuroscience fields and emphasize current advances in AI that have been inspired by the study of neural computation in humans and other animals. We conclude by highlighting shared themes that may be key for advancing future research in both fields.	[Hassabis, Demis; Kumaran, Dharshan; Summerfield, Christopher; Botvinick, Matthew] DeepMind, 5 New St Sq, London, England; [Hassabis, Demis; Botvinick, Matthew] Gatsby Computat Neurosci Unit, 25 Howland St, London, England; [Kumaran, Dharshan] UCL, Inst Cognit Neurosci, 17 Queen Sq, London, England; [Summerfield, Christopher] Univ Oxford, Dept Expt Psychol, Oxford, England	University of London; University College London; University of London; University College London; University of Oxford	Hassabis, D (corresponding author), DeepMind, 5 New St Sq, London, England.; Hassabis, D (corresponding author), Gatsby Computat Neurosci Unit, 25 Howland St, London, England.	dhcontact@google.com						Adolph KE, 2005, MINN SYM CHILD PSYCH, V33, P91; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; [Anonymous], 2016, ARXIV160903499; [Anonymous], 2014, ADV NEURAL INFORM PR; [Anonymous], 2016, ARXIV PREPRINT ARXIV; Ba J., 2015, ICLR 2015 C TRACK P; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Balaguer J, 2016, NEURON, V90, P893, DOI 10.1016/j.neuron.2016.03.037; Barlow H.B., 1959, P NPL S MECH THOUGHT; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Battaglia P., 2016, ADV NEURAL INFORM PR, P4502; Battaglia PW, 2013, P NATL ACAD SCI USA, V110, P18327, DOI 10.1073/pnas.1306572110; Bengio, 2016, ARXIV160205179; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blundell C., 2016, ARXIV160604460; Botvinick MM, 2006, PSYCHOL REV, V113, P201, DOI 10.1037/0033-295X.113.2.201; Brooks R, 2012, NATURE, V482, P462, DOI 10.1038/482462a; Browne CB, 2012, IEEE T COMP INTEL AI, V4, P1, DOI 10.1109/TCIAIG.2012.2186810; Chang M.B., 2016, ARXIV161200341; Chiappa S., 2017, P 5 INT C LEARN REPR; CHURCHLAND PS, 1988, SCIENCE, V242, P741, DOI 10.1126/science.3055294; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Constantinescu AO, 2016, SCIENCE, V352, P1464, DOI 10.1126/science.aaf0941; Cukur T, 2013, NAT NEUROSCI, V16, P763, DOI 10.1038/nn.3381; David E. R., 1987, TECHNICAL REPORT, P318, DOI 10.1016/b978-1-4832-1446-7.50035-2; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Deisseroth K, 2013, NEURON, V80, P568, DOI 10.1016/j.neuron.2013.10.032; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Denil M., 2016, ARXIV161101843; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Doll BB, 2015, NAT NEUROSCI, V18, P767, DOI 10.1038/nn.3981; Donoso M, 2014, SCIENCE, V344, P1481, DOI 10.1126/science.1252254; Doumas LAA, 2008, PSYCHOL REV, V115, P1, DOI 10.1037/0033-295X.115.1.1; Duan Y., 2016, RL2 FAST REINFORCEME; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Eslami A., 2016, ARXIV160308575; Esser SK, 2016, P NATL ACAD SCI USA, V113, P11441, DOI 10.1073/pnas.1604850113; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gallistel C., 2009, MEMORY COMPUTATIONAL, DOI 10.1002/9781444310498; Gatys LA., 2015, PROC CVPR IEEE, V16, P326, DOI [10.1167/16.12.326, DOI 10.1109/CVPR.2016.265]; Gemici M., 2017, ARXIV PREPRINT ARXIV; Gershman SJ, 2017, ANNU REV PSYCHOL, V68, P101, DOI 10.1146/annurev-psych-122414-033625; Gilmore CK, 2007, NATURE, V447, P589, DOI 10.1038/nature05850; Glasser MF, 2016, NAT NEUROSCI, V19, P1175, DOI 10.1038/nn.4361; GOLDMANRAKIC PS, 1990, PROG BRAIN RES, V85, P325; Gopnik A, 2004, TRENDS COGN SCI, V8, P371, DOI 10.1016/j.tics.2004.06.005; Graves A., 2014, ARXIV14105401; Graves A, 2016, NATURE, V538, P471, DOI 10.1038/nature20101; Gregor K, 2015, PR MACH LEARN RES, V37, P1462; Hafner R, 2011, MACH LEARN, V84, P137, DOI 10.1007/s10994-011-5235-x; Hamrick J. B., 2017, P 5 INT C LEARN REPR, P1; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Haugeland J., 1985, ARTIF INTELL; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hinton G.E., 2012, ARXIV12070580, V3, P212, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Hinton GE, 1986, PARALLEL DISTRIBUTED, P77; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI [10.1162/neco.1997.9.8.1735, 10.1162/neco.1997.9.1.1, 10.1007/978-3-642-24797-2]; Holyoak KJ, 1997, AM PSYCHOL, V52, P35, DOI 10.1037/0003-066X.52.1.35; Hong H, 2016, NAT NEUROSCI, V19, P613, DOI 10.1038/nn.4247; Hong S., 2015, ARXIV151207928; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huys QJM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002410; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jonas E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005268; Jordan M. I., 1997, ADV PSYCHOL, V121, P471, DOI [DOI 10.1016/S0166-4115(97)80111-2, 10.1016/s0166-4115(97)80111-2]; Kemp C, 2010, COGNITIVE SCI, V34, P1185, DOI 10.1111/j.1551-6709.2010.01128.x; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Kirkpatricka J, 2017, P NATL ACAD SCI USA, V114, P3521, DOI 10.1073/pnas.1611835114; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kumaran D, 2016, TRENDS COGN SCI, V20, P512, DOI 10.1016/j.tics.2016.05.004; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Kurth-Nelson Z, 2016, NEURON, V91, P194, DOI 10.1016/j.neuron.2016.05.028; Lake BM, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16001837; Lake BM, 2015, SCIENCE, V350, P1332, DOI 10.1126/science.aab3050; Larochelle Hugo, 2010, ADV NEURAL INFORM PR, V23, P1243; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Legg, 2007, ADV ARTIFICIAL GEN I, P17; Leibo JZ, 2017, CURR BIOL, V27, P62, DOI 10.1016/j.cub.2016.10.015; Lengyel M., 2007, ADV NEURAL INFORM PR, V20, P889; Liao Q., 2015, ARXIV PREPRINT ARXIV; Lillicrap TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13276; Lin, 2015, ARXIV150204156; Lloyd K, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00087; Marblestone AH, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00094; Marcus GF, 1998, COGNITIVE PSYCHOL, V37, P243, DOI 10.1006/cogp.1998.0694; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McClelland JL, 2003, NAT REV NEUROSCI, V4, P310, DOI 10.1038/nrn1076; McCulloch W., 1943, B MATH BIOPHYS, V5, P115, DOI [10.1007/BF02478259, 10.1007/bf02478259, DOI 10.1007/BF02478259]; Mnih V, 2014, ADV NEUR IN, V27; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Moore T, 2017, ANNU REV PSYCHOL, V68, P47, DOI 10.1146/annurev-psych-122414-033400; Moravcik M, 2017, SCIENCE, V356, P508, DOI 10.1126/science.aam6960; Nguyen A., 2016, ARXIV60509304; Nishiyama J, 2015, NEURON, V87, P63, DOI 10.1016/j.neuron.2015.05.043; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Oh J., 2015, ARXIV150708750; Olafsdottir HF, 2015, ELIFE, V4, DOI 10.7554/eLife.06063; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Redish AD, 2016, NAT REV NEUROSCI, V17, P147, DOI 10.1038/nrn.2015.30; Rezende DJ, 2016, PR MACH LEARN RES, V48; Rezende DJ, 2016, ADV NEUR IN, V29; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rowland DC, 2016, ANNU REV NEUROSCI, V39, P19, DOI 10.1146/annurev-neuro-070815-013824; Rusu A. A., 2016, ARXIV161004286; Rusu Andrei A, 2016, ARXIV160604671; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; Santoro A, 2017, ADV NEUR IN, V30; Santoro A, 2016, PR MACH LEARN RES, V48; Saxe A. M., 2013, ARXIV13126120V3; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schaul T., 2016, C LEARN REPR, P1; Schmidhuber J, 2014, ARXIV14047828; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI [10.1017/s0025315414000289, DOI 10.1017/CBO9780511526817]; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simonyan K., 2013, ARXIV PREPRINT ARXIV, P1; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SMITH LB, 1995, MINN SYM CHILD PSYCH, V28, P1; Solway A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003779; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STJOHN MF, 1990, ARTIF INTELL, V46, P217, DOI 10.1016/0004-3702(90)90008-N; Sukhbaatar S, 2015, ADV NEUR IN, V28; Summerfield JJ, 2006, NEURON, V49, P905, DOI 10.1016/j.neuron.2006.01.021; Sutton R. S., 1991, ACM SIGART B, V2, P160, DOI [10/cd8-9h, 10.1145/122344.122377]; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; THRUN S, 1995, ROBOT AUTON SYST, V15, P25, DOI 10.1016/0921-8890(95)00004-Y; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tsutsui KI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12554; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Turing AM. I., 1950, MIND, VLIX, P433; Vinyals Oriol, 2016, NEURAL INFORM PROCES; Wang JW, 2017, ACTA OPHTHALMOL, V95, pE10, DOI 10.1111/aos.13227; Werbos P., 1974, REGRESSION NEW TOOLS; Weston J., 2014, ARXIV14103916; Whittington JCR, 2017, NEURAL COMPUT, V29, P1229, DOI 10.1162/NECO_a_00949; Wu Yonghui, 2016, ARXIV160908144; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Yamins DLK, 2016, NAT NEUROSCI, V19, P356, DOI 10.1038/nn.4244; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zahavy T, 2016, PR MACH LEARN RES, V48; Zaremba Wojciech, 2014, CORR	170	525	541	56	402	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2017	95	2					245	258		10.1016/j.neuron.2017.06.011	http://dx.doi.org/10.1016/j.neuron.2017.06.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FB0TM	28728020	Bronze			2022-12-17	WOS:000405857500006
J	Lessard, J; Wu, JI; Ranish, JA; Wan, M; Winslow, MM; Staahl, BT; Wu, H; Aebersold, R; Graef, IA; Crabtree, GR				Lessard, Julie; Wu, Jiang I.; Ranish, Jeffrey A.; Wan, Mimi; Winslow, Monte M.; Staahl, Brett T.; Wu, Hai; Aebersold, Ruedi; Graef, Isabella A.; Crabtree, Gerald R.			An essential switch in subunit composition of a chromatin remodeling complex during neural development	NEURON			English	Article							MAMMALIAN SWI/SNF COMPLEXES; ASYMMETRIC CELL-DIVISION; STEM-CELLS; RETINOBLASTOMA PROTEIN; MASS-SPECTROMETRY; CNS PRECURSOR; CYCLE ARREST; BRG1; MAINTENANCE; GENES	Mammalian neural stem cells (NSCs) have the capacity to both self-renew and to generate all the neuronal and glial cell-types of the adult nervous system. Global chromatin changes accompany the transition from proliferating NSCs to committed neuronal lineages, but the mechanisms involved have been unclear. Using a proteomics approach, we show that a switch in subunit composition of neural, ATP-dependent SWI/SNF-like chromatin remodeling complexes accompanies this developmental transition. Proliferating neural stem and progenitor cells express complexes in which BAF45a, a Kruppel/PHD domain protein and the actin-related protein IBAF53a are quantitatively associated with the SW12/SNF2-like ATPases, Brg and Brm. As neural progenitors exit the cell cycle, these subunits are replaced by the homologous BAF45b, BAF45c, and BAF53b. BAF45a/53a subunits are necessary and sufficient for neural progenitor proliferation. Preventing the subunit switch impairs neuronal differentiation, indicating that this molecular event is essential for the transition from neural stem/progenitors to postmitotic neurons. More broadly, these studies suggest that SWI/SNF-like complexes in vertebrates achieve biological specificity by combinatorial assembly of their subunits.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Inst Syst Biol, Seattle, WA 98103 USA	Howard Hughes Medical Institute; Stanford University; Institute for Systems Biology (ISB)	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, 279 Campus Dr, Stanford, CA 94305 USA.	crabtree@stanford.edu			NHLBI NIH HHS [N01HV28179, N01-HV-28179] Funding Source: Medline; NICHD NIH HHS [R01 HD055391] Funding Source: Medline; NINDS NIH HHS [R01 NS046789-05, R01 NS046789-04, R01 NS046789, R37 NS046789, R01 NS046789-01, R01 NS046789-02, NS046789, R01 NS046789-03] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789, R01NS046789] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GILBERT SF, 2006, DEV BIOL, P373; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kondo T, 2006, CURR OPIN GENET DEV, V16, P502, DOI 10.1016/j.gde.2006.07.001; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamamichi-Nishina M, 2003, J BIOL CHEM, V278, P7422, DOI 10.1074/jbc.M208458200; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	54	525	554	2	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2007	55	2					201	215		10.1016/j.neuron.2007.06.019	http://dx.doi.org/10.1016/j.neuron.2007.06.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NW	17640523	Green Accepted, Bronze			2022-12-17	WOS:000248635800006
J	JONES, MV; WESTBROOK, GL				JONES, MV; WESTBROOK, GL			DESENSITIZED STATES PROLONG GABA(A) CHANNEL RESPONSES TO BRIEF AGONIST PULSES	NEURON			English	Article							RAT HIPPOCAMPAL SLICES; SUBUNIT MESSENGER-RNAS; MAIN CONDUCTANCE STATE; SPINAL-CORD NEURONS; SYNAPTIC TRANSMISSION; RECEPTOR DESENSITIZATION; ACETYLCHOLINE-RECEPTORS; POSTSYNAPTIC CURRENTS; KINETIC-PROPERTIES; FALSE TRANSMITTER	We studied the role of desensitization at inhibitory synapses by comparing nonequilibrium GABA(A) channel gating with inhibitory postsynaptic currents (IPSCs). Currents activated by brief pulses of 1-10 mM GABA to outside-out patches from cultured hippocampal neurons mimicked GABA-mediated IPSCs. Although the average open time of single GABA(A) channels following brief pulses was less than 10 ms, channels entered long (tau = 38-69 ms) closed states and subsequently reopened. Movement through these states resulted in paired-pulse desensitization. The time required for deactivation after removal of agonist also increased in proportion to the extent of desensitization. These results suggest that visits to desensitized states buffer the channel in bound conformations and underlie the expression of long-lasting components of the IPSC. Reopening after GABA(A) receptor desensitization may thus enhance inhibitory synaptic transmission by prolonging the response to a brief synaptic GABA transient.	OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201	Oregon Health & Science University	JONES, MV (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026494, F32NS009716, R29NS026494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER; NIDA NIH HHS [T32 DA07262] Funding Source: Medline; NINDS NIH HHS [NS26494, F32 NS09716] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1985, J PHYSIOL-LONDON, V360, P367, DOI 10.1113/jphysiol.1985.sp015622; AKAIKE N, 1989, J NEUROPHYSIOL, V62, P1400, DOI 10.1152/jn.1989.62.6.1400; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; [Anonymous], [No title captured]; BEAM KG, 1976, J PHYSIOL-LONDON, V258, P279, DOI 10.1113/jphysiol.1976.sp011420; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BORMANN J, 1985, P NATL ACAD SCI USA, V82, P2168, DOI 10.1073/pnas.82.7.2168; BORST JGG, 1994, J NEUROPHYSIOL, V71, P639, DOI 10.1152/jn.1994.71.2.639; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BUSCH C, 1990, COLD SH Q B, V55, P69; CELENTANO JJ, 1994, BIOPHYS J, V66, P1039, DOI 10.1016/S0006-3495(94)80885-9; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1977, J PHYSIOL-LONDON, V266, P361, DOI 10.1113/jphysiol.1977.sp011772; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; COVARRUBIAS M, 1990, PFLUG ARCH EUR J PHY, V416, P385, DOI 10.1007/BF00370744; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; FRANKE C, 1991, PFLUG ARCH EUR J PHY, V417, P509, DOI 10.1007/BF00370947; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; HAEFELY WE, 1989, ALLOSTERIC MODULATIO, P47; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JONES MV, 1993, J NEUROPHYSIOL, V70, P1339, DOI 10.1152/jn.1993.70.4.1339; JONES MV, 1994, BIOPHYS J, V68, pA2; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LESTER RAJ, 1992, J NEUROSCI, V12, P635; MACDONALD RL, 1989, J PHYSIOL-LONDON, V410, P479, DOI 10.1113/jphysiol.1989.sp017545; MACDONALD RL, 1992, ION CHANNELS, P315; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; MAGLEBY KL, 1981, J PHYSIOL-LONDON, V316, P225, DOI 10.1113/jphysiol.1981.sp013784; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MILLER AR, 1981, BASIC PROGRAMS SCI E, P13; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; NEWLAND CF, 1991, J PHYSIOL-LONDON, V432, P203, DOI 10.1113/jphysiol.1991.sp018382; PAN ZZ, 1993, NEURON, V11, P85; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PUIA G, 1994, NEURON, V12, P117, DOI 10.1016/0896-6273(94)90157-0; RAMAN IM, 1995, BIOPHYS J, V68, P137, DOI 10.1016/S0006-3495(95)80168-2; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; Trautmann A, 1983, SINGLE CHANNEL RECOR, P473; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; TWYMAN RE, 1990, J PHYSIOL-LONDON, V423, P193, DOI 10.1113/jphysiol.1990.sp018018; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VERDOORN TA, 1994, MOL PHARMACOL, V45, P475; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; WEISS DS, 1989, J NEUROSCI, V9, P1314; WEISS DS, 1988, J NEUROPHYSIOL, V59, P514, DOI 10.1152/jn.1988.59.2.514; WISDEN W, 1992, J NEUROSCI, V12, P1040; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; [No title captured]	60	525	535	0	8	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1995	15	1					181	191		10.1016/0896-6273(95)90075-6	http://dx.doi.org/10.1016/0896-6273(95)90075-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RL756	7542462	Bronze			2022-12-17	WOS:A1995RL75600020
J	Patterson, RD; Uppenkamp, S; Johnsrude, IS; Griffiths, TD				Patterson, RD; Uppenkamp, S; Johnsrude, IS; Griffiths, TD			The processing of temporal pitch and melody information in auditory cortex	NEURON			English	Article							ITERATED RIPPLED NOISE; HUMAN BRAIN; VOLUME MEASUREMENT; HESCHLS GYRUS; LOWER LIMIT; SUBDIVISIONS; SOUND; DISCRIMINATION; MECHANISMS; STRENGTH	An fMRI experiment was performed to identify the main stages of melody processing in the auditory pathway. Spectrally matched sounds that produce no pitch, fixed pitch, or melody were all found to activate Heschl's gyrus (HG) and planum temporale (PT). Within this region, sounds with pitch produced more activation than those without pitch only in the lateral half of HG. When the pitch was varied to produce a melody, there was activation in regions beyond HG and PT, specifically in the superior temporal gyrus (STG) and planum polare (PP). The results support the view that there is hierarchy of pitch processing in which the center of activity moves anterolaterally away from primary auditory cortex as the processing of melodic sounds proceeds.	Univ Cambridge, Ctr Neural Basis Hearing, Dept Physiol, Cambridge CB2 3EG, England; MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ Newcastle, Sch Med, Auditory Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Cambridge; University of London; University College London; Newcastle University - UK	Patterson, RD (corresponding author), Univ Cambridge, Ctr Neural Basis Hearing, Dept Physiol, Downing St, Cambridge CB2 3EG, England.	roy.patterson@mrc-cbu.cam.ac.uk	Johnsrude, Ingrid S/G-4694-2011	Johnsrude, Ingrid S/0000-0002-7810-1333				Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; EHRET G, 1997, CENTRAL AUDITORY SYS; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; PALMER AR, 1992, ADV BIOSCI, V83, P231; Palmer AR, 1998, NEUROIMAGE, V7, pS359; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1419, DOI 10.1121/1.410286; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Pressnitzer D, 2001, J ACOUST SOC AM, V109, P2074, DOI 10.1121/1.1359797; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; SAMSON S, 1988, BRAIN COGNITION, V7, P348, DOI 10.1016/0278-2626(88)90008-5; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Talairach J., 1988, APPROACH CEREBRAL IM; Tardif E, 2001, EUR J NEUROSCI, V13, P1045, DOI 10.1046/j.0953-816x.2001.01456.x; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Yost WA, 1996, J ACOUST SOC AM, V100, P511, DOI 10.1121/1.415873; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593; YOST WA, 1998, PSYCHOPHYSICAL PHYSL, P546; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	37	524	535	2	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 14	2002	36	4					767	776		10.1016/S0896-6273(02)01060-7	http://dx.doi.org/10.1016/S0896-6273(02)01060-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441063	Bronze			2022-12-17	WOS:000179313100021
J	HOKFELT, T				HOKFELT, T			NEUROPEPTIDES IN PERSPECTIVE - THE LAST 10 YEARS	NEURON			English	Review							GENE-RELATED PEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; SPINAL DORSAL HORN; NERVE GROWTH-FACTOR; GALANIN-LIKE IMMUNOREACTIVITY; RETROGRADE AXONAL-TRANSPORT; BASAL FOREBRAIN COMPLEX; PRIMARY SENSORY NEURONS; RAT FACIAL MOTONEURONS; SUBSTANCE-P RECEPTOR				HOKFELT, T (corresponding author), KAROLINSKA INST,DEPT HISTOL & NEUROBIOL,S-10401 STOCKHOLM 60,SWEDEN.				NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH043230] Funding Source: NIH RePORTER; NIMH NIH HHS [NIMH-43230] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN JM, 1982, NEUROPEPTIDES, V3, P71, DOI 10.1016/0143-4179(82)90001-4; ARVIDSSON U, 1990, EXP BRAIN RES, V79, P212; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Barron K, 1983, SPINAL CORD RECONSTR, P7; BARTFAI T, 1991, IN PRESS P NATL ACAD; BEAN AJ, 1991, J NEUROSCI, V11, P2694; BENARI Y, 1990, EUR J NEUROSCI, V2, P62, DOI 10.1111/j.1460-9568.1990.tb00381.x; BERSANI M, 1991, FEBS LETT, V283, P189, DOI 10.1016/0014-5793(91)80585-Q; Bjorklund A.H.T., 1988, HATLDBOOK CHEM NEURO, V6, P599; BOCK MG, 1989, J MED CHEM, V32, P13, DOI 10.1021/jm00121a004; BRADWEJN J, 1990, CAN J PSYCHIAT, V35, P83, DOI 10.1177/070674379003500115; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; BRENNEMAN DE, 1986, P NATL ACAD SCI USA, V83, P1159, DOI 10.1073/pnas.83.4.1159; BROWNSTEIN MJ, 1986, PROG BRAIN RES, V68, P161, DOI 10.1016/S0079-6123(08)60237-X; CASTEL MN, 1990, NEUROSCIENCE, V36, P425, DOI 10.1016/0306-4522(90)90438-A; CECCATELLI S, 1989, NEUROENDOCRINOLOGY, V49, P309, DOI 10.1159/000125133; Chan-Palay V., 1984, COEXISTENCE NEUROACT; CHANG MM, 1971, NATURE-NEW BIOL, V232, P86, DOI 10.1038/newbio232086a0; CHANPALAY V, 1988, J COMP NEUROL, V273, P543, DOI 10.1002/cne.902730409; CHANPALAY V, 1988, BRAIN RES BULL, V21, P465, DOI 10.1016/0361-9230(88)90160-8; CHRISTENSON J, 1991, IN PRESS NEUROSCI LE; CORTES R, 1990, P NATL ACAD SCI USA, V87, P7742, DOI 10.1073/pnas.87.19.7742; COSTA E, 1983, NEUROPHARMACOLOGY, V22, P1481, DOI 10.1016/0028-3908(83)90116-8; COSTA M, 1986, PROG BRAIN RES, V68, P217, DOI 10.1016/S0079-6123(08)60241-1; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; Cuello A. C., 1982, COTRANSMISSION; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; DEBIASI S, 1988, P NATL ACAD SCI USA, V85, P7820; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DEMONTIGNY C, 1989, ARCH GEN PSYCHIAT, V46, P511; DENISDONINI S, 1989, NATURE, V339, P701, DOI 10.1038/339701a0; DEWIED D, 1971, NATURE, V232, P58, DOI 10.1038/232058a0; DOURISH CT, 1989, SCIENCE, V245, P1509, DOI 10.1126/science.2781294; DOURISH CT, 1990, EUR J PHARMACOL, V176, P35, DOI 10.1016/0014-2999(90)90129-T; DUGGAN AW, 1990, NEUROSCIENCE, V35, P195, DOI 10.1016/0306-4522(90)90134-P; ECCLES JC, 1986, PROGR BRAIN RES, P3; EDWARDS AV, 1982, SYSTEMIC ROLE REGULA, P145; ELDE R, 1990, NEUROSCI LETT, V120, P134, DOI 10.1016/0304-3940(90)90187-E; EVANS BE, 1986, P NATL ACAD SCI USA, V83, P4918, DOI 10.1073/pnas.83.13.4918; FISONE G, 1987, P NATL ACAD SCI USA, V84, P7339, DOI 10.1073/pnas.84.20.7339; FITZGERALD M, 1985, BRAIN RES, V332, P131, DOI 10.1016/0006-8993(85)90396-8; FOLKERS K, 1982, ACTA CHEM SCAND B, V36, P389, DOI 10.3891/acta.chem.scand.36b-0389; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; FONTAINE B, 1986, NEUROSCI LETT, V71, P59, DOI 10.1016/0304-3940(86)90257-0; FRIED G, 1985, J NEUROSCI, V5, P450; FUXE K, 1991, VOLUME TRANSMISSION, P1; GESSER BP, 1985, J NEUROSCI, V5, P1412; GIAID A, 1989, P NATL ACAD SCI USA, V86, P7634, DOI 10.1073/pnas.86.19.7634; GIBBINS IL, 1987, CELL TISSUE RES, V248, P417; GIBSON SJ, 1984, J NEUROSCI, V4, P3101, DOI 10.1523/jneurosci.04-12-03101.1984; GOLDING DW, 1984, EXPERIENTIA, V40, P1277, DOI 10.1007/BF01946673; GOODMAN RR, 1980, P NATL ACAD SCI-BIOL, V77, P6239, DOI 10.1073/pnas.77.10.6239; GUILLEMIN R, 1978, HYPOTHALAMUS, P155; HAAS CA, 1990, J NEUROSCI RES, V27, P270, DOI 10.1002/jnr.490270305; HAEGERSTRAND A, 1989, P NATL ACAD SCI USA, V86, P5993, DOI 10.1073/pnas.86.15.5993; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; HENRY JL, 1975, CAN J PHYSIOL PHARM, V53, P423, DOI 10.1139/y75-061; HERSHEY AD, 1990, SCIENCE, V247, P958, DOI 10.1126/science.2154852; HILL EL, 1991, NEUROSCIENCE, V44, P747, DOI 10.1016/0306-4522(91)90094-5; HOHMANN EL, 1986, SCIENCE, V232, P868, DOI 10.1126/science.3518059; HOKFELT T, 1987, EXPERIENTIA, V43, P768; HOKFELT T, 1980, NEUROSCIENCE, V5, P2093, DOI 10.1016/0306-4522(80)90127-X; HOKFELT T, 1987, NEUROSCI LETT, V83, P217, DOI 10.1016/0304-3940(87)90088-7; HOKFELT T, 1980, NATURE, V284, P515, DOI 10.1038/284515a0; HOKFELT T, 1977, P NATL ACAD SCI USA, V74, P3587, DOI 10.1073/pnas.74.8.3587; HOKFELT T, 1986, COEXISTENCE NEURONAL; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; HUGHES J, 1990, P NATL ACAD SCI USA, V87, P6728, DOI 10.1073/pnas.87.17.6728; ITOH N, 1983, NATURE, V304, P547, DOI 10.1038/304547a0; IVERFELDT K, 1989, ACTA PHYSIOL SCAND, V137, P63, DOI 10.1111/j.1748-1716.1989.tb08721.x; IVERSEN LL, 1986, FAST SLOW CHEM SIGNA; JENNINGS CGB, 1989, BRAIN RES, V504, P199, DOI 10.1016/0006-8993(89)91357-7; JESSELL T, 1979, BRAIN RES, V168, P247, DOI 10.1016/0006-8993(79)90167-7; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; JONSSON G, 1982, SCIENCE, V215, P75, DOI 10.1126/science.6171883; KANEKO T, 1990, BRAIN RES, V507, P141; KANGRGA I, 1990, J NEUROSCI, V10, P2026; KASAKOV L, 1988, J AUTONOM NERV SYST, V22, P75, DOI 10.1016/0165-1838(88)90156-7; KESSLER JA, 1980, P NATL ACAD SCI-BIOL, V77, P649, DOI 10.1073/pnas.77.1.649; KOBAYASHI RM, 1977, BRAIN RES, V126, P584, DOI 10.1016/0006-8993(77)90613-8; KORDOWER JH, 1990, J COMP NEUROL, V294, P281, DOI 10.1002/cne.902940211; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; LAUFER R, 1987, EMBO J, V6, P901, DOI 10.1002/j.1460-2075.1987.tb04836.x; LAZAR P, 1991, NEUROSCI LETT, V130, P99, DOI 10.1016/0304-3940(91)90237-N; LECCI A, 1991, NEUROSCI LETT, V129, P299, DOI 10.1016/0304-3940(91)90485-C; LEE CM, 1982, N-S ARCH PHARMACOL, V318, P281, DOI 10.1007/BF00501166; LEGREVES P, 1985, EUR J PHARMACOL, V115, P309, DOI 10.1016/0014-2999(85)90706-X; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; LORD JAH, 1977, NATURE, V267, P495, DOI 10.1038/267495a0; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; LUNDBERG JM, 1983, TRENDS NEUROSCI, V6, P325, DOI 10.1016/0166-2236(83)90149-2; LUNDBERG JM, 1981, NEUROSCIENCE, V6, P1001, DOI 10.1016/0306-4522(81)90066-X; LUNDBERG JM, 1982, SYSTEMIC ROLE REGULA, P93; MAGISTRETTI PJ, 1984, NATURE, V308, P280, DOI 10.1038/308280a0; MAGISTRETTI PJ, 1981, P NATL ACAD SCI-BIOL, V78, P6535, DOI 10.1073/pnas.78.10.6535; MARLIER L, 1990, EXP BRAIN RES, V82, P40; MASTROPAOLO J, 1988, P NATL ACAD SCI USA, V85, P9841, DOI 10.1073/pnas.85.24.9841; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; MCMAHON SB, 1987, NEUROSCI LETT, V73, P9, DOI 10.1016/0304-3940(87)90022-X; MEISTER B, 1988, NEUROENDOCRINOLOGY, V48, P516, DOI 10.1159/000125058; MEISTER B, 1990, NEUROSCIENCE, V37, P603, DOI 10.1016/0306-4522(90)90094-K; MELANDER T, 1986, NEUROSCI LETT, V68, P17, DOI 10.1016/0304-3940(86)90222-3; MELANDER T, 1985, BRAIN RES, V360, P130, DOI 10.1016/0006-8993(85)91228-4; MICEVYCH P, 1988, J COMP NEUROL, V269, P381, DOI 10.1002/cne.902690306; MILETIC V, 1988, BRAIN RES, V446, P169, DOI 10.1016/0006-8993(88)91310-8; MOORE RY, 1989, J COMP NEUROL, V282, P512, DOI 10.1002/cne.902820404; NARUMI S, 1978, J NEUROCHEM, V30, P1321, DOI 10.1111/j.1471-4159.1978.tb10462.x; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; Nicholas A P, 1990, Neuroreport, V1, P235, DOI 10.1097/00001756-199011000-00016; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; NOGUCHI K, 1990, MOL BRAIN RES, V7, P299, DOI 10.1016/0169-328X(90)90080-W; OKU R, 1987, BRAIN RES, V403, P350, DOI 10.1016/0006-8993(87)90074-6; OKU R, 1988, BRAIN RES, V475, P356, DOI 10.1016/0006-8993(88)90625-7; PALACIOS JM, 1981, NATURE, V294, P587, DOI 10.1038/294587a0; PALACIOS JM, 1989, BRAIN RES, V488, P369, DOI 10.1016/0006-8993(89)90733-6; PERNOW B, 1983, PHARMACOL REV, V35, P85; PIEHL F, 1991, EUR J NEUROSCI, V3, P737, DOI 10.1111/j.1460-9568.1991.tb01670.x; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; POPPER P, 1989, BRAIN RES, V496, P180, DOI 10.1016/0006-8993(89)91064-0; RANDIC M, 1990, NEUROSCI LETT, V117, P74, DOI 10.1016/0304-3940(90)90122-P; ROA M, 1991, NEUROSCIENCE, V41, P563, DOI 10.1016/0306-4522(91)90349-S; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; RYU PD, 1988, BRAIN RES, V441, P357, DOI 10.1016/0006-8993(88)91414-X; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; SALT TE, 1983, NEUROSCIENCE, V10, P1083, DOI 10.1016/0306-4522(83)90101-X; SCHALLING M, 1990, P NATL ACAD SCI USA, V87, P8427, DOI 10.1073/pnas.87.21.8427; SCHALLY AV, 1973, SCIENCE, V179, P341, DOI 10.1126/science.179.4071.341; SCHNEIDER SP, 1985, BRAIN RES, V360, P339, DOI 10.1016/0006-8993(85)91251-X; SCHULTZBERG M, 1988, HDB CHEM NEUROANATOM, V6, P297; SHEHAB SAS, 1986, BRAIN RES, V372, P37, DOI 10.1016/0006-8993(86)91456-3; SHINMI O, 1989, BIOCHEM BIOPH RES CO, V162, P340, DOI 10.1016/0006-291X(89)92001-9; SIMERLY RB, 1987, P NATL ACAD SCI USA, V84, P2087, DOI 10.1073/pnas.84.7.2087; SMULLIN DH, 1990, PAIN, V42, P93, DOI 10.1016/0304-3959(90)91095-Z; SNEDDON P, 1984, J PHYSIOL-LONDON, V347, P561, DOI 10.1113/jphysiol.1984.sp015083; SNIDER RM, 1991, SCIENCE, V251, P435, DOI 10.1126/science.1703323; SNYDER SH, 1980, SCIENCE, V209, P976, DOI 10.1126/science.6157191; SOSSIN WS, 1990, P NATL ACAD SCI USA, V87, P4845, DOI 10.1073/pnas.87.12.4845; STREIT WJ, 1989, NEUROSCI LETT, V101, P143, DOI 10.1016/0304-3940(89)90521-1; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUNDSTROM E, 1988, NEUROSCI LETT, V88, P331, DOI 10.1016/0304-3940(88)90233-9; SWAAB DF, 1977, J HISTOCHEM CYTOCHEM, V25, P388, DOI 10.1177/25.5.325124; SWANSON LW, 1986, PROG BRAIN RES, V68, P169, DOI 10.1016/S0079-6123(08)60238-1; TAKAHASHI T, 1974, BRAIN RES, V73, P59, DOI 10.1016/0006-8993(74)91007-5; TAKAMI K, 1986, JPN J PHARMACOL, V42, P345, DOI 10.1254/jjp.42.345; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tatemoto K., 1988, Gastrointestinal hormones., P421; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Thureson-Klein A K, 1990, Int Rev Cytol, V121, P67, DOI 10.1016/S0074-7696(08)60659-2; TSUJIMOTO T, 1988, J NEUROSCI, V8, P3951; VERTES Z, 1982, LIFE SCI, V31, P119, DOI 10.1016/0024-3205(82)90423-4; VILLAR MJ, 1989, NEUROSCIENCE, V33, P587, DOI 10.1016/0306-4522(89)90411-9; VILLAR MJ, 1989, EUR J NEUROSCI, V1, P269, DOI 10.1111/j.1460-9568.1989.tb00795.x; WALKER LC, 1989, J COMP NEUROL, V280, P272, DOI 10.1002/cne.902800208; WALL PD, 1974, EXP NEUROL, V43, P580, DOI 10.1016/0014-4886(74)90197-6; WALL PD, 1984, J PHYSIOL-LONDON, V356, P443, DOI 10.1113/jphysiol.1984.sp015475; WANG R, 1987, CHOLECYSTOKININ ANTA; WHIM MD, 1989, P NATL ACAD SCI USA, V86, P9034, DOI 10.1073/pnas.86.22.9034; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WIESENFELDHALLIN Z, 1984, NEUROSCI LETT, V52, P199, DOI 10.1016/0304-3940(84)90374-4; WOODLEY SJ, 1991, BRAIN RES, V559, P17, DOI 10.1016/0006-8993(91)90281-Y; WOODRUFF GN, 1991, NEUROPEPTIDES, V19, P45, DOI 10.1016/0143-4179(91)90082-T; WOOLF C, 1986, NEUROSCI LETT, V66, P226, DOI 10.1016/0304-3940(86)90195-3; XU XJ, 1990, EUR J NEUROSCI, V2, P733, DOI 10.1111/j.1460-9568.1990.tb00464.x; XU XJ, 1989, ACTA PHYSIOL SCAND, V137, P463, DOI 10.1111/j.1748-1716.1989.tb08780.x; XU XJ, 1991, IN PRESS BR J PHARM; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; YOUNG WS, 1979, BRAIN RES, V179, P255; ZAGON IS, 1983, SCIENCE, V221, P1179, DOI 10.1126/science.6612331	171	524	533	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					867	879		10.1016/0896-6273(91)90333-U	http://dx.doi.org/10.1016/0896-6273(91)90333-U			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1684901				2022-12-17	WOS:A1991GY43800001
J	Graybiel, AM; Rauch, SL				Graybiel, AM; Rauch, SL			Toward a neurobiology of obsessive-compulsive disorder	NEURON			English	Review							NIGROSTRIATAL DOPAMINE SYSTEM; TONICALLY ACTIVE NEURONS; BASAL GANGLIA; PREFRONTAL CORTEX; STRIATAL FUNCTION; CINGULATE; RESPONSES; THERAPY; PET		MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Graybiel, AM (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	graybiel@mit.edu		Graybiel, Ann/0000-0002-4326-7720				ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Brody AL, 1998, PSYCHIAT RES-NEUROIM, V84, P1, DOI 10.1016/S0925-4927(98)00041-9; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Carelli RM, 1997, J NEUROSCI, V17, P1804; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; EBLEN F, 1995, J NEUROSCI, V15, P5999; Elliott R, 1999, NEUROPSYCHOLOGIA, V37, P403, DOI 10.1016/S0028-3932(98)00107-9; ELMANSARI M, 1995, NEUROPSYCHOPHARMACOL, V13, P117, DOI 10.1016/0893-133X(95)00045-F; Fitzgerald KD, 2000, BIOL PSYCHIAT, V47, P174, DOI 10.1016/S0006-3223(99)00286-3; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; LAPLANE D, 1989, BRAIN, V112, P699, DOI 10.1093/brain/112.3.699; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P609, DOI 10.1016/0306-4522(94)90181-3; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; MATSUMOTO N, 2000, IN PRESS J NEUROPHYS; MCDOUGLE CJ, 1994, ARCH GEN PSYCHIAT, V51, P302; Peterson BS, 1998, ARCH GEN PSYCHIAT, V55, P326, DOI 10.1001/archpsyc.55.4.326; Picard N, 1997, J NEUROPHYSIOL, V77, P2197, DOI 10.1152/jn.1997.77.4.2197; Price JL, 1996, PROG BRAIN RES, V107, P523; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; Rauch SL, 1998, OBSESSIVE COMPULSIVE, P289; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; SWERDLOW NR, 1987, BEHAV BRAIN SCI, V10, P197, DOI 10.1017/S0140525X00047488; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Weeks RA, 1996, QJM-INT J MED, V89, P401; White NM, 1998, P NATL ACAD SCI USA, V95, P6486, DOI 10.1073/pnas.95.11.6486	34	523	536	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	2000	28	2					343	347		10.1016/S0896-6273(00)00113-6	http://dx.doi.org/10.1016/S0896-6273(00)00113-6			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144344	Bronze			2022-12-17	WOS:000165493700009
J	Maruyama, M; Shimada, H; Suhara, T; Shinotoh, H; Ji, B; Maeda, J; Zhang, MR; Trojanowski, JQ; Lee, VMY; Ono, M; Masamoto, K; Takano, H; Sahara, N; Iwata, N; Okamura, N; Furumoto, S; Kudo, Y; Chang, Q; Saido, TC; Takashima, A; Lewis, J; Jang, MK; Aoki, I; Ito, H; Higuchi, M				Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Trojanowski, John Q.; Lee, Virginia M. -Y.; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Sahara, Naruhiko; Iwata, Nobuhisa; Okamura, Nobuyuki; Furumoto, Shozo; Kudo, Yukitsuka; Chang, Qing; Saido, Takaomi C.; Takashima, Akihiko; Lewis, Jada; Jang, Ming-Kuei; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto			Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls	NEURON			English	Article							IN-VIVO DETECTION; AMYLOID-BETA; DISEASE; PET; BINDING; DISORDERS; PLAQUES; TANGLES; LIGAND; TRACER	Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms of neurodegeneration in Alzheimer's disease (AD) and related tauopathies. Here, we have developed a class of tau ligands, phenyl/pyridinyl-butadienyl-benzothiazoles/benzothiazoliums (PBBs), for visualizing diverse tau inclusions in brains of living patients with AD or non-AD tauopathies and animal models of these disorders. In vivo optical and positron emission tomographic (PET) imaging of a transgenic mouse model demonstrated sensitive detection of tau inclusions by PBBs. A pyridinated PBB, [C-11]PBB3, was next applied in a clinical PET study, and its robust signal in the AD hippocampus wherein tau pathology is enriched contrasted strikingly with that of a senile plaque radioligand, [C-11]Pittsburgh Compound-B ([C-11]PIB. [C-11]PBB3-PET data were also consistent with the spreading of tau pathology with AD progression. Furthermore, increased [C-11]PBB3 signals were found in a corticobasal syndrome patient negative for [C-11]PIB-PET.	[Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 2638555, Japan; [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Sahara, Naruhiko; Takashima, Akihiko] RIKEN Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; [Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Sahara, Naruhiko; Lewis, Jada] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Sahara, Naruhiko; Lewis, Jada] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Okamura, Nobuyuki; Furumoto, Shozo] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kudo, Yukitsuka] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Chang, Qing; Jang, Ming-Kuei] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77054 USA	National Institutes for Quantum Science & Technology; University of Pennsylvania; Pennsylvania Medicine; RIKEN; RIKEN; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Tohoku University; Tohoku University; University of Texas System; UTMD Anderson Cancer Center	Higuchi, M (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	mhiguchi@nirs.go.jp	Okamura, Nobuyuki/C-3541-2017; Aoki, Ichio/ABF-7336-2020; Aoki, Ichio/G-2529-2011; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Okamura, Nobuyuki/0000-0002-5991-7812; Aoki, Ichio/0000-0002-4429-5053; Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Furumoto, Shozo/0000-0002-9296-3079; SHIMADA, Hitoshi/0000-0002-7139-7178	National Institute on Aging of the National Institutes of Health [AG10124, AG17586]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21791158, 23390235, 23111009]; Thomas H. Maren Junior Investigator Fund from College of Medicine, University of Florida; Belfer Neurodegeneration Consortium; Grants-in-Aid for Scientific Research [23591735] Funding Source: KAKEN; NATIONAL INSTITUTE ON AGING [P01AG017586, P30AG010124] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Thomas H. Maren Junior Investigator Fund from College of Medicine, University of Florida; Belfer Neurodegeneration Consortium; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Mr. T. Minamihisamatsu and Mr. Y. Matsuba for technical assistance, the staff of the Molecular Probe Group, National Institute of Radiological Sciences, for support with radiosynthesis, Dr. Y. Yoshiyama at National Hospital Organization Chiba-East Hospital for his support on clinical PET studies, and Dr. T. Iwatsubo at the University of Tokyo and Dr. H. Inoue at Kyoto University for their critical discussions. This work was supported in part by grants from the National Institute on Aging of the National Institutes of Health (AG10124 and AG17586) (to J.Q.T. and V. M.-Y.L.), Grants-in-Aid for Japan Advanced Molecular Imaging Program, Young Scientists (21791158) (to M.M.), Scientific Research (B) (23390235) (to M.H.), Core Research for Evolutional Science and Technology (to T.S.), Scientific Research on Innovative Areas ("Brain Environment") (23111009) (to M.H.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Thomas H. Maren Junior Investigator Fund from College of Medicine, University of Florida (to N.S.), and research fund of Belfer Neurodegeneration Consortium (to Q.C. and M.-K.J.). M.M., H. Shimada, T.S., M.-R.Z., and M.H. are named as inventors on a patent application 0749006WO1, claiming subject matter related to the results described in this paper.	Bacskai BJ, 2003, P NATL ACAD SCI USA, V100, P12462, DOI 10.1073/pnas.2034101100; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Hintersteiner M, 2005, NAT BIOTECHNOL, V23, P577, DOI 10.1038/nbt1085; Klunk WE, 2003, J NEUROSCI, V23, P2086; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kudo Y, 2007, J NUCL MED, V48, P553, DOI 10.2967/jnumed.106.037556; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Maeda J, 2011, J NEUROSCI, V31, P4720, DOI 10.1523/JNEUROSCI.3076-10.2011; Marx J, 2007, SCIENCE, V316, P1416, DOI 10.1126/science.316.5830.1416; Okamura N, 2005, J NEUROSCI, V25, P10857, DOI 10.1523/JNEUROSCI.1738-05.2005; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHMIDT ML, 1988, ANN NEUROL, V23, P184, DOI 10.1002/ana.410230212; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Suzuki K., 1999, Journal of Labelled Compounds and Radiopharmaceuticals, V42, pS658; Thompson PW, 2009, J NEUROCHEM, V109, P623, DOI 10.1111/j.1471-4159.2009.05996.x; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712; Zhuang ZP, 2001, J MED CHEM, V44, P1905, DOI 10.1021/jm010045q	27	522	544	3	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1094	1108		10.1016/j.neuron.2013.07.037	http://dx.doi.org/10.1016/j.neuron.2013.07.037			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050400	Green Accepted, Bronze			2022-12-17	WOS:000330329600009
J	Pinel, P; Piazza, M; Le Bihan, D; Dehaene, S				Pinel, P; Piazza, M; Le Bihan, D; Dehaene, S			Distributed and overlapping cerebral representations of number, size, and luminance during comparative judgments	NEURON			English	Article							MENTAL ROTATION; PARIETAL CORTEX; ACTIVATION; ORGANIZATION; SUBTRACTION; OBJECTS; AREAS; TASK; TIME	How are comparative judgments performed in the human brain? We scanned subjects with fMRI while they compared stimuli for size, luminance, or number. Regions involved in comparative judgments were identified using three criteria: task-related activation, presence of a distance effect, and interference of one dimension onto the other. We observed considerable overlap in the neural substrates of the three comparison tasks. Interestingly, the amount of overlap predicted the amount of cross-dimensional interference: in both behavior and fMRI, number interfered with size and size with luminance, but number did not interfere with luminance. The results suggest that during comparative judgments, the relevant continuous quantities are represented in distributed and overlapping neural populations, with number and size engaging a common parietal spatial code, while size and luminance engage shared occipito-temporal perceptual representations.	Serv Hosp Frederic Joliot, INSERM U562, CEA, DRM,DSV, F-91401 Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Pinel, P (corresponding author), Serv Hosp Frederic Joliot, INSERM U562, CEA, DRM,DSV, 4 Pl Gen Leclerc, F-91401 Orsay, France.	pinel@shfj.cea.fr	Piazza, Manuela/D-2028-2010; pinel, philippe/AAJ-3768-2020	Piazza, Manuela/0000-0003-2557-9701; pinel, philippe/0000-0001-6945-1369				BANKS WP, 1977, J EXP PSYCHOL HUMAN, V3, P278, DOI 10.1037/0096-1523.3.2.278; Burbaud P, 1999, NEUROSCI LETT, V273, P195, DOI 10.1016/S0304-3940(99)00641-2; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0096-3445.122.3.371; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Faillenot I, 1999, NEUROIMAGE, V10, P114, DOI 10.1006/nimg.1999.0449; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Fias W, 2001, COGNITIVE BRAIN RES, V12, P415, DOI 10.1016/S0926-6410(01)00078-7; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; JOHNSON DM, 1939, ARCH PSYCHOL, V241, P1; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Lammertyn J., 2002, CORTEX, V38, P878, DOI [DOI 10.1016/S0010-9452(08)70061-3, 10.1016/S0010-9452(08)70061-3]; Lauwereyns J, 2001, J NEUROPHYSIOL, V86, P2001, DOI 10.1152/jn.2001.86.4.2001; Lee KM, 2000, ANN NEUROL, V48, P657, DOI 10.1002/1531-8249(200010)48:4<657::AID-ANA13>3.3.CO;2-B; LINK S, 1990, J MATH PSYCHOL, V34, P2, DOI 10.1016/0022-2496(90)90010-7; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; MOYER RS, 1973, PERCEPT PSYCHOPHYS, V13, P180, DOI 10.3758/BF03214124; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; PAIVIO A, 1975, MEM COGNITION, V3, P635, DOI 10.3758/BF03198229; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Thioux M, 2001, NEUROIMAGE, V13, pS617; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	43	521	527	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					983	993		10.1016/S0896-6273(04)00107-2	http://dx.doi.org/10.1016/S0896-6273(04)00107-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046729	Bronze, Green Submitted			2022-12-17	WOS:000221458300016
J	Wemmie, JA; Chen, JG; Askwith, CC; Hruska-Hageman, AM; Price, MP; Nolan, BC; Yoder, PG; Lamani, E; Hoshi, T; Freeman, JH; Welsh, MJ				Wemmie, JA; Chen, JG; Askwith, CC; Hruska-Hageman, AM; Price, MP; Nolan, BC; Yoder, PG; Lamani, E; Hoshi, T; Freeman, JH; Welsh, MJ			The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory	NEURON			English	Article							MAMMALIAN DEGENERIN MDEG; LONG-TERM POTENTIATION; GATED NA+ CHANNEL; NEUROPEPTIDE-FF; PURKINJE-CELLS; CEREBELLAR LTD; NMDA; RECEPTOR; PH; BRAIN	Many central neurons possess large acid-activated currents, yet their molecular identity is unknown. We found that eliminating the acid sensing ion channel (ASIC) abolished H+-gated currents in hippocampal neurons. Neuronal H+-gated currents and transient acidification are proposed to play a role in synaptic transmission. Investigating this possibility, we found ASIC in hippocampus, in synaptosomes, and in dendrites localized at synapses. Moreover, loss of ASIC impaired hippocampal long-term potentiation. ASIC null mice had reduced excitatory postsynaptic potentials and NMDA receptor activation during high-frequency stimulation. Consistent with these findings, null mice displayed defective spatial learning and eye-blink conditioning. These results identify ASIC as a key component of acid-activated currents and implicate these currents in processes underlying synaptic plasticity, learning, and memory.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China; Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Huazhong University of Science & Technology; University of Pennsylvania	Welsh, MJ (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	mjwelsh@blue.weeg.uiowa.edu	Telch, Michael J/E-7027-2010	Wemmie, John/0000-0001-7531-9065; Welsh, Michael/0000-0002-1646-6206	NHLBI NIH HHS [HL 64645, HL 14338] Funding Source: Medline; NIDDK NIH HHS [DK 25295] Funding Source: Medline; NIGMS NIH HHS [GM 57654] Funding Source: Medline; NINDS NIH HHS [NS 38890] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038890] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen L, 1996, J NEUROSCI, V16, P2829; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOI DW, 1987, J NEUROSCI, V7, P369; COTTRELL GA, 1992, EXP PHYSIOL, V77, P881, DOI 10.1113/expphysiol.1992.sp003655; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; During MJ, 2000, SCIENCE, V287, P1453, DOI 10.1126/science.287.5457.1453; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Freeman JH, 2000, J NEUROSCI, V20, P813, DOI 10.1523/JNEUROSCI.20-02-00813.2000; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GOTTFRIED JA, 1994, J PHYSIOL-LONDON, V478, P373, DOI 10.1113/jphysiol.1994.sp020258; GRUOL DL, 1980, BRAIN RES, V183, P247, DOI 10.1016/0006-8993(80)90138-9; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; HUANG YY, 1987, NEUROSCIENCE, V22, P9, DOI 10.1016/0306-4522(87)90193-X; KAVALIERS M, 1993, NEUROSCI LETT, V157, P75, DOI 10.1016/0304-3940(93)90646-3; Kleschevnikov AM, 2001, HIPPOCAMPUS, V11, P168, DOI 10.1002/hipo.1034; KRISHTAL OA, 1981, NEUROSCI LETT, V24, P243, DOI 10.1016/0304-3940(81)90164-6; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MULLER WE, 1994, LIFE SCI, V55, P2147, DOI 10.1016/0024-3205(94)00395-5; OBRENOVITCH TP, 1988, J CEREBR BLOOD F MET, V8, P866, DOI 10.1038/jcbfm.1988.144; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Saybasili H, 1998, BRAIN RES, V786, P128, DOI 10.1016/S0006-8993(97)01461-3; Schehr RS, 1996, NAT BIOTECHNOL, V14, P1549, DOI 10.1038/nbt1196-1549; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; Traynelis SF, 2001, NEURON, V32, P960, DOI 10.1016/S0896-6273(01)00549-9; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Varming T, 1999, NEUROPHARMACOLOGY, V38, P1875, DOI 10.1016/S0028-3908(99)00079-9; VYKLICKY L, 1990, J PHYSIOL-LONDON, V430, P497, DOI 10.1113/jphysiol.1990.sp018304; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877	65	521	550	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					463	477		10.1016/S0896-6273(02)00661-X	http://dx.doi.org/10.1016/S0896-6273(02)00661-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988176	Bronze			2022-12-17	WOS:000175214700016
J	Pettmann, B; Henderson, CE				Pettmann, B; Henderson, CE			Neuronal cell death	NEURON			English	Review							NERVE GROWTH-FACTOR; EMBRYO SPINAL-CORD; CAENORHABDITIS-ELEGANS; SYMPATHETIC NEURONS; DEFICIENT MICE; CHICK-EMBRYO; BCL-2 TRANSGENE; GENETIC-CONTROL; DOWN-REGULATION; C-ELEGANS		Univ Mediterrane, INSERM U382, CNRS, Dev Biol Inst Marseille, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Henderson, CE (corresponding author), Univ Mediterrane, INSERM U382, CNRS, Dev Biol Inst Marseille, AP Marseille Campus Luminy,Case 907, F-13288 Marseille 09, France.			Henderson, Christopher/0000-0002-9936-3279				Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Ameisen JC, 1996, SCIENCE, V272, P1278, DOI 10.1126/science.272.5266.1278; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Arce V, 1998, J NEUROSCI, V18, P1440; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bottjer SW, 1997, ANNU REV NEUROSCI, V20, P459, DOI 10.1146/annurev.neuro.20.1.459; Bredesen DE, 1997, TRENDS NEUROSCI, V20, P287, DOI 10.1016/S0166-2236(96)01049-1; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; BUREK MJ, 1998, IN PRESS CELL DEATH; Caldero J, 1997, J COMP NEUROL, V387, P73; Caldero J, 1998, J NEUROSCI, V18, P356; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chinnaiyan AM, 1997, NATURE, V388, P728, DOI 10.1038/41913; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; CLARKE PGH, 1998, IN PRESS CELL DEATH; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies AM, 1997, CURR OPIN NEUROBIOL, V7, P110, DOI 10.1016/S0959-4388(97)80128-6; Dawson VL, 1996, J NEUROSCI, V16, P2479; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; deLapeyriere O, 1997, CURR OPIN GENET DEV, V7, P642, DOI 10.1016/S0959-437X(97)80012-3; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Easton RM, 1997, J NEUROSCI, V17, P9656; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, DEVELOPMENT, V112, P591; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Estevez AG, 1998, J NEUROSCI, V18, P923; Evans EK, 1997, EMBO J, V16, P7372, DOI 10.1093/emboj/16.24.7372; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frade JM, 1996, NATURE, V383, P166; Franke TF, 1997, NATURE, V390, P116, DOI 10.1038/36442; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Furuta Y, 1997, DEVELOPMENT, V124, P2203; GALLIRESTA L, 1993, J NEUROSCI, V13, P243; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Golstein P, 1997, SCIENCE, V275, P1081, DOI 10.1126/science.275.5303.1081; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; GRIESHAMMER U, 1998, IN PRESS DEV BIOL; Hall DH, 1997, J NEUROSCI, V17, P1033; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Henderson CE, 1996, NEURON, V17, P579, DOI 10.1016/S0896-6273(00)80191-9; HENGARTNER MO, 1994, CURR OPIN GENET DEV, V4, P581, DOI 10.1016/0959-437X(94)90076-F; Hengartner MO, 1997, NATURE, V388, P714, DOI 10.1038/41873; Hengartner MO, 1996, CURR OPIN GENET DEV, V6, P34, DOI 10.1016/S0959-437X(96)90007-6; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; HORYLEE F, 1995, J NEUROSCI, V15, P6453; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Iwahashi H, 1997, NATURE, V390, P413, DOI 10.1038/37144; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; James C, 1997, CURR BIOL, V7, P246, DOI 10.1016/S0960-9822(06)00120-5; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kelley MS, 1997, J COMP NEUROL, V389, P469; Kharbanda S, 1997, P NATL ACAD SCI USA, V94, P6939, DOI 10.1073/pnas.94.13.6939; Kim CN, 1997, CANCER RES, V57, P3115; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LEE KF, 1994, DEVELOPMENT, V120, P1027; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LIU AZ, 1997, J NEUROSCI, V17, P5395; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Maden M, 1997, DEVELOPMENT, V124, P2799; Majdan M, 1997, J NEUROSCI, V17, P6988; Marsh HN, 1996, J NEUROCHEM, V67, P952; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; McCall K, 1997, TRENDS GENET, V13, P222, DOI 10.1016/S0168-9525(97)01126-8; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miller TM, 1997, J BIOL CHEM, V272, P9847; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Oakley RA, 1997, J NEUROSCI, V17, P4262; OKADO N, 1984, J NEUROSCI, V4, P1639; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Peterson DA, 1997, SCIENCE, V277, P837, DOI 10.1126/science.277.5327.837; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; Pinon LGP, 1997, DEVELOPMENT, V124, P4173; PITTMAN R, 1979, J COMP NEUROL, V187, P425, DOI 10.1002/cne.901870210; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porter AG, 1997, BIOESSAYS, V19, P501, DOI 10.1002/bies.950190609; Primi MP, 1997, J NEUROSCI, V17, P4253; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; RofflerTarlov S, 1996, DEVELOPMENT, V122, P1; Sadoul R, 1996, EMBO J, V15, P3845, DOI 10.1002/j.1460-2075.1996.tb00758.x; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schwartz LM, 1996, TRENDS NEUROSCI, V19, P555, DOI 10.1016/S0166-2236(96)10067-9; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; Shindler KS, 1997, J NEUROSCI, V17, P3112; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Spear N, 1997, J NEUROCHEM, V69, P53; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tiret L, 1998, DEVELOPMENT, V125, P279; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Troy CM, 1996, J NEUROSCI, V16, P253; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Villa PG, 1998, J CELL SCI, V111, P713; Virdee K, 1997, J NEUROCHEM, V69, P550; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Watson A, 1998, J NEUROSCI, V18, P751; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; Wu DY, 1997, J BIOL CHEM, V272, P21449, DOI 10.1074/jbc.272.34.21449; Wyllie A H, 1980, Int Rev Cytol, V68, P251; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Xu X, 1997, P NATL ACAD SCI USA, V94, P12655, DOI 10.1073/pnas.94.23.12655; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Yaginuma H, 1996, J NEUROSCI, V16, P3685; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yeo TT, 1997, J NEUROSCI, V17, P7594; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Zanjani HS, 1996, J COMP NEUROL, V374, P332, DOI 10.1002/(SICI)1096-9861(19961021)374:3<332::AID-CNE2>3.0.CO;2-2; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	176	520	551	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					633	647		10.1016/S0896-6273(00)81004-1	http://dx.doi.org/10.1016/S0896-6273(00)81004-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581757	Bronze			2022-12-17	WOS:000073346500004
J	Denk, W; Svoboda, K				Denk, W; Svoboda, K			Photon upmanship: Why multiphoton imaging is more than a gimmick	NEURON			English	Review							GREEN FLUORESCENT PROTEIN; MICROSCOPY; LASER; SPECTROSCOPY; SPINES; CELLS				Denk, W (corresponding author), AT&T BELL LABS, LUCENT TECHNOL, 600 MT AVE, MURRAY HILL, NJ 07974 USA.		denk, winfried/I-6627-2012					AMOS WB, 1987, APPL OPTICS, V26, P3239, DOI 10.1364/AO.26.003239; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Bhawalkar JD, 1996, SCANNING, V18, P562, DOI 10.1002/sca.4950180805; BIRGE RR, 1986, ACCOUNTS CHEM RES, V19, P138, DOI 10.1021/ar00125a003; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Corrie J. E. T., 1993, BIOORGANIC PHOTOCHEM, P243; CURLEY PF, 1992, OPT QUANT ELECTRON, V24, P851, DOI 10.1007/BF00620198; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Denk W, 1996, J Biomed Opt, V1, P296, DOI 10.1117/12.242945; Denk Winfried, 1995, P445; FRIEDRICH DM, 1982, J CHEM EDUC, V59, P472, DOI 10.1021/ed059p472; GOSNELL TR, 1991, SELECTED PAPERS ULTR; KAISER W, 1961, PHYS REV LETT, V7, P229, DOI 10.1103/PhysRevLett.7.229; Lakowicz J R, 1992, J Fluoresc, V2, P47, DOI 10.1007/BF00866388; LARUE RA, 1993, P SOC PHOTO-OPT INS, V2022, P64, DOI 10.1117/12.158584; Maiti S, 1997, SCIENCE, V275, P530, DOI 10.1126/science.275.5299.530; Marvin M., 1961, US Patent, Patent No. [3013467, 3,013,467]; Masters B. R., 1996, SELECTED PAPERS CONF; Mayer M., 1931, ANN PHYS-LEIPZIG, V401, P273, DOI DOI 10.1002/ANDP.19314010303; NISWENDER KD, 1995, J MICROSC-OXFORD, V180, P109, DOI 10.1111/j.1365-2818.1995.tb03665.x; PISTON DW, 1992, P SOC PHOTO-OPT INS, V1640, P379, DOI 10.1117/12.58230; PISTON DW, 1995, J MICROSC-OXFORD, V178, P20, DOI 10.1111/j.1365-2818.1995.tb03576.x; Potter SM, 1996, GENE, V173, P25, DOI 10.1016/0378-1119(95)00681-8; Potter SM, 1996, CURR BIOL, V6, P1595, DOI 10.1016/S0960-9822(02)70782-3; SHEPPARD CJR, 1990, OPTIK, V86, P104; SOVBODA K, 1996, SCIENCE, V272, P716; STELZER EHK, 1994, OPT COMMUN, V104, P223, DOI 10.1016/0030-4018(94)90546-0; Summers RG, 1996, DEV BIOL, V175, P177, DOI 10.1006/dbio.1996.0105; Svoboda K, 1996, OPT LETT, V21, P1411, DOI 10.1364/OL.21.001411; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; WEITZ DA, 1993, PHYS SCRIPTA, VT49B, P610, DOI 10.1088/0031-8949/1993/T49B/040; WOKOSIN DL, 1996, BIOIMAGING, V4, P1; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	39	520	535	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1997	18	3					351	357		10.1016/S0896-6273(00)81237-4	http://dx.doi.org/10.1016/S0896-6273(00)81237-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115730	Bronze			2022-12-17	WOS:A1997WQ07400004
J	Rubin, BD; Katz, LC				Rubin, BD; Katz, LC			Optical imaging of odorant representations in the mammalian olfactory bulb	NEURON			English	Article							OSCILLATING NEURAL ASSEMBLIES; RECEPTOR GENE-EXPRESSION; PROPIONIC-ACID VAPOR; MITRAL TUFTED CELLS; FUNCTIONAL-ORGANIZATION; VISUAL-CORTEX; 2-DEOXYGLUCOSE UPTAKE; INTRINSIC SIGNALS; NEURONAL-ACTIVITY; 2-DG UPTAKE	We adapted the technique of intrinsic signal imaging to visualize how odorant concentration and structure are represented spatially in the rat olfactory bulb. Most odorants activated one or more glomeruli in the imaged region of the bulb; these optically imaged responses reflected the excitation of underlying neurons. Odorant-evoked patterns were similar across animals and symmetrical in the two bulbs of the same animal. The variable sensitivity of individual glomeruli produced distinct maps for different odorant concentrations. Using a series of homologous aldehydes, we found that glomeruli were tuned to detect particular molecular features and that maps of similar molecules were highly correlated. These characteristics suggest that odorants and their concentrations can be encoded by distinct spatial patterns of glomerular activation.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Rubin, BD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				ADRIAN ED, 1950, BRIT MED BULL, V6, P330, DOI 10.1093/oxfordjournals.bmb.a073625; BELL GA, 1987, BRAIN RES, V426, P8, DOI 10.1016/0006-8993(87)90419-7; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; BRAUN JJ, 1969, PHYSIOL BEHAV, V4, P245; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Chapman B, 1996, J NEUROSCI, V16, P6443; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; COOPERSMITH R, 1984, SCIENCE, V225, P849, DOI 10.1126/science.6474157; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Galizia CG, 1999, CELL TISSUE RES, V295, P383, DOI 10.1007/s004410051245; GESTELAND RC, 1965, J PHYSIOL-LONDON, V181, P525, DOI 10.1113/jphysiol.1965.sp007781; GREER CA, 1982, J NEUROSCI, V2, P1744; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; GUTHRIE KM, 1995, BRAIN RES BULL, V38, P129, DOI 10.1016/0361-9230(95)00078-S; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HOLLEY A, 1991, SMELL TASTE HLTH DIS, P329; HUDSON R, 1987, BRAIN RES, V421, P85, DOI 10.1016/0006-8993(87)91278-9; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; KAITZ M, 1987, DEV PSYCHOBIOL, V20, P587, DOI 10.1002/dev.420200604; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; LEON M, 1992, J NEUROBIOL, V23, P1557, DOI 10.1002/neu.480231012; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; LU XCM, 1994, BRAIN RES, V639, P26, DOI 10.1016/0006-8993(94)91760-4; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Masino SA, 1996, P NATL ACAD SCI USA, V93, P4942, DOI 10.1073/pnas.93.10.4942; MEISAMI E, 1993, DEV BRAIN RES, V71, P253, DOI 10.1016/0165-3806(93)90177-C; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; MORI K, 1995, PROG NEUROBIOL, V46, P1995; OHLOFF G, 1986, EXPERIENTIA, V42, P271, DOI 10.1007/BF01942507; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RISSER JM, 1987, PHYSIOL BEHAV, V40, P545, DOI 10.1016/0031-9384(87)90042-4; SALLAZ M, 1993, NEUROREPORT, V4, P55, DOI 10.1097/00001756-199301000-00014; SATO T, 1994, J NEUROPHYSIOL, V72, P2980, DOI 10.1152/jn.1994.72.6.2980; SCOTT JW, 1993, MICROSC RES TECHNIQ, V24, P142, DOI 10.1002/jemt.1070240206; SHARP FR, 1975, BRAIN RES, V98, P596, DOI 10.1016/0006-8993(75)90377-7; SHARP FR, 1977, J NEUROPHYSIOL, V40, P800, DOI 10.1152/jn.1977.40.4.800; Shepherd G M, 1985, Prog Clin Biol Res, V176, P99; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; SKEEN LC, 1977, BRAIN RES, V124, P147, DOI 10.1016/0006-8993(77)90871-X; Slotnick B.M., 1990, COMP PERCEPT, V1, P155; Slotnick BM, 1997, BRAIN RES, V762, P89, DOI 10.1016/S0006-8993(97)00357-0; SLOTNICK BM, 1989, BRAIN RES, V500, P161, DOI 10.1016/0006-8993(89)90310-7; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vroon P., 1994, SMELL SECRET SEDUCER; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WILSON DA, 1988, J NEUROPHYSIOL, V59, P1770, DOI 10.1152/jn.1988.59.6.1770; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	73	519	525	0	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					499	511		10.1016/S0896-6273(00)80803-X	http://dx.doi.org/10.1016/S0896-6273(00)80803-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433262	Bronze			2022-12-17	WOS:000081701000014
J	Hollingsworth, SA; Dror, RO				Hollingsworth, Scott A.; Dror, Ron O.			Molecular Dynamics Simulation for All	NEURON			English	Review							HUMAN SEROTONIN TRANSPORTER; PROTEIN-COUPLED RECEPTORS; RELAXED COMPLEX SCHEME; VOLTAGE-SENSING DOMAIN; FORCE-FIELD; CRYOELECTRON MICROSCOPY; STRUCTURAL BASIS; LIGAND-BINDING; DRUG DESIGN; FREE-ENERGY	The impact of molecular dynamics (MD) simulations in molecular biology and drug discovery has expanded dramatically in recent years. These simulations capture the behavior of proteins and other biomolecules in full atomic detail and at very fine temporal resolution. Major improvements in simulation speed, accuracy, and accessibility, together with the proliferation of experimental structural data, have increased the appeal of biomolecular simulation to experimentalists-a trend particularly noticeable in, although certainly not limited to, neuroscience. Simulations have proven valuable in deciphering functional mechanisms of proteins and other biomolecules, in uncovering the structural basis for disease, and in the design and optimization of small molecules, peptides, and proteins. Here we describe, in practical terms, the types of information MD simulations can provide and the ways in which they typically motivate further experimental work.	[Hollingsworth, Scott A.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Hollingsworth, Scott A.; Dror, Ron O.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Hollingsworth, Scott A.; Dror, Ron O.] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Hollingsworth, Scott A.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Dror, RO (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Dror, RO (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Dror, RO (corresponding author), Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA.; Dror, RO (corresponding author), Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA.	ron.dror@stanford.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Dror, Ron/0000-0002-6418-2793	NIH [R01GM127359]; NIH Biomedical Informatics postdoctoral fellowship [T15-LM007033-33]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127359] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Biomedical Informatics postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Brian Kobilka, Oliver Beckstein, Mark Sansom, Jose Faraldo-Gomez, Naomi Latorraca, Robin Betz, Raphael Townshend, Joseph Paggi, A.J. Venkatakrishnan, Albert Pan, Stefano Piana, Paul Robustelli, Morten Jensen, Matthew Lewis, Alec Follmer, and Thomas Poulos as well as the anonymous reviewers for helpful discussions and valuable suggestions. This work was supported by NIH grant R01GM127359 (to R.O.D.) and an NIH Biomedical Informatics postdoctoral fellowship (T15-LM007033-33 to S.A.H.).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALDER BJ, 1957, J CHEM PHYS, V27, P1208, DOI 10.1063/1.1743957; Amaro RE, 2008, J COMPUT AID MOL DES, V22, P693, DOI 10.1007/s10822-007-9159-2; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Bae C, 2016, ELIFE, V5, DOI 10.7554/eLife.11273; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Batabyal D, 2017, J AM CHEM SOC, V139, P13193, DOI 10.1021/jacs.7b07656; Batabyal D, 2016, BIOCHEMISTRY-US, V55, P6517, DOI 10.1021/acs.biochem.6b00913; Beckstein O, 2001, J PHYS CHEM B, V105, P12902, DOI 10.1021/jp012233y; Bernardi RC, 2015, BBA-GEN SUBJECTS, V1850, P872, DOI 10.1016/j.bbagen.2014.10.019; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Betz R.M., 2017, DABBLE, DOI DOI 10.5281/ZENODO.836914; Birkner JP, 2012, P NATL ACAD SCI USA, V109, P12944, DOI 10.1073/pnas.1205270109; Borhani DW, 2012, J COMPUT AID MOL DES, V26, P15, DOI 10.1007/s10822-011-9517-y; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P84, DOI DOI 10.1145/1188455.1188544; Bowman GR, 2015, P NATL ACAD SCI USA, V112, P2734, DOI 10.1073/pnas.1417811112; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunger AT, 2002, ACCOUNTS CHEM RES, V35, P404, DOI 10.1021/ar010034r; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Case D. A., 2017, AMBER 2017; Chevalier A, 2017, NATURE, V550, P74, DOI 10.1038/nature23912; Chodera JD, 2011, CURR OPIN STRUC BIOL, V21, P150, DOI 10.1016/j.sbi.2011.01.011; Clark AJ, 2016, J CHEM THEORY COMPUT, V12, P2990, DOI 10.1021/acs.jctc.6b00201; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cuello LG, 2017, ELIFE, V6, DOI 10.7554/eLife.28032; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Oliveira CAF, 2006, J PHYS CHEM B, V110, P22695, DOI 10.1021/jp062845o; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Dhakshnamoorthy B, 2010, J MOL BIOL, V396, P293, DOI 10.1016/j.jmb.2009.11.042; Dickson A, 2017, CURR TOP MED CHEM, V17, P2626, DOI 10.2174/1568026617666170414142908; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; Eastman P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005659; Eichel K, 2018, NATURE, V557, P381, DOI 10.1038/s41586-018-0079-1; Erokhova L, 2016, J BIOL CHEM, V291, P9712, DOI 10.1074/jbc.M115.706986; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Fernandez-Leiro R, 2016, NATURE, V537, P339, DOI 10.1038/nature19948; Fields JB, 2017, J BIOL CHEM, V292, P185, DOI 10.1074/jbc.M116.743724; Freites JA, 2006, BIOPHYS J, V91, pL90, DOI 10.1529/biophysj.106.096065; Goh GB, 2014, PROTEINS, V82, P1319, DOI 10.1002/prot.24499; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gonzalez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023815; Goricanec D, 2016, P NATL ACAD SCI USA, V113, pE3629, DOI 10.1073/pnas.1604125113; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Harpole TJ, 2018, BBA-BIOMEMBRANES, V1860, P909, DOI 10.1016/j.bbamem.2017.10.033; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Henrion U, 2012, P NATL ACAD SCI USA, V109, P8552, DOI 10.1073/pnas.1116938109; Hertig S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004746; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hollingsworth SA, 2016, P NATL ACAD SCI USA, V113, P8723, DOI 10.1073/pnas.1606474113; Hollingsworth SA, 2015, PROTEIN SCI, V24, P49, DOI 10.1002/pro.2583; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jiang T, 2017, ELIFE, V6, DOI 10.7554/eLife.28671; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kappel K, 2015, Q REV BIOPHYS, V48, P479, DOI 10.1017/S0033583515000153; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kato HE, 2018, NATURE, V561, P349, DOI 10.1038/s41586-018-0504-5; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Khafizov K, 2012, P NATL ACAD SCI USA, V109, pE3035, DOI 10.1073/pnas.1209039109; Khandogin J, 2007, P NATL ACAD SCI USA, V104, P16880, DOI 10.1073/pnas.0703832104; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kubota T, 2017, P NATL ACAD SCI USA, V114, pE1857, DOI 10.1073/pnas.1700453114; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Latorraca NR, 2018, NATURE, V557, P452, DOI 10.1038/s41586-018-0077-3; Latorraca NR, 2017, CELL, V169, P96, DOI 10.1016/j.cell.2017.03.010; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Liang RB, 2016, P NATL ACAD SCI USA, V113, pE6955, DOI 10.1073/pnas.1615471113; LIFSON S, 1968, J CHEM PHYS, V49, P5116, DOI 10.1063/1.1670007; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Liou SH, 2017, BIOCHEMISTRY-US, V56, P4371, DOI 10.1021/acs.biochem.7b00564; Liu YF, 2015, BIOPHYS J, V109, P542, DOI 10.1016/j.bpj.2015.06.037; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Maragliano L, 2006, CHEM PHYS LETT, V426, P168, DOI 10.1016/j.cplett.2006.05.062; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; McCorvy JD, 2018, NAT CHEM BIOL, V14, P126, DOI 10.1038/nchembio.2527; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Minor DL, 2007, NEURON, V54, P511, DOI 10.1016/j.neuron.2007.04.026; Mirjalili V, 2013, J CHEM THEORY COMPUT, V9, P1294, DOI 10.1021/ct300962x; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; Newman AH, 2012, J MED CHEM, V55, P6689, DOI 10.1021/jm300482h; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Nivedha AK, 2018, MOL PHARMACOL, V93, P288, DOI 10.1124/mol.117.110395; Ostmeyer J, 2013, NATURE, V501, DOI 10.1038/nature12395; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; Perez A, 2016, CURR OPIN STRUC BIOL, V36, P25, DOI 10.1016/j.sbi.2015.12.002; Perez C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5231; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Provasi D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002193; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Robustelli P, 2018, P NATL ACAD SCI USA, V115, pE4758, DOI 10.1073/pnas.1800690115; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schames JR, 2004, J MED CHEM, V47, P1879, DOI 10.1021/jm0341913; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Schmidtke P, 2011, J AM CHEM SOC, V133, P18903, DOI 10.1021/ja207494u; Schwantes CR, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895044; Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shaw DE, 2014, INT CONF HIGH PERFOR, P41, DOI 10.1109/SC.2014.9; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Spahn V, 2017, SCIENCE, V355, P966, DOI 10.1126/science.aai8636; Stelzl LS, 2014, J MOL BIOL, V426, P735, DOI 10.1016/j.jmb.2013.10.024; Stone JE, 2016, IEEE SYM PARA DISTR, P89, DOI 10.1109/IPDPSW.2016.130; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Suomivuori CM, 2017, P NATL ACAD SCI USA, V114, P7043, DOI 10.1073/pnas.1703625114; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Takemoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131094; Tan YS, 2012, ANGEW CHEM INT EDIT, V51, P10078, DOI 10.1002/anie.201205676; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Twomey EC, 2016, SCIENCE, V353, P83, DOI 10.1126/science.aaf8411; Udier-Blagovic M, 2003, J AM CHEM SOC, V125, P6016, DOI 10.1021/ja034308c; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wang L, 2015, J AM CHEM SOC, V137, P2695, DOI 10.1021/ja512751q; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wu C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003211; Zeuthen T, 2016, P NATL ACAD SCI USA, V113, pE6887, DOI 10.1073/pnas.1613744113; Zhang F, 2018, P NATL ACAD SCI USA, V115, pE317, DOI 10.1073/pnas.1717192115; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162; Zhao Y, 2016, NATURE, V536, P108, DOI 10.1038/nature18961	164	516	524	92	342	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 19	2018	99	6					1129	1143		10.1016/j.neuron.2018.08.011	http://dx.doi.org/10.1016/j.neuron.2018.08.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU1HG	30236283	Green Accepted, Bronze			2022-12-17	WOS:000445009100008
J	Dayan, P; Balleine, BW				Dayan, P; Balleine, BW			Reward, motivation, and reinforcement learning	NEURON			English	Review							NEURAL-NETWORK MODEL; NUCLEUS-ACCUMBENS; INSTRUMENTAL PERFORMANCE; COMPARTMENTAL ORGANIZATION; RESPONSE-REINFORCEMENT; ORBITOFRONTAL CORTEX; INCENTIVE SALIENCE; WATER-DEPRIVATION; TASTE REACTIVITY; VENTRAL PALLIDUM	There is substantial evidence that dopamine is involved in reward learning and appetitive conditioning. However, the major reinforcement learning-based theoretical models of classical conditioning (crudely, prediction learning) are actually based on rules designed to explain instrumental conditioning (action learning). Extensive anatomical, pharmacological, and psychological data, particularly concerning the impact of motivational manipulations, show that these models are unreasonable. We review the data and consider the involvement of a rich collection of different neural systems in various aspects of these forms of conditioning. Dopamine plays a pivotal, but complicated, role.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of London; University College London; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dayan, P (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	dayan@gatsby.ucl.ac.uk; balleine@psych.ucla.edu		Balleine, Bernard/0000-0001-8618-7950; Dayan, Peter/0000-0003-3476-1839	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056446, R29MH056446] Funding Source: NIH RePORTER; NIMH NIH HHS [MH56446] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BAIRD L, 1993, WLTR931146 WRIGHTP A; BALLEINE B, 1991, Q J EXP PSYCHOL-B, V43, P279; BALLEINE B, 1994, BEHAV BRAIN RES, V65, P181, DOI 10.1016/0166-4328(94)90104-X; BALLEINE B, 1992, Q J EXP PSYCHOL-B, V45, P285; BALLEINE B, 1994, BEHAV NEUROSCI, V108, P573, DOI 10.1037/0735-7044.108.3.573; BALLEINE B, 1994, Q J EXP PSYCHOL-B, V47, P211; BALLEINE B, 1992, J EXP PSYCHOL ANIM B, V18, P236, DOI 10.1037/0097-7403.18.3.236; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Balleine BW, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P307; Balleine BW, 2000, J NEUROSCI, V20, P8954; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; BERRIDGE KC, 1989, Q J EXP PSYCHOL-B, V41, P121; BERTINO M, 1991, AM J PHYSIOL, V261, pR59, DOI 10.1152/ajpregu.1991.261.1.R59; BINDRA D, 1974, PSYCHOL REV, V81, P199, DOI 10.1037/h0036330; BINDRA D, 1978, BEHAV BRAIN SCI, V1, P41, DOI 10.1017/S0140525X00059380; Bolles R. C, 1975, LEARNING THEORY; BRAUN JJ, 1990, CEREBRAL CORTEX RAT, P407; Byrnes CA, 1997, PROSTATE CANCER P D, V1, P26, DOI 10.1038/sj.pcan.4500202; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; CLARKE SNDA, 1995, PHARMACOL BIOCHEM BE, V51, P505, DOI 10.1016/0091-3057(95)00042-U; COLWILL RM, 1988, J EXP PSYCHOL ANIM B, V14, P155, DOI 10.1037/0097-7403.14.2.155; COLWILL RM, 1994, ANIM LEARN BEHAV, V22, P384, DOI 10.3758/BF03209158; COLWILL RM, 1986, PSYCHOL LEARN MOTIV, V20, P55; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Davidson TL, 1997, BEHAV NEUROSCI, V111, P1014; DAVIS J, 1971, J EXP ANAL BEHAV, V15, P237, DOI 10.1901/jeab.1971.15-237; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; DAYAN P, 1993, NEURAL COMPUT, V5, P613, DOI 10.1162/neco.1993.5.4.613; DAYAN P, 2002, ADV NEURAL INFORMATI; de Borchgrave R, 2002, EXP BRAIN RES, V144, P50, DOI 10.1007/s00221-002-1031-y; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; DEBOLD RC, 1965, J COMP PHYSIOL PSYCH, V59, P102, DOI 10.1037/h0021632; DELCAMPO AF, 1994, PSYCHOPHARMACOLOGY, V114, P583, DOI 10.1007/BF02244988; DICHIARA G, 1992, TRENDS PHARMACOL SCI, V13, P185; DICKINSON A, 1995, ANIM LEARN BEHAV, V23, P197, DOI 10.3758/BF03199935; DICKINSON A, 1995, CURR DIR PSYCHOL SCI, V4, P162, DOI 10.1111/1467-8721.ep11512272; Dickinson A, 2000, BEHAV NEUROSCI, V114, P468, DOI 10.1037/0735-7044.114.3.468; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; DICKINSON A, 1989, BEHAV PROCESS, V19, P167, DOI 10.1016/0376-6357(89)90039-9; DICKINSON A, 1988, Q J EXP PSYCHOL-B, V40, P113; DICKINSON A, 1987, Q J EXP PSYCHOL-B, V39, P201; Dickinson A, 1998, Q J EXP PSYCHOL-B, V51, P271; DICKINSON A, 1978, MECH LEARNING MOTIVA, P203; Dickinson A., 1997, LEARN MOTIV, P345; Dickinson A., 1994, ANIMAL LEARNING COGN, P45, DOI [10.1016/B978-0-08-057169-0.50009-7, DOI 10.1016/B978-0-08-057169-0.50009-7]; DICKINSON A, 2002, IN PRESS LEARNING MO, V3; DOYLE TG, 1993, PHARMACOL BIOCHEM BE, V46, P745, DOI 10.1016/0091-3057(93)90572-B; DREWNOWSKI A, 1992, PHYSIOL BEHAV, V51, P371, DOI 10.1016/0031-9384(92)90155-U; DWORKIN SI, 1988, PHARMACOL BIOCHEM BE, V30, P1051, DOI 10.1016/0091-3057(88)90138-4; EVERITT BJ, 1987, J COMP PSYCHOL, V101, P407, DOI 10.1037/0735-7036.101.4.407; FUDIM OK, 1978, J EXP PSYCHOL ANIM B, V4, P276, DOI 10.1037/0097-7403.4.3.276; GERFEN CR, 1985, J COMP NEUROL, V236, P454, DOI 10.1002/cne.902360404; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gluck MA, 2001, NEUROBIOL LEARN MEM, V76, P314, DOI 10.1006/nlme.2001.4031; Gong WH, 1996, BRAIN RES, V707, P64, DOI 10.1016/0006-8993(95)01222-2; GOSNELL BA, 1993, PHARM BIOCH BEHAV, V33, P805; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Haber SN, 2000, J NEUROSCI, V20, P2369; HAMMOND LJ, 1980, J EXP ANAL BEHAV, V34, P297, DOI 10.1901/jeab.1980.34-297; HENDERSEN RW, 1979, LEARN MOTIV, V10, P351, DOI 10.1016/0023-9690(79)90038-9; HERSHBERGER WA, 1986, ANIM LEARN BEHAV, V14, P443, DOI 10.3758/BF03200092; HOLLAND PC, 1979, J EXP PSYCHOL ANIM B, V5, P178, DOI 10.1037/0097-7403.5.2.178; HOLLAND PC, 1993, CURR OPIN NEUROBIOL, V3, P230, DOI 10.1016/0959-4388(93)90215-K; HOLLAND PC, 1977, J EXP PSYCHOL ANIM B, V3, P77, DOI 10.1037/0097-7403.3.1.77; Hollis KL, 1997, J COMP PSYCHOL, V111, P219, DOI 10.1037/0735-7036.111.3.219; Houk JC, 1995, MODELS INFORM PROCES, P249; Howland JG, 2002, J NEUROSCI, V22, P1137, DOI 10.1523/JNEUROSCI.22-03-01137.2002; JOHNSON PI, 1993, NEUROPHARMACOLOGY, V32, P1305, DOI 10.1016/0028-3908(93)90025-X; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; KAKADE S, 2000, ADV NEURAL INFORMATI, P131; Kearns M, 1999, ADV NEUR IN, V11, P996; Kelley AE, 1996, J PHARMACOL EXP THER, V278, P1499; Konorski J., 1967, INTEGRATIVE ACTIVITY; KREBS JR, 1978, NATURE, V275, P27, DOI 10.1038/275027a0; KRIECKHA.EE, 1970, J COMP PHYSIOL PSYCH, V73, P117, DOI 10.1037/h0030020; LOPEZ M, 1992, ANIM LEARN BEHAV, V20, P322, DOI 10.3758/BF03197955; Lopez M, 1999, ANIM LEARN BEHAV, V27, P280, DOI 10.3758/BF03199726; Mangel M., 1988, DYNAMIC MODELING BEH; MITCHELL DS, 1970, LEARN MOTIV, V1, P199, DOI 10.1016/0023-9690(70)90086-X; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; PARKER LA, 1992, BEHAV NEUROSCI, V106, P999, DOI 10.1037/0735-7044.106.6.999; Pecina S, 1997, PHARMACOL BIOCHEM BE, V58, P801, DOI 10.1016/S0091-3057(97)00044-0; Pecina S, 2000, BRAIN RES, V863, P71, DOI 10.1016/S0006-8993(00)02102-8; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; PHILLIPS AG, 1983, LIFE SCI, V33, P2505, DOI 10.1016/0024-3205(83)90159-5; RESCORLA RA, 1968, J COMP PHYSIOL PSYCH, V66, P1, DOI 10.1037/h0025984; RESCORLA RA, 1982, J EXP PSYCHOL ANIM B, V8, P23, DOI 10.1037/0097-7403.8.1.23; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rolls ET, 2000, ANNU REV PSYCHOL, V51, P599, DOI 10.1146/annurev.psych.51.1.599; ROLLS ET, 1989, J EXP BIOL, V146, P141; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1990, J NEUROPHYSIOL, V64, P1055, DOI 10.1152/jn.1990.64.4.1055; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Suri RE, 1998, EXP BRAIN RES, V121, P350, DOI 10.1007/s002210050467; Suri RE, 2002, NEURAL NETWORKS, V15, P523, DOI 10.1016/S0893-6080(02)00046-1; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Sutton R. S., 1985, 7 ANN C COGN SCI SOC, P54; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Toates F.M., 1986, MOTIVATIONAL SYSTEMS; TOATES FM, 1998, APPETITE NEURAL BEHA, P305; Wagner A. R., 1989, CONT LEARNING THEORI, P149; Watkins C.J.C.H., 1989, LEARNING DELAYED REW; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Wyvell CL, 2000, J NEUROSCI, V20, P8122; YAXLEY S, 1988, PHYSIOL BEHAV, V42, P223, DOI 10.1016/0031-9384(88)90074-1	119	516	521	6	138	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 10	2002	36	2					285	298		10.1016/S0896-6273(02)00963-7	http://dx.doi.org/10.1016/S0896-6273(02)00963-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	603JA	12383782	Bronze			2022-12-17	WOS:000178554700008
J	O'Brien, RJ; Kamboj, S; Ehlers, MD; Rosen, KR; Fischbach, GD; Huganir, RL				O'Brien, RJ; Kamboj, S; Ehlers, MD; Rosen, KR; Fischbach, GD; Huganir, RL			Activity-dependent modulation of synaptic AMPA receptor accumulation	NEURON			English	Article							HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; ACETYLCHOLINE-RECEPTORS; NMDA RECEPTOR; TRANSMISSION; SYNAPSES; CULTURE; SUBUNIT	Both theoretical and experimental work have suggested that central neurons compensate for changes in excitatory synaptic input in order to maintain a relatively constant output. We report here that inhibition of excitatory synaptic transmission in cultured spinal neurons leads to an increase in mEPSC amplitudes, accompanied by an equivalent increase in the accumulation of AMPA receptors at synapses. Conversely, increasing excitatory synaptic activity leads to a decrease in synaptic AMPA receptors and a decline in mEPSC amplitude. The time course of this synaptic remodeling is slow, similar to the metabolic half-life of neuronal AMPA receptors. Moreover, inhibiting excitatory synaptic transmission significantly prolongs the half-life, of the AMPA receptor subunit GluR1, suggesting that synaptic activity modulates the size of the mEPSC by regulating the turnover of postsynaptic AMPA receptors.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Dept Neurosci, Boston, MA 02110 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	rick.huganir@qmail.bs.jhu.edu		Kamboj, Sunjeev/0000-0003-2197-0826	NINDS NIH HHS [R01NS36715, K08NS01652, R01 NS036715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001652, R01NS036715] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVILA OL, 1989, J NEUROSCI, V9, P2902; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BERG DK, 1975, J PHYSIOL-LONDON, V252, P771, DOI 10.1113/jphysiol.1975.sp011169; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHOI DW, 1981, J NEUROPHYSIOL, V45, P632, DOI 10.1152/jn.1981.45.4.632; CLINE HT, 1990, J NEUROSCI, V10, P1197; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JACK JJB, 1994, ADV SEC MESS PHOSPH, V29, P275; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Mammen AL, 1997, J NEUROSCI, V17, P7351; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; OBRIEN RJ, 1986, J NEUROSCI, V6, P3290; OBrien RJ, 1997, J NEUROSCI, V17, P7339; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSEN KM, 1990, BIOTECHNIQUES, V8, P398; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vissavajjhala P, 1996, EXP NEUROL, V142, P296, DOI 10.1006/exnr.1996.0199; WALMSLEY B, 1995, P ROY SOC B-BIOL SCI, V261, P245, DOI 10.1098/rspb.1995.0144	31	516	523	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1067	1078		10.1016/S0896-6273(00)80624-8	http://dx.doi.org/10.1016/S0896-6273(00)80624-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856462	hybrid			2022-12-17	WOS:000077386100017
J	BECK, KD; POWELLBRAXTON, L; WIDMER, HR; VALVERDE, J; HEFTI, F				BECK, KD; POWELLBRAXTON, L; WIDMER, HR; VALVERDE, J; HEFTI, F			IGF1 GENE DISRUPTION RESULTS IN REDUCED BRAIN SIZE, CNS HYPOMYELINATION, AND LOSS OF HIPPOCAMPAL GRANULE AND STRIATAL PARVALBUMIN-CONTAINING NEURONS	NEURON			English	Article							GROWTH FACTOR-I; CENTRAL-NERVOUS-SYSTEM; FACTOR BINDING-PROTEINS; SNELL DWARF MOUSE; RAT-BRAIN; OLIGODENDROCYTE DEVELOPMENT; MOTONEURON SURVIVAL; CEREBRAL MYELINOGENESIS; NEUROTROPHIC FACTOR; CHOROID-PLEXUS	Homozygous Igf1(-/-) mice at 2 months of age had reduced brain weights, with reductions evenly affecting all major brain areas. The gross morphology of the CNS was normal, but the size of white matter structures in brain and spinal cord was strongly reduced, owing to decreased numbers of axons and oligodendrocytes. Myelinated axons were more strongly reduced in number than unmyelinated axons. The volume of the dentate gyrus granule cell layer was reduced in excess of the decrease in brain weight. Among populations of calcium-binding protein-containing neurons, there was a selective reduction in the number of striatal parvalbumin-containing cells. Numbers of mesencephalic dopaminergic neurons, striatal and basal forebrain cholinergic neurons, and spinal cord motoneurons were unaffected. Cerebellar morphology was unaltered. Our findings suggest cell type- and region-specific functions for IGF-I and emphasize prominent roles in axon growth and maturation in CNS myelination.	GENENTECH INC, DEPT ENDOCRINE RES, San Francisco, CA 94080 USA; UNIV SO CALIF, ANDRUS GERONTOL CTR, LOS ANGELES, CA 90089 USA	Roche Holding; Genentech; University of Southern California	BECK, KD (corresponding author), GENENTECH INC, DEPT NEUROSCI, San Francisco, CA 94080 USA.		Widmer, Hans R./AAC-8948-2022; Widmer, Hans Rudolf/O-5172-2017	Widmer, Hans Rudolf/0000-0003-3378-8765	NIA NIH HHS [AG10480, AG09793] Funding Source: Medline; NINDS NIH HHS [NS22933] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010480, P01AG009793] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AIZENMAN Y, 1987, BRAIN RES, V406, P32, DOI 10.1016/0006-8993(87)90766-9; AIZENMAN Y, 1986, P NATL ACAD SCI USA, V83, P2263, DOI 10.1073/pnas.83.7.2263; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ANG LC, 1992, J NEUROL SCI, V109, P168, DOI 10.1016/0022-510X(92)90164-G; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BECK KD, 1993, NEUROSCIENCE, V52, P855, DOI 10.1016/0306-4522(93)90534-M; BELIO MR, 1984, NEUROSCI LETT S, V18, P332; BERGMANN I, 1991, ANAT EMBRYOL, V184, P403, DOI 10.1007/BF00957901; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BONDY C, 1993, J NEUROSCI, V13, P5092, DOI 10.1523/JNEUROSCI.13-12-05092.1993; BONDY CA, 1991, J NEUROSCI, V11, P3442; BOTHWELL M, 1982, J NEUROSCI RES, V8, P225, DOI 10.1002/jnr.490080212; CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Clark G., 1981, STAINING PROCEDURES; CLEMMONS DR, 1993, ANN NY ACAD SCI, V692, P10; COLLARINI EJ, 1991, J CELL SCI, P117; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DAUGHADAY WH, 1989, PERSPECT BIOL MED, V32, P194; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DERCOLE AJ, 1994, DEV BRAIN RES, V82, P213; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; EAGLESON KL, 1986, DEV BRAIN RES, V29, P161, DOI 10.1016/0165-3806(86)90092-1; EAGLESON KL, 1985, DEV BRAIN RES, V17, P95, DOI 10.1016/0165-3806(85)90135-X; FAGIN JA, 1989, ENDOCRINOLOGY, V125, P2385, DOI 10.1210/endo-125-5-2385; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GARCIASEGURA LM, 1991, BRAIN RES, V560, P167, DOI 10.1016/0006-8993(91)91228-S; GHANDOUR MS, 1980, NEUROSCIENCE, V5, P559, DOI 10.1016/0306-4522(80)90053-6; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HODGKINSON SC, 1991, ENDOCRINOLOGY, V129, P2085, DOI 10.1210/endo-129-4-2085; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; HYNES MA, 1988, MOL ENDOCRINOL, V2, P47, DOI 10.1210/mend-2-1-47; KING RA, 1988, J ENDOCRINOL, V119, P117, DOI 10.1677/joe.0.1190117; KNUSEL B, 1990, J NEUROSCI, V10, P558; LEE WH, 1992, J NEUROSCI, V12, P4737; LEE WH, 1993, NEUROSCIENCE, V53, P251, DOI 10.1016/0306-4522(93)90303-W; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MATHEWS LS, 1986, P NATL ACAD SCI USA, V83, P9343, DOI 10.1073/pnas.83.24.9343; MATTHIEU JM, 1973, BRAIN RES, V55, P391, DOI 10.1016/0006-8993(73)90304-1; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MCMORRIS FA, 1990, ANN NY ACAD SCI, V605, P101, DOI 10.1111/j.1749-6632.1990.tb42385.x; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MCMORRIS FA, 1986, P NATL ACAD SCI USA, V83, P822, DOI 10.1073/pnas.83.3.822; MORELL P, 1972, J NEUROCHEM, V19, P2545, DOI 10.1111/j.1471-4159.1972.tb01313.x; MOZELL RL, 1991, J NEUROSCI RES, V30, P382, DOI 10.1002/jnr.490300214; NEFF NT, 1993, J NEUROBIOL, V24, P1578, DOI 10.1002/neu.480241203; NOBLE M, 1991, ANN NY ACAD SCI, V633, P35; NOBLE M, 1992, J NEUROIMMUNOL, V40, P287, DOI 10.1016/0165-5728(92)90145-B; NOGUCHI T, 1991, COMP BIOCHEM PHYS C, V98, P239; NOGUCHI T, 1982, J NEUROCHEM, V38, P257, DOI 10.1111/j.1471-4159.1982.tb10878.x; NOGUCHI T, 1982, J NEUROCHEM, V39, P1693, DOI 10.1111/j.1471-4159.1982.tb08004.x; NOGUCHI T, 1985, NEUROCHEM RES, V10, P1097, DOI 10.1007/BF00965884; OCRANT I, 1990, ENDOCRINOLOGY, V127, P1260, DOI 10.1210/endo-127-3-1260; OOI GT, 1990, MOL CELL ENDOCRINOL, V71, pC39, DOI 10.1016/0303-7207(90)90243-2; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RALPHS JR, 1990, DEVELOPMENT, V109, P51; RECHLER MM, 1992, GROWTH REGULAT, V2, P55; RECHLER MM, 1990, HDB EXPT PHARM, V95, P263; RESIBOIS A, 1992, NEUROSCIENCE, V46, P101, DOI 10.1016/0306-4522(92)90012-Q; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; Siddle Kenneth, 1992, Progress in Growth Factor Research, V4, P301, DOI 10.1016/0955-2235(92)90013-8; SOLBACH S, 1991, ANAT EMBRYOL, V184, P103, DOI 10.1007/BF00942742; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; SUGISAKI T, 1985, NEUROCHEM RES, V10, P767, DOI 10.1007/BF00964534; TAUBER H, 1980, NEUROSCI LETT, V16, P235, DOI 10.1016/0304-3940(80)90003-8	78	516	529	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					717	730		10.1016/0896-6273(95)90216-3	http://dx.doi.org/10.1016/0896-6273(95)90216-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718235	Bronze			2022-12-17	WOS:A1995QU82600006
J	Kang, SH; Fukaya, M; Yang, JK; Rothstein, JD; Bergles, DE				Kang, Shin H.; Fukaya, Masahiro; Yang, Jason K.; Rothstein, Jeffrey D.; Bergles, Dwight E.			NG2(+) CNS Glial Progenitors Remain Committed to the Oligodendrocyte Lineage in Postnatal Life and following Neurodegeneration	NEURON			English	Article							PDGF ALPHA-RECEPTOR; PRECURSOR CELLS; NG2-EXPRESSING CELLS; SUBVENTRICULAR ZONE; SPINAL-CORD; PROTEOGLYCAN; PROLIFERATION; NEUROGENESIS; DIFFERENTIATION; RECOMBINATION	The mammalian CNS contains a ubiquitous population of glial progenitors known as NG2(+) cells that have the ability to develop into oligodendrocytes and undergo dramatic changes in response to injury and demyelination. Although it has been reported that NG2(+) cells are multipotent, their fate in health and disease remains controversial. Here, we generated PDGF alpha R-CreER transgenic mice and followed their fate in vivo in the developing and adult CNS. These studies revealed that NG2(+) cells in the postnatal CNS generate myelinating oligodendrocytes, but not astrocytes or neurons. In regions of neurodegeneration in the spinal cord of ALS mice, NG2(+) cells exhibited enhanced proliferation and accelerated differentiation into oligodendrocytes but remained committed to the oligodendrocyte lineage. These results indicate that NG2(+) cells in the normal CNS are oligodendrocyte precursors with restricted lineage potential and that cell loss and gliosis are not sufficient to alter the lineage potential of these progenitors.	[Kang, Shin H.; Yang, Jason K.; Bergles, Dwight E.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Fukaya, Masahiro] Hokkaido Univ, Grad Sch Med, Dept Anat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Hokkaido University; Johns Hopkins University	Bergles, DE (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019; Messier, Claude/A-2322-2008; rothstein, jeffrey d/C-9470-2013	Bergles, Dwight/0000-0002-7133-7378; Messier, Claude/0000-0002-4791-1763; 	US National Institutes of Health [NS051509, NS050274, MH084020]; Muscular Dystrophy Association; Packard Center for ALS Research at Johns Hopkins; P<SUP>2</SUP>ALS; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051509, P30NS050274] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Packard Center for ALS Research at Johns Hopkins; P<SUP>2</SUP>ALS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Ye and N. Nishiyama for mouse colony maintenance and genotyping, I. Srivastava for technical assistance in histological procedures, Dr. R. Huganir (Johns Hopkins University, Baltimore, MD, USA) for antibodies to GFP, Dr. B. Novitch (University of California, Los Angeles, CA, USA) for antibodies to Olig2, Dr. W. Stallcup (Burnham Institute, San Diego, CA, USA) for antibodies to NG2 and PDGF alpha R, Dr. M. Watanabe (Hokkaido University, Japan) for antibodies to GFP and GLUT1, Dr. M. Wegner (University of Erlangen) for antibodies against Sox10, and Dr. A. Agarwal and L. DeBiase for comments on the manuscript. GLAST-CreER mice were generously provided by Drs. A. Ratner and J. Nathans (Johns Hopkins University). This work was supported by the US National Institutes of Health grants NS051509, NS050274 and MH084020, the Muscular Dystrophy Association, the Packard Center for ALS Research at Johns Hopkins, and P<SUP>2</SUP>ALS.	Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Aguirre A, 2007, NEURON GLIA BIOL, V3, P209, DOI 10.1017/S1740925X08000082; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bouslama-Oueghlani L, 2005, DEV BIOL, V285, P409, DOI 10.1016/j.ydbio.2005.07.003; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; FFRENCHCONSTANT C, 1986, NATURE, V323, P335, DOI 10.1038/323335a0; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Guan YJ, 2007, J NEUROCHEM, V102, P1125, DOI 10.1111/j.1471-4159.2007.04610.x; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Horner PJ, 2000, J NEUROSCI, V20, P2218; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LEVINE JM, 1993, GLIA, V7, P307, DOI 10.1002/glia.440070406; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Papadimitriou D, 2010, NEUROBIOL DIS, V37, P493, DOI 10.1016/j.nbd.2009.10.005; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhu XD, 2008, CRYSTENGCOMM, V10, P19, DOI 10.1039/b710633e	45	515	527	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2010	68	4					668	681		10.1016/j.neuron.2010.09.009	http://dx.doi.org/10.1016/j.neuron.2010.09.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	691KU	21092857	Green Accepted, Bronze			2022-12-17	WOS:000285079500007
J	Lee, HK; Kameyama, K; Huganir, RL; Bear, MF				Lee, HK; Kameyama, K; Huganir, RL; Bear, MF			NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; AREA CA1; POTENTIATION; INDUCTION; PHOSPHORYLATION; NEURONS; CALCIUM; PLASTICITY	Brief bath application of N-methyl-D-aspartate (NMDA) to hippocampal slices produces long-term synaptic depression (LTD) in CA1 that is (1) sensitive to postnatal age, (2) saturable, (3) induced postsynaptically, (4) reversible, and (5) not associated with a change in paired pulse facilitation. Chemically induced LTD (Chem-LTD) and homosynaptic LTD are mutually occluding, suggesting a common expression mechanism. Using phosphorylation site-specific antibodies, we found that induction of chem-LTD produces a persistent dephosphorylation of the GluR1 subunit of AMPA receptors at serine 845, a cAMP-dependent protein kinase (PKA) substrate, but not at serine 831, a substrate of protein kinase C (PKC) and calcium/calmodulin-dependent protein kinase II (CaMKII). These results suggest that dephosphorylation of AMPA receptors is an expression mechanism for LTD and indicate an unexpected role of PKA in the postsynaptic modulation of excitatory synaptic transmission.	Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Brown University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University	Bear, MF (corresponding author), Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA.			Bear, Mark/0000-0002-9903-2541; Lee, Hey-Kyoung/0000-0002-5554-983X				Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HARTLEY DM, 1989, J PHARMACOL EXP THER, V250, P752; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; ITO I, 1991, NEUROSCI LETT, V121, P1119; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu YM, 1996, J NEUROSCI, V16, P5457; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; PETIT D, 1994, SCIENCE, V266, P1881; Pizzi M, 1996, EUR J NEUROSCI, V8, P1516, DOI 10.1111/j.1460-9568.1996.tb01614.x; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SCHURR A, 1995, J NEUROSCI METH, V59, P129, DOI 10.1016/0165-0270(94)00203-S; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAN SE, 1994, J NEUROSCI, V14, P1123, DOI 10.1523/JNEUROSCI.14-03-01123.1994; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	55	515	523	1	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1151	1162		10.1016/S0896-6273(00)80632-7	http://dx.doi.org/10.1016/S0896-6273(00)80632-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856470	hybrid			2022-12-17	WOS:000077386100025
J	Kaur, D; Yantiri, F; Rajagopalan, S; Kumar, J; Mo, JO; Boonplueang, R; Viswanath, V; Jacobs, R; Yang, L; Beal, MF; DiMonte, D; Volitaskis, I; Ellerby, L; Cherny, RA; Bush, AI; Andersen, JK				Kaur, D; Yantiri, F; Rajagopalan, S; Kumar, J; Mo, JO; Boonplueang, R; Viswanath, V; Jacobs, R; Yang, L; Beal, MF; DiMonte, D; Volitaskis, I; Ellerby, L; Cherny, RA; Bush, AI; Andersen, JK			Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease	NEURON			English	Article							SUBSTANTIA-NIGRA; BASAL GANGLIA; BRAIN IRON; RAT-BRAIN; CELLULAR-DISTRIBUTION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; FREE-RADICALS; MOUSE MODEL; DOPAMINERGIC NEURODEGENERATION	Studies on postmortem brains from Parkinson's patients reveal elevated iron in the substantia nigra (SN). Selective cell death in this brain region is associated with oxidative stress, which may be exacerbated by the presence of excess iron. Whether iron plays a causative role in cell death, however, is controversial. Here, we explore the effects of iron chelation via either transgenic expression of the iron binding protein ferritin or oral administration of the bioavailable metal chelator clioquinol (CO) on susceptibility to the Parkinson's-inducing agent 1 -methyl-4-phenyl-1,2,3,6-tetrapyridine (MPTP). Reduction in reactive iron by either genetic or pharmacological means was found to be well tolerated in animals in our studies and to result in protection against the toxin, suggesting that iron chelation may be an effective therapy for prevention and treatment of the disease.	Buck Inst Age Res, Novato, CA 94945 USA; Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Div Neurogerontol, Los Angeles, CA 90089 USA; CALTECH, Biol Imaging Ctr, Pasadena, CA 91125 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Parkinsons Inst, Sunnyvale, CA 94089 USA; Univ Melbourne, Mental Hlth Res Inst, Dept Pathol, Parkville, Vic 3052, Australia; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Lab Oxidant Biol, Dept Psychiat,Genet & Aging Res Unit, Charlestown, MA 02129 USA	Buck Institute for Research on Aging; University of Southern California; California Institute of Technology; Cornell University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Harvard University; Massachusetts General Hospital	Andersen, JK (corresponding author), Buck Inst Age Res, Novato, CA 94945 USA.	jandersen@buckinstitute.org	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X; Andersen, Julie/0000-0003-1324-4875; Boonplueang, Rapee/0000-0002-4384-0363; Di Monte, Donato/0000-0002-8296-836X	NIA NIH HHS [R01 AG41264, 2R01AG12686, R01 AG12141] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012141, R01AG012686] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADAMS JD, 1991, FREE RADICAL BIO MED, V10, P161, DOI 10.1016/0891-5849(91)90009-R; Agrawal R, 2001, TOXICOLOGY, V168, P223, DOI 10.1016/S0300-483X(01)00412-7; ALI SF, 1992, NEUROTOXICOLOGY, V13, P637; Andersen J K, 2001, Novartis Found Symp, V235, P11; ANDERSEN JK, 1994, BRAIN RES, V656, P108, DOI 10.1016/0006-8993(94)91371-4; BANERJEE SA, 1992, J NEUROSCI, V12, P4460; Bartzokis G, 1997, MAGN RESON IMAGING, V15, P29, DOI 10.1016/S0730-725X(96)00234-2; BAUMGARTNER G, 1979, J NEUROL NEUROSUR PS, V42, P1073, DOI 10.1136/jnnp.42.12.1073; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; BEARD JL, 1993, PROG FOOD NUTR SCI, V17, P183; BENKOVIC SA, 1993, J COMP NEUROL, V338, P97, DOI 10.1002/cne.903380108; Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Castellani RJ, 2000, ACTA NEUROPATHOL, V100, P111, DOI 10.1007/s004010050001; CAUGHMAN SW, 1988, J BIOL CHEM, V263, P19048; Cheepsunthorn P, 1998, J COMP NEUROL, V400, P73; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chiueh C C, 1998, Adv Pharmacol, V42, P796; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; CONNOR JR, 1995, J NEUROCHEM, V65, P717; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DESOLE MS, 1993, NEUROSCI LETT, V161, P121, DOI 10.1016/0304-3940(93)90274-O; DEXTER DT, 1987, LANCET, V2, P1219; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Double KL, 1998, J NEUROCHEM, V70, P2492; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Gassen M, 1997, PHARMACOL TOXICOL, V80, P159, DOI 10.1111/j.1600-0773.1997.tb00390.x; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Gilissen EP, 1998, AM J PRIMATOL, V45, P291, DOI 10.1002/(SICI)1098-2345(1998)45:3<291::AID-AJP5>3.3.CO;2-7; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; GLINKA Y, 1996, METALS OXIDATIVE DAM, P1; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Griffiths PD, 1999, BRAIN, V122, P667, DOI 10.1093/brain/122.4.667; GUTTERIDGE JMC, 1992, ANN NEUROL, V32, pS16, DOI 10.1002/ana.410320705; Han J, 2000, CELL MOL BIOL, V46, P517; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HENTZE MW, 1986, P NATL ACAD SCI USA, V83, P7226, DOI 10.1073/pnas.83.19.7226; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hung HC, 1998, FREE RADICAL BIO MED, V24, P76, DOI 10.1016/S0891-5849(97)00206-2; Janetzky B., 1997, P407; JELLINGER K, 1990, J NEURAL TRANSM-PARK, V2, P327, DOI 10.1007/BF02252926; Jellinger KA, 1999, DRUG AGING, V14, P115, DOI 10.2165/00002512-199914020-00004; JENNER P, 1992, NEUROLOGY, V42, P2241, DOI 10.1212/WNL.42.12.2241; Kato J, 2001, AM J HUM GENET, V69, P191, DOI 10.1086/321261; KIDANI Y, 1974, JPN ANALYST, V23, P1375; Klivenyi P, 2000, J NEUROSCI, V20, P1; Lan J, 1997, J NEURAL TRANSM, V104, P649, DOI 10.1007/BF01291883; MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612; MARCIANI MG, 1991, HAEMATOLOGICA, V76, P131; MASTERS C, 2002, 8 INT C ALZH DIS REL; MEADE TW, 1975, BRIT J PREV SOC MED, V29, P157; Melov S, 2002, TRENDS NEUROSCI, V25, P121, DOI 10.1016/S0166-2236(00)02086-5; Moos T, 2000, CELL MOL BIOL, V46, P549; Morgan TE, 1999, NEUROSCIENCE, V89, P687, DOI 10.1016/S0306-4522(98)00334-0; NAKAE K, 1973, LANCET, V1, P171; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Porter J B, 1989, Baillieres Clin Haematol, V2, P459, DOI 10.1016/S0950-3536(89)80027-7; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; ROSE FC, 1984, ACTA NEUROL SCAND, V70, P137; Rucker P, 1996, J BIOL CHEM, V271, P33352, DOI 10.1074/jbc.271.52.33352; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; Tateishi J, 2000, NEUROPATHOLOGY, V20, pS20; TETRUD JW, 1989, ACTA NEUROL SCAND, V80, P35, DOI 10.1111/j.1600-0404.1989.tb01780.x; Thompson KJ, 2001, BRAIN RES BULL, V55, P155, DOI 10.1016/S0361-9230(01)00510-X; TSUBAKI T, 1971, LANCET, V1, P696, DOI 10.1016/S0140-6736(71)92699-7; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Yantiri F, 1999, IUBMB LIFE, V48, P139; Yassin MS, 2000, J NEUROL SCI, V173, P40, DOI 10.1016/S0022-510X(99)00297-X; YONG VW, 1986, NEUROSCI LETT, V63, P56, DOI 10.1016/0304-3940(86)90012-1; Yoshida S, 2001, J SYNCHROTRON RADIAT, V8, P998, DOI 10.1107/S0909049500017726; YOSHIMURA S, 1992, MOL CHEM NEUROPATHOL, V16, P59, DOI 10.1007/BF03159961; YOUDIM MBH, 1993, MOVEMENT DISORD, V8, P1, DOI 10.1002/mds.870080102; Zecca L, 2001, J NEUROCHEM, V76, P1766, DOI 10.1046/j.1471-4159.2001.00186.x	89	514	523	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					899	909		10.1016/S0896-6273(03)00126-0	http://dx.doi.org/10.1016/S0896-6273(03)00126-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670420	Bronze			2022-12-17	WOS:000181899600005
J	Sabatini, BL; Oertner, TG; Svoboda, K				Sabatini, BL; Oertner, TG; Svoboda, K			The life cycle of Ca2+ ions in dendritic spines	NEURON			English	Article							LONG-TERM POTENTIATION; BOVINE CHROMAFFIN CELLS; HIPPOCAMPAL-NEURONS; CALCIUM DYNAMICS; SINGLE SPINES; SYNAPTIC TRANSMISSION; PYRAMIDAL NEURONS; PURKINJE NEURONS; NMDA RECEPTORS; AREA CA1	Spine Ca2+ is critical for the induction of synaptic plasticity, but the factors that control Ca2+ handling in dendritic spines under physiological conditions are largely unknown. We studied [Ca2+] signaling in dendritic spines of CA1 pyramidal neurons and find that spines are specialized structures with low endogenous Ca2+ buffer capacity that allows large and extremely rapid [Ca2+] changes. Under physiological conditions, Ca2+ diffusion across the spine neck is negligible, and the spine head functions as a separate compartment on long time scales, allowing localized Ca2+ buildup during trains of synaptic stimuli. Furthermore, the kinetics of Ca2+ sources governs the time course of [Ca2+] signals and may explain the selective activation of long-term synaptic potentiation (LTP) and long-term depression (LTD) by NMDA-R-mediated synaptic Ca2+.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.org	Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528				ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hollingworth S, 1996, J GEN PHYSIOL, V108, P455, DOI 10.1085/jgp.108.5.455; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; HOLMES WR, 1990, BRAIN RES, V519, P338, DOI 10.1016/0006-8993(90)90098-V; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KOCH C, 1993, J NEUROSCI, V13, P413; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; PHILIPSON K, 1999, CALCIUM CELLULAR REG, P249; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; STORM JF, 1990, PROG BRAIN RES, V83, P161; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tank DW, 1995, J NEUROSCI, V15, P7940; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	57	513	517	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					439	452		10.1016/S0896-6273(02)00573-1	http://dx.doi.org/10.1016/S0896-6273(02)00573-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832230	Green Submitted, Bronze			2022-12-17	WOS:000173643200013
J	Impey, S; Obrietan, K; Storm, DR				Impey, S; Obrietan, K; Storm, DR			Making new connections: Role of ERK MAP kinase signaling in neuronal plasticity	NEURON			English	Review							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; RAS; GENE; CASCADE; PATHWAY; GROWTH; TRANSCRIPTION; STIMULATION; DEFICITS		Univ Washington, Sch Pharm, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Sch Pharm, Dept Pharmacol, Seattle, WA 98195 USA.							Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Berman DE, 1998, J NEUROSCI, V18, P10037; Blum S, 1999, J NEUROSCI, V19, P3535; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sgambato V, 1998, J NEUROSCI, V18, P8814; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	20	513	546	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					11	14		10.1016/S0896-6273(00)80747-3	http://dx.doi.org/10.1016/S0896-6273(00)80747-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402188	Bronze			2022-12-17	WOS:000080681200005
J	PARTIN, KM; PATNEAU, DK; WINTERS, CA; MAYER, ML; BUONANNO, A				PARTIN, KM; PATNEAU, DK; WINTERS, CA; MAYER, ML; BUONANNO, A			SELECTIVE MODULATION OF DESENSITIZATION AT AMPA VERSUS KAINATE RECEPTORS BY CYCLOTHIAZIDE AND CONCANAVALIN-A	NEURON			English	Article							METHYL-D-ASPARTATE; GLUTAMATE-OPERATED CHANNELS; MOLECULAR-CLONING; GLIAL-CELLS; PHARMACOLOGICAL PROPERTIES; STRUCTURAL DETERMINANTS; FUNCTIONAL EXPRESSION; QUISQUALATE RECEPTORS; GANGLION NEURONS; XENOPUS-OOCYTES	Potentiation by cyclothiazide of recombinant glutamate receptor responses in Xenopus oocytes showed absolute selectivity for AMPA versus kainate receptors. In contrast, concanavalin A strongly potentiated responses at kainate but not AMPA receptors. Rapid desensitization in HEK 293 cells transfected with AMPA receptors was blocked by cyclothiazide, but only weakly attenuated by concanavalin A. Desensitization at kainate receptors was blocked by concanavalin A but unaffected by cyclothiazide. Selective effects of these modulators following coexpression of subunits from different families suggest independent assembly of functional AMPA and kainate receptors. Northern biot analysis of mRNA for dorsal root ganglia revealed a predominant expression of GluR5, indicating that modulation of desensitization by concanavalin A but not cyclothiazide in sensory neurons accurately predicts subunit expression for native glutamate receptors.	NICHHD,DEV NEUROBIOL,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	PARTIN, KM (corresponding author), NICHHD,CELLULAR & MOLEC NEUROPHYSIOL LAB,BETHESDA,MD 20892, USA.		Mayer, Mark L/H-5500-2013; Partin, Kathryn/A-8706-2015; Mayer, Mark/AAE-7356-2019; Partin, Kathryn/AAI-5412-2021	Partin, Kathryn/0000-0003-3801-3299; Mayer, Mark/0000-0003-4378-8451; Partin, Kathryn/0000-0003-3801-3299				AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLANKENFELD GV, 1991, MOL NEUROBIOL, V5, P31, DOI 10.1007/BF02935611; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; GALLO V, 1992, J NEUROSCI, V12, P1010; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMAN M, 1994, IN PRESS ANN REV NEU; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; HULLEBROECK MF, 1992, BRAIN RES, V590, P187, DOI 10.1016/0006-8993(92)91094-U; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KELLER BU, 1993, P NATL ACAD SCI USA, V90, P605, DOI 10.1073/pnas.90.2.605; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; LAMBOLEZ B, 1991, NEUROSCI LETT, V123, P69, DOI 10.1016/0304-3940(91)90160-U; LESSMANN V, 1992, NEUROSCI LETT, V146, P13; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; LOVINGER DM, 1988, NEUROSCI LETT, V94, P314, DOI 10.1016/0304-3940(88)90037-7; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORITA T, 1992, MOL BRAIN RES, V14, P143, DOI 10.1016/0169-328X(92)90023-5; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; SAKIMURA K, 1992, NEURON, V8, P267, DOI 10.1016/0896-6273(92)90293-M; SHIGEMOTO R, 1992, NEUROSCI LETT, V144, P229, DOI 10.1016/0304-3940(92)90756-W; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SOMMER B, 1992, EMBO J, V11, P1561; STEIN E, 1992, MOL PHARMACOL, V42, P864; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VERDOORN TA, 1989, MOL PHARMACOL, V35, P360; VICKERS JC, 1993, J NEUROSCI, V13, P2982; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WONG LA, 1993, MOL PHARMACOL, V44, P504; YAMADA KA, 1993, J NEUROSCI, V13, P3904; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4	52	512	515	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1069	1082		10.1016/0896-6273(93)90220-L	http://dx.doi.org/10.1016/0896-6273(93)90220-L			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	7506043				2022-12-17	WOS:A1993MP54800008
J	Tufail, Y; Matyushov, A; Baldwin, N; Tauchmann, ML; Georges, J; Yoshihiro, A; Tillery, SIH; Tyler, WJ				Tufail, Yusuf; Matyushov, Alexei; Baldwin, Nathan; Tauchmann, Monica L.; Georges, Joseph; Yoshihiro, Anna; Tillery, Stephen I. Helms; Tyler, William J.			Transcranial Pulsed Ultrasound Stimulates Intact Brain Circuits	NEURON			English	Article							FOCUSED ULTRASOUND; MOTOR CORTEX; MAGNETIC STIMULATION; RESPONSES; HIPPOCAMPUS; RAT; TRANSMISSION; OSCILLATION; NETWORK; SYSTEM	Electromagnetic-based methods of stimulating brain activity require invasive procedures or have other limitations. Deep-brain stimulation requires surgically implanted electrodes. Transcranial magnetic stimulation does not require surgery, but suffers from low spatial resolution. Optogenetic-based approaches have unrivaled spatial precision, but require genetic manipulation. In search of a potential solution to these limitations, we began investigating the influence of transcranial pulsed ultrasound on neuronal activity in the intact mouse brain. In motor cortex, ultrasound-stimulated neuronal activity was sufficient to evoke motor behaviors. Deeper in subcortical circuits, we used targeted transcranial ultrasound to stimulate neuronal activity and synchronous oscillations in the intact hippocampus. We found that ultrasound triggers TTX-sensitive neuronal activity in the absence of a rise in brain temperature (<0.01 degrees C). Here, we also report that transcranial pulsed ultrasound for intact brain circuit stimulation has a lateral spatial resolution of approximately 2 mm and does not require exogenous factors or surgical invasion.	[Tufail, Yusuf; Matyushov, Alexei; Tauchmann, Monica L.; Georges, Joseph; Yoshihiro, Anna; Tyler, William J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Baldwin, Nathan; Tillery, Stephen I. Helms; Tyler, William J.] Arizona State Univ, Harrington Program Bioengn, Tempe, AZ 85287 USA; [Tillery, Stephen I. Helms] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Tillery, Stephen I. Helms] Arizona State Univ, Dept Kinesiol, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Tyler, WJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	wtyler@asu.edu	Tyler, William/J-1818-2012	Tyler, William/0000-0002-7758-5022	Arizona State University; US Army Research, Development, and Engineering Command [RDECOMW911NF-09-0431]	Arizona State University; US Army Research, Development, and Engineering Command	We thank Dr. William T. Newsome of Stanford University for his critical feedback and insightful discussions regarding this manuscript. We thank Joshua Nichols, Zachary Gilbert, and Erik Handberg for their assistance in performing some of the behavioral experiments. Funding for this research was provided by start-up funds from Arizona State University to W.J.T. and a Department of Defense grant to W.J.T. from the US Army Research, Development, and Engineering Command (RDECOMW911NF-09-0431). W.J.T. is the cofounder of SynSonix.	Anastassiou CA, 2010, J NEUROSCI, V30, P1925, DOI 10.1523/JNEUROSCI.3635-09.2010; Ang ESBC, 2006, P NATL ACAD SCI USA, V103, P12903, DOI 10.1073/pnas.0605294103; ANGEL A, 1982, BRIT J PHARMACOL, V76, P541, DOI 10.1111/j.1476-5381.1982.tb09252.x; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Bachtold MR, 1998, ULTRASOUND MED BIOL, V24, P557, DOI 10.1016/S0301-5629(98)00014-3; Barker AT, 1999, EEG CL N SU, P3; Bragin A, 1997, J NEUROSCI, V17, P2567; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; COOPER TE, 1972, J HEAT TRANSF, V94, P133, DOI 10.1115/1.3449883; Dalecki D, 2004, ANNU REV BIOMED ENG, V6, P229, DOI 10.1146/annurev.bioeng.6.040803.140126; DINNO MA, 1989, PHYS MED BIOL, V34, P1543, DOI 10.1088/0031-9155/34/11/003; FOSTER KR, 1978, J ACOUST SOC AM, V63, P1199, DOI 10.1121/1.381829; FRY FJ, 1958, SCIENCE, V127, P83, DOI 10.1126/science.127.3289.83; Gavrilov L R, 1976, Prog Brain Res, V43, P279; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; GOSS SA, 1978, J ACOUST SOC AM, V64, P423, DOI 10.1121/1.382016; GOSSSAMPSON MA, 1991, LAB ANIM, V25, P360, DOI 10.1258/002367791780810074; Harvey EN, 1929, AM J PHYSIOL, V91, P284, DOI 10.1152/ajplegacy.1929.91.1.284; Hayner M, 2001, J ACOUST SOC AM, V110, P3319, DOI 10.1121/1.1410964; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Huerta PT, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-7; Hynynen K, 2007, INT J HYPERTHER, V23, P193, DOI 10.1080/02656730701200094; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Hynynen K, 2006, EUR J RADIOL, V59, P149, DOI 10.1016/j.ejrad.2006.04.007; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Kamen G, 1996, J CLIN NEUROPHYSIOL, V13, P366, DOI 10.1097/00004691-199609000-00002; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Leighton TG, 2007, PROG BIOPHYS MOL BIO, V93, P3, DOI 10.1016/j.pbiomolbio.2006.07.026; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; LUDWIG GD, 1950, J ACOUST SOC AM, V22, P862, DOI 10.1121/1.1906706; Martin E, 2009, ANN NEUROL, V66, P858, DOI 10.1002/ana.21801; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; MIHRAN RT, 1990, ULTRASOUND MED BIOL, V16, P297, DOI 10.1016/0301-5629(90)90008-Z; Morris CE, 2007, CURR TOP MEMBR, V59, P297, DOI 10.1016/S1063-5823(06)59011-8; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; NEMA, 2004, AC OUTP MEAS STAND D; NYBORG WL, 1981, J ACOUST SOC AM, V70, P310, DOI 10.1121/1.386778; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Paxinos G., 2007, MOUSE BRAIN STEREOTA, DOI 10.1016/B978-0-12-374247-6.50004-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; RINALDI PC, 1991, BRAIN RES, V558, P36, DOI 10.1016/0006-8993(91)90711-4; SHEALY CN, 1962, ARCH NEUROL-CHICAGO, V6, P374, DOI 10.1001/archneur.1962.00450230036005; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Tsui PH, 2005, ULTRASONICS, V43, P560, DOI 10.1016/j.ultras.2004.12.003; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; TYLER WJ, 2010, NEUROSCIENT IN PRESS, DOI DOI 10.1177/1073858409348066; Velling V A, 1988, Neurosci Behav Physiol, V18, P369, DOI 10.1007/BF01193880; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; White PJ, 2006, PHYS MED BIOL, V51, P2293, DOI 10.1088/0031-9155/51/9/013; YANG JF, 1984, ARCH PHYS MED REHAB, V65, P517; YLINEN A, 1995, J NEUROSCI, V15, P30; YOUNG RR, 1961, SCIENCE, V134, P1521, DOI 10.1126/science.134.3489.1521; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.194301; Zhang YP, 2008, P NATL ACAD SCI USA, V105, P12039, DOI 10.1073/pnas.0802940105	64	511	554	5	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2010	66	5					681	694		10.1016/j.neuron.2010.05.008	http://dx.doi.org/10.1016/j.neuron.2010.05.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	612YL	20547127	Bronze			2022-12-17	WOS:000278941900009
J	Marin-Teva, JL; Dusart, I; Colin, C; Gervais, A; van Rooijen, N; Mallat, M				Marin-Teva, JL; Dusart, I; Colin, C; Gervais, A; van Rooijen, N; Mallat, M			Microglia promote the death of developing Purkinje cells	NEURON			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; NADPH OXIDASE; NEUROTROPHIC FACTOR; BRAIN MACROPHAGES; SUPEROXIDE GENERATION; OXIDATIVE STRESS; APOPTOTIC CELLS; MICE LACKING	The loss of neuronal cells, a prominent event in the development of the nervous system, involves regulated triggering of programmed cell death, followed by efficient removal of cell corpses. Professional phagocytes, such as microglia, contribute to the elimination of dead cells. Here we provide evidence that, in addition to their phagocytic activity, microglia promote the death of developing neurons engaged in synaptogenesis. In the developing mouse cerebellum, Purkinje cells die, and 60% of these neurons that already expressed activated caspase-3 were engulfed or contacted by spreading processes emitted by microglial cells. Apoptosis of Purkinje cells in cerebellar slices was strongly reduced by selective elimination of microglia. Superoxide ions produced by microglial respiratory bursts played a major role in this Purkinje cell death. Our study illustrates a mammalian form of engulfment-promoted cell death that links the execution of neuron death to the scavenging of dead cells.	INSERM, U495, IFR 70, UPMC, F-75654 Paris 13, France; Hop La Pitie Salpetriere, INSERM, U106, IFR 70, F-75013 Paris, France; Vrije Univ Amsterdam Med Ctr, Dept Mol & Cell Biol, NL-1081 BT Amsterdam, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Mallat, M (corresponding author), INSERM, U495, IFR 70, UPMC, F-75654 Paris 13, France.	michel.mallat@infobiogen.fr	Mallat, Michel/J-3609-2017; Van Rooijen, Nico/Z-1578-2019	Dusart, Isabelle/0000-0002-3211-4323				Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; ASHWELL K, 1990, DEV BRAIN RES, V55, P219, DOI 10.1016/0165-3806(90)90203-B; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; BERTOSSI M, 1986, ANAT EMBRYOL, V175, P25, DOI 10.1007/BF00315453; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BONDY CA, 1991, J NEUROSCI, V11, P3442; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; CHAMAK B, 1995, NEUROSCIENCE, V69, P177, DOI 10.1016/0306-4522(95)00236-C; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; CHAO CC, 1992, J IMMUNOL, V149, P2736; Combs CK, 2001, J NEUROSCI, V21, P1179; CUADROS MA, 1991, J ANAT, V177, P145; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Doussiere J, 1999, BIOCHEMISTRY-US, V38, P3694, DOI 10.1021/bi9823481; Dusart I, 1997, J NEUROSCI, V17, P3710; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fan HB, 2001, J COMP NEUROL, V436, P82; Flavin MP, 2000, GLIA, V29, P347, DOI 10.1002/(SICI)1098-1136(20000215)29:4<347::AID-GLIA5>3.3.CO;2-#; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; GARDETTE R, 1985, DEV BRAIN RES, V19, P47, DOI 10.1016/0165-3806(85)90230-5; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Ghoumari AM, 2002, J NEUROSCI, V22, P3531; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; HENDELMAN WJ, 1980, J COMP NEUROL, V193, P1063, DOI 10.1002/cne.901930417; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Kaal ECA, 1998, J NEUROSCI RES, V54, P778, DOI 10.1002/(SICI)1097-4547(19981215)54:6<778::AID-JNR5>3.0.CO;2-0; Kim SH, 2002, J CELL BIOL, V159, P821, DOI 10.1083/jcb.200112131; LARKFORS L, 1994, EUR J NEUROSCI, V6, P1015, DOI 10.1111/j.1460-9568.1994.tb00596.x; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001; Lindholm D, 1997, PERSPECT DEV NEUROBI, V5, P83; MALLAT M, 1994, J LEUKOCYTE BIOL, V56, P416, DOI 10.1002/jlb.56.3.416; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Morrison ME, 1998, J NEUROSCI, V18, P3563; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Murakami K, 1998, J NEUROSCI, V18, P205; NAVSCUES J, 2002, MICROGLIA DEGENERATI; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Noh KM, 2000, J NEUROSCI, V20; OPPENHEIM RW, 1999, FUNDAMENTAL NEUROSCI, P581; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Polfliet MMJ, 2001, J NEUROIMMUNOL, V116, P188, DOI 10.1016/S0165-5728(01)00282-X; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rakic S, 2000, EUR J NEUROSCI, V12, P2721, DOI 10.1046/j.1460-9568.2000.00153.x; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; ROTHS JB, 1984, J EXP MED, V159, P1, DOI 10.1084/jem.159.1.1; Sankarapandi S, 1998, ARCH BIOCHEM BIOPHYS, V353, P312, DOI 10.1006/abbi.1998.0658; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schneider SD, 1997, GENE THER, V4, P524, DOI 10.1038/sj.gt.3300432; Sears HC, 2003, DEVELOPMENT, V130, P3557, DOI 10.1242/dev.00586; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Tammariello SP, 2000, J NEUROSCI, V20; THANOS S, 1993, J NEUROSCI, V13, P455; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; TORRESALEMAN I, 1992, EUR J NEUROSCI, V4, P864, DOI 10.1111/j.1460-9568.1992.tb00196.x; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Upender MB, 1999, DEV NEUROSCI-BASEL, V21, P491, DOI 10.1159/000017416; vanRooijen N, 1997, TRENDS BIOTECHNOL, V15, P178, DOI 10.1016/S0167-7799(97)01019-6; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; WHITTEMORE ER, 1995, NEUROSCIENCE, V67, P921, DOI 10.1016/0306-4522(95)00108-U; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zanjani HS, 1996, J COMP NEUROL, V374, P332, DOI 10.1002/(SICI)1096-9861(19961021)374:3<332::AID-CNE2>3.0.CO;2-2	80	510	526	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					535	547		10.1016/S0896-6273(04)00069-8	http://dx.doi.org/10.1016/S0896-6273(04)00069-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980203	Bronze			2022-12-17	WOS:000221458100007
J	Grossman, ED; Blake, R				Grossman, ED; Blake, R			Brain areas active during visual perception of biological motion	NEURON			English	Article							FUSIFORM FACE AREA; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL MRI; OBJECT; CORTEX; ACTIVATION; ATTENTION; SYSTEMS; COLOR; SHAPE	Theories of vision posit that form and motion are represented by neural mechanisms segregated into functionally and anatomically distinct pathways. Using point-light animations of biological motion, we examine the extent to which form and motion pathways are mutually involved in perceiving figures depicted by the spatio-temporal integration of local motion components. Previous work discloses that viewing biological motion selectively activates a region on the posterior superior temporal sulcus (STSp). Here we report that the occipital and fusiform face areas (OFA and FFA) also contain neural signals capable of differentiating biological from nonbiological motion. EBA and LOC, although involved in perception of human form, do not contain neural signals selective for biological motion. Our results suggest that a network of distributed neural areas in the form and motion pathways underlie the perception of biological motion.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Vanderbilt University	Grossman, ED (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA.	e.grossman@vanderbilt.edu						Ahlstrom V, 1997, PERCEPTION, V26, P1539, DOI 10.1068/p261539; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Bonda E, 1996, J NEUROSCI, V16, P3737; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CUTTING JE, 1978, J EXP PSYCHOL HUMAN, V4, P357, DOI 10.1037/0096-1523.4.3.357; DONER J, 1984, J EXP PSYCHOL HUMAN, V10, P1; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Friston KJ, 1995, HUM BRAIN MAPP, V3, P302, DOI 10.1002/hbm.460030405; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Goodale MA, 1998, COGNITION, V67, P181, DOI 10.1016/S0010-0277(98)00017-1; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HOFFMAN E, 2000, NAT NEUROSCI, V2, P574; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; KULIKOWSKI JJ, 1973, J PHYSIOL-LONDON, V232, P149, DOI 10.1113/jphysiol.1973.sp010261; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MATHER G, 1992, P ROY SOC B-BIOL SCI, V249, P149, DOI 10.1098/rspb.1992.0097; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Puce A, 1998, J NEUROSCI, V18, P2188; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028	51	510	513	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1167	1175		10.1016/S0896-6273(02)00897-8	http://dx.doi.org/10.1016/S0896-6273(02)00897-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	594GC	12354405	Bronze			2022-12-17	WOS:000178040000016
J	JONAS, P; RACCA, C; SAKMANN, B; SEEBURG, PH; MONYER, H				JONAS, P; RACCA, C; SAKMANN, B; SEEBURG, PH; MONYER, H			DIFFERENCES IN CA2+ PERMEABILITY OF AMPA-TYPE GLUTAMATE-RECEPTOR CHANNELS IN NEOCORTICAL NEURONS CAUSED BY DIFFERENTIAL GLUR-B SUBUNIT EXPRESSION	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; KAINATE RECEPTORS; NERVOUS-SYSTEM; VISUAL-CORTEX; BRAIN-SLICES; GLIAL-CELLS; ION FLOW; CALCIUM; PERMEATION; PATCHES	Fast excitatory synaptic transmission in the CNS is mediated by AMPA-type glutamate receptor (GluR) channels. Heterologous expression suggested that the Ca2+ permeability of these receptors critically depends on the subunit composition. Using patch-clamp techniques in brain slices, we found that the Ca2+ permeability of native AMPA-type GluRs was markedly higher in nonpyramidal (P-Ca/P-K approximate to 0.63) than in pyramidal (P-Ca/P-K approximate to 0.05) neurons of rat neocortex. Analysis of mRNA in single cells indicated that the relative abundance of GluR-B-specific mRNA was significantly lower in nonpyramidal (GluR-B/ GluR-non-B approximate to 0.3) than in pyramidal (GlUR-B/GluR-non-B approximate to 3) cells. This suggests that differences in relative abundance of GluR-B-specific mRNA generate functional diversity of AMPA-type GluRs in neurons with respect to Ca2+ permeability.	UNIV HEIDELBERG, ZENTRUM MOLEK BIOL, D-69120 HEIDELBERG, GERMANY	Ruprecht Karls University Heidelberg				Monyer, Hannah/0000-0002-9332-5749; Jonas, Peter/0000-0001-5001-4804				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; GILBERTSON TA, 1991, SCIENCE, V251, P1613, DOI 10.1126/science.1849316; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; LIVSEY CT, 1993, J NEUROSCI, V13, P5324, DOI 10.1523/JNEUROSCI.13-12-05324.1993; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OZAWA S, 1993, NEUROSCI LETT, V155, P187, DOI 10.1016/0304-3940(93)90704-O; OZAWA S, 1991, J NEUROPHYSIOL, V66, P2, DOI 10.1152/jn.1991.66.1.2; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PETERS A, 1981, J COMP NEUROL, V203, P685, DOI 10.1002/cne.902030408; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STERN P, 1992, J PHYSIOL-LONDON, V449, P247, DOI 10.1113/jphysiol.1992.sp019085; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; WYLLIE DJA, 1994, J PHYSIOL-LONDON, V475, P95, DOI 10.1113/jphysiol.1994.sp020052	43	510	519	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1994	12	6					1281	1289		10.1016/0896-6273(94)90444-8	http://dx.doi.org/10.1016/0896-6273(94)90444-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	8011338				2022-12-17	WOS:A1994NT46300009
J	Sara, SJ; Bouret, S				Sara, Susan J.; Bouret, Sebastien			Orienting and Reorienting: The Locus Coeruleus Mediates Cognition through Arousal	NEURON			English	Review							LONG-TERM POTENTIATION; CORTICOTROPIN-RELEASING-FACTOR; PREFRONTAL CORTICAL FUNCTION; FRONTO-EXECUTIVE FUNCTION; SINGLE UNIT-ACTIVITY; NORADRENERGIC MODULATION; MEMORY RETRIEVAL; DENTATE GYRUS; CERULEUS NEURONS; BEHAVING RATS	Mood, motivation, attention, and arousal are behavioral states having a profound impact on cognition. Behavioral states are mediated though the peripheral nervous system and neuromodulatory systems in the brainstem. The noradrenergic nucleus locus coeruleus is activated in parallel with the autonomic system in response to biological imperatives. These responses can be spontaneous, to unexpected salient or threatening stimuli, or they can be conditioned responses to awaited behaviorally relevant stimuli. Noradrenaline, released in forebrain structures, will facilitate sensory processing, enhance cognitive flexibility and executive function in the frontal cortex, and promote offline memory consolidation in limbic structures. Central activation of neuromodulatory neurons and peripheral arousal, together, prepare the organism for a reorientation or reset of cortical networks and an adaptive behavioral response.	[Sara, Susan J.] Coll France, CNRS, UMR 7152, Lab Physiol Percept & Act, F-75005 Paris, France; [Sara, Susan J.] Paris Sci & Lettres Res Univ, MEMOLIFE Lab Excellence, F-75005 Paris, France; [Bouret, Sebastien] Hop La Pitie Salpetriere, Team Motivat Brain & Behav, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Sara, SJ (corresponding author), Coll France, CNRS, UMR 7152, Lab Physiol Percept & Act, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	susan.sara@college-de-france.fr; sebastien.bouret@icm-institute.org	Sara, Susan/AEX-0016-2022; Bouret, Sebastien/AAC-3542-2019; Bouret, Sebastien/J-9383-2013	Bouret, Sebastien/0000-0003-2279-6161; Bouret, Sebastien/0000-0003-2279-6161; Sara, Susan J./0000-0003-4537-7971	European Research Council	European Research Council(European Research Council (ERC)European Commission)	This review was written while S.J.S. was Visiting Professor at the Institute of Neurosciences, Chinese Academy of Sciences, Shanghai. S.B. is supported from a young investigators grant from the European Research Council. We pay homage to my mentor Corneliu Giurgea (S.J.S.) and to our scientific grandfather (S.J.S.) and great-grandfather (S.B.) Petr Stepanovich Kupalov.	ABERCROMBIE ED, 1987, J NEUROSCI, V7, P2837; Amiez C, 2003, EXP BRAIN RES, V149, P267, DOI 10.1007/s00221-002-1353-9; ARNSTEN AFT, 1984, BRAIN RES, V306, P9, DOI 10.1016/0006-8993(84)90351-2; Arnsten AFT, 2000, NEURAL PLAST, V7, P133, DOI 10.1155/NP.2000.133; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Asan E, 1998, Adv Anat Embryol Cell Biol, V142, P1; Astafiev SV, 2010, SCIENCE, V328, DOI 10.1126/science.1177200; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1981, J NEUROSCI, V1, P887; ASTONJONES G, 1981, J NEUROSCI, V1, P876; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bari A, 2009, PSYCHOPHARMACOLOGY, V205, P273, DOI 10.1007/s00213-009-1537-0; Berridge CW, 2008, BRAIN RES REV, V58, P1, DOI 10.1016/j.brainresrev.2007.10.013; BERRIDGE CW, 1993, NEUROSCIENCE, V55, P381, DOI 10.1016/0306-4522(93)90507-C; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bouret S, 2004, EUR J NEUROSCI, V20, P791, DOI 10.1111/j.1460-9568.2004.03526.x; Bouret S, 2003, J NEUROSCI, V23, P3491; Bouret S, 2009, J NEUROPHYSIOL, V101, P898, DOI 10.1152/jn.91048.2008; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Briand LA, 2007, PROG NEUROBIOL, V83, P69, DOI 10.1016/j.pneurobio.2007.06.007; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; CEDARBAUM JM, 1978, J COMP NEUROL, V178, P1, DOI 10.1002/cne.901780102; Chen FJ, 2007, NEUROSCIENCE, V144, P472, DOI 10.1016/j.neuroscience.2006.09.037; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DAHL D, 1989, P NATL ACAD SCI USA, V86, P4776, DOI 10.1073/pnas.86.12.4776; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; DEKEYNE A, 1986, BEHAV BRAIN RES, V20, P86, DOI 10.1016/0166-4328(86)90131-2; DEVAUGES V, 1991, BEHAV BRAIN RES, V43, P93, DOI 10.1016/S0166-4328(05)80056-7; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; Devilbiss DM, 2011, J NEUROPHYSIOL, V105, P69, DOI 10.1152/jn.00445.2010; DEWEER B, 1980, ANIM LEARN BEHAV, V8, P265, DOI 10.3758/BF03199605; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; ENNIS M, 1986, BRAIN RES, V374, P299, DOI 10.1016/0006-8993(86)90424-5; Eschenko O, 2008, CEREB CORTEX, V18, P2596, DOI 10.1093/cercor/bhn020; Eschenko O, 2012, CEREB CORTEX, V22, P426, DOI 10.1093/cercor/bhr121; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; GALLAGHER M, 1985, BRAIN RES, V347, P284, DOI 10.1016/0006-8993(85)90188-X; GIURGEA C, 1974, PAVLOVIAN J BIOL SCI, V9, P192; GIURGEA CE, 1989, PAVLOVIAN J BIOL SCI, V24, P81; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Goldstein LE, 1996, J NEUROSCI, V16, P4787; Guzman-Ramos K, 2012, LEARN MEMORY, V19, P231, DOI 10.1101/lm.024703.111; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Harley CW, 2007, PROG BRAIN RES, V163, P299, DOI 10.1016/S0079-6123(07)63018-0; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; HERVE D, 1987, BRAIN RES, V435, P71, DOI 10.1016/0006-8993(87)91588-5; HERVEMINVIELLE A, 1995, NEUROREPORT, V6, P1363, DOI 10.1097/00001756-199507100-00001; HIRATA H, 1994, J NEUROPHYSIOL, V71, P1752, DOI 10.1152/jn.1994.71.5.1752; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Howells FM, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-39; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; JACOBS BL, 1991, PROG BRAIN RES, V88, P159; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; Jones BE, 2008, ANN NY ACAD SCI, V1129, P26, DOI 10.1196/annals.1417.026; JONES BE, 1977, BRAIN RES, V127, P23, DOI 10.1016/0006-8993(77)90378-X; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; KORF J, 1973, NEUROPHARMACOLOGY, V12, P933, DOI 10.1016/0028-3908(73)90024-5; Kupalov P.S., 1948, B EKSP BIOL MED, V26, P237; Kupalov P.S., 1935, SOV VRACH GAZ ZH, V14; KUPALOV PS, 1961, ANN NY ACAD SCI, V92, P1046; Lapiz MDS, 2006, NEUROSCIENCE, V137, P1039, DOI 10.1016/j.neuroscience.2005.09.031; Lecas JC, 2004, EUR J NEUROSCI, V19, P2519, DOI 10.1111/j.0953-816X.2004.03341.x; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lestienne R, 1997, J PHYSIOLOGY-PARIS, V91, P273, DOI 10.1016/S0928-4257(97)82407-2; Lim EP, 2010, INT J NEUROPSYCHOPH, V13, P1219, DOI 10.1017/S1461145709991131; LOUGHLIN SE, 1986, NEUROSCIENCE, V18, P307, DOI 10.1016/0306-4522(86)90156-9; LUPPI PH, 1995, NEUROSCIENCE, V65, P119, DOI 10.1016/0306-4522(94)00481-J; Mana MJ, 1997, NEUROSCIENCE, V81, P1055, DOI 10.1016/S0306-4522(97)00225-X; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; McGaughy J, 2008, NEUROSCIENCE, V153, P63, DOI 10.1016/j.neuroscience.2008.01.064; McIntyre CK, 2012, NEUROSCI BIOBEHAV R, V36, P1750, DOI 10.1016/j.neubiorev.2011.11.001; MCLEAN J, 1994, BRAIN RES, V667, P83, DOI 10.1016/0006-8993(94)91716-7; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; NEUMAN RS, 1983, BRAIN RES, V273, P162, DOI 10.1016/0006-8993(83)91106-X; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; Palkovits M, 1999, J NEUROENDOCRINOL, V11, P529; Pan WHT, 2004, SYNAPSE, V53, P44, DOI 10.1002/syn.20034; Pfaff DW, 2012, TRENDS NEUROSCI, V35, P468, DOI 10.1016/j.tins.2012.04.008; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Rao TS, 2003, BRAIN RES, V990, P203, DOI 10.1016/S0006-8993(03)03532-7; RASMUSSEN K, 1986, BRAIN RES, V371, P324, DOI 10.1016/0006-8993(86)90370-7; Reyes BAS, 2011, EXP NEUROL, V230, P96, DOI 10.1016/j.expneurol.2011.04.001; Reyes BAS, 2005, EUR J NEUROSCI, V22, P93, DOI 10.1111/j.1460-9568.2005.04197.x; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Roullet P, 1998, NEURAL PLAST, V6, P63, DOI 10.1155/NP.1998.63; ROUSSEL B, 1967, CR SOC BIOL, V161, P2537; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P254, DOI 10.2174/157015908785777193; SARA SJ, 1985, ANN NY ACAD SCI, V444, P178, DOI 10.1111/j.1749-6632.1985.tb37588.x; SARA SJ, 1989, BEHAV NEURAL BIOL, V51, P401, DOI 10.1016/S0163-1047(89)91039-X; SARA SJ, 1991, PROG BRAIN RES, V88, P571; SARA SJ, 1995, P NATL ACAD SCI USA, V92, P6032, DOI 10.1073/pnas.92.13.6032; SARA SJ, 1994, BRAIN RES BULL, V35, P457, DOI 10.1016/0361-9230(94)90159-7; SARA SJ, 1980, NEUROSCI LETT, V18, P211, DOI 10.1016/0304-3940(80)90328-6; SARA SJ, 1982, BEHAV NEURAL BIOL, V36, P146, DOI 10.1016/S0163-1047(82)90145-5; Sara SJ, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00185; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Shinba T, 2000, BRAIN RES, V887, P293, DOI 10.1016/S0006-8993(00)03009-2; Snyder K, 2012, NEUROPSYCHOPHARMACOL, V37, P520, DOI 10.1038/npp.2011.218; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; STANTON PK, 1985, J NEUROSCI, V5, P2169; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Straube T, 2003, NEUROSCI LETT, V344, P5, DOI 10.1016/S0304-3940(03)00349-5; SVENSSON TH, 1987, PSYCHOPHARMACOLOGY, V92, P1, DOI 10.1007/BF00215471; Tait DS, 2007, EUR J NEUROSCI, V25, P3719, DOI 10.1111/j.1460-9568.2007.05612.x; Tjoumakaris SI, 2003, J COMP NEUROL, V466, P445, DOI 10.1002/cne.10893; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Uzakov S, 2005, LEARN MEMORY, V12, P165, DOI 10.1101/lm.89305; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; VANBOCKSTAELE EJ, 1993, BRAIN RES, V603, P1, DOI 10.1016/0006-8993(93)91293-2; VANBOCKSTAELE EJ, 1995, CLIN EXP HYPERTENS, V17, P153, DOI 10.3109/10641969509087062; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012; Waterhouse BD, 1998, BRAIN RES, V790, P33, DOI 10.1016/S0006-8993(98)00117-6; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	134	509	514	2	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2012	76	1					130	141		10.1016/j.neuron.2012.09.011	http://dx.doi.org/10.1016/j.neuron.2012.09.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	020HG	23040811	Bronze			2022-12-17	WOS:000309799000010
J	Rosin, B; Slovik, M; Mitelman, R; Rivlin-Etzion, M; Haber, SN; Israel, Z; Vaadia, E; Bergman, H				Rosin, Boris; Slovik, Maya; Mitelman, Rea; Rivlin-Etzion, Michal; Haber, Suzanne N.; Israel, Zvi; Vaadia, Eilon; Bergman, Hagai			Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating Parkinsonism	NEURON			English	Article							1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE PRIMATE MODEL; PRIMARY MOTOR CORTEX; BASAL GANGLIA; SUBTHALAMIC NUCLEUS; GLOBUS-PALLIDUS; OSCILLATORY ACTIVITY; PATHOLOGICAL SYNCHRONIZATION; MOVEMENT-DISORDERS; NEURONAL-ACTIVITY; FIRING PATTERNS	Continuous high-frequency deep brain stimulation (DBS) is a widely used therapy for advanced Parkinson's disease (PD) management. However, the mechanisms underlying DBS effects remain enigmatic and are the subject of an ongoing debate. Here, we present and test a closed-loop stimulation strategy for PD in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of PD. Application of pallidal closed-loop stimulation leads to dissociation between changes in basal ganglia (BG) discharge rates and patterns, providing insights into PD pathophysiology. Furthermore, cortico-pallidal closed-loop stimulation has a significantly greater effect on akinesia and on cortical and pallidal discharge patterns than standard open-loop DBS and matched control stimulation paradigms. Thus, closed-loop DBS paradigms, by modulating pathological oscillatory activity rather than the discharge rate of the BG-cortical networks, may afford more effective management of advanced PD. Such strategies have the potential to be effective in additional brain disorders in which a pathological neuronal discharge pattern can be recognized.	[Rosin, Boris; Slovik, Maya; Mitelman, Rea; Rivlin-Etzion, Michal; Vaadia, Eilon; Bergman, Hagai] Hebrew Univ Jerusalem, Hadassah Med Assoc, Sch Med,Dept Med Neurobiol Physiol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Rosin, Boris; Slovik, Maya; Mitelman, Rea; Rivlin-Etzion, Michal; Israel, Zvi; Vaadia, Eilon; Bergman, Hagai] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel; [Mitelman, Rea; Rivlin-Etzion, Michal; Vaadia, Eilon; Bergman, Hagai] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; [Haber, Suzanne N.] Univ Rochester, Dept Pharmacol & Physiol, Sch Med & Dent, Rochester, NY 14642 USA; [Israel, Zvi] Hebrew Univ Jerusalem, Hadassah Med Assoc, Sch Med, Ctr Funct & Restorat Neurosurg, IL-91120 Jerusalem, Israel; [Vaadia, Eilon; Bergman, Hagai] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Rochester; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rosin, B (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Assoc, Sch Med,Dept Med Neurobiol Physiol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	boris.rosin@mail.huji.ac.il	Bergman, Hagai/AAI-4683-2021; Israel, Zvi/S-5814-2016	Bergman, Hagai/0000-0002-2402-6673; Israel, Zvi/0000-0002-0060-5769; Mitelman, Rea/0000-0003-1271-7757; Rivlin, Michal/0000-0002-1310-3370	Netherlands friends of the Hebrew University (HUNA) "Fighting against Parkinson,"; Vorst family; Dekker foundation	Netherlands friends of the Hebrew University (HUNA) "Fighting against Parkinson,"; Vorst family; Dekker foundation	We thank Abraham Solomon (Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel), Gene la Morris (Department of Neurobiology, University of Haifa, Israel), Ahmed Moustafa (Center for Molecular and Behavioral Neuroscience, Rutgers University, NJ), Harry Xenias (Center for Molecular and Behavioral Neuroscience, Rutgers University, NJ), Eden Chlamtac (School of Computer Science, Tel Aviv University, Israel), and Timothy Denison (Medtronic Technology, MN) for reviewing early versions of this manuscript; Mati Joshua (Department of Clinical Neurobiology, The Hebrew University School of Medicine, Jerusalem, Israel) for suggestions in experimental design; Alpha-Omega Engineering (Nazareth, Israel) for providing the DSP used in the experiments; Tuvia Kurz for the primate illustrations in Figure 1; and Esther Singer for English editing. This study was supported by the Netherlands friends of the Hebrew University (HUNA) "Fighting against Parkinson," the Vorst family, and Dekker foundation grants. Authors' contributions: B.R. assembled the experimental setup and wrote the necessary software; B.R. and H.B. designed the experimental paradigm; E.V. performed the primate surgeries, together with M.R.-E (first primate) and Z.I. (second primate); H.B. and B.R. served as anesthesiologist and an assistant in the surgeries, respectively; B.R., M.S., R.M., and M.R.-E performed the experiments; S.N.H. performed the histological analysis; and B.R. and H.B. conducted the analysis and wrote the manuscript. All authors discussed the results, reviewed the manuscript, and made their comments.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baker KB, 2011, EXP NEUROL, V231, P309, DOI 10.1016/j.expneurol.2011.06.012; Bar-Gad I, 2004, J NEUROSCI, V24, P7410, DOI 10.1523/JNEUROSCI.1691-04.2004; Bar-Gad Izhar, 2000, Journal of Basic and Clinical Physiology and Pharmacology, V11, P305; Batista CAS, 2010, NEURAL NETWORKS, V23, P114, DOI 10.1016/j.neunet.2009.08.005; Benabid AL, 2009, PROG BRAIN RES, V175, P379, DOI 10.1016/S0079-6123(09)17525-8; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Brown P, 2006, J NEURAL TRANSM-SUPP, P27, DOI 10.1007/978-3-211-45295-0_6; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Carlson JD, 2010, J NEUROPHYSIOL, V103, P962, DOI 10.1152/jn.00363.2009; Cassim F, 2002, EPILEPTIC DISORD, V4, pS31; Chan V, 2011, NEUROBIOL DIS, V41, P2, DOI 10.1016/j.nbd.2010.08.012; de Solages C, 2010, EXP NEUROL, V221, P260, DOI 10.1016/j.expneurol.2009.11.012; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Deuschl G, 2006, MOVEMENT DISORD, V21, pS219, DOI 10.1002/mds.20957; Dorval AD, 2010, J NEUROPHYSIOL, V104, P911, DOI 10.1152/jn.00103.2010; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Eusebio A, 2007, PARKINSONISM RELAT D, V13, pS434, DOI 10.1016/S1353-8020(08)70044-0; Eusebio A, 2009, EXP NEUROL, V217, P1, DOI 10.1016/j.expneurol.2009.02.003; Feng X, 2007, J NEURAL ENG, V4, pL14, DOI 10.1088/1741-2560/4/2/L03; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frankemolle AMM, 2010, BRAIN, V133, P746, DOI 10.1093/brain/awp315; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; Gubellini P, 2009, PROG NEUROBIOL, V89, P79, DOI 10.1016/j.pneurobio.2009.06.003; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Heimer G, 2006, J NEURAL TRANSM-SUPP, P17; Heimer G, 2002, J NEUROSCI, V22, P7850; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Hurtado JA, 2005, J NEUROPHYSIOL, V93, P1569, DOI 10.1152/jn.00829.2004; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; Johnson MD, 2008, J NEUROPHYSIOL, V100, P2549, DOI 10.1152/jn.90372.2008; Johnson MD, 2009, EXP NEUROL, V219, P359, DOI 10.1016/j.expneurol.2009.04.022; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Lafreniere-Roula M, 2010, EXP BRAIN RES, V205, P251, DOI 10.1007/s00221-010-2362-8; Lalo E, 2008, J NEUROSCI, V28, P3008, DOI 10.1523/JNEUROSCI.5295-07.2008; LANGSTON J W, 1984, Neurology, V34, P268; Lathi B. P., 2004, LINEAR SYSTEMS SIGNA, V2nd; Leblois A, 2007, EUR J NEUROSCI, V26, P1701, DOI 10.1111/j.1460-9568.2007.05777.x; Lee JY, 2010, CLIN NEUROL NEUROSUR, V112, P47, DOI 10.1016/j.clineuro.2009.10.008; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Lozano Andres M, 2004, Suppl Clin Neurophysiol, V57, P733; Magill PJ, 2004, J NEUROPHYSIOL, V92, P2122, DOI 10.1152/jn.00333.2004; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; McCairn KW, 2009, J NEUROPHYSIOL, V101, P1941, DOI 10.1152/jn.91092.2008; McIntyre CC, 2009, IEEE ENG MED BIO, P4228, DOI 10.1109/IEMBS.2009.5334592; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Mikos A, 2011, NEUROIMAGE, V54, pS238, DOI 10.1016/j.neuroimage.2010.03.068; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Moran A, 2010, J NEUROSCI METH, V186, P116, DOI 10.1016/j.jneumeth.2009.10.024; Moro E, 2006, ARCH NEUROL-CHICAGO, V63, pE1, DOI 10.1001/archneur.63.9.noc60069; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nise N.S., 2007, CONTROL SYSTEMS ENG, P636; Parush N, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00022; Popovych OV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164102; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; REDMOND D E JR, 1985, Society for Neuroscience Abstracts, V11, P166; Rouse AG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036018; Stanslaski S, 2009, IEEE ENG MED BIO, P5494, DOI 10.1109/IEMBS.2009.5334562; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Tass P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016009; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; Vitek Jerrold L, 2008, Cleve Clin J Med, V75 Suppl 2, pS59; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Volkmann J, 2006, MOVEMENT DISORD, V21, pS284, DOI 10.1002/mds.20961; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Weinberger M, 2009, EXP NEUROL, V219, P58, DOI 10.1016/j.expneurol.2009.05.014; Wichmann T, 2006, J NEURAL TRANSM-SUPP, P21; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67	80	509	516	3	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					370	384		10.1016/j.neuron.2011.08.023	http://dx.doi.org/10.1016/j.neuron.2011.08.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017994	Bronze			2022-12-17	WOS:000296224000017
J	Lucin, KM; Wyss-Coray, T				Lucin, Kurt M.; Wyss-Coray, Tony			Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?	NEURON			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-BETA-PEPTIDE; TOLL-LIKE RECEPTORS; MARROW-DERIVED MICROGLIA; PROTEIN TRANSGENIC MICE; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE PATIENTS; GENE-EXPRESSION PROFILE; MOUSE MODEL; PARKINSONS-DISEASE	Until recently, the brain was studied almost exclusively by neuroscientists and the immune system by immunologists, fuelling the notion that these systems represented two isolated entities. However, as more data suggest an important role of the immune system in regulating the progression of brain aging and neurodegenerative disease, it has become clear that the crosstalk between these systems can no longer be ignored and a new interdisciplinary approach is necessary. A central question that emerges is whether immune and inflammatory pathways become hyperactivated with age and promote degeneration or whether insufficient immune responses, which fail to cope with age-related stress, may contribute to disease. We try to explore here the consequences of gain versus loss of function with an emphasis on microglia as sensors and effectors of immune function in the brain, and we discuss the potential role of the peripheral environment in neurodegenerative diseases.	[Lucin, Kurt M.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Lucin, Kurt M.; Wyss-Coray, Tony] Vet Affairs Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831	Department of Veterans Affairs; NIH [AG27505, AG30144]; Hillblom Foundation; NATIONAL INSTITUTE ON AGING [R01AG027505, R01AG030144] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank Kristina Kigerl, Kira Irving, and Philipp Jaeger for their insightful review of the manuscript. Additionally, the authors thank Saul Villeda and Jian Luo for their assistance with the aged microglia images. This work was supported by the Department of Veterans Affairs, NIH grant AG27505, AG30144 (T.W.-C.) and the Hillblom Foundation (K.M.L. and T.W.-C.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Betmouni S, 1996, NEUROSCIENCE, V74, P1, DOI 10.1016/0306-4522(96)00212-6; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Bradl M, 2005, AM J PATHOL, V166, P1441, DOI 10.1016/S0002-9440(10)62361-9; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Dandoy-Dron F, 1998, J BIOL CHEM, V273, P7691, DOI 10.1074/jbc.273.13.7691; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P313; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; FRACKOWIAK J, 1992, ACTA NEUROPATHOL, V84, P225; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Fraser H, 1996, J GEN VIROL, V77, P1935, DOI 10.1099/0022-1317-77-8-1935; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Herber DL, 2004, EXP NEUROL, V190, P245, DOI 10.1016/j.expneurol.2004.07.007; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Holers VM, 1996, CLIN IMMUNOLOGY PRIN, P363; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kalman J, 2005, PSYCHIAT GENET, V15, P1; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kerfoot SM, 2006, HEPATOLOGY, V43, P154, DOI 10.1002/hep.21003; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knuesel I, 2009, NEUROBIOL AGING, V30, P697, DOI 10.1016/j.neurobiolaging.2007.08.011; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Letiembre M, 2007, NEUROSCIENCE, V146, P248, DOI 10.1016/j.neuroscience.2007.01.004; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Majed HH, 2006, J NEUROSCI, V26, P1730, DOI 10.1523/JNEUROSCI.0702-05.2006; Majumdar A, 2008, NEUROBIOL AGING, V29, P707, DOI 10.1016/j.neurobiolaging.2006.12.001; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; MCGEER PL, 1988, ANN NEUROL, V24, P574, DOI 10.1002/ana.410240415; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monsonego A, 2006, P NATL ACAD SCI USA, V103, P5048, DOI 10.1073/pnas.0506209103; Mott RT, 2004, GLIA, V46, P369, DOI 10.1002/glia.20009; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reale M, 2005, EXP GERONTOL, V40, P165, DOI 10.1016/j.exger.2004.12.003; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Rodriguez M, 2007, NEUROBIOL DIS, V28, P316, DOI 10.1016/j.nbd.2007.07.024; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rogers J, 2006, NEUROBIOL AGING, V27, P1733, DOI 10.1016/j.neurobiolaging.2005.09.043; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Song WC, 2000, IMMUNOPHARMACOLOGY, V49, P187, DOI 10.1016/S0162-3109(00)80303-3; Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Streit WJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3423; Szabo P, 2008, AUTOIMMUN REV, V7, P415, DOI 10.1016/j.autrev.2008.03.007; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tenner AJ, 1999, CURR OPIN IMMUNOL, V11, P34, DOI 10.1016/S0952-7915(99)80007-7; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Walker LC, 2000, MOL NEUROBIOL, V21, P83, DOI 10.1385/MN:21:1-2:083; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; WEGIEL J, 1990, ACTA NEUROPATHOL, V81, P116, DOI 10.1007/BF00334499; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wilcock DM, 2004, NEUROBIOL DIS, V15, P11, DOI 10.1016/j.nbd.2003.09.015; WILLIAMS AE, 1995, ACTA NEUROPATHOL, V90, P164, DOI 10.1007/BF00294316; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; YAMADA T, 1992, ACTA NEUROPATHOL, V84, P100, DOI 10.1007/BF00427222; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; Yong VW, 2009, NEURON, V64, P55, DOI 10.1016/j.neuron.2009.09.035	165	509	522	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 15	2009	64	1					110	122		10.1016/j.neuron.2009.08.039	http://dx.doi.org/10.1016/j.neuron.2009.08.039			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840553	Green Accepted, Bronze			2022-12-17	WOS:000271454400015
J	Barria, A; Malinow, R				Barria, A; Malinow, R			NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII	NEURON			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; PROTEIN-KINASE-II; RAT VISUAL-CORTEX; CRITICAL PERIOD; NR2B SUBUNIT; THALAMOCORTICAL SYNAPSES; DIFFERENTIAL ROLES; EPSILON-1 SUBUNIT; HIPPOCAMPAL LTP	Calcium entry through postsynaptic NMDA-Rs and subsequent activation of CaMKII trigger synaptic plasticity in many brain regions. Active CaMKII can bind to NMDA-Rs, but the physiological role of this interaction is not well understood. Here, we test if association between active CaMKII and synaptic NMDA-Rs is required for synaptic plasticity. Switching synaptic NR2B-containing NMDA-Rs that bind CaMKII with high affinity with those containing NR2A, a subunit with low affinity for CaMKII, dramatically reduces LTP. Expression of NR2A with mutations that increase association to active CaMKII recovers LTP. Finally, driving into synapses NR2B with mutations that reduce association to active CaMKII prevents LTP. Spontaneous activity-driven potentiation shows similar results. We conclude that association between active CaMKII and NR2B is required for different forms of synaptic enhancement. The switch from NR2B to NR2A content in synaptic NMDA-Rs normally observed in many brain regions may contribute to reduced plasticity by controlling the binding of active CaMKII.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Barria, A (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	barria@u.washington.edu						Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; Bliss TVP, 2003, PHILOS T ROY SOC B, V358, P607, DOI 10.1098/rstb.2003.1282; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Flint AC, 1997, J NEUROSCI, V17, P2469; ISHII T, 1993, J BIOL CHEM, V268, P2836; Ito I, 1996, NEUROSCI LETT, V203, P69, DOI 10.1016/0304-3940(95)12258-3; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kohr G, 2003, J NEUROSCI, V23, P10791; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mayadevi M, 2002, BBA-PROTEINS PROTEOM, V1598, P40, DOI 10.1016/S0167-4838(02)00315-1; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	55	509	528	0	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					289	301		10.1016/j.neuron.2005.08.034	http://dx.doi.org/10.1016/j.neuron.2005.08.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242409	Bronze			2022-12-17	WOS:000232838700018
J	Meng, YH; Zhang, Y; Tregoubov, V; Janus, C; Cruz, L; Jackson, M; Lu, WY; MacDonald, JF; Wang, JY; Falls, DL; Jial, ZP				Meng, YH; Zhang, Y; Tregoubov, V; Janus, C; Cruz, L; Jackson, M; Lu, WY; MacDonald, JF; Wang, JY; Falls, DL; Jial, ZP			Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE; SYNAPTIC-TRANSMISSION; COFILIN PHOSPHORYLATION; ZINC-FINGER; ACTIN CYTOSKELETON; DENDRITIC SPINES; CELL MOTILITY; ALPHA-ACTININ; PLASTICITY	In vitro studies indicate a role for the LIM kinase family in the regulation of cofilin phosphorylation and actin dynamics. In addition, abnormal expression of LIMK-1 is associated with Williams syndrome, a mental disorder with profound deficits in visuospatial cognition. However, the in vivo function of this family of kinases remains elusive. Using LIMK-1 knockout mice, we demonstrate a significant role for LIMK-1 in vivo in regulating cofilin and the actin cytoskeleton. Furthermore, we show that the knockout mice exhibited significant abnormalities in spine morphology and in synaptic function, including enhanced hippocampal long-term potentiation. The knockout mice also showed altered fear responses and spatial learning. These results indicate that LIMK-1 plays a critical role in dendritic spine morphogenesis and brain function.	Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Emory University	Jial, ZP (corresponding author), Hosp Sick Children, Program Brain & Behav, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jia@sickkids.ca	Jackson, Mike/H-5573-2012; Jia, zhengping/AAZ-4190-2021; Lu, Wei-Yang/K-4404-2013	Jackson, Mike/0000-0002-4730-201X; 				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; FINCH DM, 1990, BRAIN RES, V518, P269, DOI 10.1016/0006-8993(90)90979-L; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; JANUS C, 1995, BEHAV PROCESS, V34, P129, DOI 10.1016/0376-6357(94)00060-T; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kim CH, 1999, J NEUROSCI, V19, P4314; Kirov SA, 1999, J NEUROSCI, V19, P2876; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lian JP, 2000, J BIOL CHEM, V275, P2869, DOI 10.1074/jbc.275.4.2869; Lu YM, 1997, J NEUROSCI, V17, P5196; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MIZUNO K, 1994, ONCOGENE, V9, P1605; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mori T, 1997, MOL BRAIN RES, V45, P247, DOI 10.1016/S0169-328X(96)00257-4; MORRIS R, 1996, HIPPOCAMPUS FUNCTION, P55; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Smart FM, 2000, HIPPOCAMPUS, V10, P542, DOI 10.1002/1098-1063(2000)10:5<542::AID-HIPO4>3.3.CO;2-Z; Smolich B, 1997, J BIOCHEM-TOKYO, V121, P382; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Sumida J, 1998, VICTORIAN STUD, V42, P147, DOI 10.2979/VIC.1998.42.1.147; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Wang JY, 1998, J BIOL CHEM, V273, P20525, DOI 10.1074/jbc.273.32.20525; Wang JY, 2000, J COMP NEUROL, V416, P319, DOI 10.1002/(SICI)1096-9861(20000117)416:3<319::AID-CNE4>3.0.CO;2-Q; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	60	509	527	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					121	133		10.1016/S0896-6273(02)00758-4	http://dx.doi.org/10.1016/S0896-6273(02)00758-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123613	Bronze			2022-12-17	WOS:000176601800015
J	MATTSON, MP; RYCHLIK, B; CHU, C; CHRISTAKOS, S				MATTSON, MP; RYCHLIK, B; CHU, C; CHRISTAKOS, S			EVIDENCE FOR CALCIUM-REDUCING AND EXCITO-PROTECTIVE ROLES FOR THE CALCIUM-BINDING PROTEIN CALBINDIN-D(28K) IN CULTURED HIPPOCAMPAL-NEURONS	NEURON			English	Article							IMMUNOCYTOCHEMICAL LOCALIZATION; RAT; GLUTAMATE; BRAIN; NEUROARCHITECTURE; PARVALBUMIN; NEUROTOXICITY; PURIFICATION; DEGENERATION; DEPENDENCE	Neuronal systems for calcium homeostasis are crucial for neuronal development and function and may also contribute to selective neuronal vulnerability in adverse conditions such as exposure to excitatory amino acids or anoxia, and in neurodegenerative diseases. Previous work demonstrated the presence and differential distribution of calcium-binding proteins in the CNS. We now report that a subpopulation of neurons in disociated cell cultures of embryonic rat hippocampus expresses calbindin-D28k (M(r) 28,000 calcium-binding protein) immunoreactivity and that these neurons are relatively resistant to neurotoxicity induced by either glutamate or calcium ionophore. Direct comparisons of dynamic aspects of intracellular calcium levels and calbindin-D28k immunoreactivity in the same neurons revealed that calbindin-D28k-positive neurons were better able to reduce free intracellular calcium levels than calbindin-D28k-negative neurons. These findings indicate that the differential expression of calbindin-D28k in hippocampal neurons occurs early in development and may be one determinant of selective neuronal vulnerability to excitotoxic insults.	UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA; UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, DEPT BIOCHEM & MOLEC BIOL, NEWARK, NJ 07103 USA	University of Kentucky; Rutgers State University New Brunswick; Rutgers State University Medical Center	MATTSON, MP (corresponding author), UNIV KENTUCKY, SANDERS BROWN RES CTR AGING, LEXINGTON, KY 40536 USA.		Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020270] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38961] Funding Source: Medline; NINDS NIH HHS [NS20270] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BAUDIER J, 1985, J BIOL CHEM, V260, P662; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BORLE AB, 1987, CALCIUM CELL FUNCTIO, V7, P159; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CACERES A, 1986, J NEUROSCI, V6, P714; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CELIO MR, 1981, NATURE, V293, P300, DOI 10.1038/293300a0; CHOI DW, 1987, J NEUROSCI, V7, P369; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; CHRISTAKOS S, 1987, METHOD ENZYMOL, V139, P534; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; FELDMAN SC, 1983, ENDOCRINOLOGY, V112, P290, DOI 10.1210/endo-112-1-290; GIBSON GE, 1987, NEUROBIOL AGING, V8, P329, DOI 10.1016/0197-4580(87)90072-8; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; IACOPINO AM, 1990, J BIOL CHEM, V265, P10177; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; ICHIMIYA Y, 1989, BRAIN RES, V499, P402, DOI 10.1016/0006-8993(89)90793-2; JANDE SS, 1981, NATURE, V294, P765, DOI 10.1038/294765a0; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KHACHATURIAN ZS, 1989, ANN NY ACAD SCI, V568, P1, DOI 10.1111/j.1749-6632.1989.tb12485.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LLINAS RR, 1982, SCI AM, V247, P56, DOI 10.1038/scientificamerican1082-56; MATTSON MP, 1989, MECH AGEING DEV, V50, P103, DOI 10.1016/0047-6374(89)90010-9; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; MATTSON MP, 1989, FASEB J, V3, P2519, DOI 10.1096/fasebj.3.13.2572500; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1990, NEURON, V4, P105, DOI 10.1016/0896-6273(90)90447-N; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MATTSON MP, 1990, CURRENT ASPECTS NEUR, P1; McLachlan D R, 1987, Alzheimer Dis Assoc Disord, V1, P171, DOI 10.1097/00002093-198701030-00009; MILLS LR, 1990, NEURON, V4, P149, DOI 10.1016/0896-6273(90)90451-K; MORGAN DW, 1986, BIOCHEM BIOPH RES CO, V138, P547, DOI 10.1016/S0006-291X(86)80531-9; NADLER JV, 1980, BRAIN RES, V195, P47; NITSCH C, 1989, NEUROSCI LETT, V105, P263, DOI 10.1016/0304-3940(89)90631-9; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SCANLON M, 1987, J BIOL CHEM, V262, P6308; SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225; SETOOHSHIMA A, 1988, LANCET, V1, P1252; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SONNENBERG J, 1990, IN PRESS MOL BRAIN R; VANELDIK LJ, 1982, INT REV CYTOL, V77, P1, DOI 10.1016/S0074-7696(08)62463-8; VARGHESE S, 1988, J BIOL CHEM, V263, P9776; WASSERMA.RH, 1966, SCIENCE, V152, P791, DOI 10.1126/science.152.3723.791	53	509	515	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1991	6	1					41	51		10.1016/0896-6273(91)90120-O	http://dx.doi.org/10.1016/0896-6273(91)90120-O			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1670921				2022-12-17	WOS:A1991EU27800005
J	Deisseroth, K; Singla, S; Toda, H; Monje, M; Palmer, TD; Malenka, RC				Deisseroth, K; Singla, S; Toda, H; Monje, M; Palmer, TD; Malenka, RC			Excitation-neurogenesis coupling in adult neural stem/progenitor cells	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; RAT DENTATE GYRUS; STEM-CELLS; OLFACTORY-BULB; HIPPOCAMPAL NEUROGENESIS; EXTRACELLULAR POTASSIUM; SYNAPTIC-TRANSMISSION; CREB PHOSPHORYLATION; SUBVENTRICULAR ZONE	A wide variety of in vivo manipulations influence neurogenesis in the adult hippocampus. It is not known, however, if adult neural stem/progenitor cells (NPCs) can intrinsically sense excitatory neural activity and thereby implement a direct coupling between excitation and neurogenesis. Moreover, the theoretical significance of activity-dependent neurogenesis in hippocampal-type memory processing networks has not been explored. Here we demonstrate that excitatory stimuli act directly on adult hippocampal NPCs to favor neuron production. The excitation is sensed via Ca(v)1.2/ 1.3 (L-type) Call channels and NMDA receptors on the proliferating precursors. Excitation through this pathway acts to inhibit expression of the glial fate genes Hes1 and Id2 and increase expression of NeuroD, a positive regulator of neuronal differentiation. These activity-sensing properties of the adult NPCs, when applied as an "excitation-neurogenesis coupling rule" within a Hebbian neural network, predict significant advantages for both the temporary storage and the clearance of memories.	Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.		Palmer, Theo/GSI-6635-2022; Toda, Hiroki/C-6932-2016	Toda, Hiroki/0000-0002-1596-4131; Palmer, Theo/0000-0002-6266-1862				Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cai L, 2000, DEVELOPMENT, V127, P3021; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 2002, DEVELOPMENT, V129, P1871; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; CLAIBORNE BJ, 1990, J COMP NEUROL, V302, P206, DOI 10.1002/cne.903020203; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Graham B, 1999, NEURAL COMPUT, V11, P117, DOI 10.1162/089976699300016845; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jinnah HA, 2000, MOVEMENT DISORD, V15, P542, DOI 10.1002/1531-8257(200005)15:3<542::AID-MDS1019>3.0.CO;2-2; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Liu JL, 1998, J NEUROSCI, V18, P7768; LONGO VG, 1988, PHARMACOL BIOCHEM BE, V29, P785, DOI 10.1016/0091-3057(88)90207-9; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MALENKA RC, 1981, SCIENCE, V214, P339, DOI 10.1126/science.7280695; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; Mitrasinovic OM, 2001, J BIOL CHEM, V276, P30142, DOI 10.1074/jbc.M104265200; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nottebohm F, 2002, BRAIN RES BULL, V57, P737, DOI 10.1016/S0361-9230(02)00750-5; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parent JM, 1997, J NEUROSCI, V17, P3727; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Petreanu L, 2002, J NEUROSCI, V22, P6106; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Sejnowski TJ, 1999, NEURON, V24, P773, DOI 10.1016/S0896-6273(00)81025-9; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toma JG, 2000, J NEUROSCI, V20, P7648; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wang DD, 2003, J NEUROPHYSIOL, V90, P2291, DOI 10.1152/jn.01116.2002; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0	80	508	567	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					535	552		10.1016/S0896-6273(04)00266-1	http://dx.doi.org/10.1016/S0896-6273(04)00266-1			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157417	Bronze			2022-12-17	WOS:000221708300006
J	Sussillo, D; Abbott, LF				Sussillo, David; Abbott, L. F.			Generating Coherent Patterns of Activity from Chaotic Neural Networks	NEURON			English	Article							CORTEX; COMPUTATION; PREMOTOR; SYSTEMS; NEURONS; DELAY	Neural circuits display complex activity patterns both spontaneously and when responding to a stimulus or generating a motor output. How are these two forms of activity related? We develop a procedure called FORCE learning for modifying synaptic strengths either external to or within a model neural network to change chaotic spontaneous activity into a wide variety of desired activity patterns. FORCE learning works even though the networks we train are spontaneously chaotic and we leave feedback loops intact and unclamped during learning. Using this approach, we construct networks that produce a wide variety of complex output patterns, input-output transformations that require memory, multiple outputs that can be switched by control inputs, and motor patterns matching human motion capture data. Our results reproduce data on premovement activity in motor and premotor cortex, and suggest that synaptic plasticity may be a more rapid and powerful modulator of network activity than generally appreciated.	[Sussillo, David; Abbott, L. F.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Dept Neurosci, New York, NY 10032 USA	Columbia University	Sussillo, D (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Dept Neurosci, New York, NY 10032 USA.	sussillo@neurotheory.columbia.edu; ifa2103@columbia.edu		Sussillo, David/0000-0003-1620-1264	NIH [5-DP1-OD114-02]; National Institute of Mental Health [MH-58754]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000114] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by an NIH Director's Pioneer Award, part of the NIH Roadmap for Medical Research, through grant number 5-DP1-OD114-02 and by National Institute of Mental Health grant MH-58754. We thank Taro Toyoizumi, Surya Ganguli, Greg Wayne, and Graham Taylor for helpful comments and suggestions.	Abarbanel HDI, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016208; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Atiya AF, 2000, IEEE T NEURAL NETWOR, V11, P697, DOI 10.1109/72.846741; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Brunel N, 2000, J PHYSIOLOGY-PARIS, V94, P445, DOI 10.1016/S0928-4257(00)01084-6; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2007, J NEUROPHYSIOL, V97, P348, DOI 10.1152/jn.00808.2006; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; DOYA K, 1992, IEEE INT S CIRCUITS, V6, P2777; FETZ EE, 1992, BEHAV BRAIN SCI, V15, P679; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Haykin S., 2002, ADAPTIVE FILTER THEO; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H., 2003, NIPS; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; MOLGEDEY L, 1992, PHYS REV LETT, V69, P3717, DOI 10.1103/PhysRevLett.69.3717; Pearlmutter BA, 1989, NEURAL COMPUT, V1, P263, DOI 10.1162/neco.1989.1.2.263; ROBINSON DA, 1992, BEHAV BRAIN SCI, V15, P644; Rumelhart D.E, 1986, EXPLORATIONS MICROST, V1; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Strogatz SH., 1994, NONLINEAR DYNAMICS C; SUSSILLO D, 2009, THESIS COLUMBIA U NE, P93; TAYLOR GW, 2006, ADV NEURAL INFORM PR, V19, P1370; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	31	507	514	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 27	2009	63	4					544	557		10.1016/j.neuron.2009.07.018	http://dx.doi.org/10.1016/j.neuron.2009.07.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491HV	19709635	Green Accepted, Bronze			2022-12-17	WOS:000269570400013
J	Gonzalez-Maeso, J; Weisstaub, NV; Zhou, MM; Chan, P; Ivic, L; Ang, R; Lira, A; Bradley-Moore, M; Ge, YC; Zhou, Q; Sealfon, SC; Gingrich, JA				Gonzalez-Maeso, Javier; Weisstaub, Noelia V.; Zhou, Mingming; Chan, Pokman; Ivic, Lidija; Ang, Rosalind; Lira, Alena; Bradley-Moore, Maria; Ge, Yongchao; Zhou, Qiang; Sealfon, Stuart C.; Gingrich, Jay A.			Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior	NEURON			English	Article							LYSERGIC-ACID DIETHYLAMIDE; RAT-BRAIN; MONOAMINERGIC RECEPTOR; ANTIPARKINSON AGENTS; DIFFERENTIAL ACTIONS; MULTIPLE CLASSES; KINASE PATHWAY; MESSENGER-RNA; LISURIDE; AGONIST	Hallucinogens, including mescaline, psilocybin, and lysergic acid diethylamide (LSD), profoundly affect perception, cognition, and mood. All known drugs of this class are 5-HT2A receptor (2AR) agonists, yet closely related 2AR agonists such as lisuride lack comparable psychoactive properties. Why only certain 2AR agonists are hallucinogens and which neural circuits mediate their effects are poorly understood. By genetically expressing 2AR only in cortex, we show that 2AR-regulated pathways on cortical neurons are sufficient to mediate the signaling pattern and behavioral response to hallucinogens. Hallucinogenic and nonhallucinogenic 2AR agonists both regulate signaling in the same 2AR-expressing cortical neurons. However, the signaling and behavioral responses to the hallucinogens are distinct. While lisuride and LSD both act at 2AR expressed by cortex neurons to regulate phospholipase C, LSD responses also involve pertussis toxin-sensitive heterotrimeric G(i/o) proteins and Src. These studies identify the long-elusive neural and signaling mechanisms responsible for the unique effects of hallucinogens.	Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Sackler Inst Labs, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Lieber Ctr Schizophrenia Res, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute	Sealfon, SC (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	Ge, Yongchao/AAG-9317-2021; Weisstaub, Noelia/ABA-1706-2021	Ge, Yongchao/0000-0001-6448-5703; SEALFON, Stuart/0000-0001-5791-1217	NIDA NIH HHS [T32 DA07135, P01 DA012923, T32 DA007135, P01 DA12923] Funding Source: Medline; NIMH NIH HHS [K08 MH01711] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135, P01DA012923] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ADAMS LM, 1985, BEHAV NEUROSCI, V99, P881, DOI 10.1037/0735-7044.99.5.881; ADAMS LM, 1985, PHARMACOL BIOCHEM BE, V23, P461, DOI 10.1016/0091-3057(85)90022-X; Banes A, 1999, J PHARMACOL EXP THER, V291, P1179; BARKAI E, 1994, J NEUROPHYSIOL, V72, P644, DOI 10.1152/jn.1994.72.2.644; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; CALLAHAN PM, 1990, PSYCHOPHARMACOLOGY, V100, P13, DOI 10.1007/BF02245782; Chan P, 2005, J COMP NEUROL, V482, P50, DOI 10.1002/cne.20377; CORNE SJ, 1967, PSYCHOPHARMACOLOGIA, V11, P65, DOI 10.1007/BF00401509; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DARMANI NA, 1990, PHARMACOL BIOCHEM BE, V37, P95, DOI 10.1016/0091-3057(90)90047-L; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Ebersole BJ, 2003, MOL PHARMACOL, V63, P36, DOI 10.1124/mol.63.1.36; Egan CT, 1998, PSYCHOPHARMACOLOGY, V136, P409, DOI 10.1007/s002130050585; FIORELLA D, 1995, PSYCHOPHARMACOLOGY, V121, P364, DOI 10.1007/BF02246076; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; GONALEZMAESO J, 2006, ENDOCRINOLOGY, P177; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2002, MOL PSYCHIATR, V7, P755, DOI 10.1038/sj.mp.4001067; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gresch PJ, 2002, NEUROSCIENCE, V114, P707, DOI 10.1016/S0306-4522(02)00349-4; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; HOROWSKI R, 1976, EUR J PHARMACOL, V36, P373, DOI 10.1016/0014-2999(76)90091-1; HOYER D, 1994, PHARMACOL REV, V46, P157; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; JOHNSON AR, 1982, APPL MULTIVARIATE ST; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; Kurrasch-Orbaugh DM, 2003, J NEUROCHEM, V86, P980, DOI 10.1046/j.1471-4159.2003.01921.x; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Lopez-Gimenez JF, 2001, J COMP NEUROL, V429, P571, DOI 10.1002/1096-9861(20010122)429:4<571::AID-CNE5>3.0.CO;2-X; LopezGimenez JF, 1997, N-S ARCH PHARMACOL, V356, P446, DOI 10.1007/PL00005075; MAJ J, 1977, J NEURAL TRANSM, V41, P253, DOI 10.1007/BF01252020; Marek GJ, 2001, NEUROSCIENCE, V105, P379, DOI 10.1016/S0306-4522(01)00199-3; Marona-Lewicka D, 2002, PSYCHOPHARMACOLOGY, V164, P93, DOI 10.1007/s00213-002-1141-z; McLoughlin DJ, 2000, J NEUROCHEM, V74, P347, DOI 10.1046/j.1471-4159.2000.0740347.x; MILLAN MJ, 1991, J PHARMACOL EXP THER, V256, P973; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; MOKLER DJ, 1984, PHARMACOL BIOCHEM BE, V21, P281, DOI 10.1016/0091-3057(84)90227-2; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P805, DOI 10.1124/jpet.102.039875; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; NIELSEN EB, 1986, EUR J PHARMACOL, V125, P85, DOI 10.1016/0014-2999(86)90086-5; Nocjar C, 2002, NEUROSCIENCE, V111, P163, DOI 10.1016/S0306-4522(01)00593-0; PAZOS A, 1985, BRAIN RES, V346, P231, DOI 10.1016/0006-8993(85)90857-1; PIERI L, 1978, NATURE, V272, P278, DOI 10.1038/272278a0; Prioleau C, 2002, J BIOL CHEM, V277, P36577, DOI 10.1074/jbc.M206223200; Quinn JC, 2002, J PHARMACOL EXP THER, V303, P746, DOI 10.1124/jpet.102.038083; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Rex A, 1998, PHARMACOL BIOCHEM BE, V59, P677, DOI 10.1016/S0091-3057(97)00461-9; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Ruf F, 2004, TRENDS ENDOCRIN MET, V15, P331, DOI 10.1016/j.tem.2004.07.008; SAPIENZA S, 1981, EXP BRAIN RES, V43, P47; Scruggs JL, 2000, J NEUROSCI, V20, P8846; Scruggs JL, 2003, NEUROSCI LETT, V346, P137, DOI 10.1016/S0304-3940(03)00547-0; SILVA MTA, 1975, PSYCHOPHARMACOLOGIA, V42, P163, DOI 10.1007/BF00429548; TRULSON ME, 1984, DEV PSYCHOBIOL, V17, P329, DOI 10.1002/dev.420170402; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; VETULANI J, 1979, POL J PHARMACOL PHAR, V31, P413; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Willins DL, 1997, J PHARMACOL EXP THER, V282, P699	63	506	527	6	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					439	452		10.1016/j.neuron.2007.01.008	http://dx.doi.org/10.1016/j.neuron.2007.01.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270739	Bronze			2022-12-17	WOS:000245126800013
J	Gilbert, CD; Sigman, M; Crist, RE				Gilbert, CD; Sigman, M; Crist, RE			The neural basis of perceptual learning	NEURON			English	Review							PRIMARY VISUAL-CORTEX; PRIMARY MOTOR CORTEX; REORGANIZATION FOLLOWING MOTOR; PRIMARY SOMATOSENSORY CORTEX; RECEPTIVE-FIELD PROPERTIES; OCULAR DOMINANCE COLUMNS; AUDITORY-CORTEX; ADULT CATS; RAPID REORGANIZATION; LINE ORIENTATION	Perceptual learning is a lifelong process. We begin by encoding information about the basic structure of the natural world and continue to assimilate information about specific patterns with which we become familiar. The specificity of the learning suggests that all areas of the cerebral cortex are plastic and can represent various aspects of learned information. The neural substrate of perceptual learning relates to the nature of the neural code itself, including changes in cortical maps, in the temporal characteristics of neuronal responses, and in modulation of contextual influences. Top-down control of these representations suggests that learning involves an interaction between multiple cortical areas.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	gilbert@rockefeller.edu						AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; ARGUIN M, 1990, NEUROPSYCHOLOGIA, V28, P733, DOI 10.1016/0028-3932(90)90128-B; Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI 10.3109/0954898X.2011.638888; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BARLOW H, 1989, COMP NEUR S, P54; BARLOW HB, 1960, CURRENT PROBLEMS ANI; Beard B. L., 1995, VISION RES, V27, P953; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; BERARDI N, 1987, J PHYSIOL-LONDON, V384, P633, DOI 10.1113/jphysiol.1987.sp016474; Bosking WH, 1997, J NEUROSCI, V17, P2112; Braun J, 1998, NATURE, V393, P424, DOI 10.1038/30875; BRAUN J, 1990, PERCEPT PSYCHOPHYS, V48, P45, DOI 10.3758/BF03205010; BURKHALTER A, 1993, J NEUROSCI, V13, P1916, DOI 10.1523/jneurosci.13-05-01916.1993; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; CALFORD MB, 1991, J NEUROPHYSIOL, V65, P178, DOI 10.1152/jn.1991.65.2.178; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; CAMERON AA, 1992, BRAIN RES, V575, P151, DOI 10.1016/0006-8993(92)90436-D; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CHINO YM, 1991, J NEUROPHYSIOL, V65, P841, DOI 10.1152/jn.1991.65.4.841; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Chowdhury SA, 2000, J NEUROPHYSIOL, V83, P1856, DOI 10.1152/jn.2000.83.4.1856; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Dan Y, 1996, J NEUROSCI, V16, P3351; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; DEVOR M, 1981, J COMP NEUROL, V199, P277, DOI 10.1002/cne.901990209; Diamond ME, 1999, J NEUROBIOL, V41, P64, DOI 10.1002/(SICI)1097-4695(199910)41:1<64::AID-NEU9>3.3.CO;2-E; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eysel UT, 1999, CEREB CORTEX, V9, P101, DOI 10.1093/cercor/9.2.101; EYSEL UT, 1981, BRAIN RES, V204, P189; EYSEL UT, 1980, BRAIN RES, V181, P285, DOI 10.1016/0006-8993(80)90613-7; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; FAHLE M, 1988, VISION RES, V28, P171, DOI 10.1016/0042-6989(88)90017-X; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; Feldman DE, 1997, J NEUROSCI, V17, P6820; FENDICK M, 1983, VISION RES, V23, P145, DOI 10.1016/0042-6989(83)90137-2; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; FIORENTINI A, 1981, VISION RES, V21, P1149, DOI 10.1016/0042-6989(81)90017-1; FLORENCE SL, 1993, BRAIN RES, V601, P343, DOI 10.1016/0006-8993(93)91734-A; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; FREGNAC Y, 1992, J NEUROSCI, V12, P1280; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; GARRAGHTY PE, 1991, NEUROREPORT, V2, P747, DOI 10.1097/00001756-199112000-00004; GIBSON EJ, 1953, PSYCHOL BULL, V50, P401, DOI 10.1037/h0055517; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GILBERT CD, 1994, P NATL ACAD SCI USA, V91, P1195, DOI 10.1073/pnas.91.4.1195; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Ito M, 1998, NEURON, V20, P1191, DOI 10.1016/S0896-6273(00)80499-7; James W., 1890, PRINCIPLES PSYCHOL, V2; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KAPADIA MK, 1994, J NEUROSCI, V14, P451; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KNUDSEN EI, 1990, J NEUROSCI, V10, P222; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Konorski J., 1948, CONDITIONED REFLEXES; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; KOVACS I, 1994, NATURE, V370, P644, DOI 10.1038/370644a0; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Kovacs I, 2000, VISION RES, V40, P1301, DOI 10.1016/S0042-6989(00)00055-9; Krupa DJ, 1999, P NATL ACAD SCI USA, V96, P8200, DOI 10.1073/pnas.96.14.8200; LAMOTTE CC, 1993, J COMP NEUROL, V330, P83, DOI 10.1002/cne.903300107; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8779, DOI 10.1073/pnas.83.22.8779; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8390, DOI 10.1073/pnas.83.21.8390; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; MCMAHON SB, 1991, J COMP NEUROL, V304, P307, DOI 10.1002/cne.903040211; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Nakamura K, 1997, INT CONGR SER, V1141, P279; Nudo RJ, 1996, J NEUROSCI, V16, P785; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; RASMUSSON DD, 1986, BRAIN RES BULL, V16, P399, DOI 10.1016/0361-9230(86)90063-8; RASMUSSON DD, 1982, J COMP NEUROL, V205, P313, DOI 10.1002/cne.902050402; RASMUSSON DD, 1988, J COMP NEUROL, V277, P549, DOI 10.1002/cne.902770408; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1057, DOI 10.1152/jn.1992.67.5.1057; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; RHOADES RW, 1987, J NEUROPHYSIOL, V57, P1577, DOI 10.1152/jn.1987.57.5.1577; Ribeiro S, 1998, NEURON, V21, P359, DOI 10.1016/S0896-6273(00)80545-0; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Rockland KS, 1982, BRAIN RES, V169, P19; SAARINEN J, 1995, VISION RES, V35, P519, DOI 10.1016/0042-6989(94)00141-8; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; SANES JN, 1990, EXP BRAIN RES, V79, P479; SANES JN, 1992, CEREB CORTEX, V2, P141, DOI 10.1093/cercor/2.2.141; SANES JN, 1988, P NATL ACAD SCI USA, V85, P2003, DOI 10.1073/pnas.85.6.2003; Schmid LM, 1996, CEREB CORTEX, V6, P388, DOI 10.1093/cercor/6.3.388; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; SNOW PJ, 1991, PROGR SENSORY PHYSL, V11, P1; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Thorndike E.L., 1970, Animal Intelligence: Experimental Studies; TREISMAN A, 1992, AM J PSYCHOL, V105, P341, DOI 10.2307/1423032; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; VOLCHAN E, 1995, VISION RES, V35, P1, DOI 10.1016/0042-6989(94)E0083-W; von Helmholtz H., 1866, TREATISE PHYSL OPTIC, VIII; Walsh V, 1998, NEUROPSYCHOLOGIA, V36, P363, DOI 10.1016/S0028-3932(97)00113-9; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WEINBERGER NM, 1990, CONCEPTS NEUROSCIENC, V1, P91; WELLS J, 1987, J COMP NEUROL, V255, P466, DOI 10.1002/cne.902550312; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI https://doi.org/10.1037/11496-005; WESTHEIMER G, 1988, AM J OPTOM PHYS OPT, V65, P395; Westheimer G, 2001, VISION RES, V41, P1133, DOI 10.1016/S0042-6989(00)00320-5; Westheimer G, 1996, P ROY SOC B-BIOL SCI, V263, P503, DOI 10.1098/rspb.1996.0076; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	169	506	514	2	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					681	697		10.1016/S0896-6273(01)00424-X	http://dx.doi.org/10.1016/S0896-6273(01)00424-X			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	472YV	11567610	Bronze			2022-12-17	WOS:000171013300005
J	Muller, D; Wang, C; Skibo, G; Toni, N; Cremer, H; Calaora, V; Rougon, G; Kiss, JZ				Muller, D; Wang, C; Skibo, G; Toni, N; Cremer, H; Calaora, V; Rougon, G; Kiss, JZ			PSA-NCAM is required for activity-induced synaptic plasticity	NEURON			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; HIPPOCAMPAL ORGANOTYPIC CULTURES; N-CAM; POLYSIALIC ACID; NEURITE OUTGROWTH; AREA CA1; ADULT; GROWTH; L1	Hippocampal organotypic slice cultures maintained 10-20 days in vitro express a high level of the polysialylated embryonic form of neural cell adhesion molecule (NCAM) (PSA-NCAM). Treatment of the cultures with endoneuraminidase-N selectively removed polysialic acid (PSA) from NCAM and completely prevented induction of long-term potentiation (LTP) and long-term depression (LTD) without affecting cellular or synaptic parameters. Similarly, slices prepared from transgenic mice lacking the NCAM gene exhibited a decaying LTP. No inhibition of N-methyl-D-aspartic acid receptor-dependent synaptic responses was detected. Washout of the enzyme resulted in reexpression of PSA immunoreactivity which correlated with a complete recovery of LTP and LTD. This reexpression was blocked by TTX and low calcium and enhanced by bicuculline. Taken together, these results indicate that neuronal activity regulates the expression of PSA-NCAM at the synapse and that this expression is required for the induction of synaptic plasticity.	AA BOGOMOLETS PHYSIOL INST,UA-252601 KIEV,UKRAINE; UNIV LUMINY,LAB GENET & PHYSIOL DEV,F-13288 MARSEILLE,FRANCE	National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Muller, D (corresponding author), UNIV GENEVA,CTR MED,DEPT MORPHOL,CH-1211 GENEVA 4,SWITZERLAND.		ROUGON, Genevieve/G-2578-2013; Toni, Nicolas/M-2057-2014	Toni, Nicolas/0000-0001-5585-268X; ROUGON, Genevieve/0000-0003-1316-8200; Skibo, Galyna/0000-0003-2187-6178; Cremer, Harold/0000-0002-8673-5176				BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P417, DOI 10.1002/hipo.450030404; Goridis C, 1992, Semin Cell Biol, V3, P189; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; KISS JZ, 1993, NEUROSCIENCE, V53, P213, DOI 10.1016/0306-4522(93)90299-U; KLINZ SG, 1995, J NEUROCHEM, V65, P84; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER D, 1994, NEUROSCIENCE, V61, P441, DOI 10.1016/0306-4522(94)90424-3; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; ROUGON G, 1993, EUR J CELL BIOL, V61, P197; ROUGON G, 1986, J CELL BIOL, V103, P2429, DOI 10.1083/jcb.103.6.2429; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SADOUL R, 1983, NATURE, V304, P347, DOI 10.1038/304347a0; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STOPPINI L, 1993, NEUROSCIENCE, V57, P985, DOI 10.1016/0306-4522(93)90043-F; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; WANG C, 1994, J NEUROSCI, V14, P4446; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; WILLIAMS EJ, 1995, MOL CELL NEUROSCI, V6, P69, DOI 10.1006/mcne.1995.1007; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992; ZUBER C, 1992, J BIOL CHEM, V267, P9965	41	505	519	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					413	422		10.1016/S0896-6273(00)80174-9	http://dx.doi.org/10.1016/S0896-6273(00)80174-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816705	Bronze			2022-12-17	WOS:A1996VJ44000008
J	Gafni, J; Munsch, JA; Lam, TH; Catlin, MC; Costa, LG; Molinski, TF; Pessah, IN				Gafni, J; Munsch, JA; Lam, TH; Catlin, MC; Costa, LG; Molinski, TF; Pessah, IN			Xestospongins: Potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor	NEURON			English	Article							INTRACELLULAR CA2+ POOLS; VASCULAR SMOOTH-MUSCLE; PROTEIN-KINASE-C; CALCIUM-RELEASE; RYANODINE RECEPTOR; PHOSPHOINOSITIDE METABOLISM; SKELETAL-MUSCLE; MARINE SPONGE; PC12 CELLS; LOCALIZATION	Xestospongins (Xe's) A, C, D, araguspongine B, and demethylxestospongin B, a group of macrocyclic bis-1-oxaquinolizidines isolated from the Australian sponge, Xestospongia species, are shown to be potent blockers of IP3-mediated Ca2+ release from endoplasmic reticulum vesicles of rabbit cerebellum. XeC blocks IP3-induced Ca2+ release (IC50 = 358 nM) without interacting with the IP3-binding site, suggesting a mechanism that is independent of the IP3 effector site. Analysis of Pheochormocytoma cells and primary astrocytes loaded with Ca2+-sensitive dye reveals that XeC selectively blocks bradykinin-and carbamylcholine-induced Ca2+ efflux from endoplasmic reticulum stores. Xe's represent a new class of potent, membrane permeable IP3 receptor blockers exhibiting a high selectivity over ryanodine receptors. Xe's are a valuable tool for investigating the structure and function of IP3 receptors and Ca2+ signaling in neuronal and nonneuronal cells.	UNIV CALIF DAVIS,SCH VET MED,DEPT MOL BIOSCI,DAVIS,CA 95616; UNIV CALIF DAVIS,GRAD PROGRAM NEUROSCI,DAVIS,CA 95616; UNIV CALIF DAVIS,DEPT CHEM,DAVIS,CA 95616; UNIV WASHINGTON,DEPT ENVIRONM HLTH,SEATTLE,WA 98195	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle			Molinski, Tadeusz F/P-2125-2018		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005002, T32ES007059] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI39987] Funding Source: Medline; NIEHS NIH HHS [ES07059, R01 ES05002] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARRANG JM, 1994, CELL MOL BIOL, V40, P275; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY IB, 1993, MOL BIOL CELL, V4, P347, DOI 10.1091/mbc.4.3.347; BRANN MR, 1993, LIFE SCI, V52, P405, DOI 10.1016/0024-3205(93)90295-E; BRETSCHNEIDER E, 1995, AGENT ACTION SUPPL, V45, P309; BRETSCHNEIDER E, 1995, BIOCHEM PHARMACOL, V49, P33, DOI 10.1016/0006-2952(94)00404-A; BRINER VA, 1993, AM J PHYSIOL, V264, pF322, DOI 10.1152/ajprenal.1993.264.2.F322; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CREWS P, 1994, DEV ONCOL, V74, P364; DAUPHIN F, 1994, J NEUROCHEM, V63, P544; ENDO M, 1986, PURE APPL CHEM, V58, P387, DOI 10.1351/pac198658030387; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Grohovaz F, 1992, Agents Actions Suppl, V38 ( Pt 2), P9; Guizzetti M, 1996, EUR J PHARMACOL, V297, P265, DOI 10.1016/0014-2999(95)00746-6; HARNICK DJ, 1995, J BIOL CHEM, V270, P2833, DOI 10.1074/jbc.270.6.2833; HOYE TR, 1994, J ORG CHEM, V59, P6904, DOI 10.1021/jo00102a012; HOYE TR, 1995, J ORG CHEM, V60, P4958, DOI 10.1021/jo00120a055; KITAGAWA I, 1989, CHEM PHARM BULL, V37, P1676; KOBAYASHI S, 1988, BIOCHEM BIOPH RES CO, V153, P625, DOI 10.1016/S0006-291X(88)81141-0; KOVACS KA, 1995, NEUROCHEM RES, V20, P939, DOI 10.1007/BF00970740; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MOHR FC, 1993, BIOCHIM BIOPHYS ACTA, V1147, P105, DOI 10.1016/0005-2736(93)90320-Y; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; NAKAGAWA M, 1984, TETRAHEDRON LETT, V25, P3227, DOI 10.1016/S0040-4039(01)91016-0; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Pessah IN, 1997, AM J PHYSIOL-CELL PH, V272, pC601, DOI 10.1152/ajpcell.1997.272.2.C601; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; Pettit GR, 1996, BIOORG MED CHEM LETT, V6, P1313, DOI 10.1016/0960-894X(96)00225-9; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; QUIRION JC, 1992, J NAT PROD, V55, P1505, DOI 10.1021/np50088a017; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; SULLIVAN KMC, 1995, P NATL ACAD SCI USA, V92, P8611, DOI 10.1073/pnas.92.19.8611; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TINKER A, 1995, BIOPHYS J, V68, P111, DOI 10.1016/S0006-3495(95)80165-7; VERMA A, 1990, CELL REGUL, V1, P781, DOI 10.1091/mbc.1.10.781; YAMADA N, 1994, BIOCHEM J, V302, P781, DOI 10.1042/bj3020781; ZACCHETTI D, 1991, J BIOL CHEM, V266, P20152	46	504	508	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					723	733		10.1016/S0896-6273(00)80384-0	http://dx.doi.org/10.1016/S0896-6273(00)80384-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331361	Bronze			2022-12-17	WOS:A1997XZ01600024
J	ROSENTHAL, A; GOEDDEL, DV; NGUYEN, T; LEWIS, M; SHIH, A; LARAMEE, GR; NIKOLICS, K; WINSLOW, JW				ROSENTHAL, A; GOEDDEL, DV; NGUYEN, T; LEWIS, M; SHIH, A; LARAMEE, GR; NIKOLICS, K; WINSLOW, JW			PRIMARY STRUCTURE AND BIOLOGICAL-ACTIVITY OF A NOVEL HUMAN NEUROTROPHIC FACTOR	NEURON			English	Article									GENENTECH INC,DEPT DEV BIOL,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech	ROSENTHAL, A (corresponding author), GENENTECH INC,DEPT MOLEC BIOL,S SAN FRANCISCO,CA 94080, USA.							BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; COUGHLIN MD, 1985, DEV BIOL, V110, P392, DOI 10.1016/0012-1606(85)90098-3; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DAVIES LM, 1989, NERVE GROWTH FACTORS, P95; Gorman CM, 1990, DNA PROTEIN ENG TECH, V2, P1; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; HEFTI F, 1986, J NEUROSCI, V6, P2155; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LEDOUARIN NM, 1988, ANNU REV CELL BIOL, V4, P375, DOI 10.1146/annurev.cb.04.110188.002111; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; LEVIMONTALCINI R, 1972, IMMUNOSYMPATHECTOMY, P55; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MULLIS K, 1987, COLD SPRING HARB SYM, V51, P263; OPPENHEIM RW, 1982, J COMP NEUROL, V210, P174, DOI 10.1002/cne.902100208; PURVES D, 1988, BODY BRAIN TROPIC TH; ROSENTHAL A, 1987, EMBO J, V6, P3641, DOI 10.1002/j.1460-2075.1987.tb02696.x; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; Smith A J, 1980, Methods Enzymol, V65, P560; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	25	504	536	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1990	4	5					767	773		10.1016/0896-6273(90)90203-R	http://dx.doi.org/10.1016/0896-6273(90)90203-R			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE975	2344409				2022-12-17	WOS:A1990DE97500012
J	Feldman, DE				Feldman, Daniel E.			The Spike-Timing Dependence of Plasticity	NEURON			English	Review							LONG-TERM POTENTIATION; NEOCORTICAL PYRAMIDAL NEURONS; PROPAGATING ACTION-POTENTIALS; DEVELOPING RETINOTECTAL SYNAPSES; PRIMARY SOMATOSENSORY CORTEX; DEPOLARIZING CURRENT PULSES; CRITICAL PERIOD PLASTICITY; HIPPOCAMPAL PLACE FIELDS; 2 COINCIDENCE DETECTORS; RAT VISUAL-CORTEX	In spike-timing-dependent plasticity (STDP), the order and precise temporal interval between presynaptic and postsynaptic spikes determine the sign and magnitude of long-term potentiation (LIP) or depression (LTD). STDP is widely utilized in models of circuit-level plasticity, development, and learning. However, spike timing is just one of several factors (including firing rate, synaptic cooperativity, and depolarization) that govern plasticity induction, and its relative importance varies across synapses and activity regimes. This review summarizes this broader view of plasticity, including the forms and cellular mechanisms for the spike-timing dependence of plasticity, and, the evidence that spike timing is an important determinant of plasticity in vivo.	[Feldman, Daniel E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Feldman, Daniel E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Feldman, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dfeldman@berkeley.edu			NSF [SBE-0542013]; NIH [R01 073912]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073912] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	D.E.F. is supported by NSF grant #SBE-0542013 to the Temporal Dynamics of Learning Center, and NIH R01 073912. I thank Daniel Shulz, Vincent Jacob, Vanessa Bender, and Kevin Bender for many discussions. I apologize for omitting important studies due to space limitations.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Badoual M, 2006, INT J NEURAL SYST, V16, P79, DOI 10.1142/S0129065706000524; Banerjee A, 2009, CEREB CORTEX, V19, P2959, DOI 10.1093/cercor/bhp067; BARANYI A, 1981, NATURE, V290, P413, DOI 10.1038/290413a0; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Buchs NJ, 2002, J COMPUT NEUROSCI, V13, P167, DOI 10.1023/A:1020210230751; Bush D, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00142; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Dahmen Johannes C, 2008, J Neurosci, V28, P13629, DOI 10.1523/JNEUROSCI.4429-08.2008; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fino E, 2009, NEUROSCIENCE, V160, P744, DOI 10.1016/j.neuroscience.2009.03.015; Fino E, 2005, J NEUROSCI, V25, P11279, DOI 10.1523/JNEUROSCI.4476-05.2005; Fino E, 2008, J PHYSIOL-LONDON, V586, P265, DOI 10.1113/jphysiol.2007.144501; Fino E, 2010, J PHYSIOL-LONDON, V588, P3045, DOI 10.1113/jphysiol.2010.188466; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Froemke Robert C, 2010, Front Synaptic Neurosci, V2, P29, DOI 10.3389/fnsyn.2010.00029; Froemke Robert C, 2010, Front Synaptic Neurosci, V2, P19, DOI 10.3389/fnsyn.2010.00019; Fu YX, 2004, J NEUROSCI, V24, P2165, DOI 10.1523/JNEUROSCI.5145-03.2004; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Fuenzalida M, 2010, J NEUROPHYSIOL, V103, P47, DOI 10.1152/jn.00416.2009; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Gutig R, 2003, J NEUROSCI, V23, P3697; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; Hardie J, 2009, J NEUROSCI, V29, P3233, DOI 10.1523/JNEUROSCI.6000-08.2009; Harvey-Girard E, 2010, J NEUROSCI, V30, P6152, DOI 10.1523/JNEUROSCI.0303-10.2010; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holbro N, 2010, P NATL ACAD SCI USA, V107, P15975, DOI 10.1073/pnas.1004562107; Honda M, 2011, J NEUROSCI, V31, P1516, DOI 10.1523/JNEUROSCI.3811-10.2011; Ito Iori, 2008, Communicative & Integrative Biology, V1, P170; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; James W., 1890, PRINCIPLES PSYCHOL, V2; Kampa BM, 2007, TRENDS NEUROSCI, V30, P456, DOI 10.1016/j.tins.2007.06.010; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kempter R, 2001, NEURAL COMPUT, V13, P2709, DOI 10.1162/089976601317098501; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Letzkus JJ, 2007, CLIN EXP PHARMACOL P, V34, P1070, DOI 10.1111/j.1440-1681.2007.04724.x; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Li L, 2009, NEURON, V64, P537, DOI 10.1016/j.neuron.2009.10.005; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman John, 2010, Front Synaptic Neurosci, V2, P140, DOI 10.3389/fnsyn.2010.00140; Litvak V, 2007, EUR J NEUROSCI, V25, P2862, DOI 10.1111/j.1460-9568.2007.05531.x; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; Masquelier T, 2009, NEURAL COMPUT, V21, P1259, DOI 10.1162/neco.2008.06-08-804; McMahon DBT, 2012, CURR BIOL, V22, P332, DOI 10.1016/j.cub.2012.01.003; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Rachmuth G, 2011, P NATL ACAD SCI USA, V108, pE1266, DOI 10.1073/pnas.1106161108; Rao RPN, 2003, PHILOS T ROY SOC A, V361, P1149, DOI 10.1098/rsta.2003.1190; Rao RPN, 2001, NOVART FDN SYMP, V239, P208; Requarth T, 2011, CURR OPIN NEUROBIOL, V21, P602, DOI 10.1016/j.conb.2011.05.031; Roberts PD, 2000, J COMPUT NEUROSCI, V9, P67, DOI 10.1023/A:1008938428112; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Rumsey CC, 2004, J NEUROPHYSIOL, V91, P2273, DOI 10.1152/jn.00900.2003; Safo P, 2008, NEUROPHARMACOLOGY, V54, P213, DOI 10.1016/j.neuropharm.2007.05.029; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sarkisov DV, 2008, J NEUROSCI, V28, P133, DOI 10.1523/JNEUROSCI.1729-07.2008; Sawtell NB, 2007, J NEUROSCI, V27, P1552, DOI 10.1523/JNEUROSCI.5302-06.2007; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shouval HZ, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00019; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Suri RE, 2002, BIOL CYBERN, V87, P440, DOI 10.1007/s00422-002-0355-9; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; von der Malsburg C, 1973, Kybernetik, V14, P85; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Young JM, 2007, NAT NEUROSCI, V10, P887, DOI 10.1038/nn1913; Yu XT, 2008, J NEUROPHYSIOL, V100, P983, DOI 10.1152/jn.01256.2007; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhao YJ, 2011, J NEUROSCI, V31, P3158, DOI 10.1523/JNEUROSCI.5303-10.2011; Zhou YD, 2005, P NATL ACAD SCI USA, V102, P19121, DOI 10.1073/pnas.0509856103; Zilberter M, 2009, CEREB CORTEX, V19, P2308, DOI 10.1093/cercor/bhn247	149	503	505	11	175	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 23	2012	75	4					556	571		10.1016/j.neuron.2012.08.001	http://dx.doi.org/10.1016/j.neuron.2012.08.001			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	994EU	22920249	Green Accepted, Bronze			2022-12-17	WOS:000307914500006
J	Ross, CA; Margolis, RL; Reading, SAJ; Pletnikov, M; Coyle, JT				Ross, Christopher A.; Margolis, Russell L.; Reading, Sarah A. J.; Pletnikov, Mikhail; Coyle, Joseph T.			Neurobiology of schizophrenia	NEURON			English	Review							BRAIN-DEVELOPMENT; BIPOLAR DISORDER; GENE-EXPRESSION; SCHIZOAFFECTIVE DISORDER; TRANSCRIPTION FACTOR; ADULT SCHIZOPHRENIA; SUSCEPTIBILITY GENE; COGNITIVE DEFICITS; NEURONAL MIGRATION; NEURITE OUTGROWTH	With its hallucinations, delusions, thought disorder, and cognitive deficits, schizophrenia affects the most basic human processes of perception, emotion, and judgment. Evidence increasingly suggests that schizophrenia is a subtle disorder of brain development and plasticity. Genetic studies are beginning to identify proteins of candidate genetic risk factors for schizophrenia, including dysbindin, neuregulin 1, DAOA, COMT, and DISC1, and neurobiological studies of the normal and variant forms of these genes are now well justified. We suggest that DISC1 may offer especially valuable insights. Mechanistic studies of the properties of these candidate genes and their protein products should clarify the molecular, cellular, and systems-level pathogenesis of schizophrenia. This can help redefine the schizophrenia phenotype and shed light on the relationship between schizophrenia and other major psychiatric disorders. Understanding these basic pathologic processes may yield novel targets for the development of more effective treatments.	Johns Hopkins Univ, Sch Med, Div Neurobiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Schizophrenia Program, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02478 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; McLean Hospital	Ross, CA (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurobiol, Baltimore, MD 21287 USA.	caross@jhu.edu	Pletnikov, Mikhail V/G-8709-2012; Ross, Christopher A/H-8395-2013; Bernardo, Miquel/P-3049-2015; Gur, Ruben/K-1999-2019; Arnold, Steven E/J-7546-2012	Pletnikov, Mikhail V/0000-0002-8819-6559; Bernardo, Miquel/0000-0001-8748-6717; Gur, Ruben/0000-0002-9657-1996; 				Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; Arnold SE, 1997, BIOL PSYCHIAT, V42, P639, DOI 10.1016/S0006-3223(97)00142-X; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Arnold SE, 1998, ARCH GEN PSYCHIAT, V55, P225, DOI 10.1001/archpsyc.55.3.225; Austin CP, 2003, NEUROREPORT, V14, P951, DOI 10.1097/01.wnr.0000074342.81633.63; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Bowie CR, 2005, PSYCHIAT CLIN N AM, V28, P613, DOI 10.1016/j.psc.2005.05.004; Bramon E, 2006, EUR PSYCHIAT, V21, P70, DOI 10.1016/j.eurpsy.2005.11.001; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Cannon TD, 2005, CURR OPIN PSYCHIATR, V18, P135, DOI 10.1097/00001504-200503000-00005; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen JS, 2006, BIOL PSYCHIAT, V59, P1180, DOI 10.1016/j.biopsych.2006.02.024; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Craddock N, 2006, MOL PSYCHIATR, V11, P446, DOI 10.1038/sj.mp.4001808; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; D'Arcangelo G, 2006, EPILEPSY BEHAV, V8, P81, DOI 10.1016/j.yebeh.2005.09.005; DeRosse P, 2006, AM J PSYCHIAT, V163, P532, DOI 10.1176/appi.ajp.163.3.532; Detera-Wadleigh SD, 2006, BIOL PSYCHIAT, V60, P106, DOI 10.1016/j.biopsych.2006.01.019; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Erwin RJ, 1998, SCHIZOPHR RES, V33, P157, DOI 10.1016/S0920-9964(98)00075-9; Ettinger U, 2006, AM J PSYCHIAT, V163, P543, DOI 10.1176/appi.ajp.163.3.543; Fallgatter AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2002, DOI 10.1038/sj.npp.1301003; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gilmore JH, 1997, SCHIZOPHR RES, V24, P365, DOI 10.1016/S0920-9964(96)00123-5; Gold JM, 2004, SCHIZOPHR RES, V72, P21, DOI 10.1016/j.schres.2004.09.008; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Gornick MC, 2005, J AUTISM DEV DISORD, V35, P831, DOI 10.1007/s10803-005-0028-3; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green EK, 2006, MOL PSYCHIATR, V11, P798, DOI 10.1038/sj.mp.4001853; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hamshere ML, 2005, ARCH GEN PSYCHIAT, V62, P1081, DOI 10.1001/archpsyc.62.10.1081; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harvey PD, 2003, PSYCHOPHARMACOLOGY, V169, P404, DOI 10.1007/s00213-002-1342-5; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hennah W, 2006, SCHIZOPHRENIA BULL, V32, P409, DOI 10.1093/schbul/sbj079; Heresco-Levy U, 2002, AM J PSYCHIAT, V159, P480, DOI 10.1176/appi.ajp.159.3.480; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honer WG, 2000, NEUROPATHOLOGY SCHIZ, P105; Hong LE, 2006, ARCH GEN PSYCHIAT, V63, P259, DOI 10.1001/archpsyc.63.3.259; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Katsel PL, 2005, INT REV NEUROBIOL, V63, P41, DOI 10.1016/S0074-7742(05)63003-6; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kirkpatrick B, 2001, ARCH GEN PSYCHIAT, V58, P165, DOI 10.1001/archpsyc.58.2.165; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kubicki M, 2005, ANN NY ACAD SCI, V1064, P134, DOI 10.1196/annals.1340.024; Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42; Lane HY, 2005, ARCH GEN PSYCHIAT, V62, P1196, DOI 10.1001/archpsyc.62.11.1196; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Long JM, 2006, NEUROGENETICS, V7, P247, DOI 10.1007/s10048-006-0054-0; Lymer GKS, 2006, NEUROIMAGE, V33, P275, DOI 10.1016/j.neuroimage.2006.06.031; MARGOLIS RL, 2006, GENETIC INSTABILITIE, P261; McEvoy JP, 2006, AM J PSYCHIAT, V163, P600, DOI 10.1176/appi.ajp.163.4.600; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Niemi LT, 2003, SCHIZOPHR RES, V60, P239, DOI 10.1016/S0920-9964(02)00234-7; Niznikiewicz MA, 2003, CURR OPIN PSYCHIATR, V16, P123, DOI 10.1097/00001504-200303000-00002; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Ogawa F, 2005, BIOCHEM BIOPH RES CO, V338, P771, DOI 10.1016/j.bbrc.2005.10.013; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Pickard BS, 2006, MOL PSYCHIATR, V11, P847, DOI 10.1038/sj.mp.4001867; Pickard BS, 2005, AM J MED GENET B, V136B, P26, DOI 10.1002/ajmg.b.30204; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Porteous DJ, 2006, BIOL PSYCHIAT, V60, P123, DOI 10.1016/j.biopsych.2006.04.008; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Riley B, 2006, EUR J HUM GENET, V14, P669, DOI 10.1038/sj.ejhg.5201571; Ross CA, 1996, TRENDS NEUROSCI, V19, P171, DOI 10.1016/S0166-2236(96)10022-9; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2005, CLIN NEUROSCI RES, V5, P3, DOI 10.1016/j.cnr.2005.07.001; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Straub RE, 2006, BIOL PSYCHIAT, V60, P81, DOI 10.1016/j.biopsych.2006.06.002; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Turner JA, 2006, NEUROINFORMATICS, V4, P21, DOI 10.1385/NI:4:1:21; Verdoux Helene, 2004, Curr Psychiatry Rep, V6, P162, DOI 10.1007/s11920-004-0060-6; Yolken RH, 2000, BRAIN RES REV, V31, P193, DOI 10.1016/S0165-0173(99)00037-5	122	503	531	1	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					139	153		10.1016/j.neuron.2006.09.015	http://dx.doi.org/10.1016/j.neuron.2006.09.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	096WS	17015232	Bronze			2022-12-17	WOS:000241408100010
J	Dakin, S; Frith, U				Dakin, S; Frith, U			Vagaries of visual perception in autism	NEURON			English	Review							BIOLOGICAL MOTION PERCEPTION; HIGH-FUNCTIONING PERSONS; RECEPTIVE-FIELDS; EYE GAZE; CHILDREN; INTEGRATION; INDIVIDUALS; STIMULI; INFORMATION; SENSITIVITY	Three classes of perceptual phenomena have repeatedly been associated with autism spectrum disorder (ASD): superior processing of fine detail (local structure), either inferior processing of overall/global structure or an ability to ignore disruptive global/contextual information, and impaired motion perception. This review evaluates the quality of the evidence bearing on these three phenomena. We argue that while superior local processing has been robustly demonstrated, conclusions about global processing cannot be definitively drawn from the experiments to date, which have generally not precluded observers using more local cues. Perception of moving stimuli is impaired in ASD, but explanations in terms of magnocellular/dorsal deficits do not appear to be sufficient. We suggest that abnormalities in the superior temporal sulcus (STS) may provide a neural basis for the range of motion-processing deficits observed in ASD, including biological motion perception. Such an explanation may also provide a link between perceptual abnormalities and specific deficits in social cognition associated with autism.	UCL, Inst Ophthalmol, London EC1V 9EL, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Dakin, S (corresponding author), UCL, Inst Ophthalmol, Bath St, London EC1V 9EL, England.	s.dakin@ucl.ac.uk	Dakin, Steven C/B-7610-2008; Frith, Uta/C-1757-2008	Dakin, Steven C/0000-0002-3548-9104; Frith, Uta/0000-0002-9063-4466				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Allen HA, 2000, VISION RES, V40, P735, DOI 10.1016/S0042-6989(99)00223-0; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; BADCOCK JC, 1990, PERCEPTION, V19, P617, DOI 10.1068/p190617; Barlow H, 1997, J NEUROSCI, V17, P7954; Bartlett F. C., 1932, REMEMBERING STUDY EX; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Bertone A, 2003, J COGNITIVE NEUROSCI, V15, P218, DOI 10.1162/089892903321208150; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Brosnan MJ, 2004, J CHILD PSYCHOL PSYC, V45, P459, DOI 10.1111/j.1469-7610.2004.00237.x; BURACK JA, 1994, J ABNORM PSYCHOL, V103, P535, DOI 10.1037/0021-843X.103.3.535; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Dakin SC, 2005, VISION RES, V45, P3027, DOI 10.1016/j.visres.2005.07.037; Derrington AM, 2004, ANNU REV PSYCHOL, V55, P181, DOI 10.1146/annurev.psych.55.090902.141903; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Foxton JM, 2003, BRAIN, V126, P2703, DOI 10.1093/brain/awg274; FRITH U, 1993, SCI AM, V268, P108, DOI 10.1038/scientificamerican0693-108; Frith U., 1989, AUTISM EXPLAINING EN; Gepner B, 2002, TRENDS COGN SCI, V6, P455, DOI 10.1016/S1364-6613(02)02004-1; Gepner B, 2002, J AUTISM DEV DISORD, V32, P231, DOI 10.1023/A:1015410015859; GEPNER B, 1995, NEUROREPORT, V6, P1211, DOI 10.1097/00001756-199505300-00034; Gerland G., 1997, REAL PERSON LIFE OUT; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grandin T., 1986, EMERGENCE LABELED AU; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; HAPPE F, 2006, IN PRESS J AUTISM DE; Happe FGE, 1996, J CHILD PSYCHOL PSYC, V37, P873, DOI 10.1111/j.1469-7610.1996.tb01483.x; Heaton P, 1998, MUSIC PERCEPT, V15, P291; Heaton P, 2003, J CHILD PSYCHOL PSYC, V44, P543, DOI 10.1111/1469-7610.00143; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jarrold C, 2005, DEVELOPMENTAL SCI, V8, P344, DOI 10.1111/j.1467-7687.2005.00422.x; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; LAGASSE LL, 1993, PERCEPT PSYCHOPHYS, V53, P89, DOI 10.3758/BF03211718; Leekam SR, 1998, J CHILD PSYCHOL PSYC, V39, P951, DOI 10.1111/1469-7610.00398; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MERIGAN WH, 1991, J NEUROSCI, V11, P3422; Michels L, 2005, NEUROREPORT, V16, P1037, DOI 10.1097/00001756-200507130-00002; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; MOORE DG, 1992, BR J DEV PSYCHOL, V15, P401; Motter BC, 2002, J VISION, V2, p274a, DOI DOI 10.1167/2.7.274; Mottron L, 2000, J CHILD PSYCHOL PSYC, V41, P1057, DOI 10.1017/S0021963099006253; Mottron L, 1999, J CHILD PSYCHOL PSYC, V40, P203, DOI 10.1111/1469-7610.00433; Mottron L, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P131; Mottron L, 2003, J CHILD PSYCHOL PSYC, V44, P904, DOI 10.1111/1469-7610.00174; MOTTRON L, 1993, BRAIN COGNITION, V23, P279, DOI 10.1006/brcg.1993.1060; Mottron L, 1999, J CHILD PSYCHOL PSYC, V40, P743, DOI 10.1111/1469-7610.00490; MOTTRON L, 2006, IN PRESS J AUTISM DE; NAVON D, 1976, J EXP PSYCHOL HUMAN, V2, P130, DOI 10.1037/0096-1523.2.1.130; NEWSOME WT, 1986, J NEUROPHYSIOL, V55, P1340, DOI 10.1152/jn.1986.55.6.1340; NISHIDA S, 1995, VISION RES, V35, P477, DOI 10.1016/0042-6989(94)00144-B; NISHIDA S, 1992, VISION RES, V32, P1635, DOI 10.1016/0042-6989(92)90156-D; Noguchi Y, 2005, CEREB CORTEX, V15, P1592, DOI 10.1093/cercor/bhi037; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; O'Riordan MA, 2004, AUTISM, V8, P229, DOI 10.1177/1362361304045219; OZONOFF S, 1994, J CHILD PSYCHOL PSYC, V35, P1015, DOI 10.1111/j.1469-7610.1994.tb01807.x; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P765, DOI 10.1017/S0021963098002601; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Polyak S. L., 1941, RETINA-J RET VIT DIS; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rinehart NJ, 2000, J CHILD PSYCHOL PSYC, V41, P769, DOI 10.1017/S002196309900596X; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Ropar D, 1999, J CHILD PSYCHOL PSYC, V40, P1283, DOI 10.1017/S0021963099004667; Ropar D, 2001, J CHILD PSYCHOL PSYC, V42, P539, DOI 10.1017/S002196300100717X; SEKULER AB, 1994, PERCEPTION, V23, P529, DOI 10.1068/p230529; Servos P, 2002, CEREB CORTEX, V12, P772, DOI 10.1093/cercor/12.7.772; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; SPENCER M, 1984, NATURE, V309, P404, DOI 10.1038/309404b0; Stuart GW, 2001, VISION RES, V41, P3205, DOI 10.1016/S0042-6989(01)00176-6; Talcott JB, 2000, NEUROPSYCHOLOGIA, V38, P935, DOI 10.1016/S0028-3932(00)00020-8; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Waiter GD, 2004, NEUROIMAGE, V22, P619, DOI 10.1016/j.neuroimage.2004.02.029; WATT RJ, 1987, J OPT SOC AM A, V4, P2006, DOI 10.1364/JOSAA.4.002006; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386	96	503	507	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					497	507		10.1016/j.neuron.2005.10.018	http://dx.doi.org/10.1016/j.neuron.2005.10.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	983RP	16269366	Bronze			2022-12-17	WOS:000233250100010
J	Peigneux, P; Laureys, S; Fuchs, S; Collette, F; Perrin, F; Reggers, J; Phillips, C; Degueldre, C; Del Fiore, G; Aerts, J; Luxen, A; Maquet, P				Peigneux, P; Laureys, S; Fuchs, S; Collette, F; Perrin, F; Reggers, J; Phillips, C; Degueldre, C; Del Fiore, G; Aerts, J; Luxen, A; Maquet, P			Are spatial memories strengthened in the human hippocampus during slow wave sleep?	NEURON			English	Article							LATE NOCTURNAL SLEEP; CEREBRAL-BLOOD-FLOW; EYE-MOVEMENT SLEEP; DECLARATIVE MEMORY; SUBSEQUENT SLEEP; REM-SLEEP; EXPERIENCE; SYSTEMS; REACTIVATION; BRAIN	In rats, the firing sequences observed in hippocampal ensembles during spatial learning are replayed during subsequent sleep, suggesting a role for posttraining sleep periods in the offline processing of spatial memories. Here, using regional cerebral blood flow measurements, we show that, in humans, hippocampal areas that are activated during route learning in a virtual town are likewise activated during subsequent slow wave sleep. Most importantly, we found that the amount of hippocampal activity expressed during slow wave sleep positively correlates with the improvement of performance in route retrieval on the next day. These findings suggest that learning-dependent modulation in hippocampal activity during human sleep reflects the offline processing of recent episodic and spatial memory traces, which eventually leads to the plastic changes underlying the subsequent improvement in performance.	Univ Liege, Cyclotron Res Ctr, B-4000 Cointe Ougree, Belgium; Univ Liege, Neuropsychol Unit, Fac Psychol & Sci Educ, B-4000 Liege, Belgium; Univ Liege, Ctr Hosp Univ, Dept Neurol, B-4000 Cointe Ougree, Belgium	University of Liege; University of Liege; University of Liege	Peigneux, P (corresponding author), Univ Liege, Cyclotron Res Ctr, B-4000 Cointe Ougree, Belgium.	philippe.peigneux@ulg.ac.be	Laureys, Steven/A-3349-2011; luxen, andre/C-2116-2009; Laureys, Steven/AAN-2097-2021; Phillips, Christophe/M-3025-2017	Laureys, Steven/0000-0002-3096-3807; , Pierre/0000-0003-3106-3357; , Fabien/0000-0002-1444-3414; Phillips, Christophe/0000-0002-4990-425X; Peigneux, Philippe/0000-0003-4745-1434				Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; BRETT M, 1999, NEUROIMAGE, V9, pS56; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; FOGEL S, 2001, ACTAS FISIOLOGIA, V7, P123; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; Hofle N, 1997, J NEUROSCI, V17, P4800; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; KRUEGER JM, 1995, BEHAV BRAIN RES, V69, P177, DOI 10.1016/0166-4328(95)00015-L; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 2001, NEUROIMAGE, V13, P743, DOI 10.1006/nimg.2000.0712; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2000, J SLEEP RES, V9, P207; Maquet P., 2003, SLEEP BRAIN PLASTICI; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nofzinger EA, 1997, BRAIN RES, V770, P192, DOI 10.1016/S0006-8993(97)00807-X; Nofzinger EA, 2002, BRAIN, V125, P1105, DOI 10.1093/brain/awf103; OKEEFE J, 1978, HIPPOCAMPUS COGNIIVE; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Plihal W, 1999, PSYCHONEUROENDOCRINO, V24, P313, DOI 10.1016/S0306-4530(98)00080-8; QIN YL, 1999, HIPPOCAMPAL PARIETAL, P305; Rauch SL, 1995, HUM BRAIN MAPP, V3, P271, DOI 10.1002/hbm.460030403; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; RIBEIRO S, 2004, LONG LASTING NOVELTY; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shelton AL, 2002, J NEUROSCI, V22, P2711, DOI 10.1523/JNEUROSCI.22-07-02711.2002; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Staba RJ, 2002, HIPPOCAMPUS, V12, P724, DOI 10.1002/hipo.10026; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; TULVING E, 1987, HUM NEUROBIOL, V6, P67; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	63	503	510	2	78	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 28	2004	44	3					535	545		10.1016/j.neuron.2004.10.007	http://dx.doi.org/10.1016/j.neuron.2004.10.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504332	Bronze, Green Submitted			2022-12-17	WOS:000224771700014
J	MCMAHON, SB; ARMANINI, MP; LING, LH; PHILLIPS, HS				MCMAHON, SB; ARMANINI, MP; LING, LH; PHILLIPS, HS			EXPRESSION AND COEXPRESSION OF TRK RECEPTORS IN SUBPOPULATIONS OF ADULT PRIMARY SENSORY NEURONS PROJECTING TO IDENTIFIED PERIPHERAL TARGETS	NEURON			English	Article							NERVE GROWTH-FACTOR; RETROGRADE AXONAL-TRANSPORT; AFFINITY NGF RECEPTOR; ROOT GANGLION NEURONS; NEUROTROPHIC FACTOR; MESSENGER-RNA; DISTINCT PATTERNS; TYROSINE KINASE; FACTOR FAMILY; RAT TRKC	To determine whether neurotrophins act on functionally distinct populations of adult sensory neurons, the distributions of mRNAs for TrkA and tyrosine kinase-containing isoforms of TrkB and TrkC were determined in rat DRG neurons projecting to different peripheral targets. Whereas trkA was expressed by a very high percentage of visceral afferents, trkC was expressed frequently only in muscle afferents. Among cutaneous afferents, the size distributions for trkA- and trkC-positive cells showed little overlap. The percentages and size distributions of cells labeled for the trks argue strongly that almost all trks-expressing cells must also express trkA or trkC. These results indicate that NGF and NT-3 act on functionally distinct populations of adult sensory neurons and suggest that a sizeable number of small DRG neurons may not respond to neurotrophins via a known Trk in the adult rat.	GENENTECH INC,DEPT NEUROSCI,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech	MCMAHON, SB (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,DEPT PHYSIOL,LAMBETH PALACE RD,LONDON SE1 7EH,ENGLAND.			McMahon, Stephen/0000-0003-4656-5536				BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; CSILLIK B, 1985, BRAIN RES, V331, P11, DOI 10.1016/0006-8993(85)90709-7; DAVIES A, 1985, DEV BIOL, V11, P62; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1987, NEUROSCIENCE, V20, P37, DOI 10.1016/0306-4522(87)90004-2; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; DONNERER J, 1992, NEUROSCIENCE, V49, P693, DOI 10.1016/0306-4522(92)90237-V; EIDE FF, 1993, EXP NEUROL, V121, P200, DOI 10.1006/exnr.1993.1087; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; GOEDERT M, 1981, P NATL ACAD SCI-BIOL, V78, P5895, DOI 10.1073/pnas.78.9.5895; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HOHN A, 1990, NATURE, V344, P3339; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; HUNT SP, 1992, SENSORY NEURONS DIVE, P60; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KLEIN R, 1994, IN PRESS NATURE; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MCMAHOON SB, 1992, SENSORY NEURONS DENS; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MU XJ, 1993, J NEUROSCI, V13, P4029; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PRIESTLEY JV, 1992, MICROSC ANAL, V32, P15; RAFFIONI S, 1993, ANNU REV BIOCHEM, V62, P823; ROSE RD, 1987, J COMP NEUROL, V263, P365, DOI 10.1002/cne.902630305; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P259, DOI 10.3109/07367228809144630; SMEYNE RJ, 1994, IN PRESS NATURE; TORRENS M, 1987, PHYSL LOWER URINARY; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VERGE VMK, 1989, J NEUROCYTOL, V18, P583, DOI 10.1007/BF01187079; VERGE VMK, 1992, J NEUROSCI, V12, P4011; Willis WD, 1991, SENSORY MECH SPINAL	53	503	507	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1161	1171		10.1016/0896-6273(94)90323-9	http://dx.doi.org/10.1016/0896-6273(94)90323-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	7514427				2022-12-17	WOS:A1994NM83100019
J	Frohlich, F; McCormick, DA				Froehlich, Flavio; McCormick, David A.			Endogenous Electric Fields May Guide Neocortical Network Activity	NEURON			English	Article							SINGLE NEURON ACTIVITY; RECURRENT ACTIVITY; SLOW OSCILLATIONS; PYRAMIDAL CELLS; WORKING-MEMORY; LESS-THAN-1 HZ; IN-VIVO; SYNCHRONIZATION; HIPPOCAMPAL; POTENTIALS	Local field potentials and the underlying endogenous electric fields (EFs) are traditionally considered to be epiphenomena of structured neuronal network activity. Recently, however, externally applied EFs have been shown to modulate pharmacologically evoked network activity in rodent hippocampus. In contrast, very little is known about the role of endogenous EFs during physiological activity states in neocortex. Here, we used the neocortical slow oscillation in vitro as a model system to show that weak sinusoidal and naturalistic EFs enhance and entrain physiological neocortical network activity with an amplitude threshold within the range of in vivo endogenous field strengths. Modulation of network activity by positive and negative feedback fields based on the network activity in real-time provide direct evidence for a feedback loop between neuronal activity and endogenous EF. This significant susceptibility of active networks to EFs that only cause small changes in membrane potential in individual neurons suggests that endogenous EFs could guide neocortical network activity.	[Froehlich, Flavio; McCormick, David A.] Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, 333 Cedar St, New Haven, CT 06510 USA.	david.mccormick@yale.edu	Frohlich, Flavio/C-9851-2009; Frohlich, Flavio/P-6429-2017	Frohlich, Flavio/0000-0002-3724-5621	National Institutes of Health; Swartz Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health. F.F. was funded by the Swartz Foundation. We thank Kristy Sundberg for her help with the in vivo experiments and her valuable input on earlier versions of this manuscript. We thank Carlos Maureira for input on an early version of this manuscript and Tatiana Engel for helpful discussions.	AMZICA F, 1995, J NEUROSCI, V15, P4658; Anastassiou CA, 2010, J NEUROSCI, V30, P1925, DOI 10.1523/JNEUROSCI.3635-09.2010; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Buzsaki G., 2006, RHYTHMS BRAIN; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dudek F E, 1986, Adv Neurol, V44, P593; FABER DS, 1989, PHYSIOL REV, V69, P821, DOI 10.1152/physrev.1989.69.3.821; Francis JT, 2003, J NEUROSCI, V23, P7255; Freeman WJ, 1975, MASS ACTION NERVOUS; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Fujisawa S, 2004, J PHYSIOL-LONDON, V561, P123, DOI 10.1113/jphysiol.2004.066639; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Grenier F, 2003, NEUROSCIENCE, V119, P277, DOI 10.1016/S0306-4522(03)00101-5; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hoffman KL, 2007, J NEUROSCI, V27, P11838, DOI 10.1523/JNEUROSCI.3501-07.2007; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Nunez P.L., 2006, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Peters A, 1996, J COMP NEUROL, V365, P232; Peters A, 1997, CEREB CORTEX, V7, P405, DOI 10.1093/cercor/7.5.405; Pikovsky A., 2001, UNIVERSAL CONCEPT NO, V12; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Rattay F, 1998, IEEE T BIO-MED ENG, V45, P766, DOI 10.1109/10.678611; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Shu YS, 2003, J NEUROSCI, V23, P10388; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SNOW RW, 1984, BRAIN RES, V323, P114, DOI 10.1016/0006-8993(84)90271-3; Spinks RL, 2008, J NEUROSCI, V28, P10961, DOI 10.1523/JNEUROSCI.1956-08.2008; Steriade M, 1996, P NATL ACAD SCI USA, V93, P2533, DOI 10.1073/pnas.93.6.2533; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Svirskis G, 1997, BIOPHYS J, V73, P3004, DOI 10.1016/S0006-3495(97)78329-2; Taylor R., 2005, ASIAN BUSINESS MANAG, V4, P5, DOI [10.1057/palgrave.abm.9200116, DOI 10.1057/PALGRAVE.ABM.9200116]; TRANCHINA D, 1986, BIOPHYS J, V50, P1139, DOI 10.1016/S0006-3495(86)83558-5; Vigmond EJ, 1997, J NEUROPHYSIOL, V78, P3107, DOI 10.1152/jn.1997.78.6.3107; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103	59	502	521	4	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					129	143		10.1016/j.neuron.2010.06.005	http://dx.doi.org/10.1016/j.neuron.2010.06.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624597	Bronze, Green Accepted			2022-12-17	WOS:000280221000014
J	Critchley, HD; Mathias, CJ; Dolan, RJ				Critchley, HD; Mathias, CJ; Dolan, RJ			Neural activity in the human brain relating to uncertainty and arousal during anticipation	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; WORKING-MEMORY; ELECTRODERMAL ACTIVITY; HUMAN AMYGDALA; RESPONSES; PERFORMANCE; NEURONS; DAMAGE	We used functional magnetic resonance neuroimaging to measure brain activity during delay between reward-related decisions and their outcomes, and the modulation of this delay activity by uncertainty and arousal. Feedback, indicating financial gain or loss, was given following a fixed delay. Anticipatory arousal was indexed by galvanic skin conductance. Delay-period activity was associated with bilateral activation in orbital and medial prefrontal, temporal, and right parietal cortices. During delay, activity in anterior cingulate and orbitofrontal cortices was modulated by outcome uncertainty, whereas anterior cingulate, dorsolateral prefrontal, and parietal cortices activity was modulated by degree of anticipatory arousal. A distinct region of anterior cingulate was commonly activated by both uncertainty and arousal. Our findings highlight distinct contributions of cognitive uncertainty and autonomic arousal to anticipatory neural activity in prefrontal cortex.	UCL, Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, Autonom Unit, London WC1N 3BG, England; St Marys Hosp, Imperial Coll Sch Med, Neurovasc Med Unit, London W2 1NY, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Imperial College London	Critchley, HD (corresponding author), UCL, Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	h.critchley@fil.ion.ucl.ac.uk	critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bouscein W., 1992, ELECTRODERMAL ACTIVI; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAMASIO AR, 1994, DESCARTES ERROR; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fredrikson M, 1998, PSYCHOPHYSIOLOGY, V35, P179; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13435, DOI 10.1073/pnas.93.24.13435; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Talairach J., 1988, COPLANAR STEREOTAXIC; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; TRANEL D, 2000, SER AFFECTIVE SCI, P192; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zahn TP, 1999, NEUROPSYCHOLOGIA, V37, P1227, DOI 10.1016/S0028-3932(99)00020-2	53	501	504	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					537	545		10.1016/S0896-6273(01)00225-2	http://dx.doi.org/10.1016/S0896-6273(01)00225-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405DD	11239442	Bronze			2022-12-17	WOS:000167141700025
J	Neumann, S; Woolf, CJ				Neumann, S; Woolf, CJ			Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury	NEURON			English	Article							ROOT GANGLION NEURONS; PERIPHERAL-NERVE AUTOGRAFTS; NEURITE GROWTH-INHIBITORS; MESSENGER-RNA EXPRESSION; PRIMARY SENSORY NEURONS; AXONAL REGENERATION; CORTICOSPINAL TRACT; GAP-43 EXPRESSION; SCHWANN-CELLS; RAT	Regeneration is abortive following adult mammalian CNS injury. We have investigated whether increasing the intrinsic growth state of primary sensory neurons by a conditioning peripheral nerve lesion increases regrowth of their central axons. After dorsal column lesions, ail fibers stop at the injury site. Animals with a peripheral axotomy concomitant with the central lesion show axonal growth into the lesion but not into the spinal cord above the lesion. A preconditioning lesion 1 or 2 weeks prior to the dorsal column injury results in growth into the spinal cord above the lesion. In vitro, the growth capacity of DRG neurite is also increased following preconditioning lesions. The intrinsic growth state of injured neurons is, therefore, a key determinant for central regeneration.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp E, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.		Woolf, Clifford/A-9784-2010					AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; BENFEY M, 1985, J NEUROCYTOL, V14, P279, DOI 10.1007/BF01258453; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cajal S., 1991, DEGENERATION REGENER; CAMPBELL G, 1992, J NEUROCYTOL, V21, P755, DOI 10.1007/BF01237903; Chong MS, 1996, J COMP NEUROL, V370, P97, DOI 10.1002/(SICI)1096-9861(19960617)370:1<97::AID-CNE9>3.0.CO;2-G; CHONG MS, 1994, J NEUROSCI, V14, P4375; Coggeshall RE, 1997, NEUROSCIENCE, V77, P1115, DOI 10.1016/S0306-4522(96)00528-3; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DAVIES SJA, 1994, J NEUROSCI, V14, P1596, DOI 10.1523/JNEUROSCI.14-03-01596.1994; Edstrom A, 1996, NEUROSCIENCE, V75, P1165, DOI 10.1016/0306-4522(96)00324-7; HUTSAI M, 1994, J NEUROSCI RES, V39, P634, DOI 10.1002/jnr.490390603; IWASHITA Y, 1994, NATURE, V367, P167, DOI 10.1038/367167a0; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; KLEITMAN N, 1988, EXP NEUROL, V102, P298, DOI 10.1016/0014-4886(88)90223-3; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; LI Y, 1994, J NEUROSCI, V14, P4050; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; PINDZOLA RR, 1993, DEV BIOL, V156, P34, DOI 10.1006/dbio.1993.1057; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1982, BRAIN RES, V237, P147, DOI 10.1016/0006-8993(82)90563-7; RICHARDSON PM, 1987, BRAIN RES, V411, P406, DOI 10.1016/0006-8993(87)91096-1; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHREYER DJ, 1991, J NEUROSCI, V11, P3738; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SMITH DS, 1997, J NEUROSCI, V17, P343; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; WOOLF CJ, 1995, J COMP NEUROL, V360, P121, DOI 10.1002/cne.903600109; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202	39	501	517	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					83	91		10.1016/S0896-6273(00)80755-2	http://dx.doi.org/10.1016/S0896-6273(00)80755-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402195	Bronze			2022-12-17	WOS:000080681200012
J	CHANG, CP; PEARSE, RV; OCONNELL, S; ROSENFELD, MG				CHANG, CP; PEARSE, RV; OCONNELL, S; ROSENFELD, MG			IDENTIFICATION OF A 7 TRANSMEMBRANE HELIX RECEPTOR FOR CORTICOTROPIN-RELEASING FACTOR AND SAUVAGINE IN MAMMALIAN BRAIN	NEURON			English	Article							ADENYLATE-CYCLASE ACTIVITY; ANTERIOR-PITUITARY CELLS; FACTOR CRF RECEPTORS; CALCITONIN GENE; FACTOR-BINDING; MESSENGER-RNA; UROTENSIN-I; CYCLIC-AMP; G-PROTEIN; AUTORADIOGRAPHIC LOCALIZATION	We have identified and characterized cDNAs encoding a novel receptor that is a member of a distinct class of seven transmembrane helix, G(s)-coupled receptors. This receptor mediates ligand-dependent stimulation of intracellular cAMP levels in response to physiologic concentrations of corticotropin-releasing factor (CRF) and to the related frog skin peptide, sauvagine. The pattern of CRF receptor mRNA expression in the brain, pituitary gland, and other organs corresponds precisely to that predicted for the classic CRF receptor, suggesting that this receptor serves to mediate the known biological effects of CRF on behavior, stress, and homeostasis. Alternative splicing events generate a second, relatively abundant gene product expressed in a distinct ontogenic pattern. These findings serve to identify the receptor for an important neuropeptide.	UNIV CALIF SAN DIEGO, GRAD PROGRAM BIOMED, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego	CHANG, CP (corresponding author), UNIV CALIF SAN DIEGO, SCH MED, HOWARD HUGHES MED INST, DEPT MED, EUKARYOT REGULATORY BIOL PROGRAM, LA JOLLA, CA 92093 USA.			Pearse, Richard/0000-0003-3972-1457	NIMH NIH HHS [NIMH MH47137] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aguilera G, 1988, Adv Exp Med Biol, V245, P83; AGUILERA G, 1987, ANN NY ACAD SCI, V512, P48; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; BARINAGA M, 1983, NATURE, V306, P84, DOI 10.1038/306084a0; BATTAGLIA G, 1987, SYNAPSE, V1, P572, DOI 10.1002/syn.890010610; BILEZIKJIAN LM, 1983, ENDOCRINOLOGY, V113, P1726, DOI 10.1210/endo-113-5-1726; BRITTON DR, 1984, BRAIN RES, V304, P201, DOI 10.1016/0006-8993(84)90322-6; BROWN MR, 1982, REGUL PEPTIDES, V4, P107, DOI 10.1016/0167-0115(82)90101-X; CHEN FM, 1986, BRAIN RES, V381, P49; CHENG TC, 1983, ENDOCRINOLOGY, V113, P1669, DOI 10.1210/endo-113-5-1669; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLINS S, 1992, TRENDS BIOCHEM SCI, V17, P37, DOI 10.1016/0968-0004(92)90425-9; De Souza E B, 1986, Methods Enzymol, V124, P560; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; EMESON RB, 1989, NATURE, V341, P76, DOI 10.1038/341076a0; FROHMAN MA, 1989, MOL ENDOCRINOL, V3, P1529, DOI 10.1210/mend-3-10-1529; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; GIGUERE V, 1982, P NATL ACAD SCI-BIOL, V79, P3466, DOI 10.1073/pnas.79.11.3466; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; GRIGORIADIS DE, 1989, PEPTIDES, V10, P179, DOI 10.1016/0196-9781(89)90095-8; GRIGORIADIS DE, 1989, ENDOCRINOLOGY, V125, P1877, DOI 10.1210/endo-125-4-1877; GUILLEMIN R, 1955, ENDOCRINOLOGY, V57, P599, DOI 10.1210/endo-57-5-599; HEN R, 1989, P NATL ACAD SCI USA, V86, P4785, DOI 10.1073/pnas.86.12.4785; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JANSSOJN JO, 1986, SCIENCE, V232, P415; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KOOB GF, 1993, CIBA F SYMP, V172, P277; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEDERIS K, 1983, CAN J BIOCHEM CELL B, V61, P602, DOI 10.1139/o83-076; LEVINE MA, 1988, P NATL ACAD SCI USA, V85, P617, DOI 10.1073/pnas.85.2.617; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V18, P113; NISHIMURA E, 1987, J BIOL CHEM, V262, P12893; OKAWARA Y, 1988, P NATL ACAD SCI USA, V85, P8439, DOI 10.1073/pnas.85.22.8439; OWENS MJ, 1993, CIBA F SYMP, V172, P296; PERRIN MH, 1986, ENDOCRINOLOGY, V118, P1171, DOI 10.1210/endo-118-3-1171; POTTER E, 1991, NATURE, V349, P423, DOI 10.1038/349423a0; POTTER E, 1992, P NATL ACAD SCI USA, V89, P4192, DOI 10.1073/pnas.89.9.4192; RIVIER C, 1983, REGUL PEPTIDES, V5, P139, DOI 10.1016/0167-0115(83)90121-0; ROGER PP, 1983, FEBS LETT, V157, P323, DOI 10.1016/0014-5793(83)80569-9; ROSENDALE BE, 1987, ENDOCRINOLOGY, V120, P2357, DOI 10.1210/endo-120-6-2357; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; SAFFRAN M, 1955, CAN J BIOCHEM PHYS, V33, P408; Sambrook J., 1989, MOL CLONING LAB MANU; SAWCHENKO PE, 1993, CIBA F SYMP, V172, P5; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; STANGL D, 1991, BIOCHEMISTRY-US, V30, P8605, DOI 10.1021/bi00099a016; STENZELPOORE MP, 1992, MOL ENDOCRINOL, V6, P1716, DOI 10.1210/me.6.10.1716; THOMPSON RC, 1987, MOL ENDOCRINOL, V1, P363, DOI 10.1210/mend-1-5-363; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; TSANG BK, 1980, J CELL PHYSIOL, V102, P19, DOI 10.1002/jcp.1041020104; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; WEBSTER EL, 1988, ENDOCRINOLOGY, V122, P609, DOI 10.1210/endo-122-2-609; WEBSTER EL, 1989, PEPTIDES, V10, P395, DOI 10.1016/0196-9781(89)90049-1; WEBSTER EL, 1991, STRESS NEUROPEPTIDES, P223; WEI ET, 1993, CIBA F SYMP, V172, P258; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; WIMALAWANSA SJ, 1992, ANN NY ACAD SCI, V657, P70, DOI 10.1111/j.1749-6632.1992.tb22758.x	66	501	512	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1187	1195		10.1016/0896-6273(93)90230-O	http://dx.doi.org/10.1016/0896-6273(93)90230-O			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274282				2022-12-17	WOS:A1993MP54800018
J	Kordasiewicz, HB; Stanek, LM; Wancewicz, EV; Mazur, C; McAlonis, MM; Pytel, KA; Artates, JW; Weiss, A; Cheng, SH; Shihabuddin, LS; Hung, G; Bennett, CF; Cleveland, DW				Kordasiewicz, Holly B.; Stanek, Lisa M.; Wancewicz, Edward V.; Mazur, Curt; McAlonis, Melissa M.; Pytel, Kimberly A.; Artates, Jonathan W.; Weiss, Andreas; Cheng, Seng H.; Shihabuddin, Lamya S.; Hung, Gene; Bennett, C. Frank; Cleveland, Don W.			Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis	NEURON			English	Article							CONDITIONAL MOUSE MODEL; EXPANDED CAG REPEAT; MUTANT HUNTINGTIN; ANTISENSE OLIGONUCLEOTIDES; MOLECULAR-MECHANISMS; EMBRYONIC LETHALITY; TRANSGENIC MICE; CEREBRAL-CORTEX; WHITE-MATTER; GENE	The primary cause of Huntington's disease (HD) is expression of huntingtin with a polyglutamine expansion. Despite an absence of consensus on the mechanism(s) of toxicity, diminishing the synthesis of mutant huntingtin will abate toxicity if delivered to the key affected cells. With antisense oligonucleotides (ASOs) that catalyze RNase H-mediated degradation of huntingtin mRNA, we demonstrate that transient infusion into the cerebrospinal fluid of symptomatic HD mouse models not only delays disease progression but mediates a sustained reversal of disease phenotype that persists longer than the huntingtin knockdown. Reduction of wildtype huntingtin, along with mutant huntingtin, produces the same sustained disease reversal. Similar ASO infusion into nonhuman primates is shown to effectively lower huntingtin in many brain regions targeted by HD pathology. Rather than requiring continuous treatment, our findings establish a therapeutic strategy for sustained HD disease reversal produced by transient ASO-mediated diminution of huntingtin synthesis.	[Kordasiewicz, Holly B.; McAlonis, Melissa M.; Pytel, Kimberly A.; Artates, Jonathan W.; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Kordasiewicz, Holly B.; McAlonis, Melissa M.; Pytel, Kimberly A.; Artates, Jonathan W.; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Stanek, Lisa M.; Cheng, Seng H.; Shihabuddin, Lamya S.] Genzyme Corp, Framingham, MA 01760 USA; [Wancewicz, Edward V.; Mazur, Curt; Hung, Gene; Bennett, C. Frank] Isis Pharmaceut, Carlsbad, CA 92010 USA; [Weiss, Andreas] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanofi-Aventis; Genzyme Corporation; Isis Pharmaceuticals Inc; Novartis	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Cheng, Seng H/AAC-6564-2022	Cleveland, Don/0000-0002-1934-3682	CHDI Inc.; Giannini Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	CHDI Inc.; Giannini Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Yang (University of California, Los Angeles) for the BACHD animal model and his technical support. We also thank G. Bates (Kings College London) for the R6/2 model and her technical support. We would like to thank S. Freier, A. Watt, and A. Salim (Isis Pharmaceuticals) for identification of the huntingtin ASOs and J. Matson for bioanalytical support on the mouse and monkey tissues. We thank J. Boubaker for her technical support. We thank R. Smith and D. Macdonald for their thoughtful discussions. H.B.K., E.V.W., C.M., G.H., and C.F.B. are employees of Isis Pharmaceuticals. L.M.S., S.H.C., and L.S.S. are employees of Genzyme Coropration. A.W. is an employee of Novartis Pharma AG. D.W.C. is a consultant to Isis Pharmaceuticals. This work was supported in part by CHDI Inc. and H.B.K. was supported by a postdoctoral fellowship from the Giannini Foundation.	Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Brooks Elizabeth, 2004, V277, P103; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Cheruvallath ZS, 2003, NUCLEOS NUCLEOT NUCL, V22, P461, DOI 10.1081/NCN-120022050; Crooke ST, 1999, BBA-GENE STRUCT EXPR, V1489, P31, DOI 10.1016/S0167-4781(99)00148-7; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Denovan-Wright EM, 2008, NEUROBIOL DIS, V29, P446, DOI 10.1016/j.nbd.2007.11.003; Diaz-Hernandez M, 2005, J NEUROSCI, V25, P9773, DOI 10.1523/JNEUROSCI.3183-05.2005; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Henry S P, 2001, Curr Opin Investig Drugs, V2, P1444; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Liu WZ, 2008, NAT METHODS, V5, P951, DOI 10.1038/nmeth.1261; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Machida Y, 2006, BIOCHEM BIOPH RES CO, V343, P190, DOI 10.1016/j.bbrc.2006.02.141; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Melone MAB, 2005, CURR DRUG TARGETS, V6, P43, DOI 10.2174/1389450053344975; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Peters-Libeu C, 2012, J MOL BIOL, V421, P587, DOI 10.1016/j.jmb.2012.01.034; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yu RZ, 2004, J PHARM SCI-US, V93, P48, DOI 10.1002/jps.10473; Yu RZ, 2001, J PHARMACOL EXP THER, V296, P388; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	49	500	534	5	71	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 21	2012	74	6					1031	1044		10.1016/j.neuron.2012.05.009	http://dx.doi.org/10.1016/j.neuron.2012.05.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963YA	22726834	Bronze, Green Accepted			2022-12-17	WOS:000305659700010
J	IP, NY; STITT, TN; TAPLEY, P; KLEIN, R; GLASS, DJ; FANDL, J; GREENE, LA; BARBACID, M; YANCOPOULOS, GD				IP, NY; STITT, TN; TAPLEY, P; KLEIN, R; GLASS, DJ; FANDL, J; GREENE, LA; BARBACID, M; YANCOPOULOS, GD			SIMILARITIES AND DIFFERENCES IN THE WAY NEUROTROPHINS INTERACT WITH THE TRK RECEPTORS IN NEURONAL AND NONNEURONAL CELLS	NEURON			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; AFFINITY NGF RECEPTOR; MOLECULAR-CLONING; GENE-TRANSFER; PHEOCHROMOCYTOMA CELLS; PROTOONCOGENE PRODUCT; FACTOR FAMILY; BRAIN; EXPRESSION	We have exploited a battery of approaches to address several controversies that have accompanied the expansion of the nerve growth factor (NGF) family of neurotrophic factors and the identification of the Trk tyrosine kinases as receptors for these factors. For example, we find that a recently cloned mammalian neurotrophin, known as either neurotrophin-4 or neurotrophin-5 and assigned widely differing receptor specificities, represents the functional counterpart of Xenopus neurotrophin-4 and is a ''preferred'' ligand for TrkB. However, its interactions with TrkB can be distinguished from those of brain-derived neurotrophic factor (BDNF) with TrkB. We also find that all of the Trks display similar dose responses to their ''preferred'' ligands in neuronal as compared with nonneuronal cells (i.e., NGF for TrkA, BDNF and NT-4/5 for TrkB, and NT-3 for TrkC), providing evidence against a role for accessory molecules expressed in neurons in generating receptors that would allow for responses to lower concentrations of the neurotrophins. However, we find that a neuronal environment does restrict the Trks in their ability to respond to their ''nonpreferred'' neurotrophin ligands.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC BIOL,PRINCETON,NJ 08543; COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032	Bristol-Myers Squibb; Columbia University; Columbia University	IP, NY (corresponding author), REGENERON PHARMACEUT INC,777 OLD SAW MILL RIVER RD,TARRYTOWN,NY 10591, USA.		Glass, David/AAI-3910-2021; Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163; Ip, Nancy Yuk-Yu/0000-0002-2763-8907	NINDS NIH HHS [NS16036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BURSTEIN DE, 1982, DEV BIOL, V94, P477, DOI 10.1016/0012-1606(82)90364-5; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOLBOOK F, 1991, NEURON, V6, P845; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JING S, 1992, IN PRESS NEURON; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MA Y, 1992, J CELL BIOL, V117, P135, DOI 10.1083/jcb.117.1.135; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; RUKENSTEIN A, 1983, BRAIN RES, V263, P177, DOI 10.1016/0006-8993(83)91218-0; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E	44	500	513	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					137	149		10.1016/0896-6273(93)90306-C	http://dx.doi.org/10.1016/0896-6273(93)90306-C			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	7679912				2022-12-17	WOS:A1993KP68500003
J	BARGMANN, CI; HORVITZ, HR				BARGMANN, CI; HORVITZ, HR			CHEMOSENSORY NEURONS WITH OVERLAPPING FUNCTIONS DIRECT CHEMOTAXIS TO MULTIPLE CHEMICALS IN C-ELEGANS	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EMBRYONIC CELL LINEAGES; MOTOR NEURONS; NERVOUS-SYSTEM; DAUER LARVA; MUTANTS; IDENTIFICATION; RESPONSES; OUTPUT; INPUT	The functions of the 11 classes of exposed chemosensory neurons of C. elegans were tested by killing cells with a laser microbeam. One pair of neurons, the ASE neurons, is uniquely important for chemotaxis: killing the ASE neurons greatly reduced chemotaxis to cAMP, biotin, Cl-, and Na+. Additional chemosensory function is distributed among several other cell types. Thus, 3 pairs of chemosensory neurons (ADF, ASG, and ASI) contribute to a residual response to cAMP, biotin, Cl-, and Na+ after ASE is killed. Chemotaxis to lysine similarly depends on the partly redundant functions of 4 pairs of chemosensory neurons (ASE, ASG, ASI, and ASK). The combined activity of several neuron types that act in parallel might increase the fidelity of chemotaxis.	MIT,DEPT BIOL,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)				Bargmann, Cornelia/0000-0002-8484-0618	NIGMS NIH HHS [GM24663] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024663, R37GM024663] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ache B.W., 1987, NEUROBIOLOGY TASTE S, P39; ADLER J, 1975, ANNU REV BIOCHEM, V44, P341, DOI 10.1146/annurev.bi.44.070175.002013; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BRENNER S, 1974, GENETICS, V77, P71; BURROWS M, 1987, J NEUROSCI, V7, P1064; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHIEL HJ, 1986, J NEUROSCI, V6, P2427; DESAI C, 1989, GENETICS, V121, P703; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEILIGENBERG W, 1988, BRAIN BEHAV EVOLUT, V31, P6, DOI 10.1159/000116571; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KOSHLAND DE, 1988, BIOCHEMISTRY-US, V27, P5829, DOI 10.1021/bi00416a001; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; LOCKERY SR, 1990, J NEUROSCI, V10, P1811; NUSBAUM MP, 1989, J NEUROSCI, V9, P1591; OKAMOTO H, 1985, J NEUROSCI, V5, P643; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rosner B., 1986, FUNDAMENTALS BIOSTAT, V2nd, P442; SCOTT TR, 1984, CHEM SENSES, V8, P297, DOI 10.1093/chemse/8.3.297; SELVERSTON AI, 1980, J NEUROPHYSIOL, V44, P1102, DOI 10.1152/jn.1980.44.6.1102; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; TRENT C, 1983, GENETICS, V104, P619; Van Houten J., 1981, BIOCH PHYSL PROTOZOA, V4, P67; VANHAASTERT PJM, 1982, EXP CELL RES, V140, P453, DOI 10.1016/0014-4827(82)90139-2; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	48	500	514	3	121	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					729	742		10.1016/0896-6273(91)90276-6	http://dx.doi.org/10.1016/0896-6273(91)90276-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1660283				2022-12-17	WOS:A1991GT93900004
J	Shimojo, H; Ohtsuka, T; Kageyama, R				Shimojo, Hiromi; Ohtsuka, Toshiyuki; Kageyama, Ryoichiro			Oscillations in notch signaling regulate maintenance of neural progenitors	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; LOOP-HELIX FACTORS; STEM-CELLS; NEGATIVE AUTOREGULATION; PRESOMITIC MESODERM; SOMITE SEGMENTATION; MAMMALIAN HAIRY; HES1 EXPRESSION; FEEDBACK LOOP; DELTA-HOMOLOG	Expression of the Notch effector gene Hes1 is required for maintenance of neural progenitors in the embryonic brain, but persistent and high levels of Hes1 expression inhibit proliferation and differentiation of these cells. Here, by using a real-time imaging method, we found that Hes1 expression dynamically oscillates in neural progenitors. Furthermore, sustained overexpression of Hes1 downregulates expression of proneural genes, Notch ligands, and cell cycle regulators, suggesting that their proper expression depends on Hes1 oscillation. Surprisingly, the proneural gene Neurogenin2 (Ngn2) and the Notch ligand Delta-like1 (Dill) are also expressed in an oscillatory manner by neural progenitors, and inhibition of Notch signaling, a condition known to induce neuronal differentiation, leads to downregulation of Hes1 and sustained upregulation of Ngn2 and Dill. These results suggest that Hes1 oscillation regulates Ngn2 and Dill oscillations, which in turn lead to maintenance of neural progenitors by mutual activation of Notch signaling.	[Shimojo, Hiromi; Ohtsuka, Toshiyuki; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Shimojo, Hiromi; Ohtsuka, Toshiyuki; Kageyama, Ryoichiro] CREST, Japan Sci & Technol Agcy, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kageyama, R (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	rkageyam@virus.kyoto-u.ac.jp		Shimojo, Hiromi/0000-0001-5455-4218				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fujita S, 2003, CELL STRUCT FUNCT, V28, P205, DOI 10.1247/csf.28.205; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hartman J, 2004, ONCOGENE, V23, P8826, DOI 10.1038/sj.onc.1208139; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Maruhashi M, 2005, DEV DYNAM, V234, P332, DOI 10.1002/dvdy.20546; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Strom A, 2000, ONCOGENE, V19, P5951, DOI 10.1038/sj.onc.1203990; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	57	498	519	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 10	2008	58	1					52	64		10.1016/j.neuron.2008.02.014	http://dx.doi.org/10.1016/j.neuron.2008.02.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	287WC	18400163	Green Submitted, Bronze			2022-12-17	WOS:000254946200010
J	STEPHENS, RM; LOEB, DM; COPELAND, TD; PAWSON, T; GREENE, LA; KAPLAN, DR				STEPHENS, RM; LOEB, DM; COPELAND, TD; PAWSON, T; GREENE, LA; KAPLAN, DR			TRK RECEPTORS USE REDUNDANT SIGNAL-TRANSDUCTION PATHWAYS INVOLVING SHC AND PLC-GAMMA-1 TO MEDIATE NGF RESPONSES	NEURON			English	Article							NERVE GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHORYLATION; SERINE THREONINE KINASE; PDGF BETA-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; PHOSPHOLIPASE-C; PC12 CELLS; NEUROTROPHIN RECEPTORS	In response to NCF, the Trk receptor tyrosine kinase forms a complex with SHC, a protein that couples receptor tyrosine kinases to p21(ras). Complex formation between Trk and SHC, SHC tyrosine phosphorylation, and association of SHC with Grb2 were mediated by autophosphorylation at Y490 in Trk (NPQYFSD). To determine the role of SHC and other Trk substrates in NGF signaling, Trk receptors with mutations in Y490 and Y785 (the PLC-gamma 1 association site) were introduced into PC12nnr5 cells. NGF treatment of PC12nnr5 cells expressing Trk with mutations in either substrate-binding site resulted in normal neurite outgrowth and Erk1 activity and tyrosine phosphorylation. However, PC12nnr5 cells expressing Trk with mutations at both sites failed to stably extend neurites and efficiently induce Erk1 activity and tyrosine phosphorylation in response to NGF. We postulate that Trk receptors can activate Erk1 by either SHC- or PLC-gamma 1-dependent signaling pathways. These results suggest a model whereby Trk receptors utilize at least partially redundant signal transduction pathways to mediate NGF responses.	COLUMBIA UNIV, DEPT PATHOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON, CANADA	Columbia University; Columbia University; University of Toronto	STEPHENS, RM (corresponding author), NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA.		Pawson, Tony J/E-4578-2013		OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACKER JM, 1992, J BIOL CHEM, V267, P1367; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BIEDLER JL, 1973, CANCER RES, V33, P2643; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DRUKER BJ, 1992, J VIROL, V66, P5770, DOI 10.1128/JVI.66.10.5770-5776.1992; DUCHESNE M, 1993, SCIENCE, V259, P525, DOI 10.1126/science.7678707; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GOMEZ N, 1990, FEBS LETT, V271, P119, DOI 10.1016/0014-5793(90)80386-W; GREEN SH, 1986, J BIOL CHEM, V261, P5316; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; GREENE LA, 1991, CULTURING NERVE CELL, P207; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HEFTI F, 1992, LOCALIZATION FUNCTIO, P25; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.bi.54.070185.004341; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KABURAGI Y, 1994, IN PRESS J BIOL CHEM; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KIM UH, 1991, J BIOL CHEM, V266, P1359; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LI BQ, 1992, SCIENCE, V256, P1456, DOI 10.1126/science.1604323; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; LOEB DM, 1992, NEURON, V9, P1053, DOI 10.1016/0896-6273(92)90065-L; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOEB DM, 1994, IN PRESS J BIOL CHEM; LOEB DM, IN PRESS J NEUROSCI; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MEDEMA RH, 1992, MOL CELL BIOL, V12, P3425, DOI 10.1128/MCB.12.8.3425; MEISENHELDER J, 1992, MOL CELL BIOL, V12, P5843, DOI 10.1128/MCB.12.12.5843; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MITRA G, 1991, ONCOGENE, V6, P2237; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PARK D, 1992, MOL CELL BIOL, V12, P5816, DOI 10.1128/MCB.12.12.5816; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; RAFFIONI S, 1992, P NATL ACAD SCI USA, V89, P9121, DOI 10.1073/pnas.89.19.9121; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SCHANENKING C, 1991, NEURON, V6, P915, DOI 10.1016/0896-6273(91)90232-O; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; SUH PG, 1988, J BIOL CHEM, V263, P14497; Summers MD, 1987, MANUAL METHODS BACUL; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	83	498	523	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1994	12	3					691	705		10.1016/0896-6273(94)90223-2	http://dx.doi.org/10.1016/0896-6273(94)90223-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155326				2022-12-17	WOS:A1994NC76900019
J	SCHECTERSON, LC; BOTHWELL, M				SCHECTERSON, LC; BOTHWELL, M			NOVEL ROLES FOR NEUROTROPHINS ARE SUGGESTED BY BDNF AND NT-3 MESSENGER-RNA EXPRESSION IN DEVELOPING NEURONS	NEURON			English	Article							NERVE GROWTH-FACTOR; SPINAL-CORD MOTONEURONS; AFFINITY NGF RECEPTOR; TRK PROTOONCOGENE; SCHWANN-CELLS; MOLECULAR-CLONING; INSITU HYBRIDIZATION; RETROGRADE TRANSPORT; SENSORY NEURONS; TYROSINE KINASE	The results of our in situ hybridization experiments demonstrate that sensory neurons, sympathetic neurons, and motoneurons express brain-derived neurotrophic factor and/or neurotrophin-3 mRNAs during development in mouse. In accordance with previous data, we also find neurotrophins in the targets of sensory neurons (skin) and motoneurons (muscle) and the neurotrophin receptors p75, trkA, and trkB in sensory and sympathetic ganglia. These results suggest that neurotrophins have roles other than being target-derived factors that support neuron survival during developmental cell death (neurotrophic hypothesis), but may be transported in an orthograde fashion in neurons and released from axon terminals. We discuss several novel roles for neurotrophins, including autocrine/paracrine regulation of neuron survival, regulation of Schwann cell activity, and neuron to target signaling.			SCHECTERSON, LC (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS SJ-40,SEATTLE,WA 98195, USA.			SCHECTERSON, LESLAYANN/0000-0002-3896-998X	NINDS NIH HHS [NS-23343, NS-07332] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023343] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; BYERS MR, 1990, DEVELOPMENT, V109, P461; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; DAMICOMARTEL A, 1980, J EMBRYOL EXP MORPH, V55, P167; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DESPRES G, 1988, NEUROSCI LETT, V85, P5, DOI 10.1016/0304-3940(88)90418-1; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HEUMANN R, 1984, EMBO J, V3, P3138; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1983, NEUROSCIENCE, V8, P631, DOI 10.1016/0306-4522(83)90204-X; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEFEBVRE PP, 1990, BRAIN RES, V507, P254, DOI 10.1016/0006-8993(90)90279-K; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDSAY RM, 1985, DEV BIOL, V112, P30, DOI 10.1016/0012-1606(85)90116-2; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; NODEN DM, 1978, DEV BIOL, V67, P313, DOI 10.1016/0012-1606(78)90202-6; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHATTEMAN GC, 1988, J NEUROSCI, V8, P860; SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TANIUCHI M, 1988, J NEUROSCI, V8, P664; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; WAYNE DB, 1988, DEV BIOL, V127, P220, DOI 10.1016/0012-1606(88)90203-5; WHEELER EF, 1992, J NEUROSCI, V12, P930; YAN Q, 1988, NEURON, V1, P335; YAN Q, 1988, J NEUROSCI, V8, P3481; YANCOPOULOS GD, 1990, SCIENCE, V247, P1446	57	498	507	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					449	463		10.1016/0896-6273(92)90183-E	http://dx.doi.org/10.1016/0896-6273(92)90183-E			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1345671				2022-12-17	WOS:A1992JM57100007
J	Arthur-Farraj, PJ; Latouche, M; Wilton, DK; Quintes, S; Chabrol, E; Banerjee, A; Woodhoo, A; Jenkins, B; Rahman, M; Turmaine, M; Wicher, GK; Mitter, R; Greensmith, L; Behrens, A; Raivich, G; Mirsky, R; Jessen, KR				Arthur-Farraj, Peter J.; Latouche, Morwena; Wilton, Daniel K.; Quintes, Susanne; Chabrol, Elodie; Banerjee, Annbily; Woodhoo, Ashwin; Jenkins, Billy; Rahman, Mary; Turmaine, Mark; Wicher, Grzegorz K.; Mitter, Richard; Greensmith, Linda; Behrens, Axel; Raivich, Gennadij; Mirsky, Rhona; Jessen, Kristjan R.			c-Jun Reprograms Schwann Cells of Injured Nerves to Generate a Repair Cell Essential for Regeneration	NEURON			English	Article							DORSAL-ROOT GANGLION; WALLERIAN DEGENERATION; NEGATIVE REGULATOR; SIGNALING PATHWAY; PERIPHERAL-NERVES; GROWTH; CNS; DIFFERENTIATION; PROLIFERATION; MYELINATION	The radical response of peripheral nerves to injury (Wallerian degeneration) is the cornerstone of nerve repair. We show that activation of the transcription factor c-Jun in Schwann cells is a global regulator of Wallerian degeneration. c-Jun governs major aspects of the injury response, determines the expression of trophic factors, adhesion molecules, the formation of regeneration tracks and myelin clearance and controls the distinctive regenerative potential of peripheral nerves. A key function of c-Jun is the activation of a repair program in Schwann cells and the creation of a cell specialized to support regeneration. We show that absence of c-Jun results in the formation of a dysfunctional repair cell, striking failure of functional recovery, and neuronal death. We conclude that a single glial transcription factor is essential for restoration of damaged nerves, acting to control the transdifferentiation of myelin and Remak Schwann cells to dedicated repair cells in damaged tissue.	[Arthur-Farraj, Peter J.; Latouche, Morwena; Wilton, Daniel K.; Quintes, Susanne; Chabrol, Elodie; Banerjee, Annbily; Jenkins, Billy; Rahman, Mary; Turmaine, Mark; Mirsky, Rhona; Jessen, Kristjan R.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Woodhoo, Ashwin] CICbioGune, Metabol Unit, Derio 48160, Bizcaia, Spain; [Wicher, Grzegorz K.] Uppsala Univ, Dept Immunol Genet & Pathol, Neurooncol Grp, S-75185 Uppsala, Sweden; [Greensmith, Linda] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Mitter, Richard; Behrens, Axel] CRUK, London Res Inst, Mammalian Genet Lab, London WC2A 3LY, England; [Raivich, Gennadij] UCL, Perinatal Brain Grp, Dept Obstet & Gynaecol, London WC1E 6BT, England; [Raivich, Gennadij] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London; Uppsala University; University of London; University College London; Cancer Research UK; University of London; University College London; University of London; University College London	Jessen, KR (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	k.jessen@ucl.ac.uk	Raivich, Gennadij/AAL-7229-2021; woodhoo, ashwin/A-4904-2015	Wicher, Grzegorz/0000-0002-7737-1374; Chabrol, Elodie/0000-0002-8780-5375; Mitter, Richard/0000-0002-1279-3760; Behrens, Axel/0000-0002-1557-1143; woodhoo, ashwin/0000-0002-8395-2837	Wellcome Trust [WT088646MA]; MRC; European Community [HEALTH-F2-2008-201535]; Spanish Ministry of Science; Instituto Carlos III [PS09/00094]; Cancer Research UK; BBSRC [S20299, B/D009537/1]; MRC [G0600967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [S20299] Funding Source: researchfish; Cancer Research UK [15679] Funding Source: researchfish; Medical Research Council [G0600967] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto Carlos III(Instituto de Salud Carlos III); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Wellcome Trust Program and project grants to K.R.J. and R. Mirsky and an MRC project grant to K.R.J. and R. Mirsky. The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement No. HEALTH-F2-2008-201535. P.J.A.-F. and B.J. were funded by PhD studentships from the MRC and Wellcome Trust, respectively. A.W. is supported by a Ramon y Cajal fellowship from the Spanish Ministry of Science and a PFIS grant (PS09/00094) from the Instituto Carlos III. The London Research Institute (A. Behrens) is funded by Cancer Research UK. G.R is supported by BBSRC grants (S20299, B/D009537/1) and Wellcome Trust grant (WT088646MA). We thank P.N. Anderson for help with in vivo injections of c-Jun virus, D.B. Parkinson for animal husbandry, M. Tillo for pilot experiments and providing mRNA samples, B. Kalmer for help with motoneuron backfilling, K. Malgapo for carrying out axonal degeneration experiments, and G. Menendez and G. Schiavo for materials and help with the microfluidic chambers. We thank M.L. Feltri and L. Wrabetz for the gift of P<INF>o-</INF>CRE mice.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Angeloni NL, 2011, BIOMATERIALS, V32, P1091, DOI 10.1016/j.biomaterials.2010.10.003; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Coggeshall RE, 1997, NEUROSCIENCE, V77, P1115, DOI 10.1016/S0306-4522(96)00528-3; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Dong ZP, 1999, J NEUROSCI RES, V56, P334, DOI 10.1002/(SICI)1097-4547(19990515)56:4<334::AID-JNR2>3.0.CO;2-#; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Hoke A, 2010, EXP NEUROL, V223, P1, DOI 10.1016/j.expneurol.2009.12.001; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.0.CO;2-0; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jiang Y, 2010, CHINESE MED J-PEKING, V123, P2695, DOI 10.3760/cma.j.issn.0366-6999.2010.19.014; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kim HA, 2000, NEURON, V26, P405, DOI 10.1016/S0896-6273(00)81173-3; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; Myers RR, 2003, EXP NEUROL, V184, P606, DOI 10.1016/S0014-4886(03)00297-8; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2001, J NEUROSCI, V21, P8572, DOI 10.1523/JNEUROSCI.21-21-08572.2001; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Puigdellivol-Sanchez A, 2000, J NEUROSCI METH, V95, P103, DOI 10.1016/S0165-0270(99)00164-8; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Wang R, 2008, NAT NEUROSCI, V11, P488, DOI 10.1038/nn2069; Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Yang DP, 2008, MOL CELL NEUROSCI, V38, P80, DOI 10.1016/j.mcn.2008.01.017; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	37	497	508	6	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 23	2012	75	4					633	647		10.1016/j.neuron.2012.06.021	http://dx.doi.org/10.1016/j.neuron.2012.06.021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	994EU	22920255	Green Published, Green Submitted, hybrid			2022-12-17	WOS:000307914500012
J	Eippert, F; Bingel, U; Schoell, ED; Yacubian, J; Klinger, R; Lorenz, J; Buchel, C				Eippert, Falk; Bingel, Ulrike; Schoell, Eszter D.; Yacubian, Juliana; Klinger, Regine; Lorenz, Juergen; Buechel, Christian			Activation of the Opioidergic Descending Pain Control System Underlies Placebo Analgesia	NEURON			English	Article							PREFRONTAL CORTICAL PROJECTIONS; PERIAQUEDUCTAL GRAY; ANTERIOR CINGULATE; LONGITUDINAL COLUMNS; COGNITIVE CONTROL; FUNCTIONAL MRI; BRAIN ACTIVITY; CORTEX; MODULATION; RESPONSES	Placebo analgesia involves the endogenous opioid system, as administration of the opioid antagonist naloxone decreases placebo analgesia. To investigate the opioidergic mechanisms that underlie placebo analgesia, we combined naloxone administration with functional magnetic resonance imaging. Naloxone reduced both behavioral and neural placebo effects as well as placebo-induced responses in pain-modulatory cortical structures, such as the rostral anterior cingulate cortex (rACC). In a brain stem-specific analysis, we observed a similar naloxone modulation of placebo-induced responses in key structures of the descending pain control system, including the hypothalamus, the periaqueductal gray (PAG), and the rostral ventromedial medulla (RVM). Most importantly, naloxone abolished placebo-induced coupling between rACC and PAG, which predicted both neural and behavioral placebo effects as well as activation of the RVM. These findings show that opioidergic signaling in pain-modulating areas and the projections to downstream effectors of the descending pain control system are crucially important for placebo analgesia.	[Eippert, Falk; Schoell, Eszter D.; Yacubian, Juliana; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Klinger, Regine] Univ Hamburg, Dept Psychol, Outpatient Clin Behav Therapy, Hamburg, Germany; [Lorenz, Juergen] Hamburg Univ Appl Sci, Dept Life Sci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Hochschule Angewandte Wissenschaft Hamburg	Eippert, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	f.eippert@uke.uni-hamburg.de	Klinger, Regine/AFQ-0795-2022; Lorenz, Juergen/H-1888-2018; Eippert, Falk/M-6188-2013	Lorenz, Juergen/0000-0002-8561-6714; Schoell, Eszter D./0000-0001-9817-521X; Eippert, Falk/0000-0002-3986-1719	German Research Foundation [DFG BU 1323]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG BU 1323). We thank Wiebke Harken and Andreas Marschner for the naloxone handling and Katrin Muller and Kathrin Wendt for help with MR scanning.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; An X, 1998, J COMP NEUROL, V401, P455; [Anonymous], 1990, QUANTITATIVE IMAGING; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Borras MC, 2004, J NEUROPHYSIOL, V91, P2723, DOI 10.1152/jn.00249.2003; Buchel C, 2002, J NEUROSCI, V22, P970, DOI 10.1523/JNEUROSCI.22-03-00970.2002; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Casey KL, 2000, J NEUROPHYSIOL, V84, P525, DOI 10.1152/jn.2000.84.1.525; Colloca L, 2008, PAIN, V139, P306, DOI 10.1016/j.pain.2008.04.021; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Craggs JG, 2007, NEUROIMAGE, V38, P720, DOI 10.1016/j.neuroimage.2007.07.057; Eippert F, 2008, J NEUROSCI, V28, P5465, DOI 10.1523/JNEUROSCI.5336-07.2008; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Fields HL, 2006, WALL MELZACKS TXB PA, P125; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Goffaux P, 2007, PAIN, V130, P137, DOI 10.1016/j.pain.2006.11.011; GRACELY RH, 1983, NATURE, V306, P264, DOI 10.1038/306264a0; GREVERT P, 1978, SCIENCE, V199, P1093, DOI 10.1126/science.343250; GREVERT P, 1983, PAIN, V16, P129, DOI 10.1016/0304-3959(83)90203-8; Gutstein HB, 2006, GOODMAN GILMANS PHAR, P547; Honey G, 2004, TRENDS PHARMACOL SCI, V25, P366, DOI 10.1016/j.tips.2004.05.009; HOSOBUCHI Y, 1977, SCIENCE, V197, P183, DOI 10.1126/science.301658; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; KIERNAN BD, 1995, PAIN, V60, P39, DOI 10.1016/0304-3959(94)00134-Z; Klinger R, 2007, PAIN, V128, P31, DOI 10.1016/j.pain.2006.08.025; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2007, REV NEUROSCIENCE, V18, P173; Leslie RA, 2000, TRENDS PHARMACOL SCI, V21, P314, DOI 10.1016/S0165-6147(00)01507-8; LEVINE JD, 1984, NATURE, V312, P755, DOI 10.1038/312755a0; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Matre D, 2006, J NEUROSCI, V26, P559, DOI 10.1523/JNEUROSCI.4218-05.2006; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Morgan MM, 2008, PAIN, V140, P376, DOI 10.1016/j.pain.2008.09.009; Naidich TP., 2009, DUVERNOYS ATLAS HUMA; Napadow V, 2006, NEUROIMAGE, V32, P1113, DOI 10.1016/j.neuroimage.2006.05.050; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Padlubnaya DB, 2006, BEHAV NEUROSCI, V120, P337, DOI 10.1037/0735-7044.120.2.337; PASCALIS VD, 2002, PAIN, V96, P393; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Petrovic P, 2004, NEUROIMAGE, V22, P995, DOI 10.1016/j.neuroimage.2004.01.046; Petrovic P, 2008, J NEUROSCI, V28, P10509, DOI 10.1523/JNEUROSCI.2807-08.2008; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Price DD, 2007, PAIN, V127, P63, DOI 10.1016/j.pain.2006.08.001; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vase L, 2005, PAIN, V115, P338, DOI 10.1016/j.pain.2005.03.014; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2006, BRAIN BEHAV IMMUN, V20, P219, DOI 10.1016/j.bbi.2006.01.007; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wagner KJ, 2007, ANESTHESIOLOGY, V106, P548, DOI 10.1097/00000542-200703000-00020; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; WILLER JC, 1979, BRAIN RES, V179, P61; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	72	497	511	1	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 27	2009	63	4					533	543		10.1016/j.neuron.2009.07.014	http://dx.doi.org/10.1016/j.neuron.2009.07.014			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491HV	19709634	Bronze			2022-12-17	WOS:000269570400012
J	Belin, D; Everitt, BJ				Belin, David; Everitt, Barry J.			Cocaine seeking habits depend upon doparnine-dependent serial connectivity linking the ventral with the dorsal striatum	NEURON			English	Article							NUCLEUS-ACCUMBENS CORE; PAVLOVIAN APPROACH BEHAVIOR; BASOLATERAL AMYGDALA; DRUG-ADDICTION; NEURAL SYSTEMS; DIFFERENTIAL CONTROL; 2ND-ORDER SCHEDULE; PREFRONTAL CORTEX; DOPAMINE RELEASE; MEMORY-CIRCUITS	A neuroanatomical principle of striatal organization has been established through which ventral domains, including the nucleus accumbens, exert control over dorsal striatal processes mediated by so-called "spiraling," striato-nigro-striatal, circuitry. We have investigated the functional significance of this circuitry in the control over a cocaine-seeking habit by using an intrastriatal disconnection procedure that combined a selective, unilateral lesion of the nucleus accumbens core and infusion of a dopamine receptor antagonist into the contralateral dorsolateral striatum, thereby disrupting striato-midbrain-striatal serial connectivity bilaterally. We show that this disconnection selectively decreased drug-seeking behavior in rats extensively trained under a second-order schedule of cocaine reinforcement. These data thereby define the importance of interactions between ventral and dorsal domains of the striatum, mediated by dopaminergic transmission, in the neural mechanisms underlying the development and performance of cocaine-seeking habits that are a key characteristic of drug addiction.	[Belin, David; Everitt, Barry J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Belin, D (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	bdb26@cam.ac.uk	Belin, David/E-1231-2014	Belin, David/0000-0002-7383-372X; Everitt, Barry/0000-0003-4431-6536	Medical Research Council [G0001354, G0600196, G9536855] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0001354B] Funding Source: researchfish; MRC [G0600196] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Baxter MG, 2000, J NEUROSCI, V20, P4311; Caine SB, 2001, BEHAV NEUROSCI, V115, P880, DOI 10.1037//0735-7044.115.4.880; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Christakou A, 2001, BEHAV NEUROSCI, V115, P812, DOI 10.1037//0735-7044.115.4.812; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Di Ciano P, 2003, BEHAV NEUROSCI, V117, P952, DOI 10.1037/0735-7044.117.5.952; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Everitt BJ, 2007, ANN NY ACAD SCI, V1121, P576, DOI 10.1196/annals.1401.022; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2000, PSYCHOPHARMACOLOGY, V153, P17, DOI 10.1007/s002130000566; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Floresco SB, 1997, J NEUROSCI, V17, P1880; Fuchs RA, 2006, J NEUROSCI, V26, P3584, DOI 10.1523/JNEUROSCI.5146-05.2006; GAFFAN D, 1990, J NEUROSCI, V10, P3479; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldberg S R, 1981, NIDA Res Monogr, V37, P241; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Han JS, 1997, J NEUROSCI, V17, P3913; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Ito R, 2002, J NEUROSCI, V22, P6247; Ito R, 2000, J NEUROSCI, V20, P7489; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018; Koob GF, 2006, NEUR ADD; Lee JLC, 2006, J NEUROSCI, V26, P5881, DOI 10.1523/JNEUROSCI.0323-06.2006; Letchworth SR, 2001, J NEUROSCI, V21, P2799, DOI 10.1523/JNEUROSCI.21-08-02799.2001; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; See RE, 2007, PSYCHOPHARMACOLOGY, V194, P321, DOI 10.1007/s00213-007-0850-8; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAKAHASHI Y, 2007, IN PRESS FRONTIERS I; Vanderschuren LJMJ, 2005, EUR J PHARMACOL, V526, P77, DOI 10.1016/j.ejphar.2005.09.037; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	61	497	509	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					432	441		10.1016/j.neuron.2007.12.019	http://dx.doi.org/10.1016/j.neuron.2007.12.019			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255035	Bronze			2022-12-17	WOS:000253075300012
J	Bi, AD; Cui, JJ; Ma, YP; Olshevskaya, E; Pu, ML; Dizhoor, AM; Pan, ZH				Bi, AD; Cui, JJ; Ma, YP; Olshevskaya, E; Pu, ML; Dizhoor, AM; Pan, ZH			Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration	NEURON			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; RETINAL GANGLION-CELLS; RETINITIS-PIGMENTOSA; GENE-THERAPY; GREEN-ALGAE; TRANSGENE EXPRESSION; BIPOLAR CELLS; BETA-SUBUNIT; MODEL; LIGHT	The death of photoreceptor cells caused by retinal degenerative diseases often results in a complete loss of retinal responses to light. We explore the feasibility of converting inner retinal neurons to photosensitive cells as a possible strategy for imparting light sensitivity to retinas lacking rods and cones. Using delivery by an adeno-associated viral vector, here, we show that long-term expression of a microbial-type rhodopsin, channelrhodopsin-2 (ChR2), can be achieved in rodent inner retinal neurons in vivo. Furthermore, we demonstrate that expression of ChR2 in surviving inner retinal neurons of a mouse with photoreceptor degeneration can restore the ability of the retina to encode light signals and transmit the light signals to the visual cortex. Thus, expression of microbial-type channelrhodopsins, such as ChR2, in surviving inner retinal neurons is a potential strategy for the restoration of vision after rod and cone degeneration.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; Penn Coll Optometry, Elkins Pk, PA 19027 USA; Peking Univ, Sch Basic Med Sci, Dept Anat & Embryol, Beijing 100083, Peoples R China	Wayne State University; Peking University	Pan, ZH (corresponding author), Jiangsu Univ, Sch Med, Dept Pharmacol, Jinagsu 212013, Peoples R China.	zhpan@med.wayne.edu		Dizhoor, Alexander/0000-0001-6770-9186	NEI NIH HHS [R01 EY011522, EY12180, P30 EY004068, R01 EY012180, R03 EY016087, EY04068, EY16087, EY11522] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011522, P30EY004068, R03EY016087, R01EY012180] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Barlow H B, 1971, Vision Res, VSuppl 3, P87; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; BOK D, 1993, INVEST OPHTH VIS SCI, V34, P473; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Cui JJ, 2003, J PHYSIOL-LONDON, V553, P895, DOI 10.1113/jphysiol.2003.052092; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Flotte TR, 2004, GENE THER, V11, P805, DOI 10.1038/sj.gt.3302233; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Jimenez AJ, 1996, CELL TISSUE RES, V284, P193, DOI 10.1007/s004410050579; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; KIM CI, 1992, ARCH BIOCHEM BIOPHYS, V294, P388, DOI 10.1016/0003-9861(92)90700-7; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lund RD, 2001, PROG RETIN EYE RES, V20, P415, DOI 10.1016/S1350-9462(01)00003-9; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; PARTRIDGE JC, 1991, VISION RES, V31, P619, DOI 10.1016/0042-6989(91)90002-M; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; STRYER L, 1991, J BIOL CHEM, V266, P10711; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WELEBER RG, 1994, RETINA, P335; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	57	497	578	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					23	33		10.1016/j.neuron.2006.02.026	http://dx.doi.org/10.1016/j.neuron.2006.02.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600853	Bronze, Green Accepted			2022-12-17	WOS:000236811300008
J	Gotz, M; Stoykova, A; Gruss, P				Gotz, M; Stoykova, A; Gruss, P			Pax6 controls radial glia differentiation in the cerebral cortex	NEURON			English	Article							GUIDED NEURONAL MIGRATION; MONOCLONAL-ANTIBODY; VENTRICULAR ZONE; PRECURSOR CELLS; NERVOUS-SYSTEM; FETAL MONKEY; ASTROCYTES; MOUSE; EXPRESSION; BRAIN	Radial glia cells perform a dual function in the developing nervous system as precursor cells and guides for migrating neurons. We show here that during forebrain neurogenesis, the transcription factor Pax6 is specifically localized in radial glia cells of the cortex but not of the basal telencephalon. In Pax6-deficient mice, cortical radial glia cells were altered in their morphology, number, tenascin-C (TN-C) expression, and cell cycle. We show that some of these alterations are cell-autonomous, whereas others were rescued by coculturing with wild-type cortical cells. Our results suggest that Pax6 plays an essential role in the differentiation of cortical radial glia. Thus, despite their widespread distribution, radial glia cells are regionally specified in the developing CNS.	Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Max Planck Society	Gruss, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany.	pgruss@gwdg.de		Gotz, Magdalena/0000-0003-1551-9203				Anton ES, 1997, DEVELOPMENT, V124, P3501; BARTSCH S, 1992, J NEUROSCI, V12, P736; BIGNAMI A, 1974, NATURE, V252, P55, DOI 10.1038/252055a0; Cajal S. Ry, 1890, ANAT ANZEIGER, V5, P111; Caric D, 1997, DEVELOPMENT, V124, P5087; CHOI BH, 1978, BRAIN RES, V148, P295, DOI 10.1016/0006-8993(78)90721-7; CULICAN SM, 1990, J NEUROSCI, V10, P684; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FENG L, 1995, DEVELOPMENT, V121, P1719; FRITSCH R, 1996, THESIS G AUGUST U GO; GADISSEUX JF, 1990, DEV BRAIN RES, V52, P39, DOI 10.1016/0165-3806(90)90220-S; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; Gotz M, 1997, EUR J NEUROSCI, V9, P496, DOI 10.1111/j.1460-9568.1997.tb01627.x; GOTZ M, 1995, EUR J NEUROSCI, V7, P889, DOI 10.1111/j.1460-9568.1995.tb01076.x; GRACHEVA N D, 1969, Tsitologiya, V11, P1521; GRAY GE, 1992, DEVELOPMENT, V114, P271; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; GROVE EA, 1993, DEVELOPMENT, V117, P553; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; HEYMAN I, 1995, DEV DYNAM, V204, P301, DOI 10.1002/aja.1002040308; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; His W., 1889, ABH MATH PHYS KSGW, V15, P313; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; KURTZ A, 1994, DEVELOPMENT, V120, P2637; LEVITT P, 1983, DEV BIOL, V96, P472, DOI 10.1016/0012-1606(83)90184-7; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Mastick GS, 1997, DEVELOPMENT, V124, P1985; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MITROVIC N, 1994, J NEUROCYTOL, V23, P364, DOI 10.1007/BF01666526; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Ramon y Cajal S, 1890, ANAT ANZEIGER, V5, P85; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHMECHEL DE, 1979, NATURE, V277, P303, DOI 10.1038/277303a0; Shibata T, 1997, J NEUROSCI, V17, P9212; Soriano E, 1997, NEURON, V18, P563, DOI 10.1016/S0896-6273(00)80298-6; STEINDLER DA, 1990, EXP NEUROL, V109, P35, DOI 10.1016/S0014-4886(05)80007-X; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1997, DEVELOPMENT, V124, P1573	55	497	503	1	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1031	1044		10.1016/S0896-6273(00)80621-2	http://dx.doi.org/10.1016/S0896-6273(00)80621-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856459	Green Published, Bronze			2022-12-17	WOS:000077386100014
J	WESTENBROEK, RE; HELL, JW; WARNER, C; DUBEL, SJ; SNUTCH, TP; CATTERALL, WA				WESTENBROEK, RE; HELL, JW; WARNER, C; DUBEL, SJ; SNUTCH, TP; CATTERALL, WA			BIOCHEMICAL-PROPERTIES AND SUBCELLULAR-DISTRIBUTION OF AN N-TYPE CALCIUM CHANNEL-ALPHA-1 SUBUNIT	NEURON			English	Article							OMEGA-CONOTOXIN GVIA; CENTRAL-NERVOUS-SYSTEM; 2 SIZE FORMS; SKELETAL-MUSCLE; BETA-SUBUNIT; CA-2+ CHANNELS; RAT-BRAIN; FUNCTIONAL EXPRESSION; CA2+ CHANNELS; DIFFERENTIAL SENSITIVITY	A site-directed anti-peptide antibody, CNB-1, that recognizes the alpha1 subunit of rat brain class B calcium channels (rbB) immunoprecipitated 43% of the N-type calcium channels labeled by [I-125]omega-conotoxin. CNB-1 recognized proteins of 240 and 210 kd, suggesting the presence of two size forms of this alpha1 subunit. Calcium channels recognized by CNB-1 were localized predominantly in dendrites; both dendritic shafts and punctate synaptic structures upon the dendrites were labeled. The large terminals of the mossy fibers of the dentate gyrus granule neurons were heavily labeled, suggesting that the punctate labeling pattern represents calcium channels in nerve terminals. The pattern of immunostaining was cell specific. The cell bodies of some pyramidal cells in layers II, III, and V of the dorsal cortex, Purkinje cells, and scattered cell bodies elsewhere in the brain were also labeled at a low level. The results define complementary distributions of N- and L-type calcium channels in dendrites, nerve terminals, and cell bodies of most central neurons and support distinct functional roles in calcium-dependent electrical activity, intracellular calcium regulation, and neurotransmitter release for these two channel types.	UNIV BRITISH COLUMBIA,DEPT ZOOL,BIOTECHNOL LAB,VANCOUVER V6T 1Z3,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT NEUROSCI,VANCOUVER V6T 1Z3,BC,CANADA	University of British Columbia; University of British Columbia	WESTENBROEK, RE (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195, USA.		Snutch, Terrance P/L-3464-2019; Hell, Johannes W./P-5085-2019	Snutch, Terrance P/0000-0001-5182-1296; 	NINDS NIH HHS [P01 NS20484] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; COHEN MW, 1991, J NEUROSCI, V11, P1032; CRILL WE, 1983, TRENDS NEUROSCI, V6, P236, DOI 10.1016/0166-2236(83)90101-7; DAYANITHI G, 1988, BIOCHEM BIOPH RES CO, V156, P255, DOI 10.1016/S0006-291X(88)80833-7; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; DUTAR P, 1989, EUR J PHARMACOL, V174, P261, DOI 10.1016/0014-2999(89)90318-X; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; FORTIER LP, 1991, MOL BRAIN RES, V9, P209, DOI 10.1016/0169-328X(91)90004-H; GRINNELL AD, 1989, J PHYSIOL-LONDON, V418, P397, DOI 10.1113/jphysiol.1989.sp017848; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JONES OT, 1989, SCIENCE, V244, P1189, DOI 10.1126/science.2543080; KERR LM, 1988, EUR J PHARMACOL, V146, P181, DOI 10.1016/0014-2999(88)90501-8; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KIM HL, 1992, P NATL ACAD SCI USA, V89, P3251, DOI 10.1073/pnas.89.8.3251; KOYANO K, 1987, EUR J PHARMACOL, V135, P337, DOI 10.1016/0014-2999(87)90683-2; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LAI Y, 1990, J BIOL CHEM, V265, P20839; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Llinas R, 1979, Prog Brain Res, V51, P323; LLINAS R, 1984, BRAIN SLICES, P7; LUNDY PM, 1988, EUR J PHARMACOL, V156, P325, DOI 10.1016/0014-2999(88)90277-4; MAGGI CA, 1990, NEUROSCI LETT, V114, P203, DOI 10.1016/0304-3940(90)90072-H; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Orth DN, 1979, METHOD HORM RADIOIMM, P245; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; PROTTI DA, 1991, BRAIN RES, V557, P336, DOI 10.1016/0006-8993(91)90156-P; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; REYNOLDS IJ, 1986, P NATL ACAD SCI USA, V83, P8804, DOI 10.1073/pnas.83.22.8804; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROTMAN EI, 1992, J BIOL CHEM, V267, P16100; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SANO K, 1987, EUR J PHARMACOL, V141, P235, DOI 10.1016/0014-2999(87)90268-8; SEABROOK GR, 1989, BRIT J PHARMACOL, V97, P1125, DOI 10.1111/j.1476-5381.1989.tb12570.x; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STANLEY EF, 1991, J NEUROSCI, V11, P985; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; Sternberger LA, 1979, IMMUNOCYTOCHEMISTRY, P104; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TAKEMURA M, 1988, BRAIN RES, V451, P386, DOI 10.1016/0006-8993(88)90790-1; TAKEMURA M, 1989, NEUROSCIENCE, V32, P405, DOI 10.1016/0306-4522(89)90089-4; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; USOWICZ MM, 1990, J PHYSIOL-LONDON, V426, P95, DOI 10.1113/jphysiol.1990.sp018128; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; VENEMA VJ, 1992, J BIOL CHEM, V267, P2610; VONSPRECKELSEN S, 1990, BRAIN RES, V514, P68, DOI 10.1016/0006-8993(90)90436-F; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; WEI XY, 1991, J BIOL CHEM, V266, P21943; WESSLER I, 1990, NEUROSCI LETT, V108, P173, DOI 10.1016/0304-3940(90)90726-P; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WOODWARD JJ, 1988, BRAIN RES, V475, P141, DOI 10.1016/0006-8993(88)90207-7; XIANG JZ, 1990, NEUROPHARMACOLOGY, V29, P439, DOI 10.1016/0028-3908(90)90165-N	84	497	505	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1099	1115		10.1016/0896-6273(92)90069-P	http://dx.doi.org/10.1016/0896-6273(92)90069-P			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1334419				2022-12-17	WOS:A1992KD71600009
J	SUDHOF, TC; JAHN, R				SUDHOF, TC; JAHN, R			PROTEINS OF SYNAPTIC VESICLES INVOLVED IN EXOCYTOSIS AND MEMBRANE RECYCLING	NEURON			English	Review							GTP-BINDING PROTEIN; FROG NEUROMUSCULAR-JUNCTION; TERMINAL-SPECIFIC PHOSPHOPROTEIN; CLATHRIN-COATED VESICLES; CENTRAL NERVOUS-SYSTEM; AMINO-ACID SEQUENCES; VACUOLAR H+-ATPASE; SYNAPSIN-I; CHROMAFFIN GRANULES; BOVINE BRAIN		MAX PLANCK INST PSYCHIAT,NEUROCHEM ABT,W-8033 PLANEGG,GERMANY	Max Planck Society	SUDHOF, TC (corresponding author), UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DEPT MOLEC GENET,DALLAS,TX 75235, USA.			Jahn, Reinhard/0000-0003-1542-3498				AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; ARAKI S, 1990, J BIOL CHEM, V265, P13007; ARCHER BT, 1990, J BIOL CHEM, V265, P17267; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BAINES AJ, 1986, NATURE, V319, P145, DOI 10.1038/319145a0; BAINES AJ, 1985, NATURE, V315, P410, DOI 10.1038/315410a0; BAJJALIEH SM, 1989, J BIOL CHEM, V264, P14354; BARKER LA, 1972, BIOCHEM J, V130, P1063, DOI 10.1042/bj1301063; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BENFENATI F, 1990, J BIOL CHEM, V265, P12584; BERNASCONI P, 1990, J BIOL CHEM, V265, P17428; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BRODSKY FM, 1983, J MOL BIOL, V167, P197, DOI 10.1016/S0022-2836(83)80041-2; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FISCHER, 1990, P NATL ACAD SCI USA, V87, P1988; GOELZ SE, 1981, P NATL ACAD SCI USA, V78, P63; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HALL FL, 1990, J BIOL CHEM, V265, P6944; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; HUANG CK, 1982, J BIOL CHEM, V257, P6524; HUTTNER WB, 1981, J BIOL CHEM, V256, P1482; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSON EM, 1972, J BIOL CHEM, V247, P5650; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; JOHNSTON PA, 1991, IN PRESS NEURON; JOHNSTON PA, 1990, J BIOL CHEM, V265, P7849; Katz B., 1966, NERVE MUSCLE SYNAPSE; KENNEDY MB, 1981, P NATL ACAD SCU US, V72, P3488; KNAUS P, 1990, NEURON, V5, P453, DOI 10.1016/0896-6273(90)90084-S; KOHTZ DS, 1988, J BIOL CHEM, V263, P7418; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; LEUBE RE, 1989, CELL, V59, P433, DOI 10.1016/0092-8674(89)90028-7; LINIAL M, 1989, NEURON, V2, P1265, DOI 10.1016/0896-6273(89)90311-5; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; NISHIZUKA Y, 1989, JAMA-J AM MED ASSOC, V262, P1826, DOI 10.1001/jama.262.13.1826; OZCELIK T, 1990, AM J HUM GENET, V47, P551; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cellbio.6.1.151; PERIN MS, 1988, EMBO J, V7, P2697, DOI 10.1002/j.1460-2075.1988.tb03123.x; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PERIN MS, 1991, IN PRESS J BIOL CHEM; PETRUCCI TC, 1988, J CELL BIOCHEM, V36, P25, DOI 10.1002/jcb.240360104; PETRUCCI TC, 1987, J CELL BIOL, V105, P1355, DOI 10.1083/jcb.105.3.1355; PFEFFER SR, 1985, CELL, V40, P949, DOI 10.1016/0092-8674(85)90355-1; PFENNINGER K, 1972, J NEUROCYTOL, V1, P129, DOI 10.1007/BF01099180; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; RAHAMIMOFF R, 1988, P NATL ACAD SCI USA, V85, P5310, DOI 10.1073/pnas.85.14.5310; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; SALKOFF L, 1978, NATURE, V273, P156, DOI 10.1038/273156a0; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SIHRA TS, 1989, P NATL ACAD SCI USA, V86, P8108, DOI 10.1073/pnas.86.20.8108; STADLER H, 1982, EMBO J, V1, P1381, DOI 10.1002/j.1460-2075.1982.tb01326.x; Steinbach J.H., 1976, P33; STEINER JP, 1987, BRAIN RES BULL, V18, P777, DOI 10.1016/0361-9230(87)90216-4; STERNBACH Y, 1990, J BIOL CHEM, V265, P3961; STONE DK, 1989, J BIOENERG BIOMEMBR, V21, P605, DOI 10.1007/BF00808116; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Sudhof TC, 1989, CURR OPIN CELL BIOL, V1, P655, DOI 10.1016/0955-0674(89)90030-6; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; THOMAS L, 1990, J CELL BIOL, V111, P2041, DOI 10.1083/jcb.111.5.2041; THURESONKLEIN A, 1983, NEUROSCIENCE, V10, P245, DOI 10.1016/0306-4522(83)90132-X; TRIFARO JM, 1989, NEUROSCIENCE, V29, P1, DOI 10.1016/0306-4522(89)90327-8; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WANG SY, 1988, J BIOL CHEM, V263, P17638; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; XIE XS, 1989, J BIOL CHEM, V264, P18870; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	107	497	500	1	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					665	677		10.1016/0896-6273(91)90165-V	http://dx.doi.org/10.1016/0896-6273(91)90165-V			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1673848				2022-12-17	WOS:A1991FM52200001
J	TANAKA, K; MASU, M; NAKANISHI, S				TANAKA, K; MASU, M; NAKANISHI, S			STRUCTURE AND FUNCTIONAL EXPRESSION OF THE CLONED RAT NEUROTENSIN RECEPTOR	NEURON			English	Article											TANAKA, K (corresponding author), KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.							AMAR S, 1985, BIOCHEM BIOPH RES CO, V129, P117, DOI 10.1016/0006-291X(85)91411-1; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BOZOU JC, 1986, MOL PHARMACOL, V29, P489; COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; DIXON RAF, 1988, ANNU REP MED CHEM, V23, P221; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; DOBNER PR, 1987, P NATL ACAD SCI USA, V84, P3516, DOI 10.1073/pnas.84.10.3516; GILBERT JA, 1984, EUR J PHARMACOL, V99, P245, DOI 10.1016/0014-2999(84)90248-6; GOEDERT M, 1984, BRAIN RES, V323, P193, DOI 10.1016/0006-8993(84)90288-9; HARADA Y, 1987, J NEUROSCI, V7, P3265; HIRONO C, 1987, J PHYSIOL-LONDON, V382, P523, DOI 10.1113/jphysiol.1987.sp016382; KITABGI P, 1985, Reviews in Clinical and Basic Pharmacology, V5, P397; KITABGI P, 1977, P NATL ACAD SCI USA, V74, P1846, DOI 10.1073/pnas.74.5.1846; KITABGI P, 1987, EUR J PHARMACOL, V140, P285, DOI 10.1016/0014-2999(87)90285-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; LEEMAN SE, 1982, ANN NY ACAD SCI, V400, P1, DOI 10.1111/j.1749-6632.1982.tb31557.x; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MAZELLA J, 1985, J BIOL CHEM, V260, P508; MAZELLA J, 1989, J BIOL CHEM, V264, P5559; MILLS A, 1988, J BIOL CHEM, V263, P13; MINAMINO N, 1984, BIOCHEM BIOPH RES CO, V122, P542, DOI 10.1016/S0006-291X(84)80067-4; NAKANISHI S, 1990, IN PRESS RECENT PROG, V46; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; PARKER I, 1986, PROC R SOC SER B-BIO, V229, P151, DOI 10.1098/rspb.1986.0079; PRITCHETT DB, 1988, EMBO J, V7, P4135, DOI 10.1002/j.1460-2075.1988.tb03308.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAI Y, 1989, BIOCHEM BIOPH RES CO, V165, P695, DOI 10.1016/S0006-291X(89)80022-1; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHIGEMOTO R, 1990, J BIOL CHEM, V265, P623; SNIDER RM, 1986, J NEUROCHEM, V47, P1214; SNUTCH TP, 1988, TRENDS NEUROSCI, V11, P250, DOI 10.1016/0166-2236(88)90102-6; STRADER CD, 1987, J BIOL CHEM, V262, P16439; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649	36	497	516	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1990	4	6					847	854		10.1016/0896-6273(90)90137-5	http://dx.doi.org/10.1016/0896-6273(90)90137-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK185	1694443				2022-12-17	WOS:A1990DK18500004
J	Yang, NB; George, AL; Horn, R				Yang, NB; George, AL; Horn, R			Molecular basis of charge movement in voltage-gated sodium channels	NEURON			English	Article							SHAKER K+-CHANNELS; GATING CHARGE; POTASSIUM CHANNELS; S4 REGION; S4-SEQUENCE; MUTATIONS; RESIDUES; IMPORT	Voltage-dependent movement of a sodium channel S4 segment was examined by cysteine scanning mutagenesis and testing accessibility of the residues to hydrophilic cysteine-modifying reagents. These experiments indicate that 2 charged S4 residues move completely from an internally accessible to an externally accessible location in response to depolarization by passage through a short ''channel'' in the protein. The energetic problems of S4 movement have thus been solved in the same way that many ion channels achieve highly selective and rapid ion permeation through an open pore, by restricting the contact region between the permion and its channel.	VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,DEPT MED,NASHVILLE,TN 37232	Vanderbilt University	Yang, NB (corresponding author), JEFFERSON MED COLL,DEPT PHYSIOL,PHILADELPHIA,PA 19107, USA.				NIAMS NIH HHS [AR41691] Funding Source: Medline; NINDS NIH HHS [NS32387] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032387, R01NS032387] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRONG CM, 1992, PHYSIOL REV, V72, pS5, DOI 10.1152/physrev.1992.72.suppl_4.S5; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Chahine M, 1995, RECEPTOR CHANNEL, V3, P161; CHAHINE M, 1994, PFLUG ARCH EUR J PHY, V427, P136, DOI 10.1007/BF00585952; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FELIG A, 1994, PFLUGERS ARCH, V427, P406; FRENCH RJ, 1996, IN PRESS NEURON; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Higuchi R., 1989, PCR TECHNOLOGY, P61; HIRSCHBERG B, 1995, IN PRESS J GEN PHYSL; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1993, NEURON, V10, P1121, DOI 10.1016/0896-6273(93)90060-5; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MADUKE M, 1993, SCIENCE, V260, P364, DOI 10.1126/science.8385804; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.bb.18.060189.000553; MERRILL AR, 1990, BIOCHEMISTRY-US, V29, P8529, DOI 10.1021/bi00489a004; MILLER C, 1982, TRANSPORT BIOL MEMBR, P99; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1993, Q REV BIOPHYS, V27, P1; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TOSTESON MT, 1990, BIOPHYS J, V58, P1367, DOI 10.1016/S0006-3495(90)82483-8; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; ZIZI M, 1995, J MEMBRANE BIOL, V144, P121	40	496	511	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					113	122		10.1016/S0896-6273(00)80028-8	http://dx.doi.org/10.1016/S0896-6273(00)80028-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562074	Bronze			2022-12-17	WOS:A1996TT30700014
J	Gunawardena, S; Her, LS; Brusch, RG; Laymon, RA; Niesman, IR; Gordesky-Gold, B; Sintasath, L; Bonini, NM; Goldstein, LSB				Gunawardena, S; Her, LS; Brusch, RG; Laymon, RA; Niesman, IR; Gordesky-Gold, B; Sintasath, L; Bonini, NM; Goldstein, LSB			Disruption of axonal transport by loss of huntingtin or expression of pathogenic PolyQ proteins in Drosophila	NEURON			English	Article							EXPANDED POLYGLUTAMINE PROTEIN; DISEASE GENE HOMOLOG; MOTOR-NEURON-DISEASE; DEPENDENT NEURODEGENERATION; INTRANUCLEAR INCLUSIONS; NUCLEAR-LOCALIZATION; EMBRYONIC LETHALITY; MUTANT HUNTINGTIN; TRANSGENIC MICE; CELL-DEATH	We tested whether proteins implicated in Huntington's and other polyglutamine (polyQ) expansion diseases can cause axonal transport defects. Reduction of Drosophila huntingtin and expression of proteins containing pathogenic polyQ repeats disrupt axonal transport. Pathogenic polyQ proteins accumulate in axonal and nuclear inclusions, titrate soluble motor proteins, and cause neuronal apoptosis and organismal death. Expression of a cytoplasmic polyQ repeat protein causes adult retinal degeneration, axonal blockages in larval neurons, and larval lethality, but not neuronal apoptosis or nuclear inclusions. A nuclear polyQ repeat protein induces neuronal apoptosis and larval lethality but no axonal blockages. We suggest that pathogenic polyQ proteins cause neuronal dysfunction and organismal death by two non-mutually exclusive mechanisms. One mechanism requires nuclear accumulation and induces apoptosis; the other interferes with axonal transport. Thus, disruption of axonal transport by pathogenic polyQ proteins could contribute to early neuropathology in Huntington's and other polyQ expansion diseases.	Univ Calif San Diego, Dept Cellular & Mol Physiol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Pennsylvania	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Physiol, La Jolla, CA 92093 USA.			Niesman, Ingrid/0000-0001-9767-6629; gunawardena, shermali/0000-0001-8776-9397	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035252] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35252] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Bowman AB, 1999, J CELL BIOL, V146, P165; Boylan K, 2000, MOL BIOL CELL, V11, P3791, DOI 10.1091/mbc.11.11.3791; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Freiman RN, 2002, SCIENCE, V296, P2149, DOI 10.1126/science.1073845; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; GUNAWARDENA S, 1994, METHOD CELL BIOL, V44, P393, DOI 10.1016/S0091-679X(08)60925-5; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hurd DD, 1996, GENETICS, V144, P1075; Ishikawa K, 1999, HUM MOL GENET, V8, P1185, DOI 10.1093/hmg/8.7.1185; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li XJ, 1996, P NATL ACAD SCI USA, V93, P4839, DOI 10.1073/pnas.93.10.4839; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Terry RD, 2000, J NEUROPATH EXP NEUR, V59, P1118, DOI 10.1093/jnen/59.12.1118; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	50	495	510	1	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					25	40		10.1016/S0896-6273(03)00594-4	http://dx.doi.org/10.1016/S0896-6273(03)00594-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527431	Bronze			2022-12-17	WOS:000185614700007
J	KOLIATSOS, VE; CLATTERBUCK, RE; WINSLOW, JW; CAYOUETTE, MH; PRICE, DL				KOLIATSOS, VE; CLATTERBUCK, RE; WINSLOW, JW; CAYOUETTE, MH; PRICE, DL			EVIDENCE THAT BRAIN-DERIVED NEUROTROPHIC FACTOR IS A TROPHIC FACTOR FOR MOTOR NEURONS INVIVO	NEURON			English	Article							NERVE GROWTH-FACTOR; AMYOTROPHIC LATERAL SCLEROSIS; HIGH-AFFINITY RECEPTORS; FACTOR NGF; SKELETAL-MUSCLE; SPINAL-CORD; CHOLINERGIC NEURONS; BIOLOGICAL-ACTIVITY; DEVELOPING RATS; MESSENGER-RNA	The neurotrophins nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3) act upon populations of neurons that express specific receptors. The present study demonstrates that BDNF rescues motor neurons from degeneration and may also play a role in the normal physiology of these cells. BDNF is expressed in the local environment and in muscle targets of motor neurons; muscle expression is up-regulated by denervation. The alpha motor neurons express the gene encoding p145trkB, a receptor involved in BDNF signal transduction, whereas a subset of motor neurons express p75NGFR. BDNF is transported selectively to a motor neurons from skeletal muscles. Finally, BDNF prevents motor neuron death in the axotomized facial nucleus of the neonatal rat. The effects of BDNF on motor neurons raise the possibility that some neurotrophins may be useful in treating patients with motor neuropathies and amyotrophic lateral sclerosis.	JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA; GENENTECH INC, S SAN FRANCISCO, CA 94080 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Roche Holding; Genentech	KOLIATSOS, VE (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA.				NIA NIH HHS [AG05146] Funding Source: Medline; NINDS NIH HHS [NS20471, NS07179] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, T32NS007179, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; APPEL SH, 1989, PROG BRAIN RES, V79, P251; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BERND P, 1984, J BIOL CHEM, V259, P5509; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; BURLS A, 1991, EUR J NEUROSCI, V3, P216, DOI 10.1111/j.1460-9568.1991.tb00082.x; CAMMERMEYER JAN, 1963, ACTA NEUROPATHOL, V2, P213; CARROLL SL, 1992, NEURON, V9, P779, DOI 10.1016/0896-6273(92)90040-K; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CORK LC, 1979, J NEUROPATH EXP NEUR, V38, P209, DOI 10.1097/00005072-197905000-00002; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; DOHRMANN U, 1987, DEV BIOL, V124, P145, DOI 10.1016/0012-1606(87)90467-2; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; GASSER UE, 1986, BRAIN RES, V376, P351, DOI 10.1016/0006-8993(86)90198-8; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HERRUP K, 1973, P NATL ACAD SCI USA, V70, P3884, DOI 10.1073/pnas.70.12.3884; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IWATA M, 1966, J CELL BIOL, V31, P113; KELLY AM, 1968, J NEUROPATHOL EXP NE, V27, P100; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KNUSEL B, 1990, EXP NEUROL, V110, P274, DOI 10.1016/0014-4886(90)90039-U; KOLIATSOS VE, 1991, BRAIN RES, V549, P297, DOI 10.1016/0006-8993(91)90471-7; KOLIATSOS VE, 1993, ANIMAL MODELS NEUR A, V25, P247; KREUTZBERG GW, 1986, FACIAL NERVE, P75; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MANNEN T, 1977, J NEUROL NEUROSUR PS, V40, P464, DOI 10.1136/jnnp.40.5.464; MANNEN T, 1982, ACTA NEUROPATHOL, V58, P255, DOI 10.1007/BF00688606; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; MIYATA Y, 1986, J NEUROSCI, V6, P2012; NURCOMBE V, 1984, BRAIN RES, V291, P19, DOI 10.1016/0006-8993(84)90646-2; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1982, J COMP NEUROL, V210, P174, DOI 10.1002/cne.902100208; ROSENTHAL A, 1991, ENDOCRINOLOGY, V129, P1289, DOI 10.1210/endo-129-3-1289; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; SCHMALBRUCH H, 1984, J COMP NEUROL, V224, P252, DOI 10.1002/cne.902240206; SCHWAB ME, 1979, BRAIN RES, V168, P473, DOI 10.1016/0006-8993(79)90303-2; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SMITH RG, 1986, J NEUROSCI, V6, P439; SNIDER WD, 1989, J COMP NEUROL, V279, P489, DOI 10.1002/cne.902790312; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TERAVAINEN H, 1968, Z ZELLFORSCH MIK ANA, V87, P249, DOI 10.1007/BF00319723; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; YAN Q, 1988, NEURON, V1, P335; YAN Q, 1988, J NEUROSCI, V8, P3481	56	495	513	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1993	10	3					359	367		10.1016/0896-6273(93)90326-M	http://dx.doi.org/10.1016/0896-6273(93)90326-M			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8080464				2022-12-17	WOS:A1993KU90100003
J	Chevaleyre, V; Castillo, PE				Chevaleyre, V; Castillo, PE			Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability	NEURON			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; CANNABINOID CB1 RECEPTORS; NEONATAL RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; ENDOGENOUS CANNABINOIDS; PYRAMIDAL CELLS; CA1 NEURONS; LASTING POTENTIATION; PURKINJE-CELLS	Neuronal excitability and long-term synaptic plasticity at excitatory synapses are critically dependent on the level of inhibition, and accordingly, changes of inhibitory synaptic efficacy should have great impact on neuronal function and neural network processing. We describe here a form of activity-dependent long-term depression at hippocampal inhibitory synapses that is triggered postsynaptically via glutamate receptor activation but is expressed presynaptically. That is, glutamate released by repetitive activation of Schaffer collaterals activates group I metabotropic glutamate receptors at CA1 pyramidal cells, triggering a persistent reduction of GABA release that is mediated by endocannabinoids. This heterosynaptic form of plasticity is involved in changes of pyramidal cell excitability associated with long-term potentiation at excitatory synapses and could account for the effects of cannabinoids on learning and memory.	Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA.			Chevaleyre, Vivien/0000-0002-3679-4856; Castillo, Pablo/0000-0002-9834-1801				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Belan PV, 2002, PFLUG ARCH EUR J PHY, V444, P26, DOI 10.1007/s00424-002-0783-3; BERNARD C, 1995, J NEUROSCI, V15, P6542; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Breakwell NA, 1996, J NEUROPHYSIOL, V76, P3126, DOI 10.1152/jn.1996.76.5.3126; Breivogel CS, 1999, J NEUROCHEM, V73, P2447, DOI 10.1046/j.1471-4159.1999.0732447.x; Caillard O, 1999, J NEUROSCI, V19, P7568, DOI 10.1523/JNEUROSCI.19-17-07568.1999; Caillard O, 1999, J PHYSIOL-LONDON, V518, P109, DOI 10.1111/j.1469-7793.1999.0109r.x; Caillard O, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0002.2000; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; COLLINS DR, 1995, BRIT J PHARMACOL, V115, P869, DOI 10.1111/j.1476-5381.1995.tb15889.x; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; DAVIES CH, 1993, J PHYSIOL-LONDON, V472, P245, DOI 10.1113/jphysiol.1993.sp019945; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; DINGLEDINE R, 1980, J PHYSIOL-LONDON, V305, P297, DOI 10.1113/jphysiol.1980.sp013364; GALARSA JL, 2002, TRENDS NEUROSCI, V25, P564; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Glaum SR, 1996, J NEUROPHYSIOL, V76, P30, DOI 10.1152/jn.1996.76.1.30; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Holmgren CD, 2001, J NEUROSCI, V21, P8270; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Irving AJ, 2000, NEUROSCIENCE, V98, P253, DOI 10.1016/S0306-4522(00)00120-2; Katona I, 1999, J NEUROSCI, V19, P4544; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Lichtman AH, 2002, PROSTAG LEUKOTR ESS, V66, P269, DOI 10.1054/plef.2001.0351; LIU YB, 1993, J NEUROPHYSIOL, V69, P1000, DOI 10.1152/jn.1993.69.3.1000; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pertwee R G., 2002, FATTY ACIDS, V66, P101; PITLER TA, 1992, J NEUROSCI, V12, P4122; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; PRESCOTT SM, 1983, J BIOL CHEM, V258, P764; PRINCE DA, 1978, ANNU REV NEUROSCI, V1, P395, DOI 10.1146/annurev.ne.01.030178.002143; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROMERO J, 1995, PHARMACOL BIOCHEM BE, V51, P731, DOI 10.1016/0091-3057(95)00023-P; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STELZER A, 1994, P NATL ACAD SCI USA, V91, P3058, DOI 10.1073/pnas.91.8.3058; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; SUGIURA T, 2002, FATTY ACIDS, V66, P173; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Vaughan CW, 1999, BRIT J PHARMACOL, V127, P935, DOI 10.1038/sj.bjp.0702636; Wang JH, 1996, J NEUROPHYSIOL, V75, P1687, DOI 10.1152/jn.1996.75.4.1687; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	68	494	508	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 8	2003	38	3					461	472		10.1016/S0896-6273(03)00235-6	http://dx.doi.org/10.1016/S0896-6273(03)00235-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741992	Bronze			2022-12-17	WOS:000182800300010
J	WILLIAMS, ME; FELDMAN, DH; MCCUE, AF; BRENNER, R; VELICELEBI, G; ELLIS, SB; HARPOLD, MM				WILLIAMS, ME; FELDMAN, DH; MCCUE, AF; BRENNER, R; VELICELEBI, G; ELLIS, SB; HARPOLD, MM			STRUCTURE AND FUNCTIONAL EXPRESSION OF ALPHA-1-SUBUNIT, ALPHA-2-SUBUNIT, AND BETA-SUBUNIT OF A NOVEL HUMAN NEURONAL CALCIUM-CHANNEL SUBTYPE	NEURON			English	Article								The primary structures of human neuronal alpha-1, alpha-2, and beta-subunits of a voltage-dependent Ca2+ channel were deduced by characterizing cDNAs. The alpha-subunit (alpha-1D) directs the recombinant expression of a dihydropyridine-sensitive L-type Ca2+ channel when coexpressed with the beta-(beta-2) and the alpha-2 (alpha-2b) subunits in Xenopus oocytes. The recombinant channel is also reversibly blocked by 10-15-mu-M omega-conotoxin. Expression of the alpha-1D Subunit alone, or coexpression with the alpha-2b subunit, did not elicit functional Ca2+ channel activity. Thus, the beta-2 subunit appears to serve an obligatory function, whereas the alpha-2b subunit appears to play an accessory role that potentiates expression of the channel. The primary transcripts encoding the alpha-1D, alpha-2, and beta-subunits are differentially processed. At least two forms of neuronal alpha-1D were identified. Different forms of alpha-2 and beta-transcripts were also identified in CNS, skeletal muscle, and aorta tissues.			WILLIAMS, ME (corresponding author), SALK INST BIOTECHNOL IND ASSOCIATES INC, 505 COAST BLVD S, LA JOLLA, CA 92037 USA.			Brenner, Robert/0000-0002-1036-8031				AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CARBONE E, 1990, PFLUG ARCH EUR J PHY, V416, P170, DOI 10.1007/BF00370239; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; DASCAL N, 1986, SCIENCE, V231, P1147, DOI 10.1126/science.2418503; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FELDMAN DH, 1987, FEBS LETT, V214, P295, DOI 10.1016/0014-5793(87)80073-X; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; GLASS DB, 1986, J BIOL CHEM, V261, P2987; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HOLZ GG, 1988, J NEUROSCI, V8, P463; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Innis M. A., 1990, PCR PROTOCOLS GUIDE, P3; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JONES SW, 1990, J NEUROSCI, V10, P2261; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NUMA S, 1986, ANN NY ACAD SCI, V479, P338, DOI 10.1111/j.1749-6632.1986.tb15580.x; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGULLA S, 1991, EMBO J, V10, P45, DOI 10.1002/j.1460-2075.1991.tb07919.x; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Sambrook J., 1989, MOL CLONING LAB MANU; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; SCROGGS RS, 1991, J NEUROSCI, V11, P1334; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SUZUKI N, 1987, NEUROSCI LETT, V75, P235, DOI 10.1016/0304-3940(87)90303-X; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; YEAGER RE, 1987, J NEUROSCI, V7, P2390	48	494	529	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					71	84		10.1016/0896-6273(92)90109-Q	http://dx.doi.org/10.1016/0896-6273(92)90109-Q			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1309651				2022-12-17	WOS:A1992HB18500006
J	KOSIK, KS; ORECCHIO, LD; BINDER, L; TROJANOWSKI, JQ; LEE, VMY; LEE, G				KOSIK, KS; ORECCHIO, LD; BINDER, L; TROJANOWSKI, JQ; LEE, VMY; LEE, G			EPITOPES THAT SPAN THE TAU-MOLECULE ARE SHARED WITH PAIRED HELICAL FILAMENTS	NEURON			English	Article									HARVARD UNIV,SCH MED,DEPT NEUROL NEUROSCI,BOSTON,MA 02115; UNIV ALABAMA,SCH MED & DENT,DEPT CELL BIOL & ANAT,BIRMINGHAM,AL 35294; UNIV PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104	Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; University of Pennsylvania	KOSIK, KS (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,DIV NEUROL,CTR NEUROL DIS,BOSTON,MA 02115, USA.		Lee, Gloria/F-5965-2011	Lee, Gloria/0000-0002-8633-1534	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K07NS000835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006172, R01AG006601] Funding Source: NIH RePORTER; NIA NIH HHS [AG06172, AG06601] Funding Source: Medline; NINDS NIH HHS [NS00835] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERTON BH, 1982, NATURE, V298, P84, DOI 10.1038/298084a0; ATASSI MZ, 1984, EUR J BIOCHEM, V145, P1, DOI 10.1111/j.1432-1033.1984.tb08516.x; BINDER LI, 1984, P NATL ACAD SCI-BIOL, V81, P5613, DOI 10.1073/pnas.81.17.5613; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Brion J. P., 1985, ARCH BIOL BRUX, V95, P229; CONNOLLY JA, 1977, P NATL ACAD SCI USA, V74, P2437, DOI 10.1073/pnas.74.6.2437; DEGARCINI EM, 1986, BIOCHEM BIOPH RES CO, V141, P790, DOI 10.1016/S0006-291X(86)80242-X; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; DRUBIN D, 1986, ANN NY ACAD SCI, V466, P257, DOI 10.1111/j.1749-6632.1986.tb38398.x; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; FRANCON J, 1982, EUR J BIOCHEM, V129, P465, DOI 10.1111/j.1432-1033.1982.tb07072.x; GALLOWAY PG, 1987, BRAIN RES, V403, P337, DOI 10.1016/0006-8993(87)90071-0; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUIROY DC, 1987, P NATL ACAD SCI USA, V84, P2073, DOI 10.1073/pnas.84.7.2073; HYMAN BT, 1988, ANN NEUROL, V23, P371, DOI 10.1002/ana.410230410; IHARA Y, 1983, NATURE, V304, P727, DOI 10.1038/304727a0; JAMESON BA, 1988, SCIENCE, V240, P1335, DOI 10.1126/science.2453925; JOACHIM CL, 1987, J NEUROPATH EXP NEUR, V46, P611, DOI 10.1097/00005072-198711000-00001; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; KOSIK KS, 1984, P NATL ACAD SCI-BIOL, V81, P7941, DOI 10.1073/pnas.81.24.7941; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KOSIK KS, 1988, IN PRESS J NEUROCHEM; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; KSIEZAKREDING H, 1987, P NATL ACAD SCI USA, V84, P3410, DOI 10.1073/pnas.84.10.3410; KSIEZAKREDING H, 1988, J BIOL CHEM, V263, P7943; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEE VMY, 1986, J NEUROSCI, V6, P850; MEHRA V, 1986, P NATL ACAD SCI USA, V83, P7013, DOI 10.1073/pnas.83.18.7013; MERZ PA, 1987, J NEUROPATH EXP NEUR, V46, P376, DOI 10.1097/00005072-198705000-00139; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; NEVE RL, 1986, MOL BRAIN RES, V1, P193, DOI 10.1016/0169-328X(86)90011-2; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; NISHIDA E, 1979, J BIOCHEM, V85, P1257; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; NUKINA N, 1988, NEUROSCI LETT, V87, P240, DOI 10.1016/0304-3940(88)90455-7; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; NUKINA N, 1983, P JPN ACAD B-PHYS, V59, P284, DOI 10.2183/pjab.59.284; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; PERRY G, 1987, BRAIN RES, V420, P233, DOI 10.1016/0006-8993(87)91243-1; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; YEN SH, 1987, AM J PATHOL, V126, P81	52	494	505	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1988	1	9					817	825		10.1016/0896-6273(88)90129-8	http://dx.doi.org/10.1016/0896-6273(88)90129-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	R1440	2483104				2022-12-17	WOS:A1988R144000006
J	Kim, S; Kwon, SH; Kam, TI; Panicker, N; Karuppagounder, SS; Lee, S; Lee, JH; Kim, WR; Kook, M; Foss, CA; Shen, C; Lee, H; Kulkarni, S; Pasricha, PJ; Lee, G; Pomper, MG; Dawson, VL; Dawson, TM; Ko, HS				Kim, Sangjune; Kwon, Seung-Hwan; Kam, Tae-In; Panicker, Nikhil; Karuppagounder, Senthilkumar S.; Lee, Saebom; Lee, Jun Hee; Kim, Wonjoong Richard; Kook, Minjee; Foss, Catherine A.; Shen, Chentian; Lee, Hojae; Kulkarni, Subhash; Pasricha, Pankaj J.; Lee, Gabsang; Pomper, Martin G.; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok			Transneuronal Propagation of Pathologic alpha-Synuclein from the Gut to the Brain Models Parkinson's Disease	NEURON			English	Article							ENTERIC NERVOUS-SYSTEM; TAIL SUSPENSION TEST; LEWY BODY; GASTROINTESTINAL-TRACT; PREFORMED FIBRILS; WATER MAZE; MICE; VAGOTOMY; RATS; INVOLVEMENT	Analysis of human pathology led Braak to postulate that a-synuclein (alpha-syn) pathology could spread from the gut to brain via the vagus nerve. Here, we test this postulate by assessing alpha-synucleinopathy in the brain in a novel gut-to-brain alpha-syn transmission mouse model, where pathological alpha-syn preformed fibrils were injected into the duodenal and pyloric muscularis layer. Spread of pathologic alpha-syn in brain, as assessed by phosphorylation of serine 129 of alpha-syn, was observed first in the dorsal motor nucleus, then in caudal portions of the hindbrain, including the locus coeruleus, and much later in basolateral amygdala, dorsal raphe nucleus, and the substantia nigra pars compacta. Moreover, loss of dopaminergic neurons and motor and non-motor symptoms were observed in a similar temporal manner. Truncal vagotomy and alpha-syn deficiency prevented the gut-to-brain spread of alpha-synucleinopathy and associated neurodegeneration and behavioral deficits. This study supports the Braak hypothesis in the etiology of idiopathic Parkinson's disease (PD).	[Kim, Sangjune; Kwon, Seung-Hwan; Kam, Tae-In; Panicker, Nikhil; Karuppagounder, Senthilkumar S.; Lee, Saebom; Lee, Jun Hee; Kim, Wonjoong Richard; Kook, Minjee; Lee, Hojae; Lee, Gabsang; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Sch Med, Baltimore, MD 21205 USA; [Kim, Sangjune; Kwon, Seung-Hwan; Kam, Tae-In; Panicker, Nikhil; Karuppagounder, Senthilkumar S.; Lee, Saebom; Lee, Jun Hee; Kim, Wonjoong Richard; Kook, Minjee; Lee, Hojae; Lee, Gabsang; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Foss, Catherine A.; Shen, Chentian; Pomper, Martin G.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA; [Kulkarni, Subhash; Pasricha, Pankaj J.] Johns Hopkins Univ, Sch Med, Ctr Neurogastroenterol, Dept Med, Baltimore, MD 21205 USA; [Lee, Gabsang; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Ko, Han Seok] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Lee, Jun Hee] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham Sch Med, Birmingham, AL 35294 USA; [Shen, Chentian] Shanghai Jiao Tong Univ, Dept Nucl Med, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Shanghai Jiao Tong University	Dawson, TM; Ko, HS (corresponding author), Johns Hopkins Univ, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Sch Med, Baltimore, MD 21205 USA.; Dawson, TM; Ko, HS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	tdawson@jhmi.edu; hko3@jhmi.edu	Dawson, Valina/Y-9757-2019; Karuppagounder, Senthilkumar/I-6752-2013; Panicker, Nikhil/A-2770-2019; Kim, Sangjune/AAA-9561-2022	Karuppagounder, Senthilkumar/0000-0002-3281-9913; Panicker, Nikhil/0000-0003-1752-4284; Kim, Richard/0000-0002-1924-6575; Kam, Tae-In/0000-0002-7241-4902; Kwon, Seung-Hwan/0000-0001-7965-5875; Shen, Chentian/0000-0001-5943-4418; Kim, Sangjune/0000-0003-3052-3163	JPB Foundation; NIH/NINDS Morris K. Udall Parkinson's Disease Research Center [NS38377]; NIH/NINDS [NS082205, NS107404, NS098006]; NIH/NIA [AG059686]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS107404, R01NS082205, P50NS038377, R21NS098006] Funding Source: NIH RePORTER	JPB Foundation; NIH/NINDS Morris K. Udall Parkinson's Disease Research Center; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We appreciate Taek-soo Lee, PhD, and Benjamin Tsui, PhD, technical assistance for SPECT-CT analysis. We thank I.-H. Wu for graphic art assistance. This work was supported by grants from the JPB Foundation, NIH/NINDS Morris K. Udall Parkinson's Disease Research Center NS38377, NIH/NINDS NS082205, NS107404, and NS098006 and NIH/NIA AG059686. The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Program M-2014.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arias N, 2015, HIPPOCAMPUS, V25, P1242, DOI 10.1002/hipo.22430; Bernhardt N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32608-7; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2007, ACTA NEUROPATHOL, V113, P421, DOI 10.1007/s00401-007-0193-x; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Chandra R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92295; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Da Cunha C, 2002, CELL MOL NEUROBIOL, V22, P227, DOI 10.1023/A:1020736131907; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Delaville C, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00031; Dodel R, 2008, J NEUROL, V255, P39, DOI 10.1007/s00415-008-5007-0; Eagle Andrew L, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1821; El-Salhy M, 2000, REGUL PEPTIDES, V88, P15, DOI 10.1016/S0167-0115(99)00107-X; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gelpi E, 2014, MOVEMENT DISORD, V29, P1010, DOI 10.1002/mds.25776; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Hawkes CH, 2009, ANN NY ACAD SCI, V1170, P615, DOI 10.1111/j.1749-6632.2009.04365.x; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Karpowicz RJ, 2019, LAB INVEST, V99, P971, DOI 10.1038/s41374-019-0195-z; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; Kuo YM, 2010, HUM MOL GENET, V19, P1633, DOI 10.1093/hmg/ddq038; Kwon SH, 2009, EUR J PHARMACOL, V619, P44, DOI 10.1016/j.ejphar.2009.06.062; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Leonard Brian E, 2006, Dialogues Clin Neurosci, V8, P163; Liu BJ, 2017, NEUROLOGY, V88, P1996, DOI 10.1212/WNL.0000000000003961; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Manfredsson FP, 2018, NEUROBIOL DIS, V112, P106, DOI 10.1016/j.nbd.2018.01.008; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Marinho-Buzelli AR, 2015, CLIN REHABIL, V29, P741, DOI 10.1177/0269215514556297; MAYEUX R, 1990, ADV NEUROL, V53, P163; Miyoshi E, 2002, BRAIN RES BULL, V58, P41, DOI 10.1016/S0361-9230(02)00754-2; O'Leary OF, 2018, EUR NEUROPSYCHOPHARM, V28, P307, DOI 10.1016/j.euroneuro.2017.12.004; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Pfeiffer RF, 2003, LANCET NEUROL, V2, P107, DOI 10.1016/S1474-4422(03)00307-7; Phelps D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10517-5; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rey NL, 2016, J EXP MED, V213, P1759, DOI 10.1084/jem.20160368; ROGERS RC, 1980, BRAIN RES BULL, V5, P365, DOI 10.1016/S0361-9230(80)80006-2; Sakata K, 2010, GENES BRAIN BEHAV, V9, P712, DOI 10.1111/j.1601-183X.2010.00605.x; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Santiago RM, 2010, PROG NEURO-PSYCHOPH, V34, P1104, DOI 10.1016/j.pnpbp.2010.06.004; Sarinana J, 2016, HIPPOCAMPUS, V26, P76, DOI 10.1002/hipo.22492; Song NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13419; Song N, 2017, MOVEMENT DISORD, V32, P1487, DOI 10.1002/mds.27095; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178; Svensson E, 2015, ANN NEUROL, V78, P522, DOI 10.1002/ana.24448; Tadaiesky MT, 2008, NEUROSCIENCE, V156, P830, DOI 10.1016/j.neuroscience.2008.08.035; Talaga AK, 2017, J NEUROSCI, V37, P5699, DOI 10.1523/JNEUROSCI.0392-17.2017; Tarutani A, 2016, J BIOL CHEM, V291, P18675, DOI 10.1074/jbc.M116.734707; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; TERHORST GJ, 1991, NEUROSCIENCE, V45, P153, DOI 10.1016/0306-4522(91)90111-Z; Tysnes OB, 2015, ANN NEUROL, V78, P1011, DOI 10.1002/ana.24531; Uemura N, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0257-5; Ulusoy A, 2013, EMBO MOL MED, V5, P1119, DOI 10.1002/emmm.201302475; Villageliu DN, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy096; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wakabayashi K, 2010, ACTA NEUROPATHOL, V120, P1, DOI 10.1007/s00401-010-0706-x; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Williams DL, 2003, ENDOCRINOLOGY, V144, P5184, DOI 10.1210/en.2003-1059; Wu CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27358	81	493	508	26	178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2019	103	4					627	+		10.1016/j.neuron.2019.05.035	http://dx.doi.org/10.1016/j.neuron.2019.05.035			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IS5GG	31255487	Bronze, Green Accepted			2022-12-17	WOS:000482179900011
J	Silberberg, G; Markram, H				Silberberg, Gilad; Markram, Henry			Disynaptic inhibition between neocortical pyramidal cells mediated by martinotti cells	NEURON			English	Article							ACTION-POTENTIAL INITIATION; DENDRITIC CALCIUM SPIKES; SOMATOSENSORY CORTEX; SYNAPTIC CONNECTIONS; INTRACELLULAR-RECORDINGS; GABAERGIC INTERNEURONS; VISUAL-CORTEX; BARREL CORTEX; RAT NEOCORTEX; ADULT-RAT	Reliable activation of inhibitory pathways is essential for maintaining the balance between excitation and inhibition during cortical activity. Little is known, however, about the activation of these pathways at the level of the local neocortical microcircuit. We report a disynaptic inhibitory pathway among neocortical pyramidal cells (PCs). Inhibitory responses were evoked in layer 5 PCs following stimulation of individual neighboring PCs with trains of action potentials. The probability for inhibition between PCs was more than twice that of direct excitation, and inhibitory responses increased as a function of rate and duration of presynaptic discharge. Simultaneous somatic and dendritic recordings indicated that inhibition originated from PC apical and tuft dendrites. Multineuron whole-cell recordings from PCs and interneurons combined with morphological reconstructions revealed the mediating interneurons as Martinotti cells. Martinotti cells received facilitating synapses from PCs and formed reliable inhibitory synapses onto dendrites of neighboring PCs. We describe this feedback pathway and propose it as a central mechanism for regulation of cortical activity.	Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, SE-17177 Stockholm, Sweden	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Karolinska Institutet	Silberberg, G (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	gilad.silberberg@ki.se	Silberberg, Gilad/A-1048-2012	Silberberg, Gilad/0000-0001-9964-505X				Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Braitenberg VB, 1998, CORTEX STAT GEOMETRY; Buckmaster PS, 1999, J NEUROSCI, V19, P9519; Carnevale N. T., 1995, Advances in Neural Information Processing Systems 7, P69; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Douglas R. J., 1990, SYNAPTIC ORG BRAIN, P389; Fairen A., 1984, CELLULAR COMPONENTS; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; Goldberg JH, 2004, J PHYSIOL-LONDON, V558, P465, DOI 10.1113/jphysiol.2004.064519; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; KILLACKEY HP, 1989, J COMP NEUROL, V282, P428, DOI 10.1002/cne.902820309; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Marco P, 1996, BRAIN, V119, P1327, DOI 10.1093/brain/119.4.1327; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Oakley JC, 2001, J NEUROPHYSIOL, V86, P514, DOI 10.1152/jn.2001.86.1.514; Oda S, 2004, NEUROSCI LETT, V367, P394, DOI 10.1016/j.neulet.2004.06.042; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Ramon y Cajal S, 1891, CELLULE, V7, P3; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; RINALDI T, 2005, AUTISM DISORDER HYPE; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2003, J NEUROSCI, V23, P7358	63	493	499	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					735	746		10.1016/j.neuron.2007.02.012	http://dx.doi.org/10.1016/j.neuron.2007.02.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329212	Bronze			2022-12-17	WOS:000245127100013
J	Dolcos, F; LaBar, KS; Cabeza, R				Dolcos, F; LaBar, KS; Cabeza, R			Interaction between the amygdala and the medial temporal lobe memory system predicts better memory for emotional events	NEURON			English	Article							DECLARATIVE MEMORY; FREE-RECALL; LONG-TERM; HIPPOCAMPAL; CONSOLIDATION; AROUSAL; CORTEX; TASK; TEMPOROPOLAR; MODULATION	Emotional events are remembered better than neutral events possibly because the amygdala enhances the function of medial temporal lobe (MTL) memory system (modulation hypothesis). Although this hypothesis has been supported by much animal research, evidence from humans has been scarce and indirect. We investigated this issue using event-related fMRI during encoding of emotional and neutral pictures. Memory performance after scanning showed a retention advantage for emotional pictures. Successful encoding activity in the amygdala and MTL memory structures was greater and more strongly correlated for emotional than for neutral pictures. Moreover, a double dissociation was found along the longitudinal axis of the MTL memory system: activity in anterior regions predicted memory for emotional items, whereas activity in posterior regions predicted memory for neutral items. These results provide direct evidence for the modulation hypothesis in humans and reveal a functional specialization within the MTL regarding the effects of emotion on memory formation.	Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2S2, Canada; Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA	University of Alberta; Duke University	Dolcos, F (corresponding author), Duke Univ, Brain Imaging & Anal Ctr, POB 3918, Durham, NC 27710 USA.	fdolcos@duke.edu	Dolcos, Florin/GZL-8448-2022	Dolcos, Florin/0000-0003-2230-4139	NIA NIH HHS [R01 AG019731, R01 AG19731] Funding Source: Medline; NIDA NIH HHS [R01 DA14094] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG019731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014094] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Adolphs R, 2000, LEARN MEMORY, V7, P180, DOI 10.1101/lm.7.3.180; Alkire MT, 1998, P NATL ACAD SCI USA, V95, P14506, DOI 10.1073/pnas.95.24.14506; AMARAL D G, 1992, P1; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brierley B, 2002, BRAIN RES REV, V39, P84, DOI 10.1016/S0165-0173(02)00160-1; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Cahill L, 1998, Adv Pharmacol, V42, P964; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Canli T, 2000, J NEUROSCI, V20; Christianson SA., 1992, HDB EMOTION MEMORY R; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Dolcos F, 2002, COGN AFFECT BEHAV NE, V2, P252, DOI 10.3758/CABN.2.3.252; Duvernoy H. M., 1999, HUMAN BRAIN SURFACE; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Jha AP, 2000, J COGNITIVE NEUROSCI, V12, P90, DOI 10.1162/089892900564091; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Pruessner JC, 2002, CEREB CORTEX, V12, P1342, DOI 10.1093/cercor/12.12.1342; Roesler R, 2002, EUR J NEUROSCI, V15, P905, DOI 10.1046/j.1460-9568.2002.01924.x; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Shields S.A, 1991, INT REV STUDIES EMOT, P227; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499	52	493	513	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					855	863		10.1016/S0896-6273(04)00289-2	http://dx.doi.org/10.1016/S0896-6273(04)00289-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182723	Bronze			2022-12-17	WOS:000221975000015
J	Hickok, G; Houde, J; Rong, F				Hickok, Gregory; Houde, John; Rong, Feng			Sensorimotor Integration in Speech Processing: Computational Basis and Neural Organization	NEURON			English	Article							DELAYED AUDITORY-FEEDBACK; SUPERIOR TEMPORAL GYRUS; SENSORY-MOTOR INTEGRATION; CONDUCTION APHASIA; PLANUM TEMPORALE; ATTENTION INCREASES; CORTICAL ACTIVATION; MIRROR NEURONS; WORKING-MEMORY; LEXICAL ACCESS	Sensorimotor integration is an active domain of speech research and is characterized by two main ideas, that the auditory system is critically involved in speech production and that the motor system is critically involved in speech perception. Despite the complementarity of these ideas, there is little crosstalk between these literatures. We propose an integrative model of the speech-related "dorsal stream" in which sensorimotor interaction primarily supports speech production, in the form of a state feedback control architecture. A critical component of this control system is forward sensory prediction, which affords a natural mechanism for limited motor influence on perception, as recent perceptual research has suggested. Evidence shows that this influence is modulatory but not necessary for speech perception. The neuroanatomy of the proposed circuit is discussed as well as some probable clinical correlates including conduction aphasia, stuttering, and aspects of schizophrenia.	[Hickok, Gregory; Rong, Feng] Univ Calif Irvine, Ctr Cognit Neurosci, Ctr Hearing Res, Dept Cognit Sci, Irvine, CA 92697 USA; [Houde, John] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California Irvine; University of California System; University of California San Francisco	Rong, F (corresponding author), Univ Calif Irvine, Ctr Cognit Neurosci, Ctr Hearing Res, Dept Cognit Sci, Irvine, CA 92697 USA.	greg.hickok@uci.edu	Rong, Feng/J-3522-2013		NIH [DC009659, 1R01DC010145-01A1]; NSF [BCS-0926196]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009659] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant DC009659 to G.H. and by NSF grant BCS-0926196 and NIH grant 1R01DC010145-01A1 to J.H.	Aliu SO, 2009, J COGNITIVE NEUROSCI, V21, P791, DOI 10.1162/jocn.2009.21055; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Anderson JM, 1999, BRAIN LANG, V70, P1, DOI 10.1006/brln.1999.2135; Baldo JV, 2008, BRAIN LANG, V105, P134, DOI 10.1016/j.bandl.2007.12.007; BENSON DF, 1973, ARCH NEUROL-CHICAGO, V28, P339, DOI 10.1001/archneur.1973.00490230075011; BISHOP DVM, 1990, J SPEECH HEAR RES, V33, P210, DOI 10.1044/jshr.3302.210; BOLLER F, 1978, CORTEX, V14, P212, DOI 10.1016/S0010-9452(78)80047-1; BOLLER F, 1978, NEUROPSYCHOLOGIA, V16, P521, DOI 10.1016/0028-3932(78)90078-7; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Buchsbaum BR, 2005, NEURON, V48, P687, DOI 10.1016/j.neuron.2005.09.029; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Buchsbaum BR, 2011, BRAIN LANG, V119, P119, DOI 10.1016/j.bandl.2010.12.001; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; CARAMAZZA A, 1988, ANNU REV NEUROSCI, V11, P395, DOI 10.1146/annurev.neuro.11.1.395; Christen HJ, 2000, DEV MED CHILD NEUROL, V42, P122, DOI 10.1017/S0012162200000232; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COOPER WE, 1974, NATURE, V252, P121, DOI 10.1038/252121a0; Corina DP, 2006, CORTEX, V42, P529, DOI 10.1016/S0010-9452(08)70393-9; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; DAMASIO AR, 1992, NEW ENGL J MED, V326, P531, DOI 10.1056/NEJM199202203260806; DAMASIO H, 1980, BRAIN, V103, P337, DOI 10.1093/brain/103.2.337; de Zubicaray GI, 2009, COGN AFFECT BEHAV NE, V9, P260, DOI 10.3758/CABN.9.3.260; DECETY J, 1989, BRAIN COGNITION, V11, P87, DOI 10.1016/0278-2626(89)90007-9; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; Delvaux V, 2007, PHONETICA, V64, P145, DOI 10.1159/000107914; Dronkers N. F., 2009, ENCYCL NEUROSCI, P343, DOI [10.1016/B978-008045046-9.01876-3, DOI 10.1016/B978-008045046-9.01876-3]; Durisko C, 2010, CORTEX, V46, P896, DOI 10.1016/j.cortex.2009.09.009; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; Emmorey K, 2010, NEUROIMAGE, V49, P994, DOI 10.1016/j.neuroimage.2009.08.001; Fadiga L, 2003, BRAIN COGNITION, V53, P514, DOI 10.1016/S0278-2626(03)00212-4; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Fadiga L, 2009, ANN NY ACAD SCI, V1169, P448, DOI 10.1111/j.1749-6632.2009.04582.x; Fairbanks G, 1954, J SPEECH HEAR DISORD, V19, P133, DOI 10.1044/jshd.1902.133; Foundas AL, 2004, NEUROLOGY, V63, P1640, DOI 10.1212/01.WNL.0000142993.33158.2A; FRANKLIN GF, 1991, FEEDBACK CONTROL DYN; Fridriksson J, 2010, J NEUROSCI, V30, P11057, DOI 10.1523/JNEUROSCI.1120-10.2010; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Fuster JM, 1995, MEMORY CEREBRAL CORT; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; GESCHWIND N, 1971, NEW ENGL J MED, V284, P654, DOI 10.1056/NEJM197103252841206; Goldberg TE, 1997, AM J PSYCHIAT, V154, P858; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Goodglass H, 1992, CONDUCTION APHASIA, P39; Goodglass H, 2001, ASSESSMENT APHASIA R, V3rd; Grafton S, 2009, COGNITIVE NEUROSCIEN, P641; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2007, J COGNITIVE NEUROSCI, V19, P617, DOI 10.1162/jocn.2007.19.4.617; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Hauser M, 2010, ANNU REV PSYCHOL, V61, P303, DOI 10.1146/annurev.psych.093008.100434; Heinks-Maldonado TH, 2007, ARCH GEN PSYCHIAT, V64, P286, DOI 10.1001/archpsyc.64.3.286; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2003, BEHAV BRAIN SCI, V26, P740, DOI 10.1017/S0140525X03340166; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hickok G, 2008, BRAIN LANG, V107, P179, DOI 10.1016/j.bandl.2008.09.006; Hickok G, 2000, NEUROSCI LETT, V287, P156, DOI 10.1016/S0304-3940(00)01143-5; Hickok G., 2000, LANGUAGE BRAIN, P87; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2010, CURR BIOL, V20, pR593, DOI 10.1016/j.cub.2010.05.047; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; Hickok G, 2010, BRAIN LANG, V112, P1, DOI 10.1016/j.bandl.2009.10.006; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hickok G, 2009, J NEUROPHYSIOL, V101, P2725, DOI 10.1152/jn.91099.2008; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Hillis AE, 2007, NEUROLOGY, V69, P200, DOI 10.1212/01.wnl.0000265600.69385.6f; Holt LL, 2005, PSYCHOL SCI, V16, P305, DOI 10.1111/j.0956-7976.2005.01532.x; Holt LL, 2008, CURR DIR PSYCHOL SCI, V17, P42, DOI 10.1111/j.1467-8721.2008.00545.x; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; JACOBS OLR, 1993, INTRO CONTROLL THEOR; Jacquemot C, 2007, COGN NEUROPSYCHOL, V24, P3, DOI 10.1080/02643290600683342; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Jazayeri M, 2007, NATURE, V446, P912, DOI 10.1038/nature05739; Kappes J, 2009, BRAIN LANG, V111, P140, DOI 10.1016/j.bandl.2009.08.008; Knapp HP, 2010, BRAIN LANG, V112, P36, DOI 10.1016/j.bandl.2009.04.002; Krigolson OE, 2007, BRAIN RES, V1155, P70, DOI 10.1016/j.brainres.2007.04.024; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LENNEBERG EH, 1962, J ABNORM PSYCHOL, V65, P419, DOI 10.1037/h0041906; Levelt W. J. M., 1989, SPEAKING FROM INTENT; Levelt WJM, 1998, J COGNITIVE NEUROSCI, V10, P553, DOI 10.1162/089892998562960; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; LIBERMAN AM, 1989, SCIENCE, V243, P489, DOI 10.1126/science.2643163; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; LIBERMAN AM, 1957, J ACOUST SOC AM, V29, P117, DOI 10.1121/1.1908635; Lotto AJ, 1997, J ACOUST SOC AM, V102, P1134, DOI 10.1121/1.419865; Lotto AJ, 2009, TRENDS COGN SCI, V13, P110, DOI 10.1016/j.tics.2008.11.008; MACNEILAGE PF, 1967, J SPEECH HEAR RES, V10, P449, DOI 10.1044/jshr.1003.449; Maguire GA, 2004, EXPERT OPIN PHARMACO, V5, P1565, DOI 10.1517/14656566.5.7.1565; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; MARTIN R, 1979, J SPEECH HEAR RES, V22, P132, DOI 10.1044/jshr.2201.132; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Massaro DW, 2008, PSYCHON B REV, V15, P453, DOI 10.3758/PBR.15.2.453; MASSARO DW, 1972, PSYCHOL REV, V79, P124, DOI 10.1037/h0032264; Max L., 2004, CONT ISSUES COMMUNIC, V31, P105, DOI [DOI 10.1044/CICSD_31_S_105, 10.1044/cicsd_31_S_105]; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCARTHY R, 1984, BRAIN, V107, P463, DOI 10.1093/brain/107.2.463; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Mottonen R, 2009, J NEUROSCI, V29, P9819, DOI 10.1523/JNEUROSCI.6018-08.2009; Mulliken G.H., 2009, COGNITIVE NEUROSCIEN, P599; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; NAESER MA, 1989, BRAIN, V112, P1, DOI 10.1093/brain/112.1.1; Navalpakkam V, 2007, NEURON, V53, P605, DOI 10.1016/j.neuron.2007.01.018; Okada K, 2006, BRAIN LANG, V98, P112, DOI 10.1016/j.bandl.2006.04.006; Oppenheim GM, 2008, COGNITION, V106, P528, DOI 10.1016/j.cognition.2007.02.006; Pa J, 2008, NEUROPSYCHOLOGIA, V46, P362, DOI 10.1016/j.neuropsychologia.2007.06.024; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Pulvermuller F, 1996, PSYCHOPHYSIOLOGY, V33, P317, DOI 10.1111/j.1469-8986.1996.tb01057.x; Purcell DW, 2006, J ACOUST SOC AM, V119, P2288, DOI 10.1121/1.2173514; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Sams M, 2005, COGNITIVE BRAIN RES, V23, P429, DOI 10.1016/j.cogbrainres.2004.11.006; Sancier ML, 1997, J PHONETICS, V25, P421, DOI 10.1006/jpho.1997.0051; Sato M, 2009, BRAIN LANG, V111, P1, DOI 10.1016/j.bandl.2009.03.002; Schwartz JL, 2012, J NEUROLINGUIST, V25, P336, DOI 10.1016/j.jneuroling.2009.12.004; Scolari M, 2009, J NEUROSCI, V29, P11933, DOI 10.1523/JNEUROSCI.5642-08.2009; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shelton JR, 1999, PSYCHON B REV, V6, P5, DOI 10.3758/BF03210809; Shiller DM, 2009, J ACOUST SOC AM, V125, P1103, DOI 10.1121/1.3058638; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Smiley JF, 2009, EUR J NEUROSCI, V30, P449, DOI 10.1111/j.1460-9568.2009.06838.x; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Stuart A, 2002, J ACOUST SOC AM, V111, P2237, DOI 10.1121/1.1466868; Stuart A, 2008, J SPEECH LANG HEAR R, V51, P889, DOI 10.1044/1092-4388(2008/065); Sundara M, 2001, NEUROREPORT, V12, P1341, DOI 10.1097/00001756-200105250-00010; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Ventura MI, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-58; Watkins K, 2004, J COGNITIVE NEUROSCI, V16, P978, DOI 10.1162/0898929041502616; WELLER M, 1993, J NEUROL, V240, P199, DOI 10.1007/BF00818705; Wernicke C., 1874, BOSTON COLL STUD PH, P34, DOI DOI 10.1007/978-94-010-3378-7_2; WIENER, 1948, CYBERNETICS CONTROL; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wilson SM, 2009, HUM BRAIN MAPP, V30, P3596, DOI 10.1002/hbm.20782; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; YATES AJ, 1963, PSYCHOL BULL, V60, P213, DOI 10.1037/h0044155	160	492	497	4	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 10	2011	69	3					407	422		10.1016/j.neuron.2011.01.019	http://dx.doi.org/10.1016/j.neuron.2011.01.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	724XM	21315253	Green Accepted, Bronze			2022-12-17	WOS:000287609700004
J	HERB, A; BURNASHEV, N; WERNER, P; SAKMANN, B; WISDEN, W; SEEBURG, PH				HERB, A; BURNASHEV, N; WERNER, P; SAKMANN, B; WISDEN, W; SEEBURG, PH			THE KA-2 SUBUNIT OF EXCITATORY AMINO-ACID RECEPTORS SHOWS WIDESPREAD EXPRESSION IN BRAIN AND FORMS ION CHANNELS WITH DISTANTLY RELATED SUBUNITS	NEURON			English	Article								A new ionotropic glutamate receptor subunit termed KA-2, cloned from rat brain cDNA, exhibits high affinity for [H-3]kainate (K(D) almost-equal-to 15 nM). KA-2 mRNA is widely expressed in embryonic and adult brain. Homomeric KA-2 expression does not generate agonist-sensitive channels, but currents are observed when KA-2 is coexpressed with GluR5 or GluR6 subunits. Specifically, coexpression of GluR5(R) and KA-2 produces channel activity, whereas homomeric expression of either subunit does not. Currents through heteromeric GluR5(Q)/KA-2 channels show more rapid desensitization and different current-voltage relations when compared with GluR5(Q) currents. GluR6/KA-2 channels are gated by AMPA, which fails to gate homomeric GluR6 receptor channels. These results suggest possible in vivo partnership relations for high affinity kainate receptors.	MAX PLANCK INST MED RES, ZELLPHYSIOL ABT, W-6900 HEIDELBERG 1, GERMANY	Max Planck Society	HERB, A (corresponding author), UNIV HEIDELBERG, CTR MOLEC BIOL, INF 282, W-6900 HEIDELBERG, GERMANY.		Burnashev, Nail/G-4056-2013; Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334				AMBROSINI A, 1991, FEBS LETT, V281, P27, DOI 10.1016/0014-5793(91)80350-C; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DAWSON TL, 1990, MOL PHARMACOL, V38, P779; DINGLEDINE R, 1991, TRENDS PHARMACOL SCI, V12, P360, DOI 10.1016/0165-6147(91)90602-O; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; FOSTER AC, 1981, NATURE, V289, P73, DOI 10.1038/289073a0; Gasic G P, 1991, Curr Opin Neurobiol, V1, P20, DOI 10.1016/0959-4388(91)90006-S; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GU YP, 1991, NEURON, V6, P777, DOI 10.1016/0896-6273(91)90174-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMPSON DR, 1987, J NEUROCHEM, V49, P1209, DOI 10.1111/j.1471-4159.1987.tb10012.x; HENLEY J M, 1989, New Biologist, V1, P153; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1990, COLD SH Q B, V55, P41; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JONAS P, 1991, J PHYSIOL-LONDON, V438, pP321; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; LONDON ED, 1979, MOL PHARMACOL, V15, P492; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MILLER LP, 1990, NEUROSCIENCE, V35, P45, DOI 10.1016/0306-4522(90)90118-N; MILLER RJ, 1991, TRENDS NEUROSCI, V14, P477, DOI 10.1016/0166-2236(91)90054-X; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; Paxinos G., 1991, ATLAS DEV RAT BRAIN; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; ROGERS SW, 1991, J NEUROSCI, V11, P2713; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEBURG PH, 1990, COLD SH Q B, V55, P29; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SOMMER B, 1992, IN PRESS EMBO J; UNNERSTALL JR, 1983, EUR J PHARMACOL, V86, P361, DOI 10.1016/0014-2999(83)90185-1; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VERDOORN TA, 1989, MOL PHARMACOL, V35, P360; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WENTHOLD RJ, 1990, FEBS LETT, V276, P147, DOI 10.1016/0014-5793(90)80529-R; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; WISDEN W, 1991, MOL NEUROBIOLOGY PRA, P205; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOUNG AB, 1990, TRENDS PHARMACOL SCI, V11, P126, DOI 10.1016/0165-6147(90)90199-I	58	492	498	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					775	785		10.1016/0896-6273(92)90098-X	http://dx.doi.org/10.1016/0896-6273(92)90098-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1373632				2022-12-17	WOS:A1992HQ18800016
J	Fulton, S; Pissios, P; Manchon, RP; Stiles, L; Frank, L; Pothos, EN; Maratos-Flier, E; Flier, JS				Fulton, Stephanie; Pissios, Pavlos; Manchon, Ramon Pinol; Stiles, Linsey; Frank, Lauren; Pothos, Emmanuel N.; Maratos-Flier, Eleftheria; Flier, Jeffrey S.			Leptin regulation of the mesoaccumbens dopamine pathway	NEURON			English	Article							BRAIN REWARD CIRCUITRY; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; OB/OB MICE; BODY-WEIGHT; EXTRACELLULAR DOPAMINE; TYROSINE-HYDROXYLASE; PREFRONTAL CORTEX; NEUROPEPTIDE-Y; FOOD REWARD	Leptin is an adipose-derived hormone that acts on hypothalamic leptin receptors to regulate energy balance. Leptin receptors are also expressed in extra-hypothalamic sites including the ventral tegmental area (VTA), critical to brain reward circuitry. We report that leptin targets DA and GABA neurons of the VTA, inducing phosphorylation of signal-transducer-and-activator-of-transcription-3 (STAT3). Retrograde tracing combined with pSTAT3 immunohistochemistry show leptin-responsive VTA neurons projecting to nucleus accumbens (NAc). Assessing leptin function in the VTA, we showed that ob/ob mice had diminished locomotor response to amphetamine and lacked locomotor sensitization to repeated amphetamine injections, both defects reversed by leptin infusion. Electrically stimulated DA release from NAc shell terminals was markedly reduced in ob/ob slice preparations, and NAc DA levels and TH expression were lower. These data define a role for leptin in mesoaccumbens DA signaling and indicate that the mesoaccumbens DA pathway, critical to integrating motivated behavior, responds to this adipose-derived signal.	Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Tufts Univ, Sch Med, Program Neurosci, Boston, MA 02111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Tufts University; Tufts University	Maratos-Flier, E (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.	emaratos@bidmc.harvard.edu	Jansen, Heiko T./A-5770-2008; Flier, jeffrey/AAG-6223-2019; Chee, Melissa/G-4150-2014	Jansen, Heiko T./0000-0003-0178-396X; Chee, Melissa/0000-0003-3815-9095; Pothos, Emmanuel/0000-0001-8825-7852; Stiles, Linsey/0000-0002-1514-458X; Pinol, Ramon/0000-0002-8877-8444	NIDDK NIH HHS [DK069983, 1R01DK065872] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069983, R01DK065872] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahn S, 2002, J NEUROSCI, V22, P10958; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bassareo V, 1999, EUR J NEUROSCI, V11, P4389, DOI 10.1046/j.1460-9568.1999.00843.x; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CIOLKOWSKI EL, 1994, ANAL CHEM, V66, P3611, DOI 10.1021/ac00093a013; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; FARNEBO LO, 1971, ACTA PHYSIOL SCAND, P35; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2004, BEHAV BRAIN RES, V155, P319, DOI 10.1016/j.bbr.2004.05.021; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hao J, 2004, PHYSIOL BEHAV, V83, P377, DOI 10.1016/j.physbeh.2004.08.007; Harada K, 1996, J NEUROCHEM, V67, P629; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Hay-Schmidt A, 2001, NEUROENDOCRINOLOGY, V73, P215, DOI 10.1159/000054638; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; HOEBEL BG, 1983, PSYCHOPHARMACOLOGY, V81, P158, DOI 10.1007/BF00429012; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jedynak JP, 2002, J NEUROCHEM, V82, P382, DOI 10.1046/j.1471-4159.2002.00982.x; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Martel P, 1996, PHARMACOL BIOCHEM BE, V53, P221, DOI 10.1016/0091-3057(95)00187-5; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PHILLIPSON OT, 1985, NEUROSCIENCE, V16, P275, DOI 10.1016/0306-4522(85)90002-8; POTHOS EN, 1995, J NEUROSCI, V15, P6640; Pothos EN, 1998, APPETITE, V31, P405, DOI 10.1006/appe.1998.0210; Robinson S, 2005, BEHAV NEUROSCI, V119, P5, DOI 10.1037/0735-7044.119.1.5; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Scislowski PWD, 1999, INT J OBESITY, V23, P425, DOI 10.1038/sj.ijo.0800893; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; Shalev U, 2001, J NEUROSCI, V21; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Zaborszky L, 2001, BEHAV GENET, V31, P47, DOI 10.1023/A:1010257808945; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885	60	490	498	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					811	822		10.1016/j.neuron.2006.09.006	http://dx.doi.org/10.1016/j.neuron.2006.09.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982425	Bronze			2022-12-17	WOS:000240997900018
J	Ross, SE; Greenberg, ME; Stiles, CD				Ross, SE; Greenberg, ME; Stiles, CD			Basic helix-loop-helix factors in cortical development	NEURON			English	Review							BHLH TRANSCRIPTION FACTORS; MAMMALIAN ACHAETE-SCUTE; CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; STEM-CELLS; OLIGODENDROCYTE DIFFERENTIATION; TARGETED DISRUPTION; DETERMINATION GENES; DYNAMIC EXPRESSION; VENTRICULAR ZONE	Transcription factors with bHLH motifs modulate critical events in the development of the mammalian neocortex. Multipotent cortical progenitors are maintained in a proliferative state by bHLH factors from the Id and Hes families. The transition from proliferation to neurogenesis involves a coordinate increase in the activity of proneural bHLH factors (Mash1, Neurogenin1,, and Neurogenin2) and a decrease in the activity of Hes and Id factors. As development proceeds, inhibition of proneural bHLH factors in cortical progenitors promotes the formation of astrocytes. Finally, the formation of oligodendrocytes is triggered by an increase in the activity of bHLH factors Olig1 and Olig2 that may be coupled with a decrease in Id activity. Thus, bHLH factors have key roles in corticogenesis, affecting the timing of differentiation and the specification of cell fate.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Neurobiol,Div Neurosci, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Stiles, CD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Microbiol & Mol Genet, 44 Binney St, Boston, MA 02115 USA.	charies_stiles@dfci.harvard.edu			NICHD NIH HHS [HD24926] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024926] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Alifragis P, 1997, P NATL ACAD SCI USA, V94, P13099, DOI 10.1073/pnas.94.24.13099; Allen T, 1999, CELL MOL BIOL, V45, P687; Altshuller Y, 1996, FEBS LETT, V393, P201, DOI 10.1016/0014-5793(96)00890-3; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Beatus P, 1998, J NEUROSCI RES, V54, P125, DOI 10.1002/(SICI)1097-4547(19981015)54:2<125::AID-JNR1>3.3.CO;2-C; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Casarosa S, 1999, DEVELOPMENT, V126, P525; Chapouton P, 2001, DEVELOPMENT, V128, P5149; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cohen SX, 2002, FEBS LETT, V528, P95, DOI 10.1016/S0014-5793(02)03257-X; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Deed RW, 1997, MOL CELL BIOL, V17, P6815, DOI 10.1128/MCB.17.12.6815; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Farah MH, 2000, DEVELOPMENT, V127, P693; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Fode C, 2000, GENE DEV, V14, P67; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; Hojo M, 2000, DEVELOPMENT, V127, P2515; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kabos P, 2002, J BIOL CHEM, V277, P8763, DOI 10.1074/jbc.C100758200; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; LEDENT V, 2002, GENOME BIOL, V3; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lee JK, 2000, DEV DYNAM, V217, P361, DOI 10.1002/(SICI)1097-0177(200004)217:4<361::AID-DVDY3>3.0.CO;2-8; Li WW, 1998, J NEUROSCI, V18, P8853; Lo LC, 2002, DEVELOPMENT, V129, P1553; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Ma QF, 1997, J NEUROSCI, V17, P3644; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; Norton JD, 2000, J CELL SCI, V113, P3897; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Park JK, 1999, J NEUROSCI, V19, P10383; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Schwab MH, 1998, J NEUROSCI, V18, P1408; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Talikka M, 2002, DEV BIOL, V247, P137, DOI 10.1006/dbio.2002.0677; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toma JG, 2000, J NEUROSCI, V20, P7648; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wu YY, 2003, DEV DYNAM, V226, P675, DOI 10.1002/dvdy.10278; Xu ZP, 2002, GENOMICS, V80, P311, DOI 10.1006/geno.2002.6833; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	110	490	516	4	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2003	39	1					13	25		10.1016/S0896-6273(03)00365-9	http://dx.doi.org/10.1016/S0896-6273(03)00365-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848929	Bronze			2022-12-17	WOS:000184057400006
J	Levy, D; Ronennus, M; Yamrom, B; Lee, YH; Leotta, A; Kendall, J; Marks, S; Lakshmi, B; Pai, D; Ye, K; Buja, A; Krieger, A; Yoon, S; Troge, J; Rodgers, L; Lossifov, I; Wigler, M				Levy, Dan; Ronennus, Michael; Yamrom, Boris; Lee, Yoon-Ha; Leotta, Anthony; Kendall, Jude; Marks, Steven; Lakshmi, B.; Pai, Deepa; Ye, Kenny; Buja, Andreas; Krieger, Abba; Yoon, Seungtai; Troge, Jennifer; Rodgers, Linda; Lossifov, Ivan; Wigler, Michael			Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders	NEURON			English	Article							RECURRENT MICRODELETIONS; ASSOCIATION; MUTATIONS; VARIANTS; MICRODUPLICATION; IDENTIFICATION; PREDISPOSE; EXPRESSION; DELETIONS; 15Q11.2	To explore the genetic contribution to autistic spectrum disorders (ASDs), we have studied genomic copy-number variation in a large cohort of families with a single affected child and at least one unaffected sibling. We confirm a major contribution from de novo deletions and duplications but also find evidence of a role for inherited "ultrarare" duplications. Our results show that, relative to males, females have greater resistance to autism from genetic causes, which raises the question of the fate of female carriers. By analysis of the proportion and number of recurrent loci, we set a lower bound for distinct target loci at several hundred. We find many new candidate regions, adding substantially to the list of potential gene targets, and confirm several loci previously observed. The functions of the genes in the regions of de novo variation point to a great diversity of genetic causes but also suggest functional convergence.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ye, Kenny] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Buja, Andreas; Krieger, Abba] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA	Cold Spring Harbor Laboratory; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania	Wigler, M (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	wigler@cshl.edu	Ye, Kenny/GSM-7731-2022; Ye, Kenny/U-2341-2019	Ye, Kenny/0000-0002-1466-855X; Wigler, Michael/0000-0003-4396-1971; Ronemus, Michael/0000-0003-0237-3540	Simons Foundation [SF51]	Simons Foundation	This work was supported by a grant from the Simons Foundation (SFARI award number SF51 to MW).	Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Glaubitz JC, 2003, MOL ECOL, V12, P1039, DOI 10.1046/j.1365-294X.2003.01790.x; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Hong S, 2002, MOL CELL NEUROSCI, V20, P298, DOI 10.1006/mcne.2002.1103; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Marie S, 1999, HUM MUTAT, V13, P197, DOI 10.1002/(SICI)1098-1004(1999)13:3<197::AID-HUMU3>3.0.CO;2-D; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Richler J, 2010, DEV PSYCHOPATHOL, V22, P55, DOI 10.1017/S0954579409990265; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; STONE RL, 1992, NAT GENET, V1, P59, DOI 10.1038/ng0492-59; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van der Zwaag B, 2010, AM J MED GENET B, V153B, P960, DOI 10.1002/ajmg.b.31055; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	41	489	506	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 9	2011	70	5					886	897		10.1016/j.neuron.2011.05.015	http://dx.doi.org/10.1016/j.neuron.2011.05.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658582	Bronze			2022-12-17	WOS:000291843500009
J	SAIDO, TC; IWATSUBO, T; MANN, DMA; SHIMADA, H; IHARA, Y; KAWASHIMA, S				SAIDO, TC; IWATSUBO, T; MANN, DMA; SHIMADA, H; IHARA, Y; KAWASHIMA, S			DOMINANT AND DIFFERENTIAL DEPOSITION OF DISTINCT BETA-AMYLOID PEPTIDE SPECIES, A-BETA(N3(PE)), IN SENILE PLAQUES	NEURON			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; CORE PROTEIN; MECHANISM; DIAGNOSIS; BRAIN	We analyzed an amino-terminal modification of beta-amyloid (A beta) peptide in brain, using anti-A beta antibodies that distinguish distinct molecular species. Examination of cortical sections from 28 aged individuals with a wide range in senile plaque density revealed that a molecular species distinct from the standard A beta is deposited in the brain in a dominant and differential manner. This modified A beta peptide (A beta(N3(pE))) starts at the 3rd aminoterminal residue of the standard A beta, glutamate, converted to pyroglutamate through intramolecular dehydration, Because plaqules composed of A beta(N3(pE)) are present in equivalent or greater densities than those composed of standard A beta bearing the first aminoterminal residue (A beta(N1)) and because deposition of the former species appears to precede deposition of the Tatter, as confirmed with specimens from Down's syndrome patients, the processes involved in A beta(N3(pE)) production and retention may play an early and critical role in senile plaque formation.	UNIV TOKYO,FAC PHARMACEUT SCI,DEPT NEUROPATHOL & NEUROSCI,BUNKYO KU,TOKYO 113,JAPAN; UNIV MANCHESTER,DEPT PATHOL SCI,MANCHESTER,LANCS,ENGLAND; TOKYO MED COLL,DEPT PATHOL,SHINJUKU KU,TOKYO 160,JAPAN; UNIV TOKYO,INST BRAIN RES,DEPT NEUROPATHOL,BUNKYO KU,TOKYO,JAPAN	University of Tokyo; University of Manchester; Tokyo Medical University; University of Tokyo	SAIDO, TC (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT MOLEC BIOL,BUNKYO KU,TOKYO 113,JAPAN.		Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903				ARMSTRONG RA, 1993, ACTA NEUROPATHOL, V86, P36, DOI 10.1007/BF00454896; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P238; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOWING E, 1994, J BIOL CHEM, V269, P10987; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KANEMARU K, 1990, AM J PATHOL, V137, P677; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KITAMOTO T, 1987, LAB INVEST, V57, P230; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MATTSON MP, 1993, TRENDS NEUROSCI, V16, P409, DOI 10.1016/0166-2236(93)90009-B; MCDONALD JK, 1986, MAMMALIAN PROTEASES, V2, P305; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; MORI H, 1992, J BIOL CHEM, V267, P17082; MULLAN M, 1993, TRENDS NEUROSCI, V16, P398, DOI 10.1016/0166-2236(93)90007-9; OLIVER C, 1986, PSYCHOL MED, V16, P307, DOI 10.1017/S0033291700009120; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J BIOL CHEM, V268, P3072; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SAIDO TC, 1994, J BIOL CHEM, V269, P15253; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; YAMAGUCHI H, 1989, AM J PATHOL, V135, P593; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201	32	489	521	0	27	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1995	14	2					457	466		10.1016/0896-6273(95)90301-1	http://dx.doi.org/10.1016/0896-6273(95)90301-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857653	Bronze			2022-12-17	WOS:A1995QH29400023
J	NAKANISHI, N; SHNEIDER, NA; AXEL, R				NAKANISHI, N; SHNEIDER, NA; AXEL, R			A FAMILY OF GLUTAMATE RECEPTOR GENES - EVIDENCE FOR THE FORMATION OF HETEROMULTIMERIC RECEPTORS WITH DISTINCT CHANNEL PROPERTIES	NEURON			English	Article									COLUMBIA UNIV COLL PHYS & SURG, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	NAKANISHI, N (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT BIOCHEM & MOLEC BIOPHYS, NEW YORK, NY 10032 USA.		Shneider, Neil/ABF-5751-2020	Shneider, Neil/0000-0002-3223-7366; Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V415, P555, DOI 10.1113/jphysiol.1989.sp017736; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DINGLEDINE R, 1988, CRIT REV NEUROBIOL, V4, P1; GILLILAND GL, 1981, J MOL BIOL, V146, P341, DOI 10.1016/0022-2836(81)90392-2; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KAO PN, 1986, J BIOL CHEM, V261, P8085; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MAO B, 1982, J BIOL CHEM, V257, P1131; MASTERS PS, 1981, J BACTERIOL, V147, P805, DOI 10.1128/JB.147.3.805-819.1981; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1987, J NEUROSCI, V7, P3230; MAYER ML, 1984, J PHYSIOL-LONDON, V354, P29, DOI 10.1113/jphysiol.1984.sp015360; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; NEWCOMER ME, 1979, J BIOL CHEM, V254, P7529; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; NUMA S, 1989, HARVEY LECT, V83, P121; OBERTHUR W, 1986, EMBO J, V5, P1815, DOI 10.1002/j.1460-2075.1986.tb04431.x; OBRIEN RJ, 1986, J NEUROSCI, V6, P3275; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PUSTELL JM, 1988, NUCLEIC ACIDS RES, V16, P1813, DOI 10.1093/nar/16.5.1813; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; RANDLE JCR, 1988, MOL CELL BIOCHEM, V80, P121; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VERDOORN TA, 1988, MOL PHARMACOL, V34, P298; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121	53	489	504	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1990	5	5					569	581		10.1016/0896-6273(90)90212-X	http://dx.doi.org/10.1016/0896-6273(90)90212-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	1699567	Green Accepted			2022-12-17	WOS:A1990EJ86800002
J	HOWARD, J; HUDSPETH, AJ				HOWARD, J; HUDSPETH, AJ			COMPLIANCE OF THE HAIR BUNDLE ASSOCIATED WITH GATING OF MECHANOELECTRICAL TRANSDUCTION CHANNELS IN THE BULLFROGS SACCULAR HAIR CELL	NEURON			English	Article											HOWARD, J (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.		Howard, Jonathon/J-7492-2016; Howard, Jonathon/D-4229-2011	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020429] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20429] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; BURTON AC, 1954, PHYSIOL REV, V34, P619, DOI 10.1152/physrev.1954.34.4.619; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; COREY DP, 1983, J NEUROSCI, V3, P942; COREY DP, 1980, J NEUROSCI METH, V3, P183, DOI 10.1016/0165-0270(80)90025-4; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FLOCK A, 1984, NATURE, V310, P597, DOI 10.1038/310597a0; FORD LE, 1981, J PHYSIOL-LONDON, V311, P219, DOI 10.1113/jphysiol.1981.sp013582; GOTTE L, 1974, J ULTRA MOL STRUCT R, V46, P23, DOI 10.1016/S0022-5320(74)80019-5; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1986, HEARING RES, V23, P93, DOI 10.1016/0378-5955(86)90178-4; HOWARD J, 1988, IN PRESS ANN REV BIO, V17; HUDSPETH A J, 1985, P193; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1983, ANNU REV NEUROSCI, V6, P187, DOI 10.1146/annurev.ne.06.030183.001155; HUDSPETH AJ, 1978, AM J PHYSIOL, V234, pC56, DOI 10.1152/ajpcell.1978.234.1.C56; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; KINSLER LE, 1982, FUNDAMENTALS ACOUSTI, P303; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; MURALT P, 1986, IBM J RES DEV, V30, P443, DOI 10.1147/rd.305.0443; OHMORI H, 1987, J PHYSIOL-LONDON, V387, P589, DOI 10.1113/jphysiol.1987.sp016590; OHMORI H, 1984, P NATL ACAD SCI-BIOL, V81, P1888, DOI 10.1073/pnas.81.6.1888; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; SAGNELLA GA, 1985, TRENDS BIOCHEM SCI, V10, P100, DOI 10.1016/0968-0004(85)90261-0; THOMAS RC, 1978, ION SENSITIVE INTRAC, P19	32	489	499	2	35	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1988	1	3					189	199		10.1016/0896-6273(88)90139-0	http://dx.doi.org/10.1016/0896-6273(88)90139-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	N5551	2483095				2022-12-17	WOS:A1988N555100003
J	Vinckier, F; Dehaene, S; Jobert, A; Dubus, JP; Sigman, M; Cohen, L				Vinckier, Fabien; Dehaene, Stanislas; Jobert, Antoinette; Dubus, Jean Philippe; Sigman, Mariano; Cohen, Laurent			Hierarchical coding of letter strings in the ventral stream: Dissecting the inner organization of the visual word-form system	NEURON			English	Article							OBJECT-PROCESSING STAGES; MEDIAL TEMPORAL-LOBE; LEFT FUSIFORM GYRUS; OCCIPITOTEMPORAL CORTEX; FIELD POTENTIALS; WRITTEN WORDS; NEURAL CODE; RECOGNITION; BRAIN; AREA	Visual word recognition has been proposed to rely on a hierarchy of increasingly complex neuronal detectors, from individual letters to bigrams and morphemes. We used fMR1 to test whether such a hierarchy is present in the left occipitotemporal cortex, at the site of the visual word-form area, and with an anterior-to-posterior progression. We exposed adult readers to (1) false-font strings; (2) strings of infrequent letters; (3) strings of frequent letters but rare bigrams; (4) strings with frequent bigrams but rare quadrigrams; (5) strings with frequent quadrigrams; (6) real words. A gradient of selectivity was observed through the entire span of the occipitotemporal cortex, with activation becoming more selective for higher-level stimuli toward the anterior fusiform region. A similar gradient was also seen in left inferior frontoinsular cortex. Those gradients were asymmetrical in favor of the left hemisphere. We conclude that the left occipitotemporal visual word-form area, far from being a homogeneous structure, presents a high degree of functional and spatial hierarchical organization which must result from a tuning process during reading acquisition.	INSERM, U562, Orsay, France; Coll France, F-75231 Paris, France; Hop La Pitie Salpetriere, Dept Neurol, AP HP, F-75013 Paris, France; Univ Paris 06, Fac Med Pitie Salpetriere, IFR 70, F-75005 Paris, France; CEA, DSV, IFR 49, F-91401 Orsay, France; Univ Paris Sud, IFR49, F-91191 Gif Sur Yvette, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Cohen, L (corresponding author), INSERM, U562, Orsay, France.	laurent.cohen@psl.aphp.fr		cohen, laurent/0000-0002-5010-9085; Vinckier, Fabien/0000-0003-4984-6296				Aghababian V, 2000, J EXP CHILD PSYCHOL, V76, P123, DOI 10.1006/jecp.1999.2540; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; DiVirgilio G, 1997, HUM BRAIN MAPP, V5, P347, DOI 10.1002/(SICI)1097-0193(1997)5:5<347::AID-HBM3>3.0.CO;2-3; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Giraud AL, 2001, J COGNITIVE NEUROSCI, V13, P754, DOI 10.1162/08989290152541421; Goswami U, 2006, TRENDS COGN SCI, V10, P142, DOI 10.1016/j.tics.2006.02.006; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hillis AE, 2004, BRAIN, V127, P1479, DOI 10.1093/brain/awh172; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Maurer U, 2006, NEUROIMAGE, V33, P749, DOI 10.1016/j.neuroimage.2006.06.025; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; Mukamel R, 2004, CEREB CORTEX, V14, P575, DOI 10.1093/cercor/bhh019; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; NOBRE AC, 1995, J NEUROSCI, V15, P1090; Nobre AC, 1998, BRAIN, V121, P1357, DOI 10.1093/brain/121.7.1357; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; PRINZMETAL W, 1990, J EXP PSYCHOL HUMAN, V16, P584; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Starrfelt R, 2007, NEUROIMAGE, V35, P334, DOI 10.1016/j.neuroimage.2006.12.003; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; TANKAKA K, 1996, ANNU REV NEUROSCI, V19, P109; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; WARRINGTON EK, 1980, BRAIN, V103, P99, DOI 10.1093/brain/103.1.99; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; Wydell TN, 2003, J COGNITIVE NEUROSCI, V15, P1052, DOI 10.1162/089892903770007434; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267	50	488	493	2	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					143	156		10.1016/j.neuron.2007.05.031	http://dx.doi.org/10.1016/j.neuron.2007.05.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	189TF	17610823	Bronze			2022-12-17	WOS:000248010700014
J	Impey, S; Mark, M; Villacres, EC; Poser, S; Chavkin, C; Storm, DR				Impey, S; Mark, M; Villacres, EC; Poser, S; Chavkin, C; Storm, DR			Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus	NEURON			English	Article							DROSOPHILA LEARNING MUTANT; APLYSIA SENSORY NEURONS; TERM POTENTIATION; CYCLIC-AMP; ADENYLATE-CYCLASE; PROTEIN-SYNTHESIS; SYNAPTIC ACTIVATION; SOMATOSTATIN GENE; PYRAMIDAL CELLS; CA-2+ CHANNELS	Gene expression regulated by the cAMP response element (CRE) has been implicated in synaptic plasticity and long-term memory. It has been proposed that CRE-mediated gene expression is stimulated by signals that induce long-term potentiation (LTP). To test this hypothesis, we made mice transgenic for a CRE-regulated reporter construct. We focused on longlasting long-term potentiation (L-LTP), because it depends on cAMP-dependent protein kinase activity (PKA) and de novo gene expression. CRE-mediated gene expression was markedly increased after L-LTP, but not after decremental LTP (D-LTP). Furthermore, inhibitors of PKA blocked L-LTP and associated increases in CRE-mediated gene expression. These data demonstrate that the signaling required for the generation of L-LTP but not D-LTP is sufficient to stimulate CRE-mediated transcription in the hippocampus.	UNIV WASHINGTON, SCH MED, DEPT PSYCHIAT & BEHAV SCI, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	Impey, S (corresponding author), UNIV WASHINGTON, SCH MED, DEPT PHARMACOL, SEATTLE, WA 98195 USA.		Mark, Melanie/ABF-9102-2020; Chavkin, Charles/G-2797-2010	Mark, Melanie/0000-0002-2788-6003; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20498] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P5637, DOI 10.1073/pnas.91.12.5637; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BARONDES SH, 1968, P NATL ACAD SCI USA, V61, P923, DOI 10.1073/pnas.61.3.923; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CHATTON B, 1994, ONCOGENE, V9, P375; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; CROW T, 1990, P NATL ACAD SCI USA, V87, P4490, DOI 10.1073/pnas.87.12.4490; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DECESARE D, 1995, ONCOGENE, V11, P365; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; FLEXNER LB, 1966, P NATL ACAD SCI USA, V55, P369, DOI 10.1073/pnas.55.2.369; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GRECKSCH G, 1980, PHARM BIOCH BEHAV, V12, P613; GROVER LM, 1994, SYNAPSE, V16, P66, DOI 10.1002/syn.890160108; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HANSE E, 1995, NEUROSCIENCE, V67, P531, DOI 10.1016/0306-4522(95)00090-6; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; HUANG YY, 1993, J NEUROSCI, V13, P568; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; IMPEY S, 1994, MOL CELL BIOL, V14, P8272, DOI 10.1128/MCB.14.12.8272; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KESNER RP, 1972, SCIENCE, V176, P432, DOI 10.1126/science.176.4033.432; KILBOURNE EJ, 1992, J BIOL CHEM, V267, P7563; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIU F, 1993, J BIOL CHEM, V268, P6714; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Matthies H, 1990, Adv Exp Med Biol, V268, P359; MEINKOTH J, 1990, CIBA F SYMP, V150, P47; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; REGEHR WG, 1992, J NEUROSCI, V12, P4202; REYMANN KG, 1989, NEUROSCI LETT, V96, P96, DOI 10.1016/0304-3940(89)90249-8; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; Slack JR, 1995, NEUROSCI LETT, V201, P25, DOI 10.1016/0304-3940(94)12121-6; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; SQUIRE LR, 1988, TRENDS NEUROSCI, V11, P170, DOI 10.1016/0166-2236(88)90144-0; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VANNGUYEN T, 1990, J NEUROSCI, V10, P2825; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; YOVELL Y, 1987, P NATL ACAD SCI USA, V84, P9285, DOI 10.1073/pnas.84.24.9285	85	488	497	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					973	982		10.1016/S0896-6273(00)80120-8	http://dx.doi.org/10.1016/S0896-6273(00)80120-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630255	Bronze			2022-12-17	WOS:A1996UN48000012
J	Lammel, S; Ion, DI; Roeper, J; Malenka, RC				Lammel, Stephan; Ion, Daniela I.; Roeper, Jochen; Malenka, Robert C.			Projection-Specific Modulation of Dopamine Neuron Synapses by Aversive and Rewarding Stimuli	NEURON			English	Article							VENTRAL TEGMENTAL AREA; COCAINE-INDUCED POTENTIATION; NUCLEUS-ACCUMBENS SHELL; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; IN-VIVO; DRUG-ADDICTION; MIDBRAIN; STRENGTH; SIGNALS	Midbrain dopamine (DA) neurons are not homogeneous but differ in their molecular properties and responses to external stimuli. We examined whether the modulation of excitatory synapses on DA neurons by rewarding or aversive stimuli depends on the brain area to which these DA neurons project. We identified DA neuron subpopulations in slices after injection of "Retrobeads" into single target areas of adult mice and found differences in basal synaptic properties. Administration of cocaine selectively modified excitatory synapses on DA cells projecting to nucleus accumbens (NAG) medial shell while an aversive stimulus selectively modified synapses on DA cells projecting to medial prefrontal cortex. In contrast, synapses on DA neurons projecting to NAc lateral shell were modified by both rewarding and aversive stimuli, which presumably reflects saliency. These results suggest that the mesocorticolimbic DA system may be comprised of three anatomically distinct circuits, each modified by distinct aspects of motivationally relevant stimuli.	[Lammel, Stephan; Ion, Daniela I.; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Roeper, Jochen] Goethe Univ Frankfurt, Ctr Neurosci, Inst Neurophysiol, D-60528 Frankfurt, Germany	Stanford University; Goethe University Frankfurt	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Lokey Stem Cell Res Bldg,265 Campus Dr,Room G1021, Stanford, CA 94305 USA.	malenka@stanford.edu	Lammel, Stephan/O-8295-2018	Lammel, Stephan/0000-0002-3350-3208; Roeper, Jochen/0000-0003-2145-8742	National Institute on Drug Abuse; German Academy of Sciences Leopoldina; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); German Academy of Sciences Leopoldina; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse and by a fellowship from the German Academy of Sciences Leopoldina (to S.L.). Retrograde tracing and immunohistochemistry were by S.L. and D.I.I. Electrophysiology was by S.L. The study was designed and results were analyzed and interpreted by S.L., J.R., and R.C.M. The manuscript was written by S.L., J.R., and R.C.M.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Chen BT, 2010, ANN NY ACAD SCI, V1187, P129, DOI 10.1111/j.1749-6632.2009.05154.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Haber SN, 2000, J NEUROSCI, V20, P2369; Heikkinen AE, 2009, NEUROPSYCHOPHARMACOL, V34, P290, DOI 10.1038/npp.2008.89; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; MA QP, 1993, PEPTIDES, V14, P561, DOI 10.1016/0196-9781(93)90145-7; Malenka Robert C., 2002, Neuron, V36, P29, DOI 10.1016/S0896-6273(02)00938-8; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Ungless MA, 2010, NEUROSCI BIOBEHAV R, V35, P151, DOI 10.1016/j.neubiorev.2010.04.006; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Young AMJ, 2004, J NEUROSCI METH, V138, P57, DOI 10.1016/j.jneumeth.2004.03.003; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang TA, 2010, NEUROPHARMACOLOGY, V59, P431, DOI 10.1016/j.neuropharm.2010.06.004	61	487	494	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 9	2011	70	5					855	862		10.1016/j.neuron.2011.03.025	http://dx.doi.org/10.1016/j.neuron.2011.03.025			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658580	Green Accepted, Bronze			2022-12-17	WOS:000291843500007
J	Cowley, MA; Pronchuk, N; Fan, W; Dinulescu, DM; Colmers, WF; Cone, RD				Cowley, MA; Pronchuk, N; Fan, W; Dinulescu, DM; Colmers, WF; Cone, RD			Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat	NEURON			English	Article							AGOUTI-RELATED PROTEIN; NEUROPEPTIDE-Y; FRAMESHIFT MUTATION; ENERGY HOMEOSTASIS; LEPTIN RECEPTOR; ARCUATE NUCLEUS; MESSENGER-RNA; IN-VIVO; NEURONS; OBESITY	Energy stores are held relatively constant in many mammals. The circuitry necessary for maintaining energy homeostasis should (1) sense the amount of energy stored in adipose tissue, (2) sense and integrate the multiple opposing signals regarding nutritional state, and (3) provide output regulating energy intake and expenditure to maintain energy homeostasis. We demonstrate that individual neurons within the paraventricular nucleus of the hypothalamus (PVH) are capable of detection and integration of orexigenic (neuropeptide Y [NPY]) and anorexigenic (melanocortin) signals, that NPY and melanocortins are functional antagonists of each other within the PVH in the regulation of feeding behavior, and that melanocortin administration within the PVH regulates both feeding behavior and energy expenditure. These data provide a cellular basis for the adipostat within neurons in the PVH that appear to be jointly regulated by NPY- and melanocortin-responsive neurons.	Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	University of Alberta; Oregon Health & Science University	Colmers, WF (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada.	william.colmers@ualberta.ca; cone@ohsu.edu	Colmers, William/C-3106-2013; Cowley, Michael A/B-9428-2008	Colmers, William/0000-0001-7902-3560; Cowley, Michael A/0000-0001-7811-134X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051730] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK51730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BILLINGTON CJ, 1991, AM J PHYSIOL, V260, pR321, DOI 10.1152/ajpregu.1991.260.2.R321; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Chieng B, 1998, J NEUROSCI, V18, P7033; COLMERS WF, 1994, TRENDS NEUROSCI, V17, P373, DOI 10.1016/0166-2236(94)90046-9; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; EGAWA M, 1991, AM J PHYSIOL, V260, P328; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; Giraudo SQ, 1998, BRAIN RES, V809, P302, DOI 10.1016/S0006-8993(98)00837-3; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Gu GB, 1997, J COMP NEUROL, V384, P142; Hakansson ML, 1996, NEUROREPORT, V7, P3087, DOI 10.1097/00001756-199611250-00059; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; HOFFMAN NW, 1991, J COMP NEUROL, V307, P405, DOI 10.1002/cne.903070306; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ingram SL, 1998, J NEUROSCI, V18, P10269; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; KENNEDY GC, 1953, P ROY SOC LOND B BIO, V140, P579; KLAPSTEIN GJ, 1990, ANN NY ACAD SCI, V611, P457; KONDA Y, 1994, J BIOL CHEM, V269, P13162; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; LARSEN PJ, 1992, BRAIN RES, V573, P181, DOI 10.1016/0006-8993(92)90761-W; LEE WS, 1993, ENDOCRINOLOGY, V133, P2248, DOI 10.1210/en.133.5.2248; MCQUISTON AR, 1992, NEUROSCI LETT, V138, P261, DOI 10.1016/0304-3940(92)90929-2; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; MITCHEL JS, 1977, PHYSIOL BEHAV, V18, P1121, DOI 10.1016/0031-9384(77)90020-8; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; NILAVER G, 1979, J CELL BIOL, V81, P50; Obrietan K, 1996, J NEUROSCI, V16, P3521; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Qian J, 1997, J NEUROSCI, V17, P8169; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; SAWCHENKO PE, 1985, J COMP NEUROL, V241, P138, DOI 10.1002/cne.902410203; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Stanley B.G., 1993, BIOL NEUROPEPTIDE RE, P457, DOI [10.1007/978-1-59259-465-8_11, DOI 10.1007/978-1-59259-465-8_11]; STEFFENS AB, 1975, AM J PHYSIOL, V228, P1738, DOI 10.1152/ajplegacy.1975.228.6.1738; Tomaszuk A, 1996, HORM RES, V46, P53, DOI 10.1159/000184996; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	52	487	503	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1999	24	1					155	163		10.1016/S0896-6273(00)80829-6	http://dx.doi.org/10.1016/S0896-6273(00)80829-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677034	Bronze			2022-12-17	WOS:000082893200016
J	ISOM, LL; DEJONGH, KS; CATTERALL, WA				ISOM, LL; DEJONGH, KS; CATTERALL, WA			AUXILIARY SUBUNITS OF VOLTAGE-GATED ION CHANNELS	NEURON			English	Review							SENSITIVE CALCIUM-CHANNEL; RABBIT SKELETAL-MUSCLE; DEPENDENT PROTEIN-KINASE; BRAIN SODIUM-CHANNEL; DENDROTOXIN-BINDING PROTEIN; CONOTOXIN GVIA RECEPTOR; AMINO-ACID-SEQUENCE; SOMATIC-CELL LINE; RAT-BRAIN; BETA-SUBUNIT				ISOM, LL (corresponding author), UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA.			Isom, Lori/0000-0002-9479-6729				AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BENESKI DA, 1980, P NATL ACAD SCI-BIOL, V77, P639, DOI 10.1073/pnas.77.1.639; BENNETT PB, 1993, FEBS LETT, V326, P21, DOI 10.1016/0014-5793(93)81752-L; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; BOSSE E, 1990, FEBS LETT, V267, P153, DOI 10.1016/0014-5793(90)80312-7; BURGESS AJ, 1988, EUR J BIOCHEM, V178, P527, DOI 10.1111/j.1432-1033.1988.tb14479.x; CANNON SC, 1993, PFLUG ARCH EUR J PHY, V423, P155, DOI 10.1007/BF00374974; CASADEI JM, 1986, J BIOL CHEM, V261, P4318; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CATTERALL WA, 1991, SCIENCE, V253, P1499, DOI 10.1126/science.1654596; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CORREA AM, 1990, BIOCHEMISTRY-US, V29, P6230, DOI 10.1021/bi00478a017; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; CURTIS BM, 1986, BIOCHEMISTRY-US, V25, P3077, DOI 10.1021/bi00359a002; CURTIS BM, 1985, P NATL ACAD SCI USA, V82, P2528, DOI 10.1073/pnas.82.8.2528; DARBON H, 1983, BIOCHEM BIOPH RES CO, V115, P415, DOI 10.1016/S0006-291X(83)80160-0; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DREYER F, 1990, REV PHYSIOL BIOCH P, V115, P93; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; GRISHIN EV, 1984, BIOL MEMBRANY, V1, P858; HARTSHORNE RP, 1980, J BIOL CHEM, V255, P572; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; HARTSHORNE RP, 1981, P NATL ACAD SCI-BIOL, V78, P4620, DOI 10.1073/pnas.78.7.4620; HARTSHORNE RP, 1982, J BIOL CHEM, V257, P3888; Hille B., 1992, IONIC CHANNELS EXCIT; HOSEY MM, 1987, BIOCHEM BIOPH RES CO, V147, P1137; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ITAGAKI K, 1992, FEBS LETT, V297, P221, DOI 10.1016/0014-5793(92)80542-O; JAHN H, 1988, EUR J BIOCHEM, V178, P535, DOI 10.1111/j.1432-1033.1988.tb14480.x; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; KIM HL, 1992, P NATL ACAD SCI USA, V89, P3251, DOI 10.1073/pnas.89.8.3251; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; KRANER SD, 1985, J BIOL CHEM, V260, P6341; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LAI Y, 1993, J NEUROCHEM, V61, P1333, DOI 10.1111/j.1471-4159.1993.tb13626.x; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; LEUNG AT, 1988, J BIOL CHEM, V263, P994; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MESSNER DJ, 1986, J BIOL CHEM, V261, P211; MESSNER DJ, 1986, J BIOL CHEM, V261, P4882; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MORTON ME, 1987, J BIOL CHEM, V262, P11904; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; NEWITT RA, 1991, EPILEPSY RES, P263; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NUMA S, 1989, HARVEY LECT, V83, P121; OCALLAHAN CM, 1988, BIOCHEMISTRY-US, V27, P6071, DOI 10.1021/bi00416a036; PARCEJ DN, 1989, BIOCHEM J, V257, P899, DOI 10.1042/bj2570899; PATTON DE, 1994, IN PRESS J BIOL CHEM; PELZER D, 1990, REV PHYSIOL BIOCH P, V114, P107; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PONGS O, 1992, TRENDS PHARMACOL SCI, V13, P359, DOI 10.1016/0165-6147(92)90109-J; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; REBER BFX, 1987, J BIOL CHEM, V262, P11369; REHM H, 1988, BIOCHEMISTRY-US, V27, P1827, DOI 10.1021/bi00406a005; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; REHM H, 1989, FEBS LETT, V247, P28, DOI 10.1016/0014-5793(89)81233-5; REHM H, 1989, FEBS LETT, V249, P224, DOI 10.1016/0014-5793(89)80628-3; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; REHM H, 1988, BIOCHEM BIOPH RES CO, V153, P231, DOI 10.1016/S0006-291X(88)81213-0; REHM H, 1991, FASEB J, V5, P164, DOI 10.1096/fasebj.5.2.2004663; RETTIG J, 1994, IN PRESS NATURE; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHMIDT J, 1985, P NATL ACAD SCI USA, V82, P4847, DOI 10.1073/pnas.82.14.4847; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; SCHMIDT RR, 1989, BIOCHEMISTRY-US, V28, P8346, DOI 10.1021/bi00447a012; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SHARP AH, 1989, J BIOL CHEM, V264, P2816; SIEBER M, 1987, EUR J BIOCHEM, V167, P117, DOI 10.1111/j.1432-1033.1987.tb13311.x; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STEA A, 1993, NEUROPHARMACOLOGY, V32, P1103, DOI 10.1016/0028-3908(93)90005-N; SUTKOWSKI EM, 1990, J BIOL CHEM, V265, P12393; TAKAHASHI M, 1989, BIOCHEM BIOPH RES CO, V163, P1182, DOI 10.1016/0006-291X(89)92345-0; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; VAGHY PL, 1987, J BIOL CHEM, V262, P14337; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WEI XY, 1991, J BIOL CHEM, V266, P21943; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; WOLLNER DA, 1988, NEURON, V1, P727, DOI 10.1016/0896-6273(88)90171-7; WOLLNER DA, 1987, J BIOL CHEM, V262, P14709; WOOD MR, 1992, J NEUROSCI, V12, P2948, DOI 10.1523/JNEUROSCI.12-08-02948.1992; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	125	487	493	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1994	12	6					1183	1194		10.1016/0896-6273(94)90436-7	http://dx.doi.org/10.1016/0896-6273(94)90436-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	7516685				2022-12-17	WOS:A1994NT46300001
J	Whitfield, J; Neame, SJ; Paquet, L; Bernard, O; Ham, J				Whitfield, J; Neame, SJ; Paquet, L; Bernard, O; Ham, J			Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release	NEURON			English	Article							PROGRAMMED CELL-DEATH; NERVE GROWTH-FACTOR; TROPHIC FACTOR DEPRIVATION; SYMPATHETIC NEURONS; BCL-2 FAMILY; FAS LIGAND; CASPASE ACTIVATION; APOPTOSIS; BAX; PROTEIN	Sympathetic neurons require nerve growth factor for survival and die by apoptosis in its absence. Key steps in the death pathway include c-Jun activation, mitochondrial cytochrome c release, and caspase activation. Here, we show that neurons rescued from NGF withdrawal-induced apoptosis by expression of dominant-negative c-Jun do not release cytochrome c from their mitochondria. Furthermore, we find that the mRNA for BIMEL, a proapoptotic BCL-2 family member, increases in level after NGF withdrawal and that this is reduced by dominant-negative c-Jun. Finally, overexpression of BIMEL in neurons induces cytochrome c redistribution and apoptosis in the presence of NGF, and neurons injected with sim antisense oligonucleotides or isolated from Bim(-/-) knockout mice die more slowly after NGF withdrawal.	UCL, Eisai London Res Labs, London WC1E 6BT, England; McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Eisai Co Ltd; University of London; University College London; McGill University; Walter & Eliza Hall Institute	Whitfield, J (corresponding author), UCL, Eisai London Res Labs, Bernard Katz Bldg,Gower St, London WC1E 6BT, England.	jonathan_whitfield@eisai.net; j.ham@ich.ucl.ac.uk	Ham, Jonathan/C-5164-2008; Whitfield, Jonathan/N-6690-2014	Neame, Stephen/0000-0002-6951-032X; Whitfield, Jonathan/0000-0002-4925-7283				Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Deckwerth TL, 1998, EXP NEUROL, V152, P150, DOI 10.1006/exnr.1998.6846; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; Eilers A, 1998, J NEUROSCI, V18, P1713; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Precious B., 1985, VIROLOGY PRACTICAL A, P193; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHLINGENSIEPEN KH, 1994, CELL MOL NEUROBIOL, V14, P487, DOI 10.1007/BF02088833; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Stefanis L, 1997, CURR OPIN NEUROL, V10, P299, DOI 10.1097/00019052-199708000-00004; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vekrellis K, 1997, DEVELOPMENT, V124, P1239; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; WANG LY, 1996, J POLYM RES, V3, P1; Watson A, 1998, J NEUROSCI, V18, P751; Wiese S, 1999, NAT NEUROSCI, V2, P978, DOI 10.1038/14777; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	60	486	501	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					629	643		10.1016/S0896-6273(01)00239-2	http://dx.doi.org/10.1016/S0896-6273(01)00239-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301023	Bronze			2022-12-17	WOS:000167868900013
J	ZIMMERMAN, L; LENDAHL, U; CUNNINGHAM, M; MCKAY, R; PARR, B; GAVIN, B; MANN, J; VASSILEVA, G; MCMAHON, A				ZIMMERMAN, L; LENDAHL, U; CUNNINGHAM, M; MCKAY, R; PARR, B; GAVIN, B; MANN, J; VASSILEVA, G; MCMAHON, A			INDEPENDENT REGULATORY ELEMENTS IN THE NESTIN GENE DIRECT TRANSGENE EXPRESSION TO NEURAL STEM-CELLS OR MUSCLE PRECURSORS	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE FILAMENT PROTEIN; ASTROCYTE-SPECIFIC EXPRESSION; NEUROFILAMENT GENE; DIFFERENTIATION; PROMOTER; ENHANCER; IDENTIFICATION; HYBRIDIZATION; PROLIFERATION	Changes in intermediate filament gene expression occur at key steps in the differentiation of cell types in the mammalian CNS. Neuroepithelial stem cells express the intermediate filament protein nestin and down-regulate it sharply at the transition from proliferating stem cell to postmitotic neuron. Nestin is also expressed in muscle precursors but not in mature muscle cells. We show here that in transgenic mice, independent cell type-specific elements in the first and second introns of the nestin gene consistently direct reporter gene expression to developing muscle and neural precursors, respectively. The second intron contains an enhancer that functions in CNS stem cells, suggesting that there may be a single transcriptional mechanism regulating the CNS stem cell state. This enhancer is much less active in the PNS. The identification of these elements facilitates analysis of mechanisms controlling the switch in gene expression that occurs when muscle and brain precursors terminally differentiate.	MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139; ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110	Massachusetts Institute of Technology (MIT)			Vassileva, Galya/A-6807-2009					BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BESNARD F, 1991, J BIOL CHEM, V266, P18877; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHING GY, 1991, J BIOL CHEM, V266, P19459; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; HAYES TE, 1991, NEW BIOL, V3, P259; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hogan B., 1986, MANIPULATING MOUSE E; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUNT P, 1991, DEVELOPMENT S, V1, P187; JULIEN JP, 1987, BIOCHIM BIOPHYS ACTA, V909, P10, DOI 10.1016/0167-4781(87)90041-8; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MIURA M, 1990, J NEUROCHEM, V55, P1180, DOI 10.1111/j.1471-4159.1990.tb03123.x; MUCKE L, 1991, NEW BIOL, V3, P465; NAKAHIRA K, 1990, J BIOL CHEM, V265, P19786; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; OSHIMA RG, 1990, GENE DEV, V4, P835, DOI 10.1101/gad.4.5.835; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; Sambrook J., 1989, MOL CLONING LAB MANU; TAKEMOTO Y, 1991, NUCLEIC ACIDS RES, V19, P2761, DOI 10.1093/nar/19.10.2761; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; ZENKE M, 1986, EMBO J, V5, P387, DOI 10.1002/j.1460-2075.1986.tb04224.x; ZOPF D, 1990, NUCLEIC ACIDS RES, V18, P521, DOI 10.1093/nar/18.3.521	31	486	526	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					11	24		10.1016/0896-6273(94)90148-1	http://dx.doi.org/10.1016/0896-6273(94)90148-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292356				2022-12-17	WOS:A1994MU49300002
J	Threlfell, S; Lalic, T; Platt, NJ; Jennings, KA; Deisseroth, K; Cragg, SJ				Threlfell, Sarah; Lalic, Tatjana; Platt, Nicola J.; Jennings, Katie A.; Deisseroth, Karl; Cragg, Stephanie J.			Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons	NEURON			English	Article							NEURONS; SIGNALS; RECEPTORS; NICOTINE; PRIMATES; SYSTEM	Striatal dopamine plays key roles in our normal and pathological goal-directed actions. To understand dopamine function, much attention has focused on how midbrain dopamine neurons modulate their firing patterns. However, we identify a presynaptic mechanism that triggers dopamine release directly, bypassing activity in dopamine neurons. We paired electrophysiological recordings of striatal channelrhodopsin2-expressing cholinergic interneurons with simultaneous detection of dopamine release at carbon-fiber microelectrodes in striatal slices. We reveal that activation of cholinergic interneurons by light flashes that cause only single action potentials in neurons from a small population triggers dopamine release via activation of nicotinic receptors on dopamine axons. This event overrides ascending activity from dopamine neurons and, furthermore, is reproduced by activating ChR2-expressing thalamostriatal inputs, which synchronize cholinergic interneurons in vivo. These findings indicate that synchronized activity in cholinergic interneurons directly generates striatal dopamine signals whose functions will extend beyond those encoded by dopamine neuron activity.	[Threlfell, Sarah; Lalic, Tatjana; Platt, Nicola J.; Jennings, Katie A.; Cragg, Stephanie J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Threlfell, Sarah; Cragg, Stephanie J.] Univ Oxford, Oxford Parkinsons Dis Ctr, Oxford OX1 3QX, England; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Oxford; University of Oxford; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Cragg, SJ (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg, Oxford OX1 3PT, England.	stephanie.cragg@dpag.ox.ac.uk		Cragg, Stephanie/0000-0001-9677-2256; Threlfell, Sarah/0000-0002-3581-1327	Parkinson's UK Monument Trust Discovery Award; Parkinson's UK [G-0808, G-0803]; Royal Society; MRC; MRC [G0700932] Funding Source: UKRI; Medical Research Council [G0700932] Funding Source: researchfish; Parkinson&quot;s UK [J-0901, G-0808] Funding Source: researchfish	Parkinson's UK Monument Trust Discovery Award; Parkinson's UK(Parkinson's UK); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	We thank Neil Blackledge, Rob Klose, Diogo Pimentel, Ole Paulsen, Dennis Kaetzel, Gero Miesenbock, P. Wendy Tynan, and Oxford Biomedical Services for their invaluable input. This work was supported by a Parkinson's UK Monument Trust Discovery Award and Parkinson's UK Grants G-0808 and G-0803, the Royal Society, and the MRC.	AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Contant C, 1996, NEUROSCIENCE, V71, P937, DOI 10.1016/0306-4522(95)00507-2; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Cragg SJ, 2003, J NEUROSCI, V23, P4378; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Owesson-White CA, 2008, P NATL ACAD SCI USA, V105, P11957, DOI 10.1073/pnas.0803896105; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; Threlfell S, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00011; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243	30	485	486	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 12	2012	75	1					58	64		10.1016/j.neuron.2012.04.038	http://dx.doi.org/10.1016/j.neuron.2012.04.038			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	975VM	22794260	Bronze			2022-12-17	WOS:000306539600008
J	Gilman, SR; Iossifov, I; Levy, D; Ronemus, M; Wigler, M; Vitkup, D				Gilman, Sarah R.; Iossifov, Ivan; Levy, Dan; Ronemus, Michael; Wigler, Michael; Vitkup, Dennis			Rare De Novo Variants Associated with Autism Implicate a Large Functional Network of Genes Involved in Formation and Function of Synapses	NEURON			English	Article							CORTICAL PYRAMIDAL NEURONS; DENDRITIC SPINE DENSITY; COPY-NUMBER VARIATION; GENOMEWIDE ASSOCIATION; COMPLEX; DISORDERS; PATHOLOGY; MTOR; WNT; EXPRESSION	Identification of complex molecular networks underlying common human phenotypes is a major challenge of modern genetics. In this study, we develop a method for network-based analysis of genetic associations (NETBAG). We use NETBAG to identify a large biological network of genes affected by rare de novo CNVs in autism. The genes forming the network are primarily related to synapse development, axon targeting, and neuron motility. The identified network is strongly related to genes previously implicated in autism and intellectual disability phenotypes. Our results are also consistent with the hypothesis that significantly stronger functional perturbations are required to trigger the autistic phenotype in females compared to males. Overall, the presented analysis of de novo variants supports the hypothesis that perturbed synaptogenesis is at the heart of autism. More generally, our study provides proof of the principle that networks underlying complex human phenotypes can be identified by a network-based functional analysis of rare genetic variants.	[Gilman, Sarah R.; Vitkup, Dennis] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Gilman, Sarah R.; Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Iossifov, Ivan; Levy, Dan; Ronemus, Michael; Wigler, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Columbia University; Columbia University; Cold Spring Harbor Laboratory	Iossifov, I (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, 1130 St Nicolas Ave, New York, NY 10032 USA.	iossifov@cshl.edu; dv2121@columbia.edu		Ronemus, Michael/0000-0003-0237-3540; Wigler, Michael/0000-0003-4396-1971	Simons Foundation [SF51]; National Centers for Biomedical Computing (MAGNet) [U54CA121852]; Simons Foundation Autism Research Initiative;  [T32 GM082797]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082797, R01GM079759] Funding Source: NIH RePORTER	Simons Foundation; National Centers for Biomedical Computing (MAGNet); Simons Foundation Autism Research Initiative; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the Simons Foundation (SFARI award number SF51 to M.W.), the National Centers for Biomedical Computing (MAGNet) grant U54CA121852 to Columbia University. S.R.G. was supported by the training grant T32 GM082797. We are grateful to all of the families at the participating SFARI Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, B. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, E. Wijsman).; We would also like to sincerely thank Simons Foundation Autism Research Initiative for generous financial support, Linda Van Aelst, Thomas Jessell, Gerald Fischbach, Marian Carlson, Alan Packer, Barry Honig, Itsik Pe'er, Lauren DeMaria, and Stephen Johnson for helpful discussions.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Iossifov I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000559; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reiner O, 2005, MOL NEUROBIOL, V31, P117, DOI 10.1385/MN:31:1-3:117; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; SALINAS PC, 1994, DEVELOPMENT, V120, P1277; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang K, 2010, CELL, V142, P351, DOI 10.1016/j.cell.2010.07.025; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	67	484	496	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 9	2011	70	5					898	907		10.1016/j.neuron.2011.05.021	http://dx.doi.org/10.1016/j.neuron.2011.05.021			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658583	Green Accepted, Bronze			2022-12-17	WOS:000291843500010
J	Murakami, T; Qamar, S; Lin, JQ; Schierle, GSK; Rees, E; Miyashita, A; Costa, AR; Dodd, RB; Chan, FTS; Michel, CH; Kronenberg-Versteeg, D; Li, Y; Yang, SP; Wakutani, Y; Meadows, W; Ferry, RR; Dong, L; Tartaglia, GG; Favrin, G; Lin, WL; Dickson, DW; Zhen, M; Ron, D; Schmitt-Ulms, G; Fraser, PE; Shneider, NA; Holt, C; Vendruscolo, M; Kaminski, CF; St George-Hyslop, P				Murakami, Tetsuro; Qamar, Seema; Lin, Julie Qiaojin; Schierle, Gabriele S. Kaminski; Rees, Eric; Miyashita, Akinori; Costa, Ana R.; Dodd, Roger B.; Chan, Fiona T. S.; Michel, Claire H.; Kronenberg-Versteeg, Deborah; Li, Yi; Yang, Seung-Pil; Wakutani, Yosuke; Meadows, William; Ferry, Rodylyn Rose; Dong, Liang; Gaetano Tartaglia, Gian; Favrin, Giorgio; Lin, Wen-Lang; Dickson, Dennis W.; Zhen, Mei; Ron, David; Schmitt-Ulms, Gerold; Fraser, Paul E.; Shneider, Neil A.; Holt, Christine; Vendruscolo, Michele; Kaminski, Clemens F.; St George-Hyslop, Peter			ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; UNFOLDED PROTEIN RESPONSE; CELL-FREE FORMATION; CAENORHABDITIS-ELEGANS; STRESS GRANULES; MESSENGER-RNA; LOCAL TRANSLATION; IN-VIVO; AGGREGATION	The mechanisms by which mutations in FUS and other RNA binding proteins cause ALS and FTD remain controversial. We propose a model in which low-complexity (LC) domains of FUS drive its physiologically reversible assembly into membrane-free, liquid droplet and hydrogel-like structures. ALS/FTD mutations in LC or non-LC domains induce further phase transition into poorly soluble fibrillar hydrogels distinct from conventional amyloids. These assemblies are necessary and sufficient for neurotoxicity in a C. elegans model of FUS-dependent neurodegeneration. They trap other ribonucleoprotein (RNP) granule components and disrupt RNP granule function. One consequence is impairment of new protein synthesis by cytoplasmic RNP granules in axon terminals, where RNP granules regulate local RNA metabolism and translation. Nuclear FUS granules may be similarly affected. Inhibiting formation of these fibrillar hydrogel assemblies mitigates neurotoxicity and suggests a potential therapeutic strategy that may also be applicable to ALS/FTD associated with mutations in other RNA binding proteins.	[Murakami, Tetsuro; Miyashita, Akinori; Yang, Seung-Pil; Wakutani, Yosuke; Ferry, Rodylyn Rose; Schmitt-Ulms, Gerold; Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Murakami, Tetsuro; Miyashita, Akinori; Yang, Seung-Pil; Wakutani, Yosuke; Ferry, Rodylyn Rose; Schmitt-Ulms, Gerold; Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Med Biophys & Lab Med, Toronto, ON M5S 3H2, Canada; [Murakami, Tetsuro; Miyashita, Akinori; Yang, Seung-Pil; Wakutani, Yosuke; Ferry, Rodylyn Rose; Schmitt-Ulms, Gerold; Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Pathobiol, Toronto, ON M5S 3H2, Canada; [Qamar, Seema; Costa, Ana R.; Dodd, Roger B.; Kronenberg-Versteeg, Deborah; Li, Yi; Meadows, William; Dong, Liang; St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge Natl Inst Hlth Res, Biomed Res Unit Dementia, Cambridge CB2 0XY, England; [Lin, Julie Qiaojin; Holt, Christine] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Schierle, Gabriele S. Kaminski; Rees, Eric; Chan, Fiona T. S.; Michel, Claire H.; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England; [Gaetano Tartaglia, Gian; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Gaetano Tartaglia, Gian] Ctr Genom Regulat, Barcelona 08003, Spain; [Gaetano Tartaglia, Gian] Univ Pompeu Fabra, Barcelona 08003, Spain; [Gaetano Tartaglia, Gian] ICREA, Barcelona 08010, Spain; [Favrin, Giorgio] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; [Favrin, Giorgio] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Lin, Wen-Lang; Dickson, Dennis W.] Mayo Clin, Coll Med, Dept Res, Neurosci, Jacksonville, FL 32224 USA; [Zhen, Mei] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Zhen, Mei] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Ron, David] Univ Cambridge, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 0XY, England; [Shneider, Neil A.] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, Dept Neurol, New York, NY 10032 USA	University of Toronto; University of Toronto; University of Toronto; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; University of Cambridge; University of Cambridge; Mayo Clinic; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Cambridge; Columbia University	St George-Hyslop, P (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada.	phs22@cam.ac.uk	Lin, Julie Qiaojin/AAY-5309-2020; Zhen, Mei/A-4967-2012; Kaminski, Clemens/G-7488-2016; Vendruscolo, Michele/F-5901-2012; Chan, Felix/O-8875-2016; Kronenberg-Versteeg, Deborah/AAW-5442-2020; Costa, Ana Rita AR/G-6341-2016; Lin, Qiaojin/ABA-3382-2020; Shneider, Neil/ABF-5751-2020; Tartaglia, Gian Gaetano/K-1229-2014	Lin, Julie Qiaojin/0000-0002-2669-6478; Zhen, Mei/0000-0003-0086-9622; Kaminski, Clemens/0000-0002-5194-0962; Vendruscolo, Michele/0000-0002-3616-1610; Chan, Felix/0000-0001-7374-2396; Kronenberg-Versteeg, Deborah/0000-0003-0965-9998; Costa, Ana Rita AR/0000-0002-2855-0472; Lin, Qiaojin/0000-0002-2669-6478; Shneider, Neil/0000-0002-3223-7366; Ron, David/0000-0002-3014-5636; St George-Hyslop, Peter/0000-0003-0796-7209; Tartaglia, Gian Gaetano/0000-0001-7524-6310; Yang, Seung-Pil/0000-0003-3980-7103; Rees, Eric/0000-0001-7478-5961; Dodd, Roger/0000-0003-4268-1863; Holt, Christine Elizabeth/0000-0003-2829-121X	Canadian Institutes of Health Research; Alzheimer Society of Ontario; Wellcome Trust; Medical Research Council; NIH Research; Alzheimer Research UK; Gates Cambridge Scholarship; Engineering and Physical Sciences Research Council; European Research Council [RIBOMYLOME_309545]; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [322817]; National Institute of Neurological Disorders and Stroke [R01 NS07377]; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [G0902243, MC_G1000734, MR/K02292X/1] Funding Source: UKRI; Alzheimers Research UK [ARUK-ESG2012-1, ARUK-PG2013-14, ARUK-EG2012A-1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H018301/1] Funding Source: researchfish; Medical Research Council [MR/K02292X/1, MC_G1000734, G0902243] Funding Source: researchfish; ICREA Funding Source: Custom	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Ontario; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Research UK(Alzheimer's Research UK (ARUK)); Gates Cambridge Scholarship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ICREA(ICREA)	Supported by Canadian Institutes of Health Research (P.E.F. and P.S.G.-H.), Alzheimer Society of Ontario (P.E.F., P.St.G.H.), Wellcome Trust (P.S.G.-H., M.V., C.F.K., G.S.K.S., D.R., and C.H.), Medical Research Council (P.S.G.-H., M.V., C.F.K., and G.S.K.S.), NIH Research, Alzheimer Research UK (C.F.K. and G.S.K.S.), Gates Cambridge Scholarship (J.Q.L.), Engineering and Physical Sciences Research Council (C.F.K. and G.S.K.S.), European Research Council Starting Grant RIBOMYLOME_309545 (G.G.T.), European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 322817 (C.H.), and National Institute of Neurological Disorders and Stroke R01 NS07377 (N.A.S.). The authors thank Tom Cech and Roy Parker for helpful discussions.	Akbalik G, 2014, SCIENCE, V343, P375, DOI 10.1126/science.1249623; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; [Anonymous], J MED CHEM, V55, P7193; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; DeJesus-Hernandez M, 2010, HUM MUTAT, V31, pE1377, DOI 10.1002/humu.21241; Dieck ST, 2015, NAT METHODS, V12, P411, DOI [10.1038/nmeth.3319, 10.1038/NMETH.3319]; Dixon SJ, 2006, DEVELOPMENT, V133, P1263, DOI 10.1242/dev.02300; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fang YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5824; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hara M, 2012, J NEUROL, V259, P2237, DOI 10.1007/s00415-012-6542-2; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kent L, 2014, AMYOTROPH LAT SCL FR, V15, P557, DOI 10.3109/21678421.2014.920033; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin AC, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-8; Liu-Yesucevitz L, 2014, J NEUROSCI, V34, P4167, DOI 10.1523/JNEUROSCI.2350-13.2014; Mao XR, 2010, MOL CELL BIOL, V30, P5033, DOI 10.1128/MCB.00922-10; Mitchell SF, 2014, MOL CELL, V54, P547, DOI 10.1016/j.molcel.2014.04.033; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Morita M, 2009, BRAIN RES, V1295, P186, DOI 10.1016/j.brainres.2009.08.002; Murakami T, 2012, HUM MOL GENET, V21, P1, DOI 10.1093/hmg/ddr417; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Rees CE, 2013, MED EDUC, V47, P154, DOI 10.1111/medu.12055; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Ticozzi N, 2010, CNS NEUROL DISORD-DR, V9, P285, DOI 10.2174/187152710791292585; Uchikado H, 2006, NEUROPATHOLOGY, V26, P417, DOI 10.1111/j.1440-1789.2006.00709.x; van der Zee J, 2014, NAT REV NEUROL, V10, P70, DOI 10.1038/nrneurol.2013.270; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Yan J, 2010, NEUROLOGY, V75, P807, DOI 10.1212/WNL.0b013e3181f07e0c	47	482	485	6	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2015	88	4					678	690		10.1016/j.neuron.2015.10.030	http://dx.doi.org/10.1016/j.neuron.2015.10.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX5TR	26526393	Green Published, hybrid			2022-12-17	WOS:000365765900010
J	Wittmann, BC; Schott, BH; Guderian, S; Frey, JU; Heinze, HJ; Duzel, E				Wittmann, BC; Schott, BH; Guderian, S; Frey, JU; Heinze, HJ; Duzel, E			Reward-related fMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation	NEURON			English	Article							SYNAPTIC PLASTICITY; BRAIN ACTIVITY; CA1 REGION; ACETYLCHOLINE-RELEASE; PROTEIN-SYNTHESIS; NEURONAL-ACTIVITY; SPATIAL MEMORY; NOVELTY; POTENTIATION; ANTICIPATION	Long-term potentiation in the hippocampus can be enhanced and prolonged by dopaminergic inputs from midbrain structures such as the substantia nigra. This improved synaptic plasticity is hypothesized to be associated with better memory consolidation in the hippocampus. We used a condition that reliably elicits a dopaminergic response, reward anticipation, to study the relationship between activity of dopaminergic midbrain areas and hippocampal long-term memory in healthy adults. Pictures of object drawings that predicted monetary reward were associated with stronger fMRI activity in reward-related brain areas, including the substantia nigra, compared with non-reward-predicting pictures. Three weeks later, recollection and source memory were better for reward-predicting than for non-reward-predicting pictures. FMRI activity in the hippocampus and the midbrain was higher for reward-predicting pictures that were later recognized compared with later forgotten Pictures. These data are consistent with the hypothesis that activation of dopaminergic midbrain regions enhances hippocampus-dependent memory formation, possibly by enhancing consolidation.	Otto Von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Ctr Adv Imaging, D-39120 Magdeburg, Germany; Leibniz Neurobiol, D-39118 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Duzel, E (corresponding author), Otto Von Guericke Univ, Dept Neurol 2, Leipziger Str 44, D-39120 Magdeburg, Germany.	emrah.duezel@medizin.uni-magdeburg.de	Schott, Björn H/B-9369-2012; Wittmann, Bianca/C-1931-2008; Schott, Björn H/U-5626-2017; Duzel, Emrah/A-1794-2010	Wittmann, Bianca/0000-0002-2583-3311; Schott, Björn H/0000-0002-8237-4481; Duzel, Emrah/0000-0002-0139-5388				Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Backman L, 2000, AM J PSYCHIAT, V157, P635; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Canli T, 2000, J NEUROSCI, V20; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Eckert T, 2004, NEUROIMAGE, V21, P229, DOI 10.1016/j.neuroimage.2003.08.028; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; HERSI AI, 1995, NEUROSCIENCE, V69, P1067, DOI 10.1016/0306-4522(95)00319-E; Holscher C, 2003, BEHAV BRAIN RES, V142, P181, DOI 10.1016/S0166-4328(02)00422-9; Honey G, 2004, TRENDS PHARMACOL SCI, V25, P366, DOI 10.1016/j.tips.2004.05.009; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kemppainen N, 2003, EUR J NEUROSCI, V18, P149, DOI 10.1046/j.1460-9568.2003.02716.x; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pappata S, 2002, NEUROIMAGE, V16, P1015, DOI 10.1006/nimg.2002.1121; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schroder N, 2003, SYNAPSE, V49, P89, DOI 10.1002/syn.10210; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Straube T, 2003, J PHYSIOL-LONDON, V552, P953, DOI 10.1113/jphysiol.2003.049452; Straube T, 2003, NEUROSCI LETT, V344, P5, DOI 10.1016/S0304-3940(03)00349-5; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Talairach J., 1988, COPLANAR STEREOTAXIC; Tracey I, 2001, J CLIN PHARMACOL, p21S; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Umegaki H, 2001, NEUROSCIENCE, V103, P27, DOI 10.1016/S0306-4522(00)00542-X; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wan HM, 1999, J NEUROSCI, V19, P1142; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961	56	482	488	4	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					459	467		10.1016/j.neuron.2005.01.010	http://dx.doi.org/10.1016/j.neuron.2005.01.010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694331	Bronze			2022-12-17	WOS:000226787700017
J	Buckner, RL; Goodman, J; Burock, M; Rotte, M; Koutstaal, W; Schacter, D; Rosen, B; Dale, AM				Buckner, RL; Goodman, J; Burock, M; Rotte, M; Koutstaal, W; Schacter, D; Rosen, B; Dale, AM			Functional-anatomic correlates of object priming in humans revealed by rapid presentation event-related fMRI	NEURON			English	Article							POSITRON-EMISSION TOMOGRAPHY; HUMAN VISUAL-CORTEX; IMPLICIT MEMORY; HUMAN BRAIN; HIPPOCAMPAL-FORMATION; TASKS; AREAS; STIMULATION; ACTIVATION; MECHANISMS	Human functional-anatomic correlates of object repetition were explored in a cohort of 20 subjects using fMRI. Subjects performed an object classification task where the target objects were either novel or repeated. Objects appeared rapidly, one every 2 s, in a randomly intermixed task design similar to traditional behavioral, event-related potential (ERP), and single-unit physiological studies. Recently developed event-related fMRI methods were used to analyze the data. Clear effects of repetition were observed. Brain areas in mid-levels of the processing hierarchy, including extrastriate visual cortex extending into inferotemporal cortex and left dorsal prefrontal cortex, showed reductions in the amount of activation after repetition. By contrast, early visual areas and output motor areas were activated equally by both novel and repeated objects and did not show effects of repetition, suggesting that the observed correlates of repetition were anatomically selective. We discuss these findings in relation to previous positron emission tomography (PET) and fMRI studies of item repetition and single-unit physiological studies; we also address the broad impact that rapid event-related fMRI is likely to have on functional neuroimaging.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychol,Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Univ Magdeburg, Dept Neurophysiol, D-39120 Magdeburg, Germany; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Harvard University; Otto von Guericke University; Harvard University	Buckner, RL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.		Dale, Anders M/A-5180-2010	Schacter, Daniel/0000-0002-2460-6061	NIA NIH HHS [AG08441] Funding Source: Medline; NIDCD NIH HHS [DC03245] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG008441, R37AG008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC003245] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Backman L, 1997, J COGNITIVE NEUROSCI, V9, P378, DOI 10.1162/jocn.1997.9.3.378; BAKER JR, 1993, P SOC MAGN RESON SCI, V1, P1400; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; BINDER JR, 1994, NEUROPSYCHOLOGY, P185; BLAMIRE AM, 1992, P NATL ACAD SCI USA, V89, P11069, DOI 10.1073/pnas.89.22.11069; BLAXTON TA, 1989, J EXP PSYCHOL LEARN, V15, P657, DOI 10.1037/0278-7393.15.4.657; Blaxton TA, 1996, CAN J EXP PSYCHOL, V50, P42, DOI 10.1037/1196-1961.50.1.42; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; BUCKNER RL, 1997, COGN NEUROSCI ANN M, V4, P67; BUCKNER RL, 1998, IN PRESS NEUROIMAGE; BUCKNER RL, 1998, IN PRESS P NATL ACAD; BUROCK M, 1998, IN PRESS P SOC MAGN; CLARK VP, 1997, NEUROIMAGE, V5, pS50; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; COHEN JD, 1997, NEUROIMAGE, V6, P93; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DEMB JB, 1995, J NEUROSCI, V15, P5870; DESIMONE R, 1992, SCIENCE, V258, P235; Desimone Robert, 1995, P475; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FRISTON KJ, 1997, MAGNET RESON MED, V39, P49; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; HALGREN E, 1997, COGN NEUROSCI SOC AN, V4, P34; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Konishi S, 1996, NEUROREPORT, V8, P19, DOI 10.1097/00001756-199612200-00005; KOUTSTAAL W, 1997, COGN NEUROSCI SOC AN, V4, P68; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Reese TG, 1995, JMRI-J MAGN RESON IM, V5, P739, DOI 10.1002/jmri.1880050621; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROEDIGER HL, 1989, VARIETIES MEMORY CON, P2; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; ROSEN BR, 1998, IN PRESS P NATL ACAD; Savoy RL, 1995, P SOC MAGN RESON MED, V3, P450; SCHACTER DL, 1992, AM PSYCHOL, V47, P559, DOI 10.1037/0003-066X.47.4.559; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHACTER DL, 1998, IN PRESS NEURO LEARN; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Talairach J, 1988, CO PLANAR STEREOTAXI; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; VanEssen DC, 1997, J NEUROSCI, V17, P7079; WAGNER AD, 1997, COG NEUROSCI SOC ANN, V4, P68; WAGNER AD, 1998, IN PRESS J COGNIT NE; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	67	482	484	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					285	296		10.1016/S0896-6273(00)80456-0	http://dx.doi.org/10.1016/S0896-6273(00)80456-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	YY510	9491989	Bronze			2022-12-17	WOS:000072154700013
J	Zeron, MM; Hansson, O; Chen, NS; Wellington, CL; Leavitt, BR; Brundin, P; Hayden, MR; Raymond, LA				Zeron, MM; Hansson, O; Chen, NS; Wellington, CL; Leavitt, BR; Brundin, P; Hayden, MR; Raymond, LA			Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease	NEURON			English	Article							RAT STRIATAL NEURONS; MUTANT HUNTINGTIN; CELL-DEATH; PROJECTION NEURONS; TERMINAL FRAGMENTS; QUINOLINIC ACID; TRANSGENIC MICE; NERVOUS-SYSTEM; PROTEIN-KINASE; LOCALIZATION	Previous work suggests N-methyl-D-aspartate receptor (NMDAR) activation may be involved in degeneration of medium-sized spiny striatal neurons in Huntington's disease (HD). Here we show that these neurons are more vulnerable to NMDAR-mediated death in a YAC transgenic FVB/N mouse model of HD expressing full-length mutant huntingtin, compared with wild-type FVB/N mice. Excitotoxic death of these neurons was increased after intrastriatal injection of quinolinate in vivo, and after NMDA but not AMPA exposure in culture. NMDA-induced cell death was abolished by an NR2B subtype-specific antagonist. In contrast, NMDAR-mediated death of cerebellar granule neurons was not enhanced, consistent with cell-type and NMDAR subtype specificity. Moreover, increased NMDA-evoked current amplitude and caspase-3 activity were observed in transgenic striatal neurons. Our data support a role for NR2B-subtype NMDAR activation as a trigger for selective neuronal degeneration in HD.	Lund Univ, Kinsmen Lab Neurol Res, Dept Psychiat, Biomed Ctr A10, S-22184 Lund, Sweden; Lund Univ, Sect Neuronal Survival, Wallenberg Neurosci Ctr, Biomed Ctr A10, S-22184 Lund, Sweden; Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Physiol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Div Neurol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada	Lund University; Lund University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Raymond, LA (corresponding author), Lund Univ, Kinsmen Lab Neurol Res, Dept Psychiat, Biomed Ctr A10, S-22184 Lund, Sweden.		Hansson, Oskar/A-7134-2013; Raymond, Lynn A./R-6707-2016; Leavitt, Blair R/G-1934-2012; Hayden, Michael R/D-8581-2011; Chen, Nansheng/E-6450-2012; Raymond, Lynn A/A-6664-2010	Hansson, Oskar/0000-0001-8467-7286; Raymond, Lynn A./0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Raymond, Lynn A/0000-0002-8610-1042				ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BRORSON JR, 1995, J NEUROSCI, V15, P4515; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cepeda C, 2001, EUR J NEUROSCI, V14, P1577, DOI 10.1046/j.0953-816x.2001.01783.x; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Chen NS, 1999, J NEUROCHEM, V72, P1890, DOI 10.1046/j.1471-4159.1999.0721890.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; GREENE JG, 1993, J NEUROCHEM, V61, P1151, DOI 10.1111/j.1471-4159.1993.tb03634.x; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; HANTRAYE P, 1990, EXP NEUROL, V108, P91, DOI 10.1016/0014-4886(90)90014-J; Harper PS, 1991, HUNTINGTONS DIS; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOWE AR, 1995, J NEUROSCI, V15, P458; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kovacs AD, 2001, EXP NEUROL, V168, P47, DOI 10.1006/exnr.2000.7576; Kuppenbender KD, 1999, J COMP NEUROL, V415, P204; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; LANDWEHRMEYER GB, 1995, J NEUROSCI, V15, P5297; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.3.CO;2-6; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 1999, J NEUROSCI, V19, P5159; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Thompson CL, 2000, NEUROSCI LETT, V283, P85, DOI 10.1016/S0304-3940(00)00930-7; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; Vallano ML, 1996, J NEUROSCI, V16, P631; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762; Zeron MM, 2001, MOL CELL NEUROSCI, V17, P41, DOI 10.1006/mcne.2000.0909	64	481	501	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					849	860		10.1016/S0896-6273(02)00615-3	http://dx.doi.org/10.1016/S0896-6273(02)00615-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906693	Bronze			2022-12-17	WOS:000174389600004
J	Ishibashi, T; Dakin, KA; Stevens, B; Lee, PR; Kozlov, SV; Stewart, CL; Fields, RD				Ishibashi, T; Dakin, KA; Stevens, B; Lee, PR; Kozlov, SV; Stewart, CL; Fields, RD			Astrocytes promote myelination in response to electrical impulses	NEURON			English	Article							LEUKEMIA INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; WHITE-MATTER ARCHITECTURE; ACTION-POTENTIALS; ALEXANDER-DISEASE; NEURAL IMPULSES; EXPRESSION; CNS; OLIGODENDROCYTES; MATURATION	Myelin, the insulating layers of membrane wrapped around axons by oligodendrocytes, is essential for normal impulse conduction. It forms during late stages of fetal development but continues into early adult life. Myelination correlates with cognitive development and can be regulated by impulse activity through unknown molecular mechanisms. Astrocytes do not form myelin, but these nonneuronal cells can promote myelination in ways that are not understood. Here, we identify a link between myelination, astrocytes, and electrical impulse activity in axons that is mediated by the cytokine leukemia inhibitory factor (LIF). These findings show that LIF is released by astrocytes in response to ATP liberated from axons firing action potentials, and LIF promotes myelination by mature oligodendrocytes. This activity-dependent mechanism promoting myelination could regulate myelination according to functional activity or environmental experience and may offer new approaches to treating demyelinating diseases.	NICHHD, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA; NCI, Lab Canc & Dev Biol, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fields, RD (corresponding author), NICHHD, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000713] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010376] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NICHD NIH HHS [Z01 HD000713-11] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BANNER LR, 1994, P NATL ACAD SCI USA, V91, P7109, DOI 10.1073/pnas.91.15.7109; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dupree JL, 2004, NEURON GLIA BIOL, V1, P179, DOI 10.1017/S1740925X04000304; Dziewulska D, 1999, FOLIA NEUROPATHOL, V37, P81; Fields R. Douglas, 1992, P67; Fields RD, 2004, SCI AM, V290, P54, DOI 10.1038/scientificamerican0404-54; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; FIELDS RD, 2006, PURINERGIC SIGNALING, V276; GARD AL, 1989, DEVELOPMENT, V106, P119; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Johnson AB, 2002, INT J DEV NEUROSCI, V20, P391, DOI 10.1016/S0736-5748(02)00045-X; Lee PR, 2004, NEURON GLIA BIOL, V1, P135, DOI 10.1017/S1740925X04000274; Li R, 2002, INT J DEV NEUROSCI, V20, P259, DOI 10.1016/S0736-5748(02)00019-9; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; MAYER M, 1994, DEVELOPMENT, V120, P143; Mey J, 2002, CELL TISSUE RES, V310, P155, DOI 10.1007/s00441-002-0624-x; Meyer-Franke A, 1999, MOL CELL NEUROSCI, V14, P385, DOI 10.1006/mcne.1999.0788; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; SCOLDING NJ, 1989, J NEUROIMMUNOL, V22, P169, DOI 10.1016/0165-5728(89)90014-3; Stankoff B, 2002, J NEUROSCI, V22, P9221; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 1998, J NEUROSCI, V18, P9303; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3; Yamakuni H, 2002, J NEUROIMMUNOL, V129, P43, DOI 10.1016/S0165-5728(02)00179-0; Zalc B, 2000, NEUROSCIENTIST, V6, P5, DOI 10.1177/107385840000600109	36	480	513	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					823	832		10.1016/j.neuron.2006.02.006	http://dx.doi.org/10.1016/j.neuron.2006.02.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543131	Green Accepted, Bronze			2022-12-17	WOS:000236227500011
J	YUSTE, R; KATZ, LC				YUSTE, R; KATZ, LC			CONTROL OF POSTSYNAPTIC CA2+ INFLUX IN DEVELOPING NEOCORTEX BY EXCITATORY AND INHIBITORY NEUROTRANSMITTERS	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL NERVOUS-SYSTEM; VISUAL-CORTEX; SYNAPTIC TRANSMISSION; NMDA RECEPTORS; HIPPOCAMPAL-NEURONS; PYRAMIDAL CELLS; CALCIUM; CAT; ANTAGONIST	We assessed the pathways by which excitatory and inhibitory neurotransmitters elicit postsynaptic changes in [Ca2+]i in brain slices of developing rat and cat neocortex, using fura 2. Glutamate, NMDA, and quisqualate transiently elevated [Ca2+]i in all neurons. While the quisqualate response relied exclusively on voltage-gated Ca2+ channels, almost all of the NMDA-induced Ca2+ influx was via the NMDA ionophore itself, rather than through voltage-gated Ca2+ channels. Glutamate itself altered [Ca2+]i almost exclusively via the NMDA receptor. Furthermore, synaptically induced Ca2+ entry relied almost completely on NMDA receptor activation, even with low-frequency stimulation. The inhibitory neurotransmitter GABA also increased [Ca2+]i, probably via voltage-sensitive Ca2+ channels, whereas the neuromodulator acetylcholine caused Ca2+ release from intracellular stores via a muscarinic receptor. Low concentrations of these agonists produced nonperiodic [Ca2+]i oscillations, which were temporally correlated in neighboring cells. Optical recording with Ca2+-sensitive indicators may thus permit the visualization of functional networks in developing cortical circuits.	ROCKEFELLER UNIV,NEUROBIOL LAB,NEW YORK,NY 10021	Rockefeller University								ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; ARMSTRONGJAMES M, 1970, Z ZELLFORSCH MIKROSK, V10, P559; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BEAR MF, 1990, J NEUROSCI, V10, P909; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONNOR JA, 1987, J NEUROSCI, V7, P1384; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; COULTER DA, 1989, ANN NEUROL, V25, P582, DOI 10.1002/ana.410250610; CURTIS DR, 1971, BRAIN RES, V34, P301, DOI 10.1016/0006-8993(71)90283-6; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; FOX K, 1989, J NEUROSCI, V9, P2443; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; JANIGRO D, 1988, DEV BRAIN RES, V41, P171, DOI 10.1016/0165-3806(88)90180-0; JENSEN AM, 1990, J NEUROSCI, V10, P1165; KATZ LC, 1987, J NEUROSCI, V7, P1223; KRIEGSTEIN AR, 1987, DEV BRAIN RES, V34, P161, DOI 10.1016/0165-3806(87)90206-9; KRNJEVIC K, 1987, J MIND BEHAV, V8, P537; LEVRAM V, 1987, BIOPHYS J, V52, P571, DOI 10.1016/S0006-3495(87)83246-0; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, TRENDS NEUROSCI, V12, P444, DOI 10.1016/0166-2236(89)90094-5; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1987, J NEUROSCI, V7, P3230; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NEHER E, 1988, FEBS LETT, V240, P88, DOI 10.1016/0014-5793(88)80345-4; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P925, DOI 10.1152/jn.1965.28.5.925; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RINK TJ, 1989, TRENDS NEUROSCI, V12, P43, DOI 10.1016/0166-2236(89)90133-1; ROSS WN, 1990, PROC R SOC SER B-BIO, V240, P173, DOI 10.1098/rspb.1990.0032; SCHARFMAN HE, 1985, BRAIN RES, V358, P385, DOI 10.1016/0006-8993(85)90990-4; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; SILLITO AM, 1977, J PHYSIOL-LONDON, V273, P775, DOI 10.1113/jphysiol.1977.sp012123; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P2834, DOI 10.1073/pnas.85.8.2834; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; UDIN SB, 1990, SCIENCE, V249, P669, DOI 10.1126/science.2166343; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	58	480	490	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					333	344		10.1016/0896-6273(91)90243-S	http://dx.doi.org/10.1016/0896-6273(91)90243-S			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1672071				2022-12-17	WOS:A1991FC47000003
J	MARTIN, LJ; BLACKSTONE, CD; HUGANIR, RL; PRICE, DL				MARTIN, LJ; BLACKSTONE, CD; HUGANIR, RL; PRICE, DL			CELLULAR-LOCALIZATION OF A METABOTROPIC GLUTAMATE RECEPTOR IN RAT-BRAIN	NEURON			English	Article							AMINO-ACID RECEPTOR; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; PYRAMIDAL CELLS; NERVOUS-SYSTEM; BIPOLAR CELLS; TRANS-ACPD; G-PROTEIN; EXPRESSION; DEPRESSION	In rat brain, the cellular localization of a phosphoinositide-linked metabotropic glutamate receptor(mGluR1-alpha) was demonstrated using antibodies that recognize the C-terminus of the receptor. mGluR1-alpha, a 142 kd protein, is enriched within the olfactory bulb, stratum oriens of CA1 and polymorph layer of dentate gyrus in hippocampus, globus pallidus, thalamus, substantia nigra, superior colliculus, and cerebellum. Lower levels of mGluR1-alpha are present within neocortex, striatum, amygdala, hypothalamus, and medulla. Dendrites, spines, and neuronal cell bodies contain mGluR1-alpha. mGluR1-alpha is not detectable in presynaptic terminals. mGluR1-alpha and ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor subunits show differential distributions, but in Purkinje cells, mGluR1-alpha and specific AMPA receptor subunits colocalize. The postsynaptic distribution of mGluR1-alpha is consistent with postulated physiological roles of this subtype of glutamate receptor.	JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	MARTIN, LJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER; NIA NIH HHS [AG05146] Funding Source: Medline; NIGMS NIH HHS [GM07309] Funding Source: Medline; NINDS NIH HHS [NS20471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; BLACKSTONE CD, 1989, P NATL ACAD SCI USA, V86, P4316, DOI 10.1073/pnas.86.11.4316; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHA JHJ, 1990, NEUROSCI LETT, V113, P78, DOI 10.1016/0304-3940(90)90498-X; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P28; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DESAI MA, 1991, J NEUROPHYSIOL, V66, P40, DOI 10.1152/jn.1991.66.1.40; FROTSCHER M, 1984, NEUROSCI LETT, V46, P137, DOI 10.1016/0304-3940(84)90431-2; FURUYA S, 1989, J PHYSIOL-LONDON, V414, P539, DOI 10.1113/jphysiol.1989.sp017702; Gasic G P, 1991, Curr Opin Neurobiol, V1, P20, DOI 10.1016/0959-4388(91)90006-S; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; HWANG PM, 1990, SCIENCE, V249, P802, DOI 10.1126/science.1975122; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LEVEY AI, 1986, J HISTOCHEM CYTOCHEM, V34, P1449, DOI 10.1177/34.11.2430010; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; PALMER E, 1989, EUR J PHARMACOL, V166, P585, DOI 10.1016/0014-2999(89)90383-X; ROSS CA, 1990, TRENDS NEUROSCI, V13, P216, DOI 10.1016/0166-2236(90)90163-5; SALT TE, 1991, EUR J NEUROSCI, V3, P1104, DOI 10.1111/j.1460-9568.1991.tb00045.x; SANDOVAL ME, 1978, NEUROSCIENCE, V3, P199, DOI 10.1016/0306-4522(78)90101-X; SCHOEPP DD, 1990, TRENDS PHARMACOL SCI, V11, P74; SEQUIER JM, 1990, EUR J NEUROSCI, V2, P1118, DOI 10.1111/j.1460-9568.1990.tb00023.x; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; STRATTON KR, 1990, EUR J PHARMACOL, V186, P357, DOI 10.1016/0014-2999(90)90461-E; STRATTON KR, 1989, EUR J PHARMACOL, V173, P235, DOI 10.1016/0014-2999(89)90529-3; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; YOUNG AB, 1974, BRAIN RES, V73, P1, DOI 10.1016/0006-8993(74)91002-6	37	478	500	2	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					259	270		10.1016/0896-6273(92)90165-A	http://dx.doi.org/10.1016/0896-6273(92)90165-A			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1323311				2022-12-17	WOS:A1992JJ33200008
J	Renthal, W; Maze, I; Krishnan, V; Covington, HE; Xiao, GH; Kumar, A; Russo, SJ; Graham, A; Tsankova, N; Kippin, TE; Kerstetter, KA; Neve, RL; Haggarty, SJ; McKinsey, TA; Bassel-Duby, R; Olson, EN; Nestler, EJ				Renthal, William; Maze, Ian; Krishnan, Vaishnav; Covington, Herbert E., III; Xiao, Guanghua; Kumar, Arvind; Russo, Scott J.; Graham, Ami; Tsankova, Nadia; Kippin, Tod E.; Kerstetter, Kerry A.; Neve, Rachael L.; Haggarty, Stephen J.; McKinsey, Timothy A.; Bassel-Duby, Rhonda; Olson, Eric N.; Nestler, Eric J.			Histone deacetylase 5 epigenetically controls Behavioral adaptations to chronic emotional stimuli	NEURON			English	Article							ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS; TRANSCRIPTION FACTOR; NEUROTROPHIC FACTOR; SEEKING BEHAVIOR; DELTA-FOSB; HISTONE H3; LYSINE 9; COCAINE; STRESS	Previous work has identified alterations in histone acetylation in animal models of drug addiction and depression. However, the mechanisms which integrate drugs and stress with changes in chromatin structure remain unclear. Here, we identify the activity-dependent class II histone deacetylase, HDAC5, as a central integrator of these stimuli with changes in chromatin structure and gene expression. Chronic, but not acute, exposure to cocaine or stress decreases HDAC5 function in the nucleus accumbens (NAc), a major brain reward region, which allows for increased histone acetylation and transcription of HDAC5 target genes. This regulation is behaviorally important, as loss of HDAC5 causes hypersensitive responses to chronic, not acute, cocaine or stress. These findings suggest that proper balance of histone acetylation is a crucial factor in the saliency of a given stimulus and that disruption of this balance is involved in the transition from an acute adaptive response to a chronic psychiatric illness.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Clin Sci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; Harvard Univ, Sch Med, Belmont, MA 02178 USA; McLean Hosp, Belmont, MA 02178 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Myogen Inc, Gilead Colorado Inc, Westminster, CO 80021 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Santa Barbara; Harvard University; Harvard University; McLean Hospital; Harvard University	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Maze, Ian/P-8077-2018; Kumar, Arvind/B-6094-2009; Haggarty, Stephen J/M-9495-2016; Russo, Scott/R-7107-2019	Haggarty, Stephen J/0000-0002-7872-168X; Russo, Scott/0000-0002-6470-1805; Kumar, Arvind/0000-0003-2879-3826; Renthal, William/0000-0003-0206-2101; Maze, Ian/0000-0003-1490-7781; Krishnan, Vaishnav/0000-0002-2847-0069				Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Ang E, 2001, J NEUROCHEM, V79, P221, DOI 10.1046/j.1471-4159.2001.00563.x; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Breslow R., 1993, PTC Int. Appl, Patent No. [9307148, WO 93/07148]; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; KALIVAS PW, 1984, NEUROSCI LETT, V48, P55, DOI 10.1016/0304-3940(84)90288-X; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kombian SB, 2003, J NEUROPHYSIOL, V89, P728, DOI 10.1152/jn.00854.2002; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JH, 2002, MOL CELL BIOL, V22, P7658, DOI 10.1128/MCB.22.21.7658-7666.2002; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; MERMELSTEIN P, 2007, NEUROBIOLOGY ADDICTI; Murtra P, 2000, NATURE, V405, P180, DOI 10.1038/35012069; Nazarian A, 2004, BRAIN RES BULL, V63, P295, DOI 10.1016/j.brainresbull.2004.03.004; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Newton SS, 2002, J NEUROSCI, V22, P10883; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Placenza FM, 2005, NEUROSCI LETT, V390, P42, DOI 10.1016/j.neulet.2005.07.050; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; PULVIRENTI L, 1992, BRAIN RES, V594, P327, DOI 10.1016/0006-8993(92)91145-5; Ruiz-Velasco V, 2002, PHYSIOL GENOMICS, V8, P41, DOI 10.1152/physiolgenomics.00085.2001; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	56	477	507	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2007	56	3					517	529		10.1016/j.neuron.2007.09.032	http://dx.doi.org/10.1016/j.neuron.2007.09.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988634	Bronze			2022-12-17	WOS:000250774600010
J	Novitch, BG; Chen, AI; Jessell, TM				Novitch, BG; Chen, AI; Jessell, TM			Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2	NEURON			English	Article							PROGENITOR-CELL IDENTITY; COMMISSURAL INTERNEURONS; TRANSCRIPTION FACTOR; DETERMINATION GENES; PRONEURAL GENES; HOMEOBOX GENES; DEVELOPING CNS; SPINAL-CORD; EXPRESSION; SPECIFICATION	Within the developing vertebrate nervous system, the mechanisms that coordinate neuronal subtype identity with generic features of neuronal differentiation are poorly defined. We show here that a bHLH protein, Olig2, is expressed selectively by motor neuron progenitors and has a key role in specifying the subtype identity and pan-neuronal properties of developing motor neurons. The role of Olig2 in the specification of motor neuron subtype identity depends on regulatory interactions with progenitor homeodomain proteins, whereas its role in promoting pan-neuronal properties is associated with expression of another bHLH protein, Ngn2. Both aspects of Olig2 function appear to depend an its activity as a transcriptional repressor. Together, these studies show that Olig2 has a critical role in integrating diverse features of motor neuron differentiation in the developing spinal cord.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu	Chen, Albert/AAH-9874-2020; Chen, Albert/E-7397-2014	Chen, Albert/0000-0001-5355-024X; Novitch, Bennett/0000-0002-2696-3708	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM08224] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Anderson D, 1997, MOL CELLULAR APPROAC, P26; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Cai J, 2000, GENESIS, V27, P6, DOI 10.1002/1526-968X(200005)27:1<6::AID-GENE20>3.3.CO;2-F; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Helms AW, 1998, DEVELOPMENT, V125, P919; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Morrow EM, 1999, DEVELOPMENT, V126, P23; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Perez SE, 1999, DEVELOPMENT, V126, P1715; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Roztocil T, 1997, DEVELOPMENT, V124, P3263; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Simmons AD, 2001, DEV BIOL, V229, P327, DOI 10.1006/dbio.2000.9984; Smith ST, 1996, DEVELOPMENT, V122, P3141; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	54	477	490	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					773	789		10.1016/S0896-6273(01)00407-X	http://dx.doi.org/10.1016/S0896-6273(01)00407-X			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567616	Bronze			2022-12-17	WOS:000171013300011
J	Hausser, M; Clark, BA				Hausser, M; Clark, BA			Tonic synaptic inhibition modulates neuronal output pattern and spatiotemporal synaptic integration	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; PASSIVE MEMBRANE-PROPERTIES; PIG HIPPOCAMPUS INVITRO; PYRAMIDAL NEURONS; GRANULE CELLS; BACKGROUND ACTIVITY; ACTION-POTENTIALS; CABLE PROPERTIES; STELLATE CELLS; RAT	Irregular firing patterns are observed in most central neurons in vivo, but their origin is controversial. Here, we shaw that two types of inhibitory neurons in the cerebellar cortex fire spontaneously and regularly in the absence of synaptic input but generate an irregular firing pattern in the presence of tonic synaptic inhibition. Paired recordings between synaptically connected neurons revealed that single action potentials in inhibitory interneurons cause highly variable delays in action potential firing in their postsynaptic cells. Activity in single and multiple inhibitory interneurons also significantly reduces postsynaptic membrane time constant and input resistance. These findings suggest that the time window for synaptic integration is a dynamic variable modulated by the level of tonic inhibition, and that rate coding and temporal coding strategies may be used in parallel in the same cell type.			Hausser, M (corresponding author), ECOLE NORMALE SUPER, NEUROBIOL LAB, 46 RUE ULM, F-75005 PARIS, FRANCE.		Hausser, Michael/AAW-6827-2020; Clark, Beverley/C-1519-2008; Oka, Yoshitaka/C-9670-2010	Hausser, Michael/0000-0002-2673-8957; Oka, Yoshitaka/0000-0002-3482-3051				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; ANDERSEN P, 1990, PROG BRAIN RES, V83, P215; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BARRETT JN, 1975, FED PROC, V34, P1398; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Bell A., 1995, INC9502; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BERNARD C, 1993, BRAIN RES, V626, P234, DOI 10.1016/0006-8993(93)90584-A; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; DURAND D, 1983, J NEUROPHYSIOL, V50, P1080, DOI 10.1152/jn.1983.50.5.1080; Eccles JC, 1967, CEREBELLUM NEURONAL; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; HOLMES WR, 1989, BRAIN RES, V505, P12, DOI 10.1016/0006-8993(89)90110-8; ITO M, 1966, EXP BRAIN RES, V2, P330; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; JACK JJB, 1983, ELECTRIC CURRENT FLO; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; JAEGER D, 1994, EXP BRAIN RES, V100, P200; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KORBO L, 1993, BRAIN RES, V609, P262, DOI 10.1016/0006-8993(93)90881-M; KUNO M, 1964, J PHYSIOL-LONDON, V175, P81, DOI 10.1113/jphysiol.1964.sp007504; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MAJOR G, 1993, BIOPHYS J, V65, P423, DOI 10.1016/S0006-3495(93)81037-3; MAJOR G, 1994, J NEUROSCI, V14, P4613; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MASON A, 1991, J NEUROSCI, V11, P72; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P355, DOI 10.1113/jphysiol.1992.sp019382; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MIYASHITA Y, 1984, J PHYSIOL-LONDON, V351, P251, DOI 10.1113/jphysiol.1984.sp015243; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Palay S.L., 1974, CEREBELLAR CORTEX CY; PERKEL DH, 1964, SCIENCE, V145, P61, DOI 10.1126/science.145.3627.61; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; RAPP M, 1992, NEURAL COMPUT, V4, P518, DOI 10.1162/neco.1992.4.4.518; Rieke F, 1997, SPIKES; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; SAYER RJ, 1990, J NEUROSCI, V10, P826; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Toth K, 1997, J PHYSIOL-LONDON, V500, P463, DOI 10.1113/jphysiol.1997.sp022033; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ueno S, 1997, J NEUROSCI, V17, P625; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	84	477	513	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1997	19	3					665	678		10.1016/S0896-6273(00)80379-7	http://dx.doi.org/10.1016/S0896-6273(00)80379-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331356	Bronze			2022-12-17	WOS:A1997XZ01600019
J	Ryba, NJP; Tirindelli, R				Ryba, NJP; Tirindelli, R			A new multigene family of putative pheromone receptors	NEURON			English	Article							ACCESSORY OLFACTORY-BULB; VOMERONASAL SYSTEM; MOLECULAR-CLONING; G-PROTEINS; DIFFERENTIAL LOCALIZATION; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; GENE-EXPRESSION; BINDING PROTEIN; NEURONS	The vomeronasal organ (VNO) mediates detection of pheromones related to social and reproductive behavior in most terrestrial vertebrates. We have identified a new multigene family of G protein-linked receptors (V2Rs) that are specifically expressed in the VNO. V2Rs have no significant homology to other putative pheromone receptors (V1Rs) or to olfactory receptors but are related to the Ca2+-sensing receptor and metabotropic glutamate receptors. V2Rs are expressed at high levels in small subpopulations of VNO neurons. V2Rs are primarily expressed in a different layer of VNO neurons from V1Rs, thus both gene families are likely to encode mammalian pheromone receptors.	UNIV PARMA,IST FISIOL UMANA,I-43100 PARMA,ITALY	University of Parma	Ryba, NJP (corresponding author), NIDR,TASTE & SMELL UNIT,ORAL INFECT & IMMUNOL BRANCH,NIH,BETHESDA,MD 20892, USA.			Ryba, Nicholas/0000-0002-2060-8393				AXEL R, 1995, SCI AM, V273, P219; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BARBER PC, 1974, BRAIN RES, V81, P21, DOI 10.1016/0006-8993(74)90476-4; BARBER PC, 1978, BRAIN RES, V147, P297, DOI 10.1016/0006-8993(78)90841-7; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Berghard A, 1996, J NEUROSCI, V16, P909; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CLANCY AN, 1984, J NEUROSCI, V4, P2222; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; JOHNS MA, 1978, NATURE, V272, P446, DOI 10.1038/272446a0; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; LOMAS DE, 1982, J REPROD FERTIL, V66, P101, DOI 10.1530/jrf.0.0660101; MEREDITH M, 1986, PHYSIOL BEHAV, V36, P737, DOI 10.1016/0031-9384(86)90362-8; MEREDITH M, 1994, PSYCHONEUROENDOCRINO, V19, P657, DOI 10.1016/0306-4530(94)90048-5; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; REYNOLDS J, 1979, J REPROD FERTIL, V57, P31; ROGERS KE, 1987, P NATL ACAD SCI USA, V84, P1704, DOI 10.1073/pnas.84.6.1704; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SHINOHARA H, 1992, J NEUROSCI, V12, P1275; TROEMEL ER, 1995, CELL, V83, P201; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; WALTON KM, 1993, NEURON, V11, P387, DOI 10.1016/0896-6273(93)90193-U; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wu YM, 1996, BIOCHEM BIOPH RES CO, V220, P900, DOI 10.1006/bbrc.1996.0503; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1980, SCIENCE, V207, P781, DOI 10.1126/science.7352288; WYSOCKI CJ, 1989, NEURAL CONTROL REPRO, P545	48	477	498	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					371	379		10.1016/S0896-6273(00)80946-0	http://dx.doi.org/10.1016/S0896-6273(00)80946-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292726	Bronze			2022-12-17	WOS:A1997XU14600015
J	Bendor, JT; Logan, TP; Edwards, RH				Bendor, Jacob T.; Logan, Todd P.; Edwards, Robert H.			The Function of alpha-Synuclein	NEURON			English	Review							MULTIPLE-SYSTEM ATROPHY; FAMILIAL PARKINSONS-DISEASE; CENTRAL-NERVOUS-SYSTEM; LEWY BODY PATHOLOGY; NULL MUTANT MICE; CLATHRIN-MEDIATED ENDOCYTOSIS; ENDOPLASMIC-RETICULUM STRESS; CANCER-CELL-SURVIVAL; A30P TRANSGENIC MICE; NIGRA PARS COMPACTA	Human genetics has indicated a causal role for the protein alpha-synuclein in the pathogenesis of familial Parkinson's disease (PD), and the aggregation of synuclein in essentially all patients with PD suggests a central role for this protein in the sporadic disorder. Indeed, the accumulation of misfolded alpha-synuclein now defines multiple forms of neural degeneration. Like many of the proteins that accumulate in other neurodegenerative disorders, however, the normal function of synuclein remains poorly understood. In this article, we review the role of synuclein at the nerve terminal and in membrane remodeling. We also consider the prion-like propagation of misfolded synuclein as a mechanism for the spread of degeneration through the neuraxis.	[Bendor, Jacob T.; Logan, Todd P.; Edwards, Robert H.] UCSF Sch Med, Dept Neurol, Grad Program Biomed Sci, San Francisco, CA 94158 USA; [Bendor, Jacob T.; Logan, Todd P.; Edwards, Robert H.] UCSF Sch Med, Dept Neurol, Grad Program Cell Biol, San Francisco, CA 94158 USA; [Bendor, Jacob T.; Logan, Todd P.; Edwards, Robert H.] UCSF Sch Med, Dept Neurol, Grad Program Neurosci, San Francisco, CA 94158 USA; [Bendor, Jacob T.; Logan, Todd P.; Edwards, Robert H.] UCSF Sch Med, Dept Physiol, Grad Program Biomed Sci, San Francisco, CA 94158 USA; [Bendor, Jacob T.; Logan, Todd P.; Edwards, Robert H.] UCSF Sch Med, Dept Physiol, Grad Program Cell Biol, San Francisco, CA 94158 USA; [Bendor, Jacob T.; Logan, Todd P.; Edwards, Robert H.] UCSF Sch Med, Dept Physiol, Grad Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Edwards, RH (corresponding author), UCSF Sch Med, Dept Neurol, Grad Program Biomed Sci, San Francisco, CA 94158 USA.	robert.edwards@ucsf.edu		Bendor, Jacob/0000-0003-1455-4891	John and Helen Cahill Family Endowed Chair in Parkinson's Disease Research; NIH; Giannini Foundation; NIH [NS062715]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062715] Funding Source: NIH RePORTER	John and Helen Cahill Family Endowed Chair in Parkinson's Disease Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giannini Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the John and Helen Cahill Family Endowed Chair in Parkinson's Disease Research, fellowships from NIH (to T.P.L.), the Giannini Foundation (to J.T.B.) and a grant from NIH (NS062715) to R.H.E.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahlskog JE, 2007, NEUROLOGY, V69, P1701, DOI 10.1212/01.wnl.0000296942.14309.4a; Ahn TB, 2008, NEUROLOGY, V70, P43, DOI 10.1212/01.wnl.0000271080.53272.c7; Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; Alonso-Canovas A, 2010, MOVEMENT DISORD, V25, P1506, DOI 10.1002/mds.23109; Annerino DM, 2012, ACTA NEUROPATHOL, V124, P665, DOI 10.1007/s00401-012-1040-2; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Barcelo-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x; Bartels T, 2013, NATURE, V498, pE6, DOI 10.1038/nature12126; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bisaglia M, 2010, BIOCHEM BIOPH RES CO, V394, P424, DOI 10.1016/j.bbrc.2010.03.044; Boassa D, 2013, J NEUROSCI, V33, P2605, DOI 10.1523/JNEUROSCI.2898-12.2013; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Boettcher JM, 2008, BIOCHEMISTRY-US, V47, P12357, DOI 10.1021/bi801450t; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Busch DJ, 2012, J COMP NEUROL, V520, P1751, DOI 10.1002/cne.23011; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Cabin DE, 2002, J NEUROSCI, V22, P8797; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2007, BIOCHEM BIOPH RES CO, V356, P548, DOI 10.1016/j.bbrc.2007.02.163; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Cockcroft S, 2002, MOL IMMUNOL, V38, P1277, DOI 10.1016/S0161-5890(02)00075-5; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dalfo E, 2004, NEUROBIOL DIS, V16, P92, DOI 10.1016/j.nbd.2004.01.001; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Dickson DW, 2010, MOVEMENT DISORD, V25, pS78, DOI 10.1002/mds.22637; Ding ZT, 2006, ACTA NEUROPATHOL, V111, P450, DOI 10.1007/s00401-005-0015-y; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer MJ, 2009, PARKINSONISM RELAT D, V15, P414, DOI 10.1016/j.parkreldis.2008.08.004; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fountaine TM, 2008, EUR J NEUROSCI, V28, P2459, DOI 10.1111/j.1460-9568.2008.06527.x; Fujita M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1101; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Galvin JE, 2001, EXP NEUROL, V168, P347, DOI 10.1006/exnr.2000.7615; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Gillette JS, 2003, TOXICOL APPL PHARM, V192, P287, DOI 10.1016/S0041-008X(03)00326-0; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goedert M, 1999, PHILOS T ROY SOC B, V354, P1101, DOI 10.1098/rstb.1999.0466; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goers J, 2003, BIOCHEMISTRY-US, V42, P8465, DOI 10.1021/bi0341152; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; Golovko MY, 2007, J NEUROCHEM, V101, P201, DOI 10.1111/j.1471-4159.2006.04357.x; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Golovko MY, 2005, BIOCHEMISTRY-US, V44, P8251, DOI 10.1021/bi0502137; Gomez-Isla T, 2003, NEUROBIOL AGING, V24, P245, DOI 10.1016/S0197-4580(02)00091-X; Goncalves S, 2013, MOL NEUROBIOL, V47, P1081, DOI 10.1007/s12035-013-8406-x; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guschina I, 2011, LIPIDS, V46, P121, DOI 10.1007/s11745-010-3486-0; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hua H, 2009, J PATHOL, V217, P507, DOI 10.1002/path.2465; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inaba S, 2005, BREAST CANCER RES TR, V94, P25, DOI 10.1007/s10549-005-6938-0; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwanaga K., 1999, NEUROLOGY, V52, P1269; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P657, DOI 10.1007/s00401-010-0672-3; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen MB, 2011, J BIOL CHEM, V286, P42603, DOI 10.1074/jbc.M111.271130; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Ji HJ, 1997, CANCER RES, V57, P759; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kholodilov NG, 1999, J NEUROCHEM, V73, P2586, DOI 10.1046/j.1471-4159.1999.0732586.x; Kim M, 2008, BIOCHEM BIOPH RES CO, V365, P628, DOI 10.1016/j.bbrc.2007.11.020; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; KRUEGER MJ, 1990, BIOCHEM BIOPH RES CO, V169, P123, DOI 10.1016/0006-291X(90)91442-U; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Kuo YM, 2010, HUM MOL GENET, V19, P1633, DOI 10.1093/hmg/ddq038; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2011, BIOCHEM BIOPH RES CO, V412, P526, DOI 10.1016/j.bbrc.2011.07.028; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Leftin A, 2013, J MOL BIOL, V425, P2973, DOI 10.1016/j.jmb.2013.04.002; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Leverenz JB, 2008, BRAIN PATHOL, V18, P220, DOI 10.1111/j.1750-3639.2007.00117.x; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; Markesbery WR, 2009, J NEUROPATH EXP NEUR, V68, P816, DOI 10.1097/NEN.0b013e3181ac10a7; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Marui W, 2002, J NEUROL SCI, V195, P153, DOI 10.1016/S0022-510X(02)00006-0; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; McLean PJ, 2000, J NEURAL TRANSM-SUPP, P53; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Miller DW, 2005, J NEURAL TRANSM, V112, P1613, DOI 10.1007/s00702-005-0378-1; Millership S, 2012, P NATL ACAD SCI USA, V109, P20943, DOI 10.1073/pnas.1210022110; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Mori F, 2002, BRAIN RES, V941, P118, DOI 10.1016/S0006-8993(02)02643-4; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Mosharov EV, 2003, J NEUROSCI, V23, P5835; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Ninkina N, 2012, J BIOL CHEM, V287, P44471, DOI 10.1074/jbc.M112.422402; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Nishie M, 2004, NEUROPATH APPL NEURO, V30, P546, DOI 10.1111/j.1365-2990.2004.00564.x; Nishie M, 2004, ACTA NEUROPATHOL, V107, P292, DOI 10.1007/s00401-003-0811-1; Nishioka K, 2010, ARCH NEUROL-CHICAGO, V67, P970, DOI 10.1001/archneurol.2010.177; Noorian AR, 2012, NEUROBIOL DIS, V48, P9, DOI 10.1016/j.nbd.2012.06.005; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Ozawa T, 2006, J NEUROL NEUROSUR PS, V77, P464, DOI 10.1136/jnnp.2005.073528; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Paillusson S, 2013, J NEUROCHEM, V125, P512, DOI 10.1111/jnc.12131; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; PAPP MI, 1994, BRAIN, V117, P235, DOI 10.1093/brain/117.2.235; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Payton JE, 2004, J MOL BIOL, V337, P1001, DOI 10.1016/j.jmb.2004.02.014; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Przedborski S, 2001, J NEUROCHEM, V76, P637, DOI 10.1046/j.1471-4159.2001.00174.x; Quilty MC, 2003, EXP NEUROL, V182, P195, DOI 10.1016/S0014-4886(03)00108-0; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Rappley I, 2009, BIOCHEMISTRY-US, V48, P1077, DOI 10.1021/bi801871h; Rekas A, 2010, EUR BIOPHYS J BIOPHY, V39, P1407, DOI 10.1007/s00249-010-0595-x; Rendon WO, 2013, HISTOCHEM CELL BIOL, V139, P671, DOI 10.1007/s00418-012-1059-4; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rideout HJ, 2003, J NEUROCHEM, V84, P803, DOI 10.1046/j.1471-4159.2003.01574.x; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sato H, 2013, REV NEUROSCIENCE, V24, P115, DOI 10.1515/revneuro-2012-0071; Sato K, 2007, MOVEMENT DISORD, V22, P2365, DOI 10.1002/mds.21732; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schluter OM, 2003, NEUROSCIENCE, V118, P985, DOI 10.1016/S0306-4522(03)00036-8; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Segarane B, 2009, NEUROLOGY, V72, P1185, DOI 10.1212/01.wnl.0000345356.40399.eb; Seidel K, 2010, ANN NEUROL, V67, P684, DOI 10.1002/ana.21966; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shannon KM, 2012, MOVEMENT DISORD, V27, P716, DOI 10.1002/mds.25020; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Soma H, 2006, J NEUROL SCI, V240, P107, DOI 10.1016/j.jns.2005.09.003; Soper JH, 2008, MOL BIOL CELL, V19, P1093, DOI 10.1091/mbc.E07-08-0827; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanis L, 2001, J NEUROCHEM, V76, P1165, DOI 10.1046/j.1471-4159.2001.00114.x; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Taschenberger G, 2013, ANN NEUROL, V74, P109, DOI 10.1002/ana.23905; Thomas B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016706; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Verca MSB, 2003, EUR J NEUROSCI, V18, P1923, DOI 10.1046/j.1460-9568.2003.02913.x; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P331, DOI 10.1007/s004010050049; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Wang LX, 2008, NEUROREPORT, V19, P873, DOI 10.1097/WNR.0b013e3282ffda5e; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Watts JC, 2012, P NATL ACAD SCI USA, V109, P3498, DOI 10.1073/pnas.1121556109; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Wietek J, 2013, FEBS LETT, V587, P2572, DOI 10.1016/j.febslet.2013.06.034; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Woods WS, 2007, J BIOL CHEM, V282, P34555, DOI 10.1074/jbc.M705283200; Yamaguchi K, 2005, ACTA NEUROPATHOL, V110, P298, DOI 10.1007/s00401-005-1042-4; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Yavich L, 2006, J NEUROCHEM, V99, P724, DOI 10.1111/j.1471-4159.2006.04098.x; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zigoneanu IG, 2012, BBA-BIOMEMBRANES, V1818, P512, DOI 10.1016/j.bbamem.2011.11.024	310	476	490	6	157	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1044	1066		10.1016/j.neuron.2013.09.004	http://dx.doi.org/10.1016/j.neuron.2013.09.004			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050397	Bronze, Green Accepted			2022-12-17	WOS:000330329600005
J	BOWIE, D; MAYER, ML				BOWIE, D; MAYER, ML			INWARD RECTIFICATION OF BOTH AMPA AND KAINATE SUBTYPE GLUTAMATE RECEPTORS GENERATED BY POLYAMINE-MEDIATED ION-CHANNEL BLOCK	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CULTURED HIPPOCAMPAL-NEURONS; PHEOCHROMOCYTOMA PC12 CELLS; CA2+ PERMEABILITY; ELICITED CURRENTS; STRUCTURAL DETERMINANTS; KINETIC-PROPERTIES; POTASSIUM-CHANNEL; CALCIUM ENTRY; HIGH-AFFINITY	Ca2+-permeable glutamate receptors assembled from subunits containing a GLN residue at the RNA editing site in membrane domain 2 show strong inward rectification. In HEK 293 cells transfected with the kainate receptor subunit GluR6(Q), inward rectification is lost in outside-out patches, suggesting a role for diffusible, cytoplasmic factors. Inclusion of different polyamines in the internal solution restored inward rectification, whereas Mg2+ (1 mM) was inactive. Spermine (K-d[0 mV] = 5.5 mu M) was of higher affinity than spermidine (K-d[0 mV] = 25.4 mu M) or putrescine (K-d[0 mV] = 1.2 mM). AMPA receptors assembled from GluR(flip), showed even higher affinity for spermine (K-d[0 mV] = 1.5 mu M) Analysis of the voltage dependence of whole-cell responses predicted intracellular free spermine and spermidine concentrations of 51 and 153 mu M, respectively.			BOWIE, D (corresponding author), NICHHD, CELLULAR & MOLEC NEUROPHYSIOL LAB, BETHESDA, MD 20892 USA.		Mayer, Mark L/H-5500-2013; Mayer, Mark/AAE-7356-2019	Mayer, Mark/0000-0003-4378-8451; Bowie, Derek/0000-0001-9491-8768				BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHARNET P, 1992, J PHYSIOL-LONDON, V450, P375, DOI 10.1113/jphysiol.1992.sp019132; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; DONEVAN SD, 1995, IN PRESS P NATL ACAD; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IFUNE CK, 1991, J PHYSIOL-LONDON, V443, P683, DOI 10.1113/jphysiol.1991.sp018858; IFUNE CK, 1993, J PHYSIOL-LONDON, V463, P431, DOI 10.1113/jphysiol.1993.sp019603; IFUNE CK, 1990, P NATL ACAD SCI USA, V87, P4794, DOI 10.1073/pnas.87.12.4794; IFUNE CK, 1992, J PHYSIOL-LONDON, V457, P143, DOI 10.1113/jphysiol.1992.sp019369; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; MATHIE A, 1991, J PHYSIOL-LONDON, V439, P717, DOI 10.1113/jphysiol.1991.sp018690; MATHIE A, 1990, J PHYSIOL-LONDON, V427, P625, DOI 10.1113/jphysiol.1990.sp018191; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; NUTT SL, 1994, NEUROREPORT, V5, P1679, DOI 10.1097/00001756-199408150-00034; OZAWA S, 1993, NEUROSCI LETT, V155, P187, DOI 10.1016/0304-3940(93)90704-O; PALMER BN, 1974, J CHEM SOC DA, V19, P2086; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PASCHEN W, 1994, NEUROSCI LETT, V174, P109, DOI 10.1016/0304-3940(94)90131-7; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; RUETER SM, 1995, SCIENCE, V267, P1491, DOI 10.1126/science.7878468; SANDS SB, 1992, J PHYSIOL-LONDON, V447, P467, DOI 10.1113/jphysiol.1992.sp019012; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WATANABE S, 1991, J BIOL CHEM, V266, P20803; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WO ZGL, 1995, J BIOL CHEM, V270, P2000, DOI 10.1074/jbc.270.5.2000; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YANG JH, 1995, NATURE, V374, P77, DOI 10.1038/374077a0	60	476	486	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1995	15	2					453	462		10.1016/0896-6273(95)90049-7	http://dx.doi.org/10.1016/0896-6273(95)90049-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR426	7646897	Bronze			2022-12-17	WOS:A1995RR42600022
J	ROSENMUND, C; WESTBROOK, GL				ROSENMUND, C; WESTBROOK, GL			CALCIUM-INDUCED ACTIN DEPOLYMERIZATION REDUCES NMDA CHANNEL ACTIVITY	NEURON			English	Article							ASPARTATE-ACTIVATED CHANNELS; DEPENDENT PROTEIN-KINASE; EXCITATORY AMINO-ACIDS; LONG-TERM POTENTIATION; DENDRITIC SPINES; HIPPOCAMPAL-NEURONS; LATERAL MOBILITY; SKELETAL-MUSCLE; SINGLE-CHANNEL; RECEPTORS	Actin filaments are highly concentrated in postsynaptic densities at central excitatory synapses, but their influence on postsynaptic glutamate receptors is unknown. We tested whether actin depolymerization influences NMDA channel activity in whole-cell recording on cultured hippocampal neurons. The ATP- and calcium-dependent rundown of NMDA channels was prevented when actin depolymerization was blocked by phalloidin. Rundown of AMPA/kainate receptors was unaffected by phalloidin. Cytochalasins, which enhance actin-ATP hydrolysis, induced NMDA channel rundown, whereas taxol or colchicine, which stabilize or disrupt microtubule assembly, had no effect. Protease inhibitors also had no effect. Our results suggest that calcium and ATP can influence NMDA channel activity by altering the state of actin polymerization and are consistent with a proposed model in which actin filaments compartmentalize a channel regulatory protein.	OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201	Oregon Health & Science University	ROSENMUND, C (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201, USA.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046613, R37MH046613] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46613] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bamburg J. R., 1991, NEURONAL CYTOSKELETO, P121; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BENNETT J, 1986, BRIT MED BULL, V42, P385, DOI 10.1093/oxfordjournals.bmb.a072156; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BIGOT D, 1990, NEUROSCI LETT, V111, P275, DOI 10.1016/0304-3940(90)90274-D; BLACK MM, 1982, J CELL BIOL, V95, P379, DOI 10.1083/jcb.95.2.379; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; EDELSTEIN NG, 1988, BIOCHEMISTRY-US, V27, P1818, DOI 10.1021/bi00406a003; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; FIFKOVA E, 1985, CELL MOL NEUROBIOL, V5, P47, DOI 10.1007/BF00711085; FORSCHER P, 1985, J GEN PHYSIOL, V85, P743, DOI 10.1085/jgp.85.5.743; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; GULLEY RL, 1981, J CELL BIOL, V91, P298, DOI 10.1083/jcb.91.1.298; HAMILL OP, 1992, P NATL ACAD SCI USA, V89, P7462, DOI 10.1073/pnas.89.16.7462; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; JONES KA, 1991, NEURON, V7, P593, DOI 10.1016/0896-6273(91)90372-7; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; MILTON RL, 1990, PFLUG ARCH EUR J PHY, V416, P758, DOI 10.1007/BF00370626; MORRIS CE, 1991, SCIENCE, V251, P1246, DOI 10.1126/science.1706535; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; PATNEAU DK, 1993, IN PRESS J NEUROSCI; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; REUNER KH, 1987, EUR J CELL BIOL, V43, P134; ROSENMUND C, 1993, IN PRESS J PHYSL; SACHS F, 1986, MEMBRANE BIOCHEM, V6, P173, DOI 10.3109/09687688609065448; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SEUBERT P, 1988, BRAIN RES, V460, P189, DOI 10.1016/0006-8993(88)91222-X; SHEPHERD GM, 1987, P NATL ACAD SCI USA, V87, P8627; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SOBUE K, 1983, P NATL ACAD SCI-BIOL, V80, P6868, DOI 10.1073/pnas.80.22.6868; SOKABE M, 1990, J CELL BIOL, V111, P599, DOI 10.1083/jcb.111.2.599; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; SRINIVASAN Y, 1990, J NEUROSCI, V10, P985; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VELAZQUEZ JL, 1989, J NEUROSCI, V9, P2163; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455	60	476	486	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					805	814		10.1016/0896-6273(93)90197-Y	http://dx.doi.org/10.1016/0896-6273(93)90197-Y			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	7684233				2022-12-17	WOS:A1993LD32200004
J	Feldman, DE				Feldman, DE			Timing-based LTP and LTD at vertical inputs to layer II/III pyramidal cells in rat barrel cortex	NEURON			English	Article							LONG-TERM POTENTIATION; EXPERIENCE-DEPENDENT PLASTICITY; INTRINSIC FIRING PATTERNS; VISUAL-CORTEX; SYNAPTIC PLASTICITY; SOMATOSENSORY CORTEX; THALAMOCORTICAL SYNAPSES; HIPPOCAMPAL-NEURONS; CORTICAL PLASTICITY; CRITICAL PERIOD	Experience-dependent plasticity in somatosensory (S1) and visual (V1) cortex involves rapid depression of responses to a deprived sensory input (a closed eye or a trimmed whisker). Such depression occurs first in layer II/III and may reflect plasticity at vertical inputs from layer IV to layer II/III pyramids. Here, I describe a timing-based, associative form of long-term potentiation and depression (LTP/LTD) at this synapse in S1. LTP occurred when excitatory postsynaptic potentials (EPSPs) led single postsynaptic action potentials (APs) within a narrow temporal window, and LTD occurred when APs led EPSPs within a significantly broader window. This long LTD window is unusual among timing-based learning rules and causes EPSPs that are uncorrelated with postsynaptic APs to become depressed. This behavior suggests a simple model for depression of deprived sensory responses in S1 and V1.	NINDS, Neural Dev Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Feldman, DE (corresponding author), NINDS, Neural Dev Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	dfeldman@codon.nih.gov						AGMON A, 1992, J NEUROSCI, V12, P319; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; AroniadouAnderjaska V, 1995, NEUROREPORT, V6, P2297, DOI 10.1097/00001756-199511270-00007; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BENUSKOVA L, 1994, P NATL ACAD SCI USA, V91, P4791, DOI 10.1073/pnas.91.11.4791; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Cynader M, 2000, SCIENCE, V287, P1943, DOI 10.1126/science.287.5460.1943; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Debarbieux F, 1998, J NEUROPHYSIOL, V79, P2911, DOI 10.1152/jn.1998.79.6.2911; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; FREGNAC Y, 1994, J NEUROPHYSIOL, V71, P1403, DOI 10.1152/jn.1994.71.4.1403; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Goldreich D, 1999, J NEUROPHYSIOL, V82, P1311, DOI 10.1152/jn.1999.82.3.1311; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; HARRIS RM, 1983, J COMP NEUROL, V220, P63, DOI 10.1002/cne.902200107; HARRIS RM, 1979, BRAIN RES, V161, P143, DOI 10.1016/0006-8993(79)90201-4; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kitagawa H, 1997, BRAIN RES, V751, P339, DOI 10.1016/S0006-8993(97)00052-8; Kondo H, 1999, EUR J NEUROSCI, V11, P4197, DOI 10.1046/j.1460-9568.1999.00844.x; KOSSUT M, 1992, PROG NEUROBIOL, V39, P389, DOI 10.1016/0301-0082(92)90013-5; LEE SM, 1991, BRAIN RES, V544, P303, DOI 10.1016/0006-8993(91)90069-8; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lorente de No R., 1922, TRAB LAB INVEST BIOL, V20, P41; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Sejnowski TJ, 1999, NEURON, V24, P773, DOI 10.1016/S0896-6273(00)81025-9; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; STENT GS, 1973, P NATL ACAD SCI USA, V95, P3245; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Wallace H, 1999, SOMATOSENS MOT RES, V16, P122; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WIESEL TN, 1965, J NEUROPHYSIOL, V40, P891; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	65	475	483	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					45	56		10.1016/S0896-6273(00)00008-8	http://dx.doi.org/10.1016/S0896-6273(00)00008-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939330	Bronze			2022-12-17	WOS:000088503800009
J	Dapretto, M; Bookheimer, SY				Dapretto, M; Bookheimer, SY			Form and content: Dissociating syntax and semantics in sentence comprehension	NEURON			English	Article							INFERIOR PREFRONTAL CORTEX; CEREBRAL BLOOD-FLOW; FUNCTIONAL MRI; LANGUAGE; ACTIVATION; APHASIA; SPEECH; PET; RETRIEVAL; KNOWLEDGE	The distinction between syntax (sentence form) and semantics (sentence meaning) is fundamental to our thinking about language. Whether and where this distinction is represented at the neural level is still a matter of considerable debate. In the present fMRI study, we examined the neural correlates of syntactic and semantic functions using an innovative activation paradigm specifically designed to unequivocally disentangle syntactic from lexicosemantic aspects of sentence processing. Our findings strongly indicate that a part of Broca's area (BA 44, pars opercularis) is critically implicated in processing syntactic information, whereas the lower portion of the left inferior frontal gyrus (BA 47, pars orbitalis) is selectively involved in processing the semantic aspects of a sentence.	Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Ahmnson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Dapretto, M (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Ahmnson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.			Bookheimer, Susan/0000-0002-3417-5891				Bavelier D, 1997, J COGNITIVE NEUROSCI, V9, P664, DOI 10.1162/jocn.1997.9.5.664; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BLUMSTEIN SE, 1982, BRAIN LANG, V17, P301, DOI 10.1016/0093-934X(82)90023-2; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; BOTTINI G, 1994, BRAIN, V117, P1241, DOI 10.1093/brain/117.6.1241; BUCKNER RL, 1995, HDB NEUROPSYCHOLOGY, V10, P439; Caplan D, 1998, J COGNITIVE NEUROSCI, V10, P541, DOI 10.1162/089892998562843; CARAMAZZA A, 1978, PSYCHOL BULL, V85, P898, DOI 10.1037/0033-2909.85.4.898; DEMB JB, 1995, J NEUROSCI, V15, P5870; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Goodglass H., 1993, UNDERSTANDING APHASI; HAGOORT P, 1993, BRAIN LANG, V45, P189, DOI 10.1006/brln.1993.1043; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; Iacoboni M, 1998, BRAIN, V121, P2135, DOI 10.1093/brain/121.11.2135; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; Muller RA, 1997, NEUROREPORT, V8, P3767; MUNTE TF, 1993, J COGNITIVE NEUROSCI, V5, P335, DOI 10.1162/jocn.1993.5.3.335; NEVILLE HJ, 1992, CEREB CORTEX, V2, P244, DOI 10.1093/cercor/2.3.244; Ojemann G, 1992, Adv Neurol, V57, P361; ROSLER F, 1993, J COGNITIVE NEUROSCI, V5, P345, DOI 10.1162/jocn.1993.5.3.345; Rueckert L, 1994, J Neuroimaging, V4, P67; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; SHAYWITZ BA, 1995, HUM BRAIN MAPP, V2, P149, DOI DOI 10.1002/HBM.460020304; STOMSWOLD K, 1996, BRAIN LANG, V52, P452; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Woods R.P., 1998, J COMPUT ASSIST TOMO, V22, P141; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21; Zurif E., 1990, NEUROPSYCHOLOGY NEUR, P123	35	475	484	0	43	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					427	432		10.1016/S0896-6273(00)80855-7	http://dx.doi.org/10.1016/S0896-6273(00)80855-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	251BA	10571235	Bronze			2022-12-17	WOS:000083423700016
J	Kim, E; Cho, KO; Rothschild, A; Sheng, M				Kim, E; Cho, KO; Rothschild, A; Sheng, M			Heteromultimerization and NMDA receptor-clustering activity of chapsyn-110, a member of the PSD-95 family of proteins	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; MOLECULAR CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; CHANNEL PROTEINS; K+ CHANNELS; RAT-BRAIN; SUBUNIT; HOMOLOG; NEURONS; CLONING	Chapsyn-110, a novel membrane-associated putative guanylate kinase (MAGUK) that binds directly to N-methyl-D-aspartate (NMDA) receptor and Shaker K+ channel subunits, is 70%-80% identical to, and shares an identical domain organization with, PSD-95/SAP90 and SAP97. In rat brain, chapsyn-110 protein shows a somatodendritic expression pattern that overlaps partly with PSD-95 but that contrasts with the axonal distribution of SAP97. Chapsyn-110 associates tightly with the postsynaptic density in brain, and mediates the clustering of both NMDA receptors and K+ channels in heterologous cells. Indeed, chapsyn-110 and PSD-95 can heteromultimerize with each other and are recruited into the same NMDA receptor and K, channel clusters. Thus, chapsyn-110 and PSD-95 may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signalling proteins.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor College of Medicine	Kim, E (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT NEUROBIOL,HOWARD HUGHES MED INST,BOSTON,MA 02114, USA.		Cho, Kyung-Ok/C-1705-2011; Kim, Eunjoon/C-1566-2011	Cho, Kyung-Ok/0000-0002-0760-2560; Sheng, Morgan/0000-0002-8703-5366				AOKI C, 1994, J NEUROSCI, V14, P5202; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; HALL ZW, 1993, NEURON S, V10, P99; Hunt CA, 1996, J NEUROSCI, V16, P1380; ISHII T, 1993, J BIOL CHEM, V268, P2836; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1995, SCIENCE, V269, P1737; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1996, J NEUROSCI, V16, P2157; PETRALIA RS, 1994, J NEUROSCI, V14, P667; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SHENG M, 1994, J NEUROSCI, V14, P2408; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; THODES KJ, 1995, J NEUROSCI, V15, P5360; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	36	474	484	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					103	113		10.1016/S0896-6273(00)80284-6	http://dx.doi.org/10.1016/S0896-6273(00)80284-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755482	Bronze			2022-12-17	WOS:A1996UY98100011
J	REGAN, LJ; SAH, DWY; BEAN, BP				REGAN, LJ; SAH, DWY; BEAN, BP			CA2+ CHANNELS IN RAT CENTRAL AND PERIPHERAL NEURONS - HIGH-THRESHOLD CURRENT RESISTANT TO DIHYDROPYRIDINE BLOCKERS AND OMEGA-CONOTOXIN	NEURON			English	Article							CHICK SENSORY NEURONS; MULTIPLE CALCIUM CHANNELS; HIGH-AFFINITY BINDING; SYNAPTIC TRANSMISSION; ATRIAL CELLS; 2 KINDS; ANTAGONISTS; RELEASE; SYNAPTOSOMES; BLOCKING	Block of Ca2+ channel current by dihydropyridines and by omega-conotoxin (omega-CgTx) was studied in a variety of freshly dissociated rat neurons. In most neurons, including those from dorsal root ganglia, sympathetic ganglia, spinal cord, cerebral cortex, and hippocampus, nitrendipine and omega-CgTx each blocked a fraction of the high-threshold current, but a substantial fraction of current remained even when the two blockers were applied together at saturating concentrations. An extreme case was cerebellar Purkinje neurons, in which very little current was blocked by either nitrendipine or omega-CgTx. These results demonstrate the existence in mammalian neurons of high-threshold channels that are resistant to both omega-CgTx and dihydropyridine blockers. Such channels might underlie instances of synaptic transmission and other processes that depend on Ca2+ entry but are not sensitive to these blockers.			REGAN, LJ (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL035043, R44HL035043] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35043] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABELE AE, 1990, NEURON, V4, P413, DOI 10.1016/0896-6273(90)90053-I; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; ANDERSON AJ, 1987, NEUROSCI LETT, V82, P177, DOI 10.1016/0304-3940(87)90125-X; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; BEAN BP, 1990, J NEUROSCI, V10, P1; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BOLAND LM, 1990, J PHYSIOL-LONDON, V420, P223, DOI 10.1113/jphysiol.1990.sp017909; BOLL W, 1985, NEUROSCI LETT, V56, P335, DOI 10.1016/0304-3940(85)90265-4; CARBONE E, 1990, NEUROSCI LETT, V111, P315, DOI 10.1016/0304-3940(90)90281-D; CARBONE E, 1990, PFLUG ARCH EUR J PHY, V416, P170, DOI 10.1007/BF00370239; DOCHERTY RJ, 1986, NEUROSCI LETT, V70, P110, DOI 10.1016/0304-3940(86)90447-7; FEDULOVA SA, 1985, J PHYSIOL-LONDON, V359, P431, DOI 10.1113/jphysiol.1985.sp015594; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P58; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUME JR, 1985, J PHARMACOL EXP THER, V234, P134; JONES SW, 1990, J NEUROSCI, V10, P2261; KAMIYA H, 1988, NEUROSCI LETT, V91, P84, DOI 10.1016/0304-3940(88)90253-4; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KONGSAMUT S, 1989, ANN NY ACAD SCI, V560, P312, DOI 10.1111/j.1749-6632.1989.tb24112.x; KUAN YF, 1986, EUR J PHARMACOL, V130, P273, DOI 10.1016/0014-2999(86)90278-5; LEONARD JP, 1987, J NEUROSCI, V7, P875; LIN JW, 1990, P NATL ACAD SCI USA, V87, P4538, DOI 10.1073/pnas.87.12.4538; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MARQUEZE B, 1988, MOL PHARMACOL, V34, P87; MCCARTHY RT, 1989, J GEN PHYSIOL, V94, P669, DOI 10.1085/jgp.94.4.669; MCCARTHY RT, 1989, NIMODIPINE CENTRAL N, P35; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; OGURA A, 1984, BRAIN RES, V301, P323, DOI 10.1016/0006-8993(84)91101-6; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; PERNEY TM, 1986, P NATL ACAD SCI USA, V83, P6656, DOI 10.1073/pnas.83.17.6656; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1987, PFLUG ARCH EUR J PHY, V409, P361, DOI 10.1007/BF00583789; REYNOLDS IJ, 1986, P NATL ACAD SCI USA, V83, P8804, DOI 10.1073/pnas.83.22.8804; SAH DWY, 1990, J NEUROSCI, V10, P136; SANGUINETTI MC, 1986, J GEN PHYSIOL, V88, P369, DOI 10.1085/jgp.88.3.369; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; SEABROOK GR, 1989, BRIT J PHARMACOL, V97, P1125, DOI 10.1111/j.1476-5381.1989.tb12570.x; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SUSZKIW JB, 1989, J NEUROCHEM, V52, P1260, DOI 10.1111/j.1471-4159.1989.tb01874.x; SUSZKIW JB, 1986, J NEUROSCI, V6, P1349; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TOSELLI M, 1990, NEUROSCI LETT, V112, P70, DOI 10.1016/0304-3940(90)90324-3; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; UEHARA A, 1985, J GEN PHYSIOL, V85, P621, DOI 10.1085/jgp.85.5.621; UEMATSU D, 1989, STROKE, V20, P1531, DOI 10.1161/01.STR.20.11.1531; USOWICZ MM, 1990, J PHYSIOL-LONDON, V426, P95, DOI 10.1113/jphysiol.1990.sp018128; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; YATANI A, 1985, CIRC RES, V56, P868, DOI 10.1161/01.RES.56.6.868; YU C, 1988, EXP BRAIN RES, V71, P467, DOI 10.1007/BF00248740	60	474	477	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					269	280		10.1016/0896-6273(91)90362-4	http://dx.doi.org/10.1016/0896-6273(91)90362-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1847065				2022-12-17	WOS:A1991EY70900009
J	BAZAN, JF				BAZAN, JF			NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD	NEURON			English	Article							COLONY-STIMULATING FACTOR; CILIARY NEUROTROPHIC FACTOR; NEURONAL DIFFERENTIATION FACTOR; LEUKEMIA INHIBITORY FACTOR; RAT SYMPATHETIC NEURONS; CELL CONDITIONED MEDIUM; CENTRAL NERVOUS-SYSTEM; GROWTH-FACTOR; MOLECULAR-CLONING; HUMAN INTERLEUKIN-6	Among the molecules that determine the developmental fate of sympathetic neurons f rom noradrenergic to cholinergic function are two apparently unrelated proteins, cholinergic differentiation factor and ciliary neurotrophic factor (CDF and CNTF, respectively). The present work suggests a structural basis for their functional overlap: sequence pattern-matching and predictive structure analysis contends that CDF and CNTF are homologous and share a common helical framework. An integrated CDF/CNTF profile also reveals similar sequence/structure motifs in a group of hematopoietic cytokines composed of granulocyte colony-stimulating factor, interleukin-6, and a novel factor called oncostatin M; a more distant relationship is indicated with interleukin-3 and interferons-alpha/beta. Evolutionary ties between neuropoietic and hematopoietic cytokines predict a distinctive tertiary architecture for the uncharacterized CDF and CNTF receptors. The intertwined cytokine/receptor networks signal a closer relationship between the molecular mechanisms underlying neuro- and hematopoiesis.			BAZAN, JF (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA.		Bazan, J. Fernando/B-4562-2010					ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; ANDERSON DJ, 1989, TRENDS NEUROSCI, V12, P83, DOI 10.1016/0166-2236(89)90160-4; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, CELL, V61, P753, DOI 10.1016/0092-8674(90)90182-E; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; BECK G, 1989, BIOESSAYS, V11, P62, DOI 10.1002/bies.950110206; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; CHANG JY, 1990, J NEUROCHEM, V55, P436, DOI 10.1111/j.1471-4159.1990.tb04155.x; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; CLARKLEWIS I, 1988, P NATL ACAD SCI USA, V85, P7897, DOI 10.1073/pnas.85.21.7897; CLOGSTON CL, 1989, ARCH BIOCHEM BIOPHYS, V272, P144, DOI 10.1016/0003-9861(89)90205-1; COHEN FE, 1986, BIOCHEMISTRY-US, V25, P266, DOI 10.1021/bi00349a037; CRAWFORD IP, 1987, PROTEINS, V2, P118, DOI 10.1002/prot.340020206; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DAMORE PA, 1990, CANCER METAST REV, V9, P227, DOI 10.1007/BF00046362; Demaeyer E., 1988, INTERFERONS OTHER RE; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOVER GA, 1991, CELL, V65, P9, DOI 10.1016/0092-8674(91)90401-J; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; ERKMAN L, 1989, DEV BIOL, V132, P375, DOI 10.1016/0012-1606(89)90234-0; FARRAR WL, 1989, BLOOD, V73, P137; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; FREI K, 1986, J IMMUNOL, V137, P3521; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; FUKADA K, 1985, P NATL ACAD SCI USA, V82, P8795, DOI 10.1073/pnas.82.24.8795; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GOUGH NM, 1989, CANCER CELL-MON REV, V1, P77; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HOOPER C, 1990, J NIH RES, V2, P54; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; IDA N, 1989, BIOCHEM BIOPH RES CO, V165, P728, DOI 10.1016/S0006-291X(89)80027-0; IMPROTA T, 1988, EXP CELL RES, V179, P1, DOI 10.1016/0014-4827(88)90342-4; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JOHNSON MS, 1990, J MOL EVOL, V30, P43, DOI 10.1007/BF02102452; KAMEGAI M, 1990, NEURON, V4, P429, DOI 10.1016/0896-6273(90)90055-K; KANAKURA Y, 1990, BLOOD, V76, P706; KRUTTGEN A, 1990, FEBS LETT, V262, P323, DOI 10.1016/0014-5793(90)80219-9; KUGA T, 1989, BIOCHEM BIOPH RES CO, V159, P103, DOI 10.1016/0006-291X(89)92410-8; Lallier T., 1990, Seminars in Developmental Biology, V1, P35; LAM A, 1991, IN PRESS GENE; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; LANDIS SC, 1981, TRENDS NEUROSCI, V4, P172, DOI 10.1016/0166-2236(81)90056-4; LARSSON I, 1978, INFECT IMMUN, V22, P786, DOI 10.1128/IAI.22.3.786-789.1978; Le Douarin N.M., 1982, NEURAL CREST; LEUTZ A, 1989, EMBO J, V8, P175, DOI 10.1002/j.1460-2075.1989.tb03362.x; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINSLEY PS, 1990, MOL CELL BIOL, V10, P1882, DOI 10.1128/MCB.10.5.1882; LJUNGDAHL A, 1989, J NEUROSCI RES, V24, P451, DOI 10.1002/jnr.490240316; LU HS, 1989, ARCH BIOCHEM BIOPHYS, V268, P81, DOI 10.1016/0003-9861(89)90567-5; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; MALIPIERO UV, 1990, J IMMUNOL, V144, P3816; MARTINOU JC, 1989, J NEUROSCI, V9, P3645; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; METCALF D, 1989, LEUKEMIA, V3, P349; MILLAR DA, 1989, ENDEAVOUR, V13, P72, DOI 10.1016/0160-9327(89)90005-7; MORRISONGRAHAM K, 1989, TRENDS GENET, V5, P116, DOI 10.1016/0168-9525(89)90042-5; NAGATA S, 1989, BIOESSAYS, V10, P113, DOI 10.1002/bies.950100405; NAWA H, 1990, NEURON, V4, P269, DOI 10.1016/0896-6273(90)90101-K; NAWA H, 1991, IN PRESS COLD SPRING; NISHIMURA C, 1991, EUR J BIOCHEM, V196, P377, DOI 10.1111/j.1432-1033.1991.tb15827.x; OLSSON T, 1989, J NEUROSCI, V9, P3870; PARK LS, 1989, J BIOL CHEM, V264, P5420; PATTERSON PH, 1990, CELL, V62, P1035, DOI 10.1016/0092-8674(90)90379-S; PATTERSON PH, 1978, ANNU REV NEUROSCI, V1, P1, DOI 10.1146/annurev.ne.01.030178.000245; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; PIETSCH T, 1990, KLIN PADIATR, V202, P235, DOI 10.1055/s-2007-1025526; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; PRESNELL SR, 1989, P NATL ACAD SCI USA, V86, P6592, DOI 10.1073/pnas.86.17.6592; RAO MS, 1990, NEURON, V5, P899, DOI 10.1016/0896-6273(90)90350-O; RAO MS, 1990, DEV BIOL, V139, P65, DOI 10.1016/0012-1606(90)90279-R; REICHARDT LF, 1977, NATURE, V270, P147, DOI 10.1038/270147a0; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROHRER H, 1990, EUR J NEUROSCI, V2, P1005, DOI 10.1111/j.1460-9568.1990.tb00013.x; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; Schwarz R, 1979, ATLAS PROTEIN SEQUEN, P353, DOI DOI 10.2307/2408678; SENDA T, 1990, P JPN ACAD B-PHYS, V66, P77, DOI 10.2183/pjab.66.77; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; STAHL J, 1990, J BIOL CHEM, V265, P8833; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Swofford D.L., 1989, PAUP PHYLOGENETIC AN; Swofford David L., 1990, P411; TEDESCHI B, 1986, J CELL BIOL, V102, P2244, DOI 10.1083/jcb.102.6.2244; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; WEBER MJ, 1981, J BIOL CHEM, V256, P3447; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; YASUKAWA K, 1987, EMBO J, V6, P2939, DOI 10.1002/j.1460-2075.1987.tb02598.x	106	473	495	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1991	7	2					197	208		10.1016/0896-6273(91)90258-2	http://dx.doi.org/10.1016/0896-6273(91)90258-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1714745				2022-12-17	WOS:A1991GB93300003
J	NEHER, E; ZUCKER, RS				NEHER, E; ZUCKER, RS			MULTIPLE CALCIUM-DEPENDENT PROCESSES RELATED TO SECRETION IN BOVINE CHROMAFFIN CELLS	NEURON			English	Article							ADRENAL-MEDULLARY CELLS; FLUORESCENT INDICATOR; EXOCYTOSIS; RELEASE; FURA-2	We have used the caged calcium compound DM-nitrophen to investigate the kinetics of calcium-dependent secretion in bovine chromaffin cells. Perfusion with partially calcium-loaded nitrophen often caused a loading transient-slow secretion for up to 1 min due to displacement of Ca2+ by cytoplasmic Mg2+. Flash photolysis elicited 100 muM [Ca2+]i steps that evoked intense secretion, lasting a few seconds. In cells experiencing a loading transient, [Ca2+]i steps evoked an especially fast secretion. A persistent, slow secretion often followed these fast phases. Distinct kinetic components may reflect secretion from pools that are differentially capable of release. Both secretion and movement of vesicles between pools appear to be [Ca2+]i sensitive. Later [Ca2+]i steps sometimes evoked a rapid capacitance decrease, indicating a fast, [Ca2+]i-dependent phase of endocytosis.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	NEHER, E (corresponding author), MAX PLANCK INST BIOPHYS CHEM, DEPT MEMBRANE BIOPHYS, W-3400 GOTTINGEN, GERMANY.		Neher, Erwin/A-2109-2013; Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343				AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUNIS D, 1988, J EXP BIOL, V139, P253; BAKER PF, 1986, BRIT MED BULL, V42, P399, DOI 10.1093/oxfordjournals.bmb.a072158; BECKER PL, 1987, AM J PHYSIOL, V253, pC613, DOI 10.1152/ajpcell.1987.253.4.C613; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; CHEEK TR, 1989, J CELL BIOL, V109, P1219, DOI 10.1083/jcb.109.3.1219; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; KAPLAN JH, 1990, ANNU REV PHYSIOL, V52, P897; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Katz B., 1969, RELEASE NEURAL TRANS; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KNIGHT DE, 1989, TRENDS NEUROSCI, V12, P451, DOI 10.1016/0166-2236(89)90095-7; KNIGHT DE, 1983, PROC R SOC SER B-BIO, V218, P177, DOI 10.1098/rspb.1983.0033; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NEHER E, 1989, NEUROMUSCULAR JUNCTI, P65; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; ZUCKER RS, 1992, CELL CALCIUM, V13, P29, DOI 10.1016/0143-4160(92)90027-P; ZUCKER RS, 1991, ANN NY ACAD SCI, V635, P191, DOI 10.1111/j.1749-6632.1991.tb36492.x; ZUCKER RS, 1993, IN PRESS CELL CALCIU	28	472	475	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					21	30		10.1016/0896-6273(93)90238-M	http://dx.doi.org/10.1016/0896-6273(93)90238-M			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427700				2022-12-17	WOS:A1993KK01200003
J	Freund, TF; Katona, I				Freund, Tamas F.; Katona, Istvan			Perisomatic inhibition	NEURON			English	Review							HIPPOCAMPAL GABAERGIC SYNAPSES; LONG-TERM PLASTICITY; GAMMA-OSCILLATIONS; RAT HIPPOCAMPUS; CA1 AREA; NETWORK OSCILLATIONS; PYRAMIDAL CELLS; GABA RELEASE; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTORS	Recent evidence supports the hypothesis of a functional dichotomy of perisomatic inhibition in the cerebral cortex: the parvalbumin- and cholecystokinin-containing basket cells that are specialized to control rhythm (as a clockwork) and "mood" (as a fine-tuning device), respectively, of network oscillations. Pathology extends this conclusion further, as the former is implicated in epilepsy and the latter in anxiety. The well-balanced cooperation of the two inhibitory systems is required for the normal network operations underlying the cognitive functions of the cerebral cortex.	Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Freund, TF (corresponding author), Hungarian Acad Sci, Inst Expt Med, POB 67, H-1450 Budapest, Hungary.	freund@koki.hu	Katona, Istvan/D-9729-2011	Katona, Istvan/0000-0003-2808-3330				Banke TG, 2006, J NEUROSCI, V26, P11720, DOI 10.1523/JNEUROSCI.2887-06.2006; Biro AA, 2006, J NEUROSCI, V26, P12487, DOI 10.1523/JNEUROSCI.3106-06.2006; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Comings DE, 1999, MOL PSYCHIATR, V4, P374, DOI 10.1038/sj.mp.4000503; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Drake CT, 2002, HIPPOCAMPUS, V12, P119, DOI 10.1002/hipo.1107; Faulkner HJ, 1998, BRIT J PHARMACOL, V125, P483, DOI 10.1038/sj.bjp.0702113; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; FREEDMAN R, 1993, J NEUROSCI, V13, P1965; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hajos N, 1998, NEUROSCIENCE, V82, P355; Halasy K, 1996, HIPPOCAMPUS, V6, P306, DOI 10.1002/(SICI)1098-1063(1996)6:3<306::AID-HIPO8>3.0.CO;2-K; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hart SA, 2007, J NEUROSCI, V27, P2102, DOI 10.1523/JNEUROSCI.5436-06.2007; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Karson MA, 2008, NEUROPHARMACOLOGY, V54, P117, DOI 10.1016/j.neuropharm.2007.06.023; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; LAMBERT NA, 1993, NEURON, V11, P1057, DOI 10.1016/0896-6273(93)90219-H; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; Makara JK, 2007, J NEUROSCI, V27, P10211, DOI 10.1523/JNEUROSCI.2104-07.2007; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Matyas F, 2004, EUR J NEUROSCI, V19, P1243, DOI 10.1111/j.1460-9568.2004.03225.x; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Morales M, 1997, J NEUROSCI, V17, P3157; Neu A, 2007, J PHYSIOL-LONDON, V578, P233, DOI 10.1113/jphysiol.2006.115691; Nyiri G, 2005, NEUROSCIENCE, V136, P811, DOI 10.1016/j.neuroscience.2005.01.026; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Palhalmi J, 2004, NEUROPHARMACOLOGY, V47, P381, DOI 10.1016/j.neuropharm.2004.04.010; Papp E, 2001, NEUROSCIENCE, V102, P715, DOI 10.1016/S0306-4522(00)00584-4; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Porter JT, 1999, J NEUROSCI, V19, P5228; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Sloviter RS, 1999, NEUROPHARMACOLOGY, V38, P1707, DOI 10.1016/S0028-3908(99)00132-X; SOLTESZ I, 2005, DIVERSITY NEUROANAL; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Szabadits E, 2007, J NEUROSCI, V27, P8101, DOI 10.1523/JNEUROSCI.1912-07.2007; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tiemeier H, 2005, MOL PSYCHIATR, V10, P806, DOI 10.1038/sj.mp.4001697; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Whittington MA, 1998, P NATL ACAD SCI USA, V95, P5807, DOI 10.1073/pnas.95.10.5807; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	87	471	475	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					33	42		10.1016/j.neuron.2007.09.012	http://dx.doi.org/10.1016/j.neuron.2007.09.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920013	Bronze			2022-12-17	WOS:000250289800008
J	Dani, JA; Heinemann, S				Dani, JA; Heinemann, S			Molecular and cellular aspects of nicotine abuse	NEURON			English	Review							ACETYLCHOLINE-RECEPTOR; RAT; NEURONS; SYSTEM; HUMANS; DRUGS		SALK INST, MOLEC NEUROBIOL LAB, SAN DIEGO, CA 92186 USA	Salk Institute	Dani, JA (corresponding author), BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA.							BENOWITZ NL, 1989, PROG BRAIN RES, V79, P279; CALABRESI P, 1989, BRIT J PHARMACOL, V98, P135, DOI 10.1111/j.1476-5381.1989.tb16873.x; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; CLARKE PBS, 1991, ADV PHAR SC, P285; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GOLDBERG SR, 1988, PHARMACOL BIOCHEM BE, V30, P227, DOI 10.1016/0091-3057(88)90450-9; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HULIHANGIBLIN BA, 1990, J PHARMACOL EXP THER, V252, P21; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; LESTER RAJ, 1994, NEUROPHARMACOLOGY, V33, P27, DOI 10.1016/0028-3908(94)90093-0; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MARKS MJ, 1993, J PHARMACOL EXP THER, V266, P1268; MARKS MJ, 1992, J NEUROSCI, V12, P2765; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; PENG X, 1994, MOL PHARMACOL, V46, P523; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; RUSSELL MAH, 1989, PROG BRAIN RES, V79, P289; SCHELLING TC, 1992, SCIENCE, V255, P430, DOI 10.1126/science.1734519; SHOAIB M, 1994, PSYCHOPHARMACOLOGY, V113, P445, DOI 10.1007/BF02245221; STOLERMAN IP, 1991, TRENDS PHARMACOL SCI, V12, P467, DOI 10.1016/0165-6147(91)90638-9; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WONNACOTT S, 1990, TRENDS PHARMACOL SCI, V11, P216, DOI 10.1016/0165-6147(90)90242-Z	25	471	483	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					905	908		10.1016/S0896-6273(00)80112-9	http://dx.doi.org/10.1016/S0896-6273(00)80112-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630247	Bronze			2022-12-17	WOS:A1996UN48000004
J	Greer, PL; Greenberg, ME				Greer, Paul L.; Greenberg, Michael E.			From synapse to nucleus: Calcium-dependent gene transcription in the control of synapse development and function	NEURON			English	Review							ELEMENT-BINDING PROTEIN; CAMP-RESPONSIVE ELEMENT; LONG-TERM POTENTIATION; NF-KAPPA-B; NMDA RECEPTOR; DENDRITIC GROWTH; BDNF TRANSCRIPTION; BIPOLAR DISORDER; NEURAL ACTIVITY; HUMAN-MEMORY	One of the unique characteristics of higher organisms is their ability to learn and adapt to changes in their environment. This plasticity is largely a result of the brain's ability to convert transient stimuli into long-lasting alterations in neuronal structure and function. This process is complex and involves changes in receptor trafficking, local mRNA translation, protein turnover, and new gene synthesis. Here, we review how neuronal activity triggers calcium-dependent gene expression to regulate synapse development, maturation, and refinement. Interestingly, many components of the activity-dependent gene expression program are mutated in human cognitive disorders, which suggest that this program is essential for proper brain development and function.	[Greer, Paul L.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Greer, Paul L.; Greenberg, Michael E.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Greer, Paul L.; Greenberg, Michael E.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Greer, Paul L.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 25 Shattuck St, Boston, MA 02115 USA.	meg@hms.harvard.edu			F. M. Kirby Foundation; Nancy Lurie Marks Family Foundation; Autism Speaks; Cure Autism Now; Boston Autism Consortium; Mental Retardation Developmental Disabilities Research Center [HD18655]; NIH [P01 NS47572]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572] Funding Source: NIH RePORTER	F. M. Kirby Foundation; Nancy Lurie Marks Family Foundation; Autism Speaks; Cure Autism Now; Boston Autism Consortium; Mental Retardation Developmental Disabilities Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Janine Zieg for generation of the figures and Elizabeth Hong, Sonia Cohen, and Steve Flavell for critical reading of the manuscript. We apologize to our colleagues whose work is not discussed or cited here because of length restrictions. Work on this subject in our laboratory has been supported by the F. M. Kirby Foundation, the Nancy Lurie Marks Family Foundation, Autism Speaks, Cure Autism Now, the Boston Autism Consortium, and Mental Retardation Developmental Disabilities Research Center grant HD18655 and NIH grant P01 NS47572.	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Altar CA, 2004, J NEUROSCI, V24, P2667, DOI 10.1523/JNEUROSCI.5377-03.2004; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; ANOKHIN KV, 1991, BRAIN RES, V544, P101, DOI 10.1016/0006-8993(91)90890-8; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bence-Hanulec KK, 2000, NEURON, V27, P121, DOI 10.1016/S0896-6273(00)00014-3; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bonni A, 1997, CAN J NEUROL SCI, V24, P272, DOI 10.1017/S0317167100032935; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen WG, 2003, J NEUROSCI, V23, P2572; Chen YC, 2005, J NEUROBIOL, V64, P4, DOI 10.1002/neu.20150; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COLEMAN PD, 1968, J ANAT, V102, P363; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; GALLIN WJ, 1995, CURR OPIN NEUROBIOL, V5, P367, DOI 10.1016/0959-4388(95)80050-6; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Ginty DD, 1997, NEURON, V18, P183, DOI 10.1016/S0896-6273(00)80258-5; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Groc L, 2002, EUR J NEUROSCI, V16, P1931, DOI 10.1046/j.1460-9568.2002.02264.x; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; HONG EJ, 2008, NEURON IN PRESS, V60; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jang H, 2007, J BIOL CHEM, V282, P11172, DOI 10.1074/jbc.M611199200; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Li HW, 2004, P NATL ACAD SCI USA, V101, P647, DOI 10.1073/pnas.0305145101; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; LIN Y, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07319; Lunyak VV, 2004, ANN NY ACAD SCI, V1014, P110, DOI 10.1196/annals.1294.011; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Park CS, 2006, J BIOL CHEM, V281, P30195, DOI 10.1074/jbc.M605876200; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Ramos B, 2007, P NATL ACAD SCI USA, V104, P9882, DOI 10.1073/pnas.0701946104; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Ribases M, 2003, MOL PSYCHIATR, V8, P745, DOI 10.1038/sj.mp.4001281; Ribases M, 2004, HUM MOL GENET, V13, P1205, DOI 10.1093/hmg/ddh137; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; SCHIBLER W, 2002, NEURON, V34, P245; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tian XJ, 2006, J BIOL CHEM, V281, P7578, DOI 10.1074/jbc.M512060200; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; ZIEG J, 2008, CELL IN PRESS; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	159	470	487	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2008	59	6					846	860		10.1016/j.neuron.2008.09.002	http://dx.doi.org/10.1016/j.neuron.2008.09.002			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	356SK	18817726	Bronze			2022-12-17	WOS:000259797700004
J	Kim, JH; Liao, DZ; Lau, LF; Huganir, RL				Kim, JH; Liao, DZ; Lau, LF; Huganir, RL			SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family	NEURON			English	Article							POSTSYNAPTIC DENSITY PROTEIN; LONG-TERM POTENTIATION; TUMOR-SUPPRESSOR PROTEIN; MESSENGER-RNA EXPRESSION; NEUROTROPHIC FACTOR; KINASE-C; GLUTAMATE RECEPTORS; BINDING-PROTEIN; RAT-BRAIN; BDNF	The PSD-95/SAP90 family of proteins has recently been implicated in the organization of synaptic structure. Here, we describe the isolation of a novel Ras-GTPase activating protein, SynGAP, that interacts with the PDZ domains of PSD-95 and SAP102 in vitro and in vivo. SynGAP is selectively expressed in brain and is highly enriched at excitatory synapses, where it is present in a large macromolecular complex with PSD-95 and the NMDA receptor. SynGAP stimulates the GTPase activity of Ras, suggesting that it negatively regulates Ras activity at excitatory synapses. Ras signaling at the postsynaptic membrane may be involved in the modulation of excitatory synaptic transmission by NMDA receptors and neurotrophins. These results indicate that SynGAP may play an important role in the modulation of synaptic plasticity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007368] Funding Source: NIH RePORTER; NINDS NIH HHS [T32NS07368] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banker G., 1991, CULTURING NERVE CELL; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; CARLIN RK, 1983, J CELL BIOL, V96, P443, DOI 10.1083/jcb.96.2.443; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; GWAG BJ, 1993, NEUROREPORT, V5, P125, DOI 10.1097/00001756-199311180-00007; Hunt CA, 1996, J NEUROSCI, V16, P1380; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1995, SCIENCE, V269, P1737; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; LUO JH, 1993, J BIOL CHEM, V268, P23580; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; PERIN MS, 1991, J BIOL CHEM, V266, P623; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	69	470	494	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					683	691		10.1016/S0896-6273(00)81008-9	http://dx.doi.org/10.1016/S0896-6273(00)81008-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581761	hybrid			2022-12-17	WOS:000073346500008
J	Jaworski, J; Kapitein, LC; Gouveia, SM; Dortland, BR; Wulf, PS; Grigoriev, I; Camera, P; Spangler, SA; Di Stefano, P; Demmers, J; Krugers, H; Defilippi, P; Akhmanova, A; Hoogenraad, CC				Jaworski, Jacek; Kapitein, Lukas C.; Gouveia, Susana Montenegro; Dortland, Bjorn R.; Wulf, Phebe S.; Grigoriev, Ilya; Camera, Paola; Spangler, Samantha A.; Di Stefano, Paola; Demmers, Jeroen; Krugers, Harm; Defilippi, Paola; Akhmanova, Anna; Hoogenraad, Casper C.			Dynamic Microtubules Regulate Dendritic Spine Morphology and Synaptic Plasticity	NEURON			English	Article							END-TRACKING PROTEINS; PLUS-END; CYTOSKELETAL DYNAMICS; BINDING PROTEIN; ACTIN; CORTACTIN; GROWTH; MECHANISMS; FAMILY; EB1	Dendritic spines are the major sites of excitatory synaptic input, and their morphological changes have been linked to learning and memory processes. Here, we report that growing microtubule plus ends decorated by the microtubule tip-tracking protein EB3 enter spines and can modulate spine morphology. We describe p140Cap/SNIP, a regulator of Src tyrosine kinase, as an EB3 interacting partner that is predominately localized to spines and enriched in the postsynaptic density. Inhibition of microtubule dynamics, or knockdown of either EB3 or p140Cap, modulates spine shape via regulation of the actin cytoskeleton. Fluorescence recovery after photobleaching revealed that EB3-binding is required for p140Cap accumulation within spines. In addition, we found that p140Cap interacts with Src substrate and F-actin-binding protein cortactin. We propose that EB3-labeled growing microtubule ends regulate the localization of p140Cap, control cortactin function, and modulate actin dynamics within dendritic spines, thus linking dynamic microtubules to spine changes and synaptic plasticity.	[Jaworski, Jacek; Kapitein, Lukas C.; Dortland, Bjorn R.; Wulf, Phebe S.; Spangler, Samantha A.; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands; [Gouveia, Susana Montenegro; Grigoriev, Ilya; Akhmanova, Anna] Erasmus MC, Dept Cell Biol & Genet, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Jaworski, Jacek] Int Inst Mol & Cell Biol, Warsaw, Poland; [Krugers, Harm] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1012 WX Amsterdam, Netherlands; [Camera, Paola; Di Stefano, Paola; Defilippi, Paola] Univ Turin, Ctr Mol Biotechnol, I-10124 Turin, Italy	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Amsterdam; University of Turin	Hoogenraad, CC (corresponding author), Erasmus MC, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands.	c.hoogenraad@erasmusmc.nl	Akhmanova, Anna S/B-8896-2011; Hoogenraad, Casper/B-8866-2011; DEFILIPPI, Paola/L-2232-2014; Demmers, Jeroen AA/F-4046-2016; Kapitein, Lukas C/J-4776-2016	Akhmanova, Anna S/0000-0002-9048-8614; Hoogenraad, Casper/0000-0002-2666-0758; Demmers, Jeroen AA/0000-0002-8757-9611; Kapitein, Lukas C/0000-0001-9418-6739; gouveia, susana/0000-0003-1220-410X; Jaworski, Jacek/0000-0001-8760-7865; Defilippi, Paola/0000-0001-6427-4906				Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Di Stefano P, 2004, MOL BIOL CELL, V15, P787, DOI 10.1091/mbc.E03-09-0689; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; He Y, 2002, J NEUROSCI, V22, P5982; Hering H, 2003, J NEUROSCI, V23, P11759; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Jaworski J, 2008, INT J BIOCHEM CELL B, V40, P619, DOI 10.1016/j.biocel.2007.10.015; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kneussel M, 2005, EMBO REP, V6, P22, DOI 10.1038/sj.embor.7400319; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Morrison EE, 2002, MOL BRAIN RES, V98, P145, DOI 10.1016/S0169-328X(01)00290-X; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Stepanova T, 2003, J NEUROSCI, V23, P2655; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; WESTRUM LE, 1980, CELL TISSUE RES, V208, P171; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	57	469	485	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 15	2009	61	1					85	100		10.1016/j.neuron.2008.11.013	http://dx.doi.org/10.1016/j.neuron.2008.11.013			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	396TP	19146815	Bronze			2022-12-17	WOS:000262614400010
J	Zuo, Y; Lin, A; Chang, P; Gan, WB				Zuo, Y; Lin, A; Chang, P; Gan, WB			Development of long-term dendritic spine stability in diverse regions of cerebral cortex	NEURON			English	Article							IN-VIVO; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; STRIATE CORTEX; VISUAL-CORTEX; ADULT CORTEX; LIVING MICE; SYNAPSES; SYNAPTOGENESIS; RAT	Synapse formation and elimination occur throughout life, but the magnitude of such changes at distinct developmental stages remains unclear. Using transgenic mice overexpressing yellow fluorescent protein and transcranial two-photon microscopy, we repeatedly imaged dendritic spines on the apical dendrites of layer 5 pyramidal neurons. In young adolescent mice (1-month-old), 13%-20% of spines were eliminated and 5%-8% formed over 2 weeks in barrel, motor, and frontal cortices, indicating a cortical-wide spine loss during this developmental period. As animals mature, there is also a substantial loss of dendritic filopodia involved in spinogenesis. In adult mice (4-6 months old), 3%-5% of spines were eliminated and formed over 2 weeks in various cortical regions. Over 18 months, only 26% of spines were eliminated and 19% formed in adult barrel cortex. Thus, after a concurrent loss of spines and spine precursors in diverse regions of young adolescent cortex, spines become stable and a majority of them can last throughout life.	NYU, Sch Med, Mol Neurobiol Program, Skirball Inst,Dept Physiol & Neurosci, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst,Dept Physiol & Neurosci, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu		Zuo, Yi/0000-0001-9020-0003				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Dailey ME, 1996, J NEUROSCI, V16, P2983; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Grossman AW, 2002, PROG BRAIN RES, V138, P91, DOI 10.1016/S0079-6123(02)38073-7; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LUBKE J, 1989, DEV BRAIN RES, V45, P29, DOI 10.1016/0165-3806(89)90004-7; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Peters A, 1998, CEREB CORTEX, V8, P671, DOI 10.1093/cercor/8.8.671; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	32	469	479	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					181	189		10.1016/j.neuron.2005.04.001	http://dx.doi.org/10.1016/j.neuron.2005.04.001			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848798	Bronze			2022-12-17	WOS:000228674800006
J	Willie, JT; Chemelli, RM; Sinston, CM; Tokita, H; Williams, SC; Kisanuki, YY; Marcus, JN; Lee, C; Elmquist, JK; Kohlmeier, KA; Leonard, CS; Richardson, JA; Hammer, RE; Yanagisawa, M				Willie, JT; Chemelli, RM; Sinston, CM; Tokita, H; Williams, SC; Kisanuki, YY; Marcus, JN; Lee, C; Elmquist, JK; Kohlmeier, KA; Leonard, CS; Richardson, JA; Hammer, RE; Yanagisawa, M			Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: Molecular genetic dissection of non-REM and REM sleep regulatory processes	NEURON			English	Article							HYPOCRETIN OREXIN; CANINE NARCOLEPSY; TUBEROMAMMILLARY NEURONS; HISTAMINERGIC NEURONS; PARADOXICAL SLEEP; BRAIN HISTAMINE; RAT-BRAIN; HYPOTHALAMUS; WAKEFULNESS; CATAPLEXY	Narcolepsy-cataplexy, a neurological disorder associated with the absence of hypothalamic orexin (hypocretin) neuropeptides, consists of two underlying problems: inability to maintain wakefulness and intrusion of rapid eye movement (REM) sleep into wakefulness. Here we document, using behavioral, electrophysiological, and pharmacological criteria, two distinct classes of behavioral arrests exhibited by mice deficient in orexin-mediated signaling. Both OX2R(-/-) and orexin(-/-) mice are similarly affected with behaviorally abnormal attacks of non-REM sleep ("sleep attacks") and show similar degrees of disrupted wakefulness. In contrast, OX2R(-/-) mice are only mildly affected with cataplexy-like attacks of REM sleep, whereas orexin(-/-) mice are severely affected. Absence of OX2Rs eliminates orexin-evoked excitation of histaminergic neurons in the hypothalamus, which gate non-REM sleep onset. While normal regulation of wake/non-REM sleep transitions depends critically upon OX2R activation, the profound dysregulation of REM sleep control unique to the narcolepsy-cataplexy syndrome emerges from loss of signaling through both OX2R-dependent and OX2R-independent pathways.	Univ Texas, SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Div Endocrinol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; ERATO, Yana Orphan Receptor Project, Japan Sci & Technol Corp, Tokyo 1350064, Japan	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; New York Medical College; Japan Science & Technology Agency (JST)	Yanagisawa, M (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.		Kisanuki, Yasushi/E-3393-2011	Kohlmeier, Kristi A./0000-0003-0183-3816; Hammer, Robert E./0000-0001-5487-7551	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027881, R55NS027881] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64150] Funding Source: Medline; NIDDK NIH HHS [DK56116] Funding Source: Medline; NIMH NIH HHS [MH61583] Funding Source: Medline; NINDS NIH HHS [NS27881] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldrich MS, 1998, NEUROLOGY, V50, pS2, DOI 10.1212/WNL.50.2_Suppl_1.S2; Alloway CED, 1999, SLEEP, V22, P191, DOI 10.1093/sleep/22.2.191; BAKER TL, 1982, EXP NEUROL, V75, P729, DOI 10.1016/0014-4886(82)90038-3; Bayer L, 2001, EUR J NEUROSCI, V14, P1571, DOI 10.1046/j.0953-816x.2001.01777.x; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DEMENT W, 1966, NEUROLOGY, V16, P18, DOI 10.1212/WNL.16.1.18; DYKEN ME, 1994, NEUROLOGY, V44, P760, DOI 10.1212/WNL.44.4.760; Dyken ME, 1996, ARCH NEUROL-CHICAGO, V53, P456, DOI 10.1001/archneur.1996.00550050086028; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; ESCHALIER A, 1988, J PHARMACOL EXP THER, V245, P963; GUILLEMINAULT C, 1975, J NEUROL SCI, V26, P377, DOI 10.1016/0022-510X(75)90209-9; GUILLEMINAULT C, 1974, ARCH NEUROL-CHICAGO, V31, P255, DOI 10.1001/archneur.1974.00490400069008; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HISHIKAWA Y, 1995, ADV NEUROL, V67, P245; Honda Y., 1988, HLA NARCOLEPSY, P24, DOI [10.1007/978-3-642-83387-8_3, DOI 10.1007/978-3-642-83387-8_3]; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Hungs M, 2001, GENOME RES, V11, P531, DOI 10.1101/gr.GR-1610R; Hungs M, 2001, BIOESSAYS, V23, P397, DOI 10.1002/bies.1058; Ishizuka T, 2002, NEUROSCI LETT, V323, P93, DOI 10.1016/S0304-3940(01)02552-6; Jones B E, 1998, Adv Neurol, V77, P75; Kanbayashi T, 2002, J SLEEP RES, V11, P91, DOI 10.1046/j.1365-2869.2002.00284.x; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; KITAHAMA K, 1980, NEUROPHARMACOLOGY, V19, P529, DOI 10.1016/0028-3908(80)90022-2; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; KUSHIDA CA, 1985, ELECTROEN CLIN NEURO, V61, P61, DOI 10.1016/0013-4694(85)91073-9; Lin JS, 1996, J NEUROSCI, V16, P1523; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; LUCAS EA, 1979, PHYSIOL BEHAV, V23, P737, DOI 10.1016/0031-9384(79)90168-9; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McGinty D, 2001, SLEEP MED REV, V5, P323, DOI 10.1053/smrv.2001.0170; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; MITLER MM, 1977, ELECTROEN CLIN NEURO, V43, P691, DOI 10.1016/0013-4694(77)90084-0; Mondal MS, 1999, BIOCHEM BIOPH RES CO, V256, P495, DOI 10.1006/bbrc.1999.0362; Nishino S, 2001, NEUROSCI LETT, V313, P125, DOI 10.1016/S0304-3940(01)02270-4; Nishino S, 2000, NEUROSCI RES, V38, P437, DOI 10.1016/S0168-0102(00)00195-4; Nishino S, 1997, PROG NEUROBIOL, V52, P27, DOI 10.1016/S0301-0082(96)00070-6; Parmentier R, 2002, J NEUROSCI, V22, P7695; Paxinos G., 1997, MOUSE BRAIN STEREOTA; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; RADULOVACKI M, 1984, J PHARMACOL EXP THER, V228, P268; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Ripley B, 2001, NEUROBIOL DIS, V8, P525, DOI 10.1006/nbdi.2001.0389; ROTH B, 1969, ELECTROEN CLIN NEURO, V26, P176, DOI 10.1016/0013-4694(69)90208-9; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sherin JE, 1998, J NEUROSCI, V18, P4705; Shneerson J. M., 2000, HDB SLEEP MED; Smith MI, 2003, NEUROSCI LETT, V341, P256, DOI 10.1016/S0304-3940(03)00066-1; Steriade M., 1990, BRAINSTEM CONTROL WA; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Tafti M, 1997, NEUROREPORT, V8, P3755, DOI 10.1097/00001756-199712010-00019; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Yamamoto H, 2002, J CLIN INVEST, V110, P43, DOI 10.1172/JCI200215595; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; ZORICK FJ, 1979, J CLIN PSYCHIAT, V40, P194	63	469	496	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 5	2003	38	5					715	730		10.1016/S0896-6273(03)00330-1	http://dx.doi.org/10.1016/S0896-6273(03)00330-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797957	Bronze			2022-12-17	WOS:000183361400008
J	HOPE, BT; NYE, HE; KELZ, MB; SELF, DW; IADAROLA, MJ; NAKABEPPU, Y; DUMAN, RS; NESTLER, EJ				HOPE, BT; NYE, HE; KELZ, MB; SELF, DW; IADAROLA, MJ; NAKABEPPU, Y; DUMAN, RS; NESTLER, EJ			INDUCTION OF A LONG-LASTING AP-1 COMPLEX COMPOSED OF ALTERED FOS-LIKE PROTEINS IN BRAIN BY CHRONIC COCAINE AND OTHER CHRONIC TREATMENTS	NEURON			English	Article							IMMEDIATE-EARLY GENE; TRANSCRIPTION; SYSTEM; PHOSPHORYLATION; ACTIVATOR; MORPHINE; ANTIGEN; FORM; JUN	Following chronic cocaine treatment, we have found a long lasting increase in AP-1 binding in the rat nucleus accumbens and striatum, two important targets of the behavioral effects of cocaine. This increase develops gradually over several days and remains at 50% of maximal levels 7 days after the last cocaine exposure. Supershift experiments, along with one and two-dimensional Western blots, indicate that this chronic AP-1 complex contains at least four Fos-related antigens (FRAs), some of which display Delta FosB-like immunoreactivity, that are induced selectively by chronic, but not acute, cocaine treatment. The same chronic FRAs were also induced by several different types of chronic treatments in a region-specific manner in the brain. Thus, the chronic FRAs and associated chronic AP-1 complex could mediate some of the long-term changes in gene expression unique to the chronic-treated state as opposed to the acute-treated and normal states.	YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06508; CONNECTICUT MENTAL HLTH CTR,NEW HAVEN,CT 06508; NIDR,NEUROBIOL & ANESTHESIOL BRANCH,BETHESDA,MD 20892; KYUSHU UNIV,MED INST BIOREGULAT,DEPT BIOCHEM,FUKUOKA 812,JAPAN	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University	HOPE, BT (corresponding author), YALE UNIV,SCH MED,DEPT PSYCHIAT,MOLEC PSYCHIAT LAB,NEW HAVEN,CT 06508, USA.		Hope, Bruce T/A-9223-2010; Jansen, Heiko T./A-5770-2008; Kelz, Max/E-4054-2010; Nakabeppu, Yusaku/A-8902-2011	Hope, Bruce T/0000-0001-5804-7061; Jansen, Heiko T./0000-0003-0178-396X; Kelz, Max/0000-0002-2803-6078; Nakabeppu, Yusaku/0000-0002-6739-242X	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH045481, R29MH045481, R01MH045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000203, R01DA007359, R37DA007359] Funding Source: NIH RePORTER; NIDA NIH HHS [DA07359, DA00203] Funding Source: Medline; NIMH NIH HHS [MH45481] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BEITNERJOHNSON D, 1992, J NEUROSCI, V12, P2165; BRONSTEIN DM, 1994, MOL BRAIN RES, V23, P191, DOI 10.1016/0169-328X(94)90226-7; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; DOBRZANSKI P, 1991, MOL CELL BIOL, V11, P5470, DOI 10.1128/MCB.11.11.5470; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; HOPE BT, 1994, J NEUROSCI, V14, P4318; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JIAN M, 1993, MOL BRAIN RES, V19, P156, DOI 10.1016/0169-328X(93)90161-H; KORNER M, 1989, NEURON, V3, P563, DOI 10.1016/0896-6273(89)90266-3; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; PRASAD SC, 1992, ANAL BIOCHEM, V207, P121, DOI 10.1016/0003-2697(92)90512-6; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291	20	469	477	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1235	1244		10.1016/0896-6273(94)90061-2	http://dx.doi.org/10.1016/0896-6273(94)90061-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946359				2022-12-17	WOS:A1994PU76300019
J	PATTERSON, SL; GROVER, LM; SCHWARTZKROIN, PA; BOTHWELL, M				PATTERSON, SL; GROVER, LM; SCHWARTZKROIN, PA; BOTHWELL, M			NEUROTROPHIN EXPRESSION IN RAT HIPPOCAMPAL SLICES - A STIMULUS PARADIGM INDUCING LTP IN CA1 EVOKES INCREASES IN BDNF AND NT-3 MESSENGER-RNAS	NEURON			English	Article							NERVE GROWTH-FACTOR; CHOLINE-ACETYLTRANSFERASE ACTIVITY; DOPAMINE-BETA-HYDROXYLASE; TYROSINE-HYDROXYLASE; SELECTIVE INDUCTION; ALZHEIMERS-DISEASE; PROTEIN-KINASE; NEURONAL DEATH; FACTOR FAMILY; NGF RECEPTOR	We report that stimulation inducing long-term potentiation (LTP) in the CA1 pyramidal cell layer of the hippocampus evokes significant increases in both BDNF and NT-3 mRNAs in CA1 neurons. No changes in BDNF or NT-3 mRNA levels were seen in the nonstimulated regions of the pyramidal cell layer or the dentate. No change was seen in the levels of NGF mRNA at the time point examined. These results suggest that relatively normal levels of activity may regulate region-specific neurotrophin levels in the hippocampus. Given that known effects of NGF (and presumably of BDNF and NT-3) include elevation of neurotransmitter levels, elevation of sodium channels, and promotion of axonal terminal sprouting, activity-associated changes in neurotrophin levels may play a role in regulating neural connections in the adult as well as the developing nervous system.	UNIV WASHINGTON,DEPT NEUROL SURG,SEATTLE,WA 98195; NE OHIO UNIV,COLL MED,DEPT NEUROBIOL,ROOTSTOWN,OH 44272	University of Washington; University of Washington Seattle; Northeast Ohio Medical University (NEOMED)	PATTERSON, SL (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.				NINDS NIH HHS [NS23343, NS20482, NS15317] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015317, R01NS023343, P01NS020482] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; [Anonymous], [No title captured]; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BAIMBRIDGE KG, 1982, BRAIN RES, V239, P519, DOI 10.1016/0006-8993(82)90526-1; BAIMBRIDGE KG, 1991, SYNAPSE, V7, P269, DOI 10.1002/syn.890070404; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; BAUDRY M, 1991, LONG TERM POTENTIATI; BECKMEIER LR, 1991, NEURON, V7, P857; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BUCK CR, 1987, P NATL ACAD SCI USA, V84, P3060, DOI 10.1073/pnas.84.9.3060; COUGHLIN MD, 1978, DEV BIOL, V66, P513, DOI 10.1016/0012-1606(78)90256-7; DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596; ERNFORS P, 1989, P NATL ACAD SCI USA, V86, P4756, DOI 10.1073/pnas.86.12.4756; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GALL C, 1990, Molecular Brain Research, V9, P113; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; HAGG T, 1990, J NEUROSCI, V10, P3087; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1984, BRAIN RES, V293, P305, DOI 10.1016/0006-8993(84)91237-X; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KALMAN D, 1990, NEURON, V4, P355, DOI 10.1016/0896-6273(90)90048-K; KESSLER JA, 1980, P NATL ACAD SCI-BIOL, V77, P649, DOI 10.1073/pnas.77.1.649; KESSLER JA, 1981, BRAIN RES, V208, P135, DOI 10.1016/0006-8993(81)90626-0; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LINDEFORS N, 1992, EXP BRAIN RES, V88, P78, DOI 10.1007/BF02259130; LU B, 1991, P NATL ACAD SCI USA, V88, P6289, DOI 10.1073/pnas.88.14.6289; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OTTEN U, 1977, BRAIN RES, V133, P291, DOI 10.1016/0006-8993(77)90765-X; OTTEN U, 1980, NATURE, V287, P158, DOI 10.1038/287158a0; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHWARTZKROIN PA, 1975, BRAIN RES, V89, P107, DOI 10.1016/0006-8993(75)90138-9; SNIDER WD, 1988, J NEUROSCI, V8, P2628; THOENEN H, 1971, P NATL ACAD SCI USA, V68, P1598, DOI 10.1073/pnas.68.7.1598; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	49	469	477	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1081	1088		10.1016/0896-6273(92)90067-N	http://dx.doi.org/10.1016/0896-6273(92)90067-N			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1463608				2022-12-17	WOS:A1992KD71600007
J	MANZONI, O; PREZEAU, L; MARIN, P; DESHAGER, S; BOCKAERT, J; FAGNI, L				MANZONI, O; PREZEAU, L; MARIN, P; DESHAGER, S; BOCKAERT, J; FAGNI, L			NITRIC-OXIDE INDUCED BLOCKADE OF NMDA RECEPTORS	NEURON			English	Article							SOLUBLE GUANYLATE-CYCLASE; CENTRAL NERVOUS-SYSTEM; METHYL-D-ASPARTATE; RELAXING FACTOR; NEURONS; DESENSITIZATION; GLYCINE; STIMULATION; RESPONSES; BRAIN	We studied the effects of nitric oxide (NO)-producing agents on N-methyl-D-aspartate (NMDA) receptor activation in cultured neurons. 3-Morpholino-sydnonimine (SIN-1) blocked both NMDA-induced currents and the associated increase in intracellular Ca2+. The actions of SIN-1 were reversible and suppressed by hemoglobin. A degraded SIN-1 solution that did not release NO was unable to block NMDA receptors. This showed that the SIN-1 effects were due to NO and not to another breakdown product. Similar results were obtained with 1-nitrosopyrrolidine (an NO-containing drug) and with NO released from NaNO2. Pretreatment with hemoglobin potentiated NMDA-induced effects, demonstrating that endogenous NO modulates NMDA receptors. Since NMDA receptor activation induces NO synthesis, these results suggest a feedback inhibition of NMDA receptors by NO under physiological condition.			MANZONI, O (corresponding author), CNRS,CTR PHARMACOL ENDOCRINOL,INSERM,RUE CARDONILLE,F-34094 MONTPELLIER 5,FRANCE.		Manzoni, Olivier/M-7899-2016	Manzoni, Olivier/0000-0002-5579-6208				AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; BARNARD EA, 1990, TRENDS PHARMACOL SCI, V11, P500, DOI 10.1016/0165-6147(90)90051-9; BARON BM, 1989, J PHARMACOL EXP THER, V250, P162; BOHME E, 1984, ADV CYCLIC NUCL PROT, V17, P259; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ito M, 1990, Neuroreport, V1, P129; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; MANZONI O, 1992, NEUROREPORT, V3, P77, DOI 10.1097/00001756-199201000-00020; MANZONI OJJ, 1991, EUR J PHARM-MOLEC PH, V207, P231; MARIN P, 1992, IN PRESS EUR J NEURO; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MONAGHAN DT, 1989, ANN REV PHARM TOXICO, V29, P3655; MURPHY DE, 1988, BRIT J PHARMACOL, V95, P932, DOI 10.1111/j.1476-5381.1988.tb11723.x; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; VANVLIET BJ, 1989, J NEUROCHEM, V52, P1229; WEISS S, 1986, P NATL ACAD SCI USA, V83, P2238, DOI 10.1073/pnas.83.7.2238	30	469	474	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					653	662		10.1016/0896-6273(92)90087-T	http://dx.doi.org/10.1016/0896-6273(92)90087-T			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314618				2022-12-17	WOS:A1992HQ18800005
J	Marder, E				Marder, Eve			Neuromodulation of Neuronal Circuits: Back to the Future	NEURON			English	Review							CENTRAL PATTERN GENERATOR; STOMATOGASTRIC NERVOUS-SYSTEM; PIGMENT-CONCENTRATING HORMONE; TRANSIENT POTASSIUM CURRENT; CRAB CANCER-BOREALIS; IDENTIFIED MODULATORY INTERNEURONE; ELECTRICALLY COUPLED NEURONS; BULLFROG SYMPATHETIC-GANGLIA; VOLUME ELECTRON-MICROSCOPY; LOBSTER HOMARUS-AMERICANUS	All nervous systems are subject to neuromodulation. Neuromodulators can be delivered as local hormones, as cotransmitters in projection neurons, and through the general circulation. Because neuromodulators can transform the intrinsic firing properties of circuit neurons and alter effective synaptic strength, neuromodulatory substances reconfigure neuronal circuits, often massively altering their output. Thus, the anatomical connectome provides a minimal structure and the neuromodulatory environment constructs and specifies the functional circuits that give rise to behavior.	[Marder, Eve] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Marder, Eve] Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Marder, E (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	marder@brandeis.edu			National Institutes of Health [NS17813]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017813, R37NS017813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	It is impossible to do justice to even a small fraction of the papers and investigators who have contributed to the changes in conceptual framework that we have seen since these beginning days of the study of circuits and their neuromodulation. I apologize to all those whose work has given us so much and yet goes unmentioned here. I thank Dr. Marie Goeritz for help with the figures. This review benefitted by support from NS17813 from the National Institutes of Health.	ADAMS ME, 1983, SCIENCE, V221, P286, DOI 10.1126/science.6134339; ADAMS PR, 1980, BRIT J PHARMACOL, V68, P353, DOI 10.1111/j.1476-5381.1980.tb14547.x; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; BARKER DL, 1972, NATURE-NEW BIOL, V236, P61, DOI 10.1038/newbio236061a0; BISHOP CA, 1987, J NEUROSCI, V7, P1769; Blitz DM, 2008, J EXP BIOL, V211, P1000, DOI 10.1242/jeb.015222; Blitz DM, 2011, CURR OPIN NEUROBIOL, V21, P544, DOI 10.1016/j.conb.2011.05.019; Blitz DM, 2004, J NEUROSCI, V24, P11381, DOI 10.1523/JNEUROSCI.3219-04.2004; BLITZ DM, 1995, J COMP NEUROL, V354, P282, DOI 10.1002/cne.903540209; Blitz DM, 1999, J NEUROSCI, V19, P5449; Brezina V, 2005, J NEUROPHYSIOL, V93, P1523, DOI 10.1152/jn.00475.2004; Brezina V, 1997, TRENDS NEUROSCI, V20, P538, DOI 10.1016/S0166-2236(97)01120-X; Brezina V, 2000, J NEUROPHYSIOL, V83, P260, DOI 10.1152/jn.2000.83.1.260; Brezina V, 2000, J NEUROPHYSIOL, V83, P232, DOI 10.1152/jn.2000.83.1.232; Brezina V, 2000, J NEUROSCI, V20, P6760, DOI 10.1523/JNEUROSCI.20-18-06760.2000; Brezina V, 2010, PHILOS T R SOC B, V365, P2363, DOI 10.1098/rstb.2010.0105; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BURROWS M, 1975, J EXP BIOL, V62, P189; BURROWS M, 1975, J EXP BIOL, V63, P713; CALABRESE RL, 1983, SYM SOC EXP BIOL, P195; Calabrese RL, 2011, INTEGR COMP BIOL, V51, P845, DOI 10.1093/icb/icr074; CAMARDO JS, 1983, COLD SPRING HARB SYM, V48, P213, DOI 10.1101/SQB.1983.048.01.024; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; CHANG MM, 1970, J BIOL CHEM, V245, P4784; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; CHRISTIE AE, 1995, J EXP BIOL, V198, P2431; Clark MC, 2006, COMP BIOCHEM PHYS B, V143, P294, DOI 10.1016/j.cbpb.2005.11.017; Clark MC, 2008, J NEUROCHEM, V104, P1006, DOI 10.1111/j.1471-4159.2007.05029.x; Clark MC, 2007, COMP BIOCHEM PHYS B, V146, P9, DOI 10.1016/j.cbpb.2006.08.018; CROPPER EC, 1987, P NATL ACAD SCI USA, V84, P3486, DOI 10.1073/pnas.84.10.3486; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; DALE HENRY, 1935, PROC ROY SOC MED, V28, P319; DANDO MR, 1972, J COMP PHYSIOL, V78, P138, DOI 10.1007/BF00693610; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; Dickinson PS, 2009, PEPTIDES, V30, P297, DOI 10.1016/j.peptides.2008.10.009; Dickinson PS, 1997, J NEUROPHYSIOL, V77, P599, DOI 10.1152/jn.1997.77.2.599; DICKINSON PS, 1983, J EXP BIOL, V105, P59; DICKINSON PS, 1989, J NEUROPHYSIOL, V61, P833, DOI 10.1152/jn.1989.61.4.833; Dickinson PS, 2001, J NEUROPHYSIOL, V85, P1424, DOI 10.1152/jn.2001.85.4.1424; DICKINSON PS, 1990, NATURE, V344, P155, DOI 10.1038/344155a0; DUDEL J., 1965, ARCH EXP PATHOL PHARMAKOL [NAUNYN SCHMIEDEBERGS], V249, P515; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; EISEN JS, 1984, J NEUROPHYSIOL, V51, P1375, DOI 10.1152/jn.1984.51.6.1375; FLAMM RE, 1986, J NEUROPHYSIOL, V55, P866, DOI 10.1152/jn.1986.55.5.866; FLAMM RE, 1986, J NEUROPHYSIOL, V55, P847, DOI 10.1152/jn.1986.55.5.847; Furukawa Y, 2003, J NEUROPHYSIOL, V89, P3114, DOI 10.1152/jn.00014.2003; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; GETTING PA, 1981, J NEUROPHYSIOL, V46, P65, DOI 10.1152/jn.1981.46.1.65; GLUSMAN S, 1982, J PHYSIOL-LONDON, V325, P223, DOI 10.1113/jphysiol.1982.sp014147; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; GOLOWASCH J, 1992, J NEUROSCI, V12, P810; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; Harris-Warrick RM, 2011, CURR OPIN NEUROBIOL, V21, P685, DOI 10.1016/j.conb.2011.05.011; Harris-Warrick RM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00047; HARRISWARRICK RM, 1984, J NEUROSCI, V4, P1976; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HEITLER WJ, 1977, J EXP BIOL, V66, P221; HOCKBERGER P, 1984, CELL MOL NEUROBIOL, V4, P319, DOI 10.1007/BF00733595; HOOPER SL, 1987, J NEUROSCI, V7, P2097; Hooper SL, 2000, CURR OPIN NEUROBIOL, V10, P676, DOI 10.1016/S0959-4388(00)00158-6; HOOPER SL, 1984, BRAIN RES, V305, P186, DOI 10.1016/0006-8993(84)91138-7; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; Jang H, 2012, NEURON, V75, P585, DOI 10.1016/j.neuron.2012.06.034; JOHNSON BR, 1990, J NEUROSCI, V10, P2066; Johnson BR, 2011, J NEUROPHYSIOL, V105, P293, DOI 10.1152/jn.00809.2010; KACZMAREK LK, 1986, PROG BRAIN RES, V69, P77; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Karhunen T, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0005.2001; Katz PS, 1995, J NEUROPHYSIOL, V74, P2281, DOI 10.1152/jn.1995.74.6.2281; KATZ PS, 1995, J NEUROSCI, V15, P6035; Katz PS, 1996, TRENDS NEUROSCI, V19, P54, DOI 10.1016/0166-2236(96)89621-4; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; KERKUT GA, 1963, COMP BIOCHEM PHYSIOL, V8, P53, DOI 10.1016/0010-406X(63)90069-0; KERKUT GA, 1966, COMP BIOCHEM PHYSIOL, V17, P435, DOI 10.1016/0010-406X(66)90579-2; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; KLEIN M, 1978, P NATL ACAD SCI USA, V75, P3512, DOI 10.1073/pnas.75.7.3512; KLEIN M, 1982, P NATL ACAD SCI-BIOL, V79, P5713, DOI 10.1073/pnas.79.18.5713; Kloppenburg P, 2000, J NEUROSCI, V20, P2523; Koh HY, 2007, J NEUROPHYSIOL, V97, P1862, DOI 10.1152/jn.01230.2006; KRISTAN WB, 1976, J EXP BIOL, V65, P643; KRISTAN WB, 1974, J COMP PHYSIOL, V94, P155, DOI 10.1007/BF00617839; KUPFERMANN I, 1991, PHYSIOL REV, V71, P683, DOI 10.1152/physrev.1991.71.3.683; LEVITAN IB, 1979, J EXP BIOL, V81, P131; LEVITAN IB, 1978, J PHYSIOL-PARIS, V74, P521; Li L, 2001, J NEUROCHEM, V77, P1569, DOI 10.1046/j.1471-4159.2001.00360.x; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; LINGLE C, 1981, J EXP BIOL, V94, P285; Ma MM, 2009, PEPTIDES, V30, P1660, DOI 10.1016/j.peptides.2009.05.023; Ma MM, 2009, J PROTEOME RES, V8, P2426, DOI 10.1021/pr801047v; Ma MM, 2009, GEN COMP ENDOCR, V161, P320, DOI 10.1016/j.ygcen.2009.01.015; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MARDER E, 1978, J PHYSIOL-LONDON, V280, P213, DOI 10.1113/jphysiol.1978.sp012381; MARDER E, 1984, TRENDS NEUROSCI, V7, P48, DOI 10.1016/S0166-2236(84)80277-5; MARDER E, 1984, J NEUROPHYSIOL, V51, P1362, DOI 10.1152/jn.1984.51.6.1362; MARDER E, 1984, J NEUROPHYSIOL, V51, P1345, DOI 10.1152/jn.1984.51.6.1345; Marder E., 1985, P319; MARDER E, 1989, NEURONAL CELLULAR OS, P317; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1989, TRENDS NEUROSCI, V12, P215, DOI 10.1016/0166-2236(89)90125-2; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; Morgan PT, 2000, J NEUROPHYSIOL, V84, P1186, DOI 10.1152/jn.2000.84.3.1186; Morris LG, 1998, J NEUROSCI, V18, P3433; MULLONEY B, 1974, J COMP PHYSIOL, V91, P53, DOI 10.1007/BF00696156; MULLONEY B, 1974, J COMP PHYSIOL, V91, P1, DOI 10.1007/BF00696154; NAGY F, 1983, J EXP BIOL, V105, P33; NAGY F, 1988, J NEUROSCI, V8, P2875; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; NUSBAUM MP, 1988, J EXP BIOL, V135, P165; NUSBAUM MP, 1989, J NEUROSCI, V9, P1600; NUSBAUM MP, 1989, J NEUROSCI, V9, P1591; Oginsky MF, 2010, J COMP NEUROL, V518, P255, DOI 10.1002/cne.22225; OTSUKA M, 1967, J NEUROPHYSIOL, V30, P725, DOI 10.1152/jn.1967.30.4.725; PASZTOR VM, 1987, NATURE, V326, P793, DOI 10.1038/326793a0; Peck JH, 2006, J NEUROPHYSIOL, V96, P2931, DOI 10.1152/jn.00423.2005; PENG YY, 1991, J NEUROSCI, V11, P85; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Prinz AA, 2003, J NEUROSCI, V23, P943; Prinz AA, 2010, PHILOS T R SOC B, V365, P2397, DOI 10.1098/rstb.2010.0029; Proekt A, 2005, J NEUROSCI, V25, P9637, DOI 10.1523/JNEUROSCI.2932-05.2005; Rodgers EW, 2011, J NEUROSCI, V31, P16387, DOI 10.1523/JNEUROSCI.3770-11.2011; Rodgers EW, 2011, J NEUROSCI, V31, P13046, DOI 10.1523/JNEUROSCI.2194-11.2011; Roffman RC, 2012, J NEUROPHYSIOL, V107, P1681, DOI 10.1152/jn.00903.2011; Saideman SR, 2007, J NEUROPHYSIOL, V97, P579, DOI 10.1152/jn.00772.2006; Saideman SR, 2006, J EXP BIOL, V209, P3664, DOI 10.1242/jeb.02415; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; SCHWARZ TL, 1980, J NEUROBIOL, V11, P623, DOI 10.1002/neu.480110611; Seung HS, 2011, NATURE, V471, P170, DOI 10.1038/471170a; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SIGVARDT KA, 1985, BRAIN RES, V336, P390, DOI 10.1016/0006-8993(85)90676-6; SIWICKI KK, 1987, J NEUROSCI, V7, P522; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Spitzer N, 2008, J NEUROPHYSIOL, V99, P2844, DOI 10.1152/jn.00986.2007; Stein W, 2009, J COMP PHYSIOL A, V195, P989, DOI 10.1007/s00359-009-0483-y; Stemmler EA, 2010, GEN COMP ENDOCR, V165, P1, DOI 10.1016/j.ygcen.2009.05.010; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; STENT GS, 1979, PHYSIOL REV, V59, P101, DOI 10.1152/physrev.1979.59.1.101; Sweedler JV, 2002, J NEUROSCI, V22, P7797; Swensen AM, 2001, J NEUROSCI, V21, P4050, DOI 10.1523/JNEUROSCI.21-11-04050.2001; Swensen AM, 2000, J NEUROSCI, V20, P6752, DOI 10.1523/JNEUROSCI.20-18-06752.2000; Szabo TM, 2011, J COMP NEUROL, V519, P2658, DOI 10.1002/cne.22654; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Thirumalai V, 2006, J NEUROPHYSIOL, V95, P1762, DOI 10.1152/jn.00764.2005; Vilim FS, 2010, J NEUROSCI, V30, P131, DOI 10.1523/JNEUROSCI.3282-09.2010; WALKER RJ, 1968, COMP BIOCHEM PHYSIOL, V24, P455, DOI 10.1016/0010-406X(68)90997-3; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Weimann JM, 1997, J NEUROSCI, V17, P1748; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; WEIMANN JM, 1994, CURR BIOL, V4, P896, DOI 10.1016/S0960-9822(00)00199-8; WEISS KR, 1978, J NEUROPHYSIOL, V41, P181, DOI 10.1152/jn.1978.41.1.181; WEISS KR, 1992, EXPERIENTIA, V48, P456, DOI 10.1007/BF01928164; WILLOWS AOD, 1973, J NEUROBIOL, V4, P207, DOI 10.1002/neu.480040306; Wilson D. M., 1966, Symposia of the Society for Experimental Biology, V20, P199; WILSON DM, 1961, J EXP BIOL, V38, P471; Wiwatpanit T, 2012, J EXP BIOL, V215, P2308, DOI 10.1242/jeb.069989; Wu JS, 2010, J NEUROPHYSIOL, V103, P2174, DOI 10.1152/jn.01054.2009; Zhang HM, 2010, J NEUROPHYSIOL, V104, P873, DOI 10.1152/jn.00195.2010; Zhao SB, 2011, J NEUROSCI, V31, P13991, DOI 10.1523/JNEUROSCI.3624-11.2011; [No title captured]	170	468	469	9	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2012	76	1					1	11		10.1016/j.neuron.2012.09.010	http://dx.doi.org/10.1016/j.neuron.2012.09.010			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	020HG	23040802	Green Accepted, Bronze			2022-12-17	WOS:000309799000001
J	Mitchell, JF; Sundberg, KA; Reynolds, JH				Mitchell, Jude F.; Sundberg, Kristy A.; Reynolds, John H.			Spatial Attention Decorrelates Intrinsic Activity Fluctuations in Macaque Area V4	NEURON			English	Article							PRIMARY VISUAL-CORTEX; NEURAL POPULATION RESPONSES; PSYCHOPHYSICAL PERFORMANCE; NEURONAL SYNCHRONIZATION; NORMALIZATION MODEL; ACTION-POTENTIALS; CORTICAL-NEURONS; HIGH-FREQUENCY; EYE-MOVEMENTS; SINGLE-UNIT	Attention typically amplifies neuronal responses evoked by task-relevant stimuli while attenuating responses to task-irrelevant distracters. In this context, visual distracters constitute an external source of noise that is diminished to improve attended signal quality. Activity that is internal to the cortex itself, stimulus-independent ongoing correlated fluctuations in firing, might also act as task-irrelevant noise. To examine this, we recorded from area V4 of macaques performing an attention-demanding task. The firing of neurons to identically repeated stimuli was highly variable. Much of this variability originates from ongoing low-frequency (<5 Hz) fluctuations in rate correlated across the neuronal population. When attention is directed to a stimulus inside a neuron's receptive field, these correlated fluctuations in rate are reduced. This attention-dependent reduction of ongoing cortical activity improves the signal-to-noise ratio of pooled neural signals substantially more than attention-dependent increases in firing rate.	[Mitchell, Jude F.; Sundberg, Kristy A.; Reynolds, John H.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Reynolds, JH (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA.	reynolds@salk.edu		Mitchell, Jude/0000-0003-0197-7545	National Eye Institute [EY016161]; National Institutes of Health Training Fellowship; National Science Foundation Graduate Research Fellowship; NATIONAL EYE INSTITUTE [R01EY016161] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank C. Williams and J. Reyes for help with animals and technical support. We thank John Curtis for helpful discussions on coherence and correlation analyses. This work was supported by a grant from the National Eye Institute (EY016161, J.M. and J.H.R.), a National Institutes of Health Training Fellowship (J.M.), and a National Science Foundation Graduate Research Fellowship (K.A.S.).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Angelucci A, 2002, J NEUROSCI, V22, P8633; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brumberg JC, 2000, J NEUROSCI, V20, P4829; CALVIN WH, 1967, SCIENCE, V155, P842, DOI 10.1126/science.155.3764.842; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Chen YZ, 2008, J NEUROPHYSIOL, V99, P1366, DOI 10.1152/jn.00698.2007; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Ghose GM, 2008, J NEUROSCI, V28, P5115, DOI 10.1523/JNEUROSCI.0138-08.2008; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Gur M, 1997, J NEUROSCI, V17, P2914; Gur M, 1999, J NEUROPHYSIOL, V82, P1451, DOI 10.1152/jn.1999.82.3.1451; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; James W., 1890, PRINCIPLES PSYCHOL, V2; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; Morita K, 2008, J NEUROSCI, V28, P1871, DOI 10.1523/JNEUROSCI.3948-07.2008; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shmuel A, 2005, J NEUROSCI, V25, P2117, DOI 10.1523/JNEUROSCI.4137-04.2005; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SOFTKY WR, 1993, J NEUROSCI, V13, P334; WANG Z, 1993, J NEUROSCI, V13, P2199; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Yanagawa T, 2009, NEUROSCI RES, V64, P177, DOI 10.1016/j.neures.2009.02.011; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	59	468	470	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					879	888		10.1016/j.neuron.2009.09.013	http://dx.doi.org/10.1016/j.neuron.2009.09.013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778515	Green Submitted, Bronze, Green Accepted			2022-12-17	WOS:000270569700019
J	Xia, J; Zhang, XQ; Staudinger, J; Huganir, RL				Xia, J; Zhang, XQ; Staudinger, J; Huganir, RL			Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1	NEURON			English	Article							LONG-TERM POTENTIATION; SILENT SYNAPSES; FASCICLIN-II; GLUTAMATE; SYSTEM; PSD-95; YEAST; LTP; RECOGNITION; HIPPOCAMPUS	Synaptic clustering of neurotransmitter receptors is crucial for efficient signal transduction and integration in neurons. PDZ domain-containing proteins such as PSD-95/SAP90 interact with the intracellular C termini of a variety of receptors and are thought to be important in the targeting and anchoring of receptors to specific synapses. Here, we show that PICK1 (protein interacting with C kinase), a PDZ domain-containing protein, interacts with the C termini of alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) receptors in vitro and in vivo. In neurons, PICK1 specifically colocalizes with AMPA receptors at excitatory synapses. Furthermore, PICK1 induces clustering of AMPA receptors in heterologous expression systems. These results suggest that PICK1 may play an important role in the modulation of synaptic transmission by regulating the synaptic targeting of AMPA receptors.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Glaxo Wellcome Inc, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA	Howard Hughes Medical Institute; Johns Hopkins University; GlaxoSmithKline	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.		Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188				Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLACKSTONE CD, 1992, ANN NEUROL, V31, P680, DOI 10.1002/ana.410310620; BLAKE DJ, 1995, TRENDS BIOCHEM SCI, V20, P133, DOI 10.1016/S0968-0004(00)88986-0; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; James P, 1996, GENETICS, V144, P1425; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	40	468	496	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					179	187		10.1016/S0896-6273(00)80689-3	http://dx.doi.org/10.1016/S0896-6273(00)80689-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027300	Bronze			2022-12-17	WOS:000078410300023
J	MONYER, H; SEEBURG, PH; WISDEN, W				MONYER, H; SEEBURG, PH; WISDEN, W			GLUTAMATE-OPERATED CHANNELS - DEVELOPMENTALLY EARLY AND MATURE FORMS ARISE BY ALTERNATIVE SPLICING	NEURON			English	Article							AMINO-ACID RECEPTORS; CENTRAL-NERVOUS-SYSTEM; NMDA RECEPTORS; ACETYLCHOLINE-RECEPTOR; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; AREA CA1; KAINATE; CORTEX; NEUROTOXICITY	The expression of two alternative splice variants, Flip and Flop, in mRNAs encoding the four AMPA-selective glutamate receptors (GluR-A, -B, -C, and -D) was studied in the developing brain by in situ hybridization. These receptors are expressed prominently before birth, and patterns of distribution for Flip versions remain largely invariant during postnatal brain development. In contrast, the Flop versions are expressed at low levels prior to postnatal day 8. Around this time, the expression of Flop mRNAs increases throughout the brain, reaching adult levels by postnatal day 14. Thus, receptors carrying the Flop module appear to participate in mature receptor forms.			MONYER, H (corresponding author), UNIV HEIDELBERG, CTR MOLEC BIOL HEIDELBERG, MOLEC NEUROENDOCRINOL LAB, W-6900 HEIDELBERG, GERMANY.		Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; Monyer, Hannah/0000-0002-9332-5749				AGHAJANIAN G. K., 1967, BRAIN RES, V6, P716, DOI 10.1016/0006-8993(67)90128-X; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BOULTER I, 1990, SCIENCE, V29, P1033; CAMBRAYDEAKIN MA, 1990, DEV BRAIN RES, V54, P265, DOI 10.1016/0165-3806(90)90149-S; CAMPOCHIARO P, 1978, P NATL ACAD SCI USA, V75, P2025, DOI 10.1073/pnas.75.4.2025; CARPENTER MK, 1990, DEV BIOL, V138, P313, DOI 10.1016/0012-1606(90)90199-S; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; GREENAMYRE T, 1987, J NEUROSCI, V7, P1022; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; HAMON B, 1988, DEV BRAIN RES, V38, P286, DOI 10.1016/0165-3806(88)90054-5; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HEADLEY PM, 1990, TRENDS PHARMACOL SCI, V11, P205, DOI 10.1016/0165-6147(90)90116-P; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; JARAMILLO F, 1988, NATURE, V335, P66, DOI 10.1038/335066a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MILLER LP, 1990, NEUROSCIENCE, V35, P45, DOI 10.1016/0306-4522(90)90118-N; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PEARCE IA, 1987, FEBS LETT, V223, P143, DOI 10.1016/0014-5793(87)80525-2; ROGERS JH, 1987, NEUROSCIENCE, V23, P343, DOI 10.1016/0306-4522(87)90295-8; SILVERSTEIN FS, 1986, NEUROSCI LETT, V71, P13, DOI 10.1016/0304-3940(86)90249-1; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SOMOGYI P, 1990, NEUROSCIENCE, V35, P9, DOI 10.1016/0306-4522(90)90116-L; STANFIELD BB, 1988, CEREB CORTEX, V7, P91; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; WISDEN W, 1991, MOL NEUROBIOLOGY PRA, V2, P205; WOLF G, 1984, DEV BRAIN RES, V14, P15, DOI 10.1016/0165-3806(84)90004-X; YOUNG AB, 1990, TRENDS PHARMACOL SCI, V11, P126, DOI 10.1016/0165-6147(90)90199-I	36	468	480	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					799	810		10.1016/0896-6273(91)90176-Z	http://dx.doi.org/10.1016/0896-6273(91)90176-Z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1673851				2022-12-17	WOS:A1991FM52200012
J	Delgado, MR; Nearing, KI; LeDoux, JE; Phelps, EA				Delgado, Mauricio R.; Nearing, Katherine I.; LeDoux, Joseph E.; Phelps, Elizabeth A.			Neural circuitry underlying the regulation of conditioned fear and its relation to extinction	NEURON			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; VOLUNTARY SUPPRESSION; NEGATIVE AFFECT; ANIMAL-MODELS; AMYGDALA; HUMANS; ACQUISITION; ACTIVATION; EMOTION; MODULATION	Recent efforts to translate basic research to the treatment of clinical disorders have led to a growing interest in exploring mechanisms for diminishing fear. This research has emphasized two approaches: extinction of conditioned fear, examined across species; and cognitive emotion regulation, unique to humans. Here, we sought to examine the similarities and differences in the neural mechanisms underlying these two paradigms for diminishing fear. Using an emotion regulation strategy, we examine the neural mechanisms of regulating conditioned fear using fMRI and compare the resulting activation pattern with that observed during classic extinction. Our results suggest that the lateral PFC regions engaged by cognitive emotion regulation strategies may influence the amygdala, diminishing fear through similar vmPFC connections that are thought to inhibit the amygdala during extinction. These findings further suggest that humans may have developed complex cognition that can aid in regulating emotional responses while utilizing phylogenetically shared mechanisms of extinction.	[LeDoux, Joseph E.; Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Delgado, Mauricio R.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Nearing, Katherine I.] Univ Miami, Sch Med, Miami, FL 33136 USA; [LeDoux, Joseph E.; Phelps, Elizabeth A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; Rutgers State University Newark; Rutgers State University New Brunswick; University of Miami; New York University	Phelps, EA (corresponding author), NYU, Dept Psychol, 550 1St Ave, New York, NY 10003 USA.	liz.phelps@nyu.edu			National Institute of Mental Health [MH072279, MHO58911]; Beatrice and Samuel A. Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH072279, P50MH058911] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Beatrice and Samuel A. Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grants to E.A.P (MH072279) and to J.E.L (MHO58911) and the Beatrice and Samuel A. Seaver Foundation. The authors wish to acknowledge Kevin Ochsner and Jennifer Trujillo for discussion and assistance.	Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Beck A.T., 2005, ANXIETY DISORDERS PH; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Davis M, 2006, BIOL PSYCHIAT, V60, P369, DOI 10.1016/j.biopsych.2006.03.084; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Groenewegen HJ, 1997, J PSYCHOPHARMACOL, V11, P99, DOI 10.1177/026988119701100202; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kalisch R, 2005, PSYCHOPHARMACOLOGY, V180, P774, DOI 10.1007/s00213-005-2252-0; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Ledoux JE, 2001, AM J PSYCHIAT, V158, P1953, DOI 10.1176/appi.ajp.158.12.1953; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mohr C, 2005, PAIN, V114, P347, DOI 10.1016/j.pain.2004.12.036; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Talairach J., 1988, COPLANAR STEREOTAXIC; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006	47	467	479	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 11	2008	59	5					829	838		10.1016/j.neuron.2008.06.029	http://dx.doi.org/10.1016/j.neuron.2008.06.029			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	349DG	18786365	Green Accepted, Bronze			2022-12-17	WOS:000259258400016
J	van den Maagdenberg, AMJM; Pietrobon, D; Pizzorusso, T; Kaja, S; Broos, LAM; Cesetti, T; van de Ven, RCG; Tottene, A; van der Kaa, J; Plomp, JJ; Frants, RR; Ferrari, MD				van den Maagdenberg, AMJM; Pietrobon, D; Pizzorusso, T; Kaja, S; Broos, LAM; Cesetti, T; van de Ven, RCG; Tottene, A; van der Kaa, J; Plomp, JJ; Frants, RR; Ferrari, MD			A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression	NEURON			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; CALCIUM-CHANNEL; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; ABSENCE EPILEPSY; CENTRAL SYNAPSE; MUTANT MICE; MUTATIONS; SUBUNIT; AURA	Migraine is a common, disabling, multifactorial, episodic neurovascular disorder of unknown etiology. Familial hemiplegic migraine type 1 (FHM-1) is a Mendelian subtype of migraine with aura that is caused by missense mutations in the CACNA1A gene that encodes the alpha(1) subunit of neuronal Ca(v)2.1 Ca2+ channels. We generated a knockin mouse model carrying the human pure FHM-1 R192Q mutation and found multiple gain-of-function effects. These include increased Ca(v)2.1 current density in cerebellar neurons, enhanced neurotransmission at the neuromuscular junction, and, in the intact animal, a reduced threshold and increased velocity of cortical spreading depression (CSD; the likely mechanism for the migraine aura). Our data show that the increased susceptibility for CSD and aura in migraine may be due to cortical hyperexcitability. The R192Q FHM-1 mouse is a promising animal model to study migraine mechanisms and treatments.	Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2333 AL Leiden, Netherlands; Univ Padua, Dept Biomed Sci, CNR, Inst Neurosci, I-35121 Padua, Italy; CNR, Inst Neurosci, Scuola Normale Super, I-56100 Pisa, Italy; Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van den Maagdenberg, AMJM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Wssenaarseweg 72, NL-2333 AL Leiden, Netherlands.	maagdenberg@lumc.nl; dani@civ.bio.unipd.it	van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Kaja, Simon/C-2267-2015; Ferrari, Michel D./ABE-3758-2021; Pizzorusso, Tommaso/D-1399-2013	Kaja, Simon/0000-0001-6878-521X; Ferrari, Michel D./0000-0001-9691-9449; Pizzorusso, Tommaso/0000-0001-5614-0668	Telethon [E.1297, E.0847] Funding Source: Medline	Telethon(Fondazione Telethon)		Ayata C, 2000, NEUROSCIENCE, V95, P639; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; Cutrer FM, 1998, ANN NEUROL, V43, P25, DOI 10.1002/ana.410430108; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dove LS, 1998, J NEUROSCI, V18, P7687; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Fletcher CF, 1999, HUM MOL GENET, V8, P1907, DOI 10.1093/hmg/8.10.1907; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Goadsby PJ, 2001, ANN NEUROL, V49, P4, DOI 10.1002/1531-8249(200101)49:1<4::AID-ANA3>3.0.CO;2-W; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hans M, 1999, J NEUROSCI, V19, P1610; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hong KW, 1999, J CEREBR BLOOD F MET, V19, P53, DOI 10.1097/00004647-199901000-00006; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Knight YE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-05-j0002.2002; Kors EE, 2002, CURR OPIN NEUROL, V15, P311, DOI 10.1097/00019052-200206000-00014; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; OPHOFF RA, 1994, GENOMICS, V22, P21, DOI 10.1006/geno.1994.1340; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Pineda JC, 1998, J NEUROPHYSIOL, V79, P2522, DOI 10.1152/jn.1998.79.5.2522; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Thomsen LL, 2002, BRAIN, V125, P1379, DOI 10.1093/brain/awf132; Timmermann DB, 2002, J NEUROSCI RES, V67, P48, DOI 10.1002/jnr.10074; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6	45	467	472	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					701	710		10.1016/S0896-6273(04)00085-6	http://dx.doi.org/10.1016/S0896-6273(04)00085-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003170	Bronze			2022-12-17	WOS:000221458200006
J	Domeniconi, M; Cao, ZU; Spencer, T; Sivasankaran, R; Wang, KC; Nikulina, E; Kimura, N; Cai, H; Deng, KW; Gao, Y; He, ZG; Filbin, MT				Domeniconi, M; Cao, ZU; Spencer, T; Sivasankaran, R; Wang, KC; Nikulina, E; Kimura, N; Cai, H; Deng, KW; Gao, Y; He, ZG; Filbin, MT			Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth	NEURON			English	Article							AXONAL REGENERATION; ADULT-RAT; GROWTH; MAG; IDENTIFICATION; PROTEIN; GANGLIOSIDES; ADHESION; ANTIBODY; LIGANDS	Myelin inhibitors of axonal regeneration, like Nogo and MAG, block regrowth after injury to the adult CNS. While a GPI-linked receptor for Nogo (NgR) has been identified, MAG's receptor is unknown. We show that MAG inhibits regeneration by interaction with NgR. Binding of and inhibition by MAG are lost if neuronal GPI-linked proteins are cleaved. Binding of MAG to NgR-expressing cells is GPI dependent and sialic acid independent. Conversely, NgR binds to MAG-expressing cells. MAG, but not a truncated MAG that binds neurons but does not inhibit regeneration, precipitates NgR from NgR-expressing cells, DRG, and cerebellar neurons, Importantly, NgR antibody, soluble NgR, or dominant-negative NgR each prevent inhibition of neurite outgrowth by MAG. Also, MAG and Nogo66 compete for binding to NgR. These results suggest redundancy in myelin inhibitors and indicate therapies for CNS injuries.	CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Boston Children's Hospital; Harvard Medical School	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	filbin@genectr.hunter.cuny.edu	Spencer, Tim/AAK-2094-2020		NINDS NIH HHS [NS 37060, NS41073] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073, R37NS037060, R01NS037060] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cheng K, 2000, PSYCHOL SCI, V11, P403, DOI 10.1111/1467-9280.00278; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248; Crocker P R, 1998, Glycobiology, V8, pv; De Bellard M, 1999, J NEUROSCI RES, V56, P213, DOI 10.1002/(SICI)1097-4547(19990415)56:2<213::AID-JNR11>3.3.CO;2-L; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; FAHRIG T, 1987, EMBO J, V6, P2875, DOI 10.1002/j.1460-2075.1987.tb02590.x; Filbin MT, 1996, MOL CELL NEUROSCI, V8, P84, DOI 10.1006/mcne.1996.0047; Fitch MT, 1999, CNS REGENERATION BAS, P55; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Franzen R, 2001, J CELL BIOL, V155, P893, DOI 10.1083/jcb.200108137; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huber AB, 2002, J NEUROSCI, V22, P3553; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.0.CO;2-K; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Quarles RH, 1997, J MOL NEUROSCI, V8, P1, DOI 10.1007/BF02736858; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Tang S, 2001, MOL CELL NEUROSCI, V18, P259, DOI 10.1006/mcne.2001.1020; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TRAPP BD, 1988, J CELL BIOL, V107, P675, DOI 10.1083/jcb.107.2.675; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814	47	467	517	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					283	290		10.1016/S0896-6273(02)00770-5	http://dx.doi.org/10.1016/S0896-6273(02)00770-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160746	Bronze			2022-12-17	WOS:000177034200008
J	Baloh, RH; Tansey, MG; Lampe, PA; Fahrner, TJ; Enomoto, H; Simburger, KS; Leitner, ML; Araki, T; Johnson, EM; Milbrandt, J				Baloh, RH; Tansey, MG; Lampe, PA; Fahrner, TJ; Enomoto, H; Simburger, KS; Leitner, ML; Araki, T; Johnson, EM; Milbrandt, J			Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFR alpha 3-RET receptor complex	NEURON			English	Article							MICE LACKING GDNF; C-RET PROTOONCOGENE; NEUROTROPHIC FACTOR; TYROSINE KINASE; SYMPATHETIC NEURONS; SURVIVAL FACTOR; SCHWANN-CELLS; NEURTURIN; PROTEIN; NERVE	The glial cell line-derived neurotrophic factor (GDNF) ligands (GDNF, Neurturin [NTN], and Persephin [PSP]) signal through a multicomponent receptor system composed of a high-affinity binding component (GFR alpha 1-GFR alpha 4) and a common signaling component (RET). Here, we report the identification of Artemin, a novel member of the GDNF family, and demonstrate that it is the ligand for the former orphan receptor GFR alpha 3-RET. Artemin is a survival factor for sensory and sympathetic neurons in culture, and its expression pattern suggests that it also influences these neurons in vivo. Artemin can also activate the GFR alpha 1-RET complex and supports the survival of dopaminergic midbrain neurons in culture, indicating that like GDNF (GFR alpha 1-RET) and NTN (GFR alpha 2-RET), Artemin has a preferred receptor (GFR alpha 3-RET) but that alternative receptor interactions also occur.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	jeff@milbrandt.wustl.edu	Araki, Toshiyuki/H-4289-2019; Lampe, Patricia/AAH-9545-2020	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689	NIA NIH HHS [R01 AG13729, R01 AG13730] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217; Enokido Y, 1998, CURR BIOL, V8, P1019, DOI 10.1016/S0960-9822(07)00422-8; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; Grondin R, 1998, J NEUROL, V245, pP35, DOI 10.1007/PL00007744; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Hishiki T, 1998, CANCER RES, V58, P2158; Horger BA, 1998, J NEUROSCI, V18, P4929; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; KOTZBAUER PT, 1994, NEURON, V12, P763, DOI 10.1016/0896-6273(94)90329-8; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Suvanto P, 1997, HUM MOL GENET, V6, P1267, DOI 10.1093/hmg/6.8.1267; Svaren J, 1998, EMBO J, V17, P6010, DOI 10.1093/emboj/17.20.6010; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Widenfalk J, 1998, EUR J NEUROSCI, V10, P1508, DOI 10.1046/j.1460-9568.1998.00192.x; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yu T, 1998, J NEUROSCI, V18, P4684	54	467	513	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1291	1302		10.1016/S0896-6273(00)80649-2	http://dx.doi.org/10.1016/S0896-6273(00)80649-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883723	Bronze			2022-12-17	WOS:000077910600012
J	Kalivas, PW; Volkow, N; Seamans, J				Kalivas, PW; Volkow, N; Seamans, J			Unmanageable motivation in addiction: A pathology in prefrontal-accumbens glutamate transmission	NEURON			English	Review							COCAINE-INDUCED REINSTATEMENT; NUCLEUS-ACCUMBENS; SEEKING; RECEPTORS; DOPAMINE; CORTEX; ACTIVATION		Med Univ S Carolina, Dept Neurosci, Charleston, SC 29465 USA; NIDA, Bethesda, MD 20892 USA	Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29465 USA.	kalivasp@musc.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550, Z01AA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Baptista MAS, 2004, J NEUROSCI, V24, P4723, DOI 10.1523/JNEUROSCI.0176-04.2004; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Capriles N, 2003, PSYCHOPHARMACOLOGY, V168, P66, DOI 10.1007/s00213-002-1283-z; Chandler LJ, 2003, PHARMACOL THERAPEUT, V99, P311, DOI 10.1016/S0163-7258(03)00096-2; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Dietrich D, 2002, NEUROPHARMACOLOGY, V42, P297, DOI 10.1016/S0028-3908(01)00193-9; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McBean GJ, 2002, TRENDS PHARMACOL SCI, V23, P299, DOI 10.1016/S0165-6147(02)02060-6; McFarland K, 2001, J NEUROSCI, V21, P8655; Moran MM, 2003, ANN NY ACAD SCI, V1003, P445, DOI 10.1196/annals.1300.048; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	23	466	478	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					647	650		10.1016/j.neuron.2005.02.005	http://dx.doi.org/10.1016/j.neuron.2005.02.005			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748840	Bronze			2022-12-17	WOS:000227446700004
J	Martin, KC; Michael, D; Rose, JC; Barad, M; Casadio, A; Zhu, HX; Kandel, ER				Martin, KC; Michael, D; Rose, JC; Barad, M; Casadio, A; Zhu, HX; Kandel, ER			MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL GROWTH-FACTOR; CYCLIC-AMP; PC12 CELLS; MACROMOLECULAR-SYNTHESIS; SUBSTRATE RECOGNITION; SYNAPTIC PLASTICITY; SENSORY NEURONS; CRITICAL PERIOD; LATE-PHASE	Long-term facilitation of the sensory to motor synapse in Aplysia requires gene expression. While some transcription factors involved in long-term facilitation are phosphorylated by PKA, others lack PKA sites but contain MAP Kinase (MAPK) phosphorylation sites. We now show that MAPK translocates into the nucleus of the presynaptic but not the postsynaptic cell during 5-HT-induced long-term facilitation. The presynaptic nuclear translocation of MAPK is also triggered by elevations in intracellular cAMP. Injection of anti-MAPK antibodies or of MAPK Kinase inhibitors into the presynaptic cell blocks long-term facilitation, without affecting basal synaptic transmission or short-term facilitation. Thus, MAPK appears to be specifically recruited and necessary for the long-term form of facilitation. This mechanism for long-term plasticity may be quite general: cAMP also activated MAPK in mouse hippocampal neurons, suggesting that MAPK may play a role in hippocampal long-term potentiation.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Columbia University	Martin, KC (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.			Michael, Dan/0000-0003-2942-4301				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BACKSAI BJ, 1993, SCIENCE, V260, P222; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1989, J NEUROSCI, V9, P1774; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Carew TJ, 1996, NEURON, V16, P5, DOI 10.1016/S0896-6273(00)80016-1; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FAURE M, 1995, MOL BIOL CELL, V6, P1025, DOI 10.1091/mbc.6.8.1025; FAURE M, 1994, J BIOL CHEM, V269, P7851; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GAUSE KC, 1993, J BIOL CHEM, V268, P16124; Geinisman Y, 1996, J COMP NEUROL, V368, P413; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Graves JD, 1995, ANN NY ACAD SCI, V766, P320, DOI 10.1111/j.1749-6632.1995.tb26684.x; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; HARRIS KE, 1993, TRENDS NEUROSCI, V16, P141; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Lisman J, 1995, J NIH RES, V7, P43; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Qian Z, 1994, Learn Mem, V1, P180; RAYPORT SG, 1986, J NEUROSCI, V6, P759; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; Sossin WS, 1996, TRENDS NEUROSCI, V19, P215; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; VOSSLER MR, 1997, CELL, V88, P73; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAO H, 1995, J BIOL CHEM, V270, P20748, DOI 10.1074/jbc.270.35.20748; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318	67	466	476	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					899	912		10.1016/S0896-6273(00)80330-X	http://dx.doi.org/10.1016/S0896-6273(00)80330-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208858	Bronze			2022-12-17	WOS:A1997XJ10200009
J	KORNHAUSER, JM; NELSON, DE; MAYO, KE; TAKAHASHI, JS				KORNHAUSER, JM; NELSON, DE; MAYO, KE; TAKAHASHI, JS			PHOTIC AND CIRCADIAN REGULATION OF C-FOS-GENE EXPRESSION IN THE HAMSTER SUPRACHIASMATIC NUCLEUS	NEURON			English	Article									NORTHWESTERN UNIV,DEPT BIOCHEM MOLEC BIOL & CELL BIOL,EVANSTON,IL 60208; NORTHWESTERN UNIV,DEPT NEUROBIOL & PHYSIOL,EVANSTON,IL 60208	Northwestern University; Northwestern University	KORNHAUSER, JM (corresponding author), NORTHWESTERN UNIV,INST NEUROSCI,EVANSTON,IL 60208, USA.		Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878				CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P15; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; CURRAN T, 1988, COLD SPRING HARB SYM, V53, P769, DOI 10.1101/SQB.1988.053.01.087; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; INOUYE ST, 1988, AM J PHYSIOL, V255, pR1055, DOI 10.1152/ajpregu.1988.255.6.R1055; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MILLBRANDT J, 1986, P NATL ACAD SCI USA, V83, P4789; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; REA MA, 1989, BRAIN RES BULL, V23, P577, DOI 10.1016/0361-9230(89)90204-9; ROBINSON BG, 1988, SCIENCE, V241, P342, DOI 10.1126/science.3388044; ROSBASH M, 1989, NEURON, V3, P387, DOI 10.1016/0896-6273(89)90199-2; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; SASSONECORSI P, 1988, COLD SPRING HARB SYM, V53, P749, DOI 10.1101/SQB.1988.053.01.085; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; SUHR ST, 1989, MOL ENDOCRINOL, V3, P1693, DOI 10.1210/mend-3-11-1693; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; TAKAHASHI JS, 1987, BRAIN RES, V405, P199, DOI 10.1016/0006-8993(87)91010-9; UHL GR, 1986, SCIENCE, V232, P390, DOI 10.1126/science.3961487; WOLLNIK F, 1989, BRAIN RES, V496, P82, DOI 10.1016/0006-8993(89)91053-6	38	466	469	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1990	5	2					127	134		10.1016/0896-6273(90)90303-W	http://dx.doi.org/10.1016/0896-6273(90)90303-W			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU559	2116813				2022-12-17	WOS:A1990DU55900003
J	McAllister, AK; Katz, LC; Lo, DC				McAllister, AK; Katz, LC; Lo, DC			Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; PROJECTION NEURONS; MOLECULAR-CLONING; MESSENGER-RNAS; VISUAL-CORTEX; BRAIN-SLICES; TRK FAMILY; RECEPTOR; EXPRESSION	Neurons within each layer of cerebral cortex express multiple members of the neurotrophin family and their corresponding receptors. This multiplicity could provide functional redundancy; alternatively, different neurotrophins may direct distinct aspects of cortical neuronal growth and differentiation. By neutralizing endogenous neurotrophins in organotypic slices of developing cortex with Trk receptor bodies (Trk-lgGs), we found that BDNF and NT-3 oppose one another in regulating the dendritic growth of pyramidal neurons. In layer 4, both endogenous and exogenous NT-3 inhibited the dendritic growth stimulated by BDNF. In contrast, in layer 6 both endogenous and exogenous BDNF inhibited dendritic growth stimulated by NT-3. These antagonistic actions of endogenous BDNF and NT-3 provide a mechanism by which dendritic growth and retraction can be dynamically regulated during cortical development, and suggest that the multiple neurotrophins expressed in developing cortex represent distinct components of an extracellular signaling system for regulating dendritic growth.	DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710	Duke University	McAllister, AK (corresponding author), DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710, USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NEI NIH HHS [EY11553, EY07690] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x; CAJAL SRR, 1929, STUDIES VERTEBRATE N; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; DECHANT G, 1993, DEVELOPMENT, V119, P545; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GIFFIN K, 1991, NEURON, V6, P321, DOI 10.1016/0896-6273(91)90242-R; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; Kalcheim C, 1996, PHILOS T ROY SOC B, V351, P375, DOI 10.1098/rstb.1996.0031; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KATZ LC, 1987, J NEUROSCI, V7, P1223; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOESTER SE, 1992, J NEUROSCI, V12, P1382; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCALLISTER AK, 1996, NEURON, V17, P1; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MILLER MW, 1988, CEREB CORTEX, P140; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123	36	465	469	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					767	778		10.1016/S0896-6273(00)80316-5	http://dx.doi.org/10.1016/S0896-6273(00)80316-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182801	Bronze			2022-12-17	WOS:A1997XB72200010
J	SURMEIER, DJ; BARGAS, J; HEMMINGS, HC; NAIRN, AC; GREENGARD, P				SURMEIER, DJ; BARGAS, J; HEMMINGS, HC; NAIRN, AC; GREENGARD, P			MODULATION OF CALCIUM CURRENTS BY A D-1 DOPAMINERGIC PROTEIN-KINASE PHOSPHATASE CASCADE IN RAT NEOSTRIATAL NEURONS	NEURON			English	Article							CAUDATE-NUCLEUS NEURONS; LONG-TERM POTENTIATION; BASAL GANGLIA; VOLTAGE-DEPENDENCE; C-FOS; HIPPOCAMPAL-NEURONS; SYMPATHETIC NEURONS; PROJECTION NEURONS; PERTUSSIS TOXIN; ALPHA-1 SUBUNIT	In rat neostriatal neurons, D-1 dopamine receptors regulate the activity of cyclic AMP-dependent protein kinase (PKA) and protein phosphatase 1(PP1). The influence of these signaling elements on high voltage-activated (HVA) calcium currents was studied using whole-cell voltage-clamp techniques. The application of D-1 agonists or cyclic AMP analogs reversibly reduced N- and P-type Ca2+ currents. Inhibition of PKA antagonized this modulation, as did inhibition of PP1, suggesting that the D-1 effect was mediated by a PKA enhancement of PP1 activity directed toward Ca2+ channels. In a subset of neurons, D-1 receptor-mediated activation of PKA enhanced L-type currents. The differential regulation of HVA currents by the D-1 pathway helps to explain the diversity of effects this pathway has on synaptic integration and plasticity in medium spiny neurons.	NATL AUTONOMOUS UNIV MEXICO, INST FISIOL CELULAR, MEXICO CITY 04510, DF, MEXICO; CORNELL UNIV, COLL MED, DEPT ANESTHESIOL, NEW YORK, NY 10021 USA; CORNELL UNIV, COLL MED, DEPT PHARMACOL, NEW YORK, NY 10021 USA; ROCKEFELLER UNIV, DEPT MOLEC & CELLULAR NEUROSCI, NEW YORK, NY 10021 USA	Universidad Nacional Autonoma de Mexico; Cornell University; Cornell University; Rockefeller University	SURMEIER, DJ (corresponding author), UNIV TENNESSEE, COLL MED, DEPT ANAT & NEUROBIOL, MEMPHIS, TN 38163 USA.			Nairn, Angus/0000-0002-7075-0195	NIDA NIH HHS [P01 DA010044] Funding Source: Medline; NIMH NIH HHS [MH 40899] Funding Source: Medline; NINDS NIH HHS [NS 26473, NS 28889] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AKAIKE A, 1987, BRAIN RES, V418, P262, DOI 10.1016/0006-8993(87)90094-1; ANDERSON KD, 1990, J COMP NEUROL, V295, P339, DOI 10.1002/cne.902950302; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BARGAS J, 1991, BRAIN RES, V541, P70, DOI 10.1016/0006-8993(91)91075-C; BARGAS J, 1989, EXP BRAIN RES, V75, P146; BARGAS J, 1994, J NEUROSCI, V14, P6667; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BREITWIESER GE, 1991, HYPERTENSION, V17, P684, DOI 10.1161/01.HYP.17.5.684; BROWN AM, 1991, FASEB J, V5, P2175, DOI 10.1096/fasebj.5.8.1708737; BUTT E, 1992, BIOCHEM PHARMACOL, V43, P2591, DOI 10.1016/0006-2952(92)90148-C; BUTT E, 1994, IN PRESS EUR J PHARM; CALABRESI P, 1987, NEUROSCIENCE, V20, P757, DOI 10.1016/0306-4522(87)90239-9; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; CHENG HC, 1986, J BIOL CHEM, V261, P989; CHERUBINI E, 1987, NEUROSCIENCE, V21, P997, DOI 10.1016/0306-4522(87)90054-6; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V451, P229, DOI 10.1113/jphysiol.1992.sp019162; FLORAN B, 1990, NEUROSCI LETT, V116, P136, DOI 10.1016/0304-3940(90)90399-T; GEILEN CC, 1992, FEBS LETT, V309, P381, DOI 10.1016/0014-5793(92)80811-T; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GINTY DD, 1992, J CELL BIOL, V116, P1465, DOI 10.1083/jcb.116.6.1465; GLASS DB, 1990, PEPT PROT PHOSPH, P209; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; GROSS RA, 1990, J PHYSIOL-LONDON, V429, P483, DOI 10.1113/jphysiol.1990.sp018268; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; HELL JW, 1994, J BIOL CHEM, V269, P7390; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HELL JW, 1993, J BIOL CHEM, V268, P19451; HEMMINGS HC, 1990, J BIOL CHEM, V265, P20369; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; HESCHELER J, 1987, EUR J BIOCHEM, V165, P261, DOI 10.1111/j.1432-1033.1987.tb11436.x; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOEHN K, 1993, J NEUROSCI, V13, P1244; HU XT, 1990, J NEUROSCI, V10, P2318; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; KLOCKNER U, 1992, PFLUG ARCH EUR J PHY, V420, P413, DOI 10.1007/BF00374479; KOPIN IJ, 1993, NEUROPSYCHOPHARMACOL, V9, P1, DOI 10.1038/npp.1993.39; LAI Y, 1993, J NEUROCHEM, V61, P1333, DOI 10.1111/j.1471-4159.1993.tb13626.x; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALECOT CO, 1988, PFLUG ARCH EUR J PHY, V411, P235, DOI 10.1007/BF00585109; MERINEY SD, 1994, NATURE, V369, P336, DOI 10.1038/369336a0; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MOGUL DJ, 1993, NEURON, V10, P327, DOI 10.1016/0896-6273(93)90322-I; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NEMEROFF CB, 1988, ANN NY ACAD SCI, V537, P273, DOI 10.1111/j.1749-6632.1988.tb42113.x; OHNO Y, 1987, LIFE SCI, V40, P1937, DOI 10.1016/0024-3205(87)90054-3; PINEDA JC, 1992, J NEUROPHYSIOL, V68, P287, DOI 10.1152/jn.1992.68.1.287; REUVENI I, 1993, J NEUROSCI, V13, P4609; ROBERTSON GS, 1990, BRAIN RES, V523, P288, DOI 10.1016/0006-8993(90)91498-6; ROBERTSON GS, 1992, NEUROSCIENCE, V49, P285, DOI 10.1016/0306-4522(92)90096-K; ROSENTHAL W, 1990, ADV SEC MESS PHOSPH, V24, P89; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, P3; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; SIM ATR, 1994, J NEUROCHEM, V62, P1552; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STEFANI A, 1992, NEUROSCI LETT, V144, P4, DOI 10.1016/0304-3940(92)90703-A; STOOF JC, 1984, LIFE SCI, V35, P2281, DOI 10.1016/0024-3205(84)90519-8; SURMEIER DJ, 1988, DEV BRAIN RES, V42, P265, DOI 10.1016/0165-3806(88)90245-3; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; Tukey JW, 1977, EXPLORATORY DATA ANA, Vxvi; UCHLMURA N, 1986, BRAIN RES, V375, P368; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WALTERS JR, 1987, SCIENCE, V236, P719; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745	80	465	475	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1995	14	2					385	397		10.1016/0896-6273(95)90294-5	http://dx.doi.org/10.1016/0896-6273(95)90294-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7531987	Bronze			2022-12-17	WOS:A1995QH29400016
J	Taniguchi, M; Yuasa, S; Fujisawa, H; Naruse, I; Saga, S; Mishina, M; Yagi, T				Taniguchi, M; Yuasa, S; Fujisawa, H; Naruse, I; Saga, S; Mishina, M; Yagi, T			Disruption of Semaphorin III/D gene causes severe abnormality in peripheral nerve projection	NEURON			English	Article							GROWTH CONE GUIDANCE; POSTERIOR TECTAL MEMBRANES; COLLAPSIN-1 MESSENGER-RNA; SPINAL-CORD; LUNG-CANCER; AXONAL GUIDANCE; EXPRESSION; SYSTEM; FAMILY; CHEMOREPELLENT	The molecules of the collapsin/semaphorin gene family have been thought to play an essential role in axon guidance during development. Semaphorin III/D is a member of this family, has been shown to repel dorsal root ganglion (DRG) axons in vitro, and has been implicated in the patterning of sensory afferents in the spinal cord. Although semaphorin III/D mRNA is expressed in a wide variety of neural and nonneural tissues in vivo, the role played by semaphorin III/D in regions other than the spinal cord is not known. Here, we show that mice homozygous for a targeted mutation in semaphorin III/D show severe abnormality in peripheral nerve projection. This abnormality is seen in the trigeminal, facial, vagus, accessory, and glossopharyngeal nerves but not in the oculomotor nerve. These results suggest that semaphorin III/D functions as a selective repellent in vivo.	INST DEV RES, AICHI HUMAN SERV CTR, DEPT MORPHOL, KASUGAI, AICHI 48003, JAPAN; CHIBA UNIV, SCH MED, DEPT ANAT, CHUO KU, CHIBA 260, JAPAN; NAGOYA UNIV, GRAD SCH SCI,DIV BIOL SCI,GRP DEV NEUROBIOL, CHIKUSA KU, NAGOYA, AICHI 46401, JAPAN; KYOTO UNIV, SCH MED, CONGENITAL ANOMALY RES CTR, SAKYO KU, KYOTO 60601, JAPAN; UNIV TOKYO, SCH MED, DEPT MOL NEUROBIOL & PHARMACOL, BUNKYO KU, TOKYO 113, JAPAN	Chiba University; Nagoya University; Kyoto University; University of Tokyo	Taniguchi, M (corresponding author), NATL INST PHYSIOL SCI, LAB NEUROBIOL & BEHAV GENET, OKAZAKI, AICHI 444, JAPAN.		Taniguchi, Masaru/N-7932-2015	Taniguchi, Masaru/0000-0001-7821-7179				Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Ozaki S, 1997, J COMP NEUROL, V380, P215; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Roche J, 1996, ONCOGENE, V12, P1289; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; WALTER J, 1987, DEVELOPMENT, V101, P909; WATANABE S, 1995, BIOCHEM BIOPH RES CO, V213, P130, DOI 10.1006/bbrc.1995.2107; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Xiang RH, 1996, GENOMICS, V32, P39, DOI 10.1006/geno.1996.0074; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	43	464	470	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1997	19	3					519	530		10.1016/S0896-6273(00)80368-2	http://dx.doi.org/10.1016/S0896-6273(00)80368-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331345	Bronze			2022-12-17	WOS:A1997XZ01600008
J	Power, JD; Fair, DA; Schlaggar, BL; Petersen, SE				Power, Jonathan D.; Fair, Damien A.; Schlaggar, Bradley L.; Petersen, Steven E.			The Development of Human Functional Brain Networks	NEURON			English	Review							RESTING-STATE NETWORKS; DEFAULT MODE NETWORK; SMALL-WORLD; MODULAR ORGANIZATION; CEREBRAL-CORTEX; NEURAL-NETWORKS; NATURAL SLEEP; SCALE-FREE; CONNECTIVITY; FMRI	Recent advances in MRI technology have enabled precise measurements of correlated activity throughout the brain, leading to the first comprehensive descriptions of functional brain networks in humans. This article reviews the growing literature on the development of functional networks, from infancy through adolescence, as measured by resting-state functional connectivity MRI. We note several limitations of traditional approaches to describing brain networks and describe a powerful framework for analyzing networks, called graph theory. We argue that characterization of the development of brain systems (e.g., the default mode network) should be comprehensive, considering not only relationships within a given system, but also how these relationships are situated within wider network contexts. We note that, despite substantial reorganization of functional connectivity, several large-scale network properties appear to be preserved across development, suggesting that functional brain networks, even in children, are organized in manners similar to other complex systems.	[Power, Jonathan D.; Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Psychol, St Louis, MO 63110 USA	Washington University (WUSTL); Oregon Health & Science University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Power, JD (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	powerj@wusm.wustl.edu	Petersen, Steve/ABF-1368-2020; Bullmore, Ed/C-1706-2012; Schlaggar, Bradley/AAZ-4153-2020	Bullmore, Ed/0000-0002-8955-8283; Power, Jonathan/0000-0002-6922-100X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046424, R21NS041255, K02NS053425, R01NS032979] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Church JA, 2010, HUM BRAIN MAPP, V31, P852, DOI 10.1002/hbm.21036; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRANSSON P, 2010, CEREB CORTE IN PRESS, DOI DOI 10.1093/CERCOR/BHQO71; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2009, PEDIATR RES, V66, P301, DOI 10.1203/PDR.0b013e3181b1bd84; Friston KJ, 2005, ANNU REV PSYCHOL, V56, P57, DOI 10.1146/annurev.psych.56.091103.070311; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Huttenlocher P., 2002, NEURAL PLASTICITY EF; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kiviniemi V, 2000, MAGN RESON MED, V44, P373, DOI 10.1002/1522-2594(200009)44:3<373::AID-MRM5>3.0.CO;2-P; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lin W, 2008, AM J NEURORADIOL, V29, P1883, DOI 10.3174/ajnr.A1256; Liu WC, 2008, BRAIN RES, V1223, P42, DOI 10.1016/j.brainres.2008.05.054; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Majewska AK, 2006, TRENDS NEUROSCI, V29, P323, DOI 10.1016/j.tins.2006.04.002; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ., 2010, NETWORKS INTRO OXFOR; NIH, 2009, RFAMH10020 NIH; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Redcay E, 2007, NEUROIMAGE, V38, P696, DOI 10.1016/j.neuroimage.2007.08.005; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	96	463	466	3	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					735	748		10.1016/j.neuron.2010.08.017	http://dx.doi.org/10.1016/j.neuron.2010.08.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826306	Bronze, Green Accepted			2022-12-17	WOS:000281938900009
J	Vyazovskiy, VV; Olcese, U; Lazimy, YM; Faraguna, U; Esser, SK; Williams, JC; Cirelli, C; Tononi, G				Vyazovskiy, Vladyslav V.; Olcese, Umberto; Lazimy, Yaniv M.; Faraguna, Ugo; Esser, Steve K.; Williams, Justin C.; Cirelli, Chiara; Tononi, Giulio			Cortical Firing and Sleep Homeostasis	NEURON			English	Article							SLOW-WAVE SLEEP; DEPENDENT SYNAPTIC PLASTICITY; LESS-THAN-1 HZ OSCILLATION; DEVELOPING VISUAL-CORTEX; ACTIVITY IN-VIVO; NEOCORTICAL NEURONS; ASSOCIATION CORTEX; CEREBRAL-CORTEX; EEG; RAT	The need to sleep grows with the duration of wakefulness and dissipates with time spent asleep, a process called sleep homeostasis. What are the consequences of staying awake on brain cells, and why is sleep needed? Surprisingly, we do not know whether the firing of cortical neurons is affected by how long an animal has been awake or asleep. Here, we found that after sustained wakefulness cortical neurons fire at higher frequencies in all behavioral states. During early NREM sleep after sustained wakefulness, periods of population activity (ON) are short, frequent, and associated with synchronous firing, while periods of neuronal silence are long and frequent. After sustained sleep, firing rates and synchrony decrease, while the duration of ON periods increases. Changes in firing patterns in NREM sleep correlate with changes in slow-wave activity, a marker of sleep homeostasis. Thus, the systematic increase of firing during wakefulness is counterbalanced by staying asleep.	[Vyazovskiy, Vladyslav V.; Olcese, Umberto; Lazimy, Yaniv M.; Faraguna, Ugo; Esser, Steve K.; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Williams, Justin C.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53719 USA; [Olcese, Umberto] Scuola Super Sant Anna, PERCRO Lab, I-56217 Pisa, Italy	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Scuola Superiore Sant'Anna	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	gtononi@wisc.edu	Faraguna, Ugo/J-6805-2012	Faraguna, Ugo/0000-0002-4814-7218; Vyazovskiy, Vladyslav/0000-0002-4336-6681; Olcese, Umberto/0000-0001-6968-2503	NIMH [P20 MH077967]; NIH; AFOSR [FA9550-08-1-0244]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH077967] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIMH P20 MH077967 (C.C.), NIH Director's Pioneer award (G.T.), and AFOSR FA9550-08-1-0244 (G.T.). We thank Tom Richner and Dr. Silvestro Micera for help with data analysis, Aaron Nelson for help with the experiments, Dr. Yuval Nir for helpful comments on the manuscript, and Dr. Lisa Krugner-Higby for advice about surgical procedures.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Badawy RAB, 2006, NEUROLOGY, V67, P1018, DOI 10.1212/01.wnl.0000237392.64230.f7; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bellina V, 2008, J SLEEP RES, V17, P39; BURNS BD, 1979, PROC R SOC SER B-BIO, V206, P281, DOI 10.1098/rspb.1979.0105; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Cajochen C, 1999, Sleep Res Online, V2, P65; CALVET J, 1973, BRAIN RES, V52, P173, DOI 10.1016/0006-8993(73)90657-4; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Civardi C, 2001, J NEUROL NEUROSUR PS, V71, P809, DOI 10.1136/jnnp.71.6.809; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Czarnecki A, 2007, J PHYSIOL-LONDON, V578, P471, DOI 10.1113/jphysiol.2006.123588; Dadvand L, 2006, NEUROSCIENCE, V143, P815, DOI 10.1016/j.neuroscience.2006.08.029; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DESIRAJU T, 1972, BRAIN RES, V47, P69, DOI 10.1016/0006-8993(72)90252-1; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; DIJK D J, 1987, Journal of Biological Rhythms, V2, P207, DOI 10.1177/074873048700200304; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HOBSON JA, 1971, ELECTROEN CLIN NEURO, V30, P97, DOI 10.1016/0013-4694(71)90271-9; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; MURATA K, 1963, Arch Ital Biol, V101, P306; NODA H, 1970, J NEUROPHYSIOL, V33, P672, DOI 10.1152/jn.1970.33.5.672; NODA H, 1973, BRAIN RES, V54, P243, DOI 10.1016/0006-8993(73)90047-4; Oleksenko A.I., 1992, Journal of Sleep Research, V1, P40; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; ROWAN AJ, 1982, ELECTROEN CLIN NEURO, V54, P357, DOI 10.1016/0013-4694(82)90199-7; Scalise A, 2006, SLEEP, V29, P1595, DOI 10.1093/sleep/29.12.1595; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; VERZEANO M, 1960, J Gen Physiol, V43(6)Suppl, P177, DOI 10.1085/jgp.43.6.177; Vyazovskiy VV, 2008, BRAIN RES BULL, V75, P591, DOI 10.1016/j.brainresbull.2007.10.040; Vyazovskiy VV, 2008, J NEUROPHYSIOL, V99, P969, DOI 10.1152/jn.01154.2007; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; Vyazovskiy VV, 2006, CEREB CORTEX, V16, P328, DOI 10.1093/cercorbhi110; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; Werth E, 1996, NEUROREPORT, V8, P123, DOI 10.1097/00001756-199612200-00025; Williams JC, 1999, NEUROCOMPUTING, V26-7, P1069, DOI 10.1016/S0925-2312(99)00106-X	83	463	469	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					865	878		10.1016/j.neuron.2009.08.024	http://dx.doi.org/10.1016/j.neuron.2009.08.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778514	Green Accepted, hybrid			2022-12-17	WOS:000270569700018
J	Zylka, MJ; Rice, FL; Anderson, DJ				Zylka, MJ; Rice, FL; Anderson, DJ			Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd	NEURON			English	Article							GRIFFONIA-SIMPLICIFOLIA I; SUPERFICIAL DORSAL-HORN; PRIMARY SENSORY NEURONS; LECTIN-BINDING ANALYSIS; RAT SPINAL-CORD; MYSTACIAL PAD; COMPREHENSIVE IMMUNOFLUORESCENCE; IMMUNOCYTOCHEMICAL LOCALIZATION; DIFFERENTIAL DEPENDENCY; GENETIC APPROACH	The brain receives sensory input from diverse peripheral tissues, including the skin, the body's largest sensory organ. Using genetically encoded axonal tracers expressed from the Mrgprd locus, we identify a subpopulation of nonpeptidergic, nociceptive neurons that project exclusively to the skin, and to no other peripheral tissue examined. Surprisingly, Mrgprd(+) innervation is restricted to the epidermis and absent from specialized sensory structures. Furthermore, Mrgprd(+) fibers terminate in a specific layer of the epidermis, the stratum granulosum. This termination zone is distinct from that innervated by most CGRP(+) neurons, revealing that peptidergic and nonpeptidergic epidermal innervation is spatially segregated. The central projections deriving from these distinct epidermal innervation zones terminate in adjacent laminae in the dorsal spinal cord. Thus, afferent input from different layers of the epidermis is conveyed by topographically segregated sensory circuits, suggesting that at least some aspects of sensory information processing may be organized along labeled lines.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Albany Medical College; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol, 216-76, Pasadena, CA 91125 USA.	wuwei@caltech.edu			NINDS NIH HHS [NS34692] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034692] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bender E, 2002, P NATL ACAD SCI USA, V99, P8573, DOI 10.1073/pnas.122016499; Bennett DL, 1996, NEUROSCI LETT, V206, P33, DOI 10.1016/0304-3940(96)12418-6; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Fundin BT, 1997, J COMP NEUROL, V385, P185, DOI 10.1002/(SICI)1096-9861(19970825)385:2<185::AID-CNE2>3.0.CO;2-Y; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Guo A, 2001, EUR J NEUROSCI, V14, P293, DOI 10.1046/j.0953-816x.2001.01665.x; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MCNEILL DL, 1988, EXP NEUROL, V99, P699, DOI 10.1016/0014-4886(88)90186-0; MOLLIVER DC, 1995, J COMP NEUROL, V361, P404, DOI 10.1002/cne.903610305; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; Pare M, 2001, J NEUROSCI, V21, P7236, DOI 10.1523/JNEUROSCI.21-18-07236.2001; Perl E. R., 1984, HDB PHYSL 2 1, VIII, P915; Petruska JC, 1997, SOMATOSENS MOT RES, V14, P17, DOI 10.1080/08990229771187; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Rice FL, 1997, J COMP NEUROL, V385, P149; RICE FL, 1993, J COMP NEUROL, V337, P386, DOI 10.1002/cne.903370304; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P259, DOI 10.3109/07367228809144630; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Ulrich-Lai YM, 2001, AM J PHYSIOL-REG I, V280, pR137, DOI 10.1152/ajpregu.2001.280.1.R137; Wang HF, 1998, BRAIN RES, V811, P34, DOI 10.1016/S0006-8993(98)00916-0; Wang HF, 1998, NEUROSCIENCE, V87, P275, DOI 10.1016/S0306-4522(98)00061-X; Woodbury CJ, 2000, J COMP NEUROL, V417, P88, DOI 10.1002/(SICI)1096-9861(20000131)417:1<88::AID-CNE7>3.0.CO;2-U; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	42	463	469	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					17	25		10.1016/j.neuron.2004.12.015	http://dx.doi.org/10.1016/j.neuron.2004.12.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629699	Bronze			2022-12-17	WOS:000226217100006
J	Stowers, RS; Megeath, LJ; Gorska-Andrzejak, J; Meinertzhagen, IA; Schwarz, TL				Stowers, RS; Megeath, LJ; Gorska-Andrzejak, J; Meinertzhagen, IA; Schwarz, TL			Axonal transport of mitochondria to synapses depends on Milton, a novel Drosophila protein	NEURON			English	Article							HUNTINGTIN-ASSOCIATED PROTEIN-1; MOTOR PROTEIN; KINESIN; MELANOGASTER; ORGANIZATION; EXPRESSION; MEMBRANE; RECEPTOR; NEURONS; ADULT	A protein required to localize mitochondria to Drosophila nerve terminals has been identified genetically. Photoreceptors mutant for milton show aberrant synaptic transmission despite normal phototransduction. Without Milton, synaptic terminals and axons lack mitochondria, although mitochondria are numerous in neuronal cell bodies. In contrast, synaptic vesicles continue to be transported to and concentrated at synapses. Milton protein is associated with mitochondria and is present primarily in axons and synapses. A likely explanation of the apparent trafficking defect is offered by the coimmunoprecipitation of Milton and kinesin heavy chain. Transfected into HEK293T cells, Milton induces a redistribution of mitochondria within the cell. We propose that Milton is a mitochondria-associated protein required for kinesin-mediated transport of mitochondria to nerve terminals.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Dalhousie Univ, Life Sci Ctr, Halifax, NS B3H 4J1, Canada; Stanford Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Harvard University; Boston Children's Hospital; University of California System; University of California Berkeley; Dalhousie University; Stanford University	Schwarz, TL (corresponding author), Childrens Hosp, Div Neurosci, Enders 208,300 Longwood Ave, Boston, MA 02115 USA.		Górska-Andrzejak, Jolanta/ABF-7770-2020	Meinertzhagen, Ian/0000-0002-6578-4526	NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041062] Funding Source: NIH RePORTER; NEI NIH HHS [EY03592] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS07473, NS41062, NS10561] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; ENGELFRIET J, 1997, HDB GRAPH GRAMMARS C, V1, P1, DOI [DOI 10.1142/9789812384720_, 10.1142/9789812384720_0001, DOI 10.1142/9789812384720_0001]; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Hermann GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hurd DD, 1996, GENETICS, V144, P1075; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; LANGFORD GM, 1995, CURR OPIN CELL BIOL, V7, P82, DOI 10.1016/0955-0674(95)80048-4; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen IA, 2000, EUR J NEUROSCI, V12, P1342, DOI 10.1046/j.1460-9568.2000.00033.x; Meinertzhagen Ian A., 1993, P1363; MORRIS RL, 1993, J CELL SCI, V104, P917; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; Peters A, 1991, FINE STRUCTURE NERVO; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Simon VR, 1997, CELL MOTIL CYTOSKEL, V37, P199, DOI 10.1002/(SICI)1097-0169(1997)37:3<199::AID-CM2>3.0.CO;2-2; Stowers RS, 1999, GENETICS, V152, P1631; STURMER K, 1995, J CELL SCI, V108, P2273; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; WERTH JL, 1994, J NEUROSCI, V14, P348; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; XU T, 1993, DEVELOPMENT, V117, P1223; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	47	463	473	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1063	1077		10.1016/S0896-6273(02)01094-2	http://dx.doi.org/10.1016/S0896-6273(02)01094-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495622	Bronze			2022-12-17	WOS:000180011600010
J	Ming, GL; Song, HJ; Berninger, B; Holt, CE; Tessier-Lavigne, M; Poo, MM				Ming, GL; Song, HJ; Berninger, B; Holt, CE; Tessier-Lavigne, M; Poo, MM			CAMP-dependent growth cone guidance by netrin-1	NEURON			English	Article							C-ELEGANS; COLORECTAL-CANCER; AXON GUIDANCE; CYCLIC-AMP; COMMISSURAL AXONS; NEURITE OUTGROWTH; ADENYLYL-CYCLASE; SPINAL NEURONS; PROTEIN-KINASE; NERVOUS-SYSTEM	Netrin-1 is known to function as a chemoattractant for several classes of developing axons and as a chemorepellent for other classes of axons, apparently dependent on the receptor type expressed by responsive cells. In culture, growth cones of embryonic Xenopus spinal neurons exhibited chemoattractive turning toward the source of netrin-1 but showed chemorepulsive responses in the presence of a competitive analog of cAMP or an inhibitor of protein kinase A. Both attractive and repulsive responses were abolished by depleting extracellular calcium and by adding a blocking antibody against the netrin-1 receptor Deleted in Colorectal Cancer. Thus, nerve growth cones may respond to the same guidance cue with opposite turning behavior, dependent on other coincident signals that set the level of cytosolic cAMP.	Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.		Ming, Guo-li/J-7880-2013; Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782; Ming, Guo-li/0000-0002-2517-6075; Holt, Christine Elizabeth/0000-0003-2829-121X				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; [Anonymous], 1996, BIOCH BASIS NEUROPHA; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; BIXBY JL, 1984, J PHYSIOL-LONDON, V353, P143, DOI 10.1113/jphysiol.1984.sp015328; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; EVERS J, 1989, J NEUROSCI, V9, P1523; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hempel CM, 1996, NATURE, V384, P166, DOI 10.1038/384166a0; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KATER SB, 1988, TRENDS NEUROSCI, V11, P317; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; LANKFORD KL, 1989, J CELL BIOL, V109, P1229, DOI 10.1083/jcb.109.3.1229; LAUDANNA G, 1997, J BIOL CHEM, V272, P24141; LAUFER R, 1987, EMBO J, V6, P901, DOI 10.1002/j.1460-2075.1987.tb04836.x; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; MARK MD, 1995, J CELL BIOL, V130, P701, DOI 10.1083/jcb.130.3.701; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; PIERCEALL WE, 1994, DEV BIOL, V166, P654, DOI 10.1006/dbio.1994.1345; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tabti N., 1991, CULTURING NERVE CELL, P137; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YAO H, 1995, J BIOL CHEM, V270, P20748, DOI 10.1074/jbc.270.35.20748; YOVELL Y, 1992, J NEUROCHEM, V59, P1736, DOI 10.1111/j.1471-4159.1992.tb11005.x; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	49	462	471	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1225	1235		10.1016/S0896-6273(00)80414-6	http://dx.doi.org/10.1016/S0896-6273(00)80414-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427246	Bronze			2022-12-17	WOS:000071236500010
J	HILLYARD, DR; MONJE, VD; MINTZ, IM; BEAN, BP; NADASDI, L; RAMACHANDRAN, J; MILJANICH, G; AZIMIZOONOOZ, A; MCINTOSH, JM; CRUZ, LJ; IMPERIAL, JS; OLIVERA, BM				HILLYARD, DR; MONJE, VD; MINTZ, IM; BEAN, BP; NADASDI, L; RAMACHANDRAN, J; MILJANICH, G; AZIMIZOONOOZ, A; MCINTOSH, JM; CRUZ, LJ; IMPERIAL, JS; OLIVERA, BM			A NEW CONUS PEPTIDE LIGAND FOR MAMMALIAN PRESYNAPTIC CA2+ CHANNELS	NEURON			English	Article							CALCIUM-CHANNEL; OMEGA-CONOTOXIN; VENOM; NEUROTOXINS; ANTAGONISTS; NEURONS; TOXIN	Voltage-sensitive Ca2+ channels that control neurotransmitter release are blocked by omega-conotoxin (omega-CgTx) GVIA from the marine snail Conus geographus, the most widely used inhibitor of neurotransmitter release. However, many mammalian synapses are omega-CgTx-GVIA insensitive. We describe a new Conus peptide, omega-CgTx-MVIIC, that is an effective inhibitor of omega-CgTx-GVIA-resistant synaptic transmission. Ca2+ channel targets that are inhibited by omega-CgTx-MVIIC but not by omega-CgTx-GVIA include those mediating depolarization-induced Ca-45(2+) uptake in rat synaptosome preparations, "P" currents in cerebellar Purkinje cells, and a subset of omega-CgTx-GVIA-resistant currents in CA1 hippocampal pyramidal cells. The characterization of omega-CgTx-MVIIC by a combination of molecular genetics and chemical synthesis defines a general approach for obtaining ligands with novel receptor subtype specificity from Conus.	UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84132; UNIV UTAH,DEPT PSYCHIAT,SALT LAKE CITY,UT 84132; HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; UNIV PHILIPPINES,INST CHEM,QUEZON CITY 1107,PHILIPPINES; UNIV PHILIPPINES,INST MARINE SCI,QUEZON CITY 1107,PHILIPPINES; NEUREX CORP,MENLO PK,CA 94025	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman	HILLYARD, DR (corresponding author), UNIV UTAH,DEPT BIOL,SALT LAKE CITY,UT 84132, USA.				NIGMS NIH HHS [GM22737] Funding Source: Medline; NIMH NIH HHS [K20 MH00929] Funding Source: Medline; NINDS NIH HHS [P01-NS02253] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K20MH000929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS002253] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P617, DOI 10.1113/jphysiol.1975.sp010950; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; CRUZ LJ, 1986, J BIOL CHEM, V261, P6230; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Katz B., 1969, RELEASE NEURAL TRANS; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LUNDY PM, 1991, EUR J PHARM-MOLEC PH, V206, P61, DOI 10.1016/0922-4106(91)90147-A; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; OLIVERA BM, 1984, BIOCHEMISTRY-US, V23, P5087, DOI 10.1021/bi00317a001; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGAN LJ, 1991, J NEUROSCI, V11, P2259; RIVIER J, 1987, J BIOL CHEM, V262, P1194; Sambrook J., 1989, MOL CLONING LAB MANU; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; YOSHIKAMI D, 1989, ANN NY ACAD SCI, V560, P230, DOI 10.1111/j.1749-6632.1989.tb24100.x	24	462	474	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					69	77		10.1016/0896-6273(92)90221-X	http://dx.doi.org/10.1016/0896-6273(92)90221-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1352986				2022-12-17	WOS:A1992JE75600007
J	Gordon, EM; Laumann, TO; Gilmore, AW; Newbold, DJ; Greene, DJ; Berg, JJ; Ortega, M; Hoyt-Drazen, C; Gratton, C; Sun, HX; Hampton, JM; Coalson, RS; Nguyen, AL; McDermott, KB; Shimony, JS; Snyder, AZ; Schlaggar, BL; Petersen, SE; Nelson, SM; Dosenbach, NUF				Gordon, Evan M.; Laumann, Timothy O.; Gilmore, Adrian W.; Newbold, Dillan J.; Greene, Deanna J.; Berg, Jeffrey J.; Ortega, Mario; Hoyt-Drazen, Catherine; Gratton, Caterina; Sun, Haoxin; Hampton, Jacqueline M.; Coalson, Rebecca S.; Nguyen, Annie L.; McDermott, Kathleen B.; Shimony, Joshua S.; Snyder, Abraham Z.; Schlaggar, Bradley L.; Petersen, Steven E.; Nelson, Steven M.; Dosenbach, Nico U. F.			Precision Functional Mapping of Individual Human Brains	NEURON			English	Article							SURFACE-BASED ANALYSIS; AREAL ORGANIZATION; MOTION ARTIFACT; DEFAULT MODE; NETWORKS; CONNECTIVITY; FMRI; REVEALS; MRI; ARCHITECTURE	Human functional MRI (fMRI) research primarily focuses on analyzing data averaged across groups, which limits the detail, specificity, and clinical utility of fMRI resting-state functional connectivity (RSFC) and task-activation maps. To push our understanding of functional brain organization to the level of individual humans, we assembled a novel MRI dataset containing 5 hr of RSFC data, 6 hr of task fMRI, multiple structural MRIs, and neuropsychological tests from each of ten adults. Using these data, we generated ten high-fidelity, individual-specific functional connectomes. This individual-connectome approach revealed several new types of spatial and organizational variability in brain networks, including unique network features and topologies that corresponded with structural and task-derived brain features. We are releasing this highly sampled, individual-focused dataset as a resource for neuroscientists, and we propose precision individual connectomics as a model for future work examining the organization of healthy and diseased individual human brains.	[Gordon, Evan M.; Nelson, Steven M.] VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX 76711 USA; [Gordon, Evan M.; Nelson, Steven M.] Univ Texas Dallas, Ctr Vital Longev, Sch Behav & Brain Sci, Dallas, TX 75235 USA; [Laumann, Timothy O.; Newbold, Dillan J.; Ortega, Mario; Hoyt-Drazen, Catherine; Gratton, Caterina; Sun, Haoxin; Hampton, Jacqueline M.; Coalson, Rebecca S.; Nguyen, Annie L.; Snyder, Abraham Z.; Schlaggar, Bradley L.; Petersen, Steven E.; Dosenbach, Nico U. F.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Gilmore, Adrian W.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; [Greene, Deanna J.; Sun, Haoxin; Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Greene, Deanna J.; Coalson, Rebecca S.; McDermott, Kathleen B.; Shimony, Joshua S.; Snyder, Abraham Z.; Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Berg, Jeffrey J.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Hoyt-Drazen, Catherine; Dosenbach, Nico U. F.] Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO 63110 USA; [Gilmore, Adrian W.; McDermott, Kathleen B.; Petersen, Steven E.] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63130 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Schlaggar, Bradley L.; Dosenbach, Nico U. F.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Petersen, Steven E.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Nelson, Steven M.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76789 USA	University of Texas System; University of Texas Dallas; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Washington University (WUSTL); Washington University (WUSTL); New York University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Baylor University	Gordon, EM; Nelson, SM (corresponding author), VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX 76711 USA.; Gordon, EM; Nelson, SM (corresponding author), Univ Texas Dallas, Ctr Vital Longev, Sch Behav & Brain Sci, Dallas, TX 75235 USA.; Laumann, TO; Dosenbach, NUF (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Dosenbach, NUF (corresponding author), Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO 63110 USA.; Dosenbach, NUF (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.; Nelson, SM (corresponding author), Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76789 USA.	evan.gordon@va.gov; laumannt@wustl.edu; steven.nelson1@va.gov; ndosenbach@wustl.edu	Schlaggar, Bradley/AAZ-4153-2020; Greene, Deanna/AAB-5956-2019; Hoyt, Catherine/AAV-6193-2021; Hoyt, Catherine R./O-6263-2016; Gordon, Evan/J-5672-2019; Petersen, Steve/ABF-1368-2020	Greene, Deanna/0000-0002-0739-7771; Hoyt, Catherine/0000-0002-3398-9439; Hoyt, Catherine R./0000-0002-3398-9439; Gordon, Evan/0000-0002-2276-5237; Laumann, Timothy/0000-0002-0428-427X; Gilmore, Adrian/0000-0001-8910-5009; Hampton, Jacqueline/0000-0003-0175-5360	National Institutes of Health [NS088590, TR000448, MH100872, MH104592, 1P30NS098577, HD087011]; Jacobs Foundation grant [2016121703]; Child Neurology Foundation; McDonnell Center for Systems Neuroscience; Mallinckrodt Institute of Radiology grant [14-011]; Hope Center for Neurological Disorders; American Psychological Association dissertation research award; Dart Neuroscience LLC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH104592, F30MH100872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS098577, K23NS088590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jacobs Foundation grant; Child Neurology Foundation; McDonnell Center for Systems Neuroscience; Mallinckrodt Institute of Radiology grant; Hope Center for Neurological Disorders; American Psychological Association dissertation research award; Dart Neuroscience LLC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants NS088590, TR000448 (N.U.F.D.), MH100872 (T.O.L.), MH104592 (D.J.G.), 1P30NS098577 (to the Neuroimaging Informatics and Analysis Center), and HD087011 (to the Intellectual and Developmental Disabilities Research Center at Washington University); the Jacobs Foundation grant 2016121703 (N.U.F.D.); the Child Neurology Foundation (N.U.F.D); the McDonnell Center for Systems Neuroscience (N.U.F.D., B.L.S.); the Mallinckrodt Institute of Radiology grant 14-011 (N.U.F.D.); the Hope Center for Neurological Disorders (N.U.F.D., B.L.S., S.E.P.); an American Psychological Association dissertation research award (A.W.G.); and Dart Neuroscience LLC. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U.S. government.	Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beucher S., 1979, USE WATERSHEDS CONTO; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144963; Chen XY, 2017, J NEUROSCI, V37, P2764, DOI 10.1523/JNEUROSCI.1534-16.2017; Ciric R, 2017, NEUROIMAGE, V154, P174, DOI 10.1016/j.neuroimage.2017.03.020; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dresler M, 2017, NEURON, V93, P1227, DOI 10.1016/j.neuron.2017.02.003; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Dubis JW, 2016, CEREB CORTEX, V26, P192, DOI 10.1093/cercor/bhu187; Dubois J, 2016, TRENDS COGN SCI, V20, P425, DOI 10.1016/j.tics.2016.03.014; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gordon EM, 2017, NEUROIMAGE, V146, P918, DOI 10.1016/j.neuroimage.2016.08.032; Gordon EM, 2017, CEREB CORTEX, V27, P386, DOI 10.1093/cercor/bhv239; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Gorgolewski KJ, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00008; Greene DJ, 2016, DEVELOPMENTAL SCI, V19, P581, DOI 10.1111/desc.12407; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Guntupalli JS, 2016, CEREB CORTEX, V26, P2919, DOI 10.1093/cercor/bhw068; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Harrison SJ, 2015, NEUROIMAGE, V109, P217, DOI 10.1016/j.neuroimage.2015.01.013; Huth AG, 2016, NATURE, V532, P453, DOI 10.1038/nature17637; Kanwisher N, 2017, J NEUROSCI, V37, P1056, DOI 10.1523/JNEUROSCI.1706-16.2016; Kaufman A.S., 2013, ENCY SPECIAL ED; Langs G, 2016, CEREB CORTEX, V26, P4004, DOI 10.1093/cercor/bhv189; Laumann TO, 2017, CEREB CORTEX, V27, P4719, DOI 10.1093/cercor/bhw265; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Marcus Daniel S, 2011, Front Neuroinform, V5, P4, DOI 10.3389/fninf.2011.00004; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; McCrae, 1992, REVISED NEO PERSONAL; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Miranda-Dominguez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111048; Mitchell TJ, 2013, NEUROSURGERY, V73, P969, DOI 10.1227/NEU.0000000000000141; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Pannunzi M, 2017, NEUROIMAGE, V157, P250, DOI 10.1016/j.neuroimage.2017.06.006; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Poldrack RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9885; Poldrack RA, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00012; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Righi G, 2012, VIS COGN, V20, P143, DOI 10.1080/13506285.2012.654624; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rugg MD, 2013, CURR OPIN NEUROBIOL, V23, P255, DOI 10.1016/j.conb.2012.11.005; Satterthwaite TD, 2015, NEURON, V87, P471, DOI 10.1016/j.neuron.2015.07.009; Schaefer A., 2017, BIORXIV; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Shannon BJ, 2013, J NEUROPHYSIOL, V109, P1444, DOI 10.1152/jn.00651.2012; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Sunaert S, 2006, J MAGN RESON IMAGING, V23, P887, DOI 10.1002/jmri.20582; Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020; Talairach J., 1988, COPLANAR STEREOTAXIC; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Welvaert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077089; Wig GS, 2014, NEUROIMAGE, V93, P276, DOI 10.1016/j.neuroimage.2013.07.035; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Xu T, 2016, CEREB CORTEX, V26, P4192, DOI 10.1093/cercor/bhw241; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2015, CEREB CORTEX, V25, P3654, DOI 10.1093/cercor/bhu217; Yeo BTT, 2015, NEUROIMAGE, V111, P147, DOI 10.1016/j.neuroimage.2015.02.018; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	103	461	463	7	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2017	95	4					791	+		10.1016/j.neuron.2017.07.011	http://dx.doi.org/10.1016/j.neuron.2017.07.011			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FD9RI	28757305	Bronze, Green Accepted			2022-12-17	WOS:000407859400011
J	Granseth, B; Odermatt, B; Royle, SJ; Lagnado, L				Granseth, Bjorn; Odermatt, Benjamin; Royle, Stephen J.; Lagnado, Leon			Clathrin-mediated endocytosis is the dominant mechanism of vesicle retrieval at hippocampal synapses	NEURON			English	Article							RETINAL BIPOLAR CELLS; KISS-AND-RUN; SINGLE SYNAPTIC VESICLES; READILY RELEASABLE POOL; CENTRAL-NERVOUS-SYSTEM; NEUROTRANSMITTER RELEASE; QUANTAL ANALYSIS; EXOCYTOSIS; MEMBRANE; KINETICS	The maintenance of synaptic transmission requires that vesicles be recycled after releasing neurotransmitter. Several modes of retrieval have been proposed to operate at small synaptic terminals of central neurons, including a fast "kiss-and-run" mechanism that releases neurotransmitter through a fusion pore. Using an improved fluorescent reporter comprising pHluorin fused to synaptophysin, we find that only a slow mode of endocytosis (tau = 15 s) operates at hippocampal synapses when vesicle fusion is triggered by a single nerve impulse or short burst. This retrieval mechanism is blocked by overexpression of the C-terminal fragment of AP180 or by knockdown of clathrin using RNAi, and it is associated with the movement of clathrin and vesicle proteins out of the synapse. These results indicate that clathrin-mediated endocytosis is the major, if not exclusive, mechanism of vesicle retrieval after physiological stimuli.	MRC, Lab Mol Biol, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Lab Mol Biol, Hills Rd, Cambridge CB2 2QH, England.	ll1@mrc-lmb.cam.ac.uk	Granseth, Björn/AAG-2142-2020	Royle, Stephen/0000-0001-8927-6967; Granseth, Bjorn/0000-0001-7526-923X	Medical Research Council [MC_U105178794] Funding Source: Medline; MRC [MC_U105178794] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aravanis AM, 2003, NEUROPHARMACOLOGY, V45, P797, DOI 10.1016/S0028-3908(03)00310-1; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bekkers John M., 1994, Current Opinion in Neurobiology, V4, P360, DOI 10.1016/0959-4388(94)90097-3; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Franks KM, 2003, J NEUROSCI, V23, P3186; Frerking M, 2005, J NEUROPHYSIOL, V94, P1528, DOI 10.1152/jn.00108.2005; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Katz B., 1969, RELEASE NEURAL TRANS; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Llobet A, 2003, NEURON, V40, P1075, DOI 10.1016/S0896-6273(03)00765-7; Marte B, 2002, NAT CELL BIOL, V4, pE123, DOI 10.1038/ncb0502-e123; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Mundigl O, 1998, J NEUROSCI, V18, P93; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rizzoli SO, 2003, NATURE, V423, P591, DOI 10.1038/423591a; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tyler WJ, 2004, CURR BIOL, V14, pR294, DOI 10.1016/j.cub.2004.03.046; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; van Santen RA, 1995, CHEM KINETICS CATALY; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Yao PJ, 2003, NEUROSCIENCE, V121, P25, DOI 10.1016/S0306-4522(03)00431-7; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	61	461	471	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					773	786		10.1016/j.neuron.2006.08.029	http://dx.doi.org/10.1016/j.neuron.2006.08.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982422	Bronze			2022-12-17	WOS:000240997900015
J	Etkin, A; Klemenhagen, KC; Dudman, JT; Rogan, MT; Hen, R; Kandel, ER; Hirsch, J				Etkin, A; Klemenhagen, KC; Dudman, JT; Rogan, MT; Hen, R; Kandel, ER; Hirsch, J			Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces	NEURON			English	Article							EMOTIONAL FACIAL EXPRESSIONS; PREFRONTAL CORTEX; BENZODIAZEPINE RECEPTORS; SPATIAL ATTENTION; FUNCTIONAL MRI; VISUAL-CORTEX; AREA V4; ACTIVATION; FMRI; PERCEPTION	Responses to threat-related stimuli are influenced by conscious and unconscious processes, but the neural systems underlying these processes and their relationship to anxiety have not been clearly delineated. Using fMRI, we investigated the neural responses associated with the conscious and unconscious (backwardly masked) perception of fearful faces in healthy volunteers who varied in threat sensitivity (Spielberger trait anxiety scale). Unconscious processing modulated activity only in the basolateral subregion of the amygdala, while conscious processing modulated activity only in the dorsal amygdala (containing the central nucleus). Whereas activation of the dorsal amygdala by conscious stimuli was consistent across subjects and independent of trait anxiety, activity in the basolateral amygdala to unconscious stimuli, and subjects' reaction times, were predicted by individual differences in trait anxiety. These findings provide a biological basis for the unconscious emotional vigilance characteristic of anxiety and a means for investigating the mechanisms and efficacy of treatments for anxiety.	Columbia Univ, Med Ctr, fMRI Res Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Med Ctr, fMRI Res Ctr, Kavli Inst Brain Sci, New York, NY 10032 USA; Columbia Univ, Med Ctr, fMRI Res Ctr, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Med Ctr, fMRI Res Ctr, Dept Radiol, New York, NY 10032 USA; Columbia Univ, Med Ctr, fMRI Res Ctr, Dept Psychol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Etkin, A (corresponding author), Columbia Univ, Med Ctr, fMRI Res Ctr, Ctr Neurobiol & Behav, 170 W 168th St,Box 108, New York, NY 10032 USA.	ae157@columbia.edu; jh2155@columbia.edu	Etkin, Amit/ABD-5761-2021	Hirsch, Joy/0000-0002-1418-6489; Dudman, Joshua/0000-0002-4436-1057	NICHD NIH HHS [HD 07430] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; AMARAL D G, 1992, P1; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Brewin CR, 1996, ANNU REV PSYCHOL, V47, P33, DOI 10.1146/annurev.psych.47.1.33; CHEESMAN J, 1986, CAN J PSYCHOL, V40, P343, DOI 10.1037/h0080103; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Di Russo F, 1999, NEUROREPORT, V10, P2755; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Ekman P., 1976, PICTURES FACIAL AFFE; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; First M. B., 1996, USERS GUIDE STRUCTUR; Fisher PL, 1999, PSYCHOL MED, V29, P1425, DOI 10.1017/S0033291799001336; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 2003, NEUROIMAGE, V19, P1240, DOI 10.1016/S1053-8119(03)00144-7; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gabbard GO, 2003, INT J PSYCHOANAL, V84, P823, DOI 10.1516/N4T0-4D5G-NNPL-H7NL; Gabbard GO, 2000, BRIT J PSYCHIAT, V177, P117, DOI 10.1192/bjp.177.2.117; GABBARD GO, 2000, BASIC PRINCIPLES DYN; Green DM., 1966, SIGNAL DETECTION THE; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; JAPEE S, 2004, 10 ANN M ORG HUM BRA; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macovski A, 1996, MAGNET RESON MED, V36, P494, DOI 10.1002/mrm.1910360327; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Merboldt KD, 2001, NEUROIMAGE, V14, P253, DOI 10.1006/nimg.2001.0802; MERIKLE PM, 1992, AM PSYCHOL, V47, P792, DOI 10.1037/0003-066X.47.6.792; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MOTTER BC, 1994, J NEUROSCI, V14, P2178; NIEHOFF DL, 1983, BRAIN RES, V276, P237, DOI 10.1016/0006-8993(83)90730-8; NIEHOFF DL, 1983, J NEUROSCI, V3, P2091; Paxinos G., 1990, HUMAN NERVOUS SYSTEM; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2003, J NEUROSCI, V23, P3990; PESSOA L, 2005, IN PRESS CURR OPIN N; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips ML, 2004, NEUROIMAGE, V21, P1484, DOI 10.1016/j.neuroimage.2003.12.013; Pierce C.S., 1884, MEMOIRS NATL ACAD SC, V3, P73; Pitkanen A., 2000, CONNECTIVITY RAT AMY; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rousseeuw P.J., 2003, REGRESSION OUTLIER D; Shevrin H., 1996, CONSCIOUS UNCONSCIOU; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Snodgrass M, 2004, PERCEPT PSYCHOPHYS, V66, P846, DOI 10.3758/BF03194978; Spielberger CD, 1970, MANUAL STATE TRAIT A; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wong PS, 1999, J AM PSYCHOANAL ASS, V47, P817, DOI 10.1177/00030651990470031901; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	67	461	478	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					1043	1055		10.1016/j.neuron.2004.12.006	http://dx.doi.org/10.1016/j.neuron.2004.12.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603746	Bronze, Green Published			2022-12-17	WOS:000225842300017
J	Price, MP; McIlwrath, SL; Xie, JH; Cheng, C; Qiao, J; Tarr, DE; Sluka, KA; Brennan, TJ; Lewin, GR; Welsh, MJ				Price, MP; McIlwrath, SL; Xie, JH; Cheng, C; Qiao, J; Tarr, DE; Sluka, KA; Brennan, TJ; Lewin, GR; Welsh, MJ			The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice	NEURON			English	Article							EPITHELIAL NA+ CHANNEL; ROOT GANGLION NEURONS; SENSORY NEURONS; TISSUE ACIDOSIS; ION CHANNELS; HAIRY SKIN; MECHANOSENSORY NEURONS; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; FINE-STRUCTURE	Cation channels in the DEG/ENaC family are proposed to detect cutaneous stimuli in mammals. We localized one such channel, DRASIC, in several different specialized sensory nerve endings of skin, suggesting it might participate in mechanosensation and/or acid-evoked nociception. Disrupting the mouse DRASIC gene altered sensory transduction in specific and distinct ways. Loss of DRASIC increased the sensitivity of mechanoreceptors detecting light touch, but it reduced the sensitivity of a mechanoreceptor responding to noxious pinch and decreased the response of acid- and noxious heat-sensitive nociceptors. The data suggest that DRASIC subunits participate in heteromultimeric channel complexes in sensory neurons. Moreover, in different cellular contexts, DRASIC may respond to mechanical stimuli or to low pH to mediate normal touch and pain sensation.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Grad Program Phys Therapy, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Anesthesia, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Max Delbruck Ctr Mol Med, Dept Neurosci, Growth Factors & Regenerat Grp, D-13092 Berlin, Germany	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	glewin@mdc.berlin.de; mjwelsh@blue.weeg.ulowa.edu	Lewin, Gary R/B-8028-2011	Welsh, Michael/0000-0002-1646-6206; Tarr, Ellen/0000-0003-1604-4545; Sluka, Kathleen/0000-0003-0207-8728; Lewin, Gary/0000-0002-2890-6352; Brennan, Timothy/0000-0002-0150-5145	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039734] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25295] Funding Source: Medline; NINDS NIH HHS [NS39734] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Burgess PR, 1973, HDB SENSORY PHYSIOLO, VII, P29; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Cervero F, 1996, PAIN, V68, P13, DOI 10.1016/S0304-3959(96)03165-X; Cesare P, 1997, CURR OPIN NEUROBIOL, V7, P493, DOI 10.1016/S0959-4388(97)80028-1; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Darian-Smith I., 1984, HDB PHYSL 2 1, VIII, P739; Diamond J, 1988, Prog Brain Res, V74, P51; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Drummond HA, 2000, BRAIN RES, V884, P1, DOI 10.1016/S0006-8993(00)02831-6; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; Fricke B, 2000, CELL TISSUE RES, V299, P327; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; HALATA Z, 1993, J INVEST DERMATOL, V101, pS75, DOI 10.1111/1523-1747.ep12362877; Hamill OP, 1996, TRENDS NEUROSCI, V19, P258, DOI 10.1016/S0166-2236(96)30009-X; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; IDE C, 1976, AM J ANAT, V147, P329, DOI 10.1002/aja.1001470307; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.neuro.15.1.227; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; KOCHER L, 1987, PAIN, V29, P363, DOI 10.1016/0304-3959(87)90051-0; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; KRUGER L, 1981, J COMP NEUROL, V198, P137, DOI 10.1002/cne.901980112; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; LeMaster AM, 1999, J NEUROSCI, V19, P5919, DOI 10.1523/JNEUROSCI.19-14-05919.1999; Lewin G.R., 2000, MOL BASIS PAIN INDUC, P129; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Mansikka H, 1999, ANESTHESIOLOGY, V90, P1643, DOI 10.1097/00000542-199906000-00021; Martin J. H., 1991, PRINCIPLES NEURAL SC, V3, P341; MCCARTHY PW, 1989, NEUROSCIENCE, V28, P745, DOI 10.1016/0306-4522(89)90019-5; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; MUNGER BL, 1988, ARCH HISTOL CYTOL, V51, P1, DOI 10.1679/aohc.51.1; Perl ER, 1992, SENSORY NEURONS DIVE, P3; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Sinclair D., 1981, MECH CUTANEOUS SENSA; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; STEEN KH, 1993, NEUROSCI LETT, V154, P113, DOI 10.1016/0304-3940(93)90184-M; STEEN KH, 1992, J NEUROSCI, V12, P86; Stucky CL, 1999, J NEUROSCI, V19, P6497; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; SZOLCSANYI J, 1988, BRAIN RES, V446, P262, DOI 10.1016/0006-8993(88)90885-2; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	73	461	485	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1071	1083		10.1016/S0896-6273(01)00547-5	http://dx.doi.org/10.1016/S0896-6273(01)00547-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754838	Bronze			2022-12-17	WOS:000172886800013
J	HUERTA, PT; LISMAN, JE				HUERTA, PT; LISMAN, JE			BIDIRECTIONAL SYNAPTIC PLASTICITY INDUCED BY A SINGLE BURST DURING CHOLINERGIC THETA-OSCILLATION IN CA1 IN-VITRO	NEURON			English	Article							LONG-TERM POTENTIATION; COMPLEX-SPIKE CELLS; RAT HIPPOCAMPAL SLICE; METHYL-D-ASPARTATE; DENTATE GYRUS; GUINEA-PIG; FREQUENCY STIMULATION; LASTING POTENTIATION; RECEPTOR SUBTYPES; FIRING PATTERNS	In standard protocols, the frequency of synaptic stimulation determines whether CA1 hippocampal synapses undergo long-term potentiation or depression. Here we show that during cholinergically induced theta oscillation (theta) synaptic plasticity is greatly sensitized and can be induced by a single burst (4 pulses, 100 Hz). A burst given at the peak of theta induces homosynaptic LTP; the same burst at a trough induces homosynaptic LTD of previously potentiated synapses. Heterosynaptic LTD is produced at inactive synapses when others undergo LTP. The synaptic modifications during theta require NMDA receptors and muscarinic receptors. The enhancement is cooperative and occludes with standard LTP. These results suggest that the similar bursts observed during theta rhythm in vivo may be a natural stimulus for inducing LTP/LTD.			HUERTA, PT (corresponding author), BRANDEIS UNIV, CTR COMPLEX SYST, DEPT BIOL, WALTHAM, MA 02254 USA.			Huerta, Patricio/0000-0003-0270-2308	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027337] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 27337] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; AGMON A, 1992, J NEUROSCI, V12, P319; Alger B.E., 1984, BRAIN SLICES, P381; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; AUERBACH JM, 1994, J NEUROPHYSIOL, V72, P2034, DOI 10.1152/jn.1994.72.4.2034; BARR DS, 1995, J NEUROSCI, V15, P5402; BARRIONUEVO G, 1980, LIFE SCI, V27, P2385, DOI 10.1016/0024-3205(80)90509-3; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BIGL V, 1990, BRAIN CHOLINERGIC SY, P364; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BLAND BH, 1993, PROG NEUROBIOL, V41, P157, DOI 10.1016/0301-0082(93)90007-F; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURGARD EC, 1990, NEUROSCI LETT, V116, P34, DOI 10.1016/0304-3940(90)90382-J; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CHRISTIE BR, 1994, HIPPOCAMPUS, V4, P127, DOI 10.1002/hipo.450040203; CHRISTIE BR, 1992, SYNAPSE, V10, P1, DOI 10.1002/syn.890100102; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DIAMOND DM, 1988, J NEUROSCI, V8, P4079; DODD J, 1981, BRAIN RES, V207, P109, DOI 10.1016/0006-8993(81)90682-X; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUTAR P, 1988, J NEUROSCI, V8, P4214; FOX SE, 1981, EXP BRAIN RES, V41, P399; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HANSE E, 1992, J NEUROSCI, V12, P3226, DOI 10.1523/JNEUROSCI.12-08-03226.1992; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; HEBB DO, 1949, ORG BEHAVIOR; Hertz J., 1991, INTRO THEORY NEURAL, DOI DOI 10.1201/9780429499661; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Horvath Z, 1988, SYNAPTIC PLASTICITY, P45; HOUNSGAARD J, 1978, EXP NEUROL, V62, P787, DOI 10.1016/0014-4886(78)90284-4; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; ITO T, 1988, BRAIN RES, V368, P347; KONOPACKI J, 1987, BRAIN RES, V405, P196, DOI 10.1016/0006-8993(87)91009-2; KRNJEVIC K, 1981, NEUROSCIENCE, V6, P2465, DOI 10.1016/0306-4522(81)90092-0; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; LEE KS, 1983, J NEUROSCI, V3, P1369; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; LEUNG LWS, 1986, BRAIN RES, V367, P323, DOI 10.1016/0006-8993(86)91611-2; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LIN JH, 1993, BRAIN RES, V603, P117, DOI 10.1016/0006-8993(93)91306-D; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; MACVICAR BA, 1989, J PHYSIOL-LONDON, V417, P197, DOI 10.1113/jphysiol.1989.sp017797; MADISON DV, 1987, J NEUROSCI, V7, P733; MAEDA T, 1993, BRAIN RES, V619, P324, DOI 10.1016/0006-8993(93)91628-6; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MARKRAM H, 1990, NEUROSCI LETT, V113, P62, DOI 10.1016/0304-3940(90)90495-U; MARKRAM H, 1992, J PHYSIOL-LONDON, V447, P513, DOI 10.1113/jphysiol.1992.sp019015; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER RU, 1987, J NEUROSCI, V7, P1935; MULLER W, 1991, NEURON, V6, P901, DOI 10.1016/0896-6273(91)90230-W; MULLER W, 1992, J NEUROPHYSIOL, V68, P2264, DOI 10.1152/jn.1992.68.6.2264; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NUNEZ A, 1987, BRAIN RES, V416, P289, DOI 10.1016/0006-8993(87)90909-7; O'Dell T J, 1994, Learn Mem, V1, P129; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; ROSE GM, 1986, NEUROSCI LETT, V69, P244, DOI 10.1016/0304-3940(86)90487-8; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SEGAL M, 1989, SYNAPSE, V4, P305, DOI 10.1002/syn.890040406; SEGAL M, 1982, BRAIN RES, V246, P77, DOI 10.1016/0006-8993(82)90144-5; SINGER W, 1990, BRAIN CHOLINERGIC SY, P314; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; STEWART M, 1992, BRAIN RES, V591, P122, DOI 10.1016/0006-8993(92)90986-J; TEYLER TJ, 1994, HIPPOCAMPUS, V4, P623, DOI 10.1002/hipo.450040602; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; TRAUB RD, 1992, J PHYSIOL-LONDON, V451, P653, DOI 10.1113/jphysiol.1992.sp019184; VALENTINO RJ, 1981, J NEUROSCI, V1, P784, DOI 10.1523/JNEUROSCI.01-07-00784.1981; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; WEXLER EM, 1993, NEUROREPORT, V4, P591, DOI 10.1097/00001756-199305000-00034; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Willshaw D, 1990, NEURAL COMPUT, V2, P85, DOI 10.1162/neco.1990.2.1.85; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0; YANG XD, 1994, J NEUROPHYSIOL, V71, P1586, DOI 10.1152/jn.1994.71.4.1586; Yim CY, 1988, NEUROSCI RES COMMUN, V2, P159; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YLINEN A, 1995, J NEUROSCI, V15, P30	96	461	472	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1995	15	5					1053	1063		10.1016/0896-6273(95)90094-2	http://dx.doi.org/10.1016/0896-6273(95)90094-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TF887	7576649	Bronze			2022-12-17	WOS:A1995TF88700011
J	Kuchibhotla, KV; Goldman, ST; Lattarulo, CR; Wu, HY; Hyman, BT; Bacskai, BJ				Kuchibhotla, Kishore V.; Goldman, Samuel T.; Lattarulo, Carli R.; Wu, Hai-Yan; Hyman, Bradley T.; Bacskai, Brian J.			A beta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks	NEURON			English	Article							ALZHEIMERS-DISEASE; CORTICAL-NEURONS; TRANSGENIC MICE; MOUSE MODEL; MUTANT PRESENILIN-1; HIPPOCAMPAL-NEURONS; SYNAPTIC DEPRESSION; AMYLOID DEPOSITION; CHANNEL ACTIVITY; CA2+	Alzheimer's disease is characterized by the deposition of senile plaques and progressive dementia. The molecular mechanisms that couple plaque deposition to neural system failure, however, are unknown. Using transgenic mouse models of AD together with multiphoton imaging, we measured neuronal calcium in individual neurites and spines in vivo using the genetically encoded calcium indicator Yellow Cameleon 3.6. Quantitative imaging revealed elevated [Ca2+]i (calcium overload) in similar to 20% of neurites in APP mice with cortical plaques, compared to less than 5% in wild-type mice, PS1 mutant mice, or young APP mice (animals without cortical plaques). Calcium overload depended on the existence and proximity to plaques. The downstream consequences included the loss of spinodendritic calcium compartmentalization (critical for synaptic integration) and a distortion of neuritic morphologies mediated, in part, by the phosphatase calcineurin. Together, these data demonstrate that senile plaques impair neuritic calcium homeostasis in vivo and result in the structural and functional disruption of neuronal networks.	[Kuchibhotla, Kishore V.; Goldman, Samuel T.; Lattarulo, Carli R.; Wu, Hai-Yan; Hyman, Bradley T.; Bacskai, Brian J.] Massachusetts Gen Hosp, Alzheimers Dis Res Lab, Dept Neurol, Charlestown, MA 02129 USA; [Kuchibhotla, Kishore V.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Bacskai, BJ (corresponding author), Massachusetts Gen Hosp, Alzheimers Dis Res Lab, Dept Neurol, 114 16th St, Charlestown, MA 02129 USA.	bbacskai@partners.org	Bacskai, Brian/AAE-9583-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS058075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R29AG008487, R01AG008487] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR025645] Funding Source: Medline; NIA NIH HHS [P50 AG005134, R01 AG008487, R01 AG008487-18, P30 AG062421, AG08487] Funding Source: Medline; NIBIB NIH HHS [R01 EB000768, EB000768, R01 EB000768-07] Funding Source: Medline; NINDS NIH HHS [NS580752, F31 NS058075-02, F31 NS058075] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akbari Y, 2004, BIOCHEM BIOPH RES CO, V322, P1145, DOI 10.1016/j.bbrc.2004.07.136; Araya R, 2006, P NATL ACAD SCI USA, V103, P18799, DOI 10.1073/pnas.0609225103; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bacskai BJ, 2002, J CEREBR BLOOD F MET, V22, P1035, DOI 10.1097/00004647-200209000-00001; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Berezovska O, 2003, J NEUROSCI, V23, P4560; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BRORSON JR, 1995, J NEUROBIOL, V26, P325, DOI 10.1002/neu.480260305; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; Ekinci FJ, 1999, J BIOL CHEM, V274, P30322, DOI 10.1074/jbc.274.42.30322; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; MacManus A, 2000, J BIOL CHEM, V275, P4713, DOI 10.1074/jbc.275.7.4713; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1993, TRENDS NEUROSCI, V16, P409, DOI 10.1016/0166-2236(93)90009-B; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; POLLARD HB, 1993, ANN NY ACAD SCI, V695, P165, DOI 10.1111/j.1749-6632.1993.tb23046.x; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Simakova O, 2006, BIOCHEMISTRY-US, V45, P5907, DOI 10.1021/bi060148g; Skoch Jesse, 2004, V299, P349; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Tanaka K, 2007, NEURON, V54, P787, DOI 10.1016/j.neuron.2007.05.014; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007	54	460	473	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 31	2008	59	2					214	225		10.1016/j.neuron.2008.06.008	http://dx.doi.org/10.1016/j.neuron.2008.06.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	334WR	18667150	Bronze, Green Accepted			2022-12-17	WOS:000258252700007
J	Zhang, JM; Wang, HK; Ye, CQ; Ge, WP; Chen, YR; Jiang, ZL; Wu, CP; Poo, MM; Duan, SM				Zhang, JM; Wang, HK; Ye, CQ; Ge, WP; Chen, YR; Jiang, ZL; Wu, CP; Poo, MM; Duan, SM			ATP released by Astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression	NEURON			English	Article							RAT SPINAL-CORD; DORSAL-HORN NEURONS; CALCIUM WAVES; HIPPOCAMPAL ASTROCYTES; SYNAPTIC TRANSMISSION; IN-VITRO; RECEPTORS; INHIBITION; ACTIVATION; ADENOSINE	Extracellular ATIP released from axons is known to assist activity-dependent signaling between neurons and Schwann cells in the peripheral nervous system. Here we report that ATP released from astrocytes as a result of neuronal activity can also modulate central synaptic transmission. In cultures of hippocampal neurons, endogenously released ATP tonically suppresses glutamatergic synapses via presynaptic P2Y receptors, an effect that depends on the presence of cocultured astrocytes. Glutamate release accompanying neuronal activity also activates non-NMDA receptors of nearby astrocytes and triggers ATIP release from these cells, which in turn causes homo- and heterosynaptic suppression. In CA1 pyramidal neurons of hippocampal slices, a similar synaptic suppression was also produced by adenosine, an immediate degradation product of ATIP released by glial cells. Thus, neuron-glia crosstalk may participate in activity-dependent synaptic modulation.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.		Wang, Huikun/V-3677-2017	Wang, Huikun/0000-0001-8556-3504				Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Bardoni R, 1997, J NEUROSCI, V17, P5297; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Burnstock G, 1995, J PHYSIOL PHARMACOL, V46, P365; Connolly GP, 2000, EUR J PHARMACOL, V397, P271, DOI 10.1016/S0014-2999(00)00273-9; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Cunha RA, 1998, J NEUROSCI, V18, P1987; Cunha RA, 2000, LIFE SCI, V68, P119, DOI 10.1016/S0024-3205(00)00923-1; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Deuchars SA, 2001, J NEUROSCI, V21, P6308, DOI 10.1523/JNEUROSCI.21-16-06308.2001; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Duan SM, 1999, J NEUROSCI, V19, P10193; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.3.CO;2-Z; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hugel S, 2000, J NEUROSCI, V20, P2121; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; Mendoza-Fernandez V, 2000, J PHARMACOL EXP THER, V293, P172; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; NAKAZAWA K, 1995, N-S ARCH PHARMACOL, V351, P202; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Pappas CA, 1996, GLIA, V16, P7, DOI 10.1002/(SICI)1098-1136(199601)16:1<7::AID-GLIA2>3.0.CO;2-2; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Porter JT, 1996, J NEUROSCI, V16, P5073; Queiroz G, 1997, NEUROSCIENCE, V78, P1203, DOI 10.1016/S0306-4522(96)00637-9; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Silinsky EM, 1996, J PHYSIOL-LONDON, V492, P815, DOI 10.1113/jphysiol.1996.sp021348; STENHAUSER C, 1996, TRENDS NEUROSCI, V19, P339; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; SWANSON RA, 1994, BRAIN RES, V664, P94, DOI 10.1016/0006-8993(94)91958-5; SZERB JC, 1987, BRAIN RES, V410, P116, DOI 10.1016/S0006-8993(87)80030-6; Trendelenburg AU, 2000, NEUROSCIENCE, V96, P249, DOI 10.1016/S0306-4522(99)00577-1; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Westfall TD, 1997, EUR J PHARMACOL, V329, P169, DOI 10.1016/S0014-2999(97)89178-9; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	460	493	1	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					971	982		10.1016/S0896-6273(03)00717-7	http://dx.doi.org/10.1016/S0896-6273(03)00717-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659095	Bronze			2022-12-17	WOS:000187042200013
J	Cruz, JC; Tseng, HC; Goldman, JA; Shih, H; Tsai, LH				Cruz, JC; Tseng, HC; Goldman, JA; Shih, H; Tsai, LH			Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; PAIRED HELICAL FILAMENTS; TRANSGENIC MICE; ALZHEIMERS-DISEASE; TAU-PROTEIN; REGULATORY SUBUNIT; NERVOUS-SYSTEM; P35; PHOSPHORYLATION; BRAIN	Cyclin-dependent kinase 5 (Cdk5) and its regulatory subunit p35 are integral players in the proper development of the mammalian central nervous system. Proteolytic cleavage of p35 generates p25, leading to aberrant Cdk5 activation. The accumulation of p25 is implicated in several neurodegenerative diseases. In primary neurons, p25 causes apoptosis and tau hyperphosphorylation. Current mouse models expressing p25, however, fail to rigorously recapitulate these phenotypes in vivo. Here, we generated inducible transgenic mouse lines overexpressing p25 in the postnatal forebrain. Induction of p25 preferentially directed Cdk5 to pathological substrates. These animals exhibited neuronal loss in the cortex and hippocampus, accompanied by forebrain atrophy, astrogliosis, and caspase-3 activation. Endogenous tau was hyperphosphorylated at many epitopes, aggregated tau accumulated, and neurofibrillary pathology developed progressively in these animals. Our cumulative findings provide compelling evidence that in vivo deregulation of Cdk5 by p25 plays a causative role in neurodegeneration and the development of neurofibrillary pathology.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cruz, JC (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.							Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Ahuja HS, 1997, DEV GENET, V21, P258, DOI 10.1002/(SICI)1520-6408(1997)21:4<258::AID-DVG3>3.0.CO;2-6; Allen B, 2002, J NEUROSCI, V22, P9340; Alvarez A, 2001, EXP CELL RES, V264, P266, DOI 10.1006/excr.2001.5152; Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; Augustinack JC, 2002, J NEUROPATH EXP NEUR, V61, P557, DOI 10.1093/jnen/61.6.557; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bian F, 2002, J COMP NEUROL, V446, P257, DOI 10.1002/cne.10186; Bird TD, 1999, BRAIN, V122, P741, DOI 10.1093/brain/122.4.741; Bu BT, 2002, J NEUROSCI, V22, P6515; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; HISANAGA SI, 1995, CELL MOTIL CYTOSKEL, V31, P283, DOI 10.1002/cm.970310405; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Keshvara L, 2002, J NEUROSCI, V22, P4869, DOI 10.1523/JNEUROSCI.22-12-04869.2002; Ko J, 2001, J NEUROSCI, V21, P6758; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Li GB, 2003, J NEUROCHEM, V84, P347, DOI 10.1046/j.1471-4159.2003.01526.x; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Takashima A, 2001, NEUROSCI LETT, V306, P37, DOI 10.1016/S0304-3940(01)01864-X; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Van den Haute C, 2001, NEUROBIOL DIS, V8, P32, DOI 10.1006/nbdi.2000.0333; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146; Zhang FL, 2002, CELL MOTIL CYTOSKEL, V53, P81, DOI 10.1002/cm.10058; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	59	460	507	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					471	483		10.1016/S0896-6273(03)00627-5	http://dx.doi.org/10.1016/S0896-6273(03)00627-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642273	Bronze			2022-12-17	WOS:000186379000008
J	Petrucelli, L; O'Farrell, C; Lockhart, PJ; Baptista, M; Kehoe, K; Vink, L; Choi, P; Wolozin, B; Farrer, M; Hardy, J; Cookson, MR				Petrucelli, L; O'Farrell, C; Lockhart, PJ; Baptista, M; Kehoe, K; Vink, L; Choi, P; Wolozin, B; Farrer, M; Hardy, J; Cookson, MR			Parkin protects against the toxicity associated with mutant alpha-synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons	NEURON			English	Article							INDUCED CELL-DEATH; SUBSTANTIA-NIGRA; WILD-TYPE; BODY FORMATION; DEGRADATION; DISEASE; GENE; AGGREGATION; EXPRESSION; MUTATION	One hypothesis for the etiology of Parkinson's disease (PD) is that subsets of neurons are vulnerable to a failure in proteasome-mediated protein turnover. Here we show that overexpression of mutant alpha-synuclein increases sensitivity to proteasome inhibitors by decreasing proteasome function. Overexpression of parkin decreases sensitivity to proteasome inhibitors in a manner dependent on parkin's ubiquitin-protein E3 ligase activity, and antisense knockdown of parkin increases sensitivity to proteasome inhibitors. Mutant alpha-synuclein also causes selective toxicity to catecholaminergic neurons in primary midbrain cultures, an effect that can be mimicked by the application of proteasome inhibitors. Parkin is capable of rescuing the toxic effects of mutant alpha-synuclein or proteasome inhibition in these cells. Therefore, parkin and alpha-synuclein are linked by common effects on a pathway associated with selective cell death in catecholaminergic neurons.	NIA, Neurogenet Lab, Bethesda, MD 20892 USA; Mayo Clin Jacksonville, Neurogenet Lab, Jacksonville, FL 32224 USA; Loyola Univ, Med Ctr, Dept Pharmacol, Maywood, IL 60153 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Mayo Clinic; Loyola University Chicago	Cookson, MR (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.	cookson@mail.nih.gov	Lockhart, Paul J/E-7753-2011; Hardy, John/C-2451-2009; Cookson, Mark/AAW-2516-2021	Lockhart, Paul J/0000-0003-2531-8413; Hardy, John/0000-0002-3122-0423; Cookson, Mark/0000-0002-1058-3831; Farrer, Matthew/0000-0003-1159-5321	NINDS NIH HHS [R01-NS41816-01, P01-NS40256] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040256, R01NS041816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000953] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Braak H, 2000, J NEUROL, V247, P3; Burke RE, 1998, J NEUROCHEM, V71, P517; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 1998, J NEUROCHEM, V70, P501; Coopersmith R, 1999, BIOTECHNIQUES, V27, P1156, DOI 10.2144/99276st01; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Farrer M, 2000, MOVEMENT DISORD, V15, P1075, DOI 10.1002/1531-8257(200011)15:6<1075::AID-MDS1004>3.0.CO;2-2; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ghee M, 2000, J NEUROCHEM, V75, P2221, DOI 10.1046/j.1471-4159.2000.0752221.x; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; IVERSKY VN, 2002, FEBS LETT, V515, P99; Junn E, 2002, NEUROSCI LETT, V320, P146, DOI 10.1016/S0304-3940(02)00016-2; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko LW, 2000, J NEUROCHEM, V75, P2546, DOI 10.1046/j.1471-4159.2000.0752546.x; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Maraganore DM, 1999, NEUROLOGY, V53, P1858, DOI 10.1212/WNL.53.8.1858; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Mena MA, 1997, J NEUROCHEM, V69, P21; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; PAKKENBERG B, 1991, J NEUROL NEUROSUR PS, V54, P30, DOI 10.1136/jnnp.54.1.30; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rathke-Hartlieb S, 2001, J NEUROCHEM, V77, P1181, DOI 10.1046/j.1471-4159.2001.00366.x; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wintermeyer P, 2000, NEUROREPORT, V11, P2079, DOI 10.1097/00001756-200007140-00004; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	53	460	470	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 19	2002	36	6					1007	1019		10.1016/S0896-6273(02)01125-X	http://dx.doi.org/10.1016/S0896-6273(02)01125-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495618	Bronze			2022-12-17	WOS:000180011600006
J	Aimone, JB; Deng, W; Gage, FH				Aimone, James B.; Deng, Wei; Gage, Fred H.			Resolving New Memories: A Critical Look at the Dentate Gyrus, Adult Neurogenesis, and Pattern Separation	NEURON			English	Article							HIPPOCAMPAL NEUROGENESIS; GRANULE CELLS; DOUBLE DISSOCIATION; NEURAL NETWORKS; CRITICAL PERIOD; WORKING-MEMORY; SPATIAL MEMORY; DORSAL CA3; NEURONS; SYSTEMS	Recently, investigation of new neurons in memory formation has focused on a specific function pattern separation. However, it has been difficult to reconcile the form of separation tested in behavioral tasks with how it is conceptualized according to computational and electrophysiology perspectives. Here, we propose a memory resolution hypothesis that considers the unique information contributions of broadly tuned young neurons and highly specific mature neurons and describe how the fidelity of memories can relate to spatial and contextual discrimination. See the related Perspective from Sahay, Wilson, and Hen, "Pattern Separation: A Common Function for New Neurons in Hippocampus and Olfactory Bulb," in this issue of Neuron.	[Aimone, James B.; Deng, Wei; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Aimone, James Bradley/H-4694-2016	Aimone, James Bradley/0000-0002-7361-253X	James S. McDonnell Foundation; National Institutes of Health [R01-MH090258]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090258] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Mary Lynn Gage for editorial comments and Jamie Simon for assistance with illustrations. This work was funded in part by the James S. McDonnell Foundation and National Institutes of Health (R01-MH090258). F.H.G. is on the Scientific Advisory Board of BrainCells Inc.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Aimone JB, 2011, EUR J NEUROSCI, V33, P1160, DOI 10.1111/j.1460-9568.2011.07615.x; Aimone JB, 2010, HIPPOCAMPUS, V20, P1124, DOI 10.1002/hipo.20867; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; AMIT DJ, 1987, ANN PHYS-NEW YORK, V173, P30, DOI 10.1016/0003-4916(87)90092-3; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Cerasti E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000759; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gilbert PE, 2006, BEHAV BRAIN RES, V169, P142, DOI 10.1016/j.bbr.2006.01.002; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Inokuchi K, 2011, CURR OPIN NEUROBIOL, V21, P360, DOI 10.1016/j.conb.2011.02.006; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Renno-Costa C, 2010, NEURON, V68, P1051, DOI 10.1016/j.neuron.2010.11.024; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Weisz VI, 2009, COGNITION, V112, P229, DOI 10.1016/j.cognition.2009.05.001; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	49	459	466	2	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 26	2011	70	4					589	596		10.1016/j.neuron.2011.05.010	http://dx.doi.org/10.1016/j.neuron.2011.05.010			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	792NR	21609818	Bronze, Green Accepted			2022-12-17	WOS:000292754300004
J	Dulabon, L; Olson, EC; Taglienti, MG; Eisenhuth, S; McGrath, B; Walsh, CA; Kreidberg, JA; Anton, ES				Dulabon, L; Olson, EC; Taglienti, MG; Eisenhuth, S; McGrath, B; Walsh, CA; Kreidberg, JA; Anton, ES			Reelin binds alpha 3 beta 1 integrin and inhibits neuronal migration	NEURON			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; LAMINAR ORGANIZATION; EXTRACELLULAR-MATRIX; CORTICAL-NEURONS; BETA-1 INTEGRIN; CEREBRAL-CORTEX; MONOCLONAL-ANTIBODY; NEURITE OUTGROWTH; DEVELOPING BRAIN; NERVOUS-SYSTEM	Mice that are mutant for Reelin or Dab1, or doubly mutant for the VLDL receptor (VLDLR) and ApoE receptor 2 (ApoER2), show disorders of cerebral cortical lamination. How Reelin and its receptors regulate laminar organization of cerebral cortex is unknown. We show that Reelin inhibits migration of cortical neurons and enables detachment of neurons from radial glia. Recombinant and native Reelin associate with alpha 3 beta 1 integrin, which regulates neuron-glia interactions and is required to achieve proper laminar organization. The effect of Reelin on cortical neuronal migration in vitro and in vivo depends on interactions between Reelin and alpha 3 alpha 1 integrin. Absence of alpha 3 beta 1 leads to a reduction of Dab1, a signaling protein acting downstream of Reelin. Thus, Reelin may arrest neuronal migration and promote normal cortical lamination by binding alpha 3 beta 1 integrin and modulating integrin-mediated cellular adhesion.	Penn State Univ, Dept Biol & Neurosci, University Pk, PA 16802 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Inst Med, Beth Israel Deaconess Med Ctr,Dept Neurol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Anton, ES (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA.	esa5@psu.edu		Eisenhuth, Scott/0000-0003-2608-2174	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039404, R01NS038097] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS38097, P01 NS39404] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andressen C, 1998, NEUROSCI LETT, V251, P165, DOI 10.1016/S0304-3940(98)00535-7; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; BUSK M, 1992, J BIOL CHEM, V267, P5790; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; DEDHAR S, 1992, EXP CELL RES, V203, P270, DOI 10.1016/0014-4827(92)90064-F; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; Grabham PW, 1997, J NEUROSCI, V17, P5455; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; HOFFARTH RM, 1995, J NEUROSCI, V15, P4838; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; KAPRIELIAN Z, 1993, J NEUROSCI, V13, P2495, DOI 10.1523/JNEUROSCI.13-06-02495.1993; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; LIESI P, 1990, EXPERIENTIA, V46, P900, DOI 10.1007/BF01939382; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Miyata T, 1997, J NEUROSCI, V17, P3599; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Patel DD, 1997, BIOCHEM J, V324, P371, DOI 10.1042/bj3240371; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Poindexter K, 1999, GENE, V237, P61, DOI 10.1016/S0378-1119(99)00302-9; Pol A, 1997, BIOCHEM J, V323, P435, DOI 10.1042/bj3230435; RAUB TJ, 1989, EXP CELL RES, V184, P407, DOI 10.1016/0014-4827(89)90340-6; Rice DS, 1998, DEVELOPMENT, V125, P3719; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Zhang ZQ, 1998, J NEUROSCI, V18, P6928	52	459	478	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					33	44		10.1016/S0896-6273(00)00007-6	http://dx.doi.org/10.1016/S0896-6273(00)00007-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939329	Bronze			2022-12-17	WOS:000088503800008
J	FENG, L; HATTEN, ME; HEINTZ, N				FENG, L; HATTEN, ME; HEINTZ, N			BRAIN LIPID-BINDING PROTEIN (BLBP) - A NOVEL SIGNALING SYSTEM IN THE DEVELOPING MAMMALIAN CNS	NEURON			English	Article							FATTY-ACID-BINDING; INTRACELLULAR VITAMIN-A; CENTRAL NERVOUS-SYSTEM; RETINOIC ACID; GROWTH INHIBITOR; EXPRESSION; MIGRATION; INVITRO; MOUSE; GENE	Using a polyclonal antibody against postnatal cerebellar cells, we have isolated a new, brain-specific member of the lipid-binding protein family (BLBP). Members of this family, such as cellular retinoic acid-binding protein, have been shown to carry small hydrophobic signaling molecules between cellular compartments. The expression of BLBP is spatially and temporally correlated with neuronal differentiation in many parts of the mouse CNS, including postnatal cerebellum, embryonic spinal cord, and cerebral cortex. In situ hybridization and immunocytochemistry show that BLBP is transiently expressed in radial glia in both the embryonic ventricular zone and the postnatal cerebellum. Subcellular localization studies by immunoelectron microscopy demonstrate that BLBP is present in the nucleus as well as the cytoplasm. Affinity-purified anti-BLBP antibodies block glial and neuronal differentiation in primary cell cultures, but have no effect on cell proliferation or adhesion. Based on these results, we propose that BLBP is required for the establishment of the radial glial fiber system in developing brain, a system that is necessary for the migration of immature neurons to establish cortical layers.			FENG, L (corresponding author), ROCKEFELLER UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10021 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030532] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 30532] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOHMER FD, 1987, J BIOL CHEM, V262, P15137; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHYTIL F, 1987, ANNU REV NUTR, V7, P321, DOI 10.1146/annurev.nu.07.070187.001541; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DOLLE P, 1989, NATURE, V342, P702, DOI 10.1038/342702a0; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FOURNIER NC, 1990, MOL CELL BIOCHEM, V98, P149; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GODBOUT R, 1993, EXP EYE RES, V56, P95, DOI 10.1006/exer.1993.1014; GORDON JI, 1985, CHEM PHYS LIPIDS, V38, P137, DOI 10.1016/0009-3084(85)90063-5; GORDON JI, 1991, CURR OPIN LIPIDOL, V2, P125; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GREEN RP, 1992, DNA CELL BIOL, V11, P31, DOI 10.1089/dna.1992.11.31; HARAYANAN V, 1991, J NEUROCHEM, V57, P75; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HATTEN ME, 1984, DEV BRAIN RES, V13, P309, DOI 10.1016/0165-3806(84)90166-4; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; KLEIN KL, 1981, J EXP ZOOL, V216, P107, DOI 10.1002/jez.1402160111; KUHAR SG, 1993, DEVELOPMENT, V117, P97; KURTZ A, 1990, J CELL BIOL, V110, P1779, DOI 10.1083/jcb.110.5.1779; MADEN M, 1991, DEVELOPMENT, P87; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MIYAMOTO M, 1993, MOL CELL BIOL, V13, P4251, DOI 10.1128/MCB.13.7.4251; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PLACZEK M, 1991, DEVELOPMENT, P105; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramon y Cajal S., 1955, HISTOLOGIE SYSTEME N; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; SIDMAN RL, 1983, GENETICS NEUROLOGICA, P379; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TWEEDIE S, 1989, NUCLEIC ACIDS RES, V17, P4374, DOI 10.1093/nar/17.11.4374; WEI LN, 1990, DNA CELL BIOL, V9, P471, DOI 10.1089/dna.1990.9.471; WOLF G, 1991, NUTR REV, V49, P1, DOI 10.1111/j.1753-4887.1991.tb07349.x; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	42	459	472	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1994	12	4					895	908		10.1016/0896-6273(94)90341-7	http://dx.doi.org/10.1016/0896-6273(94)90341-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161459				2022-12-17	WOS:A1994NH25300017
J	LUSKIN, MB; PEARLMAN, AL; SANES, JR				LUSKIN, MB; PEARLMAN, AL; SANES, JR			CELL LINEAGE IN THE CEREBRAL-CORTEX OF THE MOUSE STUDIED INVIVO AND INVITRO WITH A RECOMBINANT RETROVIRUS	NEURON			English	Article									WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT NEUROL, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	LUSKIN, MB (corresponding author), WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, 660 S EUCLIDE AVE, ST LOUIS, MO 63110 USA.							ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; ANDERTON BH, 1982, NATURE, V298, P84, DOI 10.1038/298084a0; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BENNETT GS, 1985, DEV BIOL, V107, P107, DOI 10.1016/0012-1606(85)90380-X; BERRY M, 1965, J ANAT, V99, P691; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; DEVITRY F, 1980, P NATL ACAD SCI-BIOL, V77, P4165, DOI 10.1073/pnas.77.7.4165; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GOLDOWITZ D, 1987, DEV BRAIN RES, V35, P1, DOI 10.1016/0165-3806(87)90002-2; GRAY GE, 1988, IN PRESS P NATL ACAD; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUBA R, 1988, GLIA, V1, P156, DOI 10.1002/glia.440010208; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; ICHIKAWA M, 1982, DEV BRAIN RES, V4, P369, DOI 10.1016/0165-3806(82)90180-8; KOSTOVIC I, 1980, J NEUROCYTOL, V9, P219, DOI 10.1007/BF01205159; LEVITT P, 1983, DEV BIOL, V96, P472, DOI 10.1016/0012-1606(83)90184-7; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; LIESI P, 1986, EXP CELL RES, V163, P175, DOI 10.1016/0014-4827(86)90570-7; LING EA, 1973, J COMP NEUROL, V149, P43, DOI 10.1002/cne.901490104; LUSKIN MB, 1985, J NEUROSCI, V5, P1062; MARES V, 1978, J COMP NEUROL, V177, P519, DOI 10.1002/cne.901770310; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MELLER K, 1975, CELL TISSUE RES, V163, P313; MILLER RH, 1984, J NEUROSCI, V4, P585; MISSON JP, 1988, DEV BRAIN RES, V38, P183, DOI 10.1016/0165-3806(88)90043-0; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; NOBLE M, 1985, NATURE, V316, P725, DOI 10.1038/316725a0; PETERS A, 1973, Z ANAT ENTWICKLUNGS, V141, P3, DOI 10.1007/BF00523363; PRICE J, 1985, J NEUROSCI, V5, P2205; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PRIVAT A, 1975, INT REV CYTOL, V40, P281, DOI 10.1016/S0074-7696(08)60955-9; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEME N; RATHJEN FG, 1984, EMBO J, V3, P1; RHODIN JAG, 1974, HISTOLOGY TEXT ATLAS, P314; RICKMANN M, 1977, ANAT EMBRYOL, V151, P285, DOI 10.1007/BF00318931; RIPPS H, 1985, PROGR RETINAL RES, V4, P181, DOI DOI 10.1016/0278-4327(85)90009-4; ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SCHNITZER J, 1985, J COMP NEUROL, V240, P128, DOI 10.1002/cne.902400203; SHIMADA M, 1970, J COMP NEUROL, V139, P227, DOI 10.1002/cne.901390206; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; SKOFF RP, 1980, PATHOL RES PRACT, V168, P279, DOI 10.1016/S0344-0338(80)80270-6; SMART IHM, 1982, J ANAT, V134, P273; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VAUGHAN DW, 1984, CEREB CORTEX, V2, P285; VILLIGER B, 1981, J CELL BIOL, V90, P711, DOI 10.1083/jcb.90.3.711; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	66	459	464	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1988	1	8					635	647		10.1016/0896-6273(88)90163-8	http://dx.doi.org/10.1016/0896-6273(88)90163-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	Q7276	3272182				2022-12-17	WOS:A1988Q727600002
J	Bekinschtein, P; Cammarota, M; Igaz, LM; Bevilaqua, LRM; Izquierdo, I; Medina, JH				Bekinschtein, Pedro; Cammarota, Martin; Igaz, Lionel Muller; Bevilaqua, Lia R. M.; Izquierdo, Ivan; Medina, Jorge H.			Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus	NEURON			English	Review							MEDIAL PREFRONTAL CORTEX; ELEMENT-BINDING PROTEIN; CONTEXTUAL FEAR MEMORY; 2 CRITICAL PERIODS; NEUROTROPHIC FACTOR; SPATIAL MEMORY; NMDA RECEPTOR; SYNAPTIC PLASTICITY; RETROGRADE-AMNESIA; RAT HIPPOCAMPUS	Persistence is the most characteristic attribute of long-term memory (LTM). To understand LTM, we must understand how memory traces persist over time despite the short-lived nature and rapid turnover of their molecular substrates. It is widely accepted that LTM formation is dependent upon hippocampal de novo protein synthesis and Brain-Derived Neurotrophic Factor (BDNF) signaling during or early after acquisition. Here we show that 12 hr after acquisition of a one-trial associative learning task, there is a novel protein synthesis and BDNF-dependent phase in the rat hippocampus that is critical for the persistence of LTM storage. Our findings indicate that a delayed stabilization phase is specifically required for maintenance, but not formation, of the memory trace. We propose that memory formation and memory persistence share some of the same molecular mechanisms and that recurrent rounds of consolidation-like events take place in the hippocampus for maintenance of the memory trace.	UBA, Fac Med, Inst Biol Celular & Neurociencias, Buenos Aires, DF, Argentina; UBA, Fac Med, Dept Fisiol, Buenos Aires, DF, Argentina; Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Ctr Memoria, BR-90610000 Porto Alegre, RS, Brazil	University of Buenos Aires; University of Buenos Aires; Pontificia Universidade Catolica Do Rio Grande Do Sul	Medina, JH (corresponding author), UBA, Fac Med, Inst Biol Celular & Neurociencias, Paraguay 2155 30 Piso,C1121ABG, Buenos Aires, DF, Argentina.	jmedina@fmed.uba.ar	Igaz, Lionel/AAP-3059-2020; Cammarota, Martin/AAC-7478-2021	Cammarota, Martin/0000-0001-9741-5074; Bekinschtein, Pedro/0000-0002-0004-9619; Igaz, Lionel Muller/0000-0001-9988-3242; Bevilaqua, Lia/0000-0001-8537-1289; Izquierdo, Ivan/0000-0002-7208-0869				Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alder J, 2003, J NEUROSCI, V23, P10800; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bilang-Bleuel A, 2002, EUR J NEUROSCI, V15, P1048, DOI 10.1046/j.1460-9568.2002.01934.x; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Brown AS, 2002, PSYCHON B REV, V9, P403, DOI 10.3758/BF03196300; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Burwell RD, 2004, J NEUROSCI, V24, P11023, DOI 10.1523/JNEUROSCI.3781-04.2004; Cammarota M, 2000, MOL BRAIN RES, V76, P36, DOI 10.1016/S0169-328X(99)00329-0; Countryman RA, 2005, NEUROBIOL LEARN MEM, V84, P175, DOI 10.1016/j.nlm.2005.07.005; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS HP, 1976, PHARMACOL BIOCHEM BE, V4, P13, DOI 10.1016/0091-3057(76)90168-4; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duvarci S, 2006, EUR J NEUROSCI, V24, P249, DOI 10.1111/j.1460-9568.2006.04907.x; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fleischmann A, 2003, J NEUROSCI, V23, P9116; FLOOD JF, 1975, PHYSIOL BEHAV, V14, P177, DOI 10.1016/0031-9384(75)90163-8; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Glorioso C, 2006, MOL PSYCHIATR, V11, P633, DOI 10.1038/sj.mp.4001835; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; GRECKSCH G, 1980, PHARMACOL BIOCHEM BE, V12, P663, DOI 10.1016/0091-3057(80)90145-8; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; He J, 2002, NEUROPSYCHOPHARMACOL, V26, P259, DOI 10.1016/S0893-133X(01)00332-3; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Igaz LM, 2002, J NEUROSCI, V22, P6781; Igaz LM, 2004, MOL BRAIN RES, V132, P1, DOI 10.1016/j.molbrainres.2004.08.016; Izquierdo I, 1998, TRENDS NEUROSCI, V21, P423, DOI 10.1016/S0166-2236(98)01279-X; Izquierdo I, 1999, EUR J NEUROSCI, V11, P3323, DOI 10.1046/j.1460-9568.1999.00742.x; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Johnston ANB, 1999, NEUROSCIENCE, V88, P1033, DOI 10.1016/S0306-4522(98)00362-5; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martinez A, 1998, J NEUROSCI, V18, P7336; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Merhav M, 2006, LEARN MEMORY, V13, P571, DOI 10.1101/lm.282406; MINIACI MC, 2005, SOC NEUROSCIENCE PRO; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Morrow BA, 1999, J NEUROSCI, V19, P5666; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Pilzecker, 1900, Z PSYCHOL, V1, P1; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Power AE, 2006, LEARN MEMORY, V13, P27, DOI 10.1101/lm.91206; Qiao XX, 1998, J NEUROSCI, V18, P6990; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Ring RH, 2006, J NEUROBIOL, V66, P361, DOI 10.1002/neu.20223; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sangha S, 2005, BEHAV NEUROSCI, V119, P787, DOI 10.1037/0735-7044.119.3.787; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Squire L R, 1987, Int J Neurol, V21-22, P218; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tiunova AA, 1998, LEARN MEMORY, V4, P401, DOI 10.1101/lm.4.5.401; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Tronel S, 2005, PLOS BIOL, V3, P1630, DOI 10.1371/journal.pbio.0030293; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Valjent E, 2006, J NEUROSCI, V26, P4956, DOI 10.1523/JNEUROSCI.4601-05.2006; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Viola HE, 2000, J NEUROSCI, V20; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Yasoshima Y, 2006, P NATL ACAD SCI USA, V103, P7106, DOI 10.1073/pnas.0600869103; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	126	458	466	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					261	277		10.1016/j.neuron.2006.11.025	http://dx.doi.org/10.1016/j.neuron.2006.11.025			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224407	Bronze			2022-12-17	WOS:000245126600011
J	Arber, S; Han, B; Mendelsohn, M; Smith, M; Jessell, TM; Sockanathan, S				Arber, S; Han, B; Mendelsohn, M; Smith, M; Jessell, TM; Sockanathan, S			Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity	NEURON			English	Article							RAT SPINAL-CORD; MUSCULATURE FOLLOWING TRANSPLANTATION; CHICK HIND LIMB; THORACIC MOTONEURONS; SUBTYPE IDENTITY; CULTURED-CELLS; LUMBAR REGION; EXPRESSION; SPECIFICATION; PATTERNS	The homeobox gene Hb9, like its close relative MNR2, is expressed selectively by motor neurons (MNs) in the developing vertebrate CNS. In embryonic chick spinal cord, the ectopic expression of MNR2 or Hb9 is sufficient to trigger MN differentiation and to repress the differentiation of an adjacent population of V2 interneurons. Here, we provide genetic evidence that Hb9 has an essential role in MN differentiation. In mice lacking Hb9 function, MNs are generated on schedule and in normal numbers but transiently acquire molecular features of V2 interneurons. The aberrant specification of MN identity is associated with defects in the migration of MNs, the emergence of the subtype identities of MNs, and the projection of motor axons. These findings show that HB9 has an essential function in consolidating the identity of postmitotic MNs.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Tuluc, Petronel/C-2527-2011	Arber, Silvia/0000-0002-6261-250X				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Appel B, 1999, NEURON, V22, P3, DOI 10.1016/S0896-6273(00)80669-8; BARBER RP, 1991, J COMP NEUROL, V311, P509, DOI 10.1002/cne.903110406; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; Goulding M, 1998, NEURON, V21, P943, DOI 10.1016/S0896-6273(00)80612-1; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Lo LC, 1998, DEVELOPMENT, V125, P609; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; MARKHAM JA, 1991, J NEUROBIOL, V22, P811, DOI 10.1002/neu.480220803; MOMBAERTS P, 1996, CELL, V87, P657; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; OBRIEN MK, 1990, J NEUROBIOL, V21, P341, DOI 10.1002/neu.480210208; OBRIEN MK, 1990, J NEUROBIOL, V21, P313, DOI 10.1002/neu.480210207; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; WETTS R, 1995, DEV DYNAM, V202, P215, DOI 10.1002/aja.1002020302; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	41	458	470	1	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					659	674		10.1016/S0896-6273(01)80026-X	http://dx.doi.org/10.1016/S0896-6273(01)80026-X			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482234	Bronze			2022-12-17	WOS:000082280900011
J	Golumbic, EMZ; Ding, N; Bickel, S; Lakatos, P; Schevon, CA; McKhann, GM; Goodman, RR; Emerson, R; Mehta, AD; Simon, JZ; Poeppel, D; Schroeder, CE				Golumbic, Elena M. Zion; Ding, Nai; Bickel, Stephan; Lakatos, Peter; Schevon, Catherine A.; McKhann, Guy M.; Goodman, Robert R.; Emerson, Ronald; Mehta, Ashesh D.; Simon, Jonathan Z.; Poeppel, David; Schroeder, Charles E.			Mechanisms Underlying Selective Neuronal Tracking of Attended Speech at a "Cocktail Party"	NEURON			English	Article							HUMAN AUDITORY-CORTEX; RECEPTIVE-FIELDS; CORTICAL NETWORK; PHASE PATTERNS; ATTENTION; FREQUENCY; OSCILLATIONS; RESPONSES; DYNAMICS; NOISE	The ability to focus on and understand one talker in a noisy social environment is a critical social-cognitive capacity, whose underlying neuronal mechanisms are unclear. We investigated the manner in which speech streams are represented in brain activity and the way that selective attention governs the brain's representation of speech using a "Cocktail Party" paradigm, coupled with direct recordings from the cortical surface in surgical epilepsy patients. We find that brain activity dynamically tracks speech streams using both low-frequency phase and high-frequency amplitude fluctuations and that optimal encoding likely combines the two. In and near low-level auditory cortices, attention "modulates" the representation by enhancing cortical tracking of attended speech streams, but ignored speech remains represented. In higher-order regions, the representation appears to become more "selective," in that there is no detectable tracking of ignored speech. This selectivity itself seems to sharpen as a sentence unfolds.	[Golumbic, Elena M. Zion; Schroeder, Charles E.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Schevon, Catherine A.; Emerson, Ronald] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [McKhann, Guy M.; Goodman, Robert R.] Columbia Univ Coll Phys & Surg, Dept Neurol Surg, New York, NY 10032 USA; [Golumbic, Elena M. Zion; Lakatos, Peter; Schroeder, Charles E.] Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; [Ding, Nai; Simon, Jonathan Z.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20740 USA; [Ding, Nai; Simon, Jonathan Z.] Univ Maryland, Dept Biol, College Pk, MD 20740 USA; [Bickel, Stephan; Mehta, Ashesh D.] North Shore Long Isl Jewish Hlth Syst, Dept Neurol, New Hyde Pk, NY 11040 USA; [Bickel, Stephan; Mehta, Ashesh D.] North Shore Long Isl Jewish Hlth Syst, Dept Neurosurg, New Hyde Pk, NY 11040 USA; [Bickel, Stephan; Mehta, Ashesh D.] Hofstra Univ, Sch Med, Feinstein Inst Med Res, Manhasset, NY 11549 USA; [Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA	Columbia University; Columbia University; Columbia University; Nathan Kline Institute for Psychiatric Research; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Northwell Health; Northwell Health; Hofstra University; Northwell Health; New York University	Schroeder, CE (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA.	schrod@nki.rfmh.org	Simon, Jonathan Z/A-8196-2008	Simon, Jonathan Z/0000-0003-0858-0698; Lakatos, Peter/0000-0003-0221-4021	 [MH093061];  [MH60358];  [MH086385];  [DC008342];  [DC05660]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060358, P50MH086385, F32MH093061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012947, R56DC005660, R01DC008342, R01DC005660] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by MH093061, MH60358, MH086385, DC008342, and DC05660. We thank Dr. Joseph Isler and the other members of the Columbia Oscillations Journal Club for critical comments and advice on this work.	Ahissar E, 2005, AUDITORY CORTEX: SYNTHESIS OF HUMAN AND ANIMAL RESEARCH, P295; Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Belitski A, 2010, J COMPUT NEUROSCI, V29, P533, DOI 10.1007/s10827-010-0230-y; Bishop CW, 2009, J COGNITIVE NEUROSCI, V21, P1790, DOI 10.1162/jocn.2009.21118; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; Ding N, 2012, P NATL ACAD SCI USA, V109, P11854, DOI 10.1073/pnas.1205381109; Ding N, 2012, J NEUROPHYSIOL, V107, P78, DOI 10.1152/jn.00297.2011; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Elhilali M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000129; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Golumbic EMZ, 2012, BRAIN LANG, V122, P151, DOI 10.1016/j.bandl.2011.12.010; Golumbic EZ, 2013, J NEUROSCI, V33, P1417, DOI 10.1523/JNEUROSCI.3675-12.2013; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Greenberg S, 2006, LISTENING SPEECH AUD; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Howard MF, 2010, J NEUROPHYSIOL, V104, P2500, DOI 10.1152/jn.00251.2010; Kayser C, 2007, J NEUROPHYSIOL, V98, P1806, DOI 10.1152/jn.00358.2007; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kerlin JR, 2010, J NEUROSCI, V30, P620, DOI 10.1523/JNEUROSCI.3631-09.2010; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Makinen V, 2005, NEUROIMAGE, V24, P961, DOI 10.1016/j.neuroimage.2004.10.020; Mazzoni A, 2010, NEUROIMAGE, V52, P956, DOI 10.1016/j.neuroimage.2009.12.040; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; Xiang JJ, 2010, J NEUROSCI, V30, P12084, DOI 10.1523/JNEUROSCI.0827-10.2010	49	457	461	6	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					980	991		10.1016/j.neuron.2012.12.037	http://dx.doi.org/10.1016/j.neuron.2012.12.037			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473326	Green Accepted, Bronze			2022-12-17	WOS:000316162600017
J	Preuschoff, K; Bossaerts, P; Quartz, SR				Preuschoff, Kerstin; Bossaerts, Peter; Quartz, Steven R.			Neural differentiation of expected reward and risk in human subcortical structures	NEURON			English	Article							SOMATIC MARKER HYPOTHESIS; DOPAMINE NEURONS; DECISION-MAKING; ASSET PRICES; UNCERTAINTY; RESPONSES; BRAIN; ANTICIPATION; MIDBRAIN; CORTEX	In decision-making under uncertainty, economic studies emphasize the importance of risk in addition to expected reward. Studies in neuroscience focus on expected reward and learning rather than risk. We combined functional imaging with a simple gambling task to vary expected reward and risk simultaneously and in an uncorrelated manner. Drawing on financial decision theory, we modeled expected reward as mathematical expectation of reward, and risk as reward variance. Activations in dopaminoceptive structures correlated with both mathematical parameters. These activations differentiated spatially and temporally. Temporally, the activation related to expected reward was immediate, while the activation related to risk was delayed. Analyses confirmed that our paradigm minimized confounds from learning, motivation, and salience. These results suggest that the primary task of the dopaminergic system is to convey signals of upcoming stochastic rewards, such as expected reward and risk, beyond its role in learning, motivation, and salience.	CALTECH, Computat & Neural Syst Program, Social Cognit Neurosci Lab, Pasadena, CA 91125 USA; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Preuschoff, K (corresponding author), CALTECH, Computat & Neural Syst Program, Social Cognit Neurosci Lab, 1200 E California Blvd 228-77, Pasadena, CA 91125 USA.	kerstinp@caltech.edu	Zhang, Xiao/V-9027-2017; Preuschoff, Kerstin/G-4710-2015; Bossaerts, Peter/AAZ-9851-2020; Preuschoff, Kerstin/AAG-4725-2019; Bossaerts, Peter/O-9964-2015	Zhang, Xiao/0000-0002-2932-5875; Bossaerts, Peter/0000-0003-2308-2603; Preuschoff, Kerstin/0000-0001-7254-833X; 				ABEL AB, 1990, AM ECON REV, V80, P38; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; BIALEK W, 1992, TRENDS NEUROSCI, V15, P428, DOI 10.1016/0166-2236(92)90005-S; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Bossaerts P., 2004, Review of Finance, V8, P135, DOI 10.1023/B:EUFI.0000035190.24818.e5; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Clark L, 2001, AM J PSYCHIAT, V158, P1605, DOI 10.1176/appi.ajp.158.10.1605; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DAVIDSON R, 1981, ECONOMETRICA, V49, P781, DOI 10.2307/1911522; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-7; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; LINTNER J, 1965, REV ECON STAT, V47, P13, DOI 10.2307/1924119; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; Minassian A, 2004, J AFFECT DISORDERS, V82, P203, DOI 10.1016/j.jad.2003.11.010; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MOSSIN J, 1966, ECONOMETRICA, V34, P768, DOI 10.2307/1910098; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; REAL LA, 1991, SCIENCE, V253, P980, DOI 10.1126/science.1887231; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; Samuelson W., 1988, J RISK UNCERTAINTY, V1, P7, DOI [10.1007/BF00055564, DOI 10.1007/BF00055564]; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Shurman B, 2005, SCHIZOPHR RES, V72, P215, DOI 10.1016/j.schres.2004.03.020; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; TOBIN J, 1957, REV ECON STUD, V25, P65; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	54	457	462	0	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 3	2006	51	3					381	390		10.1016/j.neuron.2006.06.024	http://dx.doi.org/10.1016/j.neuron.2006.06.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	075TT	16880132	Bronze, Green Submitted			2022-12-17	WOS:000239908800013
J	Shmuel, A; Yacoub, E; Pfeuffer, J; Van de Moortele, PF; Adriany, G; Hu, XP; Ugurbil, K				Shmuel, A; Yacoub, E; Pfeuffer, J; Van de Moortele, PF; Adriany, G; Hu, XP; Ugurbil, K			Sustained negative BOLD, blood flow and oxygen consumption response and its coupling to the positive response in the human brain	NEURON			English	Article							MAGNETIC-RESONANCE; FUNCTIONAL MRI; OXIDATIVE-METABOLISM; SENSORY STIMULATION; CEREBRAL-CORTEX; VISUAL-CORTEX; FMRI SIGNAL; ACTIVATION; TIME; INHIBITION	Most fMRI studies are based on the detection of a positive BOLD response (PBR). Here, we demonstrate and characterize a robust sustained negative BOLD response (NBR) in the human occipital cortex, triggered by stimulating part of the visual field. The NBR was spatially adjacent to but segregated from the PBR. It depended on the stimulus and thus on the pattern of neuronal activity. The time courses of the NBR and PBR were similar, and their amplitudes covaried both with increasing stimulus duration and increasing stimulus contrast. The NBR was associated with reductions in blood flow and with decreases in oxygen consumption. Our findings support the contribution to the NBR of (1) a significant component of reduction in neuronal activity and (2) possibly a component of hemodynamic changes independent of the local changes in neuronal activity.	Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Shmuel, A (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Yacoub, Essa/AAS-7757-2021; Adriany, Gregor/R-6656-2016; Van de Moortele, Pierre-François/H-5087-2011; Ugurbil, Kamil/AAD-6058-2022; Shmuel, Amir/G-8690-2013; Adriany, Gregor/AAK-1323-2020	Van de Moortele, Pierre-François/0000-0002-6941-5947; Hu, Xiaoping/0000-0001-7014-5983; Adriany, Gregor/0000-0002-6428-9005; Pfeuffer, Josef/0000-0001-9887-0458	NCRR NIH HHS [S10 RR13957, RR08079] Funding Source: Medline; NIBIB NIH HHS [EB000331] Funding Source: Medline; NIMH NIH HHS [MH55346] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055346] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Angelucci A, 2002, J NEUROSCI, V22, P8633; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BORN RT, 1991, P NATL ACAD SCI USA, V88, P7071, DOI 10.1073/pnas.88.16.7071; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Goutte C, 2001, HUM BRAIN MAPP, V13, P165, DOI 10.1002/hbm.1031; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lee SP, 2001, MAGNET RESON MED, V45, P791, DOI 10.1002/mrm.1107; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Martin E, 2000, HUM BRAIN MAPP, V10, P132, DOI 10.1002/1097-0193(200007)10:3<132::AID-HBM40>3.0.CO;2-2; Ngan SC, 2002, ARTIF INTELL MED, V25, P19, DOI 10.1016/S0933-3657(02)00006-4; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1993, MAGNET RESON MED, V29, P205, DOI 10.1002/mrm.1910290208; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P11026, DOI 10.1073/pnas.97.20.11026; OGAWA S, 1993, BIOPHYS J, V64, P800; Pfeuffer J, 2002, MAGNET RESON MED, V47, P903, DOI 10.1002/mrm.10154; Pfeuffer J, 2002, MAGN RESON MED, V47, P344, DOI 10.1002/mrm.10065; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Strupp JP, 1996, NEUROIMAGE, V3, pS607; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Ugurbil K, 2000, ANNU REV BIOMED ENG, V2, P633, DOI 10.1146/annurev.bioeng.2.1.633; Victor JD, 2000, CEREB CORTEX, V10, P2, DOI 10.1093/cercor/10.1.2; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080	50	457	463	3	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1195	1210		10.1016/S0896-6273(02)01061-9	http://dx.doi.org/10.1016/S0896-6273(02)01061-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495632	Bronze			2022-12-17	WOS:000180011600020
J	Murthy, VN; Sejnowski, TJ; Stevens, CF				Murthy, VN; Sejnowski, TJ; Stevens, CF			Heterogeneous release properties of visualized individual hippocampal synapses	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; PAIRED-PULSE; CURRENTS; FACILITATION; PROBABILITY; PLASTICITY; DEPRESSION; TERMINALS; MEMBRANE	We have used endocytotic uptake of the styryl dye FM1-43 at synaptic terminals (Betz and Bewick, 1992) to study properties of individual synapses formed by axons of single hippocampal neurons in tissue culture. The distribution of values for probability of evoked transmitter release p estimated by dye uptake is continuous, with a preponderance of low p synapses and a broad spread of probabilities. We have validated this method by demonstrating that the optically estimated distribution of p at autapses in single-neuron microislands predicts, with no free parameters, the rate of blocking of NMDA responses by the noncompetitive antagonist MK-801 at the same synapses. Different synapses made by a single axon exhibited varying amounts of paired-pulse modulation; synapses with low p tended to be facilitated more than those with high p. The increment in release probability produced by increasing external calcium ion concentration also depended on a synapse's initial p value. The size of the recycling pool of vesicles was strongly correlated with p as well, suggesting that synapses with higher release probabilities had more vesicles. Finally, p values of neighboring synapses were correlated, indicating local interactions in the dendrite or axon, or both.	SALK INST BIOL STUDIES,MOL NEUROBIOL LAB,LA JOLLA,CA 92037	Salk Institute	Murthy, VN (corresponding author), SALK INST BIOL STUDIES,COMPUTAT NEUROBIOL LAB,10010 N TORREY PINES RD,LA JOLLA,CA 92037, USA.		Sejnowski, Terrence/AAV-5558-2021	Murthy, Venkatesh/0000-0003-2443-4252	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER; NIMH NIH HHS [R1MH46482A] Funding Source: Medline; NINDS NIH HHS [NS 12961] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Frenguelli BG, 1996, LEARN MEMORY, V3, P150, DOI 10.1101/lm.3.2-3.150; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Katz B., 1969, SHERRINGTON LECT; MacKenzie PJ, 1996, NEURON, V16, P783, DOI 10.1016/S0896-6273(00)80098-7; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MALLART A, 1968, J PHYSIOL-LONDON, V196, P593, DOI 10.1113/jphysiol.1968.sp008525; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	29	457	458	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					599	612		10.1016/S0896-6273(00)80301-3	http://dx.doi.org/10.1016/S0896-6273(00)80301-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136769	Bronze			2022-12-17	WOS:A1997WW62600009
J	HSIAO, KK; BORCHELT, DR; OLSON, K; JOHANNSDOTTIR, R; KITT, C; YUNIS, W; XU, S; ECKMAN, C; YOUNKIN, S; PRICE, D; IADECOLA, C; CLARK, HB; CARLSON, G				HSIAO, KK; BORCHELT, DR; OLSON, K; JOHANNSDOTTIR, R; KITT, C; YUNIS, W; XU, S; ECKMAN, C; YOUNKIN, S; PRICE, D; IADECOLA, C; CLARK, HB; CARLSON, G			AGE-RELATED CNS DISORDER AND EARLY DEATH IN TRANSGENIC FVB/N MICE OVEREXPRESSING ALZHEIMER AMYLOID PRECURSOR PROTEINS	NEURON			English	Article							CEREBRAL GLUCOSE-UTILIZATION; OPTICAL-DENSITY RATIOS; PRION PROTEIN; BETA-PROTEIN; DISEASE; GENE; MUTATION; EXPRESSION; MOUSE; DEMENTIA	Transgenic FVB/N mice overexpressing human (Hu) or mouse (Mo) Alzheimer amyloid precursor protein (APP(695)) die early and develop a CNS disorder that includes neophobia and impaired spatial alternation, with diminished glucose utilization and astrogliosis mainly in the cerebrum. Age at onset of neophobia and age at death decrease with increasing levers of brain APP. HuAPP transgenes induce death much earlier than MoAPP transgenes expressed at similar levels. Na extracellular amyloid was detected, indicating that some deleterious processes related to APP overexpression are dissociated from formation of amyloid. A similar clinical syndrome occurs spontaneously in similar to 20% of nontransgenic mice when they reach mid- to late-adult life, suggesting that APP overexpression may accelerate a naturally occuring age-related CNS disorder in FVB/N mice.	UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; JOHNS HOPKINS UNIV, DEPT PATHOL, BALTIMORE, MD 21205 USA; MCLAUGHLIN RES INST, GREAT FALLS, MT 59405 USA; MAYO CLIN, JACKSONVILLE, FL 32224 USA	University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; McLaughlin Research Institute for Biomedical Sciences, Inc.; Mayo Clinic	HSIAO, KK (corresponding author), UNIV MINNESOTA, DEPT NEUROL, MINNEAPOLIS, MN 55455 USA.		olson, kristine/W-2029-2019; Iadecola, c/ABB-8377-2020	olson, kristine/0000-0002-5417-700X; Iadecola, Costantino/0000-0001-9797-073X	NIA NIH HHS [AG05146, AG07914] Funding Source: Medline; NINDS NIH HHS [NS20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R35AG007914] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARAKI W, 1994, NEUROSCI LETT, V167, P125, DOI 10.1016/0304-3940(94)91043-X; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BUXBAUM JD, 1993, BIOCHEM BIOPH RES CO, V197, P639, DOI 10.1006/bbrc.1993.2527; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; DELEON MJ, 1983, AM J NEURORADIOL, V4, P568; DOUGLAS RJ, 1990, SPONTANEOUS ALTERNAT, P73; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FINCH CE, 1993, TRENDS NEUROSCI, V16, P104, DOI 10.1016/0166-2236(93)90134-8; GAGE FH, 1984, J NEUROSCI, V4, P2856; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GERLAI R, 1994, BEHAV NEUROSCI, V108, P100, DOI 10.1037/0735-7044.108.1.100; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HANLEY T, 1991, BIOTECHNIQUES, V10, P56; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HIGGINS LS, 1994, ANN NEUROL, V35, P598, DOI 10.1002/ana.410350514; Hogan B., 1986, MANIPULATING MOUSE E; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; IADECOLA C, 1983, BRAIN RES, V272, P101, DOI 10.1016/0006-8993(83)90367-0; IADECOLA C, 1994, AM J PHYSIOL, V266, pR518, DOI 10.1152/ajpregu.1994.266.2.R518; KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; KINNEY HC, 1986, J NEUROPATH EXP NEUR, V45, P108, DOI 10.1097/00005072-198603000-00002; KOKMEN E, 1989, NEUROLOGY, V39, P773, DOI 10.1212/WNL.39.6.773; KUMAR A, 1991, NEUROPSYCHOPHARMACOL, V4, P35; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; LANDFIELD PW, 1977, J GERONTOL, V32, P3, DOI 10.1093/geronj/32.1.3; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Masson P, 1928, AM J PATHOL, V4, P181; MITCHELL IJ, 1984, BRAIN RES, V298, P191, DOI 10.1016/0006-8993(84)91168-5; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; PEARSON BE, 1993, P NATL ACAD SCI USA, V90, P10578, DOI 10.1073/pnas.90.22.10578; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; SANDHU FA, 1991, J BIOL CHEM, V266, P21331; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; SHARP FR, 1983, BRAIN RES, V263, P97, DOI 10.1016/0006-8993(83)91204-0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; WILLOTT JF, 1988, EXP NEUROL, V99, P615, DOI 10.1016/0014-4886(88)90178-1; WONG PC, 1990, J CELL BIOL, V111, P1987, DOI 10.1083/jcb.111.5.1987; YAMAGUCHI F, 1991, NEUROREPORT, V2, P781, DOI 10.1097/00001756-199112000-00013	63	457	489	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1995	15	5					1203	1218		10.1016/0896-6273(95)90107-8	http://dx.doi.org/10.1016/0896-6273(95)90107-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TF887	7576662	hybrid			2022-12-17	WOS:A1995TF88700024
J	CHENG, B; MATTSON, MP				CHENG, B; MATTSON, MP			NGF AND BFGF PROTECT RAT HIPPOCAMPAL AND HUMAN CORTICAL-NEURONS AGAINST HYPOGLYCEMIC DAMAGE BY STABILIZING CALCIUM HOMEOSTASIS	NEURON			English	Article							NERVE-GROWTH-FACTOR; RECEPTOR MESSENGER-RNA; CHOLINERGIC NEURONS; NEUROTROPHIC FACTOR; MOLECULAR-CLONING; BRAIN; EXPRESSION; CELLS; CULTURE; SYSTEM	NGF and bFGF have recently been shown to have biological activity in central neurons, but their normal functions and mechanisms of action are unknown. Since central neurons are particularly vulnerable to hypoglycemia that occurs with ischemia or insulin overdose, we tested the hypothesis that growth factors can protect neurons against hypoglycemic damage. NGF and bFGF each prevented glucose deprivation-induced neuronal damage in human cerebral cortical and rat hippocampal cell cultures (EGF was ineffective). Protection was afforded when the growth factors were administered before (NGF and bFGF) or up to 12 hr following (NGF) the onset of hypoglycemia. Direct measurements of intracellular calcium levels and manipulations of calcium influx demonstrated that sustained elevations in intracellular calcium levels mediated the hypoglycemic damage. NGF and bFGF each prevented the hypoglycemia-induced elevations of intracellular calcium. These findings indicate that growth factors can stabilize neuronal calcium homeostasis in central neurons and thereby protect them against environmental insults.	UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA	University of Kentucky	CHENG, B (corresponding author), UNIV KENTUCKY, SANDERS BROWN RES CTR AGING, LEXINGTON, KY 40536 USA.		Mattson, Mark P/F-6038-2012					ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; BAIRD A, 1986, RECENT PROG HORM RES, V42, P143; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BARINAGA M, 1991, SCIENCE, V252, P505, DOI 10.1126/science.1850547; BUCK CR, 1987, P NATL ACAD SCI USA, V84, P3060, DOI 10.1073/pnas.84.9.3060; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHALAZONITIS A, 1987, P NATL ACAD SCI USA, V84, P289, DOI 10.1073/pnas.84.1.289; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; ERNFORS P, 1991, INT J DEV NEUROSCI, V9, P57, DOI 10.1016/0736-5748(91)90073-U; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARTIKKA J, 1988, J NEUROSCI, V8, P2967; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1987, BIOCHEM PHARMACOL, V36, P4189, DOI 10.1016/0006-2952(87)90658-7; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KNUSEL B, 1990, J NEUROSCI, V10, P558; KOH S, 1989, EXP NEUROL, V106, P209, DOI 10.1016/0014-4886(89)90154-4; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1986, TRENDS NEUROSCI, V9, P473, DOI 10.1016/0166-2236(86)90152-9; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MARTINEZ HJ, 1985, P NATL ACAD SCI USA, V82, P7777, DOI 10.1073/pnas.82.22.7777; MASIAKOWSKI P, 1988, P NATL ACAD SCI USA, V85, P1277, DOI 10.1073/pnas.85.4.1277; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1990, BRAIN RES, V522, P204, DOI 10.1016/0006-8993(90)91462-P; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1991, BRAIN RES, V565, P94, DOI 10.1016/0006-8993(91)91740-R; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MATTSON MP, 1991, BRAIN RES, V542, P97, DOI 10.1016/0006-8993(91)91003-J; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MATTSON MP, 1992, IN PRESS EXP GERONTO; MONYER H, 1989, BRAIN RES, V483, P347, DOI 10.1016/0006-8993(89)90179-0; MORRISON RS, 1988, J NEUROSCI RES, V21, P71, DOI 10.1002/jnr.490210111; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PIORO EP, 1990, NEUROSCIENCE, V34, P57, DOI 10.1016/0306-4522(90)90304-M; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STREIT J, 1990, PFLUG ARCH EUR J PHY, V416, P368, DOI 10.1007/BF00370742; TAKAHASHI M, 1985, BRAIN RES, V341, P381, DOI 10.1016/0006-8993(85)91079-0; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P1950, DOI 10.1073/pnas.83.6.1950; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; TUSZYNSKI MH, 1990, J NEUROSCI, V10, P3604; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1989, J BIOL CHEM, V264, P4120; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020	59	457	477	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1991	7	6					1031	1041		10.1016/0896-6273(91)90347-3	http://dx.doi.org/10.1016/0896-6273(91)90347-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1662517				2022-12-17	WOS:A1991GY43800015
J	CHEN, L; HUANG, LYM				CHEN, L; HUANG, LYM			SUSTAINED POTENTIATION OF NMDA RECEPTOR MEDIATED GLUTAMATE RESPONSES THROUGH ACTIVATION OF PROTEIN-KINASE-C BY A MU-OPIOID	NEURON			English	Article							LONG-TERM POTENTIATION; DORSAL HORN NEURONS; RAT SPINAL-CORD; CENTRAL NERVOUS-SYSTEM; ROOT GANGLION NEURONS; AMINO-ACID RECEPTORS; CALCIUM CHANNELS; GENE-EXPRESSION; D-ASPARTATE; CELLS	mu-Opioids, such as morphine and certain enkephalin analogs, are known to modulate glutamate-evoked activity in dorsal horn neurons in the spinal cord and caudal brain stem. Yet the molecular mechanism by which this modulation occurs is not understood. We examined the interactions between glutamate and a selective mu-opioid receptor agonist, D-Ala2-MePhe4-Gly-ol5-enkephalin (DAGO), in spinal trigeminal neurons in thin medullary slices of rats. DAGO caused a sustained increase in glutamate-activated currents that are mediated by N-methyl-D-aspartate receptors. Intracellularly applied protein kinase C (PKC) mimics the effect of DAGO, and a specific PKC inhibitor interrupts the sustained potentiation produced by DAGO. Thus, PKC plays a key role in mediating the action of mu-opioid peptides.	UNIV TEXAS, MED BRANCH, DEPT PHYSIOL & BIOPHYS, GALVESTON, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	CHEN, L (corresponding author), UNIV TEXAS, MED BRANCH, INST MARINE BIOMED INST, GALVESTON, TX 77550 USA.				NINDS NIH HHS [NS23061, NS01050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023061, K04NS001050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AANONSEN LM, 1990, PAIN, V41, P309, DOI 10.1016/0304-3959(90)90008-2; AANONSEN LM, 1987, J PHARMACOL EXP THER, V243, P9; ASHER P, 1988, J PHYSL, V399, P247; BARKER JL, 1978, CHARACTERISTICS FUNC, V5, P87; BATTAGLIA G, 1988, J COMP NEUROL, V277, P302, DOI 10.1002/cne.902770210; Bell R M, 1986, Methods Enzymol, V124, P353; CHEN L, 1990, NEUROSCI LETT, V110, P66, DOI 10.1016/0304-3940(90)90788-B; CHERUBINI E, 1985, P NATL ACAD SCI USA, V82, P1860, DOI 10.1073/pnas.82.6.1860; CHO HJ, 1988, NEUROSCI LETT, V84, P125, DOI 10.1016/0304-3940(88)90395-3; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CRAIN SM, 1990, TRENDS PHARMACOL SCI, V11, P77, DOI 10.1016/0165-6147(90)90322-Y; DAUGHERTY PM, 1991, IN PRESS PAIN; DUBNER R, 1983, ANNU REV NEUROSCI, V6, P381, DOI 10.1146/annurev.ne.06.030183.002121; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FIELDS HL, 1987, PAIN, P133; GERBER G, 1989, J NEUROSCI, V9, P3606; GERBER G, 1989, NEUROSCI LETT, V106, P211, DOI 10.1016/0304-3940(89)90228-0; GROSS RA, 1987, P NATL ACAD SCI USA, V84, P5469, DOI 10.1073/pnas.84.15.5469; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; HUANG LYM, 1989, J PHYSIOL-LONDON, V411, P161, DOI 10.1113/jphysiol.1989.sp017566; IADAROLA MJ, 1988, PAIN, V35, P313, DOI 10.1016/0304-3959(88)90141-8; JAHR CE, 1985, J NEUROSCI, V5, P2281; KAJANDER KC, 1990, PEPTIDES, V11, P719, DOI 10.1016/0196-9781(90)90187-A; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; LOH HH, 1990, ANNU REV PHARMACOL, V30, P123; MACDERMOTT AB, 1986, J NEUROSCI, V7, P3230; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MADISON DV, 1988, J PHYSL, V398, P122; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NISHIMORI T, 1988, J COMP NEUROL, V274, P142, DOI 10.1002/cne.902740113; NORTH RA, 1986, TRENDS NEUROSCI, V9, P114; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PAN ZZ, 1990, J PHYSIOL-LONDON, V427, P519, DOI 10.1113/jphysiol.1990.sp018185; POTASHNER SJ, 1984, J NEUROCHEM, V42, P1135, DOI 10.1111/j.1471-4159.1984.tb12722.x; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; REZEL HR, 1963, METHOD ENZYMOL, V6, P211; RUDA MA, 1988, P NATL ACAD SCI USA, V85, P622, DOI 10.1073/pnas.85.2.622; SCHNEIDER SP, 1985, BRAIN RES, V360, P339, DOI 10.1016/0006-8993(85)91251-X; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; Segal M, 1988, NIDA Res Monogr, V82, P133; SIGGINS GR, 1981, P NATL ACAD SCI-BIOL, V78, P5235, DOI 10.1073/pnas.78.8.5235; SKILLING SR, 1988, J NEUROCHEM, V51, P127, DOI 10.1111/j.1471-4159.1988.tb04845.x; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; SURPRENANT A, 1990, J PHYSIOL-LONDON, V431, P585, DOI 10.1113/jphysiol.1990.sp018349; TATSUMI H, 1990, J NEUROSCI, V10, P1675; TORTELLA FC, 1988, TRENDS PHARMACOL SCI, V9, P366, DOI 10.1016/0165-6147(88)90256-8; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; UEDA H, 1988, P NATL ACAD SCI USA, V85, P7013, DOI 10.1073/pnas.85.18.7013; VANHOLDE KE, 1971, PHYSICAL BIOCH, P79; WESTLUND KN, 1989, NEUROSCI LETT, V96, P13, DOI 10.1016/0304-3940(89)90235-8; WILLCOCKSON WS, 1986, J NEUROSCI, V6, P2509; WILLIAMS JT, 1982, NATURE, V299, P74, DOI 10.1038/299074a0; WILLIS WD, 1985, PAIN SYSTEM NEURAL B, P145; WOOLF CJ, 1982, BRAIN RES, V242, P77, DOI 10.1016/0006-8993(82)90497-8; YAKSH TL, 1985, ANNU REV PHARMACOL, V25, P433, DOI 10.1146/annurev.pa.25.040185.002245; YAMAMOTO D, 1988, J PHYSIOL-LONDON, V400, P691, DOI 10.1113/jphysiol.1988.sp017144; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293	64	457	464	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					319	326		10.1016/0896-6273(91)90270-A	http://dx.doi.org/10.1016/0896-6273(91)90270-A			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1678615				2022-12-17	WOS:A1991GB93300015
J	Li, Y; Luikart, BW; Birnbaum, S; Chen, J; Kwon, CH; Kernie, SG; Bassel-Duby, R; Parada, LF				Li, Yun; Luikart, Bryan W.; Birnbaum, Shari; Chen, Jian; Kwon, Chang-Hyuk; Kernie, Steven G.; Bassel-Duby, Rhonda; Parada, Luis F.			TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment	NEURON			English	Article							ELEMENT-BINDING PROTEIN; FACTOR VAL66MET POLYMORPHISM; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; DENTATE GYRUS; ADULT NEUROGENESIS; CONDITIONAL DELETION; SIGNALING PATHWAYS; CHRONIC FLUOXETINE	Adult hippocampal neurogenesis is stimulated by chronic administration of antidepressants (ADs) and by voluntary exercise. Neural progenitor cells (NPCs) in the dentate gyrus (DG) that are capable of continuous proliferation and neuronal differentiation are the source of such structural plasticity. Here we report that mice lacking the receptor tyrosine kinase TrkB in hippocampal NPCs have impaired proliferation and neurogenesis. When exposed to chronic ADs or wheel-running, no increase in proliferation or neurogenesis is observed. Ablation of TrkB also renders these mice behaviorally insensitive to antidepressive treatment in depression- and anxiety-like paradigms. In contrast, mice lacking TrkB only in differentiated DG neurons display typical neurogenesis and respond normally to chronic ADs. Thus, our data establish an essential cell-autonomous role for TrkB in regulating hippocampal neurogenesis and behavioral sensitivity to antidepressive treatments, and support the notion that impairment of the neurogenic niche is an etiological factor for refractory responses to an antidepressive regimen.	[Li, Yun; Luikart, Bryan W.; Chen, Jian; Kwon, Chang-Hyuk; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; [Birnbaum, Shari] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Bassel-Duby, Rhonda] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Luikart, Bryan/D-2683-2012; Kwon, Chang-hyuk/E-3450-2011; Li, Yun/C-3367-2011; Kernie, Steven/AAT-9912-2020; Parada, luis F/B-9400-2014	Li, Yun/0000-0002-5849-5910; Kernie, Steven/0000-0003-1371-0549	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033199] Funding Source: NIH RePORTER; NICHD NIH HHS [K08 HD001470] Funding Source: Medline; NIMH NIH HHS [P50MH66172, P50 MH066172-070002, P50 MH066172, P50 MH066172-060002] Funding Source: Medline; NINDS NIH HHS [R37 NS033199-11, R37NS033199, R37 NS033199, R37 NS033199-10, R37 NS033199-09, R37 NS033199-08] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; ALVAREZBUYLLA A, 1992, EXP NEUROL, V115, P110, DOI 10.1016/0014-4886(92)90232-F; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Conti AC, 2002, J NEUROSCI, V22, P3262, DOI 10.1523/JNEUROSCI.22-08-03262.2002; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fagiolini A, 2003, BIOL PSYCHIAT, V53, P640, DOI 10.1016/S0006-3223(02)01670-0; Frazer A, 1997, J CLIN PSYCHOPHARM, V17, pS2, DOI 10.1097/00004714-199704001-00002; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KLEIN R, 1990, DEVELOPMENT, V109, P845; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lei L, 2005, GENE DEV, V19, P1354, DOI 10.1101/gad.1227705; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Liebl DJ, 2000, P NATL ACAD SCI USA, V97, P2297, DOI 10.1073/pnas.040562597; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Lush ME, 2008, J NEUROSCI, V28, P1580, DOI 10.1523/JNEUROSCI.5236-07.2008; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nibuya M, 1996, J NEUROSCI, V16, P2365; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; PORSOLT RD, 1987, ARCH INT PHARMACOD T, V288, P11; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Scharfman HE, 2007, SCIENCE, V315, P336, DOI 10.1126/science.1138711; Schule C, 2006, PSYCHONEUROENDOCRINO, V31, P1019, DOI 10.1016/j.psyneuen.2006.06.002; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Thase Michael E., 1995, P1081; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang JW, 2008, BIOL PSYCHIAT, V63, P640, DOI 10.1016/j.biopsych.2008.01.008; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; ZHOU XF, 1993, BRAIN RES, V622, P63, DOI 10.1016/0006-8993(93)90802-T	72	456	468	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 14	2008	59	3					399	412		10.1016/j.neuron.2008.06.023	http://dx.doi.org/10.1016/j.neuron.2008.06.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701066	Bronze, Green Accepted			2022-12-17	WOS:000258565500009
J	Feinberg, EH; VanHoven, MK; Bendesky, A; Wang, G; Fetter, RD; Shen, K; Bargmannl, CI				Feinberg, Evan H.; VanHoven, Miri K.; Bendesky, Andres; Wang, George; Fetter, Richard D.; Shen, Kang; Bargmannl, Cornelia I.			GFP reconstitution across synaptic partners (GRASP) defines cell contacts and Synapses in living nervous systems	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; ELECTRON-MICROSCOPIC EVIDENCE; CAENORHABDITIS-ELEGANS; C-ELEGANS; MOTOR-NEURONS; IMMUNOGLOBULIN SUPERFAMILY; HOMEODOMAIN PROTEIN; VISUAL-CORTEX; TETANUS TOXIN; SPECIFICITY	The identification of synaptic partners is challenging in dense nerve bundles, where many processes occupy regions beneath the resolution of conventional light microscopy. To address this difficulty, we have developed GRASP, a system to label membrane contacts and synapses between two cells in living animals. Two complementary fragments of GFP are expressed on different cells, tethered to extracellular domains of transmembrane carrier proteins. When the complementary GFP fragments are fused to ubiquitous transmembrane proteins, GFP fluorescence appears uniformly along membrane contacts between the two cells. When one or both GFP fragments are fused to synaptic transmembrane proteins, GFP fluorescence is tightly localized to synapses. GRASP marks known synaptic contacts in C. elegans, correctly identifies changes in mutants with altered synaptic specificity, and can uncover new information about synaptic locations as confirmed by electron microscopy. GRASP may prove particularly useful for defining connectivity in complex nervous systems.	[VanHoven, Miri K.; Wang, George; Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Feinberg, Evan H.; Bendesky, Andres; Bargmannl, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; [Fetter, Richard D.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Stanford University; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute	Shen, K (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu; cori@rockefeller.edu		Bendesky, Andres/0000-0002-4220-3653; VanHoven, Miri/0000-0001-7714-1555; Bargmann, Cornelia/0000-0002-8484-0618	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077391] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM077391] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; ARMSTRONG JD, 1995, NEURON, V15, P17, DOI 10.1016/0896-6273(95)90059-4; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; BRENNER S, 1974, GENETICS, V77, P71; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; CABOT JB, 1991, NEUROSCIENCE, V40, P805, DOI 10.1016/0306-4522(91)90014-F; CARD JP, 1990, J NEUROSCI, V10, P1974; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Combes D, 2003, EUR J NEUROSCI, V18, P497, DOI 10.1046/j.1460-9568.2003.02749.x; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; Mello C, 1995, METHOD CELL BIOL, V48, P451; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; PESCHANSKI M, 1985, J COMP NEUROL, V236, P29, DOI 10.1002/cne.902360104; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SCHWAB ME, 1976, BRAIN RES, V105, P213, DOI 10.1016/0006-8993(76)90422-4; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shen K, 2004, CURR OPIN NEUROBIOL, V14, P83, DOI 10.1016/j.conb.2004.01.007; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vogel BE, 2001, DEVELOPMENT, V128, P883; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITE JG, 1992, NATURE, V355, P838, DOI 10.1038/355838a0; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	48	455	467	5	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					353	363		10.1016/j.neuron.2007.11.030	http://dx.doi.org/10.1016/j.neuron.2007.11.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255029	Bronze			2022-12-17	WOS:000253075300006
J	Ferezou, I; Haiss, F; Gentet, LJ; Aronoff, R; Weber, B; Petersen, CCH				Ferezou, Isabelle; Haiss, Florent; Gentet, Luc J.; Aronoff, Rachel; Weber, Bruno; Petersen, Carl C. H.			Spatiotemporal dynamics of cortical sensorimotor integration in behaving mice	NEURON			English	Article							RAT BARREL CORTEX; VIBRISSAL MOTOR CORTEX; SENSORY RESPONSES; IN-VIVO; CORTICOTHALAMIC PROJECTIONS; FUNCTIONAL ARCHITECTURE; NEOCORTICAL NEURONS; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; FIRING PATTERNS	Tactile information is actively acquired and processed in the brain through concerted interactions between movement and sensation. Somatosensory input is often the result of self-generated movement during the active touch of objects, and conversely, sensory information is used to refine motor control. There must therefore be important interactions between sensory and motor pathways, which we chose to investigate in the mouse whisker sensorimotor system. Voltage-sensitive dye was applied to the neocortex of mice to directly image the membrane potential dynamics of sensorimotor cortex with subcolumnar spatial resolution and millisecond temporal precision. Single brief whisker deflections evoked highly distributed depolarizing cortical sensory responses, which began in the primary somatosensory barrel cortex and subsequently excited the whisker motor cortex. The spread of sensory information to motor cortex was dynamically regulated by behavior and correlated with the generation of sensory-evoked whisker movement. Sensory processing in motor cortex may therefore contribute significantly to active tactile sensory perception.	[Ferezou, Isabelle; Gentet, Luc J.; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland; [Haiss, Florent; Weber, Bruno] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Zurich	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Weber, Bruno/E-4400-2013; Gentet, Luc/GNN-0460-2022; Petersen, Carl/M-5123-2017; Gentet, Luc J/H-5127-2017; Ferezou, Isabelle/B-4454-2012; Haiss, Florent/L-1685-2015	Gentet, Luc/0000-0001-6509-1001; Petersen, Carl/0000-0003-3344-4495; Gentet, Luc J/0000-0001-6509-1001; Haiss, Florent/0000-0001-8351-3685; Aronoff, Rachel/0000-0001-5813-2899; Ferezou, Isabelle/0000-0001-7602-1295				Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; Alloway KD, 2004, J COMP NEUROL, V480, P299, DOI 10.1002/cne.20339; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Aronoff R, 2006, J CELL MOL MED, V10, P333, DOI 10.1111/j.1582-4934.2006.tb00403.x; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Berg RW, 2005, J NEUROPHYSIOL, V94, P699, DOI 10.1152/jn.01125.2004; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Borgdorff AJ, 2007, J NEUROPHYSIOL, V97, P2992, DOI 10.1152/jn.00013.2007; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bulkin DA, 2006, CURR OPIN NEUROBIOL, V16, P415, DOI 10.1016/j.conb.2006.06.008; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2006, J NEUROPHYSIOL, V96, P1691, DOI 10.1152/jn.00454.2006; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; Civillico EF, 2006, J NEUROPHYSIOL, V96, P336, DOI 10.1152/jn.00128.2006; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Cramer NP, 2007, J NEUROPHYSIOL, V97, P2148, DOI 10.1152/jn.01187.2006; Cramer NP, 2006, J NEUROPHYSIOL, V96, P209, DOI 10.1152/jn.00071.2006; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; FRANKLIN KBJ, 1996, MOUSER BRAIN STEREOT; Fu KMG, 2003, J NEUROSCI, V23, P7510; Gao PH, 2003, SOMATOSENS MOT RES, V20, P191, DOI 10.1080/08990220310001622924; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hentschke H, 2006, CEREB CORTEX, V16, P1142, DOI 10.1093/cercor/bhj056; Hoffer ZS, 2003, J COMP NEUROL, V466, P525, DOI 10.1002/cne.10895; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lavallee P, 2005, J NEUROSCI, V25, P7489, DOI 10.1523/JNEUROSCI.2301-05.2005; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; LOVICK TA, 1972, J PHYSL, V224, pP4; Macaluso E, 2006, NEUROSCIENTIST, V12, P327, DOI 10.1177/1073858406287908; Martuzzi R, 2007, CEREB CORTEX, V17, P1672, DOI 10.1093/cercor/bhl077; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Trageser JC, 2006, J NEUROPHYSIOL, V96, P1456, DOI 10.1152/jn.00423.2006; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WHITE EL, 1977, J COMP NEUROL, V175, P455, DOI 10.1002/cne.901750405; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	88	455	459	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2007	56	5					907	923		10.1016/j.neuron.2007.10.007	http://dx.doi.org/10.1016/j.neuron.2007.10.007			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054865	Green Submitted, Bronze			2022-12-17	WOS:000251659300015
J	Helmchen, F; Fee, MS; Tank, DW; Denk, W				Helmchen, F; Fee, MS; Tank, DW; Denk, W			A miniature head-mounted two-photon microscope: High-resolution brain imaging in freely moving animals	NEURON			English	Article							DENDRITIC CALCIUM DYNAMICS; NEOCORTICAL PYRAMIDAL NEURONS; GREEN FLUORESCENT PROTEINS; CORTEX IN-VIVO; ACTION-POTENTIALS; BEHAVING ANIMALS; RAT; INTEGRATION; HIPPOCAMPAL; INDICATOR	Two-photon microscopy has enabled anatomical and functional fluorescence imaging in the intact brain of rats. Here, we extend two-photon imaging from anesthetized, head-stabilized to awake, freely moving animals by using a miniaturized head-mounted microscope. Excitation light is conducted to the microscope in a single-mode optical fiber, and images are scanned using vibrations of the fiber tip. Microscope performance was first characterized in the neocortex of anesthetized rats. We readily obtained images of vasculature filled with fluorescently labeled blood and of layer 2/3 pyramidal neurons filled with a calcium indicator. Capillary blood flow and dendritic calcium transients were measured with high time resolution using line scans. In awake, freely moving rats, stable imaging was possible except during sudden head movements.	Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Alcatel-Lucent; Lucent Technologies; AT&T; Max Planck Society	Denk, W (corresponding author), Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA.		denk, winfried/I-6627-2012; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569; Fee, Michale/0000-0001-7539-1745				Agrawal G. P., 2012, NONLINEAR FIBER OPTI; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BIRGE RR, 1986, ACCOUNTS CHEM RES, V19, P138, DOI 10.1021/ar00125a003; BORST A, 1992, P NATL ACAD SCI USA, V89, P4139, DOI 10.1073/pnas.89.9.4139; Bussau LJ, 1998, J ANAT, V192, P187, DOI 10.1046/j.1469-7580.1998.19220187.x; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Davis MD, 2000, J NEUROSCI METH, V99, P9, DOI 10.1016/S0165-0270(00)00209-0; deCharms RC, 1999, J NEUROSCI METH, V93, P27, DOI 10.1016/S0165-0270(99)00087-4; Delaney P. M., 1995, P515; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Denk Winfried, 1995, P445; Dickensheets DL, 1996, OPT LETT, V21, P764, DOI 10.1364/OL.21.000764; DIRNAGL U, 1992, J MICROSC-OXFORD, V165, P147, DOI 10.1111/j.1365-2818.1992.tb04312.x; Eilers J, 1997, CURR OPIN NEUROBIOL, V7, P385, DOI 10.1016/S0959-4388(97)80067-0; Fee MS, 2000, NEURON, V27, P461, DOI 10.1016/S0896-6273(00)00057-X; FORK RL, 1984, OPT LETT, V9, P150, DOI 10.1364/OL.9.000150; GOSNELL TR, 1991, SELECTED PAPERS ULTR; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hofmann U, 1999, P SOC PHOTO-OPT INS, V3878, P29, DOI 10.1117/12.361269; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LISSAJOUS JA, 1855, CR HEBD ACAD SCI, V41, P814; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Papworth GD, 1998, J ANAT, V192, P489, DOI 10.1046/j.1469-7580.1998.19240489.x; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; Rector DM, 1997, J NEUROSCI METH, V78, P85, DOI 10.1016/S0165-0270(97)00137-4; RECTOR DM, 1993, NEUROSCIENCE, V54, P633, DOI 10.1016/0306-4522(93)90234-7; Regehr Wade G., 1994, Current Opinion in Neurobiology, V4, P373, DOI 10.1016/0959-4388(94)90099-X; Sabharwal YS, 1999, APPL OPTICS, V38, P7133, DOI 10.1364/AO.38.007133; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TREACY EB, 1969, IEEE J QUANTUM ELECT, VQE 5, P454, DOI 10.1109/JQE.1969.1076303; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; YUSTE R, 1999, IMAGING NEURONS LAB	42	455	487	6	67	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					903	912		10.1016/S0896-6273(01)00421-4	http://dx.doi.org/10.1016/S0896-6273(01)00421-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580892	Bronze			2022-12-17	WOS:000171281300007
J	Frank, LM; Brown, EN; Wilson, M				Frank, LM; Brown, EN; Wilson, M			Trajectory encoding in the hippocampus and entorhinal cortex	NEURON			English	Article							FREELY-MOVING RATS; SPATIAL FIRING PATTERNS; SINGLE UNIT-ACTIVITY; PLACE CELLS; NEURONAL-ACTIVITY; WORKING-MEMORY; DIRECTION; SYSTEM; SPACE; POSTSUBICULUM	We recorded from single neurons in the hippocampus and entorhinal cortex (EC) of rats to investigate the role of these structures in navigation and memory representation. Our results revealed two novel phenomena: first, many cells in CA1 and the EC fired at significantly different rates when the animal was in the same position depending on where the animal had come from or where it was going. Second, cells in deep layers of the EC, the targets of hippocampal outputs, appeared to represent the similarities between locations on spatially distinct trajectories through the environment. Our findings suggest that the hippocampus represents the animal's position in the context of a trajectory through space and that the EC represents regularities across different trajectories that could allow for generalization across experiences.	MIT, Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Anesthesia & Crit Care, MIT Div Hlth Sci & Technol,Stat Res Lab, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Frank, LM (corresponding author), MIT, Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	loren@srlb4.mgh.harvard.edu; wilson@ai.mit.edu		Frank, Loren/0000-0002-1752-5677	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059733, K02MH061637] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH059733, K02 MH061637, MH59733, MH61637] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; BARNES CA, 1990, PROG BRAIN RES, V83, P287; BERGER TW, 1978, BRAIN RES, V145, P323, DOI 10.1016/0006-8993(78)90866-1; Cho YH, 1996, BEHAV NEUROSCI, V110, P436, DOI 10.1037/0735-7044.110.3.436; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McCullaugh P., 1989, GEN LINEAR MODELS; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MIZUMORI SJY, 1992, BRAIN RES, V570, P188, DOI 10.1016/0006-8993(92)90581-S; Muller FO, 1996, BIOPHARM DRUG DISPOS, V17, P81; MULLER RU, 1989, J NEUROSCI, V9, P4101; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Rainer G, 1999, J NEUROSCI, V19, P5493; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; RASMUSSEN M, 1989, PSYCHOBIOLOGY, V17, P335; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; SHARP PE, 1994, J NEUROSCI, V14, P2339; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Taube JS, 1998, HIPPOCAMPUS, V8, P87, DOI 10.1002/(SICI)1098-1063(1998)8:2<87::AID-HIPO1>3.0.CO;2-4; Taube JS, 1996, BRAIN RES BULL, V40, P477, DOI 10.1016/0361-9230(96)00145-1; TAUBE JS, 1990, J NEUROSCI, V10, P420; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	34	455	458	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	2000	27	1					169	178		10.1016/S0896-6273(00)00018-0	http://dx.doi.org/10.1016/S0896-6273(00)00018-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339XU	10939340	Bronze			2022-12-17	WOS:000088503800019
J	Wojciulik, E; Kanwisher, N				Wojciulik, E; Kanwisher, N			The generality of parietal involvement in visual attention	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; HUMAN EXTRASTRIATE CORTEX; WORKING-MEMORY; SUSTAINED ATTENTION; SELECTIVE ATTENTION; UNILATERAL NEGLECT; FUNCTIONAL-ANATOMY; DIRECTED ATTENTION; NEURAL SYSTEMS; BRAIN ACTIVITY	Functional magnetic resonance imaging (fMRI) was used to determine whether different kinds of visual attention rely on a common neural substrate. Within one session, subjects performed three different attention experiments (each comparing an attentionally demanding task with an easier task using identical stimuli): (1) peripheral shifting, (2) object matching, and (3) a nonspatial conjunction task. Two areas were activated in all three experiments: one at the junction of intraparietal and transverse occipital sulci (IPTO), and another in the anterior intraparietal sulcus (AIPS). These regions are not simply involved in any effortful task, because they were not activated in a fourth experiment comparing a difficult language task with an easier control task. Thus, activity in IPTO and AIPS generalizes across a wide variety of attention-requiring tasks, supporting the existence of a common neural substrate underlying multiple modes of visual selection.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	University of California System; University of California Los Angeles; University of London; University College London; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Wojciulik, E (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	e.wojciulik@ucl.ac.uk			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056037] Funding Source: NIH RePORTER; NIMH NIH HHS [MH56037] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aguirre GK, 1998, MAGNET RESON MED, V39, P500, DOI 10.1002/mrm.1910390322; ALLPORT A, 1993, ATTENTION PERFORM, V14, P183; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; Ardaman MF, 1996, INT J NEURORADIOL, V2, P374; Behrmann M, 1999, CURR OPIN NEUROBIOL, V9, P158, DOI 10.1016/S0959-4388(99)80021-X; BEHRMANN M, 1994, ATTENTION PERFORM, V15, P351; COLBY CL, 1996, ATTENTION PERFORM, V16, P157; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DRIVER J, 1991, COGNITIVE NEUROPSYCH, V8, P475, DOI 10.1080/02643299108253384; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; DUNCAN J, 1999, IN PRESS CONTROL COG, V18; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Eglin M, 1989, J Cogn Neurosci, V1, P372, DOI 10.1162/jocn.1989.1.4.372; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Fink GR, 1997, BRAIN, V120, P2013, DOI 10.1093/brain/120.11.2013; GREEN DM, 1966, SIGNAL DETECTION THE; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Husain M, 1997, NATURE, V385, P154, DOI 10.1038/385154a0; Iacoboni M, 1996, J NEUROPHYSIOL, V76, P321, DOI 10.1152/jn.1996.76.1.321; Jiang AP, 1995, HUM BRAIN MAPP, V3, P224, DOI 10.1002/hbm.460030306; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; PRICE CJ, 1994, BRAIN, V117, P1255, DOI 10.1093/brain/117.6.1255; Puce A, 1996, J NEUROSCI, V16, P5205; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; ROLAND PE, 1993, WENN GR INT, P373; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1997, J NEUROSCI, V17, P7060; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vandenberghe R, 1997, J NEUROSCI, V17, P3739; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574	54	455	466	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					747	764		10.1016/S0896-6273(01)80033-7	http://dx.doi.org/10.1016/S0896-6273(01)80033-7			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482241	Bronze			2022-12-17	WOS:000082280900018
J	Haxby, JV; Ungerleider, LG; Clark, VP; Schouten, JL; Hoffman, EA; Martin, A				Haxby, JV; Ungerleider, LG; Clark, VP; Schouten, JL; Hoffman, EA; Martin, A			The effect of face inversion on activity in human neural systems for face and object perception	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; HUMAN EXTRASTRIATE CORTEX; HUMAN VISUAL-CORTEX; RECOGNITION; PET; KNOWLEDGE	The differential effect of stimulus inversion on face and object recognition suggests that inverted faces are processed by mechanisms for the perception of other objects rather than by face perception mechanisms. We investigated the face inversion using functional magnetic resonance imaging (fMRI). The principal effect of face inversion on was an increased response in ventral extrastriate regions that respond preferentially to another class of objects (houses). In contrast, house inversion did not produce a similar change in face-selective regions. Moreover, stimulus inversion had equivalent, minimal effects for faces in in face-selective regions and for houses in house-selective regions. The results suggest that the failure of face perception systems with inverted faces leads to the recruitment of processing resources in object perception systems, but this failure is not reflected by altered activity in face perception systems.	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Connecticut	Haxby, JV (corresponding author), NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA.		martin, alex/B-6176-2009; Clark, Vincent P/B-3343-2010	Clark, Vincent P/0000-0002-9151-2102				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Clark VP, 1996, NEUROIMAGE, V4, P1, DOI 10.1006/nimg.1996.0025; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; de Gelder B, 1998, VISION RES, V38, P2855, DOI 10.1016/S0042-6989(97)00458-6; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1991, COGNITIVE NEUROPSYCH, V8, P1, DOI 10.1080/02643299108253364; Farah MJ, 1996, BEHAV BRAIN RES, V76, P181, DOI 10.1016/0166-4328(95)00198-0; FARAH MJ, 1995, VISION RES, V35, P2089, DOI 10.1016/0042-6989(94)00273-O; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; HAXBY JV, 1993, BEHAV RES METH INSTR, V25, P400, DOI 10.3758/BF03204531; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HAXBY JV, 1999, IN PRESS MAPPING MOD; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KOHLER S, 1995, NEUROREPORT, V6, P1865, DOI 10.1097/00001756-199510020-00011; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1998, J NEUROSCI, V18, P2188; Rencher A.C., 1995, METHODS MULTIVARIATE; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Talairach J., 1988, COPLANAR STEREOTAXIC; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; YIN RK, 1970, NEUROPSYCHOLOGIA, V8, P395, DOI 10.1016/0028-3932(70)90036-9; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	37	455	461	1	48	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					189	199		10.1016/S0896-6273(00)80690-X	http://dx.doi.org/10.1016/S0896-6273(00)80690-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	163MV	10027301	Bronze			2022-12-17	WOS:000078410300024
J	Gensert, JM; Goldman, JE				Gensert, JM; Goldman, JE			Endogenous progenitors remyelinate demyelinated axons in the adult CNS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; SPINAL-CORD; LYSOPHOSPHATIDYL CHOLINE; MATURE OLIGODENDROCYTES; CELL LINEAGE; IN-VIVO; PROLIFERATION; LESIONS; MOUSE	Remyelination occurs in demyelinated CNS regions in diseases such as multiple sclerosis. Identification of the cell type(s) responsible for this remyelination, however, has been elusive. Here, we examine one potential source of remyelinating oligodendrocytes-immature, cycling cells endogenous to adult white matter-and demonstrate that this population responds to demyelination by differentiating into myelinating oligodendrocytes. Dividing cells in subcortical white matter of adult rats were labeled by stereotactic injection of a replication-deficient lacZ-encoding retrovirus (BAG). Following a focal demyelination induced with lysolecithin, many of the BAG-labeled cells differentiated into myelinating oligodendrocytes engaging in repair of the lesion. Identification of endogenous cells capable of remyelination provides a target for the study of CNS repair processes in demyelinating diseases.	COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Columbia University; Columbia University	Gensert, JM (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PHYSIOL & CELLULAR BIOPHYS, NEW YORK, NY 10032 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017125] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-17125] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen I.V., 1992, GREENFIELDS NEUROPAT, P447; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; ANDERSSON C, 1993, INT J DEV NEUROSCI, V11, P555, DOI 10.1016/0736-5748(93)90045-F; ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BLAKEMORE WF, 1996, GLIAL CELL DEV BASIC, P209; COMPSTON A, 1994, ANN NEUROL, V36, pS146, DOI 10.1002/ana.410360736; DALTON MM, 1968, J COMP NEUROL, V134, P397, DOI 10.1002/cne.901340403; DASTON MM, 1994, J NEUROCYTOL, V23, P323, DOI 10.1007/BF01188500; DEIBLER GE, 1972, PREP BIOCHEM, V2, P139, DOI 10.1080/00327487208061467; DUNCAN ID, 1992, DEV NEUROSCI-BASEL, V14, P114, DOI 10.1159/000111655; DUNCAN ID, 1994, NATO ADV SCI INST SE, V258, P195; EMMETT CJ, 1991, J COMP NEUROL, V310, P330; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; Gensert JM, 1996, GLIA, V17, P39; HALL SM, 1972, J CELL SCI, V10, P535; HALL SM, 1971, J CELL SCI, V9, P769; HOMMES OR, 1967, J COMP NEUROL, V29, P269; Honmou O, 1996, J NEUROSCI, V16, P3199; LUDWIN SK, 1993, GLIA, V8, P219, DOI 10.1002/glia.440080402; LUDWIN SK, 1994, ANN NEUROL, V36, pS143, DOI 10.1002/ana.410360735; LUDWIN SK, 1988, J NEUROSCI, V8, P1239; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; LUDWIN SK, 1987, CRIT REV NEUROBIOL, V3, P1; LUDWIN SK, 1979, AM J PATHOL, V95, P683; Noble M, 1992, Semin Cell Biol, V3, P413, DOI 10.1016/1043-4682(92)90012-K; PRICE J, 1987, DEVELOPMENT, V101, P409; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PRINEAS JW, 1993, ANN NEUROL, V33, P137, DOI 10.1002/ana.410330203; PRINEAS JW, 1989, LAB INVEST, V61, P489; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; RAINE CS, 1981, LAB INVEST, V45, P534; RAINE CS, 1991, TXB NEUROPATHOLOGY, P535; RMO S, 1995, HISTOLOGY NERVOUS SY, V2, P589; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Szuchet Sara, 1995, P23; VIGNAIS L, 1993, INT J DEV NEUROSCI, V11, P603, DOI 10.1016/0736-5748(93)90049-J; WOLSWIJK G, 1989, DEVELOPMENT, V105, P3387; WOOD PM, 1991, GLIA, V4, P225, DOI 10.1002/glia.440040214; WU E, 1992, LAB INVEST, V67, P88	42	455	467	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL	1997	19	1					197	203		10.1016/S0896-6273(00)80359-1	http://dx.doi.org/10.1016/S0896-6273(00)80359-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247275	Bronze			2022-12-17	WOS:A1997XN39400018
J	Zhou, J; Gennatas, ED; Kramer, JH; Miller, BL; Seeley, WW				Zhou, Juan; Gennatas, Efstathios D.; Kramer, Joel H.; Miller, Bruce L.; Seeley, William W.			Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome	NEURON			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; PARKINSONS-DISEASE; BETA-AMYLOIDOSIS; TRANSMISSION; CONNECTIVITY; TRANSPORT; NEURONS; HUBS	Neurodegenerative diseases target large-scale neural networks. Four competing mechanistic hypotheses have been proposed to explain network-based disease patterning: nodal stress, transneuronal spread, trophic failure, and shared vulnerability. Here, we used task-free fMRI to derive the healthy intrinsic connectivity patterns seeded by brain regions vulnerable to any of five distinct neurodegenerative diseases. These data enabled us to investigate how intrinsic connectivity in health predicts region-by-region vulnerability to disease. For each illness, specific regions emerged as critical network "epicenters" whose normal connectivity profiles most resembled the disease-associated atrophy pattern. Graph theoretical analyses in healthy subjects revealed that regions with higher total connectional flow and, more consistently, shorter functional paths to the epicenters, showed greater disease-related vulnerability. These findings best fit a transneuronal spread model of network-based vulnerability. Molecular pathological approaches may help clarify what makes each epicenter vulnerable to its targeting disease and how toxic protein species travel between networked brain structures.	[Zhou, Juan; Gennatas, Efstathios D.; Kramer, Joel H.; Miller, Bruce L.; Seeley, William W.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Seeley, WW (corresponding author), Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA.	wseeley@memory.ucsf.edu		Gennatas, Efstathios/0000-0001-9280-3609; Zhou, Juan/0000-0002-0180-8648	National Institute of Aging (NIA) [AG19724, AG1657303]; Larry L. Hillblom Foundation; John Douglas French Alzheimer Foundation; Consortium for Frontotemporal Dementia Research; NATIONAL INSTITUTE ON AGING [P01AG019724, P50AG023501, P50AG016573] Funding Source: NIH RePORTER	National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Larry L. Hillblom Foundation; John Douglas French Alzheimer Foundation; Consortium for Frontotemporal Dementia Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Aging (NIA grants AG19724 and AG1657303 to B.L.M. and W.W.S.), the Larry L. Hillblom Foundation (W.W.S. and J.H.K.), and the John Douglas French Alzheimer Foundation (W.W.S.), and the Consortium for Frontotemporal Dementia Research. We thank our research participants and their families for contributing to neurodegeneration research.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; BAKER HF, 1993, INT J EXP PATHOL, V74, P441; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kim EJ, 2005, BRAIN, V128, P1790, DOI 10.1093/brain/awh539; Kim EJ, 2012, CEREB CORTEX, V22, P251, DOI 10.1093/cercor/bhr004; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Mesulam M, 2012, NEUROIMAGE, V62, P2182, DOI 10.1016/j.neuroimage.2011.12.033; Miller B.L., 2009, BEHAV NEUROLOGY DEME; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1984, NEW ENGL J MED, V310, P661, DOI 10.1056/NEJM198403083101021; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SAPER CB, 1987, NEUROSCIENCE, V23, P389, DOI 10.1016/0306-4522(87)90063-7; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Scheinin NM, 2009, NEUROLOGY, V73, P1186, DOI 10.1212/WNL.0b013e3181bacf1b; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weintraub S., 1996, LA DEMENCE POURQUOI, P75; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	48	454	462	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 22	2012	73	6					1216	1227		10.1016/j.neuron.2012.03.004	http://dx.doi.org/10.1016/j.neuron.2012.03.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445348	Green Accepted, Bronze			2022-12-17	WOS:000301998700018
J	XUAN, SH; BAPTISTA, CA; BALAS, G; TAO, WF; SOARES, VC; LAI, E				XUAN, SH; BAPTISTA, CA; BALAS, G; TAO, WF; SOARES, VC; LAI, E			WINGED HELIX TRANSCRIPTION FACTOR BF-1 IS ESSENTIAL FOR THE DEVELOPMENT OF THE CEREBRAL HEMISPHERES	NEURON			English	Article							GENE FORK-HEAD; NERVOUS-SYSTEM; RESTRICTED EXPRESSION; TARGETED MUTATION; HOMEOBOX GENES; MOUSE EMBRYO; MICE; FAMILY; ORGANIZATION; DISRUPTION	We generated mice with a null mutation of the forebrain-restricted transcription factor BF-1 to examine its function in brain development. Heterozygous animals have an apparently normal phenotype. Homozygous null BF-1 mutants die at birth and have a dramatic reduction in the size of the cerebral hemispheres. The development of the ventral telencephalon is more severely affected than that of the dorsal telencephalon. Telencephalic neuroepithelial cells are specified in the BF-1 mutant, but their proliferation is reduced. Dorsal telencephalic neuroepithelial cells also differentiate prematurely, leading to early depletion of the progenitor population. These results suggest that BF-1 controls the morphogenesis of the telencephalon by regulating the rate of neuroepithelial cell proliferation and the timing of neuronal differentiation.	CORNELL UNIV,MEM SLOAN KETTERING CANC CTR,GRAD SCH MED SCI,SLOAN KETTERING DIV,NEW YORK,NY 10021	Cornell University; Memorial Sloan Kettering Cancer Center	XUAN, SH (corresponding author), CORNELL UNIV,MEM SLOAN KETTERING CANC CTR,GRAD SCH MED SCI,DIV ENDOCRINOL,NEW YORK,NY 10021, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029584] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD29584] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altman J. B. S., 1995, ATLAS PRENATAL RAT B; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BERRY M, 1964, NATURE, V205, P591; BONNEROT C, 1993, GUIDE TECHNIQUES MOU, P451; CALVNESS V, 1973, J COMP NEUROL, V148, P141; CHALEPAKIS G, 1993, J NEUROBIOL, V24, P1367, DOI 10.1002/neu.480241009; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; CRANDALL JE, 1986, DEV BRAIN RES, V28, P127, DOI 10.1016/0165-3806(86)90072-6; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; DURONIO RJ, 1994, DEVELOPMENT, V120, P1503; EDGAR BA, 1994, DEVELOPMENT, V120, P3131; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; HOFMAN MA, 1989, PROG NEUROBIOL, V32, P137, DOI 10.1016/0301-0082(89)90013-0; Hogan B., 1986, MANIPULATING MOUSE E; HOSHINO K, 1973, EXP CELL RES, V77, P89, DOI 10.1016/0014-4827(73)90556-9; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KEYNES R, 1990, NEURON, V4, P1, DOI 10.1016/0896-6273(90)90438-L; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEMOUELLIC H, 1990, P NATL ACAD SCI USA, V87, P4712, DOI 10.1073/pnas.87.12.4712; LI J, 1993, P NATL ACAD SCI USA, V90, P4490, DOI 10.1073/pnas.90.10.4490; MARINPADILLA M, 1990, J COMP NEUROL, V299, P89, DOI 10.1002/cne.902990107; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MILLAR JBA, 1992, CELL, V68, P407, DOI 10.1016/0092-8674(92)90177-E; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WALTHER C, 1991, DEVELOPMENT, V113, P1435	44	454	457	0	7	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1995	14	6					1141	1152		10.1016/0896-6273(95)90262-7	http://dx.doi.org/10.1016/0896-6273(95)90262-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RF987	7605629	hybrid			2022-12-17	WOS:A1995RF98700006
J	TREVARROW, B; MARKS, DL; KIMMEL, CB				TREVARROW, B; MARKS, DL; KIMMEL, CB			ORGANIZATION OF HINDBRAIN SEGMENTS IN THE ZEBRAFISH EMBRYO	NEURON			English	Article									UNIV OREGON,INST NEUROSCI,EUGENE,OR 97403	University of Oregon					NIGMS NIH HHS [T32 GMO 7413] Funding Source: Medline; NINDS NIH HHS [NS17963] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017963] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAM M, 1988, DEVELOPMENT, V104, P123; CIMENT G, 1982, DEV BIOL, V93, P355, DOI 10.1016/0012-1606(82)90123-3; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; EATON RC, 1988, J NEUROSCI, V8, P2758; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; Herrick CJ, 1914, J COMP NEUROL, V24, P343, DOI 10.1002/cne.900240402; HILL C, 1900, ZOOL JB, V13, P393; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; JACOBS JR, 1989, J NEUROSCI, V9, P2412; Kappers CUA, 1936, COMP ANATOMY NERVOUS, VI; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; KIMMEL CB, 1985, J COMP NEUROL, V233, P365, DOI 10.1002/cne.902330306; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1988, DEVELOPMENT, V104, P197; KIMMEL CB, 1989, TRENDS GENET, V5, P283, DOI 10.1016/0168-9525(89)90103-0; Kuhlenbeck H., 1973, CENTRAL NERVOUS SY 2, V3; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MATTHEW WD, 1983, COLD SPRING HARB SYM, V48, P625, DOI 10.1101/SQB.1983.048.01.066; MENDELSON B, 1986, J COMP NEUROL, V251, P160, DOI 10.1002/cne.902510203; MENDELSON B, 1986, J COMP NEUROL, V251, P172, DOI 10.1002/cne.902510204; Metcalfe W.K., 1989, P147; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; MITTENTHAL JE, 1979, J THEOR BIOL, V81, P129, DOI 10.1016/0022-5193(79)90086-9; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; Nieuwenhuys R, 1977, Ann N Y Acad Sci, V299, P97, DOI 10.1111/j.1749-6632.1977.tb41902.x; PATTERSON PH, 1988, NEURON, V1, P263, DOI 10.1016/0896-6273(88)90074-8; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; STEINDLER DA, 1989, COMMENTS DEV NEUROBI, V1, P29; STERNBERGER LA, 1973, IMMUNOCYTOCHEMISTRY; TEUGELS E, 1985, NATURE, V314, P558, DOI 10.1038/314558a0; THOMAS JB, 1984, DEV BIOL, V102, P531, DOI 10.1016/0012-1606(84)90222-7; TUCKETT F, 1985, J EMBRYOL EXP MORPH, V88, P231; TUCKETT F, 1985, J EMBRYOL EXP MORPH, V87, P215; Vaage S., 1969, ERG ANAT ENTWICKLU, V41, P1; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WRIGHT CVE, 1989, CELL, V59, P81, DOI 10.1016/0092-8674(89)90871-4; [No title captured]	44	454	455	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1990	4	5					669	679		10.1016/0896-6273(90)90194-K	http://dx.doi.org/10.1016/0896-6273(90)90194-K			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE975	2344406				2022-12-17	WOS:A1990DE97500003
J	Britt, JP; Benaliouad, F; McDevitt, RA; Stuber, GD; Wise, RA; Bonci, A				Britt, Jonathan P.; Benaliouad, Faiza; McDevitt, Ross A.; Stuber, Garret D.; Wise, Roy A.; Bonci, Antonello			Synaptic and Behavioral Profile of Multiple Glutamatergic Inputs to the Nucleus Accumbens	NEURON			English	Article							PREFRONTAL CORTICAL INPUTS; MIDBRAIN DOPAMINE NEURONS; AMPA RECEPTOR TRAFFICKING; EXCITATORY TRANSMISSION; MOLECULAR-MECHANISMS; PROLONGED WITHDRAWAL; PROJECTION NEURONS; DIRECTED BEHAVIOR; STRIATAL NEURONS; COCAINE	Excitatory afferents to the nucleus accumbens (NAc) are thought to facilitate reward seeking by encoding reward-associated cues. Selective activation of different glutamatergic inputs to the NAc can produce divergent physiological and behavioral responses, but mechanistic explanations for these pathway-specific effects are lacking. Here, we compared the innervation patterns and synaptic properties of ventral hippocampus, basolateral amygdala, and prefrontal cortex input to the NAc. Ventral hippocampal input was found to be uniquely localized to the medial NAc shell, where it was predominant and selectively potentiated after cocaine exposure. In vivo, bidirectional optogenetic manipulations of this pathway attenuated and enhanced cocaine-induced locomotion. Challenging the idea that any of these inputs encode motivationally neutral information, activation of each discrete pathway reinforced instrumental behaviors. Finally, direct optical activation of medium spiny neurons proved to be capable of supporting self-stimulation, demonstrating that behavioral reinforcement is an explicit consequence of strong excitatory drive to the NAc.	[Bonci, Antonello] Johns Hopkins Univ, Solomon H Snyder Neurosci Inst, Sch Med, Baltimore, MD 21205 USA; [Britt, Jonathan P.; Benaliouad, Faiza; McDevitt, Ross A.; Wise, Roy A.; Bonci, Antonello] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Britt, Jonathan P.; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Stuber, Garret D.] Univ N Carolina, Dept Psychiat, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bonci, A (corresponding author), Johns Hopkins Univ, Solomon H Snyder Neurosci Inst, Sch Med, Baltimore, MD 21205 USA.	antonello.bonci@nih.gov	Stuber, Garret/E-1160-2011; Britt, jonathan/D-8877-2011	Britt, jonathan/0000-0003-3044-9565; Stuber, Garret/0000-0003-1730-4855	National Institute on Drug Abuse [DA029325, DA032750]; National Institutes of Health, National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000578, ZIADA000471, R37DA032750, R21DA029325, R01DA032750] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Janice Joo, Dhara Patel, Stephanie Chung, Saemi Cho, and Michael Chiang for technical help. This work was supported by the National Institute on Drug Abuse (DA029325 and DA032750; G.D.S.) and the Intramural Research Program of the National Institutes of Health, National Institute on Drug Abuse.	Badiani A, 2011, NAT REV NEUROSCI, V12, P685, DOI 10.1038/nrn3104; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Britt J. P., 2012, CURR PROTOC NEUROSCI, V58; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Carlezon WA, 1996, PSYCHOPHARMACOLOGY, V128, P413, DOI 10.1007/s002130050151; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Dobi A, 2011, J NEUROSCI, V31, P1895, DOI 10.1523/JNEUROSCI.5375-10.2011; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Finch DM, 1996, HIPPOCAMPUS, V6, P495; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; French SJ, 2003, NEUROSCIENCE, V119, P19, DOI 10.1016/S0306-4522(03)00150-7; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; Friedman DP, 2002, J COMP NEUROL, V450, P345, DOI 10.1002/cne.10336; German PW, 2007, J NEUROPHYSIOL, V97, P2083, DOI 10.1152/jn.00303.2006; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; GLICKMAN SE, 1967, PSYCHOL REV, V74, P81, DOI 10.1037/h0024290; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Hull C, 2009, J NEUROSCI, V29, P9127, DOI 10.1523/JNEUROSCI.5971-08.2009; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Koya E, 2011, BIOL PSYCHIAT, V69, P1013, DOI 10.1016/j.biopsych.2011.04.001; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McGinty VB, 2009, J NEUROPHYSIOL, V101, P1823, DOI 10.1152/jn.91162.2008; Nicola SM, 2007, PSYCHOPHARMACOLOGY, V191, P521, DOI 10.1007/s00213-006-0510-4; ODONNELL P, 1995, J NEUROSCI, V15, P3622; OLDS ME, 1963, J COMP NEUROL, V120, P259, DOI 10.1002/cne.901200206; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Pennartz CMA, 2011, TRENDS NEUROSCI, V34, P548, DOI 10.1016/j.tins.2011.08.001; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; PHILLIPSON OT, 1985, NEUROSCIENCE, V16, P275, DOI 10.1016/0306-4522(85)90002-8; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; Schultz W, 2011, NEURON, V69, P603, DOI 10.1016/j.neuron.2011.02.014; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smeal RM, 2008, EUR J NEUROSCI, V28, P2041, DOI 10.1111/j.1460-9568.2008.06505.x; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Sun X, 2008, J NEUROSCI, V28, P4216, DOI 10.1523/JNEUROSCI.0258-08.2008; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Uslaner J, 2001, BRAIN RES, V920, P106, DOI 10.1016/S0006-8993(01)03040-2; Vezina P, 2009, NEUROPHARMACOLOGY, V56, P160, DOI 10.1016/j.neuropharm.2008.06.070; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013	66	453	459	1	78	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 21	2012	76	4					790	803		10.1016/j.neuron.2012.09.040	http://dx.doi.org/10.1016/j.neuron.2012.09.040			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	049JD	23177963	Green Accepted, Green Submitted, Bronze			2022-12-17	WOS:000311977900012
J	Davidson, TJ; Kloosterman, F; Wilson, MA				Davidson, Thomas J.; Kloosterman, Fabian; Wilson, Matthew A.			Hippocampal Replay of Extended Experience	NEURON			English	Article							SLOW-WAVE SLEEP; PLACE CELLS; UNIT-ACTIVITY; TEMPORAL SEQUENCES; FIRING PATTERNS; BEHAVING RAT; SHARP WAVES; OSCILLATIONS; RIPPLES; MEMORY	During pauses in exploration, ensembles of place cells in the rat hippocampus re-express firing sequences corresponding to recent spatial experience. Such "replay" co-occurs with ripple events: short-lasting (similar to 50-120 ms), high-frequency (similar to 200 Hz) oscillations that are associated with increased hippocampal-cortical communication. In previous studies, rats exploring small environments showed replay anchored to the rat's current location and compressed in time into a single ripple event. Here, we show, using a neural decoding approach, that firing sequences corresponding to long runs through a large environment are replayed with high fidelity and that such replay can begin at remote locations on the track. Extended replay proceeds at a characteristic virtual speed of similar to 8 m/s and remains coherent across trains of ripple events. These results suggest that extended replay is composed of chains of shorter subsequences, which may reflect a strategy for the storage and flexible expression of memories of prolonged experience.	[Davidson, Thomas J.; Kloosterman, Fabian; Wilson, Matthew A.] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Kloosterman, F (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave,46-5233, Cambridge, MA 02139 USA.	fkloos@mit.edu	Davidson, Thomas/B-3345-2008; Kloosterman, Fabian/AAB-1567-2020	Kloosterman, Fabian/0000-0001-6680-9660; Davidson, Thomas/0000-0003-0836-6333	National Institutes of Health (NIH) [MH061976]; Singleton Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061976, R56MH061976] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singleton Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E.N. Brown, D. A M.S. Fee, B.B. Scott, A.S. Andalman, D.P. Nguyen, and Z. Chen for helpful discussions and comments on the manuscript. This research was supported by National Institutes of Health (NIH) grant MH061976 (M.A.W.) and a Singleton Fellowship (T.J.D.).	August DA, 1999, J COMPUT NEUROSCI, V6, P71, DOI 10.1023/A:1008861001091; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Brown EN, 1998, J NEUROSCI, V18, P7411; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Davison AC, 1997, BOOTSTRAP METHODS TH; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jackson W.B., 1982, P1077; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kloosterman F, 2004, HIPPOCAMPUS, V14, P1026, DOI 10.1002/hipo.20022; KOSSLYN SM, 1978, J EXP PSYCHOL HUMAN, V4, P47, DOI 10.1037/0096-1523.4.1.47; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; MULLER RU, 1994, J NEUROSCI, V14, P7235; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Skaggs WE, 2007, J NEUROPHYSIOL, V98, P898, DOI 10.1152/jn.00401.2007; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; SUZUKI SS, 1987, ELECTROEN CLIN NEURO, V67, P348, DOI 10.1016/0013-4694(87)90123-4; Toft P., 1996, THESIS TU DENMARK; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	51	453	456	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 27	2009	63	4					497	507		10.1016/j.neuron.2009.07.027	http://dx.doi.org/10.1016/j.neuron.2009.07.027			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491HV	19709631	Bronze, Green Published, Green Accepted			2022-12-17	WOS:000269570400009
J	MacLeod, D; Dowman, J; Hammond, R; Leete, T; Inoue, K; Abeliovich, A				MacLeod, David; Dowman, Julia; Hammond, Rachel; Leete, Thomas; Inoue, Keiichi; Abeliovich, Asa			The familial parkinsonism gene LRRK2 regulates neurite process morphology	NEURON			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; MUTATIONS; TRANSCRIPTION; OUTGROWTH; SYNUCLEIN	Mutations in LRRK2 underlie an autosomal-dominant, inherited form of Parkinson's disease (PD) that mimics the clinical features of the common "sporadic" form of PD. The LRRK2 protein includes putative GTPase, protein kinase, WD40 repeat, and leucine-rich repeat (LRR) domains of unknown function. Here we show that PD-associated LRRK2 mutations display disinhibited kinase activity and induce a progressive reduction in neurite length and branching both in primary neuronal cultures and in the intact rodent CNS. In contrast, LRRK2 deficiency leads to increased neurite length and branching. Neurons that express PD-associated LRRK2 mutations additionally harbor prominent phospho-tau-positive inclusions with lysosomal characteristics and ultimately undergo apoptosis.	Columbia Univ Coll Phys & Surg, Dept Pathol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Taub Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Abeliovich, A (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Ctr Neurobiol & Behav, 15-403 630 W 168th St, New York, NY 10032 USA.	aa900@columbia.edu		Inoue, Keiichi/0000-0002-7101-486X; Leete, Thomas/0000-0001-8655-1476				Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; TROY CM, 1992, J CELL BIOL, V117, P1085, DOI 10.1083/jcb.117.5.1085; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	17	453	470	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					587	593		10.1016/j.neuron.2006.10.008	http://dx.doi.org/10.1016/j.neuron.2006.10.008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114044	Bronze			2022-12-17	WOS:000242413100007
J	Selkoe, DJ				Selkoe, DJ			Clearing the brain's amyloid cobwebs	NEURON			English	Review							INSULIN-DEGRADING ENZYME; BETA-PROTEIN; ALZHEIMER-DISEASE; EXTRACELLULAR LEVELS; DEGRADATION; PROTEOLYSIS; PATHOLOGY; NEURONS; SYSTEM	Elevated cerebral levels of amyloid beta -protein occur universally in Alzheimer's disease, yet only a few patients show evidence of increased A beta production. Therefore, defects in proteases that degrade A beta could underlie some or many cases of familial and sporadic AD. This previously neglected topic has begun receiving serious attention. Understanding how proteolysis regulates A beta levels in the cerebral cortex has implications for both the pathogenesis and the treatment of this protean disorder.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.							Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; DEMATTOS RB, 2001, BIOL CHEM, V276, P24540; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; McDermott JR, 1996, NEUROREPORT, V7, P2163, DOI 10.1097/00001756-199609020-00021; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; Mukherjee A, 2000, J NEUROSCI, V20, P8745; Nilsson LNG, 2001, J NEUROSCI, V21, P1444, DOI 10.1523/JNEUROSCI.21-05-01444.2001; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Savage MJ, 1998, J NEUROSCI, V18, P1743; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Tucker HM, 2000, J NEUROSCI, V20, P3937; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Yamin R, 1999, J BIOL CHEM, V274, P18777, DOI 10.1074/jbc.274.26.18777	23	453	494	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					177	180		10.1016/S0896-6273(01)00475-5	http://dx.doi.org/10.1016/S0896-6273(01)00475-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683988	Bronze			2022-12-17	WOS:000171893700003
J	Ishihara, T; Hong, M; Zhang, B; Nakagawa, Y; Lee, MK; Trojanowski, JQ; Lee, VMY				Ishihara, T; Hong, M; Zhang, B; Nakagawa, Y; Lee, MK; Trojanowski, JQ; Lee, VMY			Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform	NEURON			English	Article							PAIRED HELICAL FILAMENTS; AMYOTROPHIC LATERAL SCLEROSIS; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; PARKINSONISM-DEMENTIA; SUPRANUCLEAR PALSY; PROTEIN-TAU; FETAL TAU; PHOSPHORYLATION	Filamentous tau aggregates are hallmarks of tauopathies, e.g., frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC). Since FTDP-17 tau gene mutations alter levels/functions of tau, we overexpressed the smallest human tau isoform in the CNS of transgenic (Tg) mice to model tauopathies. These mice acquired age-dependent CNS pathology similar to FTDP-17 and ALS/PDC, including insoluble, hyperphosphorylated tau and argyrophilic intraneuronal inclusions formed by tau-immunoreactive filaments. Inclusions were present in cortical and brainstem neurons but were most abundant in spinal cord neurons, where they were associated with axon degeneration, diminished microtubules (Mis), and reduced axonal transport in ventral roots, as well as spinal cord gliosis and motor weakness. These Tg mice recapitulate key features of tauopathies and provide models for elucidating mechanisms underlying diverse tauopathies, including Alzheimer's disease (AD).	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Sch Med, Neuropathol Lab, Baltimore, MD 21205 USA	University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.		Lee, Michael K/D-9491-2013	Lee, Michael K/0000-0001-5865-9682				ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brion JP, 1999, AM J PATHOL, V154, P255, DOI 10.1016/S0002-9440(10)65272-8; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Clark W, 1998, J AM ETHNIC HIST, V17, P95; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Goedert M., 1997, MOL GENETIC BASIS NE, P613; Goetz Juergen, 1995, EMBO (European Molecular Biology Organization) Journal, V14, P1304; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HIRANO A, 1961, BRAIN, V84, P642, DOI 10.1093/brain/84.4.642; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iijima M, 1999, NEUROREPORT, V10, P497, DOI 10.1097/00001756-199902250-00010; KATO T, 1986, ACTA NEUROPATHOL, V71, P11, DOI 10.1007/BF00687955; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; MATSUMOTO S, 1990, NEUROLOGY, V40, P975, DOI 10.1212/WNL.40.6.975; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; NAKAZATO Y, 1984, ACTA NEUROPATHOL, V64, P30, DOI 10.1007/BF00695603; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PERRY G, 1985, P NATL ACAD SCI USA, V82, P3916, DOI 10.1073/pnas.82.11.3916; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Reed LA, 1998, J NEUROPATH EXP NEUR, V57, P588, DOI 10.1097/00005072-199806000-00006; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; SCHMIDT ML, 1991, LAB INVEST, V64, P352; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; SHANKAR SK, 1989, ANN NEUROL, V25, P146, DOI 10.1002/ana.410250207; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; TOMONAGA M, 1977, ACTA NEUROPATHOL, V37, P177, DOI 10.1007/BF00692065; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; TU PH, 1995, J CELL BIOL, V129, P1629, DOI 10.1083/jcb.129.6.1629; Tu PH, 1997, LAB INVEST, V76, P441; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	47	453	474	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					751	762		10.1016/S0896-6273(00)81127-7	http://dx.doi.org/10.1016/S0896-6273(00)81127-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595524	Bronze			2022-12-17	WOS:000083913000028
J	MESSERSMITH, EK; LEONARDO, ED; SHATZ, CJ; TESSIERLAVIGNE, M; GOODMAN, CS; KOLODKIN, AL				MESSERSMITH, EK; LEONARDO, ED; SHATZ, CJ; TESSIERLAVIGNE, M; GOODMAN, CS; KOLODKIN, AL			SEMAPHORIN-III CAN FUNCTION AS A SELECTIVE CHEMOREPELLENT TO PATTERN SENSORY PROJECTIONS IN THE SPINAL-CORD	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPRESSED SEQUENCE TAGS; DORSAL-ROOT GANGLIA; GROWTH CONES; AFFERENT-PROJECTIONS; NEURITE OUTGROWTH; RETINAL AXONS; NEURONS; COLLAPSE; CONTACT	Distinct classes of primary sensory neurons in dorsal root ganglia subserve different sensory modalities, terminate in different dorsoventral locations in the spinal cord, and display different neurotrophin response profiles. Large diameter muscle afferents that terminate in the ventral spinal cord are NT-3 responsive, whereas small diameter afferents subserving pain and temperature are NGF responsive and terminate in the dorsal spinal cord. Previous in vitro studies showed that the developing ventral spinal cord secretes a diffusible factor that inhibits the growth of sensory axons. Here we show that this factor repels NGF-responsive axons but has little effect on NT-3-responsive axons, We also provide evidence implicating semaphorin III/collapsin, a diffusible guidance molecule expressed by ventral spinal cord cells, in mediating this effect. These results suggest that semaphorin III functions to pattern sensory projections by selectively repelling axons that normally terminate dorsally.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, CELL BIOL PROGRAM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM DEV BIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	MESSERSMITH, EK (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOLEC & CELL BIOL, DIV NEUROBIOL, LIFE SCI ADDIT, BERKELEY, CA 94720 USA.		Leonardo, Eduardo/AAH-1525-2020	Leonardo, Eduardo/0000-0001-7426-0217	NICHD NIH HHS [HD21294] Funding Source: Medline; NIGMS NIH HHS [GM07618] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Brown AG, 1981, ORG SPINAL CORD; BURKE D, 1977, ACTA PHYSIOL SCAND, V100, P187, DOI 10.1111/j.1748-1716.1977.tb05936.x; CHRISTENSEN BN, 1970, J NEUROPHYSIOL, V33, P293, DOI 10.1152/jn.1970.33.2.293; COLAMARINO SA, 1995, IN PRESS CELL; DAVIES AM, 1986, DEV BIOL, V115, P56, DOI 10.1016/0012-1606(86)90227-7; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; ECCLES JC, 1957, J PHYSL, V154, P89; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOODMAN CS, 1994, CELL, V78, P353, DOI 10.1016/0092-8674(94)90413-8; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KNYIHAR E, 1978, SCIENCE, V202, P1206, DOI 10.1126/science.103200; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KUDO N, 1985, J PHYSIOL-LONDON, V369, P127, DOI 10.1113/jphysiol.1985.sp015892; LEE MT, 1988, J NEUROSCI, V8, P2530; LEE VMY, 1987, J NEUROSCI, V7, P3474; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; MATTHES DJ, 1995, IN PRESS CELL; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MENDELSON B, 1992, NEUROSCI LETT, V138, P72, DOI 10.1016/0304-3940(92)90475-M; MOORMAN SJ, 1990, J NEUROSCI, V10, P3158; MU XJ, 1993, J NEUROSCI, V13, P4029; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; PETERSON ER, 1981, DEV BRAIN RES, V2, P363, DOI 10.1016/0165-3806(81)90044-4; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Ramon y Cajal S., 1909, HISTOLOGIE SYSTEME N, DOI [DOI 10.5962/BHL.TITLE.48637, 10.5962/bhl.title.48637]; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; Sambrook J., 1989, MOL CLONING LAB MANU; SCHEIBEL MADGE E., 1968, BRAIN RES, V9, P32, DOI 10.1016/0006-8993(68)90256-4; SHARMA K, 1994, DEVELOPMENT, V120, P1315; SMITH CL, 1983, J COMP NEUROL, V220, P29, DOI 10.1002/cne.902200105; SNIDER WD, 1992, J NEUROSCI, V12, P3494; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; WALTER J, 1987, DEVELOPMENT, V101, P909; Willis WD, 1991, SENSORY MECH SPINAL; Windle WF, 1936, J COMP NEUROL, V63, P189, DOI 10.1002/cne.900630203; ZHANG L, 1994, J NEUROSCI, V14, P5187; ZISKINDCONHAIM L, 1990, J NEUROSCI, V10, P125	58	453	465	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1995	14	5					949	959		10.1016/0896-6273(95)90333-X	http://dx.doi.org/10.1016/0896-6273(95)90333-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748562	Bronze			2022-12-17	WOS:A1995QY93500007
J	HALEY, JE; WILCOX, GL; CHAPMAN, PF				HALEY, JE; WILCOX, GL; CHAPMAN, PF			THE ROLE OF NITRIC-OXIDE IN HIPPOCAMPAL LONG-TERM POTENTIATION	NEURON			English	Article							PROTEIN-KINASE ACTIVITY; RELAXING FACTOR; ENHANCEMENT; STIMULATION; ACTIVATION; INHIBITORS; INDUCTION; BRAIN	Long-term potentiation is a long-lasting use-dependent increase in the strength of synaptic connections. We investigated the role of nitric oxide (NO) in determining the duration of potentiation induced by high frequency stimulation of afferents in the CA1 region of the rat hippocampus. The calcium/calmodulin-dependent production of NO can be initiated by activation of excitatory aminoacid receptors and results in increased levels of cGMP in target cells. Here we report that only a relatively short-term potentiation can be induced in the presence of nitro-L-arginine methyl ester (L-NAME), an NO synthase inhibitor. The effects of L-NAME on the duration of potentiation are partially reversed by coadministration of L-arginine, a precursor of neuronal NO, and by dibutyryl cGMP. Hemoglobin, which binds extracellular NO, also shortens the duration of stimulus-induced potentiation. The results suggest a role for NO in the maintenance of activity-dependent synaptic enhancements, possibly via the generation of cGMP.	UNIV MINNESOTA, DEPT PHARMACOL, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	HALEY, JE (corresponding author), UNIV MINNESOTA, DEPT PSYCHOL, MINNEAPOLIS, MN 55455 USA.			Wilcox, George/0000-0002-6411-0423; Haley, Jane/0000-0001-6178-2673	NIDA NIH HHS [R01-DA-04274] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004274] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BLISS T V P, 1988, P3; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; EAST SJ, 1991, NEUROSCI LETT, V123, P17, DOI 10.1016/0304-3940(91)90147-L; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; KELSO SR, 1986, SCIENCE, V232, P85, DOI 10.1126/science.3952501; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; REYMANN KG, 1988, BRAIN RES, V440, P305, DOI 10.1016/0006-8993(88)91000-1; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; SOUTHAM E, 1991, EUR J NEUROSCI, V3, P379, DOI 10.1111/j.1460-9568.1991.tb00825.x; TSIEN RW, 1990, ADV SEC MESS PHOSPH, V24, P101	25	453	463	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1992	8	2					211	216		10.1016/0896-6273(92)90288-O	http://dx.doi.org/10.1016/0896-6273(92)90288-O			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1371216				2022-12-17	WOS:A1992HE93000002
J	Wilson, RC; Takahashi, YK; Schoenbaum, G; Niv, Y				Wilson, Robert C.; Takahashi, Yuji K.; Schoenbaum, Geoffrey; Niv, Yael			Orbitofrontal Cortex as a Cognitive Map of Task Space	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; ENCODES RESPONSE; DECISION-MAKING; ATTENTIONAL SET; DISTINCT ROLES; FRONTAL-CORTEX; REWARD VALUE; LESIONS; REVERSAL	Orbitofrontal cortex (OFC) has long been known to play an important role in decision making. However, the exact nature of that role has remained elusive. Here, we propose a unifying theory of OFC function. We hypothesize that OFC provides an abstraction of currently available information in the form of a labeling of the current task state, which is used for reinforcement learning (RL) elsewhere in the brain. This function is especially critical when task states include unobservable information, for instance, from working memory. We use this framework to explain classic findings in reversal learning, delayed alternation, extinction, and devaluation as well as more recent findings showing the effect of OFC lesions on the firing of dopaminergic neurons in ventral tegmental area (VTA) in rodents performing an RL task. In addition, we generate a number of testable experimental predictions that can distinguish our theory from other accounts of OFC function.	[Wilson, Robert C.; Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Wilson, Robert C.; Niv, Yael] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [Takahashi, Yuji K.; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	Princeton University; Princeton University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, RC (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	rcw2@princeton.edu; yael@princeton.edu			NIMH [5T32MH065214, 1R01MH098861]; NIDA; National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065214, R01MH098861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This-work was supported in part by T32 training grant 5T32MH065214 in quantitative neuroscience from the NIMH and NIDA (R.C.W.), by NIMH grant 1R01MH098861 (Y.N.), and by the Intramural Research Program at the National Institute on Drug Abuse (G.S. and Y.T.). The opinions expressed in this article are the authors' own and do not reflect the views of the NIH/DHHS.	Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; Bohn I, 2003, BEHAV BRAIN RES, V143, P49, DOI 10.1016/S0166-4328(03)00008-1; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Brass M, 2008, NEUROSCIENCE RULE GU; Brown TI, 2010, J NEUROSCI, V30, P7414, DOI 10.1523/JNEUROSCI.6021-09.2010; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; BUTTER CM, 1963, EXP NEUROL, V7, P65, DOI 10.1016/0014-4886(63)90094-3; BUTTERS N, 1973, EXP NEUROL, V39, P204, DOI 10.1016/0014-4886(73)90223-9; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Chudasama Y, 2003, J NEUROSCI, V23, P8771; COLWILL RM, 1985, J EXP PSYCHOL ANIM B, V11, P520, DOI 10.1037/0097-7403.11.4.520; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Damasio A.R., 1994, DESCARTES ERROR EMOT; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; de Araujo IE, 2006, NEURON, V51, P483, DOI 10.1016/j.neuron.2006.07.009; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Ferrier D, 1876, FUNCTIONS BRAIN; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Fuster J., 2015, PREFRONTAL CORTEX; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gershman SJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00623; Gershman SJ, 2010, CURR OPIN NEUROBIOL, V20, P251, DOI 10.1016/j.conb.2010.02.008; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Gottfried, 2011, NEUROBIOLOGY SENSATI; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Jones JL, 2012, SCIENCE, V338, P953, DOI 10.1126/science.1227489; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kim J, 2005, NEUROBIOL LEARN MEM, V83, P125, DOI 10.1016/j.nlm.2004.10.003; Lara AH, 2009, J NEUROSCI, V29, P765, DOI 10.1523/JNEUROSCI.4637-08.2009; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; MCENANEY KW, 1969, J COMP PHYSIOL PSYCH, V68, P558, DOI 10.1037/h0027639; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MILLER MH, 1972, NEUROPSYCHOLOGIA, V10, P291, DOI 10.1016/0028-3932(72)90020-6; MISHKIN M, 1969, NEUROPSYCHOLOGIA, V7, P357, DOI 10.1016/0028-3932(69)90060-8; MISHKIN M, 1978, BRAIN RES, V143, P313, DOI 10.1016/0006-8993(78)90571-1; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; NAPIER RM, 1992, J EXP PSYCHOL ANIM B, V18, P182, DOI 10.1037/0097-7403.18.2.182; Nee DE, 2012, NEUROIMAGE, V63, P1285, DOI 10.1016/j.neuroimage.2012.08.034; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; Noonan MP, 2011, J NEUROSCI, V31, P14399, DOI 10.1523/JNEUROSCI.6456-10.2011; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Otto AR, 2009, PSYCHON B REV, V16, P957, DOI 10.3758/PBR.16.5.957; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Petrides M., 2000, BRAIN MAPPING SYSTEM, P159; Pickens CL, 2003, J NEUROSCI, V23, P11078; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Ramus SJ, 2000, J NEUROSCI, V20, P8199, DOI 10.1523/jneurosci.20-21-08199.2000; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Ricker ST, 1996, ANIM LEARN BEHAV, V24, P423, DOI 10.3758/BF03199014; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rudebeck PH, 2011, ANN NY ACAD SCI, V1239, P1, DOI 10.1111/j.1749-6632.2011.06267.x; Rudebeck PH, 2011, J NEUROSCI, V31, P10569, DOI 10.1523/JNEUROSCI.0091-11.2011; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Schoenbaum G, 2003, BEHAV BRAIN RES, V146, P19, DOI 10.1016/j.bbr.2003.09.013; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Simmons JM, 2008, CEREB CORTEX, V18, P93, DOI 10.1093/cercor/bhm034; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Takahashi YK, 2011, NAT NEUROSCI, V14, P1590, DOI 10.1038/nn.2957; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Tsujimoto S, 2011, J NEUROSCI, V31, P4583, DOI 10.1523/JNEUROSCI.5816-10.2011; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Wilson RC, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00189; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008	96	452	458	4	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2014	81	2					267	279		10.1016/j.neuron.2013.11.005	http://dx.doi.org/10.1016/j.neuron.2013.11.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299UH	24462094	Green Accepted, Bronze			2022-12-17	WOS:000330420700006
J	MacAskill, AF; Rinholm, JE; Twelvetrees, AE; Arancibia-Carcamo, IL; Muir, J; Fransson, A; Aspenstrom, P; Attwell, D; Kittler, JT				MacAskill, Andrew F.; Rinholm, Johanne E.; Twelvetrees, Alison E.; Arancibia-Carcamo, I. Lorena; Muir, James; Fransson, Asa; Aspenstrom, Pontus; Attwell, David; Kittler, Josef T.			Miro1 Is a Calcium Sensor for Glutamate Receptor-Dependent Localization of Mitochondria at Synapses	NEURON			English	Article							KINESIN HEAVY-CHAIN; AXONAL-TRANSPORT; IN-VIVO; MOTILITY; MEMBRANE; ASSOCIATION; MILTON; DOMAIN; KIF5B; MORPHOGENESIS	Energy use, mainly to reverse ion movements in neurons, is a fundamental constraint on brain information processing. Trafficking of mitochondria to locations in neurons where there are large ion fluxes is essential for powering neural function. Mitochondrial trafficking is regulated by Ca2+ entry through ionotropic glutamate receptors, but the underlying mechanism is unknown. We show that the protein Miro1 links mitochondria to KIF5 motor proteins, allowing mitochondria to move along microtubules. This linkage is inhibited by micromolar levels of Ca2+ binding to Miro1. With the EF hand domains of Miro1 mutated to prevent Ca2+ binding, Miro1 could still facilitate mitochondrial motility, but mitochondrial stopping induced by glutamate or neuronal activity was blocked. Activating neuronal NMDA receptors with exogenous or synaptically released glutamate led to Miro1 positioning mitochondria at the postsynaptic side of synapses. Thus, Miro1 is a key determinant of how energy supply is matched to energy usage in neurons.	[MacAskill, Andrew F.; Rinholm, Johanne E.; Twelvetrees, Alison E.; Arancibia-Carcamo, I. Lorena; Muir, James; Attwell, David; Kittler, Josef T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Fransson, Asa; Aspenstrom, Pontus] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden	University of London; University College London; Ludwig Institute for Cancer Research; Uppsala University	Kittler, JT (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	j.kittler@ucl.ac.uk	Rinholm, Johanne/AFM-9043-2022; Twelvetrees, Alison/K-8712-2019; Attwell, David/ABE-6750-2020; Kittler, Josef/N-7589-2019; MacAskill, Andrew/AFO-2061-2022; Kittler, Josef T/E-9113-2010	Twelvetrees, Alison/0000-0002-1796-1508; Kittler, Josef/0000-0002-3437-9456; MacAskill, Andrew/0000-0002-0196-3779; Kittler, Josef T/0000-0002-3437-9456; Arancibia Carcamo, Irma Lorena/0000-0002-0624-3850; Rinholm, Johanne Egge/0000-0003-3741-850X	MRC; Royal Society; Wellcome Trust; EMBIO; Norwegian Research Council; MRC [G120/972] Funding Source: UKRI; Medical Research Council [G120/972] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); EMBIO; Norwegian Research Council(Research Council of NorwayEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Tiago Branco, Gyorgy Szabadkai, Michael Duchen, and Michelangelo Campagnella for helpful discussions. This work was supported by the MRC (J.T.K), the Royal Society (J.T.K), the Wellcome Trust (D.A), EMBIO and the Norwegian Research Council (J.E.R). A.F.M. is in the 4 year PhD in Neuroscience at UCL; J.M. is in the CoMPLEX PhD Programme at UCL.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Banker G., 1991, CULTURING NERVE CELL; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI [10.1242/jcs.02745, 10.1242/jcs.053850]; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; KITTLER JT, 2006, FRON NEUROS, P205; Lane JD, 1999, MOL BIOL CELL, V10, P1909, DOI 10.1091/mbc.10.6.1909; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Li J, 2001, NEUROSCI LETT, V304, P29, DOI 10.1016/S0304-3940(01)01742-6; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V86, P859; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Overly CC, 1996, J CELL SCI, V109, P971; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Payne C, 2003, CELL MOTIL CYTOSKEL, V56, P245, DOI 10.1002/cm.10151; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schuman E, 2004, CELL, V119, P738, DOI 10.1016/j.cell.2004.12.003; Sloane JA, 2007, J NEUROSCI, V27, P11366, DOI 10.1523/JNEUROSCI.2326-07.2007; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	57	452	461	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 26	2009	61	4					541	555		10.1016/j.neuron.2009.01.030	http://dx.doi.org/10.1016/j.neuron.2009.01.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	413TV	19249275	Green Published, hybrid			2022-12-17	WOS:000263816300009
J	Yehuda, R; Ledoux, J				Yehuda, Rachel; Ledoux, Joseph			Response variation following trauma: A translational neuroscience approach to understanding PTSD	NEURON			English	Review							POSTTRAUMATIC-STRESS-DISORDER; VENTROMEDIAL PREFRONTAL CORTEX; ANIMAL-MODEL; HIPPOCAMPAL VOLUME; INDIVIDUAL-DIFFERENCES; COMBAT VETERANS; CORTISOL-LEVELS; RISK-FACTORS; LONGITUDINAL COURSE; D-CYCLOSERINE	Exposure to traumatic stress is a requirement for the development of posttraumatic stress disorder (PTSD). However, because the majority of trauma-exposed persons do not develop PTSD, examination of the typical effects of a stressor will not identify the critical components of PTSD risk or pathogenesis. Rather, PTSD represents a specific phenotype associated with a failure to recover from the normal effects of trauma. Thus, research must focus on identifying pre- and posttraumatic risk factors that explain the development of the disorder and the failure to reinstate physiological homeostasis. In this review, we summarize what is known about the clinical and biological characteristics of PTSD and articulate some of the gaps in knowledge that can be addressed by basic neuroscience research. We emphasize how knowledge about individual differences related to genetic and epigenetic factors in behavioral and brain responses to stress offers the hope of a deeper understanding of PTSD.	Mt Sinai Sch Med, James J Peters Vet Affairs, Div Traumat Stress Studies, Bronx, NY 10468 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; New York University	Yehuda, R (corresponding author), Mt Sinai Sch Med, James J Peters Vet Affairs, Div Traumat Stress Studies, Bronx, NY 10468 USA.	rachel.yehuda@med.va.gov			NIMH NIH HHS [R01 MH46516, R01 MH64104-01, R01 MH064675-02, P50 MH58911, R37 MH38774, R56 MH077321, K05 MH067048] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, R56MH077321, P50MH058911, K05MH067048, R37MH038774, R01MH064675, R01MH064104] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adamec RE, 2006, NEUROSCI BIOBEHAV R, V30, P356, DOI 10.1016/j.neubiorev.2005.04.004; Adams RE, 2006, J NERV MENT DIS, V194, P485, DOI 10.1097/01.nmd.0000228503.95503.e9; Aerni A, 2004, AM J PSYCHIAT, V161, P1488, DOI 10.1176/appi.ajp.161.8.1488; [Anonymous], [No title captured]; Bachmann AW, 2005, PSYCHONEUROENDOCRINO, V30, P297, DOI 10.1016/j.psyneuen.2004.08.006; BOHUS B, 1981, LIFE SCI, V28, P433, DOI 10.1016/0024-3205(81)90090-4; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; BREMNER JD, 2007, IN PRESS J NERV MENT; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Bromet E, 1998, AM J EPIDEMIOL, V147, P353; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Bush DEA, 2007, J TRAUMA STRESS, V20, P413, DOI 10.1002/jts.20261; Charney DS, 1996, CRIT REV NEUROBIOL, V10, P419; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; COHEN H, 2007, IN PRESS INT J NEURO, DOI DOI 10.1017/S141145707007912; Cohen H, 2007, EUR NEUROPSYCHOPHARM, V17, P464, DOI 10.1016/j.euroneuro.2006.11.003; Cohen H, 2006, ANN NY ACAD SCI, V1071, P335, DOI 10.1196/annals.1364.026; Cohen H, 2006, BIOL PSYCHIAT, V60, P767, DOI 10.1016/j.biopsych.2006.03.013; Cohen H, 2006, BIOL PSYCHIAT, V59, P1208, DOI 10.1016/j.biopsych.2005.12.003; COOLS AR, 1990, BRAIN RES BULL, V24, P49, DOI 10.1016/0361-9230(90)90288-B; CURE M, 1992, PHYSIOL BEHAV, V51, P771, DOI 10.1016/0031-9384(92)90114-H; De Quervain DJF, 2006, ANN NY ACAD SCI, V1071, P216, DOI 10.1196/annals.1364.016; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Debiec Jacek, 2006, Cerebrum, P2; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; Delahanty DL, 2003, J ANXIETY DISORD, V17, P149, DOI 10.1016/S0887-6185(02)00185-8; Dolan RJ, 2003, ANN NY ACAD SCI, V985, P348, DOI 10.1111/j.1749-6632.2003.tb07093.x; Francis DD, 1999, ANN NY ACAD SCI, V896, P66, DOI 10.1111/j.1749-6632.1999.tb08106.x; Freeman T, 2006, PSYCHIAT RES-NEUROIM, V146, P59, DOI 10.1016/j.pscychresns.2005.07.007; Garcia A, 2001, PSYCHONEUROENDOCRINO, V26, P363, DOI 10.1016/S0306-4530(00)00060-3; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Golier JA, 2005, PSYCHIAT RES-NEUROIM, V139, P53, DOI 10.1016/j.pscychresns.2005.02.007; Golier JA, 2006, ANN NY ACAD SCI, V1071, P54, DOI 10.1196/annals.1364.006; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Heresco-Levy U, 2002, INT J NEUROPSYCHOPH, V5, P301, DOI 10.1017/S1461145702003061; Holsboer Florian, 2003, Curr Opin Investig Drugs, V4, P46; KAGAN J, GALENS PROPHECY TEMP; Kardiner A., 1941, TRAUMATIC NEUROSES W, DOI [10.1037/10581-000, DOI 10.1037/10581-000]; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koenen KC, 2007, PSYCHOL MED, V37, P181, DOI 10.1017/S0033291706009019; Koenen KC, 2002, J NERV MENT DIS, V190, P209, DOI 10.1097/00005053-200204000-00001; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; LeDoux J. E., 1996, EMOTIONAL BRAIN; Levy A, 2001, Mil Med, V166, P74; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; MANION ST, 2004, PHARM BIOCH BEHAV, V66, P559; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MASON JW, 1986, J NERV MENT DIS, V174, P145, DOI 10.1097/00005053-198603000-00003; Matar MA, 2006, NEUROPSYCHOPHARMACOL, V31, P2610, DOI 10.1038/sj.npp.1301132; MCEWEN BS, 1992, BRIT J PSYCHIAT, V160, P18, DOI 10.1192/S0007125000296645; McFarlane AC, 2000, J CLIN PSYCHIAT, V61, P15; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Neylan TC, 2003, BIOL PSYCHIAT, V54, P1118, DOI 10.1016/S0006-3223(02)01974-1; Neylan TC, 2006, AM J PSYCHIAT, V163, P2186, DOI 10.1176/appi.ajp.163.12.2186; Nishith P, 2000, J ABNORM PSYCHOL, V109, P20, DOI 10.1037/0021-843X.109.1.20; Novik K. L., 2002, Current Issues in Molecular Biology, V4, P111; O'Donnell T, 2004, NEUROPSYCHOBIOLOGY, V50, P273, DOI 10.1159/000080952; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Parker KJ, 2005, BIOL PSYCHIAT, V57, P848, DOI 10.1016/j.biopsych.2004.12.024; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Pitman RK, 2006, ANN NY ACAD SCI, V1071, P242, DOI 10.1196/annals.1364.019; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Richter-Levin G, 1998, PSYCHIAT RES, V79, P73, DOI 10.1016/S0165-1781(98)00030-4; RITTENHOUSE PA, 1992, BRAIN RES, V580, P205, DOI 10.1016/0006-8993(92)90946-7; Schelling G, 2006, ANN NY ACAD SCI, V1071, P46, DOI 10.1196/annals.1364.005; Segman RH, 2003, CNS SPECTRUMS, V8, P693, DOI 10.1017/S1092852900008889; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Shinba T, 2001, PROG NEURO-PSYCHOPH, V25, P1629, DOI 10.1016/S0278-5846(01)00203-2; Siegmund A, 2007, PHYSIOL BEHAV, V90, P103, DOI 10.1016/j.physbeh.2006.08.032; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vyas A, 2002, J NEUROSCI, V22, P6810; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Yehuda R, 2005, HANDB EXP PHARM, V169, P371; Yehuda R, 1998, BIOL PSYCHIAT, V43, P855, DOI 10.1016/S0006-3223(97)00554-4; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 2005, J CLIN ENDOCR METAB, V90, P4115, DOI 10.1210/jc.2005-0550; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2002, PSYCHIAT CLIN N AM, V25, P341, DOI 10.1016/S0193-953X(02)00002-3; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; YEHUDA R, 1993, BIOL PSYCHIAT, V33, P479, DOI 10.1016/0006-3223(93)90001-T; Yehuda R, 1996, PSYCHONEUROENDOCRINO, V21, P1, DOI 10.1016/0306-4530(95)00055-0; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3; Yehuda R, 2001, J PSYCHIAT RES, V35, P261, DOI 10.1016/S0022-3956(01)00032-2; Yehuda R, 1998, BIOL PSYCHIAT, V44, P56, DOI 10.1016/S0006-3223(98)80007-3; YEHUDA R, 2007, IN PRESS J TRAUMA ST; Yehuda R, 2007, J TRAUMA STRESS, V20, P435, DOI 10.1002/jts.20260; Yehuda R, 2007, ARCH GEN PSYCHIAT, V64, P1040, DOI 10.1001/archpsyc.64.9.1040; Yehuda R, 2007, AM J PSYCHIAT, V164, P163, DOI 10.1176/appi.ajp.164.1.163; Yehuda R, 2007, J PSYCHIATR RES, V41, P435, DOI 10.1016/j.jpsychires.2005.12.002	130	452	464	4	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					19	32		10.1016/j.neuron.2007.09.006	http://dx.doi.org/10.1016/j.neuron.2007.09.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920012	Bronze			2022-12-17	WOS:000250289800007
J	Lisman, JE				Lisman, JE			Relating hippocampal circuitry to function: Recall of memory sequences by reciprocal dentate-CA3 interactions	NEURON			English	Review							LONG-TERM POTENTIATION; CA3 PYRAMIDAL CELLS; PHASE PRECESSION; GRANULE CELLS; PLACE CELLS; RAT HIPPOCAMPUS; NEURAL NETWORKS; SYNAPTIC CONNECTIONS; NEURONAL ENSEMBLES; SAMPLE PERFORMANCE		Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University	Lisman, JE (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA.							BARNES CA, 1990, PROG BRAIN RES, V86, P89, DOI DOI 10.1016/S0079-6123(08)63169-6; BLACKWOOD DHR, 1987, BRIT J PSYCHIAT, V150, P154, DOI 10.1192/bjp.150.2.154; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRAGIN AG, 1979, NEUROPHYSIOLOGY+, V11, P389; BROWN TH, 1983, J NEUROPHYSIOL, V50, P487, DOI 10.1152/jn.1983.50.2.487; BUCKMASTER PS, 1994, HIPPOCAMPUS, V4, P393, DOI 10.1002/hipo.450040402; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; BUZSAKI G, 1979, ELECTROEN CLIN NEURO, V47, P64, DOI 10.1016/0013-4694(79)90033-6; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; COLOMBO M, 1994, BEHAV NEUROSCI, V108, P443, DOI 10.1037/0735-7044.108.3.443; COWEY A, 1964, J NEUROPHYSIOL, V27, P366, DOI 10.1152/jn.1964.27.3.366; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Dore FY, 1998, HIPPOCAMPUS, V8, P323, DOI 10.1002/(SICI)1098-1063(1998)8:4<323::AID-HIPO2>3.0.CO;2-I; Eichenbaum H, 1997, SCIENCE, V277, P330, DOI 10.1126/science.277.5324.330; Eichenbaum H, 1996, CURR OPIN NEUROBIOL, V6, P187, DOI 10.1016/S0959-4388(96)80072-9; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HALGREN E, 1980, SCIENCE, V210, P803, DOI 10.1126/science.7434000; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 1997, BEHAV BRAIN RES, V89, P1, DOI 10.1016/S0166-4328(97)00048-X; HETHERINGTON PA, 1994, HIPPOCAMPUS, V4, P422, DOI 10.1002/hipo.450040405; Honey RC, 1998, J NEUROSCI, V18, P2226; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HOWARD MW, 1998, IN PRESS J EXP PSYCH; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jackson MB, 1996, J NEUROPHYSIOL, V76, P601, DOI 10.1152/jn.1996.76.1.601; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 1996, LEARN MEMORY, V3, P257, DOI 10.1101/lm.3.2-3.257; Jensen O, 1998, J NEUROSCI, V18, P10688; JOHNSTON D, 1998, SYNAPTIC ORG BRAIN, P417; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KOHONEN T, 1978, ASS MEMORY; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; LYNCH G, 1992, J COGNITIVE NEUROSCI, V4, P189, DOI 10.1162/jocn.1992.4.3.189; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON N, 1987, BEHAV BRAIN RES, V24, P39, DOI 10.1016/0166-4328(87)90034-9; MINAI AA, 1998, ENCODING SPATIAL CON; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; Naber PA, 1998, J COMP NEUROL, V393, P284; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OTMAKHOVA N, 1999, IN PRESS J NEUROSCI; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Qin YL, 1997, PHILOS T R SOC B, V352, P1525, DOI 10.1098/rstb.1997.0139; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Samsonovich A, 1997, J NEUROSCI, V17, P5900; SCHARFMAN HE, 1991, J NEUROSCI, V11, P1660; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; SOMPOLINSKY H, 1986, PHYS REV LETT, V57, P2861, DOI 10.1103/PhysRevLett.57.2861; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; Vinogradova OS, 1984, HIPPOCAMPUS, P1; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WOLFER DP, 1995, HIPPOCAMPUS, V5, P329, DOI 10.1002/hipo.450050406; Wu K, 1998, HIPPOCAMPUS, V8, P217, DOI 10.1002/(SICI)1098-1063(1998)8:3<217::AID-HIPO5>3.3.CO;2-Y; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832	82	452	459	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1999	22	2					233	242		10.1016/S0896-6273(00)81085-5	http://dx.doi.org/10.1016/S0896-6273(00)81085-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	171QN	10069330	Bronze			2022-12-17	WOS:000078875200009
J	Chen, HJ; Rojas-Soto, M; Oguni, A; Kennedy, MB				Chen, HJ; Rojas-Soto, M; Oguni, A; Kennedy, MB			A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II	NEURON			English	Article							LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY FRACTION; D-ASPARTATE RECEPTOR; HIPPOCAMPAL-NEURONS; MUTANT MICE; BRAIN; SUBUNIT; PHOSPHORYLATION; IDENTIFICATION; PURIFICATION	Ca2+ influx through N-methyl-D-aspartate-(NMDA-) type glutamate receptors plays a critical role in synaptic plasticity in the brain. One of the proteins activated by the increase in Ca2+ is CaM kinase II (CaMKII). Here, we report a novel synaptic Ras-GTPase activating protein (p135 SynGAP) that is a major component of the postsynaptic density, a complex of proteins associated with synaptic NMDA receptors. p135 SynGAP is almost exclusively localized at synapses in hippocampal neurons where it binds to and closely colocalizes with the scaffold protein PSD-95 and colocalizes with NMDA receptors. The Ras-GTPase activating activity of p135 SynGAP is inhibited by phosphorylation by CaMKII located in the PSD protein complex. Inhibition of p135 SynGAP by CaMKII will stop inactivation of GTP-bound Ras and thus could result in activation of the mitogen-activated protein (MAP) kinase pathway in hippocampal neurons upon activation of NMDA receptors.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Kennedy, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.			Kennedy, Mary/0000-0003-1369-0525	NINDS NIH HHS [NS-28710, NS-17660] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028710, R01NS017660] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Apperson ML, 1996, J NEUROSCI, V16, P6839; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CAMPBELLBURK SL, 1995, METHOD ENZYMOL, V255, P3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Nakamura T, 1998, J BIOL CHEM, V273, P6960, DOI 10.1074/jbc.273.12.6960; Niethammer M, 1996, J NEUROSCI, V16, P2157; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; OU SKH, 1993, J IMMUNOL METHODS, V165, P75, DOI 10.1016/0022-1759(93)90108-J; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Prakash N, 1996, NATURE, V381, P702, DOI 10.1038/381702a0; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH DB, 1995, CURRENT PROTOCOLS MO, P1671; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WIGLER MH, 1990, NATURE, V346, P696, DOI 10.1038/346696a0; XIA X, 1996, J NEUROSCI, V16, P5425	58	452	467	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					895	904		10.1016/S0896-6273(00)80471-7	http://dx.doi.org/10.1016/S0896-6273(00)80471-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620694	Bronze			2022-12-17	WOS:000073864700009
J	Friedrich, RW; Korsching, SI				Friedrich, RW; Korsching, SI			Combinatorial and chemotopic odorant coding in the zebrafish olfactory bulb visualized by optical imaging	NEURON			English	Article							MITRAL TUFTED CELLS; FUNCTIONAL-ORGANIZATION; NEURONAL-ACTIVITY; CHANNEL CATFISH; RECEPTOR-CELLS; RAINBOW-TROUT; DISCRIMINATION; MOLECULES; SYSTEM; SENSITIVITY	Odors are thought to be represented by a distributed code across the glomerular modules in the olfactory bulb (OB). Here, we optically imaged presynaptic activity in glomerular modules of the zebrafish OB induced by a class of natural odorants (amino acids [AAs]) after labeling of primary afferents with a calcium-sensitive dye. AAs induce complex combinatorial patterns of active glomerular modules that are unique for different stimuli and concentrations. Quantitative analysis shows that defined molecular features of stimuli are correlated with activity in spatially confined groups of glomerular modules. These results provide direct evidence that identity and concentration of odorants are encoded by glomerular activity patterns and reveal a coarse chemotopic organization of the array of glomerular modules.			Friedrich, RW (corresponding author), MAX PLANCK INST ENTWICKLUNGSBIOL,ABT PHYS BIOL,D-72076 TUBINGEN,GERMANY.			Friedrich, Rainer/0000-0001-9107-0482				ADAMEK GD, 1984, BRAIN RES, V310, P87, DOI 10.1016/0006-8993(84)90012-X; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Andres K.H., 1970, CIBA FDN S TASTE SME, P177; AXEL R, 1995, SCI AM, V273, P130; BALER H, 1994, J NEUROSCI, V14, P219; Barth AL, 1996, NEURON, V16, P23, DOI 10.1016/S0896-6273(00)80020-3; BIEBER SL, 1986, CHEM SENSES, V11, P19, DOI 10.1093/chemse/11.1.19; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; BYRD CA, 1995, J COMP NEUROL, V358, P247, DOI 10.1002/cne.903580207; CANCALON P, 1983, TISSUE CELL, V15, P245, DOI 10.1016/0040-8166(83)90020-4; CAPRIO J, 1984, J GEN PHYSIOL, V84, P403, DOI 10.1085/jgp.84.3.403; Caprio J., 1988, P313; Carr W.E.S., 1988, P3; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; DOVING KB, 1980, ACTA PHYSIOL SCAND, V108, P123, DOI 10.1111/j.1748-1716.1980.tb06509.x; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; GETCHELL TV, 1986, PHYSIOL REV, V66, P772, DOI 10.1152/physrev.1986.66.3.772; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; IVANOVA TT, 1993, J GEN PHYSIOL, V102, P1085, DOI 10.1085/jgp.102.6.1085; KANG JS, 1995, J NEUROPHYSIOL, V73, P172, DOI 10.1152/jn.1995.73.1.172; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; KORSCHING S, 1997, IN PRESS SEMIN CELL; LANCET D, 1982, P NATL ACAD SCI-BIOL, V79, P670, DOI 10.1073/pnas.79.2.670; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; MEREDITH M, 1981, CHEM SENSES, V6, P277, DOI 10.1093/chemse/6.4.277; MICHEL WC, 1995, J COMP PHYSIOL A, V177, P191; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; MOULTON DG, 1967, OLFACTION TASTE, V2, P109; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Oka Y, 1982, CHEMORECEPTION FISHE, P61; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; REVIAL MF, 1982, CHEM SENSES, V7, P175, DOI 10.1093/chemse/7.2.175; RHEIN LD, 1983, J NEUROCHEM, V41, P569, DOI 10.1111/j.1471-4159.1983.tb04777.x; RIDDLE DR, 1992, J COMP NEUROL, V324, P575, DOI 10.1002/cne.903240410; RUMMEL RJ, 1970, APPLIED FACTOR ANAL; Satou M., 1992, FISH CHEMORECEPTION, P40; SCOTT JW, 1993, MICROSC RES TECHNIQ, V24, P142, DOI 10.1002/jemt.1070240206; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Shipley MT, 1996, J NEUROBIOL, V30, P123; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.biochem.63.1.101; Treloar H, 1996, J COMP NEUROL, V367, P550; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Weth F, 1996, P NATL ACAD SCI USA, V93, P13321, DOI 10.1073/pnas.93.23.13321; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; ZIPPEL HP, 1993, J COMP PHYSIOL A, V172, P81, DOI 10.1007/BF00214717	54	452	457	1	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					737	752		10.1016/S0896-6273(00)80314-1	http://dx.doi.org/10.1016/S0896-6273(00)80314-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182799	Bronze			2022-12-17	WOS:A1997XB72200008
J	WADICHE, JI; AMARA, SG; KAVANAUGH, MP				WADICHE, JI; AMARA, SG; KAVANAUGH, MP			ION FLUXES ASSOCIATED WITH EXCITATORY AMINO-ACID-TRANSPORT	NEURON			English	Article							RAT-BRAIN; GLUTAMATE TRANSPORTER; XENOPUS OOCYTES; CHLORIDE CHANNEL; GLIAL-CELL; SALAMANDER; EXPRESSION; MEMBRANE; BLOCKERS; CARRIER	Flux of substrate and charge mediated by three cloned excitatory amino acid transporters widely expressed in human brain were studied in voltage-clamped Xenopus oocytes. Superfusion of L-glutamate or D-aspartate resulted in currents due in part to electrogenic Na+ cotransport, which contributed 1 net positive charge per transport cycle. A significant additional component of the currents was due to activation of a reversible anion flux that was not thermodynamically coupled to amino acid transport. The selectivity sequence of this ligand-activated conductance was NO3- > l(-) > Br- > Cl- > F-. The results suggest that these proteins mediate both transporter- and channel-like modes of permeation, providing a potential mechanism for dampening cell excitability, in addition to removal of transmitter.	OREGON HLTH SCI UNIV, HOWARD HUGHES MED INST, PORTLAND, OR 97201 USA	Howard Hughes Medical Institute; Oregon Health & Science University	WADICHE, JI (corresponding author), OREGON HLTH SCI UNIV, VOLLUM INST, L474, PORTLAND, OR 97201 USA.			Wadiche, Jacques/0000-0001-8180-2061; Amara, Susan/0000-0001-8914-1106	NIGMS NIH HHS [GM 48709] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048709] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATO A, 1994, J PHYSIOL-LONDON, V479, P371, DOI 10.1113/jphysiol.1994.sp020302; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; BREW H, 1987, NATURE, V328, P742, DOI 10.1038/328742c0; CAMMACK JN, 1994, NEURON, V13, P949, DOI 10.1016/0896-6273(94)90260-7; ELIASOF S, 1993, J NEUROSCI, V13, P402; ERECINSKA M, 1983, J BIOL CHEM, V258, P9069; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FRANCIOLINI F, 1994, J GEN PHYSIOL, V104, P711, DOI 10.1085/jgp.104.4.711; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; GREGER R, 1990, METHOD ENZYMOL, V191, P793; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KAVANAUGH MP, 1991, BIOCHEM J, V277, P899, DOI 10.1042/bj2770899; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROBINSON KR, 1979, P NATL ACAD SCI USA, V76, P837, DOI 10.1073/pnas.76.2.837; SARANTIS M, 1988, NATURE, V332, P451, DOI 10.1038/332451a0; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; STALLCUP WB, 1979, J NEUROCHEM, V32, P57, DOI 10.1111/j.1471-4159.1979.tb04509.x; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TACHIBANA M, 1988, P NATL ACAD SCI USA, V85, P5315, DOI 10.1073/pnas.85.14.5315; VANDENBERG RJ, 1995, IN PRESS J BIOL CHEM; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WHITE MM, 1990, MOL PHARMACOL, V37, P720	28	452	458	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1995	15	3					721	728		10.1016/0896-6273(95)90159-0	http://dx.doi.org/10.1016/0896-6273(95)90159-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RV945	7546750	Bronze			2022-12-17	WOS:A1995RV94500024
J	NESTLER, EJ; HOPE, BT; WIDNELL, KL				NESTLER, EJ; HOPE, BT; WIDNELL, KL			DRUG-ADDICTION - A MODEL FOR THE MOLECULAR-BASIS OF NEURAL PLASTICITY	NEURON			English	Review							LOCUS-CERULEUS NEURONS; AMP-REGULATED PHOSPHOPROTEINS; MESOLIMBIC DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; RAT NUCLEUS-ACCUMBENS; PROTEIN KINASE-A; CHRONIC MORPHINE; ADENYLATE-CYCLASE; C-FOS; OPIATE WITHDRAWAL		YALE UNIV, SCH MED, DEPT PHARMACOL, NEW HAVEN, CT 06510 USA; CONNECTICUT MENTAL HLTH CTR, NEW HAVEN, CT 06508 USA	Yale University	NESTLER, EJ (corresponding author), YALE UNIV, SCH MED, DEPT PSYCHIAT, MOLEC PSYCHIAT, NEW HAVEN, CT 06510 USA.		Hope, Bruce T/A-9223-2010	Hope, Bruce T/0000-0001-5804-7061				AGHAJANIAN GK, 1987, NEUROPHARMACOLOGY, V26, P793, DOI 10.1016/0028-3908(87)90054-2; AGHAJANIAN GK, 1978, NATURE, V276, P186, DOI 10.1038/276186a0; ALREJA M, 1991, BRAIN RES, V556, P339, DOI 10.1016/0006-8993(91)90327-R; ALREJA M, 1993, J NEUROSCI, V13, P3525; BEITNER DB, 1989, MOL PHARMACOL, V35, P559; BEITNERJOHNSON D, 1992, J NEUROSCI, V12, P2165; BEITNERJOHNSON D, 1993, NEUROREPORT, V5, P57, DOI 10.1097/00001756-199310000-00014; BEITNERJOHNSON D, 1991, J NEUROCHEM, V57, P344, DOI 10.1111/j.1471-4159.1991.tb02133.x; BEITNERJOHNSON D, 1993, J NEUROCHEM, V61, P1766, DOI 10.1111/j.1471-4159.1993.tb09814.x; BEITNERJOHNSON D, 1992, ANN NY ACAD SCI, V654, P70, DOI 10.1111/j.1749-6632.1992.tb25957.x; BEITNERJOHNSON D, 1991, BRAIN RES, V561, P147, DOI 10.1016/0006-8993(91)90759-O; BOZARTH MA, 1989, CAN J PHYSIOL PHARM, V67, P1158, DOI 10.1139/y89-185; CHILDERS SR, 1991, LIFE SCI, V48, P1991, DOI 10.1016/0024-3205(91)90154-4; CHRISTIE MJ, 1987, MOL PHARMACOL, V32, P633; COLE AJ, 1992, J NEUROCHEM, V58, P1420, DOI 10.1111/j.1471-4159.1992.tb11358.x; COLE BJ, 1990, LIFE SCI, V47, P1715, DOI 10.1016/0024-3205(90)90344-Q; CUNNINGHAM ST, 1993, J NEUROSCI, V13, P2342, DOI 10.1523/JNEUROSCI.13-06-02342.1993; DUMAN RS, 1988, J PHARMACOL EXP THER, V246, P1033; DWORKIN SI, 1993, BIOL BASIS SUBSTANCE, P327; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FIBIGER HC, 1992, CIBA F SYMP, V166, P96; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GUITART X, 1990, BRAIN RES, V516, P57, DOI 10.1016/0006-8993(90)90897-K; GUITART X, 1990, J NEUROSCI, V10, P2649; GUITART X, 1989, J NEUROSCI, V9, P4371; GUITART X, 1992, SYNAPSE, V12, P242, DOI 10.1002/syn.890120310; GUITART X, 1993, BRAIN RES, V611, P7, DOI 10.1016/0006-8993(93)91770-S; GUITART X, 1992, J NEUROCHEM, V58, P1168, DOI 10.1111/j.1471-4159.1992.tb09377.x; HARRIS GC, 1991, J NEUROSCI, V11, P2574; HAYWARD MD, 1990, BRAIN RES, V525, P256, DOI 10.1016/0006-8993(90)90872-9; HENRY DJ, 1991, J PHARMACOL EXP THER, V258, P882; HENTZE MW, 1991, BIOCHIM BIOPHYS ACTA, V1090, P281, DOI 10.1016/0167-4781(91)90191-N; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; HOPE BT, 1994, IN PRESS J NEUROSCI; HYMAN SE, 1993, MOL F PSYCHIATRY; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KOGAN JH, 1992, EUR J PHARMACOL, V211, P47, DOI 10.1016/0014-2999(92)90261-2; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; MAKMAN MH, 1988, BRAIN RES, V445, P303, DOI 10.1016/0006-8993(88)91193-6; MALDONADO R, 1993, BRAIN RES, V605, P128, DOI 10.1016/0006-8993(93)91364-X; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; MISERENDINO MJD, 1993, MOL CELL NEUROSCI, V4, P440, DOI 10.1006/mcne.1993.1055; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NESTLER EJ, 1989, BRAIN RES, V476, P230, DOI 10.1016/0006-8993(89)91243-2; NESTLER EJ, 1990, J NEUROCHEM, V55, P1079, DOI 10.1111/j.1471-4159.1990.tb04602.x; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1988, MOL PHARMACOL, V33, P127; NESTLER EJ, 1993, IN PRESS ANN NY ACAD; NGUYEN TV, 1992, P NATL ACAD SCI USA, V89, P4270, DOI 10.1073/pnas.89.10.4270; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; PIAZZA PV, 1991, P NATL ACAD SCI USA, V88, P2088, DOI 10.1073/pnas.88.6.2088; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; REDMOND DE, 1984, ANNU REV NEUROSCI, V7, P443, DOI 10.1146/annurev.ne.07.030184.002303; ROBINSON TE, 1993, BIOL BASIS SUBSTANCE, P327; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; STEKETEE JD, 1991, BRAIN RES, V545, P287, DOI 10.1016/0006-8993(91)91299-G; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STRIPLIN CD, 1992, BRAIN RES, V579, P181, DOI 10.1016/0006-8993(92)90049-F; SURI C, 1993, J NEUROSCI, V13, P1280; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; VRANA SL, 1993, IN PRESS J NEUROCHEM; WANG YY, 1990, J NEUROSCI, V10, P3335; WISE RA, 1990, PSYCHOTROPIC DRUGS A, P23; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291	70	452	469	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					995	1006		10.1016/0896-6273(93)90213-B	http://dx.doi.org/10.1016/0896-6273(93)90213-B			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274284				2022-12-17	WOS:A1993MP54800001
J	QIU, MS; GREEN, SH				QIU, MS; GREEN, SH			PC12 CELL NEURONAL DIFFERENTIATION IS ASSOCIATED WITH PROLONGED P21(RAS) ACTIVITY AND CONSEQUENT PROLONGED ERK ACTIVITY	NEURON			English	Article							NERVE GROWTH-FACTOR; PROTEIN-KINASE-C; LIGAND-INDUCED INTERNALIZATION; SERINE THREONINE KINASES; SIGNAL-REGULATED KINASES; SERUM-RESPONSE ELEMENT; TYROSINE PHOSPHORYLATION; NEURITE OUTGROWTH; FACTOR RECEPTOR; PHEOCHROMOCYTOMA CELLS	Expression of oncogenic ras in PC12 cells causes neuronal differentiation 'and sustained protein tyrosine phosphorylation and activity of extracellular signal-regulated kinases (ERKs), p42erk2 and p44erk1. Oncogenic N-ras-induced neuronal differentiation is inhibited by compounds that block ERK protein tyrosine phosphorylation or ERK activity, indicating that ERKs are not only activated by p21ras but serve as the primary downstream effectors of p21ras. Treatment of PC12 cells with nerve growth factor or fibroblast growth factor results in neuronal differentiation and in a sustained elevation of p21ras activity, of ERK activity, and of ERK tyrosine phosphorylation. Epidermal growth factor, which does not cause neuronal differentiation, stimulates only transient (< 1 hr) activation of p21ras and ERKs. These data indicate that transient activation of p21ras and, consequently, ERKs is not sufficient for induction of neuronal differentiation. Prolonged ERK activity is required: a consequence of sustained activation of p21ras by the growth factor receptor protein tyrosine kinase.			QIU, MS (corresponding author), UNIV IOWA,DEPT BIOL,IOWA CITY,IA 52242, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026538] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26538] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHN NG, 1991, J BIOL CHEM, V266, P4220; AHN NG, 1990, J BIOL CHEM, V265, P11487; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ANDERSON NG, 1991, BIOCHEM J, V277, P573, DOI 10.1042/bj2770573; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Ausubel F.M., 1989, SHORT PROTOCOLS MOL; BALLESTER R, 1985, J BIOL CHEM, V260, P5194; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BERGER FG, 1984, J BIOL CHEM, V259, P7941; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BURSTEIN DE, 1982, DEV BIOL, V94, P477, DOI 10.1016/0012-1606(82)90364-5; CAMPOSGONZALEZ R, 1991, CELL REGUL, V2, P663, DOI 10.1091/mbc.2.8.663; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CHO KO, 1989, MOL CELL BIOL, V9, P135, DOI 10.1128/MCB.9.1.135; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHUNG J, 1991, P NATL ACAD SCI USA, V88, P4981, DOI 10.1073/pnas.88.11.4981; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; DECKER SJ, 1990, J BIOL CHEM, V265, P7009; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; FUKUMOTO Y, 1990, J BIOL CHEM, V265, P774; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GAUTHIERROUVIERE C, 1990, EMBO J, V9, P171, DOI 10.1002/j.1460-2075.1990.tb08093.x; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1978, NATURE, V276, P191, DOI 10.1038/276191a0; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1990, J NEUROSCI, V10, P1479; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; GUERRERO I, 1988, BIOCHEM BIOPH RES CO, V150, P1185, DOI 10.1016/0006-291X(88)90754-1; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HEISERMANN GJ, 1990, J BIOL CHEM, V265, P12820; HUFF KR, 1979, BIOCHEM BIOPH RES CO, V89, P176; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KIM UH, 1991, J BIOL CHEM, V266, P1359; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LACAL JC, 1987, MOL CELL BIOL, V7, P4146, DOI 10.1128/MCB.7.11.4146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LI P, 1991, CELL, V64, P479, DOI 10.1016/0092-8674(91)90228-Q; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LUND KA, 1990, J BIOL CHEM, V265, P20517; MAHER PA, 1989, J NEUROSCI RES, V24, P29, DOI 10.1002/jnr.490240106; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MORRIS JDH, 1989, ONCOGENE, V4, P27; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NJA A, 1978, J PHYSIOL-LONDON, V277, P53; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; PRESTA M, 1991, CELL REGUL, V2, P719, DOI 10.1091/mbc.2.9.719; PURVES D, 1976, J PHYSIOL-LONDON, V259, P159, DOI 10.1113/jphysiol.1976.sp011459; QIU MS, 1991, J CELL BIOL, V115, P795, DOI 10.1083/jcb.115.3.795; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SCHANENKING C, 1991, NEURON, V6, P915, DOI 10.1016/0896-6273(91)90232-O; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SIGMUND O, 1990, J BIOL CHEM, V265, P2257; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TOGARI A, 1985, J NEUROSCI, V5, P307; TROTTA RJ, 1990, J CELL PHYSIOL, V143, P68, DOI 10.1002/jcp.1041430109; TSAO H, 1991, J BIOL CHEM, V266, P12981; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; VOLONTE C, 1989, J CELL BIOL, V109, P2395, DOI 10.1083/jcb.109.5.2395; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	90	452	458	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					705	717		10.1016/0896-6273(92)90033-A	http://dx.doi.org/10.1016/0896-6273(92)90033-A			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1382473				2022-12-17	WOS:A1992JT51600011
J	Britanova, O; de Juan Romero, C; Cheung, A; Kwan, KY; Schwark, M; Gyorgy, A; Vogel, T; Akopov, S; Mitkovski, M; Agoston, D; Sestan, N; Molnar, Z; Tarabykin, V				Britanova, Olga; de Juan Romero, Camino; Cheung, Amanda; Kwan, Kenneth Y.; Schwark, Manuela; Gyorgy, Andrea; Vogel, Tanja; Akopov, Sergey; Mitkovski, Mico; Agoston, Denes; Sestan, Nenad; Molnar, Zoltan; Tarabykin, Victor			Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex	NEURON			English	Article							MAR-BINDING PROTEIN; CEREBRAL-CORTEX; PROJECTION NEURONS; DENDRITIC MORPHOLOGY; SUBVENTRICULAR ZONE; PYRAMIDAL NEURONS; GENE-EXPRESSION; CELL-CYCLE; DIFFERENTIATION; MIGRATION	Pyramidal neurons of the neocortex can be subdivided into two major groups: deep- (DL) and upperlayer(UL) neurons. Here we report that the expression of the AT-rich DNA-binding protein Satb2 defines two subclasses of UL neurons: UL1 (Satb2 positive) and UL2 (Satb2 negative). In the absence of Satb2, UL1 neurons lose their identity and activate DL- and UL2-specific genetic programs. UL1 neurons in Satb2 mutants fail to migrate to superficial layers and do not contribute to the corpus callosum but to the corticospinal tract, which is normally populated by DL axons. Ctip2, a gene required for the formation of the corticospinal tract, is ectopically expressed in all UL1 neurons in the absence of Satb2. Satb2 protein interacts with the Ctip2 genomic region and controls chromatin remodeling at this locus. Satb2 therefore is required for the initiation of the UL2-specific genetic program and for the inactivation of DL- and UL2-specific genes.	[Britanova, Olga; de Juan Romero, Camino; Schwark, Manuela; Mitkovski, Mico; Tarabykin, Victor] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [de Juan Romero, Camino; Tarabykin, Victor] DFG Res Ctr Mol Physiol Brain CMPB, D-37073 Gottingen, Germany; [Britanova, Olga; Akopov, Sergey] Shemiakin & Ovchinnikov Inst Bioorgan Chem RAS, Moscow 117871, Russia; [Cheung, Amanda; Molnar, Zoltan] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Kwan, Kenneth Y.; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Vogel, Tanja] Univ Gottingen, Dept Anat, D-3400 Gottingen, Germany; [Gyorgy, Andrea] USU, Dept Anat Physiol & Genet, Sch Med, Bethesda, MD 20814 USA	Max Planck Society; German Research Foundation (DFG); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Oxford; Yale University; University of Gottingen	Tarabykin, V (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	tarabykin@em.mpg.de	de Juan Romero, Camino/G-9934-2015; Molnar, Zoltan/J-7281-2012; Kwan, Kenneth Y/F-8489-2011; Tarabykin, Victor/F-9467-2014; Kwan, Kenneth/AAI-2841-2021	Molnar, Zoltan/0000-0002-6852-6004; Kwan, Kenneth Y/0000-0003-4711-071X; Kwan, Kenneth/0000-0003-4711-071X; de Juan, Camino/0000-0001-7890-8447; Tarabykin, Viktor/0000-0001-8931-7263; Mitkovski, Miso/0000-0001-9195-2434	Medical Research Council [G0300200, G0700377] Funding Source: Medline; MRC [G0700377, G0300200] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alvarez JD, 2000, GENE DEV, V14, P521; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Britanova O, 2006, DEV BIOL, V298, P299, DOI 10.1016/j.ydbio.2006.06.040; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; COCKERILL PN, 1986, FEBS LETT, V204, P5, DOI 10.1016/0014-5793(86)81377-1; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Desai AR, 2000, DEVELOPMENT, V127, P2863; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Fukuda T, 1997, J COMP NEUROL, V382, P141; GYORGY A, 2008, IN PRESS EUR J NEURO; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; IZAURRALDE E, 1988, J MOL BIOL, V200, P111, DOI 10.1016/0022-2836(88)90337-3; Mallamaci A, 2006, EUR J NEUROSCI, V23, P847, DOI 10.1111/j.1460-9568.2006.04634.x; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Molnar ZN, 2002, J NEUROSCI, V22, P10313; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	35	451	458	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 7	2008	57	3					378	392		10.1016/j.neuron.2007.12.028	http://dx.doi.org/10.1016/j.neuron.2007.12.028			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255031	Bronze			2022-12-17	WOS:000253075300008
J	Mitchell, JF; Sundberg, KA; Reynolds, JH				Mitchell, Jude F.; Sundberg, Kristy A.; Reynolds, John H.			Differential attention-dependent response modulation across cell classes in macaque visual area V4	NEURON			English	Article							FAST-SPIKING INTERNEURONS; DORSOLATERAL PREFRONTAL CORTEX; RAT FRONTAL-CORTEX; PYRAMIDAL CELLS; INHIBITORY NEURONS; CORTICAL-NEURONS; MORPHOLOGICAL-CHARACTERISTICS; SYNAPTIC CONNECTIONS; NEOCORTICAL NEURONS; SELECTIVE ATTENTION	The cortex contains multiple cell types, but studies of attention have not distinguished between them, limiting understanding of the local circuits that transform attentional feedback into improved visual processing. Parvalbumin-expressing inhibitory interneurons can be distinguished from pyramidal neurons based on their briefer action potential durations. We recorded neurons in area V4 as monkeys performed an attention-demanding task. We find that the distribution of action potential durations is strongly bimodal. Neurons with narrow action potentials have higher firing rates and larger attention-dependent increases in absolute firing rate than neurons with broad action potentials. The percentage increase in response is similar across the two classes. We also find evidence that attention increases the reliability of the neuronal response. This modulation is more than twofold stronger among putative interneurons. These findings lead to the surprising conclusion that the strongest attentional modulation occurs among local interneurons that do not transmit signals between areas.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Mitchell, JF (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA.	jude@salk.edu; reynolds@salk.edu		Mitchell, Jude/0000-0003-0197-7545	NEI NIH HHS [EY016161] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016161] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Berry MJ, 1998, J NEUROSCI, V18, P2200; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Bruno RM, 2002, J NEUROSCI, V22, P10966; BUZSAKI G, 1982, J NEUROPHYSIOL, V48, P597, DOI 10.1152/jn.1982.48.3.597; Cauli B, 1997, J NEUROSCI, V17, P3894; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Contreras D, 2003, J NEUROSCI, V23, P6936; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; FOEHRING RC, 1991, J NEUROPHYSIOL, V66, P1825, DOI 10.1152/jn.1991.66.6.1825; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Gonzalez-Burgos G, 2004, CEREB CORTEX, V14, P530, DOI 10.1093/cercor/bhh015; Gur M, 1997, J NEUROSCI, V17, P2914; Gur M, 1999, J NEUROPHYSIOL, V82, P1451, DOI 10.1152/jn.1999.82.3.1451; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Krimer LS, 2005, J NEUROPHYSIOL, V94, P3009, DOI 10.1152/jn.00156.2005; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 1998, J NEUROSCI, V18, P8111; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Povysheva NV, 2006, CEREB CORTEX, V16, P541, DOI 10.1093/cercor/bhj002; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Spinks RL, 2003, J NEUROPHYSIOL, V90, P1324, DOI 10.1152/jn.00169.2003; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tamura H, 2004, J NEUROPHYSIOL, V91, P2782, DOI 10.1152/jn.01267.2003; Tasker JG, 1996, J NEUROPHYSIOL, V75, P931, DOI 10.1152/jn.1996.75.2.931; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	64	451	457	1	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					131	141		10.1016/j.neuron.2007.06.018	http://dx.doi.org/10.1016/j.neuron.2007.06.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610822	Bronze, Green Submitted			2022-12-17	WOS:000248010700013
J	Murthy, VN; Schikorski, T; Stevens, CF; Zhu, YL				Murthy, VN; Schikorski, T; Stevens, CF; Zhu, YL			Inactivity produces increases in neurotransmitter release and synapse size	NEURON			English	Article							BARREL FIELD CORTEX; HIPPOCAMPAL SYNAPSES; DENDRITIC SPINES; QUANTAL ANALYSIS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; NEURONS; RECEPTOR; AMPA; EXPRESSION	When hippocampal synapses in culture are pharmacologically silenced for several days, synaptic strength increases. The structural correlate of this change in strength is an increase in the size of the synapses, with all synaptic components-active zone, postsynaptic density, and bouton-becoming larger. Further, the number of docked vesicles and the total number of vesicles per synapse increases, although the number of docked vesicles per area of active zone is unchanged. In parallel with these anatomical changes, the physiologically measured size of the readily releasable pool (RRP) and the release probability are increased. Ultrastructural analysis of individual synapses in which the RRP was previously measured reveals that, within measurement error, the same number of vesicles are docked as are estimated to be in the RRP.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Harvard University; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Schikorski, Thomas/0000-0003-3902-2461; Murthy, Venkatesh/0000-0003-2443-4252				ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benson DL, 1996, J NEUROSCI, V16, P6424; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; Cannon WB, 1939, AM J MED SCI, V198, P737, DOI 10.1097/00000441-193912000-00001; Casey DE, 2000, J CLIN PSYCHIAT, V61, P5; CLARK CV, 1989, EYE, V3, P349, DOI 10.1038/eye.1989.50; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; FAMBROUGH DM, 1970, SCIENCE, V168, P372, DOI 10.1126/science.168.3929.372; GRAMPP W, 1972, J PHYSIOL-LONDON, V221, P743, DOI 10.1113/jphysiol.1972.sp009780; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mackinnon P, 2000, AUSTRALAS J AGEING, V19, P3; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nusser Z, 1998, J NEUROSCI, V18, P1693; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; SHARPLESS SK, 1964, ANNU REV PHYSIOL, V26, P357, DOI 10.1146/annurev.ph.26.030164.002041; SHARPLESS SK, 1975, DEV NEUROPSYCHOL, P125; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7	52	451	457	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					673	682		10.1016/S0896-6273(01)00500-1	http://dx.doi.org/10.1016/S0896-6273(01)00500-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719207	Bronze			2022-12-17	WOS:000172363900013
J	Aakalu, G; Smith, WB; Nguyen, N; Jiang, CG; Schuman, EM				Aakalu, G; Smith, WB; Nguyen, N; Jiang, CG; Schuman, EM			Dynamic visualization of local protein synthesis in hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; MESSENGER-RNA; TETANIC STIMULATION; NEUROTROPHIC FACTOR; KINASE-II; LOCALIZATION; REQUIREMENT; DENDRITES; REGION; ALPHA	Using pharmacological approaches, several recent studies suggest that local protein synthesis is required for synaptic plasticity. Convincing demonstrations of bona fide dendritic protein synthesis in mammalian neurons are rare, however. We developed a protein synthesis reporter in which the coding sequence of green fluorescent protein is flanked by the 5' and 3' untranslated regions from CAMKII-alpha, conferring both dendritic mRNA localization and translational regulation. In cultured hippocampal neurons, we show that BDNF, a growth factor involved in synaptic plasticity, stimulates protein synthesis of the reporter in intact, mechanically, or "optically" isolated dendrites. The stimulation of protein synthesis is blocked by anisomycin and not observed in untreated neurons. In addition, dendrites appear to possess translational hot spots, regions near synapses where protein synthesis consistently occurs over time.	CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011					Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; FEIG S, 1993, J NEUROSCI, V13, P1010; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Goslin K., 1990, CULTURING NERVE CELL; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; RAO A, 1991, J NEUROSCI, V11, P2881; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; SRINIVASAN Y, 1990, J NEUROSCI, V10, P985; STANTON PK, 1984, J NEUROSCI, V4, P3080; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Torre ER, 1996, J NEUROSCI, V16, P5967; TORRE ER, 1992, J NEUROSCI, V12, P762; WEILER I J, 1991, Molecular and Cellular Neuroscience, V2, P305, DOI 10.1016/1044-7431(91)90060-2; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; WELSL DG, 2000, CURR OPIN NEUROBIOL, V10, P132; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	43	451	469	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					489	502		10.1016/S0896-6273(01)00295-1	http://dx.doi.org/10.1016/S0896-6273(01)00295-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395009	Bronze			2022-12-17	WOS:000168962000020
J	RYAN, TA; REUTER, H; WENDLAND, B; SCHWEIZER, FE; TSIEN, RW; SMITH, SJ				RYAN, TA; REUTER, H; WENDLAND, B; SCHWEIZER, FE; TSIEN, RW; SMITH, SJ			THE KINETICS OF SYNAPTIC VESICLE RECYCLING MEASURED AT SINGLE PRESYNAPTIC BOUTONS	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; CULTURED HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; MEMBRANE; GLUTAMATE; PROTEINS; EXOCYTOSIS; CELLS	We used the fluorescent membrane probe FM 1-43 to label recycling synaptic vesicles within the presynaptic boutons of dissociated hippocampal neurons in culture. Quantitative time-lapse fluorescence imaging was employed in combination with rapid superfusion techniques to study the dynamics of synaptic vesicles within single boutons. This approach enabled us to measure exocytosis and to analyze the kinetics of endocytosis and the preparation of endocytosed vesicles for re-release (repriming). Our measurements indicate that under sustained membrane depolarization, endocytosis persists much longer than exocytosis, with a t1/2 almost-equal-to 60 s (approximately 24-degrees-C); once internalized, vesicles become reavailable for exocytosis in approximately 30 s. Furthermore, we have shown that endocytosis is not dependent on membrane potential and, unlike exocytosis, that it is independent of extracellular Ca2+.	UNIV BERN,DEPT PHARMACOL,CH-3010 BERN,SWITZERLAND	University of Bern	RYAN, TA (corresponding author), STANFORD UNIV,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		Ryan, Timothy/AAO-8286-2020	Smith, Stephen/0000-0002-2290-8701; Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587, R01NS024067] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS 24067, NS 28587] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; FORSCHER P, 1987, J NEUROSCI, V7, P3600; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JACOBSON K, 1987, ANNU REV PHYSIOL, V49, P163, DOI 10.1146/annurev.ph.49.030187.001115; Katz B., 1969, RELEASE NEURAL TRANS; KELLY RB, 1993, NEURON S, V10, P43; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V	27	451	457	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					713	724		10.1016/0896-6273(93)90081-2	http://dx.doi.org/10.1016/0896-6273(93)90081-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398156				2022-12-17	WOS:A1993MD06800014
J	McGlone, F; Wessberg, J; Olausson, H				McGlone, Francis; Wessberg, Johan; Olausson, Hakan			Discriminative and Affective Touch: Sensing and Feeling	NEURON			English	Review							UNMYELINATED TACTILE AFFERENTS; HAIRY SKIN; PREFRONTAL CORTEX; MATERNAL-CARE; HUMAN HAND; CUTANEOUS MECHANORECEPTORS; INTERPERSONAL TOUCH; SOCIAL EXPERIENCE; SENSORY NEURONS; PLEASANT TOUCH	The multimodal properties of the human somatosensory system continue to be unravelled. There is mounting evidence that one of these submodalities-touch-has another dimension, providing not only its well-recognized discriminative input to the brain, but also an affective input. It has long been recognized that touch plays an important role in many forms of social communication and a number of theories have been proposed to explain observations and beliefs about the "power of touch." Here, we propose that a class of low-threshold mechanosensitive C fibers that innervate the hairy skin represent the neurobiological substrate for the affective and rewarding properties of touch.	[McGlone, Francis] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England; [Wessberg, Johan] Univ Gothenburg, Inst Neurosci & Physiol, S-40530 Gothenburg, Sweden; [McGlone, Francis] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Olausson, Hakan] Linkoping Univ, Fac Hlth Sci, Div Neurosci, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden	Liverpool John Moores University; University of Gothenburg; University of Liverpool; Linkoping University	McGlone, F (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England.	f.p.mcglone@ljmu.ac.uk	McGlone, Francis Philip/AAA-5058-2022; McGlone, Francis/F-8349-2011	McGlone, Francis/0000-0002-0881-635X	Leverhulme Trust [RPG-2013-058]	Leverhulme Trust(Leverhulme Trust)	We are indebted to Professor Jonathan Cole and Dr. Susannah Walker for invaluable comments and suggestions in earlier drafts of the manuscript. Dr India Morrison provided essential input to the schematic figure. And we are all following in the footsteps of Professor Ake Vallbo. This work was supported by a Leverhulme Trust Project Grant RPG-2013-058.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; AINSWORTH MDS, 1979, AM PSYCHOL, V34, P932, DOI 10.1037/0003-066X.34.10.932; ALAGNA FJ, 1979, J COUNS PSYCHOL, V26, P465, DOI 10.1037/0022-0167.26.6.465; Andrew D, 2010, J PHYSIOL-LONDON, V588, P117, DOI 10.1113/jphysiol.2009.181511; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Arabin B, 1996, ULTRASOUND OBST GYN, V8, P166, DOI 10.1046/j.1469-0705.1996.08030166.x; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Bartholomew K., 1993, LEARNING RELATIONSHI, V2, P30; Bartocci M, 2006, PAIN, V122, P109, DOI 10.1016/j.pain.2006.01.015; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Bentley, 1900, AM J PSYCHOL, V11, P405, DOI [10.2307/1412750, DOI 10.2307/1412750, 10.2307/1412750.]; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Bilderbeck A.C., 2013, SOC COGN AFFECT NEUR; Bilderbeck AC, 2011, BIOL PSYCHIAT, V69, P720, DOI 10.1016/j.biopsych.2010.12.038; Bjornsdotter M, 2009, J NEUROSCI, V29, P9314, DOI 10.1523/JNEUROSCI.0400-09.2009; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; Bottorff J L, 1993, Oncol Nurs Forum, V20, P1531; Bowlby J, 1973, ATTACHMENT LOSS; Bowlby J., 1970, ATTACHMENT, V1; BURGOON JK, 1992, HUM COMMUN RES, V19, P237, DOI 10.1111/j.1468-2958.1992.tb00301.x; BURGOON JK, 1991, J NONVERBAL BEHAV, V15, P233, DOI 10.1007/BF00986924; Bystrova K, 2009, BIRTH-ISS PERINAT C, V36, P97, DOI 10.1111/j.1523-536X.2009.00307.x; Bystrova K, 2009, MED HYPOTHESES, V72, P143, DOI 10.1016/j.mehy.2008.09.033; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Cascio C, 2008, J AUTISM DEV DISORD, V38, P127, DOI 10.1007/s10803-007-0370-8; Cascio CJ, 2010, J NEURODEV DISORD, V2, P62, DOI 10.1007/s11689-010-9046-3; CASLER L, 1961, MONOGR SOC RES CHILD, V26, P1, DOI 10.2307/1165564; CAUNA N, 1973, J ANAT, V115, P277; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Chris, 2002, PARADOX NATURAL MOTH; Clarke AS, 1999, BIOL PSYCHIAT, V46, P221, DOI 10.1016/S0006-3223(99)00027-X; COLE JD, 1992, J PHYSIOL-LONDON, V449, P503, DOI 10.1113/jphysiol.1992.sp019099; Cole J, 2006, MUSCLE NERVE, V34, P105, DOI 10.1002/mus.20534; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Craig A. D., 2008, HDB EMOTIONS, V3, P272, DOI DOI 10.1017/S0140525X13001489; Crucianelli Laura, 2013, Front Psychol, V4, P703, DOI 10.3389/fpsyg.2013.00703; CRUSCO AH, 1984, PERS SOC PSYCHOL B, V10, P512, DOI 10.1177/0146167284104003; Cushing BS, 2005, NEUROSCI BIOBEHAV R, V29, P1089, DOI 10.1016/j.neubiorev.2005.04.001; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; DEAKIN JFW, 1990, PSYCHOPHARMACOLOGY, V101, P85, DOI 10.1007/BF02253723; Delfini MC, 2013, CELL REP, V5, P378, DOI 10.1016/j.celrep.2013.09.013; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; DICHIARA G, 1992, TRENDS PHARMACOL SCI, V13, P185; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DOUGLAS WW, 1957, J PHYSIOL-LONDON, V139, P385, DOI 10.1113/jphysiol.1957.sp005899; Drew LJ, 2009, NATURE, V462, P580, DOI 10.1038/462580a; Dum RP, 2009, J NEUROSCI, V29, P14223, DOI 10.1523/JNEUROSCI.3398-09.2009; Dunbar R., 1997, GROOMING GOSSIP EVOL; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; EDIN BB, 1992, J NEUROPHYSIOL, V67, P1105, DOI 10.1152/jn.1992.67.5.1105; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; Eghbal-Ahmadi M, 1999, J NEUROSCI, V19, P3982; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Ellingsen DM, 2014, PSYCHONEUROENDOCRINO, V39, P11, DOI 10.1016/j.psyneuen.2013.09.017; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; FIELD T, 1995, ADOLESCENCE, V30, P133; Field T., 2001, TOUCH; FLEMING AS, 1994, PSYCHOBIOLOGY, V22, P44; Foerster O, 1932, Z GESAMTE NEUROL PSY, V138, P1, DOI 10.1007/BF02870563; Foerster O.E., 1936, HDB NEUROLOGIE, V5, P239; FORGET R, 1987, HUM NEUROBIOL, V6, P27; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; Gazzola V, 2012, P NATL ACAD SCI USA, V109, pE1657, DOI 10.1073/pnas.1113211109; Gescheider G.A., 2010, INFORM PROCESSING TA; GESCHEIDER GA, 1985, J ACOUST SOC AM, V78, P534, DOI 10.1121/1.392475; Giummarra MJ, 2010, PERCEPTION, V39, P1396, DOI 10.1068/p6582; Gordon I, 2013, HUM BRAIN MAPP, V34, P914, DOI 10.1002/hbm.21480; Grandin T., 1992, HIGH FUNCTIONING IND, P105, DOI [10.1007/978-1-4899-2456-8_6, DOI 10.1007/978-1-4899-2456-8_6]; Grandin T., 1986, EMERGENCE LABELED AU; Griffin JW, 2001, CURR OPIN NEUROL, V14, P655, DOI 10.1097/00019052-200110000-00016; Grudt TJ, 2002, J PHYSIOL-LONDON, V540, P189, DOI 10.1113/jphysiol.2001.012890; HAGBARTH KE, 1967, ACTA PHYSIOL SCAND, V69, P121, DOI 10.1111/j.1748-1716.1967.tb03498.x; Hanson R F, 2000, Child Maltreat, V5, P137, DOI 10.1177/1077559500005002005; HARLOW HARRY F., 1958, PROC AMER PHIL SOC, V102, P501; HARLOW HF, 1962, B MENNINGER CLIN, V26, P213; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Hertenstein MJ, 2006, EMOTION, V6, P528, DOI 10.1037/1528-3542.6.3.528; Hooker D., 1943, CHILD BEHAV DEV, P17; Hooker D., 1952, PRENATAL ORIGIN BEHA; HUMPHREY T, 1966, J COMP NEUROL, V126, P91, DOI 10.1002/cne.901260108; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; IGGO A, 1977, J PHYSIOL-LONDON, V271, P549, DOI 10.1113/jphysiol.1977.sp012014; Insel TR, 1998, BIOL PSYCHIAT, V44, P207, DOI 10.1016/S0006-3223(98)00094-8; Jean ADL, 2009, INFANT BEHAV DEV, V32, P344, DOI 10.1016/j.infbeh.2009.04.005; JOHANSSON RS, 1988, EXP BRAIN RES, V72, P204, DOI 10.1007/BF00248518; JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X; Jones RSP, 2003, J INTELLECT DEV DIS, V28, P112, DOI 10.1080/1366825031000147058; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; KAITZ M, 1992, DEV PSYCHOL, V28, P35, DOI 10.1037/0012-1649.28.1.35; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kern JK, 2007, AUTISM, V11, P123, DOI 10.1177/1362361307075702; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Kida T, 2013, NEUROSCI LETT, V541, P63, DOI 10.1016/j.neulet.2013.01.048; Kiser D, 2012, NEUROSCI BIOBEHAV R, V36, P786, DOI 10.1016/j.neubiorev.2011.12.009; Knox SS, 1998, PSYCHONEUROENDOCRINO, V23, P877, DOI 10.1016/S0306-4530(98)00061-4; KORNER AF, 1966, CHILD DEV, V37, P867; Kramer HH, 2007, PAIN, V133, P72, DOI 10.1016/j.pain.2007.03.001; KUMAZAWA T, 1977, J NEUROPHYSIOL, V40, P1325, DOI 10.1152/jn.1977.40.6.1325; LAHUERTA J, 1994, J NEUROSURG, V80, P975, DOI 10.3171/jns.1994.80.6.0975; LEEM JW, 1993, J NEUROPHYSIOL, V69, P1684, DOI 10.1152/jn.1993.69.5.1684; Leonard J.A., 2014, Q J EXP PSYCHOL; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liedloff J., 1985, CONTINUUM CONCEPTS S; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; Liljencrantz J, 2013, PAIN, V154, P227, DOI 10.1016/j.pain.2012.10.024; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Lloyd DM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00207; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lyons DM, 2010, P NATL ACAD SCI USA, V107, P14823, DOI 10.1073/pnas.0914568107; Main M., 1990, ATTACHMENT PRESCHOOL, P161, DOI DOI 10.1016/J.NCL.2015.11.007; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Marshall KL, 2012, ADV EXP MED BIOL, V739, P142, DOI 10.1007/978-1-4614-1704-0_9; Maxwell DJ, 2007, J PHYSIOL-LONDON, V584, P521, DOI 10.1113/jphysiol.2007.140996; McCabe C, 2008, SOC COGN AFFECT NEUR, V3, P97, DOI 10.1093/scan/nsn005; McGlone F, 2002, BEHAV BRAIN RES, V135, P147, DOI 10.1016/S0166-4328(02)00144-4; McGlone F, 2007, CAN J EXP PSYCHOL, V61, P173, DOI 10.1037/cjep2007019; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Menard JL, 2004, NEUROSCIENCE, V129, P297, DOI 10.1016/j.neuroscience.2004.08.009; Miles R, 2006, EARLY HUM DEV, V82, P447, DOI 10.1016/j.earlhumdev.2005.11.008; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Montagu Ashley, 1978, TOUCHING HUMAN SIGNI; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Morrison I, 2011, BRAIN, V134, P1116, DOI 10.1093/brain/awr011; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; Mountcastle V.B., 2005, SENSORY HAND; Naber FBA, 2007, J AUTISM DEV DISORD, V37, P1123, DOI 10.1007/s10803-006-0255-2; Nagi SS, 2011, J PHYSIOL-LONDON, V589, P4065, DOI 10.1113/jphysiol.2011.211326; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nichols D E, 1993, Drug Des Discov, V9, P299; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; OCHOA J, 1983, J PHYSIOL-LONDON, V342, P633, DOI 10.1113/jphysiol.1983.sp014873; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson H, 2008, EXP BRAIN RES, V184, P135, DOI 10.1007/s00221-007-1175-x; PANKSEPP J, 1979, TRENDS NEUROSCI, V2, P174, DOI 10.1016/0166-2236(79)90071-7; Panksepp J, 2006, PROG NEURO-PSYCHOPH, V30, P774, DOI 10.1016/j.pnpbp.2006.01.004; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Pecina S, 2006, NEUROSCIENTIST, V12, P500, DOI 10.1177/1073858406293154; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Pine DS, 1997, ARCH GEN PSYCHIAT, V54, P839; Prescott J.W., 1979, CHILD ABUSE VIOLENCE, P66; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; RALEIGH MJ, 1980, EXP NEUROL, V68, P322, DOI 10.1016/0014-4886(80)90089-8; Reilly DM, 1997, BRIT J DERMATOL, V137, P163, DOI 10.1046/j.1365-2133.1997.18001893.x; Rogers SJ, 2003, J CHILD PSYCHOL PSYC, V44, P763, DOI 10.1111/1469-7610.00162; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; ROSENBLUM LA, 1994, BIOL PSYCHIAT, V35, P221, DOI 10.1016/0006-3223(94)91252-1; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Sewards TV, 2002, BRAIN RES BULL, V58, P243, DOI 10.1016/S0361-9230(02)00783-9; Sharp H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045446; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; Spitz RA, 1946, PSYCHOANAL STUD CHIL, V2, P113, DOI 10.1080/00797308.1946.11823540; Spitz RA, 1945, PSYCHOANAL STUD CHIL, V1, P53, DOI 10.1080/00797308.1945.11823126; STACK DM, 1992, CHILD DEV, V63, P1509; STACK DM, 1990, BRIT J DEV PSYCHOL, V8, P131, DOI 10.1111/j.2044-835X.1990.tb00828.x; Starr MA, 2008, J PHARMACOL EXP THER, V327, P20, DOI 10.1124/jpet.108.139337; Stenneken P, 2006, BRAIN RES, V1084, P123, DOI 10.1016/j.brainres.2006.02.057; STERMAN AB, 1980, ANN NEUROL, V7, P354, DOI 10.1002/ana.410070413; Strumia R, 2005, AM J CLIN DERMATOL, V6, P165, DOI 10.2165/00128071-200506030-00003; Sugiura Y, 1996, PROG BRAIN RES, V113, P319, DOI 10.1016/S0079-6123(08)61096-1; Suomi SJ, 2011, J CAN ACAD CHILD ADO, V20; THAYER S, 1986, J NONVERBAL BEHAV, V10, P7, DOI 10.1007/BF00987201; Thompson MR, 2007, NEUROSCIENCE, V146, P509, DOI 10.1016/j.neuroscience.2007.02.032; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Trulsson M, 2001, NEUROIMAGE, V13, P613, DOI 10.1006/nimg.2000.0723; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; VALLBO A, 1993, BRAIN RES, V628, P301, DOI 10.1016/0006-8993(93)90968-S; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; VALLBO AB, 1995, J PHYSIOL-LONDON, V483, P783, DOI 10.1113/jphysiol.1995.sp020622; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; VALLBO AB, 1984, BRAIN, V107, P727, DOI 10.1093/brain/107.3.727; van Stralen HE, 2014, COGNITION, V131, P147, DOI 10.1016/j.cognition.2013.11.020; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; VERRILLO RT, 1963, J ACOUST SOC AM, V35, P1962, DOI 10.1121/1.1918868; VERRILLO RT, 1968, SKIN SENSES, P135; Voos AC, 2013, SOC COGN AFFECT NEUR, V8, P378, DOI 10.1093/scan/nss009; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Walker SC, 2013, NEUROPEPTIDES, V47, P379, DOI 10.1016/j.npep.2013.10.008; Wasling HB, 2005, EXP BRAIN RES, V166, P147, DOI 10.1007/s00221-005-2343-5; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002; WHITCHER SJ, 1979, J PERS SOC PSYCHOL, V37, P87, DOI 10.1037/0022-3514.37.1.87; Willis W.D., 1978, SENSORY MECH SPINAL; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	213	450	455	12	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 21	2014	82	4					737	755		10.1016/j.neuron.2014.05.001	http://dx.doi.org/10.1016/j.neuron.2014.05.001			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AH8IA	24853935	Bronze			2022-12-17	WOS:000336379800006
J	Bosman, CA; Schoffelen, JM; Brunet, N; Oostenveld, R; Bastos, AM; Womelsdorf, T; Rubehn, B; Stieglitz, T; De Weerd, P; Fries, P				Bosman, Conrado A.; Schoffelen, Jan-Mathijs; Brunet, Nicolas; Oostenveld, Robert; Bastos, Andre M.; Womelsdorf, Thilo; Rubehn, Birthe; Stieglitz, Thomas; De Weerd, Peter; Fries, Pascal			Attentional Stimulus Selection through Selective Synchronization between Monkey Visual Areas	NEURON			English	Article							GAMMA-BAND SYNCHRONIZATION; OSCILLATORY NEURONAL RESPONSES; EXTRASTRIATE AREAS; THETA-OSCILLATIONS; CORTICAL NETWORKS; TOP-DOWN; FREQUENCY; CORTEX; MODULATION; COHERENCE	A central motif in neuronal networks is convergence, linking several input neurons to one target neuron. In visual cortex, convergence renders target neurons responsive to complex stimuli. Yet, convergence typically sends multiple stimuli to a target, and the behaviorally relevant stimulus must be selected. We used two stimuli, activating separate electrocorticographic V1 sites, and both activating an electrocorticographic V4 site equally strongly. When one of those stimuli activated one V1 site, it gamma synchronized (60-80 Hz) to V4. When the two stimuli activated two V1 sites, primarily the relevant one gamma synchronized to V4. Frequency bands of gamma activities showed substantial overlap containing the band of interareal coherence. The relevant V1 site had its gamma peak frequency 2-3 Hz higher than the irrelevant V1 site and 4-6 Hz higher than V4. Gamma-mediated interareal influences were predominantly directed from V1 to V4. We propose that selective synchronization renders relevant input effective, thereby modulating effective connectivity.	[Bosman, Conrado A.; Schoffelen, Jan-Mathijs; Brunet, Nicolas; Oostenveld, Robert; Bastos, Andre M.; Womelsdorf, Thilo; De Weerd, Peter; Fries, Pascal] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Bosman, Conrado A.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Cognit & Syst Neurosci Grp, NL-1098 XH Amsterdam, Netherlands; [Bastos, Andre M.; Fries, Pascal] Max Planck Gesell, Ernst Strungmann Inst ESI Neurosci Cooperat, D-60528 Frankfurt, Germany; [Bastos, Andre M.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Bastos, Andre M.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95618 USA; [Rubehn, Birthe; Stieglitz, Thomas] Univ Freiburg, Lab Biomed Microtechnol, Dept Microsyst Engn IMTEK, D-79110 Freiburg, Germany; [Rubehn, Birthe; Stieglitz, Thomas] Univ Freiburg, Bernstein Ctr Freiburg, D-79110 Freiburg, Germany; [De Weerd, Peter] Univ Maastricht, Dept Neurocognit, NL-6229 ER Maastricht, Netherlands	Radboud University Nijmegen; University of Amsterdam; Max Planck Society; University of California System; University of California Davis; University of California System; University of California Davis; University of Freiburg; University of Freiburg; Maastricht University	Bosman, CA (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands.	c.a.bosmanvittini@uva.nl; pascal.fries@esi-frankfurt.de	Womelsdorf, Thilo/C-3096-2015; Oostenveld, Robert/D-3259-2009; Schoffelen, Jan-Mathijs/D-3716-2009; Stieglitz, Thomas/C-7916-2013; Fries, Pascal/E-3196-2010; Bosman, Conrado/I-6617-2019	Womelsdorf, Thilo/0000-0001-6921-4187; Oostenveld, Robert/0000-0002-1974-1293; Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Stieglitz, Thomas/0000-0002-7349-4254; Fries, Pascal/0000-0002-4270-1468; Bosman, Conrado/0000-0003-2433-6126; Bastos, Andre/0000-0003-1804-4418	European Science Foundation; European Union; National Science Foundation; U.S. Department of State; Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture, and Science; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	European Science Foundation(European Science Foundation (ESF)European Commission); European Union(European Commission); National Science Foundation(National Science Foundation (NSF)); U.S. Department of State; Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture, and Science; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Mark Roberts and Eric Lowet for support, Edward Chang for help with implanting monkey P, Mingzhou Ding for providing the code for spectral matrix factorization, and Karl Friston and Wolf Singer for helpful comments on earlier versions of this manuscript. This work was supported by the European Young Investigator program of the European Science Foundation (P.F.), the European Union's seventh framework program (P.F.), the National Science Foundation Graduate Student Fellowship Program (A.M.B.), and a Fulbright grant from the U.S. Department of State (A.M.B.). R.O. and J.-M.S. gratefully acknowledge the support of the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture, and Science.	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Barone P, 2000, J NEUROSCI, V20, P3263, DOI 10.1523/JNEUROSCI.20-09-03263.2000; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Boergers C, 2008, NEURAL COMPUT, V20, P383, DOI 10.1162/neco.2007.07-06-289; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Busse L, 2008, P NATL ACAD SCI USA, V105, P16380, DOI 10.1073/pnas.0707369105; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hoogenboom N, 2010, NEUROIMAGE, V51, P1162, DOI 10.1016/j.neuroimage.2010.03.041; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Nalatore H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031123; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Popescu AT, 2009, NAT NEUROSCI, V12, P801, DOI 10.1038/nn.2305; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rubehn B, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/036003; Schoffelen JM, 2011, J NEUROSCI, V31, P6750, DOI 10.1523/JNEUROSCI.4882-10.2011; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Taylor K, 2005, CEREB CORTEX, V15, P1424, DOI 10.1093/cercor/bhi023; Tiesinga PH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00196; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; van Elswijk G, 2010, J NEUROSCI, V30, P4481, DOI 10.1523/JNEUROSCI.2794-09.2010; van Pelt S, 2012, J NEUROSCI, V32, P3388, DOI 10.1523/JNEUROSCI.5592-11.2012; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256	64	450	452	2	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 6	2012	75	5					875	888		10.1016/j.neuron.2012.06.037	http://dx.doi.org/10.1016/j.neuron.2012.06.037			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	004LX	22958827	Green Submitted, Green Accepted, Bronze			2022-12-17	WOS:000308684300014
J	Bar, M; Aminoff, E				Bar, M; Aminoff, E			Cortical analysis of visual context	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; POSITRON EMISSION TOMOGRAPHY; HUMAN OBJECT AREAS; EPISODIC MEMORY; RETROSPLENIAL AMNESIA; SEMANTIC MEMORY; BRAIN ACTIVITY; HIPPOCAMPAL; RECOGNITION; INFORMATION	Objects in our environment tend to be grouped in typical contexts. How does the human brain analyze such associations between visual objects and their specific context? We addressed this question in four functional neuroimaging experiments and revealed the cortical mechanisms that are uniquely activated when people recognize highly contextual objects (e.g., a traffic light). Our findings indicate that a region in the parahippocampal cortex and a region in the retrosplenial cortex together comprise a system that mediates both spatial and nonspatial contextual processing. Interestingly, each of these regions has been identified in the past with two functions: the processing of spatial information and episodic memory. Attributing contextual analysis to these two areas, instead, provides a framework for bridging between previous reports.	NMR Ctr, Massachusetts Gen Hosp, Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Bar, M (corresponding author), NMR Ctr, Massachusetts Gen Hosp, Harvard Med Sch, Charlestown, MA 02129 USA.		Aminoff, Elissa/AAF-7718-2019	Aminoff, Elissa/0000-0002-6455-8930; Bar, Moshe/0000-0003-3362-3709				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aguirre GK, 1997, J NEUROSCI, V17, P2512; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Bar M, 1996, PERCEPTION, V25, P343, DOI 10.1068/p250343; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Biederman I., 1981, PERCEPTUAL ORG, P213, DOI 10.4324/9781315512372-8; BOWERS D, 1988, BRAIN COGNITION, V8, P47, DOI 10.1016/0278-2626(88)90038-3; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 2000, NAT NEUROSCI, V3, P1068, DOI 10.1038/80569; BUNSEY M, 1993, BEHAV NEUROSCI, V107, P740, DOI 10.1037/0735-7044.107.5.740; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.0.CO;2-5; Cooper BG, 2001, J NEUROSCI, V21, P3986, DOI 10.1523/JNEUROSCI.21-11-03986.2001; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fink GR, 1996, J NEUROSCI, V16, P4275; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; HOCK HS, 1978, MEM COGNITION, V6, P423, DOI 10.3758/BF03197475; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; JACKSON O, 2002, ANN M COGN NEUR SOC; Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133; Kosslyn SM, 1995, HUM BRAIN MAPP, V3, P107, DOI 10.1002/hbm.460030207; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; Maeshima S, 2001, J CLIN NEUROSCI, V8, P450, DOI 10.1054/jocn.2000.0801; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; MANDLER JM, 1976, J EXP PSYCHOL-HUM L, V2, P529, DOI 10.1037/0278-7393.2.5.529; MARKOWSKA AL, 1989, EXP BRAIN RES, V74, P187; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Mellet E, 2000, NEUROIMAGE, V12, P588, DOI 10.1006/nimg.2000.0648; Mishkin M, 1998, HIPPOCAMPUS, V8, P212; Montaldi D, 1998, HUM BRAIN MAPP, V6, P85, DOI 10.1002/(SICI)1097-0193(1998)6:2<85::AID-HBM2>3.3.CO;2-S; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Redish AD, 2001, BEHAV BRAIN RES, V127, P81, DOI 10.1016/S0166-4328(01)00356-4; Rombouts SARB, 1997, HIPPOCAMPUS, V7, P594, DOI 10.1002/(SICI)1098-1063(1997)7:6<594::AID-HIPO2>3.3.CO;2-I; Schacter DL, 1997, NEUROREPORT, V8, P3993, DOI 10.1097/00001756-199712220-00028; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Vann SD, 2002, BEHAV NEUROSCI, V116, P85, DOI 10.1037//0735-7044.116.1.85; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wiggs CL, 1999, NEUROPSYCHOLOGIA, V37, P103; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035	60	450	454	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 24	2003	38	2					347	358		10.1016/S0896-6273(03)00167-3	http://dx.doi.org/10.1016/S0896-6273(03)00167-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	672AM	12718867	Bronze			2022-12-17	WOS:000182498300022
J	Pnevmatikakis, EA; Soudry, D; Gao, YJ; Machado, TA; Merel, J; Pfau, D; Reardon, T; Mu, Y; Lacefield, C; Yang, WJ; Ahrens, M; Bruno, R; Jessell, TM; Peterka, DS; Yuste, R; Paninski, L				Pnevmatikakis, Eftychios A.; Soudry, Daniel; Gao, Yuanjun; Machado, Timothy A.; Merel, Josh; Pfau, David; Reardon, Thomas; Mu, Yu; Lacefield, Clay; Yang, Weijian; Ahrens, Misha; Bruno, Randy; Jessell, Thomas M.; Peterka, Darcy S.; Yuste, Rafael; Paninski, Liam			Simultaneous Denoising, Deconvolution, and Demixing of Calcium Imaging Data	NEURON			English	Article							NEURONAL-ACTIVITY; INFERENCE; SCALE	We present a modular approach for analyzing calcium imaging recordings of large neuronal ensembles. Our goal is to simultaneously identify the locations of the neurons, demix spatially overlapping components, and denoise and deconvolve the spiking activity from the slow dynamics of the calcium indicator. Our approach relies on a constrained nonnegative matrix factorization that expresses the spatiotemporal fluorescence activity as the product of a spatial matrix that encodes the spatial footprint of each neuron in the optical field and a temporal matrix that characterizes the calcium concentration of each neuron over time. This framework is combined with a novel constrained deconvolution approach that extracts estimates of neural activity from fluorescence traces, to create a spatiotemporal processing algorithm that requires minimal parameter tuning. We demonstrate the general applicability of our method by applying it to in vitro and in vivo multi-neuronal imaging data, whole-brain light-sheet imaging data, and dendritic imaging data.	[Pnevmatikakis, Eftychios A.] Simons Fdn, Ctr Computat Biol, New York, NY 10010 USA; [Pnevmatikakis, Eftychios A.; Soudry, Daniel; Gao, Yuanjun; Machado, Timothy A.; Merel, Josh; Pfau, David; Paninski, Liam] Columbia Univ, Dept Stat, Ctr Theoret Neurosci, New York, NY 10027 USA; [Pnevmatikakis, Eftychios A.; Soudry, Daniel; Gao, Yuanjun; Machado, Timothy A.; Merel, Josh; Pfau, David; Paninski, Liam] Columbia Univ, Grossman Ctr Stat Mind, New York, NY 10027 USA; [Machado, Timothy A.; Reardon, Thomas; Jessell, Thomas M.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Machado, Timothy A.; Reardon, Thomas; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Machado, Timothy A.; Merel, Josh; Pfau, David; Reardon, Thomas; Lacefield, Clay; Bruno, Randy; Jessell, Thomas M.; Yuste, Rafael; Paninski, Liam] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Machado, Timothy A.; Merel, Josh; Pfau, David; Reardon, Thomas; Lacefield, Clay; Bruno, Randy; Jessell, Thomas M.; Yuste, Rafael; Paninski, Liam] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Machado, Timothy A.; Reardon, Thomas; Jessell, Thomas M.; Peterka, Darcy S.; Paninski, Liam] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Mu, Yu; Ahrens, Misha] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Yang, Weijian; Peterka, Darcy S.; Yuste, Rafael; Paninski, Liam] Columbia Univ, Neurotechnol Ctr, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Pnevmatikakis, EA (corresponding author), Simons Fdn, Ctr Computat Biol, New York, NY 10010 USA.; Pnevmatikakis, EA; Paninski, L (corresponding author), Columbia Univ, Dept Stat, Ctr Theoret Neurosci, New York, NY 10027 USA.; Pnevmatikakis, EA; Paninski, L (corresponding author), Columbia Univ, Grossman Ctr Stat Mind, New York, NY 10027 USA.; Paninski, L (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.; Paninski, L (corresponding author), Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA.; Paninski, L (corresponding author), Columbia Univ, Neurotechnol Ctr, Dept Biol Sci, New York, NY 10027 USA.	epnevmatikakis@simonsfoundation.org; liam@stat.columbia.edu	Bruno, Randy M./ABC-2117-2021; Mu, Yu/F-9234-2016	Bruno, Randy M./0000-0002-5122-4632; Pnevmatikakis, Eftychios/0000-0003-1509-6394; Peterka, Darcy/0000-0001-7351-5820; Mu, Yu/0000-0001-9297-4854; Machado, Tim/0000-0003-3762-1460	Gruss Lipper Charitable Foundation [ARO MURI W911NF-12-1-0594]; DARPA [W91NF-14-1-0269]; NSF CAREER [IOS-0641912]; DARPA (SIMPLEX) [N66001-15-C-4032]; NIDA [5R21DA034195]; NIMH [1R01MH101218, R41MH100895]; NEI [DP1EY024503, R01EY011787]; NINDS [R21NS081393]; Gatsby Foundation; NATIONAL EYE INSTITUTE [DP1EY024503, R01EY011787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101218, R41MH100895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA034195] Funding Source: NIH RePORTER	Gruss Lipper Charitable Foundation; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); DARPA (SIMPLEX); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Gatsby Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank D. Chklovskii, J. Freeman, J. Friedrich, A. Giovannucci, L. Grosenick, P. Kaifosh, P. Mineault, A. Packer, and B. Shababo for useful discussions, and Y. Shin for technical assistance. This work was partially supported by the Gruss Lipper Charitable Foundation (D.S.), and grants ARO MURI W911NF-12-1-0594 (L.P. and R.Y.), DARPA W91NF-14-1-0269 (L.P. and R.Y.), NSF CAREER IOS-0641912 (L. P.), DARPA N66001-15-C-4032 (SIMPLEX) (L.P. and R.Y.), and NIDA 5R21DA034195 (R.Y.), NIMH 1R01MH101218 (R.Y.), NIMH R41MH100895 (R.Y.), NEI DP1EY024503 (R.Y.), NEI R01EY011787 (R.Y.) and NINDS R21NS081393 (R.Y.). Additional support was provided by the Gatsby Foundation.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cotton RJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00151; Diego F., 2014, ADV NEURAL INFORM PR, P64; Diego F., 2013, ADV NEURAL INFORM PR, p[818, 41]; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Haeffele BD, 2014, PR MACH LEARN RES, V32, P2007; Kaifosh P, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00080; Machado TA, 2015, CELL, V162, P338, DOI 10.1016/j.cell.2015.06.036; Maruyama R, 2014, NEURAL NETWORKS, V55, P11, DOI 10.1016/j.neunet.2014.03.007; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Pachitariu M., 2013, ADV NEURAL INFORM PR; Pnevmatikakis EA, 2013, CONF REC ASILOMAR C, P349, DOI 10.1109/ACSSC.2013.6810293; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/nmeth.2964, 10.1038/NMETH.2964]; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Theis L., 2015, ARXIV150300135; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	23	449	453	8	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2016	89	2					285	299		10.1016/j.neuron.2015.11.037	http://dx.doi.org/10.1016/j.neuron.2015.11.037			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI5TZ	26774160	Green Accepted, Bronze			2022-12-17	WOS:000373564700007
J	Smart, SL; Lopantsev, V; Zhang, CL; Robbins, CA; Wang, H; Chiu, SY; Schwartzkroin, PA; Messing, A; Tempel, BL				Smart, SL; Lopantsev, V; Zhang, CL; Robbins, CA; Wang, H; Chiu, SY; Schwartzkroin, PA; Messing, A; Tempel, BL			Deletion of the K(v)1.1 potassium channel causes epilepsy in mice	NEURON			English	Article							HETEROMULTIMERIC K+ CHANNELS; DENTATE GRANULE CELLS; EMBRYONIC STEM-CELLS; CA3 PYRAMIDAL CELLS; RAT-BRAIN; EXTRACELLULAR POTASSIUM; HIPPOCAMPAL SLICE; BETA-SUBUNIT; SHAKER LOCUS; MOUSE-BRAIN	Mice lacking the voltage-gated potassium channel a subunit, K(v)1.1, display frequent spontaneous seizures throughout adult life. In hippocampal slices from homozygous K(v)1.1 null animals, intrinsic passive properties of CA3 pyramidal cells are normal. However, antidromic action potentials are recruited at lower thresholds in K(v)1.1 null slices. Furthermore, in a subset of slices, mossy fiber stimulation triggers synaptically mediated long-latency epileptiform burst discharges. These data indicate that loss of K(v)1.1 from its normal localization in axons and terminals of the CA3 region results in increased excitability in the CA3 recurrent axon collateral system, perhaps contributing to the limbic and tonic-clonic components of the observed epileptic phenotype. Axonal action potential conduction was altered as well in the sciatic nerve-a deficit potentially related to the pathophysiology of episodic ataxia/myokymia, a disease associated with missense mutations of the human K(v)1.1 gene.	Univ Washington, Sch Med, VM Bloedel Hearig Res Ctr, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Physiol Biophys, Seattle, WA 98195 USA; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; Univ Wisconsin, Dept Neurophysiol, Madison, WI 53706 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tempel, BL (corresponding author), Univ Washington, Sch Med, VM Bloedel Hearig Res Ctr, Seattle, WA 98195 USA.							Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; BAGETTA G, 1992, NEUROSCI LETT, V139, P34, DOI 10.1016/0304-3940(92)90851-W; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BOSMA MM, 1993, J NEUROSCI, V13, P5242, DOI 10.1523/JNEUROSCI.13-12-05242.1993; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BUCKMASTER PS, 1993, J NEUROPHYSIOL, V70, P1281, DOI 10.1152/jn.1993.70.4.1281; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; CRONIN J, 1992, BRAIN RES, V573, P305, DOI 10.1016/0006-8993(92)90777-7; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; ELMSLIE F, 1995, CURR OPIN NEUROL, V8, P126, DOI 10.1097/00019052-199504000-00007; FISHER RS, 1976, ARCH NEUROL-CHICAGO, V33, P76, DOI 10.1001/archneur.1976.00500020004002; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FRANCK JE, 1995, EPILEPSIA, V36, P543, DOI 10.1111/j.1528-1157.1995.tb02566.x; Gutman G.A., 1993, SEMIN NEUROSCI, P101; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; Hille B., 1992, IONIC CHANNELS EXCIT; Ho CS, 1997, P NATL ACAD SCI USA, V94, P1533, DOI 10.1073/pnas.94.4.1533; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; JENSEN FE, 1991, ANN NEUROL, V29, P629, DOI 10.1002/ana.410290610; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KIMURA J, 1981, DEMYELINATING DIS BA, V31, P239; KOCSIS JD, 1983, J NEUROPHYSIOL, V50, P449, DOI 10.1152/jn.1983.50.2.449; LOCK LF, 1994, GENOMICS, V20, P354, DOI 10.1006/geno.1994.1188; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; MI HY, 1995, J NEUROSCI, V15, P3761; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; Noebels JL, 1996, NEURON, V16, P241, DOI 10.1016/S0896-6273(00)80042-2; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PRICHARD JW, 1969, J PHARMACOL EXP THER, V166, P170; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RHODES KJ, 1995, J NEUROSCI, V15, P5360; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; RUTECKI PA, 1990, J NEUROPHYSIOL, V64, P1077, DOI 10.1152/jn.1990.64.4.1077; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; Scharfman HE, 1996, NEUROSCIENCE, V72, P655, DOI 10.1016/0306-4522(95)00569-2; SCHWARTZKROIN PA, 1994, EPILEPSY RES, V17, P185, DOI 10.1016/0920-1211(94)90049-3; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Street VA, 1997, J NEUROSCI, V17, P635; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TRAUB RD, 1987, J NEUROPHYSIOL, V58, P752, DOI 10.1152/jn.1987.58.4.752; TRAUB RD, 1983, J NEUROPHYSIOL, V49, P459, DOI 10.1152/jn.1983.49.2.459; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442	66	449	459	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					809	819		10.1016/S0896-6273(00)81018-1	http://dx.doi.org/10.1016/S0896-6273(00)81018-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581771	Bronze			2022-12-17	WOS:000073346500018
J	McGowan, E; Pickford, F; Kim, J; Onstead, L; Eriksen, J; Yu, C; Skipper, L; Murphy, MP; Beard, J; Das, P; Jansen, K; DeLucia, M; Lin, WL; Dolios, G; Wang, R; Eckman, CB; Dickson, DW; Hutton, M; Hardy, J; Golde, T				McGowan, E; Pickford, F; Kim, J; Onstead, L; Eriksen, J; Yu, C; Skipper, L; Murphy, MP; Beard, J; Das, P; Jansen, K; DeLucia, M; Lin, WL; Dolios, G; Wang, R; Eckman, CB; Dickson, DW; Hutton, M; Hardy, J; Golde, T			A beta 42 is essential for parenchymal and vascular amyloid deposition in mice	NEURON			English	Article							FAMILIAL BRITISH DEMENTIA; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR-PROTEIN; APOLIPOPROTEIN-E; MEMORY DEFICITS; PEPTIDE; MUTANT; BRAIN	Considerable circumstantial evidence suggests that A beta 42 is the initiating molecule in Alzheimer's disease (AD) pathogenesis. However, the absolute requirement for A beta 42 for amyloid deposition has never been demonstrated in vivo. We have addressed this by developing transgenic models that express A beta 1-40 or A beta 1-42 in the absence of human amylold 0 protein precursor (APP) overexpression. Mice expressing high levels of A beta 1-40 do not develop overt amyloid pathology. In contrast, mice expressing lower levels of A beta 1-42 accumulate insoluble A beta 1-42 and develop compact amyloid plaques, congophilic amyloid angiopathy (CAA), and diffuse A beta deposits. When mice expressing A beta 1-42 are crossed with mutant APP (Tg2576) mice, there is also a massive increase in amyloid deposition. These data establish that A beta 1-42 is essential for amyloid deposition in the parenchyma and also in vessels.	Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	Mayo Clinic; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	McGowan, E (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	mcgowan.eileen@mayo.edu; golde.todd@mayo.edu	Kim, Jungsu/F-2457-2012; Eriksen, Jason/A-8054-2008; Hardy, John/C-2451-2009; Kim, Jungsu/A-1372-2009; Wang, Rong/A-8721-2009	Kim, Jungsu/0000-0002-6931-8581; Eriksen, Jason/0000-0003-1549-4165; Hardy, John/0000-0002-3122-0423; Dickson, Dennis W/0000-0001-7189-7917; Skipper, Lisa/0000-0002-1524-9787	NCI NIH HHS [R24 CA088325, CA88325] Funding Source: Medline; NIA NIH HHS [R01 AG022595, R01 AG022595-02, R01 AG022595-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R24CA088325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022595] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Ghiso J, 2000, ANN NY ACAD SCI, V920, P84; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lewis PA, 2001, BBA-MOL BASIS DIS, V1537, P58, DOI 10.1016/S0925-4439(01)00054-0; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Pype S, 2003, J NEUROCHEM, V84, P602, DOI 10.1046/j.1471-4159.2003.01556.x; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	39	448	465	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					191	199		10.1016/j.neuron.2005.06.030	http://dx.doi.org/10.1016/j.neuron.2005.06.030			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039562	Bronze, Green Accepted			2022-12-17	WOS:000230693900007
J	Bhave, G; Zhu, WG; Wang, HB; Brasier, DJ; Oxford, GS; Gereau, RW				Bhave, G; Zhu, WG; Wang, HB; Brasier, DJ; Oxford, GS; Gereau, RW			cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation	NEURON			English	Article							ROOT GANGLION NEURONS; RAT SENSORY NEURONS; VANILLOID RECEPTOR-1; TRANSDUCTION CASCADE; PAIN; HYPERALGESIA; ANANDAMIDE; ACTIVATION; CURRENTS; MUTATION	The capsaicin receptor, VR1 (also known as TRPV1), is a ligand-gated ion channel expressed on nociceptive sensory neurons that responds to noxious thermal and chemical stimuli. Capsaicin responses in sensory neurons exhibit robust potentiation by cAMP-dependent protein kinase (PKA). In this study, we demonstrate that PKA reduces VR1 desensitization and directly phosphorylates VR1. In vitro phosphorylation, phosphopeptide mapping, and protein sequencing of VR1 cytoplasmic domains delineate several candidate PKA phosphorylation sites. Electrophysiological analysis of phosphorylation site mutants clearly pinpoints Ser116 as the residue responsible for PKA-dependent modulation of VR1. Given the significant roles of VR1 and PKA in inflammatory pain hypersensitivity, VR1 phosphorylation at Ser116 by PKA may represent an important molecular mechanism involved in the regulation of VR1 function after tissue injury.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gereau, RW (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018788, P01NS039420, R01NS042595] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH60230] Funding Source: Medline; NINDS NIH HHS [R01NS18788, R01NS42595, P01NS39420] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; HINGTGEN CM, 1995, J NEUROSCI, V15, P5411; HU HJ, 2002, IN PRESS J NEUROSCI; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Koplas PA, 1997, J NEUROSCI, V17, P3525; Kuzhikandathil EV, 2001, J NEUROSCI, V21, P8697, DOI 10.1523/JNEUROSCI.21-22-08697.2001; Lee YS, 2000, NEUROSCI LETT, V288, P57, DOI 10.1016/S0304-3940(00)01208-8; LEVINE JD, 1989, NEUROSCIENCE, V32, P571, DOI 10.1016/0306-4522(89)90279-0; Levine JD, 1999, TXB PAIN, P59; Liu SW, 1996, GEOL J U, p[2, 75 ]; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Mammen A L, 1999, Methods Enzymol, V294, P353; Piper AS, 1999, J PHYSIOL-LONDON, V518, P721, DOI 10.1111/j.1469-7793.1999.0721p.x; Szallasi A, 1999, PHARMACOL REV, V51, P159; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	29	448	476	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					721	731		10.1016/S0896-6273(02)00802-4	http://dx.doi.org/10.1016/S0896-6273(02)00802-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194871	Green Published, Bronze			2022-12-17	WOS:000177521000012
J	Larsson, HP; Baker, OS; Dhillon, DS; Isacoff, EY				Larsson, HP; Baker, OS; Dhillon, DS; Isacoff, EY			Transmembrane movement of the Shaker K+ channel S4	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; INACTIVATION; RECEPTOR; SEQUENCE	We have probed internal and external accessibility of S4 residues to the membrane-impermeant thiol reagent methanethiosulfonate-ethyltrimethylammonium (MTSET) in both open and closed, cysteine-substituted Shaker K+ channels. Our results indicate that S4 traverses the membrane with no more than 5 amino acids in the closed state, and that the distribution of buried residues changes when channels open. This change argues for a displacement of S4 through the plane of the membrane in which an initially intracellular residue moves to within 3 amino acids of the extracellular solution. These results demonstrate that the putative voltage-sensing charges of S4 actually reside in the membrane and that they move outward when channels open. We consider constraints placed on channel structure by these results.	UNIV CALIF BERKELEY,GRAD GRP BIOPHYS,BERKELEY,CA 94720	University of California System; University of California Berkeley	Larsson, HP (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,229 STANLEY HALL,BERKELEY,CA 94720, USA.		isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOFFER AM, 1995, FASEB J, V9, P788; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STRYER L, 1988, NATURE, V339, P597; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	34	448	458	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					387	397		10.1016/S0896-6273(00)80056-2	http://dx.doi.org/10.1016/S0896-6273(00)80056-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789953	Bronze			2022-12-17	WOS:A1996TW95700018
J	SCHOEPFER, R; CONROY, WG; WHITING, P; GORE, M; LINDSTROM, J				SCHOEPFER, R; CONROY, WG; WHITING, P; GORE, M; LINDSTROM, J			BRAIN ALPHA-BUNGAROTOXIN BINDING-PROTEIN CDNAS AND MABS REVEAL SUBTYPES OF THIS BRANCH OF THE LIGAND-GATED ION CHANNEL GENE SUPERFAMILY	NEURON			English	Article											SCHOEPFER, R (corresponding author), SALK INST BIOL STUDIES, RECEPTOR BIOL LAB, SAN DIEGO, CA 92138 USA.			Whiting, Paul/0000-0002-4121-1379	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011323] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 11323] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; BALLIVET M, 1988, NEURON, V1, P847, DOI 10.1016/0896-6273(88)90132-8; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; BERG DK, 1989, TRENDS NEUROSCI, V12, P16, DOI 10.1016/0166-2236(89)90151-3; BERGER SL, 1987, GUIDE MOL CLONING TE, V152; BETZ H, 1984, J NEUROSCI, V4, P2095; BETZ H, 1988, NEUROCHEM INT, V13, P137, DOI 10.1016/0197-0186(88)90048-4; BETZ H, 1982, J BIOL CHEM, V257, P1390; BOSSY B, 1988, EMBO J, V7, P611, DOI 10.1002/j.1460-2075.1988.tb02854.x; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BRUNS RF, 1983, ANAL BIOCHEM, V132, P74, DOI 10.1016/0003-2697(83)90427-X; CARBONETTO ST, 1978, P NATL ACAD SCI USA, V75, P1016, DOI 10.1073/pnas.75.2.1016; CHANGEUX JP, 1987, TRENDS PHARMACOL SCI, V8, P459, DOI 10.1016/0165-6147(87)90039-3; CHIAPPINELLI VA, 1985, PHARMACOL THERAPEUT, V31, P1, DOI 10.1016/0163-7258(85)90035-X; CHIAPPINELLI VA, 1988, NICOTINIC ACETYLCHOL, P15; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; CONTITRONCONI BM, 1985, P NATL ACAD SCI USA, V82, P5208, DOI 10.1073/pnas.82.15.5208; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; GREENE LA, 1973, NATURE, V243, P163, DOI 10.1038/243163a0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HALVORSEN SW, 1986, J NEUROSCI, V6, P3405; HARTMAN DS, 1990, NATURE, V343, P372, DOI 10.1038/343372a0; HERMANSBORGMEYER I, 1986, EMBO J, V5, P1503, DOI 10.1002/j.1460-2075.1986.tb04389.x; HERMANSBORGMEYER I, 1988, NICOTINIC ACETYLCHOL, P77; HOCHSCHWENDER S, 1985, HYBRIDOMAS BIOTECHNO, P223; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JACOB MH, 1983, J NEUROSCI, V3, P260; KAO PN, 1984, J BIOL CHEM, V259, P1662; KAO PN, 1986, J BIOL CHEM, V261, P8085; KEHOE JS, 1979, ADV PHARMACOL THER, V8, P285; KEMP G, 1985, BRAIN RES, V347, P274, DOI 10.1016/0006-8993(85)90187-8; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LINDSTROM J, 1987, MOL NEUROBIOL, V1, P281, DOI 10.1007/BF02935740; LINDSTROM J, 1990, CIBA F S, V152, P23; LIPTON SA, 1987, PFLUG ARCH EUR J PHY, V410, P37, DOI 10.1007/BF00581893; LORING RH, 1989, J NEUROSCI, V9, P2423; LORING RH, 1985, NEUROSCIENCE, V14, P645, DOI 10.1016/0306-4522(85)90316-1; Maniatis T., 1982, MOL CLONING; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCARTHY MP, 1986, ANNU REV NEUROSCI, V9, P383; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NORMAN RI, 1982, P NATL ACAD SCI-BIOL, V79, P1321, DOI 10.1073/pnas.79.4.1321; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; PATRICK J, 1977, J BIOL CHEM, V252, P8629; PETERS JA, 1989, TRENDS PHARMACOL SCI, V10, P172, DOI 10.1016/0165-6147(89)90230-7; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; QUIK M, 1989, J NEUROCHEM, V53, P1320, DOI 10.1111/j.1471-4159.1989.tb07431.x; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2621, DOI 10.1021/bi00357a051; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2633, DOI 10.1021/bi00357a052; RAVDIN PM, 1979, P NATL ACAD SCI USA, V76, P2072, DOI 10.1073/pnas.76.4.2072; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SCHLOSS P, 1988, EMBO J, V7, P2889, DOI 10.1002/j.1460-2075.1988.tb03146.x; SCHOEPFER R, 1989, FEBS LETT, V257, P393, DOI 10.1016/0014-5793(89)81580-7; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; SMITH MA, 1983, J NEUROSCI, V3, P2395; STEINBACH JH, 1989, TRENDS NEUROSCI, V12, P3, DOI 10.1016/0166-2236(89)90145-8; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; UTKIN YN, 1989, GEBS LETT, V255, P111; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WANG GK, 1978, J BIOL CHEM, V253, P8507; WHITE TJ, 1989, TRENDS GENET, V5, P185, DOI 10.1016/0168-9525(89)90073-5; WHITING P, 1986, J NEUROSCI, V6, P3061; WHITING P, 1987, FEBS LETT, V213, P55, DOI 10.1016/0014-5793(87)81464-3; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; WHITING PJ, 1986, BIOCHEMISTRY-US, V25, P2082, DOI 10.1021/bi00356a037; WHITING PJ, 1988, J NEUROSCI, V8, P3395; WHITING PJ, 1987, J NEUROSCI, V7, P4005; WOLF KM, 1988, BRAIN RES, V439, P249, DOI 10.1016/0006-8993(88)91481-3; WONG LA, 1989, NATURE, V341, P439, DOI 10.1038/341439a0; WONNACOTT S, 1986, J NEUROCHEM, V47, P1706, DOI 10.1111/j.1471-4159.1986.tb13078.x	79	448	455	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1990	5	1					35	48		10.1016/0896-6273(90)90031-A	http://dx.doi.org/10.1016/0896-6273(90)90031-A			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU546	2369519				2022-12-17	WOS:A1990DU54600004
J	Duvarci, S; Pare, D				Duvarci, Sevil; Pare, Denis			Amygdala Microcircuits Controlling Learned Fear	NEURON			English	Review							MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; PARVALBUMIN-IMMUNOREACTIVE CELLS; GLUTAMIC-ACID DECARBOXYLASE; DEPENDENT NEURONAL-ACTIVITY; GABA-LIKE IMMUNOREACTIVITY; RAT BASOLATERAL AMYGDALA; LATERAL AMYGDALA; CONDITIONED FEAR	We review recent work on the role of intrinsic amygdala networks in the regulation of classically conditioned defensive behaviors, commonly known as conditioned fear. These new developments highlight how conditioned fear depends on far more complex networks than initially envisioned. Indeed, multiple parallel inhibitory and excitatory circuits are differentially recruited during the expression versus extinction of conditioned fear. Moreover, shifts between expression and extinction circuits involve coordinated interactions with different regions of the medial prefrontal cortex. However, key areas of uncertainty remain, particularly with respect to the connectivity of the different cell types. Filling these gaps in our knowledge is important because much evidence indicates that human anxiety disorders results from an abnormal regulation of the networks supporting fear learning.	[Duvarci, Sevil] Goethe Univ Frankfurt, Ctr Neurosci, Inst Neurophysiol, D-60054 Frankfurt, Germany; [Pare, Denis] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Goethe University Frankfurt; Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	pare@andromeda.rutgers.edu			NIMH [MH-083710, MH-098738]; EMBO Long-Term Fellowship; Marie Curie Actions; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098738, R01MH083710] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Actions(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by R01 grants MH-083710 and MH-098738 from NIMH (to D.P.) and EMBO Long-Term Fellowship and Marie Curie Actions (to S.D.).	Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Amir A, 2011, J NEUROPHYSIOL, V105, P3054, DOI 10.1152/jn.00136.2011; Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Armony JL, 1998, J NEUROSCI, V18, P2592; Bergado-Acosta JR, 2008, LEARN MEMORY, V15, P163, DOI 10.1101/lm.705408; BERNARD JF, 1993, J COMP NEUROL, V329, P201, DOI 10.1002/cne.903290205; BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473, DOI 10.1152/jn.1990.63.3.473; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; BROOKS DC, 1993, J EXP PSYCHOL ANIM B, V19, P77, DOI 10.1037/0097-7403.19.1.77; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Bush DEA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00154; Busti D, 2011, J NEUROSCI, V31, P5131, DOI 10.1523/JNEUROSCI.6100-10.2011; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; Chhatwal JP, 2005, J NEUROSCI, V25, P502, DOI 10.1523/JNEUROSCI.3301-04.2005; Chhatwal JP, 2005, NEUROPSYCHOPHARMACOL, V30, P516, DOI 10.1038/sj.npp.1300655; CHIANG C, 1993, NEUROSCIENCE, V53, P705, DOI 10.1016/0306-4522(93)90618-P; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Davis M., 2000, AMYGDALA, P213; De Armentia ML, 2004, J NEUROPHYSIOL, V92, P1285, DOI 10.1152/jn.00211.2004; Domjan MP, 2006, PRINCIPLES LEARNING; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dumont EC, 2002, EUR J NEUROSCI, V15, P545, DOI 10.1046/j.0953-816x.2001.01879.x; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fitzgerald P.J., 2013, NEUROBIOL LEARN MEM; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Geracitano R, 2007, J PHYSIOL-LONDON, V585, P117, DOI 10.1113/jphysiol.2007.142570; Geracitano R, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00032; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Graham BM, 2011, AM J PSYCHIAT, V168, P1255, DOI 10.1176/appi.ajp.2011.11040557; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3; HALL E, 1972, Z ZELLFORSCH MIK ANA, V134, P439, DOI 10.1007/BF00307668; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Heidi SA, 2007, EUR J NEUROSCI, V26, P3631, DOI 10.1111/j.1460-9568.2007.05970.x; HERKENHAM M, 1982, J NEUROSCI, V2, P1129; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2003, J NEUROSCI, V23, P8410; HOPKINS DA, 1978, EXP BRAIN RES, V32, P529; Jacobsen KX, 2006, NEUROSCIENCE, V141, P2007, DOI 10.1016/j.neuroscience.2006.05.054; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; Jasnow AM, 2009, J NEUROPHYSIOL, V101, P1494, DOI 10.1152/jn.91149.2008; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Jolkkonen E, 1998, J COMP NEUROL, V395, P53, DOI 10.1002/(SICI)1096-9861(19980525)395:1<53::AID-CNE5>3.0.CO;2-G; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kamal A M, 1975, J Hirnforsch, V16, P175; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Kim D, 2013, J NEUROSCI, V33, P14354, DOI 10.1523/JNEUROSCI.2430-13.2013; Kim D, 2013, LEARN MEMORY, V20, P421, DOI 10.1101/lm.030262.113; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Knapska E, 2012, P NATL ACAD SCI USA, V109, P17093, DOI 10.1073/pnas.1202087109; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; KRETTEK JE, 1977, J COMP NEUROL, V172, P687, DOI 10.1002/cne.901720408; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lin HC, 2009, BIOL PSYCHIAT, V66, P665, DOI 10.1016/j.biopsych.2009.04.003; Linke R, 2000, EXP BRAIN RES, V134, P520, DOI 10.1007/s002210000475; Livneh U, 2012, J NEUROSCI, V32, P8598, DOI 10.1523/JNEUROSCI.0323-12.2012; Lutz B, 2007, MOL NEUROBIOL, V36, P92, DOI 10.1007/s12035-007-8004-x; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martina M, 1999, J NEUROPHYSIOL, V82, P1843, DOI 10.1152/jn.1999.82.4.1843; Mascagni F, 2007, NEUROSCIENCE, V144, P1015, DOI 10.1016/j.neuroscience.2006.10.044; MCALLISTER WR, 1986, J ABNORM PSYCHOL, V95, P365, DOI 10.1037/0021-843X.95.4.365; McDonald AJ, 2001, NEUROSCIENCE, V105, P681, DOI 10.1016/S0306-4522(01)00214-7; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; MCDONALD AJ, 1993, NEUROSCIENCE, V52, P281, DOI 10.1016/0306-4522(93)90156-A; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McDonald AJ, 2002, BRAIN RES, V943, P237, DOI 10.1016/S0006-8993(02)02650-1; McDonald AJ, 2001, NEUROSCIENCE, V102, P413, DOI 10.1016/S0306-4522(00)00481-4; McDonald AJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00046; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MILLHOUSE OE, 1986, J COMP NEUROL, V247, P246, DOI 10.1002/cne.902470209; Muller C., 2014, NATURE; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Muller JF, 2007, J COMP NEUROL, V500, P513, DOI 10.1002/cne.21185; Muller JF, 2003, J COMP NEUROL, V456, P217, DOI 10.1002/cne.10435; Muller JF, 2006, J COMP NEUROL, V494, P635, DOI 10.1002/cne.20832; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; NITECKA L, 1987, J COMP NEUROL, V266, P45, DOI 10.1002/cne.902660105; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2003, ANN NY ACAD SCI, V985, P92; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; PARE D, 1995, J NEUROPHYSIOL, V74, P1179, DOI 10.1152/jn.1995.74.3.1179; PARE D, 1993, NEUROSCIENCE, V57, P1061, DOI 10.1016/0306-4522(93)90049-L; PARE D, 1995, NEUROSCIENCE, V69, P567, DOI 10.1016/0306-4522(95)00272-K; Pare D, 2003, ANN NY ACAD SCI, V985, P78; Petrovich GD, 1997, BRAIN RES, V763, P247, DOI 10.1016/S0006-8993(96)01361-3; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PITKANEN A, 1993, J COMP NEUROL, V331, P14, DOI 10.1002/cne.903310103; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; Poulin JF, 2008, J COMP NEUROL, V506, P943, DOI 10.1002/cne.21587; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69, DOI 10.1152/jn.1999.82.1.69; Rainnie DG, 2006, J COMP NEUROL, V498, P142, DOI 10.1002/cne.21049; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Roche M, 2007, EUR J NEUROSCI, V26, P2643, DOI 10.1111/j.1460-9568.2007.05861.x; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Royer S, 1999, J NEUROSCI, V19, P10575; Royer S, 2000, J NEUROPHYSIOL, V83, P3509, DOI 10.1152/jn.2000.83.6.3509; Royer S, 2000, J NEUROSCI, V20, P9034; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Samson RD, 2006, NEUROSCIENCE, V141, P1599, DOI 10.1016/j.neuroscience.2006.04.077; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Samson RD, 2003, J NEUROSCI, V23, P1966; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Smith Y, 1998, J COMP NEUROL, V391, P164, DOI 10.1002/(SICI)1096-9861(19980209)391:2<164::AID-CNE2>3.0.CO;2-0; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Smith Y, 2000, J COMP NEUROL, V416, P496; SORVARI H, 1995, J COMP NEUROL, V360, P185, DOI 10.1002/cne.903600202; Sosulina L, 2006, MOL CELL NEUROSCI, V33, P57, DOI 10.1016/j.mcn.2006.06.005; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Spampanato J, 2011, NEUROPHARMACOLOGY, V60, P765, DOI 10.1016/j.neuropharm.2010.11.006; Steriade M, 2007, GATING IN CEREBRAL NETWORKS, P1, DOI 10.2277/ 052185122X; Stork O, 2002, NEUROSCI LETT, V327, P138, DOI 10.1016/S0304-3940(02)00387-7; Stutzmann GE, 1999, J NEUROSCI, V19; Trouche S, 2013, NEURON, V80, P1054, DOI 10.1016/j.neuron.2013.07.047; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Unal G, 2014, J COMP NEUROL, V522, P1915, DOI 10.1002/cne.23511; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; WATANABE Y, 1995, NEUROSCI RES, V21, P317, DOI 10.1016/0168-0102(94)00867-F; Weinberger NM, 2011, HEARING RES, V274, P61, DOI 10.1016/j.heares.2010.03.093; Wilensky AE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0006.1999; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	182	447	453	6	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 4	2014	82	5					966	980		10.1016/j.neuron.2014.04.042	http://dx.doi.org/10.1016/j.neuron.2014.04.042			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ0QH	24908482	Bronze, Green Accepted			2022-12-17	WOS:000337359800006
J	Lu, W; Shi, Y; Jackson, AC; Bjorgan, K; During, MJ; Sprengel, R; Seeburg, PH; Nicoll, RA				Lu, Wei; Shi, Yun; Jackson, Alexander C.; Bjorgan, Kirsten; During, Matthew J.; Sprengel, Rolf; Seeburg, Peter H.; Nicoll, Roger A.			Subunit Composition of Synaptic AMPA Receptors Revealed by a Single-Cell Genetic Approach	NEURON			English	Article							SILENT SYNAPSES; ABSOLUTE QUANTIFICATION; HIPPOCAMPAL-NEURONS; KAINATE RECEPTORS; DENDRITIC SPINES; MESSENGER-RNAS; MICE DEFICIENT; GLUR2 SUBUNIT; TRAFFICKING; STARGAZIN	The precise subunit composition of synaptic ionotropic receptors in the brain is poorly understood. This information is of particular importance with regard to AMPA-type glutamate receptors, the multimeric complexes assembled from GluA1-A4 subunits, as the trafficking of these receptors into and out of synapses is proposed to depend upon the subunit composition of the receptor. We report a molecular quantification of synaptic AMPA receptors (AMPARs) by employing a single-cell genetic approach coupled with electrophysiology in hippocampal CA1 pyramidal neurons. In contrast to prevailing views, we find that GIuA1A2 heteromers are the dominant AMPARs at CA1 cell synapses (similar to 80%). In cells lacking GluA1, -A2, and -A3, synapses are devoid of AMPARs, yet synaptic NMDA receptors (NMDARs) and dendritic morphology remain unchanged. These data demonstrate a functional dissociation of AMPARs from trafficking of NMDARs and neuronal morphogenesis. This study provides a functional quantification of the subunit composition of AMPARs in the CNS and suggests novel roles for AMPAR subunits in receptor trafficking.	[Lu, Wei; Shi, Yun; Jackson, Alexander C.; Bjorgan, Kirsten; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Sprengel, Rolf; Seeburg, Peter H.] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	University of California System; University of California San Francisco; University System of Ohio; Ohio State University; Max Planck Society	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Lu, Wei/S-5617-2018; During, Matthew/AAC-1388-2020; Shi, Yun/B-5623-2009; Lu, Wei/E-8110-2011; Shi, Yun S/T-8845-2018	Lu, Wei/0000-0001-6668-8432; Shi, Yun/0000-0002-8842-9818; 	National Research Service Award (NRSA); postdoctoral fellowship from the National Institutes of Health (NIH); National Institute of Mental Health (NIMH); Max Planck Society and EUSynapse; American Heart Association; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH081430, R01MH080379, R01MH070957] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); postdoctoral fellowship from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Max Planck Society and EUSynapse; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Hillel Adesnik for help on neonatal injections, Aaron Milstein for Igor software, and Ye Bing for neuronal morphology. We thank the Nicoll lab members for discussions, as well as Pierre Apostolides; for help in slice cultures. We are grateful to G. Kerchner,A. Milstein, G. Elias, M. Howard, and T. Hnasko for critical comments on the manuscript. P.H.S. and R.S. are funded by the Max Planck Society and EUSynapse. W.L. is funded by a postdoctoral fellowship from the American Heart Association, A.C.J. is funded by a National Research Service Award (NRSA) postdoctoral fellowship from the National Institutes of Health (NIH), and R.A.N. is funded by grants from the National Institute of Mental Health (NIMH).	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bureau I, 1999, J NEUROSCI, V19, P653; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Dingledine R, 1999, PHARMACOL REV, V51, P7; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mateos JM, 2007, J PHYSIOL-LONDON, V581, P129, DOI 10.1113/jphysiol.2006.120550; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; Panicker S, 2008, P NATL ACAD SCI USA, V105, P1032, DOI 10.1073/pnas.0711313105; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sans N, 2003, J NEUROSCI, V23, P9367; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shimshek DR, 2005, PLOS BIOL, V3, P2017, DOI 10.1371/journal.pbio.0030354; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Tsuzuki K, 2001, J NEUROCHEM, V77, P1650, DOI 10.1046/j.1471-4159.2001.00388.x; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	83	447	453	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 30	2009	62	2					254	268		10.1016/j.neuron.2009.02.027	http://dx.doi.org/10.1016/j.neuron.2009.02.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	441MU	19409270	Green Accepted, Bronze			2022-12-17	WOS:000265774100013
J	Cajigas, IJ; Tushev, G; Will, TJ; Dieck, ST; Fuerst, N; Schuman, EM				Cajigas, Ivan J.; Tushev, Georgi; Will, Tristan J.; Dieck, Susanne Tom; Fuerst, Nicole; Schuman, Erin M.			The Local Transcriptome in the Synaptic Neuropil Revealed by Deep Sequencing and High-Resolution Imaging	NEURON			English	Article							DENDRITIC PROTEIN-SYNTHESIS; MESSENGER-RNA; GENE-EXPRESSION; CAMKII-ALPHA; LOCALIZATION; TRANSLATION; PLASTICITY; SYNAPSES; SPINES; IDENTIFICATION	In neurons, dendritic protein synthesis is required for many forms of long-term synaptic plasticity. The population of mRNAs that are localized to dendrites, however, remains sparsely identified. Here, we use deep sequencing to identify the mRNAs resident in the synaptic neuropil in the hippocampus. Analysis of a neuropil data set yielded a list of 8,379 transcripts of which 2,550 are localized in dendrites and/or axons. Using a fluorescent barcode strategy to label individual mRNAs, we show that their relative abundance in the neuropil varies over 3 orders of magnitude. High-resolution in situ hybridization validated the presence of mRNAs in both cultured neurons and hippocampal slices. Among the many mRNAs identified, we observed a large fraction of known synaptic proteins including signaling molecules, scaffolds and receptors. These results reveal a previously unappreciated enormous potential for the local protein synthesis machinery to supply, maintain and modify the dendritic and synaptic proteome.	[Cajigas, Ivan J.; Tushev, Georgi; Will, Tristan J.; Dieck, Susanne Tom; Fuerst, Nicole; Schuman, Erin M.] Max Planck Inst Brain Res, D-60438 Frankfurt, Germany; [Cajigas, Ivan J.; Tushev, Georgi; Will, Tristan J.; Dieck, Susanne Tom; Fuerst, Nicole; Schuman, Erin M.] Goethe Univ Frankfurt, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Schuman, EM (corresponding author), Max Planck Inst Brain Res, Max von Laue Str 3, D-60438 Frankfurt, Germany.	erin.schuman@brain.mpg.de	Schuman, Erin M/D-6204-2011		DFG [902]	DFG(German Research Foundation (DFG))	Financial support was provided in part by the DFG-funded Collaborative Research Center 902: "Molecular Principles of RNA-based Regulation." We are extremely grateful to Mona Khan, Christian Lozanoski, and Peter Mombaerts for assistance with the Nanostring technology. We thank Ben Barres for discussions on glial transcriptomes. We thank Ed Lein for assistance in compiling interneuron-enriched transcripts. We thank Ina Bartnik for the preparation of cultured hippocampal neurons. We thank Gilles Laurent, Mona Khan, and Schuman lab members for comments on the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Allen Institute for Brain Science, 2011, ALL MOUS BRAIN ATL; Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bradshaw KD, 2003, EUR J NEUROSCI, V18, P3150, DOI 10.1111/j.1460-9568.2003.03054.x; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [10.1007/BF01386390, DOI 10.1007/BF01386390]; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Herb A, 1997, MOL CELL NEUROSCI, V8, P367, DOI 10.1006/mcne.1996.0594; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, J NEUROSCI, V23, P6188; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Kamme F, 2003, J NEUROSCI, V23, P3607; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Makara JK, 2009, NAT NEUROSCI, V12, P1485, DOI 10.1038/nn.2428; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Ouyang Y, 1999, J NEUROSCI, V19, P7823; PATANJALI SR, 1991, P NATL ACAD SCI USA, V88, P1943, DOI 10.1073/pnas.88.5.1943; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sambrook J, 2001, MOL CLONING LAB MANU; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; STEWARD O, 1982, J NEUROSCI, V2, P284; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Torre ER, 1996, J NEUROSCI, V16, P5967; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; Varshavsky R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002247; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	58	446	454	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 10	2012	74	3					453	466		10.1016/j.neuron.2012.02.036	http://dx.doi.org/10.1016/j.neuron.2012.02.036			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	941OB	22578497	Bronze, Green Accepted			2022-12-17	WOS:000303971400006
J	Dani, A; Huang, B; Bergan, J; Dulac, C; Zhuang, XW				Dani, Adish; Huang, Bo; Bergan, Joseph; Dulac, Catherine; Zhuang, Xiaowei			Superresolution Imaging of Chemical Synapses in the Brain	NEURON			English	Article							ACCESSORY OLFACTORY-BULB; OPTICAL RECONSTRUCTION MICROSCOPY; POSTSYNAPTIC DENSITY; AMPA RECEPTORS; ACTIVE ZONE; DENDRITIC SPINES; SILENT SYNAPSES; MITRAL CELLS; SUBDIFFRACTION RESOLUTION; FLUORESCENCE MICROSCOPY	Determination of the molecular architecture of synapses requires nanoscopic image resolution and specific molecular recognition, a task that has so far defied many conventional imaging approaches. Here, we present a superresolution fluorescence imaging method to visualize the molecular architecture of synapses in the brain. Using multicolor, three-dimensional stochastic optical reconstruction microscopy, the distributions of synaptic proteins can be measured with nanometer precision. Furthermore, the wide-field, volumetric imaging method enables high-throughput, quantitative analysis of a large number of synapses from different brain regions. To demonstrate the capabilities of this approach, we have determined the organization of ten protein components of the presynaptic active zone and the postsynaptic density. Variations in synapse morphology, neurotransmitter receptor composition, and receptor distribution were observed both among synapses and across different brain regions. Combination with optogenetics further allowed molecular events associated with synaptic plasticity to be resolved at the single-synapse level.	[Dani, Adish; Huang, Bo; Bergan, Joseph; Dulac, Catherine; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Dani, Adish; Bergan, Joseph; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Huang, Bo; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu; zhuang@chemistry.harvard.edu	Huang, Bo/D-4854-2009	Dulac, Catherine/0000-0001-5024-5418	NIH NIDCD; Howard Hughes Medical Institute [43667]; Gatsby Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009019] Funding Source: NIH RePORTER	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gatsby Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Professor Venkatesh Murthy for helpful discussions and for providing the ORC-V mouse line. This work was in part supported by a NIH NIDCD grant (to C.D.), and a Collaborative Innovation Award (#43667) from Howard Hughes Medical Institute and a Gatsby Foundation Grant (to X.Z.). X.Z. and C.D. are Howard Hughes Medical Institute investigators.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Antal M, 2008, J NEUROSCI, V28, P9692, DOI 10.1523/JNEUROSCI.1551-08.2008; Arthur CP, 2007, METHOD CELL BIOL, V79, P241, DOI 10.1016/S0091-679X(06)79010-0; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Castro JB, 2007, J NEUROSCI, V27, P5664, DOI 10.1523/JNEUROSCI.0613-07.2007; Chen XB, 2008, J NEUROSCI, V28, P9321, DOI 10.1523/JNEUROSCI.2992-08.2008; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Heintzmann R, 2009, NAT PHOTONICS, V3, P362, DOI 10.1038/nphoton.2009.102; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kharazia VN, 1997, NEUROSCI LETT, V238, P41, DOI 10.1016/S0304-3940(97)00846-X; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klar TA, 1999, OPT LETT, V24, P954, DOI 10.1364/OL.24.000954; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Peters A, 1991, FINE STRUCTURE NERVO; Petersen JD, 2003, J NEUROSCI, V23, P11270; Rumpel S, 1998, J NEUROSCI, V18, P8863; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shepherd G.M., 2004, NEUROBIOLOGY; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Tovar KR, 2002, NEURON, V34, P253; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; Urban NN, 2005, J NEUROSCI, V25, P5024, DOI 10.1523/JNEUROSCI.0297-05.2005; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	61	446	456	2	146	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					843	856		10.1016/j.neuron.2010.11.021	http://dx.doi.org/10.1016/j.neuron.2010.11.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21144999	Green Accepted, Bronze			2022-12-17	WOS:000285664900007
J	Boorman, ED; Behrens, TEJ; Woolrich, MW; Rushworth, MFS				Boorman, Erie D.; Behrens, Timothy E. J.; Woolrich, Mark W.; Rushworth, Matthew F. S.			How Green Is the Grass on the Other Side? Frontopolar Cortex and the Evidence in Favor of Alternative Courses of Action	NEURON			English	Article							ANTERIOR PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; DECISION-MAKING; PARIETAL CORTEX; VISUOMOTOR ASSOCIATIONS; INTERTEMPORAL CHOICE; COGNITIVE CONTROL; MACAQUE MONKEYS; FRONTAL-CORTEX; ECONOMIC VALUE	Behavioral flexibility is the hallmark of goal-directed behavior. Whereas a great deal is known about the neural substrates of behavioral adjustment when it is explicitly cued by features of the external environment, little is known about how we adapt our behavior when such changes are made on the basis of uncertain evidence. Using a Bayesian reinforcement-learning model and fMRI, we show that frontopolar cortex (FPC) tracks the relative advantage in favor of switching to a foregone alternative when choices are made voluntarily. Changes in FPC functional connectivity occur when subjects finally decide to switch to the alternative behavior. Moreover, interindividual variation in the FPC signal predicts interindividual differences in effectively adapting behavior. By contrast, ventromedial prefrontal cortex (vmPFC) encodes the relative value of the current decision. Collectively, these findings reveal complementary prefrontal computations essential for promoting short- and long-term behavioral flexibility.	[Boorman, Erie D.; Behrens, Timothy E. J.; Woolrich, Mark W.; Rushworth, Matthew F. S.] Univ Oxford, Ctr Funct MRI Brain, Oxford OX3 9DU, England; [Boorman, Erie D.; Behrens, Timothy E. J.; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Boorman, ED (corresponding author), Univ Oxford, Ctr Funct MRI Brain, Oxford OX3 9DU, England.	erie.boorman@psy.ox.ac.uk		Woolrich, Mark/0000-0001-8460-8854; Behrens, Timothy/0000-0003-0048-1177; Rushworth, Matthew/0000-0002-5578-9884	Wellcome Trust; EPSRC; MRC; MRC [G0600994, G0700399, G0501316] Funding Source: UKRI; Medical Research Council [G0700399, G0501316, G0600994] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the Wellcome Trust (E.D.B.), the EPSRC (M.W.W.), and the MRC (T.E.J.B., M.F.S.R.). We would like to thank Dr Mark Walton and Professor Richard Passingham for helpful discussions and Mr Steven Knight for help with scanning.	Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P., 2001, THEORETICAL NEUROSCI; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Genovesio A., 2008, NEUROSCIENCE RULE GU, P81; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Grol MJ, 2006, J NEUROSCI, V26, P117, DOI 10.1523/JNEUROSCI.2786-05.2006; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jubault T, 2007, J NEUROSCI, V27, P11028, DOI 10.1523/JNEUROSCI.1986-07.2007; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2008, SENSORIMOTOR FDN HIG, P483; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; McConnell CR, 2004, MICROECONOMICS PRINC; MILLER EK, 2008, NEUROSCIENCE RULE GU, P419; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Parent A, 1986, COMP NEUROBIOLOGY BA; Passingham RE, 2008, WHAT IS SPECIAL HUMA; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Toni I, 2001, EXP BRAIN RES, V141, P359, DOI 10.1007/s002210100877; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wendelken C, 2008, J COGNITIVE NEUROSCI, V20, P682, DOI 10.1162/jocn.2008.20055; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	70	446	451	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 11	2009	62	5					733	743		10.1016/j.neuron.2009.05.014	http://dx.doi.org/10.1016/j.neuron.2009.05.014			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459QT	19524531	Bronze			2022-12-17	WOS:000267119500014
J	Cirrito, JR; Kang, JE; Lee, J; Stewart, FR; Verges, DK; Silverio, LM; Bu, GJ; Mennerick, S; Holtzman, DM				Cirrito, John R.; Kang, Jae-Eun; Lee, Jiyeon; Stewart, Floy R.; Verges, Deborah K.; Silverio, Luz M.; Bu, Guojun; Mennerick, Steven; Holtzman, David M.			Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo	NEURON			English	Article							CLATHRIN-COATED VESICLES; PRECURSOR-PROTEIN; CELL-SURFACE; A-BETA; INTERSTITIAL FLUID; PSYCHOLOGICAL DISTRESS; ALZHEIMERS-DISEASE; SECRETASE; TRAFFICKING; METABOLISM	Aggregation of amyloid-beta (A beta) peptide into soluble and insoluble forms within the brain extracellular space is central to the pathogenesis of Alzheimer's disease. Full-length amyloid precursor protein (APP) is endocytosed from the cell surface into endosomes where it is cleaved to produce A beta. A beta is subsequently released into the brain interstitial fluid (ISF). We hypothesized that synaptic transmission results in more APP endocytosis, thereby increasing A beta generation and release into the ISF. We found that inhibition of clathrin-mediated endocytosis immediately lowers ISF A beta levels in vivo. Two distinct methods that increased synaptic transmission resulted in an elevation of ISF A beta levels. Inhibition of endocytosis, however, prevented the activity-dependent increase in A beta. We estimate that similar to 70% of ISF A beta arises from endocytosis-associated mechanisms, with the vast majority of this pool also dependent on synaptic activity. These findings have implications for AD pathogenesis and may provide insights into therapeutic intervention.	[Cirrito, John R.; Kang, Jae-Eun; Stewart, Floy R.; Verges, Deborah K.; Silverio, Luz M.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cirrito, John R.; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Mennerick, Steven] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Lee, Jiyeon; Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Cirrito, John R.; Holtzman, David M.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Cirrito, JR (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	cirritoj@neuro.wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Lee, Jiyeon/0000-0002-8952-7938	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054174, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013956, K01AG029524, R01AG013956, R01AG027924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261] Funding Source: NIH RePORTER; NIA NIH HHS [AG027924, R01 AG027924, R01 AG013956, K01 AG029524-01A1, K01 AG029524, AG13956, R37 AG013956, AG029524] Funding Source: Medline; NIDA NIH HHS [T32 DA007261, DA07261] Funding Source: Medline; NIMH NIH HHS [R01 MH078823, MH78823] Funding Source: Medline; NINDS NIH HHS [NS54174, R01 NS054174, P30 NS057105] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Csernansky JG, 2006, AM J PSYCHIAT, V163, P2164, DOI 10.1176/appi.ajp.163.12.2164; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; Losonczy A, 2003, J NEUROPHYSIOL, V89, P1910, DOI 10.1152/jn.00842.2002; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nitsch RM, 2000, ANN NEUROL, V48, P913, DOI 10.1002/1531-8249(200012)48:6<913::AID-ANA12>3.3.CO;2-J; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng JG, 2002, J NEUROSCI, V22, P9794; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wilson RS, 2005, NEUROLOGY, V64, P380, DOI 10.1212/01.WNL.0000149525.53525.E7; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006	50	446	467	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2008	58	1					42	51		10.1016/j.neuron.2008.02.003	http://dx.doi.org/10.1016/j.neuron.2008.02.003			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	287WC	18400162	Green Accepted, Bronze			2022-12-17	WOS:000254946200009
J	Graus-Porta, D; Blaess, S; Senften, M; Littlewood-Evans, A; Damsky, C; Huang, Z; Orban, P; Klein, R; Schittny, JC; Muller, U				Graus-Porta, D; Blaess, S; Senften, M; Littlewood-Evans, A; Damsky, C; Huang, Z; Orban, P; Klein, R; Schittny, JC; Muller, U			beta 1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CAJAL-RETZIUS CELLS; NEURONAL MIGRATION; MUSCULAR-DYSTROPHY; ALPHA-6 INTEGRINS; NEURITE OUTGROWTH; MICE; EXPRESSION; GENE; NEOCORTEX	Mice that lack all beta1-class integrins in neurons and glia die prematurely after birth with severe brain malformations. Cortical hemispheres and cerebellar folia fuse, and cortical laminae are perturbed. These defects result from disorganization of the cortical marginal zone, where beta1-class integrins regulate glial endfeet anchorage, meningeal basement membrane remodeling, and formation of the Cajal-Retzius cell layer. Surprisingly, beta1-class integrins are not essential for neuron-glia interactions and neuronal migration during corticogenesis. The phenotype of the beta1-deficient mice resembles pathological changes observed in human cortical dysplasias, suggesting that defective integrin-mediated signal transduction contributes to the development of some of these diseases.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Bern, Inst Anat, CH-3000 Bern, Switzerland; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Hosp San Raffaele, Sci Res Inst, I-20132 Milan, Italy; European Mol Biol Lab, D-69117 Heidelberg, Germany	Friedrich Miescher Institute for Biomedical Research; University of Bern; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; European Molecular Biology Laboratory (EMBL)	Muller, U (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	umuller@fmi.ch	Klein, Ruediger/C-6147-2008; Blaess, Sandra/K-8503-2015; Schittny, Johannes C/U-2956-2017	Klein, Ruediger/0000-0002-3109-0163; Schittny, Johannes C/0000-0003-4025-3961; Blaess, Sandra/0000-0002-1898-4891	NINDS NIH HHS [NS19090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; BARTSCH S, 1992, J NEUROSCI, V12, P736; Bayer, 1997, RELATION ITS EVOLUTI; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; BURRI PH, 1974, ANAT REC, V180, P77, DOI 10.1002/ar.1091800109; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; FRASCA JM, 1965, J CELL BIOL, V25, P157, DOI 10.1083/jcb.25.1.157; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Goslin, 1998, CULTURING NERVE CELL, P419; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HAUSMANN B, 1985, J COMP NEUROL, V241, P50, DOI 10.1002/cne.902410105; Hemler M. E., 1999, GUIDEBOOK EXTRACELLU, P196; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; HUSMANN K, 1992, J CELL BIOL, V116, P1475, DOI 10.1083/jcb.116.6.1475; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LIESI P, 1985, EMBO J, V4, P1163, DOI 10.1002/j.1460-2075.1985.tb03755.x; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; MILNER R, 1994, DEVELOPMENT, V120, P3497; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; RAKIC P, 1970, J COMP NEUROL, V139, P473, DOI 10.1002/cne.901390407; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Taverna D, 1998, J CELL BIOL, V143, P849, DOI 10.1083/jcb.143.3.849; TOMASELLI KJ, 1990, NEURON, V5, P651, DOI 10.1016/0896-6273(90)90219-6; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; WEISENHORN DMV, 1994, DEV BRAIN RES, V82, P293; Zhang ZQ, 1998, J NEUROSCI, V18, P6928; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	56	446	459	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2001	31	3					367	379		10.1016/S0896-6273(01)00374-9	http://dx.doi.org/10.1016/S0896-6273(01)00374-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516395	Bronze, Green Published			2022-12-17	WOS:000170601000007
J	Gil, Z; Connors, BW; Amitai, Y				Gil, Z; Connors, BW; Amitai, Y			Differential regulation of neocortical synapses by neuromodulators and activity	NEURON			English	Article							BUNGAROTOXIN BINDING-SITES; TERM SYNAPTIC PLASTICITY; RAT PREFRONTAL CORTEX; CROSS-CORRELATION; NUCLEUS BASALIS; PERFORANT PATH; BARREL CORTEX; MESSENGER-RNA; VISUAL-CORTEX; RECEPTORS	Synapses are continually regulated by chemical modulators and by their own activity. We tested the specificity of regulation in two excitatory pathways of the neocortex: thalamocortical (TC) synapses, which mediate specific inputs, and intracortical (IC) synapses, which mediate the recombination of cortical information. Frequency-sensitive depression was much stronger in TC synapses than in IC synapses. The two synapse types were differentially sensitive to presynaptic neuromodulators: only IC synapses were suppressed by activation of GABA, receptors, only TC synapses were enhanced by nicotinic acetylcholine receptors, and muscarinic acetylcholine receptors suppressed both synapse types. Modulators also differentially altered the frequency sensitivity of the synapses. Our results suggest a mechanism by which the relative strength and dynamics of input and associational pathways of neocortex are regulated during changes in behavioral state.	BEN GURION UNIV NEGEV,ZLOTOWSKI CTR NEUROSCI,DEPT PHYSIOL,IL-84105 BEER SHEVA,ISRAEL; BROWN UNIV,DEPT NEUROSCI,PROVIDENCE,RI 02912	Ben Gurion University; Brown University			Connors, Barry/AAX-1975-2020; Amitai, Yael/G-2791-2013	Connors, Barry/0000-0002-3739-3157; Amitai, Yael/0000-0001-6664-8705				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADAMS RW, 1988, ELECTROEN CLIN NEURO, V69, P45, DOI 10.1016/0013-4694(88)90034-X; AGMON A, 1992, J NEUROSCI, V12, P319; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; ALBUQUERQUE EX, 1995, SEMIN NEUROSCI, V7, P91, DOI 10.1006/smns.1995.0011; BINA KG, 1995, J COMP NEUROL, V363, P321, DOI 10.1002/cne.903630212; BROIDE RS, 1995, NEUROSCIENCE, V67, P83, DOI 10.1016/0306-4522(94)00623-D; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; CastroAlamancos MA, 1996, J NEUROSCI, V16, P2767; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; ECKENSTEIN F, 1987, CEREB CORTEX, V6, P129; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Gil Z, 1996, J NEUROSCI, V16, P6567; GRANON S, 1995, PSYCHOPHARMACOLOGY, V119, P139, DOI 10.1007/BF02246154; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Johnson MJ, 1996, J NEUROPHYSIOL, V75, P1444, DOI 10.1152/jn.1996.75.4.1444; KAHLE JS, 1989, BRAIN RES, V482, P159, DOI 10.1016/0006-8993(89)90554-4; Kang Y, 1995, J NEUROSCI, V15, P8268; Katz PS, 1996, TRENDS NEUROSCI, V19, P54, DOI 10.1016/0166-2236(96)89621-4; Lavine N, 1997, J COMP NEUROL, V380, P175, DOI 10.1002/(SICI)1096-9861(19970407)380:2<175::AID-CNE3>3.0.CO;2-0; LEWANDOWSKI MH, 1993, EXP BRAIN RES, V96, P1; Marder E, 1996, CURR BIOL, V6, P119, DOI 10.1016/S0960-9822(02)00438-4; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1986, J PHYSIOL-LONDON, V375, P169, DOI 10.1113/jphysiol.1986.sp016112; McGehee DS, 1996, CURR OPIN NEUROBIOL, V6, P342, DOI 10.1016/S0959-4388(96)80118-8; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; METHERATE R, 1992, J NEUROSCI, V12, P4701; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Ramoa AS, 1996, CEREB CORTEX, V6, P640, DOI 10.1093/cercor/6.4.640; RYE DB, 1984, NEUROSCIENCE, V13, P627, DOI 10.1016/0306-4522(84)90083-6; SAHIN M, 1992, BRAIN RES, V579, P135, DOI 10.1016/0006-8993(92)90752-U; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Steriade M, 1993, Curr Opin Neurobiol, V3, P619, DOI 10.1016/0959-4388(93)90064-6; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; TANG AC, 1994, BRAIN RES, V659, P75, DOI 10.1016/0006-8993(94)90865-6; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P19; TSODYKS M, 1996, P NATL ACAD SCI USA, V94, P719; VIDAL C, 1993, NEUROSCIENCE, V56, P23, DOI 10.1016/0306-4522(93)90558-W; WARD JM, 1990, FEBS LETT, V270, P45, DOI 10.1016/0014-5793(90)81231-C; White E.L., 1989, CORTICAL CIRCUITS SY; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	57	446	448	4	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					679	686		10.1016/S0896-6273(00)80380-3	http://dx.doi.org/10.1016/S0896-6273(00)80380-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331357	Bronze			2022-12-17	WOS:A1997XZ01600020
J	LAMBOLEZ, B; AUDINAT, E; BOCHET, P; CREPEL, F; ROSSIER, J				LAMBOLEZ, B; AUDINAT, E; BOCHET, P; CREPEL, F; ROSSIER, J			AMPA RECEPTOR SUBUNITS EXPRESSED BY SINGLE PURKINJE-CELLS	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; FUNCTIONAL EXPRESSION; SLICE CULTURES; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; MOLECULAR-CLONING; CEREBELLAR SLICES; XENOPUS OOCYTES; RAT; KAINATE	Several subunits of the glutamate receptor of the AMPA subtype have been cloned recently. These subunits, named GluR1, GluR2, GluR3, and GluR4, exist as two splicing variants (flip and flop). We have determined the subset of AMPA receptor subunits expressed by single cerebellar Purkinje cells in culture. This was achieved by combining whole-cell patch-clamp recordings and a molecular analysis, based on the polymerase chain reaction, of the messenger RNAs harvested into the patch pipette at the end of each recording. We found that each single cell expresses the messenger RNAs encoding the following five subunits: the flip and flop versions of GluR1 and GluR2 as well as GluR3flip, GluR2 being the most abundant. In addition, GluR3flop and GluR4flip were scarcely expressed in half of these neurons, and GluR4flop was never detected.	CNRS,NEUROBIOL & NEUROPHARMACOL DEV LAB,F-91405 ORSAY,FRANCE	Centre National de la Recherche Scientifique (CNRS)	LAMBOLEZ, B (corresponding author), CNRS,INST ALFRED FESSARD,F-91190 GIF SUR YVETTE,FRANCE.		Audinat, Etienne/F-4789-2019	Audinat, Etienne/0000-0002-6389-422X; lambolez, bertrand/0000-0002-0653-480X				AUDINAT E, 1990, J PHYSIOL-LONDON, V430, P297, DOI 10.1113/jphysiol.1990.sp018292; BARNARD EA, 1990, TRENDS PHARMACOL SCI, V11, P500, DOI 10.1016/0165-6147(90)90051-9; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CREPEL F, 1982, J PHYSIOL-LONDON, V329, P297, DOI 10.1113/jphysiol.1982.sp014304; DAWSON TL, 1990, MOL PHARMACOL, V38, P779; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; GAHWILER BH, 1984, EXPERIENTIA, V40, P235, DOI 10.1007/BF01947561; GEOFFROY M, 1991, MOL PHARMACOL, V39, P587; Gilliland G., 1990, PCR PROTOCOLS GUIDE, P60; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KNOPFEL T, 1990, EUR J NEUROSCI, V2, P726, DOI 10.1111/j.1460-9568.1990.tb00463.x; LAMBOLEZ B, 1991, NEUROSCI LETT, V123, P69, DOI 10.1016/0304-3940(91)90160-U; LECLERC N, 1988, J COMP NEUROL, V273, P399, DOI 10.1002/cne.902730310; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MILER RJ, 1991, TRENDS NEUROSCI, V14, P477; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; RANDLE JCR, 1988, MOL CELL BIOCHEM, V80, P121; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; WANG AM, 1990, PCR PROTOCOLS GUIDE, P70; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383	36	446	454	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					247	258		10.1016/0896-6273(92)90164-9	http://dx.doi.org/10.1016/0896-6273(92)90164-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1323310				2022-12-17	WOS:A1992JJ33200007
J	Buzsaki, G; Logothetis, N; Singer, W				Buzsaki, Gyoergy; Logothetis, Nikos; Singer, Wolf			Scaling Brain Size, Keeping Timing: Evolutionary Preservation of Brain Rhythms	NEURON			English	Review							GAMMA-OSCILLATIONS; VISUAL-CORTEX; NEURONAL OSCILLATIONS; THETA-OSCILLATIONS; HIGH-FREQUENCY; PHASE SYNCHRONIZATION; NEOCORTICAL NEURONS; PREFRONTAL CORTEX; GENETIC-VARIATION; HIPPOCAMPAL EEG	Despite the several-thousand-fold increase of brain volume during the course of mammalian evolution, the hierarchy of brain oscillations remains remarkably preserved, allowing for multiple-time-scale communication within and across neuronal networks at approximately the same speed, irrespective of brain size. Deployment of large-diameter axons of long-range neurons could be a key factor in the preserved time management in growing brains. We discuss the consequences of such preserved network constellation in mental disease, drug discovery, and interventional therapies.	[Buzsaki, Gyoergy] NYU, Sch Med, Neurosci Inst, Ctr Neural Sci, New York, NY 10016 USA; [Buzsaki, Gyoergy] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Logothetis, Nikos] Univ Manchester, Manchester, Lancs, England; [Singer, Wolf] Frankfurt Inst Adv Studies, Max Planck Inst Brain Res MPI, Ernst Struengmann Inst Neurosci Cooperat, Max Planck Soc, Frankfurt, Germany	New York University; Max Planck Society; University of Manchester; Max Planck Society	Buzsaki, G (corresponding author), NYU, Sch Med, Neurosci Inst, Ctr Neural Sci, New York, NY 10016 USA.	gyorgy.buzsaki@nyumc.org	Singer, Wolf/D-6874-2012; Logothetis, Nikos/U-9282-2019	Buzsaki, Gyorgy/0000-0002-3100-4800	National Institutes of Health [NS-034994, MH-54671, NS074015]; National Science Foundation Directorate for Social, Behavioral, and Economic Sciences [0542013]; J.D. McDonnell Foundation; Global Institute for Scientific Thinking; Max Planck Society; Ernst Strungmann Institute; Frankfurt Institute for Advanced Studies; Hertie Foundation; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS074015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Directorate for Social, Behavioral, and Economic Sciences; J.D. McDonnell Foundation; Global Institute for Scientific Thinking; Max Planck Society(Max Planck Society); Ernst Strungmann Institute; Frankfurt Institute for Advanced Studies; Hertie Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grants NS-034994, MH-54671, and NS074015), National Science Foundation Directorate for Social, Behavioral, and Economic Sciences grant 0542013, the J.D. McDonnell Foundation, the Global Institute for Scientific Thinking (G.B.), the Max Planck Society (W.S. and N.L.), the Ernst Strungmann Institute, the Frankfurt Institute for Advanced Studies, The Hertie Foundation, and the Deutsche Forschungsgemeinschaft (W.S.). We thank Heather McKellar for support and help.	Aboitiz F, 2003, BIOL RES, V36, P89, DOI 10.4067/S0716-97602003000100007; Agid Y, 2007, NAT REV DRUG DISCOV, V6, P189, DOI 10.1038/nrd2217; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alhaj H, 2011, J PSYCHOPHARMACOL, V25, P1175, DOI 10.1177/0269881110388323; Allman J., 1999, EVOLVING BRAINS; ANOKHIN A, 1992, HUM GENET, V90, P99; ARNOLDS DEAT, 1980, ELECTROEN CLIN NEURO, V50, P324, DOI 10.1016/0013-4694(80)90160-1; ARNOLDS DEAT, 1979, ELECTROEN CLIN NEURO, V46, P552, DOI 10.1016/0013-4694(79)90009-9; Balanoff AM, 2013, NATURE, V501, P93, DOI 10.1038/nature12424; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bereshpolova Y, 2007, J NEUROSCI, V27, P9392, DOI 10.1523/JNEUROSCI.2218-07.2007; Bishop GH, 1933, AM J PHYSIOL, V103, P213, DOI 10.1152/ajplegacy.1932.103.1.213; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bonjean M, 2012, J NEUROSCI, V32, P5250, DOI 10.1523/JNEUROSCI.6141-11.2012; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Buckelmuller J, 2006, NEUROSCIENCE, V138, P351, DOI 10.1016/j.neuroscience.2005.11.005; Buzaki G., 1992, INDUCED RHYTHMS BRAI, P235; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Caminiti R., 2013, CEREB CORTEX; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Caputi A, 2013, CURR OPIN NEUROBIOL, V23, P179, DOI 10.1016/j.conb.2013.01.021; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; De Gennaro L, 2008, ANN NEUROL, V64, P455, DOI 10.1002/ana.21434; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; Gou ZK, 2011, BEHAV BRAIN RES, V220, P263, DOI 10.1016/j.bbr.2011.01.048; GRASTYAN E, 1959, ELECTROEN CLIN NEURO, V11, P409, DOI 10.1016/0013-4694(59)90040-9; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Grutzner C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00088; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Hong LE, 2010, NEUROPSYCHOPHARMACOL, V35, P632, DOI 10.1038/npp.2009.168; HOUZEL JC, 1994, EUR J NEUROSCI, V6, P898, DOI 10.1111/j.1460-9568.1994.tb00585.x; Hursh JB, 1939, AM J PHYSIOL, V127, P131, DOI 10.1152/ajplegacy.1939.127.1.131; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; KANAMORI N, 1985, BRAIN RES, V334, P180, DOI 10.1016/0006-8993(85)90584-0; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2008, PROG BRAIN RES, V170, P243, DOI 10.1016/S0079-6123(08)00421-4; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; LINDSLEY DB, 1952, ELECTROEN CLIN NEURO, V4, P443, DOI 10.1016/0013-4694(52)90075-8; Linkenkaer-Hansen K, 2007, J NEUROSCI, V27, P13882, DOI 10.1523/JNEUROSCI.3083-07.2007; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Matousek M., 1973, AUTOMATION CLIN ELEC, P75; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mizuseki K, 2013, CELL REP, V4, P1010, DOI 10.1016/j.celrep.2013.07.039; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Nokia MS, 2010, J NEUROSCI, V30, P11486, DOI 10.1523/JNEUROSCI.2165-10.2010; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; Nunez P.L., 1981, ELECT FIELDS BRAIN; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olivares R, 2001, BRAIN BEHAV EVOLUT, V57, P98, DOI 10.1159/000047229; Patel J., 2013, J NEUROSCI IN PRESS; Patel J, 2012, NEURON, V75, P410, DOI 10.1016/j.neuron.2012.07.015; PEETERS BWMM, 1992, BEHAV GENET, V22, P361, DOI 10.1007/BF01066667; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1017/S1472928803000074; Peyrache A, 2011, P NATL ACAD SCI USA, V108, P17207, DOI 10.1073/pnas.1103612108; Posthuma D, 2001, BEHAV GENET, V31, P567, DOI 10.1023/A:1013345411774; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SINGER W, 1969, EXP BRAIN RES, V7, P195; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Skaggs WE, 2007, J NEUROPHYSIOL, V98, P898, DOI 10.1152/jn.00401.2007; Smit CM, 2006, INT J PSYCHOPHYSIOL, V61, P235, DOI 10.1016/j.ijpsycho.2005.10.004; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; STANFIELD BB, 1992, PROG NEUROBIOL, V38, P169, DOI 10.1016/0301-0082(92)90039-H; Stark E, 2012, J NEUROPHYSIOL, V108, P349, DOI 10.1152/jn.00153.2012; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Swadlow H. A., 2000, TIME BRAIN; Tafti Mehdi, 2007, Dialogues Clin Neurosci, V9, P273; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tasaki I, 1939, AM J PHYSIOL, V127, P211, DOI 10.1152/ajplegacy.1939.127.2.211; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; VADASZ C, 1995, AM J MED GENET, V60, P55, DOI 10.1002/ajmg.1320600111; van Pelt S, 2012, J NEUROSCI, V32, P3388, DOI 10.1523/JNEUROSCI.5592-11.2012; vanBeijsterveldt CEM, 1996, AM J HUM GENET, V58, P562; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; VOGEL F, 1970, HUMANGENETIK, V10, P91, DOI 10.1007/BF00295509; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y	149	445	460	5	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2013	80	3					751	764		10.1016/j.neuron.2013.10.002	http://dx.doi.org/10.1016/j.neuron.2013.10.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247IA	24183025	Green Accepted, Bronze			2022-12-17	WOS:000326609900019
J	Guillery, RW; Sherman, SM				Guillery, RW; Sherman, SM			Thalamic relay functions and their role in corticocortical communication: Generalizations from the visual system	NEURON			English	Review							LATERAL GENICULATE-NUCLEUS; METABOTROPIC GLUTAMATE RECEPTORS; CONTRAST GAIN-CONTROL; ELECTRON-MICROSCOPIC ANALYSIS; POSTERIOR-PULVINAR COMPLEX; STRIATE-RECIPIENT ZONE; CORTICOTHALAMIC PROJECTIONS; SUPERIOR COLLICULUS; MACAQUE MONKEY; PHA-L	All neocortical areas receive thalamic inputs. Some thalamocortical pathways relay information from ascending pathways (first order thalamic relays) and others relay information from other cortical areas (higher order thalamic relays), thus serving a role in corticocortical communication. Most, possibly all, afferents reaching thalamus, ascending and cortical, are branches of axons that innervate lower (motor) centers, so that thalamocortical pathways can be viewed generally as monitors of ongoing motor instructions. In terms of numbers, the thalamic relay is dominated by synapses that modulate the relay functions. One of the roles of these modulatory pathways is to change the transfer of information through the thalamus, in accord with current attentional demands. Other roles remain to be explored. These modulatory functions can be expected to act on corticocortical communication in addition to their action on ascending pathways.	SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA; Univ Wisconsin, Sch Med, Dept Anat, Madison, WI 53706 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wisconsin System; University of Wisconsin Madison	Sherman, SM (corresponding author), SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA.	s.sherman@sunysb.edu			NEI NIH HHS [EY11494, EY11409, EY0308, EY12936] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012936, R01EY011494, R01EY011409] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams MM, 2000, J COMP NEUROL, V419, P377, DOI 10.1002/(SICI)1096-9861(20000410)419:3<377::AID-CNE9>3.0.CO;2-E; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; ALLISON JD, 1993, VISUAL NEUROSCI, V10, P1129, DOI 10.1017/S0952523800010233; Bartlett EL, 2000, NEUROSCIENCE, V100, P811, DOI 10.1016/S0306-4522(00)00340-7; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; BENDER DB, 1981, J NEUROPHYSIOL, V46, P672, DOI 10.1152/jn.1981.46.3.672; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; BOWLING DB, 1984, J NEUROSCI, V4, P198; BROWN AG, 1978, J PHYSIOL-LONDON, V274, P111, DOI 10.1113/jphysiol.1978.sp012137; CASANOVA C, 1993, EXP BRAIN RES, V96, P247; CHALUPA LM, 1989, J NEUROSCI, V9, P347; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Darian-Smith C, 1999, J COMP NEUROL, V410, P211, DOI 10.1002/(SICI)1096-9861(19990726)410:2<211::AID-CNE4>3.0.CO;2-X; DESCHENES M, 1994, BRAIN RES, V664, P215, DOI 10.1016/0006-8993(94)91974-7; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Erisir A, 1997, J COMP NEUROL, V377, P535; Feig S, 1998, J COMP NEUROL, V395, P281, DOI 10.1002/(SICI)1096-9861(19980808)395:3<281::AID-CNE2>3.0.CO;2-Z; Felisberti F, 1999, VISUAL NEUROSCI, V16, P943, DOI 10.1017/S0952523899165143; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Godwin DW, 1996, J NEUROSCI, V16, P8181; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Guillery RW, 2001, J COMP NEUROL, V438, P66, DOI 10.1002/cne.1302; GUILLERY RW, 1961, CYTOLOGY NERVOUS TIS, P64; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HARDING BN, 1973, BRAIN RES, V54, P341, DOI 10.1016/0006-8993(73)90058-9; Harting JK, 2000, BRAIN RES, V881, P244, DOI 10.1016/S0006-8993(00)02849-3; Hendry SHC, 1998, TRENDS NEUROSCI, V21, P344, DOI 10.1016/S0166-2236(98)01245-4; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HOOGLAND PV, 1991, EXP BRAIN RES, V87, P159, DOI 10.1007/BF00228517; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Hughes SW, 1999, J PHYSIOL-LONDON, V517, P805, DOI 10.1111/j.1469-7793.1999.0805s.x; HUTCHINS B, 1989, J COMP NEUROL, V285, P350, DOI 10.1002/cne.902850306; IRVIN GE, 1993, VISUAL NEUROSCI, V10, P363, DOI 10.1017/S0952523800003758; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Jones EG, 1985, THALAMUS; KAAS JH, 1995, CURR BIOL, V5, P1126, DOI 10.1016/S0960-9822(95)00228-4; Kakei S, 2001, J COMP NEUROL, V437, P170, DOI 10.1002/cne.1277; KALIL RE, 1970, J NEUROPHYSIOL, V33, P459, DOI 10.1152/jn.1970.33.3.459; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KOLLIKER A, 1996, HDB GERWEBELEHRE MEN, V2; KULTASILINSKY K, 1991, J COMP NEUROL, V314, P319, DOI 10.1002/cne.903140209; Latawiec D, 2000, J COMP NEUROL, V419, P306, DOI 10.1002/(SICI)1096-9861(20000410)419:3<306::AID-CNE4>3.0.CO;2-2; LU SM, 1993, VISUAL NEUROSCI, V10, P631, DOI 10.1017/S0952523800005332; MAATTANEN LM, 1991, EXP BRAIN RES, V87, P205; MATHERS LH, 1972, J COMP NEUROL, V146, P43, DOI 10.1002/cne.901460104; MATHERS LH, 1971, BRAIN RES, V35, P357; MCCLURKIN JW, 1994, VISUAL NEUROSCI, V11, P601, DOI 10.1017/S0952523800002492; MCCLURKIN JW, 1984, J PHYSIOL-LONDON, V348, P135, DOI 10.1113/jphysiol.1984.sp015103; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MCCREA RA, 1978, J COMP NEUROL, V181, P397, DOI 10.1002/cne.901810210; MOTT DD, 1994, INT REV NEUROBIOL, V36, P97, DOI 10.1016/S0074-7742(08)60304-9; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OGREN MP, 1979, J COMP NEUROL, V188, P179, DOI 10.1002/cne.901880113; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; OJIMA H, 1994, CEREB CORTEX, V4, P646, DOI 10.1093/cercor/4.6.646; PARTLOW GD, 1977, J COMP NEUROL, V171, P285, DOI 10.1002/cne.901710302; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PIN JP, 1995, CURR OPIN NEUROBIOL, V5, P342, DOI 10.1016/0959-4388(95)80047-6; Przybyszewski AW, 2000, VISUAL NEUROSCI, V17, P485, DOI 10.1017/S0952523800174012; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEME N; RECASENS M, 1995, ANN NY ACAD SCI, V757, P418, DOI 10.1111/j.1749-6632.1995.tb17501.x; ROBSON JA, 1977, J COMP NEUROL, V173, P355, DOI 10.1002/cne.901730210; Rouiller EM, 1998, J COMP NEUROL, V396, P169, DOI 10.1002/(SICI)1096-9861(19980629)396:2<169::AID-CNE3>3.0.CO;2-Z; ROUILLER EM, 1991, HEARING RES, V56, P179, DOI 10.1016/0378-5955(91)90168-9; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; SCHWARTZ ML, 1991, J COMP NEUROL, V309, P289, DOI 10.1002/cne.903090302; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHERMAN SM, 1985, PROG PSYCHOB PHYSIOL, V11, P233; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; SHINODA Y, 1988, BEHAV BRAIN RES, V28, P59, DOI 10.1016/0166-4328(88)90076-9; Shore SE, 1998, HEARING RES, V116, P33, DOI 10.1016/S0378-5955(97)00207-4; SOMOGYI G, 1978, EXP BRAIN RES, V31, P417; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1990, THALAMIC OSCILLATION; SUR M, 1987, J NEUROPHYSIOL, V58, P1; TAMAMAKI N, 1995, J COMP NEUROL, V354, P583, DOI 10.1002/cne.903540408; Tassinari G, 1997, BRAIN RES BULL, V43, P127, DOI 10.1016/S0361-9230(96)00215-8; Truchard AM, 2000, J NEUROSCI, V20, P3017; UPDYKE BV, 1983, J COMP NEUROL, V219, P143, DOI 10.1002/cne.902190204; UPDYKE BV, 1981, J COMP NEUROL, V201, P477, DOI 10.1002/cne.902010403; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; VETTER DE, 1993, HEARING RES, V70, P173, DOI 10.1016/0378-5955(93)90156-U; VIDNYANSZKY Z, 1994, J COMP NEUROL, V349, P259, DOI 10.1002/cne.903490208; Vidnyanszky Z, 1996, EXP BRAIN RES, V109, P63; Wang ST, 2001, J COMP NEUROL, V440, P321, DOI 10.1002/cne.1389; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Xu XM, 2001, J PHYSIOL-LONDON, V531, P203, DOI 10.1111/j.1469-7793.2001.0203j.x	98	445	450	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					163	175		10.1016/S0896-6273(01)00582-7	http://dx.doi.org/10.1016/S0896-6273(01)00582-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804565	Bronze			2022-12-17	WOS:000173387700005
J	Brenner, N; Bialek, W; van Steveninck, RD				Brenner, N; Bialek, W; van Steveninck, RD			Adaptive rescaling maximizes information transmission	NEURON			English	Article							NEURAL SPIKE TRAINS; SENSITIVE NEURON; VISUAL-SYSTEM; ADAPTATION; CONTRAST; SUMMATION	Adaptation is a widespread phenomenon in nervous systems, providing flexibility to function under Varying external conditions. Here, we relate an adaptive property of a sensory system directly to its function as a carrier of information about input signals. We show that the input/output relation of a sensory system in a dynamic environment changes with the statistical properties of the environment. Specifically, when the dynamic range of inputs changes, the input/output relation rescales so as to match the dynamic range of responses to that of the inputs. We give direct evidence that the scaling of the input/output relation is set to maximize information transmission for each distribution of signals. This adaptive behavior should be particularly useful in dealing with the intermittent statistics of natural signals.	NEC Res Inst, Princeton, NJ 08540 USA	NEC Corporation	Bialek, W (corresponding author), NEC Res Inst, 4 Independence Way, Princeton, NJ 08540 USA.			Brenner, Naama/0000-0002-8021-1208				Adrian E.D., 1928, BASIS SENSATION; ATICK JJ, 1992, PRINCETON LECTURES ON BIOPHYSICS, P223; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H., 1961, SENSORY COMMUNICATIO, P217; BORST A, 1987, BIOL CYBERN, V56, P209, DOI 10.1007/BF00365215; BRENNER N, 2000, IN PRESS NEURAL COMP; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Franceschini N., 1989, P360; Hausen K., 1989, P391; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Rieke F., 1997, SPIKES EXPLORING NEU; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SHAPLEY RM, 1980, J PHYSIOL-LONDON, V302, P535; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; Simoncelli EP, 1999, ADV NEUR IN, V11, P153; SMIMAKIS SM, 1997, NATURE, V386, P69; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; vanSteveninck RD, 1996, PROCEEDINGS OF THE IEEE TWENTY-SECOND ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P40, DOI 10.1109/NEBC.1996.503207; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; vanSteveninck RRD, 1996, NATURAL & ARTIFICIAL PARALLEL COMPUTATION, P21; Wiener Norbert, 1949, TIME SERIES	30	445	451	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2000	26	3					695	702		10.1016/S0896-6273(00)81205-2	http://dx.doi.org/10.1016/S0896-6273(00)81205-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330ZH	10896164	Bronze			2022-12-17	WOS:000087991600019
J	Laumann, TO; Gordon, EM; Adeyemo, B; Snyder, AZ; Joo, SJ; Chen, MY; Gilmore, AW; McDermott, KB; Nelson, SM; Dosenbach, NUF; Schlaggar, BL; Mumford, JA; Poldrack, RA; Petersen, SE				Laumann, Timothy O.; Gordon, Evan M.; Adeyemo, Babatunde; Snyder, Abraham Z.; Joo, Sung Jun; Chen, Mei-Yen; Gilmore, Adrian W.; McDermott, Kathleen B.; Nelson, Steven M.; Dosenbach, Nico U. F.; Schlaggar, Bradley L.; Mumford, Jeanette A.; Poldrack, Russell A.; Petersen, Steven E.			Functional System and Areal Organization of a Highly Sampled Individual Human Brain	NEURON			English	Article							HUMAN CEREBRAL-CORTEX; RESTING-STATE FMRI; SURFACE-BASED ANALYSIS; HEMISPHERIC ASYMMETRIES; TEDIOUS ANATOMY; CONNECTIVITY; NETWORKS; MEMORY; ARCHITECTURE; VARIABILITY	Resting state functional MRI (fMRI) has enabled description of group-level functional brain organization at multiple spatial scales. However, cross-subject averaging may obscure patterns of brain organization specific to each individual. Here, we characterized the brain organization of a single individual repeatedly measured over more than a year. We report a reproducible and internally valid subject-specific areal-level parcellation that corresponds with subject-specific task activations. Highly convergent correlation network estimates can be derived from this parcellation if sufficient data are collected-considerably more than typically acquired. Notably, within-subject correlation variability across sessions exhibited a heterogeneous distribution across the cortex concentrated in visual and somato-motor regions, distinct from the pattern of intersubject variability. Further, although the individual's systems-level organization is broadly similar to the group, it demonstrates distinct topological features. These results provide a foundation for studies of individual differences in cortical organization and function, especially for special or rare individuals.	[Laumann, Timothy O.; Gordon, Evan M.; Adeyemo, Babatunde; Snyder, Abraham Z.; Dosenbach, Nico U. F.; Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA; [Snyder, Abraham Z.; McDermott, Kathleen B.; Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Radiol, Sch Med, St Louis, MO 63110 USA; [Joo, Sung Jun; Chen, Mei-Yen; Poldrack, Russell A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Gilmore, Adrian W.; McDermott, Kathleen B.; Petersen, Steven E.] Washington Univ, Dept Psychol, St Louis, MO 63110 USA; [Nelson, Steven M.] VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX 76711 USA; [Nelson, Steven M.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr Vital Longev, Dallas, TX 75235 USA; [Schlaggar, Bradley L.] Washington Univ, Dept Psychiat, Sch Med, St Louis, MO 63110 USA; [Schlaggar, Bradley L.] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Anat & Neurobiol, Sch Med, St Louis, MO 63110 USA; [Mumford, Jeanette A.] Univ Wisconsin, Ctr Investigating Hlth Minds, Waisman Ctr, Madison, WI 53705 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Poldrack, Russell A.] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78712 USA; [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Austin; Washington University (WUSTL); University of Texas System; University of Texas Dallas; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Stanford University	Laumann, TO (corresponding author), Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA.	laumannt@wusm.wustl.edu	Schlaggar, Bradley/AAZ-4153-2020; Petersen, Steve/ABF-1368-2020; Gordon, Evan/J-5672-2019	Gordon, Evan/0000-0002-2276-5237; Laumann, Timothy/0000-0002-0428-427X; Gilmore, Adrian/0000-0001-8910-5009; Poldrack, Russell/0000-0001-6755-0259	McDonnell Foundation Collaborative Activity award; Hope Center for Neurological Disorders Pilot Award; Intellectual and Developmental Disabilities Research Center at Washington University [NIH/NICHDP30 HD062171]; Mallinckrodt Institute of Radiology Pilot Grant; Child Neurology Foundation Scientific Research Award; WU Child Health Research Center [K12-HD076224]; McDonnell Center for Systems Neuroscience New Resource Proposal; Dart NeuroScience LLC; Texas Emerging Technology Fund;  [MH100872];  [NS61144];  [NS46424];  [P30NS048056];  [NS088590];  [DGE-1143954];  [MH091657]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD076224, P30HD062171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657, F30MH100872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS088590, R21NS061144, R01NS046424, P30NS048056] Funding Source: NIH RePORTER	McDonnell Foundation Collaborative Activity award; Hope Center for Neurological Disorders Pilot Award; Intellectual and Developmental Disabilities Research Center at Washington University; Mallinckrodt Institute of Radiology Pilot Grant; Child Neurology Foundation Scientific Research Award; WU Child Health Research Center; McDonnell Center for Systems Neuroscience New Resource Proposal; Dart NeuroScience LLC; Texas Emerging Technology Fund; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by MH100872 (T.O.L.), NS61144 (S.E.P.), NS46424 (S.E.P.), P30NS048056 (A.Z.S.), a McDonnell Foundation Collaborative Activity award (S.E.P.), Hope Center for Neurological Disorders Pilot Award (B.L.S.), Intellectual and Developmental Disabilities Research Center at Washington University (NIH/NICHDP30 HD062171), Mallinckrodt Institute of Radiology Pilot Grant (N.U.F.D.), Child Neurology Foundation Scientific Research Award (N.U.F.D.), WU Child Health Research Center K12-HD076224 (Alan Schwartz), McDonnell Center for Systems Neuroscience New Resource Proposal (N.U.F.D.), NS088590 (N.U.F.D.), Dart NeuroScience LLC (K.B.M.), DGE-1143954 (A.W.G.), MH091657 (Van Essen), and the Texas Emerging Technology Fund (D. Johnston, PI). We thank Alex Huk for facilitating data collection and Jonathan Power for helpful comments on the manuscript.	Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; BOURGEOIS F, 1971, COMMUN ACM, V14, P802, DOI 10.1145/362919.362945; Buckner RL, 2014, NEUROIMAGE, V93, P292, DOI 10.1016/j.neuroimage.2013.12.036; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; CHURCHLAND PS, 1988, SCIENCE, V242, P741, DOI 10.1126/science.3055294; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; Frost MA, 2012, NEUROIMAGE, V59, P1369, DOI 10.1016/j.neuroimage.2011.08.035; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gordon E.M., 2014, CEREB CORTEX; Gordon EM, 2014, HUM BRAIN MAPP, V35, P1004, DOI 10.1002/hbm.22230; Greene DJ, 2014, J NEUROSCI, V34, P5842, DOI 10.1523/JNEUROSCI.3069-13.2014; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; Hodkinson DJ, 2014, J CEREBR BLOOD F MET, V34, P1493, DOI 10.1038/jcbfm.2014.109; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; McAvoy M, 2008, J NEUROPHYSIOL, V100, P922, DOI 10.1152/jn.90426.2008; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rack-Gomer AL, 2009, NEUROIMAGE, V46, P56, DOI 10.1016/j.neuroimage.2009.02.001; Robinson EC, 2014, NEUROIMAGE, V100, P414, DOI 10.1016/j.neuroimage.2014.05.069; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sabuncu MR, 2010, CEREB CORTEX, V20, P130, DOI 10.1093/cercor/bhp085; Shannon BJ, 2013, J NEUROPHYSIOL, V109, P1444, DOI 10.1152/jn.00651.2012; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Van Essen DC, 2007, NEUROIMAGE, V37, P1050, DOI 10.1016/j.neuroimage.2007.02.021; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Wig GS, 2014, CEREB CORTEX, V24, P2036, DOI 10.1093/cercor/bht056; Wig GS, 2014, NEUROIMAGE, V93, P276, DOI 10.1016/j.neuroimage.2013.07.035; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Xu PF, 2014, NEUROIMAGE, V90, P246, DOI 10.1016/j.neuroimage.2013.12.060; Yeo B.T., 2014, CEREB CORTEX; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008	51	444	445	3	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2015	87	3					657	670		10.1016/j.neuron.2015.06.037	http://dx.doi.org/10.1016/j.neuron.2015.06.037			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR2GR	26212711	Green Accepted, Bronze			2022-12-17	WOS:000361145000016
J	Schendan, HE; Searl, MM; Melrose, RJ; Stern, CE				Schendan, HE; Searl, MM; Melrose, RJ; Stern, CE			An fMRI study of the role of the medial temporal lobe in implicit and explicit sequence learning	NEURON			English	Article							EPISODIC MEMORY; BASAL GANGLIA; FRONTAL LOBES; BRAIN SYSTEMS; MOTOR SKILL; HIPPOCAMPUS; TIME; ASSOCIATIONS; STRIATUM; AMNESIA	fMRI was used to investigate the neural substrates supporting implicit and explicit sequence learning, focusing especially upon the role of the medial temporal lobe. Participants performed a serial reaction time task (SRTT). For implicit learning, they were naive about a repeating pattern, whereas for explicit learning, participants memorized another repeating sequence. fMRI analyses comparing repeating versus random sequence blocks demonstrated activation of frontal, parietal, cingulate, and striatal regions implicated in previous SRTT studies. Importantly, medio-temporal lobe regions were active in both explicit and implicit SRTT learning. Moreover, the results provide evidence of a role for the hippocampus and related cortices in the formation of higher order associations under both implicit and explicit learning conditions, regardless of conscious awareness of sequence knowledge.	Boston Univ, Ctr Memory & Brain, Dept Psychol, Boston, MA 02215 USA; Harvard Univ, Sch Med, MGH NMR Ctr, Dept Radiol, Charlestown, MA 02129 USA	Boston University; Harvard University	Schendan, HE (corresponding author), Boston Univ, Ctr Memory & Brain, Dept Psychol, Boston, MA 02215 USA.	haline@mind.bu.edu	Schendan, Haline/I-6125-2019	Schendan, Haline/0000-0001-8925-5605	NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005914] Funding Source: NIH RePORTER; NIA NIH HHS [F32 AG05914] Funding Source: Medline; NIMH NIH HHS [R21 MH066213] Funding Source: Medline; NINDS NIH HHS [R01 NS40239] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Agster KL, 2002, J NEUROSCI, V22, P5760; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buchel C, 1999, J NEUROSCI, V19, P10869; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; CORKIN S, 1968, NEUROPSYCHOLOGIA, V6, P255, DOI 10.1016/0028-3932(68)90024-9; Curran T, 1997, J COGNITIVE NEUROSCI, V9, P522, DOI 10.1162/jocn.1997.9.4.522; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Dolan RJ, 1999, HIPPOCAMPUS, V9, P25, DOI 10.1002/(SICI)1098-1063(1999)9:1<25::AID-HIPO3>3.0.CO;2-4; Downes JJ, 2002, NEUROPSYCHOLOGIA, V40, P853, DOI 10.1016/S0028-3932(01)00172-5; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Doyon J, 1998, NEUROPSYCHOLOGIA, V36, P625, DOI 10.1016/S0028-3932(97)00168-1; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Duvernoy H. M., 1999, HUMAN BRAIN SURFACE; Elliott R, 1999, J NEUROSCI, V19, P5066; EMERSON PL, 1995, BEHAV RES METH INSTR, V27, P88, DOI 10.3758/BF03203627; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Goel V, 2000, J COGNITIVE NEUROSCI, V12, P110, DOI 10.1162/08989290051137639; Grafton ST, 1998, J NEUROSCI, V18, P9420; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Grunwald T, 1998, P NATL ACAD SCI USA, V95, P3193, DOI 10.1073/pnas.95.6.3193; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; JACKSON GM, 1995, NEUROPSYCHOLOGIA, V33, P577, DOI 10.1016/0028-3932(95)00010-Z; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kesner RP, 2001, NEUROPSYCHOLOGY, V15, P58, DOI 10.1037/0894-4105.15.1.58; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; KNOPMAN D, 1991, NEUROPSYCHOLOGIA, V29, P245, DOI 10.1016/0028-3932(91)90085-M; Knowlton B J, 1994, Learn Mem, V1, P106; KNOWLTON BJ, 1992, PSYCHOL SCI, V3, P172, DOI 10.1111/j.1467-9280.1992.tb00021.x; Mai J, 1998, ATLAS HUMAN BRAIN; MCCARTHY G, 1989, J NEUROSCI, V9, P4253; McGlincheyBerroth R, 1997, BEHAV NEUROSCI, V111, P873, DOI 10.1037/0735-7044.111.5.873; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; NISSEN MJ, 1989, NEUROPSYCHOLOGIA, V27, P341, DOI 10.1016/0028-3932(89)90023-7; NISSEN MJ, 1987, NEUROLOGY, V37, P789, DOI 10.1212/WNL.37.5.789; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Rah SKY, 2000, PSYCHON B REV, V7, P309, DOI 10.3758/BF03212986; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rauch SL, 1998, NEUROREPORT, V9, P865, DOI 10.1097/00001756-199803300-00019; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; Rauch SL, 1995, HUM BRAIN MAPP, V3, P271, DOI 10.1002/hbm.460030403; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Reber PJ, 1998, J COGNITIVE NEUROSCI, V10, P248, DOI 10.1162/089892998562681; REBER PJ, 1994, LEARN MEMORY, V1, P217; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Schacter DL, 1997, PHILOS T R SOC B, V352, P1689, DOI 10.1098/rstb.1997.0150; Shanks DR, 1999, J EXP PSYCHOL LEARN, V25, P1435, DOI 10.1037/0278-7393.25.6.1435; Small SA, 2001, NAT NEUROSCI, V4, P442, DOI 10.1038/86115; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Stern CE, 2000, NEUROIMAGE, V11, P392, DOI 10.1006/nimg.2000.0569; Stern CE, 2001, HIPPOCAMPUS, V11, P337; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Toni I, 2001, NEUROIMAGE, V14, P1048, DOI 10.1006/nimg.2001.0894; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	76	444	447	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					1013	1025		10.1016/S0896-6273(03)00123-5	http://dx.doi.org/10.1016/S0896-6273(03)00123-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670429	Bronze			2022-12-17	WOS:000181899600014
J	Ishai, A; Ungerleider, LG; Haxby, JV				Ishai, A; Ungerleider, LG; Haxby, JV			Distributed neural systems for the generation of visual images	NEURON			English	Article							FUSIFORM FACE AREA; MENTAL-IMAGERY; NEURONAL CORRELATE; SUSTAINED ACTIVITY; WORKING-MEMORY; TERM-MEMORY; CORTEX; ACTIVATION; PET; REPRESENTATION	Visual perception of houses, faces, and chairs evoke differential responses in ventral temporal cortex. Using fMRI, we compared activations evoked by perception and imagery of these object categories. We found content-related activation during imagery in extrastriate cortex, but this activity was restricted to small subsets of the regions that showed category-related activation during perception. Within ventral temporal cortex, activation during imagery evoked stronger responses on the left whereas perception evoked stronger responses on the right. Additionally, visual imagery evoked activity in parietal and frontal cortex, but this activity was not content related. These results suggest that content-related activation during imagery in visual extrastriate cortex may be implemented by "top-down" mechanisms in parietal and frontal cortex that mediate the retrieval of face and object representations from long-term memory and their maintenance through visual imagery.	NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Ishai, A (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	alumit@in.nimh.nih.gov			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002035, ZIAMH002035] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chen W, 1998, NEUROREPORT, V9, P3669, DOI 10.1097/00001756-199811160-00019; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah M J, 1989, J Cogn Neurosci, V1, P302, DOI 10.1162/jocn.1989.1.4.302; FARAH MJ, 1988, J EXP PSYCHOL GEN, V117, P248, DOI 10.1037/0096-3445.117.3.248; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P1455, DOI 10.1016/0028-3932(95)00075-E; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; GOLDENBERG G, 1989, NEUROPSYCHOLOGIA, V27, P641, DOI 10.1016/0028-3932(89)90110-3; Graham KS, 1999, CURR OPIN NEUROBIOL, V9, P245, DOI 10.1016/S0959-4388(99)80035-X; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HAXBY JV, 1993, BEHAV RES METH INSTR, V25, P400, DOI 10.3758/BF03204531; Haxby JV, 2000, NEUROIMAGE, V11, P145, DOI 10.1006/nimg.1999.0527; HAXBY JV, 1908, MAPPING MODELING HUM; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Ishai A, 1997, J COGNITIVE NEUROSCI, V9, P476, DOI 10.1162/jocn.1997.9.4.476; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1485, DOI 10.1016/0028-3932(95)00077-G; LEBIHAN D, 1993, P NATL ACAD SCI USA, V90, P11802, DOI 10.1073/pnas.90.24.11802; LEVINE DN, 1985, NEUROLOGY, V35, P1010, DOI 10.1212/WNL.35.7.1010; MAISOG JM, 1995, HUM BRAIN MAP S, V1, P147; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Mellet E, 1996, J NEUROSCI, V16, P6504; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OCRAVEN K, 2000, IN PRESS J COGN NEUR, V12; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; Petit L, 1998, J NEUROSCI, V18, P9429; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; ROLAND PE, 1987, J NEUROSCI, V7, P2373; SAKAI K, 1994, TRENDS NEUROSCI, V17, P287, DOI 10.1016/0166-2236(94)90058-2; SERGENT J, 1989, J EXP PSYCHOL HUMAN, V15, P170, DOI 10.1037/0096-1523.15.1.170; Talairach J., 1988, COPLANAR STEREOTAXIS; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	55	444	449	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					979	990		10.1016/S0896-6273(00)00168-9	http://dx.doi.org/10.1016/S0896-6273(00)00168-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163281	Bronze			2022-12-17	WOS:000166057500031
J	Power, JD; Schlaggar, BL; Lessov-Schlaggar, CN; Petersen, SE				Power, Jonathan D.; Schlaggar, Bradley L.; Lessov-Schlaggar, Christina N.; Petersen, Steven E.			Evidence for Hubs in Human Functional Brain Networks	NEURON			English	Article							MODULAR ORGANIZATION; SMALL-WORLD; COMMUNITY STRUCTURE; CONNECTIVITY; CORTEX	Hubs integrate and distribute information in powerful ways due to the number and positioning of their contacts in a network. Several resting-state functional connectivity MRI reports have implicated regions of the default mode system as brain hubs; we demonstrate that previous degree-based approaches to hub identification may have identified portions of large brain systems rather than critical nodes of brain networks. We utilize two methods to identify hub-like brain regions: (1) finding network nodes that participate in multiple subnetworks of the brain, and (2) finding spatial locations in which several systems are represented within a small volume. These methods converge on a distributed set of regions that differ from previous reports on hubs. This work identifies regions that support multiple systems, leading to spatially constrained predictions about brain function that may be tested in terms of lesions, evoked responses, and dynamic patterns of activity.	[Power, Jonathan D.; Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Sch Med St Louis, Dept Neurol, St Louis, MO 63110 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Radiol, Sch Med St Louis, St Louis, MO 63110 USA; [Schlaggar, Bradley L.] Washington Univ, Dept Pediat, Sch Med St Louis, St Louis, MO 63110 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Anat & Neurobiol, Sch Med St Louis, St Louis, MO 63110 USA; [Lessov-Schlaggar, Christina N.] Washington Univ, Dept Psychiat, Sch Med St Louis, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Neurosurg, Sch Med St Louis, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Petersen, Steven E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Power, JD (corresponding author), Washington Univ, Sch Med St Louis, Dept Neurol, 660 South Euclid Ave, St Louis, MO 63110 USA.	powerj@wusm.wustl.edu	Schlaggar, Bradley/AAZ-4153-2020; Petersen, Steve/ABF-1368-2020	Power, Jonathan/0000-0002-6922-100X	NIH [F30 MH940322, R21NS061144, 5R01 HD057076-03-S1, R01HD057076, K12 EY16336, K01DA027046]; McDonnell Foundation Collaborative Action Award; Simons Foundation Award [95177]; NSF IGERT [DGE-0548890]; Barnes-Jewish Hospital Foundation; McDonnell Center for Systems Neuroscience at Washington University; Alvin J. Siteman Cancer Center (via NCI Cancer Center Support Grand) [P30 CA91842]; Intellectual and Developmental Disabilities Research Center at Washington University [NIH/NICHD P30 HD062171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057076, P30HD062171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K12EY016336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH094032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA027046] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation Collaborative Action Award; Simons Foundation Award; NSF IGERT(National Science Foundation (NSF)); Barnes-Jewish Hospital Foundation; McDonnell Center for Systems Neuroscience at Washington University; Alvin J. Siteman Cancer Center (via NCI Cancer Center Support Grand); Intellectual and Developmental Disabilities Research Center at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The impetus to write this paper came from discussions during the 2011 Summer Institute for Cognitive Neuroscience. We thank Tom Pearce, Steve Nelson, Chris Fetsch, and Brad Miller for comments on an earlier version of the manuscript, and Jessica Church, Joe Dubis, Eric Feczko, Katie Ihnen, Maital Neta, and Alecia Vogel for data contribution. This work was funded by NIH F30 MH940322 (J.D.P.), NIH R21NS061144 (S.E.P.), a McDonnell Foundation Collaborative Action Award (S.E.P.), Simons Foundation Award 95177 (S.E.P.), NIH 5R01 HD057076-03-S1 (B.L.S.), NIH R01HD057076 (B.L.S.), and NSF IGERT DGE-0548890 (Kurt Thoroughman). Data were acquired with the support of NIH K12 EY16336 (John Pruett), NIH K01DA027046 (C.N.L.-S.), the Barnes-Jewish Hospital Foundation (C.N.L.-S.), the McDonnell Center for Systems Neuroscience at Washington University (C.N.L.-S.), and the Alvin J. Siteman Cancer Center (via NCI Cancer Center Support Grand P30 CA91842) (C.N.L.-S.). This project was supported by the Intellectual and Developmental Disabilities Research Center at Washington University (NIH/NICHD P30 HD062171).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Adamic LA, 2005, INT WORKSHOP LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P366, DOI 10.1002/cne.903460305; Chang C, 2010, FILM COMMENT, V46, P81; CHURCHLAND PS, 1988, SCIENCE, V242, P741, DOI 10.1126/science.3055294; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Frank A., 2010, CEREB CORTEX; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser P., 2003, COMMUNITY STRUCTURE; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Knuth DE., 1993, STANFORD GRAPH BASE; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ., 2010, NETWORKS INTRO OXFOR; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	57	443	449	6	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					798	813		10.1016/j.neuron.2013.07.035	http://dx.doi.org/10.1016/j.neuron.2013.07.035			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972601	Green Accepted, Bronze			2022-12-17	WOS:000323587000017
J	Kelleher, RJ; Govindarajan, A; Tonegawa, S				Kelleher, RJ; Govindarajan, A; Tonegawa, S			Translational regulatory mechanisms in persistent forms of synaptic plasticity	NEURON			English	Review							LONG-TERM POTENTIATION; LOCAL PROTEIN-SYNTHESIS; FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; IN-SITU HYBRIDIZATION; CAMKII MESSENGER-RNA; DEPENDENT LATE-PHASE; CA1 REGION; HIPPOCAMPAL-NEURONS; DENTATE GYRUS	Memory and synaptic plasticity exhibit distinct temporal phases, with long-lasting forms distinguished by their dependence on macromolecular synthesis. Prevailing models for the molecular mechanisms underlying long-lasting synaptic plasticity have largely focused on transcriptional regulation. However, a growing body of evidence now supports a crucial role for neuronal activity-dependent mRNA translation, which may occur in dendrites for a subset of neuronal mRNAs. Recent work has begun to define the signaling mechanisms coupling synaptic activation to the protein synthesis machinery. The ERK and mTOR signaling pathways have been shown to regulate the activity of the general translational machinery, while the translation of particular classes of mRNAs is additionally controlled by gene-specific mechanisms. Rapid enhancement of the synthesis of a diverse array of neuronal proteins through such mechanisms provides the components necessary for persistent forms of UP and LTD. These findings have important implications for the synapse specificity and associativity of protein synthesis-dependent changes in synaptic strength.	MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr,Ctr Canc Res,Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory,Dept Brain & Cognit, Howard Hughes Med Inst,Ctr Canc Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Harvard University; Harvard Medical School; Massachusetts General Hospital	Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr,Ctr Canc Res,Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu			NIMH NIH HHS [P50-MH58880] Funding Source: Medline; NINDS NIH HHS [R01-NS32925, K08-NS02071] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS002071, R01NS032925] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; AUTILIO LA, 1968, BIOCHEMISTRY-US, V7, P2615, DOI 10.1021/bi00847a025; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BANCO JL, 2004, IN PRESS J NEUROCHEM; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; BODIAN D, 1965, P NATL ACAD SCI USA, V53, P418, DOI 10.1073/pnas.53.2.418; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Carthew RW, 2002, CURR BIOL, V12, pR852, DOI 10.1016/S0960-9822(02)01352-0; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; FEIG S, 1993, J NEUROSCI, V13, P1010; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Frey J U, 2001, Results Probl Cell Differ, V34, P27; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KATZ JOSEPH J., 1950, COMPAR PSYCHOL MONOGR, V20, P1; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; Moccia R, 2003, J NEUROSCI, V23, P9409; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MORGAN IG, 1968, J NEUROCHEM, V15, P41, DOI 10.1111/j.1471-4159.1968.tb06172.x; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Carroll CM, 2004, NEUROPHARMACOLOGY, V47, P324, DOI 10.1016/j.neuropharm.2004.04.005; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Proud C, 2000, COLD SPRING HARBOR M, V39, P719; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sharma SK, 2003, J NEUROSCI, V23, P3899; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; STEWARD O, 1983, PROG BRAIN RES, V58, P131, DOI 10.1016/S0079-6123(08)60013-8; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stewart JJ, 2000, J CLIN PHARMACOL, V40, P347, DOI 10.1177/00912700022009044; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tiedge H, 1996, J NEUROSCI, V16, P7171; Torre ER, 1996, J NEUROSCI, V16, P5967; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WENZEL J, 1993, BRAIN RES, V619, P331, DOI 10.1016/0006-8993(93)91629-7; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	113	443	455	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					59	73		10.1016/j.neuron.2004.09.013	http://dx.doi.org/10.1016/j.neuron.2004.09.013			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450160	Bronze			2022-12-17	WOS:000224232600007
J	ADELMAN, JP; SHEN, KZ; KAVANAUGH, MP; WARREN, RA; WU, YN; LAGRUTTA, A; BOND, CT; NORTH, RA				ADELMAN, JP; SHEN, KZ; KAVANAUGH, MP; WARREN, RA; WU, YN; LAGRUTTA, A; BOND, CT; NORTH, RA			CALCIUM-ACTIVATED POTASSIUM CHANNELS EXPRESSED FROM CLONED COMPLEMENTARY DNAS	NEURON			English	Article							K+-CHANNEL; XENOPUS-OOCYTES; PROTEIN-KINASE; ION CHANNELS; RAT-BRAIN; SHAKER LOCUS; TEA BLOCKADE; DROSOPHILA; CURRENTS; NEURONS	Calcium-activated potassium channels were expressed in Xenopus oocytes by injection of RNA transcribed in vitro from complementary DNAs derived from the slo locus of Drosophila melanogaster. Many cDNAs were found that encode closely related proteins of about 1200 aa. The predicted sequences of these proteins differ by the substitution of blocks of amino acids at five identified positions within the putative intracellular region between residues 327 and 797. Excised inside-out membrane patches showed potassium channel openings only with micromolar calcium present at the cytoplasmic side; activity increased steeply both with depolarization and with increasing calcium concentration. The single-channel conductance was 126 pS with symmetrical potassium concentrations. The mean open time of the channels was clearly different for channels having different subsituent blocks of amino acids. The results suggest that alternative splicing gives rise to a large family of functionally diverse, calcium-activated potassium channels.			ADELMAN, JP (corresponding author), OREGON HLTH SCI UNIV, VOLLUM INST, PORTLAND, OR 97201 USA.		North, Richard/GQA-6156-2022					ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BLATZ AL, 1987, TRENDS NEUROSCI, V10, P463, DOI 10.1016/0166-2236(87)90101-9; BOND CT, 1991, MOL ENDOCRINOL, V5, P931, DOI 10.1210/mend-5-7-931; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; DASWSON RMC, 1969, DATA BIOCH RES; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; DURELL SR, 1992, IN PRESS BIOPHYS J; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Ewald D, 1987, NEUROMODULATION BIOC, P138; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; GHO M, 1986, PFLUG ARCH EUR J PHY, V407, P526, DOI 10.1007/BF00657511; GORMAN ALF, 1979, J PHYSIOL-LONDON, V296, P393, DOI 10.1113/jphysiol.1979.sp013012; GORMAN ALF, 1978, J PHYSIOL-LONDON, V275, P357, DOI 10.1113/jphysiol.1978.sp012194; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HAYLETT DG, 1990, POTASSIUM CHANNELS S, P70; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; JENKINSON DH, 1983, CELL CALCIUM, V4, P429, DOI 10.1016/0143-4160(83)90019-2; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KOMATSU A, 1990, NEURON, V4, P313, DOI 10.1016/0896-6273(90)90105-O; KRNJEVIC K, 1972, J PHYSIOL-LONDON, V225, P363, DOI 10.1113/jphysiol.1972.sp009945; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MARTY A, 1989, TRENDS NEUROSCI, V12, P420, DOI 10.1016/0166-2236(89)90090-8; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MARTY A, 1974, TRENDS NEUROSCI, V237, P256; MEECH RW, 1974, J PHYSIOL-LONDON, V237, P259, DOI 10.1113/jphysiol.1974.sp010481; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; REINHART PH, 1991, J NEUROSCI, V11, P1627; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SAITO M, 1991, J NEUROSCI, V11, P2135; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHEN KZ, 1992, J PHYSIOL-LONDON, V445, P581, DOI 10.1113/jphysiol.1992.sp018941; SINGH S, 1989, NEURON, V2, P1325, DOI 10.1016/0896-6273(89)90070-6; SMITH SJ, 1987, J PHYSIOL-LONDON, V382, P425, DOI 10.1113/jphysiol.1987.sp016376; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1984, J GEN PHYSIOL, V84, P157, DOI 10.1085/jgp.84.2.157; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	56	443	450	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1992	9	2					209	216		10.1016/0896-6273(92)90160-F	http://dx.doi.org/10.1016/0896-6273(92)90160-F			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497890				2022-12-17	WOS:A1992JJ33200003
J	Witten, IB; Steinberg, EE; Lee, SY; Davidson, TJ; Zalocusky, KA; Brodsky, M; Yizhar, O; Cho, SL; Gong, SC; Ramakrishnan, C; Stuber, GD; Tye, KM; Janak, PH; Deisseroth, K				Witten, Ilana B.; Steinberg, Elizabeth E.; Lee, Soo Yeun; Davidson, Thomas J.; Zalocusky, Kelly A.; Brodsky, Matthew; Yizhar, Ofer; Cho, Saemi L.; Gong, Shiaoching; Ramakrishnan, Charu; Stuber, Garret D.; Tye, Kay M.; Janak, Patricia H.; Deisseroth, Karl			Recombinase-Driver Rat Lines: Tools, Techniques, and Optogenetic Application to Dopamine-Mediated Reinforcement	NEURON			English	Article							VENTRAL TEGMENTAL AREA; INTRACRANIAL SELF-STIMULATION; POSITIVE REINFORCEMENT; NUCLEUS-ACCUMBENS; FOREBRAIN-BUNDLE; WORKING-MEMORY; NEURONS; REWARD; BRAIN; MODULATION	Currently there is no general approach for achieving specific optogenetic control of genetically defined cell types in rats, which provide a powerful experimental system for numerous established neurophysiological and behavioral paradigms. To overcome this challenge we have generated genetically restricted recombinase-driver rat lines suitable for driving gene expression in specific cell types, expressing Cre recombinase under the control of large genomic regulatory regions (200-300 kb). Multiple tyrosine hydroxylase (Th)::Cre and choline acetyltransferase (Chat)::Cre lines were produced that exhibited specific opsin expression in targeted cell types. We additionally developed methods for utilizing optogenetic tools in freely moving rats and leveraged these technologies to clarify the causal relationship between dopamine (DA) neuron firing and positive reinforcement, observing that optical stimulation of DA neurons in the ventral tegmental area (VTA) of Th::Cre rats is sufficient to support vigorous intracranial self-stimulation (ICSS). These studies complement existing targeting approaches by extending the generalizability of optogenetics to traditionally non-genetically-tractable but vital animal models.	[Witten, Ilana B.; Lee, Soo Yeun; Davidson, Thomas J.; Zalocusky, Kelly A.; Brodsky, Matthew; Yizhar, Ofer; Ramakrishnan, Charu; Tye, Kay M.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Witten, Ilana B.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Witten, Ilana B.] Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Steinberg, Elizabeth E.; Cho, Saemi L.; Janak, Patricia H.] UCSF, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Steinberg, Elizabeth E.; Janak, Patricia H.] UCSF, Grad Program Neurosci, San Francisco, CA 94158 USA; [Lee, Soo Yeun; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Brodsky, Matthew] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Yizhar, Ofer] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Gong, Shiaoching] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA; [Stuber, Garret D.] Univ N Carolina, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] HHMI, Stanford, CA 94305 USA; [Zalocusky, Kelly A.; Deisseroth, Karl] Stanford Univ, Grad Program Neurosci, Stanford, CA 94305 USA	Stanford University; Princeton University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Stanford University; University of Washington; University of Washington Seattle; Weizmann Institute of Science; Rockefeller University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Massachusetts Institute of Technology (MIT); Northwell Health; Stanford University; Howard Hughes Medical Institute; Stanford University	Witten, IB (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	iwitten@princeton.edu; pjanak@gallo.ucsf.edu; deissero@stanford.edu	Tye, Kay/J-6158-2013; Stuber, Garret/E-1160-2011; YIZHAR, OFER/AAV-8497-2021	Tye, Kay/0000-0002-2435-0182; Yizhar, Ofer/0000-0003-4228-1448; Stuber, Garret/0000-0003-1730-4855; Janak, Patricia/0000-0002-3333-9049; Ramakrishnan, Charu/0000-0002-3474-6332; Davidson, Thomas/0000-0003-0836-6333	Helen Hay Whitney Foundation; NSF; Berry postdoctoral fellowship; NRSA [F32 MH880102]; PILM (MIT); State of California for medical research on alcohol and substance abuse through UCSF; Keck, Snyder, Woo, Yu; McKnight Foundations,; CIRM; DARPA REPAIR; Gatsby Charitable Foundation; National Institute of Mental Health,; National Institute on Drug Abuse;  [P50 AA017072];  [R01 DA015096]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096, R01DA020794, DP2DA035149] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NSF(National Science Foundation (NSF)); Berry postdoctoral fellowship; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PILM (MIT); State of California for medical research on alcohol and substance abuse through UCSF; Keck, Snyder, Woo, Yu; McKnight Foundations,; CIRM(California Institute for Regenerative Medicine); DARPA REPAIR; Gatsby Charitable Foundation; National Institute of Mental Health,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank lnbal Goshen and Ramesh Ramakrishnan for advice and experimental assistance, as well as Stephan Lammel and Elyssa Margolis for advice on the in vitro VTA recordings. I.B.W. is supported by the Helen Hay Whitney Foundation; E.E.S and K.A.Z. are supported by an NSF Graduate Research Fellowship; T.J.D. is supported by a Berry postdoctoral fellowship; K.M.T is supported by NRSA fellowship F32 MH880102 and PILM (MIT). P.H.J. is supported by P50 AA017072 and R01 DA015096, and funds from the State of California for medical research on alcohol and substance abuse through UCSF. Full funding support for K.D. is listed at www.optogenetics. org/funding, and includes the Keck, Snyder, Woo, Yu, and McKnight Foundations, as well as CIRM, the DARPA REPAIR program, the Gatsby Charitable Foundation, the National Institute of Mental Health, and the National Institute on Drug Abuse.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Berke JD, 2009, J NEUROPHYSIOL, V101, P1575, DOI 10.1152/jn.91106.2008; BIELAJEW C, 1986, J NEUROSCI, V6, P919; BROBECK JR, 1963, SCIENCE, V140, P218, DOI 10.1126/science.140.3563.218; BUZSAKI G, 1989, J NEUROSCI METH, V28, P209, DOI 10.1016/0165-0270(89)90038-1; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chudasama Y, 2004, NEUROPSYCHOPHARMACOL, V29, P1628, DOI 10.1038/sj.npp.1300490; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; CORBETT D, 1980, BRAIN RES, V185, P1, DOI 10.1016/0006-8993(80)90666-6; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Filipiak WE, 2006, TRANSGENIC RES, V15, P673, DOI 10.1007/s11248-006-9002-x; FOURIEZOS G, 1976, BRAIN RES, V103, P377, DOI 10.1016/0006-8993(76)90809-X; GALLISTEL CR, 1985, J NEUROSCI, V5, P1246; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERMAN DC, 1974, BRAIN RES, V73, P381, DOI 10.1016/0006-8993(74)90666-0; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gutierrez R, 2010, J NEUROSCI, V30, P287, DOI 10.1523/JNEUROSCI.0855-09.2010; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; MOGENSON GJ, 1979, BRAIN RES, V171, P247, DOI 10.1016/0006-8993(79)90331-7; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Nathanson JL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.019.2009; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; OLDS ME, 1963, INT J NEUROPHARMACOL, V2, P309, DOI 10.1016/0028-3908(63)90007-8; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Owesson-White CA, 2008, P NATL ACAD SCI USA, V105, P11957, DOI 10.1073/pnas.0803896105; PEDERSEN CA, 1982, SCIENCE, V216, P648, DOI 10.1126/science.7071605; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Pontecorvo MJ, 1996, COGNITIVE BRAIN RES, V3, P205, DOI 10.1016/0926-6410(96)00007-9; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Wang YM, 1999, HUM GENE THER, V10, P1763, DOI 10.1089/10430349950017446; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011	61	442	452	0	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					721	733		10.1016/j.neuron.2011.10.028	http://dx.doi.org/10.1016/j.neuron.2011.10.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153370	Green Accepted, Bronze, Green Submitted			2022-12-17	WOS:000297971100008
J	Geiger, JRP; Jonas, P				Geiger, JRP; Jonas, P			Dynamic control of presynaptic ca2+inflow by fast-inactivating K+ channels in hippocampal mossy fiber boutons	NEURON			English	Article							LONG-TERM POTENTIATION; GATED POTASSIUM CHANNELS; VOLTAGE-CLAMP ANALYSIS; SQUID GIANT SYNAPSE; RAT HIPPOCAMPUS; NERVE-TERMINALS; TRANSMITTER RELEASE; EXCITATORY SYNAPSES; MAMMALIAN BRAIN; CALCIUM CURRENT	Analysis of presynaptic determinants of synaptic strength has been difficult at cortical synapses, mainly due to the lack of direct access to presynaptic elements. Here we report patch-clamp recordings from mossy fiber boutons (MFBs) in rat hippocampal slices. The presynaptic action potential is very short during low-frequency stimulation but is prolonged up to 3-fold during high-frequency stimulation. Voltage-gated K+ channels in MFBs inactivate rapidly but recover from inactivation very slowly, suggesting that cumulative K+ channel inactivation mediates activity-dependent spike broadening. Prolongation of the presynaptic voltage waveform leads to an increase in the number of Ca2+ ions entering the terminal per action potential and to a consecutive potentiation of evoked excitatory postsynaptic currents at MFB-CA3 pyramidal cell synapses. Thus, inactivation of presynaptic K+ channels contributes to the control of efficacy of a glutamatergic synapse in the cortex.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	jonasp@uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804				Acsady L, 1998, J NEUROSCI, V18, P3386; ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P531, DOI 10.1113/jphysiol.1979.sp012829; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; BROWN TH, 1983, J NEUROPHYSIOL, V50, P487, DOI 10.1152/jn.1983.50.2.487; Byrne JH, 1996, J NEUROSCI, V16, P425; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; Cooper EC, 1998, J NEUROSCI, V18, P965; DERRICK BE, 1994, P NATL ACAD SCI USA, V91, P10290, DOI 10.1073/pnas.91.22.10290; DRAIN P, 1994, NEURON, V12, P1097, DOI 10.1016/0896-6273(94)90317-4; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GRIFFITH WH, 1990, J NEUROPHYSIOL, V63, P491, DOI 10.1152/jn.1990.63.3.491; HOPKINS WF, 1984, SCIENCE, V226, P350, DOI 10.1126/science.6091272; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; JONAS P, 1989, P NATL ACAD SCI USA, V86, P7238, DOI 10.1073/pnas.86.18.7238; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Ma MH, 1996, J NEUROSCI, V16, P4089; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; QUATTROCKI EA, 1994, NEURON, V12, P73, DOI 10.1016/0896-6273(94)90153-8; REGEHR WG, 1991, NEURON, V7, P451, DOI 10.1016/0896-6273(91)90297-D; REGEHR WG, 1994, J NEUROSCI, V14, P523; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Simmons ML, 1996, MOL PHARMACOL, V50, P80; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Southan AP, 1998, J NEUROSCI, V18, P948; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; Spruston N, 1997, J COMP NEUROL, V385, P427; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; STEINHAUSER C, 1993, HIPPOCAMPUS, V3, P113; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; THORN PJ, 1991, J PHYSIOL-LONDON, V432, P313, DOI 10.1113/jphysiol.1991.sp018386; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Villacres EC, 1998, J NEUROSCI, V18, P3186; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WANG H, 1994, J NEUROSCI, V14, P4588; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wheeler DB, 1996, J NEUROSCI, V16, P2226; Wiebe SP, 1999, J NEUROSCI, V19, P10562; Yeckel MF, 1998, J NEUROSCI, V18, P438; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	59	442	447	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					927	939		10.1016/S0896-6273(00)00164-1	http://dx.doi.org/10.1016/S0896-6273(00)00164-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163277	Bronze			2022-12-17	WOS:000166057500027
J	Petersen, CCH				Petersen, Carl C. H.			The functional organization of the barrel cortex	NEURON			English	Review							RAT SOMATOSENSORY CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; LONG-TERM DEPRESSION; IN-VIVO; SENSORY RESPONSES; THALAMOCORTICAL SYNAPSES; PYRAMIDAL NEURONS; MOTOR CORTEX; DENDRITIC SPINES; CEREBRAL-CORTEX	The tactile somatosensory pathway from whisker to cortex in rodents provides a well-defined system for exploring the link between molecular mechanisms, synaptic circuits, and behavior. The primary somatosensory cortex has an exquisite somatotopic map where each individual whisker is represented in a discrete anatomical unit, the "barrel," allowing precise delineation of functional organization, development, and plasticity. Sensory information is actively acquired in awake behaving rodents and processed differently within the barrel map depending upon whisker-related behavior. The prominence of state-dependent cortical sensory processing is likely to be crucial in our understanding of active sensory perception, experience-dependent plasticity and learning.	Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Sensory Proc, SV BMI LSENS, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Sensory Proc, SV BMI LSENS, Stn 15, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495				Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; ANDERMANN ML, 2006, PLOS BIOL, V3, pE17, DOI DOI 10.1371/JOURNAL.PBIO.0030017; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Aronoff R, 2006, J CELL MOL MED, V10, P333, DOI 10.1111/j.1582-4934.2006.tb00403.x; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Borgdorff AJ, 2007, J NEUROPHYSIOL, V97, P2992, DOI 10.1152/jn.00013.2007; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2003, J NEUROSCI, V23, P9565; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Chakraibarti S, 2006, J COMP NEUROL, V498, P624, DOI 10.1002/cne.21052; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cramer NP, 2007, J NEUROPHYSIOL, V97, P2148, DOI 10.1152/jn.01187.2006; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Erchova IA, 2004, J NEUROSCI, V24, P5931, DOI 10.1523/JNEUROSCI.1202-04.2004; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Furuta T, 2006, J NEUROSCI, V26, P10548, DOI 10.1523/JNEUROSCI.1746-06.2006; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Hentschke H, 2006, CEREB CORTEX, V16, P1142, DOI 10.1093/cercor/bhj056; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Higley MJ, 2003, J NEUROSCI, V23, P10190; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kim U, 1999, J COMP NEUROL, V408, P489; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Laaris N, 2002, J NEUROPHYSIOL, V87, P1028, DOI 10.1152/jn.00512.2001; Land PW, 2005, J COMP NEUROL, V490, P414, DOI 10.1002/cne.20677; Lavallee P, 2005, J NEUROSCI, V25, P7489, DOI 10.1523/JNEUROSCI.2301-05.2005; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Leiser SC, 2007, NEURON, V53, P117, DOI 10.1016/j.neuron.2006.10.036; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Molnar ZN, 2002, J NEUROSCI, V22, P10313; Moore CI, 2004, J NEUROPHYSIOL, V91, P2390, DOI 10.1152/jn.00925.2003; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Neimark MA, 2003, J NEUROSCI, V23, P6499; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pierret T, 2000, J NEUROSCI, V20, P7455; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Reyes A, 1999, J NEUROSCI, V19, P3827; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Schubert D, 2003, J NEUROSCI, V23, P2961; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Siucinska E, 2004, NEUROSCIENCE, V127, P961, DOI 10.1016/j.neuroscience.2004.06.004; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Timofeeva E, 2003, J NEUROSCI, V23, P10717; Trageser JC, 2006, J NEUROPHYSIOL, V96, P1456, DOI 10.1152/jn.00423.2006; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Veinante P, 1999, J NEUROSCI, V19, P5085; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WELKER E, 1988, EXP BRAIN RES, V73, P411, DOI 10.1007/BF00248234; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; WHITE EL, 1977, J COMP NEUROL, V175, P455, DOI 10.1002/cne.901750405; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	128	441	456	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 25	2007	56	2					339	355		10.1016/j.neuron.2007.09.017	http://dx.doi.org/10.1016/j.neuron.2007.09.017			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	228PA	17964250	Bronze			2022-12-17	WOS:000250740700011
J	Nishimune, A; Isaac, JTR; Molnar, E; Noel, J; Nash, SR; Tagaya, M; Collingridge, GL; Nakanishi, S; Henley, JM				Nishimune, A; Isaac, JTR; Molnar, E; Noel, J; Nash, SR; Tagaya, M; Collingridge, GL; Nakanishi, S; Henley, JM			NSF binding to GluR2 regulates synaptic transmission	NEURON			English	Article							SENSITIVE FUSION PROTEIN; LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; NMDA RECEPTOR SUBUNITS; MEMBRANE-FUSION; POSTSYNAPTIC DENSITY; GUANYLATE KINASES; SILENT SYNAPSES; AMPA; EXPRESSION	Here, we show that N-ethylmaleimide-sensitive fusion protein (NSF) interacts directly and selectively with the intracellular C-terminal domain of the GluR2 subunit of AMPA receptors. The interaction requires all three domains of, NSF but occurs between residues Lys-844 and Gln-853 of rat GluR2, with Asn-851 playing a critical role. Loading of decapeptides corresponding to the NSF-binding domain of GluR2 into rat hippocampal CA1 pyramidal neurons results in a marked, progressive decrement of AMPA receptor-mediated synaptic transmission. This reduction in synaptic transmission was also observed when an anti-NSF monoclonal antibody (mAb) was loaded into CA1 neurons. These results demonstrate a previously unsuspected direct interaction in the postsynaptic neuron between two major proteins involved in synaptic transmission and suggest a rapid NSF-dependent modulation of AMPA receptor function.	Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 606, Japan; Univ Bristol, Sch Med, Dept Anat, Bristol BS8 1TD, Avon, England; Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan	Kyoto University; University of Bristol; Tokyo University of Pharmacy & Life Sciences	Henley, JM (corresponding author), Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 606, Japan.		collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Molnár, Elek/D-1427-2019; Henley, Jeremy M/A-2776-2009	Collingridge, Graham L/0000-0002-9572-5359; Molnár, Elek/0000-0002-3525-4671; Henley, Jeremy/0000-0003-3589-8335	MRC [G9629038] Funding Source: UKRI; Medical Research Council [G9629038] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONG RM, 1994, FEBS LETT, V350, P253, DOI 10.1016/0014-5793(94)00778-0; Hu BR, 1998, J NEUROSCI, V18, P625; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Mammen AL, 1997, J NEUROSCI, V17, P7351; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Miller J.H., 1972, EXPT MOL GENETICS; Niethammer M, 1996, J NEUROSCI, V16, P2157; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PUSCHEL AW, 1994, FEBS LETT, V347, P55, DOI 10.1016/0014-5793(94)00505-2; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RAMAN IM, 1994, J NEUROSCI, V14, P4998; Richmond SA, 1996, NEUROSCIENCE, V75, P69, DOI 10.1016/0306-4522(96)00217-5; ROTHMAN JE, 1994, ADV SEC MESS PHOSPH, V29, P81; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WALSH MJ, 1992, J NEUROCHEM, V59, P667, DOI 10.1111/j.1471-4159.1992.tb09421.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945	46	441	457	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					87	97		10.1016/S0896-6273(00)80517-6	http://dx.doi.org/10.1016/S0896-6273(00)80517-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697854	Green Submitted, Bronze			2022-12-17	WOS:000075061900009
J	Abud, EM; Ramirez, RN; Martinez, ES; Healy, LM; Nguyen, CHH; Newman, SA; Yeromin, AV; Scarfone, VM; Marsh, SE; Fimbres, C; Caraway, CA; Fote, GM; Madany, AM; Agrawal, A; Kayed, R; Gylys, KH; Cahalan, MD; Cummings, BJ; Antel, JP; Mortazavi, A; Carson, MJ; Poon, WW; Blurton-Jones, M				Abud, Edsel M.; Ramirez, Ricardo N.; Martinez, Eric S.; Healy, Luke M.; Nguyen, Cecilia H. H.; Newman, Sean A.; Yeromin, Andriy V.; Scarfone, Vanessa M.; Marsh, Samuel E.; Fimbres, Cristhian; Caraway, Chad A.; Fote, Gianna M.; Madany, Abdullah M.; Agrawal, Anshu; Kayed, Rakez; Gylys, Karen H.; Cahalan, Michael D.; Cummings, Brian J.; Antel, Jack P.; Mortazavi, Ali; Carson, Monica J.; Poon, Wayne W.; Blurton-Jones, Mathew			iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; AMYLOID-BETA; BRAIN-DEVELOPMENT; LANGERHANS CELLS; TRANSGENIC MICE; CEREBRAL-CORTEX; INNATE IMMUNITY; MYELOID CELLS	Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of Ab fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease.	[Abud, Edsel M.; Martinez, Eric S.; Nguyen, Cecilia H. H.; Fote, Gianna M.; Blurton-Jones, Mathew] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Abud, Edsel M.; Martinez, Eric S.; Nguyen, Cecilia H. H.; Yeromin, Andriy V.; Fote, Gianna M.; Blurton-Jones, Mathew] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Abud, Edsel M.; Martinez, Eric S.; Nguyen, Cecilia H. H.; Fimbres, Cristhian; Caraway, Chad A.; Fote, Gianna M.; Kayed, Rakez; Blurton-Jones, Mathew] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Ramirez, Ricardo N.; Blurton-Jones, Mathew] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Gylys, Karen H.; Carson, Monica J.; Poon, Wayne W.; Blurton-Jones, Mathew] Montreal Neurol Hosp & Inst, McGill Univ, Dept Neurol & Neurosurg, Neuroimmunol Unit, Montreal, PQ, Canada; [Fimbres, Cristhian; Caraway, Chad A.; Agrawal, Anshu; Cummings, Brian J.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Nguyen, Cecilia H. H.; Fimbres, Cristhian; Agrawal, Anshu; Cummings, Brian J.] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92697 USA; [Cummings, Brian J.; Antel, Jack P.; Poon, Wayne W.] Univ Texas Med Branch, Dept Neurol, George P & Cynthia Woods Mitchell Ctr Neurodegene, Galveston, TX 77555 USA; [Mortazavi, Ali] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90095 USA; [Cummings, Brian J.] Univ Calif Irvine, Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; McGill University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Los Angeles; University of California System; University of California Irvine	Blurton-Jones, M (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.; Blurton-Jones, M (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA.; Blurton-Jones, M (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA.; Blurton-Jones, M (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.; Poon, WW; Blurton-Jones, M (corresponding author), Montreal Neurol Hosp & Inst, McGill Univ, Dept Neurol & Neurosurg, Neuroimmunol Unit, Montreal, PQ, Canada.	wpoon@uci.edu; mblurton@uci.edu	Cummings, Brian J/C-9180-2012; Healy, Luke/Y-5604-2019; Agrawal, Anshu/AAU-6341-2021	Cummings, Brian J/0000-0003-3628-5290; Healy, Luke/0000-0001-9496-2216; Poon, Wayne/0000-0003-0625-3968; Marsh, Samuel/0000-0002-3012-6945; antel, jack/0000-0002-5148-0636; Blurton-Jones, Mathew/0000-0002-7770-7157; Scarfone, Vanessa/0000-0001-8786-4191	NIH [AG048099, AG016573, AG054025]; CIRM [RT3-07893]; Alzheimer's Association [BFG-14-317000]; Stem Cell Research Center SEED grant; UC Irvine MSTP NIH [T32-GM008620]; Burden Fellowship; NCRR; NCATS [UL1 TR001414]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG054025, RF1AG048099, P50AG016573, R56AG027465, P01AG000538, P50AG005142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Alzheimer's Association(Alzheimer's Association); Stem Cell Research Center SEED grant; UC Irvine MSTP NIH; Burden Fellowship; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH AG048099 (M.B.-J.), AG016573 (M.B.-J. and W.W.P.), AG054025 (R.K.), CIRM RT3-07893 (M.B.-J.), Alzheimer's Association BFG-14-317000 (M.B.-J.), a Stem Cell Research Center SEED grant for BORGs (B.J.C.), UC Irvine MSTP NIH T32-GM008620 (E.M.A. and G.M.F.), a Burden Fellowship (A.M.M.), and a generous gift from the Susan Scott Foundation (M.B.-J.). iPSC lines were generated by the UCI-ADRC iPS cell core funded by NIH AG016573. We thank the UCI High-Throughput Genomics Core, the Institute for Immunology, and Dr. Jennifer Atwood and Dr. Melanie Oakes. Blood donor program was supported by the NCRR and the NCATS through Grant UL1 TR001414. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abbas N, 2002, J NEUROIMMUNOL, V126, P50, DOI 10.1016/S0165-5728(02)00050-4; Abutbul S, 2012, GLIA, V60, P1160, DOI 10.1002/glia.22343; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Baron R, 2014, AGING CELL, V13, P584, DOI 10.1111/acel.12210; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Biber K, 2016, NAT REV DRUG DISCOV, V15, P110, DOI 10.1038/nrd.2015.14; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; Blumdegen D, 2014, NAT NEUROSCI, V17, P131; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durafourt Bryce A, 2013, Methods Mol Biol, V1041, P199, DOI 10.1007/978-1-62703-520-0_19; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fu YH, 2016, J ALZHEIMERS DIS, V54, P569, DOI 10.3233/JAD-160456; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Greer PL, 2016, CELL, V165, P1734, DOI 10.1016/j.cell.2016.05.001; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guillot-Sestier MV, 2013, CNS NEUROL DISORD-DR, V12, P593; Gylys KH, 2000, J NEUROSCI RES, V61, P186, DOI 10.1002/1097-4547(20000715)61:2<186::AID-JNR9>3.0.CO;2-X; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Karch CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148717; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linnartz-Gerlach B, 2014, NEUROSCIENCE, V275, P113, DOI 10.1016/j.neuroscience.2014.05.061; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Marsh SE, 2016, P NATL ACAD SCI USA, V113, pE1316, DOI 10.1073/pnas.1525466113; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Moore CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000080; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Rezaie P, 1999, MICROSC RES TECHNIQ, V45, P359, DOI 10.1002/(SICI)1097-0029(19990615)45:6<359::AID-JEMT4>3.3.CO;2-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rustenhoven J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19371; Schilling T, 2001, EUR J NEUROSCI, V14, P463, DOI 10.1046/j.0953-816x.2001.01661.x; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shulman JM, 2014, HUM MOL GENET, V23, P870, DOI 10.1093/hmg/ddt478; Sirkis DW, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0367-7; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	78	440	450	9	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2017	94	2					278	+		10.1016/j.neuron.2017.03.042	http://dx.doi.org/10.1016/j.neuron.2017.03.042			25	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ES3TF	28426964	Green Accepted, Bronze, Green Submitted			2022-12-17	WOS:000399451400012
J	Catterall, WA; Few, AP				Catterall, William A.; Few, Alexandra P.			Calcium channel regulation and presynaptic plasticity	NEURON			English	Review							FAMILIAL HEMIPLEGIC MIGRAINE; PROTEIN-INTERACTION SITE; SQUID GIANT SYNAPSE; G-BETA-GAMMA; CULTURED HIPPOCAMPAL-NEURONS; FROG NEUROMUSCULAR-JUNCTION; READILY RELEASABLE POOL; EPISODIC ATAXIA TYPE-2; VISININ-LIKE PROTEIN-2; SHORT-TERM PLASTICITY	Voltage-gated calcium (Ca2+) channels initiate release of neurotransmitters at synapses, and regulation of presynaptic Ca2+ channels has a powerful influence on synaptic strength. Presynaptic Ca2+ channels form a large signaling complex, which targets synaptic vesicles to Ca2+ channels for efficient release and mediates Ca2+ channel regulation. Presynaptic plasticity regulates synaptic function on the timescale of milliseconds to minutes in response to neurotransmitters and the frequency of action potentials. This article reviews the regulation of presynaptic Ca2+ channels by effectors and regulators of Ca2+ signaling and describes the emerging evidence for a critical role of Ca2+ channel regulation in control of neurotransmission and in presynaptic plasticity. Failure of function and regulation of presynaptic Ca2+ channels leads to migraine, ataxia, and potentially other forms of neurological disease. We propose that presynaptic Ca2+ channels serve as the regulatory node in a dynamic, multilayered signaling network that exerts short-term control of neurotransmission in response to synaptic activity.	[Catterall, William A.; Few, Alexandra P.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu						Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Altier C, 2007, J NEUROSCI, V27, P6363, DOI 10.1523/JNEUROSCI.0307-07.2007; Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bezprozvanny I, 2000, P NATL ACAD SCI USA, V97, P13943, DOI 10.1073/pnas.220389697; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Brager DH, 2003, NAT NEUROSCI, V6, P551, DOI 10.1038/nn1067; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Cao YQ, 2005, P NATL ACAD SCI USA, V102, P2590, DOI 10.1073/pnas.0409896102; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; Chaudhuri D, 2005, J NEUROSCI, V25, P8282, DOI 10.1523/JNEUROSCI.2253-05.2005; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; COHEN MW, 1991, J NEUROSCI, V11, P1032; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DICKINSONNELSON A, 1983, J NEUROSCI, V3, P42; Dittman JS, 2000, J NEUROSCI, V20, P1374; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Eungdamrong NJ, 2004, BIOL CELL, V96, P355, DOI 10.1016/j.biolcel.2004.03.004; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Furukawa T, 1998, J BIOL CHEM, V273, P17585, DOI 10.1074/jbc.273.28.17585; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Guida S, 2001, AM J HUM GENET, V68, P759, DOI 10.1086/318804; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Habets RLP, 2006, J NEUROPHYSIOL, V96, P2868, DOI 10.1152/jn.00427.2006; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Hans M, 1999, J NEUROSCI, V19, P1610; Harkins AB, 2004, P NATL ACAD SCI USA, V101, P15219, DOI 10.1073/pnas.0401001101; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HOCHNER B, 1991, NEUROSCI LETT, V125, P215, DOI 10.1016/0304-3940(91)90032-O; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; HUBBARD JI, 1963, J PHYSIOL-LONDON, V169, P641, DOI 10.1113/jphysiol.1963.sp007286; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Inchauspe CG, 2007, J PHYSIOL-LONDON, V584, P835, DOI 10.1113/jphysiol.2007.139683; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Ishikawa T, 2005, J PHYSIOL-LONDON, V568, P199, DOI 10.1113/jphysiol.2005.089912; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jarvis SE, 2005, CELL CALCIUM, V37, P483, DOI 10.1016/j.ceca.2005.01.017; Jarvis SE, 2001, J NEUROSCI, V21, P2939, DOI 10.1523/JNEUROSCI.21-09-02939.2001; Jeng CJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1209, DOI 10.1152/ajpcell.00247.2005; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; KATZ B, 1970, J PHYSIOL-LONDON, V207, P789, DOI 10.1113/jphysiol.1970.sp009095; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Keith RK, 2007, J NEUROSCI, V27, P265, DOI 10.1523/JNEUROSCI.4213-06.2007; KENNEDY MB, 1990, COLD SH Q B, V55, P101; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Korogod N, 2007, P NATL ACAD SCI USA, V104, P15923, DOI 10.1073/pnas.0704603104; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; Kreitzer AC, 2000, J NEUROSCI, V20, P1348; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Lee A, 2000, BIOPHYS J, V78, p265A; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; Li B, 2004, MOL PHARMACOL, V66, P761; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lin YQ, 1998, J AUTONOM NERV SYST, V73, P26, DOI 10.1016/S0165-1838(98)00108-8; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Lu FM, 2006, P NATL ACAD SCI USA, V103, P4264, DOI 10.1073/pnas.0508162103; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; Maximov A, 2002, J NEUROSCI, V22, P6939; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; MILJANICH GP, 1995, ANNU REV PHARMACOL, V35, P707, DOI 10.1146/annurev.pa.35.040195.003423; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Muller M, 2007, J NEUROSCI, V27, P2261, DOI 10.1523/JNEUROSCI.5582-06.2007; Nakamura T, 2008, J PHYSIOL-LONDON, V586, P2253, DOI 10.1113/jphysiol.2007.142521; Narita K, 2000, J GEN PHYSIOL, V115, P519, DOI 10.1085/jgp.115.4.519; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Park HY, 2008, P NATL ACAD SCI USA, V105, P542, DOI 10.1073/pnas.0710810105; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Piedras-Renteria ES, 2001, J NEUROSCI, V21, P9185, DOI 10.1523/JNEUROSCI.21-23-09185.2001; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; RAHAMIMOFF R, 1973, J PHYSIOL-LONDON, V228, P241, DOI 10.1113/jphysiol.1973.sp010084; Raike RS, 2007, MOL CELL NEUROSCI, V34, P168, DOI 10.1016/j.mcn.2006.10.011; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; REGEHR WG, 1994, J NEUROSCI, V14, P523; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Rettig J, 1997, J NEUROSCI, V17, P6647; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Stanley EF, 1997, NATURE, V385, P340, DOI 10.1038/385340a0; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Striessnig J, 2006, BIOCHEM SOC T, V34, P903, DOI 10.1042/BST0340903; Strock J, 2004, MOL PHARMACOL, V66, P1071, DOI 10.1124/mol.104.002261; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sullivan JM, 2007, J NEUROPHYSIOL, V97, P948, DOI 10.1152/jn.00554.2006; Szabo Z, 2006, EUR J NEUROSCI, V24, P709, DOI 10.1111/j.1460-9568.2006.04947.x; Takago H, 2005, P NATL ACAD SCI USA, V102, P7368, DOI 10.1073/pnas.0408514102; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; VANDERKLOOT W, 1993, J NEUROPHYSIOL, V69, P717, DOI 10.1152/jn.1993.69.3.717; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xie M, 2007, J CELL BIOL, V178, P489, DOI 10.1083/jcb.200702072; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yokoyama CT, 2005, MOL CELL NEUROSCI, V28, P1, DOI 10.1016/j.mcn.2004.08.019; Yokoyama CT, 1997, J NEUROSCI, V17, P6929; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	197	440	449	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2008	59	6					882	901		10.1016/j.neuron.2008.09.005	http://dx.doi.org/10.1016/j.neuron.2008.09.005			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	356SK	18817729	Bronze			2022-12-17	WOS:000259797700007
J	Alcamo, EA; Chirivella, L; Dautzenberg, M; Dobreva, G; Farinas, I; Grosschedl, R; McConnell, SK				Alcamo, Elizabeth A.; Chirivella, Laura; Dautzenberg, Marcel; Dobreva, Gergana; Farinas, Isabel; Grosschedl, Rudolf; McConnell, Susan K.			Satb2 regulates callosal projection neuron identity in the developing cerebral cortex	NEURON			English	Article							CORTICOSTRIATAL NEURONS; DENDRITIC MORPHOLOGY; PYRAMIDAL NEURONS; CORPUS-CALLOSUM; BINDING PROTEIN; MOUSE; RAT; CHROMATIN; CELL; SPECIFICATION	Satb2 is a DNA-binding protein that regulates chromatin organization and gene expression. In the developing brain, Satb2 is expressed in cortical neurons that extend axons across the corpus callosum. To assess the role of Satb2 in neurons, we analyzed mice in which the Satb2 locus was disrupted by insertion of a LacZ gene. In mutant mice, beta-galactosidase-labeled axons are absent from the corpus callosum and instead descend along the corticospinal tract. Stab2 mutant neurons acquire expression of Ctip2, a transcription factor that is necessary and sufficient for the extension of subcortical projections by cortical neurons. Conversely, ectopic expression of Satb2 in neural stem cells markedly decreases Ctip2 expression. Finally, we find that Satb2 binds directly to regulatory regions of Ctip2 and induces changes in chromatin structure. These data suggest that Satb2 functions as a repressor of Ctip2 and regulatory determinant of corticocortical connections in the developing cerebral cortex.	[Dautzenberg, Marcel; Dobreva, Gergana; Grosschedl, Rudolf] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Alcamo, Elizabeth A.; McConnell, Susan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Chirivella, Laura; Farinas, Isabel] Univ Valencia, Dept Biol Celular, Burjassot 46100, Spain; [Chirivella, Laura; Farinas, Isabel] Univ Valencia, Unidad Mixta CIPF UVEG, Burjassot 46100, Spain	Max Planck Society; Stanford University; University of Valencia; Prince Felipe Research Center; University of Valencia	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol, D-79108 Freiburg, Germany.	grosschedl@immunbio.mpg.de; suemcc@stanford.edu	Chirivella, Laura/L-5932-2017; Farinas, Isabel/L-7118-2014	Chirivella, Laura/0000-0002-3637-5168; Dobreva, Gergana/0000-0002-4814-9416; Farinas, Isabel/0000-0003-2903-4960	NEI NIH HHS [EY08411] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008411] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ashwell KWS, 1997, INT J DEV NEUROSCI, V15, P883, DOI 10.1016/S0736-5748(97)00036-1; AULADELL C, 1995, NEUROSCIENCE, V64, P1091, DOI 10.1016/0306-4522(94)00393-J; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Brown LL, 1998, J COMP NEUROL, V392, P468; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Canty AJ, 2006, P NATL ACAD SCI USA, V103, P15629, DOI 10.1073/pnas.0607350103; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; ENCODE, 2007, NATURE, V447, P799; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Finger JH, 2002, J NEUROSCI, V22, P10346; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Fujimori KE, 2000, J COMP NEUROL, V417, P275, DOI 10.1002/(SICI)1096-9861(20000214)417:3<275::AID-CNE2>3.0.CO;2-7; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; KOESTER SE, 1994, PROG BRAIN RES, V102, P207; KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mintz CD, 2003, J COMP NEUROL, V464, P438, DOI 10.1002/cne.10809; Mitchell BD, 2005, J COMP NEUROL, V482, P17, DOI 10.1002/cne.20428; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Namciu SJ, 2004, MAMM GENOME, V15, P162, DOI 10.1007/s00335-003-2311-y; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411; Ozaki HS, 1998, J COMP NEUROL, V400, P197, DOI 10.1002/(SICI)1096-9861(19981019)400:2<197::AID-CNE3>3.0.CO;2-4; Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; ROUILLER EM, 1991, HEARING RES, V56, P179, DOI 10.1016/0378-5955(91)90168-9; Shu TZ, 2003, DEVELOPMENT, V130, P2929, DOI 10.1242/dev.00514; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; STEFANKO S Z, 1980, Patologia Polska, V31, P263; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075	58	440	449	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					364	377		10.1016/j.neuron.2007.12.012	http://dx.doi.org/10.1016/j.neuron.2007.12.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255030	Bronze			2022-12-17	WOS:000253075300007
J	Poirazi, P; Brannon, T; Mel, BW				Poirazi, P; Brannon, T; Mel, BW			Pyramidal neuron as two-layer neural network	NEURON			English	Article							BINOCULAR DISPARITY; VISUAL-CORTEX; DENDRITES; CELLS; PERCEPTION; MODELS	The pyramidal neuron is the principal cell type in the mammalian forebrain, but its function remains poorly understood. Using a detailed compartmental model of a hippocampal CA1 pyramidal cell, we recorded responses to complex stimuli consisting of dozens of high-frequency activated synapses distributed throughout the apical dendrites. We found the cell's firing rate could be predicted by a simple formula that maps the physical components of the cell onto those of an abstract two-layer "neural network." In the first layer, synaptic inputs drive independent sigmoidal subunits corresponding to the cell's several dozen long, thin terminal dendrites. The subunit outputs are then summed within the main trunk and cell body prior to final thresholding. We conclude that insofar as the neural code is mediated by average firing rate, a two-layer neural network may provide a useful abstraction for the computing function of the individual pyramidal neuron.	FORTH, Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Greece; Metaperl IT Consulting, Staten Isl, NY 10301 USA; Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA	Foundation for Research & Technology - Hellas (FORTH); University of Southern California; University of Southern California	Poirazi, P (corresponding author), FORTH, Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, POB 1527, GR-71110 Iraklion, Greece.			Poirazi, Panayiota/0000-0001-6152-595X				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; CAULLER LJ, 1993, SINGLE NEURON COMPUT, P199; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; LLINAS R., 1971, J NEUROPHYSIOL, V34, P534; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MEL BW, 1992, ADV NEUR IN, V4, P35; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Mel BW, 1998, J NEUROSCI, V18, P4325; MEL BW, 1999, WHY DENDRITES COMPUT, P271; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; PETERHANS E, 1989, J NEUROSCI, V9, P1749; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Rosenblatt F., 1961, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rumelhart D. E., 1986, PARALLEL DISTRIBUTED, V1, P45, DOI [DOI 10.1016/B978-1-4832-1446-7.50010-8, 10.1016/B978-1-4832-1446-7.50010-8]; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHEPHERD GM, 1987, NEUROSCIENCE, V21, P151, DOI 10.1016/0306-4522(87)90329-0; STUAT G, 1999, DENDRITES; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	36	440	445	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 27	2003	37	6					989	999		10.1016/S0896-6273(03)00149-1	http://dx.doi.org/10.1016/S0896-6273(03)00149-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670427	Bronze			2022-12-17	WOS:000181899600012
J	Zhou, Q; Choi, G; Anderson, DJ				Zhou, Q; Choi, G; Anderson, DJ			The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2	NEURON			English	Article							SPINAL-CORD OLIGODENDROCYTES; PROGENITOR-CELL IDENTITY; MAMMALIAN NEURAL CREST; PRIMARY NEUROGENESIS; NERVOUS-SYSTEM; NEURONAL FATE; IN-VIVO; LINEAGE; SPECIFICATION; TUBE	Olig2, a basic helix-loop-helix (bHLH) transcription factor, is expressed in a restricted domain of the spinal cord ventricular zone that sequentially generates motoneurons and oligodendrocytes. Just prior to oligodendrocyte precursor formation, the domains of Olig2 and Nkx2.2 expression switch from being mutually exclusive to overlapping, and Neurogenins1 and 2 are extinguished within this region. Coexpression of Olig2 with Nkx2.2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation. Both proteins function as transcriptional repressors in this assay. This effect is blocked by forced expression of Neurogenin1. By contrast, misexpression of Olig2 alone derepresses Neurogenins and promotes motoneuron differentiation. Olig2 therefore functions sequentially in motoneuron and oligodendrocyte, fate specification. This dual action is enabled by spatio-temporal changes in the expression domains of other transcription factors with which Olig2 functionally interacts.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, 1201 E Calif Blvd, Pasadena, CA 91125 USA.	mancusog@caltech.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Zhou, Qiao/0000-0002-0099-3909	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS23476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Desai AR, 2000, DEVELOPMENT, V127, P2863; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Hall A, 1996, DEVELOPMENT, V122, P4085; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; ONO K, 1995, DEVELOPMENT, V121, P1743; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PHILIPPE E, 1986, DEV BRAIN RES, V27, P275, DOI 10.1016/0165-3806(86)90255-5; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Soula C, 2001, DEVELOPMENT, V128, P1369; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Villegas EMP, 1999, DEV BIOL, V216, P98, DOI 10.1006/dbio.1999.9438; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; Wettstein DA, 1997, DEVELOPMENT, V124, P693; White PM, 1999, DEVELOPMENT, V126, P4351; Xu XH, 2000, MOL CELL NEUROSCI, V16, P740, DOI 10.1006/mcne.2000.0916; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	49	440	457	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					791	807		10.1016/S0896-6273(01)00414-7	http://dx.doi.org/10.1016/S0896-6273(01)00414-7			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567617	Bronze			2022-12-17	WOS:000171013300012
J	Cai, DM; Shen, YJ; De Bellard, M; Tang, S; Filbin, MT				Cai, DM; Shen, YJ; De Bellard, M; Tang, S; Filbin, MT			Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC SPINAL-CORD; RAT-BRAIN; NEURITE OUTGROWTH; WHITE-MATTER; GROWTH CONES; PC12 CELLS; GLYCOPROTEIN; NEURONS; ELONGATION	MAG is a potent inhibitor of axonal regeneration. Here, inhibition by MAG, and myelin in general, is blocked if neurons are exposed to neurotrophins before encountering the inhibitor; priming cerebellar neurons with BDNF or GDNF, but not NGF, or priming DRG neurons with any of these neurotrophins blocks inhibition by MAG/myelin. Dibutyryl cAMP also overcomes inhibition by MAG/myelin, and cAMP is elevated by neurotrophins. A PKA inhibitor present during priming abrogates the block of inhibition. Finally, if neurons are exposed to MAG/myelin and neurotrophins simultaneously, but with the G(i) protein inhibitor, inhibition is blocked. We suggest that priming neurons with particular neurotrophins elevates cAMP and activates PKA, which blocks subsequent inhibition of regeneration and that priming is required because MAG/myelin activates a G(i) protein, which blocks increases in cAMP. This is important for encouraging axons to regrow in vivo.	CUNY Hunter Coll, Dept Biol, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol, New York, NY 10021 USA.		de Bellard, Maria Elena/D-5312-2009; de Bellard, Maria Elena/M-6510-2019	de Bellard, Maria Elena/0000-0001-9881-0447; de Bellard, Maria Elena/0000-0001-9881-0447; Cai, Dongming/0000-0002-0601-6826	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037060, R01NS037060] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 37060] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; BATES CA, 1993, EXP NEUROL, V123, P106, DOI 10.1006/exnr.1993.1144; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; BREGMAN BS, 1998, FRONTIERS NEURAL DEV; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CRUTCHER KA, 1989, EXP NEUROL, V104, P39, DOI 10.1016/0014-4886(89)90007-1; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; Filbin MT, 1996, MOL CELL NEUROSCI, V8, P84, DOI 10.1006/mcne.1996.0047; FILBIN MT, 1995, CURR OPIN NEUROBIOL, V5, P588, DOI 10.1016/0959-4388(95)80063-8; Grill R, 1997, J NEUROSCI, V17, P5560; HASAN SJ, 1993, J NEUROSCI, V13, P492; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Jelsma Tony N., 1994, Current Opinion in Neurobiology, V4, P717, DOI 10.1016/0959-4388(94)90015-9; JOHNSON AR, 1993, BIOESSAYS, V15, P807, DOI 10.1002/bies.950151206; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; Katoh H, 1996, J BIOL CHEM, V271, P29780, DOI 10.1074/jbc.271.47.29780; KEIRSTEAD HS, 1992, P NATL ACAD SCI USA, V89, P11664, DOI 10.1073/pnas.89.24.11664; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Keynes Roger J., 1995, Current Opinion in Neurobiology, V5, P75, DOI 10.1016/0959-4388(95)80090-5; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; KNIPPER M, 1993, FEBS LETT, V324, P147, DOI 10.1016/0014-5793(93)81382-A; KNIPPER M, 1993, NEUROREPORT, V4, P483, DOI 10.1097/00001756-199305000-00005; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.0.CO;2-K; LI Y, 1993, BRAIN RES, V629, P115, DOI 10.1016/0006-8993(93)90489-A; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 1997, J NEUROSCI, V17, P7860; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Post GR, 1996, FASEB J, V10, P741, DOI 10.1096/fasebj.10.7.8635691; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SCHWEGLER G, 1995, J NEUROSCI, V15, P2756; Shen YJ, 1998, MOL CELL NEUROSCI, V12, P79, DOI 10.1006/mcne.1998.0700; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Tigyi G, 1996, J NEUROCHEM, V66, P537; Turnley AM, 1998, NEUROREPORT, V9, P1987, DOI 10.1097/00001756-199806220-00013; Tuttle R, 1998, MOL CELL NEUROSCI, V11, P1, DOI 10.1006/mcne.1998.0671; Wang Q, 1998, J NEUROSCI, V18, P4973	58	440	477	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					89	101		10.1016/S0896-6273(00)80681-9	http://dx.doi.org/10.1016/S0896-6273(00)80681-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027292	Bronze			2022-12-17	WOS:000078410300015
J	Cirelli, C; Gutierrez, CM; Tononi, G				Cirelli, C; Gutierrez, CM; Tononi, G			Extensive and divergent effects of sleep and wakefulness on brain gene expression	NEURON			English	Article							CEREBRAL PROTEIN-SYNTHESIS; CIRCADIAN-RHYTHMS; MESSENGER-RNAS; WAKING; DEPRIVATION; PLASTICITY; LIVER; TRANSCRIPTION; HOMEOSTASIS; MICROARRAY	Sleep is present in all species where it has been studied, but its functions remain unknown. To investigate what benefits sleep may bring at the cellular level, we profiled gene expression in awake and sleeping rats by using high-density microarrays. We find that similar to10% of the transcripts in the cerebral cortex change their expression between day and night and demonstrate that half of them are modulated by sleep and wakefulness independent of time of day. We also show that molecular correlates of sleep are found in the cerebellum, a structure not known for generating sleep rhythms. Finally, we show that different functional categories of genes are selectively associated with sleep and wakefulness. The similar to100 known genes whose expression increases during sleep provide molecular support for the proposed involvement of sleep in protein synthesis and neural plasticity and point to a novel role for sleep in membrane trafficking and maintenance.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	ccirelli@wisc.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; [Anonymous], 1996, BIOCH BASIS NEUROPHA; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cirelli C, 2002, J APPL PHYSIOL, V92, P394, DOI 10.1152/jappl.2002.92.1.394; Cirelli C, 2000, J NEUROSCI, V20, P9187; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hobson J.A., 1989, SLEEP; HOBSON JA, 1972, ELECTROEN CLIN NEURO, V33, P457, DOI 10.1016/0013-4694(72)90210-6; HORNE JA, 1988, WHY SLEEP FUNCTIONS; Jurevics H, 2000, J LIPID RES, V41, P1048; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kramer EM, 2001, MICROSC RES TECHNIQ, V52, P656, DOI 10.1002/jemt.1050; KRUEGER JM, 1995, BEHAV BRAIN RES, V69, P177, DOI 10.1016/0166-4328(95)00015-L; LI WWF, 1993, J BIOL CHEM, V268, P12003; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; MAQUET P, 1995, BEHAV BRAIN RES, V69, P75, DOI 10.1016/0166-4328(95)00017-N; Maquet P, 2000, J SLEEP RES, V9, P207; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Meuth SG, 2003, J NEUROSCI, V23, P6460; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; Nakanishi H, 1997, EUR J NEUROSCI, V9, P271, DOI 10.1111/j.1460-9568.1997.tb01397.x; Ogawa A, 1997, HEPATOLOGY, V26, P1580, DOI 10.1002/hep.510260628; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Petit JM, 2002, EUR J NEUROSCI, V16, P1163, DOI 10.1046/j.1460-9568.2002.02145.x; RAMM P, 1990, PHYSIOL BEHAV, V48, P749, DOI 10.1016/0031-9384(90)90220-X; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RHYNER TA, 1990, EUR J NEUROSCI, V2, P1063, DOI 10.1111/j.1460-9568.1990.tb00018.x; Shaffery JP, 2002, NEUROSCIENCE, V110, P431, DOI 10.1016/S0306-4522(01)00589-9; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Steriade M, 1976, Prog Neurobiol, V6, P155; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Terao A, 2003, NEUROSCIENCE, V116, P187, DOI 10.1016/S0306-4522(02)00695-4; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tononi G, 2001, ARCH ITAL BIOL, V139, P221; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Yamada M, 2000, BIOL CHEM, V381, P1149, DOI 10.1515/BC.2000.142	60	439	445	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					35	43		10.1016/S0896-6273(03)00814-6	http://dx.doi.org/10.1016/S0896-6273(03)00814-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715133	Bronze			2022-12-17	WOS:000187942800007
J	Augustine, GJ; Santamaria, F; Tanaka, K				Augustine, GJ; Santamaria, F; Tanaka, K			Local calcium signaling in neurons	NEURON			English	Review							LONG-TERM DEPRESSION; PRESYNAPTIC ACTIVE ZONES; PROTEIN-INTERACTION SITE; METABOTROPIC GLUTAMATE RECEPTORS; PROPAGATING ACTION-POTENTIALS; RAT SYMPATHETIC NEURONS; DISTAL APICAL DENDRITES; TRANSMITTER RELEASE; CA2+ CHANNELS; N-TYPE	Transient rises in the cytoplasmic concentration of calcium ions serve as second messenger signals that control many neuronal functions. Selective triggering of these functions is achieved through spatial localization of calcium signals. Several qualitatively different forms of local calcium signaling can be distinguished by the location of open calcium channels as well as by the distance between these channels and the calcium binding proteins that serve as the molecular targets of calcium action. Local calcium signaling is especially prominent at presynaptic active zones and postsynaptic densities, structures that are distinguished by highly organized macromolecular arrays that yield precise spatial arrangements of calcium signaling proteins. Similar forms of local calcium signaling may be employed throughout the nervous system, though much remains to be learned about the molecular underpinnings of these events.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	georgea@neuro.duke.edu	Santamaria, Fidel/H-4721-2019; Augustine, George James/J-9228-2013; Santamaria, Fidel/I-2544-2012	Santamaria, Fidel/0000-0001-8750-2932; Santamaria, Fidel/0000-0001-8750-2932; Tanaka-Yamamoto, Keiko/0000-0002-1246-9784	NINDS NIH HHS [NS-34045, NS-21624] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021624, R01NS034045] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE T, 1993, ANN NY ACAD SCI, V707, P373, DOI 10.1111/j.1749-6632.1993.tb38074.x; ADLER EM, 1991, J NEUROSCI, V11, P1496; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; [Anonymous], 1999, DENDRITES; Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bear MF, 2001, SYNAPSES, P455; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Blackstone C, 2002, FRONT BIOSCI, V7, pD872, DOI 10.2741/blacksto; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bootman MD, 2001, J CELL SCI, V114, P2213; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Caillard O, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0002.2000; Cao YJ, 1999, NEUROSCIENCE, V92, P1511, DOI 10.1016/S0306-4522(99)00077-9; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Cohen R, 2003, J BIOL CHEM, V278, P9258, DOI 10.1074/jbc.M210270200; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Conroy WG, 2003, NEURON, V38, P759, DOI 10.1016/S0896-6273(03)00324-6; Crank J., 1979, MATH DIFFUSION; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; Dosemeci A, 2001, P NATL ACAD SCI USA, V98, P10428, DOI 10.1073/pnas.181336998; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Duprat F, 2003, PHILOS T ROY SOC B, V358, P715, DOI 10.1098/rstb.2002.1215; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; ELFAR O, 1995, FEBS LETT, V361, P101, DOI 10.1016/0014-5793(95)00156-4; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng W, 2002, J BIOL CHEM, V277, P44722, DOI 10.1074/jbc.M207675200; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; GRAB DJ, 1979, J BIOL CHEM, V254, P8690; Guatimosim S, 2002, J MOL CELL CARDIOL, V34, P941, DOI 10.1006/jmcc.2002.2032; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Horne JH, 1997, SCIENCE, V276, P1690, DOI 10.1126/science.276.5319.1690; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JAFFE LF, 1993, CELL CALCIUM, V14, P736, DOI 10.1016/0143-4160(93)90099-R; Kasai H, 1996, J PHYSIOL-LONDON, V494, P53, DOI 10.1113/jphysiol.1996.sp021475; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Katz B., 1969, RELEASE NEURAL TRANS; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; Kishimoto T, 2001, J PHYSIOL-LONDON, V533, P627, DOI 10.1111/j.1469-7793.2001.t01-1-00627.x; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KNOPFEL T, 1991, EUR J NEUROSCI, V3, P343, DOI 10.1111/j.1460-9568.1991.tb00821.x; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Korkotian E, 2000, HIPPOCAMPUS, V10, P587, DOI 10.1002/1098-1063(2000)10:5<587::AID-HIPO9>3.0.CO;2-C; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Larkum ME, 2003, J PHYSIOL-LONDON, V549, P471, DOI 10.1113/jphysiol.2002.037614; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Lazarewicz JW, 1998, J NEUROSCI RES, V51, P76, DOI 10.1002/(SICI)1097-4547(19980101)51:1<76::AID-JNR8>3.0.CO;2-I; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; LINO M, 1990, JPN J PHARMACOL, V54, P345; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MARTINMOUTOT N, 1993, J PHYSIOLOGY-PARIS, V87, P37, DOI 10.1016/0928-4257(93)90022-L; MARTONE ME, 1993, J NEUROSCI, V13, P4636; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Mochida S, 1998, P NATL ACAD SCI USA, V95, P14523, DOI 10.1073/pnas.95.24.14523; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Narita K, 1998, J GEN PHYSIOL, V112, P593, DOI 10.1085/jgp.112.5.593; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ohnuma K, 2001, J PHYSIOL-LONDON, V535, P647, DOI 10.1111/j.1469-7793.2001.00647.x; Ouanounou A, 1996, NEUROSCIENCE, V75, P99, DOI 10.1016/0306-4522(96)00319-3; Petersen OH, 2002, BIOL RES, V35, P177, DOI 10.4067/S0716-97602002000200008; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Qian J, 1999, J NEUROPHYSIOL, V81, P288, DOI 10.1152/jn.1999.81.1.288; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Rettig J, 1997, J NEUROSCI, V17, P6647; Rios E, 1997, ANNU REV BIOPH BIOM, V26, P47, DOI 10.1146/annurev.biophys.26.1.47; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schmidt H, 2003, BIOPHYS J, V84, P2599, DOI 10.1016/S0006-3495(03)75065-6; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Seagar M, 1999, PHILOS T ROY SOC B, V354, P289, DOI 10.1098/rstb.1999.0380; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Sinha SR, 1997, BIOPHYS J, V72, P637, DOI 10.1016/S0006-3495(97)78702-2; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TAKEI K, 1992, J NEUROSCI, V12, P489; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Usachev YM, 1997, J NEUROSCI, V17, P7404; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang SSH, 1995, BIOPHYS J, V69, P1683, DOI 10.1016/S0006-3495(95)80086-X; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WESTWOOD M, 1998, J REPROD FERTIL, V21, P18; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; WU LG, 1994, J NEUROSCI, V14, P5613; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yamauchi T, 2002, MASS SPECTROM REV, V21, P266, DOI 10.1002/mas.10033; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1999, J NEUROSCI, V19, P1976; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	221	439	447	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 9	2003	40	2					331	346		10.1016/S0896-6273(03)00639-1	http://dx.doi.org/10.1016/S0896-6273(03)00639-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	731GK	14556712	Bronze			2022-12-17	WOS:000185875800010
J	Schneggenburger, R; Meyer, AC; Neher, E				Schneggenburger, R; Meyer, AC; Neher, E			Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse	NEURON			English	Article							SQUID GIANT SYNAPSE; NEUROTRANSMITTER RELEASE; RECEPTOR DESENSITIZATION; PRESYNAPTIC DEPRESSION; HIPPOCAMPAL SYNAPSES; GLUTAMATE RECEPTORS; CALCIUM-DEPENDENCE; CHROMAFFIN CELLS; GABA(B) RECEPTOR; MEDIAL NUCLEUS	The size of a pool of readily releasable vesicles at a giant brainstem synapse, the calyx of Held, was probed with three independent approaches. Using simultaneous pre- and postsynaptic whole-cell recordings, two forms of presynaptic Ca2+ stimuli were applied in rapid succession: uncaging of Ca2+ by flash photolysis and the opening of voltage-gated Ca2+ channels. The ensuing transmitter release showed a nearly complete cross-inhibition between the two stimuli, indicating the depletion of a limited pool of about 700 transmitter quanta. The pool size was confirmed in experiments using enhanced extracellular Ca2+ concentrations, as well as short, high-frequency stimulus trains. The results reveal a surprisingly large pool of functionally available vesicles, of which a fraction of about 0.2 is released by a single presynaptic action potential under physiological conditions.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany	Max Planck Society	Schneggenburger, R (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Am Fassberg 11, D-37077 Gottingen, Germany.	rschneg@gwdg.de	Meyer, Alexander/F-2479-2010; Neher, Erwin/A-2109-2013					AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Caicedo A, 1999, EUR J NEUROSCI, V11, P51, DOI 10.1046/j.1460-9568.1999.00410.x; Chuhma N, 1998, J NEUROSCI, V18, P512; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P245, DOI 10.1113/jphysiol.1957.sp005809; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Katz B., 1969, RELEASE NEURAL TRANS; KEMP JA, 1988, P NATL ACAD SCI USA, V85, P6547, DOI 10.1073/pnas.85.17.6547; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Martell A. E., 1974, CRITICAL STABILITY C, V1; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Otis T, 1996, J NEUROSCI, V16, P7496; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Reid CA, 1998, J NEUROSCI, V18, P2849; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryugo DK, 1996, J COMP NEUROL, V365, P141, DOI 10.1002/(SICI)1096-9861(19960129)365:1<141::AID-CNE11>3.0.CO;2-T; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Takahashi T, 1998, J NEUROSCI, V18, P3138; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, J NEUROSCI, V19, P726; Xu T, 1997, BIOPHYS J, V73, P532, DOI 10.1016/S0006-3495(97)78091-3; YAMADA KA, 1993, J NEUROSCI, V13, P3904; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	54	439	443	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1999	23	2					399	409		10.1016/S0896-6273(00)80789-8	http://dx.doi.org/10.1016/S0896-6273(00)80789-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399944	Bronze, Green Published			2022-12-17	WOS:000081218600023
J	ROBINSON, PR; COHEN, GB; ZHUKOVSKY, EA; OPRIAN, DD				ROBINSON, PR; COHEN, GB; ZHUKOVSKY, EA; OPRIAN, DD			CONSTITUTIVELY ACTIVE MUTANTS OF RHODOPSIN	NEURON			English	Article							DOMINANT RETINITIS-PIGMENTOSA; SCHIFF-BASE COUNTERION; BOVINE RHODOPSIN; G-PROTEIN; TRANSDUCIN ACTIVATION; METARHODOPSIN-II; RESONANCE RAMAN; VISUAL PIGMENTS; GENE; MUTATIONS	Two critical amino acids in the visual pigment rhodopsin are Lys-296, the site of attachment of retinal to the protein through a protonated Schiff base linkage, and Glu-113, the Schiff base counterion. Mutation of Lys-296 or Glu-113 results in constitutive activation of opsin, as assayed by its ability to activate transducin in the absence of added chromophore. We conclude that opsin is constrained to an inactive conformation by a salt bridge between Lys-296 and Glu-113. Recently, one of the mutants, K296E, was found in a family with retinitis pigmentosa, suggesting that degeneration of the photoreceptor cells in individuals with this mutation may result from persistent stimulation of the phototransduction pathway.			ROBINSON, PR (corresponding author), BRANDEIS UNIV,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.		Zhukovsky, Eugene/Q-3218-2019		NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY007965, EY07965] Funding Source: Medline; NIGMS NIH HHS [5T32 GM0796] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; APPLEBURY ML, 1990, NATURE, V343, P316, DOI 10.1038/343316a0; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DOUKAS AG, 1978, BIOCHEMISTRY-US, V17, P2430, DOI 10.1021/bi00605a028; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; FARRAR GJ, 1990, AM J HUM GENET, V47, P941; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FINDLAY JBC, 1986, BIOCHEM J, V238, P6265; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HONIG B, 1979, P NATL ACAD SCI USA, V76, P2503, DOI 10.1073/pnas.76.6.2503; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; LONGSTAFF C, 1986, P NATL ACAD SCI USA, V83, P4209, DOI 10.1073/pnas.83.12.4209; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; OPRIAN DD, 1992, J BIOENERG BIOMEMBR, V24, P211, DOI 10.1007/BF00762679; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OSEROFF AR, 1974, BIOCHEMISTRY-US, V13, P4243, DOI 10.1021/bi00717a027; OVCHINNIKOV YA, 1982, BIOORG KHIM+, V8, P1011; RADDING CM, 1956, J GEN PHYSIOL, V39, P909, DOI 10.1085/jgp.39.6.909; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; STROSBERG AD, 1991, EUR J BIOCHEM, V196, P1, DOI 10.1111/j.1432-1033.1991.tb15778.x; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	42	439	442	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					719	725		10.1016/0896-6273(92)90034-B	http://dx.doi.org/10.1016/0896-6273(92)90034-B			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1356370				2022-12-17	WOS:A1992JT51600012
J	Sharon, R; Bar-Joseph, I; Frosch, MP; Walsh, DM; Hamilton, JA; Selkoe, DJ				Sharon, R; Bar-Joseph, I; Frosch, MP; Walsh, DM; Hamilton, JA; Selkoe, DJ			The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease	NEURON			English	Article							RAT FRONTAL-CORTEX; LEWY BODIES; PROTEIN; BINDING; TRANSPORT; MEMBRANES; AGGREGATION; METABOLISM; DIFFUSION; DEMENTIA	Accumulation of misfolded proteins as insoluble aggregates occurs in several neurodegenerative diseases. In Parkinson's disease (PD) and dementia with Lewy bodies (DLB), alpha-synuclein (alphaS) accumulates in insoluble inclusions. To identify soluble alphaS oligomers that precede insoluble aggregates, we probed the cytosols of mesencephalic neuronal (MES) cells, normal and alphaS-transgenic mouse brains, and normal, PD, and DLB human brains. All contained highly soluble oligomers; of alphaS whose detection was enhanced by delipidation. Exposure of living MES neurons to polyunsaturated fatty acids (PUFAs) increased alphaS oligomer levels, whereas saturated FAs decreased them. PUFAs directly promoted oligomerization of recombinant alphaS. Transgenic mice accumulated soluble oligomers with age. PD and DLB brains had elevated amounts of the soluble, lipid-dependent oligomers. We conclude that alphaS interacts with PUFAs in vivo to promote the formation of highly soluble oligomers that precede the insoluble alphaS aggregates associated with neurodegeneration.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02215 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861; Hamilton, James/0000-0002-4747-7071	NINDS NIH HHS [NS 38375] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Baba M, 1998, AM J PATHOL, V152, P879; Bonen A, 1999, AM J PHYSIOL-ENDOC M, V276, pE642, DOI 10.1152/ajpendo.1999.276.4.E642; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; CRAWFORD GDJ, 1992, J NEUROSCI, V12, P3382; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; EYLAR EH, 1969, ARCH BIOCHEM BIOPHYS, V132, P34, DOI 10.1016/0003-9861(69)90336-1; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hamilton JA, 1999, PROSTAG LEUKOTR ESS, V60, P291, DOI 10.1016/S0952-3278(99)80002-7; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; JAGER WAD, 1969, ARCH NEUROL-CHICAGO, V21, P615; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Nelson SO, 2000, IEEE INSTRU MEAS MAG, V3, P17, DOI 10.1109/5289.823818; OSHIRO Y, 1970, ARCH BIOCHEM BIOPHYS, V138, P392, DOI 10.1016/0003-9861(70)90361-9; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RICHIERI GV, 1992, J BIOL CHEM, V267, P23495; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; SPILLANTINI MG, 1997, NATURE, V388, P389; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zimmer L, 2000, NEUROSCI LETT, V284, P25, DOI 10.1016/S0304-3940(00)00950-2; Zimmer L, 1998, NEUROSCI LETT, V240, P177, DOI 10.1016/S0304-3940(97)00938-5	37	438	451	0	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 20	2003	37	4					583	595		10.1016/S0896-6273(03)00024-2	http://dx.doi.org/10.1016/S0896-6273(03)00024-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597857	Bronze			2022-12-17	WOS:000181136500008
J	Deans, MR; Gibson, JR; Sellitto, C; Connors, BW; Paul, DL				Deans, MR; Gibson, JR; Sellitto, C; Connors, BW; Paul, DL			Synchronous activity of inhibitory networks in neocortex requires electrical synapses containing Connexin36	NEURON			English	Article							GAP-JUNCTIONS; PLEXIFORM LAYER; FREEZE-FRACTURE; RAT NEOCORTEX; CHICK RETINA; NEURONS; CORTEX; INTERNEURONS; EXPRESSION; BRAIN	Inhibitory interneurons often generate synchronous activity as an emergent property of their interconnections. To determine the role of electrical synapses in such activity, we constructed mice expressing histochemical reporters in place of the gap junction protein Cx36. Localization of the reporter with somatostatin and parvalbumin suggested that Cx36 was expressed largely by Interneurons. Electrical synapses were common among cortical interneurons in controls but were nearly absent in knockouts. A metabotropic glutamate receptor agonist excited LTS interneurons, generating rhythmic inhibitory potentials in surrounding neurons of both wild-type and knockout animals. However, the synchrony of these rhythms was weaker and more spatially restricted in the knockout. We conclude that electrical synapses containing Cx36 are critical for the generation of widespread, synchronous inhibitory activity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Harvard University; Harvard Medical School; Brown University	Paul, DL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	dpaul@hms.harvard.edu	Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157	NIDA NIH HHS [DA12500] Funding Source: Medline; NIGMS NIH HHS [GM37751, GM18974] Funding Source: Medline; NINDS NIH HHS [NS25983] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018974, R01GM018974, R01GM037751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012500] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Belluardo N, 1999, J NEUROSCI RES, V57, P740, DOI 10.1002/(SICI)1097-4547(19990901)57:5<740::AID-JNR16>3.0.CO;2-Z; Benardo LS, 1997, J NEUROPHYSIOL, V77, P3134, DOI 10.1152/jn.1997.77.6.3134; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; CONNORS BW, 1983, J NEUROSCI, V3, P773; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MICEVYCH PE, 1991, J COMP NEUROL, V305, P96, DOI 10.1002/cne.903050110; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; RAVIOLA E, 1982, J COMP NEUROL, V209, P233, DOI 10.1002/cne.902090303; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIOSAKA S, 1989, J COMP NEUROL, V281, P282, DOI 10.1002/cne.902810210; Sohl G, 1998, FEBS LETT, V428, P27, DOI 10.1016/S0014-5793(98)00479-7; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	37	438	451	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2001	31	3					477	485		10.1016/S0896-6273(01)00373-7	http://dx.doi.org/10.1016/S0896-6273(01)00373-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516403	Bronze			2022-12-17	WOS:000170601000015
J	Cacalano, G; Farinas, I; Wang, LC; Hagler, K; Forgie, A; Moore, M; Armanini, M; Phillips, H; Ryan, AM; Reichardt, LF; Hynes, M; Davies, A; Rosenthal, A				Cacalano, G; Farinas, I; Wang, LC; Hagler, K; Forgie, A; Moore, M; Armanini, M; Phillips, H; Ryan, AM; Reichardt, LF; Hynes, M; Davies, A; Rosenthal, A			GFR alpha 1 is an essential receptor component for GDNF in the developing nervous system and kidney	NEURON			English	Article							MICE LACKING GDNF; MIDBRAIN DOPAMINERGIC-NEURONS; TYROSINE KINASE RECEPTOR; NEUROTROPHIC FACTOR; SURVIVAL FACTOR; IN-VIVO; BRAIN; TRKB; RET; DEGENERATION	Glial cell line-derived neurotrophic factor (GDNF) is a distant member of the TGF beta protein family that is essential for neuronal survival and renal morphogenesis. We show that mice who are deficient in the glycosyl-phosphatidyl inositol (GPI)-linked protein GFR alpha 1 (GDNFR alpha) display deficits in the kidneys, the enteric nervous system, and spinal motor and sensory neurons that are strikingly similar to those of the GDNF- and Ret-deficient mice. GFR alpha 1-deficient dopaminergic and nodose sensory ganglia neurons no longer respond to GDNF or to the structurally related protein neurturin (NTN) but can be rescued when exposed to GDNF or neurturin in the presence of soluble GFR alpha 1. in contrast, GFR alpha 1-deficient submandibular parasympathetic neurons retain normal response to these two factors. Taken together with the available genetic and biochemical data, these findings support the idea that GFR alpha 1 and the transmembrane tyrosine kinase net are both necessary receptor components for GDNF in the developing kidney and nervous system, and that GDNF and neurturin can mediate some of their activities through a second receptor.	Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, S San Francisco, CA 94080 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ St Andrews, St Andrews, Fife, Scotland; Deltagen Inc, San Carlos, CA 94070 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of St Andrews	Rosenthal, A (corresponding author), Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA.		Davies, Alun M/A-4334-2010; Farinas, Isabel/L-7118-2014	Davies, Alun M/0000-0001-5841-8176; Hynes, Mary/0000-0001-6623-6727; Farinas, Isabel/0000-0003-2903-4960	NINDS NIH HHS [P01 NS016033-180014, P01 NS016033-260014, P01 NS016033] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; BALOH RH, 1997, RET NEURON, V18, P793; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Durbec PL, 1996, DEVELOPMENT, V122, P349; Eng C, 1998, ONCOGENE, V16, P597, DOI 10.1038/sj.onc.1201573; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LICHING L, 1995, NEURON, V15, P527; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Masure S, 1998, EUR J BIOCHEM, V251, P622, DOI 10.1046/j.1432-1327.1998.2510622.x; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 1993, GENE TARGETING PRACT; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Nosrat CA, 1997, EXP BRAIN RES, V115, P410, DOI 10.1007/PL00005711; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Saxen L., 1987, ORGANOGENESIS KIDNEY; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Thompson J, 1998, MOL CELL NEUROSCI, V11, P117, DOI 10.1006/mcne.1998.0682; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502; YAN Q, 1995, NATURE, V373, P41	41	437	445	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					53	62		10.1016/S0896-6273(00)80514-0	http://dx.doi.org/10.1016/S0896-6273(00)80514-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697851	Green Accepted, Bronze			2022-12-17	WOS:000075061900006
J	Oliet, SHR; Malenka, RC; Nicoll, RA				Oliet, SHR; Malenka, RC; Nicoll, RA			Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; AREA CA1; PHARMACOLOGICAL CHARACTERIZATION; POSTSYNAPTIC INDUCTION; PROTEIN PHOSPHATASES; CA2+ CHANNELS; VISUAL-CORTEX; NITRIC-OXIDE	Two distinct forms of long-term depression (LTD), one dependent on the activation of NMDA receptors (NMDARs) and the other dependent on the activation of metabotropic glutamate receptors (mGluRs), are shown to coexist in CA1 hippocampal pyramidal cells of juvenile (11-35 day-old) rats. Both forms were pathway specific and required membrane depolarization and a rise in postsynaptic Ca2+. mGluR-LTD, but not NMDAR-LTD, required the activation of T-type Ca2+ channels, group 1 mGluRs, and protein kinase C, while NMDAR-LTD, but not mGluR-LTD, required protein phosphatase activity. NMDAR-LTD was associated with a decrease in the size of quantal excitatory postsynaptic currents, whereas for mGluR-LTD there was no change in quantal size, but a large decrease in the frequency of events. NMDAR-LTD, but not mGluR-LTD, reversed NMDAR-dependent long-term potentiation, and NMDAR-LTD was unaffected by prior saturation of mGluR-LTD. These findings indicate that NMDAR-LTD and mGluR-LTD are mechanistically distinct forms of synaptic plasticity.	UNIV CALIF SAN FRANCISCO,DEPT CELLULAR & MOL PHARMACOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Oliet, Stephane/0000-0003-0595-9029				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; AMES A, 1964, J NEUROPHYSIOL, V27, P672, DOI 10.1152/jn.1964.27.4.672; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, NEUROPHARMACOLOGY, V34, P1581, DOI 10.1016/0028-3908(95)00127-R; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; BORTOLOTTO ZA, 1993, NEUROPHARMACOLOGY, V32, P1, DOI 10.1016/0028-3908(93)90123-K; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Cavus I, 1996, J NEUROPHYSIOL, V76, P3038, DOI 10.1152/jn.1996.76.5.3038; CHRISTOFI G, 1993, J NEUROPHYSIOL, V69, P219, DOI 10.1152/jn.1993.69.1.219; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HALEY JE, 1993, NEUROSCI LETT, V160, P85, DOI 10.1016/0304-3940(93)90919-C; HEINEMANN U, 1977, EXP BRAIN RES, V27, P237; Hensch TK, 1996, SCIENCE, V272, P554, DOI 10.1126/science.272.5261.554; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Hrabetova S, 1996, J NEUROSCI, V16, P5324; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; IZUMI Y, 1993, NEUROREPORT, V4, P1131; JOLY C, 1995, J NEUROSCI, V15, P3970; KATO N, 1993, P NATL ACAD SCI USA, V90, P3650, DOI 10.1073/pnas.90.8.3650; KERR DS, 1995, P NATL ACAD SCI USA, V92, P11637, DOI 10.1073/pnas.92.25.11637; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Dell T J, 1994, Learn Mem, V1, P129; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Otani S, 1996, J PHYSIOL-LONDON, V492, P225, DOI 10.1113/jphysiol.1996.sp021303; PELLICCIARI R, 1995, J MED CHEM, V38, P3717, DOI 10.1021/jm00019a002; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SAUGSTAD JA, 1995, EUR J PHARM-MOLEC PH, V289, P395, DOI 10.1016/0922-4106(95)90120-5; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; STANTON PK, 1991, NEUROSCI LETT, V127, P61, DOI 10.1016/0304-3940(91)90895-Z; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; TAKAHASHI K, 1991, J PHARMACOL EXP THER, V256, P169; TAKAHASHI K, 1991, J NEUROPHYSIOL, V65, P148, DOI 10.1152/jn.1991.65.1.148; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; WANG JH, 1995, NEURON, V15, P443, DOI 10.1016/0896-6273(95)90048-9; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x; YANG XD, 1994, J NEUROPHYSIOL, V71, P1586, DOI 10.1152/jn.1994.71.4.1586	75	437	445	1	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					969	982		10.1016/S0896-6273(00)80336-0	http://dx.doi.org/10.1016/S0896-6273(00)80336-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208864	Bronze			2022-12-17	WOS:A1997XJ10200015
J	BARRES, BA; SILVERSTEIN, BE; COREY, DP; CHUN, LLY				BARRES, BA; SILVERSTEIN, BE; COREY, DP; CHUN, LLY			IMMUNOLOGICAL, MORPHOLOGICAL, AND ELECTROPHYSIOLOGICAL VARIATION AMONG RETINAL GANGLION-CELLS PURIFIED BY PANNING	NEURON			English	Article									MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,NEUROSCI GRP,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	BARRES, BA (corresponding author), HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115, USA.				NINDS NIH HHS [NS-21269, NS-22059, F32 NS-07970] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021269, R01NS022059, F32NS007970] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; ARMSON PF, 1983, NEUROSCI LETT, V38, P181, DOI 10.1016/0304-3940(83)90037-X; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ARVIEUX J, 1986, MOL IMMUNOL, V23, P983, DOI 10.1016/0161-5890(86)90129-X; ASSOULINE JG, 1983, BRAIN RES, V277, P389, DOI 10.1016/0006-8993(83)90953-8; BADER CR, 1978, P NATL ACAD SCI USA, V75, P3507, DOI 10.1073/pnas.75.7.3507; BARKER CR, 1975, IMMUNOLOGY, V29, P765; BARKLEY DS, 1973, J CELL PHYSIOL, V81, P271, DOI 10.1002/jcp.1040810215; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; BARRES BA, 1987, 2ND SAT S WORLD C NE; BEALE R, 1982, NEUROCHEM INT, V4, P587, DOI 10.1016/0197-0186(82)90049-3; BEALE R, 1983, NEUROCHEM INT, V5, P691, DOI 10.1016/0197-0186(83)90094-3; BENTIVOGLIO M, 1980, NEUROSCI LETT, V18, P25, DOI 10.1016/0304-3940(80)90208-6; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; CALOF AL, 1984, DEV BIOL, V106, P194, DOI 10.1016/0012-1606(84)90075-7; Corey D. P., 1983, SINGLE CHANNEL RECOR, P53; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HINDS JW, 1983, J COMP NEUROL, V213, P1, DOI 10.1002/cne.902130102; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; KORNGUTH S, 1981, EXP EYE RES, V33, P413, DOI 10.1016/S0014-4835(81)80093-0; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; KUYPERS HGJM, 1980, EXP BRAIN RES, V40, P383; LAKE P, 1979, EUR J IMMUNOL, V9, P875, DOI 10.1002/eji.1830091109; LAM DMK, 1972, P NATL ACAD SCI USA, V69, P1987, DOI 10.1073/pnas.69.7.1987; LAM K, 1982, DEV BRAIN RES, V3, P487, DOI 10.1016/0165-3806(82)90014-1; LEIFER D, 1984, SCIENCE, V224, P303, DOI 10.1126/science.6143400; LEVICK WR, 1975, NATURE, V254, P659, DOI 10.1038/254659a0; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; LIPTON SA, 1987, J PHYSIOL-LONDON, V385, P361, DOI 10.1113/jphysiol.1987.sp016497; MACLEISH PR, 1983, P NATL ACAD SCI-BIOL, V80, P7014, DOI 10.1073/pnas.80.22.7014; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MAGE MG, 1977, J IMMUNOL METHODS, V15, P47, DOI 10.1016/0022-1759(77)90016-3; MASON DW, 1980, BIOCHEM J, V187, P1; MICHAELSON IC, 1954, RAT, P64; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; OBRIEN RJ, 1986, J NEUROSCI, V6, P3265; PERRY VH, 1984, J NEUROCYTOL, V13, P809, DOI 10.1007/BF01148495; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; POTTS RA, 1982, DEV BRAIN RES, V3, P481, DOI 10.1016/0165-3806(82)90013-X; SARTHY PV, 1983, J NEUROSCI, V3, P2532; SHIOSAKA S, 1984, J NEUROSCI METH, V10, P229, DOI 10.1016/0165-0270(84)90059-1; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; WILLIAMS AF, 1982, SCIENCE, V216, P696, DOI 10.1126/science.6177036; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844; YEH HH, 1986, SOC NEUR ABSTR, V12	50	437	453	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1988	1	9					791	803		10.1016/0896-6273(88)90127-4	http://dx.doi.org/10.1016/0896-6273(88)90127-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	R1440	2908449				2022-12-17	WOS:A1988R144000004
J	Hein, G; Silani, G; Preuschoff, K; Batson, CD; Singer, T				Hein, Grit; Silani, Giorgia; Preuschoff, Kerstin; Batson, C. Daniel; Singer, Tania			Neural Responses to Ingroup and Outgroup Members' Suffering Predict Individual Differences in Costly Helping	NEURON			English	Article							ALTRUISTIC MOTIVATION; SOCIAL NEUROSCIENCE; PERSPECTIVE-TAKING; PROSOCIAL BEHAVIOR; MODERATING ROLE; HUMAN EMPATHY; PAIN; BRAIN; FEEL; OXYTOCIN	Little is known about the neurobiological mechanisms underlying prosocial decisions and how they are modulated by social factors such as perceived group membership. The present study investigates the neural processes preceding the willingness to engage in costly helping toward ingroup and outgroup members. Soccer fans witnessed a fan of their favorite team (ingroup member) or of a rival team (outgroup member) experience pain. They were subsequently able to choose to help the other by enduring physical pain themselves to reduce the other's pain. Helping the ingroup member was best predicted by anterior insula activation when seeing him suffer and by associated self-reports of empathic concern. In contrast, not helping the outgroup member was best predicted by nucleus accumbens activation and the degree of negative evaluation of the other. We conclude that empathy-related insula activation can motivate costly helping, whereas an antagonistic signal in nucleus accumbens reduces the propensity to help.	[Hein, Grit; Silani, Giorgia; Preuschoff, Kerstin; Singer, Tania] Univ Zurich, Inst Empir Res Econ, Lab Social & Neural Syst Res, CH-8006 Zurich, Switzerland; [Batson, C. Daniel] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, D-04103 Leipzig, Germany	University of Zurich; University of Kansas; Max Planck Society	Hein, G (corresponding author), Univ Zurich, Inst Empir Res Econ, Lab Social & Neural Syst Res, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.		Hein, Grit/AAF-7964-2019; Preuschoff, Kerstin/G-4710-2015; Preuschoff, Kerstin/ABF-6733-2021; Preuschoff, Kerstin/AAG-4725-2019	Preuschoff, Kerstin/0000-0001-7254-833X; silani, giorgia/0000-0002-4284-3618	Society in Science; "Foundations of Human Social Behavior" at the University of Zurich	Society in Science; "Foundations of Human Social Behavior" at the University of Zurich	G H is supported by a Branco Weiss Fellowship from the Society in Science We also gratefully acknowledge support from the Research Priority Program "Foundations of Human Social Behavior" at the University of Zurich We would like to thank Adrian Etter for technical support, Claus Lamm for providing the masks from previous empathy-for-pain studies, Vincent van Veen for helpful discussions, and Michael Wolf for statistical support	Akitsuki Y, 2009, NEUROIMAGE, V47, P722, DOI 10.1016/j.neuroimage.2009.04.091; [Anonymous], 1997, MULTIPLE REGRESSION; Batson C. D, 1991, ALTRUISM QUESTION SO; Batson CD, 2007, J PERS SOC PSYCHOL, V93, P65, DOI 10.1037/0022-3514.93.1.65; BATSON CD, 1983, J PERS SOC PSYCHOL, V45, P706, DOI 10.1037//0022-3514.45.3.706; BATSON CD, 1988, J PERS SOC PSYCHOL, V55, P52, DOI 10.1037/0022-3514.55.1.52; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Brett M., 2009, NEUROIMAGE, V16, P2; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; COKE JS, 1978, J PERS SOC PSYCHOL, V36, P752, DOI 10.1037/0022-3514.36.7.752; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; DOVIDIO JF, 1990, J PERS SOC PSYCHOL, V59, P249, DOI 10.1037/0022-3514.59.2.249; DUVERNOY H, 1999, SURFACE BLOOD SUPPLY; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; FRISTON K, 2009, HUM BRAIN MAPP, V2, P189; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1995, HUM BRAIN MAPP, V3, P302, DOI 10.1002/hbm.460030405; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kawakami K, 2009, SCIENCE, V323, P276, DOI 10.1126/science.1164951; Keller T, 2002, ARTIF ORGANS, V26, P219, DOI 10.1046/j.1525-1594.2002.06934.x; Knutson B, 2008, NEURON, V58, P814, DOI 10.1016/j.neuron.2008.05.018; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; Nimon K, 2008, BEHAV RES METHODS, V40, P457, DOI 10.3758/BRM.40.2.457; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Penner L., 2006, SOCIAL PSYCHOL PROSO; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Romano JP, 2005, ECONOMETRICA, V73, P1237, DOI 10.1111/j.1468-0262.2005.00615.x; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Singer T, 2008, EMOTION, V8, P781, DOI 10.1037/a0014195; Sturmer S, 2006, PERS SOC PSYCHOL B, V32, P943, DOI 10.1177/0146167206287363; Sturmer S, 2005, J PERS SOC PSYCHOL, V88, P532, DOI 10.1037/0022-3514.88.3.532; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; WANN DL, 1993, INT J SPORT PSYCHOL, V24, P1; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009	59	436	451	14	151	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					149	160		10.1016/j.neuron.2010.09.003	http://dx.doi.org/10.1016/j.neuron.2010.09.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	674AA	20920798	Green Accepted, Bronze			2022-12-17	WOS:000283704200015
J	Adhikari, A; Topiwala, MA; Gordon, JA				Adhikari, Avishek; Topiwala, Mihir A.; Gordon, Joshua A.			Synchronized Activity between the Ventral Hippocampus and the Medial Prefrontal Cortex during Anxiety	NEURON			English	Article							ELEVATED-PLUS-MAZE; PREPULSE INHIBITION; GAMMA OSCILLATIONS; SOCIAL-INTERACTION; PRELIMBIC CORTEX; MICE LACKING; FEAR; PROJECTIONS; EXPRESSION; LESIONS	The ventral hippocampus, unlike its dorsal counterpart, is required for anxiety-like behavior. The means by which it acts are unknown. We hypothesized that the hippocampus synchronizes with downstream targets that influence anxiety, such as the medial prefrontal cortex (mPFC). To test this hypothesis, we recorded mPFC and hippocampal activity in mice exposed to two anxiogenic arenas. Theta-frequency activity in the mPFC and ventral, but not dorsal, hippocampus was highly correlated at baseline, and this correlation increased in both anxiogenic environments. Increases in mPFC theta power predicted avoidance of the aversive compartments of each arena and were larger in serotonin 1A receptor knockout mice, a genetic model of increased anxiety-like behavior. These results suggest a role for theta-frequency synchronization between the ventral hippocampus and the mPFC in anxiety. They are consistent with the notion that such synchronization is a general mechanism by which the hippocampus communicates with downstream structures of behavioral relevance.	[Topiwala, Mihir A.; Gordon, Joshua A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Adhikari, Avishek] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; [Gordon, Joshua A.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Gordon, JA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	jg343@columbia.edu	Adhikari, Avishek/A-3339-2012; Adhikari, Avishek/AAF-4444-2021; Adhikari, Avishek/N-1284-2015	Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211	National Institute of Mental Health [K08 MH098623, R01 MH081958]; NARSAD/Bowman Family Foundation; APIRE/GlaxoSmithKline; citizens of the State of New York; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH069823, R01MH081968] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD/Bowman Family Foundation(NARSAD); APIRE/GlaxoSmithKline(GlaxoSmithKline); citizens of the State of New York; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank G. Buzsaki, R. Hen, E. B. Likhtik, T. Sigurdsson, and K. Remole for helpful comments on the manuscript, as well as the members of the Gordon, Hen, and Buzsaki laboratories for helpful discussions of the experimental design and analysis. We thank P. Mitra and collaborators for making the Chronux package available and T. Sigurdsson for providing analysis scripts. This work was supported by grants to J.A.G. from the National Institute of Mental Health (K08 MH098623 and R01 MH081958). J.A.G. is also the recipient of a NARSAD/Bowman Family Foundation Young Investigator Award and an APIRE/GlaxoSmithKline Young Faculty Award. Finally, we thank the citizens of the State of New York for their support of the New York State Psychiatric Institute.; A.A. designed and performed the experiments, conducted the data analysis, and wrote the paper. M.A.T. assisted in performing the experiments and did the histology and genotyping. J.A.G. designed the experiments, supervised the performance of the experiments and data analysis, and wrote the paper.	Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; BURWELL RD, 2002, BASIC ANATOMY PARAHI; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cannizzaro C, 2003, EUR NEUROPSYCHOPHARM, V13, P209, DOI 10.1016/S0924-977X(03)00012-9; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Fee JR, 2004, ALCOHOL CLIN EXP RES, V28, P1459, DOI 10.1097/01.ALC.0000141809.53115.71; File SE, 1996, J NEUROSCI, V16, P4810; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Gonzalez LE, 2000, BRAIN RES, V887, P7, DOI 10.1016/S0006-8993(00)02931-0; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Lacroix L, 1998, NEUROSCIENCE, V84, P431, DOI 10.1016/S0306-4522(97)00521-6; Lacroix L, 2000, BEHAV NEUROSCI, V114, P1119, DOI 10.1037//0735-7044.114.6.1119; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Parent MA, 2010, CEREB CORTEX, V20, P393, DOI 10.1093/cercor/bhp108; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Puumala T, 1998, NEUROSCIENCE, V83, P489, DOI 10.1016/S0306-4522(97)00392-8; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Resstel LBM, 2008, PHYSIOL BEHAV, V93, P200, DOI 10.1016/j.physbeh.2007.08.009; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shah AA, 2004, BRAIN RES, V1028, P112, DOI 10.1016/j.brainres.2004.08.061; Shah AA, 2004, BRAIN RES, V996, P31, DOI 10.1016/j.brainres.2003.10.015; Shah AA, 2003, BRAIN RES, V969, P183, DOI 10.1016/S0006-8993(03)02299-6; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota Anton, 2005, Thalamus & Related Systems, V3, P245, DOI 10.1017/S1472928807000258; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sustkova-Fiserova M, 2009, NEUROENDOCRINOL LETT, V30, P79; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Verwer RWH, 1997, HIPPOCAMPUS, V7, P397, DOI 10.1002/(SICI)1098-1063(1997)7:4<397::AID-HIPO5>3.0.CO;2-G; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Yee BK, 2000, NEUROSCIENCE, V95, P675; ZHU XO, 1994, INT J NEUROSCI, V79, P91, DOI 10.3109/00207459408986070	50	436	438	3	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 28	2010	65	2					257	269		10.1016/j.neuron.2009.12.002	http://dx.doi.org/10.1016/j.neuron.2009.12.002			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	550OA	20152131	Bronze, Green Accepted			2022-12-17	WOS:000274136100012
J	Huettel, SA; Stowe, CJ; Gordon, EM; Warner, BT; Platt, ML				Huettel, SA; Stowe, CJ; Gordon, EM; Warner, BT; Platt, ML			Neural signatures of economic preferences for risk and ambiguity	NEURON			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; COGNITIVE CONTROL; RESPONSE SELECTION; ANTERIOR CINGULATE; PARIETAL CORTICES; FRONTAL-CORTEX; UNCERTAINTY; BRAIN; CHOICE	People often prefer the known over the unknown, sometimes sacrificing potential rewards for the sake of surety. Overcoming impulsive preferences for certainty in order to exploit uncertain but potentially lucrative options may require specialized neural mechanisms. Here, we demonstrate by functional magnetic resonance imaging (fMRI) that individuals' preferences for risk (uncertainty with known probabilities) and ambiguity (uncertainty with unknown probabilities) predict brain activation associated with decision making. Activation within the lateral prefrontal cortex was predicted by ambiguity preference and was also negatively correlated with an independent clinical measure of behavioral impulsiveness, suggesting that this region implements contextual analysis and inhibits impulsive responses. In contrast, activation of the posterior parietal cortex was predicted by risk preference. Together, this novel double dissociation indicates that decision making under ambiguity does not represent a special, more complex case of risky decision making; instead, these two forms of uncertainty are supported by distinct mechanisms.	Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; Duke Univ, Fuqua Sch Business, Res Triangle Pk, NC 27708 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Ctr Neuroecon Studies, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Huettel, SA (corresponding author), Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA.	scott.huettel@duke.edu	Gordon, Evan/J-5672-2019	Gordon, Evan/0000-0002-2276-5237	NIMH NIH HHS [MH 70685] Funding Source: Medline; NINDS NIH HHS [NS 41328] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041328] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bechara A, 1999, J NEUROSCI, V19, P5473; BECKER SW, 1964, J POLIT ECON, V72, P62, DOI 10.1086/258854; Bernoulli D., 1738, COMMENT ACAD SCI IMP, P175; Best M, 2002, P NATL ACAD SCI USA, V99, P8448, DOI 10.1073/pnas.112604099; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brass M, 2004, J NEUROSCI, V24, P8847, DOI 10.1523/JNEUROSCI.2513-04.2004; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Chapman GB, 2001, PSYCHON B REV, V8, P615, DOI 10.3758/BF03196198; CHIPMAN JS, 1960, DECISIONS VALUES GRO, P70; Cools R, 2005, NEUROPSYCHOPHARMACOL, V30, P1362, DOI 10.1038/sj.npp.1300704; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Dickhaut J, 2003, P NATL ACAD SCI USA, V100, P3536, DOI 10.1073/pnas.0530279100; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Ghirardato P, 2004, J ECON THEORY, V118, P133, DOI 10.1016/j.jet.2003.12.004; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goel V, 2004, COGNITION, V93, pB109, DOI 10.1016/j.cognition.2004.03.001; HEATH C, 1991, J RISK UNCERTAINTY, V4, P177; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knight, 1933, RISK UNCERTAINTY PRO; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Lauriola M, 2001, J BEHAV DECIS MAKING, V14, P107, DOI 10.1002/bdm.368; Leland DS, 2005, DRUG ALCOHOL DEPEN, V78, P83, DOI 10.1016/j.drugalcdep.2004.10.001; Luce RD, 2000, UTILITY GAINS LOSSES; McCoy A, 2005, J COMP PHYSIOL A, V191, P201, DOI 10.1007/s00359-004-0565-9; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Parrott AC, 2000, NEUROPSYCHOBIOLOGY, V42, P17, DOI 10.1159/000026666; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031; Paulus MP, 2001, NEUROIMAGE, V13, P91, DOI 10.1006/nimg.2000.0667; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Walderhaug E, 2002, PSYCHOPHARMACOLOGY, V164, P385, DOI 10.1007/s00213-002-1238-4	51	436	442	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					765	775		10.1016/j.neuron.2006.01.024	http://dx.doi.org/10.1016/j.neuron.2006.01.024			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	022QL	16504951	Bronze			2022-12-17	WOS:000236070600017
J	Guo, XF; Macleod, GT; Wellington, A; Hu, F; Panchumarthi, S; Schoenfield, M; Marin, L; Charlton, MP; Atwood, HL; Zinsmaier, KE				Guo, XF; Macleod, GT; Wellington, A; Hu, F; Panchumarthi, S; Schoenfield, M; Marin, L; Charlton, MP; Atwood, HL; Zinsmaier, KE			The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses	NEURON			English	Article							MOTOR-NERVE TERMINALS; HEREDITARY SPASTIC PARAPLEGIA; SYNAPTIC-TRANSMISSION; CYTOCHROME-OXIDASE; CYTOSOLIC CA2+; PROTEIN; MUTATIONS; RELEASE; MICROTUBULES; STIMULATION	We have identified EMS-induced mutations in Drosophila Miro (dMiro), an atypical mitochondrial GTPase that is orthologous to human Miro (hMiro). Mutant dmiro animals exhibit defects in locomotion and die prematurely. Mitochondria in dmiro mutant muscles and neurons are abnormally distributed. Instead of being transported into axons and dendrites mitochondria accumulate in parallel rows in neuronal somata. Mutant neuromuscular junctions (NMJs) lack presynaptic mitochondria, but neurotransmitter release and acute Ca2+ buffering is only impaired during prolonged stimulation. Neuronal, but not muscular, expression of dMiro in dmiro mutants restored viability, transport of mitochondria to NMJs, the structure of synaptic boutons, the organization of presynaptic microtubules, and the size of postsynaptic muscles. In addition, gain of dMiro function causes an abnormal accumulation of mitochondria in distal synaptic boutons of NMJs. Together, our findings suggest that dMiro is required for controlling anterograde transport of mitochondria and their proper distribution within nerve terminals.	Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Program Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Undergrad Biol Res Program, Tucson, AZ 85721 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Penn, Sch Med, Program Neurosci, Philadelphia, PA 19104 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Toronto; University of Pennsylvania	Zinsmaier, KE (corresponding author), Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA.	kez@neurobio.arizona.edu		Macleod, Gregory/0000-0003-3782-6968; Wellington, Andrea/0000-0002-8679-9225				Babcock MC, 2003, GENETICS, V165, P171; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bindokas VP, 1998, J NEUROSCI, V18, P4570; BLOOM GS, 1993, J CELL BIOL, V120, P467, DOI 10.1083/jcb.120.2.467; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chen B, 1998, GENETICS, V149, P157; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; David G, 2000, J NEUROSCI, V20, P7290; David G, 1998, J PHYSIOL-LONDON, V509, P59, DOI 10.1111/j.1469-7793.1998.059bo.x; David G, 1999, J NEUROSCI, V19, P7495, DOI 10.1523/JNEUROSCI.19-17-07495.1999; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; De Vos KJ, 2003, MOL BIOL CELL, V14, P3636, DOI 10.1091/mbc.E02-10-0638; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hurd DD, 1996, GENETICS, V144, P1075; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kammermeier L, 2003, DEV GENES EVOL, V213, P412, DOI 10.1007/s00427-003-0340-x; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; MORRIS RL, 1993, J CELL SCI, V104, P917; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; Ohnuma K, 1999, BIOPHYS J, V76, P1819, DOI 10.1016/S0006-3495(99)77342-X; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Stowers RS, 1999, GENETICS, V152, P1631; Suzuki S, 2002, J NEUROPHYSIOL, V87, P1816, DOI 10.1152/jn.00456.2001; Talbot JD, 2003, J NEUROPHYSIOL, V90, P491, DOI 10.1152/jn.00012.2003; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; WONGRILEY M, 1984, NATURE, V307, P262, DOI 10.1038/307262a0; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	52	436	445	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 4	2005	47	3					379	393		10.1016/j.neuron.2005.06.027	http://dx.doi.org/10.1016/j.neuron.2005.06.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055062	Bronze			2022-12-17	WOS:000231051900009
J	HUGANIR, RL; GREENGARD, P				HUGANIR, RL; GREENGARD, P			REGULATION OF NEUROTRANSMITTER RECEPTOR DESENSITIZATION BY PROTEIN-PHOSPHORYLATION	NEURON			English	Review									ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021	Rockefeller University	HUGANIR, RL (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,HOWARD HUGHES MED INST,BALTIMORE,MD 21205, USA.							ADAMO S, 1985, FEBS LETT, V190, P161, DOI 10.1016/0014-5793(85)80449-X; ALBUQUERQUE EX, 1986, FEBS LETT, V199, P113, DOI 10.1016/0014-5793(86)81235-2; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BENOVIC JL, 1986, NATURE, V322, P869; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; BROWNING MD, 1990, P NATL ACAD SCI USA, V87, P1315, DOI 10.1073/pnas.87.4.1315; CHANGEUX JP, 1984, SCIENCE, V225, P1333; CHEUNG AH, 1989, MOL PHARMACOL, V34, P132; CLAPHAM DE, 1984, J PHYSIOL-LONDON, V347, P255, DOI 10.1113/jphysiol.1984.sp015065; CLARK RB, 1989, MOL PHARMACOL, V36, P343; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; DECAMILLI P, 1990, IN PRESS ANN REV CEL, V6; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DOWNING JEG, 1987, P NATL ACAD SCI USA, V84, P7739, DOI 10.1073/pnas.84.21.7739; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EUSEBI F, 1985, J CELL BIOL, V100, P1339, DOI 10.1083/jcb.100.4.1339; GORDON AS, 1977, NATURE, V267, P539, DOI 10.1038/267539a0; GREENGARD P, 1978, SCIENCE, V199, P146, DOI 10.1126/science.22932; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HANLEY MR, 1980, MOL PHARMACOL, V18, P78; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Heinemann S., 1987, P45; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; HEUSCHNEIDER G, 1989, P NATL ACAD SCI USA, V86, P2938, DOI 10.1073/pnas.86.8.2938; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HOSHI T, 1988, SCIENCE, V240, P1652, DOI 10.1126/science.2454506; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1983, P NATL ACAD SCI-BIOL, V80, P1130, DOI 10.1073/pnas.80.4.1130; HUGANIR RL, 1987, TRENDS PHARMACOL SCI, V8, P472, DOI 10.1016/0165-6147(87)90041-1; HUGANIR RL, 1984, P NATL ACAD SCI USA, V81, P6963; HUGANIR RL, 1989, CRIT REV BIOCHEM MOL, V24, P182; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.bi.54.070185.004341; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KAO PN, 1984, J BIOL CHEM, V259, P1662; KELLEHER DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4316, DOI 10.1073/pnas.81.14.4316; KIRKNESS EF, 1989, BIOCHEM J, V259, P613, DOI 10.1042/bj2590613; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; Kuhn H, 1984, PROGR RETINAL RES, V3, P123; KWATRA MM, 1986, J BIOL CHEM, V261, P2429; KWATRA MM, 1987, J BIOL CHEM, V262, P16314; KWATRA MM, 1989, BIOCHEMISTRY-US, V28, P4543, DOI 10.1021/bi00437a005; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; LINDSTROM J, 1987, MOL NEUROBIOL, V1, P281, DOI 10.1007/BF02935740; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MIDDLETON P, 1988, J NEUROSCI, V8, P3405; MIDDLETON P, 1986, P NATL ACAD SCI USA, V83, P4967, DOI 10.1073/pnas.83.13.4967; MILES K, 1989, NEURON, V2, P1517, DOI 10.1016/0896-6273(89)90198-0; MILES K, 1987, P NATL ACAD SCI USA, V84, P6591, DOI 10.1073/pnas.84.18.6591; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PORTER NM, 1990, IN PRESS NEURON; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; RICHARDSON RM, 1990, BIOCHEMISTRY-US, V29, P8555, DOI 10.1021/bi00489a008; ROLE LW, 1984, P NATL ACAD SCI-BIOL, V81, P2924, DOI 10.1073/pnas.81.9.2924; ROSENBAUM LC, 1987, BIOCHEMISTRY-US, V26, P8183, DOI 10.1021/bi00399a024; ROSS A, 1988, J CELL BIOL, V107, P1139, DOI 10.1083/jcb.107.3.1139; ROSS AF, 1987, J BIOL CHEM, V262, P14640; SAFRAN A, 1987, J BIOL CHEM, V262, P10506; SIBLEY DR, 1985, J BIOL CHEM, V260, P3883; SIBLEY DR, 1984, BIOCHEM BIOPH RES CO, V121, P973, DOI 10.1016/0006-291X(84)90772-1; SIBLEY DR, 1984, J BIOL CHEM, V259, P9742; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; SIMMONS LK, 1990, NEURON, V4, P393, DOI 10.1016/0896-6273(90)90051-G; SMITH MM, 1987, P NATL ACAD SCI USA, V84, P6601, DOI 10.1073/pnas.84.18.6601; SMITH MM, 1989, J BIOL CHEM, V264, P12813; STADEL JM, 1983, P NATL ACAD SCI-BIOL, V80, P3173, DOI 10.1073/pnas.80.11.3173; STALLCUP WB, 1980, P NATL ACAD SCI-BIOL, V77, P634, DOI 10.1073/pnas.77.1.634; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRASSER RH, 1986, BIOCHEMISTRY-US, V25, P1371, DOI 10.1021/bi00354a027; SWEETNAM PM, 1988, J NEUROCHEM, V51, P1274, DOI 10.1111/j.1471-4159.1988.tb03097.x; TEHRANI MHJ, 1989, SYNAPSE, V4, P126, DOI 10.1002/syn.890040206; TEICHBERG VI, 1977, NATURE, V267, P540, DOI 10.1038/267540a0; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; WAGONER PK, 1988, SCIENCE, V240, P1655, DOI 10.1126/science.2454507; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; YEE GH, 1987, J BIOL CHEM, V262, P16748	98	436	440	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1990	5	5					555	567		10.1016/0896-6273(90)90211-W	http://dx.doi.org/10.1016/0896-6273(90)90211-W			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	1699566				2022-12-17	WOS:A1990EJ86800001
J	Cheng, HYM; Papp, JW; Varlamova, O; Dziema, H; Russell, B; Curfman, JP; Nakazawa, T; Shimizu, K; Okamura, H; Impey, S; Obrietan, K				Cheng, Hai-Ying M.; Papp, Joseph W.; Varlamova, Olga; Dziema, Heather; Russell, Brandon; Curfman, John P.; Nakazawa, Takanobu; Shimizu, Kimiko; Okamura, Hitoshi; Impey, Soren; Obrietan, Karl			microRNA modulation of circadian-clock period and entrainment	NEURON			English	Article							DEFICIENT MICE LACKING; SUPRACHIASMATIC NUCLEUS; RESPONSE ELEMENT; GENE-EXPRESSION; PHOTIC RESPONSIVENESS; DEPENDENT MECHANISM; BIOLOGICAL CLOCK; MESSENGER-RNAS; C-ELEGANS; PROTEIN	microRNAs (miRNAs) are a class of small, noncoding RNAs that regulate the stability or translation of mRNA transcripts. Although recent work has implicated miRNAs in development and in disease, the expression and function of miRNAs in the adult mammalian nervous system have not been extensively characterized. Here, we examine the role of two brain-specific miRNAs, miR-219 and miR-132, in modulating the circadian clock located in the suprachiasmatic nucleus. miR-219 is a target of the CLOCK and BMAL1 complex, exhibits robust circadian rhythms of expression, and the in vivo knockdown of miR-219 lengthens the circadian period. miR-132 is induced by photic entrainment cues via a MAPK/CREB-dependent mechanism, modulates clock-gene expression, and attenuates the entraining effects of light. Collectively, these data reveal miRNAs; as clock- and light-regulated genes and provide a mechanistic examination of their roles as effectors of pacemaker activity and entrainment.	Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan	University System of Ohio; Ohio State University; Oregon Health & Science University; University of Tokyo; University of Washington; University of Washington Seattle; Kobe University	Cheng, HYM (corresponding author), Ohio State Univ, Dept Neurosci, 333 W 10th Ave, Columbus, OH 43210 USA.	hymcheng@yahoo.ca; obrietan.1@osu.edu	Nakazawa, Takanobu/E-1012-2014; Kimiko, Shimizu/ACS-9013-2022; Shimizu, Kimiko/G-4956-2014	Nakazawa, Takanobu/0000-0002-5049-9140; Kimiko, Shimizu/0000-0003-4943-2552; Shimizu, Kimiko/0000-0003-4943-2552; NAKAZAWA, Takanobu/0000-0003-4863-1277	NIMH NIH HHS [MH62335, R01 MH062335-06, R01 MH062335, MH64954, K01 MH064954, R01 MH062335-05] Funding Source: Medline; NINDS NIH HHS [P30 NS045758, R01 NS047176, NS47176, 5P30NS045758, R01 NS047176-03] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH064954, R01MH062335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047176, P30NS045758] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Araki R, 2004, J BIOL CHEM, V279, P10237, DOI 10.1074/jbc.M312761200; Araki R, 2006, BRAIN RES, V1098, P9, DOI 10.1016/j.brainres.2006.04.096; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Cheng HYM, 2006, J NEUROSCI, V26, P12984, DOI 10.1523/JNEUROSCI.4253-06.2006; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Comas M, 2006, J BIOL RHYTHM, V21, P362, DOI 10.1177/0748730406292446; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Masubuchi S, 2005, J NEUROSCI, V25, P4719, DOI 10.1523/JNEUROSCI.4761-04.2005; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; MCMAHON DG, 1987, J COMP PHYSIOL A, V161, P335, DOI 10.1007/BF00603959; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	44	435	466	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 7	2007	54	5					813	829		10.1016/j.neuron.2007.05.017	http://dx.doi.org/10.1016/j.neuron.2007.05.017			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553428	Green Accepted, Bronze			2022-12-17	WOS:000247329900013
J	Dragoi, G; Buzsaki, G				Dragoi, G; Buzsaki, G			Temporal encoding of place sequences by hippocampal cell assemblies	NEURON			English	Article							THETA-PHASE PRECESSION; NEURAL-NETWORK MODEL; PATH-INTEGRATION; PYRAMIDAL CELLS; ENTORHINAL CORTEX; MEMORY RETRIEVAL; MEDIAL SEPTUM; BEHAVING RAT; FREE-RECALL; EEG-THETA	Both episodic memory and spatial navigation require temporal encoding of the relationships between events or locations. In a linear maze, ordered spatial distances between sequential locations were represented by the temporal relations of hippocampal place cell pairs within cycles of theta oscillation in a compressed manner. Such correlations could arise due to spike "phase precession" of independent neurons driven by common theta pacemaker or as a result of temporal coordination among specific hippocampal cell assemblies. We found that temporal correlation between place cell pairs was stronger than predicted by a pacemaker drive of independent neurons, indicating a critical role for synaptic interactions and precise timing within and across cell assemblies in place sequence representation. CA1 and CA3 ensembles, identifying spatial locations, were active preferentially on opposite phases of theta cycles. These observations suggest that interleaving CA3 neuronal sequences bind CA1 assemblies representing overlapping past, present, and future locations into single episodes.	State Univ New Jersey, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Massachusetts Institute of Technology (MIT); Northwell Health	Dragoi, G (corresponding author), State Univ New Jersey, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	gdragoi@mit.edu; buzsaki@axon.rutgers.edu		Buzsaki, Gyorgy/0000-0002-3100-4800				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Gulyas AI, 2003, EUR J NEUROSCI, V17, P1861, DOI 10.1046/j.1460-9568.2003.02630.x; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kanerva P., 1988, SPARSE DISTRIBUTED M; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; KONOPACKI J, 1988, BRAIN RES, V451, P33, DOI 10.1016/0006-8993(88)90746-9; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Samsonovich AV, 2005, LEARN MEMORY, V12, P193, DOI 10.1101/lm.85205; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.3.CO;2-J; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; TULVING E, 1969, SCIENCE, V164, P88, DOI 10.1126/science.164.3875.88; Tulving E., 1972, ORG MEMORY, V1, P381, DOI DOI 10.1007/978-1-4419-0463-8_37; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yamaguchi Y, 2002, J NEUROPHYSIOL, V87, P2629, DOI 10.1152/jn.2002.87.6.2629; Zugaro MB, 2005, NAT NEUROSCI, V8, P67, DOI 10.1038/nn1369	67	435	442	3	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 6	2006	50	1					145	157		10.1016/j.neuron.2006.02.023	http://dx.doi.org/10.1016/j.neuron.2006.02.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600862	Bronze			2022-12-17	WOS:000236811300017
J	Neumann, S; Bradke, F; Tessier-Lavigne, M; Basbaum, AI				Neumann, S; Bradke, F; Tessier-Lavigne, M; Basbaum, AI			Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH; CNS MYELIN; ADULT; RAT; NEURONS; LESION; SCAR; PROJECTIONS	The peripheral branch of primary sensory neurons regenerates after injury, but there is no regeneration when their central branch is severed by spinal cord injury. Here we show that microinjection of a membrane-permeable analog of cAMP in lumbar dorsal root ganglia markedly increases the regeneration of injured central sensory branches. The injured axons regrow into the spinal cord lesion, often traversing the injury site. This result mimics the effect of a conditioning peripheral nerve lesion. We also demonstrate that sensory neurons exposed to cAMP in vivo, when subsequently cultured in vitro, show enhanced growth of neurites and an ability to overcome inhibition by CNS myelin. Thus, stimulating cAMP signaling increases the intrinsic growth capacity of injured sensory axons. This approach may be useful in promoting regeneration after spinal cord injury.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Sci Biol, 371 Serra Mall, Stanford, CA 94305 USA.			Bradke, Frank/0000-0002-0345-3772				Andersen PL, 2000, EXP NEUROL, V166, P153, DOI 10.1006/exnr.2000.7485; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; BENFEY M, 1985, J NEUROCYTOL, V14, P279, DOI 10.1007/BF01258453; Blesch A, 1999, J NEUROSCI, V19, P3556; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DEHOOP MJ, 1997, CELL BIOL LAB HDB, P154; FAWCETT JW, 1992, TRENDS NEUROSCI, V15, P5, DOI 10.1016/0166-2236(92)90338-9; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; KALDERON N, 1990, P NATL ACAD SCI USA, V87, P10058, DOI 10.1073/pnas.87.24.10058; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; RAMONYCAJAL S, 1991, DEGENERATION REGENER; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; ROBERTSON B, 1989, J NEUROCYTOL, V18, P77, DOI 10.1007/BF01188426; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SHAW G, 1986, EUR J CELL BIOL, V42, P1; Smith DS, 1997, J NEUROSCI, V17, P646; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515	37	435	480	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					885	893		10.1016/S0896-6273(02)00702-X	http://dx.doi.org/10.1016/S0896-6273(02)00702-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086637	Bronze			2022-12-17	WOS:000176249700007
J	Hubner, CA; Stein, V; Hermans-Borgmeyer, I; Meyer, T; Ballanyi, K; Jentsch, TJ				Hubner, CA; Stein, V; Hermans-Borgmeyer, I; Meyer, T; Ballanyi, K; Jentsch, TJ			Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition	NEURON			English	Article							SPINAL-CORD PREPARATION; RESPIRATORY RHYTHM; NA+-K+-2CL(-) COTRANSPORTER; HYPOKALEMIC ALKALOSIS; BARTTERS-SYNDROME; CHLORIDE CHANNEL; RAT-BRAIN; GABA; NEURONS; EXPRESSION	Synaptic inhibition by GABA, and glycine receptors, which are ligand-gated anion channels, depends on the electrochemical potential for chloride. Several potassium-chloride cotransporters can lower the intracellular chloride concentration [Cl-](i), including the neuronal isoform KCC2. We show that KCC2 knockout mice died immediately after birth due to severe motor deficits that also abolished respiration. Sciatic nerve recordings revealed abnormal spontaneous electrical activity and altered spinal cord responses to peripheral electrical stimuli. In the spinal cord of wild-type animals, the KCC2 protein was found at inhibitory synapses. Patch-clamp measurements of embryonic day 18.5 spinal cord motoneurons demonstrated an excitatory GABA and glycine action in the absence, but not in the presence, of KCC2, revealing a crucial role of KCC2 for synaptic inhibition.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Univ Gottingen, Zentrum Physiol & Pathophysiol, D-37073 Gottingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Martinistr 52, D-20246 Hamburg, Germany.		Stein, Valentin/A-8025-2008; Hübner, Christian/A-2950-2017	Stein, Valentin/0000-0003-1222-4928; Hübner, Christian/0000-0002-1030-4943; Jentsch, Thomas/0000-0002-3509-2553				Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BISCOE TJ, 1986, J PHYSIOL-LONDON, V379, P275, DOI 10.1113/jphysiol.1986.sp016253; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; BUCKLE PJ, 1981, N-S ARCH PHARMACOL, V315, P211, DOI 10.1007/BF00499837; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Clayton GH, 1998, DEV BRAIN RES, V109, P281, DOI 10.1016/S0165-3806(98)00078-9; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; FELDMAN JL, 1989, ANN NY ACAD SCI, V563, P114, DOI 10.1111/j.1749-6632.1989.tb42194.x; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; GAO BX, 1995, J NEUROPHYSIOL, V74, P113, DOI 10.1152/jn.1995.74.1.113; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; KIRSCH J, 1995, J NEUROSCI, V15, P418; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lloyd DPC, 1943, J NEUROPHYSIOL, V6, P317, DOI 10.1152/jn.1943.6.4.317; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Obrietan K, 1997, J NEUROSCI, V17, P4785; ONIMARU H, 1987, BRAIN RES, V403, P380, DOI 10.1016/0006-8993(87)90080-1; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; PRICHARD JW, 1969, J PHARMACOL EXP THER, V166, P170; Randall J, 1997, AM J PHYSIOL-CELL PH, V273, pC1267, DOI 10.1152/ajpcell.1997.273.4.C1267; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SCHNEIDER SP, 1992, J NEUROPHYSIOL, V68, P397, DOI 10.1152/jn.1992.68.2.397; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH RL, 1995, J NEUROSCI, V15, P4057; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; Sung KW, 2000, J NEUROSCI, V20, P7531; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Vardi N, 2000, J NEUROSCI, V20, P7657; VOIPIO J, 2000, GABAERGIC EXCITATION, V125; Vu TQ, 2000, J NEUROSCI, V20, P1414; WENTWORTH LE, 1984, J COMP NEUROL, V222, P81, DOI 10.1002/cne.902220108; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942	44	435	441	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					515	524		10.1016/S0896-6273(01)00297-5	http://dx.doi.org/10.1016/S0896-6273(01)00297-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395011	hybrid, Green Published			2022-12-17	WOS:000168962000022
J	Huth, AG; Nishimoto, S; Vu, AT; Gallant, JL				Huth, Alexander G.; Nishimoto, Shinji; Vu, An T.; Gallant, Jack L.			A Continuous Semantic Space Describes the Representation of Thousands of Object and Action Categories across the Human Brain	NEURON			English	Article							VENTRAL TEMPORAL CORTEX; HUMAN VISUAL-CORTEX; HUMAN EXTRASTRIATE CORTEX; FUSIFORM GYRUS; FUNCTIONAL-ANATOMY; BIOLOGICAL MOTION; NATURAL IMAGES; FACE PATCH; HUMAN-BODY; FMRI	Humans can see and name thousands of distinct object and action categories, so it is unlikely that each category is represented in a distinct brain area. A more efficient scheme would be to represent categories as locations in a continuous semantic space mapped smoothly across the cortical surface. To search for such a space, we used fMRI to measure human brain activity evoked by natural movies. We then used voxelwise models to examine the cortical representation of 1,705 object and action categories. The first few dimensions of the underlying semantic space were recovered from the fit models by principal components analysis. Projection of the recovered semantic space onto cortical flat maps shows that semantic selectivity is organized into smooth gradients that cover much of visual and nonvisual cortex. Furthermore, both the recovered semantic space and the cortical organization of the space are shared across different individuals.	[Huth, Alexander G.; Nishimoto, Shinji; Gallant, Jack L.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Vu, An T.; Gallant, Jack L.] Univ Calif Berkeley, Bioengn Program, Berkeley, CA 94720 USA; [Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Vu, An/ACV-0346-2022	Vu, An/0000-0003-2463-7789; Nishimoto, Shinji/0000-0001-8015-340X	National Eye Institute [EY019684]; Center for Science of Information (CSoI), an NSF Science and Technology Center [CCF-0939370]; William Orr Dingwall Neurolinguistics Fellowship; NATIONAL EYE INSTITUTE [R01EY019684] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Center for Science of Information (CSoI), an NSF Science and Technology Center; William Orr Dingwall Neurolinguistics Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by grants from the National Eye Institute (EY019684) and from the Center for Science of Information (CSoI), an NSF Science and Technology Center, under grant agreement CCF-0939370. A.G.H. was also supported by the William Orr Dingwall Neurolinguistics Fellowship. We thank Natalia Bilenko and Tolga Cukur for helping with fMRI data collection, Neil Thompson for assistance with the Word Net analysis, and Tom Griffiths and Sonia Bishop for discussions regarding the manuscript. A.G.H., S.N., and J.L.G. conceived and designed the experiment. A.G.H., S.N., and A.T.V. collected the fMRI data. A.T.V. and Tolga Cukur customized and optimized the fMRI pulse sequence. A.T.V. did brain flattening and localizer analysis. A.G.H. tagged the movies. S.N. and A.G.H. analyzed the data. A.G.H. and J.L.G. wrote the paper.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Clark VP, 1996, NEUROIMAGE, V4, P1, DOI 10.1006/nimg.1996.0025; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Connolly AC, 2012, J NEUROSCI, V32, P2608, DOI 10.1523/JNEUROSCI.5547-11.2012; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Hansen KA, 2007, J NEUROSCI, V27, P11896, DOI 10.1523/JNEUROSCI.2991-07.2007; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones E., 2001, SCIPY OPEN SOURCE SC; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; O'Toole AJ, 2005, J COGNITIVE NEUROSCI, V17, P580, DOI 10.1162/0898929053467550; Oliphant T.E., 2006, A GUIDE TO NUMPY, VVol. 1; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajimehra R, 2009, P NATL ACAD SCI USA, V106, P1995, DOI 10.1073/pnas.0807304106; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Smith AT, 1998, J NEUROSCI, V18, P3816; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322	56	434	446	10	118	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 20	2012	76	6					1210	1224		10.1016/j.neuron.2012.10.014	http://dx.doi.org/10.1016/j.neuron.2012.10.014			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	065NI	23259955	Green Accepted, Bronze			2022-12-17	WOS:000313154800017
J	Hasenstaub, A; Shu, YS; Haider, B; Kraushaar, U; Duque, A; McCormick, DA				Hasenstaub, A; Shu, YS; Haider, B; Kraushaar, U; Duque, A; McCormick, DA			Inhibitory postsynaptic potentials carry synchronized frequency information in active cortical networks	NEURON			English	Article							RAT FRONTAL-CORTEX; CAT VISUAL-CORTEX; NEURONS IN-VIVO; PYRAMIDAL CELLS; SOMATOSENSORY CORTEX; ELECTRICAL SYNAPSES; NEOCORTICAL NEURONS; AUDITORY-CORTEX; CEREBRAL-CORTEX; GABAERGIC INTERNEURONS	Temporal precision in spike timing is important in cortical function, interactions, and plasticity. We found that, during periods of recurrent network activity (UP states), cortical pyramidal cells in vivo and in vitro receive strong barrages of both excitatory and inhibitory postsynaptic potentials, with the inhibitory potentials showing much higher power at all frequencies above approximately 10 Hz and more synchrony between nearby neurons. Fast-spiking inhibitory interneurons discharged strongly in relation to higher-frequency oscillations in the field potential in vivo and possess membrane, synaptic, and action potential properties that are advantageous for transmission of higher-frequency activity. Intracellular injection of synaptic conductances having the characteristics of the recorded EPSPs and IPSPs reveal that IPSPs are Important in controlling the timing and probability of action potential generation in pyramidal cells. Our results support the hypothesis that inhibitory networks are largely responsible for the dissemination of higher-frequency activity in cortex.	Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	david.mccormick@yale.edu	Kobelt, Liza/F-5926-2011; Shu, Yousheng/AAC-3881-2020	Shu, Yousheng/0000-0002-2834-2876; Haider, Bilal/0000-0002-6382-1426; Kraushaar, Udo/0000-0002-4660-1093				BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Fellous JM, 2001, J NEUROPHYSIOL, V85, P1782, DOI 10.1152/jn.2001.85.4.1782; Foffani G, 2004, J NEUROSCI, V24, P7266, DOI 10.1523/JNEUROSCI.2523-04.2004; Fregnac Y, 2003, J PHYSIOLOGY-PARIS, V97, P441, DOI 10.1016/j.jphysparis.2004.02.004; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gao WJ, 2003, P NATL ACAD SCI USA, V100, P2836, DOI 10.1073/pnas.262796399; Gibson JR, 2005, J NEUROPHYSIOL, V93, P467, DOI 10.1152/jn.00520.2004; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Jones MS, 2000, J NEUROPHYSIOL, V84, P1505, DOI 10.1152/jn.2000.84.3.1505; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mann EO, 2005, J PHYSIOL-LONDON, V562, P55, DOI 10.1113/jphysiol.2004.078758; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shu YS, 2003, J NEUROSCI, V23, P10388; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Varela JA, 1999, J NEUROSCI, V19, P4293; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0	60	434	444	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					423	435		10.1016/j.neuron.2005.06.016	http://dx.doi.org/10.1016/j.neuron.2005.06.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055065	Bronze			2022-12-17	WOS:000231051900012
J	Quirk, GJ; Armony, JL; LeDoux, JE				Quirk, GJ; Armony, JL; LeDoux, JE			Fear conditioning enhances different temporal components of tone-evoked spike trains in auditory cortex and lateral amygdala	NEURON			English	Article							MEDIAL GENICULATE-BODY; RECEPTIVE-FIELD PLASTICITY; POTENTIATED STARTLE; SINGLE NEURONS; PHYSIOLOGICAL PLASTICITY; UNCONDITIONED STIMULUS; RESPONSE PROPERTIES; PERIRHINAL CORTEX; HEART-RATE; NUCLEUS	Single neurons were recorded in freely behaving rats during fear conditioning from areas of auditory cortex that project to the lateral nucleus of the amygdala (LA). The latency and rate of conditioning and extinction were analyzed, and the results were compared to previous recordings from LA itself. Auditory cortex neurons took more trials to learn, and they responded more slowly than LA neurons within trials. Short-latency plasticity in LA, therefore, reflects inputs from the auditory thalamus rather than the auditory cortex. Unlike LA cells, some auditory cortex cells showed late conditioned responses that seemed to anticipate the unconditioned stimulus, while others showed extinction-resistant memory storage. Thus, rapid conditioning of fear responses to potentially dangerous stimuli depends on plasticity in the amygdala, while cortical areas may be particularly involved in higher cognitive (mnemonic and attentional) processing of fear experiences.	NYU,CTR NEURAL SCI,NEW YORK,NY 10003	New York University					NIMH NIH HHS [MH46516, MH38774, MH00956] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038774, R01MH038774, R01MH046516, K02MH000956] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adey W R, 1967, Prog Brain Res, V27, P228; Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Armony JL, 1997, TRENDS COGN SCI, V1, P28, DOI 10.1016/S1364-6613(97)01007-3; BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; BIRT D, 1979, BRAIN RES, V167, P129, DOI 10.1016/0006-8993(79)90268-3; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BORDI F, 1992, J NEUROSCI, V12, P2493; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; BOUTON ME, 1994, CURR DIR PSYCHOL SCI, V3, P49, DOI 10.1111/1467-8721.ep10769943; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; CHAMEY DS, 1996, CRIT REV NEUROBIOL, V10, P419; CLUGNET MC, 1990, J NEUROSCI, V10, P2818; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; CRUIKSHANK SJ, 1992, BEHAV NEUROSCI, V106, P471, DOI 10.1037/0735-7044.106.3.471; DAVIS M, 1989, J EXP PSYCHOL-ANIM B, V15, P295, DOI 10.1037/0097-7403.15.4.295; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; DIAMOND DM, 1984, BEHAV NEUROSCI, V98, P189, DOI 10.1037/0735-7044.98.2.189; DIAMOND DM, 1986, BRAIN RES, V372, P357, DOI 10.1016/0006-8993(86)91144-3; DISTERHOFT JF, 1976, J NEUROPHYSIOL, V39, P266, DOI 10.1152/jn.1976.39.2.266; EDELINE JM, 1990, PSYCHOBIOLOGY, V18, P382; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P539, DOI 10.1037/0735-7044.107.4.539; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; FALLS WA, 1992, J NEUROSCI, V12, P854; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P275; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P124; GALLISTEL CR, 1990, ORG LEARNING, P287; GONZALEZLIMA F, 1986, BEHAV BRAIN RES, V20, P281, DOI 10.1016/0166-4328(86)90228-7; JARELL TW, 1987, BRAIN RES, V412, P285; KAPP B S, 1992, P229; KRAUS N, 1982, BRAIN RES, V246, P205, DOI 10.1016/0006-8993(82)91168-4; KUBIE JL, 1984, PHYSIOL BEHAV, V32, P115, DOI 10.1016/0031-9384(84)90080-5; Ledoux J E, 1989, J Cogn Neurosci, V1, P238, DOI 10.1162/jocn.1989.1.3.238; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEDOUX JE, 1984, J NEUROSCI, V4, P683; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; LEDOUX JE, 1983, SCIENCE, V221, P576, DOI 10.1126/science.6867731; LI XF, 1995, EXP BRAIN RES, V105, P87; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; MASCAGNI F, 1993, NEUROSCIENCE, V57, P697, DOI 10.1016/0306-4522(93)90016-9; MCECHRON MD, 1995, BRAIN RES, V682, P157, DOI 10.1016/0006-8993(95)00331-J; MISERENDINO MJD, 1990, NATURE, V163, P109; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Ohman A., 1992, HDB EMOTIONS, P511; OLESON TD, 1975, J NEUROPHYSIOL, V38, P1114, DOI 10.1152/jn.1975.38.5.1114; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Quirk GJ, 1996, COLD SPRING HARB SYM, V61, P247; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; ROSEN JB, 1992, J NEUROSCI, V12, P4624; RYUGO DK, 1978, BEHAV BIOL, V22, P275, DOI 10.1016/S0091-6773(78)92351-9; SEGAL M, 1973, J NEUROPHYSIOL, V36, P840, DOI 10.1152/jn.1973.36.5.840; SHALEV AY, 1992, BIOL PSYCHIAT, V31, P863, DOI 10.1016/0006-3223(92)90113-E; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Swanson L., 1992, BRAIN MAPS STRUCTURE; TEICH AH, 1989, BRAIN RES, V480, P210, DOI 10.1016/0006-8993(89)91584-9; TIAN B, 1994, J NEUROPHYSIOL, V71, P1959, DOI 10.1152/jn.1994.71.5.1959; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; WEINBERGER NM, 1984, BEHAV NEUROSCI, V98, P171, DOI 10.1037/0735-7044.98.2.171; Weinberger Norman M., 1995, P1071; WOLPE J, 1988, BEHAV RES THER, V26, P441, DOI 10.1016/0005-7967(88)90138-6; WOOLF NJ, 1994, NEUROREPORT, V5, P1045, DOI 10.1097/00001756-199405000-00007; Zilles K., 1985, RAT NERVOUS SYSTEM F, V1, P375	74	434	442	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					613	624		10.1016/S0896-6273(00)80375-X	http://dx.doi.org/10.1016/S0896-6273(00)80375-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XZ016	9331352	hybrid			2022-12-17	WOS:A1997XZ01600015
J	TOMASIEWICZ, H; ONO, K; YEE, DL; THOMPSON, C; GORIDIS, C; RUTISHAUSER, U; MAGNUSON, T				TOMASIEWICZ, H; ONO, K; YEE, DL; THOMPSON, C; GORIDIS, C; RUTISHAUSER, U; MAGNUSON, T			GENETIC DELETION OF A NEURAL CELL-ADHESION MOLECULE VARIANT (N-CAM-180) PRODUCES DISTINCT DEFECTS IN THE CENTRAL-NERVOUS-SYSTEM	NEURON			English	Article							EMBRYONIC STEM-CELLS; GERM-LINE TRANSMISSION; N-CAM; NEURITE OUTGROWTH; POLYSIALIC ACID; TRANSMEMBRANE DISPOSITION; RETINOTECTAL PROJECTION; SURFACE MODULATION; CYTOPLASMIC DOMAIN; 180-KD COMPONENT	N-CAM is abundantly expressed in the nervous system in the form of numerous structural variants with characteristic distribution patterns and functional properties. N-CAM-180, the variant having the largest cytoplasmic domain, is expressed by all neurons. The N-CAM-180-specific exon 18 has been deleted to generate homozygous mice unable to express this N-CAM form. The most conspicuous mutant phenotype was in the olfactory bulb, where granule cells were both reduced in number and disorganized. In addition, precursors of these cells were found to be accumulated at their origin in the subependymal zone at the lateral ventricle. Analysis of the mutant in this region suggests that the mutant phenotype involves a defect in cell migration, possibly through specific loss of the polysialylated form of N-CAM-180, which is expressed in the migration pathway. Subtle but distinct abnormalities also were observed in other regions of the brain.	CNRS,CTR IMMUNOL,INSERM,F-13288 MARSEILLE 9,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	TOMASIEWICZ, H (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106, USA.				NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD26722, HD18369] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369, R01HD026722] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006107] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BRONNERFRASER M, 1992, DEV BIOL, V153, P291, DOI 10.1016/0012-1606(92)90114-V; BRUNJES PC, 1986, BRAIN RES REV, V11, P1, DOI 10.1016/0165-0173(86)90008-1; BUSKIRK DR, 1980, NATURE, V285, P488, DOI 10.1038/285488a0; CALEY DW, 1973, AM J ANAT, V133, P179; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CHUONG CM, 1984, J NEUROSCI, V4, P2354; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; DOHERTY P, 1992, J NEUROCHEM, V58, P2338, DOI 10.1111/j.1471-4159.1992.tb10984.x; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FRASER SE, 1988, DEV BIOL, V129, P217, DOI 10.1016/0012-1606(88)90176-5; FREDETTE B, 1993, IN PRESS J CELL BIOL; FREI T, 1992, J CELL BIOL, V118, P177, DOI 10.1083/jcb.118.1.177; GENNARINI G, 1984, EUR J BIOCHEM, V142, P65, DOI 10.1111/j.1432-1033.1984.tb08251.x; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; GENNARINI G, 1986, J NEUROSCI, V6, P1983; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; INOUYE M, 1980, J COMP NEUROL, V190, P357, DOI 10.1002/cne.901900209; KEY B, 1991, NEURON, V6, P381, DOI 10.1016/0896-6273(91)90247-W; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; KOHLER BH, 1989, P NATL ACAD SCI USA, V86, P8927; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MAXWELL IH, 1986, CANCER RES, V46, P4660; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MIRAGALL F, 1990, J NEUROCYTOL, V19, P889; MURRAY BA, 1986, J CELL BIOL, V103, P1431, DOI 10.1083/jcb.103.4.1431; NOBLE M, 1985, NATURE, V316, P725, DOI 10.1038/316725a0; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; RUTISHAUSER U, 1980, J CELL BIOL, V87, P370, DOI 10.1083/jcb.87.2.370; RUTISHAUSER U, 1983, J CELL BIOL, V97, P145, DOI 10.1083/jcb.97.1.145; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; RUTISHAUSER U, 1991, RECEPTORS EXTRACELLU, P132; RUTISHAUSER U, 1993, CURR OPIN NEUROBIOL, V3, P7096; SADOUL R, 1983, NATURE, V304, P347, DOI 10.1038/304347a0; SANTONI MJ, 1987, NUCLEIC ACIDS RES, V15, P8621, DOI 10.1093/nar/15.21.8621; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; SHIGA T, 1983, ANAT EMBRYOL, V167, P203, DOI 10.1007/BF00298511; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SMALL SJ, 1988, NEURON, V1, P1007, DOI 10.1016/0896-6273(88)90158-4; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMPSON J, 1989, GENE DEV, V3, P348, DOI 10.1101/gad.3.3.348; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TOSNEY KW, 1986, DEV BIOL, V114, P468; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992	68	434	446	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1163	1174		10.1016/0896-6273(93)90228-J	http://dx.doi.org/10.1016/0896-6273(93)90228-J			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274281				2022-12-17	WOS:A1993MP54800016
J	Saudou, F; Humbert, S				Saudou, Frederic; Humbert, Sandrine			The Biology of Huntingtin	NEURON			English	Review							WILD-TYPE HUNTINGTIN; FULL-LENGTH HUNTINGTIN; N-TERMINAL FRAGMENTS; DISEASE GENE HOMOLOG; MUTANT HUNTINGTIN; BINDING-PROTEIN; MOUSE MODELS; LACKING HUNTINGTIN; AXONAL-TRANSPORT; SELECTIVE MACROAUTOPHAGY	Huntingtin (HTT) is now a famous protein because an abnormal expansion of a glutamine stretch (polyQ) in its N-terminal sequence leads to the devastating neurodegenerative disorder Huntington's disease (HD). The gene encoding huntingtin, HTT, and its dominantly inherited mutation were identified more than 20 years ago. Subsequently, in the hope of finding a cure for HD, there has been intense research aimed at understanding the molecular mechanisms underlying the deleterious effects of the presence of the abnormal polyQ expansion in HTT. Notwithstanding with the value of this approach, evidence has been emerging of a potential role of context and function of the HTT protein in the specificity and severity of the pathogenicity. HTT is ubiquitous both at the tissue and subcellular levels. It interacts with many partners and has long been considered having no clearly defined cellular function. Based on research over the past 20 years, specifically focused on the function of wild-type HTT, we reconsider the literature describing HTT-regulated molecular and cellular mechanisms that could be dysfunctional in HD and their possible physiological consequences for patients.	[Saudou, Frederic; Humbert, Sandrine] Univ Grenoble Alpes, Grenoble Inst Neurosci, F-38000 Grenoble, France; [Saudou, Frederic; Humbert, Sandrine] INSERM, U1216, F-38000 Grenoble, France; [Saudou, Frederic] CHU Grenoble Alpes, F-38000 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes	Saudou, F; Humbert, S (corresponding author), Univ Grenoble Alpes, Grenoble Inst Neurosci, F-38000 Grenoble, France.; Saudou, F; Humbert, S (corresponding author), INSERM, U1216, F-38000 Grenoble, France.; Saudou, F (corresponding author), CHU Grenoble Alpes, F-38000 Grenoble, France.	frederic.saudou@inserm.fr; sandrine.humbert@univ-grenoble-alpes.fr	Humbert, Sandrine/S-2981-2016; SAUDOU, Frédéric/L-3454-2014	SAUDOU, Frédéric/0000-0001-6107-1046; Humbert, Sandrine/0000-0002-9501-2658	Agence Nationale pour la Recherche [ANR-12-BLAN-SVSE2-HURIT, ANR-14-CE35-0027-PASSAGE, ANR-12-BLANC-SVSE4]; Fondation pour la Recherche Medicale (FRM, equipe labellisee); Canceropole Ile-de France [INCA_6517]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM, equipe labellisee); Canceropole Ile-de France(Region Ile-de-France)	This review is dedicated to HD patients and their families. We acknowledge Joan S. Steffan for helpful comments on the manuscript, Agnieszka Kawska at IlluScientia. com for the graphical design of the figures, lab members for discussion, and Association Huntington France (AHF) for continuous support. F.S. and S.H. laboratories are members of the Grenoble Center of Excellence in Neurodegeneration (GREEN) and are supported by grants from Agence Nationale pour la Recherche (ANR-12-BLAN-SVSE2-HURIT and ANR-14-CE35-0027-PASSAGE, F.S.; ANR-12-BLANC-SVSE4, S.H.), Fondation pour la Recherche Medicale (FRM, equipe labellisee, S.H.), Canceropole Ile-de France (INCA_6517, S.H.).	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Aylward EH, 2011, J NEUROL NEUROSUR PS, V82, P405, DOI 10.1136/jnnp.2010.208264; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; Becanovic K, 2015, NAT NEUROSCI, V18, P807, DOI 10.1038/nn.4014; Ben M'Barek K, 2013, J NEUROSCI, V33, P8608, DOI 10.1523/JNEUROSCI.5110-12.2013; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Caviston JP, 2011, MOL BIOL CELL, V22, P478, DOI 10.1091/mbc.E10-03-0233; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Cong X, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009829; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Dietrich P, 2009, HUM MOL GENET, V18, P142, DOI 10.1093/hmg/ddn324; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Drouet V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099341; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; El-Daher MT, 2015, EMBO J, V34, P2255, DOI 10.15252/embj.201490808; Elias S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002142; Elias S, 2014, STEM CELL REP, V2, P491, DOI 10.1016/j.stemcr.2014.02.011; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Futter M, 2009, J MED GENET, V46, P438, DOI 10.1136/jmg.2009.066399; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Haremaki T, 2015, DEV BIOL, V408, P305, DOI 10.1016/j.ydbio.2015.07.013; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Huang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121055; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Hughes AC, 2014, J MOL BIOL, V426, P1428, DOI 10.1016/j.jmb.2013.12.028; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karam A, 2015, NEUROBIOL DIS, V80, P15, DOI 10.1016/j.nbd.2015.05.008; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Legendre-Guillemin V, 2002, J BIOL CHEM, V277, P19897, DOI 10.1074/jbc.M112310200; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; Li X, 2008, NEUROREPORT, V19, P1643, DOI 10.1097/WNR.0b013e328315cd4c; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; Liot G, 2013, J NEUROSCI, V33, P6298, DOI 10.1523/JNEUROSCI.2033-12.2013; Lo Sardo V, 2012, NAT NEUROSCI, V15, P713, DOI 10.1038/nn.3080; Lumsden AL, 2007, HUM MOL GENET, V16, P1905, DOI 10.1093/hmg/ddm138; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Marcora E, 2003, P NATL ACAD SCI USA, V100, P9578, DOI 10.1073/pnas.1133382100; Martin DDO, 2014, HUM MOL GENET, V23, P3166, DOI 10.1093/hmg/ddu027; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Neveklovska M, 2012, J HUNTINGTONS DIS, V1, P71, DOI 10.3233/JHD-2012-120016; O'Kusky JR, 1999, BRAIN RES, V818, P468, DOI 10.1016/S0006-8993(98)01312-2; Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reiner A, 2001, J NEUROSCI, V21, P7608, DOI 10.1523/JNEUROSCI.21-19-07608.2001; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101; Ruzo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127687; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shimojo M, 2008, J BIOL CHEM, V283, P34880, DOI 10.1074/jbc.M804183200; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Sousa CM, 2013, J HUNTINGTONS DIS, V2, P395, DOI 10.3233/JHD-130082; Sousa CM, 2013, EMBO MOL MED, V5, P309, DOI 10.1002/emmm.201201546; Steffan JS, 2010, CELL CYCLE, V9, P3401, DOI [10.4161/cc.9.17.12718, 10.4161/cc.9.17.12671]; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Takano H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-15; Tartari M, 2008, MOL BIOL EVOL, V25, P330, DOI 10.1093/molbev/msm258; Thion MS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv208; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Tong YA, 2011, J NEUROSCI, V31, P14794, DOI 10.1523/JNEUROSCI.2774-11.2011; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Valor LM, 2015, MOL NEUROBIOL, V51, P406, DOI 10.1007/s12035-014-8715-8; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Waelter S, 2001, HUM MOL GENET, V10, P1807, DOI 10.1093/hmg/10.17.1807; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Watkin EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088284; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yohrling GJ, 2003, MOL CELL NEUROSCI, V23, P28, DOI 10.1016/S1044-7431(03)00032-0; Zala D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060162; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	148	433	438	13	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2016	89	5					910	926		10.1016/j.neuron.2016.02.003	http://dx.doi.org/10.1016/j.neuron.2016.02.003			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI5UG	26938440	Bronze			2022-12-17	WOS:000373565400006
J	Ecker, JL; Dumitrescu, ON; Wong, KY; Alam, NM; Chen, SK; LeGates, T; Renna, JM; Prusky, GT; Berson, DM; Hattar, S				Ecker, Jennifer L.; Dumitrescu, Olivia N.; Wong, Kwoon Y.; Alam, Nazia M.; Chen, Shih-Kuo; LeGates, Tara; Renna, Jordan M.; Prusky, Glen T.; Berson, David M.; Hattar, Samer			Melanopsin-Expressing Retinal Ganglion-Cell Photoreceptors: Cellular Diversity and Role in Pattern Vision	NEURON			English	Article							HYPOTHALAMIC SUPRACHIASMATIC NUCLEUS; SPATIAL VISION; KNOCKOUT MICE; LIGHT; MOUSE; RESPONSES; PROJECTIONS; CONE; REVEALS; SYSTEM	Using the photopigment melanopsin, intrinsically photosensitive retinal ganglion cells (ipRGCs) respond directly to light to drive circadian clock resetting and pupillary constriction. We now report that ipRGCs are more abundant and diverse than previously appreciated, project more widely within the brain, and can support spatial visual perception. A Cre-based melanopsin reporter mouse line revealed at least five subtypes of ipRGCs with distinct morphological and physiological characteristics. Collectively, these cells project beyond the known brain targets of ipRGCs to heavily innervate the superior colliculus and dorsal lateral geniculate nucleus, retinotopically organized nuclei mediating object localization and discrimination. Mice lacking classical rod-cone photoreception, and thus entirely dependent on melanopsin for light detection, were able to discriminate grating stimuli from equiluminant gray and had measurable visual acuity. Thus, nonclassical retinal photoreception occurs within diverse cell types and influences circuits and functions encompassing luminance as well as spatial information.	[Dumitrescu, Olivia N.; Wong, Kwoon Y.; Renna, Jordan M.; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Ecker, Jennifer L.; Chen, Shih-Kuo; LeGates, Tara; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Alam, Nazia M.; Prusky, Glen T.] Weill Cornell Med Coll, Burke Med Res Inst, Dept Physiol & Biophys, White Plains, NY 10605 USA; [Hattar, Samer] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Brown University; Johns Hopkins University; Cornell University; Johns Hopkins University	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	david_berson@brown.edu; shattar@jhu.edu	Hattar, Samer/W-6927-2019	Wong, Kwoon/0000-0001-9279-7827; LeGates, Tara/0000-0002-6005-4786; CHEN, SHIH-KUO/0000-0002-7921-1358	National Institutes of Health [GM076430, EY012793, K99EY018863]; David and Lucile Packard Foundation; Alfred P. Sloan Foundation; NATIONAL EYE INSTITUTE [R01EY012793, K99EY018863, R00EY018863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank several people for providing reagents used in making the targeting construct: Naren Ramanan and David Ginty for the original Cre recombinase plasmid and FAT-flanked neomycin resistance cassette, and Jason Well and Karen Beemon for the human beta-globin intron. The melanopsin antiserum was a kind gift from Ignacio Provencio. Z/AP mice were obtained from Tudor Badea in Jeremy Nathans' laboratory who also provided lots of valuable discussions, and Z/EG mice from Seth Blackshaw. We also thank Dr. Rejji Kuruvilla, Dr. Haiqing Zhao, and David McNeill for their careful reading of the manuscript and helpful suggestions and the Johns Hopkins University Mouse Tri-Lab for support. This work was supported by the National Institutes of Health grants GM076430 (S.H.), EY012793 (D.M.B.), and K99EY018863 (K.W.), the David and Lucile Packard Foundation (S.H.), and the Alfred P. Sloan Foundation (S.H.).	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dkhissi-Benyabya O, 2006, INVEST OPHTH VIS SCI, V47, P1636, DOI 10.1167/iovs.05-1459; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; KAYAMA Y, 1979, J NEUROPHYSIOL, V42, P1495, DOI 10.1152/jn.1979.42.6.1495; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Mrosovsky N, 2002, NATURWISSENSCHAFTEN, V89, P525, DOI 10.1007/s00114-002-0369-0; Mrosovsky N, 1997, NEUROSCI LETT, V222, P204, DOI 10.1016/S0304-3940(97)13374-2; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Prichard JR, 2002, NEUROSCIENCE, V114, P781, DOI 10.1016/S0306-4522(02)00293-2; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, VISION RES, V44, P3411, DOI 10.1016/j.visres.2004.09.001; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034	48	433	437	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					49	60		10.1016/j.neuron.2010.05.023	http://dx.doi.org/10.1016/j.neuron.2010.05.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624591	Bronze, Green Accepted			2022-12-17	WOS:000280221000008
J	Bhat, MA; Rios, JC; Lu, Y; Garcia-Fresco, GP; Ching, W; St Martin, M; Li, JJ; Einheber, S; Chesler, M; Rosenbluth, J; Salzer, JL; Bellen, HJ				Bhat, MA; Rios, JC; Lu, Y; Garcia-Fresco, GP; Ching, W; St Martin, M; Li, JJ; Einheber, S; Chesler, M; Rosenbluth, J; Salzer, JL; Bellen, HJ			Axon-glia interactions and the domain organization of myelinated axons requires Neurexin IV/Caspr/Paranodin	NEURON			English	Article							PROTEIN-COUPLED RECEPTOR-2; SEPTATE JUNCTION; CUTTING EDGE; IDENTIFICATION; EXPRESSION; LOCALIZATION; RANVIER; BINDING; CASPR; CCR10	Myelinated fibers are organized into distinct domains that are necessary for saltatory conduction. These domains include the nodes of Ranvier and the flanking paranodal regions where glial cells closely appose and form specialized septate-like junctions with axons. These junctions contain a Drosophila Neurexin IV-related protein, Caspr/Paranodin (NCP1). Mice that lack NCP1 exhibit tremor, ataxia, and significant motor paresis. In the absence of NCP1, normal paranodal junctions fail to form, and the organization of the paranodal loops is disrupted. Contactin is undetectable in the paranodes, and K+ channels are displaced from the juxtaparanodal into the paranodal domains. Loss of NCP1 also results in a severe decrease in peripheral nerve conduction velocity. These results show a critical role for NCP1 in the delineation of specific axonal domains and the axon-glia interactions required for normal saltatory conduction.	CUNY Mt Sinai Sch Med, Dept Med, Cardiovasc Res Inst, Dept Biochem & Mol Biol, New York, NY 10029 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; NYU, Sch Med, Rusk Inst, New York, NY 10016 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Program Dev Biol, Houston, TX 77030 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; New York University; New York University; New York University; Baylor College of Medicine; Howard Hughes Medical Institute	Bhat, MA (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, Cardiovasc Res Inst, Dept Biochem & Mol Biol, New York, NY 10029 USA.	bhatm01@doc.mssm.edu	; BHAT, MANZOOR/S-9273-2018	Bellen, Hugo/0000-0001-5992-5989; BHAT, MANZOOR/0000-0003-0989-1498; Salzer, James/0000-0001-9126-7197; Chesler, Mitchell/0000-0002-3189-8234	NCI NIH HHS [KO1-CA 78437] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07308] Funding Source: Medline; NINDS NIH HHS [NS38208, NS37475] Funding Source: Medline; CSR NIH HHS [RG2539] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA078437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037475, R01NS038208] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRES KH, 1965, Z ZELLFORSCH MIK ANA, V65, P701, DOI 10.1007/BF00342591; BARGMANN W, 1964, Z ZELLFORSCH MIK ANA, V64, P868, DOI 10.1007/BF00323315; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bennett V, 1999, J NEUROCYTOL, V28, P303, DOI 10.1023/A:1007005528505; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Bonini JA, 1997, DNA CELL BIOL, V16, P1023, DOI 10.1089/dna.1997.16.1023; Bosio A, 1998, CELL TISSUE RES, V292, P199, DOI 10.1007/s004410051051; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Collinson JM, 1998, GLIA, V23, P11, DOI 10.1002/(SICI)1098-1136(199805)23:1<11::AID-GLIA2>3.0.CO;2-7; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dupree JL, 1999, J NEUROCYTOL, V28, P271, DOI 10.1023/A:1007049310758; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dupree JL, 1998, J NEUROSCI, V18, P1642; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; FaivreSarrailh C, 1997, MOL CELL NEUROSCI, V9, P109, DOI 10.1006/mcne.1997.0609; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Jarmin DI, 2000, J IMMUNOL, V164, P3460, DOI 10.4049/jimmunol.164.7.3460; Koch T, 1997, GLIA, V19, P199, DOI 10.1002/(SICI)1098-1136(199703)19:3<199::AID-GLIA3>3.0.CO;2-V; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; RAINE CS, 1982, J NEUROCYTOL, V11, P935, DOI 10.1007/BF01148309; RLOS JC, 2000, J NEUROSCI, V20, P8354; ROBERTSON JD, 1957, J PHYSIOL-LONDON, V137, pP8; Rosenbluth Jack, 1995, P613; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; TALT S, 2000, J CELL BIOL, V150, P657; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Thullier F, 1999, PHARMACOL BIOCHEM BE, V63, P213, DOI 10.1016/S0091-3057(98)00228-7; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463	40	433	440	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					369	383		10.1016/S0896-6273(01)00294-X	http://dx.doi.org/10.1016/S0896-6273(01)00294-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395000	Bronze			2022-12-17	WOS:000168962000011
J	HILLE, B				HILLE, B			G-PROTEIN-COUPLED MECHANISMS AND NERVOUS SIGNALING	NEURON			English	Review							RAT SYMPATHETIC NEURONS; BETA-GAMMA-SUBUNITS; GTP-BINDING-PROTEINS; MUSCARINIC K+-CHANNEL; ADRENERGIC MODULATION; DOPAMINE OVERFLOW; RECEPTOR SUBTYPES; CALCIUM CURRENTS; GANGLION NEURONS; ADENYLYL CYCLASE				HILLE, B (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER; NINDS NIH HHS [NS08174] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BERNHEIM L, 1992, IN PRESS P NATL ACAD; BERNSTEIN G, 1992, J BIOL CHEM, V267, P8081; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BULL DR, 1990, J NEUROSCI METH, V32, P37, DOI 10.1016/0165-0270(90)90069-R; CAVALIE A, 1991, PFLUG ARCH EUR J PHY, V419, P433, DOI 10.1007/BF00370785; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DOLPHIN AC, 1991, BIOCHIM BIOPHYS ACTA, V1091, P68, DOI 10.1016/0167-4889(91)90224-L; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; Fuxe K, 1991, VOLUME TRANSMISSION; HARTZELL HC, 1980, J CELL BIOL, V86, P6, DOI 10.1083/jcb.86.1.6; HARTZELL HC, 1988, PROG BIOPHYS MOL BIO, V52, P165, DOI 10.1016/0079-6107(88)90014-4; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; HERKENHAM M, 1991, VOLUME TRANSMISSION, P63; HILLE B, 1986, DISCUSSIONS NEUROSCI, V3, P75; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JELSEMA CL, 1987, P NATL ACAD SCI USA, V84, P3623, DOI 10.1073/pnas.84.11.3623; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; KIM D, 1989, NATURE, V337, P557, DOI 10.1038/337557a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KURACHI Y, 1989, PFLUG ARCH EUR J PHY, V413, P325, DOI 10.1007/BF00583550; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; MCCORMICK DA, 1989, P NATL ACAD SCI USA, V86, P8098, DOI 10.1073/pnas.86.20.8098; MCCORMICK DA, 1989, TRENDS NEUROSCI, V12, P215, DOI 10.1016/0166-2236(89)90125-2; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; NICHOLSON C, 1988, Acta Morphologica Neerlando-Scandinavica, V26, P69; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; PARKER EM, 1991, J BIOL CHEM, V266, P519; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; ROONEY TA, 1991, J BIOL CHEM, V266, P15068; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; STRYER L, 1991, J BIOL CHEM, V266, P10711; SURPRENANT A, 1988, PROC R SOC SER B-BIO, V234, P85, DOI 10.1098/rspb.1988.0039; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	67	433	437	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					187	195		10.1016/0896-6273(92)90158-A	http://dx.doi.org/10.1016/0896-6273(92)90158-A			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1353972				2022-12-17	WOS:A1992JJ33200001
J	Meyer-Franke, A; Wilkinson, GA; Kruttgen, A; Hu, M; Munro, E; Hanson, MG; Reichardt, LF; Barres, BA				Meyer-Franke, A; Wilkinson, GA; Kruttgen, A; Hu, M; Munro, E; Hanson, MG; Reichardt, LF; Barres, BA			Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; SYMPATHETIC NEURONS; PROTEIN-KINASE; PC12 CELLS; MAP KINASE; IN-VITRO; GLUCOSE-TRANSPORT; NEURITE OUTGROWTH; SURVIVAL	Here, we describe a novel mechanism for the rapid regulation of surface levels of the neurotrophin receptor TrkB. Unlike nodose ganglion neurons, both retinal ganglion cells (RGCs) and spinal motor neurons (SMNs) in culture display only low levels of surface TrkB, though high levels are present intracellularly. Within minutes of depolarization or cAMP elevation, surface TrkB levels increase by nearly 4-fold, and this increase is not blocked by cycloheximide. These findings suggest that activity and cAMP elevation rapidly recruit TrkB to the plasma membrane by translocation from intracellular stores. We propose that a fundamental difference between peripheral nervous system (PNS) and central nervous system (CNS) neurons is the activity dependence of CNS neurons for responsiveness to their peptide trophic factors and that differences in membrane compartmentalization of the receptors underlie this difference.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Physiol, Neurosci Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.		Kruttgen, Alexander P/E-9232-2010		NEI NIH HHS [R01 EY11030] Funding Source: Medline; NIGMS NIH HHS [GM 07449, T32 GM007449] Funding Source: Medline; NIMH NIH HHS [MH48200, P50 MH048200-080005] Funding Source: Medline; NATIONAL EYE INSTITUTE [U10EY011030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1989, J NEUROSCI, V9, P3169; BARTLETT PF, 1981, BRAIN RES, V204, P339, DOI 10.1016/0006-8993(81)90593-X; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Canossa M, 1996, EMBO J, V15, P3369, DOI 10.1002/j.1460-2075.1996.tb00702.x; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DECURTIS I, 1991, J CELL BIOL, V113, P405, DOI 10.1083/jcb.113.2.405; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GOSH A, 1995, SCIENCE, V268, P239; GRIMES M, 1997, J NEUROSCI, V16, P7950; HANSON MG, 1998, IN PRESS J NEUROSCI; HERMAN GA, 1994, P NATL ACAD SCI USA, V91, P12750, DOI 10.1073/pnas.91.26.12750; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; KIMURA K, 1994, J BIOL CHEM, V269, P18961; KOIKE T, 1991, P NATL ACAD SCI USA, V88, P3892, DOI 10.1073/pnas.88.9.3892; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENCER WI, 1990, J CELL BIOL, V111, P379, DOI 10.1083/jcb.111.2.379; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LEWIS SA, 1984, J MEMBRANE BIOL, V82, P123, DOI 10.1007/BF01868937; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murer H, 1996, ANNU REV PHYSIOL, V58, P607, DOI 10.1146/annurev.physiol.58.1.607; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SANCHEZMARGALET V, 1994, BIOCHEM BIOPH RES CO, V204, P446, DOI 10.1006/bbrc.1994.2480; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; SCHWARTZ GJ, 1986, ANNU REV PHYSIOL, V48, P153; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; SOMMER I, 1982, NEUROSCI LETT, V29, P183, DOI 10.1016/0304-3940(82)90351-2; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; TWISS JL, 1995, J NEUROCHEM, V64, P550; Virdee K, 1996, J NEUROCHEM, V67, P1801; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WADE JB, 1986, ANNU REV PHYSIOL, V48, P213; WAKADE AR, 1983, EXP CELL RES, V144, P377, DOI 10.1016/0014-4827(83)90417-2; WILKINSON GA, 1997, THESIS U CALIFORNIA; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Yao XB, 1996, AM J PHYSIOL-CELL PH, V271, pC61, DOI 10.1152/ajpcell.1996.271.1.C61	54	432	444	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					681	693		10.1016/S0896-6273(00)80586-3	http://dx.doi.org/10.1016/S0896-6273(00)80586-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808456	Green Accepted, Bronze			2022-12-17	WOS:000076697300013
J	MINTZ, IM; SABATINI, BL; REGEHR, WG				MINTZ, IM; SABATINI, BL; REGEHR, WG			CALCIUM CONTROL OF TRANSMITTER RELEASE AT A CEREBELLAR SYNAPSE	NEURON			English	Article							SQUID GIANT SYNAPSE; RAT PHEOCHROMOCYTOMA CELLS; PURKINJE-CELLS; OMEGA-CONOTOXIN; CONCENTRATION-DEPENDENCE; FUNCTIONAL EXPRESSION; FLUORESCENT INDICATOR; PERIPHERAL NEURONS; BINDING-SITES; CA2+ CHANNEL	The manner in which presynaptic Ca2+ influx controls the release of neurotransmitter was investigated at the granule cell to Purkinje cell synapse in rat cerebellar slices, Excitatory postsynaptic currents were measured using whole-cell voltage clamp, and changes in presynaptic Ca2+ influx were determined with the Ca2+-sensitive dye furaptra. We manipulated presynaptic Ca2+ entry by altering external Ca2+ levels and by blocking Ca2+ channels with Cd2+ or with the toxins omega-conotoxin GVIA and omega-Aga-IVA. For all of the manipulations, other than the application of omega-Aga-IVA, the relationship between Ca2+ influx and release was well approximated by a power law, n approximate to 2.5. When omega-Aga-IVA was applied, release appeared to be more steeply dependent on Ca2+ (n approximate to 4), suggesting that omega-Aga-IVA-sensitive channels are more effective at triggering release. Based on interactive effects of toxins on synaptic currents, we conclude that multiple types of Ca2+ channels synergistically control individual release sites.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School					NATIONAL EYE INSTITUTE [T32EY007110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405] Funding Source: NIH RePORTER; NEI NIH HHS [T32EY07110-06] Funding Source: Medline; NINDS NIH HHS [R01-NS32405] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; AUGUSTINE G, 1985, J PHYSIOL-LONDON, V369, P143; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; AUGUSTINE GJ, 1991, CALCIUM ENTRY ACTION, P365; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V369, P163; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; COHEN MW, 1991, J NEUROSCI, V11, P1032; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Eccles JC, 1967, CEREBELLUM NEURONAL; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HERRINGTON J, 1994, PULSE CONTROL V3 0 I; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KUO CC, 1993, J PHYSIOL-LONDON, V466, P629; KUO CC, 1993, J PHYSIOL-LONDON, V466, P657; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MARCHETTI C, 1995, J NEUROPHYSIOL, V73, P1169, DOI 10.1152/jn.1995.73.3.1169; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; Palay S.L., 1974, CEREBELLAR CORTEX CY; PALKOVIT.M, 1971, BRAIN RES, V34, P1, DOI 10.1016/0006-8993(71)90347-7; PEARSON HA, 1995, J PHYSIOL-LONDON, V482, P493, DOI 10.1113/jphysiol.1995.sp020535; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; PFRIEGER FW, 1992, J NEUROSCI, V12, P4347; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; REGEHR WG, 1994, J NEUROSCI, V14, P523; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; STANLEY EF, 1989, BRAIN RES, V505, P341, DOI 10.1016/0006-8993(89)91465-0; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; STANLEY EF, 1986, J NEUROSCI, V6, P782; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; TRIGGLE DJ, 1989, TRENDS PHARMACOL SCI, V10, P507, DOI 10.1016/0165-6147(89)90051-5; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WU LG, 1994, J NEUROSCI, V14, P645; WU LG, 1994, J NEUROSCI, V14, P5613	57	432	439	0	11	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1995	15	3					675	688		10.1016/0896-6273(95)90155-8	http://dx.doi.org/10.1016/0896-6273(95)90155-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RV945	7546746	Bronze			2022-12-17	WOS:A1995RV94500020
J	Sperling, R; Mormino, E; Johnson, K				Sperling, Reisa; Mormino, Elizabeth; Johnson, Keith			The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials	NEURON			English	Review							MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; NORMAL OLDER INDIVIDUALS; AMYLOID-BETA DEPOSITION; NEUROFIBRILLARY TANGLE PATHOLOGY; INTRINSIC NETWORK CONNECTIVITY; CEREBROSPINAL-FLUID BIOMARKERS; ACCELERATED CORTICAL ATROPHY; ADULT LIFE-SPAN; IN-VIVO MODEL	As the field begins to test the concept of a "preclinical'' stage of neurodegenerative disease, when the pathophysiological process has begun in the brain, but clinical symptoms are not yet manifest, a number of intriguing questions have already arisen. In particular, in preclinical Alzheimer's disease (AD), the temporal relationship of amyloid markers to markers of neurodegeneration and their relative utility in the prediction of cognitive decline among clinically normal older individuals remains to be fully elucidated. Secondary prevention trials in AD have already begun in both genetic at-risk and amyloid at-risk cohorts, with several more trials in the planning stages, and should provide critical answers about whether intervention at this very early stage of disease can truly bend the curve of clinical progression. This review will highlight recent progress in cognitive, imaging, and biomarker outcomes in the field of preclinical AD, and the remaining gaps in knowledge.	[Sperling, Reisa] Brigham & Womens Hosp, Ctr Alzheimer Res & Treatment, Dept Neurol, Boston, MA 02115 USA; [Sperling, Reisa; Mormino, Elizabeth; Johnson, Keith] Massachusetts Gen Hosp, Harvard Aging Brain Study, Dept Neurol, Boston, MA 02114 USA; [Johnson, Keith] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sperling, Reisa; Johnson, Keith] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sperling, R (corresponding author), Brigham & Womens Hosp, Ctr Alzheimer Res & Treatment, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	reisa@rics.bwh.harvard.edu			National Institute on Aging [P01AG036694, R01 AG046396, R01 AG027435, K24 AG035007, F32AG044054]; Alzheimer's Association; Janssen; Eli Lilly; Bright Focus Foundation; Harvard NeuroDiscovery Center; National Institutes on Aging; Geoffrey Beene Global Neurodiscovery Challenge; Avid Pharmaceuticals; Biogen Idec; Merck; NIH; NATIONAL INSTITUTE ON AGING [P01AG036694, R01AG046396, F32AG044054, K24AG035007, R01AG027435] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly(Eli Lilly); Bright Focus Foundation(BrightFocus Foundation); Harvard NeuroDiscovery Center; National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Geoffrey Beene Global Neurodiscovery Challenge; Avid Pharmaceuticals; Biogen Idec(Biogen); Merck(Merck & Company); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are supported by the National Institute on Aging (P01AG036694; R01 AG046396; R01 AG027435; K24 AG035007; and F32AG044054) and the Alzheimer's Association. The authors want to acknowledge the invaluable contributions of the NIA-AA Preclinical Workgroup. The authors also wish to thank Nayiri Arzoumanian for assistance with editing the manuscript, and all of the research participants who have contributed to our findings. R. S. has served as a consultant for Merck, Eisai, Janssen, Boehringer-Ingelheim, Isis, Lundbeck, Roche, and Genetech. She has research support from Janssen, Eli Lilly, Alzheimer's Association, Bright Focus Foundation, Harvard NeuroDiscovery Center, and the National Institutes on Aging. E. M. has received a financial award from the Geoffrey Beene Global Neurodiscovery Challenge. K.J. has served as a consultant for Piramal, Lilly/Avid, GEHC, Biogen Idec, Isis, Lundbeck, Janssen, and Siemens, and has research support from Avid Pharmaceuticals, Biogen Idec, Merck, Alzheimer's Association, Harvard NeuroDiscovery Center, and the NIH.	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Becker JA, 2011, ANN NEUROL, V69, P1032, DOI 10.1002/ana.22333; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Benzinger TLS, 2013, P NATL ACAD SCI USA, V110, pE4502, DOI 10.1073/pnas.1317918110; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brier M.R., 2014, NEUROLOGY; Brier MR, 2014, NEUROBIOL AGING, V35, P757, DOI 10.1016/j.neurobiolaging.2013.10.081; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buerger K, 2007, BRAIN, V130, DOI 10.1093/brain/awm140; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Chetelat G, 2013, NAT REV NEUROL, V9, P123, DOI [10.1038/nrneurol.2013.21, 10.1038/nrneurol.2013.21-c2]; Chetelat G, 2010, BRAIN, V133, P3349, DOI 10.1093/brain/awq187; Chhatwal JP, 2013, NEUROLOGY, V81, P736, DOI 10.1212/WNL.0b013e3182a1aafe; Chhatwal JP, 2012, J ALZHEIMERS DIS, V31, pS155, DOI 10.3233/JAD-2012-120730; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Choi S.H., 2014, NATURE; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Delacourte A, 2002, EXP GERONTOL, V37, P1291, DOI 10.1016/S0531-5565(02)00141-9; Desikan RS, 2011, ANN NEUROL, V70, P657, DOI 10.1002/ana.22509; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Doraiswamy PM, 2014, MOL PSYCHIATR, V19, P1044, DOI 10.1038/mp.2014.9; Doraiswamy PM, 2012, NEUROLOGY, V79, P1636, DOI 10.1212/WNL.0b013e3182661f74; Dore V, 2013, JAMA NEUROL, V70, P903, DOI 10.1001/jamaneurol.2013.1062; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Duyckaerts C, 1997, NEUROBIOL AGING, V18, P362, DOI 10.1016/S0197-4580(97)00047-X; Eberling JL, 2004, NEUROIMAGE, V21, P364, DOI 10.1016/j.neuroimage.2003.08.037; Elman JA, 2014, NAT NEUROSCI, V17, P1316, DOI 10.1038/nn.3806; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Fleisher AS, 2012, LANCET NEUROL, V11, P1057, DOI 10.1016/S1474-4422(12)70227-2; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Hampel H, 2013, J ALZHEIMERS DIS, V33, pS79, DOI 10.3233/JAD-2012-129003; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jack CR, 2014, NEUROLOGY, V82, P1605, DOI 10.1212/WNL.0000000000000386; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jacobsen H, 2014, J NEUROSCI, V34, P11621, DOI 10.1523/JNEUROSCI.1405-14.2014; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jagust WJ, 2011, TRENDS COGN SCI, V15, P520, DOI 10.1016/j.tics.2011.09.004; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kantarci K, 2012, NEUROLOGY, V78, P232, DOI 10.1212/WNL.0b013e31824365ab; Kawas CH, 2013, ALZHEIMERS DEMENT, V9, P199, DOI 10.1016/j.jalz.2012.06.005; Kennedy KM, 2012, NEUROIMAGE, V62, P1, DOI 10.1016/j.neuroimage.2012.03.077; Knopman DS, 2012, NEUROLOGY, V78, P1576, DOI 10.1212/WNL.0b013e3182563bbe; Knopman DS, 2014, NEUROBIOL AGING, V35, P2096, DOI 10.1016/j.neurobiolaging.2014.03.006; Knopman DS, 2013, JAMA NEUROL, V70, P1030, DOI 10.1001/jamaneurol.2013.182; Kryscio RJ, 2014, NEUROLOGY, V83, P1359, DOI 10.1212/WNL.0000000000000856; Landau SM, 2012, ARCH NEUROL-CHICAGO, V69, P623, DOI 10.1001/archneurol.2011.2748; Lee HG, 2004, ANN NY ACAD SCI, V1019, P1, DOI 10.1196/annals.1297.001; LEITERSDORF E, 1995, AM J CARDIOL, V76, pA84; Li G, 2014, JAMA NEUROL, V71, P742, DOI 10.1001/jamaneurol.2014.445; Li SM, 2013, NEURON, V77, P929, DOI 10.1016/j.neuron.2012.12.040; Lim H.K., 2014, BRAIN; Lim Y.Y., 2014, ALZHEIMERS DEMENT; Lim YY, 2014, BRAIN, V137, P221, DOI 10.1093/brain/awt286; Lim YY, 2013, ALZHEIMERS DEMENT, V9, P538, DOI 10.1016/j.jalz.2012.07.004; Lim YY, 2013, NEUROBIOL AGING, V34, P2457, DOI 10.1016/j.neurobiolaging.2013.05.006; Lim YY, 2013, J ALZHEIMERS DIS, V33, P675, DOI 10.3233/JAD-2012-121516; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Mattsson N, 2014, JAMA NEUROL, V71, P725, DOI 10.1001/jamaneurol.2014.446; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mills SM, 2013, REV NEUROL-FRANCE, V169, P737, DOI 10.1016/j.neurol.2013.07.017; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Montine TJ, 2011, TOXICOL PATHOL, V39, P99, DOI 10.1177/0192623310391481; Mormino E.C., 2014, JAMA NEUROL; Mormino EC, 2014, NEUROLOGY, V82, P1760, DOI 10.1212/WNL.0000000000000431; Mormino EC, 2011, CEREB CORTEX, V21, P2399, DOI 10.1093/cercor/bhr025; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Myers N, 2014, BRAIN, V137, P2052, DOI 10.1093/brain/awu103; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nosheny R.L., 2014, NEUROBIOL AGING; O'Brien JL, 2010, NEUROLOGY, V74, P1969, DOI 10.1212/WNL.0b013e3181e3966e; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; PEDERSEN TR, 1994, LANCET, V344, P1383; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Perrotin A, 2012, ARCH NEUROL-CHICAGO, V69, P223, DOI 10.1001/archneurol.2011.666; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Pihlajamaki M, 2010, ALZ DIS ASSOC DIS, V24, P28, DOI 10.1097/WAD.0b013e3181a785c9; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Quiroz YT, 2010, ANN NEUROL, V68, P865, DOI 10.1002/ana.22105; Rami L, 2012, J ALZHEIMERS DIS, V31, P517, DOI 10.3233/JAD-2012-120223; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Rentz DM, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt222; Rentz DM, 2011, NEUROPSYCHOLOGIA, V49, P2776, DOI 10.1016/j.neuropsychologia.2011.06.006; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Resnick SM, 2010, NEUROLOGY, V74, P807, DOI 10.1212/WNL.0b013e3181d3e3e9; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Roe CM, 2011, ARCH NEUROL-CHICAGO, V68, P1145, DOI 10.1001/archneurol.2011.192; Rowe CC, 2013, ANN NEUROL, V74, P905, DOI 10.1002/ana.24040; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Snitz BE, 2013, NEUROLOGY, V80, P1378, DOI 10.1212/WNL.0b013e31828c2fc8; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Sperling RA, 2013, NEUROBIOL AGING, V34, P822, DOI 10.1016/j.neurobiolaging.2012.06.014; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Stark SM, 2013, NEUROPSYCHOLOGIA, V51, P2442, DOI 10.1016/j.neuropsychologia.2012.12.014; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Storandt M, 2009, ARCH NEUROL-CHICAGO, V66, P1476, DOI 10.1001/archneurol.2009.272; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Thomas JB, 2014, JAMA NEUROL, V71, P1111, DOI 10.1001/jamaneurol.2014.1654; Toledo JB, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-26; van Harten AC, 2013, NEUROLOGY, V81, P1409, DOI 10.1212/WNL.0b013e3182a8418b; Vemuri P, 2012, ANN NEUROL, V72, P730, DOI 10.1002/ana.23665; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wang L, 2013, JAMA NEUROL, V70, P1242, DOI 10.1001/jamaneurol.2013.3253; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Whitwell JL, 2013, NEUROIMAGE-CLIN, V2, P249, DOI 10.1016/j.nicl.2013.01.006; Wilson RS, 2010, NEUROLOGY, V75, P990, DOI 10.1212/WNL.0b013e3181f25b5e; Wilson RS, 2013, JAMA NEUROL, V70, P1418, DOI 10.1001/jamaneurol.2013.3961; Wilson RS, 2013, NEUROLOGY, V81, P314, DOI 10.1212/WNL.0b013e31829c5e8a; Wirth M, 2013, JAMA NEUROL, V70, P1512, DOI 10.1001/jamaneurol.2013.4013; Wirth M, 2013, J NEUROSCI, V33, P5553, DOI 10.1523/JNEUROSCI.4409-12.2013; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712	156	431	438	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 5	2014	84	3					608	622		10.1016/j.neuron.2014.10.038	http://dx.doi.org/10.1016/j.neuron.2014.10.038			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS3HK	25442939	Green Accepted, Bronze			2022-12-17	WOS:000344168100014
J	Luscher, C; Huber, KM				Luscher, Christian; Huber, Kimberly M.			Group 1 mGIuR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease	NEURON			English	Review							METABOTROPIC GLUTAMATE-RECEPTOR; MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; IMMEDIATE-EARLY GENE; GROUP-I MGLUR; CYTOSKELETON-ASSOCIATED PROTEIN; CEREBELLAR PURKINJE-CELLS; ARC MESSENGER-RNA; DHPG-INDUCED LTD; CA1 REGION	Many excitatory synapses express Group 1, or Gq coupled, metabotropic glutamate receptors (Gp1 mGIuRs) at the periphery. of their postsynaptic density. Activation of Gpl mGIuRs typically occurs in response to strong activity and triggers long-term plasticity of synaptic transmission in many brain regions, including the neocortex, hippocampus, midbrain, striatum, and cerebellum. Here we focus on mGIuR-induced long-term synaptic depression (LTD) and review the literature that implicates Gpl mGIuRs in the plasticity of behavior, learning, and memory. Moreover, recent studies investigating the molecular mechanisms of mGIuR-LTD have discovered links to mental retardation, autism, Alzheimer's disease, Parkinson's disease, and drug addiction. We discuss how mGIuRs lead to plasticity of neural circuits and how the understanding of the molecular mechanisms of mGIuR plasticity provides insight into brain disease.	[Luscher, Christian] Univ Hosp Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luscher, Christian] Univ Hosp Geneva, Neurol Clin, CH-1211 Geneva, Switzerland; [Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Geneva; University of Geneva; University of Texas System; University of Texas Southwestern Medical Center Dallas	Luscher, C (corresponding author), Univ Hosp Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.		Lüscher, Christian/A-2496-2011; Huber, Kimberly/X-5534-2019	Lüscher, Christian/0000-0001-7917-4596; 	NIH [NS045711, HD052731]; Simons Foundation; Swiss National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045711] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	K M H is supported by grants from the NIH (NS045711, HD052731), Autism Speaks, and Simons Foundation C L is supported by grants from the Swiss National Science Foundation and the Swiss initiative in system biology (SystemsX neurochoice) K M H is a shareholder and paid SAB member of Seaside Therapeutics We would like to thank Carlos Gonzalez for assistance with the figures	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bastrikova N, 2008, P NATL ACAD SCI USA, V105, P3123, DOI 10.1073/pnas.0800027105; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bear MF, 2001, SYNAPSES, P455; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; Berry-Kravis E, 2008, J DEV BEHAV PEDIATR, V29, P293, DOI 10.1097/DBP.0b013e31817dc447; Bianchi R, 2009, J NEUROSCI, V29, P3497, DOI 10.1523/JNEUROSCI.5447-08.2009; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Calabresi P, 1997, J NEUROSCI, V17, P1940; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Choi SK, 1997, J NEUROSCI, V17, P8613; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chuang SC, 2005, J NEUROSCI, V25, P8048, DOI 10.1523/JNEUROSCI.1777-05.2005; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; COLE AE, 1983, SCIENCE, V221, P1299, DOI 10.1126/science.6612345; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Fitzjohn SM, 2001, J PHYSIOL-LONDON, V537, P421, DOI 10.1111/j.1469-7793.2001.00421.x; Fourgeaud L, 2004, J NEUROSCI, V24, P6939, DOI 10.1523/JNEUROSCI.0671-04.2004; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gerfen CR, 2006, NAT NEUROSCI, V9, P157, DOI 10.1038/nn0206-157; GLADDING CM, 2009, MOL MECH PHARM REV, V61, P395; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Griffiths S, 2008, NEURON, V58, P186, DOI 10.1016/j.neuron.2008.02.022; Grueter BA, 2006, J NEUROSCI, V26, P3210, DOI 10.1523/JNEUROSCI.0170-06.2006; Gubellini P, 2001, NEUROPHARMACOLOGY, V40, P839, DOI 10.1016/S0028-3908(01)00021-1; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Haber SN, 2000, J NEUROSCI, V20, P2369; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito-Ishida A, 2006, EUR J NEUROSCI, V24, P1617, DOI 10.1111/j.1460-9568.2006.05055.x; Jo J, 2006, NAT NEUROSCI, V9, P170, DOI 10.1038/nn1637; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kamikubo Y, 2006, EUR J NEUROSCI, V24, P1606, DOI 10.1111/j.1460-9568.2006.05032.x; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Karachot L, 2001, J NEUROPHYSIOL, V86, P280, DOI 10.1152/jn.2001.86.1.280; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kemp A, 2008, CEREB CORTEX, V18, P968, DOI 10.1093/cercor/bhm136; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Kemp N, 1999, NEUROPHARMACOLOGY, V38, P495, DOI 10.1016/S0028-3908(98)00222-6; Kleppisch T, 2001, J NEUROSCI, V21, P4943, DOI 10.1523/JNEUROSCI.21-14-04943.2001; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kumar A, 2007, J NEUROPHYSIOL, V98, P2729, DOI 10.1152/jn.00514.2007; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lu YM, 1997, J NEUROSCI, V17, P5196; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Massey PV, 2001, EUR J NEUROSCI, V14, P145, DOI 10.1046/j.0953-816x.2001.01631.x; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Merlin LR, 1998, J NEUROPHYSIOL, V80, P989, DOI 10.1152/jn.1998.80.2.989; Moult PR, 2008, J PHYSIOL-LONDON, V586, P2499, DOI 10.1113/jphysiol.2008.153122; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Moult PR, 2002, NEUROPHARMACOLOGY, V43, P175, DOI 10.1016/S0028-3908(02)00110-7; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Naie K, 2005, NEUROPHARMACOLOGY, V49, P35, DOI 10.1016/j.neuropharm.2005.06.001; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Ons S, 2004, J NEUROCHEM, V89, P1111, DOI 10.1111/j.1471-4159.2004.02396.x; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Pan B, 2008, J NEUROSCI, V28, P1385, DOI 10.1523/JNEUROSCI.4033-07.2008; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Redish A. D., 2008, BEHAV BRAIN SCI, V31, P437, DOI DOI 10.1017/S0110525X0100472X; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schnabel R, 1999, NEUROPHARMACOLOGY, V38, P1585, DOI 10.1016/S0028-3908(99)00062-3; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Seog DH, 2004, BIOSCI BIOTECH BIOCH, V68, P1808, DOI 10.1271/bbb.68.1808; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Singla S, 2007, J NEUROSCI, V27, P5260, DOI 10.1523/JNEUROSCI.0018-07.2007; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Steinberg JP, 2004, P NATL ACAD SCI USA, V101, P18212, DOI 10.1073/pnas.0408278102; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Wong RKS, 2004, ADV EXP MED BIOL, V548, P69; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yin HH, 2006, J NEUROSCI, V26, P11811, DOI 10.1523/JNEUROSCI.3196-06.2006; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	158	431	459	0	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					445	459		10.1016/j.neuron.2010.01.016	http://dx.doi.org/10.1016/j.neuron.2010.01.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188650	Green Accepted, Bronze			2022-12-17	WOS:000275359800004
J	Zhou, FQ; Zhou, J; Dedhar, S; Wu, YH; Snider, WD				Zhou, FQ; Zhou, J; Dedhar, S; Wu, YH; Snider, WD			NGF-induced axon growth is mediated by localized inactivation of GSK-30 and functions of the microtubule plus end binding protein APC	NEURON			English	Article							ADENOMATOUS-POLYPOSIS-COLI; GLYCOGEN-SYNTHASE KINASE-3-BETA; TUMOR-SUPPRESSOR PROTEIN; INTEGRIN-LINKED KINASE; CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; CELL POLARITY; COMPARTMENTALIZED CULTURES	Little is known about how nerve growth factor (NGF) signaling controls the regulated assembly of microtubules that underlies axon growth. Here we demonstrate that a tightly regulated and localized activation of phosphatidylinositol 3-kinase (PI3K) at the growth cone is essential for rapid axon growth induced by NGF. This spatially activated PI3K signaling is conveyed downstream through a localized inactivation of glycogen synthase kinase 3P (GSK-3beta). These two spatially coupled kinases control axon growth via regulation of a microtubule plus end binding protein, adenomatous polyposis coli (APC). Our results demonstrate that NGF signals are transduced to the axon cytoskeleton via activation of a conserved cell polarity signaling pathway.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Jack Bell Res Ctr, BC Canc Agcy, Vancouver, BC V6H 3Z6, Canada	University of North Carolina; University of North Carolina Chapel Hill; British Columbia Cancer Agency; University of British Columbia	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.	william_snider@med.unc.edu		Dedhar, Shoukat/0000-0003-4355-1657	NINDS NIH HHS [NS031768, P30 NS045892] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031768, P30NS045892] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Baas Peter W., 2001, Neuron, V32, P981, DOI 10.1016/S0896-6273(01)00556-6; BHAT RV, 1994, J NEUROSCI, V14, P3059; Brakeman JSF, 1999, NEUROSCIENCE, V91, P661, DOI 10.1016/S0306-4522(98)00605-8; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; CAMPENOT RB, 1982, DEV BIOL, V93, P13, DOI 10.1016/0012-1606(82)90233-0; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gallo G, 2002, J CELL BIOL, V158, P1219, DOI 10.1083/jcb.200204140; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Goold RG, 2001, J CELL SCI, V114, P4273; Goold RG, 1999, J CELL SCI, V112, P3373; GORDONWEEKS PR, 1991, BIOESSAYS, V13, P235, DOI 10.1002/bies.950130506; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Gundersen GG, 2003, SCIENCE, V300, P2040, DOI 10.1126/science.1084938; He Y, 2002, J NEUROSCI, V22, P5982; Hetman M, 2000, J NEUROSCI, V20, P2567; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mills J, 2003, J NEUROSCI, V23, P1638; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mimori-Kiyosue Y, 2001, J CELL BIOL, V154, P1105, DOI 10.1083/jcb.200106113; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Morrison EE, 1997, NEUROSCI LETT, V235, P129, DOI 10.1016/S0304-3940(97)00739-8; Morrison EE, 2002, MOL BRAIN RES, V98, P145, DOI 10.1016/S0169-328X(01)00290-X; Nakagawa H, 1998, CANCER RES, V58, P5176; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Sayas CL, 2002, J NEUROSCI, V22, P6863; Schindelholz B, 1999, METHODS, V18, P487, DOI 10.1006/meth.1999.0817; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Smith DS, 1997, J NEUROSCI, V17, P646; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wagner U, 1996, J CELL SCI, V109, P1537; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; WOODGETT JR, 2001, SCI STKE, pRE12; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	71	431	451	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					897	912		10.1016/j.neuron.2004.05.011	http://dx.doi.org/10.1016/j.neuron.2004.05.011			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207235	Bronze, Green Published			2022-12-17	WOS:000222329300006
J	Kenny, PJ				Kenny, Paul J.			Reward Mechanisms in Obesity: New Insights and Future Directions	NEURON			English	Review							NUCLEUS-ACCUMBENS SHELL; DOPAMINE-RECEPTOR GENE; HIGH-FAT FOOD; GENETICALLY-DETERMINED DIFFERENCES; STIMULATES LOCOMOTOR-ACTIVITY; COMPULSIVE DRUG-SEEKING; GASTRIC BYPASS-SURGERY; VENTRAL TEGMENTAL AREA; SELF-STIMULATION; FEEDING-BEHAVIOR	Food is consumed in order to maintain energy balance at homeostatic levels. In addition, palatable food is also consumed for its hedonic properties independent of energy status. Such reward-related consumption can result in caloric intake exceeding requirements and is considered a major culprit in the rapidly increasing rates of obesity in developed countries. Compared with homeostatic mechanisms of feeding, much less is known about how hedonic systems in brain influence food intake. Intriguingly, excessive consumption of palatable food can trigger neuroadaptive responses in brain reward circuitries similar to drugs of abuse. Furthermore, similar genetic vulnerabilities in brain reward systems can increase predisposition to drug addiction and obesity. Here, recent advances in our understanding of the brain circuitries that regulate hedonic aspects of feeding behavior will be reviewed. Also, emerging evidence suggesting that obesity and drug addiction may share common hedonic mechanisms will also be considered.	Scripps Res Inst, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute	Kenny, PJ (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA.	pjkenny@scripps.edu			National Institute on Drug Abuse (NIDA); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025983] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The author is supported by grants from the National Institute on Drug Abuse (NIDA). The author is grateful to Paul Johnson and Christie Fowler for valuable insights and comments on the manuscript. This is manuscript number 21042 from The Scripps Research Institute.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Ahmed SH, 2005, PSYCHOPHARMACOLOGY, V180, P473, DOI 10.1007/s00213-005-2180-z; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; BALAGURA S, 1967, PHYSIOL BEHAV, V2, P337, DOI 10.1016/0031-9384(67)90048-0; Baldo BA, 2004, EUR J NEUROSCI, V19, P376, DOI 10.1111/j.1460-9568.2004.03093.x; Balleine BW, 2000, J NEUROSCI, V20, P8954; Barnard ND, 2009, NUTRITION, V25, P58, DOI 10.1016/j.nut.2008.07.012; Basso AM, 1999, BEHAV NEUROSCI, V113, P324, DOI 10.1037/0735-7044.113.2.324; Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bean MK, 2008, J CLIN PSYCHOL MED S, V15, P214, DOI 10.1007/s10880-008-9124-9; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; BLUNDELL JE, 1968, NATURE, V219, P627, DOI 10.1038/219627a0; Booth ML, 2008, J PAEDIATR CHILD H, V44, P248, DOI 10.1111/j.1440-1754.2007.01267.x; BRAGULAT V, 2010, FOOD RELATED ODOR PR; CABANAC M, 1983, PHYSIOL BEHAV, V31, P249, DOI 10.1016/0031-9384(83)90128-2; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cannon CM, 2003, J NEUROSCI, V23, P10827; CARR KD, 1984, BRAIN RES, V297, P369, DOI 10.1016/0006-8993(84)90578-X; Centers for Disease Control and Prevention, 2009, US OB TRENDS; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Cornelius JR, 2010, SLEEP, V33, P81; Cornier MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006310; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; Dagher A, 2009, INT J OBESITY, V33, pS30, DOI 10.1038/ijo.2009.69; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Davis C, 2004, APPETITE, V42, P131, DOI 10.1016/j.appet.2003.07.004; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; de Araujo IE, 2010, RESULTS PROBL CELL D, V52, P69, DOI 10.1007/978-3-642-14426-4_7; Delin CR, 1997, OBES SURG, V7, P405, DOI 10.1381/096089297765555386; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Devlin MJ, 2007, INT J EAT DISORDER, V40, pS83, DOI 10.1002/eat.20430; Doknic M, 2002, EUR J ENDOCRINOL, V147, P77, DOI 10.1530/eje.0.1470077; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Felsted JA, 2010, J NEUROSCI, V30, P2428, DOI 10.1523/JNEUROSCI.5483-09.2010; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2001, PHYSIOL BEHAV, V73, P229, DOI 10.1016/S0031-9384(01)00486-3; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Foo H, 2005, P NATL ACAD SCI USA, V102, P16865, DOI 10.1073/pnas.0506226102; Franken IHA, 2005, APPETITE, V45, P198, DOI 10.1016/j.appet.2005.04.004; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Geiger BM, 2008, FASEB J, V22, P2740, DOI 10.1096/fj.08-110759; Gluck ME, 2004, PSYCHOSOM MED, V66, P876, DOI 10.1097/01.psy.0000143637.63508.47; Goldstone AP, 2009, EUR J NEUROSCI, V30, P1625, DOI 10.1111/j.1460-9568.2009.06949.x; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; HOEBEL BG, 1969, J COMP PHYSIOL PSYCH, V68, P536, DOI 10.1037/h0027651; HOEBEL BG, 1969, ANN NY ACAD SCI, V157, P758, DOI 10.1111/j.1749-6632.1969.tb12919.x; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Hofmann W, 2010, PSYCHOL SCI, V21, P1863, DOI 10.1177/0956797610389186; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Imaizumi M, 2001, APPETITE, V36, P237, DOI 10.1006/appe.2001.0399; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Johnson PI, 1996, BRAIN RES, V722, P109, DOI 10.1016/0006-8993(96)00202-8; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kalarchian MA, 2002, OBES SURG, V12, P270, DOI 10.1381/096089202762552494; Kandiah J, 2006, NUTR RES, V26, P118, DOI 10.1016/j.nutres.2005.11.010; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kelley AE, 1996, J PHARMACOL EXP THER, V278, P1499; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Kim KS, 2010, J BIOL CHEM, V285, P8905, DOI 10.1074/jbc.M109.079590; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kok P, 2006, J CLIN ENDOCR METAB, V91, P3236, DOI 10.1210/jc.2005-2529; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Krugel U, 2003, EUR J PHARMACOL, V482, P185, DOI 10.1016/j.ejphar.2003.09.047; la Fleur SE, 2006, PHYSIOL BEHAV, V89, P110, DOI 10.1016/j.physbeh.2006.01.028; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Latagliata EC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-15; Lawford BR, 2000, AM J MED GENET, V96, P592, DOI 10.1002/1096-8628(20001009)96:5<592::AID-AJMG3>3.0.CO;2-Y; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Leshan RL, 2010, J NEUROSCI, V30, P5713, DOI 10.1523/JNEUROSCI.1001-10.2010; Louis GW, 2010, J NEUROSCI, V30, P11278, DOI 10.1523/JNEUROSCI.1340-10.2010; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Lutter M, 2009, J NUTR, V139, P629, DOI 10.3945/jn.108.097618; Macht M, 2007, APPETITE, V49, P667, DOI 10.1016/j.appet.2007.05.004; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; Man MS, 2009, CEREB CORTEX, V19, P899, DOI 10.1093/cercor/bhn137; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; MARKOU A, 1987, PHYSIOL BEHAV, V41, P303, DOI 10.1016/0031-9384(87)90392-1; Mastronardi CA, 2001, P NATL ACAD SCI USA, V98, P14720, DOI 10.1073/pnas.251543598; MATHENY M, 2011, NEUROPHARMA IN PRESS, DOI DOI 10.1016/J.NEUROPHARM.2010.11.002; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mount G., 1967, PSYCHON SCI, V9, P265; Nair SG, 2011, NEUROPSYCHOPHARMACOL, V36, P497, DOI 10.1038/npp.2010.181; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Nirenberg MJ, 2006, MOVEMENT DISORD, V21, P524, DOI 10.1002/mds.20757; Noble EP, 2000, AM J MED GENET, V96, P622, DOI 10.1002/1096-8628(20001009)96:5<622::AID-AJMG7>3.0.CO;2-5; Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X; NOBLE EP, 1993, DRUG ALCOHOL DEPEN, V33, P271, DOI 10.1016/0376-8716(93)90113-5; O'Connor DB, 2008, HEALTH PSYCHOL, V27, pS20, DOI 10.1037/0278-6133.27.1.S20; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Park TH, 1998, BRAIN RES, V805, P169, DOI 10.1016/S0006-8993(98)00719-7; Pecina S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; Pecina S, 2006, NEUROSCIENTIST, V12, P500, DOI 10.1177/1073858406293154; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Petrovich GD, 2009, J NEUROSCI, V29, P15205, DOI 10.1523/JNEUROSCI.3656-09.2009; Pfaffly J, 2010, SYNAPSE, V64, P503, DOI 10.1002/syn.20755; Puhl RM, 2008, HEALTH EDUC RES, V23, P347, DOI 10.1093/her/cym052; Rada P, 2010, PHYSIOL BEHAV, V101, P394, DOI 10.1016/j.physbeh.2010.07.005; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Rolls ET, 2008, ACTA PHYSIOL HUNG, V95, P131, DOI 10.1556/APhysiol.95.2008.2.1; Rolls ET, 2011, INT J OBESITY, V35, P550, DOI 10.1038/ijo.2010.155; ROLLS ET, 1983, PHYSIOL BEHAV, V30, P185, DOI 10.1016/0031-9384(83)90003-3; Roseberry AG, 2007, J NEUROSCI, V27, P7021, DOI 10.1523/JNEUROSCI.1235-07.2007; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Salas R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00036; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Saunders R, 2001, OBES SURG, V11, P757, DOI 10.1381/09608920160558731; Scarpace PJ, 2010, PHYSIOL BEHAV, V100, P173, DOI 10.1016/j.physbeh.2010.02.017; Schiltz CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-16; Schur EA, 2009, INT J OBESITY, V33, P653, DOI 10.1038/ijo.2009.56; Sclafani A, 1998, APPETITE, V31, P406, DOI 10.1006/appe.1998.0211; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Shomaker LB, 2010, AM J CLIN NUTR, V92, P697, DOI 10.3945/ajcn.2010.29812; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 2010, BRAIN STRUCT FUNCT, V214, P551, DOI 10.1007/s00429-010-0266-9; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Soderpalm AHV, 2000, PHARMACOL BIOCHEM BE, V66, P429, DOI 10.1016/S0091-3057(00)00220-3; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; STOECKEL LE, 2010, SCI AM          0608; Stratford TR, 1999, J NEUROSCI, V19, P11040, DOI 10.1523/JNEUROSCI.19-24-11040.1999; Stratford TR, 1997, J NEUROSCI, V17, P4434; SUAREZ SD, 1981, LEARN MOTIV, V12, P342, DOI 10.1016/0023-9690(81)90013-8; SUNDAY SR, 1983, PHYSIOL BEHAV, V30, P915, DOI 10.1016/0031-9384(83)90257-3; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Taha SA, 2009, NEUROSCIENCE, V161, P718, DOI 10.1016/j.neuroscience.2009.03.057; Taha SA, 2005, J NEUROSCI, V25, P1193, DOI 10.1523/JNEUROSCI.3975-04.2005; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Thanos PK, 2008, SYNAPSE, V62, P50, DOI 10.1002/syn.20468; Thompson RH, 2010, P NATL ACAD SCI USA, V107, P15235, DOI 10.1073/pnas.1009112107; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Vendruscolo LE, 2010, NEUROPHARMACOLOGY, V59, P388, DOI 10.1016/j.neuropharm.2010.05.015; Vendruscolo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009296; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2007, AM J PSYCHIAT, V164, P708, DOI 10.1176/appi.ajp.164.5.708; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wang Gene-Jack, 2002, Expert Opin Ther Targets, V6, P601, DOI 10.1517/14728222.6.5.601; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wassum KM, 2009, P NATL ACAD SCI USA, V106, P12512, DOI 10.1073/pnas.0905874106; Wassum KM, 2011, J NEUROSCI, V31, P1591, DOI 10.1523/JNEUROSCI.3102-10.2011; WILKINSON HA, 1962, AM J PHYSIOL, V203, P537, DOI 10.1152/ajplegacy.1962.203.3.537; Will MJ, 2003, J NEUROSCI, V23, P2882; Wilson ME, 2008, PHYSIOL BEHAV, V94, P586, DOI 10.1016/j.physbeh.2008.03.019; Yurcisin BM, 2009, CLIN CHEST MED, V30, P539, DOI 10.1016/j.ccm.2009.05.013; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007	204	430	445	1	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					664	679		10.1016/j.neuron.2011.02.016	http://dx.doi.org/10.1016/j.neuron.2011.02.016			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338878	Bronze, Green Accepted			2022-12-17	WOS:000288413200010
J	Fischbach, GD; Lord, C				Fischbach, Gerald D.; Lord, Catherine			The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors	NEURON			English	Editorial Material							NEUROPSYCHIATRIC CONDITIONS; SPECTRUM; DISORDERS	In an effort to identify de novo genetic variants that contribute to the overall risk of autism, the Simons Foundation Autism Research Initiative (SFARI) has gathered a unique sample called the Simons Simplex Collection (SSC). More than 2000 families have been evaluated to date. On average, probands in the current sample exhibit moderate to severe autistic symptoms with relatively little intellectual disability. An interactive database has been created to facilitate correlations between clinical, genetic, and neurobiological data.	[Fischbach, Gerald D.] Simons Fdn Autism Res Initiat, New York, NY 10010 USA; [Lord, Catherine] Univ Michigan, Dept Psychol Pediat & Psychiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fischbach, GD (corresponding author), Simons Fdn Autism Res Initiat, 160 5th Ave, New York, NY 10010 USA.	gf@simonsfoundation.org						Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Johnson SB, 2010, J AM MED INFORM ASSN, V17, P689, DOI 10.1136/jamia.2009.002063; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	10	430	434	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 21	2010	68	2					192	195		10.1016/j.neuron.2010.10.006	http://dx.doi.org/10.1016/j.neuron.2010.10.006			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	681IJ	20955926	Bronze			2022-12-17	WOS:000284304300007
J	Andersen, RA; Cui, H				Andersen, Richard A.; Cui, He			Intention, Action Planning, and Decision Making in Parietal-Frontal Circuits	NEURON			English	Review							LATERAL INTRAPARIETAL AREA; LOCAL-FIELD POTENTIALS; COMMON ATTENTIONAL MECHANISM; SELECTIVE VISUAL-ATTENTION; CENTERED REFERENCE FRAME; SACCADE-RELATED ACTIVITY; REACH REGION; PREFRONTAL CORTEX; PREMOTOR CORTEX; ASSOCIATION CORTEX	The posterior parietal cortex and frontal cortical areas to which it connects are responsible for sensorimotor transformations. This review covers new research on four components of this transformation process: planning, decision making, forward state estimation, and relative-coordinate representations. These sensorimotor functions can be harnessed for neural prosthetic operations by decoding intended goals (planning) and trajectories (forward state estimation) of movements as well as higher cortical functions related to decision making and potentially the coordination of multiple body parts (relative-coordinate representations).	[Andersen, Richard A.; Cui, He] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Andersen, RA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	andersen@vis.caltech.edu			National Institutes of Health; Boswell Foundation; McKnight Foundation; Sloan Foundation; Swartz Foundation; Moore Foundation; Defense Advanced Research Projects Agency	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boswell Foundation; McKnight Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Swartz Foundation; Moore Foundation(Gordon and Betty Moore Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We wish to acknowledge Viktor Shcherbatyuk, Tessa Yao, Carol Andersen, Kelsie Pejsa, and Nicole Sammons for technical and editorial assistance and Aaron Batista, Chris Buneo, Bijan Pesaran, and Antonio Rangel for discussions. We wish to thank the National Institutes of Health, the Boswell Foundation, the McKnight Foundation, the Sloan Foundation, the Swartz Foundation, the Moore Foundation, and the Defense Advanced Research Projects Agency for support.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1985, J COMP NEUROL, V232, P443, DOI 10.1002/cne.902320403; ANDERSEN RA, 1987, EXP BRAIN RES, V67, P316; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Andersen RA, 1987, HDB PHYSL 1, VV, P483; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Baldauf D, 2008, J NEUROSCI, V28, P10081, DOI 10.1523/JNEUROSCI.3423-08.2008; Baldauf D, 2006, VISION RES, V46, P4355, DOI 10.1016/j.visres.2006.08.021; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Basso MA, 1998, J NEUROSCI, V18, P7519; Bastian A, 2003, EUR J NEUROSCI, V18, P2047, DOI 10.1046/j.1460-9568.2003.02906.x; Batista AP, 2008, IEEE T NEUR SYS REH, V16, P24, DOI 10.1109/TNSRE.2007.906958; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bhattacharyya R, 2009, J NEUROPHYSIOL, V102, P805, DOI 10.1152/jn.90359.2008; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brodmann K., 1909, VERGLEICHENDE LOKALI; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Brozovic M, 2008, J COMPUT NEUROSCI, V25, P158, DOI 10.1007/s10827-007-0070-6; Brozovic M, 2007, J NEUROSCI, V27, P10588, DOI 10.1523/JNEUROSCI.2685-07.2007; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Campos M, 2009, J NEUROPHYSIOL, V101, P448, DOI 10.1152/jn.90704.2008; Cassanello CR, 2007, J PHYSIOL-LONDON, V582, P647, DOI 10.1113/jphysiol.2007.128801; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Constantin AG, 2007, J NEUROPHYSIOL, V98, P696, DOI 10.1152/jn.00206.2007; Critchley M, 1953, PARIETAL LOBE; CSORBA M, 1997, SPIE ORL FL; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Della-Maggiore V, 2004, J NEUROSCI, V24, P9971, DOI 10.1523/JNEUROSCI.2833-04.2004; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Deubel H, 1998, VIS COGN, V5, P81, DOI 10.1080/713756776; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; EVARTS EV, 1969, ANNU REV PHYSIOL, V31, P451, DOI 10.1146/annurev.ph.31.030169.002315; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Ferrier D., 1876, FUNCTION BRAIN; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fritsch G.T., 1960, SOME PAPERS CEREBRAL; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; Gail A, 2009, J NEUROSCI, V29, P9490, DOI 10.1523/JNEUROSCI.1095-09.2009; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; GOLDBERG ME, 1987, NEUROPSYCHOLOGIA, V25, P107, DOI 10.1016/0028-3932(87)90047-9; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb J, 2009, VISION RES, V49, P1216, DOI 10.1016/j.visres.2008.03.023; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; Haarmeier T, 2001, NEURON, V32, P527, DOI 10.1016/S0896-6273(01)00486-X; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; Histed MH, 2006, PLOS BIOL, V4, P826, DOI 10.1371/journal.pbio.0040134; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Ipata AE, 2006, NAT NEUROSCI, V9, P1071, DOI 10.1038/nn1734; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Kalaska JF, 1996, CAN J PHYSIOL PHARM, V74, P483, DOI 10.1139/cjpp-74-4-483; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lawrence BM, 2006, J NEUROPHYSIOL, V96, P1393, DOI 10.1152/jn.01368.2005; Lee B, 2007, J NEUROSCI, V27, P2582, DOI 10.1523/JNEUROSCI.3416-06.2007; Levy I, 2007, J NEUROSCI, V27, P4687, DOI 10.1523/JNEUROSCI.0459-07.2007; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lu XF, 2005, NEURON, V45, P967, DOI 10.1016/j.neuron.2005.01.036; LYNCH JC, 1977, J NEUROPHYSIOL, V40, P362, DOI 10.1152/jn.1977.40.2.362; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Miller EK, 2008, NEURON, V60, P483, DOI 10.1016/j.neuron.2008.10.033; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mishra J, 2006, NEURAL NETWORKS, V19, P1329, DOI 10.1016/j.neunet.2006.08.005; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Monosov IE, 2008, NEURON, V57, P614, DOI 10.1016/j.neuron.2007.12.030; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Mullette-Gillman OA, 2009, CEREB CORTEX, V19, P1761, DOI 10.1093/cercor/bhn207; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; NEWMAN PM, 1999, SOLUTION SIMULTANEOU; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Ohbayashi M, 2003, SCIENCE, V301, P233, DOI 10.1126/science.1084884; OLFATI R, 2002, P 15 IFAC WORLD C; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Quiroga RQ, 2006, J NEUROSCI, V26, P3615, DOI 10.1523/JNEUROSCI.3468-05.2006; Rangel A, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P425, DOI 10.1016/B978-0-12-374176-9.00028-2; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schall JD, 2004, ANNU REV PSYCHOL, V55, P23, DOI 10.1146/annurev.psych.55.090902.141907; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; Schall JD, 2007, SCIENCE, V318, DOI 10.1126/science.1144865; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Shenoy KV, 1999, J NEUROPHYSIOL, V81, P2764, DOI 10.1152/jn.1999.81.6.2764; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Snyder LH, 2000, J NEUROPHYSIOL, V83, P1099, DOI 10.1152/jn.2000.83.2.1099; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Srinivasan L, 2006, NEURAL COMPUT, V18, P2465, DOI 10.1162/neco.2006.18.10.2465; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Thier P, 1996, P NATL ACAD SCI USA, V93, P4962, DOI 10.1073/pnas.93.10.4962; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Torres E, 2006, J NEUROPHYSIOL, V96, P2613, DOI 10.1152/jn.00188.2006; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Vaziri S, 2006, J NEUROSCI, V26, P4188, DOI 10.1523/JNEUROSCI.4747-05.2006; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; von Economo CF, 1929, CYTOARCHITECTONICS H; von Helmoltz H., 1866, HDB PHYSL OPTICS; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; WISE SP, 1985, ANNU REV NEUROSCI, V8, P1, DOI 10.1146/annurev.ne.08.030185.000245; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xing J, 2000, J NEUROPHYSIOL, V84, P651, DOI 10.1152/jn.2000.84.2.651; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097; Zhang MS, 2004, J NEUROPHYSIOL, V91, P1424, DOI 10.1152/jn.00504.2003; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	191	430	434	1	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 10	2009	63	5					568	583		10.1016/j.neuron.2009.08.028	http://dx.doi.org/10.1016/j.neuron.2009.08.028			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755101	Bronze			2022-12-17	WOS:000269852300005
J	Wintermantel, TM; Campbell, RE; Porteous, R; Bock, D; Grone, HJ; Todman, MG; Korach, KS; Greiner, E; Perez, CA; Schutz, G; Herbison, AE				Wintermantel, Tim M.; Campbell, Rebecca E.; Porteous, Robert; Bock, Dagmar; Groene, Hermann-Josef; Todman, Martin G.; Korach, Kenneth S.; Greiner, Erich; Perez, Cristian A.; Schuetz, Guenther; Herbison, Allan E.			Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LUTEINIZING-HORMONE; PREOPTIC AREA; RAT-BRAIN; PSEUDORABIES VIRUS; NERVOUS-SYSTEM; LHRH NEURONS; FEMALE RAT; SURGE; ALPHA	The mechanisms through which estrogen regulates gonadotropin-releasing hormone (GnRH) neurons to control mammalian ovulation are unknown. We found that estrogen positive feedback to generate the preovulatory gonadotropin surge was normal in estrogen receptor beta knockout (ER beta) mutant mice, but absent in ER alpha mutant mice. An ER alpha-selective compound was sufficient to generate positive feedback in wild-type mice. As GnRH neurons do not express ER alpha, estrogen positive feedback upon GnRH neurons must be indirect in nature. To establish the cell type responsible, we generated a neuron-specific ERa mutant mouse line. These mice failed to exhibit estrogen positive feedback, demonstrating that neurons expressing ER alpha are critical. We then used a GnRH neuron-specific Pseudorabies virus (PRV) tracing approach to show that the ER alpha-expressing neurons innervating GnRH neurons are located within rostral periventricular regions of the hypothalamus. These studies demonstrate that ovulation is driven by estrogen actions upon ER alpha-expressing neuronal afferents to GnRH neurons.	German Canc Res Ctr, D-69120 Heidelberg, Germany; Univ Otago, Sch Med Sci, Ctr Neuroendocrinol, Dunedin 9001, New Zealand; Univ Otago, Sch Med Sci, Dept Physiol, Dunedin 9001, New Zealand; NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA; Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Otago; University of Otago; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rockefeller University	Schutz, G (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.schuetz@dkfz.de; allan.herbison@stonebow.otago.ac.nz	Campbell, Rebecca E/F-6430-2010; Perez, Cristian A./A-2341-2008; Oka, Yoshitaka/C-9670-2010	Campbell, Rebecca E/0000-0002-0309-532X; Oka, Yoshitaka/0000-0002-3482-3051; Korach, Kenneth/0000-0002-7765-418X; Herbison, Allan/0000-0002-9615-3022	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065] Funding Source: NIH RePORTER; Wellcome Trust [063216] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham IM, 2003, J NEUROSCI, V23, P5771; BRONSON FH, 1981, ENDOCRINOLOGY, V108, P506, DOI 10.1210/endo-108-2-506; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CARD JP, 1995, CRIT REV NEUROBIOL, V9, P137; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Couse JF, 1999, ENDOCRINOLOGY, V140, P5855, DOI 10.1210/en.140.12.5855; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; DELFALCO J, 2001, SCIENCE, V291, P2608; Dupont S, 2000, DEVELOPMENT, V127, P4277; Evans NP, 1997, ENDOCRINOLOGY, V138, P5408, DOI 10.1210/en.138.12.5408; Gu GB, 1997, J COMP NEUROL, V384, P142; Hegele-Hartung C, 2004, P NATL ACAD SCI USA, V101, P5129, DOI 10.1073/pnas.0306720101; Herbison AE, 1998, ENDOCR REV, V19, P302, DOI 10.1210/edrv.19.3.0332; Herbison AE, 2001, FRONT NEUROENDOCRIN, V22, P292, DOI 10.1006/frne.2001.0219; HERBISON AE, 1995, J NEUROENDOCRINOL, V7, P377, DOI 10.1111/j.1365-2826.1995.tb00772.x; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Horvath S, 2002, EUR J NEUROSCI, V15, P937, DOI 10.1046/j.1460-9568.2002.01923.x; HORVATH TL, 1993, J NEUROENDOCRINOL, V5, P71, DOI 10.1111/j.1365-2826.1993.tb00365.x; Hrabovszky E, 2001, ENDOCRINOLOGY, V142, P3261, DOI 10.1210/en.142.7.3261; Karsch FJ, 1997, BIOL REPROD, V56, P303, DOI 10.1095/biolreprod56.2.303; Le WW, 1999, ENDOCRINOLOGY, V140, P510, DOI 10.1210/en.140.1.510; LEE WS, 1990, P NATL ACAD SCI USA, V87, P5163, DOI 10.1073/pnas.87.13.5163; LEGAN SJ, 1975, ENDOCRINOLOGY, V96, P50, DOI 10.1210/endo-96-1-50; Levine JE, 1997, BIOL REPROD, V56, P293, DOI 10.1095/biolreprod56.2.293; Li C, 1999, BRAIN RES, V824, P267, DOI 10.1016/S0006-8993(99)01217-2; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; Paxinos G., 1997, MOUSE BRAIN STEREOTA; PETERSEN SL, 1989, BRAIN RES, V484, P279, DOI 10.1016/0006-8993(89)90371-5; Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745; Prevot V, 2002, J NEUROENDOCRINOL, V14, P247, DOI 10.1046/j.0007-1331.2001.00772.x; Rage F, 1997, J NEUROSCI, V17, P9145; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Shughrue PJ, 1997, ENDOCRINOLOGY, V138, P5476, DOI 10.1210/en.138.12.5476; Shupnik MA, 1996, TRENDS ENDOCRIN MET, V7, P272, DOI 10.1016/S1043-2760(96)00124-5; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Simonian SX, 1999, J COMP NEUROL, V411, P346, DOI 10.1002/(SICI)1096-9861(19990823)411:2<346::AID-CNE13>3.0.CO;2-S; Skinner DC, 2005, J NEUROENDOCRINOL, V17, P29, DOI 10.1111/j.1365-2826.2005.01271.x; Skynner MJ, 1999, ENDOCRINOLOGY, V140, P5195, DOI 10.1210/en.140.11.5195; Skynner MJ, 1999, J NEUROSCI, V19, P5955, DOI 10.1523/JNEUROSCI.19-14-05955.1999; Smith MJ, 2001, REPRODUCTION, V122, P1, DOI 10.1530/rep.0.1220001; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vente A, 1999, NAT GENET, V22, P22, DOI 10.1038/8734; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335; XIA L, 1992, ENDOCRINOLOGY, V131, P2812, DOI 10.1210/en.131.6.2812; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	50	430	438	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					271	280		10.1016/j.neuron.2006.07.023	http://dx.doi.org/10.1016/j.neuron.2006.07.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046690	Green Accepted, Bronze			2022-12-17	WOS:000241799900008
J	Gabernet, L; Jadhav, SP; Feldman, DE; Carandini, M; Scanziani, M				Gabernet, L; Jadhav, SP; Feldman, DE; Carandini, M; Scanziani, M			Somatosensory integration controlled by dynamic thalamocortical feed-forward inhibition	NEURON			English	Article							RAT BARREL CORTEX; CAT VISUAL-CORTEX; SYNAPTIC CONNECTIONS; PYRAMIDAL CELLS; SPINY STELLATE; LAYER 4; WHISKER DEFLECTIONS; RECEPTIVE-FIELDS; AUDITORY-CORTEX; NEURONS	The temporal features of tactile stimuli are faithfully represented by the activity of neurons in the somatosensory cortex. However, the cellular mechanisms that enable cortical neurons to report accurate temporal information are not known. Here, we show that in the rodent barrel cortex, the temporal window for integration of thalamic inputs is under the control of thalamocortical feed-forward inhibition and can vary from 1 to 10 ms. A single thalamic fiber can trigger feed-forward inhibition and contacts both excitatory and inhibitory cortical neurons. The dynamics of feed-forward inhibition exceed those of each individual synapse in the circuit and are captured by a simple disynaptic model of the thalamocortical projection. The variations in the integration window produce changes in the temporal precision of cortical responses to whisker stimulation. Hence, feed-forward inhibitory circuits, classically known to sharpen spatial contrast of tactile inputs, also increase the temporal resolution in the somatosensory cortex.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	University of Zurich; University of California System; University of California San Diego; The Smith-Kettlewell Eye Research Institute	Scanziani, M (corresponding author), Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland.	massimo@ucsd.edu	Jadhav, Shantanu/H-6654-2013; Carandini, Matteo/C-1922-2008; Carandini, Matteo/ABD-8296-2021	Jadhav, Shantanu/0000-0001-5821-0551; Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682; gabernet, laetitia/0000-0001-5306-169X	NIMH NIH HHS [MH70058, MH71401] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071401, R01MH070058] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; Berger T, 2003, CEREB CORTEX, V13, P274, DOI 10.1093/cercor/13.3.274; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Bruno RM, 2002, J NEUROSCI, V22, P10966; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P396, DOI 10.1113/jphysiol.1955.sp005414; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FOX K, 1992, J NEUROSCI, V12, P1826; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1996, J NEUROSCI, V16, P6567; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Gordon S.., 1998, SYNAPTIC ORG BRAIN, V5; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KELLER A, 1987, J COMP NEUROL, V262, P1, DOI 10.1002/cne.902620102; KELLER A, 1995, SYNAPTIC ORG BARREL, V11; Khatri V, 2004, J NEUROPHYSIOL, V92, P3244, DOI 10.1152/jn.00257.2004; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Laaris N, 2000, J NEUROSCI, V20, P1529; Lavallee P, 2004, J NEUROSCI, V24, P6098, DOI 10.1523/JNEUROSCI.0973-04.2004; LLOYD DPC, 1946, J NEUROPHYSIOL, V9, P421, DOI 10.1152/jn.1946.9.6.421; LONDON JA, 1989, J NEUROSCI, V9, P2182; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P201; MOUNTCASTLE VB, 1968, MED PHYSL, V2; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; PHILLIPS JR, 1988, P NATL ACAD SCI USA, V85, P1317, DOI 10.1073/pnas.85.4.1317; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Shimegi S, 1999, J NEUROSCI, V19, P10164; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	59	430	432	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					315	327		10.1016/j.neuron.2005.09.022	http://dx.doi.org/10.1016/j.neuron.2005.09.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242411	Bronze			2022-12-17	WOS:000232838700020
J	Nagerl, UV; Eberhorn, N; Cambridge, SB; Bonhoeffer, T				Nagerl, UV; Eberhorn, N; Cambridge, SB; Bonhoeffer, T			Bidirectional activity-dependent morphological plasticity in hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; DENDRITIC SPINES; AREA CA1; STIMULATION; DEPRESSION; EXPERIENCE; INDUCTION; SYNAPSES; LTP	Dendritic spines on pyramidal neurons receive the vast majority of excitatory input and are considered electrobiochemical processing units, integrating and compartmentalizing synaptic input. Following synaptic plasticity, spines can undergo morphological plasticity, which possibly forms the structural basis for long-term changes in neuronal circuitry. Here, we demonstrate that spines on CA1 pyramidal neurons from organotypic slice cultures show bidirectional activity-dependent morphological plasticity. Using two-photon time-lapse microscopy, we observed that low-frequency stimulation induced NMDA receptor-dependent spine retractions, whereas theta burst stimulation led to the formation of new spines. Moreover, without stimulation the number of spine retractions was on the same order of magnitude as the stimulus-induced spine gain or loss. Finally, we found that the ability of neurons to eliminate spines in an activity-dependent manner decreased with developmental age. Taken together, our data show that hippocampal neurons can undergo bidirectional morphological plasticity; spines are formed and eliminated in an activity-dependent way.	Max Planck Inst Neurobiol, D-82152 Munich, Germany	Max Planck Society	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Am Klopferspitz 18, D-82152 Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de	Cambridge, Sidney/GYQ-5764-2022; Bonhoeffer, Tobias/B-9481-2009; Nägerl, Valentin/AAD-2575-2022	Bonhoeffer, Tobias/0000-0001-7897-6634; Nägerl, Valentin/0000-0001-6831-9008				BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cooper L. N., 1973, P NOBEL S COLLECTIVE, P252; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; PALM G, 1982, CYBERNETICS SYSTEM R; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEME N; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	22	430	440	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					759	767		10.1016/j.neuron.2004.11.016	http://dx.doi.org/10.1016/j.neuron.2004.11.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572108	Bronze			2022-12-17	WOS:000225548400005
J	Rauschecker, JP; Leaver, AM; Muhlau, M				Rauschecker, Josef P.; Leaver, Amber M.; Muehlau, Mark			Tuning Out the Noise: Limbic-Auditory Interactions in Tinnitus	NEURON			English	Article							DEEP BRAIN-STIMULATION; PARTIAL COCHLEAR LESIONS; NUCLEUS-ACCUMBENS; CORTICAL REORGANIZATION; FREQUENCY ORGANIZATION; SLEEP DISTURBANCE; MUSIC CORRELATE; ANIMAL-MODELS; HEARING-LOSS; ADULT CATS	Tinnitus, the most common auditory disorder, affects about 40 million people in the United States alone, and its incidence is rising due to an aging population and increasing noise exposure. Although several approaches for the alleviation of tinnitus exist, there is as of yet no cure. The present article proposes a testable model for tinnitus that is grounded in recent findings from human imaging and focuses on brain areas in cortex, thalamus, and ventral striatum. Limbic and auditory brain areas are thought to interact at the thalamic level. While a tinnitus signal originates from lesion-induced plasticity of the auditory pathways, it can be tuned out by feedback connections from limbic regions, which block the tinnitus signal from reaching auditory cortex. If the limbic regions are compromised, this "noise-cancellation" mechanism breaks down, and chronic tinnitus results. Hopefully, this model will ultimately enable the development of effective treatment.	[Rauschecker, Josef P.; Leaver, Amber M.] Georgetown Univ, Med Ctr, Lab Integrat Neurosci & Cognit, Washington, DC 20057 USA; [Muehlau, Mark] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany	Georgetown University; Technical University of Munich	Rauschecker, JP (corresponding author), Georgetown Univ, Med Ctr, Lab Integrat Neurosci & Cognit, Washington, DC 20057 USA.	rauschej@georgetown.edu	Rauschecker, Josef P/A-4120-2013	Rauschecker, Josef P./0000-0003-4353-9084	National Institutes of Health [R01 NS052494, RC1 DC010720]; Tinnitus Research Consortium (TRC); Tinnitus Research Initiative (TRI); Skirball Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [RC1DC010720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tinnitus Research Consortium (TRC); Tinnitus Research Initiative (TRI); Skirball Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Grant support was provided by the National Institutes of Health (grants R01 NS052494, RC1 DC010720), the Tinnitus Research Consortium (TRC), the Tinnitus Research Initiative (TRI), and the Skirball Foundation. We thank P. Chablani and A. Seydell for critical comments on the manuscript, and D. Klemm, P. Kusmierek and X. Zhan for help with the graphics.	Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; ALSTER J, 1993, BIOL PSYCHIAT, V34, P84, DOI 10.1016/0006-3223(93)90260-K; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Baldo P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003853.pub2; Bauer CA, 2003, OTOLARYNG CLIN N AM, V36, P267, DOI 10.1016/S0030-6665(02)00171-8; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Brown P, 2000, J NEUROSCI, V20, P1952; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Calford MB, 2005, NATURE, V438, pE3, DOI 10.1038/nature04359; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; DREVETS WC, 1997, NATURE, V386, P827; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eichhammer P, 2007, PROG BRAIN RES, V166, P83, DOI 10.1016/S0079-6123(07)66008-7; Elbert T, 1998, NEUROREPORT, V9, P3571, DOI 10.1097/00001756-199811160-00006; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; FIELDS RD, 2007, SCI AM MIND, V18, P12; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Flor H, 2009, NEUROREHABILITATION, V25, P19, DOI 10.3233/NRE-2009-0496; Florence SL, 1995, J NEUROSCI, V15, P8083; Folmer RL, 2000, AM J OTOLARYNG, V21, P287, DOI 10.1053/ajot.2000.9871; Folmer RL, 2001, OTOLARYNG HEAD NECK, V124, P394, DOI 10.1067/mhn.2001.114673; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Gruber AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005062; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hallam RS, 1996, SCAND AUDIOL, V25, P263, DOI 10.3109/01050399609074965; HELLER MF, 1953, ANN OTO RHINOL LARYN, V62, P73, DOI 10.1177/000348945306200107; Hirata Y, 2004, NEUROREPORT, V15, P815, DOI 10.1097/00001756-200404090-00015; Hoffman HJ, 2004, TINNITUS THEORY MANA; HOKE M, 1989, HEARING RES, V37, P281, DOI 10.1016/0378-5955(89)90028-2; Insel TR, 2007, SCIENCE, V317, P757, DOI 10.1126/science.1147565; Irvine DRF, 2001, AUDIOL NEURO-OTOL, V6, P192, DOI 10.1159/000046831; Jastreboff P. J., 2000, HDB TINNITUS, P357; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Jones E. G., 2007, THALAMUS, V2; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; LEAVER AM, 2006, SOC NEUROSCI, V32; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Lobarinas Edward, 2008, Seminars in Hearing, V29, P333, DOI 10.1055/s-0028-1095893; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; MARRIAGE J, 1995, J LARYNGOL OTOL, V109, P915, DOI 10.1017/S0022215100131676; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; MCCORMICK DA, 1991, J PHYSIOL-LONDON, V442, P235, DOI 10.1113/jphysiol.1991.sp018791; McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009; MCCULLOUGH LD, 1993, NEUROSCIENCE, V52, P919, DOI 10.1016/0306-4522(93)90538-Q; MCKENNA L, 2006, TINNITUS TREATMENT; Melcher JR, 2009, HEARING RES, V257, P63, DOI 10.1016/j.heares.2009.08.005; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; ODonnell P, 1997, J NEUROSCI, V17, P2143; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Rajan R, 1998, J COMP NEUROL, V399, P35; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Rauschecker JP, 1999, SCIENCE, V285, P1686, DOI 10.1126/science.285.5434.1686; Roberts LE, 2007, PROG BRAIN RES, V166, P487, DOI 10.1016/S0079-6123(07)66047-6; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Robinson S, 2007, PROG BRAIN RES, V166, P263, DOI 10.1016/S0079-6123(07)66024-5; Salvi R, 2009, DRUG FUTURE, V34, P381, DOI 10.1358/dof.2009.034.05.1362442; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schneider P, 2009, NEUROIMAGE, V45, P927, DOI 10.1016/j.neuroimage.2008.12.045; SCHWABER MK, 1993, AM J OTOL, V14, P252; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Sherman S.M., 2006, EXPLORING THALAMUS I, V2nd; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shulman Abraham, 2009, Int Tinnitus J, V15, P5; Simpson JJ, 2000, HEARING RES, V145, P1, DOI 10.1016/S0378-5955(00)00093-9; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Tyler R, 2008, AM J AUDIOL, V17, pS176, DOI 10.1044/1059-0889(2008/07-0044); Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yu XJ, 2009, J NEUROPHYSIOL, V101, P980, DOI 10.1152/jn.91130.2008	103	429	455	1	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 24	2010	66	6					819	826		10.1016/j.neuron.2010.04.032	http://dx.doi.org/10.1016/j.neuron.2010.04.032			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620868	Green Accepted, Bronze			2022-12-17	WOS:000279420800005
J	Jhou, TC; Fields, HL; Baxter, MG; Saper, CB; Holland, PC				Jhou, Thomas C.; Fields, Howard L.; Baxter, Mark G.; Saper, Clifford B.; Holland, Peter C.			The Rostromedial Tegmental Nucleus (RMTg), a GABAergic Afferent to Midbrain Dopamine Neurons, Encodes Aversive Stimuli and Inhibits Motor Responses	NEURON			English	Article							MEDIAN RAPHE NUCLEUS; LATERAL HABENULA; BASOLATERAL AMYGDALA; STRIA TERMINALIS; SUBSTANTIA-NIGRA; BED NUCLEUS; TEMPORARY INACTIVATION; ORBITOFRONTAL CORTEX; MESOLIMBIC DOPAMINE; MEDULLA-OBLONGATA	Separate studies have implicated the lateral habenula (LHb) or amygdala-related regions in processing aversive stimuli, but their relationships to each other and to appetitive motivational systems are poorly understood. We show that neurons in the recently identified GABAergic rostromedial tegmental nucleus (RMTg), which receive a major LHb input, project heavily to midbrain dopamine neurons, and show phasic activations and/or Fos induction after aversive stimuli (footshocks, shock-predictive cues, food deprivation, or reward omission) and inhibitions after rewards or reward-predictive stimuli. RMTg lesions markedly reduce passive fear behaviors (freezing, open-arm avoidance) dependent on the extended amygdala, periaqueductal gray, or septum, all regions that project directly to the RMTg. In contrast, RMTg lesions spare or enhance active fear responses (treading, escape) in these same paradigms. These findings suggest that aversive inputs from widespread brain regions and stimulus modalities converge onto the RMTg, which opposes reward and motor-activating functions of midbrain dopamine neurons.	[Jhou, Thomas C.] NIDA, Behav Neurosci Branch, Baltimore, MD 21224 USA; [Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Baxter, Mark G.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Saper, Clifford B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Holland, Peter C.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of Oxford; Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University	Jhou, TC (corresponding author), NIDA, Behav Neurosci Branch, Baltimore, MD 21224 USA.	tomjhou@gmail.com	Saper, Clifford/L-3815-2019; Fields, Howard/ABG-9073-2020		NIH [HL60292, MH53667, MH60179]; Merck; Cephalon; Sepracor; Allen Brain Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH053667, R01MH053667, R01MH060179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Cephalon; Sepracor; Allen Brain Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful for comments on the manuscript draft from Daniel S. Zahm. We also acknowledge excellent technical assistance from Quan Ha, Minh Ha, and Weidong Hu. This research was supported by NIH grants HL60292 (to C.B.S.), MH53667 (to P.C.H.), and MH60179 (to Michela Gallagher), and also by the State of California Research Program for Alcoholism and Addiction and by the Intramural Research Program of the NIH, NIDA. C.B.S. has received consulting fees and grant support from Merck, Cephalon, Sepracor, and the Allen Brain Institute. These compensations are each under $10,000. C.B.S. also receives a stipend as editor-in-chief of the Joumal of Comparative Neurology and President-Elect of the Sleep Research Society, which exceed $10,000. These have not influenced the results or interpretation of the current work.	ARAKI M, 1988, BRAIN RES, V441, P319, DOI 10.1016/0006-8993(88)91410-2; Avanzi V, 1998, BRAIN RES, V790, P178, DOI 10.1016/S0006-8993(97)01538-2; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dickinson A., 1979, MECH LEARNING MOTIVA, P203; Feenstra MGP, 2001, EUR J NEUROSCI, V13, P1051, DOI 10.1046/j.0953-816x.2001.01471.x; Fendt M, 2003, J NEUROSCI, V23, P23; Ferreira JGP, 2008, NEUROSCIENCE, V153, P196, DOI 10.1016/j.neuroscience.2008.02.003; Fields HL, 2007, REGION ANESTH PAIN M, V32, P242, DOI 10.1016/j.rapm.2007.01.001; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Geisler S, 2008, NEUROPSYCHOPHARMACOL, V33, P2688, DOI 10.1038/sj.npp.1301650; Geisler S, 2008, CNS SPECTRUMS, V13, P484, DOI 10.1017/S1092852900016710; Heldt SA, 2006, BRAIN RES, V1073, P229, DOI 10.1016/j.brainres.2005.12.053; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HOLSTEGE G, 1991, PROG BRAIN RES, V87, P307; HOLSTEGE G, 1985, EXP BRAIN RES, V58, P379; HOPKINS DA, 1978, EXP BRAIN RES, V32, P529; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Ikemoto S, 1997, BEHAV NEUROSCI, V111, P369, DOI 10.1037/0735-7044.111.2.369; Ikemoto S, 1998, PHARMACOL BIOCHEM BE, V61, P87, DOI 10.1016/S0091-3057(98)00086-0; Ikemoto S, 2002, J NEUROSCI, V22, P9895; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jhou T, 2005, J COMP NEUROL, V493, P111, DOI 10.1002/cne.20734; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KONORSKI J, 1967, INTEGRATIVE ACITIVIT; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; LaBar KS, 1996, BEHAV NEUROSCI, V110, P991, DOI 10.1037/0735-7044.110.5.991; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lee JLC, 2005, BEHAV BRAIN RES, V159, P221, DOI 10.1016/j.bbr.2004.11.003; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; LENARD LG, 1975, PHARMACOL BIOCHEM BE, V3, P873, DOI 10.1016/0091-3057(75)90120-3; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; McNally GP, 2006, LEARN MEMORY, V13, P245, DOI 10.1101/lm.196606; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Muller M, 2006, BEHAV BRAIN RES, V167, P57, DOI 10.1016/j.bbr.2005.08.016; Murphy CA, 1996, BEHAV BRAIN RES, V81, P43, DOI 10.1016/S0166-4328(96)00041-1; Olson VG, 2007, SYNAPSE, V61, P87, DOI 10.1002/syn.20345; Olson VG, 2005, J NEUROSCI, V25, P5553, DOI 10.1523/JNEUROSCI.0345-05.2005; Owings D.H., 1998, ANIMAL VOCAL COMMUNI; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Pezuk P, 2008, BRAIN RES, V1228, P199, DOI 10.1016/j.brainres.2008.06.071; Phillips PEM, 2007, PSYCHOPHARMACOLOGY, V191, P483, DOI 10.1007/s00213-006-0626-6; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schulz D, 2000, BRAIN RES BULL, V52, P83, DOI 10.1016/S0361-9230(00)00235-5; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SPARKS PD, 1995, BEHAV NEUROSCI, V109, P184; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; SWERDLOW NR, 1993, PHARMACOL BIOCHEM BE, V45, P629, DOI 10.1016/0091-3057(93)90518-X; Tepper JM, 2007, PROG BRAIN RES, V160, P189, DOI 10.1016/S0079-6123(06)60011-3; Treit D, 1997, BEHAV NEUROSCI, V111, P653; TREIT D, 2005, BEHAV LAB RAT HDB TE; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WIRTSHAFTER D, 1992, PHARMACOL BIOCHEM BE, V41, P501, DOI 10.1016/0091-3057(92)90364-L; Zangen A, 2002, J NEUROSCI, V22, P7225	78	429	445	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 12	2009	61	5					786	800		10.1016/j.neuron.2009.02.001	http://dx.doi.org/10.1016/j.neuron.2009.02.001			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	421NZ	19285474	Green Accepted, Bronze			2022-12-17	WOS:000264366900017
J	Masliah, E; Rockenstein, E; Adame, A; Alford, M; Crews, L; Hashimoto, M; Seubert, P; Lee, M; Goldstein, J; Chilcote, T; Games, D; Schenk, D				Masliah, E; Rockenstein, E; Adame, A; Alford, M; Crews, L; Hashimoto, M; Seubert, P; Lee, M; Goldstein, J; Chilcote, T; Games, D; Schenk, D			Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease	NEURON			English	Article							LEWY-BODY-DISEASE; RECEPTOR-RELATED PROTEIN; AMYLOID-BETA IMMUNIZATION; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISORDERS; TRANSGENIC MICE; NACP/ALPHA-SYNUCLEIN; DOPAMINERGIC-NEURONS	Abnormal folding of alpha-synucleln (alpha-syn) is thought to lead to neurodegeneration and the characteristic symptoms of Lewy body disease (LBD). Since previous studies suggest that immunization might be a potential therapy for Alzheimer's disease, we hypothesized that immunization with human (h)alpha-syn might have therapeutic effects in LBD. For this purpose, h alpha-syn transgenic (tg) mice were vaccinated with h alpha-syn. In mice that produced high relative affinity antibodies, there was decreased accumulation of aggregated h alpha-syn in neuronal cell bodies and synapses that was associated with reduced neurodegeneration. Furthermore, antibodies produced by immunized mice recognized abnormal h alpha-syn associated with the neuronal membrane and promoted the degradation of h alpha-syn aggregates, probably via lysosomal pathways. Similar effects were observed with an exogenously applied FITC-tagged h alpha-syn antibody. These results suggest that vaccination is effective in reducing neuronal accumulation of h alpha-syn aggregates and that further development of this approach might have a potential role in the treatment of LBD.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Elan Pharmaceut Inc, San Francisco, CA 94080 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067	NATIONAL INSTITUTE ON AGING [P50AG005131, R37AG018440, R01AG018440, P01AG022074] Funding Source: NIH RePORTER; NIA NIH HHS [AG022074, AG18440, AG5131] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALFORD MF, 1994, J HISTOCHEM CYTOCHEM, V42, P283, DOI 10.1177/42.2.8288869; Bainbridge J, 2003, CLIN EXP IMMUNOL, V133, P310, DOI 10.1046/j.1365-2249.2003.02242.x; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BRAAK H, 2002, J NEUROL S, V3, P1; Burton EA, 2003, GENE THER, V10, P1721, DOI 10.1038/sj.gt.3302116; Coleman T, 1996, J PHARMACOL EXP THER, V277, P685; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; DAMATO RJ, 1986, SCIENCE, V231, P987, DOI 10.1126/science.3080808; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; DODD P, 1981, BRAIN RES, V224, P419, DOI 10.1016/0006-8993(81)90871-4; DODD PR, 1981, BRAIN RES, V226, P107, DOI 10.1016/0006-8993(81)91086-6; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Emadi S, 2004, BIOCHEMISTRY-US, V43, P2871, DOI 10.1021/bi036281f; FABIAN RH, 1990, NEUROLOGY, V40, P419, DOI 10.1212/WNL.40.3_Part_1.419; FABIAN RH, 1987, NEUROLOGY, V37, P1780, DOI 10.1212/WNL.37.11.1780; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; FORNO L, 1996, ADV NEUROL, P217; Frenkel D, 2001, BIOLOGICALS, V29, P243, DOI 10.1006/biol.2001.0294; Games D, 2000, ANN NY ACAD SCI, V920, P274; Garzon J, 1999, MOL BRAIN RES, V65, P151, DOI 10.1016/S0169-328X(98)00350-7; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; HANSEN L, 1990, NEUROLOGY, V40, P1; HANSEN LA, 1992, CURR OPIN NEUROL NEU, V5, P889; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; HERZ J, 1990, J BIOL CHEM, V265, P21355; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; Hussain MM, 2001, FRONT BIOSCI, V6, pD417, DOI 10.2741/Hussain1; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwai A, 2000, BBA-MOL BASIS DIS, V1502, P95, DOI 10.1016/S0925-4439(00)00036-3; Iwatsubo T, 1996, AM J PATHOL, V148, P1517; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Kim DW, 2004, YONSEI MED J, V45, P23, DOI 10.3349/ymj.2004.45.6.1203; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; KOSAKA K, 1984, CLIN NEUROPATHOL, V3, P185; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lemere CA, 2003, NEUROCHEM RES, V28, P1017, DOI 10.1023/A:1023203122036; Luthi-Carter R, 2003, MOL THER, V7, P569, DOI 10.1016/S1525-0016(03)00107-2; Marr RA, 2003, J NEUROSCI, V23, P1992; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; MEEKER ML, 1987, BRAIN RES, V423, P45, DOI 10.1016/0006-8993(87)90823-7; Miller TW, 2003, MOL THER, V7, P572, DOI 10.1016/S1525-0016(03)00063-7; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Salmon DP, 1996, BRAIN COGNITION, V31, P148, DOI 10.1006/brcg.1996.0039; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Shastry BS, 2001, NEUROSCI RES, V41, P5, DOI 10.1016/S0168-0102(01)00254-1; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, LAB INVEST, V78, P1169; Takeda A, 1998, AM J PATHOL, V152, P367; Takeda A, 2000, ACTA NEUROPATHOL, V99, P296, DOI 10.1007/PL00007441; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; UBOL S, 1995, J VIROL, V69, P1990, DOI 10.1128/JVI.69.3.1990-1993.1995; Veldman BAJ, 1998, CLIN NEUROL NEUROSUR, V100, P15, DOI 10.1016/S0303-8467(98)00009-2; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; White AR, 2003, J NEUROCHEM, V87, P801, DOI 10.1046/j.1471-4159.2003.02064.x; Yoshizaki T, 2004, NEUROSCI LETT, V363, P33, DOI 10.1016/j.neulet.2004.03.074; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	82	429	510	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					857	868		10.1016/j.neuron.2005.05.010	http://dx.doi.org/10.1016/j.neuron.2005.05.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953415	Bronze			2022-12-17	WOS:000229922500006
J	Putcha, GV; Le, SY; Frank, S; Besirli, CG; Clark, K; Chu, BY; Alix, S; Youle, RJ; LaMarche, A; Maroney, AC; Johnson, EM				Putcha, GV; Le, SY; Frank, S; Besirli, CG; Clark, K; Chu, BY; Alix, S; Youle, RJ; LaMarche, A; Maroney, AC; Johnson, EM			JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis	NEURON			English	Article							N-TERMINAL KINASE; CEREBELLAR GRANULE CELLS; BCL-2 FAMILY MEMBERS; CYTOCHROME-C RELEASE; SYMPATHETIC NEURONS; CEP-1347 KT7515; PHOSPHATIDYLINOSITOL 3-KINASE; INDUCE APOPTOSIS; DEATH PATHWAY; RELATIVE BIM	Trophic factor deprivation (TFD) activates c-Jun N-terminal kinases (JNKs), culminating in coordinate AP1- dependent transactivation of the BH3-only BCL-2 proteins BIMEL and HRK, which in turn are critical for BAX-dependent cytochrome c release, caspase activation, and apoptosis. Here, we report that TFD caused not only induction but also phosphorylation of BIMEL. Mitochondrially localized JNKs but not upstream activators, like mixed-lineage kinases (MLKs) or mitogen-activated protein kinase kinases (MKKs), specifically phosphorylated BIMEL at Ser65, potentiating its proapoptotic activity. Inhibition of the JNK pathway attenuated BIMEL expression, prevented BIMEL phosphorylation, and abrogated TFD-induced apoptosis. Conversely, activation of this pathway promoted BIMEL expression and phosphorylation, causing BIM- and BAX-dependent cell death. Thus, JNKs regulate the proapoptotic activity of BIMEL during TFD, both transcriptionally and posttranslationally.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Cephalon Inc, W Chester, PA 19380 USA; NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; Upstate USA, Lake Placid, NY 12946 USA	Washington University (WUSTL); Washington University (WUSTL); Teva Pharmaceutical Industries; Cephalon Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Johnson, EM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.			Besirli, Cagri/0000-0001-7154-2024	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002859, R01NS038651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012947] Funding Source: NIH RePORTER; NIA NIH HHS [R37AG-12947] Funding Source: Medline; NINDS NIH HHS [R01NS38651] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Crowder RJ, 1999, J NEUROCHEM, V73, P466, DOI 10.1046/j.1471-4159.1999.0730466.x; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eilers A, 1998, J NEUROSCI, V18, P1713; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Haase M, 1997, VIRCHOWS ARCH, V431, P441, DOI 10.1007/s004280050121; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI200112466; Harris C, 2002, J NEUROCHEM, V83, P992, DOI 10.1046/j.1471-4159.2002.01219.x; Harris CA, 2001, J BIOL CHEM, V276, P37754; Harris CA, 2002, J NEUROSCI, V22, P103, DOI 10.1523/JNEUROSCI.22-01-00103.2002; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; JOHNSON MI, 1983, METHOD ENZYMOL, V103, P334; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; Miller TM, 1996, J NEUROSCI, V16, P7487; Miller TM, 1997, J BIOL CHEM, V272, P9847; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Mota M, 2001, J NEUROSCI, V21, P4949, DOI 10.1523/JNEUROSCI.21-14-04949.2001; Moulder KL, 1999, J NEUROSCI, V19, P705; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ogita K, 2002, J NEUROSCI, V22, P2561, DOI 10.1523/JNEUROSCI.22-07-02561.2002; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Putcha GV, 2000, J CELL BIOL, V149, P1011, DOI 10.1083/jcb.149.5.1011; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Trotter L, 2002, NEUROSCI LETT, V320, P29, DOI 10.1016/S0304-3940(02)00005-8; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Xu X, 1997, P NATL ACAD SCI USA, V94, P12655, DOI 10.1073/pnas.94.23.12655; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	53	429	438	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 19	2003	38	6					899	914		10.1016/S0896-6273(03)00355-6	http://dx.doi.org/10.1016/S0896-6273(03)00355-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818176	Bronze			2022-12-17	WOS:000183691400010
J	Steriade, M; Timofeev, I				Steriade, M; Timofeev, I			Neuronal plasticity in thalamocortical networks during sleep and waking oscillations	NEURON			English	Review							INTRATHALAMIC AUGMENTING RESPONSES; SHORT-TERM PLASTICITY; LESS-THAN-1 HZ OSCILLATION; NEOCORTICAL NEURONS; IN-VIVO; PYRAMIDAL NEURONS; THALAMIC NEURONS; MORPHOLOGICAL-CHARACTERISTICS; CELLULAR MECHANISMS; SLOW INACTIVATION	Spontaneous brain oscillations during states of vigilance are associated with neuronal plasticity due to rhythmic spike bursts and spike trains fired by thalamic and neocortical neurons during low-frequency rhythms that characterize slow-wave sleep and fast rhythms occurring during waking and REM sleep. Intracellular recordings from thalamic and related cortical neurons in vivo demonstrate that, during natural slow-wave sleep oscillations or their experimental models, both thalamic and cortical neurons progressively enhance their responsiveness. This potentiation lasts for several minutes after the end of oscillatory periods. Cortical neurons display self-sustained activity, similar to responses evoked during previous epochs of stimulation, despite the fact that thalamic neurons remain under a powerful hyperpolarizing pressure. These data suggest that, far from being a quiescent state during which the cortex and subcortical structures are globally inhibited, slow-wave sleep may consolidate memory traces acquired during wakefulness in corticothalamic networks. Similar phenomena occur as a consequence of fast oscillations during brain-activated states.	Univ Laval, Fac Med, Neurophysiol Lab, Quebec City, PQ G1K 7P4, Canada	Laval University	Steriade, M (corresponding author), Univ Laval, Fac Med, Neurophysiol Lab, Quebec City, PQ G1K 7P4, Canada.		Timofeev, Igor/E-8828-2012; Timofeev, Igor/AAP-7529-2021	Timofeev, Igor/0000-0002-1389-5857	NINDS NIH HHS [NS-40522] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040522] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Bazhenov M, 1998, J NEUROSCI, V18, P6444; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bazhenov M, 1998, J NEUROPHYSIOL, V79, P2730, DOI 10.1152/jn.1998.79.5.2730; Bremer F., 1960, ARCH ITAL BIOL, V98, P229; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CastroAlamancos MA, 1996, J NEUROSCI, V16, P7742; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; Contreras D, 1997, J NEUROPHYSIOL, V78, P335, DOI 10.1152/jn.1997.78.1.335; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Contreras D, 1996, J PHYSIOL-LONDON, V490, P159, DOI 10.1113/jphysiol.1996.sp021133; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; delaPena E, 1996, J NEUROSCI, V16, P5301; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Elton M, 1997, J SLEEP RES, V6, P78, DOI 10.1046/j.1365-2869.1997.00033.x; EVARTS EV, 1964, J NEUROPHYSIOL, V27, P152, DOI 10.1152/jn.1964.27.2.152; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; HERNANDEZCRUZ A, 1989, J NEUROPHYSIOL, V61, P1270, DOI 10.1152/jn.1989.61.6.1270; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P793, DOI 10.1017/S0140525X00003976; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; Kammermeier PJ, 1997, J NEUROPHYSIOL, V77, P465, DOI 10.1152/jn.1997.77.1.465; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kandel A, 1997, J NEUROSCI, V17, P6783; Kandel ER, 2000, SCIENCE, V290, P1113, DOI 10.1126/science.290.5494.1113; KANG YN, 1994, J NEUROPHYSIOL, V72, P578, DOI 10.1152/jn.1994.72.2.578; KATO N, 1990, BRAIN RES, V509, P150, DOI 10.1016/0006-8993(90)90323-4; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Marder E, 1998, ANNU REV NEUROSCI, V21, P25, DOI 10.1146/annurev.neuro.21.1.25; Massimini M, 2001, J NEUROPHYSIOL, V85, P1346, DOI 10.1152/jn.2001.85.3.1346; Molle M, 2002, J NEUROSCI, V22, P10941; Morison RS, 1943, AM J PHYSIOL, V138, P0297, DOI 10.1152/ajplegacy.1943.138.2.297; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; MORUZZI G, 1966, BRAIN CONSCIOUS EXPE, P345; Nielsen TA, 2000, BEHAV BRAIN SCI, V23, P851, DOI 10.1017/S0140525X0000399X; NUNEZ A, 1992, NEUROSCIENCE, V51, P7, DOI 10.1016/0306-4522(92)90464-D; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Qin YL, 1997, PHILOS T R SOC B, V352, P1525, DOI 10.1098/rstb.1997.0139; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; SCHWINDT PC, 1992, J NEUROPHYSIOL, V67, P216, DOI 10.1152/jn.1992.67.1.216; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Simon NR, 2000, BRAIN RES, V860, P64, DOI 10.1016/S0006-8993(00)01974-0; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Slotnick SD, 2002, P NATL ACAD SCI USA, V99, P6440, DOI 10.1073/pnas.092514899; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 1998, J NEUROSCI, V18, P6425; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; STERIADE M, 1993, J NEUROSCI, V13, P3284; Steriade M, 1997, J NEUROSCI, V17, P3778; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1995, J NEUROSCI, V15, P623; Steriade M, 1996, J NEUROSCI, V16, P2788; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1964, ELECTROEN CLIN NEURO, V16, P221, DOI 10.1016/0013-4694(64)90105-1; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Steriade M., 2001, INTACT SLICED BRAIN; Steriade M., 2003, NEURONAL SUBSTRATES; STERIADE M, 1974, BASIC SLEEP MECH, P144; STERIADE M, 1978, BEHAV BRAIN SCI, V3, P465; Steriade M., 1991, NORMAL ALTERED STATE, V9, P279, DOI [10.1007/978-1-4615-6622-9_8, DOI 10.1007/978-1-4615-6622-9_8]; Steriade Mircea, 2001, Thalamus & Related Systems, V1, P225, DOI 10.1016/S1472-9288(01)00022-X; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Timofeev I, 1998, J NEUROPHYSIOL, V79, P2716, DOI 10.1152/jn.1998.79.5.2716; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2002, J PHYSIOL-LONDON, V542, P583, DOI 10.1113/jphysiol.2001.013479; Timofeev I, 2000, J PHYSIOLOGY-PARIS, V94, P343, DOI 10.1016/S0928-4257(00)01097-4; Timofeev I., 2001, Thalamus & Related Systems, V1, P53, DOI 10.1017/S1472928801000048; Timofeev I, 1998, J NEUROPHYSIOL, V80, P1495, DOI 10.1152/jn.1998.80.3.1495; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Timofeev I, 1996, J PHYSIOL-LONDON, V494, P265, DOI 10.1113/jphysiol.1996.sp021489; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yang CR, 1996, J NEUROSCI, V16, P1904; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	100	429	436	0	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 20	2003	37	4					563	576		10.1016/S0896-6273(03)00065-5	http://dx.doi.org/10.1016/S0896-6273(03)00065-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597855	Bronze			2022-12-17	WOS:000181136500006
J	Cases, O; Vitalis, T; Seif, I; DeMaeyer, E; Sotelo, C; Gaspar, P				Cases, O; Vitalis, T; Seif, I; DeMaeyer, E; Sotelo, C; Gaspar, P			Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: Role of a serotonin excess during the critical period	NEURON			English	Article							VISUAL CORTICAL PLASTICITY; MOUSE CEREBRAL-CORTEX; POSTNATAL-DEVELOPMENT; NEONATAL RAT; NEOCORTEX; ORGANIZATION; FIELD; INNERVATION; RECEPTORS; NEURONS	In a transgenic mouse line (Tg8) deficient for the gene encoding monoamine oxidase A (MAOA), we show that the primary somatosensory cortex (S1) lacks the characteristic barrel-like clustering of layer IV neurons, whereas normal pattern formation exists in the thalamus and the trigeminal nuclei. No barrel-like patterns were visible with tenascin or serotonin immunostaining or with labeling of thalamocortical axons. An excess of brain serotonin during the critical period of barrel formation appears to have a causal role in these cortical abnormalities, since early administration of parachlorophenylalanine, an inhibitor of serotonin synthesis, in Tg8 pups restored the formation of barrels in S1, whereas inhibition of catecholamine synthesis did not. Transient inactivation of MAOA in normal newborns reproduced a barrelless phenotype in parts of S1.	HOP LA PITIE SALPETRIERE, INSERM, U106, F-75651 PARIS, FRANCE; INST CURIE, CNRS, URA 1343, F-91405 ORSAY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie			Gaspar, Patricia/G-8892-2011; De Granzial, Nadine-Tania Vitalis/K-8485-2017; cases, olivier/G-4882-2017; Sotelo, Constantino/AAS-5475-2021	Gaspar, Patricia/0000-0003-4217-5717; De Granzial, Nadine-Tania Vitalis/0000-0002-5531-3771; cases, olivier/0000-0002-5678-7362; Sotelo, Constantino/0000-0001-8051-2492				AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BELFORD GR, 1979, J COMP NEUROL, V188, P63, DOI 10.1002/cne.901880106; BELFORD GR, 1980, J COMP NEUROL, V193, P335, DOI 10.1002/cne.901930203; BENNETTCLARKE CA, 1993, P NATL ACAD SCI USA, V90, P153, DOI 10.1073/pnas.90.1.153; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; Blue ME, 1991, CEREB CORTEX, V1, P380, DOI 10.1093/cercor/1.5.380; BOSCHERT U, 1994, NEUROSCIENCE, V58, P167, DOI 10.1016/0306-4522(94)90164-3; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CAVINESS VS, 1980, J COMP NEUROL, V194, P335, DOI 10.1002/cne.901940205; CHEN L, 1994, NEUROSCI RES, V19, P111, DOI 10.1016/0168-0102(94)90014-0; CHIAIA NL, 1989, J COMP NEUROL, V285, P325; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; CHUBAKOV AR, 1986, BRAIN RES, V369, P285, DOI 10.1016/0006-8993(86)90537-8; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; CROSSIN KL, 1989, DEV BIOL, V136, P381, DOI 10.1016/0012-1606(89)90264-9; DAMATO RJ, 1987, P NATL ACAD SCI USA, V84, P4322, DOI 10.1073/pnas.84.12.4322; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; GOLDBERG JI, 1991, J NEUROBIOL, V22, P182, DOI 10.1002/neu.480220208; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; HALLMAN H, 1984, MED BIOL, V62, P198; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; HURWITZ BE, 1990, BRAIN RES, V512, P210, DOI 10.1016/0006-8993(90)90628-O; JEANMONOD D, 1981, NEUROSCIENCE, V6, P1503, DOI 10.1016/0306-4522(81)90222-0; JENSEN KF, 1987, J NEUROSCI, V7, P3544; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; KASAMATSU T, 1979, J COMP NEUROL, V185, P163, DOI 10.1002/cne.901850110; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIDOV HGW, 1978, BRAIN RES, V153, P577, DOI 10.1016/0006-8993(78)90341-4; LINDVALL O, 1978, HDB PSYCHOPHARMACOLO, V9, P139; LOEB EP, 1987, BRAIN RES, V403, P113, DOI 10.1016/0006-8993(87)90129-6; MA PM, 1993, J COMP NEUROL, V327, P376, DOI 10.1002/cne.903270306; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OSTERHELDHAAS MC, 1994, DEV BRAIN RES, V77, P189, DOI 10.1016/0165-3806(94)90196-1; RHOADES RW, 1994, J NEUROPHYSIOL, V72, P2438, DOI 10.1152/jn.1994.72.5.2438; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; RIAD M, 1994, DEV BRAIN RES, V82, P245, DOI 10.1016/0165-3806(94)90167-8; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; Roubertoux Pierre L., 1992, V8, P423; SAMSA JM, 1979, BIOL NEONATE, V35, P249; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; STEINDLER DA, 1995, J NEUROSCI, V15, P1971, DOI 10.1523/JNEUROSCI.15-03-01971.1995; STEINDLER DA, 1990, EXP NEUROL, V109, P35, DOI 10.1016/S0014-4886(05)80007-X; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VANDERLOOS H, 1976, NEUROSCI LETT, V2, P1, DOI 10.1016/0304-3940(76)90036-7; VANDERLOOS H, 1991, NATO ADV SCI I A-LIF, V200, P229; VERNEY C, 1982, DEV BRAIN RES, V5, P41, DOI 10.1016/0165-3806(82)90111-0; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; WALLACE MN, 1987, BRAIN RES, V418, P178, DOI 10.1016/0006-8993(87)90977-2; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; WELKER E, 1986, J NEUROSCI, V6, P3355; WEYLER W, 1990, PHARMACOL THERAPEUT, V47, P391, DOI 10.1016/0163-7258(90)90064-9; WHITAKERAZMITIA PM, 1990, ANN NY ACAD SCI, V600, P315, DOI 10.1111/j.1749-6632.1990.tb16892.x; WHITAKERAZMITIA PM, 1989, BRAIN RES, V497, P80, DOI 10.1016/0006-8993(89)90972-4; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; WU HF, 1993, MOL PHARMACOL, V43, P888	64	429	437	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					297	307		10.1016/S0896-6273(00)80048-3	http://dx.doi.org/10.1016/S0896-6273(00)80048-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789945	Bronze			2022-12-17	WOS:A1996TW95700010
J	ISHII, N; WADSWORTH, WG; STERN, BD; CULOTTI, JG; HEDGECOCK, EM				ISHII, N; WADSWORTH, WG; STERN, BD; CULOTTI, JG; HEDGECOCK, EM			UNC-6, A LAMININ-RELATED PROTEIN, GUIDES CELL AND PIONEER AXON MIGRATIONS IN C-ELEGANS	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; BASEMENT-MEMBRANE PROTEIN; RETINAL GANGLION-CELLS; CAENORHABDITIS-ELEGANS; BASAL LAMINA; B1 CHAIN; NEUROMUSCULAR-JUNCTION; TRANSPOSABLE ELEMENT; MULTIDOMAIN PROTEIN; DROSOPHILA LAMININ	The unc-6 gene is required for the guidance of pioneer axons and migrating cells along the body wall in C. elegans. In mutants, dorsal and ventral migrations are disrupted, but longitudinal movements are largely unaffected. The gene was tagged for molecular cloning by two independent transposon insertions. Based on genomic and cDNA sequencing, the gene encodes a novel laminin-related protein, UNC-6 (591 amino acids). The N-terminus is homologous to the N-termini (i.e., domains VI, V-1, V-2, and V-3) of laminin subunits, while the C-terminus is a unique domain. We propose that UNC-6 is a component of an extracellular matrix cue that guides dorsoventral migrations on the epidermis.	TOKAI UNIV, SCH MED, DEPT MOLEC BIOL, ISEHARA, KANAGAWA 25911, JAPAN; JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA; MT SINAI HOSP, RES INST, DEPT MOLEC IMMUNOL & NEUROBIOL, TORONTO M5G 1X5, ONTARIO, CANADA	Tokai University; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	ISHII, N (corresponding author), ROCHE INST MOLEC BIOL, DEPT CELL & DEV BIOL, NUTLEY, NJ 07110 USA.		Culotti, Joseph/G-6467-2013; Wadsworth, William G/N-7866-2014	Wadsworth, William G/0000-0003-3824-2948; Culotti, Joseph/0000-0001-6325-4612	NINDS NIH HHS [NS26295] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026295, R37NS026295] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON H, 1988, DEVELOPMENT, V104, P601; BARLOW DP, 1984, EMBO J, V3, P2355, DOI 10.1002/j.1460-2075.1984.tb02140.x; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BEVERELY SM, 1990, CURRENT PROTOCOLS MO; BRONNERFRASER M, 1988, J CELL BIOL, V106, P1321, DOI 10.1083/jcb.106.4.1321; BUETTNER HM, 1991, DEV BIOL, V145, P266, DOI 10.1016/0012-1606(91)90125-M; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CHI HC, 1989, J BIOL CHEM, V264, P1543; COHEN J, 1986, NATURE, V322, P465, DOI 10.1038/322465a0; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; CONDIC ML, 1989, NEURON, V3, P427, DOI 10.1016/0896-6273(89)90202-X; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; FISHELSONZ, 1991, MOL IMMUNOL, V28, P545; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; GOODMAN SL, 1989, DEVELOPMENT CAMB, V106, P795; GRANT P, 1989, DEV BIOL, V133, P502, DOI 10.1016/0012-1606(89)90053-5; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; HAGG T, 1989, NEURON, V3, P721, DOI 10.1016/0896-6273(89)90241-9; HALFTER W, 1987, J NEUROSCI, V7, P3712; HAMMARBACK JA, 1988, DEV BIOL, V126, P29, DOI 10.1016/0012-1606(88)90235-7; HAVILAND DL, 1991, J BIOL CHEM, V266, P11818; Hedgecock E.M., 1990, Seminars in the Neurosciences, V2, P159; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; KALLUNKI T, 1991, J BIOL CHEM, V266, P221; KOUZIKOLIAKOS K, 1989, J BIOL CHEM, V264, P17971; LETOURNEAU PC, 1988, DEV BIOL, V125, P135, DOI 10.1016/0012-1606(88)90066-8; LEUNGHAGESTEIJN C, 1992, IN PRESS CELL; LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; MARTINEZ E, 1991, EMBO J, V10, P263, DOI 10.1002/j.1460-2075.1991.tb07946.x; MCKENNA MP, 1988, DEV BIOL, V130, P232, DOI 10.1016/0012-1606(88)90429-0; MCLOON SC, 1988, J NEUROSCI, V8, P1981; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTELL DJ, 1989, J CELL BIOL, V109, P2441, DOI 10.1083/jcb.109.5.2441; MONTELL DJ, 1988, CELL, V53, P463, DOI 10.1016/0092-8674(88)90166-3; MORI I, 1988, P NATL ACAD SCI USA, V85, P861, DOI 10.1073/pnas.85.3.861; MORI I, 1988, GENETICS, V120, P397; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; OGAWA K, 1988, J BIOL CHEM, V263, P8384; OZKAYNAK E, 1987, BIOTECHNIQUES, V5, P770; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; PERRIS R, 1989, COMM DEV NEUROBIOL, V1, P61; PLACZEK M, 1990, DEVELOPMENT, V110, P19; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SANDROCK AW, 1987, SCIENCE, V237, P1605, DOI 10.1126/science.3306923; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VUOLTEENAHO R, 1990, J BIOL CHEM, V265, P15611; WETSEL RA, 1988, BIOCHEMISTRY-US, V27, P1474, DOI 10.1021/bi00405a012; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YAMAMOTO T, 1988, J NEUROL SCI, V84, P1, DOI 10.1016/0022-510X(88)90169-4; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I; [No title captured]	72	429	440	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1992	9	5					873	881		10.1016/0896-6273(92)90240-E	http://dx.doi.org/10.1016/0896-6273(92)90240-E			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1329863				2022-12-17	WOS:A1992JY55200007
J	Leon, MI; Shadlen, MN				Leon, MI; Shadlen, MN			Representation of time by neurons in the posterior parietal cortex of the macaque	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; SCALAR EXPECTANCY-THEORY; MOTOR INTENTION ACTIVITY; VISUAL-CORTEX; PSYCHOPHYSICAL PERFORMANCE; PREFRONTAL CORTEX; SACCADIC TARGETS; CORTICAL-NEURONS; SINGLE NEURON; PERCEPTION	The neural basis of time perception is unknown. Here we show that neurons in the posterior parietal cortex (area LIP) represent elapsed time relative to a remembered duration. We trained rhesus monkeys to report whether the duration of a test light was longer or shorter than a remembered "standard" (316 or 800 ms) by making an eye movement to one of two choice targets. While timing the test light, the responses of LIP neurons signaled changes in the monkey's perception of elapsed time. The variability of the neural responses explained the monkey's uncertainty about its temporal judgments. Thus, in addition to their role in spatial processing and sensorimotor integration, posterior parietal neurons encode signals related to the perception of time.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210				Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COMMENGES D, 1986, COMPUT METH PROG BIO, V23, P123, DOI 10.1016/0169-2607(86)90107-0; Davison M., 1988, MATCHING LAW RES REV; Finney DJ, 1952, PROBIT ANAL STAT TRE; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Gallistel CR, 1990, ORG LEARNING; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GREEN DM, 1966, SIGNAL DETECTION THE; Harrington DL, 1998, J NEUROSCI, V18, P1085; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hernandez A, 1997, J NEUROSCI, V17, P6391; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lee D, 1998, J NEUROSCI, V18, P1161; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Platt ML, 1998, EXP BRAIN RES, V121, P65, DOI 10.1007/s002210050438; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Roitman JD, 2002, J NEUROSCI, V22, P9475; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	57	428	436	2	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 24	2003	38	2					317	327		10.1016/S0896-6273(03)00185-5	http://dx.doi.org/10.1016/S0896-6273(03)00185-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	672AM	12718864	Bronze			2022-12-17	WOS:000182498300019
J	Mander, BA; Winer, JR; Walker, MP				Mander, Bryce A.; Winer, Joseph R.; Walker, Matthew P.			Sleep and Human Aging	NEURON			English	Review							SLOW-WAVE SLEEP; AGE-RELATED-CHANGES; DECLARATIVE MEMORY CONSOLIDATION; HIPPOCAMPAL-DEPENDENT MEMORY; MILD COGNITIVE IMPAIRMENT; CURRENT STIMULATION TDCS; SELF-REPORTED SLEEP; OLDER-ADULTS; LOCUS-COERULEUS; OSCILLATORY ACTIVITY	Older adults do not sleep as well as younger adults. Why? What alterations in sleep quantity and quality occur as we age, and are there functional consequences? What are the underlying neural mechanisms that explain age-related sleep disruption? This review tackles these questions. First, we describe canonical changes in human sleep quantity and quality in cognitively normal older adults. Second, we explore the underlying neurobiological mechanisms that may account for these human sleep alterations. Third, we consider the functional consequences of age-related sleep disruption, focusing on memory impairment as an exemplar. We conclude with a discussion of a still-debated question: do older adults simply need less sleep, or rather, are they unable to generate the sleep that they still need?	[Mander, Bryce A.; Winer, Joseph R.; Walker, Matthew P.] Univ Calif Berkeley, Dept Psychol, Sleep & Neuroimaging Lab, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Walker, Matthew P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Walker, MP (corresponding author), Univ Calif Berkeley, Dept Psychol, Sleep & Neuroimaging Lab, 3210 Tolman Hall, Berkeley, CA 94720 USA.; Walker, MP (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	mpwalker@berkeley.edu	Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431; Mander, Bryce/0000-0002-0831-7980; Winer, Joseph/0000-0003-4069-3158	NIH [R01-AG031164, R01-AG054019, R01-MH093537]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054106, R01AG031164, RF1AG054019] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by awards R01-AG031164, R01-AG054019, and R01-MH093537 to M.P.W. from the NIH.	Adam M, 2006, SLEEP, V29, P55, DOI 10.1093/sleep/29.1.55; Andrade KC, 2011, J NEUROSCI, V31, P10331, DOI 10.1523/JNEUROSCI.5660-10.2011; Antonenko D, 2013, EUR J NEUROSCI, V37, P1142, DOI 10.1111/ejn.12118; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Backhaus W, 2016, RESTOR NEUROL NEUROS, V34, P153, DOI 10.3233/RNN-150521; Baran B, 2016, J COGNITIVE NEUROSCI, V28, P792, DOI 10.1162/jocn_a_00938; Barrett-Connor E, 2008, J CLIN ENDOCR METAB, V93, P2602, DOI 10.1210/jc.2007-2622; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; Bergmann TO, 2012, NEUROIMAGE, V59, P2733, DOI 10.1016/j.neuroimage.2011.10.036; Borbely A A, 1982, Hum Neurobiol, V1, P195; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brayet P, 2016, CLIN EEG NEUROSCI, V47, P134, DOI 10.1177/1550059415603050; Brownell SE, 2010, NEUROSCI LETT, V472, P29, DOI 10.1016/j.neulet.2010.01.048; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Cavuoto MG, 2016, J SLEEP RES, V25, P475, DOI 10.1111/jsr.12391; CHEE CA, 1988, NEUROBIOL AGING, V9, P307, DOI 10.1016/S0197-4580(88)80070-8; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Cheng JT, 2000, NEUROSCI LETT, V283, P227, DOI 10.1016/S0304-3940(00)00961-7; Cirelli C, 2005, J NEUROSCI, V25, P4503, DOI 10.1523/JNEUROSCI.4845-04.2005; Clewett DV, 2016, NEUROBIOL AGING, V37, P117, DOI 10.1016/j.neurobiolaging.2015.09.019; Conte F, 2014, GERONTOLOGY, V60, P448, DOI 10.1159/000358083; Craik F.I.M., 1977, HDB PSYCHOL AGING, P384; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; de Souza L, 2012, PROG NEURO-PSYCHOPH, V39, P23, DOI 10.1016/j.pnpbp.2012.01.018; DESARRO GB, 1988, BRIT J PHARMACOL, V95, P1278; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dijk DJ, 2010, SLEEP, V33, P211, DOI 10.1093/sleep/33.2.211; DIJK DJ, 1989, NEUROBIOL AGING, V10, P677, DOI 10.1016/0197-4580(89)90004-3; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; dos Santos Moraes WA, 2006, SLEEP, V29, P199, DOI 10.1093/sleep/29.2.199; Downs JL, 2007, NEUROBIOL AGING, V28, P1286, DOI 10.1016/j.neurobiolaging.2006.05.025; Dube J, 2015, J NEUROSCI, V35, P7795, DOI 10.1523/JNEUROSCI.3956-14.2015; Dumay N, 2016, CORTEX, V74, P289, DOI 10.1016/j.cortex.2015.06.007; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; Eggert T, 2013, BRAIN STIMUL, V6, P938, DOI 10.1016/j.brs.2013.05.006; Ehlers CL, 1997, J SLEEP RES, V6, P211, DOI 10.1046/j.1365-2869.1997.00041.x; Ekonomou A, 2000, J NEUROSCI RES, V60, P257, DOI 10.1002/(SICI)1097-4547(20000415)60:2<257::AID-JNR15>3.0.CO;2-U; FEINBERG I, 1968, ARCH GEN PSYCHIAT, V18, P239; Feld GB, 2013, SLEEP, V36, P1317, DOI 10.5665/sleep.2954; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fogel S, 2017, NEUROBIOL AGING, V49, P154, DOI 10.1016/j.neurobiolaging.2016.10.009; Fogel SM, 2014, HUM BRAIN MAPP, V35, P3625, DOI 10.1002/hbm.22426; Foley DJ, 2007, AM J GERIAT PSYCHIAT, V15, P344, DOI 10.1097/01.JGP.0000249385.50101.67; Gagnon JF, 2008, CURR PHARM DESIGN, V14, P3430, DOI 10.2174/138161208786549353; Garcia-Falgueras A, 2011, J COMP NEUROL, V519, P3061, DOI 10.1002/cne.22666; Guzman-Marin R, 2007, NEUROSCIENCE, V148, P325, DOI 10.1016/j.neuroscience.2007.05.030; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hall-Porter JM, 2014, J CLIN SLEEP MED, V10, P27, DOI 10.5664/jcsm.3352; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Harrison Y, 2000, SLEEP, V23, P1067; Hassainia F, 1997, EUR NEUROL, V37, P219, DOI 10.1159/000117446; Hita-Yanez E, 2012, CURR ALZHEIMER RES, V9, P290, DOI 10.2174/156720512800107609; Holth J.K., 2016, NEUROBIOL SLEEP CIRC, V2, P4; Hunt NJ, 2015, NEUROBIOL AGING, V36, P292, DOI 10.1016/j.neurobiolaging.2014.08.010; Ingiosi AM, 2013, CURR OPIN NEUROBIOL, V23, P806, DOI 10.1016/j.conb.2013.02.003; Irwin MR, 2015, ANNU REV PSYCHOL, V66, P143, DOI 10.1146/annurev-psych-010213-115205; Ishunina TA, 2003, BRAIN RES, V988, P84, DOI 10.1016/S0006-8993(03)03347-X; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kakimoto A, 2016, J NUCL MED, V57, P221, DOI 10.2967/jnumed.115.166439; KALES A, 1967, J AM GERIATR SOC, V15, P405, DOI 10.1111/j.1532-5415.1967.tb02072.x; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kasanuki K, 2014, NEUROSCI LETT, V569, P68, DOI 10.1016/j.neulet.2014.03.020; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; King BR, 2017, CEREB CORTEX, V27, P1588, DOI 10.1093/cercor/bhv347; Klerman EB, 2008, CURR BIOL, V18, P1118, DOI 10.1016/j.cub.2008.06.047; Kloppel S, 2001, NEUROREPORT, V12, P669; Ladenbauer J, 2016, NEUROIMAGE, V142, P301, DOI 10.1016/j.neuroimage.2016.06.057; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Landolt HP, 2001, CLIN NEUROPHYSIOL, V112, P369, DOI 10.1016/S1388-2457(00)00542-3; Latta F, 2005, SLEEP, V28, P1519, DOI 10.1093/sleep/28.12.1519; Liguori C, 2014, JAMA NEUROL, V71, P1498, DOI 10.1001/jamaneurol.2014.2510; Lim ASP, 2016, SLEEP, V39, P227, DOI 10.5665/sleep.5354; Lim ASP, 2014, BRAIN, V137, P2847, DOI 10.1093/brain/awu222; Lim ASP, 2013, JAMA NEUROL, V70, P1544, DOI 10.1001/jamaneurol.2013.4215; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Lo JC, 2016, SLEEP MED, V17, P87, DOI 10.1016/j.sleep.2015.08.021; Lo JC, 2014, SLEEP, V37, P665, DOI 10.5665/sleep.3564; Lord C, 2014, PATHOL BIOL, V62, P302, DOI 10.1016/j.patbio.2014.07.005; Luppi P.H., 2016, SLEEP MED REV; Mackiewicz M, 2006, NEUROBIOL AGING, V27, P351, DOI 10.1016/j.neurobiolaging.2005.01.015; Mander B.A., 2016, SLEEP, V39, pA22; Mander BA, 2016, TRENDS NEUROSCI, V39, P552, DOI 10.1016/j.tins.2016.05.002; Mander BA, 2015, NAT NEUROSCI, V18, P1051, DOI 10.1038/nn.4035; Mander BA, 2014, CEREB CORTEX, V24, P3301, DOI 10.1093/cercor/bht188; Mander BA, 2013, NAT NEUROSCI, V16, P357, DOI 10.1038/nn.3324; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; Mary A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00750; Mednick SC, 2013, J NEUROSCI, V33, P4494, DOI 10.1523/JNEUROSCI.3127-12.2013; Menkes-Caspi N, 2015, NEURON, V85, P959, DOI 10.1016/j.neuron.2015.01.025; Meyer PT, 2007, NEUROBIOL AGING, V28, P1914, DOI 10.1016/j.neurobiolaging.2006.08.005; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; Monk TH, 2005, J BIOL RHYTHM, V20, P366, DOI 10.1177/0748730405277378; Munch M, 2005, NEUROBIOL AGING, V26, P1307, DOI 10.1016/j.neurobiolaging.2005.03.004; Munch M, 2004, EUR J NEUROSCI, V20, P1402, DOI 10.1111/j.1460-9568.2004.03580.x; Murillo-Rodriguez E, 2004, NEUROSCIENCE, V123, P361, DOI 10.1016/j.neuroscience.2003.09.015; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Neikrug AB, 2010, GERONTOLOGY, V56, P181, DOI 10.1159/000236900; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Novak M, 1997, DRUG SAFETY, V16, P133, DOI 10.2165/00002018-199716020-00005; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Osorio RS, 2011, J AM GERIATR SOC, V59, P559, DOI 10.1111/j.1532-5415.2010.03288.x; PAGONOPOULOU O, 1992, NEUROREPORT, V3, P735, DOI 10.1097/00001756-199209000-00003; Papalambros NA, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00109; Park JJ, 1997, J COMP NEUROL, V389, P277; Passmann S, 2016, BRAIN STIMUL, V9, P730, DOI 10.1016/j.brs.2016.04.016; Peters KR, 2008, J SLEEP RES, V17, P23, DOI 10.1111/j.1365-2869.2008.00634.x; Petit D, 2004, J PSYCHOSOM RES, V56, P487, DOI 10.1016/j.jpsychores.2004.02.001; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; Piantoni G, 2013, J NEUROSCI, V33, P227, DOI 10.1523/JNEUROSCI.2030-12.2013; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Prediger RDS, 2004, EUR J PHARMACOL, V499, P147, DOI 10.1016/j.ejphar.2004.07.106; Rando K, 2011, AM J PSYCHIAT, V168, P183, DOI 10.1176/appi.ajp.2010.10020233; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Rex CS, 2005, J NEUROSCI, V25, P5956, DOI 10.1523/JNEUROSCI.0880-05.2005; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Sahlem GL, 2015, BRAIN STIMUL, V8, P528, DOI 10.1016/j.brs.2015.01.414; Saletin JM, 2013, NEUROIMAGE, V83, P658, DOI 10.1016/j.neuroimage.2013.06.021; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Scullin MK, 2015, PERSPECT PSYCHOL SCI, V10, P97, DOI 10.1177/1745691614556680; Scullin MK, 2013, PSYCHOL AGING, V28, P105, DOI 10.1037/a0028830; Sonni A, 2015, NEUROBIOL AGING, V36, P2272, DOI 10.1016/j.neurobiolaging.2015.03.010; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; Sprecher KE, 2015, NEUROBIOL AGING, V36, P2568, DOI 10.1016/j.neurobiolaging.2015.05.004; Staresina BP, 2015, NAT NEUROSCI, V18, P1679, DOI 10.1038/nn.4119; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Stern AL, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-014-0777-6; SWAAB DF, 1985, SCIENCE, V228, P1112, DOI 10.1126/science.3992248; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Thakkar MM, 2015, ALCOHOL, V49, P299, DOI 10.1016/j.alcohol.2014.07.019; Tucker M, 2011, J AM GERIATR SOC, V59, P603, DOI 10.1111/j.1532-5415.2011.03324.x; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Van Der Werf YD, 2009, NAT NEUROSCI, V12, P122, DOI 10.1038/nn.2253; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Varga AW, 2016, NEUROBIOL AGING, V42, P142, DOI 10.1016/j.neurobiolaging.2016.03.008; Veldhuis JD, 2000, J CLIN ENDOCR METAB, V85, P1477, DOI 10.1210/jc.85.4.1477; Vienne J, 2016, SLEEP, V39, P1613, DOI 10.5665/sleep.6032; Vienne J, 2012, SLEEP, V35, P1071, DOI 10.5665/sleep.1992; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wang JL, 2015, ANN NEUROL, V78, P317, DOI 10.1002/ana.24432; Webb W B, 1979, Waking Sleeping, V3, P319; WEBB WB, 1982, PSYCHOPHYSIOLOGY, V19, P272, DOI 10.1111/j.1469-8986.1982.tb02561.x; WEBB WB, 1985, PSYCHOPHYSIOLOGY, V22, P156, DOI 10.1111/j.1469-8986.1985.tb01579.x; Westerberg CE, 2015, NEUROBIOL AGING, V36, P2577, DOI 10.1016/j.neurobiolaging.2015.05.014; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; ZEPELIN H, 1984, J GERONTOL, V39, P294, DOI 10.1093/geronj/39.3.294; ZHOU JN, 1995, NEUROBIOL AGING, V16, P571, DOI 10.1016/0197-4580(95)00043-E	156	427	442	27	173	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2017	94	1					19	36		10.1016/j.neuron.2017.02.004	http://dx.doi.org/10.1016/j.neuron.2017.02.004			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EQ7KD	28384471	Green Accepted, Bronze			2022-12-17	WOS:000398262000005
J	Ngo, HVV; Martinetz, T; Born, J; Molle, M				Ngo, Hong-Viet V.; Martinetz, Thomas; Born, Jan; Moelle, Matthias			Auditory Closed-Loop Stimulation of the Sleep Slow Oscillation Enhances Memory	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; K-COMPLEX REPRESENTS; CORTICAL DOWN-STATE; EYE-MOVEMENT SLEEP; ELECTRICAL-STIMULATION; NEURONAL PLASTICITY; SPINDLES; WAVES; CONSOLIDATION; EEG	Brain rhythms regulate information processing in different states to enable learning and memory formation. The <1 Hz sleep slow oscillation hallmarks slow-wave sleep and is critical to memory consolidation. Here we show in sleeping humans that auditory stimulation in phase with the ongoing rhythmic occurrence of slow oscillation up states profoundly enhances the slow oscillation rhythm, phase-coupled spindle activity, and, consequently, the consolidation of declarative memory. Stimulation out of phase with the ongoing slow oscillation rhythm remained ineffective. Closed-loop in-phase stimulation provides a straight-forward tool to enhance sleep rhythms and their functional efficacy.	[Ngo, Hong-Viet V.; Born, Jan; Moelle, Matthias] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72076 Tubingen, Germany; [Ngo, Hong-Viet V.; Born, Jan; Moelle, Matthias] Univ Tubingen, Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Ngo, Hong-Viet V.; Martinetz, Thomas] Med Univ Lubeck, Inst Neuro & Bioinformat, D-23538 Lubeck, Germany; [Ngo, Hong-Viet V.] Med Univ Lubeck, Grad Sch Comp Med & Life Sci, D-23538 Lubeck, Germany; [Born, Jan; Moelle, Matthias] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Lubeck; University of Lubeck; University of Lubeck	Born, J (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72076 Tubingen, Germany.	jan.born@uni-tuebingen.de	Ngo, Hong-Viet/AAL-1457-2021; Born, Jan/K-2596-2016	Ngo, Hong-Viet/0000-0001-5828-5588; Born, Jan/0000-0002-1847-6248	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 654 and Graduate School 235). We are grateful to J. Beyer and S. Janz for conducting parts of the experiments. H.-V.V.N.. and M.M. performed the experiments and related analysis. H.-V.V.N., J.B., and M.M. designed the experiments. H.-V.V.N., T.M., J.B., and M.M. interpreted the data and contributed to writing the manuscript.	Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Amzica F, 2010, SCIENCE, V330, DOI 10.1126/science.1182138; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Bergmann TO, 2012, J NEUROSCI, V32, P243, DOI 10.1523/JNEUROSCI.4792-11.2012; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Landsness EC, 2009, SLEEP, V32, P1273; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Molle M, 2011, PROG BRAIN RES, V193, P93, DOI 10.1016/B978-0-444-53839-0.00007-7; Molle M, 2002, J NEUROSCI, V22, P10941; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Riemann D, 2011, PHARMACOPSYCHIATRY, V44, P1, DOI 10.1055/s-0030-1267978; Rosanova M, 2005, J PHYSIOL-LONDON, V562, P569, DOI 10.1113/jphysiol.2004.071381; Ruch S, 2012, NEUROPSYCHOLOGIA, V50, P2389, DOI 10.1016/j.neuropsychologia.2012.06.008; Schabus Manuel, 2012, Front Neurol, V3, P40, DOI 10.3389/fneur.2012.00040; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; Timofeev I, 2002, J PHYSIOL-LONDON, V542, P583, DOI 10.1113/jphysiol.2001.013479; Timofeev I, 2011, PROG BRAIN RES, V193, P121, DOI 10.1016/B978-0-444-53839-0.00009-0; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G., 2010, MEDICAMUNDI, V54, P82, DOI DOI 10.3389/FNSYS.2014.00208; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	40	427	450	12	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2013	78	3					545	553		10.1016/j.neuron.2013.03.006	http://dx.doi.org/10.1016/j.neuron.2013.03.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23583623	Bronze			2022-12-17	WOS:000318961700015
J	Brickley, SG; Mody, I				Brickley, Stephen G.; Mody, Istvan			Extrasynaptic GABA(A) Receptors: Their Function in the CNS and Implications for Disease	NEURON			English	Review							CEREBELLAR GRANULE CELLS; HIPPOCAMPAL PYRAMIDAL NEURONS; GABAERGIC SYNAPTIC-TRANSMISSION; AMINOBUTYRIC ACID(A) RECEPTORS; SUBUNIT-CONTAINING RECEPTORS; MEDIATED TONIC INHIBITION; RAT SOMATOSENSORY CORTEX; THALAMIC RELAY NEURONS; SLOW-WAVE SLEEP; DELTA-SUBUNIT	Over the past two decades, research has identified extrasynaptic GABA(A) receptor populations that enable neurons to sense the low ambient GABA concentrations present in the extracellular space in order to generate a form of tonic inhibition not previously considered in studies of neuronal excitability. The importance of this tonic inhibition in regulating states of consciousness is highlighted by the fact that extrasynaptic GABA(A) receptors (GABA(A)Rs) are believed to be key targets for anesthetics, sleep-promoting drugs, neurosteroids, and alcohol. The neurosteroid sensitivity of these extrasynaptic GABA(A)Rs may explain their importance in stress-, ovarian cycle-, and pregnancy-related mood disorders. Moreover, disruptions in network dynamics associated with schizophrenia, epilepsy, and Parkinson's disease may well involve alterations in the tonic GABA(A)R-mediated conductance. Extrasynaptic GABA(A)Rs may therefore present a therapeutic target for treatment of these diseases, with the potential to enhance cognition and aid post-stroke functional recovery.	[Brickley, Stephen G.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	Imperial College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brickley, SG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, S Kensington Campus, London SW7 2AZ, England.	s.brickley@imperial.ac.uk		Brickley, Stephen/0000-0002-0930-7346	Wellcome Trust [WT094211MA]; MRC [G0501584]; NIH [NS030549, MH076994]; Coelho Endowment; MRC [G0901892, G0800506] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, R37NS030549] Funding Source: NIH RePORTER; Medical Research Council [G0501584, G0800506, G0901892] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coelho Endowment; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S.G.B.'s research in this area is currently funded by the Wellcome Trust (WT094211MA) and the MRC (G0501584). I.M.'s research is supported by the NIH (NS030549 and MH076994) and the Coelho Endowment.	Ade KK, 2008, J NEUROSCI, V28, P1185, DOI 10.1523/JNEUROSCI.3908-07.2008; Agnati LF, 2010, BRAIN RES REV, V64, P137, DOI 10.1016/j.brainresrev.2010.03.003; Anton RF, 2011, AM J PSYCHIAT, V168, P709, DOI 10.1176/appi.ajp.2011.10101436; Atack JR, 2010, PHARMACOL THERAPEUT, V125, P11, DOI 10.1016/j.pharmthera.2009.09.001; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Ballard TM, 2009, PSYCHOPHARMACOLOGY, V202, P207, DOI 10.1007/s00213-008-1357-7; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Beghi E., 2010, ADV NEUROL DISORD, V3, P85; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Belelli D, 2003, J NEUROSCI, V23, P10013; BENARI Y, 1994, PROG BRAIN RES, V102, P261; Biagini G, 2010, CURR OPIN NEUROL, V23, P170, DOI 10.1097/WCO.0b013e32833735cf; Birnir B, 2000, J MEMBRANE BIOL, V174, P21, DOI 10.1007/s002320001028; BLISS TV, 1970, J PHYSL, V207, P61; Boehm SL, 2006, EUR J PHARMACOL, V541, P158, DOI 10.1016/j.ejphar.2006.02.054; Borghese CM, 2006, J PHARMACOL EXP THER, V319, P208, DOI 10.1124/jpet.106.104406; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Bright DP, 2011, J NEUROSCI, V31, P753, DOI 10.1523/JNEUROSCI.2996-10.2011; BROWN DA, 1979, J PHYSIOL-PARIS, V75, P667; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chambers MS, 2004, J MED CHEM, V47, P5829, DOI 10.1021/jm040863t; Chaudhuri KR, 2008, J NEUROL, V255, P33, DOI 10.1007/s00415-008-5006-1; Chiron C, 2011, NAT REV NEUROL, V7, P189, DOI 10.1038/nrneurol.2011.25; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Collinson N, 2002, J NEUROSCI, V22, P5572; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Dawson GR, 2006, J PHARMACOL EXP THER, V316, P1335, DOI 10.1124/jpet.105.092320; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Drasbek KR, 2007, J NEUROPHYSIOL, V97, P2293, DOI 10.1152/jn.00651.2006; Drasbek KR, 2006, CEREB CORTEX, V16, P1134, DOI 10.1093/cercor/bhj055; Ehrenberg B, 2000, NEUROLOGY, V54, pS33; Errington AC, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/790590; FARIELLO RG, 1987, NEUROPHARMACOLOGY, V26, P161, DOI 10.1016/0028-3908(87)90204-8; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Faulhaber J, 1997, PSYCHOPHARMACOLOGY, V130, P285, DOI 10.1007/s002130050241; Feng Y, 2010, GENES BRAIN BEHAV, V9, P668, DOI 10.1111/j.1601-183X.2010.00598.x; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Hadley SH, 2007, J PHYSIOL-LONDON, V581, P1001, DOI 10.1113/jphysiol.2007.132886; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; HARRISON NL, 1984, BRAIN RES, V323, P287, DOI 10.1016/0006-8993(84)90299-3; Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Jia F, 2008, J PHARMACOL EXP THER, V326, P475, DOI 10.1124/jpet.108.139303; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Katayama S, 2007, ANESTH ANALG, V104, P1422, DOI 10.1213/01.ane.0000261519.04083.3e; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kekesi KA, 1997, NEUROREPORT, V8, P1183, DOI 10.1097/00001756-199703240-00025; Kirmse K, 2008, J PHYSIOL-LONDON, V586, P5665, DOI 10.1113/jphysiol.2008.161943; KISH SJ, 1986, ANN NEUROL, V20, P26, DOI 10.1002/ana.410200106; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Knust H, 2009, BIOORG MED CHEM LETT, V19, P5940, DOI 10.1016/j.bmcl.2009.08.053; Korpi ER, 2007, ALCOHOL, V41, P163, DOI 10.1016/j.alcohol.2007.03.007; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Levy LM, 2002, ANN NEUROL, V52, P755, DOI 10.1002/ana.10372; Liang J, 2007, J NEUROSCI, V27, P12367, DOI 10.1523/JNEUROSCI.2786-07.2007; Linden AM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00003; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Maldonado-Aviles JG, 2009, AM J PSYCHIAT, V166, P450, DOI 10.1176/appi.ajp.2008.08101484; Maneuf YP, 2003, CELL MOL LIFE SCI, V60, P742, DOI 10.1007/s00018-003-2108-x; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Markwardt SJ, 2011, NAT NEUROSCI, V14, P1407, DOI 10.1038/nn.2935; Martin LJ, 2009, BIOCHEM SOC T, V37, P1334, DOI 10.1042/BST0371334; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mitchell EA, 2008, NEUROCHEM INT, V52, P588, DOI 10.1016/j.neuint.2007.10.007; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Mulley JC, 2005, HUM MOL GENET, V14, pR243, DOI 10.1093/hmg/ddi355; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Navarro JF, 2002, PROG NEURO-PSYCHOPH, V26, P1389, DOI 10.1016/S0278-5846(02)00305-6; Nie H, 2011, P NATL ACAD SCI USA, V108, P4459, DOI 10.1073/pnas.1016156108; NUSSER Z, 1995, J NEUROSCI, V15, P2948; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Nutt DJ, 2007, NEUROPHARMACOLOGY, V53, P810, DOI 10.1016/j.neuropharm.2007.08.008; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; Owens DF, 1999, J NEUROPHYSIOL, V82, P570, DOI 10.1152/jn.1999.82.2.570; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Perucca E, 1998, EPILEPSIA, V39, P5, DOI 10.1111/j.1528-1157.1998.tb01268.x; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P1401, DOI 10.4088/JCP.v66n1109; Porcello DM, 2003, J NEUROPHYSIOL, V89, P1378, DOI 10.1152/jn.00899.2002; Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006; Prut L, 2010, GENES BRAIN BEHAV, V9, P478, DOI 10.1111/j.1601-183X.2010.00575.x; Rau V, 2009, ANESTH ANALG, V109, P1816, DOI 10.1213/ANE.0b013e3181bf6ae6; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; Rewal M, 2009, J NEUROSCI, V29, P543, DOI 10.1523/JNEUROSCI.3199-08.2009; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Sanna E, 2004, J NEUROSCI, V24, P6521, DOI 10.1523/JNEUROSCI.0075-04.2004; Santhakumar V, 2010, NEUROSCIENCE, V167, P644, DOI 10.1016/j.neuroscience.2010.02.048; Santhakumar V, 2007, ALCOHOL, V41, P211, DOI 10.1016/j.alcohol.2007.04.011; Saul S., 2007, NY TIMES        0329; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Serra M, 2006, J NEUROCHEM, V98, P122, DOI 10.1111/j.1471-4159.2006.03850.x; Shen H, 2007, NAT NEUROSCI, V10, P469, DOI 10.1038/nn1868; Shen H, 2010, SCIENCE, V327, P1515, DOI 10.1126/science.1184245; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; SOLTESZ I, 1990, EUR J NEUROSCI, V2, P414, DOI 10.1111/j.1460-9568.1990.tb00434.x; Spigelman I, 2002, EPILEPSIA, V43, P3, DOI 10.1046/j.1528-1157.43.s.5.8.x; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; STERIADE M, 1993, J NEUROSCI, V13, P3284; STEWART GO, 1983, ANAESTH INTENS CARE, V11, P107, DOI 10.1177/0310057X8301100203; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tassone DM, 2007, CLIN THER, V29, P26, DOI 10.1016/j.clinthera.2007.01.013; Tokuda K, 2011, J NEUROSCI, V31, P9905, DOI 10.1523/JNEUROSCI.1660-11.2011; Tokuda K, 2010, J NEUROSCI, V30, P16788, DOI 10.1523/JNEUROSCI.4101-10.2010; Tolman JA, 2009, EXPERT OPIN PHARMACO, V10, P3077, DOI 10.1517/14656560903451690; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VALEYEV AY, 1993, NEUROSCI LETT, V155, P199, DOI 10.1016/0304-3940(93)90707-R; Vargas-Caballero M, 2010, NEUROPHARMACOLOGY, V58, P668, DOI 10.1016/j.neuropharm.2009.11.005; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Wafford KA, 2009, NEUROPHARMACOLOGY, V56, P182, DOI 10.1016/j.neuropharm.2008.08.004; Wafford KA, 2006, CURR OPIN PHARMACOL, V6, P30, DOI 10.1016/j.coph.2005.10.004; Wafford KA, 2008, NAT REV DRUG DISCOV, V7, P530, DOI 10.1038/nrd2464; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Winsky-Sommerer R, 2007, EUR J NEUROSCI, V25, P1893, DOI 10.1111/j.1460-9568.2007.05455.x; Winter L, 2003, ANESTH ANALG, V97, P798, DOI 10.1213/01.ANE.0000075835.73967.F3; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yamada J, 2007, CEREB CORTEX, V17, P1782, DOI 10.1093/cercor/bhl087; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; Yee BK, 2004, EUR J NEUROSCI, V20, P1928, DOI 10.1111/j.1460-9568.2004.03642.x; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Zarnowska ED, 2009, J NEUROPHYSIOL, V101, P1179, DOI 10.1152/jn.91203.2008; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	163	427	437	10	185	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					23	34		10.1016/j.neuron.2011.12.012	http://dx.doi.org/10.1016/j.neuron.2011.12.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243744	Green Accepted, Bronze			2022-12-17	WOS:000299446800005
J	Wayman, GA; Lee, YS; Tokumitsu, H; Silva, A; Soderling, TR				Wayman, Gary A.; Lee, Yong-Seok; Tokumitsu, Hiroshi; Silva, Alcino; Soderling, Thomas R.			Calmodulin-kinases: Modulators of neuronal development and plasticity	NEURON			English	Review							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; ELEMENT-BINDING PROTEIN; LIGHT-CHAIN KINASE; CA2+-PERMEABLE AMPA RECEPTORS; GTPASE-ACTIVATING PROTEIN; ANTERIOR CINGULATE CORTEX; RAT HIPPOCAMPAL-NEURONS; CAMKII MESSENGER-RNA; II INHIBITOR PROTEIN	In the nervous system, many intracellular responses to elevated calcium are mediated by CaM kinases (CaMKs), a family of protein kinases whose activities are initially modulated by binding Ca2+/calmodulin and subsequently by protein phosphorylation. One member of this family, CaMKII, is well-established for its effects on modulating synaptic plasticity and learning and memory. However, recent studies indicate that some actions on neuronal development and function attributed to CaMKII may instead or in addition be mediated by other members of the CaMK cascade, such as CaMKK, CaMKI, and CaMKIV. This review summarizes key neuronal functions of the CaMK cascade in signal transduction, gene transcription, synaptic development and plasticity, and behavior. The technical challenges of mapping cellular protein kinase signaling pathways are also discussed.	[Lee, Yong-Seok; Silva, Alcino] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Tokumitsu, Hiroshi] Kagawa Univ, Dept Signal Transduct Sci, Kagawa 7610793, Japan; [Wayman, Gary A.; Soderling, Thomas R.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of California System; University of California Los Angeles; Kagawa University; Oregon Health & Science University	Soderling, TR (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99163 USA.	soderlit@ohsu.edu	Silva, Alcino/ABD-7684-2021; Tokumitsu, Hiroshi/M-3978-2015	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Tokumitsu, Hiroshi/0000-0002-2193-6794	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG013622, R01 AG013622-09] Funding Source: Medline; NIGMS NIH HHS [R01 GM041292-21, R01 GM041292] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P1707, DOI 10.2174/1568026043387223; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Blackstone C, 1999, CELL CALCIUM, V26, P181, DOI 10.1054/ceca.1999.0071; Blaeser F, 2006, MOL CELL BIOL, V26, P9105, DOI 10.1128/MCB.01452-06; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Ciani L, 2008, NEURON, V57, P3, DOI 10.1016/j.neuron.2007.12.017; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Colbran RJ, 2004, J NEUROSCI, V24, P8404, DOI 10.1523/JNEUROSCI.3602-04.2004; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Cooke SF, 2006, J PHYSIOL-LONDON, V574, P805, DOI 10.1113/jphysiol.2006.111559; Corcoran EE, 2003, J BIOL CHEM, V278, P10516, DOI 10.1074/jbc.M210642200; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Du L, 2005, RNA, V11, P1340, DOI 10.1261/rna.2870505; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ENSLEN H, 1994, J BIOL CHEM, V269, P20872; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; FEDER R, 1973, EXP NEUROL, V41, P532, DOI 10.1016/0014-4886(73)90291-4; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Fujimoto T, 2008, BIOCHEMISTRY-US, V47, P4151, DOI 10.1021/bi702528r; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HASHIMOTO Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P41, DOI 10.1016/0003-9861(90)90228-Q; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; Hidaka H, 1996, Adv Pharmacol, V36, P193, DOI 10.1016/S1054-3589(08)60583-9; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; IMPEY S, 2001, SCI STKE, pPE1; Inagaki N, 2000, J BIOL CHEM, V275, P27165; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Ko J, 2003, J NEUROSCI, V23, P1667; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Kuhn TB, 1998, J NEUROSCI, V18, P184; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; LEE JC, 1994, P NATL ACAD SCI USA, V91, P6413, DOI 10.1073/pnas.91.14.6413; Lemrow SM, 2004, J BIOL CHEM, V279, P11664, DOI 10.1074/jbc.M312613200; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Mizuno K, 2007, NEUROSCIENCE, V145, P393, DOI 10.1016/j.neuroscience.2006.11.056; Mizuno K, 2005, J PHARMACOL SCI, V98, P191, DOI 10.1254/jphs.CRJ05005X; Mizuno K, 2006, MOL CELL BIOL, V26, P9094, DOI 10.1128/MCB.01221-06; MOCHIZUKI H, 1993, J BIOL CHEM, V268, P9143; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Mott HR, 2005, BIOCHEMISTRY-US, V44, P10977, DOI 10.1021/bi050374a; Nakamura Y, 2001, NEUROSCI RES, V39, P175, DOI 10.1016/S0168-0102(00)00209-1; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peters M, 2003, J NEUROSCI, V23, P9752; PICCIOTTO MR, 1995, SYNAPSE, V20, P75, DOI 10.1002/syn.890200111; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Qin H, 2003, J BIOL CHEM, V278, P48570, DOI 10.1074/jbc.M308781200; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Sakagami H, 2000, EUR J NEUROSCI, V12, P89, DOI 10.1046/j.1460-9568.2000.00883.x; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Sanhueza M, 2007, J NEUROSCI, V27, P5190, DOI 10.1523/JNEUROSCI.5049-06.2007; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Smolen P, 2006, BIOPHYS J, V90, P2760, DOI 10.1529/biophysj.105.072470; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; SOLEM M, 1995, J NEUROSCI, V15, P5966; Song T, 2004, FEBS LETT, V570, P133, DOI 10.1016/j.febslet.2004.05.083; Stedman DR, 2004, FEBS LETT, V566, P275, DOI 10.1016/j.febslet.2004.04.042; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Suizu F, 2002, BIOCHEM J, V367, P335, DOI 10.1042/BJ20020536; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Takemoto-Kimura S, 2003, J BIOL CHEM, V278, P18597, DOI 10.1074/jbc.M300578200; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tokumitsu H, 2005, J BIOL CHEM, V280, P35108, DOI 10.1074/jbc.M503912200; Tokumitsu H, 2004, J BIOL CHEM, V279, P40296, DOI 10.1074/jbc.M406534200; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Tokumitsu H, 2006, FEBS LETT, V580, P5797, DOI 10.1016/j.febslet.2006.09.043; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Ueda T, 1999, J NEUROCHEM, V73, P2119; Uezu A, 2002, J NEUROCHEM, V82, P585, DOI 10.1046/j.1471-4159.2002.00984.x; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; WILLIAMS EJ, 1995, MOL CELL NEUROSCI, V6, P69, DOI 10.1006/mcne.1995.1007; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Wu LJ, 2008, EUR J NEUROSCI, V27, P1923, DOI 10.1111/j.1460-9568.2008.06183.x; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	200	427	442	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2008	59	6					914	931		10.1016/j.neuron.2008.08.021	http://dx.doi.org/10.1016/j.neuron.2008.08.021			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	356SK	18817731	Green Accepted, Bronze			2022-12-17	WOS:000259797700009
J	Shadlen, MN; Movshon, JA				Shadlen, MN; Movshon, JA			Synchrony unbound: A critical evaluation of the temporal binding hypothesis	NEURON			English	Article									NYU, Howard Hughes Med Inst, New York, NY 10003 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University	Movshon, JA (corresponding author), NYU, Howard Hughes Med Inst, New York, NY 10003 USA.		Shadlen, Michael Neil/AAL-1870-2020		NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY02017, EY11378] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378, R01EY002017] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	427	431	1	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1999	24	1					67	77		10.1016/S0896-6273(00)80822-3	http://dx.doi.org/10.1016/S0896-6273(00)80822-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241QC	10677027	Bronze			2022-12-17	WOS:000082893200009
J	Lipton, JO; Sahin, M				Lipton, Jonathan O.; Sahin, Mustafa			The Neurology of mTOR	NEURON			English	Review							TUBEROUS SCLEROSIS COMPLEX; AUTISM SPECTRUM DISORDERS; RAPAMYCIN SIGNALING PATHWAY; EXTENDS LIFE-SPAN; P70 S6 KINASE; MAMMALIAN TARGET; MOUSE MODEL; PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; RAG GTPASES	The mechanistic target of rapamycin (mTOR) signaling pathway is a crucial cellular signaling hub that, like the nervous system itself, integrates internal and external cues to elicit critical outputs including growth control, protein synthesis, gene expression, and metabolic balance. The importance of mTOR signaling to brain function is underscored by the myriad disorders in which mTOR pathway dysfunction is implicated, such as autism, epilepsy, and neurodegenerative disorders. Pharmacological manipulation of mTOR signaling holds therapeutic promise and has entered clinical trials for several disorders. Here, we review the functions of mTOR signaling in the normal and pathological brain, highlighting ongoing efforts to translate our understanding of cellular physiology into direct medical benefit for neurological disorders.	[Lipton, Jonathan O.; Sahin, Mustafa] Boston Childrens Hosp, Dept Neurol, Translat Neurosci Ctr, FM Kirby Ctr Neurobiol, Boston, MA 02115 USA; [Lipton, Jonathan O.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Sahin, M (corresponding author), Boston Childrens Hosp, Dept Neurol, Translat Neurosci Ctr, FM Kirby Ctr Neurobiol, Boston, MA 02115 USA.	mustafa.sahin@childrens.harvard.edu	SAHIN, MUSTAFA/I-8653-2019	SAHIN, MUSTAFA/0000-0001-7044-2953	NIH/NICHD [K08HD071026-03]; NIH [U01 NS082320, P20 NS080199, U54 NS092090, P30 HD018655]; Department of Defense; Tuberous Sclerosis Alliance; Autism Speaks; Nancy Lurie Marks Family Foundation; Simons Foundation; Boston Children's Hospital Translational Research Program; Novartis; Roche; Shire; NCATS; NIMH; NINDS; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD071026, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P20NS080199, U01NS082320, U54NS092090] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Tuberous Sclerosis Alliance; Autism Speaks; Nancy Lurie Marks Family Foundation; Simons Foundation; Boston Children's Hospital Translational Research Program; Novartis(Novartis); Roche(Roche Holding); Shire; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Robin Kleiman, Peter Tsai, Duyu Nie, Alessia Di Nardo, and Lara Boyle for critically reviewing the manuscript. Due to limited space, we have not quoted all literature in the field, and we apologize to those whose articles are not referenced. J.L. is funded by NIH/NICHD K08HD071026-03. Research in the Sahin lab is supported by the NIH (U01 NS082320, P20 NS080199, U54 NS092090, P30 HD018655), Department of Defense, Tuberous Sclerosis Alliance, Autism Speaks, Nancy Lurie Marks Family Foundation, Simons Foundation, Boston Children's Hospital Translational Research Program, Novartis, Roche, and Shire. Developmental Synaptopathies Consortium (U54 NS092090) is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR), NCATS, and is funded through collaboration between NCATS, NIMH, NINDS, and NICHD.	Abs E, 2013, ANN NEUROL, V74, P569, DOI 10.1002/ana.23943; Alfaiz AA, 2014, HUM MUTAT, V35, P447, DOI 10.1002/humu.22529; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Asato MR, 2004, J CHILD NEUROL, V19, P241, DOI 10.1177/088307380401900401; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Banerjee S, 2011, P NATL ACAD SCI USA, V108, P15996, DOI 10.1073/pnas.1019012108; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Barbero-Camps E, 2013, HUM MOL GENET, V22, P3460, DOI 10.1093/hmg/ddt201; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Boer K, 2008, NEUROPATHOLOGY, V28, P577, DOI 10.1111/j.1440-1789.2008.00920.x; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BRUNI O, 1995, BRAIN DEV-JPN, V17, P52, DOI 10.1016/0387-7604(94)00118-H; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Caccamo A, 2011, J BIOL CHEM, V286, P8924, DOI 10.1074/jbc.M110.180638; Cao R, 2013, NEURON, V79, P712, DOI 10.1016/j.neuron.2013.06.026; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Capo-Chichi JM, 2013, J MED GENET, V50, P740, DOI 10.1136/jmedgenet-2013-101680; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Crino PB, 2010, NEUROLOGY, V74, P1716, DOI 10.1212/WNL.0b013e3181e04325; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dasgupta B, 2005, J NEUROSCI, V25, P5584, DOI 10.1523/JNEUROSCI.4693-04.2005; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; Davies DM, 2011, CLIN CANCER RES, V17, P4071, DOI 10.1158/1078-0432.CCR-11-0445; Di Nardo A, 2014, HUM MOL GENET, V23, P3865, DOI 10.1093/hmg/ddu101; Dibbens LM, 2013, NAT GENET, V45, P546, DOI 10.1038/ng.2599; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Diggs-Andrews KA, 2013, TRENDS NEUROSCI, V36, P237, DOI 10.1016/j.tins.2012.12.002; Dixon-Salazar TJ, 2014, J NEUROSCI, V34, P11844, DOI 10.1523/JNEUROSCI.4642-12.2014; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Ehninger D, 2012, MOL PSYCHIATR, V17, P469, DOI 10.1038/mp.2011.39; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Endo M, 2013, CLIN CANCER RES, V19, P450, DOI 10.1158/1078-0432.CCR-12-1067; Ertan G, 2010, J NEURORADIOLOGY, V37, P231, DOI 10.1016/j.neurad.2009.12.006; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haemel AK, 2010, ARCH DERMATOL, V146, P715, DOI 10.1001/archdermatol.2010.125; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Hobert JA, 2014, EUR J HUM GENET, V22, P273, DOI 10.1038/ejhg.2013.114; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; HUNT A, 1994, DEV MED CHILD NEUROL, V36, P108; Husain AM, 2000, J CHILD NEUROL, V15, P81, DOI 10.1177/088307380001500203; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jansen FE, 2008, NEUROLOGY, V70, P916, DOI 10.1212/01.wnl.0000280579.04974.c0; Jeste SS, 2008, J CHILD NEUROL, V23, P520, DOI 10.1177/0883073807309788; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kapahi Pankaj, 2004, Sci Aging Knowledge Environ, V2004, pPE34, DOI 10.1126/sageke.2004.36.pe34; Kassai H, 2014, CELL REP, V7, P1626, DOI 10.1016/j.celrep.2014.04.048; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Klein S, 2013, AUTISM RES, V6, P51, DOI 10.1002/aur.1266; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Krueger DA, 2013, ANN NEUROL, V74, P679, DOI 10.1002/ana.23960; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; Lewis WW, 2013, CEREB CORTEX, V23, P1526, DOI 10.1093/cercor/bhs135; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu Y, 2014, CURR OPIN NEUROBIOL, V27, P135, DOI 10.1016/j.conb.2014.03.007; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Lynch NE, 2009, ARCH DIS CHILD, V94, P553, DOI 10.1136/adc.2008.155663; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Miyata H, 2004, ANN NEUROL, V56, P510, DOI 10.1002/ana.20234; Mohamed AR, 2012, NEUROLOGY, V79, P2249, DOI 10.1212/WNL.0b013e3182768923; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Normand EA, 2013, NEURON, V78, P895, DOI 10.1016/j.neuron.2013.03.030; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Peters JM, 2013, FUTUR NEUROL, V8, P583, DOI 10.2217/FNL.13.37; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pilarski R, 2013, JNCI-J NATL CANCER I, V105, P1607, DOI 10.1093/jnci/djt277; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; Qin W, 2010, BRAIN PATHOL, V20, P1096, DOI 10.1111/j.1750-3639.2010.00416.x; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reith RM, 2013, NEUROBIOL DIS, V51, P93, DOI 10.1016/j.nbd.2012.10.014; Reith RM, 2011, NEUROBIOL DIS, V43, P113, DOI 10.1016/j.nbd.2011.02.014; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2295; Scheffer IE, 2014, ANN NEUROL, V75, P782, DOI 10.1002/ana.24126; Seibt Julie, 2012, Commun Integr Biol, V5, P491, DOI 10.4161/cib.21010; Seibt J, 2012, CURR BIOL, V22, P676, DOI 10.1016/j.cub.2012.02.016; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; STAN R, 1994, J BIOL CHEM, V269, P32027; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Tillema JM, 2012, NEUROLOGY, V78, P526, DOI 10.1212/WNL.0b013e318247ca8d; Tononi G, 2007, J CLIN INVEST, V117, P3648, DOI 10.1172/JCI34250; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Urbanska M, 2012, J BIOL CHEM, V287, P30240, DOI 10.1074/jbc.M112.374405; van Slegtenhorst M, 1999, J MED GENET, V36, P285; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; von der Brelie C, 2006, EUR J NEUROSCI, V23, P686, DOI 10.1111/j.1460-9568.2006.04594.x; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; Waltereit R, 2011, BEHAV GENET, V41, P364, DOI 10.1007/s10519-010-9399-0; Wang C, 2014, MOL NEUROBIOL, V49, P120, DOI 10.1007/s12035-013-8505-8; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yoon BC, 2009, RESULTS PROBL CELL D, V48, P269, DOI 10.1007/400_2009_5; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2011, HUM MOL GENET, V20, P445, DOI 10.1093/hmg/ddq491; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang SQ, 2010, BIOCHEM BIOPH RES CO, V398, P337, DOI 10.1016/j.bbrc.2010.06.017; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhou MO, 2013, NEURON, V77, P647, DOI 10.1016/j.neuron.2012.12.033; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	213	426	442	6	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 22	2014	84	2					275	291		10.1016/j.neuron.2014.09.034	http://dx.doi.org/10.1016/j.neuron.2014.09.034			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS3HI	25374355	Bronze, Green Accepted			2022-12-17	WOS:000344167900008
J	Belluscio, L; Gold, GH; Nemes, A; Axel, R				Belluscio, L; Gold, GH; Nemes, A; Axel, R			Mice deficient in G(olf) are anosmic	NEURON			English	Article							OLFACTORY RECEPTOR-CELLS; GTP-BINDING PROTEINS; NUCLEOTIDE-GATED CONDUCTANCE; SENSITIVE ADENYLATE-CYCLASE; 2ND MESSENGER PATHWAYS; MITRAL TUFTED CELLS; MOVEMENT-DISORDERS; GENE-EXPRESSION; ODOR MOLECULES; 2-DEOXYGLUCOSE METHOD	We have used gene targeting to examine the role of the G alpha subunit, G(olf) in olfactory signal transduction. Mice homozygous for a null mutation in G(olf) show a striking reduction in the electrophysiological response of primary olfactory sensory neurons to a wide variety of odors. Despite this profound diminution in response to odors, the topographic map of primary sensory projections to the olfactory bulb remains unaltered in G(olf) mutants. Greater than 75% of the G(olf) mutant mice are unable to nurse and die within 2 days after birth. Rare surviving homozygotes mate and are fertile, but mutant females exhibit inadequate maternal behaviors. Surviving homozygous mutant mice also exhibit hyperactive behaviors. These behavioral phenotypes, taken together with the patterns of G(olf) expression, suggest that G(olf) is required for olfactory signal transduction and may also function as an essential signaling molecule more centrally in the brain.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Monell Chemical Senses Center	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.			Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NCI NIH HHS [5PO1 CA23767] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHE BW, 1995, CURR OPIN NEUROBIOL, V5, P461, DOI 10.1016/0959-4388(95)80006-9; ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; ALTAR CA, 1988, ANN NY ACAD SCI, V515, P343, DOI 10.1111/j.1749-6632.1988.tb33006.x; ANHOLT RRH, 1990, BIOCHEMISTRY-US, V29, P4049, DOI 10.1021/bi00469a004; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BREER H, 1993, CIBA F SYMP, V179, P97; BREER H, 1991, CHEM SENSES, V16, P19, DOI 10.1093/chemse/16.1.19; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BRESSLER SL, 1988, BEHAV NEUROSCI, V102, P740, DOI 10.1037/0735-7044.102.5.740; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1992, CURR OPIN GENET DEV, V2, P467, DOI 10.1016/S0959-437X(05)80159-5; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; CALAMANDREI G, 1992, PHYSIOL BEHAV, V52, P901, DOI 10.1016/0031-9384(92)90369-D; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Conklin BR, 1996, MOL PHARMACOL, V50, P885; COPPOLA DM, 1994, PHYSIOL BEHAV, V56, P729, DOI 10.1016/0031-9384(94)90234-8; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DI PG, 1985, BEHAV NEUROSCI, V99, P964; DRINNAN S L, 1991, Molecular and Cellular Neuroscience, V2, P66, DOI 10.1016/1044-7431(91)90040-U; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; FRINGS S, 1991, J GEN PHYSIOL, V97, P1, DOI 10.1085/jgp.97.1.1; Gerfen CR, 1995, J NEUROSCI, V15, P8167; Griffith MK, 1996, BIOL REPROD, V54, P761, DOI 10.1095/biolreprod54.4.761; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hauber W, 1996, NEUROSCIENCE, V73, P121, DOI 10.1016/0306-4522(96)00036-X; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; HERVE D, 1995, MOL BRAIN RES, V32, P125, DOI 10.1016/0169-328X(95)00070-9; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JONES DT, 1988, COLD SPRING HARB SYM, V53, P349, DOI 10.1101/SQB.1988.053.01.042; JONES DT, 1990, J BIOL CHEM, V265, P2671; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES DT, 1990, CHEM SENSES, V15, P333, DOI 10.1093/chemse/15.3.333; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; KEEFE KA, 1995, NEUROSCIENCE, V66, P903, DOI 10.1016/0306-4522(95)00024-D; KLEENE SJ, 1994, J EXP BIOL, V195, P307; Koob GF, 1996, MOL PSYCHIATR, V1, P186; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; KURAHASHI T, 1989, IN PRESS J PHYSL LON, V424, P561; LANCET D, 1982, P NATL ACAD SCI-BIOL, V79, P670, DOI 10.1073/pnas.79.2.670; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; MARSHALL JF, 1979, SCIENCE, V206, P477, DOI 10.1126/science.504992; MARSHALL JF, 1988, ANN NY ACAD SCI, V515, P215, DOI 10.1111/j.1749-6632.1988.tb32988.x; MASTERS SB, 1986, PROTEIN ENG, V1, P47, DOI 10.1093/protein/1.1.47; MASTERS SB, 1990, ADV ENZYME REGUL, V30, P75; MAYER AD, 1993, J COMP PSYCHOL, V107, P12; MEEK LR, 1994, BIOL REPROD, V51, P400, DOI 10.1095/biolreprod51.3.400; MENCO BPM, 1994, J NEUROCYTOL, V23, P708, DOI 10.1007/BF01181645; MEREDITH M, 1994, PSYCHONEUROENDOCRINO, V19, P657, DOI 10.1016/0306-4530(94)90048-5; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MONSMA FJ, 1990, P NATL ACAD SCI USA, V87, P6723, DOI 10.1073/pnas.87.17.6723; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; Nakamura T, 1996, BIOPHYS J, V70, P813, DOI 10.1016/S0006-3495(96)79625-X; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; OKANO M, 1974, J PHYSIOL-LONDON, V242, P353, DOI 10.1113/jphysiol.1974.sp010711; OTTOSON D, 1956, ACTA PHYSIOL SCAND, V35, P7; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; RAJENDREN G, 1990, NEUROENDOCRINOLOGY, V52, P368, DOI 10.1159/000125619; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Restrepo D, 1996, J NEUROBIOL, V30, P37; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROMEYER A, 1994, PHYSIOL BEHAV, V56, P693, DOI 10.1016/0031-9384(94)90229-1; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shiosaki K, 1996, EUR J PHARMACOL, V317, P183, DOI 10.1016/S0014-2999(96)00718-2; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; SULLIVAN KA, 1986, P NATL ACAD SCI USA, V83, P6687, DOI 10.1073/pnas.83.18.6687; TAKAGI SF, 1968, J GEN PHYSIOL, V51, P552, DOI 10.1085/jgp.51.4.552; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; VANDERWOLF CH, 1992, BRAIN RES, V593, P197, DOI 10.1016/0006-8993(92)91308-2; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; ZEBROWSKALUPINA I, 1977, N-S ARCH PHARMACOL, V297, P227, DOI 10.1007/BF00509265; ZIGMAN JM, 1993, ENDOCRINOLOGY, V133, P2508, DOI 10.1210/en.133.6.2508	99	426	443	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1998	20	1					69	81		10.1016/S0896-6273(00)80435-3	http://dx.doi.org/10.1016/S0896-6273(00)80435-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459443	hybrid			2022-12-17	WOS:000071719700010
J	Liu, Y; Holmgren, M; Jurman, ME; Yellen, G				Liu, Y; Holmgren, M; Jurman, ME; Yellen, G			Gated access to the pore of a voltage-dependent K+ channel	NEURON			English	Article							SHAKER POTASSIUM CHANNELS; BINDING-SITE; TETRAETHYLAMMONIUM ION; TEA BLOCKADE; RECEPTOR; MUTATIONS; INACTIVATION; REGION; CONDUCTANCE; ACTIVATION	Voltage-activated K+ channels are integral membrane proteins that open or close a K+-selective pore in response to changes in transmembrane voltage. Although the S4 region of these channels has been implicated as the voltage sensor, little is known about how opening and closing of the pore is accomplished. We explored the gating process by introducing cysteines at various positions thought to lie in or near the pore of the Shaker K+ channel, and by testing their ability to be chemically modified. We found a series of positions in the S6 transmembrane region that react rapidly with water-soluble thiol reagents in the open state but not the closed state. An open-channel blocker can protect several of these cysteines, showing that they lie in the ion-conducting pore. At two of these sites, Cd2+ ions bind to the cysteines without affecting the energetics of gating; at a third site, Cd2+ binding holds the channel open. The results suggest that these channels open and close by the movement of an intracellular gate, distinct from the selectivity filter, that regulates access to the pore.	MASSACHUSETTS GEN HOSP,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital	Liu, Y (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02114, USA.			Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 29693, R01 NS029693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRONG CM, 1982, J GEN PHYSIOL, V80, P663, DOI 10.1085/jgp.80.5.663; ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; ARMSTRONG CM, 1975, QUART REV BIOPH, V7, P179; Baukrowitz T, 1996, P NATL ACAD SCI USA, V93, P13357, DOI 10.1073/pnas.93.23.13357; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; CHERVITZ SA, 1995, J BIOL CHEM, V270, P24043, DOI 10.1074/jbc.270.41.24043; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; Fitzgerald MM, 1996, NAT STRUCT BIOL, V3, P626, DOI 10.1038/nsb0796-626; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; GRISSMER S, 1989, J GEN PHYSIOL, V93, P609, DOI 10.1085/jgp.93.4.609; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LORING RH, 1992, MOL BRAIN RES, V15, P113, DOI 10.1016/0169-328X(92)90158-8; LUKIN SH, 1997, IN PRESS EMBO J; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHIEH CC, 1994, BIOPHYS J, V67, P2316, DOI 10.1016/S0006-3495(94)80718-0; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; TAGLIALATELA M, 1994, J BIOL CHEM, V269, P13867; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TOTH MS, 1993, PROTEIN SCI, V2, P1024; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	47	426	434	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					175	184		10.1016/S0896-6273(00)80357-8	http://dx.doi.org/10.1016/S0896-6273(00)80357-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247273	Bronze			2022-12-17	WOS:A1997XN39400016
J	KAUER, JA; MALENKA, RC; NICOLL, RA				KAUER, JA; MALENKA, RC; NICOLL, RA			A PERSISTENT POSTSYNAPTIC MODIFICATION MEDIATES LONG-TERM POTENTIATION IN THE HIPPOCAMPUS	NEURON			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	KAUER, JA (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143, USA.			Kauer, Julie/0000-0002-3362-1642	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256, R01MH038256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024205] Funding Source: NIH RePORTER; NIMH NIH HHS [MH38256, MH00437] Funding Source: Medline; NINDS NIH HHS [NS24205] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLAKE JF, 1988, NEUROSCI LETT, V89, P182, DOI 10.1016/0304-3940(88)90378-3; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1986, J PHYSIOL-LONDON, V377, P391, DOI 10.1113/jphysiol.1986.sp016193; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V398, pP22; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; FORSYTHE ID, 1988, N PHYSL, V396, P515; GISPEN WH, 1986, PHOSPHORPROTEINS NEU, V69; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; GUSTAFSSON B, 1988, NEUROSCI LETT, V85, P77, DOI 10.1016/0304-3940(88)90432-6; HERRON CE, 1985, NEUROSCI LETT, V60, P19, DOI 10.1016/0304-3940(85)90375-1; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; LYNCH GS, 1976, NATURE, V263, P151, DOI 10.1038/263151a0; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; REYMANN KG, 1988, BRAIN RES, V440, P305, DOI 10.1016/0006-8993(88)91000-1; TAUBE JS, 1988, J NEUROSCI, V8, P1632; WIGSTROM H, 1988, P73; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x	37	426	429	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1988	1	10					911	917		10.1016/0896-6273(88)90148-1	http://dx.doi.org/10.1016/0896-6273(88)90148-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	R4674	2908443				2022-12-17	WOS:A1988R467400002
J	Kheirbek, MA; Drew, LJ; Burghardt, NS; Costantini, DO; Tannenholz, L; Ahmari, SE; Zeng, HK; Fenton, AA; Hen, R				Kheirbek, Mazen A.; Drew, Liam J.; Burghardt, Nesha S.; Costantini, Daniel O.; Tannenholz, Lindsay; Ahmari, Susanne E.; Zeng, Hongkui; Fenton, Andre A.; Hen, Rene			Differential Control of Learning and Anxiety along the Dorsoventral Axis of the Dentate Gyrus	NEURON			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; POSTTRAUMATIC-STRESS-DISORDER; PATTERN SEPARATION; VENTRAL HIPPOCAMPUS; DOUBLE DISSOCIATION; CONTEXTUAL FEAR; SPATIAL MEMORY; DORSAL HIPPOCAMPUS; NMDA RECEPTORS; CA3	The dentate gyrus (DG), in addition to its role in learning and memory, is increasingly implicated in the pathophysiology of anxiety disorders. Here, we show that, dependent on their position along the dorsoventral axis of the hippocampus, DG granule cells (GCs) control specific features of anxiety and contextual learning. Using optogenetic techniques to either elevate or decrease GC activity, we demonstrate that GCs in the dorsal DG control exploratory drive and encoding, not retrieval, of contextual fear memories. In contrast, elevating the activity of GCs in the ventral DG has no effect on contextual learning but powerfully suppresses innate anxiety. These results suggest that strategies aimed at modulating the excitability of the ventral DG may be beneficial for the treatment of anxiety disorders.	[Kheirbek, Mazen A.; Drew, Liam J.; Burghardt, Nesha S.; Ahmari, Susanne E.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Kheirbek, Mazen A.; Drew, Liam J.; Burghardt, Nesha S.; Ahmari, Susanne E.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Tannenholz, Lindsay; Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Kheirbek, Mazen A.; Drew, Liam J.; Burghardt, Nesha S.; Costantini, Daniel O.; Tannenholz, Lindsay; Ahmari, Susanne E.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Fenton, Andre A.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Allen Institute for Brain Science; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hen, R (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	rh95@columbia.edu	Kheirbek, Mazen A/J-3656-2015; Ahmari, Susanne E./J-5812-2013	Kheirbek, Mazen A/0000-0001-9157-7363; Ahmari, Susanne E./0000-0003-4576-076X; Fenton, Andre/0000-0002-5063-1156	NIMH [1K01MH099371-01]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; Sackler Institute Award; Kavli Institute postdoctoral fellowship; NARSAD; New York Stem Cell Initiative [NYSTEM C026430]; NIH [R37 MH068542]; Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH068542, K01MH099371, K08MH087718, T32MH015174] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); Sackler Institute Award; Kavli Institute postdoctoral fellowship; NARSAD(NARSAD); New York Stem Cell Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Ledoux and A. Losonczy for comments on previous versions of this manuscript, G. Stuber, J. Britt, and A. Bond for assistance in optogenetic manipulation, S. Tonegawa for POMC-Cre mice, K. Deisseroth for ChR2 and eNpHR constructs, and C. Dupre, A. Goldberg and E. Balough for technical assistance. This work was supported by NIMH 1K01MH099371-01, a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award and a Sackler Institute Award (M.A.K.); a Kavli Institute postdoctoral fellowship (L.J.D.), and NARSAD, the New York Stem Cell Initiative (NYSTEM C026430), NIH R37 MH068542, and Hope for Depression Research Foundation grants (R.H.). R.H. receives compensation as a consultant for Lundbeck and Roche.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Cimadevilla JM, 2000, NEUROSCI LETT, V285, P53, DOI 10.1016/S0304-3940(00)01019-3; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Czerniawski J, 2012, HIPPOCAMPUS, V22, P1528, DOI 10.1002/hipo.20992; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Gilbertson MW, 2007, BIOL PSYCHIAT, V62, P513, DOI 10.1016/j.biopsych.2006.12.023; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Kheirbek MA, 2011, NEUROPSYCHOPHARMACOL, V36, P373, DOI 10.1038/npp.2010.148; Kishi T, 2006, J COMP NEUROL, V496, P349, DOI 10.1002/cne.20919; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McNish KA, 1997, J NEUROSCI, V17, P9353; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang SH, 2012, HIPPOCAMPUS, V22, P2157, DOI 10.1002/hipo.22036; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	65	425	428	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					955	968		10.1016/j.neuron.2012.12.038	http://dx.doi.org/10.1016/j.neuron.2012.12.038			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473324	Green Accepted, Bronze			2022-12-17	WOS:000316162600015
J	Johnson, MB; Kawasawa, YI; Mason, CE; Krsnik, Z; Coppola, G; Bogdanovic, D; Geschwind, DH; Mane, SM; State, MW; Sestan, N				Johnson, Matthew B.; Kawasawa, Yuka Imamura; Mason, Christopher E.; Krsnik, Zeljka; Coppola, Giovanni; Bogdanovic, Darko; Geschwind, Daniel H.; Mane, Shrikant M.; State, Matthew W.; Sestan, Nenad			Functional and Evolutionary Insights into Human Brain Development through Global Transcriptome Analysis	NEURON			English	Article							CONSERVED NONCODING SEQUENCES; DEVELOPING CEREBRAL-CORTEX; GENE-EXPRESSION; ALTERNATIVE PROMOTER; POSITIVE SELECTION; FOXP2 EXPRESSION; NEURONS; GENOME; MICROARRAYS; DISORDERS	Our understanding of the evolution, formation, and pathological disruption of human brain circuits is impeded by a lack of comprehensive data on the developing brain transcriptome. A whole-genome, exon-level expression analysis of 13 regions from left and right sides of the mid-fetal human brain revealed that 76% of genes are expressed, and 44% of these are differentially regulated. These data reveal a large number of specific gene expression and alternative splicing patterns, as well as coexpression networks, associated with distinct regions and neuro-developmental processes. Of particular relevance to cognitive specializations, we have characterized the transcriptional landscapes of prefrontal cortex and perisylvian speech and language areas, which exhibit a population-level global expression symmetry. We show that differentially expressed genes are more frequently associated with human-specific evolution of putative cis-regulatory elements. These data provide a wealth of biological insights into the complex transcriptional and molecular underpinnings of human brain development and evolution.	[Johnson, Matthew B.; Kawasawa, Yuka Imamura; Krsnik, Zeljka; Bogdanovic, Darko; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Johnson, Matthew B.; Kawasawa, Yuka Imamura; Krsnik, Zeljka; Bogdanovic, Darko; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA; [Mason, Christopher E.; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; [Mason, Christopher E.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Mane, Shrikant M.] Yale Univ, Sch Med, Keck Biotechnol Resource Lab, New Haven, CT 06520 USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Los Angeles, CA 90095 USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA	Yale University; Yale University; Yale University; Yale University; Yale University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	nenad.sestan@yale.edu	Mason, Christopher/HCH-3977-2022; Krsnik, Zeljka/AAI-2999-2020; State, Matthew/W-2256-2019	Krsnik, Zeljka/0000-0001-5238-6820; State, Matthew/0000-0003-1624-8302	NIH [NS054273, MH081896, NS056276, NS051869, MH060233]; Kavli Foundation; NARSAD; James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896, R01MH060233, R37MH060233, R56MH060233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051869, R01NS056276, R01NS054273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Foundation; NARSAD(NARSAD); James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Bradford Poulos for assistance with tissue acquisition, Aiping Lin for help with microarray platform comparisons, James Noonan for advice on analysis of haCNSs, Fuying Gao for statistical analysis, Donna Karolchik and Andy Pohl for assistance in creating tracks for the Genome Browser, and many colleagues for their help and comments. This work was supported by NIH grants NS054273, MH081896 (to N.S.), NS056276 (to M.W.S.), NS051869 (to S.M.M.), MH060233 (to D.H.G.), Kavli Foundation, NARSAD, and the James S. McDonnell Foundation Scholar Award (to N.S.).	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Cheng AW, 2007, J NEUROCHEM, V100, P1515, DOI 10.1111/j.1471-4159.2006.07337.x; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; DEHAY C, 1988, NATURE, V331, P348, DOI 10.1038/331348a0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Funatsu N, 2004, CEREB CORTEX, V14, P1031, DOI 10.1093/cercor/bhh063; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KAAS JH, 2007, EVOLUTION PRIMATE NE, V4; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kostovic I., 1990, PROG BRAIN RES, V85, P223; Kudo LC, 2007, CEREB CORTEX, V17, P2108, DOI 10.1093/cercor/bhl118; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; LaMantia AS, 1999, BIOL PSYCHIAT, V46, P19, DOI 10.1016/S0006-3223(99)00002-5; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Levitt P, 2005, NEURON, V46, P407, DOI 10.1016/j.neuron.2005.04.015; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Muehlfriedel S, 2007, EUR J NEUROSCI, V26, P33, DOI 10.1111/j.1460-9568.2007.05639.x; Nomoto S, 1999, GENE, V236, P259, DOI 10.1016/S0378-1119(99)00280-2; Nural HF, 2007, GENE EXPR PATTERNS, V7, P837, DOI 10.1016/j.modgep.2007.07.004; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; SAJIN B, 1992, NEUROSCI LETT, V140, P117, DOI 10.1016/0304-3940(92)90695-4; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; Sherwood CC, 2008, J ANAT, V212, P426, DOI 10.1111/j.1469-7580.2008.00868.x; Shoichet SA, 2005, HUM GENET, V117, P536, DOI 10.1007/s00439-005-1310-3; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Vallender EJ, 2008, TRENDS NEUROSCI, V31, P637, DOI 10.1016/j.tins.2008.08.010; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74	76	425	430	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 28	2009	62	4					494	509		10.1016/j.neuron.2009.03.027	http://dx.doi.org/10.1016/j.neuron.2009.03.027			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	453OH	19477152	Green Accepted, Bronze			2022-12-17	WOS:000266619700007
J	Chang, QA; Khare, G; Dani, V; Nelson, S; Jaenisch, R				Chang, QA; Khare, G; Dani, V; Nelson, S; Jaenisch, R			The disease progression mutant mice is affected of Mecp2 by the level of BDNF expression	NEURON			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; TRANSCRIPTIONAL REPRESSOR; MOUSE MODEL; NEUROTROPHIC FACTOR; METHYLATED DNA; CNS NEURONS; SURVIVAL; MUTATIONS; CHROMATIN	Mutations in the MECP2 gene cause Rett syndrome (RTT). Bdnf is a MeCP2 target gene; however, its role in RTT pathogenesis is unknown. We examined Bdnf conditional mutant mice for RTT-relevant pathologies and observed that loss of BDNF caused smaller brain size, smaller CA2 neurons, smaller glomerulus size, and a characteristic hindlimb-clasping phenotype. BDNF protein level was reduced in Mecp2 mutant mice, and deletion of Bdnf in Mecp2 mutants caused an earlier onset of RTT-like symptoms. To assess whether this interaction was functional and potentially therapeutically relevant, we increased BDNF expression in the Mecp2 mutant brain with a conditional Bdnf transgene. BDNF overexpression extended the lifespan, rescued a locomotor defect, and reversed an electrophysiological deficit observed in Mecp2 mutants. Our results provide in vivo evidence for a functional interaction between Mecp2and Bdnf and demonstrate the physiological significance of altered BDNF expression/signaling in RTT disease progression.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Brandeis University; Brandeis University	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Nelson, Sacha/0000-0002-0108-8599	NCI NIH HHS [R01 CA087869] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087869] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; BEARD C, 2005, IN PRESS GENESIS; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Cepeda C, 2004, J NEUROSCI RES, V78, P855, DOI 10.1002/jnr.20344; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P5; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.1093/biomet/69.3.553; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Matarazzo V, 2004, MOL CELL NEUROSCI, V27, P44, DOI 10.1016/j.mcn.2004.05.005; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shieh PB, 1999, J NEUROBIOL, V41, P127, DOI 10.1002/(SICI)1097-4695(199910)41:1<127::AID-NEU16>3.0.CO;2-J; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	37	425	450	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					341	348		10.1016/j.neuron.2005.12.027	http://dx.doi.org/10.1016/j.neuron.2005.12.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446138	Bronze			2022-12-17	WOS:000235260900006
J	CHEYETTE, BNR; GREEN, PJ; MARTIN, K; GARREN, H; HARTENSTEIN, V; ZIPURSKY, SL				CHEYETTE, BNR; GREEN, PJ; MARTIN, K; GARREN, H; HARTENSTEIN, V; ZIPURSKY, SL			THE DROSOPHILA SINE OCULIS LOCUS ENCODES A HOMEODOMAIN-CONTAINING PROTEIN REQUIRED FOR THE DEVELOPMENT OF THE ENTIRE VISUAL-SYSTEM	NEURON			English	Article							DNA-BINDING SPECIFICITY; POLARITY GENE HEDGEHOG; DEVELOPING OPTIC LOBES; PATTERN-FORMATION; EMBRYONIC-DEVELOPMENT; MORPHOGENETIC FURROW; CRYSTAL-STRUCTURE; IMAGINAL DISKS; NERVOUS-SYSTEM; FUSHI-TARAZU	The transformation of an unpatterned epithelium into a patterned one isa fundamental issue in morphogenesis. This transformation occurs in a dramatic fashion in the developing eye imaginal disc, the primordium of the Drosophila compound eye. Molecular and developmental analyses reveals that the sine oculis (so) locus encodes a homeodomain-containing protein that is expressed and required in the unpatterned epithelium prior to morphogenesis. In mutants, cells undergo apoptosis. These findings argue that so plays an essential role in controlling the initial events of pattern formation in the eye disc. So is also expressed and required for the development of the rest of the fly visual system, including the optic lobes (i.e., those regions of the brain that process visual information). So is expressed in the optic lobe primordium prior to its invagination from the embryonic ectoderm; in so mutants, the optic robe primordium fails to invaginate.	UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, HOWARD HUGHES MED INST, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	CHEYETTE, BNR (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA.		Cheyette, Benjamin/K-5535-2014	Cheyette, Benjamin/0000-0001-9934-7941; Zipursky, Stephen/0000-0001-5630-7181				ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; ANDERSON H, 1978, J EMBRYOL EXP MORPH, V45, P55; ASHBURNER M, 1989, DROSOPHILA LABORATOR; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; BLUMBERG B, 1991, SCIENCE, V253, P194, DOI 10.1126/science.1677215; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; CAGAN RL, 1992, DETERMINANTS NEURONA, P190; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; EBENS AJ, 1993, Z ZELLFORSCH MIKROSK, V74, P15; ELOFSSON R, 1970, Z ZELLFORSCH MIK ANA, V107, P343, DOI 10.1007/BF00336672; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; GEHRING WJ, 1985, CELL, V40, P3, DOI 10.1016/0092-8674(85)90300-9; GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HEITZLER P, 1993, GENETICS, V135, P105; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; HOFBAUER A, 1976, ROUX ARCH DEV BIOL, V179, P275, DOI 10.1007/BF00848237; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; Lindsley D.L., 1992, GENOME DROSOPHILA ME; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Maniatis T., 1982, MOL CLONING; Milani R, 1941, D I S, V14, P52; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; OCHMAN H, 1988, GENETICS, V120, P621; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pardue ML, 1986, DROSOPHILA PRACTICAL, P111; POECK B, 1993, DEVELOPMENT, V117, P1017; RANSOM R, 1979, J EMBRYOL EXP MORPH, V53, P225; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; SAIKI R. K., 1990, PCR PROTOCOLS GUIDE, P13; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; SCHIER AF, 1992, NATURE, V356, P804, DOI 10.1038/356804a0; SCHMUCKER D, 1992, NEURON, V9, P1025, DOI 10.1016/0896-6273(92)90063-J; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; SPREIJ T E, 1971, Netherlands Journal of Zoology, V21, P221; STJOHNSTON D, 1992, CELL, V68, P201; Strindberg H, 1913, Z WISS ZOOL ABT A, V106, P1; STRUHL G, 1981, DEV BIOL, V84, P386, DOI 10.1016/0012-1606(81)90407-3; SWEETON D, 1991, DEVELOPMENT, V112, P775; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; TIX S, 1989, DEVELOPMENT, V105, P739; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TREISMAN J, 1989, CELL, V59, P553; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VIALLANES MH, 1882, ANN SCI NAT ZOOL, V14, P1; WANG BB, 1993, CELL, V74, P29, DOI 10.1016/0092-8674(93)90292-X; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; WOLFF T, 1991, DEVELOPMENT, V113, P841; YOUNOSSIHARTENSTEIN A, 1993, ROUX ARCH DEV BIOL, V203, P60, DOI 10.1007/BF00539891	66	425	427	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1994	12	5					977	996		10.1016/0896-6273(94)90308-5	http://dx.doi.org/10.1016/0896-6273(94)90308-5			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	7910468				2022-12-17	WOS:A1994NM83100004
J	Xu, YL; Reinscheid, RK; Huitron-Resendiz, S; Clark, SD; Wang, ZW; Lin, SH; Brucher, FA; Zeng, JA; Ly, NK; Henriksen, SJ; Lecea, LC; Civelli, O				Xu, YL; Reinscheid, RK; Huitron-Resendiz, S; Clark, SD; Wang, ZW; Lin, SH; Brucher, FA; Zeng, JA; Ly, NK; Henriksen, SJ; Lecea, LC; Civelli, O			Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects	NEURON			English	Article							PROTEIN-COUPLED RECEPTORS; LOCUS-CERULEUS NEURONS; BARRINGTONS NUCLEUS; COERULEUS; ANXIETY; SLEEP; STRESS; MICE; SUSCEPTIBILITY; PROJECTIONS	Arousal and anxiety are behavioral responses that involve complex neurocircuitries and multiple neurochemical components. Here, we report that a neuropeptide, neuropeptide S (NPS), potently modulates wakefulness and could also regulate anxiety. NIPS acts by activating its cognate receptor (NPSR) and inducing mobilization of intracellular Ca2+. The NPSR mRNA is widely distributed in the brain, including the amygdala and the midline thalamic nuclei. Central administration of NPS increases locomotor activity in mice and decreases paradoxical (REM) sleep and slow wave sleep in rats. NPS was further shown to produce anxiolytic-like effects in mice exposed to four different stressful paradigms. Interestingly, NPS is expressed in a previously undefined cluster of cells located between the locus coeruleus (LC) and Barrington's nucleus. These results indicate that NIPS could be a new modulator of arousal and anxiety. They also show that the LC region encompasses distinct nuclei expressing different arousal-promoting neurotransmitters.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Scripps Research Institute; Scripps Research Institute	Reinscheid, RK (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	rreinsch@uci.edu	Civelli, Olivier/A-8392-2012; de Lecea, Luis/B-3171-2009; de Lecea, Luis/ABE-4005-2021	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942				ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BING O, 1993, NEUROSCI LETT, V164, P17, DOI 10.1016/0304-3940(93)90846-D; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Bourgin P, 2000, J NEUROSCI, V20, P7760; Chaouloff F, 1997, BEHAV BRAIN RES, V85, P27, DOI 10.1016/S0166-4328(96)00160-X; Charney DS, 1996, CRIT REV NEUROBIOL, V10, P419; Chojnacka-Wojcik E, 2001, Curr Opin Investig Drugs, V2, P1112; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; Clark SD, 2001, BRAIN RES, V923, P120, DOI 10.1016/S0006-8993(01)03208-5; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hascoet M, 1998, PHARMACOL BIOCHEM BE, V60, P645, DOI 10.1016/S0091-3057(98)00031-8; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; Hunsley MS, 2003, SLEEP, V26, P521; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; JONES BE, 1991, PROG BRAIN RES, V88, P533; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ohayon MM, 1998, COMPR PSYCHIAT, V39, P185, DOI 10.1016/S0010-440X(98)90059-1; Paine TA, 2002, BEHAV PHARMACOL, V13, P511, DOI 10.1097/00008877-200211000-00001; Paxinos G., 1998, RAT BRAIN STEROTAXIC; REDMOND DE, 1979, LIFE SCI, V25, P2149, DOI 10.1016/0024-3205(79)90087-0; Reinscheid RK, 2002, NEUROPEPTIDES, V36, P72, DOI 10.1054/npep.2002.0901; RIZVI TA, 1994, J COMP NEUROL, V347, P1, DOI 10.1002/cne.903470102; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sato S, 2002, World Patent Application, Patent No. [WO 02/ 31145 A1, 0231145]; Shimomura Y, 2002, J BIOL CHEM, V277, P35826, DOI 10.1074/jbc.M205337200; Silva AP, 2002, CLIN CHIM ACTA, V326, P3, DOI 10.1016/S0009-8981(02)00301-7; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; SUTIN EL, 1988, J COMP NEUROL, V270, P243, DOI 10.1002/cne.902700206; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Ursin R, 2002, SLEEP MED REV, V6, P57, DOI 10.1053/smrv.2001.0174; Valentino RJ, 1995, J COMP NEUROL, V363, P402, DOI 10.1002/cne.903630306; Valentino RJ, 2000, J COMP NEUROL, V417, P399; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Wilson S, 1998, BRIT J PHARMACOL, V125, P1387, DOI 10.1038/sj.bjp.0702238	49	424	443	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					487	497		10.1016/j.neuron.2004.08.005	http://dx.doi.org/10.1016/j.neuron.2004.08.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312648	Bronze			2022-12-17	WOS:000223436400008
J	Ohno, M; Sametsky, EA; Younkin, LH; Oakley, H; Younkin, SG; Citron, M; Vassar, R; Disterhoft, JF				Ohno, M; Sametsky, EA; Younkin, LH; Oakley, H; Younkin, SG; Citron, M; Vassar, R; Disterhoft, JF			BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; LONG-TERM POTENTIATION; A-BETA; TRANSGENIC MICE; SPONTANEOUS-ALTERNATION; CORTICAL-NEURONS; SOCIAL RECOGNITION; KNOCKOUT MICE; IN-VIVO	beta-site APP cleaving enzyme 1 (BACE1) is the beta-secretase enzyme required for generating pathogenic beta-amyloid (Abeta) peptides in Alzheimer's disease (AD). BACE1 knockout mice lack Abeta and are phenotypically normal, suggesting that therapeutic inhibition of BACE1 may be free of mechanism-based side effects. However, direct evidence that BACE1 inhibition would improve cognition is lacking. Here we show that BACE1 null mice engineered to overexpress human APP (BACE1(-/-.)Tg2576(+)) are rescued from Abeta-dependent hippocampal memory deficits. Moreover, impaired hippocampal cholinergic regulation of neuronal excitability found in the Tg2576 AD model is ameliorated in BACE1(-/-.)Tg2576(+) bigenic mice. The behavioral and electrophysiological rescue of deficits in BACE1(-/-.)Tg2576(+) mice is correlated with a dramatic reduction of cerebral Abeta40 and Abeta42 levels and occurs before amyloid deposition in Tg2576 mice. Our gene-based approach demonstrates that lower Abeta levels are beneficial for AD-associated memory impairments, validating BACE1 as a therapeutic target for AD.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Mayo Clin, Jacksonville, FL 32224 USA; Amgen Inc, Dept Neurosci, Thousand Oaks, CA 91320 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Mayo Clinic; Amgen	Ohno, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	ohno@northwestern.edu; r-vassar@northwestern.edu; jdisterhoft@northwestern.edu		Disterhoft, John/0000-0002-8817-7913	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008796] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG08796] Funding Source: Medline; NIMH NIH HHS [R01 MH067251] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Auld DS, 1998, TRENDS NEUROSCI, V21, P43, DOI 10.1016/S0166-2236(97)01144-2; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dodel RC, 2003, LANCET NEUROL, V2, P215, DOI 10.1016/S1474-4422(03)00349-1; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang HM, 2000, NEUROCHEM RES, V25, P303, DOI 10.1023/A:1007592007956; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; John V, 2003, J MED CHEM, V46, P4625, DOI 10.1021/jm030247h; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kelly JF, 1996, P NATL ACAD SCI USA, V93, P6753, DOI 10.1073/pnas.93.13.6753; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lelong V, 2003, N-S ARCH PHARMACOL, V367, P621, DOI 10.1007/s00210-003-0743-2; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; NICOLL JA, 2003, NAT MED, V9, P389; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Saar D, 2001, J NEUROSCI, V21, P1385; Savage LM, 2003, LEARN MEMORY, V10, P242, DOI 10.1101/lm.60003; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Suh YH, 1997, J NEUROCHEM, V68, P1781; Tang J, 2003, J MOL NEUROSCI, V20, P299, DOI 10.1385/JMN:20:3:299; Tran MH, 2002, PEPTIDES, V23, P1271, DOI 10.1016/S0196-9781(02)00062-1; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Wu WW, 2002, AGEING RES REV, V1, P181, DOI 10.1016/S1568-1637(01)00009-5; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhong P, 2003, J BIOL CHEM, V278, P26888, DOI 10.1074/jbc.M302789200	61	424	477	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					27	33		10.1016/S0896-6273(03)00810-9	http://dx.doi.org/10.1016/S0896-6273(03)00810-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715132	Bronze			2022-12-17	WOS:000187942800006
J	Mizuseki, K; Sirota, A; Pastalkova, E; Buzsaki, G				Mizuseki, Kenji; Sirota, Anton; Pastalkova, Eva; Buzsaki, Gyoergy			Theta Oscillations Provide Temporal Windows for Local Circuit Computation in the Entorhinal-Hippocampal Loop	NEURON			English	Article							SOURCE DENSITY ANALYSIS; FREELY BEHAVING RAT; PHASE-PRECESSION; PYRAMIDAL CELLS; GRID CELLS; PLACE CELLS; FREQUENCY OSCILLATIONS; LAMINAR DISTRIBUTION; CELLULAR MECHANISMS; ELECTRICAL ACTIVITY	Theta oscillations are believed to play an important role in the coordination of neuronal firing in the entorhinal (EC)-hippocampal system but the underlying mechanisms are not known. We simultaneously recorded from neurons in multiple regions of the EC-ippocampal loop and examined their temporal relationships. Theta-coordinated synchronous spiking of EC neuronal populations predicted the timing of current sinks in target layers in the hippocampus. However, the temporal delays between population activities in successive anatomical stages were longer (typically by a half theta cycle) than expected from axon conduction velocities and passive synaptic integration of feed-forward excitatory inputs. We hypothesize that the temporal windows set by the theta cycles allow for local circuit interactions and thus a considerable degree of computational independence in subdivisions of the EC-hippocampal loop.	[Mizuseki, Kenji; Sirota, Anton; Pastalkova, Eva; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Mizuseki, Kenji/A-9214-2011; Sirota, Anton/G-1395-2011	Mizuseki, Kenji/0000-0002-1456-2149; Buzsaki, Gyorgy/0000-0002-3100-4800	National Institutes of Health [NS034994, MH54671]; National Science Foundation [SBE 0542013]; J.D. McDonnell Foundation; Uehara Memorial Foundation; Astellas Foundation; Japan Society; Robert Leet & Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); J.D. McDonnell Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation(Astellas Pharmaceuticals); Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert Leet & Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Amarasingham, K. Diba, S. Fujisawa, C. Geisler, A. Grosmark, S.M. Montgomery, S. Ozen, J. Patel, P. Quilichini, S. Sakata, E. Stark, D. Sullivan, and D. Robbe for valuable discussions and comments on the manuscript. Supported by National Institutes of Health (NS034994; MH54671), National Science Foundation (SBE 0542013), the J.D. McDonnell Foundation, Uehara Memorial Foundation, Astellas Foundation for Research on Metabolic Disorders, Japan Society for the Promotion of Science, and the Robert Leet & Clara Guthrie Patterson Trust.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Amaral D, 2007, HIPPOCAMPUS BOOK, P37; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ANDERSEN P, 1969, ACTA PHYSIOL SCAND, V76, pA4; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Diba K, 2008, J NEUROSCI, V28, P13448, DOI 10.1523/JNEUROSCI.3824-08.2008; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; FOX SE, 1989, EXP BRAIN RES, V77, P283, DOI 10.1007/BF00274985; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GRASTYAN E, 1959, ELECTROEN CLIN NEURO, V11, P409, DOI 10.1016/0013-4694(59)90040-9; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hasselmo ME, 2007, LEARN MEMORY, V14, P782, DOI 10.1101/lm.686607; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; HOLMES JE, 1960, AM J PHYSIOL, V199, P741, DOI 10.1152/ajplegacy.1960.199.5.741; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kiss J, 1996, HIPPOCAMPUS, V6, P239, DOI 10.1002/(SICI)1098-1063(1996)6:3<239::AID-HIPO3>3.0.CO;2-I; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; KONOPACKI J, 1987, BRAIN RES, V405, P196, DOI 10.1016/0006-8993(87)91009-2; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; LEUNG LWS, 1984, J NEUROPHYSIOL, V52, P1051, DOI 10.1152/jn.1984.52.6.1051; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; Maurer AP, 2006, HIPPOCAMPUS, V16, P785, DOI 10.1002/hipo.20202; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; MITCHELL SJ, 1980, BRAIN RES, V189, P49, DOI 10.1016/0006-8993(80)90006-2; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Orban G, 2006, J NEUROPHYSIOL, V96, P2889, DOI 10.1152/jn.01233.2005; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SOLLESZ I, 1993, J NEUROPHYSIOL, V70, P97; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; STEWART M, 1992, EXP BRAIN RES, V90, P21; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	94	423	428	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					267	280		10.1016/j.neuron.2009.08.037	http://dx.doi.org/10.1016/j.neuron.2009.08.037			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874793	Green Accepted, Bronze			2022-12-17	WOS:000271889900015
J	Parikh, V; Kozak, R; Martinez, V; Sarter, M				Parikh, Vinay; Kozak, Rouba; Martinez, Vicente; Sarter, Martin			Prefrontal acetylcholine release controls cue detection on multiple timescales	NEURON			English	Article							FOREBRAIN CHOLINERGIC SYSTEM; VISUAL ATTENTIONAL TASK; REACTION-TIME-TASK; BASAL FOREBRAIN; CORTICAL ACETYLCHOLINE; NUCLEUS-ACCUMBENS; NEURONAL-ACTIVITY; PERFORMANCE; LESIONS; CORTEX	Cholinergic neurons originating from the basal forebrain innervate the entire cortical mantle. Choline-sensitive microelectrodes were used to measure the synaptic release of cortical acetylcholine (ACh) at a subsecond resolution in rats performing a task involving the detection of cues. Cues that were detected, defined behaviorally, evoked transient increases in cholinergic activity (at the scale of seconds) in the medial prefrontal cortex (mPFC), but not in a nonassociational control region (motor cortex). In trials involving missed cues, cholinergic transients were not observed. Cholinergic deafferentation of the mPFC, but not motor cortex, impaired cue detection. Furthermore, decreases and increases in precue cholinergic activity predicted subsequent cue detection or misses, respectively. Finally, cue-evoked cholinergic transients were superimposed over slower (at the timescale of minutes) changes in cholinergic activity. Cortical cholinergic neurotransmission is regulated on multiple timescales to mediate the detection of behaviorally significant cues and to support cognitive performance.	Univ Michigan, Dept Psychol & Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sarter, M (corresponding author), Univ Michigan, Dept Psychol & Neurosci Program, Ann Arbor, MI 48109 USA.	msarter@umich.edu	Parikh, Vinay/M-1439-2016		NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001072, R03MH073600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037026] Funding Source: NIH RePORTER; NIMH NIH HHS [2 R03 MH073600, R03 MH073600, K02 MH001072-09, K02 MH001072, R03 MH073600-02, 1 K02 MH01072] Funding Source: Medline; NINDS NIH HHS [R01 NS037026-09, 5 R01 NS37026, R01 NS037026] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arnold HM, 2002, NEUROSCIENCE, V114, P451, DOI 10.1016/S0306-4522(02)00292-0; ASHE JH, 1989, SYNAPSE, V4, P44, DOI 10.1002/syn.890040106; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Braff DL, 2004, PSYCHOPHARMACOLOGY, V174, P75, DOI 10.1007/s00213-004-1848-0; Burmeister JJ, 2003, TRAC-TREND ANAL CHEM, V22, P498, DOI 10.1016/S0165-9936(03)00904-X; Burmeister JJ, 2003, ANAL CHIM ACTA, V481, P65, DOI 10.1016/S0003-2670(03)00067-9; CHIBA AA, 1995, J NEUROSCI, V15, P7315; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Dalley JW, 2004, CEREB CORTEX, V14, P922, DOI 10.1093/cercor/bhh052; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Detari L, 1999, PROG NEUROBIOL, V58, P249, DOI 10.1016/S0301-0082(98)00084-7; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Himmelheber AM, 2000, COGNITIVE BRAIN RES, V9, P313, DOI 10.1016/S0926-6410(00)00012-4; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; HOLLAND PC, 1993, CURR OPIN NEUROBIOL, V3, P230, DOI 10.1016/0959-4388(93)90215-K; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; McGaughy J, 1996, BEHAV NEUROSCI, V110, P247, DOI 10.1037/0735-7044.110.2.247; McGaughy J, 2000, BEHAV BRAIN RES, V115, P251, DOI 10.1016/S0166-4328(00)00262-X; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MUIR JL, 1992, EXP BRAIN RES, V89, P611; MUIR JL, 1994, J NEUROSCI, V14, P2313; Neigh GN, 2004, NEUROSCIENCE, V123, P635, DOI 10.1016/j.neuroscience.2003.10.006; Parikh V, 2006, NEUROSCIENCE, V141, P379, DOI 10.1016/j.neuroscience.2006.03.055; Parikh V, 2006, J NEUROCHEM, V97, P488, DOI 10.1111/j.1471-4159.2006.03766.x; Parikh V, 2004, EUR J NEUROSCI, V20, P1545, DOI 10.1111/j.1460-9568.2004.03614.x; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; RICHARDSON RT, 1990, J NEUROSCI, V10, P2528; Sarter M, 2005, SCHIZOPHRENIA BULL, V31, P117, DOI 10.1093/schbul/sbi006; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; TREMBLAY N, 1990, J NEUROPHYSIOL, V64, P1199, DOI 10.1152/jn.1990.64.4.1199; Turchi J, 1997, COGNITIVE BRAIN RES, V6, P147, DOI 10.1016/S0926-6410(97)00027-X; VOYTKO ML, 1994, J NEUROSCI, V14, P167; WAITE JJ, 1994, NEUROSCI LETT, V169, P154, DOI 10.1016/0304-3940(94)90379-4; Weinberger NM, 2003, NEUROBIOL LEARN MEM, V80, P268, DOI 10.1016/S1074-7427(03)00072-8; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; WILSON FAW, 1990, J NEUROSCI, V10, P1254; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x; Zaborszky L, 2002, PROG BRAIN RES, V136, P359; Zmarowski A, 2005, EUR J NEUROSCI, V22, P1731, DOI 10.1111/j.1460-9568.2005.04333.x; Zmarowski A, 2007, SYNAPSE, V61, P115, DOI 10.1002/syn.20354	50	423	425	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					141	154		10.1016/j.neuron.2007.08.025	http://dx.doi.org/10.1016/j.neuron.2007.08.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920021	Green Accepted, Bronze			2022-12-17	WOS:000250289800016
J	Tricomi, EM; Delgado, MR; Fiez, JA				Tricomi, EM; Delgado, MR; Fiez, JA			Modulation of caudate activity by action contingency	NEURON			English	Article							COCAINE-SEEKING BEHAVIOR; FUNCTIONAL-PROPERTIES; ORBITOFRONTAL CORTEX; DOPAMINE RELEASE; NEURAL RESPONSES; DORSAL STRIATUM; PARIETAL CORTEX; BRAIN ACTIVITY; REWARD; ACTIVATION	Research has increasingly implicated the striatum in the processing of reward-related information in both animals and humans. However, it is unclear whether human striatal activation is driven solely by the hedonic properties of rewards or whether such activation is reliant on other factors, such as anticipation of upcoming reward or performance of an action to earn a reward. We used event-related functional magnetic resonance imaging to investigate hemodynamic responses to monetary rewards and punishments in three experiments that made use of an oddball paradigm. We presented reward and punishment displays randomly in time, following an anticipatory cue, or following a button press response. Robust and differential activation of the caudate nucleus occurred only when a perception of contingency existed between the button press response and the outcome. This finding suggests that the caudate is involved in reinforcement of action potentially leading to reward, rather than in processing reward per se.	Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; NYU, Dept Psychol, New York, NY 10003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University	Tricomi, EM (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	elt6@pitt.edu		Tricomi, Elizabeth/0000-0002-3659-2656	NIDA NIH HHS [R01 DA14103] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014103] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; COX W, 1998, COMPUT BIOMED RES, V29, P162; Critchley HD, 2000, J NEUROSCI, V20, P3033; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fissell K, 2003, NEUROINFORMATICS, V1, P111, DOI 10.1385/NI:1:1:111; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Hikosaka O, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.43.s.9.4.x; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Ito R, 2002, J NEUROSCI, V22, P6247; Ito R, 2000, J NEUROSCI, V20, P7489; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kiehl KA, 2003, HUM BRAIN MAPP, V18, P42, DOI 10.1002/hbm.10074; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; KOOB GF, 1992, SEMIN NEUROSCI, V4, P139; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Menon V, 1997, NEUROREPORT, V8, P3029, DOI 10.1097/00001756-199709290-00007; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Rolls ET, 1999, NEUROCASE, V5, P301, DOI 10.1093/neucas/5.4.301; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Zink CF, 2003, J NEUROSCI, V23, P8092	53	423	426	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					281	292		10.1016/S0896-6273(03)00848-1	http://dx.doi.org/10.1016/S0896-6273(03)00848-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741108	Bronze			2022-12-17	WOS:000221457800013
J	Sjostrom, PJ; Turrigiano, GG; Nelson, SB				Sjostrom, PJ; Turrigiano, GG; Nelson, SB			Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors	NEURON			English	Article							LONG-TERM DEPRESSION; HIPPOCAMPAL PYRAMIDAL NEURONS; D-ASPARTATE RECEPTOR; SYNAPTIC PLASTICITY; ENDOGENOUS CANNABINOIDS; VISUAL-CORTEX; AREA CA1; SUBCELLULAR-LOCALIZATION; RELEASE PROBABILITY; PURKINJE-CELLS	There is a consensus that NMDA receptors (NMDARs) detect coincident pre- and postsynaptic activity during induction of long-term potentiation (LTP), but their role in timing-dependent long-term depression (tLTD) is unclear. We examine tLTD in neocortical layer 5 (L5) pyramidal pairs and find that tLTD is expressed presynaptically, implying retrograde signaling. CB1 agonists produce depression that mimics and occludes tLTD. This agonist-induced LTD requires presynaptic activity and NMDAR activation, but not postsynaptic Ca2+ influx. Further experiments demonstrate the existence of presynaptic NMDARs that underlie the presynaptic activity dependence. Finally, manipulating cannabinoid breakdown alters the temporal window for tLTD. In conclusion, tLTD requires simultaneous activation of presynaptic NMDA and CB1 receptors. This novel form of coincidence detection may explain the temporal window of tLTD and may also impart synapse specificity to cannabinoid retrograde signaling.	Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Nelson, SB (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Mailstop 008,415 South St, Waltham, MA 02454 USA.		Sjöström, Per Jesper/B-9696-2019	Sjöström, Per Jesper/0000-0001-7085-2223; Nelson, Sacha/0000-0002-0108-8599	NEI NIH HHS [EY11116] Funding Source: Medline; NIMH NIH HHS [MH66338, MH58754] Funding Source: Medline; NINDS NIH HHS [NS36853] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754, R01MH066338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AOKI C, 1994, J NEUROSCI, V14, P5202; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Auclair N, 2000, J NEUROPHYSIOL, V83, P3287, DOI 10.1152/jn.2000.83.6.3287; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bisogno T, 1998, BIOCHEM BIOPH RES CO, V248, P515, DOI 10.1006/bbrc.1998.8874; Buonomano DV, 1999, J NEUROSCI, V19, P6748, DOI 10.1523/JNEUROSCI.19-16-06748.1999; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Charton JP, 1999, BRAIN RES, V816, P609, DOI 10.1016/S0006-8993(98)01243-8; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cline HT, 1998, CURR BIOL, V8, pR836, DOI 10.1016/S0960-9822(07)00525-8; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dittman JS, 1998, J NEUROSCI, V18, P6147; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glitsch M, 1999, J NEUROSCI, V19, P511; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Liu HT, 1997, NATURE, V386, P721, DOI 10.1038/386721a0; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Medina I, 1996, J PHYSIOL-LONDON, V495, P411, DOI 10.1113/jphysiol.1996.sp021603; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Ong WY, 1999, NEUROSCIENCE, V92, P1177, DOI 10.1016/S0306-4522(99)00025-1; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Pananceau M, 1998, J PHYSIOL-LONDON, V508, P503, DOI 10.1111/j.1469-7793.1998.503bq.x; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; PITLER TA, 1992, J NEUROSCI, V12, P4122; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Sawtell NB, 1999, J NEUROPHYSIOL, V82, P3594, DOI 10.1152/jn.1999.82.6.3594; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Selig DK, 1999, J NEUROSCI, V19, P1236; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Solowij N., 1998, CANNABIS COGNITIVE F; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Sullivan JM, 1999, J NEUROPHYSIOL, V82, P1286, DOI 10.1152/jn.1999.82.3.1286; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Trettel J, 2003, J NEUROPHYSIOL, V89, P2334, DOI 10.1152/jn.01037.2002; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Woodhall G, 2001, J NEUROPHYSIOL, V86, P1644, DOI 10.1152/jn.2001.86.4.1644; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	84	423	433	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 14	2003	39	4					641	654		10.1016/S0896-6273(03)00476-8	http://dx.doi.org/10.1016/S0896-6273(03)00476-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925278	Bronze			2022-12-17	WOS:000184779500009
J	Kruger, GM; Mosher, JT; Bixby, S; Joseph, N; Iwashita, T; Morrison, SJ				Kruger, GM; Mosher, JT; Bixby, S; Joseph, N; Iwashita, T; Morrison, SJ			Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness	NEURON			English	Article							RAT GASTROINTESTINAL-TRACT; PERIPHERAL NERVOUS-SYSTEM; IN-VIVO; SEROTONERGIC NEURONS; SYMPATHETIC NEURONS; MYENTERIC PLEXUS; GROWTH-FACTOR; DIFFERENTIATION; IDENTIFICATION; NEUROGENESIS	We found neural crest stem cells (NCSCs) in the adult gut. Postnatal gut NCSCs were isolated by flow-cytometry and compared to fetal gut NCSCs. They self-renewed extensively in culture but less than fetal gut NCSCs. Postnatal gut NCSCs made neurons that expressed a variety of neurotransmitters but lost the ability to make certain subtypes of neurons that are generated during fetal development. Postnatal gut NCSCs also differed in their responsiveness to lineage determination factors, affecting cell fate determination in vivo and possibly explaining their reduced neuronal subtype potential. These perinatal changes in gut NCSCs parallel perinatal changes in hematopoietic stem cells, suggesting that stem cells in different tissues undergo similar developmental transitions. The persistence of NCSCs in the adult PNS opens up new possibilities for regeneration after injury or disease.	Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.		Morrison, Sean/ABD-5326-2021; Crane, Genevieve M/AAK-9224-2020	Crane, Genevieve M/0000-0001-9274-0214; Morrison, Sean/0000-0003-1587-8329	NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310, P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NCI NIH HHS [CA46592, P30 CA046592] Funding Source: Medline; NIAMS NIH HHS [1 P30 AR48310, P30 AR048310, AR20557] Funding Source: Medline; NIDDK NIH HHS [5P60-DK20572, P60 DK020572] Funding Source: Medline; NIGMS NIH HHS [GM07863, T32 GM007863] Funding Source: Medline; NINDS NIH HHS [R01 NS40750-01, R01 NS040750-01, R01 NS040750] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ANDERSON DJ, 1985, CELL, V42, P649, DOI 10.1016/0092-8674(85)90122-9; BARBE MF, 1991, J NEUROSCI, V11, P519; BAROFFIO A, 1991, DEVELOPMENT, V112, P301; BELIN MF, 1991, NEUROSCI LETT, V125, P101, DOI 10.1016/0304-3940(91)90001-A; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Cai L, 1997, J NEUROSCI, V17, P2088; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Desai AR, 2000, DEVELOPMENT, V127, P2863; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GERSHON MD, 1977, P NATL ACAD SCI USA, V74, P3086, DOI 10.1073/pnas.74.7.3086; Gershon Michael D., 1994, P381; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Jarvinen MK, 1999, ANAT EMBRYOL, V199, P99, DOI 10.1007/s004290050213; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; Kubu CJ, 2002, DEV BIOL, V244, P199, DOI 10.1006/dbio.2002.0568; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; Lim DA, 1997, P NATL ACAD SCI USA, V94, P14832, DOI 10.1073/pnas.94.26.14832; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 2000, J NEUROSCI, V20, P7370; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Pisano JM, 1999, DEVELOPMENT, V126, P2855; Pisano JM, 2000, DEV BIOL, V227, P1, DOI 10.1006/dbio.2000.9876; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Reissmann E, 1996, DEVELOPMENT, V122, P2079; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; ROTHMAN TP, 1990, DEVELOPMENT, V109, P411; Schafer KH, 1997, BRAIN RES PROTOC, V1, P109, DOI 10.1016/S1385-299X(96)00017-7; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5	51	423	440	3	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					657	669		10.1016/S0896-6273(02)00827-9	http://dx.doi.org/10.1016/S0896-6273(02)00827-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194866	Bronze, Green Accepted			2022-12-17	WOS:000177521000007
J	Blennow, K; Hardy, J; Zetterberg, H				Blennow, Kaj; Hardy, John; Zetterberg, Henrik			The Neuropathology and Neurobiology of Traumatic Brain Injury	NEURON			English	Review							AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; NATIONAL-FOOTBALL-LEAGUE; APOLIPOPROTEIN-E; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; HEAD-INJURY; COGNITIVE IMPAIRMENT; DEMENTIA-PUGILISTICA; ENTORHINAL CORTEX	The acute and long-term consequences of traumatic brain injury (TBI) have received increased attention in recent years. In this Review, we discuss the neuropathology and neural mechanisms associated with TBI, drawing on findings from sports-induced TBI in athletes, in whom acute TBI damages axons and elicits both regenerative and degenerative tissue responses in the brain and in whom repeated concussions may initiate a long-term neurodegenerative process called dementia pugilistica or chronic traumatic encephalopathy (CTE). We also consider how the neuropathology and neurobiology of CTE in many ways resembles other neurodegenerative illnesses such as Alzheimer's disease, particularly with respect to mismetabolism and aggregation of tau, beta-amyloid, and TDP-43. Finally, we explore how translational research in animal models of acceleration/deceleration types of injury relevant for concussion together with clinical studies employing imaging and biochemical markers may further elucidate the neurobiology of TBI and CTE.	[Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Inst Neurosci & Physiol,Clin Neurochem Lab, SE-43183 Molndal, Sweden; [Hardy, John; Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England; [Hardy, John; Zetterberg, Henrik] UCL Inst Neurol, Reta Lilla Weston Labs, London WC1N 1PJ, England	Sahlgrenska University Hospital; University of Gothenburg; University of London; University College London; University of London; University College London	Blennow, K (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Inst Neurosci & Physiol,Clin Neurochem Lab, SE-43183 Molndal, Sweden.	kaj.blennow@neuro.gu.se	Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423				ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALVAREZ J, 1992, NEUROSCI LETT, V144, P130, DOI 10.1016/0304-3940(92)90733-N; ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Baird LC, 2010, NEUROSURGERY, V67, P1444, DOI 10.1227/NEU.0b013e3181e5e2cd; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Blain JF, 2006, NEUROBIOL DIS, V21, P505, DOI 10.1016/j.nbd.2005.08.010; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen YN, 2006, BIOCHEM BIOPH RES CO, V341, P1, DOI 10.1016/j.bbrc.2005.12.150; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Ellenbogen RG, 2010, WORLD NEUROSURG, V74, P560, DOI 10.1016/j.wneu.2010.11.016; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Goldstein L.E., 2012, SCI TRANSL MED, V4; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Horsburgh K, 2000, NEUROPATH APPL NEURO, V26, P124, DOI 10.1046/j.1365-2990.2000.026002124.x; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Johnson VE, 2012, EXP NEUROL; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kadokura A, 2009, NEUROPATHOLOGY, V29, P566, DOI 10.1111/j.1440-1789.2009.01017.x; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kanaan NM, 2012, EXP NEUROL; Kelly JP, 1997, NEUROLOGY, V48, P581; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Loosemore Mike, 2008, Br J Sports Med, V42, P564; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKENZIE JE, 1994, NEUROREPORT, V6, P161, DOI 10.1097/00001756-199412300-00041; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Millspaugh J. A., 1937, US NAV MED B, V35, P297; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Ohhashi G, 2002, BRIT J SPORT MED, V36, P346, DOI 10.1136/bjsm.36.5.346; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Petzold Axel, 2008, J Stroke Cerebrovasc Dis, V17, P196, DOI 10.1016/j.jstrokecerebrovasdis.2008.02.002; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Roses AD, 1996, CURR OPIN NEUROL, V9, P265, DOI 10.1097/00019052-199608000-00004; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Small D H, 1999, J Alzheimers Dis, V1, P275; Small DH, 1998, NEUROCHEM RES, V23, P795, DOI 10.1023/A:1022471729291; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; STILLER JW, 1985, PSYCHIAT CLIN N AM, V8, P339; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teter B, 1999, J NEUROCHEM, V73, P2613, DOI 10.1046/j.1471-4159.1999.0732613.x; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Unterharnscheidt F, 1995, Rev Neurol, V23, P661; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Weiner Michael W, 2013, Alzheimers Dement, V9, pe111, DOI [10.1016/j.jalz.2011.09.172, 10.1016/j.jalz.2013.05.1769]; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WISNIEWSKI K, 1979, ANN NEUROL, V5, P288, DOI 10.1002/ana.410050311; World Medical Association (WMA), 2005, WMA STAT BOX; Xie YY, 2003, J NEUROSCI RES, V73, P557, DOI 10.1002/jnr.10667; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2009, BRAIN INJURY, V23, P723, DOI 10.1080/02699050903120399; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	152	422	442	15	270	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2012	76	5					886	899		10.1016/j.neuron.2012.11.021	http://dx.doi.org/10.1016/j.neuron.2012.11.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	053OX	23217738	Bronze			2022-12-17	WOS:000312283400006
J	Chubykin, AA; Atasoy, D; Etherton, MR; Brose, N; Kavalali, ET; Gibson, JR; Sudhof, TC				Chubykin, Alexander A.; Atasoy, Deniz; Etherton, Mark R.; Brose, Nils; Kavalali, Ege T.; Gibson, Jay R.; Suedhof, Thomas C.			Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2	NEURON			English	Article							NMDA RECEPTOR SUBUNITS; CELL-ADHESION MOLECULE; ALPHA-NEUREXINS; SILENT SYNAPSES; BETA-NEUREXINS; PSD-95; AUTISM; TRANSMISSION; MUTATION; BINDING	Neuroligins enhance synapse formation in vitro, but surprisingly are not required for the generation of synapses in vivo. We now show that in cultured neurons, neuroligin-1 overexpression increases excitatory, but not inhibitory, synaptic responses, and potentiates synaptic NMDAR/AMPAR ratios. In contrast, neuroligin-2 overexpression increases inhibitory, but not excitatory, synaptic responses. Accordingly, deletion of neuroligin-1 in knockout mice selectively decreases the NMDAR/AMPAR ratio, whereas deletion of neuroligin-2 selectively decreases inhibitory synaptic responses. Strikingly, chronic inhibition of NMDARs or CaM-Kinase 11, which signals downstream of NMDARs, suppresses the synapse-boosting activity of neuroligin-1, whereas chronic inhibition of general synaptic activity suppresses the synapse-boosting activity of neuroligin-2. Taken together, these data indicate that neuroligins do not establish, but specify and validate, synapses via an activity-dependent mechanism, with different neuroligins acting on distinct types of synapses. This hypothesis reconciles the overexpression and knockout phenotypes and suggests that neuroligins contribute to the use-dependent formation of neural circuits.	Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Atasoy, Deniz/B-3414-2018; Atasoy, Deniz/AAR-7917-2020	Atasoy, Deniz/0000-0002-3325-8820; Chubykin, Alexander/0000-0001-8224-9296	NIMH NIH HHS [R01 MH069585, R37 MH52804-08, R01 MH069585-04, R37 MH052804] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069585, R37MH052804] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Cantallops I, 2000, CURR BIOL, V10, pR620, DOI 10.1016/S0960-9822(00)00663-1; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gomperts SN, 2000, J NEUROSCI, V20, P2229; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hussain NK, 2005, SCIENCE, V307, P1207, DOI 10.1126/science.1110011; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Levinson JN, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-12; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Niethammer M, 1996, J NEUROSCI, V16, P2157; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	422	438	0	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 21	2007	54	6					919	931		10.1016/j.neuron.2007.05.029	http://dx.doi.org/10.1016/j.neuron.2007.05.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582332	Bronze, Green Accepted			2022-12-17	WOS:000247645600011
J	Wang, SSH; Kloth, AD; Badura, A				Wang, Samuel S. -H.; Kloth, Alexander D.; Badura, Aleksandra			The Cerebellum, Sensitive Periods, and Autism	NEURON			English	Review							VENTRAL TEGMENTAL AREA; ORBITAL FRONTAL-CORTEX; SPECTRUM DISORDERS; PREFRONTAL CORTEX; MATERNAL INFECTION; SOCIAL-BEHAVIOR; INTERNAL-MODELS; YOUNG-CHILDREN; MOUSE MODELS; BRAIN	Cerebellar research has focused principally on adult motor function. However, the cerebellum also maintains abundant connections with nonmotor brain regions throughout postnatal life. Here we review evidence that the cerebellum may guide the maturation of remote nonmotor neural circuitry and influence cognitive development, with a focus on its relationship with autism. Specific cerebellar zones influence neocortical substrates for social interaction, and we propose that sensitive-period disruption of such internal brain communication can account for autism's key features.	[Wang, Samuel S. -H.; Kloth, Alexander D.; Badura, Aleksandra] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Wang, Samuel S. -H.; Kloth, Alexander D.; Badura, Aleksandra] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Wang, SSH (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	sswang@princeton.edu	Badura, Aleksandra/ABC-5427-2020	Badura, Aleksandra/0000-0002-0119-5108	NIH [R01 NS045193, F31 MH098651]; Nancy Lurie Marks Family Foundation; Sutherland Cook Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH098651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045193] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Lurie Marks Family Foundation; Sutherland Cook Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Benjamin Campbell, Sara Connolly, Cristina Domnisoru, Jeff Erlich, Daniel Geschwind, Elizabeth Gould, David Heeger, Mala Murthy, Bence Olveczky, Jordan Taylor, Huda Zoghbi, and members of the S.S.-H.W. lab for discussion and comments. We thank Randy Buckner and Partha Mitra for the use of images. This work was supported by NIH R01 NS045193 (S.S.-H.W.), NIH F31 MH098651 (A. D. K.), the Nancy Lurie Marks Family Foundation (S.S.-H.W), and the Sutherland Cook Fund (S.S.-H.W).	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Al-Afif S, 2013, BEHAV BRAIN RES, V250, P293, DOI 10.1016/j.bbr.2013.05.013; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Asrican B, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00160; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Attwell PJE, 2002, ANN NY ACAD SCI, V978, P79, DOI 10.1111/j.1749-6632.2002.tb07557.x; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Bachevalier J, 2011, ANN NY ACAD SCI, V1239, P71, DOI 10.1111/j.1749-6632.2011.06211.x; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Bargmann C., 2013, ADV COMM NIH DIR INT; Barkat TR, 2011, NAT NEUROSCI, V14, P1189, DOI 10.1038/nn.2882; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S, 1998, AUTISM, V2, P296, DOI [10.1177/1362361398023008, DOI 10.1177/1362361398023008]; Basson MA, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00029; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Becker EBE, 2013, INT REV NEUROBIOL, V113, P1, DOI 10.1016/B978-0-12-418700-9.00001-0; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Bliss-Moreau E, 2011, BEHAV NEUROSCI, V125, P848, DOI 10.1037/a0025757; Bobee S, 2000, BEHAV BRAIN RES, V112, P107, DOI 10.1016/S0166-4328(00)00166-2; Bolduc ME, 2012, CEREBELLUM, V11, P531, DOI 10.1007/s12311-011-0312-z; Boltshauser E, 2004, AM J MED GENET A, V126A, P376, DOI 10.1002/ajmg.a.20662; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; Brielmaier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040914; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Campbell BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030405; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; Chlebowski C, 2013, PEDIATRICS, V131, pE1121, DOI 10.1542/peds.2012-1525; Chow T W, 2000, Curr Psychiatry Rep, V2, P446, DOI 10.1007/s11920-000-0031-5; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; COHN JF, 1987, DEV PSYCHOL, V23, P68, DOI 10.1037/0012-1649.23.1.68; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; D'Angelo E, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00116; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Daniels AM, 2014, J AM ACAD CHILD PSY, V53, P141, DOI 10.1016/j.jaac.2013.11.002; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; De Bellis MD, 2000, BIOL PSYCHIAT, V48, P51, DOI 10.1016/S0006-3223(00)00835-0; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; Elison JT, 2013, AM J PSYCHIAT, V170, P899, DOI 10.1176/appi.ajp.2012.12091150; Ellegood J, 2014, MOL PSYCHIATR, V19, P99, DOI 10.1038/mp.2013.112; Ellegood J, 2010, NEUROIMAGE, V53, P1023, DOI 10.1016/j.neuroimage.2010.03.038; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Friel KM, 2007, J NEUROSCI, V27, P11083, DOI 10.1523/JNEUROSCI.2814-07.2007; Galgliani J.E., 2012, THESIS U PITTSBURGH; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; GirgiS RR, 2007, PROG NEURO-PSYCHOPH, V31, P41, DOI 10.1016/j.pnpbp.2006.06.007; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Gudsnuk KMA, 2011, CLIN PERINATOL, V38, P703, DOI 10.1016/j.clp.2011.08.005; Hadland KA, 2003, NEUROPSYCHOLOGIA, V41, P919, DOI 10.1016/S0028-3932(02)00325-1; HASHIMOTO T, 1995, J AUTISM DEV DISORD, V25, P1, DOI 10.1007/BF02178163; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hilton CL, 2010, J AUTISM DEV DISORD, V40, P633, DOI 10.1007/s10803-009-0905-2; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Kanner L, 1943, NERV CHILD, V2, P217; Kaufmann WE, 2003, J CHILD NEUROL, V18, P463, DOI 10.1177/08830738030180070501; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kinney DK, 2008, NEUROSCI BIOBEHAV R, V32, P1519, DOI 10.1016/j.neubiorev.2008.06.004; Kinney DK, 2008, J AUTISM DEV DISORD, V38, P481, DOI 10.1007/s10803-007-0414-0; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Limperopoulos C, 2014, CEREB CORTEX, V24, P728, DOI 10.1093/cercor/bhs354; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; Magnusson C, 2012, BRIT J PSYCHIAT, V201, P109, DOI 10.1192/bjp.bp.111.095125; Malkova L, 2010, BEHAV NEUROSCI, V124, P742, DOI 10.1037/a0021622; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Meehan Terrence F, 2011, J Biomed Inform, V44 Suppl 1, pS5, DOI 10.1016/j.jbi.2011.03.003; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Menashe I, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003128; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; Nielsen KJ, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00048; Novak MA, 2008, PRIMATE MODELS OF CHILDREN'S HEALTH AND DEVELOPMENTAL DISABILITIES, P141, DOI 10.1016/B978-012373743-4.50008-4; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oristaglio J, 2013, NEUROSCIENCE, V248, P708, DOI 10.1016/j.neuroscience.2013.06.007; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; PANKSEPP J, 1984, NEUROSCI BIOBEHAV R, V8, P465, DOI 10.1016/0149-7634(84)90005-8; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Patterson PH, 2012, BRAIN BEHAV IMMUN, V26, P393, DOI 10.1016/j.bbi.2011.09.008; Paul LK, 2010, J NEURODEV DISORD, V2, P165, DOI 10.1007/s11689-010-9056-1; PHILLIPSON OT, 1979, J COMP NEUROL, V187, P117, DOI 10.1002/cne.901870108; Piaget J., 1983, HDB CHILD PSYCHOL, V1, P103; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Prevosto V, 2010, CEREB CORTEX, V20, P214, DOI 10.1093/cercor/bhp091; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Roberts AL, 2014, RES AUTISM SPECT DIS, V8, P608, DOI 10.1016/j.rasd.2014.02.004; Romaniella R., 2012, HDB CEREBELLUM CEREB, P1855; Romberg AR, 2010, WIRES COGN SCI, V1, P906, DOI 10.1002/wcs.78; Rutter M, 1999, J CHILD PSYCHOL PSYC, V40, P537, DOI 10.1017/S0021963099003935; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sadakata T, 2012, P NATL ACAD SCI USA, V109, P21104, DOI 10.1073/pnas.1210055109; Sasson NJ, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-11; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schneider ER, 2013, J NEUROPHYSIOL, V109, P2282, DOI 10.1152/jn.00925.2012; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schumann CM, 2011, NEUROPSYCHOLOGIA, V49, P745, DOI 10.1016/j.neuropsychologia.2010.09.028; Schumann CM, 2011, BRAIN RES, V1380, P175, DOI 10.1016/j.brainres.2010.09.061; Scott JA, 2009, AUTISM RES, V2, P246, DOI 10.1002/aur.97; SEARS LL, 1994, J AUTISM DEV DISORD, V24, P737, DOI 10.1007/BF02172283; Smalley SL, 1998, J AUTISM DEV DISORD, V28, P407, DOI 10.1023/A:1026052421693; Smyke AT, 2009, CHILD ADOL PSYCH CL, V18, P721, DOI 10.1016/j.chc.2009.03.003; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; STACK DM, 1992, CHILD DEV, V63, P1509; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Steadman PE, 2014, AUTISM RES, V7, P124, DOI 10.1002/aur.1344; Stein JL, 2013, NEURON, V77, P209, DOI 10.1016/j.neuron.2013.01.010; Stigler KA, 2011, BRAIN RES, V1380, P146, DOI 10.1016/j.brainres.2010.11.076; Stiles J, 2005, TRENDS COGN SCI, V9, P136, DOI 10.1016/j.tics.2005.01.002; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Sun XR, 2012, CELL, V149, P1650, DOI 10.1016/j.cell.2012.06.009; Suzuki L, 2012, J NEUROSCI, V32, P10854, DOI 10.1523/JNEUROSCI.0857-12.2012; Swaiman Kenneth F, 2012, SWAIMANS PEDIAT NEUR; Tavano A, 2007, BRAIN, V130, P2646, DOI 10.1093/brain/awm201; ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.ne.15.030192.002155; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Timmann D, 2003, NEUROCASE, V9, P402, DOI 10.1076/neur.9.5.402.16555; Timmann D, 2008, CEREBELLUM, V7, P602, DOI 10.1007/s12311-008-0066-4; Tobia MJ, 2009, BEHAV NEUROSCI, V123, P665, DOI 10.1037/a0015662; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Voogd J, 2012, CEREBELLUM, V11, P392, DOI 10.1007/s12311-010-0204-7; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Watson TC, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.018.2009; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wells EM, 2008, DEV DISABIL RES REV, V14, P221, DOI 10.1002/ddrr.25; Wess J, 2013, TRENDS PHARMACOL SCI, V34, P385, DOI 10.1016/j.tips.2013.04.006; Wiesel T.N., 1981, NOBLE LECT PHYSL MED, P61; Wilber AA, 2011, NEUROSCIENCE, V177, P56, DOI 10.1016/j.neuroscience.2011.01.010; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wolf U, 2009, J NEUROPSYCH CLIN N, V21, P245, DOI 10.1176/appi.neuropsych.21.3.245; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Yang EJ, 2012, P NATL ACAD SCI USA, V109, P17213, DOI 10.1073/pnas.1200705109; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	163	421	429	6	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 6	2014	83	3					518	532		10.1016/j.neuron.2014.07.016	http://dx.doi.org/10.1016/j.neuron.2014.07.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN3HY	25102558	Green Accepted, Bronze			2022-12-17	WOS:000340479100005
J	Tritsch, NX; Sabatini, BL				Tritsch, Nicolas X.; Sabatini, Bernardo L.			Dopaminergic Modulation of Synaptic Transmission in Cortex and Striatum	NEURON			English	Review							RAT PREFRONTAL CORTEX; MEDIUM SPINY NEURONS; NUCLEUS-ACCUMBENS NEURONS; CORTICAL PYRAMIDAL NEURONS; FAST-SPIKING INTERNEURONS; PROTEIN-KINASE-C; RECEPTOR-MEDIATED INHIBITION; NEOSTRIATAL CHOLINERGIC INTERNEURONS; LONG-TERM POTENTIATION; NMDA RECEPTOR	Among the many neuromodulators used by the mammalian brain to regulate circuit function and plasticity, dopamine (DA) stands out as one of the most behaviorally powerful. Perturbations of DA signaling are implicated in the pathogenesis or exploited in the treatment of many neuropsychiatric diseases, including Parkinson's disease (PD), addiction, schizophrenia, obsessive compulsive disorder, and burette's syndrome. Although the precise mechanisms employed by DA to exert its control over behavior are not fully understood, DA is known to regulate many electrical and biochemical aspects of neuronal function including excitability, synaptic transmission, integration and plasticity, protein trafficking, and gene transcription. In this Review, we discuss the actions of DA on ionic and synaptic signaling in neurons of the prefrontal cortex and striatum, brain areas in which dopaminergic dysfunction is thought to be central to disease.	[Tritsch, Nicolas X.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Tritsch, Nicolas/U-5266-2019	Tritsch, Nicolas/0000-0003-3181-7681	National Institutes of Health [NS046579]; Lefler family fund; Howard Hughes Medical Institute; Nancy Lurie Marks Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lefler family fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Nancy Lurie Marks Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We apologize to those authors whose work was not cited due to space restrictions. Work in our laboratory on neuromodulation is supported by grants from the National Institutes of Health (NS046579 to B.L.S.), the Lefler family fund, and the Howard Hughes Medical Institute. N.X.T. is supported by a fellowship from the Nancy Lurie Marks Family Foundation.	Ade KK, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00032; Andre VM, 2010, EUR J NEUROSCI, V31, P14, DOI 10.1111/j.1460-9568.2009.07047.x; Aosaki T, 1998, J NEUROSCI, V18, P5180, DOI 10.1523/JNEUROSCI.18-14-05180.1998; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bentivoglio M, 2005, HAND CHEM N, V21, P1; Bergson C, 1995, J NEUROSCI, V15, P7821; Beurrier C, 2002, J NEUROSCI, V22, P5817; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; CALABRESI P, 1995, EUR J NEUROSCI, V7, P1674, DOI 10.1111/j.1460-9568.1995.tb00689.x; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; CARLSSON A, 1959, PHARMACOL REV, V11, P490; CARLSSON A, 1958, SCIENCE, V127, P471, DOI 10.1126/science.127.3296.471; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; CARLSSON A, 1962, ACTA PHYSIOL SCAND, V56, P7; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Castro NG, 1999, BRIT J PHARMACOL, V126, P1847, DOI 10.1038/sj.bjp.0702479; Ceci A, 1999, NEUROSCIENCE, V93, P107, DOI 10.1016/S0306-4522(99)00123-2; Centonze D, 2003, J NEUROSCI, V23, P6245; Centonze D, 2002, EUR J NEUROSCI, V15, P2049, DOI 10.1046/j.1460-9568.2002.02052.x; CEPEDA C, 1995, J NEUROPHYSIOL, V74, P1343, DOI 10.1152/jn.1995.74.3.1343; Cepeda C, 1998, J NEUROPHYSIOL, V79, P82, DOI 10.1152/jn.1998.79.1.82; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chen CF, 1997, J NEUROSCI, V17, P8687; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen L, 2007, J NEUROPHYSIOL, V97, P2448, DOI 10.1152/jn.00317.2006; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Chiu CQ, 2010, J NEUROSCI, V30, P7236, DOI 10.1523/JNEUROSCI.0736-10.2010; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Delgado A, 2000, NEUROSCIENCE, V95, P1043; Deng P, 2007, J NEUROSCI, V27, P3148, DOI 10.1523/JNEUROSCI.5535-06.2007; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Dong Y, 2005, J NEUROSCI, V25, P936, DOI 10.1523/JNEUROSCI.4715-04.2005; Dong Y, 2004, J NEUROSCI, V24, P3077, DOI 10.1523/JNEUROSCI.4715-03.2004; Dong Y, 2003, J NEUROSCI, V23, P2686; Dumartin B, 2007, NEUROSCI LETT, V419, P273, DOI 10.1016/j.neulet.2007.04.034; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; FALCK B, 1982, BRAIN RES BULL, V9, pR11, DOI 10.1016/0361-9230(82)90113-7; Fisone G., 2010, DOPAMINE HDB, P100; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Flores-Hernandez J, 2000, J NEUROPHYSIOL, V83, P2996, DOI 10.1152/jn.2000.83.5.2996; Franceschetti S, 2000, J PHYSIOL-LONDON, V528, P291, DOI 10.1111/j.1469-7793.2000.00291.x; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Gao WJ, 2003, J NEUROSCI, V23, P1622; Gao WJ, 2003, P NATL ACAD SCI USA, V100, P2836, DOI 10.1073/pnas.262796399; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; GASPAR P, 1995, EUR J NEUROSCI, V7, P1050, DOI 10.1111/j.1460-9568.1995.tb01092.x; Gee S, 2012, J NEUROSCI, V32, P4959, DOI 10.1523/JNEUROSCI.5835-11.2012; GEIJOBARRIENTOS E, 1995, EUR J NEUROSCI, V7, P358, DOI 10.1111/j.1460-9568.1995.tb00331.x; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GERMAN DC, 1993, J COMP NEUROL, V331, P297, DOI 10.1002/cne.903310302; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; Gladding CM, 2011, MOL CELL NEUROSCI, V48, P308, DOI 10.1016/j.mcn.2011.05.001; Glausier JR, 2009, CEREB CORTEX, V19, P1820, DOI 10.1093/cercor/bhn212; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Gonzalez-Islas C, 2001, J NEUROPHYSIOL, V86, P2911, DOI 10.1152/jn.2001.86.6.2911; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Graziane NM, 2009, J BIOL CHEM, V284, P8329, DOI 10.1074/jbc.M807387200; GREIF GJ, 1995, J NEUROSCI, V15, P4533; Gulledge AT, 2003, J NEUROSCI, V23, P11363; Gulledge AT, 1998, J NEUROSCI, V18, P9139; Guzman JN, 2003, J NEUROSCI, V23, P8931; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Harvey J, 1997, J NEUROSCI, V17, P5271; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Hernandez-Echeagaray E, 2004, EUR J NEUROSCI, V19, P2455, DOI 10.1111/j.0953-816X.2004.03344.x; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Hoover BR, 2004, SYNAPSE, V52, P100, DOI 10.1002/syn.20007; Hopf FW, 2010, EUR J NEUROSCI, V31, P1946, DOI 10.1111/j.1460-9568.2010.07231.x; Hu XT, 2005, J NEUROPHYSIOL, V93, P1406, DOI 10.1152/jn.00771.2004; Jocoy EL, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00028; Khan ZU, 1998, J COMP NEUROL, V402, P353, DOI 10.1002/(SICI)1096-9861(19981221)402:3<353::AID-CNE5>3.0.CO;2-4; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; KITAI ST, 1993, ADV NEUROL, V60, P40; Kohnomi S, 2012, J NEUROPHYSIOL, V107, P692, DOI 10.1152/jn.00281.2011; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kroener S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006507; Kroner S, 2007, CEREB CORTEX, V17, P1020, DOI 10.1093/cercor/bhl012; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lavin A, 2001, NEUROSCIENCE, V104, P335, DOI 10.1016/S0306-4522(01)00096-3; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; LeMoine C, 1998, MOL BRAIN RES, V58, P231, DOI 10.1016/S0169-328X(98)00118-1; LESTER J, 1993, BRAIN RES, V621, P106, DOI 10.1016/0006-8993(93)90303-5; Levine MS, 1996, SYNAPSE, V24, P65, DOI 10.1002/syn.890240102; Levine MS, 1996, J NEUROSCI, V16, P5870; Li YC, 2010, J NEUROCHEM, V114, P62, DOI 10.1111/j.1471-4159.2010.06720.x; Li YC, 2009, J NEUROSCI, V29, P15551, DOI 10.1523/JNEUROSCI.3336-09.2009; Lin JY, 2003, BRAIN RES, V959, P251, DOI 10.1016/S0006-8993(02)03757-5; Liu XY, 2006, NEURON, V52, P897, DOI 10.1016/j.neuron.2006.10.011; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Momiyama T, 2001, J PHYSIOL-LONDON, V533, P479, DOI 10.1111/j.1469-7793.2001.0479a.x; Moore AR, 2011, BRAIN RES, V1370, P1, DOI 10.1016/j.brainres.2010.10.111; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nicola SM, 1997, J NEUROSCI, V17, P5697; Nicola SM, 1998, J NEUROPHYSIOL, V79, P1768, DOI 10.1152/jn.1998.79.4.1768; Oldenburg IA, 2011, CURR OPIN NEUROBIOL, V21, P425, DOI 10.1016/j.conb.2011.04.004; PachecoCano MT, 1996, EXP BRAIN RES, V110, P205; PENNARTZ CMA, 1992, J NEUROPHYSIOL, V67, P1325, DOI 10.1152/jn.1992.67.5.1325; Perez MF, 2006, J NEUROPHYSIOL, V96, P2217, DOI 10.1152/jn.00254.2006; Peterson JD, 2006, J NEUROSCI, V26, P3164, DOI 10.1523/JNEUROSCI.2375-05.2006; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Pisani A, 2000, J NEUROSCI, V20, part. no.; Plotkin JL, 2011, NAT NEUROSCI, V14, P881, DOI 10.1038/nn.2848; Rivera A, 2002, EUR J NEUROSCI, V16, P2049, DOI 10.1046/j.1460-9568.2002.02280.x; Rotaru DC, 2007, J PHYSIOL-LONDON, V581, P981, DOI 10.1113/jphysiol.2007.130864; Sahu A, 2009, MOL PHARMACOL, V75, P447, DOI 10.1124/mol.108.053017; Salgado H, 2005, J NEUROPHYSIOL, V94, P3771, DOI 10.1152/jn.00455.2005; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; SCHIFFMANN SN, 1995, J PHYSIOL-LONDON, V483, P95, DOI 10.1113/jphysiol.1995.sp020570; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Seong HJ, 2012, J NEUROSCI, V32, P10516, DOI 10.1523/JNEUROSCI.1367-12.2012; SESACK SR, 1994, J NEUROSCI, V14, P88; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi WX, 1997, SYNAPSE, V26, P415, DOI 10.1002/(SICI)1098-2396(199708)26:4<415::AID-SYN9>3.0.CO;2-9; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song WJ, 1996, J NEUROPHYSIOL, V76, P2290, DOI 10.1152/jn.1996.76.4.2290; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Sun XD, 2000, PFLUG ARCH EUR J PHY, V440, P530, DOI 10.1007/s004240050004; Sun X, 2008, J NEUROSCI, V28, P4216, DOI 10.1523/JNEUROSCI.0258-08.2008; SURMEIER DJ, 1993, PROG BRAIN RES, V99, P309; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Taverna S, 2005, J NEUROPHYSIOL, V93, P1816, DOI 10.1152/jn.00672.2004; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tecuapetla F, 2009, J NEUROSCI, V29, P8977, DOI 10.1523/JNEUROSCI.6145-08.2009; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Tong H, 2008, J PHYSIOL-LONDON, V586, P4693, DOI 10.1113/jphysiol.2008.158931; Towers SK, 2008, J NEUROSCI, V28, P2633, DOI 10.1523/JNEUROSCI.5079-07.2008; Tozzi A, 2011, J NEUROSCI, V31, P1850, DOI 10.1523/JNEUROSCI.4082-10.2011; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Trantham-Davidson H, 2008, CEREB CORTEX, V18, P951, DOI 10.1093/cercor/bhm133; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; UCHIMURA N, 1990, BRIT J PHARMACOL, V99, P736, DOI 10.1111/j.1476-5381.1990.tb12999.x; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; Vilchis C, 2000, NEUROSCIENCE, V95, P745; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; Wang WG, 2012, J PHYSIOL-LONDON, V590, P3743, DOI 10.1113/jphysiol.2012.235200; Wang X, 2003, J NEUROSCI, V23, P9852; Wang X, 2002, J NEUROSCI, V22, P9185; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wang Y, 2004, P NATL ACAD SCI USA, V101, P5093, DOI 10.1073/pnas.0400954101; Wickens JR, 2005, HAND CHEM N, V21, P199; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009; Witkowski G, 2008, NEUROSCIENCE, V155, P53, DOI 10.1016/j.neuroscience.2008.05.021; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wu JP, 2005, J NEUROSCI, V25, P6322, DOI 10.1523/JNEUROSCI.1405-05.2005; Xu TX, 2010, P NATL ACAD SCI USA, V107, P16366, DOI 10.1073/pnas.1004108107; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Yan Z, 1997, NEURON, V19, P1115, DOI 10.1016/S0896-6273(00)80402-X; Yang CR, 1996, J NEUROSCI, V16, P1922; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103; Young CE, 2004, J NEUROSCI, V24, P8, DOI 10.1523/JNEUROSCI.1650-03.2004; Zhang XF, 2002, J PHARMACOL EXP THER, V301, P1119, DOI 10.1124/jpet.301.3.1119; Zhang XF, 1998, J NEUROSCI, V18, P488; Zhang ZW, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00021; Zheng P, 1999, NEUROSCIENCE, V91, P527, DOI 10.1016/S0306-4522(98)00604-6; Zhou FM, 1999, J NEUROPHYSIOL, V81, P967, DOI 10.1152/jn.1999.81.3.967; Zhou WL, 2012, J PHYSIOL-LONDON, V590, P3891, DOI 10.1113/jphysiol.2011.227157	191	421	429	10	141	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2012	76	1					33	50		10.1016/j.neuron.2012.09.023	http://dx.doi.org/10.1016/j.neuron.2012.09.023			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	020HG	23040805	Green Accepted, Bronze			2022-12-17	WOS:000309799000004
J	Kamal, A; Stokin, GB; Yang, ZH; Xia, CH; Goldstein, LSB				Kamal, A; Stokin, GB; Yang, ZH; Xia, CH; Goldstein, LSB			Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I	NEURON			English	Article							HEAVY-CHAIN; ALZHEIMERS-DISEASE; CYTOPLASMIC DYNEIN; NERVOUS-SYSTEM; TAIL DOMAIN; DROSOPHILA; MOTOR; MOTILITY; KINECTIN; MOUSE	We analyzed the mechanism of axonal transport of the amyloid precursor protein (APP), which plays a major role in the development of Alzheimer's disease. Coimmunoprecipitation, sucrose gradient, and direct in vitro binding demonstrated that APP forms a complex with the microtubule motor, conventional kinesin (kinesin-1), by binding directly to the TPR domain of the kinesin light chain (KLC) subunit. The estimated apparent K-d for binding is 15-20 nM, with a binding stoichiometry of two APP per KLC. In addition, association of APP with microtubules and axonal transport of APP is greatly decreased in a gene-targeted mouse mutant of the neuronally enriched KLC1 gene. We propose that one of the normal functions of APP may be as a membrane cargo receptor for kinesin-1 and that KLC is important for kinesin-1-driven transport of APP into axons.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Stokin, Gorazd Bernard/D-9480-2015	Stokin, Gorazd Bernard/0000-0001-8430-8755	NIGMS NIH HHS [GM35252] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035252] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMARATUNGA A, 1995, J NEUROCHEM, V64, P2374; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Bowman AB, 1999, J CELL BIOL, V146, P165; BOWMAN AB, 2000, IN PRESS CELL, V103; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; De Strooper B, 2000, J CELL SCI, V113, P1857; DECUEVAS M, 1992, J CELL BIOL, V116, P957, DOI 10.1083/jcb.116.4.957; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; GAUGER AK, 1993, J BIOL CHEM, V268, P13657; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gindhart JG, 1996, TRENDS BIOCHEM SCI, V21, P52, DOI 10.1016/0968-0004(96)80865-6; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hurd DD, 1996, GENETICS, V142, P195; Hurd DD, 1996, GENETICS, V144, P1075; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, CURR OPIN CELL BIOL, V12, P503, DOI 10.1016/S0955-0674(00)00123-X; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KUMAR J, 1995, SCIENCE, V267, P1834, DOI 10.1126/science.7892610; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; STEINBERG G, 1995, MOL BIOL CELL, V6, P1605, DOI 10.1091/mbc.6.11.1605; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Toyoshima I, 1996, NEUROSCI LETT, V211, P171, DOI 10.1016/0304-3940(96)12752-X; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745	57	421	438	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	2000	28	2					449	459		10.1016/S0896-6273(00)00124-0	http://dx.doi.org/10.1016/S0896-6273(00)00124-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	377CE	11144355	Bronze			2022-12-17	WOS:000165493700020
J	HEGINBOTHAM, L; MACKINNON, R				HEGINBOTHAM, L; MACKINNON, R			THE AROMATIC BINDING-SITE FOR TETRAETHYLAMMONIUM ION ON POTASSIUM CHANNELS	NEURON			English	Article							MOLECULAR RECOGNITION; K+ CHANNELS; EXPRESSION; DIVERSITY; RECEPTOR; BRAIN; MEDIA	K+ channels are quite variable in their sensitivity to the pore-blocking agent tetraethylammonium ion (TEA) when it is applied to the extracellular side of the membrane. A Shaker K+ channel can be made highly sensitive by introducing a tyrosine (or phenylalanine) at residue 449 in each of the four subunits. A shift in the voltage dependence of blockade indicates that TEA senses a smaller fraction of the transmembrane electric field in the highly sensitive channels. There is a linear relationship between the free energy for TEA blockade and the number of subunits (zero, two, or four) containing tyrosine at 449, as if these four residues interact simultaneously with a TEA molecule to produce a high affinity binding site. The temperature dependence of blockade suggests that the interaction is not purely hydrophobic. These findings are consistent with a TEA-binding site formed by a bracelet of pore-lining aromatic residues. The center of the bracelet could bind a TEA molecule through a cation-pi-orbital interaction.			HEGINBOTHAM, L (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; CANTOR CR, 1980, BIOPHYSICAL CHEM 1, P287; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; MILLER C, 1982, J GEN PHYSIOL, V79, P869, DOI 10.1085/jgp.79.5.869; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEPODD TJ, 1988, J AM CHEM SOC, V110, P1983, DOI 10.1021/ja00214a063; STAUFFER DA, 1988, TETRAHEDRON LETT, V29, P6039, DOI 10.1016/S0040-4039(00)82259-5; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SUNNER J, 1981, J PHYS CHEM-US, V85, P1814, DOI 10.1021/j150613a011; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7	27	421	424	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					483	491		10.1016/0896-6273(92)90276-J	http://dx.doi.org/10.1016/0896-6273(92)90276-J			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550673				2022-12-17	WOS:A1992HK67500008
J	TRUSSELL, LO; FISCHBACH, GD				TRUSSELL, LO; FISCHBACH, GD			GLUTAMATE RECEPTOR DESENSITIZATION AND ITS ROLE IN SYNAPTIC TRANSMISSION	NEURON			English	Article											TRUSSELL, LO (corresponding author), WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA.				NINDS NIH HHS [NS22828, NS18458] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS022828, R01NS018458] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1986, J PHYSIOL-LONDON, V379, P171, DOI 10.1113/jphysiol.1986.sp016246; ANTONOV SM, 1988, NEUROSCI LETT, V93, P204, DOI 10.1016/0304-3940(88)90082-1; BAEV K V, 1987, Neirofiziologiya, V19, P251; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P45, DOI 10.1113/jphysiol.1987.sp016646; BRETT RS, 1986, BIOPHYS J, V50, P987, DOI 10.1016/S0006-3495(86)83539-1; COTMAN CW, 1986, J PHYSIOL-LONDON, V378, P403, DOI 10.1113/jphysiol.1986.sp016227; CURTIS DR, 1960, J PHYSIOL-LONDON, V150, P656, DOI 10.1113/jphysiol.1960.sp006410; CURTIS DR, 1960, J PHYSIOL-LONDON, V150, P374, DOI 10.1113/jphysiol.1960.sp006393; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; DUDEL J, 1988, NEUROSCI LETT, V88, P33, DOI 10.1016/0304-3940(88)90311-4; DUDEL J, 1979, J PHYSIOLOGY PARIS, V75, P601; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; EPSTEIN R, 1970, J GEN PHYSIOL, V56, P33, DOI 10.1085/jgp.56.1.33; FELTZ A, 1982, J PHYSIOL-LONDON, V322, P257, DOI 10.1113/jphysiol.1982.sp014036; FRANKE C, 1987, NEUROSCI LETT, V77, P199, DOI 10.1016/0304-3940(87)90586-6; HABLITZ JJ, 1985, CELL MOL NEUROBIOL, V5, P389, DOI 10.1007/BF00755403; HERRON CE, 1985, NEUROSCI LETT, V60, P19, DOI 10.1016/0304-3940(85)90375-1; HILLE B, 1984, IONIC CHANNELS EXCIT, P157; HONIG MG, 1983, J NEUROPHYSIOL, V49, P886, DOI 10.1152/jn.1983.49.4.886; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Iversen L, 1977, SYNAPSES, P137; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; JAHR CE, 1985, J NEUROSCI, V5, P2281; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KRISHTAL OA, 1988, NEUROSCI LETT, V84, P271, DOI 10.1016/0304-3940(88)90519-8; KRISHTAL OA, 1983, NEUROSCI LETT, V35, P41, DOI 10.1016/0304-3940(83)90524-4; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; LORING RH, 1987, J NEUROSCI, V7, P2153; MAGAZANIK LG, 1975, J PHYSIOL-LONDON, V249, P285, DOI 10.1113/jphysiol.1975.sp011016; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; MAGLEBY KL, 1981, J PHYSIOL-LONDON, V316, P225, DOI 10.1113/jphysiol.1981.sp013784; MATHERS DA, 1976, NATURE, V259, P409, DOI 10.1038/259409a0; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; NELSON PG, 1986, J PHYSIOL-LONDON, V372, P169, DOI 10.1113/jphysiol.1986.sp016003; OBRIEN RJ, 1986, J NEUROSCI, V6, P3284; OBRIEN RJ, 1986, J NEUROSCI, V6, P3275; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; OTSUKA M, 1962, JPN J PHYSIOL, V12, P573; OZAWA S, 1988, BRAIN RES, V443, P85, DOI 10.1016/0006-8993(88)91601-0; SALMANN B, 1983, SINGLE CHANNEL RECOR, P37; SHINOZAKI H, 1979, BRAIN RES, V161, P493, DOI 10.1016/0006-8993(79)90678-4; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; THESLEFF S, 1959, J PHYSIOL-LONDON, V148, P659, DOI 10.1113/jphysiol.1959.sp006314; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; VLACHOVA V, 1987, J PHYSIOL-LONDON, V386, P425, DOI 10.1113/jphysiol.1987.sp016542; YAKEL JL, 1988, J NEUROSCI, V8, P1273; ZORUMSKI CF, 1989, CELL MOL NEUROBIOL, V9, P95, DOI 10.1007/BF00711446; ZORUMSKI CF, 1988, J NEUROSCI, V8, P4277	52	421	423	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1989	3	2					209	218		10.1016/0896-6273(89)90034-2	http://dx.doi.org/10.1016/0896-6273(89)90034-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM324	2576213				2022-12-17	WOS:A1989AM32400008
J	Schuler, V; Luscher, C; Blanchet, C; Klix, N; Sansig, G; Klebs, K; Schmutz, M; Heid, J; Gentry, C; Urban, L; Fox, A; Spooren, W; Jaton, AL; Vigouret, JM; Pozza, M; Kelly, PH; Mosbacher, J; Froestl, W; Kaslin, E; Korn, R; Bischoff, S; Kaupmann, K; van der Putten, H; Bettler, B				Schuler, V; Luscher, C; Blanchet, C; Klix, N; Sansig, G; Klebs, K; Schmutz, M; Heid, J; Gentry, C; Urban, L; Fox, A; Spooren, W; Jaton, AL; Vigouret, JM; Pozza, M; Kelly, PH; Mosbacher, J; Froestl, W; Kaslin, E; Korn, R; Bischoff, S; Kaupmann, K; van der Putten, H; Bettler, B			Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1))	NEURON			English	Article							RECEPTOR ANTAGONISTS; PRESYNAPTIC INHIBITION; RAT HIPPOCAMPUS; HETEROMERIC COMPLEXES; IN-VITRO; ADENOSINE; RELEASE; HETERODIMERIZATION; RETENTION; SUBTYPES	GABA(B) (gamma -aminobutyric acid type B) receptors are important for keeping neuronal excitability under control. Cloned GABA(B) receptors do not show the expected pharmacological diversity of native receptors and it is unknown whether they contribute to pre- as well as postsynaptic functions. Here, we demonstrate that Balb/c mice lacking the GABA(B(1)) subunit are viable, exhibit spontaneous seizures, hyperalgesia, hyperlocomotor activity, and memory impairment. Upon GABA(B) agonist application, null mutant mice show neither the typical muscle relaxation, hypothermia, or delta EEG waves. These behavioral findings are paralleled by a loss of all biochemical and electrophysiological GABA(B) responses in null mutant mice. This demonstrates that GABA(B(1)) is an essential component of pre- and postsynaptic GABA(B) receptors and casts doubt on the existence of proposed receptor subtypes.	Novartis Pharma AG, TA Nervous Syst, CH-4002 Basel, Switzerland; Novartis Inst Med Sci, London WC1E 6B9, England; Univ Geneva, Dept Pharmacol APSIC, CH-1211 Geneva, Switzerland; Univ Geneva, Dept Physiol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Neurol, CH-1211 Geneva 4, Switzerland	Novartis; Novartis; University of Geneva; University of Geneva; University of Geneva	Bettler, B (corresponding author), Novartis Pharma AG, TA Nervous Syst, CH-4002 Basel, Switzerland.		bettler, bernhard/AAO-8018-2020; Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Bettler, Bernhard/0000-0003-0842-8207; Kaupmann, Klemens/0000-0001-8903-2508				AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; BABBINI M, 1972, BRIT J PHARMACOL, V46, P213, DOI 10.1111/j.1476-5381.1972.tb06866.x; Badran S, 1997, EUR J PHARMACOL, V333, P135, DOI 10.1016/S0014-2999(97)01111-4; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bischoff S, 1999, J COMP NEUROL, V412, P1; BITTIGER H, 1993, TRENDS PHARMACOL SCI, V14, P391, DOI 10.1016/0165-6147(93)90056-P; BONANNO G, 1993, TRENDS PHARMACOL SCI, V14, P259, DOI 10.1016/0165-6147(93)90124-3; Brucato FH, 1996, NEUROSCIENCE, V74, P331, DOI 10.1016/0306-4522(96)00131-5; Calver AR, 2001, J NEUROSCI, V21, P1203; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; CASTELLANO C, 1993, PSYCHOPHARMACOLOGY, V111, P134, DOI 10.1007/BF02245514; Clark JA, 2000, BRAIN RES, V860, P41, DOI 10.1016/S0006-8993(00)01958-2; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; Dinkel A, 1999, J IMMUNOL METHODS, V223, P255, DOI 10.1016/S0022-1759(99)00005-8; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Getova D, 1997, EUR J PHARMACOL, V320, P9, DOI 10.1016/S0014-2999(96)00877-1; Gines S, 2000, P NATL ACAD SCI USA, V97, P8606, DOI 10.1073/pnas.150241097; JONESGOTMAN M, 1994, EPILEPSIA, V35, P61, DOI 10.1111/j.1528-1157.1994.tb02913.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Lin Q, 1996, J NEUROPHYSIOL, V75, P109, DOI 10.1152/jn.1996.75.1.109; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P179; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mohler H, 1999, Trends Pharmacol Sci, V20, P87, DOI 10.1016/S0165-6147(99)01323-1; Mondadori C, 1996, BEHAV BRAIN RES, V77, P227, DOI 10.1016/0166-4328(95)00226-X; MOTT DD, 1994, INT REV NEUROBIOL, V36, P97, DOI 10.1016/S0074-7742(08)60304-9; Ng TKY, 2001, J COMP NEUROL, V433, P458, DOI 10.1002/cne.1153; OLPE HR, 1980, BRAIN RES BULL, V5, P507, DOI 10.1016/0361-9230(80)90082-9; Pagano A, 2001, J NEUROSCI, V21, P1189; Patel S, 2001, PAIN, V90, P217, DOI 10.1016/S0304-3959(00)00404-8; PROCTOR WR, 1987, BRAIN RES, V426, P187, DOI 10.1016/0006-8993(87)90441-0; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; SAHA N, 1993, PHARMACOL TOXICOL, V72, P159, DOI 10.1111/j.1600-0773.1993.tb00309.x; SANDYK R, 1985, CLIN NEUROPHARMACOL, V8, P294, DOI 10.1097/00002826-198509000-00011; SAWYNOK J, 1987, PHARMACOL BIOCHEM BE, V26, P463, DOI 10.1016/0091-3057(87)90148-1; Schwartz RH, 2000, SOUTH MED J, V93, P558; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; VENABLE N, 1990, PSYCHOPHARMACOLOGY, V100, P215, DOI 10.1007/BF02244409; WALDMEIER PC, 1994, BRIT J PHARMACOL, V113, P1515, DOI 10.1111/j.1476-5381.1994.tb17168.x; Walker K, 1999, MOL MED TODAY, V5, P319, DOI 10.1016/S1357-4310(99)01493-8; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6	54	420	445	2	58	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					47	58		10.1016/S0896-6273(01)00345-2	http://dx.doi.org/10.1016/S0896-6273(01)00345-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498050	Bronze			2022-12-17	WOS:000170101100010
J	Litt, B; Esteller, R; Echauz, J; D'Alessandro, M; Shor, R; Henry, T; Pennell, P; Epstein, C; Bakay, R; Dichter, M; Vachtsevanos, G				Litt, B; Esteller, R; Echauz, J; D'Alessandro, M; Shor, R; Henry, T; Pennell, P; Epstein, C; Bakay, R; Dichter, M; Vachtsevanos, G			Epileptic seizures may begin hours in advance of clinical onset: A report of five patients	NEURON			English	Article							INDUCED INTERICTAL DISCHARGES; CAT HIPPOCAMPUS; SPIKING; PATTERNS; FOCI; EPILEPTOGENESIS; EXCITABILITY; STIMULATION; MECHANISMS; TRANSITION	Mechanisms underlying seizure generation are traditionally thought to act over seconds to minutes before clinical seizure onset. We analyzed continuous 3- to 14-day intracranial EEG recordings from five patients with mesial temporal lobe epilepsy obtained during evaluation for epilepsy surgery. We found localized quantitative EEG changes identifying prolonged bursts of complex epileptiform discharges that became more prevalent 7 hr before seizures and highly localized subclinical seizure-like activity that became more frequent 2 hr prior to seizure onset. Accumulated energy increased in the 50 min before seizure onset, compared to baseline. These observations, from a small number of patients, suggest that epileptic seizures may begin as a cascade of electrophysiological events that evolve over hours and that quantitative measures of preseizure electrical activity could possibly be used to predict seizures far in advance of clinical onset.	Hosp Univ Penn, Dept Neurol & Bioengn, Philadelphia, PA 19104 USA; Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; Univ Puerto Rico, Dept Elect & Comp Engn, Mayaguez, PR 00681 USA; Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Univ Simon Bolivar, Dept Tecnol Ind, Caracas, Edo Miranda, Venezuela	University of Pennsylvania; Pennsylvania Medicine; University System of Georgia; Georgia Institute of Technology; University of Puerto Rico; University of Puerto Rico Mayaguez; Emory University; Emory University; Simon Bolivar University	Litt, B (corresponding author), Hosp Univ Penn, Dept Neurol & Bioengn, 3 W Gates,3400 Spruce St, Philadelphia, PA 19104 USA.	littb@mail.med.upenn.edu	Henry, Thomas/X-1756-2019	Henry, Thomas/0000-0002-5708-903X	NIMH NIH HHS [MH-62298RO1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062298] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Burgess DL, 1999, EPILEPSY RES, V36, P111, DOI 10.1016/S0920-1211(99)00045-5; DASILVA FHL, 1994, PROG BRAIN RES, V102, P359; DICHTER M, 1969, J NEUROPHYSIOL, V32, P649, DOI 10.1152/jn.1969.32.5.649; DICHTER M, 1969, J NEUROPHYSIOL, V32, P663, DOI 10.1152/jn.1969.32.5.663; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; DICHTER MA, 1972, BRAIN RES, V48, P173, DOI 10.1016/0006-8993(72)90177-1; Eder HG, 1997, EPILEPSY RES, V29, P17, DOI 10.1016/S0920-1211(97)00061-2; Engel Jr J., 1987, SURG TREATMENT EPILE, P553; Fanselow EE, 2000, J NEUROSCI, V20, P8160; FEINDEL WILLIAM WILDER PENFIELD, 1952, TRANS AMER NEUROL ASSOC, V77, P14; Franaszczuk PJ, 1999, BIOL CYBERN, V81, P3, DOI 10.1007/s004220050540; GLANZ J, 1994, SCIENCE, V265, P1174, DOI 10.1126/science.8066457; Gluckman BJ, 2001, J NEUROSCI, V21, P590, DOI 10.1523/JNEUROSCI.21-02-00590.2001; GOTMAN J, 1991, CAN J NEUROL SCI, V18, P573, DOI 10.1017/S031716710003273X; GOTMAN J, 1987, METHODS ANAL BRAIN E, P171; Haut SR, 1997, EPILEPSIA, V38, P937, DOI 10.1111/j.1528-1157.1997.tb01260.x; Heffernan MS, 1996, INTEGR PHYS BEH SCI, V31, P202, DOI 10.1007/BF02691450; Iaseemidis Leon D., 1996, Epilepsia, V37, P90; IASEMIDIS L, 1997, ANN NEUROL, V42, P429; IASEMIDIS L D, 1990, Brain Topography, V2, P187, DOI 10.1007/BF01140588; IASEMIDIS LD, 1994, EPILEPSY RES, V17, P81, DOI 10.1016/0920-1211(94)90081-7; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; KATZ A, 1991, ELECTROEN CLIN NEURO, V79, P153, DOI 10.1016/0013-4694(91)90054-8; LANGE HH, 1983, ELECTROEN CLIN NEURO, V56, P543, DOI 10.1016/0013-4694(83)90022-6; Lehnertz K, 1998, PHYS REV LETT, V80, P5019, DOI 10.1103/PhysRevLett.80.5019; Liang FY, 1997, BRAIN RES, V778, P281, DOI 10.1016/S0006-8993(97)01049-4; LOTHMAN EW, 1994, BRAIN RES, V649, P71, DOI 10.1016/0006-8993(94)91050-2; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; Noebels J L, 1999, Adv Neurol, V79, P227; NOEBELS JL, 1990, BRAIN RES, V524, P225, DOI 10.1016/0006-8993(90)90695-8; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; Osorio I, 1998, EPILEPSIA, V39, P615, DOI 10.1111/j.1528-1157.1998.tb01430.x; PENFIELD W, 1950, AMA ARCH NEUROL PSY, V64, P491, DOI 10.1001/archneurpsyc.1950.02310280003001; Penfield W., 1941, EPILEPSY CEREBRAL LO, DOI [10.1097/00007611-194202000-00031, DOI 10.1097/00007611-194202000-00031]; QIN DY, 1995, COMP MED SY, P151, DOI 10.1109/CBMS.1995.465436; Qu H, 1997, IEEE T BIO-MED ENG, V44, P115, DOI 10.1109/10.552241; Rajna P, 1997, SEIZURE-EUR J EPILEP, V6, P361, DOI 10.1016/S1059-1311(97)80035-0; RALSTON BL, 1958, ELECTROEN CLIN NEURO, V10, P217, DOI 10.1016/0013-4694(58)90029-4; RISINGER MW, 1989, NEUROLOGY, V39, P1288, DOI 10.1212/WNL.39.10.1288; ROGOWSKI Z, 1981, BIOL CYBERN, V42, P9, DOI 10.1007/BF00335153; Schiller Y, 1998, EPILEPSIA, V39, P380, DOI 10.1111/j.1528-1157.1998.tb01390.x; Schuh LA, 2000, EPILEPSIA, V41, P316, DOI 10.1111/j.1528-1157.2000.tb00161.x; Schwartzkroin PA, 1998, EPILEPSY RES, V32, P275, DOI 10.1016/S0920-1211(98)00058-8; SPENCER SS, 1992, EPILEPSIA, V33, P537, DOI 10.1111/j.1528-1157.1992.tb01706.x; Sperling M, 1986, MECH EPILEPTOGENESIS, P17; SPERLING MR, 1990, ANN NEUROL, V28, P320, DOI 10.1002/ana.410280304; Stein AG, 2000, EPILEPSY RES, V39, P103, DOI 10.1016/S0920-1211(99)00107-2; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Vachtsevanos GJ, 1998, J INTELL FUZZY SYST, V6, P259; VANQUYEN ML, 2001, LANCET, V357, P183; VIGLIONE S, 1970, METHODOLOGY DETECTIN; Wang LL, 2000, MOL THER, V1, P154, DOI 10.1006/mthe.2000.0031; WARD S, 1998, Patent No. 5713923	54	420	437	4	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					51	64		10.1016/S0896-6273(01)00262-8	http://dx.doi.org/10.1016/S0896-6273(01)00262-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343644	Bronze			2022-12-17	WOS:000168412900010
J	Sasaki, S; Shionoya, A; Ishida, M; Gambello, MJ; Yingling, J; Wynshaw-Boris, A; Hirotsune, S				Sasaki, S; Shionoya, A; Ishida, M; Gambello, MJ; Yingling, J; Wynshaw-Boris, A; Hirotsune, S			A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; LISSENCEPHALY GENE LIS1; CYTOPLASMIC DYNEIN; NUCLEAR MIGRATION; ASPERGILLUS-NIDULANS; NEURONAL MIGRATION; DROSOPHILA HOMOLOG; MICE LACKING; PROTEIN; BRAIN	Mutations in mammalian Lis1 (Pafah1b1) result in neuronal migration defects. Several lines of evidence suggest that LIS1 participates in pathways regulating microtubule function, but the molecular mechanisms are unknown. Here, we demonstrate that LIS1 directly interacts with the cytoplasmic dynein heavy chain (CDHC) and NUDEL, a murine homolog of the Aspergillus nidulans nuclear migration mutant NudE. LIS1 and NUDEL colocalize predominantly at the centrosome in early neuroblasts but redistribute to axons in association with retrograde dynein motor proteins. NUDEL is phosphorylated by Cdk5/p35, a complex essential for neuronal migration. NUDEL and LIS1 regulate the distribution of CDHC along microtubules, and establish a direct functional link between LIS1, NUDEL, and microtubule motors. These results suggest that LIS1 and NUDEL regulate CDHC activity during neuronal migration and axonal retrograde transport in a Cdk5/p35-dependent fashion.	Shirakawa Inst Anim Genet, Fukushima 9618061, Japan; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Wynshaw-Boris, A (corresponding author), Shirakawa Inst Anim Genet, Fukushima 9618061, Japan.	awynshawboris@ucsd.edu; shinjih@cocoa.ocn.ne.jp			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039404] Funding Source: NIH RePORTER; NINDS NIH HHS [1PO1NS39404-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chiu YH, 1997, MOL BIOL CELL, V8, P1735, DOI 10.1091/mbc.8.9.1735; Cunniff J, 1997, MECH DEVELOP, V66, P55, DOI 10.1016/S0925-4773(97)00085-3; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Liu Z, 1999, DEVELOPMENT, V126, P4477; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nevill-Manning CG, 1998, P NATL ACAD SCI USA, V95, P5865, DOI 10.1073/pnas.95.11.5865; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; PASCHAL BM, 1991, METHOD ENZYMOL, V196, P181; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; PORTER ME, 1989, ANNU REV CELL BIOL, V5, P119; Qi Z, 1998, J BIOL CHEM, V273, P2329, DOI 10.1074/jbc.273.4.2329; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; REINER O, 1995, J NEUROSCI, V15, P3730; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Sharma P, 1998, BIOCHEMISTRY-US, V37, P4759, DOI 10.1021/bi972746o; Sheffield PJ, 2000, PROTEINS, V39, P1, DOI 10.1002/(SICI)1097-0134(20000401)39:1<1::AID-PROT1>3.0.CO;2-N; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Suelmann R, 1997, MOL MICROBIOL, V25, P757, DOI 10.1046/j.1365-2958.1997.5131873.x; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Vallee RB, 2000, BBA-MOL CELL RES, V1496, P89, DOI 10.1016/S0167-4889(00)00011-2; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; Willins DA, 1997, MOL GEN GENET, V255, P194, DOI 10.1007/s004380050489; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100	52	420	437	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					681	696		10.1016/S0896-6273(00)00146-X	http://dx.doi.org/10.1016/S0896-6273(00)00146-X			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163259	Bronze			2022-12-17	WOS:000166057500009
J	SHENG, M; TSAUR, ML; JAN, YN; JAN, LY				SHENG, M; TSAUR, ML; JAN, YN; JAN, LY			SUBCELLULAR SEGREGATION OF 2 A-TYPE K+ CHANNEL PROTEINS IN RAT CENTRAL NEURONS	NEURON			English	Article							LONG-TERM POTENTIATION; TRANSIENT POTASSIUM CURRENT; DEPENDENT SODIUM-CHANNELS; SHAKER LOCUS; HIPPOCAMPAL-NEURONS; MAMMALIAN BRAIN; XENOPUS-OOCYTES; NERVOUS-SYSTEM; VOLTAGE-CLAMP; HETEROMULTIMERIC CHANNELS	In the mammalian nervous system, K+ channels regulate diverse aspects of neuronal function and are encoded by a large set of K+ channel genes. The roles of different K+ channel proteins could be dictated by their localization to specific subcellular domains. We report that two K+ channel polypeptides, Kv1.4 and Kv4.2, which form transient (A-type) K+ channels when expressed in Xenopus oocytes, are segregated in rat central neurons. Kv1.4 protein is targeted to axons and possibly terminals, while Kv4.2 is concentrated in dendrites and somata. This differential distribution implies distinct roles for these channel proteins in vivo. Their localizations suggest that Kv1.4 and Kv4.2 may regulate synaptic transmission via presynaptic, or postsynaptic mechanisms, respectively.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	SHENG, M (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Sheng, Morgan/0000-0002-8703-5366; Jan, Lily/0000-0003-3938-8498	NIMH NIH HHS [MH48200] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; AGHAJANIAN GK, 1985, NATURE, V315, P501, DOI 10.1038/315501a0; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; ATKINS PT, 1990, NATURE, V344, P240; AWAN KA, 1991, NEUROSCIENCE, V40, P29, DOI 10.1016/0306-4522(91)90172-K; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Bayer S.A, 1985, RAT NERVOUS SYSTEM, V1, P335; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; BRAMHAM CR, 1988, BRAIN RES, V449, P352, DOI 10.1016/0006-8993(88)91052-9; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; CASSELL JF, 1986, J PHYSIOL-LONDON, V374, P273, DOI 10.1113/jphysiol.1986.sp016079; CHEN QX, 1991, J NEUROSCI, V11, P337; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1975, J NEUROPHYSIOL, V38, P922, DOI 10.1152/jn.1975.38.4.922; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; DAHL D, 1990, EXP BRAIN RES, V83, P172; DAUT J, 1973, NATURE-NEW BIOL, V246, P193, DOI 10.1038/newbio246193a0; DREWE JA, 1992, J NEUROSCI, V12, P538; DUBOIS JM, 1983, PROG BIOPHYS MOL BIO, V42, P1, DOI 10.1016/0079-6107(83)90002-0; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; HAGIWARA S, 1959, J PHYSIOL-LONDON, V148, P161, DOI 10.1113/jphysiol.1959.sp006279; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; HAUG FMS, 1973, ADV ANAT EMBRYOL CEL, V47, P1; HEIMER L, 1985, RAT NERVOUS SYSTEM F, V1, P37; Hille B., 1991, IONIC CHANNELS EXCIT; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Ito M, 1984, CEREBELLUM NEURAL CO; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KAHLE JS, 1989, BRAIN RES, V482, P159, DOI 10.1016/0006-8993(89)90554-4; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; NAKAJIMA Y, 1986, P NATL ACAD SCI USA, V83, P3022, DOI 10.1073/pnas.83.9.3022; NEHER E, 1971, J GEN PHYSIOL, V58, P36, DOI 10.1085/jgp.58.1.36; NELSON TJ, 1990, SCIENCE, V247, P1479, DOI 10.1126/science.2108498; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; Palay S.L., 1974, CEREBELLAR CORTEX CY; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; POMPEIANO M, 1992, J NEUROSCI, V12, P440; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; ROGAWSKI MA, 1985, TRENDS NEUROSCI, V8, P214, DOI 10.1016/0166-2236(85)90082-7; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; SEGAL M, 1984, J NEUROSCI, V4, P604; SHIMAHARA T, 1981, NEUROSCI LETT, V24, P139, DOI 10.1016/0304-3940(81)90237-8; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STRONG JA, 1984, J NEUROSCI, V4, P2772; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WEISS RE, 1986, J GEN PHYSIOL, V87, P955, DOI 10.1085/jgp.87.6.955; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WITER MP, 1989, HIPPOCAMPUS NEW VIST; WONDERLIN WF, 1991, P NATL ACAD SCI USA, V88, P4391, DOI 10.1073/pnas.88.10.4391; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	77	420	427	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					271	284		10.1016/0896-6273(92)90166-B	http://dx.doi.org/10.1016/0896-6273(92)90166-B			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497894				2022-12-17	WOS:A1992JJ33200009
J	WANAKA, A; JOHNSON, EM; MILBRANDT, J				WANAKA, A; JOHNSON, EM; MILBRANDT, J			LOCALIZATION OF FGF RECEPTOR MESSENGER-RNA IN THE ADULT-RAT CENTRAL-NERVOUS-SYSTEM BY INSITU HYBRIDIZATION	NEURON			English	Article									WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	WANAKA, A (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,ST LOUIS,MO 63110, USA.		Wanaka, Akio/ABE-4671-2020; Wanaka, Akio/AAC-9754-2019; Wanaka, Akio/GPW-8926-2022	Wanaka, Akio/0000-0001-9951-9862; Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024679] Funding Source: NIH RePORTER; NCI NIH HHS [P0I CA49712] Funding Source: Medline; NINDS NIH HHS [NS 24679] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; BAIRD A, 1986, RECENT PROG HORM RES, V42, P143; Bjorklund A, 1984, HDB CHEM NEUROANAT 1, V2, P55; BLOTTNER D, 1989, EUR J NEUROSCI, V1, P471, DOI 10.1111/j.1460-9568.1989.tb00353.x; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Collingridge GL, 1983, J PHYSIOL-LONDON, V334, P34; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; FERRARI G, 1989, DEV BIOL, V133, P140, DOI 10.1016/0012-1606(89)90305-9; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HOBSON JA, 1983, BRAIN RES, V275, P127, DOI 10.1016/0006-8993(83)90424-9; HOBSON JA, 1990, J NEUROSCI, V10, P371; KOH S, 1989, EXP NEUROL, V106, P209, DOI 10.1016/0014-4886(89)90154-4; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; MARICS I, 1989, ONCOGENE, V4, P335; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MAWDSLEY C, 1975, RECENT ADV CLIN NEUR, V1, P118; Moore R. Y., 1984, HDB CHEM NEUROANAT 1, V2, P123; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; NEUFELD G, 1986, J BIOL CHEM, V261, P5631; REID HH, 1990, P NATL ACAD SCI USA, V87, P1569; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; RUTA M, 1988, ONCOGENE, V3, P9; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SAFRAN A, 1990, ONCOGENE, V5, P635; SAKANAKA M, 1983, BRAIN RES, V259, P123, DOI 10.1016/0006-8993(83)91073-9; SCHUBERT D, 1987, J CELL BIOL, V104, P635, DOI 10.1083/jcb.104.3.635; SMITH RG, 1985, J CELL BIOL, V101, P1608, DOI 10.1083/jcb.101.4.1608; SMITH RG, 1983, SCIENCE, V219, P1079, DOI 10.1126/science.6823568; SPRANGER M, 1990, EUR J NEUROSCI, V2, P69, DOI 10.1111/j.1460-9568.1990.tb00382.x; Steinbusch H. W., 1983, CHEM NEUROANATOMY, P131; TOGARI A, 1985, J NEUROSCI, V5, P307; TOGARI A, 1983, BIOCHEM BIOPH RES CO, V114, P1189, DOI 10.1016/0006-291X(83)90688-5; TORRESALEMAN I, 1990, DEV BRAIN RES, V52, P253, DOI 10.1016/0165-3806(90)90242-Q; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; VINCENT SR, 1983, NATURE, V306, P691; WAGNER JA, 1986, J CELL BIOL, V103, P1363, DOI 10.1083/jcb.103.4.1363; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1989, J BIOL CHEM, V264, P4120; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WALICKE PA, 1988, DEV BRAIN RES, V40, P711; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; WOOLF NJ, 1986, BRAIN RES BULL, V16, P603, DOI 10.1016/0361-9230(86)90134-6; YAN Q, 1988, J NEUROSCI, V8, P3481; ZAHN X, 1988, MOL CELL BIOL, V8, P3487; [No title captured]	53	420	421	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1990	5	3					267	281		10.1016/0896-6273(90)90164-B	http://dx.doi.org/10.1016/0896-6273(90)90164-B			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ279	2169267				2022-12-17	WOS:A1990DZ27900005
J	JESSELL, TM				JESSELL, TM			ADHESION MOLECULES AND THE HIERARCHY OF NEURAL DEVELOPMENT	NEURON			English	Review									COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032	Columbia University	JESSELL, TM (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,CTR NEUROBIOL,NEW YORK,NY 10032, USA.							ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; ASCH AS, 1986, P NATL ACAD SCI USA, V83, P2904, DOI 10.1073/pnas.83.9.2904; AUMAILLEY M, 1987, J BIOL CHEM, V262, P11532; BARBERA AJ, 1973, P NATL ACAD SCI USA, V70, P2482, DOI 10.1073/pnas.70.9.2482; BARLOW DP, 1984, EMBO J, V3, P2355, DOI 10.1002/j.1460-2075.1984.tb02140.x; BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; BILOZUR ME, 1988, DEV BIOL, V125, P19, DOI 10.1016/0012-1606(88)90055-3; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; BOUCAUT JC, 1984, J CELL BIOL, V99, P1822, DOI 10.1083/jcb.99.5.1822; BOURDON MA, 1985, J CELL BIOCHEM, V28, P183, DOI 10.1002/jcb.240280302; BOZYCZKO D, 1986, J NEUROSCI, V6, P1241; BRONNERFRASER M, 1986, DEV BIOL, V117, P528, DOI 10.1016/0012-1606(86)90320-9; BRONNERFRASER M, 1985, J CELL BIOL, V101, P610, DOI 10.1083/jcb.101.2.610; BRONNERFRASER M, 1988, IN PRESS J CELL BIOL; CARBONETTO S, 1983, J NEUROSCI, V3, P2324; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHIQUET M, 1984, J CELL BIOL, V98, P1937, DOI 10.1083/jcb.98.6.1937; CHIQUETEHRISMAN.M, 1986, CELL, V47, P131; COHEN J, 1987, DEV BIOL, V122, P407, DOI 10.1016/0012-1606(87)90305-8; COHEN J, 1986, NATURE, V322, P465, DOI 10.1038/322465a0; COLE GJ, 1986, J CELL BIOL, V103, P1739, DOI 10.1083/jcb.103.5.1739; CONSTANTINEPATON M, 1986, NATURE, V324, P459, DOI 10.1038/324459a0; Cowan WM, 1985, MOL BASES NEURAL DEV, P481; CRITTENDEN SL, 1987, DEVELOPMENT, V101, P729; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DAMSKY CH, 1983, CELL, V34, P455, DOI 10.1016/0092-8674(83)90379-3; DICKSON G, 1987, CELL, V50, P1119, DOI 10.1016/0092-8674(87)90178-4; DODD J, 1986, J EXP BIOL, V124, P225; DODD J, 1988, IN PRESS NEURON; DRICKAMER K, 1987, KIDNEY INT, V32, P5167; DUBAND JL, 1987, J CELL BIOL, V104, P1361, DOI 10.1083/jcb.104.5.1361; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; ERICKSON HP, 1987, J CELL BIOL, V105, P1387, DOI 10.1083/jcb.105.3.1387; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FISCHER G, 1986, J NEUROSCI, V6, P605; FRANK E, 1982, J PHYSIOL-LONDON, V324, P495, DOI 10.1113/jphysiol.1982.sp014126; GALLIN WJ, 1987, P NATL ACAD SCI USA, V84, P2808, DOI 10.1073/pnas.84.9.2808; GOODMAN SL, 1985, EMBO J, V4, P2769, DOI 10.1002/j.1460-2075.1985.tb04002.x; GOTTLIEB DI, 1976, P NATL ACAD SCI USA, V73, P410, DOI 10.1073/pnas.73.2.410; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0; GRUMET M, 1985, P NATL ACAD SCI USA, V82, P8075, DOI 10.1073/pnas.82.23.8075; GRUMET M, 1984, J CELL BIOL, V98, P1746, DOI 10.1083/jcb.98.5.1746; HALFTER W, 1981, NATURE, V292, P67, DOI 10.1038/292067a0; HALL DE, 1987, J CELL BIOL, V104, P623, DOI 10.1083/jcb.104.3.623; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; HE HT, 1986, EMBO J, V5, P2489, DOI 10.1002/j.1460-2075.1986.tb04526.x; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HORWITZ A, 1985, J CELL BIOL, V101, P2134, DOI 10.1083/jcb.101.6.2134; HUMPHRIES MJ, 1988, IN PRESS J CELL BIOL; HUNT RK, 1987, IN PRESS BRAIN CIRCU; HYAFIL F, 1983, TERATOCARCINOMA STEM, P197; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; JACOB L, 1987, CELL, V50, P215, DOI 10.1016/0092-8674(87)90217-0; JOUBERT R, 1987, DEV BRAIN RES, V36, P146, DOI 10.1016/0165-3806(87)90073-3; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; LANGENAUER C, 1987, P NATL ACAD SCI USA, V84, P7753; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LEMMON V, 1986, J NEUROSCI, V6, P2987; LEPTIN M, 1987, EMBO J, V6, P1037, DOI 10.1002/j.1460-2075.1987.tb04856.x; LETOURNEAU PC, 1988, DEV BIOL, V125, P135, DOI 10.1016/0012-1606(88)90066-8; LIESI P, 1985, EMBO J, V4, P1163, DOI 10.1002/j.1460-2075.1985.tb03755.x; LUMSDEN A, 1987, IN PRESS MAKING NERV; LUTZELSCHWAB R, 1987, EMBO J, V6, P1791, DOI 10.1002/j.1460-2075.1987.tb02432.x; MARCHASE RB, 1977, J CELL BIOL, V75, P237, DOI 10.1083/jcb.75.1.237; MCKAY RDG, 1983, SCIENCE, V222, P678; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NOSE A, 1987, EMBO J, V6, P3655, DOI 10.1002/j.1460-2075.1987.tb02698.x; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; OBRINK B, 1986, EXP CELL RES, V163, P1, DOI 10.1016/0014-4827(86)90554-9; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; PIGOTT R, 1986, DEV BRAIN RES, V29, P111, DOI 10.1016/0165-3806(86)90087-8; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; PURVES D, 1981, STUDIES DEV NEUROBIO, P231; RATHJEN FG, 1984, EMBO J, V3, P1; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; RATHJEN FG, 1987, J CELL BIOL, V51, P841; REGAN LJ, 1986, P NATL ACAD SCI USA, V83, P2248, DOI 10.1073/pnas.83.7.2248; RIGGOTT MJ, 1987, J COMP NEUROL, V258, P580, DOI 10.1002/cne.902580408; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; ROVASIO RA, 1983, J CELL BIOL, V96, P462, DOI 10.1083/jcb.96.2.462; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RUTISHAUSER U, 1986, TRENDS NEUROSCI, V9, P374, DOI 10.1016/0166-2236(86)90117-7; RUTISHAUSER U, 1988, IN PRESS PHYSL REV; SADOUL R, 1983, NATURE, V304, P349; SAJOVIC P, 1987, J NEUROCHEM, V49, P756, DOI 10.1111/j.1471-4159.1987.tb00958.x; SALTON SRJ, 1983, J NEUROSCI, V3, P2420; SANDROCK AW, 1987, SCIENCE, V237, P1605, DOI 10.1126/science.3306923; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SHIRAYOSHI Y, 1986, EMBO J, V5, P2485, DOI 10.1002/j.1460-2075.1986.tb04525.x; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; STEINBERG MS, 1978, CELL CELL RECOGNITIO, P24; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; SUNSHINE J, 1987, P NATL ACAD SCI USA, V84, P5986, DOI 10.1073/pnas.84.16.5986; SWEADNER KJ, 1983, J NEUROSCI, V3, P2504; TACKE R, 1987, NEUROSCI LETT, V82, P89, DOI 10.1016/0304-3940(87)90176-5; TAKEICHI M, 1987, TRENDS GENET, V3, P213, DOI 10.1016/0168-9525(87)90238-1; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; TRISLER D, 1987, SCIENCE, V237, P1208, DOI 10.1126/science.3629237; TRISLER GD, 1981, P NATL ACAD SCI-BIOL, V78, P2145, DOI 10.1073/pnas.78.4.2145; VOLK T, 1987, CELL, V50, P987, DOI 10.1016/0092-8674(87)90525-3; VOLK T, 1986, J CELL BIOL, V103, P1441, DOI 10.1083/jcb.103.4.1441; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WHEELOCK MJ, 1987, J CELL BIOCHEM, V34, P187, DOI 10.1002/jcb.240340305; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; WOLFF JM, 1987, EUR J BIOCHEM, V168, P551, DOI 10.1111/j.1432-1033.1987.tb13453.x; YAMAMOTO M, 1986, J NEUROSCI, V6, P3576; YOSHIDANORO C, 1984, DEV BIOL, V101, P19, DOI 10.1016/0012-1606(84)90112-X	122	420	427	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1988	1	1					3	13		10.1016/0896-6273(88)90204-8	http://dx.doi.org/10.1016/0896-6273(88)90204-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	N3326	3078409				2022-12-17	WOS:A1988N332600002
J	da Silva, FL				da Silva, Fernando Lopes			EEG and MEG: Relevance to Neuroscience	NEURON			English	Review							HIGH-FREQUENCY OSCILLATIONS; ELECTROCORTICOGRAPHIC SPECTRAL-ANALYSIS; VISUAL FEATURE INTEGRATION; HUMAN SENSORIMOTOR CORTEX; GAMMA-BAND RESPONSE; ALPHA-OSCILLATIONS; THETA-OSCILLATIONS; NEURONAL SYNCHRONIZATION; PHASE SYNCHRONY; WORKING-MEMORY	To understand dynamic cognitive processes, the high time resolution of EEG/MEG is invaluable. EEG/MEG signals can play an important role in providing measures of functional and effective connectivity in the brain. After a brief description of the foundations and basic methodological aspects of EEG/MEG signals, the relevance of the signals to obtain novel insights into the neuronal mechanisms underlying cognitive processes is surveyed, with emphasis on neuronal oscillations (ultra-slow, theta, alpha, beta, gamma, and HFO5) and combinations of oscillations. Three main functional roles of brain oscillations are put in evidence: (1) coding specific information, (2) setting and modulating brain attentional states, and (3) assuring the communication between neuronal populations such that specific dynamic workspaces may be created. The latter form the material core of cognitive functions.	[da Silva, Fernando Lopes] Ctr Neurosci, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [da Silva, Fernando Lopes] Univ Lisbon, Inst Super Tecn, P-1049001 Lisbon, Portugal	University of Amsterdam; Universidade de Lisboa; Instituto Superior Tecnico	da Silva, FL (corresponding author), Ctr Neurosci, Swammerdam Inst Life Sci, Sci Pk 904,Kamer C3-274, NL-1098 XH Amsterdam, Netherlands.	f.h.lopesdasilva@uva.nl						Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; Amzica F., 2011, NIEDERMEYERS ELECTRO, P33; Anderson KL, 2011, NEUROSCIENCE, V180, P165, DOI 10.1016/j.neuroscience.2011.02.004; Andrade-Valenca L, 2012, CLIN NEUROPHYSIOL, V123, P100, DOI 10.1016/j.clinph.2011.06.004; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ARNOLDS DEAT, 1980, ELECTROEN CLIN NEURO, V50, P324, DOI 10.1016/0013-4694(80)90160-1; Axmacher N, 2008, BRAIN, V131, P1806, DOI 10.1093/brain/awn103; Baillet S, 2010, MEG INTRO METHODS, P83; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; Bauer M, 2012, CURR BIOL, V22, P397, DOI 10.1016/j.cub.2012.01.022; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; BOEIJINGA PH, 1989, ELECTROEN CLIN NEURO, V73, P198, DOI 10.1016/0013-4694(89)90120-X; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; BOUYER JJ, 1982, ARCH ITAL BIOL, V120, P95; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Bragin A, 1999, HIPPOCAMPUS, V9, P137; BRESSLER SL, 1980, ELECTROEN CLIN NEURO, V50, P19, DOI 10.1016/0013-4694(80)90319-3; Brown P, 1998, J NEUROPHYSIOL, V80, P2911, DOI 10.1152/jn.1998.80.6.2911; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2012, PROG NEUROBIOL, V98, P241, DOI 10.1016/j.pneurobio.2012.02.004; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2012, J NEUROPHYSIOL, V107, P2020, DOI 10.1152/jn.00610.2011; Caplan JB, 2003, J NEUROSCI, V23, P4726; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; COHEN D, 1990, ANN NEUROL, V28, P811, DOI 10.1002/ana.410280613; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; da Silva Fernando, 2011, NIEDERMEYERS ELECTRO, P91; DASILVA FHL, 1977, NEUROSCI LETT, V6, P237, DOI 10.1016/0304-3940(77)90024-6; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; David O., 2011, NEUROIMAGE, V58, P310; David O, 2011, NEUROIMAGE, V58, P306, DOI 10.1016/j.neuroimage.2009.09.073; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Einevoll GT, 2010, J COMPUT NEUROSCI, V29, P367, DOI 10.1007/s10827-010-0283-y; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Ewald A, 2013, BIOMED ENG-BIOMED TE, V58, P165, DOI 10.1515/bmt-2012-0028; Fahrenfort JJ, 2012, P NATL ACAD SCI USA, V109, P21504, DOI 10.1073/pnas.1207414110; Freeman Walter J, 2003, J Integr Neurosci, V2, P3, DOI 10.1142/S0219635203000214; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Friston KJ, 2012, NEUROIMAGE, V59, P439, DOI 10.1016/j.neuroimage.2011.07.048; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; GEVINS AS, 1979, SCIENCE, V203, P665, DOI 10.1126/science.760212; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gmann G. E., 2010, MEG INTRO METHODS, P437; Gotman J, 2006, J MAGN RESON IMAGING, V23, P906, DOI 10.1002/jmri.20577; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Grutzner C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00088; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hari R., 2011, NIEDERMEYERS ELECTRO, P865; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Holmes MD, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01505.x; Hughes SW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00193; Jacobs J, 2012, PROG NEUROBIOL, V98, P302, DOI 10.1016/j.pneurobio.2012.03.001; Jacobs J, 2010, TRENDS COGN SCI, V14, P162, DOI 10.1016/j.tics.2010.01.005; Jefferys JGR, 2012, PROG NEUROBIOL, V98, P250, DOI 10.1016/j.pneurobio.2012.02.005; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jerbi K, 2009, BRAIN TOPOGR, V22, P18, DOI 10.1007/s10548-009-0078-5; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Khan S, 2013, P NATL ACAD SCI USA, V110, P3107, DOI 10.1073/pnas.1214533110; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kovach CK, 2011, NEUROIMAGE, V54, P213, DOI 10.1016/j.neuroimage.2010.08.002; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Loo SK, 2012, NEUROTHERAPEUTICS, V9, P569, DOI 10.1007/s13311-012-0131-z; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Malmivuo J, 2012, BRAIN TOPOGR, V25, P1, DOI 10.1007/s10548-011-0202-1; Manshanden I, 2002, CLIN NEUROPHYSIOL, V113, P1937, DOI 10.1016/S1388-2457(02)00304-8; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mayhew SD, 2013, NEUROIMAGE, V76, P362, DOI 10.1016/j.neuroimage.2013.02.070; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Melloni L, 2009, NEURON, V62, P8, DOI 10.1016/j.neuron.2009.04.002; Michel C., 2011, NIEDERMEYERS ELECTRO, P1179; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; Ni AM, 2012, NEURON, V73, P803, DOI 10.1016/j.neuron.2012.01.006; Niedermeyer E, 1997, INT J PSYCHOPHYSIOL, V26, P31, DOI 10.1016/S0167-8760(97)00754-X; NIEDERMEYER E, 1990, CLIN ELECTROENCEPHAL, V21, P210, DOI 10.1177/155005949002100410; Niedermeyer E, 2011, NIEDERMEYERS ELECTRO, P1; NUNEZ PL, 1995, NEOCORTICAL DYNAMICS, P708; Ogrim G, 2012, PSYCHIAT RES, V198, P482, DOI 10.1016/j.psychres.2011.12.041; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; PFURTSCHELLER G, 1993, NEUROSCI LETT, V164, P179, DOI 10.1016/0304-3940(93)90886-P; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Popov T, 2012, PSYCHOPHYSIOLOGY, V49, P1545, DOI 10.1111/j.1469-8986.2012.01484.x; Quiroga RQ, 1999, CLIN NEUROPHYSIOL, V110, P643, DOI 10.1016/S1388-2457(99)00011-5; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roebroeck A, 2011, NEUROIMAGE, V58, P296, DOI 10.1016/j.neuroimage.2009.09.036; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Romei V, 2012, EUR J NEUROSCI, V35, P968, DOI 10.1111/j.1460-9568.2012.08020.x; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Ryynanen ORM, 2006, IEEE T BIO-MED ENG, V53, P1851, DOI 10.1109/TBME.2006.873744; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Schomer D. L, 2011, NIEDERMEYERS ELECTRO; Schomer DL, 2000, J CLIN NEUROPHYSIOL, V17, P43, DOI 10.1097/00004691-200001000-00005; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Sederberg PB, 2007, PSYCHOL SCI, V18, P927, DOI 10.1111/j.1467-9280.2007.02003.x; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1999, TRENDS NEUROSCI, V22, P337, DOI 10.1016/S0166-2236(99)01407-1; Suffczynski P, 2001, INT J PSYCHOPHYSIOL, V43, P25, DOI 10.1016/S0167-8760(01)00177-5; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; ter Huurne N, 2013, BIOL PSYCHIAT, V74, P227, DOI 10.1016/j.biopsych.2013.02.001; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TIIHONEN J, 1991, NEUROSCI LETT, V129, P303, DOI 10.1016/0304-3940(91)90486-D; Trujillo LT, 2005, CLIN NEUROPHYSIOL, V116, P172, DOI 10.1016/j.clinph.2004.07.025; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Valdes-Sosa PA, 2009, HUM BRAIN MAPP, V30, P2701, DOI 10.1002/hbm.20704; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; Vulliemoz S, 2010, EPILEPSIA, V51, P491, DOI 10.1111/j.1528-1167.2009.02342.x; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Worden MS, 2000, J NEUROSCI, V20; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	172	419	423	25	180	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2013	80	5					1112	1128		10.1016/j.neuron.2013.10.017	http://dx.doi.org/10.1016/j.neuron.2013.10.017			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	264ZM	24314724	Bronze			2022-12-17	WOS:000327919500004
J	Herholz, SC; Zatorre, RJ				Herholz, Sibylle C.; Zatorre, Robert J.			Musical Training as a Framework for Brain Plasticity: Behavior, Function, and Structure	NEURON			English	Review							AUDITORY CORTICAL REPRESENTATIONS; HUMAN MOTOR CORTEX; NON-MUSICIANS; MULTISENSORY INTEGRATION; PROFESSIONAL PIANISTS; PITCH DISCRIMINATION; MISMATCH NEGATIVITY; TEMPORAL PLASTICITY; COMPARING MUSICIANS; GENETIC INFLUENCES	Musical training has emerged as a useful framework for the investigation of training-related plasticity in the human brain. Learning to play an instrument is a highly complex task that involves the interaction of several modalities and higher-order cognitive functions and that results in behavioral, structural, and functional changes on time scales ranging from days to years. While early work focused on comparison of musical experts and novices, more recently an increasing number of controlled training studies provide clear experimental evidence for training effects. Here, we review research investigating brain plasticity induced by musical training, highlight common patterns and possible underlying mechanisms of such plasticity, and integrate these studies with findings and models for mechanisms of plasticity in other domains.	[Herholz, Sibylle C.; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3 A2B4, Canada	McGill University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ H3 A2B4, Canada.	robert.zatorre@mcgill.ca			Deutsche Forschungsgemeinschaft [HE 6067/1-1]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Fund for Innovation; Fonds de recherche du Quebec Nature et Technologies via Centre for Research in Brain, Language, and Music (CRBLM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Fund for Innovation(Canada Foundation for Innovation); Fonds de recherche du Quebec Nature et Technologies via Centre for Research in Brain, Language, and Music (CRBLM)	We thank Karl Herholz and Virginia Penhune for their helpful comments on an earlier version of this manuscript; we also thank Nadine Gaab, Nina Kraus, Patrick Wong, Erika Skoe, Patrick Ragert, and John Rothwell for their assistance in reproducing material from their publications. S.C.H. is supported by Deutsche Forschungsgemeinschaft (HE 6067/1-1), and R.J.Z. is funded via the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, the Canada Fund for Innovation, and by the Fonds de recherche du Quebec Nature et Technologies, via its funding of the Centre for Research in Brain, Language, and Music (CRBLM).	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Ahissar E, 1998, NEUROPHARMACOLOGY, V37, P633, DOI 10.1016/S0028-3908(98)00068-9; Alain C, 2007, CEREB CORTEX, V17, P1074, DOI 10.1093/cercor/bhl018; Altenmuller E, 2009, ANN NY ACAD SCI, V1169, P395, DOI 10.1111/j.1749-6632.2009.04580.x; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Bailey JA, 2010, EXP BRAIN RES, V204, P91, DOI 10.1007/s00221-010-2299-y; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Bangert M, 2006, EUR J NEUROSCI, V24, P1832, DOI 10.1111/j.1460-9568.2006.05031.x; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Baumann S, 2007, BRAIN RES, V1161, P65, DOI 10.1016/j.brainres.2007.05.045; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergan JF, 2005, J NEUROSCI, V25, P9816, DOI 10.1523/JNEUROSCI.2533-05.2005; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Bezzola L, 2011, J NEUROSCI, V31, P12444, DOI 10.1523/JNEUROSCI.1996-11.2011; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bieszczad KM, 2010, NEUROBIOL LEARN MEM, V93, P229, DOI 10.1016/j.nlm.2009.10.003; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Buch ER, 2011, J NEUROSCI, V31, P17669, DOI 10.1523/JNEUROSCI.1513-11.2011; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carcagno S, 2011, JARO-J ASSOC RES OTO, V12, P89, DOI 10.1007/s10162-010-0236-1; Chandrasekaran B, 2012, J NEUROPHYSIOL, V107, P1325, DOI 10.1152/jn.00923.2011; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Chen JL, 2012, NEUROIMAGE, V59, P1200, DOI 10.1016/j.neuroimage.2011.08.012; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; Cuppini C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00077; D'Ausilio A, 2006, EUR J NEUROSCI, V24, P955, DOI 10.1111/j.1460-9568.2006.04960.x; David SV, 2012, P NATL ACAD SCI USA, V109, P2144, DOI 10.1073/pnas.1117717109; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; de Vries MH, 2010, NEUROPSYCHOLOGIA, V48, P3193, DOI 10.1016/j.neuropsychologia.2010.06.024; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eggermont JJ, 2007, PROG BRAIN RES, V166, P19, DOI 10.1016/S0079-6123(07)66002-6; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Elmer S, 2012, INT J PSYCHOPHYSIOL, V83, P259, DOI 10.1016/j.ijpsycho.2011.09.011; Fee MS, 2010, ILAR J, V51, P362, DOI 10.1093/ilar.51.4.362; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; Floel A, 2008, EUR J NEUROSCI, V27, P1301, DOI 10.1111/j.1460-9568.2008.06079.x; Folland NA, 2012, J ACOUST SOC AM, V131, P993, DOI 10.1121/1.3651254; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Fritz J, 2005, HEARING RES, V206, P159, DOI 10.1016/j.heares.2005.01.015; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Gaser C, 2003, J NEUROSCI, V23, P9240; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; Golestani N, 2011, J NEUROSCI, V31, P4213, DOI 10.1523/JNEUROSCI.3891-10.2011; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Gutfreund Y, 2006, J NEUROPHYSIOL, V96, P813, DOI 10.1152/jn.01144.2005; Halwani GF, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00156; Hanna-Pladdy B, 2011, NEUROPSYCHOLOGY, V25, P378, DOI 10.1037/a0021895; Hannon EE, 2004, J EXP PSYCHOL HUMAN, V30, P956, DOI 10.1037/0096-1523.30.5.956; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; He C, 2009, J NEUROSCI, V29, P7718, DOI 10.1523/JNEUROSCI.0157-09.2009; Herholz SC, 2011, EUR J NEUROSCI, V34, P524, DOI 10.1111/j.1460-9568.2011.07775.x; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jancke L, 2001, COGNITIVE BRAIN RES, V12, P479, DOI 10.1016/S0926-6410(01)00092-1; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; JUSCZYK PW, 1993, J EXP PSYCHOL HUMAN, V19, P627, DOI 10.1037/0096-1523.19.3.627; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kleber B, 2007, NEUROIMAGE, V36, P889, DOI 10.1016/j.neuroimage.2007.02.053; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; KRUMHANSL CL, 1982, J EXP PSYCHOL HUMAN, V8, P24, DOI 10.1037/0096-1523.8.1.24; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Kuo MF, 2008, CEREB CORTEX, V18, P648, DOI 10.1093/cercor/bhm098; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lappe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021493; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Magosso E, 2008, NEURAL NETWORKS, V21, P817, DOI 10.1016/j.neunet.2008.06.003; Margulis EH, 2009, HUM BRAIN MAPP, V30, P267, DOI 10.1002/hbm.20503; Marmel F, 2011, NEUROREPORT, V22, P504, DOI 10.1097/WNR.0b013e328348ab19; McDermott J, 2008, NATURE, V453, P287, DOI 10.1038/453287a; Menning H, 2002, LEARN MEMORY, V9, P253, DOI 10.1101/lm.49402; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Mercado E, 2001, COGN AFFECT BEHAV NE, V1, P37, DOI 10.3758/CABN.1.1.37; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Nicholas JG, 2007, J SPEECH LANG HEAR R, V50, P1048, DOI 10.1044/1092-4388(2007/073); Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pacchetti C, 2000, PSYCHOSOM MED, V62, P386, DOI 10.1097/00006842-200005000-00012; Pantev C, 1999, BRAIN RES, V842, P192, DOI 10.1016/S0006-8993(99)01835-1; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Paraskevopoulos E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036534; Parbery-Clark A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.015; Parbery-Clark A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018082; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Penhune VB, 2011, CORTEX, V47, P1126, DOI 10.1016/j.cortex.2011.05.010; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Ragert P, 2004, EUR J NEUROSCI, V19, P473, DOI 10.1111/j.0953-816X.2003.03142.x; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rodriguez-Fornells A, 2012, ANN NY ACAD SCI, V1252, P282, DOI 10.1111/j.1749-6632.2011.06425.x; Rosser N, 2008, ARCH PHYS MED REHAB, V89, P1633, DOI 10.1016/j.apmr.2008.02.030; Rogasch NC, 2009, J APPL PHYSIOL, V107, P1874, DOI 10.1152/japplphysiol.00443.2009; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Schecklmann M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027088; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; Schlaug G, 2008, MUSIC PERCEPT, V25, P315, DOI 10.1525/MP.2008.25.4.315; Schlaug G, 2010, FUTUR NEUROL, V5, P657, DOI 10.2217/FNL.10.44; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Schulte Michael, 2002, Neural Plasticity, V9, P161, DOI 10.1155/NP.2002.161; Schulz M, 2003, NEUROREPORT, V14, P157, DOI 10.1097/00001756-200301200-00029; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin A, 2004, NEUROREPORT, V15, P1917, DOI 10.1097/00001756-200408260-00017; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Shetake JA, 2012, EXP NEUROL, V233, P342, DOI 10.1016/j.expneurol.2011.10.026; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Song JH, 2012, CEREB CORTEX, V22, P1180, DOI 10.1093/cercor/bhr196; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Strait DL, 2012, CORTEX, V48, P360, DOI 10.1016/j.cortex.2011.03.015; Thiel CM, 2007, RESTOR NEUROL NEUROS, V25, P435; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Toiviainen P, 2003, PERCEPTION, V32, P741, DOI 10.1068/p3312; Trainor LJ, 1998, INFANT BEHAV DEV, V21, P77, DOI 10.1016/S0163-6383(98)90055-8; Tschida K, 2012, CURR OPIN NEUROBIOL, V22, P320, DOI 10.1016/j.conb.2011.11.006; Ueki Y, 2006, ANN NEUROL, V59, P60, DOI 10.1002/ana.20692; Van de Winckel A, 2004, CLIN REHABIL, V18, P253, DOI 10.1191/0269215504cr750oa; van Zuijen TL, 2005, COGNITIVE BRAIN RES, V23, P270, DOI 10.1016/j.cogbrainres.2004.10.007; van Zuijen TL, 2004, J COGNITIVE NEUROSCI, V16, P331, DOI 10.1162/089892904322984607; Vines BW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00230; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; Watanabe D, 2007, EXP BRAIN RES, V176, P332, DOI 10.1007/s00221-006-0619-z; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Wong PCM, 2009, MUSIC PERCEPT, V27, P81, DOI 10.1525/MP.2009.27.2.81; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; Zarate JM, 2008, NEUROIMAGE, V40, P1871, DOI 10.1016/j.neuroimage.2008.01.026; Zarate JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011181; Zatorre R, 2005, NATURE, V434, P312, DOI 10.1038/434312a; Zatorre R.J., FRONTIERS A IN PRESS; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zelcer I, 2006, CEREB CORTEX, V16, P460, DOI 10.1093/cercor/bhi125	180	419	433	16	281	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2012	76	3					486	502		10.1016/j.neuron.2012.10.011	http://dx.doi.org/10.1016/j.neuron.2012.10.011			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	036WT	23141061	Bronze			2022-12-17	WOS:000311063700005
J	Threadgill, R; Bobb, K; Ghosh, A				Threadgill, R; Bobb, K; Ghosh, A			Regulation of dendritic growth and remodeling by Rho, Rac, and Cdc42	NEURON			English	Article							ACTIN STRESS FIBERS; VISUAL-CORTEX; PROJECTION NEURONS; SIGNALING PATHWAY; SMALL GTPASES; PC12 CELLS; DIFFERENTIATION; MORPHOLOGY; NUCLEUS; PATTERN	The acquisition of cell type-specific morphologies is a central feature of neuronal differentiation and has important consequences for nervous system function. To begin to identify the underlying molecular mechanisms, we have explored the role of Rho-related GTPases in the dendritic development of cortical neurons. Expression of dominant negative mutants of Rac or Cdc42, the Rho-inhibitory molecule C3 transferase, or the GTPase-activating protein RhoGAP p190 causes a marked reduction in the number of primary dendrites in nonpyramidal (multipolar) neurons and in the number of basal dendrites in neurons with pyramidal morphologies. Conversely, the expression of constitutively active mutants of Rho, Rac, or Cdc42 leads to an increase in the number of primary and basal dendrites. In cortical cultures, as in vivo, dendritic remodeling leads to an apparent transformation from pyramidal to nonpyramidal morphologies over time. Strikingly, this shift in favor of nonpyramidal morphologies is also inhibited by the expression of dominant negative mutants of Cdc42 and Rac and by RhoGAP p190. These observations indicate that Rho, Rac, and Cdc42 play a central role in dendritic development and suggest that differential activation of Rho-related GTPases may contribute to the generation of morphological diversity in the developing cortex.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University								BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; BRAY D, 1985, J NEUROSCI, V5, P3204; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DALVA MB, 1994, J NEUROSCI, V14, P3588; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GREENOUGH WT, 1988, DEV BRAIN RES, V43, P148, DOI 10.1016/0165-3806(88)90160-5; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HALLMAN LE, 1988, J COMP NEUROL, V272, P149, DOI 10.1002/cne.902720111; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; HUBENER M, 1990, J COMP NEUROL, V301, P655, DOI 10.1002/cne.903010412; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; KOESTER SE, 1992, J NEUROSCI, V12, P1382; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MACKAY DJG, 1995, TRENDS NEUROSCI, V18, P496, DOI 10.1016/0166-2236(95)92773-J; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Rall W., 1964, THEORETICAL SIGNIFIC; RAMOA AS, 1988, J NEUROSCI, V8, P4239; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RIDLEY AJ, 1993, EMBO J, V7, P5150; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; WISE SP, 1979, NEUROSCIENCE, V4, P1275, DOI 10.1016/0306-4522(79)90157-X	33	419	423	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					625	634		10.1016/S0896-6273(00)80376-1	http://dx.doi.org/10.1016/S0896-6273(00)80376-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331353	hybrid			2022-12-17	WOS:A1997XZ01600016
J	Kiebler, MA; Bassell, GJ				Kiebler, Michael A.; Bassell, Gary J.			Neuronal RNA granules: Movers and makers	NEURON			English	Review							MESSENGER-RNAS; HIPPOCAMPAL-NEURONS; PROTEIN-SYNTHESIS; LIVING NEURONS; LOCALIZATION; TRANSPORT; BRAIN; STAUFEN; TRANSLOCATION; TRANSLATION		Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	University of Vienna; Emory University	Kiebler, MA (corresponding author), Univ Vienna, Ctr Brain Res, Waehringer Guertel 18, A-1090 Vienna, Austria.	michael.kiebler@meduniwien.ac.at		Kiebler, Michael/0000-0002-8850-6297				AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eom T, 2003, J NEUROSCI, V23, P10433; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; WILHELM JE, 1993, J CELL BIOL, V123, P269, DOI 10.1083/jcb.123.2.269; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	32	418	424	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					685	690		10.1016/j.neuron.2006.08.021	http://dx.doi.org/10.1016/j.neuron.2006.08.021			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982415	Bronze			2022-12-17	WOS:000240997900008
J	Maejima, T; Hashimoto, K; Yoshida, T; Aiba, A; Kano, M				Maejima, T; Hashimoto, K; Yoshida, T; Aiba, A; Kano, M			Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; LONG-TERM DEPRESSION; CLIMBING FIBER INNERVATION; MICE LACKING MGLUR1; SYNAPTIC TRANSMISSION; MUTANT MICE; RAT-BRAIN; MOLECULAR CHARACTERIZATION; NEUROTRANSMITTER RELEASE; MOTOR COORDINATION	We report a type of synaptic modulation that involves retrograde signaling from postsynaptic metabotropic glutamate receptors (mGluRs) to presynaptic cannabinoid receptors. Activation of mGluR subtype 1 (mGluR1) expressed in cerebellar Purkinje cells (PCs) reduced neurotransmitter release from excitatory climbing fibers. This required activation of G proteins but not Ca2+ elevation in postsynaptic PCs. This effect was occluded by a cannabinoid agonist and totally abolished by cannabinoid antagonists. Depolarization-induced Ca2+ transients in PCs also caused cannabinoid receptor-mediated presynaptic inhibition. Thus, endocannabinoid production in PCs can be initiated by two distinct stimuli. Activation of mGIuR1 by repetitive stimulation of parallel fibers, the other excitatory input to PCs, caused transient cannabinoid receptor-mediated depression of climbing fiber input. Our data highlight a signaling mechanism whereby activation of postsynaptic mGluR retrogradely influences presynaptic functions via endocannabinoid system.	Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan; Kobe Univ, Fac Med, Div Cell Biol, Kobe, Hyogo 6500017, Japan	Kanazawa University; Kobe University	Kano, M (corresponding author), Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan.		Yoshida, Takayuki/A-4243-2012	Hashimoto, Kouichi/0000-0002-3884-8213; Aiba, Atsu/0000-0002-8192-0778; Kano, Masanobu/0000-0002-0725-3292				ABE T, 1992, J BIOL CHEM, V267, P13361; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Altman J., 1996, DEV CEREBELLAR SYSTE; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; BATSHELOR AM, 1997, NATURE, V385, P74; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; Cadas H, 1997, J NEUROSCI, V17, P1226; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Levenes C, 1997, NEUROREPORT, V8, P571, DOI 10.1097/00001756-199701200-00038; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; LUJAN R, 1996, EUR J NEUROSCI, V17, P5196; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Montgomery JM, 2001, NEURON, V29, P567, DOI 10.1016/S0896-6273(01)00233-1; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	60	418	422	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2001	31	3					463	475		10.1016/S0896-6273(01)00375-0	http://dx.doi.org/10.1016/S0896-6273(01)00375-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516402	Green Submitted, Bronze			2022-12-17	WOS:000170601000014
J	SATHER, WA; TANABE, T; ZHANG, JF; MORI, Y; ADAMS, ME; TSIEN, RW				SATHER, WA; TANABE, T; ZHANG, JF; MORI, Y; ADAMS, ME; TSIEN, RW			DISTINCTIVE BIOPHYSICAL AND PHARMACOLOGICAL PROPERTIES OF CLASS-A (BI) CALCIUM-CHANNEL ALPHA(1)-SUBUNITS	NEURON			English	Article							DEPENDENT CA2+ CHANNELS; OMEGA-AGA-IVA; FUNCTIONAL EXPRESSION; BETA-SUBUNIT; SKELETAL-MUSCLE; N-TYPE; P-TYPE; DIHYDROPYRIDINE RECEPTOR; PERIPHERAL NEURONS; MOLECULAR-CLONING	Transcripts for the class A Ca2+ channel alpha1 subunit (also known as BI) are present at high levels in many parts of the mammalian CNS and are widely assumed to encode the P-type Ca2+ channel. To characterize the biophysical and pharmacological properties of alpha1A channels, macroscopic and single-channel recordings were made in Xenopus oocytes injected with alpha1A cRNA. Alpha1-specific properties were identified by making systematic comparisons with the more familiar class C alpha1 subunit under the condition of a standard ancillary subunit (alpha2/delta + beta) makeup. alpha1A currents activate and inactivate more rapidly and display steeper voltage dependence of gating than alpha1C currents. Unlike alpha1C, alpha1A channels are largely insensitive to dihydropyridines and FPL 64176, but respond to the cone snail peptide omega-CTx-MVIIC (SNX-230), a potent and fairly selective inhibitor. In comparison with P-type Ca2+ channels in rat cerebellar Purkinje cells, alpha1A channels in oocytes are approximately 10(2)-fold less sensitive to omega-Aga-IVA and approximately 10-fold more sensitive to omega-CTx-MVIIC. Alpha1A channels are not inhibited by Bay K 8644 and inactivate much more rapidly than P-type Ca2+ channels. Thus, alpha1A is capable of generating a Ca2+ channel phenotype quite different from P-type current.	YALE UNIV,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536; KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN; YALE UNIV,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06536; UNIV CALIF RIVERSIDE,DEPT ENTOMOL,RIVERSIDE,CA 92521; UNIV CALIF RIVERSIDE,DEPT NEUROSCI,RIVERSIDE,CA 92521	Howard Hughes Medical Institute; Yale University; Kyoto University; Yale University; University of California System; University of California Riverside; University of California System; University of California Riverside	SATHER, WA (corresponding author), STANFORD UNIV,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		Adams, Michael/ABF-6728-2020	Adams, Michael/0000-0003-0519-6113; Sather, William/0000-0003-1482-8055	NINDS NIH HHS [NS24067] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS ME, 1992, NEUROTOX 91, P33; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAGIWARA S, 1983, TRENDS NEUROSCI, V6, P189, DOI 10.1016/0166-2236(83)90084-X; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HESS P, 1990, ANNU REV NEUROSCI, V13, P1337; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LEE KS, 1982, NATURE, V297, P498, DOI 10.1038/297498a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1991, P NATL ACAD SCI USA, V88, P6628, DOI 10.1073/pnas.88.15.6628; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NACHSHEN DA, 1984, J GEN PHYSIOL, V83, P941, DOI 10.1085/jgp.83.6.941; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REUTER H, 1977, J PHYSIOL-LONDON, V264, P17, DOI 10.1113/jphysiol.1977.sp011656; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; VENEMA VJ, 1992, J BIOL CHEM, V267, P2610; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; ZHENG W, 1991, MOL PHARMACOL, V40, P734	56	418	430	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					291	303		10.1016/0896-6273(93)90185-T	http://dx.doi.org/10.1016/0896-6273(93)90185-T			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394721				2022-12-17	WOS:A1993LU06500009
J	Raj, A; Kuceyeski, A; Weiner, M				Raj, Ashish; Kuceyeski, Amy; Weiner, Michael			A Network Diffusion Model of Disease Progression in Dementia	NEURON			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; NEURODEGENERATIVE DISEASES; FIBER ORIENTATIONS; CORTICAL NETWORKS; OLDEST-OLD; PREVALENCE; ATROPHY; PATTERNS; VULNERABILITY	Patterns of dementia are known to fall into dissociated but dispersed brain networks, suggesting that the disease is transmitted along neuronal pathways rather than by proximity. This view is supported by neuropathological evidence for "prion-like" transsynaptic transmission of disease agents like misfolded tau and beta amyloid. We mathematically model this transmission by a diffusive mechanism mediated by the brain's connectivity network obtained from tractography of 14 healthy-brain MRIs. Subsequent graph theoretic analysis provides a fully quantitative, testable, predictive model of dementia. Specifically, we predict spatially distinct "persistent modes," which, we found, recapitulate known patterns of dementia and match recent reports of selectively vulnerable dissociated brain networks. Model predictions also closely match T1-weighted MRI volumetrics of 18 Alzheimer's and 18 frontotemporal dementia subjects. Prevalence rates predicted by the model strongly agree with published data. This work has many important implications, including dimensionality reduction, differential diagnosis, and especially prediction of future atrophy using baseline MRI morphometrics.	[Raj, Ashish; Kuceyeski, Amy] Cornell Univ, Dept Radiol, Weill Med Coll, New York, NY 10044 USA; [Weiner, Michael] Univ Calif San Francisco, Dept Radiol, Ctr Imaging Neurodegenerat Dis CIND, SF Vet Adm Hosp 114M, San Francisco, CA 94121 USA	Cornell University; University of California System; University of California San Francisco	Raj, A (corresponding author), Cornell Univ, Dept Radiol, Weill Med Coll, 515 E 71 St,Suite S123, New York, NY 10044 USA.	ashish@med.cornell.edu			National Institutes of Health [R01 NS075425, F32 EB012404-01, P41 RR023953-02, P41 RR023953-02S1, R21 EB008138-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB012404, R21EB008138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by the following grants from the National Institutes of Health: R01 NS075425, F32 EB012404-01, P41 RR023953-02, P41 RR023953-02S1, and R21 EB008138-02. Author Contributions: A.R. conceptualized this study and developed the mathematical model, performed all correlations and statistical tests, and wrote the manuscript. He is responsible for the classification results as well as the disease prevalence results and the corresponding model predictions. A.K. performed volumetric analysis of AD/bvFTD/aged patients and extracted the healthy-brain structural network. She also helped fine-tune the manuscript. M.W. provided guidance, clinical input, and interpretation, MRI data for volumetric analysis, and improvement of the manuscript. A.R. would like to thank Dr. Norman Relkin for valuable advice.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Aleman-Gomez Y, 2005, 12 ANN M ORG HUM BRA; Almond DP, 2011, SPRINGER PROC MATH, V3, P3, DOI 10.1007/978-3-642-16876-5_1; Apostolova LG, 2007, ARCH NEUROL-CHICAGO, V64, P1489, DOI 10.1001/archneur.64.10.1489; Barreda JL, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-5; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bhalla US, 2003, PROG BIOPHYS MOL BIO, V81, P45, DOI 10.1016/S0079-6107(02)00046-9; Boxer AL, 2006, ARCH NEUROL-CHICAGO, V63, P81, DOI 10.1001/archneur.63.1.81; Boxer AL, 2005, ALZ DIS ASSOC DIS, V19, pS3, DOI 10.1097/01.wad.0000183086.99691.91; Braak H, 2000, ANN NY ACAD SCI, V924, P53; Broe M, 2003, NEUROLOGY, V60, P1005, DOI 10.1212/01.WNL.0000052685.09194.39; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Di Carlo A, 2002, J AM GERIATR SOC, V50, P41, DOI 10.1046/j.1532-5415.2002.50006.x; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Klauschen F, 2009, HUM BRAIN MAPP, V30, P1310, DOI 10.1002/hbm.20599; Kobayashi Mie, 2009, Brain and Nerve (Tokyo), V61, P972; Kondor R. I., 2002, P 19 INT C MACHINE L, P315; Kuczynski B, 2010, ALZHEIMERS DEMENT, V6, P54, DOI 10.1016/j.jalz.2009.04.1228; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lomasko T, 2009, J THEOR BIOL, V256, P104, DOI 10.1016/j.jtbi.2008.08.025; Martinez S, 2007, IEEE CONTR SYST MAG, V27, P75, DOI 10.1109/MCS.2007.384124; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morrison PJ, 2010, LANCET NEUROL, V9, P1147, DOI 10.1016/S1474-4422(10)70287-8; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 1996, BRAIN COGNITION, V31, P176, DOI 10.1006/brcg.1996.0041; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pereira JMS, 2009, NEUROLOGY, V72, P1653, DOI 10.1212/WNL.0b013e3181a55fa2; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Rabinovici GD, 2009, BEHAV NEUROL, V21, P117, DOI [10.3233/BEN-2009-0232, 10.1155/2009/609839]; Rabinovici GD, 2010, BRAIN, V133, P512, DOI 10.1093/brain/awp326; Raj A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014832; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Santos SF, 2010, REV NEUROSCIENCE, V21, P153; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shalizi C. R., 2001, THESIS U WISCONSIN M; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thompson PM, 2003, J NEUROSCI, V23, P994; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Whitwell JL, 2009, NEURODEGENER DIS, V6, P106, DOI 10.1159/000209507; Whitwell JL, 2005, ARCH NEUROL-CHICAGO, V62, P1402, DOI 10.1001/archneur.62.9.1402; Wu MJ, 2007, NEUROIMAGE, V34, P1612, DOI 10.1016/j.neuroimage.2006.07.050; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	63	417	423	9	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 22	2012	73	6					1204	1215		10.1016/j.neuron.2011.12.040	http://dx.doi.org/10.1016/j.neuron.2011.12.040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445347	Green Accepted, Green Submitted, Bronze			2022-12-17	WOS:000301998700017
J	Csicsvari, J; Hirase, H; Czurko, A; Buzsaki, G				Csicsvari, J; Hirase, H; Czurko, A; Buzsaki, G			Reliability and state dependence of pyramidal cell-interneuron synapses in the hippocampus: an ensemble approach in the behaving rat	NEURON			English	Article							LONG-TERM POTENTIATION; TRANSMITTER RELEASE; THETA-RHYTHM; INHIBITORY CELLS; NEURONS; CA3; TRANSMISSION; CONNECTIONS; OSCILLATION; RECORDINGS	Spike transmission probability between pyramidal cells and interneurons in the CA1 pyramidal layer was investigated in the behaving rat by the simultaneous recording of neuronal ensembles. Population synchrony was strongest during sharp wave (SPW) bursts. However, the increase was three times larger for pyramidal cells than for interneurons. The contribution of single pyramidal cells to the discharge of interneurons was often large (up to 0.6 probability), as assessed by the presence of significant (<3 ms) peaks in the cross-correlogram. Complex-spike bursts were more effective than single spikes. Single cell contribution was higher between SPW bursts than during SPWs or theta activity. Hence, single pyramidal cells can reliably discharge interneurons, and the probability of spike transmission is behavior dependent.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.		Czurkó, András/H-5500-2019; Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905; Czurko, Andras/0000-0002-1985-7296; Buzsaki, Gyorgy/0000-0002-3100-4800	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NCRR NIH HHS [1P41RR09754] Funding Source: Medline; NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS34994] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; AIKA Y, 1994, EXP BRAIN RES, V99, P267; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; ARANCIO O, 1994, J PHYSIOL-LONDON, V481, P395, DOI 10.1113/jphysiol.1994.sp020448; BANKMAN IN, 1993, IEEE T BIO-MED ENG, V40, P836, DOI 10.1109/10.238472; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Fortunato C, 1996, EUR J NEUROSCI, V8, P1758, DOI 10.1111/j.1460-9568.1996.tb01319.x; FOX SE, 1981, EXP BRAIN RES, V41, P399; FOX SE, 1986, EXP BRAIN RES, V62, P495; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; KUBIE JL, 1990, J NEUROSCI, V10, P1110; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McBain CJ, 1997, CAN J PHYSIOL PHARM, V75, P488, DOI 10.1139/cjpp-75-5-488; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; NADASDY Z, 1998, LARGE SCALE RECORDIN, P17; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PERLMAN G, 1980, BEHAV RES METH INSTR, V12, P554, DOI 10.3758/BF03201835; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; RAASTAD M, 1995, EUR J NEUROSCI, V7, P1882, DOI 10.1111/j.1460-9568.1995.tb00709.x; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; SIK A, 1995, J NEUROSCI, V15, P6651; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Traub RD, 1995, J COMPUT NEUROSCI, V2, P291, DOI 10.1007/BF00961441; Tsodyks MV, 1997, J NEUROSCI, V17, P4382; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YLINEN A, 1995, J NEUROSCI, V15, P30; Zador AM, 1997, NEURON, V19, P1, DOI 10.1016/S0896-6273(00)80341-4; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	63	417	421	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					179	189		10.1016/S0896-6273(00)80525-5	http://dx.doi.org/10.1016/S0896-6273(00)80525-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697862	Bronze			2022-12-17	WOS:000075061900017
J	Jia, ZP; Agopyan, N; Miu, P; Xiong, ZG; Henderson, J; Gerlai, R; Taverna, FA; Velumian, A; MacDonald, J; Carlen, P; AbramowNewerly, W; Roder, J				Jia, ZP; Agopyan, N; Miu, P; Xiong, ZG; Henderson, J; Gerlai, R; Taverna, FA; Velumian, A; MacDonald, J; Carlen, P; AbramowNewerly, W; Roder, J			Enhanced LTP in mice deficient in the AMPA receptor GluR2	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; CALCIUM-PERMEABLE AMPA; GLUTAMATE RECEPTORS; STRUCTURAL DETERMINANTS; METABOTROPIC RECEPTORS; HIPPOCAMPAL-NEURONS; KAINATE RECEPTORS; RAT HIPPOCAMPUS; MURINE NEURONS	AMPA receptors (AMPARs) are not thought to be involved in the induction of long-term potentiation (LTP), but may be involved in its expression via second messenger pathways. However, one subunit of the AMPARs, GluR2, is also known to control Ca2+ influx. To test whether GluR2 plays any role in the induction of LTP, we generated mice that lacked this subunit. In GluR2 mutants, LTP in the CA1 region of hippocampal slices was markedly enhanced (2-fold) and nonsaturating, whereas neuronal excitability and paired-pulse facilitation were normal. The 9-fold increase in Ca2+ permeability, in response to kainate application, suggests one possible mechanism for enhanced LTP. Mutant mice exhibited increased mortality, and those surviving showed reduced exploration and impaired motor coordination. These results suggest an important role for GluR2 in regulating synaptic plasticity and behavior.	TORONTO HOSP,PLAYFAIR NEUROSCI UNIT,TORONTO,ON M5T 2S8,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Jia, ZP (corresponding author), MT SINAI HOSP,SAMUEL LUNENFELD RES INST,600 UNIV AVE,TORONTO,ON M5G 1X5,CANADA.		Jia, zhengping/AAZ-4190-2021; Roder, John/G-6468-2013	Carlen, Peter/0000-0002-3339-8102				ANDERSEN P, 1978, BRAIN RES, V144, P11, DOI 10.1016/0006-8993(78)90431-6; ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; BARRETT EF, 1976, BIOL CHOLINERGIC FUN, P29; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BLANTON M, 1990, J NEUROSCI METH, V30, P203; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; CHIAIA NL, 1992, NEUROSCIENCE, V49, P141, DOI 10.1016/0306-4522(92)90082-D; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; EHLERS MD, 1996, CELL, V84, P746; GELGER JRP, 1995, NEURON, V15, P193; GERBER G, 1989, J NEUROSCI, V9, P3606; GERLAI R, 1993, BEHAV BRAIN RES, V55, P51, DOI 10.1016/0166-4328(93)90006-C; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; GROVER LM, 1990, BRAIN RES, V506, P53, DOI 10.1016/0006-8993(90)91198-P; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1991, SCIENCE, V52, P81; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MACDONALD JF, 1982, CAN J PHYSIOL PHARM, V60, P282, DOI 10.1139/y82-039; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; PURPURA D P, 1968, Brain Research, V7, P310, DOI 10.1016/0006-8993(68)90109-1; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; TURNER RW, 1982, NEUROSCIENCE, V7, P1411, DOI 10.1016/0306-4522(82)90254-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I	58	417	423	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					945	956		10.1016/S0896-6273(00)80225-1	http://dx.doi.org/10.1016/S0896-6273(00)80225-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938126	Bronze			2022-12-17	WOS:A1996VV15100016
J	VERNINO, S; AMADOR, M; LUETJE, CW; PATRICK, J; DANI, JA				VERNINO, S; AMADOR, M; LUETJE, CW; PATRICK, J; DANI, JA			CALCIUM MODULATION AND HIGH CALCIUM PERMEABILITY OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS	NEURON			English	Article								Two properties were found to distinguish neuronal from muscle nicotinic acetylcholine receptors (nAChRs). First, neuronal nAChRs have a greater Cal+ permeability. The high Ca2+ flux through neuronal nAChRs activates a Ca2+-dependent Cl- conductance, and the Ca2+ to CS+ permeability ratio (P(Ca)/P(Cs) is 7 times greater for neuronal than for muscle nAChRs. A second difference between the receptor types is that neuronal nAChRs are potently modulated by physiological levels of external Ca2+. Neuronal nAChR currents are enhanced by external Ca2+ in a dose-dependent manner. The results indicate that changes in extracellular Ca2+ Modulate neuronal nAChRs and may modulate cholinergic synapses in the CNS. Also, activation of neuronal nAChRs produces a significant influx of Ca2+ that could be an important intracellular signal.	BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA	Baylor College of Medicine	VERNINO, S (corresponding author), BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA.		Vernino, Steven/AAD-5181-2020	Vernino, Steven/0000-0001-7799-8495				ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; AQUILONIUS SM, 1990, CHOLINERGIC NEUROTRA; ARMSTRONG CM, 1990, P NATL ACAD SCI USA, V87, P7579, DOI 10.1073/pnas.87.19.7579; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BREGESTOVSKI PD, 1979, NATURE, V279, P638, DOI 10.1038/279638a0; CHANG HW, 1976, P NATL ACAD SCI USA, V73, P3364, DOI 10.1073/pnas.73.10.3364; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DANI JA, 1989, J NEUROSCI, V9, P884; DANI JA, 1987, J GEN PHYSIOL, V89, P959, DOI 10.1085/jgp.89.6.959; DECKER ER, 1990, J NEUROSCI, V10, P3413; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; GREENBERG A, 1982, CELL TISSUE RES, V226, P655; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUANG LYM, 1978, J GEN PHYSIOL, V71, P397, DOI 10.1085/jgp.71.4.397; HUGANIR RL, 1988, CURR TOP MEMBR TRANS, V33, P147; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KATZ B, 1969, J PHYSIOL-LONDON, V203, P689, DOI 10.1113/jphysiol.1969.sp008887; LAUFER R, 1989, MOL NEUROBIOL, V3, P1, DOI 10.1007/BF02935587; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; LEWIS CA, 1983, P NATL ACAD SCI-BIOL, V80, P6110, DOI 10.1073/pnas.80.19.6110; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; LEWIS CA, 1979, MEMBRANE TRANSPORT P, V3, P89; LIVSEY CT, 1990, VISION RES, V30, P853, DOI 10.1016/0042-6989(90)90054-O; LUETJE CW, 1990, FASEB J, V4, P2753, DOI 10.1096/fasebj.4.10.2197155; LUETJE CW, 1991, J NEUROSCI, V11, P837; MACDERMOTT AB, 1987, TRENDS NEUROSCI, V10, P280, DOI 10.1016/0166-2236(87)90173-1; MAGLEBY KL, 1980, J PHYSIOL-LONDON, V299, P203, DOI 10.1113/jphysiol.1980.sp013120; MATHIE A, 1987, PROC R SOC SER B-BIO, V232, P239, DOI 10.1098/rspb.1987.0072; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MILEDI R, 1980, J PHYSIOL-LONDON, V300, P197, DOI 10.1113/jphysiol.1980.sp013158; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; PARSONS RL, 1978, CALCIUM DRUG ACTION, P289; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1984, BIOPHYS J, V45, P175, DOI 10.1016/S0006-3495(84)84146-6; WHITE MM, 1990, MOL PHARMACOL, V37, P720; WONG LA, 1991, J PHYSIOL-LONDON, V436, P325, DOI 10.1113/jphysiol.1991.sp018553	43	417	423	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					127	134		10.1016/0896-6273(92)90114-S	http://dx.doi.org/10.1016/0896-6273(92)90114-S			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1370370				2022-12-17	WOS:A1992HB18500011
J	GOLDE, TE; ESTUS, S; USIAK, M; YOUNKIN, LH; YOUNKIN, SG				GOLDE, TE; ESTUS, S; USIAK, M; YOUNKIN, LH; YOUNKIN, SG			EXPRESSION OF BETA-AMYLOID PROTEIN-PRECURSOR MESSENGER-RNAS - RECOGNITION OF A NOVEL ALTERNATIVELY SPLICED FORM AND QUANTITATION IN ALZHEIMERS-DISEASE USING PCR	NEURON			English	Article											GOLDE, TE (corresponding author), CASE WESTERN RESERVE UNIV,SCH MED,INST PATHOL,DEPT PHARMACOL,DIV NEUROPATHOL,CLEVELAND,OH 44106, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH043444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006656] Funding Source: NIH RePORTER; NIA NIH HHS [AG06656] Funding Source: Medline; NIGMS NIH HHS [5T32GM0250] Funding Source: Medline; NIMH NIH HHS [MH43444] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANGERER LM, 1987, IN SITU HYBRIDIZATIO, P42; BAHMANYAR S, 1987, SCIENCE, V237, P77, DOI 10.1126/science.3299701; Battey, 1986, BASIC METHODS MOL BI; BREITNER JCS, 1984, PSYCHOL MED, V14, P63, DOI 10.1017/S0033291700003081; BURGER PC, 1973, AM J PATHOL, V73, P457; CARD JP, 1988, NEURON, V1, P835, DOI 10.1016/0896-6273(88)90131-6; CASTANO EM, 1988, LAB INVEST, V58, P122; CHELLY J, 1988, NATURE, V333, P958; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLARK AW, 1989, ANN NEUROL, V25, P331, DOI 10.1002/ana.410250404; COHEN AS, 1987, J PATHOL, V151, P1, DOI 10.1002/path.1711510102; COHEN ML, 1988, P NATL ACAD SCI USA, V85, P1227, DOI 10.1073/pnas.85.4.1227; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; DONNELLY RJ, 1988, NEUROBIOL AGING, V9, P33; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOEDERT M, 1987, EMBO J, V6, P3627, DOI 10.1002/j.1460-2075.1987.tb02694.x; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HIGGINS GA, 1988, P NATL ACAD SCI USA, V85, P1297, DOI 10.1073/pnas.85.4.1297; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOHNSON SA, 1988, EXP NEUROL, V102, P264, DOI 10.1016/0014-4886(88)90104-5; KALARIA RN, 1988, J CEREBR BLOOD F MET, V8, P32, DOI 10.1038/jcbfm.1988.5; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KHATCHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; LEWIS DA, 1988, P NATL ACAD SCI USA, V85, P1691, DOI 10.1073/pnas.85.5.1691; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MIHOVILOVIC M, 1989, BIOTECHNIQUES, V7, P14; MOTTE J, 1989, ACTA NEUROPATHOL, V77, P535, DOI 10.1007/BF00687256; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PASTERNACK JM, 1989, AM J PATHOL, V135, P827; PODLISNY MB, 1987, SCIENCE, V238, P669, DOI 10.1126/science.2960019; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; Schmechel D E, 1988, Alzheimer Dis Assoc Disord, V2, P96, DOI 10.1097/00002093-198802020-00002; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1987, SCIENCE, V238, P664, DOI 10.1126/science.2890206; TANAKA S, 1988, BIOCHEM BIOPH RES CO, V157, P472, DOI 10.1016/S0006-291X(88)80273-0; TANZI RE, 1987, SCIENCE, V238, P666, DOI 10.1126/science.2890207; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TERRY RD, 1963, EXP NEUROL, V46, P262; VANBROECKHOVEN CL, 1987, NATURE, V329, P353; VITEK MP, 1988, MOL BRAIN RES, V4, P121, DOI 10.1016/0169-328X(88)90004-6; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; ZAIN SB, 1988, P NATL ACAD SCI USA, V85, P929, DOI 10.1073/pnas.85.3.929	56	417	428	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1990	4	2					253	267		10.1016/0896-6273(90)90100-T	http://dx.doi.org/10.1016/0896-6273(90)90100-T			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT254	2106330				2022-12-17	WOS:A1990CT25400008
J	Yeh, FL; Wang, YY; Tom, I; Gonzalez, LC; Sheng, M				Yeh, Felix L.; Wang, Yuanyuan; Tom, Irene; Gonzalez, Lino C.; Sheng, Morgan			TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia	NEURON			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; A-BETA; IDENTIFIES VARIANTS; TYPE-4 ALLELE; MOUSE MODEL; CELLS; CLEARANCE; RISK	Genetic variants of TREM2, a protein expressed selectively by microglia in the brain, are associated with Alzheimer's disease (AD). Starting from an unbiased protein microarray screen, we identified a set of lipoprotein particles (including LDL) and apolipoproteins (including CLU/APOJ and APOE) as ligands of TREM2. Binding of these ligands by TREM2 was abolished or reduced by disease-associated mutations. Overexpression of wild-type TREM2 was sufficient to enhance uptake of LDL, CLU, and APOE in heterologous cells, whereas TREM2 disease variants were impaired in this activity. Trem2 knockout microglia showed reduced internalization of LDL and CLU. beta-amyloid (A beta) binds to lipoproteins and this complex is efficiently taken up by microglia in a TREM2-dependent fashion. Uptake of A beta-lipoprotein complexes was reduced in macrophages from human subjects carrying a TREM2 AD variant. These data link three genetic risk factors for AD and reveal a possible mechanism by which mutant TREM2 increases risk of AD.	[Yeh, Felix L.; Wang, Yuanyuan; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Tom, Irene; Gonzalez, Lino C.] Genentech Inc, Dept Prote & Biol Resources, San Francisco, CA 94080 USA; [Gonzalez, Lino C.] 23andMe Inc, Mountain View, CA 94041 USA	Roche Holding; Genentech; Roche Holding; Genentech	Sheng, M (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.; Gonzalez, LC (corresponding author), Genentech Inc, Dept Prote & Biol Resources, San Francisco, CA 94080 USA.; Gonzalez, LC (corresponding author), 23andMe Inc, Mountain View, CA 94041 USA.	gonzalez.lino@gene.com; sheng.morgan@gene.com	Wang, Yuan/HHC-1520-2022; Lv, Yuanjie/AER-0767-2022	Sheng, Morgan/0000-0002-8703-5366				Allen M, 2012, NEUROLOGY, V79, P221, DOI 10.1212/WNL.0b013e3182605801; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Calero M, 1999, BIOCHEM J, V344, P375, DOI 10.1042/0264-6021:3440375; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Del-Aguila JL, 2015, CURR OPIN GENET DEV, V33, P49, DOI 10.1016/j.gde.2015.07.008; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Giraldo M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.016; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.06.005; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Haddick PCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084823; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Holtzman DM, 2007, ALZHEIMERS DIS ADV G, P179; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Jaworski A, 2015, SCIENCE, V350, P961, DOI 10.1126/science.aad2615; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kandalepas PC, 2014, CURR ALZHEIMER RES, V11, P441, DOI 10.2174/1567205011666140604122059; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kelker MS, 2004, J MOL BIOL, V342, P1237, DOI 10.1016/j.jmb.2004.07.089; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kondo T, 2002, NEUROLOGY, V59, P1105, DOI 10.1212/WNL.59.7.1105; LaDu MJ, 2012, BBA-MOL CELL BIOL L, V1821, P295, DOI 10.1016/j.bbalip.2011.11.005; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Liao F, 2014, J NEUROSCI, V34, P7281, DOI 10.1523/JNEUROSCI.0646-14.2014; Ling IF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033923; Lobito AA, 2011, J BIOL CHEM, V286, P18969, DOI 10.1074/jbc.M111.224626; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Rosenthal Samantha L, 2014, Curr Genet Med Rep, V2, P85; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Stefano L, 2009, J NEUROCHEM, V110, P284, DOI 10.1111/j.1471-4159.2009.06130.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Tom Irene, 2013, Curr Protoc Protein Sci, VChapter 27, DOI 10.1002/0471140864.ps2703s72; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Van Uden E, 2002, J NEUROSCI, V22, P9298; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; Wildsmith KR, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt187; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	78	416	425	9	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 20	2016	91	2					328	340		10.1016/j.neuron.2016.06.015	http://dx.doi.org/10.1016/j.neuron.2016.06.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU7LH	27477018	Bronze			2022-12-17	WOS:000382395200012
J	Stevens, B; Porta, S; Haak, LL; Gallo, V; Fields, RD				Stevens, B; Porta, S; Haak, LL; Gallo, V; Fields, RD			Adenosine: A neuron-glial transmitter promoting myelination in the CNS in response to action potentials	NEURON			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; THYROID-HORMONE; OPTIC-NERVE; RETINOIC ACID; SCHWANN-CELLS; SPINAL-CORD; LINEAGE; DIFFERENTIATION; PROLIFERATION; ACTIVATION	Neuronal activity influences myelination of the brain, but the molecular mechanisms involved are largely unknown. Here, we report that oligodendrocyte progenitor cells (OPCs) express functional adenosine receptors, which are activated in response to action potential firing. Adenosine acts as a potent neuronglial transmitter to inhibit OPC proliferation, stimulate differentiation, and promote the formation of myelin. This neuron-glial signal provides a molecular mechanism for promoting oligodendrocyte development and myelination in response to impulse activity and may help resolve controversy on the opposite effects of impulse activity on myelination in the central and peripheral nervous systems.	NICHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, RD (corresponding author), NICHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.	fields@helix.nih.gov	Haak, Laurel L./C-4986-2008; Messier, Claude/A-2322-2008	Haak, Laurel L./0000-0001-5109-3700; Messier, Claude/0000-0002-4791-1763	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000713, K04HD000713] Funding Source: NIH RePORTER; NICHD NIH HHS [Z01 HD000713-11] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baas D, 2002, P NATL ACAD SCI USA, V99, P2907, DOI 10.1073/pnas.052482299; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Belachew S, 2001, DEV NEUROSCI-BASEL, V23, P287, DOI 10.1159/000048712; Bernstein M, 1996, J NEUROSCI RES, V46, P152, DOI 10.1002/(SICI)1097-4547(19961015)46:2<152::AID-JNR3>3.0.CO;2-G; Bunge RP, 1987, PROG BRAIN RES <D>, V71, P143; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Calza L, 2002, P NATL ACAD SCI USA, V99, P3258, DOI 10.1073/pnas.052704499; Canoll PD, 1999, MOL CELL NEUROSCI, V13, P79, DOI 10.1006/mcne.1998.0733; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Fields R. Douglas, 1992, P67; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; FIELDS RD, 1997, CURRENT PROTOCOLS NE; FITZGERALD M, 1987, NATURE, V326, P603, DOI 10.1038/326603a0; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; GALLO V, 1995, J NEUROSCI, V15, P394; Gao FB, 1998, DEV BIOL, V197, P54, DOI 10.1006/dbio.1998.8877; Ghiani CA, 1999, DEVELOPMENT, V126, P1077; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; HE MH, 1994, J NEUROCHEM, V63, P501; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; KASTRITSIS CH, 1993, GLIA, V8, P106, DOI 10.1002/glia.440080206; KIRISCHUK S, 1995, J PHYSIOL-LONDON, V483, P41, DOI 10.1113/jphysiol.1995.sp020566; Kreisberg MS, 1997, AM J PHYSIOL-HEART C, V272, pH1231, DOI 10.1152/ajpheart.1997.272.3.H1231; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; KUPERMAN AS, 1964, NATURE, V204, P1000, DOI 10.1038/2041000a0; Li MX, 1996, J NEUROPHYSIOL, V76, P2595, DOI 10.1152/jn.1996.76.4.2595; LUBETZKI C, 1993, P NATL ACAD SCI USA, V90, P6820, DOI 10.1073/pnas.90.14.6820; MAIRE JC, 1984, J PHYSIOL-LONDON, V357, P67, DOI 10.1113/jphysiol.1984.sp015489; Mayer C, 1998, GLIA, V23, P374, DOI 10.1002/(SICI)1098-1136(199808)23:4<374::AID-GLIA9>3.0.CO;2-2; Mirsky R, 1996, CURR OPIN NEUROBIOL, V6, P89, DOI 10.1016/S0959-4388(96)80013-4; Omlin FX, 1997, BRAIN RES BULL, V44, P627, DOI 10.1016/S0361-9230(97)00283-9; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Rogister B, 1999, MOL CELL NEUROSCI, V14, P287, DOI 10.1006/mcne.1999.0790; SCOTT S, 1992, SENSORY NEURONS; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; Stevens B, 1998, J NEUROSCI, V18, P9303; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; STEWART HJS, 1993, EUR J NEUROSCI, V5, P1136, DOI 10.1111/j.1460-9568.1993.tb00968.x; TAKEDA M, 1995, GLIA, V14, P225, DOI 10.1002/glia.440140308; TAUBER H, 1980, NEUROSCI LETT, V16, P235, DOI 10.1016/0304-3940(80)90003-8; Tokumoto YM, 1999, DEV BIOL, V213, P327, DOI 10.1006/dbio.1999.9397; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; WOOD PM, 1990, J NEUROSCI, V10, P3635; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Zalc B, 2000, NEUROSCIENTIST, V6, P5, DOI 10.1177/107385840000600109; Zimmermann H, 1998, NEUROCHEM INT, V32, P421, DOI 10.1016/S0197-0186(97)00126-5	54	416	429	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					855	868		10.1016/S0896-6273(02)01067-X	http://dx.doi.org/10.1016/S0896-6273(02)01067-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467589	Green Accepted, Bronze			2022-12-17	WOS:000179667800010
J	Emptage, NJ; Reid, CA; Fine, A				Emptage, NJ; Reid, CA; Fine, A			Calcium stores in hippocampal synaptic boutons mediate short-term plasticity, store-operated Ca2+ entry, and spontaneous transmitter release	NEURON			English	Article							PRESYNAPTIC NERVE-TERMINALS; SINGLE ACTION-POTENTIALS; PC12 CELLS; INTRACELLULAR CALCIUM; RYANODINE RECEPTOR; DENDRITIC SPINES; NEUROTRANSMITTER RELEASE; SEQUESTRATION MECHANISM; ENDOPLASMIC-RETICULUM; CULTURED HIPPOCAMPAL	Evoked transmitter release depends upon calcium influx into synaptic boutons, but mechanisms regulating bouton calcium levels and spontaneous transmitter release are obscure. To understand these processes better, we monitored calcium transients in axons and presynaptic terminals of pyramidal neurons in hippocampal slice cultures. Action potentials reliably evoke calcium transients in axons and boutons. Calcium-induced calcium release (CICR) from internal stores contributes to the transients in boutons and to paired-pulse facilitation of EPSPs. Store depletion activates store-operated calcium channels, influencing the frequency of spontaneous transmitter release. Boutons display spontaneous Ca2+ transients; blocking CICR reduces the frequency of these transients and of spontaneous miniature synaptic events. Thus, spontaneous transmitter release is largely calcium mediated, driven by Ca2+ release from internal stores. Bouton store release is important for short-term synaptic plasticity and may also contribute to long-term plasticity.	Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	MRC National Institute for Medical Research; Dalhousie University	Fine, A (corresponding author), Natl Inst Med Res, Div Neurophysiol, Mill Hill, London NW7 1AA, England.	afine@nimr.mrc.ac.uk	Fine, Alan/P-5936-2014; Reid, Christopher A/F-4387-2014	Fine, Alan/0000-0002-4960-6973; Reid, Christopher/0000-0002-1457-8028				AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Bennett DL, 1998, BIOCHEM J, V329, P349; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLAUSTEIN MP, 1978, J GEN PHYSIOL, V72, P43, DOI 10.1085/jgp.72.1.43; BLAUSTEIN MP, 1978, J GEN PHYSIOL, V72, P15, DOI 10.1085/jgp.72.1.15; BLAUSTEIN MP, 1980, FED PROC, V39, P2790; BORNSTEIN JC, 1978, J PHYSIOL-LONDON, V282, P375, DOI 10.1113/jphysiol.1978.sp012470; BORST JGG, 1998, J PHYSL, V513, P14; Brain KL, 1997, J PHYSIOL-LONDON, V502, P521, DOI 10.1111/j.1469-7793.1997.521bj.x; Chen CF, 1999, J NEUROSCI, V19, P6257; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CLEMENTI E, 1992, J BIOL CHEM, V267, P2164; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Emptage N. J., 1999, Society for Neuroscience Abstracts, V25, P1255; EPTAGE NJ, 2000, EUR J NEUROSCI, V11, P366; ERULKAR SD, 1978, J PHYSIOL-LONDON, V278, P501, DOI 10.1113/jphysiol.1978.sp012320; Fomina AF, 1999, J NEUROSCI, V19, P3711; Frenguelli BG, 1996, SEMIN NEUROSCI, V8, P301, DOI 10.1006/smns.1996.0037; HARTTER DE, 1987, NEUROSCIENCE, V23, P371, DOI 10.1016/0306-4522(87)90297-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HENKART MP, 1978, SCIENCE, V202, P1300, DOI 10.1126/science.725607; Jonas EA, 1999, SCIENCE, V286, P1347, DOI 10.1126/science.286.5443.1347; KANO M, 1995, J PHYSIOL-LONDON, V487, P1; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koizumi S, 1999, J BIOL CHEM, V274, P33327, DOI 10.1074/jbc.274.47.33327; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Krizaj D, 1999, J NEUROSCI, V19, P7249, DOI 10.1523/JNEUROSCI.19-17-07249.1999; LEE WL, 1987, BRAIN RES, V426, P250, DOI 10.1016/0006-8993(87)90879-1; LLANO I, 1991, NEURON, V7, P577, DOI 10.1016/0896-6273(91)90370-F; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MacKenzie PJ, 1996, NEURON, V16, P783, DOI 10.1016/S0896-6273(00)80098-7; Mackenzie PJ, 1998, J NEUROPHYSIOL, V80, P2089, DOI 10.1152/jn.1998.80.4.2089; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MATHES C, 1995, J GEN PHYSIOL, V106, P975, DOI 10.1085/jgp.106.5.975; MCGRAW CF, 1980, J CELL BIOL, V85, P228, DOI 10.1083/jcb.85.2.228; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MELAMED N, 1993, J NEUROSCI, V13, P632; Melamed-Book N, 1999, P NATL ACAD SCI USA, V96, P15217, DOI 10.1073/pnas.96.26.15217; MILEDI R, 1973, PROC R SOC SER B-BIO, V183, P421, DOI 10.1098/rspb.1973.0026; Narita K, 1998, J GEN PHYSIOL, V112, P593, DOI 10.1085/jgp.112.5.593; ONODERA K, 1973, JPN J PHYSIOL, V23, P587; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peng YY, 1996, J NEUROSCI, V16, P6703; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Putney JW, 1999, BIOESSAYS, V21, P38; Qian J, 1999, J NEUROPHYSIOL, V81, P288, DOI 10.1152/jn.1999.81.1.288; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; Reyes M, 1996, J NEUROSCI, V16, P5951; Sabatini BL, 1997, J NEUROSCI, V17, P3425; SABATINI BL, 1995, NEUROPHARMACOLOGY, V34, P1453, DOI 10.1016/0028-3908(95)00129-T; SAH P, 1991, NEURON, V7, P257, DOI 10.1016/0896-6273(91)90264-Z; Savic N, 1998, EUR J NEUROSCI, V10, P3379, DOI 10.1046/j.1460-9568.1998.00342.x; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; SHARP AH, 1993, J NEUROSCI, V13, P3051; SHMIGOL A, 1994, PFLUG ARCH EUR J PHY, V426, P174, DOI 10.1007/BF00374686; SIMPSON PB, 1993, J NEUROCHEM, V61, P760; Sinha SR, 1997, BIOPHYS J, V72, P637, DOI 10.1016/S0006-3495(97)78702-2; Smith AB, 1996, J PHYSIOL-LONDON, V497, P657, DOI 10.1113/jphysiol.1996.sp021797; Smith PM, 1996, BIOCHEM J, V317, P779, DOI 10.1042/bj3170779; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TAKEMURA H, 1991, BIOCHEM BIOPH RES CO, V180, P1518, DOI 10.1016/S0006-291X(05)81368-3; Toescu EC, 1998, NEUROSCIENCE, V86, P925, DOI 10.1016/S0306-4522(98)00123-7; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Voronin LL, 1999, NEUROSCIENCE, V92, P399, DOI 10.1016/S0306-4522(99)00150-5; WU LG, 1994, J NEUROSCI, V14, P645; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	81	416	427	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					197	208		10.1016/S0896-6273(01)00190-8	http://dx.doi.org/10.1016/S0896-6273(01)00190-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182091	Bronze			2022-12-17	WOS:000166702700019
J	McAllister, AK; Katz, LC; Lo, DC				McAllister, AK; Katz, LC; Lo, DC			Neurotrophin regulation of cortical dendritic growth requires activity	NEURON			English	Review							RAT VISUAL-CORTEX; MESSENGER-RNA; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; NEURONAL PLASTICITY; MOLECULAR-CLONING; NERVOUS-SYSTEM; TRK FAMILY; NGF; SURVIVAL	Neurotrophins have been proposed to mediate several forms of activity-dependent competition in the central nervous system. A key element of such hypotheses is that neurotrophins act preferentially on active neurons; however, little direct evidence supports this postulate. We therefore examined, in ferret cortical brain slices, the interactions between activity and neurotrophins in regulating dendritic growth of layer 4 pyramidal neurons. Inhibition of spontaneous electrical activity, synaptic transmission, or L-type calcium channels each prevented the otherwise dramatic increase in dendritic arborizations elicited by brain-derived neurotrophic factor. In developing cortex, this requirement for conjoint neurotrophin signaling and activity provides a mechanism for selectively enhancing the growth and connectivity of active neurons.	DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA	Duke University	McAllister, AK (corresponding author), DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DURHAM, NC 27710 USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NEI NIH HHS [EY11553, EY07690] Funding Source: Medline; NINDS NIH HHS [NS32742] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032742, R01NS032742] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BERARDI N, 1994, P NATL ACAD SCI USA, V91, P684, DOI 10.1073/pnas.91.2.684; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; COHENCORY S, 1991, J NEUROSCI, V11, P462; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; FRANKLIN JL, 1994, PHILOS T ROY SOC B, V345, P251, DOI 10.1098/rstb.1994.0102; GALUSKE RAW, 1996, IN PRESS EUR J NEURO; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; GU Q, 1994, P NATL ACAD SCI USA, V91, P8408, DOI 10.1073/pnas.91.18.8408; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; KATZ LC, 1989, J NEUROSCI, V9, P1389; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; PURVES D, 1988, BODY BRAIN; REH TA, 1985, J NEUROSCI, V5, P1132; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SCHOUPS AA, 1995, DEV BRAIN RES, V86, P326, DOI 10.1016/0165-3806(95)00043-D; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; VALVERDE F, 1968, EXP BRAIN RES, V5, P274; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6	51	416	421	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1057	1064		10.1016/S0896-6273(00)80239-1	http://dx.doi.org/10.1016/S0896-6273(00)80239-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982155				2022-12-17	WOS:A1996WA24800005
J	JING, SQ; TAPLEY, P; BARBACID, M				JING, SQ; TAPLEY, P; BARBACID, M			NERVE GROWTH-FACTOR MEDIATES SIGNAL TRANSDUCTION THROUGH TRK HOMODIMER RECEPTORS	NEURON			English	Article							TUMOR-NECROSIS-FACTOR; TYROSINE PROTEIN-KINASE; HIGH-AFFINITY RECEPTORS; MOLECULAR-CLONING; NGF RECEPTOR; PROTOONCOGENE PRODUCT; NEUROTROPHIC FACTOR; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; GENE-TRANSFER	We have investigated the molecular nature of the high affinity nerve growth factor (NGF) receptors by using cell lines expressing gp75LNGFR and gp140trk. Our results suggest that gp75LNGFR and gp140trk interact with NGF independently and that only gp140trk mediates NGF signaling. NGF binds to gp140trk with picomolar affinity and induces its phosphorylation on tyrosine residues regardless of the presence of gp75LNGFR. NGF-gp140trk complexes display the slow dissociation rate and rapid internalization characteristics of high affinity NGF receptors. Cross-linking studies reveal the existence of gp75LNGFR and gp140trk homodimers. However, we were unable to detect gp75LNGFR-gp140trk heterodimers. Coexpression in COS cells of wild-type and kinase deficient mutants reveals that gp140trk receptors can undergo intermolecular phosphorylation, indicating the formation of functional homodimers. Moreover, these kinase deficient mutants inhibit NGF-induced signaling through wild-type gp140trk receptors. These results indicate that the functional high affinity NGF receptors consist of gp140trk homodimeric (or oligomeric) complexes.			JING, SQ (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT,RES INST,DEPT MOLEC BIOL,PRINCETON,NJ 08543, USA.							BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; Barbacid Mariano, 1993, P123; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BNORMAN JA, 1992, MOL PHARMACOL, V41, P53; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BOTHWELLM, 1990, CURR TOP MICROBIOL, V165, P55; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DUBAU L, 1989, NUCLEIC ACIDS RES, V17, P2873; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HARLOW E, 1988, ANTIBODIES LABORATOR; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; Maniatis T., 1982, MOL CLONING; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RADZIEJEWSKI SM, 1991, CELL, V65, P885; RAGSDALE C, 1991, NATURE, V350, P660, DOI 10.1038/350660a0; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TAPLEY P, 1992, ONCOGENE, V7, P371; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	67	416	433	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1067	1079		10.1016/0896-6273(92)90066-M	http://dx.doi.org/10.1016/0896-6273(92)90066-M			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1281417				2022-12-17	WOS:A1992KD71600006
J	LAI, C; LEMKE, G				LAI, C; LEMKE, G			AN EXTENDED FAMILY OF PROTEIN-TYROSINE KINASE GENES DIFFERENTIALLY EXPRESSED IN THE VERTEBRATE NERVOUS-SYSTEM	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; NICOTINIC ACETYLCHOLINE-RECEPTOR; CELL-CELL-INTERACTION; PDGF RECEPTOR; C-KIT; PHOSPHOTYROSINE ANTIBODY; NEURONAL DIFFERENTIATION; DROSOPHILA-MELANOGASTER; INSITU HYBRIDIZATION; SEVENLESS PROTEIN	We have used PCR to identify 13 novel protein-tyrosine kinase genes (tyro-1 to -13), six of which (tyro-1 to -6) are preferentially expressed in the developing vertebrate nervous system. The tyro-2 and tyro-9 genes encode kinase domains that exhibit strong amino acid sequence similarity to the equivalent regions of the receptors for EGF and FGF, respectively, and may encode novel receptors for these or related polypeptide ligands. The tyro-1 to-6 genes are all expressed during central nervous system neurogenesis and exhibit distinct and highly regionalized patterns of expression in the adult brain. Together with recent studies in invertebrates, these data are consistent with the hypothesis that protein-tyrosine kinases play a central role in neural development.	Scripps Res Inst, RES INST, LA JOLLA, CA 92037 USA	Scripps Research Institute	LAI, C (corresponding author), SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA.							BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BASLER K, 1988, TRENDS GENET, V4, P74, DOI 10.1016/0168-9525(88)90044-3; BASLER K, 1988, CELL, V54, P299; BOWTELL DDL, 1989, P NATL ACAD SCI USA, V86, P6245, DOI 10.1073/pnas.86.16.6245; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GREGORY RJ, 1987, MOL CELL BIOL, V7, P2119, DOI 10.1128/MCB.7.6.2119; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAO QL, 1989, MOL CELL BIOL, V9, P1587, DOI 10.1128/MCB.9.4.1587; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; HUNTER T, 1990, N HORIZ TH, P119; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.bi.54.070185.004341; KALCHEIM C, 1989, DEV BIOL, V134, P1, DOI 10.1016/0012-1606(89)90072-9; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; KRUH GD, 1986, SCIENCE, V234, P1545, DOI 10.1126/science.3787260; LEE KH, 1990, MOL CELL BIOL, V10, P2237, DOI 10.1128/MCB.10.5.2237; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LETWIN K, 1988, ONCOGENE, V3, P621; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; Mugnaini E, 1985, HDB CHEM NEUROANATOM, P436; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; ROEBROEK AJM, 1985, EMBO J, V4, P2897, DOI 10.1002/j.1460-2075.1985.tb04020.x; ROTHWELL VM, 1987, ONCOGENE RES, V1, P311; RUBIN GM, 1989, CELL, V57, P519, DOI 10.1016/0092-8674(89)90120-7; RUTA M, 1988, ONCOGENE, V3, P9; SAFRAN A, 1990, ONCOGENE, V5, P635; SHIBUYA M, 1990, ONCOGENE, V5, P519; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STEVENS LM, 1990, NATURE, V346, P660, DOI 10.1038/346660a0; TOGARI A, 1985, J NEUROSCI, V5, P307; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WAGNER JA, 1986, J CELL BIOL, V103, P1363, DOI 10.1083/jcb.103.4.1363; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	77	416	479	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	1991	6	5					691	704		10.1016/0896-6273(91)90167-X	http://dx.doi.org/10.1016/0896-6273(91)90167-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	2025425				2022-12-17	WOS:A1991FM52200003
J	Sakata, S; Harris, KD				Sakata, Shuzo; Harris, Kenneth D.			Laminar Structure of Spontaneous and Sensory-Evoked Population Activity in Auditory Cortex	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; LAYER-V NEURONS; VISUAL-CORTEX; IN-VIVO; BARREL CORTEX; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; SUSPECTED INTERNEURONS; RESPONSE PROPERTIES; EFFERENT NEURONS	Spontaneous activity plays an important role in the function of neural circuits. Although many similarities between spontaneous and sensory-evoked neocortical activity have been reported, little is known about consistent differences between them. Here, using simultaneously recorded cortical populations and morphologically identified pyramidal cells, we compare the laminar structure of spontaneous and sensory-evoked population activity in rat auditory cortex. Spontaneous and evoked patterns both exhibited sparse, spatially localized activity in layer 2/3 pyramidal cells, with densely distributed activity in larger layer 5 pyramidal cells and putative interneurons. However, the propagation of spontaneous and evoked activity differed, with spontaneous activity spreading upward from deep layers and slowly across columns, but sensory responses initiating in presumptive thalamorecipient layers, spreading rapidly across columns. The similarity of sparseness patterns for both neural events and distinct spread of activity may reflect similarity of local processing and differences in the flow of information through cortical circuits, respectively.	[Sakata, Shuzo; Harris, Kenneth D.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Harris, KD (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	kdharris@andromeda.rutgers.edu		Harris, Kenneth/0000-0002-5930-6456; Sakata, Shuzo/0000-0001-6796-411X	NIH [MH073245, DC009947]; NSF [SBE-0542013]; Alfred P Sloan Foundation; Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad and the Sound Technology Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009947] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Alfred P Sloan Foundation(Alfred P. Sloan Foundation); Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad and the Sound Technology Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Marguet, P. Bartho, T. Klausberger, A. Luczak, and N. Lee for outstanding technical advice and assistance; G. Buzsaki, D. Pare, P. Chadderton, A. Renart, and J. de la Rocha for their generous support, advice, and comments on the manuscript; B. Krekelberg and members of the Harris lab for discussion. This work was supported by NIH (MH073245 and DC009947), NSF (SBE-0542013 to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center), the Alfred P Sloan Foundation to K.D.H, and the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad and the Sound Technology Foundation to S.S.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; CONSUL PC, 1973, TECHNOMETRICS, V15, P791, DOI 10.2307/1267389; COOGAN TA, 1993, J NEUROSCI, V13, P3749; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Curto C, 2009, J NEUROSCI, V29, P10600, DOI 10.1523/JNEUROSCI.2053-09.2009; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hoffman KL, 2007, J NEUROSCI, V27, P11838, DOI 10.1523/JNEUROSCI.3501-07.2007; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hunter MD, 2006, P NATL ACAD SCI USA, V103, P189, DOI 10.1073/pnas.0506268103; Itskov V, 2008, NEURAL COMPUT, V20, P644, DOI 10.1162/neco.2007.3179; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kampa BM, 2007, TRENDS NEUROSCI, V30, P456, DOI 10.1016/j.tins.2007.06.010; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; Kjaer T W, 1994, J Comput Neurosci, V1, P109, DOI 10.1007/BF00962721; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; OJIMA H, 1992, CEREB CORTEX, V2, P197, DOI 10.1093/cercor/2.3.197; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rieke F., 1997, SPIKES EXPLORING NEU; ROMANSKI LM, 1993, CEREB CORTEX, V3, P499, DOI 10.1093/cercor/3.6.499; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; SWADLOW HA, 1988, J NEUROPHYSIOL, V59, P1162, DOI 10.1152/jn.1988.59.4.1162; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; SZENTAGOTHAI J, 1983, REV PHYSIOL BIOCH P, V98, P11, DOI 10.1007/BFb0033866; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Turner JG, 2005, HEARING RES, V202, P129, DOI 10.1016/j.heares.2004.09.011; VANBREDERODE JFM, 1995, J NEUROPHYSIOL, V74, P1149, DOI 10.1152/jn.1995.74.3.1149; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wang X, 2008, NEUROSCIENCE, V154, P294, DOI 10.1016/j.neuroscience.2008.03.065; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Winer JA, 2007, HEARING RES, V229, P3, DOI 10.1016/j.heares.2007.01.017; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035	95	415	418	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					404	418		10.1016/j.neuron.2009.09.020	http://dx.doi.org/10.1016/j.neuron.2009.09.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914188	Bronze, Green Accepted			2022-12-17	WOS:000271924800014
J	Yamashita, T; Tucker, KL; Barde, YA				Yamashita, T; Tucker, KL; Barde, YA			Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth	NEURON			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; ACTIN STRESS FIBERS; SENSORY NEURONS; ADP-RIBOSYLTRANSFERASE; MESSENGER-RNA; EXPRESSION; DEATH; APOPTOSIS; PROTEIN	While the neurotrophin receptor p75(NTR) is expressed by many developing neurons, its function in cells escaping elimination by programmed cell death remains unclear. The lack of intrinsic enzymatic activity of p75(NTR) prompted a search for protein interactors expressed in the developing retina, which resulted in the identification of the GTPase RhoA. In transfected cells, p75(NTR) activated RhoA, and neurotrophin binding abolished RhoA activation. In cultured neurons, inactivation of Rho proteins mimicked the effect of neurotrophins by increasing the rate of neurite elongation. In vivo, axonal outgrowth was retarded in mice carrying a mutation in the p75(NTR) gene. These results indicate that p75(NTR) modulates in a ligand-dependent fashion the activity of intracellular proteins known to regulate actin assembly.	Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Martinsried, Germany	Max Planck Society	Barde, YA (corresponding author), Max Planck Inst Neurobiol, Dept Neurobiochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Barde, Yves/F-6019-2011	Yamashita, Toshihide/0000-0003-4559-7018; Barde, Yves/0000-0002-7627-461X				AKTORIES K, 1987, FEBS LETT, V212, P109, DOI 10.1016/0014-5793(87)81566-1; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BORASIO GD, 1989, NEURON, V2, P1087; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; BUCK CR, 1987, P NATL ACAD SCI USA, V84, P3060, DOI 10.1073/pnas.84.9.3060; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; COLLINS F, 1983, P NATL ACAD SCI-BIOL, V80, P2091, DOI 10.1073/pnas.80.7.2091; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Davey F, 1998, CURR BIOL, V8, P915, DOI 10.1016/S0960-9822(07)00371-5; DAVIES AM, 1993, J NEUROSCI, V13, P4961; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; FEINSTEIN DL, 1990, FEBS LETT, V272, P7, DOI 10.1016/0014-5793(90)80437-N; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1996, NATURE, V383, P166; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Gomez J, 1998, IMMUNOL CELL BIOL, V76, P125, DOI 10.1046/j.1440-1711.1998.00723.x; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P12655; Hotchin NA, 1996, CANCER SURV, V27, P311; Jin Z, 1997, J NEUROSCI, V17, P6256; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; KOCH G, 1991, FEBS LETT, V291, P336, DOI 10.1016/0014-5793(91)81315-Y; KOCH G, 1992, BIOCHEM BIOPH RES CO, V186, P448, DOI 10.1016/S0006-291X(05)80828-9; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LEE HJ, 1990, J NEUROSCI, V10, P1779; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Liu JP, 1998, DEVELOPMENT, V125, P5055; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NARUMIYA S, 1988, J BIOL CHEM, V263, P17255; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schropel A, 1995, MOL CELL NEUROSCI, V6, P544, DOI 10.1006/mcne.1995.0006; Stucky CL, 1997, J NEUROSCI, V17, P4398; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; VONBARTHELD CS, 1991, J COMP NEUROL, V310, P103, DOI 10.1002/cne.903100110; YAN Q, 1988, J NEUROSCI, V8, P3481	54	415	421	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					585	593		10.1016/S0896-6273(00)81114-9	http://dx.doi.org/10.1016/S0896-6273(00)81114-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595511	Bronze			2022-12-17	WOS:000083913000015
J	Colledge, M; Snyder, EM; Crozier, RA; Soderling, JA; Jin, YT; Langeberg, LK; Lu, H; Bear, MF; Scott, JD				Colledge, M; Snyder, EM; Crozier, RA; Soderling, JA; Jin, YT; Langeberg, LK; Lu, H; Bear, MF; Scott, JD			Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression	NEURON			English	Article							LONG-TERM DEPRESSION; BIDIRECTIONAL SYNAPTIC PLASTICITY; D-ASPARTATE RECEPTORS; PROTEIN-KINASE-A; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; PROTEASOME SYSTEM; ADENOVIRUS E4-ORF1; TUMOR-SUPPRESSOR; E6 ONCOPROTEINS	PSD-95 is a major scaffolding protein of the postsynaptic density, tethering NMDA- and AMPA-type glutamate receptors to signaling proteins and the neuronal cytoskeleton. Here we show that PSD-95 is regulated by the ubiquitin-proteasome pathway. PSD-95 interacts with and is ubiquitinated by the E3 ligase Mdm2. In response to NMDA receptor activation, PSD-95 is ubiquitinated and rapidly removed from synaptic sites by proteasome-dependent degradation. Mutations that block PSD-95 ubiquitination prevent NMDA-induced AMPA receptor endocytosis. Likewise, proteasome inhibitors prevent NMDA-induced AMPA receptor internalization and synaptically induced long-term depression. This is consistent with the notion that PSD-95 levels are an important determinant of AMPA receptor number at the synapse. These data suggest that ubiquitination of PSD-95 through an Mdm2-mediated pathway is critical in regulating AMPA receptor surface expression during synaptic plasticity.	Oregon Hlth Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Scott, JD (corresponding author), Oregon Hlth Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97239 USA.			Bear, Mark/0000-0002-9903-2541	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048231, R01GM048231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM048231, R37 GM048231, GM48231] Funding Source: Medline; NINDS NIH HHS [P01 NS039321, NS39321] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; Ehlers M.D., 2003, NAT NEUROSCI, V10, P10; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Joazeiro CAP, 2000, SCIENCE, V289, P2061, DOI 10.1126/science.289.5487.2061; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SS, 2000, J VIROL, V74, P9680, DOI 10.1128/JVI.74.20.9680-9693.2000; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; LUNA RMD, 1995, NATURE, V378, P203; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Moss A, 2002, J NEUROSCI, V22, P1363, DOI 10.1523/JNEUROSCI.22-04-01363.2002; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stein V, 2003, J NEUROSCI, V23, P5503; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	62	414	434	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					595	607		10.1016/S0896-6273(03)00687-1	http://dx.doi.org/10.1016/S0896-6273(03)00687-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642282	Green Accepted, Bronze			2022-12-17	WOS:000186379000017
J	Mitchell, SJ; Silver, RA				Mitchell, SJ; Silver, RA			Shunting inhibition modulates neuronal gain during synaptic excitation	NEURON			English	Article							GRANULE CELLS; TIME-COURSE; POSTSYNAPTIC CURRENTS; CONTRAST INVARIANCE; CORTICAL-NEURONS; SILENT SYNAPSES; AMPA RECEPTORS; RAT; CAT; SPILLOVER	Neuronal gain control is important for processing information in the brain. Shunting inhibition is not thought to control gain since it shifts input-output relationships during tonic excitation rather than changing their slope. Here we show that tonic inhibition reduces the gain and shifts the offset of cerebellar granule cell input-output relationships during frequency-dependent excitation with synaptic conductance waveforms. Shunting inhibition scales subthreshold voltage, increasing the excitation frequency required to attain a particular firing rate. This reduces gain because frequency-dependent increases in input variability, which couple mean subthreshold voltage to firing rate, boost voltage fluctuations during inhibition. Moreover, synaptic time course and the number of inputs also influence gain changes by setting excitation variability. Our results suggest that shunting inhibition can multiplicatively scale rate-coded information in neurons with high-variability synaptic inputs.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Silver, Robin/0000-0002-5480-6638				ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Barlow H., 1961, SENSORY COMMUNICATIO, P217; BERGER AJ, 1992, NEUROSCI LETT, V143, P164, DOI 10.1016/0304-3940(92)90257-8; BERMAN NJ, 1992, PROG BRAIN RES, V90, P443; BLOMFIELD S, 1974, BRAIN RES, V69, P115, DOI 10.1016/0006-8993(74)90375-8; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; BURNS BD, 1976, PROC R SOC SER B-BIO, V194, P211, DOI 10.1098/rspb.1976.0074; Capaday C, 2002, EXP BRAIN RES, V143, P67, DOI 10.1007/s00221-001-0970-z; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P396, DOI 10.1113/jphysiol.1955.sp005414; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Doiron B, 2001, NEURAL COMPUT, V13, P227, DOI 10.1162/089976601300014691; duLac S, 1996, ANN NY ACAD SCI, V781, P489; Eccles J.C., 1967, CEREBELLUM COMPUTATI; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FATT P, 1953, J PHYSIOL-LONDON, V121, P374, DOI 10.1113/jphysiol.1953.sp004952; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GRANIT R, 1966, J PHYSIOL-LONDON, V187, P379, DOI 10.1113/jphysiol.1966.sp008097; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Hsiao CF, 1997, J NEUROPHYSIOL, V77, P2910, DOI 10.1152/jn.1997.77.6.2910; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaacson JS, 1996, J NEUROPHYSIOL, V76, P1566, DOI 10.1152/jn.1996.76.3.1566; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Koch Christof, 1999, P1; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Maffei A, 2002, J NEUROPHYSIOL, V88, P627, DOI 10.1152/jn.2002.88.2.627; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MENNERICK S, 1995, J NEUROSCI, V15, P3178; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PUIA G, 1994, NEURON, V12, P117, DOI 10.1016/0896-6273(94)90157-0; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Rice SO, 1954, SELECTED PAPERS NOIS, P133; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Stacey WC, 2001, J NEUROPHYSIOL, V86, P1104, DOI 10.1152/jn.2001.86.3.1104; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; TOMKO GJ, 1974, BRAIN RES, V79, P405, DOI 10.1016/0006-8993(74)90438-7; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WYATT HJ, 1975, J NEUROPHYSIOL, V38, P613, DOI 10.1152/jn.1975.38.3.613; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346	69	414	427	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2003	38	3					433	445		10.1016/S0896-6273(03)00200-9	http://dx.doi.org/10.1016/S0896-6273(03)00200-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741990	Bronze			2022-12-17	WOS:000182800300008
J	Zhang, HL; Craciun, LC; Mirshahi, T; Rohacs, T; Lopes, CMB; Jin, TH; Logothetis, DE				Zhang, HL; Craciun, LC; Mirshahi, T; Rohacs, T; Lopes, CMB; Jin, TH; Logothetis, DE			PIP2 activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents	NEURON			English	Article							KCNQ2/KCNQ3 K+ CHANNELS; VOLTAGE-SENSITIVE K; POTASSIUM CHANNEL; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOLIPASE-C; PHOSPHOINOSITIDE TURNOVER; MUSCARINIC SUPPRESSION; ACH CHANNEL; SUBUNITS; MODULATION	KCNO channels belong to a family of potassium ion channels with crucial roles in physiology and disease. Heteromers of KCNQ2/3 subunits constitute the neuronal M channels. Inhibition of M currents, by pathways that stimulate phospholipase C activity, controls excitability throughout the nervous system. Here we show that a common feature of all KCNQ channels is their activation by the signaling membrane phospholipid phosphatidylinositol-bis-phosphate (PIP2). We show that wortmannin, at concentrations that prevent recovery from receptor-mediated inhibition of M currents, blocks PIP2 replenishment to the cell surface. Moreover, we identify a C-terminal histidine residue, immediately proximal to the plasma membrane, mutation of which renders M channels less sensitive to PIP2 and more sensitive to receptor-mediated inhibition. Finally, native or recombinant channels inhibited by muscarinic agonists can be activated by PIP2. Our data strongly suggest that PIP2 acts as a membrane-diffusible second messenger to regulate directly the activity of KCNQ currents.	NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University	Logothetis, DE (corresponding author), NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA.	diomedes@inka.mssm.edu			NHLBI NIH HHS [HL-59949, HL10307] Funding Source: Medline; NIGMS NIH HHS [GM20856] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, F32HL010307] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS PR, 1980, BRIT J PHARMACOL, V68, P353, DOI 10.1111/j.1476-5381.1980.tb14547.x; ADAMS PR, 1983, BRIT J PHARMACOL, V79, P330, DOI 10.1111/j.1476-5381.1983.tb11004.x; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Filippov AK, 1998, J NEUROSCI, V18, P5170, DOI 10.1523/JNEUROSCI.18-14-05170.1998; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haruna T, 2002, CIRC RES, V91, P232, DOI 10.1161/01.RES.0000029971.60214.49; Hawrot E, 1979, Methods Enzymol, V58, P574; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Ikeda SR, 2002, NEURON, V35, P411, DOI 10.1016/S0896-6273(02)00792-4; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lupu VD, 1998, J BIOL CHEM, V273, P14067, DOI 10.1074/jbc.273.23.14067; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; MARRION NV, 1993, NEURON, V11, P77, DOI 10.1016/0896-6273(93)90272-S; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Oketani N, 2002, AM J PHYSIOL-HEART C, V282, pH757, DOI 10.1152/ajpheart.00246.2001; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; SELYANKO AA, 1993, J PHYSIOL-LONDON, V472, P711, DOI 10.1113/jphysiol.1993.sp019968; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Shapiro MS, 2000, J NEUROSCI, V20, P1710; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TOKIMASA T, 1995, BRIT J PHARMACOL, V114, P489, DOI 10.1111/j.1476-5381.1995.tb13253.x; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Womack KB, 2000, J NEUROSCI, V20, P2792; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhang Y, 1999, TUMOR TARGET, V4, P158	63	414	427	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					963	975		10.1016/S0896-6273(03)00125-9	http://dx.doi.org/10.1016/S0896-6273(03)00125-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670425	Bronze			2022-12-17	WOS:000181899600010
J	WONG, ROL; MEISTER, M; SHATZ, CJ				WONG, ROL; MEISTER, M; SHATZ, CJ			TRANSIENT PERIOD OF CORRELATED BURSTING ACTIVITY DURING DEVELOPMENT OF THE MAMMALIAN RETINA	NEURON			English	Article							RECEPTIVE-FIELD CHARACTERISTICS; LATERAL GENICULATE-NUCLEUS; GANGLION-CELLS; AMACRINE CELLS; CAT RETINA; RETINOGENICULATE PATHWAY; PRENATAL DEVELOPMENT; IMPULSE ACTIVITY; LUCIFER YELLOW; RABBIT RETINA	The refinement of early connections in the visual pathway requires electrical activity in the retina before the onset of vision. Using a multielectrode array, we have shown that the spontaneous activity of cells in the neonatal ferret retina is correlated by patterns of periodically generated traveling waves. Here, we examine developmental changes in the characteristics of the waves and show that retinal ganglion cells participate in these patterns of activity, which are seen during the same period as synaptic modification in the lateral geniculate nucleus; that the waves subside gradually as the connectivity in the lateral geniculate nucleus stabilizes; and that their spatial structure allows for refinement of the retinotopic map, as well as for eye-specific segregation in the lateral geniculate nucleus.	STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University				Meister, Markus/0000-0003-2136-6506				AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; BLOOMFIELD SA, 1992, J NEUROPHYSIOL, V68, P711, DOI 10.1152/jn.1992.68.3.711; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.neuro.13.1.475; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CUCCHIARO J, 1984, PROC R SOC SER B-BIO, V223, P141, DOI 10.1098/rspb.1984.0087; DUBIN MW, 1986, J NEUROSCI, V6, P1021; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GREINER JV, 1980, EXP EYE RES, V30, P439, DOI 10.1016/0014-4835(80)90059-7; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MEISTER M, 1993, IN PRESS J NEUROSCI; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; RAPISARDI SC, 1975, EXP BRAIN RES, V22, P295; REDBURN DA, 1992, NEUROCHEM RES, V17, P61, DOI 10.1007/BF00966865; REGEHR WG, 1989, J NEUROSCI METH, V30, P91, DOI 10.1016/0165-0270(89)90055-1; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SINGER W, 1990, J EXP BIOL, V153, P177; SPEAR PD, 1972, BRAIN RES, V45, P67, DOI 10.1016/0006-8993(72)90216-8; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1987, J COMP NEUROL, V255, P386, DOI 10.1002/cne.902550306; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; SUR M, 1984, NATURE, V310, P246, DOI 10.1038/310246a0; TSO DY, 1986, J NEUROSCI, V6, P1160; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VITEK DJ, 1985, J COMP NEUROL, V241, P1, DOI 10.1002/cne.902410102; WASSLE H, 1987, J COMP NEUROL, V265, P391, DOI 10.1002/cne.902650308; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; WINGATE RJT, 1992, J COMP NEUROL, V323, P449, DOI 10.1002/cne.903230402; WONG ROL, 1987, J COMP NEUROL, V255, P159, DOI 10.1002/cne.902550202; YANG G, 1992, SCIENCE, V268, P1949	42	414	416	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					923	938		10.1016/0896-6273(93)90122-8	http://dx.doi.org/10.1016/0896-6273(93)90122-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240814				2022-12-17	WOS:A1993MJ04100014
J	LaMonte, BH; Wallace, KE; Holloway, BA; Shelly, SS; Ascano, J; Tokito, M; Van Winkle, T; Howland, DS; Holzbaur, ELF				LaMonte, BH; Wallace, KE; Holloway, BA; Shelly, SS; Ascano, J; Tokito, M; Van Winkle, T; Howland, DS; Holzbaur, ELF			Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration	NEURON			English	Article							CYTOPLASMIC DYNEIN; DYNACTIN COMPLEX; P150(GLUED) COMPONENT; NEUROFILAMENT SUBUNIT; TRANSGENIC MICE; PROTEIN; SOD1; SPECTRIN; REVEALS; DISEASE	To test the hypothesis that inhibition of axonal transport is sufficient to cause motor neuron degeneration such as that observed in amyotrophic lateral sclerosis (ALS), we engineered a targeted disruption of the dynein-dynactin complex in postnatal motor neurons of transgenic mice. Dynamitin overexpression was found to disassemble dynactin, a required activator of cytoplasmic dynein, resulting in an inhibition of retrograde axonal transport. Mice overexpressing dynamitin demonstrate a late-onset progressive motor neuron degenerative disease characterized by decreased strength and endurance, motor neuron degeneration and loss, and denervation of muscle. Previous transgenic mouse models of ALS have shown abnormalities in microtubule-based axonal transport. In this report, we describe a mouse model that confirms the critical role of disrupted axonal transport in the pathogenesis of motor neuron degenerative disease.	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol Anim, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Wyeth Ayerst Res, Princeton, NJ 08543 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pfizer	Holzbaur, ELF (corresponding author), Univ Penn, Sch Med, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu			NIGMS NIH HHS [GM56707, GM48661] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056707, R01GM048661] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Borchelt DR, 1998, BRAIN PATHOL, V8, P735, DOI 10.1111/j.1750-3639.1998.tb00198.x; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Dillman JF, 1996, J NEUROSCI, V16, P6742; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Julien JP, 1997, TRENDS CELL BIOL, V7, P243, DOI 10.1016/S0962-8924(97)01049-0; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Li JY, 2000, J NEUROSCI RES, V61, P151, DOI 10.1002/1097-4547(20000715)61:2<151::AID-JNR6>3.3.CO;2-E; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; MELLONI RH, 1995, J COMP NEUROL, V357, P15, DOI 10.1002/cne.903570103; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Murphey RK, 1999, DEV BIOL, V209, P86, DOI 10.1006/dbio.1999.9217; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Pagala MK, 1998, MUSCLE NERVE, V21, P1729, DOI 10.1002/(SICI)1097-4598(199812)21:12<1729::AID-MUS16>3.0.CO;2-V; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reddy S, 1997, J NEUROBIOL, V33, P711, DOI 10.1002/(SICI)1097-4695(19971120)33:6<711::AID-NEU1>3.0.CO;2-C; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SCHMUED L, 1994, ELSEVIERS NEUROSCIEN, V50, P1; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Xu ZS, 1996, J CELL BIOL, V133, P1061, DOI 10.1083/jcb.133.5.1061; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	48	413	432	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					715	727		10.1016/S0896-6273(02)00696-7	http://dx.doi.org/10.1016/S0896-6273(02)00696-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062019	Bronze			2022-12-17	WOS:000175951800007
J	Cummings, CJ; Reinstein, E; Sun, YL; Antalffy, B; Jiang, YH; Ciechanover, A; Orr, HT; Beaudet, AL; Zoghbi, HY				Cummings, CJ; Reinstein, E; Sun, YL; Antalffy, B; Jiang, YH; Ciechanover, A; Orr, HT; Beaudet, AL; Zoghbi, HY			Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; SPINOCEREBELLAR ATAXIA; TRANSGENIC MICE; PURKINJE-CELLS; PROTEIN; PROTEASOME; REPEAT; P53; NEURODEGENERATION; AGGREGATION	Mutant ataxin-1, the expanded polyglutamine protein causing spinocerebellar ataxia type 1 (SCA1), aggregates in ubiquitin-positive nuclear inclusions (NI) that alter proteasome distribution in affected SCA1 patient neurons. Here, we observed that ataxin-1 is degraded by the ubiquitin-proteasome pathway. While ataxin-1 [2Q] and mutant ataxin-1 [92Q] are polyubiquitinated equally well in vitro, the mutant form is three times more resistant to degradation. Inhibiting proteasomal degradation promotes ataxin-1 aggregation in transfected cells. And in mice, Purkinje cells that express mutant ataxin-1 but not a ubiquitin-protein ligase have significantly fewer Nls. Nonetheless, the Purkinje cell pathology is markedly worse than that of SCA1 mice. Taken together, Nts are not necessary to induce neurodegeneration, but impaired proteasomal degradation of mutant ataxin-1 may contribute to SCA1 pathogenesis.	Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Technion Israel Inst Technol, Dept Biochem, IL-31096 Haifa, Israel; Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Technion Israel Institute of Technology; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA.		Ciechanover, Aaron J/C-9166-2017	Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022920, R37NS027699, R01NS022920, R01NS027699] Funding Source: NIH RePORTER; NICHD NIH HHS [HD37283] Funding Source: Medline; NINDS NIH HHS [NS22920, NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Clark HB, 1997, J NEUROSCI, V17, P7385; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Hayashi Y, 1998, ACTA NEUROPATHOL, V95, P479, DOI 10.1007/s004010050828; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MAYER RJ, 1998, UBIQUITIN BIOL CELL, P429; Mourre C, 1997, BRAIN RES, V778, P405, DOI 10.1016/S0006-8993(97)01165-7; NORMAN DJ, 1995, DEVELOPMENT, V121, P1183; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; STEINER M, 1998, UBIQUITIN BIOL CELL, P147; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Wells R.D., 1998, GENETIC INSTABILITIE; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609	54	413	426	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1999	24	4					879	892		10.1016/S0896-6273(00)81035-1	http://dx.doi.org/10.1016/S0896-6273(00)81035-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269UE	10624951	Bronze			2022-12-17	WOS:000084495300016
J	Corriveau, RA; Huh, GS; Shatz, CJ				Corriveau, RA; Huh, GS; Shatz, CJ			Regulation of class I MHC gene expression in the developing and mature CNS by neural activity	NEURON			English	Review							LONG-TERM POTENTIATION; COMPLEX CLASS-I; GLUTAMATE RECEPTOR SUBUNIT; LATERAL GENICULATE-NUCLEUS; CENTRAL-NERVOUS-SYSTEM; NICOTINIC ACETYLCHOLINE-RECEPTOR; ACTIVITY-DEPENDENT REGULATION; MESSENGER-RNA EXPRESSION; OCULAR DOMINANCE COLUMNS; CELL-ADHESION MOLECULES	To elucidate molecular mechanisms underlying activity-dependent synaptic remodeling in the developing mammalian visual system, we screened for genes whose expression in the lateral geniculate nucleus (LGN) is regulated by spontaneously generated action potentials present prior to vision. Activity blockade did not alter expression in the LGN of 32 known genes. Differential mRNA display, however, revealed a decrease in mRNAs encoding class I major histocompatibility complex antigens (class I MHC). Postnatally, visually driven activity can regulate class I MHC in the LGN during the final remodeling of retinal ganglion cell axon terminals. Moreover, in the mature hippocampus, class I MHC mRNA levels are increased by kainic acid-induced seizures. Normal expression of class I MHC mRNA is correlated with times and regions of synaptic plasticity, and immunohistochemistry confirms that class I MHC is present in specific subsets of CNS neurons. Finally, beta 2-microglobulin, a cosubunit of class I MHC, and CD3 zeta, a component of a receptor complex for class I MHC, are also expressed by CNS neurons. These observations indicate that class I MHC molecules, classically thought to mediate cell-cell interactions exclusively in immune function, may play a novel role in neuronal signaling and activity-dependent changes in synaptic connectivity.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Shatz, CJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.				NIMH NIH HHS [MH48108] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; ARCEGOMEZ B, 1978, TISSUE ANTIGENS, V11, P96, DOI 10.1111/j.1399-0039.1978.tb01233.x; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; Bittigau P, 1997, J CHILD NEUROL, V12, P471, DOI 10.1177/088307389701200802; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; BOTTINO C, 1994, EUR J IMMUNOL, V24, P2527, DOI 10.1002/eji.1830241040; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; Campbell G, 1997, VISUAL NEUROSCI, V14, P779, DOI 10.1017/S0952523800012724; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CLINE HT, 1990, J NEUROSCI, V10, P1197; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DALVA MB, 1994, J NEUROSCI, V14, P3588; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DUBIN MW, 1986, J NEUROSCI, V6, P1021; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FUKUMOTO T, 1982, EUR J IMMUNOL, V12, P237, DOI 10.1002/eji.1830120313; GALL C, 1990, P NATL ACAD SCI USA, V87, P7643, DOI 10.1073/pnas.87.19.7643; GERVAIS AG, 1970, NATURE, V225, P647, DOI 10.1038/225647a0; GERVAIS AG, 1968, TRANSPLANTATION, V6, P261; GOLDEN GT, 1991, NEUROREPORT, V2, P141, DOI 10.1097/00001756-199103000-00008; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; GUILLERY RW, 1973, J COMP NEUROL, V148, P417, DOI 10.1002/cne.901480402; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HART DNJ, 1981, TRANSPLANTATION, V31, P318, DOI 10.1097/00007890-198105010-00003; HOLLMANN M, 1990, COLD SH Q B, V55, P41; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; JOLY E, 1992, NEURON, V8, P1185, DOI 10.1016/0896-6273(92)90138-4; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; KANDEL ER, 1992, SCIENCE, V258, P243, DOI 10.1126/science.1411522; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LAMPSON LA, 1987, TRENDS NEUROSCI, V10, P211, DOI 10.1016/0166-2236(87)90153-6; LAMPSON LA, 1995, MICROSC RES TECHNIQ, V32, P267, DOI 10.1002/jemt.1070320402; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PLOEGH HL, 1979, P NATL ACAD SCI USA, V76, P2273, DOI 10.1073/pnas.76.5.2273; POTTER TA, 1984, J EXP MED, V160, P317, DOI 10.1084/jem.160.1.317; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; RAO K, 1993, J COMP NEUROL, V336, P613, DOI 10.1002/cne.903360413; SCHMIDT JT, 1983, BRAIN RES, V269, P29, DOI 10.1016/0006-8993(83)90959-9; SCHMIDT JT, 1983, BRAIN RES, V269, P15, DOI 10.1016/0006-8993(83)90958-7; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SEGUELA P, 1993, J NEUROSCI, V13, P596; SHATZ CJ, 1986, ANNU REV NEUROSCI, V9, P171, DOI 10.1146/annurev.ne.09.030186.001131; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SPENCER SC, 1987, IMMUNOGENETICS, V25, P91, DOI 10.1007/BF00364273; SPENCER SC, 1987, J EXP MED, V165, P1595, DOI 10.1084/jem.165.6.1595; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STREIT WJ, 1989, J NEUROIMMUNOL, V21, P117, DOI 10.1016/0165-5728(89)90167-7; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SUR M, 1984, NATURE, V310, P246, DOI 10.1038/310246a0; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tully T, 1997, P NATL ACAD SCI USA, V94, P4239, DOI 10.1073/pnas.94.9.4239; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WASTERLAIN CG, 1994, BRAIN DEV-JPN, V16, P279, DOI 10.1016/0387-7604(94)90025-6; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; WORLEY PF, 1990, COLD SH Q B, V55, P213, DOI 10.1101/SQB.1990.055.01.023; XU J, 1994, NEUROSCIENCE, V60, P959, DOI 10.1016/0306-4522(94)90275-5; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yamagata K, 1994, Learn Mem, V1, P140; YEE KT, 1990, BRAIN RES, V530, P121, DOI 10.1016/0006-8993(90)90667-Z; YUHKI N, 1994, J MOL EVOL, V39, P22, DOI 10.1007/BF00178246; YUHKI N, 1988, IMMUNOGENETICS, V27, P414, DOI 10.1007/BF00364427; YUHKI N, 1990, J EXP MED, V172, P621, DOI 10.1084/jem.172.2.621; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	125	413	421	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1998	21	3					505	520		10.1016/S0896-6273(00)80562-0	http://dx.doi.org/10.1016/S0896-6273(00)80562-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768838	Bronze			2022-12-17	WOS:000076196400008
J	NICOLL, RA; KAUER, JA; MALENKA, RC				NICOLL, RA; KAUER, JA; MALENKA, RC			THE CURRENT EXCITEMENT IN LONG-TERM POTENTIATION	NEURON			English	Review									UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	NICOLL, RA (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143, USA.			Kauer, Julie/0000-0002-3362-1642				AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; ANDERSEN P, 1975, HIPPOCAMPUS, V1, P155; ASCHER P, 1988, IN PRESS J PHYSL; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1986, J PHYSIOL-LONDON, V377, P391, DOI 10.1113/jphysiol.1986.sp016193; CAJAL SRY, 1911, HISTOLOGIE SYSTEME N, V2, P993; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COLLINGRIDGE GL, 1988, IN PRESS J PHYSL; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; ECCLES JC, 1953, NEUROPHYSIOLOGICAL B, P314; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HEBB DO, 1949, ORG BEHAVIOR; HERRON CE, 1985, NEUROSCI LETT, V60, P19, DOI 10.1016/0304-3940(85)90375-1; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KAUER JA, 1988, IN PRESS J PHYSL; KAUER JA, 1988, IN PRESS EXP BRAIN S; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LLOYD DPC, 1949, J GEN PHYSIOL, V33, P147, DOI 10.1085/jgp.33.2.147; LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; LOVINGER DM, 1986, BRAIN RES, V399, P205, DOI 10.1016/0006-8993(86)91510-6; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; LYNCH MA, 1988, IN PRESS EXP BRAIN S; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MADISON DV, 1988, IN PRESS J PHYSL; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, J NEUROSCI, V7, P3230; MAYER ML, 1984, NATURE, V309, P262; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; SASTRY BR, 1986, SCIENCE, V232, P988, DOI 10.1126/science.3010459; SPENCER WA, 1970, SHORT TERM CHANGES N, P433; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V124, P475, DOI 10.1111/j.1748-1716.1985.tb07685.x; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986	54	413	420	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1988	1	2					97	103		10.1016/0896-6273(88)90193-6	http://dx.doi.org/10.1016/0896-6273(88)90193-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	N3327	2856092				2022-12-17	WOS:A1988N332700001
J	Poldrack, RA				Poldrack, Russell A.			Inferring Mental States from Neuroimaging Data: From Reverse Inference to Large-Scale Decoding	NEURON			English	Article							HUMAN BRAIN ACTIVITY; NATURAL IMAGES; INTENTIONS; ACTIVATION; PATTERNS; MACHINE	A common goal of neuroimaging research is to use imaging data to identify the mental processes that are engaged when a subject performs a mental task. The use of reasoning from activation to mental functions, known as "reverse inference," has been previously criticized on the basis that it does not take into account how selectively the area is activated by the mental process in question. In this Perspective, I outline the critique of informal reverse inference and describe a number of new developments that provide the ability to more formally test the predictive power of neuroimaging data.	[Poldrack, Russell A.] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78759 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Psychol, Austin, TX 78759 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Neurobiol, Austin, TX 78759 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Poldrack, RA (corresponding author), Univ Texas Austin, Imaging Res Ctr, 3925-BW Braker Lane, Austin, TX 78759 USA.	poldrack@mail.utexas.edu		Poldrack, Russell/0000-0001-6755-0259	National Institutes of Health [RO1MH082795]; National Science Foundation [OCI-1131441]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health grant RO1MH082795 and the National Science Foundation grant OCI-1131441. Thanks to Tyler Davis, Steve Hanson, Rajeev Raizada, Rebecca Saxe, Tom Schonberg, Gael Varoquax, Corey White, and Tal Yarkoni for helpful comments on a draft of this paper.	Aguirre G.K., 2003, BEHAV NEUROLOGY COGN, P85; [Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Carroll MK, 2009, NEUROIMAGE, V44, P112, DOI 10.1016/j.neuroimage.2008.08.020; Cohen JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00047; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Gilbert SJ, 2011, J NEUROSCI, V31, P2888, DOI 10.1523/JNEUROSCI.5336-10.2011; Hanson SJ, 2008, NEURAL COMPUT, V20, P486, DOI 10.1162/neco.2007.09-06-340; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; IACOBONI M, 2007, NY TIMES        1111; Jimura K., 2011, NEUROPSYCHO IN PRESS; Kahneman D, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P523, DOI 10.1016/B978-0-12-374176-9.00033-6; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Lenartowicz A, 2010, TOP COGN SCI, V2, P678, DOI 10.1111/j.1756-8765.2010.01100.x; Lindstrom M., 2011, NY TIMES, pA21; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Pereira F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00072; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Pierce C.S., 1998, ESSENTIAL PIERCE, V2, p[1893, 331]; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Poldrack Russell A, 2011, Front Neuroinform, V5, P17, DOI 10.3389/fninf.2011.00017; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Sarter M, 1996, AM PSYCHOL, V51, P13, DOI 10.1037/0003-066X.51.1.13; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137	36	412	414	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					692	697		10.1016/j.neuron.2011.11.001	http://dx.doi.org/10.1016/j.neuron.2011.11.001			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	860TR	22153367	Bronze, Green Accepted			2022-12-17	WOS:000297971100005
J	Butt, SJB; Fuccillo, M; Nery, S; Noctor, S; Kriegstein, A; Corbin, JG; Fishell, G				Butt, SJB; Fuccillo, M; Nery, S; Noctor, S; Kriegstein, A; Corbin, JG; Fishell, G			The temporal and spatial origins of cortical interneurons predict their physiological subtype	NEURON			English	Article							MEDIAL GANGLIONIC EMINENCE; GABAERGIC CELL SUBTYPES; DOUBLE BOUQUET CELLS; MORPHOLOGICAL-CHARACTERISTICS; PYRAMIDAL CELLS; VISUAL-CORTEX; BRAIN-SLICES; NEURONS; EXPRESSION; DIVERSITY	Interneurons of the cerebral cortex represent a heterogeneous population of cells with important roles in network function. At present, little is known about how these neurons are specified in the developing telencephalon. To explore whether this diversity is established in the early progenitor populations, we conducted in utero fate-mapping of the mouse medial and caudal ganglionic eminences (MGE and CGE, respectively), from which most cortical interneurons arise. Mature interneuron subtypes were assessed by electrophysiological and immunological analysis, as well as by morphological reconstruction. At E13.5, the MGE gives rise to fast-spiking (FS) interneurons, whereas the CGE generates predominantly regular-spiking interneurons (RSNP). Later at E15.5, the CGE produces RSNP classes distinct from those generated from the E13.5 CGE. Thus, we provide evidence that the spatial and temporal origin of interneuron precursors in the developing telencephalic eminences predicts the intrinsic physiological properties of mature interneurons.	NYU, Med Ctr, Dev Gen Program, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	New York University; New York University; Columbia University; Columbia University	Fishell, G (corresponding author), NYU, Med Ctr, Dev Gen Program, 550 1St Ave, New York, NY 10016 USA.	fishell@saturn.med.nyu.edu	Butt, Simon/I-2689-2019; Nery, Susana Vaz/P-4518-2014	Butt, Simon/0000-0002-2399-0102; Vaz Nery, Susana/0000-0002-2399-7785; Fishell, Gordon/0000-0002-9640-9278; Fuccillo, Marc/0000-0002-6569-706X				Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Anderson SA, 2001, DEVELOPMENT, V128, P353; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Chow A, 1999, J NEUROSCI, V19, P9332; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Dodt HU, 1998, HISTOCHEM J, V30, P141, DOI 10.1023/A:1003291218707; Du J, 1996, J NEUROSCI, V16, P506; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Peters A, 1997, J NEUROCYTOL, V26, P779, DOI 10.1023/A:1018518515982; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Sharma K, 2001, NEURON, V29, P321, DOI 10.1016/S0896-6273(01)00208-2; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; SOMOGYI P, 1981, J COMP NEUROL, V195, P547, DOI 10.1002/cne.901950402; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sussel L, 1999, DEVELOPMENT, V126, P3359; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yozu M, 2005, J NEUROSCI, V25, P7268, DOI 10.1523/JNEUROSCI.2072-05.2005; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	48	412	417	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					591	604		10.1016/j.neuron.2005.09.034	http://dx.doi.org/10.1016/j.neuron.2005.09.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301176	Bronze			2022-12-17	WOS:000233677300013
J	Milbrandt, J; de Sauvage, FJ; Fahrner, TJ; Baloh, RH; Leitner, ML; Tansey, MG; Lampe, PA; Heuckeroth, RO; Kotzbauer, PT; Simburger, KS; Golden, JP; Davies, JA; Vejsada, R; Kato, AC; Hynes, M; Sherman, D; Nishimura, M; Wang, LC; Vandlen, R; Moffat, B; Klein, RD; Poulsen, K; Gray, C; Garces, A; Henderson, CE; Phillips, HS; Johnson, EM				Milbrandt, J; de Sauvage, FJ; Fahrner, TJ; Baloh, RH; Leitner, ML; Tansey, MG; Lampe, PA; Heuckeroth, RO; Kotzbauer, PT; Simburger, KS; Golden, JP; Davies, JA; Vejsada, R; Kato, AC; Hynes, M; Sherman, D; Nishimura, M; Wang, LC; Vandlen, R; Moffat, B; Klein, RD; Poulsen, K; Gray, C; Garces, A; Henderson, CE; Phillips, HS; Johnson, EM			Persephin, a novel neurotrophic factor related to GDNF and neurturin	NEURON			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; MICE LACKING GDNF; SURVIVAL FACTOR; IN-VIVO; KIDNEY DEVELOPMENT; TYROSINE KINASE; MOTOR-NEURONS; CELL-DEATH; RECEPTOR; MOTONEURONS	A novel neurotrophic factor named Persephin that is similar to 40% identical to glial eel line-derived neurotrophic factor (GDNF) and neurturin (NTN) has been identified using degenerate PCR. Persephin, like GDNF and NTN, promotes the survival of ventral midbrain dopaminergic neurons in culture and prevents their degeneration after 6-hydroxydopamine treatment in vivo. Persephin also supports the survival of motor neurons in culture and in vivo after sciatic nerve axotomy and, like GDNF, promotes ureteric bud branching. However, in contrast to GDNF and NTN, persephin does not support any of the peripheral neurons that were examined. Fibroblasts transfected with Ret and one of the core-ceptors GFR alpha-1 or GFR alpha-2 do not respond to persephin, suggesting that persephin utilizes additional, or different, receptor components than GDNF and NTN.	Washington Univ, Sch Med, St Louis, MO 63110 USA; Genentech Inc, S San Francisco, CA 94080 USA; Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Geneva, Sch Med, CH-1211 Geneva 4, Switzerland; Univ Mediterranee, CNRS, INSERM, U382, Marseille 09, France	Washington University (WUSTL); Roche Holding; Genentech; University of Edinburgh; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Milbrandt, J (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.		de Sauvage, Frederic/ABE-8400-2020; Davies, Jamie/AAE-7111-2019; Lampe, Patricia/AAH-9545-2020	de Sauvage, Frederic/0000-0002-5275-2584; Davies, Jamie/0000-0001-6660-4032; Heuckeroth, Robert/0000-0002-3282-1765; Golden, Judith/0000-0002-5168-8525; Garces, Alain/0000-0001-6252-9995; Henderson, Christopher/0000-0002-9936-3279; Hynes, Mary/0000-0001-6623-6727; Milbrandt, Jeffrey/0000-0002-5477-7689	NIA NIH HHS [R01 AG13729, R01 AG13730] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; DAVIES J, 1995, DEVELOPMENT, V121, P1507; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; FARLEY JR, 1978, ARCH BIOCHEM BIOPHYS, V185, P376, DOI 10.1016/0003-9861(78)90180-7; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HYNES MA, 1994, J NEUROSCI RES, V37, P144, DOI 10.1002/jnr.490370118; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; RAPRAEGER AC, 1991, SCIENCE, V252, P371; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Suvanto P, 1997, HUM MOL GENET, V6, P1267, DOI 10.1093/hmg/6.8.1267; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; WIDENFALK J, 1997, J NEUROSCI, V17, P8505; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0	39	412	445	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					245	253		10.1016/S0896-6273(00)80453-5	http://dx.doi.org/10.1016/S0896-6273(00)80453-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491986	Bronze			2022-12-17	WOS:000072154700010
J	Wang, HU; Anderson, DJ				Wang, HU; Anderson, DJ			Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth	NEURON			English	Article							RECEPTOR TYROSINE KINASES; CELL-MIGRATION; CHICK-EMBRYO; AVIAN EMBRYO; NEURITE GROWTH; BINDING; PROTEIN; TISSUES; INHIBITORS; EXPRESSION	In vertebrate embryos, neural crest cell migration and motor axon outgrowth are restricted to rostral somite halves by repulsive factors located in the caudal somite compartment. We show that two Eph family transmembrane ligands, Lerk2 and HtkL, are expressed in caudal somite halves, and that crest cells and motor axons express receptors for these ligands. In several independent in vitro assays, preclustered ligand-Fc fusion proteins can repulsively guide both crest migration and motor axon outgrowth. These repulsive activities depend on a graded or discontinuous presentation of the ligands when tested in the context of permissive substrates, such as laminin or fibronectin. These results identify Lerk2 and HtkL as potential determinants of segmental pattern in the peripheral nervous system.			Wang, HU (corresponding author), CALTECH,HOWARD HUGHES MED INST,DIV BIOL 21676,PASADENA,CA 91125, USA.							ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BECKER N, 1994, MECH DEVELOP, V47, P3, DOI 10.1016/0925-4773(94)90091-4; BENNETT BD, 1995, P NATL ACAD SCI USA, V92, P1866, DOI 10.1073/pnas.92.6.1866; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Brambilla R, 1995, MOL CELL NEUROSCI, V6, P487, DOI 10.1006/mcne.1995.0001; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; BRONNERFRASER M, 1991, DEV BIOL, V143, P213, DOI 10.1016/0012-1606(91)90071-A; BRONNERFRASER M, 1992, J NEUROBIOL, V24, P233; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DAVIES JA, 1990, NEURON, V2, P11; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; ERICKSON CA, 1992, DEV BIOL, V151, P251, DOI 10.1016/0012-1606(92)90231-5; FLETCHER FA, 1994, ONCOGENE, V9, P3241; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; Friedman GC, 1996, CURR OPIN NEUROBIOL, V6, P127, DOI 10.1016/S0959-4388(96)80018-3; Gale NW, 1996, ONCOGENE, V13, P1343; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hotary KB, 1996, DEV BIOL, V176, P22, DOI 10.1006/dbio.1996.9997; Irving C, 1996, DEV BIOL, V173, P26, DOI 10.1006/dbio.1996.0004; KEYNES RJ, 1984, NATURE, V310, P413; KRULL CE, 1995, DEVELOPMENT, V121, P3733; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOISEIWITSCH JR, 1995, P NATL ACAD SCI USA, V921, P7182; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; OAKLEY RA, 1994, DEVELOPMENT, V120, P103; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; Ohta K, 1996, MECH DEVELOP, V54, P59, DOI 10.1016/0925-4773(95)00461-0; Orike N, 1996, CURR BIOL, V6, P108, DOI 10.1016/S0960-9822(02)00435-9; PANDEY A, 1995, CURR BIOL, V5, P986, DOI 10.1016/S0960-9822(95)00195-3; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; PERRIS R, 1987, J CELL BIOL, V105, P2511, DOI 10.1083/jcb.105.6.2511; RANSCHT B, 1991, DEVELOPMENT, V111, P15; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P437; Ring C, 1996, DEV BIOL, V180, P41, DOI 10.1006/dbio.1996.0283; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STERN CD, 1987, DEVELOPMENT, V99, P261; TEILLET MA, 1987, DEV BIOL, V120, P329, DOI 10.1016/0012-1606(87)90236-3; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TOSNEY KW, 1991, BIOESSAYS, V13, P17; TUCKER GC, 1988, DEVELOPMENT, V103, P82; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xu QL, 1995, DEVELOPMENT, V121, P4005	57	412	421	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					383	396		10.1016/S0896-6273(00)81240-4	http://dx.doi.org/10.1016/S0896-6273(00)81240-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115733	Bronze			2022-12-17	WOS:A1997WQ07400007
J	Clapcote, SJ; Lipina, TV; Millar, JK; Mackie, S; Christie, S; Ogawa, F; Lerch, JP; Trimble, K; Uchiyama, M; Sakuraba, Y; Kaneda, H; Shiroishi, T; Houslay, MD; Henkelman, RM; Sled, JG; Gondo, Y; Porteous, DJ; Roder, JC				Clapcote, Steven J.; Lipina, Tatiana V.; Millar, J. Kirsty; Mackie, Shaun; Christie, Sheila; Ogawa, Fumiaki; Lerch, Jason P.; Trimble, Keith; Uchiyama, Masashi; Sakuraba, Yoshiyuki; Kaneda, Hideki; Shiroishi, Toshihiko; Houslay, Miles D.; Henkelman, R. Mark; Sled, John G.; Gondo, Yoichi; Porteous, David J.; Roder, John C.			Behavioral phenotypes of Disc1 missense mutations in mice	NEURON			English	Article							CHRONIC MILD STRESS; PREPULSE INHIBITION; SCHIZOPHRENIC-PATIENTS; LATENT INHIBITION; BIPOLAR DISORDER; PHOSPHODIESTERASE ENZYME; STRAIN DIFFERENCES; NEURITE OUTGROWTH; GATING DEFICITS; CEREBRAL-CORTEX	To support the role of DISC1 in human psychiatric disorders, we identified and analyzed two independently derived ENU-induced mutations in Exon 2 of mouse Disc1. Mice with mutation Q31L showed depressive-like behavior with deficits in the forced swim test and other measures that were reversed by the antidepressant bupropion, but not by rolipram, a phosphodiesterase-4 (PDE4) inhibitor. In contrast, L100P mutant mice exhibited schizophrenic-like behavior, with profound deficits in prepulse inhibition and latent inhibition that were reversed by antipsychotic treatment. Both mutant DISC1 proteins exhibited reduced binding to the known DISC1 binding partner PDE4B. Q31L mutants had lower PDE4B activity, consistent with their resistance to rolipram, suggesting decreased PDE4 activity as a contributory factor in depression. This study demonstrates that Disc1 missense mutations in mice give rise to phenotypes related to depression and schizophrenia, thus supporting the role of DISC1 in major mental illness.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Edinburgh, Med Genet Sect, Ctr Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Auditory Sci Lab, Toronto, ON M5G 1X8, Canada; RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Univ Glasgow, IBLS, Mol Pharmacol Grp, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Edinburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); RIKEN; University of Glasgow; University of Toronto; University of Toronto	Clapcote, SJ (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	mail.steve@btinternet.com; david.porteous@ed.ac.uk	HENKELMAN, MARK/W-6847-2019; Porteous, David/AAA-3446-2021; Houslay, Miles D/A-6825-2011; Lipina, Tatiana/G-9148-2014; Houslay, Miles/AAM-5281-2020; Porteous, David J/C-7289-2013; Sled, John G/D-8268-2012; Roder, John/G-6468-2013; Sakuraba, Yoshiyuki/D-5614-2009; Gondo, Yoichi/A-5375-2016	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Sled, John G/0000-0002-4461-283X; Sakuraba, Yoshiyuki/0000-0003-4698-5530; Gondo, Yoichi/0000-0003-2184-6489; Trimble, Keith/0000-0001-9166-060X; Houslay, Miles/0000-0002-3826-8091	MRC [G0100266, G0600214] Funding Source: UKRI; Medical Research Council [G0600214, G0100266] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*AM PSYCH ASS, 1909, DIAGN STAT MAN MENT; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Austin CP, 2003, NEUROREPORT, V14, P951, DOI 10.1097/01.wnr.0000074342.81633.63; Avgustinovich DF, 2000, BEHAV GENET, V30, P101, DOI 10.1023/A:1001999020138; Baillie GS, 2000, BRIT J PHARMACOL, V131, P811, DOI 10.1038/sj.bjp.0703636; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; CADENHEAD KS, 1993, AM J PSYCHIAT, V150, P1862; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Chen XJ, 2006, NEUROIMAGE, V29, P99, DOI 10.1016/j.neuroimage.2005.07.008; Clapcote SJ, 2005, BEHAV GENET, V35, P591, DOI 10.1007/s10519-005-5634-5; Clapcote SJ, 2006, GENETICS, V173, P2407, DOI 10.1534/genetics.106.060749; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; David DJP, 2003, PSYCHOPHARMACOLOGY, V166, P373, DOI 10.1007/s00213-002-1335-4; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; Egashira N, 2005, NEUROPSYCHOPHARMACOL, V30, P1996, DOI 10.1038/sj.npp.1300784; Geyer MA, 2003, PROG NEURO-PSYCHOPH, V27, P1071, DOI 10.1016/j.pnpbp.2003.09.003; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hasler G, 2006, BIOL PSYCHIAT, V60, P93, DOI 10.1016/j.biopsych.2005.11.006; Hennah W, 2005, MOL PSYCHIATR, V10, P1097, DOI 10.1038/sj.mp.4001731; Hennah W, 2006, SCHIZOPHRENIA BULL, V32, P409, DOI 10.1093/schbul/sbj079; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huston E, 1997, BIOCHEM J, V328, P549, DOI 10.1042/bj3280549; Insel TR, 2006, MOL PSYCHIATR, V11, P11, DOI 10.1038/sj.mp.4001777; ISHIZUKA K, 2007, IN PRESS MOL PSYCHIA; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Lipina T, 2005, PSYCHOPHARMACOLOGY, V179, P54, DOI 10.1007/s00213-005-2210-x; Maeda K, 2006, BIOL PSYCHIAT, V60, P929, DOI 10.1016/j.biopsych.2006.03.032; MARCHMONT RJ, 1980, BIOCHEM J, V187, P381, DOI 10.1042/bj1870381; MCINTOSH AM, 2006, IN PRESS BIOL PSYCHI; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Michaud EJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-164; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; PERRY W, 1994, AM J PSYCHIAT, V151, P363; Porteous DJ, 2006, BIOL PSYCHIAT, V60, P123, DOI 10.1016/j.biopsych.2006.04.008; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Pouzet B, 2005, PSYCHOPHARMACOLOGY, V178, P9, DOI 10.1007/s00213-004-1976-6; Ralph RJ, 2001, J PHARMACOL EXP THER, V298, P148; Rascle C, 2001, SCHIZOPHR RES, V51, P149, DOI 10.1016/S0920-9964(00)00162-6; ROGERS RJ, 1994, EUR J PHARMACOL, V261, P321; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sakic B, 1996, BRAIN RES BULL, V41, P305, DOI 10.1016/S0361-9230(96)00190-6; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; SCHEIDER HH, 1984, BIOCHEM PHARMACOL, V33, P1690; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strakowski SM, 1999, ARCH GEN PSYCHIAT, V56, P254, DOI 10.1001/archpsyc.56.3.254; SWERDLOW NR, 1994, ARCH GEN PSYCHIAT, V51, P139; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; UEDA T, 1979, J CELL BIOL, V83, P308, DOI 10.1083/jcb.83.2.308; WACHTEL H, 1983, NEUROPHARMACOLOGY, V22, P267, DOI 10.1016/0028-3908(83)90239-3; Weiner I, 2003, PSYCHOPHARMACOLOGY, V169, P257, DOI 10.1007/s00213-002-1313-x; Williams JH, 1998, BRIT J PSYCHIAT, V172, P243, DOI 10.1192/bjp.172.3.243; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	86	411	431	0	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 3	2007	54	3					387	402		10.1016/j.neuron.2007.04.015	http://dx.doi.org/10.1016/j.neuron.2007.04.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481393	Green Submitted, Bronze			2022-12-17	WOS:000246855700010
J	Hansson, BS; Stensmyr, MC				Hansson, Bill S.; Stensmyr, Marcus C.			Evolution of Insect Olfaction	NEURON			English	Review							PHEROMONE-SENSITIVE NEURONS; DROSOPHILA ODORANT RECEPTORS; ANTENNAL LOBE; BINDING-PROTEIN; SEXUAL-DIMORPHISM; GENE FAMILY; ANTHERAEA-POLYPHEMUS; MOLECULAR EVOLUTION; GAS-CHROMATOGRAPHY; MAXILLARY PALP	Neuroethology utilizes a wide range of multidisciplinary approaches to decipher neural correlates of natural behaviors associated with an animal's ecological niche. By placing emphasis on comparative analyses of adaptive and evolutionary trends across species, a neuroethological perspective is uniquely suited to uncovering general organizational and biological principles that shape the function and anatomy of the nervous system. In this review, we focus on the application of neuroethological principles in the study of insect olfaction and discuss how ecological environment and other selective pressures influence the development of insect olfactory neurobiology, not only informing our understanding of olfactory evolution but also providing broader insights into sensory processing.	[Hansson, Bill S.; Stensmyr, Marcus C.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07749 Jena, Germany	Max Planck Society	Hansson, BS (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Hans Knoell Str 8, D-07749 Jena, Germany.	hansson@ice.mpg.de; mstensmyr@ice.mpg.de	Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223; Stensmyr, Marcus/0000-0003-4009-9212	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The writing of this review was funded by the Max Planck Society.	ALLISON AC, 1949, BRAIN, V72, P186, DOI 10.1093/brain/72.2.186; Andersson MN, 2009, J INSECT PHYSIOL, V55, P556, DOI 10.1016/j.jinsphys.2009.01.018; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; BEERSMA DGM, 1977, J COMP PHYSIOL, V119, P207, DOI 10.1007/BF00656634; Bengtsson JM, 2011, CHEM SENSES, V36, P499, DOI 10.1093/chemse/bjr002; Bengtsson JM, 2009, J CHEM ECOL, V35, P1063, DOI 10.1007/s10886-009-9684-7; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Boddum T, 2010, J INSECT PHYSIOL, V56, P1306, DOI 10.1016/j.jinsphys.2010.04.007; BOECKH J, 1979, J COMP PHYSIOL, V132, P235, DOI 10.1007/BF00614495; Boursot P, 1996, J EVOLUTION BIOL, V9, P391, DOI 10.1046/j.1420-9101.1996.9040391.x; Bretschneider F., 1924, Jenaische Zeitschrift fuer Naturwissenschaft, V60, P563; Buck LB, 2005, ANGEW CHEM INT EDIT, V44, P6128, DOI 10.1002/anie.200501120; BURUGA J H, 1971, Biotropica, V3, P151, DOI 10.2307/2989820; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; CHRISTENSEN TA, 1995, CHEM SENSES, V20, P313, DOI 10.1093/chemse/20.3.313; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2010, J COMP PHYSIOL A, V196, P97, DOI 10.1007/s00359-009-0496-6; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Dethier V. G., 1947, Chemical Insect Attractants and Repellents.; Distler PG, 1996, J COMP NEUROL, V370, P35; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Grimaldi David, 2005, pi; Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hansson BS, 1999, PHYSIOL ENTOMOL, V24, P121, DOI 10.1046/j.1365-3032.1999.00121.x; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hildebrand JG., 1980, INSECT NEUROBIOLOGY, P375; Hill SR, 2010, ARTHROPOD STRUCT DEV, V39, P322, DOI 10.1016/j.asd.2010.05.005; HOSL M, 1990, J COMP PHYSIOL A, V167, P321, DOI 10.1007/BF00192567; Ignell R, 2001, BRAIN BEHAV EVOLUT, V57, P1, DOI 10.1159/000047222; JAWLOWSKI H., 1948, ANN UNIV MARIAE CURIE SKLODOWSKA SECT C BIOL, V3, P1; KAISSLING KE, 1989, ARCH INSECT BIOCHEM, V10, P273, DOI 10.1002/arch.940100403; Karpati Z, 2008, J EXP BIOL, V211, P2841, DOI 10.1242/jeb.017319; King JR, 2000, J NEUROSCI, V20, P2391; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kleineidam CJ, 2005, CHEM SENSES, V30, P383, DOI 10.1093/chemse/bji033; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; KOONTZ MA, 1987, CELL TISSUE RES, V249, P39, DOI 10.1007/BF00215416; Kristoffersen L, 2008, CHEM SENSES, V33, P759, DOI 10.1093/chemse/bjn034; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; LACEY MJ, 1992, J CHEM ECOL, V18, P1421, DOI 10.1007/BF00994366; LACHAISE D, 1988, EVOL BIOL, V22, P159; LACHAISE D, 1982, EVOLUTION, V36, P141, DOI 10.1111/j.1558-5646.1982.tb05019.x; LACHAISE D, 1974, ANN SOC ENTOMOL FR, V10, P3; Lachaise D., 1983, GENET BIOL DROSOPHIL, P221; Lachaise D., 1979, THESIS U P M CURIE P; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Larsson MC, 2003, J CHEM ECOL, V29, P1253, DOI 10.1023/A:1023893926038; Lau T. F. S., 2007, Journal of Asia-Pacific Entomology, V10, P27; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; MUSTAPARTA H, 1979, J CHEM ECOL, V5, P109, DOI 10.1007/BF00987692; NEGUS V, 1957, ARCHIV OTOLARYNGOL, V66, P414; Oland LA, 1996, J NEUROBIOL, V30, P92; PAYNE RS, 1971, J EXP BIOL, V54, P535; Pitts RJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-26; RIO B, 1983, ANN SOC ENTOMOL FR, V19, P235; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHALLER A., 1926, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V4, P370, DOI 10.1007/BF00340839; SCHEICH H, 1986, NATURE, V319, P401, DOI 10.1038/319401a0; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Schneider D., 1968, Symposia of the Zoological Society of London, VNo. 23, P279; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shiraiwa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002191; Steinbrecht RA, 1997, INT J INSECT MORPHOL, V26, P229, DOI 10.1016/S0020-7322(97)00024-X; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stensmyr MC, 2002, NATURE, V420, P625, DOI 10.1038/420625a; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Stranden M, 2003, J COMP PHYSIOL A, V189, P563, DOI 10.1007/s00359-003-0434-y; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Thornhill R., 1983, pi; TODD JL, 1993, NATURWISSENSCHAFTEN, V80, P183; TOLBERT LP, 1981, PROC R SOC SER B-BIO, V213, P279, DOI 10.1098/rspb.1981.0067; Urru I, 2011, PHYTOCHEMISTRY, V72, P1655, DOI 10.1016/j.phytochem.2011.02.014; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WADHAMS LJ, 1982, Z NATURFORSCH C, V37, P947; Wibe A, 1997, J COMP PHYSIOL A, V180, P585, DOI 10.1007/s003590050075; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331	114	410	429	13	258	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					698	711		10.1016/j.neuron.2011.11.003	http://dx.doi.org/10.1016/j.neuron.2011.11.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153368	Bronze			2022-12-17	WOS:000297971100006
J	Beck, JM; Ma, WJ; Kiani, R; Hanks, T; Churchland, AK; Roitman, J; Shadlen, MN; Latham, PE; Pouget, A				Beck, Jeffrey M.; Ma, Wei Ji; Kiani, Roozbeh; Hanks, Tim; Churchland, Anne K.; Roitman, Jamie; Shadlen, Michael N.; Latham, Peter E.; Pouget, Alexandre			Probabilistic Population Codes for Bayesian Decision Making	NEURON			English	Article							PARIETAL CORTEX; VISUAL-CORTEX; PERCEPTUAL DECISION; ORIENTATION SELECTIVITY; MULTIPLE ALTERNATIVES; SUPERIOR COLLICULUS; MOTION SIGNALS; REACTION-TIME; NEURAL BASIS; NEURONS	When making a decision, one must first accumulate evidence, often overtime, and then select the appropriate action. Here, we present a neural model of decision making that can perform both evidence accumulation and action selection optimally. More specifically, we show that, given a Poisson-like distribution of spike counts, biological neural networks can accumulate evidence without loss of information through linear integration of neural activity and can select the most likely action through attractor dynamics. This holds for arbitrary correlations, any tuning curves, continuous and discrete variables, and sensory evidence whose reliability varies over time. Our model predicts that the neurons in the lateral intraparietal cortex involved in evidence accumulation encode, on every trial, a probability distribution which predicts the animal's performance. We present experimental evidence consistent with this prediction and discuss other predictions applicable to more general settings.	[Beck, Jeffrey M.; Ma, Wei Ji; Pouget, Alexandre] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Ma, Wei Ji] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Kiani, Roozbeh; Hanks, Tim; Churchland, Anne K.; Shadlen, Michael N.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Kiani, Roozbeh; Hanks, Tim; Churchland, Anne K.; Shadlen, Michael N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Roitman, Jamie] Univ Illinois, Dept Psychol, Chicago, IL 60607 USA; [Latham, Peter E.] Gatsby Computat Neurosci Unit, London WC1N 3AR, England; [Pouget, Alexandre] Coll France, Theoret Neurosci Grp, F-75005 Paris, France	University of Rochester; Baylor College of Medicine; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of London; University College London; UDICE-French Research Universities; PSL Research University Paris; College de France	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	alex@bcs.rochester.edu	Shadlen, Michael Neil/AAL-1870-2020	Ma, Wei Ji/0000-0002-9835-9083; Pouget, Alexandre/0000-0003-3054-6365; Shadlen, Michael/0000-0002-2002-2210	Gatsby Charitable Foundation; National Institute of Mental Health [R01 MH62447, BCS0446730]; MURI [N00014-07-1-0937]; NIDA [BCS0346785]; James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022780] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MURI(MURI); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	P.E.L. is supported by the Gatsby Charitable Foundation and National Institute of Mental Health Grant R01 MH62447 and A.P. by NSF grant # BCS0446730 and MURI grant N00014-07-1-0937. M.N.S. and A.P. are jointly supported by NIDA grants #BCS0346785 and a research grant from the James S. McDonnell Foundation. We thank Daphne Bavelier for her suggestions and comments.	Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; [Anonymous], 2003, NEURAL ENG COMPUTATI; Barber MJ, 2003, NEURAL COMPUT, V15, P1843, DOI 10.1162/08997660360675062; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kim B, 2008, J NEUROSCI, V28, P2991, DOI 10.1523/JNEUROSCI.5424-07.2008; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Laming D. R. J., 1968, INFORM THEORY CHOICE; Latham PE, 2003, J PHYSIOL-PARIS, V97, P683, DOI 10.1016/j.jphysparis.2004.01.022; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Link SW, 1992, WAVE THEORY DIFFEREN; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McMillen T, 2006, J MATH PSYCHOL, V50, P30, DOI 10.1016/j.jmp.2005.10.003; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Papoulis A., 1991, COMMUNICATIONS SIGNA, V3; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RATCLIFF R, 2006, N NEUROPHYSIOL, V97, P1756; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Roitman JD, 2002, J NEUROSCI, V22, P9475; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Shadlen M., 2006, BAYESIAN BRAIN PROBA; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; STONE M, 1960, PSYCHOMETRIKA, V25, P251, DOI 10.1007/BF02289729; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Vickers D., 1979, DECISION PROCESSES V; WALD A, 1948, ANN MATH STAT, V19, P326, DOI 10.1214/aoms/1177730197; Wald A., 1947, SEQUENTIAL ANAL; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Zhang K, 1996, J NEUROSCI, V16, P2112; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	52	410	411	1	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2008	60	6					1142	1152		10.1016/j.neuron.2008.09.021	http://dx.doi.org/10.1016/j.neuron.2008.09.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	391BW	19109917	Green Submitted, Bronze, Green Accepted			2022-12-17	WOS:000262208900018
J	Goldberg, MS; Pisani, A; Haburcak, M; Vortherms, TA; Kitada, T; Costa, C; Tong, Y; Martella, G; Tscherter, A; Martins, A; Bernardi, G; Roth, BL; Pothos, EN; Calabresi, P; Shen, J				Goldberg, MS; Pisani, A; Haburcak, M; Vortherms, TA; Kitada, T; Costa, C; Tong, Y; Martella, G; Tscherter, A; Martins, A; Bernardi, G; Roth, BL; Pothos, EN; Calabresi, P; Shen, J			Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1	NEURON			English	Article							SYNAPTIC PLASTICITY; MICE; NEURONS; DISEASE; MUTATIONS; MOTOR	The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the striatum. Loss-of-function mutations in the DJ-1 gene cause early-onset familial parkinsonism. To investigate a possible role for DJ-1 in the dopaminergic system, we generated a mouse model bearing a germline disruption of DJ-1. Although DJ-1(-/-) mice had normal numbers of dopaminergic neurons in the substantia nigra, evoked dopamine overflow in the striatum was markedly reduced, primarily as a result of increased reuptake. Nigral neurons lacking DJ-1 were less sensitive to the inhibitory effects of D2 autoreceptor stimulation. Corticostriatal long-term potentiation was normal in medium spiny neurons of DJ-1(-/-) mice, but long-term depression (LTD) was absent. The LTD deficit was reversed by treatment with D2 but not D1 receptor agonists. Furthermore, DJ-1(-/-) mice displayed hypoactivity in the open field. Collectively, our findings suggest an essential role for DJ-1 in dopaminergic physiology and D2 receptor-mediated functions.	Harvard Univ, Sch Med, Ctr Neurol Dis, Brigham & Womens Hosp,Program Neurosci, Boston, MA 02115 USA; Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; IRCCS, Fondaz Santa Lucia, Rome, Italy; Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Case Western Reserve Univ, Sch Med, Dept Biochem Psychiat & Neurosci, Cleveland, OH 44106 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Rome Tor Vergata; IRCCS Santa Lucia; Tufts University; Case Western Reserve University	Shen, J (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Brigham & Womens Hosp,Program Neurosci, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Goldberg, Matthew/T-7827-2019; G, Martella/H-5142-2018; Martella, Giuseppina/L-9465-2019; Roth, Bryan L/F-3928-2010; Costa, Cinzia/K-8485-2016; Shen, Jie/GXH-9449-2022; Pisani, Antonio/G-2492-2012; Calabresi, Paolo/G-8496-2011	G, Martella/0000-0002-8927-7107; Martella, Giuseppina/0000-0002-8927-7107; Costa, Cinzia/0000-0002-4862-4221; Pisani, Antonio/0000-0002-8432-594X; Calabresi, Paolo/0000-0003-0326-5509; Tscherter, Anne/0000-0002-6972-482X; Goldberg, Matthew/0000-0002-5172-9841; Haburcak, Marian/0000-0003-0662-0756; Pothos, Emmanuel/0000-0001-8825-7852				Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Donovan DM, 1999, MOL BRAIN RES, V73, P37, DOI 10.1016/S0169-328X(99)00235-1; Fowler SC, 2002, INT J DEV NEUROSCI, V20, P309, DOI 10.1016/S0736-5748(02)00009-6; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Jung MY, 1999, NEUROSCIENCE, V91, P911, DOI 10.1016/S0306-4522(98)00705-2; Kelly MA, 1998, J NEUROSCI, V18, P3470; Kitamura Y, 2003, NEUROCHEM RES, V28, P1035, DOI 10.1023/A:1023207222944; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; MERCURI NB, 1990, BRIT J PHARMACOL, V100, P257, DOI 10.1111/j.1476-5381.1990.tb15792.x; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; Whone AL, 2002, NEUROLOGY, V58, pA82; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	28	410	417	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					489	496		10.1016/j.neuron.2005.01.041	http://dx.doi.org/10.1016/j.neuron.2005.01.041			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721235	Green Submitted, Bronze			2022-12-17	WOS:000227099700005
J	Rao, A; Craig, AM				Rao, A; Craig, AM			Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons	NEURON			English	Article							CEREBELLAR GRANULE CELLS; DEVELOPING NEUROMUSCULAR-JUNCTION; K+-INDUCED DEPOLARIZATION; VISUAL-CORTEX; UP-REGULATION; RAT-BRAIN; GLUTAMATE RECEPTORS; MONKEY HIPPOCAMPUS; GUANYLATE KINASES; CORTICAL-NEURONS	We describe here a novel effect of activity on the subcellular distribution of NMDA receptors in hippocampal neurons in culture. In spontaneously active neurons, NMDA receptors were clustered at a few synaptic and nonsynaptic sites. Chronic blockade of NMDA receptor activity induced a 380% increase in the number of NMDA receptor clusters and a shift to a more synaptic distribution. This effect was reversible. The distributions of the presynaptic marker synaptophysin, the AMPA-type glutamate receptor subunit GluR1, and the putative NMDA receptor clustering protein PSD-95 were not affected by blockade. Regulation of the synaptic localization of NMDA receptors by activity may define a novel mechanism by which input controls a neuron's ability to modify its synapses.	UNIV ILLINOIS,DEPT CELL & STRUCT BIOL,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign			Craig, Ann Marie/M-2054-2014		NINDS NIH HHS [NS33184] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033184] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; AOKI C, 1994, J NEUROSCI, V14, P5202; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; DEBSKI EA, 1991, J NEUROSCI, V11, P2947; DIDIER M, 1994, EUR J NEUROSCI, V6, P1536, DOI 10.1111/j.1460-9568.1994.tb00544.x; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; DURAND GM, 1993, P NATL ACAD SCI USA, V90, P6731, DOI 10.1073/pnas.90.14.6731; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Feldmeyer D, 1996, J NEUROCYTOL, V25, P857, DOI 10.1007/BF02284847; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Follesa P, 1996, J NEUROSCI, V16, P2172; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Goslin K., 1991, CULTURING NERVE CELL, P251; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HUNTLEY GW, 1994, J NEUROSCI, V14, P3603; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ISHII T, 1993, J BIOL CHEM, V268, P2836; Johnson RR, 1996, J COMP NEUROL, V368, P335, DOI 10.1002/(SICI)1096-9861(19960506)368:3<335::AID-CNE2>3.0.CO;2-6; JONES K, 1991, NEURON, V17, P103; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCDONALD JW, 1990, NEUROSCIENCE, V38, P103, DOI 10.1016/0306-4522(90)90377-G; McIlhinney RAJ, 1996, NEUROSCIENCE, V70, P989, DOI 10.1016/0306-4522(95)00419-X; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Niethammer M, 1996, J NEUROSCI, V16, P2157; OBRIETAN K, 1995, J NEUROPHYSIOL, V73, P1524, DOI 10.1152/jn.1995.73.4.1524; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PETRALIA RS, 1994, J NEUROSCI, V14, P667; RESINK A, 1995, J NEUROCHEM, V64, P558; SCHEETZ AJ, 1994, FASEB J, V8, P744; SEGAL M, 1995, J PHYSIOL-LONDON, V486, P283, DOI 10.1113/jphysiol.1995.sp020811; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SIEGEL SJ, 1995, J NEUROSCI, V15, P2707; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vallano ML, 1996, J NEUROSCI, V16, P631; WILLIAMS K, 1992, MOL PHARMACOL, V42, P147; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0	66	410	420	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					801	812		10.1016/S0896-6273(00)80962-9	http://dx.doi.org/10.1016/S0896-6273(00)80962-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354327	Bronze			2022-12-17	WOS:A1997YD18900008
J	SIMAN, R; NOSZEK, JC				SIMAN, R; NOSZEK, JC			EXCITATORY AMINO-ACIDS ACTIVATE CALPAIN-I AND INDUCE STRUCTURAL PROTEIN BREAKDOWN INVIVO	NEURON			English	Article											SIMAN, R (corresponding author), DUPONT CO,NEUROSCI GRP,E400-3430,WILMINGTON,DE 19898, USA.							Barrett A.J., 1997, PROTEINASES MAMMALIA, P240; BAUDRY M, 1986, J NEUROBIOL, V17, P15, DOI 10.1002/neu.480170103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGOYNE RD, 1982, FEBS LETT, V146, P273, DOI 10.1016/0014-5793(82)80933-2; CARLIN RK, 1983, J CELL BIOL, V96, P443, DOI 10.1083/jcb.96.2.443; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHIU FC, 1982, J NEUROCHEM, V39, P1252, DOI 10.1111/j.1471-4159.1982.tb12562.x; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; DAVIS J, 1983, J BIOL CHEM, V258, P7757; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; DEMARTINO GN, 1981, ARCH BIOCHEM BIOPHYS, V211, P253, DOI 10.1016/0003-9861(81)90452-5; ENG LF, 1971, BRAIN RES, V28, P315; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; FUXE K, 1983, EXCITOTOXINS; GILBERT DS, 1975, NATURE, V256, P586, DOI 10.1038/256586a0; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; HAMON M, 1979, J NEUROCHEM, V32, P1837, DOI 10.1111/j.1471-4159.1979.tb02298.x; HUBER G, 1984, J NEUROSCI, V4, P151; Imahori K., 1982, CALCIUM CELL FUNCTIO, V3, P473; INOUE M, 1977, J BIOL CHEM, V252, P7610; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; KUDO Y, 1986, BRIT J PHARMACOL, V89, P191, DOI 10.1111/j.1476-5381.1986.tb11135.x; LASEK RJ, 1976, CELL MOTILITY, P1021; LEBEUX YJ, 1975, CELL TISSUE RES, V160, P1; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MAYER ML, 1987, J NEUROSCI, V7, P3230; McGeer E.G., 1978, KAINIC ACID TOOL NEU; MELLGREN RL, 1987, FASEB J, V1, P110, DOI 10.1096/fasebj.1.2.2886390; MELLONI E, 1982, BIOCH BIOPHYS RES CO, V106, P713; MURACHI T, 1983, TRENDS BIOCHEM SCI, V8, P167, DOI 10.1016/0968-0004(83)90165-2; MURPHY SN, 1987, J NEUROSCI, V7, P4145; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NIXON RA, 1986, J NEUROSCI, V6, P1264; OHNO S, 1987, METHOD ENZYMOL, V139, P363; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; PACHTER JS, 1985, J CELL BIOL, V101, P1316, DOI 10.1083/jcb.101.4.1316; PERLMUTTER LS, 1988, SYNAPSE, V2, P79, DOI 10.1002/syn.890020111; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; Reich E.I., 1975, PROTEASES BIOL CONTR; SANDOVAL IV, 1978, EUR J BIOCHEM, V92, P463, DOI 10.1111/j.1432-1033.1978.tb12768.x; SASAKI T, 1983, J BIOCHEM-TOKYO, V94, P2055, DOI 10.1093/oxfordjournals.jbchem.a134561; SCHLAEPFER WW, 1979, PROGR NEUROPATHOLOGY, V4, P101; SCHWARTZ JP, 1986, ANNU REV NEUROSCI, V9, P277; SEUBERT P, 1987, SYNAPSE, V1, P16; SHAW G, 1981, EUR J CELL BIOL, V26, P68; SIMAN R, 1985, BRAIN RES, V347, P399, DOI 10.1016/0006-8993(85)90208-2; SIMAN R, 1987, J NEUROSCI, V7, P55; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; SIMAN R, 1985, NATURE, V313, P225, DOI 10.1038/313225a0; SIMAN R, 1987, SYNAPTIC FUNCTION, P519; SUZUKI K, 1987, FEBS LETT, V220, P271, DOI 10.1016/0014-5793(87)80828-1; TOGARI A, 1986, BIOCHEM BIOPH RES CO, V134, P749, DOI 10.1016/S0006-291X(86)80484-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALLEE RB, 1984, MOL BIOL CYTOSKELETO, P111; VITTO A, 1986, J NEUROCHEM, V47, P1039; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; ZAGON IS, 1984, J NEUROSCI, V4, P3089; ZIMMERMAN UJP, 1984, PROG NEUROBIOL, V23, P63, DOI 10.1016/0301-0082(84)90012-1	62	410	426	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1988	1	4					279	287		10.1016/0896-6273(88)90076-1	http://dx.doi.org/10.1016/0896-6273(88)90076-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	P0129	2856162				2022-12-17	WOS:A1988P012900003
J	Schon, EA; Przedborski, S				Schon, Eric A.; Przedborski, Serge			Mitochondria: The Next (Neurode)Generation	NEURON			English	Review							MARIE-TOOTH-DISEASE; HEREDITARY SPASTIC PARAPLEGIA; AMYOTROPHIC-LATERAL-SCLEROSIS; M-AAA PROTEASE; SUBSTANTIA-NIGRA NEURONS; KINESIN HEAVY-CHAIN; ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; PARKINSONS-DISEASE; MUTANT HUNTINGTIN	Adult-onset neurodegenerative disorders are disabling and often fatal diseases of the nervous system whose underlying mechanisms of cell death remain unknown. Defects in mitochondrial respiration had previously been proposed to contribute to the occurrence of many, if not all, of the most common neurodegenerative disorders. However, the discovery of genes mutated in hereditary forms of these enigmatic diseases has additionally suggested defects in mitochondria! dynamics. Such disturbances can lead to changes in mitochondrial trafficking, in interorganellar communication, and in mitochondrial quality control. These new mechanisms by which mitochondria may also be linked to neurodegeneration will likely have far-reaching implications for our understanding of the pathophysiology and treatment of adult-onset neurodegenerative disorders.	[Schon, Eric A.; Przedborski, Serge] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Schon, Eric A.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Przedborski, Serge] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Schon, Eric A.; Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Schon, Eric A.] Columbia Univ, H Houston Merritt Clin Res Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Przedborski, S (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.	sp30@columbia.edu			National Institutes of Health [HD32062, NS042269, NS064191, NS38370, NS070276, NS072182]; U.S. Department of Defense [W81XWH-08-1-0522, W81XWH-08-1-0465, W81XWH-09-1-0245]; Parkinson Disease Foundation; Thomas Hartman Foundation For Parkinson's Research; Muscular Dystrophy Association; Ellison Medical Foundation; Alzheimer Drug Discovery Foundation; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042269, RC2NS070276, R21NS072182, R21NS064191, P50NS038370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Parkinson Disease Foundation; Thomas Hartman Foundation For Parkinson's Research; Muscular Dystrophy Association(Muscular Dystrophy Association); Ellison Medical Foundation(Lawrence Ellison Foundation); Alzheimer Drug Discovery Foundation; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. William Dauer, Salvatore DiMauro, Michio Hirano, Peter Hollenbeck, Orian Shirihai, and Jean Paul Vonsattel for critical comments, and Robert Lee and Arnaud Jacquier for their expert assistance with the figure. This work was supported by grants from the National Institutes of Health (HD32062 to E.A.S.; and NS042269, NS064191, NS38370, NS070276, and NS072182 to S.P.), the U.S. Department of Defense (W81XWH-08-1-0522, W81XWH-08-1-0465, and W81XWH-09-1-0245 to S.P.), the Parkinson Disease Foundation, the Thomas Hartman Foundation For Parkinson's Research, Project A.L.S, the Muscular Dystrophy Association, the Ellison Medical Foundation, the Alzheimer Drug Discovery Foundation, and the Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF).	Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Braschi E, 2010, BIOESSAYS, V32, P958, DOI 10.1002/bies.201000073; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Brownlees J, 2002, HUM MOL GENET, V11, P2837, DOI 10.1093/hmg/11.23.2837; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Dagda RK, 2008, J BIOL CHEM, V283, P36241, DOI 10.1074/jbc.M800989200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.3.CO;2-Q; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Fuse N, 2010, TOHOKU J EXP MED, V221, P1, DOI 10.1620/tjem.221.1; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Higashi S, 2010, J NEUROCHEM, V115, P423, DOI 10.1111/j.1471-4159.2010.06930.x; Hollenbeck, 1996, FRONT BIOSCI, V1, pD91; Hooper C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-72; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Huizing M, 2010, MOL GENET METAB, V100, P149, DOI 10.1016/j.ymgme.2010.03.005; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jung CH, 2004, J NEUROSCI, V24, P9486, DOI 10.1523/JNEUROSCI.1665-04.2004; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kasher PR, 2009, J NEUROCHEM, V110, P34, DOI 10.1111/j.1471-4159.2009.06104.x; Kelleher JF, 2000, CURR BIOL, V10, P1489, DOI 10.1016/S0960-9822(00)00828-9; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013; Lu J, 2006, J NEUROCHEM, V98, P1908, DOI 10.1111/j.1471-4159.2006.04008.x; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Martignoni M, 2008, AM J HUM GENET, V83, P127, DOI 10.1016/j.ajhg.2008.05.014; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McDermott CJ, 2003, ANN NEUROL, V54, P748, DOI 10.1002/ana.10757; Milewska M, 2009, J NEUROCHEM, V111, P1022, DOI 10.1111/j.1471-4159.2009.06382.x; Millecamps S, 2005, BBA-MOL CELL RES, V1745, P84, DOI 10.1016/j.bbamcr.2004.12.008; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Nishioka K, 2010, PARKINSONISM RELAT D, V16, P686, DOI 10.1016/j.parkreldis.2010.09.007; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Oliveira JMA, 2010, J BIOENERG BIOMEMBR, V42, P227, DOI 10.1007/s10863-010-9287-6; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Pandey M, 2010, J BIOENERG BIOMEMBR, V42, P217, DOI 10.1007/s10863-010-9288-5; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121; Perez-Olle R, 2005, J NEUROCHEM, V93, P861, DOI 10.1111/j.1471-4159.2005.03095.x; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z; Sack GH, 2010, J BIOENERG BIOMEMBR, V42, P189, DOI 10.1007/s10863-010-9291-x; Sadun AA, 2011, CURR TREAT OPTION NE, V13, P109, DOI 10.1007/s11940-010-0100-y; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Schon EA, 2010, J ALZHEIMERS DIS, V20, pS281, DOI 10.3233/JAD-2010-100495; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P707, DOI 10.1016/j.bbadis.2010.05.008; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simon DK, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-53; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Viscomi C., 2011, CELL METAB IN PRESS, V14; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zampese E, 2011, P NATL ACAD SCI USA, V108, P2777, DOI 10.1073/pnas.1100735108; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zinsmaier KE, 2009, RESULTS PROBL CELL D, V48, P107, DOI 10.1007/400_2009_20; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	157	409	414	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 23	2011	70	6					1033	1053		10.1016/j.neuron.2011.06.003	http://dx.doi.org/10.1016/j.neuron.2011.06.003			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689593	Green Accepted, Bronze			2022-12-17	WOS:000292410700005
J	Small, SA; Duff, K				Small, Scott A.; Duff, Karen			Linking A beta and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis	NEURON			English	Article							APOLIPOPROTEIN E-DEFICIENT; CEREBROSPINAL-FLUID TAU; E EPSILON-4 ALLELE; AGE-OF-ONSET; REQUIRES RETROMER; TRANSGENIC MICE; MOUSE MODEL; NEUROFIBRILLARY PATHOLOGY; AMYLOID HYPOTHESIS; MISSENSE MUTATIONS	Alzheimer's disease is characterized by abnormal elevation of A beta peptide and abnormal hyperphosphorylation of the tau protein. The "amyloid hypothesis," which is based on molecular defects observed in autosomal-dominant early-onset Alzheimer's disease (EOAD), suggests a serial model of causality, whereby elevation of A beta drives other disease features including tau hyperphosphorylation. Here, we review recent evidence from drug trials, genetic studies, and experimental work in animal models that suggests that an alternative model might exist in late-onset AD (LOAD), the complex and more common form of the disease. Specifically, we hypothesize a "dual pathway" model of causality, whereby A beta and tau can be linked by separate mechanisms driven by a common upstream driver. This model may account for the results of recent drug trials and, if confirmed, may guide future drug development.	[Small, Scott A.; Duff, Karen] Columbia Univ Coll Phys & Surg, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Small, Scott A.; Duff, Karen] Columbia Univ Coll Phys & Surg, Dept Pathol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University	Small, SA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA.	sas68@columbia.edu; ked2115@columbia.edu		Duff, Karen/0000-0002-6177-868X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702, P01AG007232, P01AG017216, R01AG025161] Funding Source: NIH RePORTER; NIA NIH HHS [AG025161, P50 AG008702, P01 AG007232, R01 AG025161-04, AG07232, R01 AG025161-02, P01 AG017216, R01 AG025161, AG008702, AG017216, R01 AG025161-01, R01 AG025161-03] Funding Source: Medline; NINDS NIH HHS [P01 NS048447, NS048447] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aisen PS, 2007, CURR ALZHEIMER RES, V4, P473, DOI 10.2174/156720507781788882; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Asuni AA, 2006, EUR J NEUROSCI, V24, P3387, DOI 10.1111/j.1460-9568.2006.05243.x; Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; Bales K. R., 2002, MOL INTERV, V2, P339, DOI DOI 10.1124/MI.2.6.363; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bertram L, 2007, J MED GENET, V44, DOI 10.1136/jmg.2005.039263; Bi XN, 2001, P NATL ACAD SCI USA, V98, P8832, DOI 10.1073/pnas.151253098; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Caruso A, 2006, J NEUROCHEM, V98, P364, DOI 10.1111/j.1471-4159.2006.03867.x; Cedazo-Minguez A, 2003, J NEUROCHEM, V87, P1152, DOI 10.1046/j.1471-4159.2003.02088.x; Chacon MA, 2008, J CELL PHYSIOL, V217, P215, DOI 10.1002/jcp.21497; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dodart JC, 2005, P NATL ACAD SCI USA, V102, P1211, DOI 10.1073/pnas.0409072102; Duff K, 2001, BIOCHEM SOC SYMP, V67, P195; Eaton S, 2008, DEV CELL, V14, P4, DOI 10.1016/j.devcel.2007.12.014; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; George A, 2007, NEUROBIOL DIS, V26, P125, DOI 10.1016/j.nbd.2006.12.004; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; Gibb GM, 2000, FEBS LETT, V485, P99, DOI 10.1016/S0014-5793(00)02196-7; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Glodzik-Sobanska L, 2009, NEUROBIOL AGING, V30, P672, DOI 10.1016/j.neurobiolaging.2007.08.019; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golombowski S, 1997, NEUROSCI LETT, V225, P213, DOI 10.1016/S0304-3940(97)00228-0; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hoe HS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-18; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Houlden H, 1999, NEUROSCI LETT, V260, P193, DOI 10.1016/S0304-3940(98)00931-8; HUANG DY, 1995, NEUROSCI LETT, V192, P209, DOI 10.1016/0304-3940(95)11649-H; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Irizarry MC, 2000, ACTA NEUROPATHOL, V100, P451, DOI 10.1007/s004010000263; Irizarry MC, 2000, ANN NY ACAD SCI, V920, P171; Jack CR, 2002, NEUROLOGY, V58, P750, DOI 10.1212/WNL.58.5.750; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mateo I, 2006, DEMENT GERIATR COGN, V21, P228, DOI 10.1159/000091044; Mercado-Gomez O, 2008, NEUROCHEM RES, V33, P1599, DOI 10.1007/s11064-008-9714-9; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Ohkubo N, 2002, FASEB J, V16, P295, DOI 10.1096/fj.02-0434fje; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Pastor P, 2003, ANN NEUROL, V54, P163, DOI 10.1002/ana.10636; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pickering-Brown SM, 2000, EXP NEUROL, V163, P452, DOI 10.1006/exnr.2000.7387; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Reilly JF, 2003, P NATL ACAD SCI USA, V100, P4837, DOI 10.1073/pnas.0330745100; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; Schaffer BAJ, 2008, ARCH NEUROL-CHICAGO, V65, P1368, DOI 10.1001/archneur.65.10.1368; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shiurba RA, 1996, BRAIN RES, V737, P119, DOI 10.1016/0006-8993(96)00717-2; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; St George-Hyslop PH, 2008, LANCET, V372, P180, DOI 10.1016/S0140-6736(08)61047-8; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Su Y, 2004, BIOCHEMISTRY-US, V43, P6899, DOI 10.1021/bi035627j; Sunderland T, 2004, BIOL PSYCHIAT, V56, P670, DOI 10.1016/j.biopsych.2004.07.021; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; Tesseur I, 2000, AM J PATHOL, V157, P1495, DOI 10.1016/S0002-9440(10)64788-8; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; VAN BROECKHOVEN C, 1994, NEUROSCI LETT, V169, P179, DOI 10.1016/0304-3940(94)90385-9; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Wisniewski T, 2008, LANCET NEUROL, V7, P805, DOI 10.1016/S1474-4422(08)70170-4; WOODGETT JR, 2001, SCI STKE, pRE12; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	110	409	424	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 26	2008	60	4					534	542		10.1016/j.neuron.2008.11.007	http://dx.doi.org/10.1016/j.neuron.2008.11.007			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	382JX	19038212	Green Accepted, Bronze			2022-12-17	WOS:000261603200005
J	Weissman, TA; Riquelme, PA; Ivic, L; Flint, AC; Kriegstein, AR				Weissman, TA; Riquelme, PA; Ivic, L; Flint, AC; Kriegstein, AR			Calcium waves propagate through radial glial cells and modulate proliferation in the developing neocortex	NEURON			English	Article							CORTICAL PROGENITOR CELLS; GAP-JUNCTION HEMICHANNELS; VENTRICULAR ZONE; CEREBRAL-CORTEX; DNA-SYNTHESIS; EMBRYONIC NEOCORTEX; PRECURSOR CELLS; NEURONS ARISE; ATP RELEASE; ASTROCYTES	The majority of neurons in the adult neocortex are produced embryonically during a brief but intense period of neuronal proliferation. The radial glial cell, a transient embryonic cell type known for its crucial role in neuronal migration, has recently been shown to function as a neuronal progenitor cell and appears to produce most cortical pyramidal neurons. Radial glial cell modulation could thus affect neuron production, neuronal migration, and overall cortical architecture; however, signaling mechanisms among radial glia have not been studied directly. We demonstrate here that calcium waves propagate through radial glial cells in the proliferative cortical ventricular zone (VZ). Radial glial calcium waves occur spontaneously and require connexin hemichannels, P2Y(1) ATP receptors, and intracellular IP3-mediated calcium release. Furthermore, we show that wave disruption decreases VZ proliferation during the peak of embryonic neurogenesis. Taken together, these results demonstrate a radial glial signaling mechanism that may regulate cortical neuronal production.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Kriegstein, AR (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	ark17@columbia.edu		Weissman, Tamily/0000-0001-9361-6071; Flint, Alexander/0000-0002-3721-2694	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21223] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Bayer S.A., 1991, NEOCORTICAL DEV; Behar TN, 1996, J NEUROSCI, V16, P1808; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bittman K, 1997, J NEUROSCI, V17, P7037; Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Cai L, 1997, J NEUROSCI, V17, P2088; Campbell K, 2003, GLIA, V43, P44, DOI 10.1002/glia.10247; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.3.CO;2-Z; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Goto T, 2002, J NEUROSCI RES, V69, P714, DOI 10.1002/jnr.10361; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Grafstein B, 2000, ANN NEUROL, V47, P18, DOI 10.1002/1531-8249(200001)47:1<18::AID-ANA6>3.3.CO;2-E; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hofer A, 1998, GLIA, V24, P141, DOI 10.1002/(SICI)1098-1136(199809)24:1<141::AID-GLIA13>3.0.CO;2-R; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Moll V, 2002, INVEST OPHTH VIS SCI, V43, P766; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Neary JT, 1996, TRENDS NEUROSCI, V19, P13, DOI 10.1016/0166-2236(96)81861-3; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Pearson R, 2002, J NEUROSCI, V22, P7569; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Ralevic V, 1998, PHARMACOL REV, V50, P413; Sanches G, 2002, INT J DEV NEUROSCI, V20, P21, DOI 10.1016/S0736-5748(02)00004-7; Scemes E, 2003, J NEUROSCI, V23, P11444; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sugioka M, 1999, INT J DEV NEUROSCI, V17, P135, DOI 10.1016/S0736-5748(98)00066-5; Syed MM, 2004, J NEUROPHYSIOL, V91, P1999, DOI 10.1152/jn.01129.2003; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takahashi T, 1996, J NEUROSCI, V16, P6183; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Uckermann O, 2002, J NEUROSCI RES, V70, P209, DOI 10.1002/jnr.10406; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zanotti S, 1997, J NEUROCHEM, V69, P594; Zupanc GKH, 2003, GLIA, V43, P77, DOI 10.1002/glia.10236	67	409	413	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					647	661		10.1016/j.neuron.2004.08.015	http://dx.doi.org/10.1016/j.neuron.2004.08.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339647	Bronze			2022-12-17	WOS:000223691900011
J	Togashi, H; Abe, K; Mizoguchi, A; Takaoka, K; Chisaka, O; Takeichi, M				Togashi, H; Abe, K; Mizoguchi, A; Takaoka, K; Chisaka, O; Takeichi, M			Cadherin regulates dendritic spine morphogenesis	NEURON			English	Article							LONG-TERM POTENTIATION; CELL-CELL ADHESION; ALPHA-CATENIN; N-CADHERIN; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; CYTOPLASMIC DOMAIN; JUNCTIONAL COMPLEX; BINDING-ACTIVITY; IN-VIVO	Synaptic remodeling has been postulated as a mechanism underlying synaptic plasticity, and cadherin adhesion molecules are thought to be a regulator of such a process. We examined the effects of cadherin blockage on synaptogenesis in cultured hippocampal neurons. This blockade resulted in alterations of dendritic spine morphology, such as filopodia-like elongation of the spine and bifurcation of its head structure, along with concomitant disruption of the distribution of postsynaptic proteins. The accumulation of synapsin at presynaptic sites and synaptic vesicle recycling were also perturbed, although these synaptic responses to the cadherin blockade became less evident upon the maturation of the synapses. These findings suggest that cadherin regulates dendritic spine morphogenesis and related synaptic functions, presumably cooperating with cadherin-independent adhesive mechanisms to maintain spine-axon contacts.	Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Fac Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; RIKEN	Takeichi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.		Abe, Kentaro/T-2247-2019; Takeichi, Masatoshi/G-5903-2012; Abe, Kentaro/A-6197-2008	Abe, Kentaro/0000-0002-3923-6323; Takeichi, Masatoshi/0000-0002-9931-3378; Togashi, Hideru/0000-0002-3967-5940				Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Goslin K., 1998, CULTURING NERVE CELL, P339; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Honjo Y, 2000, GENES CELLS, V5, P309, DOI 10.1046/j.1365-2443.2000.00327.x; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; Huntley GW, 1999, J COMP NEUROL, V407, P453; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.3.CO;2-R; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Janssens B, 2001, J CELL SCI, V114, P3177; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; Rao A, 1998, J NEUROSCI, V18, P1217; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Roe S, 1998, CELL ADHES COMMUN, V5, P283, DOI 10.3109/15419069809040298; Rusakov DA, 1997, HIPPOCAMPUS, V7, P489, DOI 10.1002/(SICI)1098-1063(1997)7:5<489::AID-HIPO5>3.0.CO;2-C; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Scotti AL, 2001, P NATL ACAD SCI USA, V98, P3489, DOI 10.1073/pnas.061028798; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; Spacek J, 1998, J COMP NEUROL, V393, P58, DOI 10.1002/(SICI)1096-9861(19980330)393:1<58::AID-CNE6>3.0.CO;2-P; SPACEK J, 1985, ANAT EMBRYOL, V171, P235, DOI 10.1007/BF00341418; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	71	409	417	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					77	89		10.1016/S0896-6273(02)00748-1	http://dx.doi.org/10.1016/S0896-6273(02)00748-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123610	Bronze			2022-12-17	WOS:000176601800012
J	Nieto, M; Schuurmans, C; Britz, O; Guillemot, F				Nieto, M; Schuurmans, C; Britz, O; Guillemot, F			Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; LIPID-BINDING PROTEIN; CREST STEM-CELLS; RADIAL GLIA; RESTRICTED PRECURSORS; TRANSCRIPTION FACTORS; CEREBRAL-CORTEX; EXPRESSION; ADULT; RAT	We have addressed the role of the proneural bHLH genes Neurogenin2 (Ngn2) and Mash1 in the selection of neuronal and glial fates by neural stem cells. We show that mice mutant for both genes present severe defects in development of the cerebral cortex, including a reduction of neurogenesis and a premature and excessive generation of astrocytic precursors. An analysis of wild-type and mutant cortical progenitors in culture showed that a large fraction of Ngn2; Mash1 double-mutant progenitors failed to adopt a neuronal fate, instead remaining pluripotent or entering an astrocytic differentiation pathway. Together, these results demonstrate that proneural genes are involved in lineage restriction of cortical progenitors, promoting the acquisition of the neuronal fate and inhibiting the astrocytic fate.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guillemot, F (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Boite Postale 163, F-67404 Illkirch Graffenstaden, France.	francois@igbmc.u-strasbg.fr	Guillemot, Francois/AAV-1482-2021; Nieto, Marta/F-1434-2013	Nieto, Marta/0000-0002-8349-8435; Schuurmans, Carol/0000-0003-3567-0058				AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; Anderson D, 1997, MOL CELLULAR APPROAC, P26; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BARTSCH S, 1992, J NEUROSCI, V12, P736; Bayer S.A., 1991, NEOCORTICAL DEV; BEDDINGTON RSP, 1989, DEVELOPMENT, V106, P37; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 1997, DEVELOPMENT, V124, P1611; CHOI BH, 1978, BRAIN RES, V148, P295, DOI 10.1016/0006-8993(78)90721-7; DAHL D, 1973, BRAIN RES, V61, P279, DOI 10.1016/0006-8993(73)90533-7; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gao FB, 1997, J CELL BIOL, V138, P1367, DOI 10.1083/jcb.138.6.1367; Ghosh MM, 1995, BIOREMED SER, V3, P15; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kondo T, 2000, DEVELOPMENT, V127, P2989; LAGENAUR C, 1981, J SUPRAMOL STR CELL, V15, P335, DOI 10.1002/jsscb.1981.380150404; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; Lillien L, 1998, CURR OPIN NEUROBIOL, V8, P37, DOI 10.1016/S0959-4388(98)80006-8; Lo LC, 1998, DEVELOPMENT, V125, P609; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; LUND RD, 1985, NEUROSCI LETT, V61, P221, DOI 10.1016/0304-3940(85)90428-8; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; McKay R, 2000, J NEUROSCI RES, V59, P298, DOI 10.1002/(SICI)1097-4547(20000201)59:3<298::AID-JNR2>3.0.CO;2-U; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MITROVIC N, 1994, J NEUROCYTOL, V23, P364, DOI 10.1007/BF01666526; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Park JK, 1999, J NEUROSCI, V19, P10383; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; REH TA, 1992, J NEUROBIOL, V23, P1067, DOI 10.1002/neu.480230811; Rousselot P, 1997, J COMP NEUROL, V385, P415; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; Soriano E, 1997, NEURON, V18, P563, DOI 10.1016/S0896-6273(00)80298-6; SUN Y, 2001, IN PRESS CELL; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Torii MA, 1999, DEVELOPMENT, V126, P443; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811	74	409	432	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					401	413		10.1016/S0896-6273(01)00214-8	http://dx.doi.org/10.1016/S0896-6273(01)00214-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239431	Bronze			2022-12-17	WOS:000167141700014
J	Applebury, ML; Antoch, MP; Baxter, LC; Chun, LLY; Falk, JD; Farhangfar, F; Kage, K; Krzystolik, MG; Lyass, LA; Robbins, JT				Applebury, ML; Antoch, MP; Baxter, LC; Chun, LLY; Falk, JD; Farhangfar, F; Kage, K; Krzystolik, MG; Lyass, LA; Robbins, JT			The murine cone photoreceptor: A single cone type expresses both S and M opsins with retinal spatial patterning	NEURON			English	Article							IN-SITU HYBRIDIZATION; HUMAN COLOR-VISION; MOUSE RETINA; VISUAL PIGMENTS; MOLECULAR-GENETICS; HUMAN RED; GREEN; CELL; MECHANISMS; ANTIBODIES	Mice express S and M opsins that form visual pigments for the detection of light and visual signaling in cones. Here, we show that S opsin transcription is higher than that of M opsin, which supports ultraviolet (UV) sensitivity greater than midwavelength sensitivity. Surprisingly, most cones coexpress both S and M opsins in a common cone cell type throughout the retina. All cones express M opsin, but the levels are graded from dorsal to ventral. The levels of S opsin are relatively constant. However, in the far dorsal retina, S opsin is repressed stochastically, such that some cones express M opsin only. These observations indicate that two different mechanisms control M and S opsin expression. We suggest that a common cone type is patterned across the retinal surface to produce phenotypic cone subtypes.	Harvard Univ, Sch Med, Howe Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Applebury, ML (corresponding author), Harvard Univ, Sch Med, Howe Lab, Boston, MA 02114 USA.			Baxter, Leslie/0000-0002-3971-863X; Antoch, mantoch/0000-0003-3001-8511	NEI NIH HHS [R01-EY04801, R01 EY004801-18] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004801] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; ARCHER SN, 1990, VISION RES, V30, P225, DOI 10.1016/0042-6989(90)90038-M; Ausubel F., 1999, CURRENT PROTOCOLS MO; BAEHR W, 1988, FEBS LETT, V238, P253, DOI 10.1016/0014-5793(88)80490-3; Brennan CA, 2000, CELL MOL LIFE SCI, V57, P195, DOI 10.1007/PL00000684; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chan YM, 1999, CURR OPIN NEUROBIOL, V9, P582, DOI 10.1016/S0959-4388(99)00017-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONLON RA, 1993, METHOD ENZYMOL, V225, P373; Deeb SS, 1996, BEHAV GENET, V26, P195, DOI 10.1007/BF02359380; Drager UC, 1997, PROG RETIN EYE RES, V16, P323, DOI 10.1016/S1350-9462(96)00029-8; FEKETE DM, 1983, J NEUROCYTOL, V12, P785, DOI 10.1007/BF01258151; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; Glosmann Martin, 1998, IOVS, V39, pS1059; HARGRAVE PA, 1986, EXP EYE RES, V42, P363, DOI 10.1016/0014-4835(86)90030-8; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; HASSL A, 1988, J IMMUNOL METHODS, V110, P225, DOI 10.1016/0022-1759(88)90107-X; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jacobs GH, 1999, J NEUROSCI, V19, P3258; JENSENIUS JC, 1981, J IMMUNOL METHODS, V46, P63, DOI 10.1016/0022-1759(81)90333-1; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KIRSCHFELD K, 1983, BIOPHYS STRUCT MECH, V10, P81, DOI 10.1007/BF00535544; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V163, P421, DOI 10.1007/BF00604896; Kitamoto J, 1998, J EXP BIOL, V201, P1255; LEM J, 1991, NEURON, V6, P200; Loew ER, 1996, VISUAL NEUROSCI, V13, P247, DOI 10.1017/S0952523800007483; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MAX M, 1995, SCIENCE, V267, P1502, DOI 10.1126/science.7878470; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; MOLLON JD, 1992, NATURE, V360, P677, DOI 10.1038/360677a0; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NOLTE J, 1972, J GEN PHYSIOL, V59, P186, DOI 10.1085/jgp.59.2.186; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Rodieck RW., 1998, 1 STEPS SEEING, V1; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; ROHLICH P, 1993, CURR EYE RES, V12, P935, DOI 10.3109/02713689309020400; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scott MP, 2000, CELL, V100, P27, DOI 10.1016/S0092-8674(00)81681-5; Shaaban SA, 1998, INVEST OPHTH VIS SCI, V39, P1036; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; SZEL A, 1992, EXP EYE RES, V55, P47; SZEL A, 1994, CELL TISSUE RES, V276, P143, DOI 10.1007/BF00354793; Szel A, 1996, MICROSC RES TECHNIQ, V35, P445; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; SZEL A, 1993, J COMP NEUROL, V331, P561; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Wang Y, 1999, P NATL ACAD SCI USA, V96, P5251, DOI 10.1073/pnas.96.9.5251; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO; WOOD P, 1993, P ROY SOC B-BIOL SCI, V254, P227, DOI 10.1098/rspb.1993.0150; Yokoyama S, 1998, MOL BIOL EVOL, V15, P560, DOI 10.1093/oxfordjournals.molbev.a025956; Yokoyama S, 1998, FEBS LETT, V423, P155, DOI 10.1016/S0014-5793(98)00086-6	60	409	415	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	2000	27	3					513	523		10.1016/S0896-6273(00)00062-3	http://dx.doi.org/10.1016/S0896-6273(00)00062-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359FR	11055434	Bronze			2022-12-17	WOS:000089601300015
J	Bergles, DE; Jahr, CE				Bergles, DE; Jahr, CE			Synaptic activation of glutamate transporters in hippocampal astrocytes	NEURON			English	Article							HIGH-AFFINITY UPTAKE; CEREBELLAR PURKINJE-CELLS; MULTIPLE RELEASE SITES; RAT-BRAIN SLICES; GLIAL-CELLS; TIME-COURSE; 3-DIMENSIONAL STRUCTURE; POSTNATAL-DEVELOPMENT; PYRAMIDAL CELLS; EXPRESSION	Glutamate transporters in the CNS are expressed in neurons and glia and mediate high affinity, electrogenic uptake of extracellular glutamate. Although glia have the highest capacity for glutamate uptake, the amount of glutamate that reaches glial membranes following release and the rate that glial transporters bind and sequester transmitter is not known. We find that stimulation of Schaffer collateral/commissural fibers in hippocampal slices evokes glutamate transporter currents in CA1 astrocytes that activate rapidly, indicating that a significant amount of transmitter escapes the synaptic cleft shortly after release. Transporter currents in outside-out patches from astrocytes have faster kinetics than synaptically elicited currents, suggesting that the glutamate concentration attained at astrocytic membranes is lower but remains elevated for longer than in the synaptic cleft.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Bergles, DE (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378				AITKEN PG, 1986, BRAIN RES, V369, P163, DOI 10.1016/0006-8993(86)90524-X; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BALCAR VJ, 1977, J NEUROCHEM, V28, P1145, DOI 10.1111/j.1471-4159.1977.tb10682.x; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DEBARRY J, 1982, NEUROSCIENCE, V7, P1289, DOI 10.1016/0306-4522(82)91134-4; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; ISAACSON JS, 1995, NEURON, V15, P1; JOHNSTON GAR, 1979, J NEUROCHEM, V32, P121, DOI 10.1111/j.1471-4159.1979.tb04518.x; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KARPEN JW, 1992, J PHYSIOL-LONDON, V448, P257, DOI 10.1113/jphysiol.1992.sp019040; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KLOCKNER U, 1994, J NEUROSCI, V14, P5759; KONEINTZKO U, 1994, HIPPOCAMPUS, V4, P297; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; MCLENNAN H, 1976, BRAIN RES, V115, P139, DOI 10.1016/0006-8993(76)90828-3; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mennerick S, 1996, J NEUROSCI, V16, P55; NEWMAN EA, 1986, SCIENCE, V233, P453, DOI 10.1126/science.3726539; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Palay S.L., 1974, CEREBELLAR CORTEX CY; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROTHSTEIN D, 1996, NEURON, V16, P675; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Sakmann Bert, 1995, P199; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SCHMIDT W, 1988, EXP BRAIN RES, V70, P50; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SCHWARTZKROIN PA, 1979, BRAIN RES, V161, P533, DOI 10.1016/0006-8993(79)90683-8; Shibata T, 1996, NEUROREPORT, V7, P705, DOI 10.1097/00001756-199602290-00006; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SORRA KE, 1993, J NEUROSCI, V13, P3736; SPACEK J, 1985, ANAT EMBRYOL, V171, P245, DOI 10.1007/BF00341419; SPACEK J, 1971, Z ZELLFORSCH MIK ANA, V112, P430; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; STEINHAUSER C, 1994, HIPPOCAMPUS, V4, P19, DOI 10.1002/hipo.450040105; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Takahashi M, 1996, J PHYSIOL-LONDON, V497, P523, DOI 10.1113/jphysiol.1996.sp021785; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WILKIN GP, 1982, BRAIN RES, V244, P69, DOI 10.1016/0006-8993(82)90905-2; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; YAMAMOTO T, 1992, DEV BRAIN RES, V66, P165, DOI 10.1016/0165-3806(92)90077-A; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705	65	409	415	1	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1297	1308		10.1016/S0896-6273(00)80420-1	http://dx.doi.org/10.1016/S0896-6273(00)80420-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427252	Bronze			2022-12-17	WOS:000071236500016
J	Gao, TY; Yatani, A; DellAcqua, ML; Sako, H; Green, SA; Dascal, N; Scott, JD; Hosey, MM				Gao, TY; Yatani, A; DellAcqua, ML; Sako, H; Green, SA; Dascal, N; Scott, JD; Hosey, MM			CAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits	NEURON			English	Article							PROTEIN-KINASE-A; CALCIUM CHANNELS; ANCHORING PROTEIN; ALPHA(1) SUBUNIT; BETA-SUBUNITS; MUSCLE CELLS; ASSOCIATION; EXPRESSION; RECEPTORS; SKELETAL	The cardiac L-type Ca2+ channel is a textbook example of an ion channel regulated by protein phosphorylation; however, the molecular events that underlie its regulation remain unknown. Here, we report that in transiently transfected HEK293 cells expressing L-type channels, elevations in cAMP resulted in phosphorylation of the alpha(1C) and beta(2a) channel subunits and increases in channel activity. Channel phosphorylation and regulation were facilitated by submembrane targeting of protein kinase A (PKA), through association with an A-kinase anchoring protein called AKAP79. In transfected cells expressing a mutant AKAP79 that is unable to bind PKA, phosphorylation of the alpha(1C) subunit and regulation of channel activity were not observed. Furthermore, we have demonstrated that the association of an AKAP with PKA was required for beta-adrenergic receptor-mediated regulation of L-type channels in native cardiac myocytes, illustrating that the events observed in the heterologous expression system reflect those occurring in the native system. Mutation of Ser1928 to alanine in the C-terminus of the alpha(1C) subunit resulted in a complete loss of cAMP-mediated phosphorylation and a loss of channel regulation. Thus, the PKA-mediated regulation of L-type Ca2+ channels is critically dependent on a functional AKAP and phosphorylation of the alpha(1C) subunit at Ser1928.	UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267; HOWARD HUGHES MED INST,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201; UNIV CINCINNATI,COLL MED,DEPT PULM MED,CINCINNATI,OH 45267; TEL AVIV UNIV,SACKLER SCH MED,DEPT PHYSIOL & PHARMACOL,IL-69978 RAMAT AVIV,ISRAEL	University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; Oregon Health & Science University; University System of Ohio; University of Cincinnati; Tel Aviv University; Sackler Faculty of Medicine	Gao, TY (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT BIOL CHEM & MOL PHARMACOL,CHICAGO,IL 60611, USA.		Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146; Dell'Acqua, Mark/0000-0003-3798-3461	NHLBI NIH HHS [HL23306] Funding Source: Medline; NIGMS NIH HHS [GM48231] Funding Source: Medline; NINDS NIH HHS [R21 NS094453] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL023306, R01HL023306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048231, R01GM048231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094453] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CARR DW, 1992, J BIOL CHEM, V267, P13376; CHANG FC, 1988, J BIOL CHEM, V263, P18929; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; COGHLAN VM, 1995, BIOCHEM SOC T, V23, P592, DOI 10.1042/bst0230592; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; De Waard M, 1996, Ion Channels, V4, P41; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; GAO T, 1997, IN PRESS J BIOL CHEM; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; Hosey MM, 1996, TRENDS CARDIOVAS MED, V6, P265, DOI 10.1016/S1050-1738(96)00109-0; Johnson BD, 1997, J NEUROSCI, V17, P1243; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Masaki H, 1997, AM J PHYSIOL-HEART C, V272, pH606, DOI 10.1152/ajpheart.1997.272.2.H606; MCCARTNEY S, 1995, J BIOL CHEM, V270, P9327, DOI 10.1074/jbc.270.16.9327; MCCARTNEY S, 1995, BIOCHEM SOC T, V23, pS268, DOI 10.1042/bst023268s; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Mitterdorfer J, 1996, BIOCHEMISTRY-US, V35, P9400, DOI 10.1021/bi960683o; NDUBUKA C, 1993, J BIOL CHEM, V268, P7621; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004, DOI 10.1074/jbc.270.48.29004; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; PEREZGARCIA MT, 1995, J GEN PHYSIOL, V105, P289, DOI 10.1085/jgp.105.2.289; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PEREZREYES E, 1994, FEBS LETT, V342, P119, DOI 10.1016/0014-5793(94)80484-2; PURI TS, 1997, IN PRESS BIOCHEMISTR; RICHARDSON RM, 1992, J BIOL CHEM, V267, P22249; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SINGERLAHAT D, 1994, RECEPTOR CHANNEL, V2, P215; WEI XY, 1994, J BIOL CHEM, V269, P1635; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Yamamoto S, 1996, J PHYSIOL-LONDON, V495, P733, DOI 10.1113/jphysiol.1996.sp021629; YATANI A, 1994, CIRC RES, V75, P315, DOI 10.1161/01.RES.75.2.315; YATANI A, 1995, CIRC RES, V76, P335, DOI 10.1161/01.RES.76.3.335; YOSHIDA A, 1992, FEBS LETT, V309, P343, DOI 10.1016/0014-5793(92)80804-P; ZONG XG, 1995, PFLUG ARCH EUR J PHY, V430, P340, DOI 10.1007/BF00373908	39	409	423	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					185	196		10.1016/S0896-6273(00)80358-X	http://dx.doi.org/10.1016/S0896-6273(00)80358-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247274	Bronze			2022-12-17	WOS:A1997XN39400017
J	MILWARD, EA; PAPADOPOULOS, R; FULLER, SJ; MOIR, RD; SMALL, D; BEYREUTHER, K; MASTERS, CL				MILWARD, EA; PAPADOPOULOS, R; FULLER, SJ; MOIR, RD; SMALL, D; BEYREUTHER, K; MASTERS, CL			THE AMYLOID PROTEIN-PRECURSOR OF ALZHEIMERS-DISEASE IS A MEDIATOR OF THE EFFECTS OF NERVE GROWTH-FACTOR ON NEURITE OUTGROWTH	NEURON			English	Article							BETA-PROTEIN; MESSENGER-RNA; HUMAN-BRAIN; SOLUBLE DERIVATIVES; PRION PROTEIN; SECRETED FORM; NEXIN-II; EXPRESSION; GENE; CELLS	The beta-A4 protein, the major component of the amyloid deposition characterizing Alzheimer's disease, derives from the amyloid protein precursor (APP), an integral membrane protein with soluble derivatives. The function of APP is unknown. Both soluble and membrane-associated human brain APP (10(-10) M) significantly increased (P < 0.025) neurite length and branching in pheochromocytoma PC12 cells, but did not affect the number of neurites per cell. At higher concentrations, APP was cytotoxic, with a half-maximal concentration of 5 x 10(-9) M. Nerve growth factor (NGF) is known to affect APP expression in vivo and in vitro. Antibodies to APP specifically diminished the effects of NGF on neurite length and branching. Thus APP may act to mediate neurite outgrowth promotion by NGF.	UNIV HEIDELBERG,CTR MOLEC BIOL,W-6900 HEIDELBERG,GERMANY; MENTAL HLTH RES INST,PARKVILLE,VIC 3052,AUSTRALIA	Ruprecht Karls University Heidelberg; Florey Institute of Neuroscience & Mental Health	MILWARD, EA (corresponding author), UNIV MELBOURNE,DEPT PATHOL,PARKVILLE,VIC 3052,AUSTRALIA.		Moir, Robert D./M-7612-2017	Moir, Robert D./0000-0001-5431-3553; Milward, Adrienne/0000-0002-1023-7795				BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; CHEN M, 1991, NEUROSCI LETT, V125, P223, DOI 10.1016/0304-3940(91)90034-Q; COHEN ML, 1988, P NATL ACAD SCI USA, V85, P1227, DOI 10.1073/pnas.85.4.1227; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GEDDES JW, 1986, EXP NEUROL, V94, P767, DOI 10.1016/0014-4886(86)90254-2; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; JOHNSON SA, 1990, SCIENCE, V248, P854, DOI 10.1126/science.2111579; JOHNSON SA, 1989, NEUROBIOL AGING, V10, P267, DOI 10.1016/0197-4580(89)90061-4; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KLIER FG, 1990, BRAIN RES, V515, P336, DOI 10.1016/0006-8993(90)90619-M; KONIG G, 1991, MOL BRAIN RES, V9, P259, DOI 10.1016/0169-328X(91)90010-U; KONIG G, 1990, FEBS LETT, V269, P305, DOI 10.1016/0014-5793(90)81181-M; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; MASLIAH E, 1991, NEURON, V6, P729, DOI 10.1016/0896-6273(91)90170-5; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; NEVE RL, 1990, NEURON, V5, P329, DOI 10.1016/0896-6273(90)90169-G; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; PALMERT MR, 1989, BIOCHEM BIOPH RES CO, V165, P182, DOI 10.1016/0006-291X(89)91052-8; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; QUON D, 1990, BIOCHEM BIOPH RES CO, V167, P96, DOI 10.1016/0006-291X(90)91735-B; REFOLO LM, 1989, BIOCHEM BIOPH RES CO, V164, P664, DOI 10.1016/0006-291X(89)91511-8; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SCHUBERT D, 1989, BIOCHEM BIOPH RES CO, V162, P83, DOI 10.1016/0006-291X(89)91965-7; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SCHUBERT D, 1978, BRAIN RES, V155, P196, DOI 10.1016/0006-8993(78)90325-6; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P4055, DOI 10.1073/pnas.74.9.4055; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMALL DH, 1991, BIOCHEMISTRY-US, V30, P10795, DOI 10.1021/bi00108a027; SMITH CJ, 1991, MOL BRAIN RES, V10, P351, DOI 10.1016/0169-328X(91)90095-F; SPILLANTINI MG, 1989, MOL BRAIN RES, V6, P143, DOI 10.1016/0169-328X(89)90048-X; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; VANNOSTRAND WE, 1989, NATURE, V341, P546; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WHITSON JS, 1990, NEUROSCI LETT, V110, P319, DOI 10.1016/0304-3940(90)90867-9; WHITSON JS, 1989, SCIENCE, V243, P1488, DOI 10.1126/science.2928783; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WION D, 1988, INT J DEV NEUROSCI, V6, P387, DOI 10.1016/0736-5748(88)90021-4; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020	63	409	415	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					129	137		10.1016/0896-6273(92)90228-6	http://dx.doi.org/10.1016/0896-6273(92)90228-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1632967				2022-12-17	WOS:A1992JE75600014
J	Lehtinen, MK; Zappaterra, MW; Chen, X; Yang, YJ; Hill, AD; Lun, ML; Maynard, T; Gonzalez, D; Kim, S; Ye, P; D'Ercole, AJ; Wong, ET; LaMantia, AS; Walsh, CA				Lehtinen, Maria K.; Zappaterra, Mauro W.; Chen, Xi; Yang, Yawei J.; Hill, Anthony D.; Lun, Melody; Maynard, Thomas; Gonzalez, Dilenny; Kim, Seonhee; Ye, Ping; D'Ercole, A. Joseph; Wong, Eric T.; LaMantia, Anthony S.; Walsh, Christopher A.			The Cerebrospinal Fluid Provides a Proliferative Niche for Neural Progenitor Cells	NEURON			English	Article							GROWTH-FACTOR-I; EMBRYONIC CEREBRAL-CORTEX; LIPID PHOSPHATASE PTEN; STEM-CELLS; RETINOIC ACID; IGF-I; VENTRICULAR ZONE; GENE-EXPRESSION; NERVOUS-SYSTEM; VASCULAR NICHE	Cortical development depends on the active integration of cell-autonomous and extrinsic cues, but the coordination of these processes is poorly understood. Here, we show that the apical complex protein Pals1 and Pten have opposing roles in localizing the Igf1R to the apical, ventricular domain of cerebral cortical progenitor cells. We found that the cerebrospinal fluid (CSF), which contacts this apical domain, has an age-dependent effect on proliferation, much of which is attributable to Igf2, but that CSF contains other signaling activities as well. CSF samples from patients with glioblastoma multiforme show elevated Igf2 and stimulate stem cell proliferation in an Igf2-dependent manner. Together, our findings demonstrate that the apical complex couples intrinsic and extrinsic signaling, enabling progenitors to sense and respond appropriately to diffusible CSF-borne signals distributed widely throughout the brain. The temporal control of CSF composition may have critical relevance to normal development and neuropathological conditions.	[Lehtinen, Maria K.; Zappaterra, Mauro W.; Chen, Xi; Yang, Yawei J.; Hill, Anthony D.; Lun, Melody; Gonzalez, Dilenny; Walsh, Christopher A.] Childrens Hosp Boston, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA; [Lehtinen, Maria K.; Zappaterra, Mauro W.; Chen, Xi; Yang, Yawei J.; Hill, Anthony D.; Lun, Melody; Gonzalez, Dilenny; Walsh, Christopher A.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Lehtinen, Maria K.; Zappaterra, Mauro W.; Chen, Xi; Yang, Yawei J.; Hill, Anthony D.; Lun, Melody; Gonzalez, Dilenny; Walsh, Christopher A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zappaterra, Mauro W.; Yang, Yawei J.; Walsh, Christopher A.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Chen, Xi; Yang, Yawei J.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Maynard, Thomas; LaMantia, Anthony S.] George Washington Univ, Sch Med, Dept Physiol & Pharmacol, George Washington Inst Neurosci, Washington, DC 20037 USA; [Lun, Melody; Wong, Eric T.] Beth Israel Deaconess Med Ctr, Brain Tumor Ctr & Neuro Oncol Unit, Boston, MA 02215 USA; [Lun, Melody; Wong, Eric T.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Ye, Ping; D'Ercole, A. Joseph] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Kim, Seonhee] Univ Texas Hlth Sci Ctr Houston, Pediat Res Ctr, Dept Pediat, Houston, TX 77030 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; George Washington University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston	Walsh, CA (corresponding author), Childrens Hosp Boston, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Maynard, Thomas/I-9039-2012	Maynard, Thomas/0000-0001-6976-3936; Walsh, Christopher/0000-0002-0156-2238; Gonzalez, Dilenny/0000-0003-0661-5930; HILL, ANTHONY/0000-0003-2179-6493	Sigrid Juselius Fellowship; Ellison/AFAR Postdoctoral Fellowship; NINDS [K99NS072192, R01 NSO48868, 3 RO1 NS032457]; Stuart H.Q. & Victoria Quan Fellowship; NIH [HD029178]; Child Neurology Foundation; A Reason To Ride research fund; NICHD [R01 HD008299]; UNC-CH; Manton Center for Orphan Disease Research; Intellectual and Developmental Disabilities Research Centers (CHB DDRC) [P30 HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042182, P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD029178, R01HD008299, R01HD029178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS048868, K99NS072192, R37NS035129, R01NS032457] Funding Source: NIH RePORTER	Sigrid Juselius Fellowship(Sigrid Juselius Foundation); Ellison/AFAR Postdoctoral Fellowship; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stuart H.Q. & Victoria Quan Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Child Neurology Foundation; A Reason To Ride research fund; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UNC-CH; Manton Center for Orphan Disease Research; Intellectual and Developmental Disabilities Research Centers (CHB DDRC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Bonni, S. Gygi, R. Segal, and members of the Walsh laboratory for helpful discussions; H. Steen for assistance with mass spectrometry; D. Rubin and J. Sheng for pMSCVhyg-Igf2; U. Berger, J. Buchanan, M. Ericsson, Y. Lin, A. Peters, C. Kourkoulis, and S. White for technical assistance. This work was supported by a Sigrid Juselius Fellowship, an Ellison/AFAR Postdoctoral Fellowship, and Award Number K99NS072192 from the NINDS (M.K.L); a Stuart H.Q. & Victoria Quan Fellowship (M.W.Z.), a NIH MSTP grant (M.W.Z. and Y.J.Y.); the Child Neurology Foundation (X.C.); A Reason To Ride research fund (M.L. and E.T.W.), a NINDS grant (R01 NSO48868) (A.J.D. and P.Y.), a NICHD grant (R01 HD008299) (A.J.D.), a NIH grant (HD029178), and an UNC-CH Reynolds Faculty Fellowship (A.S.L.); a NINDS grant (3 RO1 NS032457), the Manton Center for Orphan Disease Research, and the Intellectual and Developmental Disabilities Research Centers (CHB DDRC, P30 HD18655)(C.A.W.). C.A.W. is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the NIH.	[Anonymous], [No title captured]; AYERLELIEVRE C, 1991, DEVELOPMENT, V111, P105; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; BINOUX M, 1986, J CLIN ENDOCR METAB, V63, P1151, DOI 10.1210/jcem-63-5-1151; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; COHEN E, 1988, BIOL CELL, V62, P165, DOI 10.1016/0248-4900(88)90033-0; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; DZIEGIELEWSKA KM, 1981, DEV BIOL, V83, P193, DOI 10.1016/S0012-1606(81)80024-3; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Gorski JA, 2002, J NEUROSCI, V22, P6309; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Grove EA, 1998, DEVELOPMENT, V125, P2315; Haskell GT, 2005, J NEUROSCI, V25, P7636, DOI 10.1523/JNEUROSCI.0485-05.2005; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; JOHANSSON PA, 2010, PLOS BIOL, V6, pE254, DOI DOI 10.1371/J0URNAL.PBI0.0060254; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Kim S, 2010, NEURON, V66, P69, DOI 10.1016/j.neuron.2010.03.019; LAMANTIA AS, 1993, NEURON, V10, P1035, DOI 10.1016/0896-6273(93)90052-S; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Liu W, 2009, J NEUROSCI RES, V87, P2821, DOI 10.1002/jnr.22129; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Martin C, 2006, DEV BIOL, V297, P402, DOI 10.1016/j.ydbio.2006.05.010; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parada C, 2005, J PROTEOME RES, V4, P2420, DOI 10.1021/pr050213t; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; STYLIANOPOULOU F, 1988, DEVELOPMENT, V103, P497; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; WEBER MM, 1992, ENDOCRINOLOGY, V131, P2147, DOI 10.1210/en.131.5.2147; Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Ye P, 2010, GLIA, V58, P1031, DOI 10.1002/glia.20984; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007	64	408	419	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					893	905		10.1016/j.neuron.2011.01.023	http://dx.doi.org/10.1016/j.neuron.2011.01.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382550	Green Accepted, Green Published, Bronze			2022-12-17	WOS:000288736500008
J	Kim, J; Lo, L; Dormand, E; Anderson, DJ				Kim, J; Lo, L; Dormand, E; Anderson, DJ			SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells	NEURON			English	Article							TRANSCRIPTION FACTOR SOX10; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; MOUSE MODEL; HIRSCHSPRUNG-DISEASE; GENE-EXPRESSION; CHICKEN SOX2; GLIAL-CELLS; PHOX2A; FATE	The mechanisms that establish and maintain the multipotency of stem cells are poorly understood. In neural crest stem cells (NCSCs), the HMG-box factor SOX10 preserves not only glial, but surprisingly, also neuronal potential from extinction by lineage commitment signals. The latter function is reflected in the requirement of SOX10 in vivo for induction of MASH1 and PHOX2B, two neurogenic transcription factors. Simultaneously, SOX10 inhibits or delays overt neuronal differentiation, both in vitro and in vivo. However, this activity requires a higher SOX10 gene dosage than does the maintenance of neurogenic potential. The opponent functions of SOX10 to maintain neural lineage potentials, while simultaneously serving to inhibit or delay neuronal differentiation, suggest that it functions in stem or progenitor cell maintenance, in addition to its established role in peripheral gliogenesis.	CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA.							Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Anderson DJ, 1997, TRENDS GENET, V13, P276, DOI 10.1016/S0168-9525(97)01187-6; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Buescher M, 2002, DEVELOPMENT, V129, P4193; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Greenwood AL, 1999, DEVELOPMENT, V126, P3545; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Le Douarin NM, 1999, NEURAL CREST; Lo LC, 2002, DEVELOPMENT, V129, P1553; Lo LC, 1998, DEVELOPMENT, V125, P609; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Overton PM, 2002, DEVELOPMENT, V129, P4219; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Potterf SB, 2001, DEV BIOL, V237, P245, DOI 10.1006/dbio.2001.0372; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.0.CO;2-K; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tsai RYL, 2002, DEV CELL, V2, P707, DOI 10.1016/S1534-5807(02)00195-8; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; White PM, 1999, DEVELOPMENT, V126, P4351; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	68	408	415	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 10	2003	38	1					17	31		10.1016/S0896-6273(03)00163-6	http://dx.doi.org/10.1016/S0896-6273(03)00163-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691661	Bronze			2022-12-17	WOS:000182202300006
J	Hormuzdi, SG; Pais, I; LeBeau, FEN; Towers, SK; Rozov, A; Buhl, EH; Whittington, MA; Monyer, H				Hormuzdi, SG; Pais, I; LeBeau, FEN; Towers, SK; Rozov, A; Buhl, EH; Whittington, MA; Monyer, H			Impaired electrical signaling disrupts gamma frequency oscillations in connexin 36-deficient mice	NEURON			English	Article							HIPPOCAMPUS IN-VITRO; GAP-JUNCTIONS; NETWORK OSCILLATIONS; NERVOUS-SYSTEM; BRAIN NEURONS; RAT; EXPRESSION; CX36; SYNCHRONIZATION; RECOMBINATION	Neural processing occurs in parallel in distant cortical areas even for simple perceptual tasks. Associated cognitive binding is believed to occur through the interareal synchronization of rhythmic activity in the gamma (30-80 Hz) range. Such oscillations arise as an emergent property of the neuronal network and require conventional chemical neurotransmission. To test the potential role of gap junction-mediated electrical signaling in this network property, we generated mice lacking connexin 36, the major neuronal connexin. Here we show that the loss of this protein disrupts gamma frequency network oscillations in vitro but leaves high frequency (150 Hz) rhythms, which may involve gap junctions between principal cells (Schmitz et al., 2001), unaffected. Thus, specific connexins differentially deployed throughout cortical networks are likely to regulate different functional aspects of neuronal information processing in the mature brain.	Univ Hosp Neurol, Dept Clin Neurobiol, Heidelberg, Germany; Univ Leeds, Sch Biomed Sci, Leeds LS2 9NQ, W Yorkshire, England; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Leeds; Max Planck Society	Monyer, H (corresponding author), Univ Hosp Neurol, Dept Clin Neurobiol, Neuenheimer Feld 364, Heidelberg, Germany.	monyer@urz.unl-hd.de	Rozov, Andrei/C-1997-2015	LeBeau, Fiona/0000-0003-1453-4022; Monyer, Hannah/0000-0002-9332-5749; Whittington, Miles Adrian/0000-0002-0247-1362				Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRONSON SK, 1994, J BIOL CHEM, V269, P27155; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Cape EG, 2000, J NEUROSCI, V20, P8452, DOI 10.1523/JNEUROSCI.20-22-08452.2000; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gulisano M, 2000, NEUROREPORT, V11, P3823, DOI 10.1097/00001756-200011270-00045; Jones MS, 1999, J NEUROPHYSIOL, V82, P1599, DOI 10.1152/jn.1999.82.3.1599; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Karbowski J, 2000, NEURAL COMPUT, V12, P1573, DOI 10.1162/089976600300015277; Parenti R, 2000, NEUROREPORT, V11, P1497, DOI 10.1097/00001756-200005150-00027; SCHMITZ D, 2001, IN PRESS NEURON; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Sohl G, 1998, FEBS LETT, V428, P27, DOI 10.1016/S0014-5793(98)00479-7; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Traub RD, 1999, J NEUROSCI, V19, P1088; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; Whittington MA, 2001, J NEUROSCI, V21, P1727, DOI 10.1523/JNEUROSCI.21-05-01727.2001; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	34	408	415	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2001	31	3					487	495		10.1016/S0896-6273(01)00387-7	http://dx.doi.org/10.1016/S0896-6273(01)00387-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516404	Bronze			2022-12-17	WOS:000170601000016
J	Niethammer, M; Smith, DS; Ayala, R; Peng, JM; Ko, J; Lee, MS; Morabito, M; Tsai, LH				Niethammer, M; Smith, DS; Ayala, R; Peng, JM; Ko, J; Lee, MS; Morabito, M; Tsai, LH			NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein	NEURON			English	Article							PLATELET-ACTIVATING-FACTOR; DIEKER LISSENCEPHALY GENE; FACTOR ACETYLHYDROLASE; ASPERGILLUS-NIDULANS; NUCLEAR MIGRATION; NEURONAL MIGRATION; AXONAL-TRANSPORT; POSTSYNAPTIC DENSITY; CORTICAL DEVELOPMENT; INTERMEDIATE CHAIN	Disruption of one allele of the LIS1 gene causes a severe developmental brain abnormality, type I lissencephaly. In Aspergillus nidulans, the LIS1 homolog, NUDE, and cytoplasmic dynein are genetically linked and regulate nuclear movements during hyphal growth. Recently, we demonstrated that mammalian LIS1 regulates dynein functions. Here we characterize NUDEL, a novel LIS1-interacting protein with sequence homology to gene products also implicated in nuclear distribution in fungi. Like LIS1, NUDEL is robustly expressed in brain, enriched at centrosomes and neuronal growth cones, and interacts with cytoplasmic dynein. Furthermore, NUDEL is a substrate of Cdk5, a kinase known to be critical during neuronal migration. Inhibition of Cdk5 modifies NUDEL distribution in neurons and affects neuritic morphology. Our findings point to crosstalk between two prominent pathways that regulate neuronal migration.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	Smith, Deanna/AFU-2285-2022; Peng, Junmin/N-2614-2018	Smith, Deanna/0000-0002-3014-641X; Peng, Junmin/0000-0003-0472-7648				Abe TK, 1997, BIOCHEM BIOPH RES CO, V233, P295, DOI 10.1006/bbrc.1997.6447; ADACHI H, 1995, BIOCHEM BIOPH RES CO, V214, P180, DOI 10.1006/bbrc.1995.2272; Adachi T, 1997, NEUROSCI LETT, V235, P133, DOI 10.1016/S0304-3940(97)00742-8; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; Allen MJ, 1999, J NEUROSCI, V19, P9374; Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Dillman JF, 1996, J NEUROSCI, V16, P6742; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Hattori M, 1995, J BIOL CHEM, V270, P31345, DOI 10.1074/jbc.270.52.31345; HATTORI M, 1994, J BIOL CHEM, V269, P23150; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Homayouni R, 2000, CURR BIOL, V10, pR331, DOI 10.1016/S0960-9822(00)00459-0; Humbert S, 2000, J CELL SCI, V113, P975; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Kwon YT, 2000, RES PRO CEL, V30, P241; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Murphey RK, 1999, DEV BIOL, V209, P86, DOI 10.1006/dbio.1999.9217; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; OSHIMA T, 1996, P NATL ACAD SCI USA, V93, P11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Phillis R, 1996, DEVELOPMENT, V122, P2955; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiner O, 1998, INT J MOL MED, V1, P849; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Sapir T, 1999, EUR J BIOCHEM, V265, P181, DOI 10.1046/j.1432-1327.1999.00711.x; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; TAKADA K, 1988, CLIN NEUROPATHOL, V7, P111; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Xiang X, 2000, CURR BIOL, V10, P603, DOI 10.1016/S0960-9822(00)00488-7; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3; [No title captured]	71	407	427	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	2000	28	3					697	711		10.1016/S0896-6273(00)00147-1	http://dx.doi.org/10.1016/S0896-6273(00)00147-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163260	Bronze			2022-12-17	WOS:000166057500010
J	CARSON, MJ; BEHRINGER, RR; BRINSTER, RL; MCMORRIS, FA				CARSON, MJ; BEHRINGER, RR; BRINSTER, RL; MCMORRIS, FA			INSULIN-LIKE GROWTH FACTOR-I INCREASES BRAIN GROWTH AND CENTRAL-NERVOUS-SYSTEM MYELINATION IN TRANSGENIC MICE	NEURON			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; SNELL DWARF MOUSE; RAT-BRAIN; OLIGODENDROCYTE DEVELOPMENT; GENE-EXPRESSION; SOMATOMEDIN-C; CEREBRAL MYELINOGENESIS; CHOROID-PLEXUS; GLIAL-CELLS; IGF-I	Insulin-like growth factor I (IGF-I) is a potent regulator of oligodendrocyte development and myelination in vitro, but its effect on myelination in vivo has never been tested directly. Therefore, we examined brain growth and myelination in a transgenic mouse line that overexpresses IGF-I. By postnatal day 55, when brain growth and myelination are essentially complete in normal mice, the brains of transgenic mice were 55% larger than those of controls owing to an increase in cell size and apparently in cell number. Most or all brain structures appeared to be affected. At the same time, total myelin content of the transgenic mice was 130% greater than that of controls. Oligodendrocyte number as a percentage of total cell number was not increased in the transgenic mouse brains; the increase in myelin content was primarily the result of an increase in myelin production per oligodendrocyte. These findings indicate that IGF-I is a potent inducer of brain growth and myelination in vivo.	WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH VET MED,PHILADELPHIA,PA 19104	The Wistar Institute; University of Pennsylvania				Brinster, Ralph/0000-0003-1408-7656	NINDS NIH HHS [NS 26119, NS 11036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011036, P50NS011036, R01NS026119] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; BALLOTTI R, 1987, EMBO J, V6, P3633, DOI 10.1002/j.1460-2075.1987.tb02695.x; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BASKIN DG, 1988, TRENDS NEUROSCI, V11, P107, DOI 10.1016/0166-2236(88)90155-5; BONDY CA, 1991, J NEUROSCI, V11, P3442; BRAUN PE, 1988, J NEUROSCI, V8, P3057; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; BROWN AL, 1986, J BIOL CHEM, V261, P3144; DELANEY AJ, 1981, J NUTR, V111, P746, DOI 10.1093/jn/111.4.746; DERCOLE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P935, DOI 10.1073/pnas.81.3.935; EGWIM PO, 1986, COMP BIOCHEM PHYS A, V83, P67, DOI 10.1016/0300-9629(86)90089-7; FAGIN JA, 1989, ENDOCRINOLOGY, V125, P2385, DOI 10.1210/endo-125-5-2385; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; GABBOTT PLA, 1987, NEUROSCIENCE, V21, P833, DOI 10.1016/0306-4522(87)90040-6; GHANDOUR MS, 1980, NEUROSCIENCE, V5, P559, DOI 10.1016/0306-4522(80)90053-6; GRANT DB, 1973, ARCH DIS CHILD, V48, P596, DOI 10.1136/adc.48.8.596; HAN VKM, 1987, J NEUROSCI, V7, P501; HINTZ RL, 1978, J PEDIATR-US, V92, P153, DOI 10.1016/S0022-3476(78)80099-7; HODGKINSON SC, 1991, ENDOCRINOLOGY, V129, P2085, DOI 10.1210/endo-129-4-2085; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HYNES MA, 1988, MOL ENDOCRINOL, V2, P47, DOI 10.1210/mend-2-1-47; KING RA, 1988, J ENDOCRINOL, V119, P117, DOI 10.1677/joe.0.1190117; KOMOLY S, 1992, P NATL ACAD SCI USA, V89, P1894, DOI 10.1073/pnas.89.5.1894; KRIGMAN MR, 1976, BRAIN RES, V107, P239, DOI 10.1016/0006-8993(76)90224-9; KURIHARA T, 1967, J NEUROCHEM, V14, P1167, DOI 10.1111/j.1471-4159.1967.tb06164.x; LAMSON G, 1989, ENDOCRINOLOGY, V125, P1100, DOI 10.1210/endo-125-2-1100; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND PK, 1986, J BIOL CHEM, V261, P4539; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MATHEWS LS, 1986, P NATL ACAD SCI USA, V83, P9343, DOI 10.1073/pnas.83.24.9343; MCMORRIS FA, 1983, J NEUROCHEM, V41, P506, DOI 10.1111/j.1471-4159.1983.tb04768.x; MCMORRIS FA, 1990, ANN NY ACAD SCI, V605, P101, DOI 10.1111/j.1749-6632.1990.tb42385.x; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MCMORRIS FA, 1986, P NATL ACAD SCI USA, V83, P822, DOI 10.1073/pnas.83.3.822; MORELL P, 1989, BASIC NEUROCHEMISTRY, P109; MOZELL RL, 1991, J NEUROSCI RES, V30, P382, DOI 10.1002/jnr.490300214; NIELSEN FC, 1991, J NEUROCHEM, V56, P12, DOI 10.1111/j.1471-4159.1991.tb02556.x; NOGUCHI T, 1982, J NEUROCHEM, V38, P257, DOI 10.1111/j.1471-4159.1982.tb10878.x; NOGUCHI T, 1982, J NEUROCHEM, V39, P1693, DOI 10.1111/j.1471-4159.1982.tb08004.x; NOGUCHI T, 1985, NEUROCHEM RES, V10, P1097, DOI 10.1007/BF00965884; Norton W., 1984, OLIGODENDROGLIA; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; OOI GT, 1990, MOL CELL ENDOCRINOL, V71, pC39, DOI 10.1016/0303-7207(90)90243-2; PELTON EW, 1977, NEUROLOGY, V27, P282, DOI 10.1212/WNL.27.3.282; PHILLIPS LS, 1979, AM J CLIN NUTR, V32, P1082, DOI 10.1093/ajcn/32.5.1082; PHILLIPS LS, 1978, ENDOCRINOLOGY, V103, P121, DOI 10.1210/endo-103-1-121; PROHASKA JR, 1973, ANAL BIOCHEM, V56, P275, DOI 10.1016/0003-2697(73)90189-9; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; SHEMER J, 1987, J BIOL CHEM, V262, P7693; Sims N.R., 1978, ADV NEUROCHEMISTRY, V3, P1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STURROCK RR, 1974, J ANAT, V117, P37; STURROCK RR, 1976, J ANAT, V122, P521; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; SUGISAKI T, 1985, NEUROCHEM RES, V10, P767, DOI 10.1007/BF00964534; SWANSON LW, 1985, NATURE, V317, P363, DOI 10.1038/317363a0; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X; WIGGINS RC, 1982, BRAIN RES REV, V4, P151, DOI 10.1016/0165-0173(82)90016-9; WOOD TL, 1990, MOL ENDOCRINOL, V4, P1257, DOI 10.1210/mend-4-8-1257; YOUNG JK, 1991, GLIA, V4, P602, DOI 10.1002/glia.440040607; [No title captured]	63	407	416	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					729	740		10.1016/0896-6273(93)90173-O	http://dx.doi.org/10.1016/0896-6273(93)90173-O			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386530				2022-12-17	WOS:A1993KY50100015
J	LEMMON, V; FARR, KL; LAGENAUR, C				LEMMON, V; FARR, KL; LAGENAUR, C			L1-MEDIATED AXON OUTGROWTH OCCURS VIA A HOMOPHILIC BINDING MECHANISM	NEURON			English	Article									UNIV PITTSBURGH,DEPT NEUROBIOL ANAT & CELL SCI,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Lemmon, Vance/A-2565-2008; Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576	NEI NIH HHS [R01 EY005285, EY5285] Funding Source: Medline; NINDS NIH HHS [NS25543] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025543] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BOCK E, 1985, EMBO J, V4, P2765, DOI 10.1002/j.1460-2075.1985.tb04001.x; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; COLE GJ, 1986, J CELL BIOL, V102, P403, DOI 10.1083/jcb.102.2.403; COVAULT J, 1987, J CELL BIOL, V105, P2479, DOI 10.1083/jcb.105.6.2479; DANILOFF JK, 1986, J NEUROSCI, V6, P739; FRIEDLANDER DR, 1986, J CELL BIOL, V102, P413, DOI 10.1083/jcb.102.2.413; GRUMET M, 1984, P NATL ACAD SCI-BIOL, V81, P7989, DOI 10.1073/pnas.81.24.7989; GRUMET M, 1984, J CELL BIOL, V98, P1746, DOI 10.1083/jcb.98.5.1746; GRUMET M, 1988, J CELL BIOL, V106, P487, DOI 10.1083/jcb.106.2.487; GRUMET M, 1984, P NATL ACAD SCI-BIOL, V81, P267, DOI 10.1073/pnas.81.1.267; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LEMMON V, 1986, J NEUROSCI, V6, P2987; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LUND RD, 1985, NEUROSCI LETT, V61, P221, DOI 10.1016/0304-3940(85)90428-8; Mage M G, 1980, Methods Enzymol, V70, P142; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NIEKE J, 1985, DIFFERENTIATION, V30, P141, DOI 10.1111/j.1432-0436.1985.tb00525.x; RATHJEN FG, 1984, EMBO J, V3, P1; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685; SAJOVIC P, 1986, J NEUROCHEM, V47, P541; SEILHEIMER B, 1988, J CELL BIOL, V107, P347; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; STGROTH SFD, 1980, J IMMUNOL METHODS, V35, P313; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659	28	407	410	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1989	2	6					1597	1603		10.1016/0896-6273(89)90048-2	http://dx.doi.org/10.1016/0896-6273(89)90048-2			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC665	2627381				2022-12-17	WOS:A1989AC66500009
J	Dugas, JC; Cuellar, TL; Scholze, A; Ason, B; Ibrahim, A; Emery, B; Zamanian, JL; Foo, LC; McManus, MT; Barres, BA				Dugas, Jason C.; Cuellar, Trinna L.; Scholze, Anja; Ason, Brandon; Ibrahim, Adiljan; Emery, Ben; Zamanian, Jennifer L.; Foo, Lynette C.; McManus, Michael T.; Barres, Ben A.			Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination	NEURON			English	Article							GLIAL PROGENITOR-CELL; MICRORNA EXPRESSION; GROWTH-FACTOR; TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; CYCLE EXIT; PROTEIN; IDENTIFICATION; LINEAGE; NEURONS	To investigate the role of microRNAs in regulating oligodendrocyte (OL) differentiation and myelination, we utilized transgenic mice in which microRNA processing was disrupted in OL precursor cells (OPCs) and OLs by targeted deletion of Dicer1. We found that inhibition of OPC-OL miRNA processing disrupts normal CNS myelination and that OPCs lacking mature miRNAs fail to differentiate normally in vitro. We identified three miRNAs (miR-219, miR-138, and miR-338) that are induced 10-100x during OL differentiation; the most strongly induced of these, miR-219, is necessary and sufficient to promote OL differentiation, and partially rescues OL differentiation defects caused by total miRNA loss. miR-219 directly represses the expression of PDGFR alpha, Sox6, FoxJ3, and ZFP238 proteins, all of which normally help to promote OPC proliferation. Together, these findings show that miR-219 plays a critical role in coupling differentiation to proliferation arrest in the OL lineage, enabling the rapid transition from proliferating OPCs to myelinating OLs.	[Dugas, Jason C.; Scholze, Anja; Ibrahim, Adiljan; Emery, Ben; Zamanian, Jennifer L.; Foo, Lynette C.; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Cuellar, Trinna L.; Ason, Brandon; McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Dugas, JC (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	jcdugas@alum.mit.edu	mcmanus, michael/AAB-1239-2020; Emery, Ben/I-6223-2013	mcmanus, michael/0000-0003-3013-6569; Zamanian, Jennifer/0000-0003-1256-7496; Emery, Ben/0000-0002-9132-3045; Cuellar, Trinna/0000-0002-9991-9505	Myelin Repair Foundation; NIH [5R03DA022201]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA022201] Funding Source: NIH RePORTER	Myelin Repair Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Prof. Klaus-Armin Nave for kindly providing the CNP-Cre mouse line. Prof. David Flowitch for providing the Olig2-Cre mouse line, and Prof. Chang-Zheng Chen for providing the floxed-Dicer mouse line. We would also like to thank Prof. Michael Wegner for generously providing the Sox6 antibody, This work was funded by the Myelin Repair Foundation and by NIH grant 5R03DA022201.	Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BESNARD F, 1987, NEUROSCI LETT, V73, P287, DOI 10.1016/0304-3940(87)90260-6; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Durand B, 2000, BIOESSAYS, V22, P64; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landgren H, 2004, DEV DYNAM, V231, P396, DOI 10.1002/dvdy.20131; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; MATTHIEU JM, 1980, J NEUROCHEM, V35, P1345, DOI 10.1111/j.1471-4159.1980.tb09008.x; Okado H, 2009, DEV BIOL, V331, P140, DOI 10.1016/j.ydbio.2009.04.030; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Raff MC, 1998, INT J DEV BIOL, V42, P263; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; Tokumoto YM, 2001, EMBO J, V20, P5261, DOI 10.1093/emboj/20.18.5261; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Uhrbom L, 2000, INT J CANCER, V85, P398, DOI 10.1002/(SICI)1097-0215(20000201)85:3<398::AID-IJC17>3.0.CO;2-L; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	57	406	427	1	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 11	2010	65	5					597	611		10.1016/j.neuron.2010.01.027	http://dx.doi.org/10.1016/j.neuron.2010.01.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223197	Green Accepted, Bronze			2022-12-17	WOS:000275758000005
J	Putcha, GV; Moulder, KL; Golden, JP; Bouillet, P; Adams, JA; Strasser, A; Johnson, EM				Putcha, GV; Moulder, KL; Golden, JP; Bouillet, P; Adams, JA; Strasser, A; Johnson, EM			Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis	NEURON			English	Article							NERVE GROWTH-FACTOR; PROGRAMMED CELL-DEATH; TROPHIC-FACTOR DEPRIVATION; CEREBELLAR GRANULE CELLS; DEPENDENT SYMPATHETIC NEURONS; BAX-DEFICIENT MICE; CYTOCHROME-C; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-KINASE; TRANSCRIPTION FACTOR	Sympathetic neuronal death induced by nerve growth factor (NGF) deprivation requires the macromolecular synthesis-dependent translocation of BAX from the cytosol to mitochondria and its subsequent integration into the mitochondrial outer membrane, followed by BAX-mediated cytochrome c (cyt c) release. The gene products triggering this process remain unknown. Here, we report that BIM, a member of the BH3-only proapoptotic subfamily of the BCL-2 protein family, is one such molecule. NGF withdrawal induced expression of BIMEL, an integral mitochondrial membrane protein that functions upstream of (or in parallel with) the BAX/BCL-2 and caspase checkpoints. aim deletion conferred protection against developmental and induced neuronal apoptosis in both central and peripheral populations, but only transiently, suggesting that BIM-and perhaps other BH3-only proteins-serve partially redundant functions upstream of BAX-mediated cyt c release.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Washington University (WUSTL); Washington University (WUSTL); Walter & Eliza Hall Institute	Johnson, EM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.		Adams, Jerry M/E-1199-2013; Strasser, Andreas/C-7581-2013; Bouillet, Philippe/E-1241-2013	Strasser, Andreas/0000-0002-5020-4891; Bouillet, Philippe/0000-0002-9012-6058; Adams, Jerry/0000-0002-4360-8628; Golden, Judith/0000-0002-5168-8525	NIA NIH HHS [R37AG-12947] Funding Source: Medline; NINDS NIH HHS [R01NS38651] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012947] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Crowder RJ, 1998, J NEUROSCI, V18, P2933; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deckwerth TL, 1998, EXP NEUROL, V152, P150, DOI 10.1006/exnr.1998.6846; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; DEL PL, 1997, SCIENCE, V278, P687; Deshmukh M, 2000, CELL DEATH DIFFER, V7, P250, DOI 10.1038/sj.cdd.4400641; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Easton RM, 1997, J NEUROSCI, V17, P9656; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; Eilers A, 1998, J NEUROSCI, V18, P1713; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; JOHNSON EM, 1989, NEUROBIOL AGING, V10, P549, DOI 10.1016/0197-4580(89)90127-9; JOHNSON MI, 1983, METHOD ENZYMOL, V103, P334; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Maroney AC, 1998, J NEUROSCI, V18, P104; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; McCarthy MJ, 1997, J CELL SCI, V110, P2165; Miller TM, 1996, J NEUROSCI, V16, P7487; Miller TM, 1997, J BIOL CHEM, V272, P9847; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 1998, BIOTECHNIQUES, V25, P824, DOI 10.2144/98255st03; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; OPPENHEIM RW, 1990, DEV BIOL, V138, P104, DOI 10.1016/0012-1606(90)90180-Q; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Putcha GV, 2000, J CELL BIOL, V149, P1011, DOI 10.1083/jcb.149.5.1011; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; RUIT KG, 1990, J NEUROSCI, V10, P2412; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Shindler KS, 1998, CELL DEATH DIFFER, V5, P901, DOI 10.1038/sj.cdd.4400421; Shindler KS, 1997, J NEUROSCI, V17, P3112; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Tsui-Pierchala BA, 2000, J NEUROSCI, V20, P7228; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Virdee K, 1997, J NEUROCHEM, V69, P550; White FA, 1998, J NEUROSCI, V18, P1428; YIP HK, 1984, J NEUROSCI, V4, P2986; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	75	405	428	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2001	29	3					615	628		10.1016/S0896-6273(01)00238-0	http://dx.doi.org/10.1016/S0896-6273(01)00238-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301022	Bronze			2022-12-17	WOS:000167868900012
J	Jackson, EL; Garcia-Verdugo, JM; Gil-Perotin, S; Roy, M; Quinones-Hinojosa, A; VandenBerg, S; Alvarez-Buylla, A				Jackson, Erica L.; Garcia-Verdugo, Jose Manuel; Gil-Perotin, Sara; Roy, Monica; Quinones-Hinojosa, Alfredo; VandenBerg, Scott; Alvarez-Buylla, Arturo			PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling	NEURON			English	Article							SUBVENTRICULAR ZONE; PROGENITOR CELLS; FACTOR RECEPTOR; BRAIN; OLIGODENDROCYTES; IDENTIFICATION; ASTROCYTE; EXPRESSION; OLIG2; CNS	Neurons and oligodendrocytes are produced in the adult brain subventricular zone (SVZ) from neural stem cells (B cells), which express GFAP and have morphological properties of astrocytes. We report here on the identification B cells expressing the PDGFR alpha in the adult SVZ. Specifically labeled PDGFR alpha expressing B cells in vivo generate neurons and oligodendrocytes. Conditional ablation of PDGFR alpha in a subpopulation of postnatal stem cells showed that this receptor is required for oligodendrogenesis, but not neurogenesis. Infusion of PDGF alone was sufficient to arrest neuroblast production and induce SVZ B cell proliferation contributing to the generation of large hyperplasias with some features of gliomas. The work demonstrates that PDGFR alpha signaling occurs early in the adult stem cell lineage and may help regulate the balance between oligodendrocyte and neuron production. Excessive PDGF activation in the SVZ in stem cells is sufficient to induce hallmarks associated with early stages of tumor formation.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Valencia, Burjassot 4610, Valencia, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Valencia	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017; Gil-Perotin, Sara/AAK-9942-2021; Gil-Perotin, Sara/I-2467-2015	García-Verdugo, José Manuel/0000-0001-9872-6499; Gil-Perotin, Sara/0000-0003-3793-0116; Gil-Perotin, Sara/0000-0003-3793-0116; Alvarez-Buylla, Arturo/0000-0003-4426-8925	NICHD NIH HHS [HD-32116] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andrae J, 2001, MOL CELL NEUROSCI, V17, P1001, DOI 10.1006/mcne.2001.0989; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; BUICK RN, 1979, BLOOD, V54, P95; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chatterjee G, 2002, AM J PATHOL, V161, P2241, DOI 10.1016/S0002-9440(10)64500-2; Chojnacki A, 2004, J NEUROSCI, V24, P10888, DOI 10.1523/JNEUROSCI.3302-04.2004; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; ELLISON JA, 1994, J NEUROSCI RES, V37, P116, DOI 10.1002/jnr.490370116; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; FFRENCHCONSTANT C, 1986, J CELL BIOL, V102, P844, DOI 10.1083/jcb.102.3.844; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Globus J.H., 1944, J NEUROPATH EXP NEUR, V3, P1; GRINSPAN JB, 1995, J NEUROSCI RES, V41, P540, DOI 10.1002/jnr.490410414; GUHA A, 1995, INT J CANCER, V60, P168, DOI 10.1002/ijc.2910600206; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hall A, 1996, DEVELOPMENT, V122, P4085; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lachapelle F, 2002, MOL CELL NEUROSCI, V20, P390, DOI 10.1006/mcne.2002.1124; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Lim DA, 2001, CONT NEUROS, P71; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lotery AJ, 2003, HUM GENE THER, V14, P1663, DOI 10.1089/104303403322542301; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; LUSKIN MB, 1994, CHEM SENSES, V19, P695, DOI 10.1093/chemse/19.6.695; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; MENN B, IN PRESS J NEUROSCI; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Recht L, 2003, J CELL BIOCHEM, V88, P11, DOI 10.1002/jcb.10208; Redwine JM, 1997, J NEUROSCI RES, V50, P229; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Sonoda Y, 2001, CANCER RES, V61, P4956; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uhrbom L, 1998, CANCER RES, V58, P5275; Varela M, 2004, J SURG ONCOL, V86, P34, DOI 10.1002/jso.20036; Wang JJ, 2000, P NATL ACAD SCI USA, V97, P3497, DOI 10.1073/pnas.97.7.3497; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	70	404	423	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 20	2006	51	2					187	199		10.1016/j.neuron.2006.06.012	http://dx.doi.org/10.1016/j.neuron.2006.06.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846854	Bronze			2022-12-17	WOS:000239535100007
J	Ross, CA				Ross, CA			Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington's disease and related disorders	NEURON			English	Review							CREB-BINDING PROTEIN; NEURODEGENERATIVE DISEASES; STRIATAL NEURONS; TOXICITY; TRANSCRIPTION	The mechanisms of neurodegeneration in the CAG repeat polyglutamine diseases, including Spinal and Bulbar Muscular Atrophy (SBMA), Huntington's disease (HD), DentatoRubral and PallidoLuysian Atrophy (DRPLA), and Spino-Cerebellar Ataxia (SCA), have been controversial. Issues have included the role of polyglutamine aggregation and possible amyloid formation, localization in the cell nucleus, and possible proteolytic processing. Proposed mechanisms have included activation of caspases or other triggers of apoptosis, mitochondrial or metabolic toxicity, and interference with gene transcription. Recent studies using transgenic mouse and Drosophila models have helped resolve some of these issues and raise hopes for development of therapeutic targets.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA	Johns Hopkins University	Ross, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.	caross@jhu.edu	Ross, Christopher A/H-8395-2013					Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Dyer RB, 2001, NAT GENET, V29, P270, DOI 10.1038/ng745; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Margolis RL, 2001, TRENDS MOL MED, V7, P479, DOI 10.1016/S1471-4914(01)02179-7; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Merry DE, 2001, BRAIN RES BULL, V56, P203, DOI 10.1016/S0361-9230(01)00594-9; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; POIRIER MA, 2002, IN PRESS J BIOL CHEM; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Toneff T, 2002, J NEUROCHEM, V82, P84, DOI 10.1046/j.1471-4159.2002.00940.x; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503	26	404	424	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					819	822		10.1016/S0896-6273(02)00872-3	http://dx.doi.org/10.1016/S0896-6273(02)00872-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372277	Bronze			2022-12-17	WOS:000177779800005
J	Wilson, RI; Kunos, G; Nicoll, RA				Wilson, RI; Kunos, G; Nicoll, RA			Presynaptic specificity of endocannabinoid signaling in the hippocampus	NEURON			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; CALCIUM-CHANNEL INVOLVEMENT; CANNABINOID CB1 RECEPTORS; BETA-GAMMA-SUBUNITS; RAT HIPPOCAMPUS; N-TYPE; SYNAPTIC TRANSMISSION; GABA RELEASE; AREA CA1; MESENTERIC VASODILATION	Endocannabinoids are retrograde messengers released by neurons to modulate the strength of their synaptic inputs. Endocannabinoids are thought to mediate the suppression of GABA release that follows depolarization of a hippocampal CA1 pyramidal neuron-termed "depolarization-induced suppression of inhibition" (DSI). Here, we report that DSI is absent in mice which lack cannabinoid receptor-1 (CB1). Pharmacological and kinetic evidence suggests that CB1 activation inhibits presynaptic Ca2+ channels through direct G protein inhibition. Paired recordings show that endocannabinoids selectively inhibit a subclass of synapses distinguished by their fast kinetics and large unitary conductance. Furthermore, cannabinoid-sensitive inputs are unusual among central nervous system synapses in that they use N- but not P/Q-type Ca2+ channels for neurotransmitter release. These results indicate that endocannabinoids are highly selective, rapid modulators of hippocampal inhibition.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; NIAAA, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350, Z01AA000350] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Banks MI, 1998, J NEUROSCI, V18, P1305; Breivogel CS, 2001, MOL PHARMACOL, V60, P155, DOI 10.1124/mol.60.1.155; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; Currie KPM, 1997, J NEUROSCI, V17, P4570; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOZE VA, 1995, J NEUROPHYSIOL, V74, P43, DOI 10.1152/jn.1995.74.1.43; Du J, 1996, J NEUROSCI, V16, P506; EVANS DM, 1994, J PHARMACOL EXP THER, V268, P1271; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hescheler J, 1993, Curr Opin Neurobiol, V3, P360, DOI 10.1016/0959-4388(93)90129-M; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hoffman AF, 2000, J NEUROSCI, V20, P2470; HOWLETT AC, 1984, MOL PHARMACOL, V26, P532; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Katona I, 1999, J NEUROSCI, V19, P4544; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lenz RA, 1998, J PHYSIOL-LONDON, V512, P61, DOI 10.1111/j.1469-7793.1998.061bf.x; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Morishita W, 1997, J PHYSIOL-LONDON, V505, P307, DOI 10.1111/j.1469-7793.1997.307bb.x; Morishita W, 1998, J NEUROSCI, V18, P4870; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; OHNOSHOSAKU T, 1994, NEUROSCI LETT, V181, P145, DOI 10.1016/0304-3940(94)90580-0; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli D, 1998, NEUROBIOL DIS, V5, P462, DOI 10.1006/nbdi.1998.0221; PITLER TA, 1994, NEURON, V13, P1447; PITLER TA, 1992, J NEUROSCI, V12, P4122; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; SIK A, 1995, J NEUROSCI, V15, P6651; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Wagner JA, 1999, HYPERTENSION, V33, P429, DOI 10.1161/01.HYP.33.1.429; Wagner JJ, 1996, J PHYSIOL-LONDON, V495, P107, DOI 10.1113/jphysiol.1996.sp021577; WILLIAMS S, 1994, J NEUROPHYSIOL, V71, P2217, DOI 10.1152/jn.1994.71.6.2217; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	55	404	418	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2001	31	3					453	462		10.1016/S0896-6273(01)00372-5	http://dx.doi.org/10.1016/S0896-6273(01)00372-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516401	Bronze			2022-12-17	WOS:000170601000013
J	MCMANUS, OB; HELMS, LMH; PALLANCK, L; GANETZKY, B; SWANSON, R; LEONARD, RJ				MCMANUS, OB; HELMS, LMH; PALLANCK, L; GANETZKY, B; SWANSON, R; LEONARD, RJ			FUNCTIONAL-ROLE OF THE BETA-SUBUNIT OF HIGH-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS	NEURON			English	Article							K+ CHANNELS; MUSCLE; KINETICS	Mammalian high conductance, calcium-activated potassium (maxi-K) channels are composed of two dissimilar subunits, alpha and beta. We have examined the functional contribution of the beta subunit to the properties of maxi-K channels expressed heterologously in Xenopus oocytes. Channels from oocytes injected with cRNAs encoding both alpha and beta subunits were much more sensitive to activation by voltage and calcium than channels composed of the a subunit alone, while expression levels, single-channel conductance, and ionic selectivity appeared unaffected. Channels from oocytes expressing both subunits were sensitive to DHS-I, a patent agonist of native maxi-K channels, whereas channels composed of the a subunit alone were insensitive. Thus, alpha and beta subunits together contribute to the functional properties of expressed maxi-K channels, Regulation of coassembly might contribute to the functional diversity noted among members of this family of potassium channels.	MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT PHARMACOL,RAHWAY,NJ 07065; UNIV WISCONSIN,GENET LAB,MADISON,WI 53706	Merck & Company; University of Wisconsin System; University of Wisconsin Madison	MCMANUS, OB (corresponding author), MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT MEMBRANE BIOCHEM & BIOPHYS,RAHWAY,NJ 07065, USA.							ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CANDIA S, 1993, BIOPHYS J, V63, P583; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GARCIACALVO M, 1994, J BIOL CHEM, V269, P676; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; MCMANUS OB, 1993, BIOCHEMISTRY-US, V32, P6128, DOI 10.1021/bi00075a002; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; PEREZ G, 1994, BIOPHYS J, V66, P1022, DOI 10.1016/S0006-3495(94)80883-5; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0	19	404	410	0	7	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					645	650		10.1016/0896-6273(95)90321-6	http://dx.doi.org/10.1016/0896-6273(95)90321-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695911	Bronze			2022-12-17	WOS:A1995QP23000018
J	Hikida, T; Kimura, K; Wada, N; Funabiki, K; Nakanishi, S				Hikida, Takatoshi; Kimura, Kensuke; Wada, Norio; Funabiki, Kazuo; Nakanishi, Shigetada			Distinct Roles of Synaptic Transmission in Direct and Indirect Striatal Pathways to Reward and Aversive Behavior	NEURON			English	Article							CONDITIONED PLACE PREFERENCE; COCAINE-INDUCED LOCOMOTION; BASAL GANGLIA; DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; NEURAL MECHANISMS; GENE-EXPRESSION; D1 RECEPTOR; MICE; MODULATION	In the basal ganglia, convergent input and dopaminergic modulation of the direct striatonigral and the indirect striatopallidal pathways are critical in rewarding and aversive learning and drug addiction. To explore how the basal ganglia information is processed and integrated through these two pathways, we developed a reversible neurotransmission blocking technique, in which transmission of each pathway was selectively blocked by specific expression of transmission-blocking tetanus toxin in a doxycycline-dependent manner. The results indicated that the coordinated modulation of these two pathways was necessary for dopamine-mediated acute psychostimulant actions. This modulation, however, shifted to the predominant roles of the direct pathway in reward learning and cocaine sensitization and the indirect pathway in aversive behavior. These two pathways thus have distinct roles: the direct pathway critical for distinguishing associative rewarding stimuli from nonassociative ones and the indirect pathway for rapid memory formation to avoid aversive stimuli.	[Hikida, Takatoshi; Kimura, Kensuke; Wada, Norio; Funabiki, Kazuo; Nakanishi, Shigetada] Osaka Biosci Inst, Dept Syst Biol, Osaka 5650874, Japan; [Hikida, Takatoshi] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kimura, Kensuke] Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 6068501, Japan	Japan Science & Technology Agency (JST); Kyoto University	Nakanishi, S (corresponding author), Osaka Biosci Inst, Dept Syst Biol, 6-2-4 Furuedai, Osaka 5650874, Japan.	snakanis@obi.or.jp	Hikida, Takatoshi/J-5561-2017	Hikida, Takatoshi/0000-0002-8653-311X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 17002016, 20790264]; JST; Takeda Science Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	We thank R. Sprengel and M. Yokoi for plasmids and T. Kaneko and M. Takahashi for antibodies. This work was supported by Grants KAKENHI 17002016 (S.N.) and 20790264 (T.H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST PRESTO program (T.H.); and by grants from the Takeda Science Foundation (S.N.) and Uehara Memorial Foundation (T.H.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Baker DA, 1996, J PHARMACOL EXP THER, V279, P392; Baker DA, 1998, SYNAPSE, V30, P181, DOI 10.1002/(SICI)1098-2396(199810)30:2<181::AID-SYN8>3.0.CO;2-8; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; CUELLO AC, 1978, J COMP NEUROL, V178, P129, DOI 10.1002/cne.901780108; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; DI CG, 1988, P NATL ACAD SCI USA, V85, P5274; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Han JS, 1997, J NEUROSCI, V17, P3913; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Liu ZH, 2008, NEUROPSYCHOPHARMACOL, V33, P3010, DOI 10.1038/npp.2008.4; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; MAENO H, 1982, MOL CELL BIOCHEM, V43, P65, DOI 10.1007/BF00423094; Marshall J F, 1998, Adv Pharmacol, V42, P678; Masugi M, 1999, J NEUROSCI, V19, P955; MILLER RJ, 1980, J HISTOCHEM CYTOCHEM, V28, P903, DOI 10.1177/28.8.7003009; Miner LL, 1995, NEUROREPORT, V6, P2314, DOI 10.1097/00001756-199511270-00011; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smith JW, 2002, NEUROSCIENCE, V113, P755, DOI 10.1016/S0306-4522(02)00257-9; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Wada N, 2007, P NATL ACAD SCI USA, V104, P16690, DOI 10.1073/pnas.0708165104; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Xu M, 2000, BRAIN RES, V852, P198, DOI 10.1016/S0006-8993(99)02258-1; Yamamoto M, 2003, J NEUROSCI, V23, P6759	51	403	409	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					896	907		10.1016/j.neuron.2010.05.011	http://dx.doi.org/10.1016/j.neuron.2010.05.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620875	Bronze			2022-12-17	WOS:000279420800012
J	Bats, C; Groc, L; Choquet, D				Bats, Cecile; Groc, Laurent; Choquet, Daniel			The interaction between stargazin and PSD-95 regulates AMPA receptor surface trafficking	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; MOLECULAR-MECHANISMS; DEPENDENT REGULATION; DIFFUSION DYNAMICS; LATERAL MOVEMENTS	Accumulation of AMPA receptors at synapses is a fundamental feature of glutamatergic synaptic transmission. Stargazin, a member of the TARP family, is an AMPAR auxiliary subunit allowing interaction of the receptor with scaffold proteins of the postsynaptic density, such as PSD-95. How PSD-95 and Stargazin regulate AMPAR number in synaptic membranes remains elusive. We show, using single quantum dot and FRAP imaging in live hippocampal neurons, that exchange of AMPAR by lateral diffusion between extrasynaptic and synaptic sites mostly depends on the interaction of Stargazin with PSD-95 and not upon the GluR2 AMPAR subunit C terminus. Disruption of interactions between Stargazin and PSD-95 strongly increases AMPAR surface diffusion, preventing AMPAR accumulation at postsynaptic sites. Furthermore, AMPARs and Stargazin diffuse as complexes in and out synapses. These results propose a model in which the StargazinPSD-95 interaction plays a key role to trap and transiently stabilize diffusing AMPARs in the postsynaptic density.	Univ Bordeaux, Inst Francois Magendie, CNRS, UMR 5091, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Choquet, D (corresponding author), Univ Bordeaux, Inst Francois Magendie, CNRS, UMR 5091, F-33077 Bordeaux, France.	dchoquet@u-bordeaux2.fr	Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/E-4203-2013	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Bats, Cecile/0000-0002-2246-7248				Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; AEL DE, 2002, CELL, V108, P849; Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rao A, 1998, J NEUROSCI, V18, P1217; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stein V, 2003, J NEUROSCI, V23, P5503; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Triller A, 2003, BIOL CELL, V95, P465, DOI 10.1016/j.biolcel.2003.07.001; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X	75	403	416	0	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					719	734		10.1016/j.neuron.2007.01.030	http://dx.doi.org/10.1016/j.neuron.2007.01.030			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329211	Bronze			2022-12-17	WOS:000245127100012
J	Kellendonk, C; Simpson, EH; Polan, HJ; Malleret, G; Vronskaya, S; Winiger, V; Moore, H; Kandel, ER				Kellendonk, C; Simpson, EH; Polan, HJ; Malleret, G; Vronskaya, S; Winiger, V; Moore, H; Kandel, ER			Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning	NEURON			English	Article							WORKING-MEMORY DEFICITS; DOUBLE-BLIND PET; BASAL GANGLIA; ANTIPSYCHOTIC-DRUGS; SCHIZOPHRENIC SUBJECTS; C957T POLYMORPHISM; DELAYED-RESPONSE; SPATIAL MEMORY; D-2 RECEPTORS; IN-VIVO	Increased activity of D2 receptors (D2Rs) in the striatum has been linked to the pathophysiology of schizophrenia. To determine directly the behavioral and physiological consequences of increased D2R function in the striatum, we generated mice with reversibly increased levels of D2Rs restricted to the striatum. D2 transgenic mice exhibit selective cognitive impairments in working memory tasks and behavioral flexibility without more general cognitive deficits. The deficit in the working memory task persists even after the transgene has been switched off, indicating that it results not from continued overexpression of D2Rs but from excess expression during development. To determine the effects that may mediate the observed cognitive deficits, we analyzed the prefrontal cortex, the brain structure mainly associated with working memory. We found that D2R overexpression in the striatum impacts dopamine levels, rates of dopamine turnover, and activation of D1 receptors in the prefrontal cortex, measures that are critical for working memory.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Lieber Ctr Schizophrenia Res, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Cornell University	Simpson, EH (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	es534@columbia.edu; erk5@columbia.edu	Kellendonk, Christoph/O-7229-2018	Kellendonk, Christoph/0000-0003-3302-2188; Simpson, Eleanor/0000-0002-9092-2230	NIMH NIH HHS [P50 MH066171] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066171] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Akil M, 1999, AM J PSYCHIAT, V156, P1580, DOI 10.1176/ajp.156.10.1580; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BATTIG K, 1960, J COMP PHYSIOL PSYCH, V53, P400, DOI 10.1037/h0047392; Birrell JM, 2000, J NEUROSCI, V20, P4320; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; BUNNEY BS, 1976, BRAIN RES, V117, P423, DOI 10.1016/0006-8993(76)90751-4; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Carpenter WT, 2002, BIOL PSYCHIAT, V51, P969, DOI 10.1016/S0006-3223(02)01399-9; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Colacicco G, 2002, BEHAV BRAIN RES, V132, P95, DOI 10.1016/S0166-4328(01)00391-6; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; DIVAC I, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P461; Floresco SB, 1997, J NEUROSCI, V17, P1880; Fuster J., 1997, PREFRONTAL CORTEX AN, P66; Glickstein SB, 2002, J NEUROSCI, V22, P5619; Goldman-Rakic PS, 1999, ANN NY ACAD SCI, V868, P13, DOI 10.1111/j.1749-6632.1999.tb11270.x; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Guo NN, 2003, NEUROPSYCHOPHARMACOL, V28, P1703, DOI 10.1038/sj.npp.1300224; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hirvonen J, 2005, ARCH GEN PSYCHIAT, V62, P371, DOI 10.1001/archpsyc.62.4.371; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; JASKIW GE, 1990, BRAIN RES, V534, P263, DOI 10.1016/0006-8993(90)90138-2; KAHN RS, 1994, SCHIZOPHR RES, V11, P217, DOI 10.1016/0920-9964(94)90015-9; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Laruelle M, 1998, Q J NUCL MED, V42, P211; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lawford BR, 2005, SCHIZOPHR RES, V73, P31, DOI 10.1016/j.schres.2004.08.020; Lee I, 2003, J NEUROSCI, V23, P1517, DOI 10.1523/JNEUROSCI.23-04-01517.2003; LOUGHLIN SE, 1984, NEUROSCIENCE, V11, P425, DOI 10.1016/0306-4522(84)90034-4; MARKOWITSCH HJ, 1977, PSYCHOL BULL, V84, P817, DOI 10.1037/0033-2909.84.5.817; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Meltzer HY, 2004, CURR OPIN PHARMACOL, V4, P53, DOI 10.1016/j.coph.2003.09.010; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227, DOI 10.1016/0006-3223(93)90288-O; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Ohtani N, 2003, J NEUROSCI, V23, P2840; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; Partiot A, 1996, NEUROPSYCHOLOGIA, V34, P709, DOI 10.1016/0028-3932(95)00143-3; Paxinos G., 1997, MOUSE BRAIN STEREOTA; ROBERTS AC, 1994, J NEUROSCI, V14, P2531; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 1998, J NEUROSCI, V18, P1613; Seeman P, 2000, P NATL ACAD SCI USA, V97, P7673, DOI 10.1073/pnas.97.14.7673; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Velakoulis D, 1996, AUST NZ J PSYCHIAT, V30, P195, DOI 10.3109/00048679609076095; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zvara A, 2005, DIS MARKERS, V21, P61, DOI 10.1155/2005/275318	66	403	411	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					603	615		10.1016/j.neuron.2006.01.023	http://dx.doi.org/10.1016/j.neuron.2006.01.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476668	Bronze			2022-12-17	WOS:000235643800012
J	Diez del Corral, R; Olivera-Martinez, I; Goriely, A; Gale, E; Maden, M; Storey, K				Diez del Corral, R; Olivera-Martinez, I; Goriely, A; Gale, E; Maden, M; Storey, K			Opposing FGF and retinoid pathways control ventral neural pattern, neuronal differentiation, and segmentation during body axis extension	NEURON			English	Article							PROMOTE PRIMARY NEUROGENESIS; RECEPTOR-GAMMA TRANSCRIPTS; PROGENITOR-CELL IDENTITY; DEVELOPING SPINAL-CORD; CHICK SKIN DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; MOTOR-NEURON; GENE-EXPRESSION; SONIC HEDGEHOG	Vertebrate body axis extension involves progressive generation and subsequent differentiation of new cells derived from a caudal stem zone; however, molecular mechanisms that preserve caudal progenitors and coordinate differentiation are poorly understood. FGF maintains caudal progenitors and its attenuation is required for neuronal and mesodermal differentiation and to position segment boundaries. Furthermore, somitic mesoderm promotes neuronal differentiation in part by downregulating Fgf8. Here we identify retinoic acid (RA) as this somitic signal and show that retinoid and FGF pathways have opposing actions. FGF is a general repressor of differentiation, including ventral neural patterning, while RA attenuates Fgf8 in neuroepithelium and paraxial mesoderm, where it controls somite boundary position. RA is further required for neuronal differentiation and expression of key ventral neural patterning genes. Our data demonstrate that FGF and RA pathways are mutually inhibitory and suggest that their opposing actions provide a global mechanism that controls differentiation during axis extension.	Univ Dundee, Wellcome Trust Bioctr, Fac Life Sci, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	University of Dundee; University of Oxford; University of London; King's College London	Storey, K (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Fac Life Sci, Div Cell & Dev Biol, Dow St, Dundee DD1 5EH, Scotland.	k.g.storey@dundee.ac.uk	Goriely, Anne/AAR-1133-2020; DIEZ DEL CORRAL, RUTH/K-7974-2014	Storey, Kate/0000-0003-3506-1287; Goriely, Anne/0000-0001-9229-7216; DIEZ DEL CORRAL, RUTH/0000-0003-2649-7214				Abu-Abed S, 2003, DEVELOPMENT, V130, P1449, DOI 10.1242/dev.00357; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bertrand N, 2000, DEVELOPMENT, V127, P4837; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brown JM, 2000, CURR BIOL, V10, P869, DOI 10.1016/S0960-9822(00)00601-1; Cai J, 1999, DEV DYNAM, V216, P459, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<459::AID-DVDY14>3.3.CO;2-Z; Calle-Mustienes ED, 2002, MECH DEVELOP, V119, P69, DOI 10.1016/S0925-4773(02)00296-4; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.3.CO;2-X; CHIANG C, 1996, NATURE, V381, P155; DERSCH H, 1993, DEV BIOL, V160, P424, DOI 10.1006/dbio.1993.1318; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Dubrulle J, 2002, CURR OPIN GENET DEV, V12, P519, DOI 10.1016/S0959-437X(02)00335-0; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dupe V, 2001, DEVELOPMENT, V128, P2199; EAGER NSC, 1991, FEBS LETT, V292, P103, DOI 10.1016/0014-5793(91)80844-S; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Franco PG, 1999, DEVELOPMENT, V126, P4257; Gale E, 1996, DEVELOPMENT, V122, P783; Gavalas A, 2002, TRENDS NEUROSCI, V25, P61, DOI 10.1016/S0166-2236(02)02067-2; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Irving C, 2000, DEVELOPMENT, V127, P177; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; LAWSON KA, 1992, CIBA F SYMP, V165, P3; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Liem KF, 2000, DEVELOPMENT, V127, P4855; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; Maden M, 2001, INT REV CYTOL, V209, P1; Maden M, 1998, DEVELOPMENT, V125, P4133; Maden M, 2000, INT J DEV BIOL, V44, P151; MADEN M, 1989, DEV BIOL, V135, P124, DOI 10.1016/0012-1606(89)90163-2; MAHMOOD R, 1995, DEVELOPMENT, V121, P1399; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mathis L, 2000, DEVELOPMENT, V127, P1277; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Mercader N, 2000, DEVELOPMENT, V127, P3961; MICHAILLE JJ, 1995, INT J DEV BIOL, V39, P587; MICHAILLE JJ, 1994, DEV DYNAM, V201, P334, DOI 10.1002/aja.1002010405; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Nicolas JF, 1996, DEVELOPMENT, V122, P2933; Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohuchi H, 2000, MECH DEVELOP, V95, P55, DOI 10.1016/S0925-4773(00)00331-2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; Patten I, 2002, CURR BIOL, V12, P47, DOI 10.1016/S0960-9822(01)00631-5; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pituello F, 1999, DEVELOPMENT, V126, P587; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; RIESE J, 1995, MECH DEVELOP, V49, P13, DOI 10.1016/0925-4773(94)00296-Y; ROWE A, 1991, DEVELOPMENT, V111, P771; ROWE A, 1991, DEVELOPMENT, V111, P1007; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SCHOENWOLF GC, 1992, ANAT REC, V233, P281, DOI 10.1002/ar.1092330211; SECHRIST J, 1991, NEURON, V7, P947, DOI 10.1016/0896-6273(91)90340-6; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; Shamim H, 1999, MECH DEVELOP, V85, P189, DOI 10.1016/S0925-4773(99)00093-3; Sharpe C, 2000, INT J DEV BIOL, V44, P463; Sharpe CR, 1997, DEVELOPMENT, V124, P515; SHIGA T, 1995, J COMP NEUROL, V360, P463, DOI 10.1002/cne.903600308; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; STERN CD, 1992, DEVELOPMENT, P151; Storey KG, 1998, DEVELOPMENT, V125, P473; Stratford T, 1996, CURR BIOL, V6, P1124, DOI 10.1016/S0960-9822(02)70679-9; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Teillet MA, 1998, P NATL ACAD SCI USA, V95, P11733, DOI 10.1073/pnas.95.20.11733; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; YAGINUMA H, 1990, DEVELOPMENT, V108, P705; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	95	403	404	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2003	40	1					65	79						15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527434				2022-12-17	WOS:000185614700010
J	Furukawa, T; Mukherjee, S; Bao, ZZ; Morrow, EM; Cepko, CL				Furukawa, T; Mukherjee, S; Bao, ZZ; Morrow, EM; Cepko, CL			rax, hes1, and notch1 promote the formation of Muller glia by postnatal retinal progenitor cells	NEURON			English	Article							MAMMALIAN NEURONAL DIFFERENTIATION; VERTEBRATE RETINA; HOMEOBOX GENE; EYE DEVELOPMENT; XENOPUS RETINA; EXPRESSION; DROSOPHILA; MOUSE; FATE; GLIOGENESIS	We are interested in the mechanisms of glial cell development in the vertebrate central nervous system. We have identified genes that can direct the formation of glia in the retina, rax, a homeobox gene, Hes1, a basic helix-loop-helix gene, and notch1, a transmembrane receptor gene, are expressed in retinal progenitor cells, downregulated in differentiated neurons, and expressed in Muller glia. Retroviral transduction of any of these genes resulted in expression of glial markers. In contrast, misexpression of a dominant-negative Hes1 gene reduced the number of glia. Cotransfection of rax with reporter constructs containing the Hes1 or notch1 regulatory regions led to the upregulation of reporter transcription. These data suggest a regulatory heirarchy that controls the formation of glia at the expense of neurons.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu	Morrow, Eric/J-2767-2013	Morrow, Eric/0000-0003-3430-3520	NATIONAL EYE INSTITUTE [R01EY008064] Funding Source: NIH RePORTER; NEI NIH HHS [EYO 8064, EY06726-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bao ZZ, 1997, J NEUROSCI, V17, P1425; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; CEPKO C, 1997, CURRENT PROTOCALS MO; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Molday RS, 1989, PROG RET RES, V8, P173; Morrow EM, 1999, DEVELOPMENT, V126, P23; NYE JS, 1994, DEVELOPMENT, V120, P2421; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; OSBORNE NN, 1991, VISUAL NEUROSCI, V7, P637, DOI 10.1017/S0952523800010427; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rajan P, 1998, J NEUROSCI, V18, P3620; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Sambrook J, 1989, MOL CLONING LAB MANU, V1; SARTHY V, 1995, DNA CELL BIOL, V14, P313, DOI 10.1089/dna.1995.14.313; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	39	403	418	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2000	26	2					383	394		10.1016/S0896-6273(00)81171-X	http://dx.doi.org/10.1016/S0896-6273(00)81171-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318QZ	10839357	Bronze			2022-12-17	WOS:000087296500015
J	SHARP, AH; LOEV, SJ; SCHILLING, G; LI, SH; LI, XJ; BAO, J; WAGSTER, MV; KOTZUK, JA; STEINER, JP; LO, A; HEDREEN, J; SISODIA, S; SNYDER, SH; DAWSON, TM; RYUGO, DK; ROSS, CA				SHARP, AH; LOEV, SJ; SCHILLING, G; LI, SH; LI, XJ; BAO, J; WAGSTER, MV; KOTZUK, JA; STEINER, JP; LO, A; HEDREEN, J; SISODIA, S; SNYDER, SH; DAWSON, TM; RYUGO, DK; ROSS, CA			WIDESPREAD EXPRESSION OF HUNTINGTONS-DISEASE GENE (IT15) PROTEIN PRODUCT	NEURON			English	Article							TRINUCLEOTIDE CAG REPEAT; D-ASPARTATE RECEPTOR; STRIATAL NEURONS; QUINOLINIC ACID; KAINIC ACID; GLUTAMATE; LENGTH; CORTEX; DEGENERATION; EXPANSION	Huntington's Disease (HD) is caused by expansion of a CAG repeat within a putative open reading frame of a recently identified gene, IT15. We have examined the expression of the gene's protein product using antibodies developed against the N-terminus and an internal epitope. Both antisera recognize a 350 kDa protein, the predicted size, indicating that the CAG repeat is translated into polyglutamine. The HD protein product is widely expressed, most highly in neurons in the brain. There is no enrichment in the striatum, the site of greatest pathology in HD. Within neurons, the protein is diminished in nuclei and mitochondria and is present in the soluble cytoplasmic compartment, as well as loosely associated with membranes or cytoskeleton, in cell bodies, dendrites, and axons. It is concentrated in nerve terminals, including terminals within the caudate and putamen. Thus, the normal HD gene product may be involved in common intracellular functions, and possibly in regulation of nerve terminal function. The product of the expanded allele is expressed, consistent with a gain of function mechanism for HD at the protein level.	JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,NEUROPATHOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	SHARP, AH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,MOLEC NEUROBIOL LAB,BALTIMORE,MD 21205, USA.		Ross, Christopher A/H-8395-2013; Ryugo, David K./G-1940-2012; Lo, Amy C. Y./C-1195-2009	Ryugo, David K./0000-0002-5250-7503; Lo, Amy C. Y./0000-0003-4239-6851	NIDCD NIH HHS [DC00232] Funding Source: Medline; NINDS NIH HHS [P01 NS16375, NS 01578] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375, K08NS001578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000232] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; AYLWARD EH, 1994, NEUROLOGY, V44, P823, DOI 10.1212/WNL.44.5.823; BEAL MF, 1991, J NEUROSCI, V11, P1649; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BEAL MF, 1993, J NEUROSCI, V13, P4181; BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BIZIERE K, 1979, J NEUROSCI RES, V4, P383, DOI 10.1002/jnr.490040507; BRAAK H, 1982, CELL TISSUE RES, V227, P319, DOI 10.1007/BF00210889; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CHOI DW, 1992, SCIENCE, V258, P241, DOI 10.1126/science.1357748; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; CUDKOWICZ M, 1990, ANN NEUROL, V27, P200, DOI 10.1002/ana.410270217; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DIFIGLIA M, 1976, BRAIN RES, V114, P245, DOI 10.1016/0006-8993(76)90669-7; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FERRANTE RJ, 1987, J NEUROPATH EXP NEUR, V46, P12, DOI 10.1097/00005072-198701000-00002; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; GRAY EG, 1962, J ANAT, V96, P79; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; HARLOW E, 1988, ANTIBODIES LABORATOR; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; HEDREEN JC, 1995, HUNTINGTON DISEASE P, P1; HOOGEVEEN AT, 1993, HUM MOL GENET, V12, P2069; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KAWAGUCHI Y, 1995, NAT GENET, V8, P221; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGE H W, 1981, Verhandlungen der Anatomischen Gesellschaft, V75, P923; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEE WS, 1993, ENDOCRINOLOGY, V133, P2248, DOI 10.1210/en.133.5.2248; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MCGEER EG, 1978, BRAIN RES, V139, P381, DOI 10.1016/0006-8993(78)90941-1; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; RYUGO DK, 1991, J COMP NEUROL, V308, P209, DOI 10.1002/cne.903080208; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; 1993, CELL, V72, P971	58	403	417	0	17	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					1065	1074		10.1016/0896-6273(95)90345-3	http://dx.doi.org/10.1016/0896-6273(95)90345-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748554	hybrid			2022-12-17	WOS:A1995QY93500019
J	Kutsuwada, T; Sakimura, K; Manabe, T; Takayama, C; Katakura, N; Kushiya, E; Natsume, R; Watanabe, M; Inoue, Y; Yagi, T; Aizawa, S; Arakawa, M; Takahashi, T; Nakamura, Y; Mori, H; Mishina, M				Kutsuwada, T; Sakimura, K; Manabe, T; Takayama, C; Katakura, N; Kushiya, E; Natsume, R; Watanabe, M; Inoue, Y; Yagi, T; Aizawa, S; Arakawa, M; Takahashi, T; Nakamura, Y; Mori, H; Mishina, M			Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice	NEURON			English	Article							LONG-TERM POTENTIATION; SPINAL-CORD NEURONS; CYTOCHROME-OXIDASE; AREA CA1; DEVELOPMENTAL-CHANGES; PURKINJE-CELLS; NEONATAL RATS; CHANNEL; ADULT; MOUSE	Multiple epsilon subunits are major determinants of the NMDA receptor channel diversity. Based on their functional properties in vitro and distributions, we have proposed that the epsilon 1 and epsilon 2 subunits play a role in synaptic plasticity. To investigate the physiological significance of the NMDA receptor channel diversity, we generated mutant mice defective in the epsilon 2 subunit. These mice showed no suckling response and died shortly after birth but could survive by hand feeding. The mutation hindered the formation of the whisker-related neuronal barrelette structure and the clustering of primary sensory afferent terminals in the brain-stem trigeminal nucleus. In the hippocampus of the mutant mice, synaptic NMDA responses and long-term depression were abolished. These results suggest that the epsilon 2 subunit plays an essential role in both neuronal pattern formation and synaptic plasticity.	UNIV TOKYO, FAC MED, INST BRAIN RES, DEPT NEUROPHYSIOL, TOKYO 113, JAPAN; HOKKAIDO UNIV, SCH MED, DEPT ANAT, SAPPORO, HOKKAIDO 060, JAPAN; TOKYO MED & DENT UNIV, FAC DENT, DEPT PHYSIOL, TOKYO 113, JAPAN; TSUKUBA LIFE SCI CTR, INST PHYS & CHEM RES, MOLEC ONCOL LAB, IBARAKI, OSAKA 305, JAPAN; UNIV TOKYO, FAC MED, DEPT PHARMACOL, TOKYO 113, JAPAN; NIIGATA UNIV, FAC MED, DEPT INTERNAL MED 2, NIIGATA 951, JAPAN	University of Tokyo; Hokkaido University; Tokyo Medical & Dental University (TMDU); RIKEN; University of Tokyo; Niigata University	Kutsuwada, T (corresponding author), NIIGATA UNIV, BRAIN RES INST, DEPT NEUROPHARMACOL, NIIGATA 951, JAPAN.		WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Arakawa, Masao/0000-0002-2729-8666; Katakura, Nobuo/0000-0002-3495-0886				ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; ASCHER P, 1986, J PHYSIOL-LONDON, V377, pP35; ASHWELL KW, 1982, J ANAT, V135, P531; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BELFORD GR, 1979, J COMP NEUROL, V183, P305, DOI 10.1002/cne.901830207; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BROSE N, 1993, J BIOL CHEM, V268, P22663; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHIAIA NL, 1992, NEUROSCIENCE, V49, P141, DOI 10.1016/0306-4522(92)90082-D; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; ERZURUMLU RS, 1992, J NEUROSCI, V12, P3946; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; IZUMI Y, 1995, SYNAPSE, V20, P19, DOI 10.1002/syn.890200104; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MA PM, 1991, J COMP NEUROL, V309, P161, DOI 10.1002/cne.903090202; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; MISHINA M, 1993, ANN NY ACAD SCI, V707, P136, DOI 10.1111/j.1749-6632.1993.tb38049.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1989, DEV BRAIN RES, V49, P105, DOI 10.1016/0165-3806(89)90063-1; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; QUINLAN JE, 1985, NEUROSCI LETT, V60, P39, DOI 10.1016/0304-3940(85)90378-7; SAKIMURA K, 1980, J NEUROCHEM, V34, P687, DOI 10.1111/j.1471-4159.1980.tb11198.x; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SCHMECHEL D, 1978, SCIENCE, V199, P313, DOI 10.1126/science.339349; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHEN H, 1994, BRAIN RES, V635, P159, DOI 10.1016/0006-8993(94)91435-4; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; WATANABE M, 1994, NEUROSCI LETT, V165, P183, DOI 10.1016/0304-3940(94)90740-4; WESTNEAT MW, 1992, BEHAV NEUROSCI, V106, P539, DOI 10.1037/0735-7044.106.3.539; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I	59	402	407	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					333	344		10.1016/S0896-6273(00)80051-3	http://dx.doi.org/10.1016/S0896-6273(00)80051-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789948	Bronze			2022-12-17	WOS:A1996TW95700013
J	Kalatsky, VA; Stryker, MP				Kalatsky, VA; Stryker, MP			New paradigm for optical imaging: Temporally encoded maps of intrinsic signal	NEURON			English	Article							PRIMARY VISUAL-CORTEX; VOLTAGE-SENSITIVE DYES; MONKEY STRIATE CORTEX; RETINOTOPIC ORGANIZATION; FUNCTIONAL ARCHITECTURE; MOUSE; ORIENTATION; CONNECTIONS; AREA; PLASTICITY	We present a new technique for acquiring and analyzing intrinsic signal optical images of brain activity, using continuous stimulus presentation and data acquisition. The main idea is to present a temporally periodic stimulus and to analyze the component of the response at the stimulus frequency. Advantages of the new technique include the removal of heart, respiration, and vasomotor artifacts, a dramatic increase in spatial resolution, and a 30-fold or greater reduction in acquisition time. We also present a novel approach to localizing instantaneous neuronal responses using time-reversed stimuli that is widely applicable to brain imaging. To demonstrate the power of the technique, we present high-resolution retinotopic maps of five visual areas in mouse cortex and orientation maps in cat visual cortex.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.			Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [R01 EY002874, EY 02874, R37 EY002874-24] Funding Source: Medline; NINDS NIH HHS [P01 NS016033, NS 16033] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002874, R37EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016033, P01NS016033] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonini A, 1999, J NEUROSCI, V19, P4388; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Bosking WH, 2000, J NEUROSCI, V20, P2346; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; METIN C, 1988, EXP BRAIN RES, V69, P594; MITRA PP, 1999, IMAGING NEURONS LAB; OLAVARRIA J, 1982, EXP NEUROL, V78, P775, DOI 10.1016/0014-4886(82)90090-5; OLAVARRIA J, 1989, VISUAL NEUROSCI, V3, P59, DOI 10.1017/S0952523800012517; Schuett S, 2002, J NEUROSCI, V22, P6549; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; Williams RW, 1996, J NEUROSCI, V16, P7193; ZEKI S, 1980, PROC R SOC SER B-BIO, V207, P239, DOI 10.1098/rspb.1980.0022; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	37	401	408	1	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 22	2003	38	4					529	545		10.1016/S0896-6273(03)00286-1	http://dx.doi.org/10.1016/S0896-6273(03)00286-1			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765606	Bronze			2022-12-17	WOS:000183104000005
J	Thompson-Schill, SL; D'Esposito, M; Kan, IP				Thompson-Schill, SL; D'Esposito, M; Kan, IP			Effects of repetition and competition on activity in left prefrontal cortex during word generation	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; BOLD FMRI STATISTICS; SHORT-TERM-MEMORY; ELECTRICAL-STIMULATION; ALZHEIMERS-DISEASE; SEMANTIC KNOWLEDGE; EMPIRICAL ANALYSES; CATEGORY FLUENCY; FIELD POTENTIALS; NULL-HYPOTHESIS	Neuroimaging studies have revealed an association between word generation and activity in the left inferior frontal gyrus (IFG) that is attentuated with item repetition. The experiment reported here examined the effects of repeated word generation, under conditions in which completion was either decreased or increased, on activity measured during whole-brain echoplanar functional magnetic resonance imaging. Activity in left IFG decreased during repetition conditions that reduced competition but increased during repetition conditions that increased competition; this pattern was contrasted to repetition effects observed in other cortical areas, specifically regions of left temporal cortex. The increase in left IFG activity, which is not predicted by a simple semantic retrieval account of prefrontal function, is consistent with the hypothesis that left IFG subserves the selection of semantic knowledge among competing alternatives.	Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thompson-Schill, SL (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	thompson@psych.upenn.edu	Thompson-Schill, Sharon/M-1788-2013		NIA NIH HHS [AG13483, AG05743] Funding Source: Medline; NINDS NIH HHS [NS01762] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013483] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Aguirre GK, 1997, NEUROIMAGE, V5, P199, DOI 10.1006/nimg.1997.0264; ALEXANDER MP, 1989, ARCH NEUROL-CHICAGO, V46, P885, DOI 10.1001/archneur.1989.00520440075023; ALEXANDER MP, 1997, BEHAV NEUROLOGY NEUR, P133; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; BOGEN JE, 1976, ANN NY ACAD SCI, V280, P834, DOI 10.1111/j.1749-6632.1976.tb25546.x; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; BURNSTINE TH, 1990, NEUROLOGY, V40, P966, DOI 10.1212/WNL.40.6.966; CHERTKOW H, 1990, BRAIN, V113, P397, DOI 10.1093/brain/113.2.397; COSLETT HB, 1991, ARCH NEUROL-CHICAGO, V48, P949, DOI 10.1001/archneur.1991.00530210075027; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; Dronkers N. F., 1998, HDB NEUROLINGUISTICS, DOI DOI 10.1016/B978-012666055-5/50015-0; Farah M.J., 1990, VISUAL AGNOSIA DISOR; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; GOLDENBERG G, 1994, BRAIN LANG, V47, P684, DOI 10.1006/brln.1994.1063; Goodglass H., 1983, ASSESSMENT APHASIA R, V2; HODGES JR, 1994, COGNITIVE NEUROPSYCH, V11, P505, DOI 10.1080/02643299408251984; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P1089, DOI 10.1136/jnnp.53.12.1089; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; KLEIN D, 1995, P NATL ACAD SCI USA, V92, P2899, DOI 10.1073/pnas.92.7.2899; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LUDERS H, 1986, NEUROLOGY, V36, P505, DOI 10.1212/WNL.36.4.505; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; MARTIN A, 1983, BRAIN LANG, V19, P124, DOI 10.1016/0093-934X(83)90059-7; MARTIN A, 1999, IN PRESS COGNITIVE N; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; MILLER EK, 1993, J NEUROSCI, V13, P1460; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Milner B., 1964, FRONTAL GRANULAR COR, P313; MOSCOVITCH M, 1992, NEUROPSYCHOLOGY MEMO, P5; Mummery CJ, 1996, P ROY SOC B-BIOL SCI, V263, P989, DOI 10.1098/rspb.1996.0146; Newcombe F, 1969, MISSLE WOUNDS BRAIN; NOBRE AC, 1995, J NEUROSCI, V15, P1090; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Randolph C., 1993, NEUROPSYCHOLOGY, V7, P82, DOI [10.1037/0894-4105.7.1.82, DOI 10.1037/0894-4105.7.1.82]; RICHES IP, 1991, J NEUROSCI, V11, P1763; Robinson G, 1998, BRAIN, V121, P77, DOI 10.1093/brain/121.1.77; ROSSER A, 1994, J NEUROL NEUROSUR PS, V57, P1389, DOI 10.1136/jnnp.57.11.1389; SCARBOROUGH DL, 1979, MEM COGNITION, V7, P3, DOI 10.3758/BF03196928; SEGER CA, 1999, IN PRESS BRAIN COGN; SRINIVAS K, 1990, J MEM LANG, V29, P389, DOI 10.1016/0749-596X(90)90063-6; Swaab TY, 1998, NEUROPSYCHOLOGIA, V36, P737, DOI 10.1016/S0028-3932(97)00174-7; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1999, J EXP PSYCHOL LEARN, V25, P41, DOI 10.1037/0278-7393.25.1.41; Thompson-Schill SL, 1999, NEUROPSYCHOLOGIA, V37, P671, DOI 10.1016/S0028-3932(98)00126-2; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WELDON MS, 1991, J EXP PSYCHOL LEARN, V17, P526, DOI 10.1037/0278-7393.17.3.526; WERNICKE K, 1968, P BOST C PHIL SCI, V4, P34; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	60	401	403	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1999	23	3					513	522		10.1016/S0896-6273(00)80804-1	http://dx.doi.org/10.1016/S0896-6273(00)80804-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	221AA	10433263	Bronze, Green Submitted			2022-12-17	WOS:000081701000015
J	Isaac, JTR; Crair, MC; Nicoll, RA; Malenka, RC				Isaac, JTR; Crair, MC; Nicoll, RA; Malenka, RC			Silent synapses during development of thalamocortical inputs	NEURON			English	Article							LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; SOMATOSENSORY CORTEX; CRITICAL PERIOD; NMDA RECEPTORS; PLASTICITY; TRANSMISSION; DEPRESSION; RESPONSES; BLOCKADE	During development, activity-dependent mechanisms are thought to contribute to the refinement of topographical projections from the thalamus to the cortex. Because activity-dependent increases in synaptic strength may contribute to the stabilization of synaptic connections, we have explored the mechanisms of long-term potentiation (LTP) at thalamocortical synapses in rat somatosensory (barrel) cortex. During early postnatal development (postnatal days 2-5), we find that a significant proportion of thalamocortical synapses are functionally silent and that these are converted to functional synapses during LTP. Silent synapses disappear by postnatal day 8-9, the exact time at which the susceptibility of these synapses to LTP is lost. These findings suggest that the activity-dependent conversion of silent to functional synapses due to correlated pre- and postsynaptic activity may contribute to the early development and refinement of thalamocortical inputs to cortex.	UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MOL & CELLULAR PHARMACOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco								AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1992, J NEUROPHYSIOL, V67, P1; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CATALANO SM, 1996, J COMP NEUROL, V366, P36; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P217, DOI 10.1113/jphysiol.1985.sp015821; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FOX K, 1993, TRENDS NEUROSCI, V16, P116, DOI 10.1016/0166-2236(93)90136-A; GOODMAN CS, 1993, CELL S, V10, P77; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONES EG, 1969, PROC R SOC SER B-BIO, V172, P173, DOI 10.1098/rspb.1969.0018; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIMURA F, 1989, J PHYSIOL-LONDON, V414, P125, DOI 10.1113/jphysiol.1989.sp017680; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124, DOI 10.1152/jn.1988.59.1.124; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; PATENEAU DK, 1990, J NEUROSCI, V10, P2385; PERKINS AT, 1988, BRAIN RES, V439, P222; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; TSUMOTO T, 1992, PROG NEUROBIOL, V39, P209, DOI 10.1016/0301-0082(92)90011-3; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	41	401	411	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					269	280		10.1016/S0896-6273(00)80267-6	http://dx.doi.org/10.1016/S0896-6273(00)80267-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052797	Bronze			2022-12-17	WOS:A1997WK82200010
J	STEVENS, CF; WANG, YY				STEVENS, CF; WANG, YY			FACILITATION AND DEPRESSION AT SINGLE CENTRAL SYNAPSES	NEURON			English	Article							RAT HIPPOCAMPAL SLICES; QUANTAL ANALYSIS; GLUTAMATE; NEURONS; PROBABILITY; RECEPTORS; RELEASE	Using whole-cell recording from CA1 hippocampal pyramidal neurons and minimal stimulation of Schaffer collaterals, we have studied what seem to be single synapses. Although the transmission at a putative single synapse is quite unreliable, the synapse can be made to release transmitter reliably in response to the second stimulus in a pair of stimuli that are presented in rapid succession (e.g., 50 ms separation). Statistical analysis of transmission failures seen with such paired pulse stimulation reveals that the majority of stimulus-evoked synaptic currents (>90%) are produced by a single synapse under the conditions of minimal stimulation, even if multiple synapses are actually present. individual synapses appear to release either zero or one quantum; that is, a single synapse seems to have only one functional release site at any time. After the release site has been used, similar to 20 ms is required to refill the site so that it can be used again.			STEVENS, CF (corresponding author), SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 12961] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; ANDERSEN P, 1978, BRAIN RES, V144, P11, DOI 10.1016/0006-8993(78)90431-6; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; EDWARDS FA, 1990, J PHYSL, V117, P109; Feller W, 1950, INTRO PROBABILITY TH; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HUBBARD JI, 1963, J PHYSL, V169, P6461; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P2834, DOI 10.1073/pnas.85.8.2834; ZUKER RS, 1988, ANN REV NEUROSCI, V12, P13	19	401	405	0	11	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					795	802		10.1016/0896-6273(95)90223-6	http://dx.doi.org/10.1016/0896-6273(95)90223-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718241	Bronze			2022-12-17	WOS:A1995QU82600013
J	van den Pol, AN				van den Pol, Anthony N.			Neuropeptide Transmission in Brain Circuits	NEURON			English	Review							RAT SUPRAOPTIC NUCLEUS; CENTRAL-NERVOUS-SYSTEM; METABOTROPIC GLUTAMATE RECEPTORS; CORTICOTROPIN-RELEASING-FACTOR; PROTEIN-COUPLED RECEPTORS; AGOUTI-RELATED PEPTIDE; MOSSY FIBER SYNAPSES; MONOMERIC G-PROTEINS; HYPOCRETIN OREXIN; SYNAPTIC-TRANSMISSION	Neuropeptides are found in many mammalian CNS neurons where they play key roles in modulating neuronal activity. In contrast to amino acid transmitter release at the synapse, neuropeptide release is not restricted to the synaptic specialization, and after release, a neuropeptide may diffuse some distance to exert its action through a G protein-coupled receptor. Some neuropeptides such as hypocretin/orexin are synthesized only in single regions of the brain, and the neurons releasing these peptides probably have similar functional roles. Other peptides such as neuropeptide Y (NPY) are synthesized throughout the brain, and neurons that synthesize the peptide in one region have no anatomical or functional connection with NPY neurons in other brain regions. Here, I review converging data revealing a complex interaction between slow-acting neuromodulator peptides and fast-acting amino acid transmitters in the control of energy homeostasis, drug addiction, mood and motivation, sleep-wake states, and neuroendocrine regulation.	Yale Univ, Dept Neurosurg, New Haven, CT 06520 USA	Yale University	van den Pol, AN (corresponding author), Yale Univ, Dept Neurosurg, New Haven, CT 06520 USA.	anthony.vandenpol@yale.edu			US National Institute of Health [NS48476, NS079274, DK084052]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079274, R01NS048476, R01NS041454, R01NS031573] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I am indebted to Dr. Guido Wollmann for generous help with some of the figures, and Drs. M. Whim, W.E. Armstrong, Q. Pittman, M.N. Nitabach, J. Paglino, X. Zhang, and J. Davis for suggestions on the manuscript. Neuromodulation work in the lab is supported by the US National Institute of Health NS48476, NS079274, and DK084052.	Acsady L, 1996, NEUROSCIENCE, V73, P299, DOI 10.1016/0306-4522(95)00610-9; Acsady L, 2000, J NEUROSCI, V20, P6907, DOI 10.1523/JNEUROSCI.20-18-06907.2000; Acuna-Goycolea C, 2004, J NEUROSCI, V24, P8141, DOI 10.1523/JNEUROSCI.1607-04.2004; Antonucci F, 2012, J NEUROSCI, V32, P1989, DOI 10.1523/JNEUROSCI.2720-11.2012; Ariel P, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00018; Armstrong WE, 2006, AM J PHYSIOL-REG I, V291, pR26, DOI 10.1152/ajpregu.00879.2005; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Azmitia EC, 1996, NEUROPSYCHOPHARMACOL, V14, P35, DOI 10.1016/S0893-133X(96)80057-1; Bacci A, 2002, P NATL ACAD SCI USA, V99, P17125, DOI 10.1073/pnas.012481899; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bering R, 1997, EXP BRAIN RES, V115, P423, DOI 10.1007/PL00005712; BICKNELL RJ, 1981, NEUROENDOCRINOLOGY, V33, P295, DOI 10.1159/000123248; Billova S, 2007, NEUROSCIENCE, V147, P403, DOI 10.1016/j.neuroscience.2007.04.039; BONDY CA, 1987, NEUROENDOCRINOLOGY, V46, P258, DOI 10.1159/000124829; Borgland SL, 2008, EUR J NEUROSCI, V28, P1545, DOI 10.1111/j.1460-9568.2008.06397.x; Bradley SR, 1996, J NEUROSCI, V16, P2044; Brown CH, 2004, J PHYSIOL-LONDON, V557, P949, DOI 10.1113/jphysiol.2004.063818; Brown CH, 2004, NEUROSCIENCE, V124, P105, DOI 10.1016/j.neuroscience.2003.11.038; Burgess CR, 2012, J NEUROSCI, V32, P12305, DOI 10.1523/JNEUROSCI.2630-12.2012; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Castillo PE, 1996, J NEUROSCI, V16, P5942; CAZALIS M, 1985, J PHYSIOL-LONDON, V369, P45, DOI 10.1113/jphysiol.1985.sp015887; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Choi C, 2012, CELL REP, V2, P332, DOI 10.1016/j.celrep.2012.06.021; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; CHURCH PJ, 1991, J NEUROSCI, V11, P618; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; COLMERS WF, 1988, J NEUROSCI, V8, P3827; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dayanithi G, 2012, CELL CALCIUM, V51, P293, DOI 10.1016/j.ceca.2012.02.002; de Kock CPJ, 2003, J NEUROSCI, V23, P2726; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DECAVEL C, 1990, J COMP NEUROL, V302, P1019, DOI 10.1002/cne.903020423; DEPAOLI AM, 1994, MOL CELL NEUROSCI, V5, P327, DOI 10.1006/mcne.1994.1039; Dicken MS, 2012, J NEUROSCI, V32, P4042, DOI 10.1523/JNEUROSCI.6032-11.2012; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; DREIFUSS JJ, 1975, ANN NY ACAD SCI, V248, P184, DOI 10.1111/j.1749-6632.1975.tb34185.x; DREIFUSS JJ, 1971, J PHYSIOL-LONDON, V215, P805, DOI 10.1113/jphysiol.1971.sp009499; DUN NJ, 1994, P NATL ACAD SCI USA, V91, P2955, DOI 10.1073/pnas.91.8.2955; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; DUTTON A, 1979, J PHYSIOL-LONDON, V290, P433, DOI 10.1113/jphysiol.1979.sp012781; Elmquist JK, 2001, PHYSIOL BEHAV, V74, P703, DOI 10.1016/S0031-9384(01)00613-8; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; EVERITT BJ, 1986, BRAIN RES REV, V11, P97, DOI 10.1016/S0006-8993(86)80192-5; FINK G, 1995, FRONT NEUROENDOCRIN, V16, P183, DOI 10.1006/frne.1995.1006; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUNDMERCIER MJ, 1994, J PHYSIOL-LONDON, V480, P155, DOI 10.1113/jphysiol.1994.sp020349; Fu LY, 2008, J NEUROSCI, V28, P5433, DOI 10.1523/JNEUROSCI.0749-08.2008; Fu LY, 2004, J NEUROSCI, V24, P8741, DOI 10.1523/JNEUROSCI.2268-04.2004; Fuenzalida LC, 2011, ENDOCRINOLOGY, V152, P4310, DOI 10.1210/en.2011-1416; Fuxe K, 2005, J NEURAL TRANSM, V112, P65, DOI 10.1007/s00702-004-0158-3; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; GAINER H, 1986, NEUROENDOCRINOLOGY, V43, P557, DOI 10.1159/000124582; Gao XB, 2002, J PHYSIOL-LONDON, V542, P273, DOI 10.1113/jphysiol.2002.019372; Gao XB, 2001, J PHYSIOL-LONDON, V533, P237, DOI 10.1111/j.1469-7793.2001.0237b.x; Gardner S, 2009, NEUROENDOCRINOLOGY, V89, P241, DOI 10.1159/000165377; Giesbrecht CJ, 2010, J NEUROSCI, V30, P16970, DOI 10.1523/JNEUROSCI.2306-10.2010; Gompf HS, 2005, NEUROSCIENCE, V132, P955, DOI 10.1016/j.neuroscience.2004.11.057; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Gundlach AL, 2002, EUR J PHARMACOL, V440, P255, DOI 10.1016/S0014-2999(02)01433-4; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; HATTON GI, 1984, PEPTIDES, V5, P121, DOI 10.1016/0196-9781(84)90271-7; Hazell GGJ, 2012, FRONT NEUROENDOCRIN, V33, P45, DOI 10.1016/j.yfrne.2011.07.002; HERKENHAM M, 1987, NEUROSCIENCE, V23, P1, DOI 10.1016/0306-4522(87)90268-5; Hirasawa M, 2004, J PHYSIOL-LONDON, V559, P611, DOI 10.1113/jphysiol.2004.066159; Hirasawa M, 2001, J PHYSIOL-LONDON, V532, P595, DOI 10.1111/j.1469-7793.2001.0595e.x; Hoang QV, 2003, J NEUROPHYSIOL, V90, P693, DOI 10.1152/jn.00001.2003; HOKFELT T, 1990, PROG CLIN BIOL RES, V342, P257; Horvath TL, 1999, J NEUROSCI, V19, P1072; HOSOYA Y, 1979, EXP BRAIN RES, V35, P315; Hurbin A, 2002, ENDOCRINOLOGY, V143, P456, DOI 10.1210/en.143.2.456; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; Jansson Anders, 2002, P83; JURZAK M, 1995, NEUROSCIENCE, V65, P1145, DOI 10.1016/0306-4522(94)00539-H; Kaneko M, 2012, J NEUROSCI, V32, P4790, DOI 10.1523/JNEUROSCI.4462-11.2012; Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kimelberg H., 1988, GLIAL CELL RECEPTORS; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; Kombian SB, 2002, PROG BRAIN RES, V139, P235; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; Kozniewska E, 2008, J PHYSIOL PHARMACOL, V59, P109; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Krude H, 2003, ANN NY ACAD SCI, V994, P233, DOI 10.1111/j.1749-6632.2003.tb03185.x; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; LAMBERT RC, 1994, J PHYSIOL-LONDON, V478, P275, DOI 10.1113/jphysiol.1994.sp020249; Landry M, 2003, EUR J NEUROSCI, V17, P579, DOI 10.1046/j.1460-9568.2003.02472.x; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lemos JR, 2012, CELL CALCIUM, V51, P284, DOI 10.1016/j.ceca.2012.01.008; Leng G, 2008, NEUROCHEM RES, V33, P668, DOI 10.1007/s11064-007-9500-0; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Li Y, 2008, J NEUROSCI, V28, P2814, DOI 10.1523/JNEUROSCI.5447-07.2008; Li Y, 2006, J NEUROSCI, V26, P13037, DOI 10.1523/JNEUROSCI.3380-06.2006; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lopez-Huerta VG, 2012, J NEUROPHYSIOL, V108, P1032, DOI 10.1152/jn.00244.2012; Lovinger David M., 2008, V184, P435; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lujan R, 2009, NAT REV NEUROSCI, V10, P475, DOI 10.1038/nrn2668; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Marsh DJ, 1999, BRAIN RES, V848, P66, DOI 10.1016/S0006-8993(99)01962-9; Marsh DJ, 1999, P NATL ACAD SCI USA, V96, P13518, DOI 10.1073/pnas.96.23.13518; Mencarelli M., 2012, EUR J HUM GENET; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Miyata S, 2001, J COMP NEUROL, V434, P413, DOI 10.1002/cne.1184; MORRIS JF, 1973, J ENDOCRINOL, V57, P517, DOI 10.1677/joe.0.0570517; MORRIS JF, 1991, ANAT REC, V231, P437, DOI 10.1002/ar.1092310406; Murray HJ, 2004, BRAIN RES, V1000, P85, DOI 10.1016/j.brainres.2003.11.044; Muschol M, 2000, J NEUROSCI, V20, P6773, DOI 10.1523/JNEUROSCI.20-18-06773.2000; Nakatsuka T, 2008, J PHYSIOL-LONDON, V586, P2511, DOI 10.1113/jphysiol.2007.146076; Nassirpour R, 2010, J NEUROSCI, V30, P13419, DOI 10.1523/JNEUROSCI.2966-10.2010; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; NORDMANN JJ, 1984, P NATL ACAD SCI-BIOL, V81, P180, DOI 10.1073/pnas.81.1.180; Oliet SHR, 2004, GLIA, V47, P258, DOI 10.1002/glia.20032; Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163; Pan PY, 2012, NAT NEUROSCI, V15, P813, DOI 10.1038/nn.3099; Pennock RL, 2012, J NEUROSCI, V32, P10192, DOI 10.1523/JNEUROSCI.1227-12.2012; PETERS A, 1991, FINE STRUCTURE NERVO, P1; Peyron C, 1998, J NEUROSCI, V18, P9996; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Raggenbass M, 2008, EUR J PHARMACOL, V583, P243, DOI 10.1016/j.ejphar.2007.11.074; Ramamoorthy P, 2008, J NEUROSCI, V28, P13815, DOI 10.1523/JNEUROSCI.5361-07.2008; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Roberto M, 2006, P NATL ACAD SCI USA, V103, P9715, DOI 10.1073/pnas.0601899103; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saleh TM, 1996, J NEUROSCI, V16, P6046; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Schone C, 2012, J NEUROSCI, V32, P12437, DOI 10.1523/JNEUROSCI.0706-12.2012; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott V, 2009, J PHYSIOL-LONDON, V587, P5679, DOI 10.1113/jphysiol.2009.180232; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Shakiryanova D, 2011, P NATL ACAD SCI USA, V108, P4477, DOI 10.1073/pnas.1017837108; Shepherd GM, 1998, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; SIMMONS ML, 1995, NEURON, V14, P1265, DOI 10.1016/0896-6273(95)90273-2; SKOFITSCH G, 1985, PEPTIDES, V6, P307, DOI 10.1016/0196-9781(85)90057-9; Smith JT, 2007, REV ENDOCR METAB DIS, V8, P1, DOI 10.1007/s11154-007-9026-4; Sobota JA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-32; Sperk G, 2007, PROG BRAIN RES, V163, P285, DOI 10.1016/S0079-6123(07)63017-9; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Tallent Melanie K., 2008, V44, P177, DOI 10.1007/400_2007_037; Tallent MK, 1997, J NEUROPHYSIOL, V78, P3008, DOI 10.1152/jn.1997.78.6.3008; Tasker JG, 2012, J NEUROENDOCRINOL, V24, P566, DOI 10.1111/j.1365-2826.2011.02259.x; Thapliyal A, 2008, AM J PHYSIOL-CELL PH, V295, pC1417, DOI 10.1152/ajpcell.00341.2008; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Tobin V, 2012, J NEUROENDOCRINOL, V24, P629, DOI 10.1111/j.1365-2826.2011.02237.x; Tobin VA, 2007, J PHYSIOL-LONDON, V582, P1337, DOI 10.1113/jphysiol.2007.132639; Tobin VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025366; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Ubink R, 2000, GLIA, V32, P71, DOI 10.1002/1098-1136(200010)32:1<71::AID-GLIA70>3.0.CO;2-0; UBINK R, 1994, NEUROSCIENCE, V60, P709, DOI 10.1016/0306-4522(94)90499-5; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; van den Pol AN, 1998, J NEUROSCI, V18, P7962; van den Pol AN, 1999, J NEUROSCI, V19, P3171; VANDENPOL AN, 1991, J NEUROSCI, V11, P2087; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759; VANDENPOL AN, 1989, J MICROSC-OXFORD, V155, P27, DOI 10.1111/j.1365-2818.1989.tb04297.x; VANDENPOL AN, 1993, J NEUROSCI, V13, P2829; Vogler O, 2008, BBA-BIOMEMBRANES, V1778, P1640, DOI 10.1016/j.bbamem.2008.03.008; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Wang L, 2012, J NEUROENDOCRINOL, V24, P664, DOI 10.1111/j.1365-2826.2011.02239.x; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; Whim MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019478; Whim MD, 2006, J NEUROSCI, V26, P6637, DOI 10.1523/JNEUROSCI.5100-05.2006; Whim MD, 2001, NEURON, V30, P37, DOI 10.1016/S0896-6273(01)00261-6; WHIM MD, 1992, J NEUROSCI, V12, P3545; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; Wong MY, 2012, CELL, V148, P1029, DOI 10.1016/j.cell.2011.12.036; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wyeth MS, 2012, NEUROSCIENCE, V202, P371, DOI 10.1016/j.neuroscience.2011.11.056; Xie KQ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00049; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 2000, QJM-INT J MED, V93, P7, DOI 10.1093/qjmed/93.1.7; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Zhang XB, 2012, J NEUROSCI, V32, P3032, DOI 10.1523/JNEUROSCI.5966-11.2012; Zupanc GKH, 1996, MICRON, V27, P35, DOI 10.1016/0968-4328(95)00028-3	203	400	403	9	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2012	76	1					98	115		10.1016/j.neuron.2012.09.014	http://dx.doi.org/10.1016/j.neuron.2012.09.014			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	020HG	23040809	Green Accepted, Bronze			2022-12-17	WOS:000309799000008
J	Losonczy, A; Magee, JC				Losonczy, A; Magee, JC			Integrative properties of radial oblique Dendrites in hippocampal CA1 pyramidal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; VOLTAGE ATTENUATION; RAT HIPPOCAMPUS; BASAL DENDRITES; SPINE-NECK; SPIKES; INITIATION; MECHANISM; SUMMATION; CHANNELS	Although radial oblique dendrites are a major synaptic input site in CA1 pyramidal neurons, little is known about their integrative properties. We have used multisite two-photon glutamate uncaging to deliver different spatiotemporal input patterns to single branches while simultaneously recording the uncaging-evoked excitatory postsynaptic potentials and local Ca2+ signals. Asynchronous input patterns sum linearly in spite of the spatial clustering and produce Ca2+ signals that are mediated by NMDA receptors (NMDARs). Appropriately timed and sized input patterns (similar to 20 inputs within similar to 6 ms) produce a supralinear summation due to the initiation of a dendritic spike. The Ca2+ signals associated with synchronous input were larger and mediated by influx through both NMDARs and voltage-gated Ca2+ channels (VGCCs). The oblique spike is a fast Na+ spike whose duration is shaped by the coincident activation of NMDAR, VGCCs, and transient K+ currents. Our results suggest that individual branches can function as single integrative compartments.	Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Losonczy, A (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA.	aloson@lsuhsc.edu			NINDS NIH HHS [R01 NS035865, R01 NS035865-08, NS39458] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039458, R01NS035865] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ariav G, 2003, J NEUROSCI, V23, P7750; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 2005, CURR OPIN NEUROBIOL, V15, P334, DOI 10.1016/j.conb.2005.05.013; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Majewska A, 2000, J NEUROSCI, V20, P1722; Marchetti C, 2003, MOL BRAIN RES, V117, P139, DOI 10.1016/S0169-328X(03)00293-6; McDermott CM, 2006, J PHYSIOL-LONDON, V570, P553, DOI 10.1113/jphysiol.2005.093781; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Stuart G, 1998, J NEUROSCI, V18, P3501; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x	39	400	406	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					291	307		10.1016/j.neuron.2006.03.016	http://dx.doi.org/10.1016/j.neuron.2006.03.016			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630839	Bronze			2022-12-17	WOS:000237176700015
J	Stobrawa, SM; Breiderhoff, T; Takamori, S; Engel, D; Schweizer, M; Zdebik, AA; Bosl, MR; Ruether, K; Jahn, H; Draguhn, A; Jahn, R; Jentsch, TJ				Stobrawa, SM; Breiderhoff, T; Takamori, S; Engel, D; Schweizer, M; Zdebik, AA; Bosl, MR; Ruether, K; Jahn, H; Draguhn, A; Jahn, R; Jentsch, TJ			Disruption of CIC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus	NEURON			English	Article							FUNCTIONAL EXPRESSION; GLUTAMATE TRANSPORTER; MEMBRANE; LOCALIZATION; PROTEIN; GENE; IDENTIFICATION; CLC-5; GABA; MUTATIONS	Several plasma membrane chloride channels are well characterized, but much less is known about the molecular identity and function of intracellular Cl- channels. ClC-3 is thought to mediate swelling-activated plasma membrane currents, but we now show that this broadly expressed chloride channel is present in endosomal compartments and synaptic vesicles of neurons. While swelling-activated currents are unchanged in mice with disrupted ClC-3, acidification of synaptic vesicles is impaired and there is severe postnatal degeneration of the retina and the hippocampus. Electrophysiological analysis of juvenile hippocampal slices revealed no major functional abnormalities despite slightly increased amplitudes of miniature excitatory postsynaptic currents. Mice almost lacking the hippocampus survive and show several behavioral abnormalities but are still able to acquire motor skills.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Humboldt Univ, Johannes Muller Inst Physiol, D-10117 Berlin, Germany; Univ Hamburg, Klin Augenheilkunde, D-20246 Hamburg, Germany; Univ Hamburg, Psychiat Klin, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Humboldt University of Berlin; University of Hamburg; University of Hamburg	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Martinistr 52, D-20246 Hamburg, Germany.	jentsch@uke.uni-hamburg.de	Jahn, Holger/A-9255-2008; Breiderhoff, Tilman/X-9364-2019	Jahn, Holger/0000-0003-3607-7651; Breiderhoff, Tilman/0000-0002-1676-7498; Jentsch, Thomas/0000-0002-3509-2553; Engel, Dominique/0000-0002-5962-3152; Jahn, Reinhard/0000-0003-1542-3498				Adler DA, 1997, P NATL ACAD SCI USA, V94, P9244, DOI 10.1073/pnas.94.17.9244; ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BORSANI G, 1995, GENOMICS, V27, P131, DOI 10.1006/geno.1995.1015; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; CHAPMAN RE, 1994, EMBO J, V13, P2305, DOI 10.1002/j.1460-2075.1994.tb06514.x; Coutureau E, 2000, EXP BRAIN RES, V131, P381, DOI 10.1007/s002219900301; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Dittmer F, 1999, J CELL SCI, V112, P1591; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; FACCI L, 1990, J NEUROSCI RES, V27, P202, DOI 10.1002/jnr.490270210; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; HARTMANN D, 1995, DEV NEUROSCI-BASEL, V17, P246, DOI 10.1159/000111293; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KOMAK U, 2001, IN PRESS CELL, V104; Li Y, 1999, MOL CELL BIOL, V19, P3588; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311; Neuhoff H, 1999, EUR J NEUROSCI, V11, P4241, DOI 10.1046/j.1460-9568.1999.00856.x; NUNN JA, 1994, BEHAV BRAIN RES, V62, P41, DOI 10.1016/0166-4328(94)90036-1; Owe-Larsson B, 1999, EUR J NEUROSCI, V11, P1981, DOI 10.1046/j.1460-9568.1999.00614.x; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; Ruether K, 1997, INVEST OPHTH VIS SCI, V38, P710; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimada K, 2000, AM J PHYSIOL-GASTR L, V279, pG268, DOI 10.1152/ajpgi.2000.279.2.G268; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Szewczyk A, 1998, MOL MEMBR BIOL, V15, P49, DOI 10.3109/09687689809027518; Takamori S, 2000, J NEUROSCI, V20, P4904; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; TAMIR H, 1994, ENDOCRINOLOGY, V135, P2045, DOI 10.1210/en.135.5.2045; Zdebik A, 1997, PFLUG ARCH EUR J PHY, V434, P188, DOI 10.1007/s004240050382; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	55	400	426	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	2001	29	1					185	196		10.1016/S0896-6273(01)00189-1	http://dx.doi.org/10.1016/S0896-6273(01)00189-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	397NX	11182090	Bronze			2022-12-17	WOS:000166702700018
J	HYNES, M; PORTER, JA; CHIANG, C; CHANG, D; TESSIERLAVIGNE, M; BEACHY, PA; ROSENTHAL, A				HYNES, M; PORTER, JA; CHIANG, C; CHANG, D; TESSIERLAVIGNE, M; BEACHY, PA; ROSENTHAL, A			INDUCTION OF MIDBRAIN DOPAMINERGIC-NEURONS BY SONIC HEDGEHOG	NEURON			English	Article							FLOOR PLATE; CELL PATTERN; TYROSINE-HYDROXYLASE; SUBSTANTIA-NIGRA; NERVOUS-SYSTEM; RAT; DIFFERENTIATION; LOCALIZATION; RECEPTORS; NOTOCHORD	Midbrain dopaminergic neurons, whose loss in adults results in Parkinson's disease, can be specified during embryonic development by a contact-dependent signal from floor plate cells. Here we show that the aminoterminal product of Sonic hedgehog autoproteolysis (SHH-N), an inductive signal expressed by floor plate cells, can induce dopaminergic neurons in vitro. We show further that manipulations to increase the activity of cyclic AMP-dependent protein kinase A, which is known to antagonize hedgehog signaling, can block dopaminergic neuron induction by floor plate cells. Our results and those of other studies indicate that SHH-N can function in a dose-dependent manner to induce different cell types within the neural tube. Our results also provide the basis for a potential cell transplantation therapy for Parkinson's disease.	GENENTECH INC,DEPT NEUROSCI,S SAN FRANCISCO,CA 94080; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,CELL BIOL PROGRAM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,PROGRAM DEV BIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143	Roche Holding; Genentech; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco				Hynes, Mary/0000-0001-6623-6727				ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; ALTMAN J, 1981, J COMP NEUROL, V198, P677, DOI 10.1002/cne.901980409; Bjorklund A, 1984, HDB CHEM NEUROANATOM, P55; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; CHANG DT, 1994, DEVELOPMENT, V120, P3339; CONCORDET JP, 1995, NATURE, V375, P279, DOI 10.1038/375279a0; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Dickinson ME, 1992, CURR OPIN GENET DEV, V2, P562, DOI 10.1016/S0959-437X(05)80172-8; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; GREENBERG D, 1974, SCIENCE, V184, P1243; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; JESSELL TM, 1992, HARVEY LECT, V86, P87; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; LAUDER JM, 1974, J COMP NEUROL, V155, P469, DOI 10.1002/cne.901550407; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; LEPAGE T, 1995, DNATURE, V373, P711; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; MARCHAND R, 1983, NEUROSCIENCE, V9, P373, DOI 10.1016/0306-4522(83)90300-7; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; PICKEL VM, 1975, J HISTOCHEM CYTOCHEM, V23, P1, DOI 10.1177/23.1.234988; PLACZEK M, 1993, DEVELOPMENT, V117, P205; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; SASAKI H, 1993, DEVELOPMENT, V118, P47; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SEEMAN P, 1993, NATURE, V365, P441, DOI 10.1038/365441a0; SHIH A, 1994, J BIOL CHEM, V269, P27679; SMITH JC, 1994, CELL, V76, P193, DOI 10.1016/0092-8674(94)90325-5; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; STRUTT DI, 1995, NATURE, V373, P705, DOI 10.1038/373705a0; TANABE Y, 1995, IN PRESS CURR BIOL; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; URFER R, 1994, EMBO J, V13, P5896, DOI 10.1002/j.1460-2075.1994.tb06935.x; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	48	400	426	0	15	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1995	15	1					35	44		10.1016/0896-6273(95)90062-4	http://dx.doi.org/10.1016/0896-6273(95)90062-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RL756	7619528	Bronze			2022-12-17	WOS:A1995RL75600007
J	Morris, G; Arkadir, D; Nevet, A; Vaadia, E; Bergman, H				Morris, G; Arkadir, D; Nevet, A; Vaadia, E; Bergman, H			Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons	NEURON			English	Article							CORTICOSTRIATAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; MONKEY STRIATUM; RAT NEOSTRIATUM; IN-VITRO; CHOLINERGIC INTERNEURONS; MUSCARINIC RECEPTORS; PARKINSONS-DISEASE; PRIMATES STRIATUM; BASAL GANGLIA	Midbrain dopamine and striatal tonically active neurons (TANs, presumed acetylcholine interneurons) signal behavioral significance of environmental events. Since striatal dopamine and acetylcholine affect plasticity of cortico-striatal transmission and are both crucial to learning, they may serve as teachers in the basal ganglia circuits. We recorded from both neuronal populations in monkeys performing a probabilistic instrumental conditioning task. Both neuronal types respond robustly to reward-related events. Although different events yielded responses with different latencies, the responses of the two populations coincided, indicating integration at the target level. Yet, while the dopamine neurons' response reflects mismatch between expectation and outcome in the positive domain, the TANs are invariant to reward predictability. Finally, TAN pairs are synchronized, compared to a minority of dopamine neuron pairs. We conclude that the striatal cholinergic and dopaminergic systems carry distinct messages by different means, which can be integrated differently to shape the basal ganglia responses to reward-related events.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Morris, G (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel.	genela@md.huji.ac.il	Vaadia, Eilon/E-9347-2011; Morris, Genela/B-7844-2008	Morris, Genela/0000-0002-5417-8977				ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; [Anonymous], 2002, Mov Disord, V17 Suppl 4, pS7; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 1998, J NEUROPHYSIOL, V80, P3341, DOI 10.1152/jn.1998.80.6.3341; Apicella P, 1997, EXP BRAIN RES, V116, P456, DOI 10.1007/PL00005773; ATKINS PT, 1990, NATURE, V344, P240; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; BAUM WM, 1979, J EXP ANAL BEHAV, V32, P269, DOI 10.1901/jeab.1979.32-269; Bennett BD, 1999, J NEUROSCI, V19, P5586; Blazquez PM, 2002, NEURON, V33, P973, DOI 10.1016/S0896-6273(02)00627-X; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Centonze D, 2003, REV NEUROSCIENCE, V14, P207; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Centonze D, 1999, J NEUROPHYSIOL, V82, P3575, DOI 10.1152/jn.1999.82.6.3575; Cragg SJ, 2000, J NEUROSCI, V20, P8209; CRUTCHER MD, 1984, EXP BRAIN RES, V53, P244, DOI 10.1007/BF00238154; DeBoer P, 1996, J PHARMACOL EXP THER, V277, P775; DRUKARCH B, 1989, J NEUROCHEM, V52, P1680, DOI 10.1111/j.1471-4159.1989.tb07244.x; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Flores-Hernandez J, 2000, J NEUROPHYSIOL, V83, P2996, DOI 10.1152/jn.2000.83.5.2996; Goodie AS, 2004, J GEN PSYCHOL, V131, P18, DOI 10.3200/GENP.131.1.18-28; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Kimura M, 2003, NEUROREPORT, V14, P799, DOI 10.1097/00001756-200305060-00004; Kitabatake Y, 2003, P NATL ACAD SCI USA, V100, P7965, DOI 10.1073/pnas.1032899100; KITAI ST, 1993, ADV NEUROL, V60, P40; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; KUDERNATSCH M, 1994, NEUROSCI LETT, V181, P107, DOI 10.1016/0304-3940(94)90571-1; LAVOIE B, 1989, J COMP NEUROL, V289, P36, DOI 10.1002/cne.902890104; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Martin RF, 2000, PRIMATE BRAIN MAPS S; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; NISENBAUM LK, 1995, MOL CELLULAR MECH NE, P273; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pisani A, 2003, NEUROPHARMACOLOGY, V45, P45, DOI 10.1016/S0028-3908(03)00137-0; Pisani A, 2000, J NEUROSCI, V20, part. no.; Ravel S, 1999, EXP BRAIN RES, V128, P531, DOI 10.1007/s002210050876; Ravel S, 2003, J NEUROSCI, V23, P8489; Ravel S, 2001, J NEUROSCI, V21, P5730, DOI 10.1523/JNEUROSCI.21-15-05730.2001; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shimo Y, 2001, J NEUROSCI, V21, P7804, DOI 10.1523/JNEUROSCI.21-19-07804.2001; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Sutton R.S., 2017, REINFORCEMENT LEARNI, V2nd, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; Tobler PN, 2003, J NEUROSCI, V23, P10402; Venton BJ, 2003, J NEUROCHEM, V87, P1284, DOI 10.1046/j.1471-4159.2003.02109.x; Vulkan N, 2000, J ECON SURV, V14, P101, DOI 10.1111/1467-6419.00106; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wolford G, 2000, J NEUROSCI, V20, part. no.; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	69	399	402	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					133	143		10.1016/j.neuron.2004.06.012	http://dx.doi.org/10.1016/j.neuron.2004.06.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233923	Bronze			2022-12-17	WOS:000222549800013
J	Li, YH; Maher, P; Schubert, D				Li, YH; Maher, P; Schubert, D			A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion	NEURON			English	Article							ARACHIDONIC-ACID METABOLISM; EMBRYONIC CORTICAL-NEURONS; AMYLOID-BETA PROTEIN; GLUTAMATE TOXICITY; OXIDATIVE STRESS; PARKINSONS-DISEASE; LEUKOTRIENE BIOSYNTHESIS; SELECTIVE INHIBITOR; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE	An early and highly specific decrease in glutathione (GSH) in the substantia nigra is associated with Parkinson's disease, and low levels of GSH lead to the degeneration of cultured dopaminergic neurons. Using immature cortical neurons and a clonal nerve cell line, it is shown that a decrease in GSH triggers the activation of neuronal 12-lipoxygenase (12-LOX), which leads to the production of peroxides, the influx of Ca2+, and ultimately to cell death. The supporting evidence includes: 1) inhibitors of arachidonate metabolism and 12-LOX block cell death induced by GSH depletion; 2) there is an increase in 12-LOX activity and a membrane translocation in HT22 cells, and an induction of the enzyme in primary cortical neurons following the reduction of GSH; 3) 12-LOX is directly inhibited by GSH; and 4) exogenous arachidonic acid potentiates cell death. These data show that the LOX pathway is a critical intermediate in at least some forms of neuronal degeneration.	Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute	Li, YH (corresponding author), SALK INST BIOL STUDIES, CELLULAR NEUROBIOL LAB, 10010 N TORREY PINES RD, LA JOLLA, CA 92037 USA.			Li, Yonghong/0000-0001-7326-0717	NIA NIH HHS [1 F32 AG 05769-01] Funding Source: Medline; NINDS NIH HHS [R01 NS09658, 5PO1-NS28121] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009658, P01NS028121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005769] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABE K, 1990, JPN J PHARMACOL, V53, P221, DOI 10.1254/jjp.53.221; BABA A, 1989, J BIOL CHEM, V264, P15790; BEHL C, 1993, BIOCHEM BIOPH RES CO, V197, P949, DOI 10.1006/bbrc.1993.2571; BENDANI MK, 1995, NEUROSCI LETT, V189, P159, DOI 10.1016/0304-3940(95)11482-C; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; DEXTER DT, 1994, ANN NEUROL, V35, P38, DOI 10.1002/ana.410350107; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; DUMUIS A, 1993, MOL PHARMACOL, V43, P976; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGMANN W, 1993, PROSTAGLANDINS, V46, P471, DOI 10.1016/0090-6980(93)90066-G; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; HALLIWELL B, 1989, FREE RADICAL BIO MED, P93; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; JUNE CH, 1991, CURR PROT IMMUNOL; Kinzig A, 1997, FEBS LETT, V402, P162, DOI 10.1016/S0014-5793(96)01517-7; Korystov YN, 1996, FEBS LETT, V388, P238, DOI 10.1016/0014-5793(96)00538-8; KOSHIHARA Y, 1984, BIOCHIM BIOPHYS ACTA, V792, P92; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maher P, 1996, J NEUROSCI, V16, P6394; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; McConkey David J., 1994, Trends in Cell Biology, V4, P370, DOI 10.1016/0962-8924(94)90087-6; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURPHY T, 1989, ANN NY ACAD SCI, V559, P474; MURPHY TH, 1990, DEV BRAIN RES, V57, P146, DOI 10.1016/0165-3806(90)90195-5; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; NATARAJAN R, 1993, P NATL ACAD SCI USA, V90, P4947, DOI 10.1073/pnas.90.11.4947; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; PILEBLAD E, 1989, J NEUROCHEM, V52, P978, DOI 10.1111/j.1471-4159.1989.tb02550.x; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; RAO GN, 1993, NUCLEIC ACIDS RES, V21, P1259, DOI 10.1093/nar/21.5.1259; RATAN RR, 1994, J NEUROCHEM, V62, P376; RATAN RR, 1994, J NEUROSCI, V14, P4385; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SAUTEBIN L, 1978, PROSTAGLANDINS, V16, P985, DOI 10.1016/0090-6980(78)90115-6; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; SCHUBERT D, 1992, P NATL ACAD SCI USA, V89, P8264, DOI 10.1073/pnas.89.17.8264; SEKIYA K, 1982, BIOCHEM BIOPH RES CO, V105, P1090, DOI 10.1016/0006-291X(82)91081-6; SHIMIZU T, 1987, J NEUROCHEM, V48, P1541, DOI 10.1111/j.1471-4159.1987.tb05698.x; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; SHORNICK LP, 1993, J BIOL CHEM, V268, P371; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; SNIDER RM, 1984, P NATL ACAD SCI-BIOL, V81, P3905, DOI 10.1073/pnas.81.12.3905; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; SOK DE, 1982, BIOCHEM BIOPH RES CO, V107, P101, DOI 10.1016/0006-291X(82)91675-8; STERN N, 1993, ENDOCRINOLOGY, V133, P843, DOI 10.1210/en.133.2.843; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Tang DG, 1996, P NATL ACAD SCI USA, V93, P5241, DOI 10.1073/pnas.93.11.5241; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; VOGT M, 1963, P NATL ACAD SCI USA, V49, P171, DOI 10.1073/pnas.49.2.171; WATANABE T, 1993, EUR J BIOCHEM, V212, P605, DOI 10.1111/j.1432-1033.1993.tb17699.x; Wullner U, 1996, NEUROREPORT, V7, P921; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470	62	399	417	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1997	19	2					453	463		10.1016/S0896-6273(00)80953-8	http://dx.doi.org/10.1016/S0896-6273(00)80953-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292733	Bronze			2022-12-17	WOS:A1997XU14600022
J	Yanamandra, K; Kfoury, N; Jiang, H; Mahan, TE; Ma, SM; Maloney, SE; Wozniak, DF; Diamond, MI; Holtzman, DM				Yanamandra, Kiran; Kfoury, Najla; Jiang, Hong; Mahan, Thomas E.; Ma, Shengmei; Maloney, Susan E.; Wozniak, David F.; Diamond, Marc I.; Holtzman, David M.			Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo	NEURON			English	Article							A-BETA BURDEN; MOUSE MODEL; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; PASSIVE-IMMUNIZATION; PROTEIN; IMMUNOTHERAPY; PROPAGATION; ACTIVATION; TAUOPATHY	Tau aggregation occurs in neurodegenerative diseases including Alzheimer's disease and many other disorders collectively termed tauopathies. trans-cellular propagation of tau pathology, mediated by extracellular tau aggregates, may underlie pathogenesis of these conditions. P301S tau transgenic mice express mutant human tau protein and develop progressive tau pathology. Using a cell-based biosensor assay, we screened anti-tau monoclonal antibodies for their ability to block seeding activity present in P301S brain lysates. We infused three effective antibodies or controls into the lateral ventricle of P301S mice for 3 months. The antibodies markedly reduced hyperphosphorylated, aggregated, and insoluble tau. They also blocked development of tau seeding activity detected in brain lysates using the biosensor assay, reduced microglial activation, and improved cognitive deficits. These data imply a central role for extracellular tau aggregates in the development of pathology. They also suggest that immunotherapy specifically designed to block trans-cellular aggregate propagation will be a productive treatment strategy.	[Yanamandra, Kiran; Kfoury, Najla; Jiang, Hong; Mahan, Thomas E.; Ma, Shengmei; Diamond, Marc I.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Yanamandra, Kiran; Kfoury, Najla; Jiang, Hong; Mahan, Thomas E.; Ma, Shengmei; Diamond, Marc I.; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Yanamandra, Kiran; Kfoury, Najla; Jiang, Hong; Mahan, Thomas E.; Ma, Shengmei; Diamond, Marc I.; Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Maloney, Susan E.; Wozniak, David F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MI (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	diamondm@neuro.wustl.edu; holtzman@neuro.wustl.edu	Yanamandra, Kiran/M-4037-2014	Yanamandra, Kiran/0000-0002-4908-5848; Maloney, Ph.D., Susan E./0000-0001-5585-4722; Mahan, Thomas/0000-0001-9811-7490	Tau consortium; C2N Diagnostics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071835] Funding Source: NIH RePORTER	Tau consortium; C2N Diagnostics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was from the Tau consortium (D.M.H. and M.I.D.) and from a research grant from C2N Diagnostics (D.M.H. and M.I.D.). D.M.H. is a cofounder and has ownership interests in C2N Diagnostics. We thank Floy Stewart and Mary Beth Finn for expert technical advice and assistance.	Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Mohamed HA, 2002, J NEUROSCI RES, V69, P110, DOI 10.1002/jnr.10271; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Sato C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048180; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sigurdsson EM, 2009, CURR ALZHEIMER RES, V6, P446, DOI 10.2174/156720509789207930; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	55	398	439	0	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 16	2013	80	2					402	414		10.1016/j.neuron.2013.07.046	http://dx.doi.org/10.1016/j.neuron.2013.07.046			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241VI	24075978	Green Accepted, Bronze			2022-12-17	WOS:000326196400021
J	Hipp, JF; Engel, AK; Siegel, M				Hipp, Joerg F.; Engel, Andreas K.; Siegel, Markus			Oscillatory Synchronization in Large-Scale Cortical Networks Predicts Perception	NEURON			English	Article							VISUAL-ATTENTION; TOP-DOWN; NEURONAL OSCILLATIONS; CORTEX; INTEGRATION; MODULATION; RESPONSES; COHERENCE; REFLECTS; DISCRIMINATION	Normal brain function requires the dynamic interaction of functionally specialized but widely distributed cortical regions. Long-range synchronization of oscillatory signals has been suggested to mediate these interactions within large-scale cortical networks, but direct evidence is sparse. Here we show that oscillatory synchronization is organized in such large-scale networks. We implemented an analysis approach that allows for imaging synchronized cortical networks and applied this technique to EEG recordings in humans. We identified two networks: beta-band synchronization (similar to 20 Hz) in a fronto-parieto-occipital network and gamma-band synchronization (similar to 80 Hz) in a centro-temporal network. Strong perceptual correlates support their functional relevance: the strength of synchronization within these networks predicted the subjects' percept of an ambiguous audiovisual stimulus as well as the integration of auditory and visual information. Our results provide evidence that oscillatory neuronal synchronization mediates neuronal communication within frequency-specific, large-scale cortical networks.	[Hipp, Joerg F.; Engel, Andreas K.; Siegel, Markus] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; [Siegel, Markus] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Siegel, Markus] Univ Tubingen, Ctr Integrat Neurosci, D-72076 Tubingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Massachusetts Institute of Technology (MIT); Northwell Health; Eberhard Karls University of Tubingen	Hipp, JF (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany.	j.hipp@uke.de	Siegel, Markus/H-5225-2012; Hipp, Joerg F/D-8936-2014; Engel, Andreas K./AAH-6384-2019; Engel, Andreas K/C-7781-2012	Siegel, Markus/0000-0001-5115-936X; Hipp, Joerg F/0000-0002-7875-2988; Engel, Andreas K./0000-0003-4899-8466; Engel, Andreas K/0000-0003-4899-8466	European Union [IST-2005-027268, NEST-PATH-043457, HEALTH-F2-2008-200728]; German Research Foundation [GRK 1247/1, 1247/2]; German Federal Ministry of Education and Research [01GW0561]	European Union(European Commission); German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We thank T.H. Donner, C. Hipp, T.J. Buschman, J. Roy, G.G. Supp, and E.K. Miller for helpful discussions and comments on the manuscript. This work was supported by grants from the European Union (IST-2005-027268, NEST-PATH-043457, and HEALTH-F2-2008-200728), the German Research Foundation (GRK 1247/1 and 1247/2), and the German Federal Ministry of Education and Research (01GW0561, Neuroimage Nord).	Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; Donner TH, 2007, J NEUROPHYSIOL, V98, P345, DOI 10.1152/jn.01141.2006; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Green DM., 1966, SIGNAL DETECTION THE; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; HOLM S, 1979, SCAND J STAT, V6, P65; Hummel F, 2005, CEREB CORTEX, V15, P670, DOI 10.1093/cercor/bhh170; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kujala J, 2008, NEUROIMAGE, V39, P1706, DOI 10.1016/j.neuroimage.2007.10.042; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Meredith MA, 2009, HEARING RES, V258, P64, DOI 10.1016/j.heares.2009.03.005; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nunez P.L., 2006, ELECT FIELDS BRAIN; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rose M, 2005, J NEUROSCI, V25, P10101, DOI 10.1523/JNEUROSCI.2998-05.2005; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; Siegel M, 2003, J NEUROSCI, V23, P4251; Siegel M, 2007, CEREB CORTEX, V17, P732, DOI 10.1093/cercor/bhk025; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Stein BE., 1993, MERGING SENSES; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	82	398	404	3	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					387	396		10.1016/j.neuron.2010.12.027	http://dx.doi.org/10.1016/j.neuron.2010.12.027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262474	Bronze, Green Published			2022-12-17	WOS:000286792900019
J	Dobritsa, AA; van der Goes van Naters, W; Warr, CG; Steinbrecht, RA; Carlson, JR				Dobritsa, AA; van der Goes van Naters, W; Warr, CG; Steinbrecht, RA; Carlson, JR			Integrating the molecular and cellular basis of odor coding in the Drosophila antenna	NEURON			English	Article							OLFACTORY RECEPTOR NEURONS; SEX-PHEROMONE; EXPRESSION; ORGANIZATION; RESPONSES; MELANOGASTER; PROJECTIONS; DEFICIENT; PROTEIN; SUBSET	We investigate how the molecular and cellular maps of the Drosophila olfactory system are integrated. A correspondence is established between individual odor receptors, neurons, and odors. We describe the expression of the Or22a and Or22b receptor genes, show localization to dendritic membranes, and find sexual dimorphism. Or22a maps to the ab3A neuron, which responds to ethyl butyrate. Analysis of a deletion mutant lacking Or22a, along with transgenic rescue experiments, confirms the mapping and demonstrates that an Or gene is required for olfactory function in vivo. Ectopic expression of Or47a in a mutant cell identifies the neuron from which it derives and its odor ligands. Ectopic expression in a wild-type cell shows that two receptors can function in a single cell. The ab3A neuron does not depend on normal odor receptor gene expression to navigate to its target in the CNS.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; Max Planck Inst Verhaltensphysiol, D-823196 Seewiesen, Germany	Yale University; Monash University; Max Planck Society	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	Warr, Coral/0000-0002-5289-3950; van der Goes van Naters, Wynand/0000-0002-6808-0161	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729, R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-02174, DC-04729] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Ashburner M., 1989, DROSOPHILA LAB HDB; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Elmore T, 2001, INSECT BIOCHEM MOLEC, V31, P791, DOI 10.1016/S0965-1748(00)00184-3; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Grant AJ, 1998, J COMP PHYSIOL A, V183, P433, DOI 10.1007/s003590050269; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kaissling K. E., 1980, RECEPTORS NEUROTRANS; KRIEGER J, 1994, EUR J BIOCHEM, V219, P829, DOI 10.1111/j.1432-1033.1994.tb18564.x; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laue M, 1997, INT J INSECT MORPHOL, V26, P217, DOI 10.1016/S0020-7322(97)00023-8; LEAL W, 2003, IN PRESS INSECT PHER; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Menco BPM, 1997, J NEUROCYTOL, V26, P691, DOI 10.1023/A:1018554029186; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shanbhag SR, 2000, ARTHROPOD STRUCT DEV, V29, P211, DOI 10.1016/S1467-8039(00)00028-1; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; STROTMANN J, 1995, EUR J NEUROSCI, V7, P492, DOI 10.1111/j.1460-9568.1995.tb00345.x; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	50	398	436	8	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2003	37	5					827	841		10.1016/S0896-6273(03)00094-1	http://dx.doi.org/10.1016/S0896-6273(03)00094-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628173	Bronze			2022-12-17	WOS:000181452800012
J	Beauchamp, MS; Lee, KE; Haxby, JV; Martin, A				Beauchamp, MS; Lee, KE; Haxby, JV; Martin, A			Parallel visual motion processing streams for manipulable objects and human movements	NEURON			English	Article							EVENT-RELATED FMRI; BIOLOGICAL MOTION; TEMPORAL CORTEX; FACE PERCEPTION; AREAS; STIMULI; SYSTEMS; PSYCHOPHYSICS; ACTIVATION; KNOWLEDGE	We tested the hypothesis that different regions of lateral temporal cortex are specialized for processing different types of visual motion by studying the cortical responses to moving gratings and to humans and manipulable objects (tools and utensils) that were either stationary or moving with natural or artificially generated motions. Segregated responses to human and tool stimuli were observed in both ventral and lateral regions of posterior temporal cortex. Relative to ventral cortex, lateral temporal cortex showed a larger response for moving compared with static humans and tools. Superior temporal cortex preferred human motion, and middle temporal gyrus preferred tool motion. A greater response was observed in STS to articulated compared with unarticulated human motion. Specificity for different types of complex motion (in combination with visual form) may be an organizing principle in lateral temporal cortex.	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Beauchamp, MS (corresponding author), NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA.		martin, alex/B-6176-2009; Beauchamp, Michael/AAK-9813-2020	Beauchamp, Michael/0000-0002-7599-9934				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Bonda E, 1996, J NEUROSCI, V16, P3737; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox R, 2001, NEUROIMAGE, V13, pS101; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2000, TRENDS COGN SCI, V4, P3, DOI 10.1016/S1364-6613(99)01423-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MARTIN A, 2000, NEW COGNITIVE NEUROS, P1023; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; OCRAVEN KM, 1997, NEURON, V21, P1988; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Puce A, 1998, J NEUROSCI, V18, P2188; Rao RPN, 1999, VISION RES, V39, P1963, DOI 10.1016/S0042-6989(98)00279-X; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Snowden RJ, 1999, TRENDS COGN SCI, V3, P369, DOI 10.1016/S1364-6613(99)01381-9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Vaina LM, 1998, CURR OPIN NEUROBIOL, V8, P494, DOI 10.1016/S0959-4388(98)80037-8; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79	45	398	403	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					149	159		10.1016/S0896-6273(02)00642-6	http://dx.doi.org/10.1016/S0896-6273(02)00642-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931749	Bronze			2022-12-17	WOS:000174695100017
J	Frith, U				Frith, U			Mind blindness and the brain in autism	NEURON			English	Review							ANTERIOR CINGULATE; PERCEPTION; AMYGDALA; REPRESENTATION; IMPAIRMENTS; ACTIVATION; CHILDREN; CORTEX; GAZE; FACE	Experimental evidence shows that the inability to attribute mental states, such as desires and beliefs, to self and others (mentalizing) explains the social and communication impairments of individuals with autism. Brain imaging studies in normal volunteers highlight a circumscribed network that is active during mentalizing and links medial prefrontal regions with posterior superior temporal sulcus and temporal poles. The brain abnormality that results in mentalizing failure in autism may involve weak connections between components of this system.	UCL Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Frith, U (corresponding author), UCL Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.		Frith, Uta/C-1757-2008	Frith, Uta/0000-0002-9063-4466				Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Asperger H., 1944, AUTISM ASPERGER SYND, P37; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Baldwin DA, 1996, CHILD DEV, V67, P3135, DOI 10.1111/j.1467-8624.1996.tb01906.x; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Baron-Cohen Simon, 1996, British Journal of Psychiatry, V168, P158, DOI 10.1192/bjp.168.2.158; BaronCohen S, 1997, CHILD DEV, V68, P48; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1986, BRIT J DEV PSYCHOL, V4, P113, DOI 10.1111/j.2044-835X.1986.tb01003.x; BARONCOHEN S, 1999, UNDERSTANDING OTHER, V2; Bauman M.L, 1994, NEUROBIOLOGY AUTISM, P119; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Black Ira B., 1998, Neuron, V20, P1073, DOI 10.1016/S0896-6273(00)80489-4; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Bloom Paul, 2002, CHILDREN LEARN MEANI; Bonda E, 1996, J NEUROSCI, V16, P3737; BRETHERTON I, 1992, SOCIAL REFERENCING I; Brothers L., 1997, FRIDAYS FOOTPRINT SO; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Cheney DL., 1990, MONKEYS SEE WORLD IN; de Waal Frans B.M., 1992, Evolutionary Anthropology, V1, P86, DOI 10.1002/evan.1360010306; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Frith C.D., 2000, UNDERSTANDING OTHER, P335; FRITH U, 1991, TRENDS NEUROSCI, V14, P433, DOI 10.1016/0166-2236(91)90041-R; Frith U, 1998, DEVELOPMENTAL SCI, V1, P267, DOI 10.1111/1467-7687.00041; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Happe F, 1996, BRAIN, V119, P1377, DOI 10.1093/brain/119.4.1377; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.1111/j.1467-8624.1995.tb00909.x; Hobson P., 1993, AUTISM DEV MIND; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; KANNER L, 1968, ACTA PAEDOPSYCHIATR, V35, P100; Kawashima R, 1999, NEUROIMAGE, V10, P209, DOI 10.1006/nimg.1999.0452; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LESLIE AM, 1992, COGNITION, V43, P225, DOI 10.1016/0010-0277(92)90013-8; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Maestrini E, 2000, NEURON, V28, P19, DOI 10.1016/S0896-6273(00)00081-7; McGuire PK, 1996, BRAIN, V119, P907, DOI 10.1093/brain/119.3.907; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; PERRETT DI, 1989, J EXP BIOL, V146, P87; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Puce A, 1998, J NEUROSCI, V18, P2188; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Repacholi BM, 1998, DEV PSYCHOL, V34, P1017, DOI 10.1037/0012-1649.34.5.1017; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Russell J., 1998, AUTISM EXECUTIVE DIS; Scheuffgen K, 2000, DEV PSYCHOPATHOL, V12, P83, DOI 10.1017/S095457940000105X; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Sigman M, 1997, CHILDREN AUTISM DEV; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Toni I, 2001, NEUROIMAGE, V14, pS110, DOI 10.1006/nimg.2001.0841; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; WHO, 1992, ICD10 CLASS MENT BEH; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	83	398	408	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					969	979		10.1016/S0896-6273(01)00552-9	http://dx.doi.org/10.1016/S0896-6273(01)00552-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	504ZT	11754830	Bronze			2022-12-17	WOS:000172886800006
J	LEE, G; NEVE, RL; KOSIK, KS				LEE, G; NEVE, RL; KOSIK, KS			THE MICROTUBULE BINDING DOMAIN OF TAU-PROTEIN	NEURON			English	Article									HARVARD UNIV, BRIGHAM & WOMENS HOSP, CTR NEUROL DIS, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT NEUROSCI, BOSTON, MA 02115 USA; CHILDRENS HOSP MED CTR, DIV GENET, MENTAL RETARDAT PROGRAM, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	LEE, G (corresponding author), HARVARD UNIV, SCH MED, DEPT NEUROL NEUROSCI, BOSTON, MA 02115 USA.		Lee, Gloria/F-5965-2011	Lee, Gloria/0000-0002-8633-1534	NIA NIH HHS [R01 AG06601-01] Funding Source: Medline; NIGMS NIH HHS [R29 GM39300-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AIZAWA H, 1988, J BIOL CHEM, V263, P7703; AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BISHAI WR, 1987, J BACTERIOL, V169, P5140, DOI 10.1128/jb.169.11.5140-5151.1987; BRION JP, 1985, ARCH BIOL, V96, P229; CHOU CC, 1987, P NATL ACAD SCI USA, V84, P2575, DOI 10.1073/pnas.84.9.2575; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; COLLINS CA, 1987, J CELL BIOL, V105, P2847, DOI 10.1083/jcb.105.6.2847; COLLINS J, 1979, GENE, V6, P29, DOI 10.1016/0378-1119(79)90083-0; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; DEVRIES JK, 1967, P NATL ACAD SCI USA, V57, P1010, DOI 10.1073/pnas.57.4.1010; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; DRUBIN D, 1986, ANN NY ACAD SCI, V466, P257, DOI 10.1111/j.1749-6632.1986.tb38398.x; DRUBIN DG, 1984, J CELL BIOL, V98, P1090, DOI 10.1083/jcb.98.3.1090; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; ERICKSON HP, 1976, P NATL ACAD SCI USA, V73, P2813, DOI 10.1073/pnas.73.8.2813; FELLOUS A, 1977, EUR J BIOCHEM, V78, P167, DOI 10.1111/j.1432-1033.1977.tb11726.x; FRANCON J, 1982, EUR J BIOCHEM, V129, P465, DOI 10.1111/j.1432-1033.1982.tb07072.x; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GIL G, 1987, P NATL ACAD SCI USA, V84, P1863, DOI 10.1073/pnas.84.7.1863; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; HERZOG W, 1978, EUR J BIOCHEM, V92, P1, DOI 10.1111/j.1432-1033.1978.tb12716.x; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; JOACHIM CL, 1987, J NEUROPATH EXP NEUR, V46, P611, DOI 10.1097/00005072-198711000-00001; JOBLING SA, 1987, NATURE, V325, P622, DOI 10.1038/325622a0; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1987, J NEUROSCI, V7, P3142; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KUZNETSOV SA, 1981, FEBS LETT, V135, P241, DOI 10.1016/0014-5793(81)80791-0; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEE JC, 1978, BIOCHEMISTRY-US, V17, P2783, DOI 10.1021/bi00607a013; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; Maniatis T., 1982, MOL CLONING; MARECK A, 1980, NATURE, V284, P353, DOI 10.1038/284353a0; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MORI H, 1989, BIOCHEM BIOPH RES CO, V159, P1221, DOI 10.1016/0006-291X(89)92240-7; MURPHY DB, 1977, BIOCHEMISTRY-US, V16, P2598, DOI 10.1021/bi00631a004; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; PFEFFER SR, 1983, J CELL BIOL, V97, P40, DOI 10.1083/jcb.97.1.40; SANDOVAL IV, 1981, J BIOL CHEM, V256, P8795; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SERRANO L, 1985, EUR J BIOCHEM, V153, P595, DOI 10.1111/j.1432-1033.1985.tb09342.x; STORMO GD, 1986, MAXIMIZING GENE EXPR, P195; VALLEE RB, 1986, METHOD ENZYMOL, V134, P104; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; YAFFE D, 1985, NUCLEIC ACIDS RES, V13, P3723, DOI 10.1093/nar/13.10.3723; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	64	398	413	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1989	2	6					1615	1624		10.1016/0896-6273(89)90050-0	http://dx.doi.org/10.1016/0896-6273(89)90050-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC665	2516729				2022-12-17	WOS:A1989AC66500011
J	AIZENMAN, E; LIPTON, SA; LORING, RH				AIZENMAN, E; LIPTON, SA; LORING, RH			SELECTIVE MODULATION OF NMDA RESPONSES BY REDUCTION AND OXIDATION	NEURON			English	Article									CHILDRENS HOSP MED CTR,DEPT NEUROL RES,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School			Aizenman, Elias/K-2726-2012	Aizenman, Elias/0000-0001-9610-4194; Lipton, Stuart/0000-0002-3490-1259	NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R23NS022472, R01NS022472, K07NS000879, R29NS022472] Funding Source: NIH RePORTER; NEI NIH HHS [EY05477] Funding Source: Medline; NINDS NIH HHS [NS22472, NS00879] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIZENMAN E, 1988, J PHYSIOL-LONDON, V396, P75, DOI 10.1113/jphysiol.1988.sp016951; ARONSTAM RS, 1978, MOL PHARMACOL, V14, P575; AULT B, 1980, J NEUROPHYSIOL, V32, P424; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BRAESTRUP C, 1987, J NEUROCHEM, V48, P1667, DOI 10.1111/j.1471-4159.1987.tb05721.x; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.ne.11.030188.000425; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; GANONG AH, 1983, BRAIN RES, V273, P170, DOI 10.1016/0006-8993(83)91108-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KAO PN, 1984, J BIOL CHEM, V259, P1662; KARLIN A, 1966, BIOCHIM BIOPHYS ACTA, V126, P525, DOI 10.1016/0926-6585(66)90010-0; KARSCHIN A, 1988, J NEUROSCI, V8, P2895; KISKIN NI, 1986, NEUROSCI LETT, V66, P305, DOI 10.1016/0304-3940(86)90036-4; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; LEIFER D, 1984, SCIENCE, V224, P303, DOI 10.1126/science.6143400; LIPTON SA, 1987, J PHYSIOL-LONDON, V385, P361, DOI 10.1113/jphysiol.1987.sp016497; LORING RH, 1989, IN PRESS J NEUROSCI; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MOXHAM CP, 1985, BIOCHEMISTRY-US, V24, P6072, DOI 10.1021/bi00343a007; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; ROSENBERG PA, 1988, J NEUROSCI, V8, P2887, DOI 10.1523/jneurosci.08-08-02887.1988; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SIMON EJ, 1978, ANNU REV PHARMACOL, V18, P371, DOI 10.1146/annurev.pa.18.040178.002103; SNODGRASS SR, 1980, BRAIN RES, V190, P123, DOI 10.1016/0006-8993(80)91164-6; TERRAMANI T, 1988, MOL PHARMACOL, V34, P117; TOLLIVER JM, 1988, BRAIN RES, V456, P49, DOI 10.1016/0006-8993(88)90345-9; TOLLIVER JM, 1987, BRAIN RES, V404, P133, DOI 10.1016/0006-8993(87)91364-3; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	33	398	408	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1989	2	3					1257	1263		10.1016/0896-6273(89)90310-3	http://dx.doi.org/10.1016/0896-6273(89)90310-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	T8021	2696504				2022-12-17	WOS:A1989T802100007
J	Barria, A; Malinow, R				Barria, A; Malinow, R			Subunit-specific NMDA receptor trafficking to synapses	NEURON			English	Article							D-ASPARTATE RECEPTOR; ER RETENTION SIGNAL; LONG-TERM DEPRESSION; NR1 SPLICE VARIANTS; AMPA RECEPTOR; VISUAL-CORTEX; THALAMOCORTICAL SYNAPSES; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; CRITICAL PERIOD	To elucidate mechanisms controlling the number and subunit composition of synaptic NMDA-Rs in hippocampal slice neurons, the NR1, NR2A, and NR2B subunits were optically and electrophysiologically tagged. The NR2 subunit directs delivery of receptors to synapses with different rules controlling NR2A and NR2B. Synaptic incorporation of NR2B-containing receptors is not limited by synaptic transmission nor enhanced by increased subunit expression. NR2A-containing receptors whose expression normally increases with age replace synaptic NR2B-containing receptors. Replacement is enhanced by increased NR2A expression and requires synaptic activity. Surprisingly, spontaneously released transmitter acting on synaptic NMDARs is sufficient for replacement and reduces NMDA-R responses. Thus, as with AMPA-Rs, synaptic trafficking of NMDA-Rs is tightly regulated and has subunit-specific rules with functionally important consequences.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.							Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Calver AR, 2001, J NEUROSCI, V21, P1203; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dingledine R, 1999, PHARMACOL REV, V51, P7; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Flint AC, 1997, J NEUROSCI, V17, P2469; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Pagano A, 2001, J NEUROSCI, V21, P1189; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; PICCINI A, 2002, IN PRESS J NEUROSCI; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Single FN, 2000, J NEUROSCI, V20, P2558; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	54	397	411	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					345	353		10.1016/S0896-6273(02)00776-6	http://dx.doi.org/10.1016/S0896-6273(02)00776-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160751	Bronze			2022-12-17	WOS:000177034200013
J	TRUSSELL, LO; ZHANG, S; RAMAN, IM				TRUSSELL, LO; ZHANG, S; RAMAN, IM			DESENSITIZATION OF AMPA RECEPTORS UPON MULTIQUANTAL NEUROTRANSMITTER RELEASE	NEURON			English	Article							EXCITATORY SYNAPTIC CURRENTS; LONG-TERM POTENTIATION; AVIAN COCHLEAR NUCLEUS; D-ASPARTATE RECEPTORS; MOUSE CENTRAL NEURONS; AMINO-ACID RECEPTORS; HIPPOCAMPAL-NEURONS; TIME COURSE; ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR-JUNCTION	We have investigated the role of AMPA receptor desensitization during transmission at a calyceal synapse. Cyclothiazide blocked the rapid desensitization of AMPA receptors and markedly prolonged the decay time of the evoked excitatory postsynaptic current (PSC). This effect was greater than what would be expected from a simple prolongation of channel open time. Additionally, the drug reduced the depression of PSCs evoked at brief intervals. The effects of cyclothiazide on the PSC were reduced when the level of transmitter release was lowered. These data indicate that AMPA receptors are de sensitized by neurotransmitter and that this desensitization depends on the number of quanta in the synaptic cleft. We propose that release of transmitter from many closely spaced sites prolongs the time of receptor-transmitter contact and thereby promotes desensitization. Desensitization may therefore contribute to synaptic depression and prevent the interaction of transmitter quanta within the synaptic cleft.	UNIV WISCONSIN,SCH MED,NEUROSCI TRAINING PROGRAM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	TRUSSELL, LO (corresponding author), UNIV WISCONSIN,SCH MED,DEPT NEUROPHYSIOL,MADISON,WI 53706, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901, R37NS028901] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28901] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P45, DOI 10.1113/jphysiol.1987.sp016646; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; CURTIS DR, 1960, J PHYSIOL-LONDON, V150, P656, DOI 10.1113/jphysiol.1960.sp006410; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DUDEL J, 1990, J COMP PHYSIOL A, V166, P757; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FABER DS, 1988, P NATL ACAD SCI USA, V85, P8708, DOI 10.1073/pnas.85.22.8708; FINCH DM, 1990, BRAIN RES, V518, P257, DOI 10.1016/0006-8993(90)90978-K; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; HACKETT JT, 1982, NEUROSCIENCE, V7, P1455, DOI 10.1016/0306-4522(82)90257-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10396; Iversen L, 1977, SYNAPSES, P137; JENKINSON DH, 1957, J PHYSIOL-LONDON, V138, P434, DOI 10.1113/jphysiol.1957.sp005860; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KATZ B, 1965, P ROY SOC B, V161, P495; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KISKIN NI, 1990, EUR J NEUROSCI, V2, P461, DOI 10.1111/j.1460-9568.1990.tb00437.x; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; MAGAZANIK LG, 1975, J PHYSIOL-LONDON, V249, P285, DOI 10.1113/jphysiol.1975.sp011016; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V244, P467, DOI 10.1113/jphysiol.1975.sp010808; MAGLEBY KL, 1981, J PHYSIOL-LONDON, V316, P225, DOI 10.1113/jphysiol.1981.sp013784; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NEMETH EF, 1983, NEUROSCI LETT, V40, P39, DOI 10.1016/0304-3940(83)90089-7; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PARKS TN, 1981, J COMP NEUROL, V203, P425, DOI 10.1002/cne.902030307; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; PATNEAU DK, 1993, IN PRESS J NEUROSCI; PEUSNER KD, 1984, J COMP NEUROL, V230, P372, DOI 10.1002/cne.902300306; RAMAN IM, 1992, NEURON, V9, P173, DOI 10.1016/0896-6273(92)90232-3; Rubel EW, 1988, AUDITORY FUNCTION NE, P3; SZENTAGOTHAI J, 1955, Acta Morphol Acad Sci Hung, V5, P43; TAKEUCHI AKIRA, 1958, JAPANESE JOUR PHYSIOL, V8, P102; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; THIO LL, 1992, J NEUROPHYSIOL, V68, P1930, DOI 10.1152/jn.1992.68.6.1930; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P409, DOI 10.1113/jphysiol.1992.sp019424; YAMADA KA, 1993, IN PRESS J NEUROSCI; ZHOU N, 1992, DEV BRAIN RES, V67, P145, DOI 10.1016/0165-3806(92)90215-I	57	397	400	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1185	1196		10.1016/0896-6273(93)90066-Z	http://dx.doi.org/10.1016/0896-6273(93)90066-Z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	7686382				2022-12-17	WOS:A1993LK37300018
J	Alami, NH; Smith, RB; Carrasco, MA; Williams, LA; Winborn, CS; Han, SSW; Kiskinis, E; Winborn, B; Freibaum, BD; Kanagaraj, A; Clare, AJ; Badders, NM; Bilican, B; Chaum, E; Chandran, S; Shaw, CE; Eggan, KC; Maniatis, T; Taylor, JP				Alami, Nael H.; Smith, Rebecca B.; Carrasco, Monica A.; Williams, Luis A.; Winborn, Christina S.; Han, Steve S. W.; Kiskinis, Evangelos; Winborn, Brett; Freibaum, Brian D.; Kanagaraj, Anderson; Clare, Alison J.; Badders, Nisha M.; Bilican, Bilada; Chaum, Edward; Chandran, Siddharthan; Shaw, Christopher E.; Eggan, Kevin C.; Maniatis, Tom; Taylor, J. Paul			Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN; FUS/TLS; STABILITY; DEPLETION; TARGETS; ROLES	The RNA-binding protein TDP-43 regulates RNA metabolism at multiple levels, including transcription, RNA splicing, and mRNA stability. TDP-43 is a major component of the cytoplasmic inclusions characteristic of amyotrophic lateral sclerosis and some types of frontotemporal lobar degeneration. The importance of TDP-43 in disease is underscored by the fact that dominant missense mutations are sufficient to cause disease, although the role of TDP-43 in pathogenesis is unknown. Here we show that TDP-43 forms cytoplasmic mRNP granules that undergo bidirectional, microtubule-dependent transport in neurons in vitro and in vivo and facilitate delivery of target mRNA to distal neuronal compartments. TDP-43 mutations impair this mRNA transport function in vivo and in vitro, including in stem cell-derived motor neurons from ALS patients bearing any one of three different TDP-43 ALS-causing mutations. Thus, TDP-43 mutations that cause ALS lead to partial loss of a novel cytoplasmic function of TDP-43.	[Alami, Nael H.; Smith, Rebecca B.; Winborn, Brett; Freibaum, Brian D.; Kanagaraj, Anderson; Clare, Alison J.; Badders, Nisha M.; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Carrasco, Monica A.; Maniatis, Tom] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Williams, Luis A.; Han, Steve S. W.; Kiskinis, Evangelos; Eggan, Kevin C.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Winborn, Christina S.; Chaum, Edward] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Han, Steve S. W.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Bilican, Bilada; Chandran, Siddharthan] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Med Res Council Ctr Regenerat Med, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland; [Shaw, Christopher E.] Kings Coll London, Dept Clin Neurosci, London SE5 8AF, England; [Shaw, Christopher E.] Kings Coll London, Dept Neurodegenerat & Brain Injury, London SE5 8AF, England; [Shaw, Christopher E.] Kings Hlth Partners, MRC Ctr Neurodegenerat Res, London SE5 8AF, England	St Jude Children's Research Hospital; Columbia University; Harvard University; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Massachusetts General Hospital; University of Edinburgh; University of London; King's College London; University of London; King's College London; University of London; King's College London	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jpaul.taylor@stjude.org	Alami, Nael H/ABG-2027-2020; KANAGARAJ, A/GZG-4720-2022; Eggan, Kevin/P-7119-2018; Taylor, J. Paul/N-2482-2018; Chaum, Edward/AAR-1512-2021	Alami, Nael H/0000-0002-1802-8250; Taylor, J. Paul/0000-0002-5794-0349; , Palsamy Kanagaraj/0000-0003-3297-3125; Chaum, Edward/0000-0003-3542-8376; Shaw, Christopher/0000-0003-0251-0146; Clare, Alison/0000-0003-0048-8838	Packard Foundation; Target ALS; ALS Association; NIH [NS053825, AG031587, 8DP1NS082099]; MRC [G1100695, G0501573, G0500289, G0600974, G0900688, G0900635, G0300329, MC_G1000733] Funding Source: UKRI; Medical Research Council [G0300329, G1100695, G0900688, G0501573, MC_G1000733, G0500289, G0900635, G0600974, G0500289B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053825, DP1NS082099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031587] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); Target ALS; ALS Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Mitsumoto and C. Henderson (Project A.L.S./Columbia) and R. Brown (UMass Medical School) for collection of Patient 47 and Patient RB20 material. We also thank D. Zarnescu for providing the UAS-YFP-TDP-43<INF>(A315T)</INF> Drosophila lines and C. Gu and D. Solecki for provision of YFP-EB1 and pCIG2-GFP expression plasmids, respectively. This work was supported by grants from the Packard Foundation, Target ALS, the ALS Association, and NIH grants NS053825 and AG031587 to J.P.T., and an NIH Director's Pioneer Award to T. M. (8DP1NS082099). Images were acquired in the Cell & Tissue Imaging Center at St. Jude, which is supported by the American-Lebanese-Syrian Associated Charities and NCI P30 CA021765-34.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Broeck LV, 2013, CELL REP, V3, P160, DOI 10.1016/j.celrep.2012.12.014; Brown A., 2013, NEUROSCIENCE 21 CENT, P255; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen AK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq436; Chen AK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp837; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Fallini C, 2012, HUM MOL GENET, V21, P3703, DOI 10.1093/hmg/dds205; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Narayanan RK, 2013, AMYOTROPH LAT SCL FR, V14, P252, DOI 10.3109/21678421.2012.734520; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Xiao SX, 2011, MOL CELL NEUROSCI, V47, P167, DOI 10.1016/j.mcn.2011.02.013	36	396	404	3	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2014	81	3					536	543		10.1016/j.neuron.2013.12.018	http://dx.doi.org/10.1016/j.neuron.2013.12.018			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA3AO	24507191	Green Accepted, Bronze			2022-12-17	WOS:000330965500009
J	Um, JW; Kaufman, AC; Kostylev, M; Heiss, JK; Stagi, M; Takahashi, H; Kerrisk, ME; Vortmeyer, A; Wisniewski, T; Koleske, AJ; Gunther, EC; Nygaard, HB; Strittmatter, SM				Um, Ji Won; Kaufman, Adam C.; Kostylev, Mikhail; Heiss, Jacqueline K.; Stagi, Massimiliano; Takahashi, Hideyuki; Kerrisk, Meghan E.; Vortmeyer, Alexander; Wisniewski, Thomas; Koleske, Anthony J.; Gunther, Erik C.; Nygaard, Haakon B.; Strittmatter, Stephen M.			Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer A beta Oligomer Bound to Cellular Prion Protein	NEURON			English	Article							LONG-TERM POTENTIATION; AMYLOID-PRECURSOR PROTEIN; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; DENDRITIC SPINES; DISEASE BRAIN; UP-REGULATION; MOUSE MODELS; FYN KINASE; IN-VIVO	Soluble amyloid-beta oligomers (A beta o) trigger Alzheimer's disease (AD) pathophysiology and bind with high affinity to cellular prion protein (PrPC). At the postsynaptic density (PSD), extracellular A beta o bound to lipid-anchored PrPC activates intracellular Fyn kinase to disrupt synapses. Here, we screened transmembrane PSD proteins heterologously for the ability to couple A beta o-PrPC with Fyn. Only coexpression of the metabotropic glutamate receptor, mGluR5, allowed PrPC-bound A beta o to activate Fyn. PrPC and mGluR5 interact physically, and cytoplasmic Fyn forms a complex with mGluR5. A beta o-PrPC generates mGluR5-mediated increases of intracellular calcium in Xenopus oocytes and in neurons, and the latter is also driven by human AD brain extracts. In addition, signaling by A beta o-PrPC-mGluR5 complexes mediates eEF2 phosphorylation and dendritic spine loss. For mice expressing familial AD transgenes, mGluR5 antagonism reverses deficits in learning, memory, and synapse density. Thus, A beta o-PrPC complexes at the neuronal surface activate mGluR5 to disrupt neuronal function.	[Um, Ji Won; Kaufman, Adam C.; Kostylev, Mikhail; Heiss, Jacqueline K.; Stagi, Massimiliano; Takahashi, Hideyuki; Gunther, Erik C.; Nygaard, Haakon B.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA; [Um, Ji Won; Kaufman, Adam C.; Kostylev, Mikhail; Heiss, Jacqueline K.; Stagi, Massimiliano; Takahashi, Hideyuki; Gunther, Erik C.; Nygaard, Haakon B.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06536 USA; [Kerrisk, Meghan E.; Koleske, Anthony J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06536 USA; [Vortmeyer, Alexander] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06536 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA	Yale University; Yale University; Yale University; Yale University; New York University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Wisniewski, Thomas/Q-6525-2019; Stagi, Massimiliano/ABF-5894-2020; Strittmatter, Stephen/F-5739-2011	Wisniewski, Thomas/0000-0002-3379-8966; Stagi, Massimiliano/0000-0002-5827-902X; Kostylev, Mikhail/0000-0003-0435-8141; Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health; Falk Medical Research Trust; Alzheimer's Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073502, R01NS074319, R01NS080388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG034924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Medical Research Trust; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Yiguang Fu and Stefano Sodi for excellent technical support. We thank Xinran Liu of the Yale Center for Cell Imaging for advice on synapse ultrastructure analysis. S.M.S. is a cofounder of Axerion Therapeutics, seeking to develop NgR- and PrP-based therapeutics. H.B.N. is an Ellison Medical Foundation AFAR Postdoctoral Fellow and S.M.S. is a member of the Kavli Institute for Neuroscience at Yale University. We acknowledge support from the National Institutes of Health to S.M.S., A.J.K., and T.W., and from the Falk Medical Research Trust and the Alzheimer's Association to S.M.S.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bizat N, 2010, J NEUROSCI, V30, P5394, DOI 10.1523/JNEUROSCI.5831-09.2010; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Choi KY, 2011, J NEUROSCI, V31, P5921, DOI 10.1523/JNEUROSCI.6253-10.2011; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Dravid SM, 2004, BRAIN RES, V1006, P8, DOI 10.1016/j.brainres.2004.01.059; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Heidinger V, 2002, J NEUROSCI, V22, P5452; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lu YM, 1997, J NEUROSCI, V17, P5196; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Menard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028666; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; Nicolle MM, 1999, J NEUROSCI, V19, P9604; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shinoda Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010390; Simonyi A, 2010, EUR J PHARMACOL, V639, P17, DOI 10.1016/j.ejphar.2009.12.039; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; STRITTMATTER SM, 1993, P NATL ACAD SCI USA, V90, P5327, DOI 10.1073/pnas.90.11.5327; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	61	396	403	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					887	902		10.1016/j.neuron.2013.06.036	http://dx.doi.org/10.1016/j.neuron.2013.06.036			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012003	Bronze, Green Accepted			2022-12-17	WOS:000330269100008
J	Krichevsky, AM; Kosik, KS				Krichevsky, AM; Kosik, KS			Neuronal RNA granules: A link between RNA localization and stimulation-dependent translation	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LOCAL PROTEIN-SYNTHESIS; LONG-TERM FACILITATION; HEAT-SHOCK RESPONSE; MESSENGER-RNA; TARGETING ELEMENT; STRESS GRANULES; LIVING NEURONS; KINASE-II; BC1 RNA	RNA granules are a macromolecular structure observed in neurons, where they serve as motile units that translocate mRNAs. Isolated RNA granules are highly enriched in Staufen protein and ultrastructurally contain densely packed clusters of ribosomes. With depolarization, many mRNAs, including those involved in plasticity, rapidly shift from the RNA granule fraction to polysomes. Depolarization reorganizes granules and induces a less compact organization of their ribosomes. RNA granules are not translationally competent, as indicated by the failure to incorporate radioactive amino acids and the absence of eIF4E, 4G, and tRNAs. We concluded that RNA granules are a local storage compartment for mRNAs under translational arrest but are poised for release to actively translated pools. Local release of mRNAs and ribosomes from granules may serve as a macromolecular mechanism linking RNA localization to translation and synaptic plasticity.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kosik, KS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.			Krichevsky, Anna/0000-0002-5080-5507	NIA NIH HHS [AG06601] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG006601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BARBARESE E, 1995, J CELL SCI, V108, P2781; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; ESCOBAR MI, 1986, NEUROSCIENCE, V17, P975, DOI 10.1016/0306-4522(86)90074-6; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FORRISTALL C, 1995, DEVELOPMENT, V121, P201; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kashikawa M, 1999, DEV GROWTH DIFFER, V41, P495; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; KLOC M, 1995, DEVELOPMENT, V121, P287; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kobayashi S, 1998, BIOCHEM BIOPH RES CO, V253, P448, DOI 10.1006/bbrc.1998.9704; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Muslimov IA, 1997, J NEUROSCI, V17, P4722; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; NOVER L, 1991, NEW BIOL, V3, P855; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Racca C, 1997, J NEUROSCI, V17, P1691; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; SIERRA JM, 1994, MOL BIOL REP, V19, P211, DOI 10.1007/BF00986963; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; SUNDELL CL, 1990, J CELL BIOL, V111, P2397, DOI 10.1083/jcb.111.6.2397; Tiedge H, 1996, J NEUROSCI, V16, P7171; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Tujebajeva RM, 2000, J BIOL CHEM, V275, P6288, DOI 10.1074/jbc.275.9.6288; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wallace CS, 1998, J NEUROSCI, V18, P26; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wanner I, 1997, HISTOCHEM CELL BIOL, V108, P345, DOI 10.1007/s004180050175; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; ZIMMERMAN JL, 1989, PLANT CELL, V1, P1137, DOI 10.1105/tpc.1.12.1137	52	396	408	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					683	696		10.1016/S0896-6273(01)00508-6	http://dx.doi.org/10.1016/S0896-6273(01)00508-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719208	Bronze			2022-12-17	WOS:000172363900014
J	THOMPSON, RC; MANSOUR, A; AKIL, H; WATSON, SJ				THOMPSON, RC; MANSOUR, A; AKIL, H; WATSON, SJ			CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A RAT MU-OPIOID RECEPTOR	NEURON			English	Article							INHIBIT ADENYLATE-CYCLASE; SITE-DIRECTED ALKYLATION; KAPPA-OPIATE AGONISTS; NALORPHINE-LIKE DRUGS; CHRONIC SPINAL DOG; BINDING-SITES; HIGH-AFFINITY; HETEROLOGOUS DESENSITIZATION; EXPRESSION CLONING; MORPHINE-LIKE	We have isolated a rat cDNA clone that displays 75% amino acid homology with the mouse delta and rat kappa opioid receptors. The cDNA (designated pRMuR-12) encodes a protein of 398 amino acids comprising, in part, seven hydrophobic domains similar to those described for other G protein-linked receptors. Data from binding assays conducted with COS-1 cells transiently transfected with a CMV mammalian expression vector containing the full coding region of pRMuR-12 demonstrated mu receptor selectivity. In situ hybridization mRNA analysis revealed an mRNA distribution in rat brain that corresponds well to the distribution of binding sites labeled with mu-selective ligands. Based upon these observations, we conclude that pRMuR-12 encodes a mu opioid receptor.			THOMPSON, RC (corresponding author), UNIV MICHIGAN, MENTAL HLTH RES INST, ANN ARBOR, MI 48109 USA.				NIADDK NIH HHS [P30-AM34933] Funding Source: Medline; NIDA NIH HHS [NIDA RO1 DA02265] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002265] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ATTALI B, 1989, J NEUROCHEM, V52, P360, DOI 10.1111/j.1471-4159.1989.tb09130.x; BARCHFELD CC, 1984, BIOCHEM BIOPH RES CO, V121, P641, DOI 10.1016/0006-291X(84)90230-4; BESSE D, 1990, BRAIN RES, V521, P15, DOI 10.1016/0006-8993(90)91519-M; BESSE D, 1991, BRAIN RES, V548, P287, DOI 10.1016/0006-8993(91)91134-M; BIDLACK JM, 1980, LIFE SCI, V27, P331, DOI 10.1016/0024-3205(80)90201-5; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN C, 1993, MOL CELL BIOL, V44, P8; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CHO TM, 1981, LIFE SCI, V28, P2651, DOI 10.1016/0024-3205(81)90723-2; CHO TM, 1986, P NATL ACAD SCI USA, V83, P4138, DOI 10.1073/pnas.83.12.4138; CHOW T, 1983, MOL PHARMACOL, V24, P203; CLARK RB, 1989, MOL PHARMACOL, V36, P343; DEMOLIOUMASON CD, 1984, FEBS LETT, V170, P378, DOI 10.1016/0014-5793(84)81348-4; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; GILBERT PE, 1976, J PHARMACOL EXP THER, V198, P66; GILLAN MGC, 1982, BRIT J PHARMACOL, V77, P461, DOI 10.1111/j.1476-5381.1982.tb09319.x; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; GOLDSTEIN A, 1984, MOL PHARMACOL, V25, P343; HERLING S, 1981, LIFE SCI, V28, P1571, DOI 10.1016/0024-3205(81)90311-8; HOWELLS RD, 1982, J PHARMACOL EXP THER, V222, P629; HSIA JA, 1984, J BIOL CHEM, V259, P1086; IYENGAR S, 1986, LIFE SCI, V39, P637, DOI 10.1016/0024-3205(86)90045-7; JAMES IF, 1984, MOL PHARMACOL, V25, P337; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; LEANDER JD, 1985, J PHARMACOL EXP THER, V234, P463; LUTZ RA, 1992, J RECEPTOR RES, V12, P267, DOI 10.3109/10799899209074796; MANECKJEE R, 1985, P NATL ACAD SCI USA, V82, P594, DOI 10.1073/pnas.82.2.594; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MANSOUR A, 1993, ANATOMICAL DISTRIBUT; MANZANARES J, 1990, NEUROENDOCRINOLOGY, V52, P200, DOI 10.1159/000125582; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MCLEAN S, 1986, BRAIN RES, V378, P49, DOI 10.1016/0006-8993(86)90285-4; MENG F, 1993, IN PRESS P NATL ACAD; MORLEY JE, 1983, PEPTIDES, V4, P797, DOI 10.1016/0196-9781(83)90069-4; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NOCK B, 1988, EUR J PHARMACOL, V154, P27, DOI 10.1016/0014-2999(88)90359-7; PASTERNAK GW, 1986, LIFE SCI, V38, P1889, DOI 10.1016/0024-3205(86)90217-1; PASTERNAK GW, 1975, NATURE, V253, P563, DOI 10.1038/253563a0; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; PUTTFARCKEN PS, 1988, MOL PHARMACOL, V33, P520; ROCHE PC, 1992, ENDOCRINOLOGY, V131, P268, DOI 10.1210/en.131.1.268; ROTHMAN RB, 1987, PEPTIDES, V8, P1015, DOI 10.1016/0196-9781(87)90130-6; RUEGG UT, 1980, EUR J PHARMACOL, V64, P367, DOI 10.1016/0014-2999(80)90247-2; SCHOFIELD PR, 1989, EMBO J, V8, P489, DOI 10.1002/j.1460-2075.1989.tb03402.x; SIMON EJ, 1991, MED RES REV, V11, P357, DOI 10.1002/med.2610110402; SIMON EJ, 1975, SCIENCE, V190, P389, DOI 10.1126/science.1182043; SIMONDS WF, 1980, P NATL ACAD SCI-BIOL, V77, P4623, DOI 10.1073/pnas.77.8.4623; TEMPEL A, 1987, P NATL ACAD SCI USA, V84, P4308, DOI 10.1073/pnas.84.12.4308; UEDA H, 1987, NEUROSCI LETT, V75, P339, DOI 10.1016/0304-3940(87)90546-5; UNTERWALD EM, 1991, BRAIN RES, V562, P57, DOI 10.1016/0006-8993(91)91186-5; WOLOZIN BL, 1981, P NATL ACAD SCI-BIOL, V78, P6181, DOI 10.1073/pnas.78.10.6181; WOOD PL, 1982, NEUROPHARMACOLOGY, V21, P487, DOI 10.1016/0028-3908(82)90038-7; WOOD PL, 1988, PEPTIDES, V1, P49; XIE GX, 1992, P NATL ACAD SCI USA, V89, P4124, DOI 10.1073/pnas.89.9.4124; XIE YB, 1990, J BIOL CHEM, V265, P21411; YASUDA K, 1993, IN PRESS P NATL ACAD; 1991, PROGRAM MANUAL GCG P	60	396	405	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					903	913		10.1016/0896-6273(93)90120-G	http://dx.doi.org/10.1016/0896-6273(93)90120-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240812	Green Submitted			2022-12-17	WOS:A1993MJ04100012
J	IP, NY; MCCLAIN, J; BARREZUETA, NX; ALDRICH, TH; PAN, L; LI, YP; WIEGAND, SJ; FRIEDMAN, B; DAVIS, S; YANCOPOULOS, GD				IP, NY; MCCLAIN, J; BARREZUETA, NX; ALDRICH, TH; PAN, L; LI, YP; WIEGAND, SJ; FRIEDMAN, B; DAVIS, S; YANCOPOULOS, GD			THE ALPHA COMPONENT OF THE CNTF RECEPTOR IS REQUIRED FOR SIGNALING AND DEFINES POTENTIAL CNTF TARGETS IN THE ADULT AND DURING DEVELOPMENT	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA-INHIBITORY FACTOR; NEURONAL DIFFERENTIATION FACTOR; REGIONAL DISTRIBUTION; MOLECULAR-CLONING; RAT-BRAIN; SYMPATHETIC NEURONS; TROPHIC FACTOR; MESSENGER-RNA; SPINAL-CORD	We recently proposed that ciliary neurotrophic factor (CNTF) shares two receptor components with a generally acting cytokine, leukemia inhibitory factor (LIF), but that CNTF also requires a third receptor component (CNTFRalpha) that is mostly restricted to the nervous system in its expression. Here we demonstrate that a transfected CNTFRalpha gene is sufficient to confer CNTF responsiveness upon hemopoietic cells normally responsive only to LIF, providing evidence that CNTFRalpha is a required receptor component that uniquely characterizes CNTF-responding cells. Consistent with this notion, CNTFRalpha expression could be localized to neurons within all known peripheral targets of CNTF. CNTFRalpha was also widely expressed within neurons of the CNS, suggesting that CNTF has broader CNS actions than previously appreciated. However, in vivo localization of CNTFRalpha, as well as of CNTF itself, is consistent with a particularly important role for CNTF in motor function as well as during neuropoiesis.			IP, NY (corresponding author), REGENERON PHARMACEUT INC, 777 OLD SAW MILL RIVER RD, TARRYTOWN, NY 10591 USA.			Ip, Nancy Yuk-Yu/0000-0002-2763-8907				ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BAUMANN M, 1990, J BIOL CHEM, V265, P19853; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BLOTTNER D, 1989, NEUROSCI LETT, V105, P316, DOI 10.1016/0304-3940(89)90640-X; Bothwell A., 1990, METHODS CLONING ANAL; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DAVIS S, 1993, IN PRESS CURR OPIN N; DAVIS S, 1993, IN PRESS SCIENCE; ECKENSTEIN FP, 1990, NEURON, V4, P623, DOI 10.1016/0896-6273(90)90120-5; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; HAGG T, 1992, NEURON, V8, P145, DOI 10.1016/0896-6273(92)90116-U; HALL AK, 1992, TRENDS NEUROSCI, V15, P35, DOI 10.1016/0166-2236(92)90022-Z; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hughes J T, 1982, Adv Neurol, V36, P61; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IP NY, 1992, IN PRESS PROG GROWTH; IP NY, 1993, IN PRESS EUR J NEURO; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LAVAIL MM, 1992, IN PRESS P NATL ACAD; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAO MS, 1990, DEV BIOL, V139, P65, DOI 10.1016/0012-1606(90)90279-R; RENDE M, 1992, GLIA, V5, P25, DOI 10.1002/glia.440050105; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SKAPER SD, 1986, DEV BRAIN RES, V24, P39, DOI 10.1016/0165-3806(86)90171-9; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546	57	396	408	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					89	102		10.1016/0896-6273(93)90245-M	http://dx.doi.org/10.1016/0896-6273(93)90245-M			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8381290				2022-12-17	WOS:A1993KK01200010
J	MacLeod, DA; Rhinn, H; Kuwahara, T; Zolin, A; Di Paolo, G; MacCabe, BD; Marder, KS; Honig, LS; Clark, LN; Small, SA; Abeliovich, A				MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Marder, Karen S.; Honig, Lawrence S.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa			RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson's Disease Risk	NEURON			English	Article							GENE-EXPRESSION; RETROMER; ALPHA; MICE; NEURODEGENERATION; LOCALIZATION; TRAFFICKING; TRANSPORT; COMPLEX; KINASE	Recent genome-wide association studies have linked common variants in the human genome to Parkinson's disease (PD) risk. Here we show that the consequences of variants at 2 such loci, PARK16 and LRRK2, are highly interrelated, both in terms of their broad impacts on human brain transcriptomes of unaffected carriers, and in terms of their associations with PD risk. Deficiency of the PARK16 locus gene RAB7L1 in primary rodent neurons, or of a RAB7L1 ortholog in Drosophila dopamine neurons, recapitulated degeneration observed with expression of a familial PD mutant form of LRRK2, whereas RAB7L1 overexpression rescued the LRRK2 mutant phenotypes. PD-associated defects in RAB7L1 or LRRK2 led to endolysosomal and Golgi apparatus sorting defects and deficiency of the VPS35 component of the retromer complex. Expression of wildtype VPS35, but not a familial PD-associated mutant form, rescued these defects. Taken together, these studies implicate retromer and lysosomal pathway alterations in PD risk.	[MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Marder, Karen S.; Honig, Lawrence S.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Marder, Karen S.; Honig, Lawrence S.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa] Columbia Univ, Taub Inst, New York, NY 10032 USA; [MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Marder, Karen S.; Honig, Lawrence S.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Abeliovich, A (corresponding author), Columbia Univ, Dept Neurol, Black Bldg 1208,650 West 168th St, New York, NY 10032 USA.	aa900@columbia.edu	Kuwahara, Tomoki/AAT-7119-2021; Kuwahara, Tomoki/AAX-2459-2020	Kuwahara, Tomoki/0000-0003-1788-7018; McCabe, Brian/0000-0003-1620-0501; Zolin, Aryeh/0000-0002-0752-9770	Michael J. Fox Foundation; NIH [NS064433, NS060876, NS060113, NS063660, UL1 TR000040, AG025161, AG08702-21, P50AG08702]; Daiichi-Sankyo Foundation; Japan Society for the Promotion of Science; Parkinson's Disease Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060876, R01NS036630, R01NS060113, R56NS036630, R01NS064433, R01NS056049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025161, P50AG008702] Funding Source: NIH RePORTER	Michael J. Fox Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daiichi-Sankyo Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Parkinson's Disease Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the New York Brain Bank and Jean Paul Vonsattel for banked tissue samples. We are grateful to all the contributors who made their data publicly available at the Gene Expression Omnibus. We thank Oliver Hobert for reviewing the manuscript. The work was supported by grants from the Michael J. Fox Foundation (A.A.), the NIH (NS064433 and NS060876 to A.A.; NS060113 to L.N.C.; NS063660 and UL1 TR000040 to K.S.M.; AG025161 to S.A.S.; AG08702-21 to B.D.M.; and P50AG08702 to L.S.H.), the Daiichi-Sankyo Foundation and the Japan Society for the Promotion of Science (T.K.), and the Parkinson's Disease Foundation (L. N. C. and K.S.M.). A.A. designed studies and interpreted data. H.R. designed and performed the human genetics analyses, and performed the bioinformatics and the splicing experiments. D.A.M. performed the Drosophila and mouse experiments. D.A.M., T. K., and A.Z performed the cell culture experiments. B.D.M. helped designing and interpreting the Drosophila experiments, L.N.C. the human genetics, G.D.P. and S.A.S. the retromer and trafficking experiments. A.A. and H.R wrote the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Higashi S, 2009, J NEUROPATH EXP NEUR, V68, P994, DOI 10.1097/NEN.0b013e3181b44ed8; Kim E, 2010, BIOCHEM BIOPH RES CO, V403, P167, DOI 10.1016/j.bbrc.2010.10.121; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Latourelle JC, 2011, MOVEMENT DISORD, V26, P2039, DOI 10.1002/mds.23781; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shimizu F, 1997, CYTOGENET CELL GENET, V77, P261, DOI 10.1159/000134591; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skinner CF, 2009, RES PER ALZ, P125, DOI 10.1007/978-3-540-87941-1_10; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; St George-Hyslop P., 2009, INTRACELLULAR TRAFFI; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	46	395	405	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2013	77	3					425	439		10.1016/j.neuron.2012.11.033	http://dx.doi.org/10.1016/j.neuron.2012.11.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395371	Green Accepted, Bronze			2022-12-17	WOS:000317030800007
J	Liu, J; Lillo, C; Jonsson, PA; Velde, CV; Ward, CM; Miller, TM; Subramaniam, JR; Rothstein, JD; Marklund, S; Andersen, PM; Brannstrom, T; Gredal, O; Wong, PC; Williams, DS; Cleveland, DW				Liu, J; Lillo, C; Jonsson, PA; Velde, CV; Ward, CM; Miller, TM; Subramaniam, JR; Rothstein, JD; Marklund, S; Andersen, PM; Brannstrom, T; Gredal, O; Wong, PC; Williams, DS; Cleveland, DW			Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MOUSE MODEL; MOLECULAR-WEIGHT COMPLEXES; DEAFNESS DYSTONIA SYNDROME; MOTOR-NEURON DEATH; CU,ZN-SUPEROXIDE DISMUTASE; DISEASE PROGRESSION; COPPER CHAPERONE; MUTATIONS	One cause of amyotrophic lateral sclerosis (ALS) is mutation in ubiquitously expressed copper/zinc superoxide dismutase (SOD1), but the mechanism of toxicity to motor neurons is unknown. Multiple disease-causing mutants, but not wild-type SOD1, are now demonstrated to be recruited to mitochondria, but only in affected tissues. This is independent of the copper chaperone for SOD1 and dismutase activity. Highly preferential association with spinal cord mitochondria is seen in human ALS for a mutant SOD1 that accumulates only to trace cytoplasmic levels. Despite variable proportions that are successfully imported, nearly constant amounts of SOD1 mutants and covalently damaged adducts of them accumulate as apparent import intermediates and/or are tightly aggregated or crosslinked onto integral membrane components on the cytoplasmic face of those mitochondria. These findings implicate damage from action of spinal cord-specific factors that recruit mutant SOD1 to spinal mitochondria as the basis for their selective toxicity in ALS.	Ludwig Inst Canc Res, Dept Neurosci Med & Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Umea Univ, Univ Hosp, Inst Clin Neurosci, Dept Med Biosci, S-90187 Umea, Sweden; Umea Univ, Univ Hosp, Inst Clin Neurosci, Dept Neurol, S-90187 Umea, Sweden; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Bispebjerg Hosp, Dept Neurol, Copenhagen, Denmark	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Umea University; Umea University; Johns Hopkins University; University of Copenhagen; Bispebjerg Hospital	Cleveland, DW (corresponding author), Ludwig Inst Canc Res, Dept Neurosci Med & Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Velde, Christine Vande/AAB-8828-2020; Lillo, Concepcion/A-6321-2009; rothstein, jeffrey d/C-9470-2013; Cleveland, Don/AAN-9783-2021; Vande Velde, Christine/F-2721-2016	Lillo, Concepcion/0000-0001-5814-9826; Vande Velde, Christine/0000-0001-5926-1529; Jonsson, Andreas/0000-0002-1938-0707; Subramaniam, Jamuna R/0000-0003-0343-2469; Cleveland, Don/0000-0002-1934-3682	NATIONAL EYE INSTITUTE [R01EY007042, P30EY012598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040014, R01NS027036, R37NS027036] Funding Source: NIH RePORTER; NEI NIH HHS [EY12598, R01 EY007042, EY07042] Funding Source: Medline; NIA NIH HHS [AG 000975] Funding Source: Medline; NINDS NIH HHS [R37 NS027036, NS40014, NS27036] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Andrus PK, 1998, J NEUROCHEM, V71, P2041; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Guegan C, 2002, MOL CELL NEUROSCI, V20, P553, DOI 10.1006/mcne.2002.1136; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Orr HT, 2002, NAT NEUROSCI, V5, P287, DOI 10.1038/nn0402-287; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pfanner N, 2002, CURR OPIN CELL BIOL, V14, P400, DOI 10.1016/S0955-0674(02)00355-1; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Van Landeghem GF, 1999, EUR J NEUROL, V6, P639; Vukosavic S, 2000, J NEUROSCI, V20, P9119; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	62	395	405	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					5	17		10.1016/j.neuron.2004.06.016	http://dx.doi.org/10.1016/j.neuron.2004.06.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233913	Bronze			2022-12-17	WOS:000222549800003
J	Noble, W; Olm, V; Takata, K; Casey, E; O, M; Meyerson, J; Gaynor, K; LaFrancois, J; Wang, LL; Kondo, T; Davies, P; Burns, M; Nixon, VR; Dickson, D; Matsuoka, Y; Ahlijanian, M; Lau, LF; Duff, K				Noble, W; Olm, V; Takata, K; Casey, E; O, M; Meyerson, J; Gaynor, K; LaFrancois, J; Wang, LL; Kondo, T; Davies, P; Burns, M; Nixon, VR; Dickson, D; Matsuoka, Y; Ahlijanian, M; Lau, LF; Duff, K			Cdk5 is a key factor in tau aggregation and tangle formation in vivo	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMER-LIKE PHOSPHORYLATION; CYCLIN-DEPENDENT KINASE-5; NEUROFIBRILLARY TANGLES; ACTIVATOR P35; PROTEIN-TAU; BETA; HYPERPHOSPHORYLATION; PATHOLOGY; P25	Tau aggregation is a common feature of neurodegenerative diseases such as Alzheimer's disease, and hyperphosphorylation of tau has been implicated as a fundamental pathogenic mechanism in this process. To examine the impact of cdk5 in tau aggregation and tangle formation, we crossed transgenic mice overexpressing the cdk5 activator p25, with transgenic mice overexpressing mutant (P301L) human tau. Tau was hyperphosphorylated at several sites in the double transgenics, and there was a highly significant accumulation of aggregated tau in brainstem and cortex. This was accompanied by increased numbers of silver-stained neurofibrillary tangles (NFTs). Insoluble tau was also associated with active GSK. Thus, cdk5 can initiate a major impact on tau pathology progression that probably involves several kinases. Kinase inhibitors may thus be beneficial therapeutically.	NYU, Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Mayo Clin, Jacksonville, FL 32224 USA; Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA	Nathan Kline Institute for Psychiatric Research; New York University; Yeshiva University; Albert Einstein College of Medicine; Mayo Clinic; Pfizer	Duff, K (corresponding author), NYU, Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	duff@nki.rfmh.org	Noble, Wendy/C-3756-2009; Duff, Karen EK/C-2510-2009	Noble, Wendy/0000-0002-7898-4295; Dickson, Dennis W/0000-0001-7189-7917; Duff, Karen/0000-0002-6177-868X; Burns, Mark P/0000-0003-4750-2000	NIA NIH HHS [AG 172116] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alvarez A, 2001, EXP CELL RES, V264, P266, DOI 10.1006/excr.2001.5152; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bancroft JD, 1990, THEORY PRACTICE HIST; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bian F, 2002, J COMP NEUROL, V446, P257, DOI 10.1002/cne.10186; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; BRAAK H, 1988, STAIN TECHNOL, V63, P197, DOI 10.3109/10520298809107184; Bu BT, 2002, J NEUROSCI, V22, P6515; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7; Friedhoff P, 2000, BBA-MOL BASIS DIS, V1502, P122, DOI 10.1016/S0925-4439(00)00038-7; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, NEUROREPORT, V12, P2007; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Ishiguro K, 1995, NEUROSCI LETT, V202, P81, DOI 10.1016/0304-3940(95)12206-0; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Lund ET, 2001, J NEUROCHEM, V76, P1221, DOI 10.1046/j.1471-4159.2001.00130.x; Michel G, 1998, BBA-GEN SUBJECTS, V1380, P177, DOI 10.1016/S0304-4165(97)00139-6; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Planel E, 2002, DRUG DEVELOP RES, V56, P491, DOI 10.1002/ddr.10100; Rank KB, 2002, FEBS LETT, V514, P263, DOI 10.1016/S0014-5793(02)02376-1; Ratner N, 1998, J NEUROSCI, V18, P7717; Sengupta A, 1997, MOL CELL BIOCHEM, V167, P99, DOI 10.1023/A:1006883924775; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Tomidokoro Y, 2001, NEUROSCI LETT, V299, P169, DOI 10.1016/S0304-3940(00)01767-5; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Veeranna, 1998, J NEUROSCI, V18, P4008; Veeranna, 1996, NEUROCHEM RES, V21, P629, DOI 10.1007/BF02527763; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Yamaguchi H, 1996, ACTA NEUROPATHOL, V92, P232, DOI 10.1007/s004010050513	49	395	424	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2003	38	4					555	565		10.1016/S0896-6273(03)00259-9	http://dx.doi.org/10.1016/S0896-6273(03)00259-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765608	Bronze			2022-12-17	WOS:000183104000007
J	Schmitz, F; Konigstorfer, A; Sudhof, TC				Schmitz, F; Konigstorfer, A; Sudhof, TC			RIBEYE, a component of synaptic ribbons: A protein's journey through evolution provides insight into synaptic ribbon function	NEURON			English	Article							RETINAL BIPOLAR NEURONS; SACCULAR HAIR-CELLS; MAMMALIAN RETINA; TRANSCRIPTIONAL REPRESSION; VESICLE PROTEINS; SYNAPSES; PHOTORECEPTOR; COMPLEX; SYNAPTOPHYSIN; ENDOCYTOSIS	Photoreceptor cells utilize ribbon synapses to transmit sensory signals at high resolution. Ribbon synapses release neurotransmitters tonically, with a high release rate made possible by continuous docking of synaptic vesicles on presynaptic ribbons. We have partially purified synaptic ribbons from retina and identified a major protein component called RIBEYE. RIBEYE is composed of a unique A domain specific for ribbons, and a B domain identical with CtBP2, a transcriptional repressor that in turn is related to 2-hydroxyacid dehydrogenases. The A domain mediates assembly of RIBEYE into large structures, whereas the B domain binds NAD(+) with high affinity, similar to 2-hydroxyacid dehydrogenases. Our results define a unique component of synaptic ribbons and suggest that RIBEYE evolved in vertebrates under utilization of a preexisting protein to build a unique scaffold for a specialized synapse.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, Dallas, TX 75390 USA; Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Leibniz Inst Neurobiol, Abt Neurochem Mol Biol, D-39118 Magdeburg, Germany	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society; Leibniz Institut fur Neurobiologie (LIN)	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.							Borjigin J, 1999, ANNU REV PHARMACOL, V39, P53, DOI 10.1146/annurev.pharmtox.39.1.53; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; Brandstatter JH, 1996, EUR J NEUROSCI, V8, P823, DOI 10.1111/j.1460-9568.1996.tb01268.x; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; DIGIROLAMO M, 1995, P NATL ACAD SCI USA, V92, P7065, DOI 10.1073/pnas.92.15.7065; Dowling J.E., 1987, RETINA APPROACHABLE; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; GEPPERT M, 1994, EMBO J, V13, P3720, DOI 10.1002/j.1460-2075.1994.tb06681.x; GOLDBERG JD, 1994, J MOL BIOL, V236, P1123, DOI 10.1016/0022-2836(94)90016-7; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HOPSU VK, 1964, EXP CELL RES, V37, P484; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; JASTROW H, 1997, CELL TISSUE RES, V287, P55; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Morgans CW, 1996, J NEUROSCI, V16, P6713; Muresan V, 1999, J NEUROSCI, V19, P1027; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NAEGELE JR, 1991, BRAIN RES, V559, P118, DOI 10.1016/0006-8993(91)90294-6; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Sambrook J, 1989, MOL CLONING LAB MANU; SCHAEFFER SF, 1982, J COMP NEUROL, V204, P253, DOI 10.1002/cne.902040305; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; SCHMITZ F, 1993, HISTOCHEMISTRY, V100, P35, DOI 10.1007/BF00268876; Schmitz F, 1996, J NEUROSCI, V16, P7109; SCHMITZ F, 1997, HISTOCHEM CELL BIOL, V108, P245; SMITH CA, 1961, J ULTRA MOL STRUCT R, V5, P523, DOI 10.1016/S0022-5320(61)80025-7; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; THOMPSON ST, 1976, P NATL ACAD SCI USA, V73, P361, DOI 10.1073/pnas.73.2.361; TRUJILLOCENOZ O, 1972, HDB SENSORY PHYSL, V2, P5; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; ULLRICH B, 1994, J PHYSIOL-PARIS, V88, P249, DOI 10.1016/0928-4257(94)90088-4; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Zhang HL, 1999, P NATL ACAD SCI USA, V96, P535, DOI 10.1073/pnas.96.2.535	50	395	410	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	2000	28	3					857	872		10.1016/S0896-6273(00)00159-8	http://dx.doi.org/10.1016/S0896-6273(00)00159-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386JJ	11163272	Bronze			2022-12-17	WOS:000166057500022
J	Liedtke, W; Edelmann, W; Bieri, PL; Chiu, FC; Cowan, NJ; Kucherlapati, R; Raine, CS				Liedtke, W; Edelmann, W; Bieri, PL; Chiu, FC; Cowan, NJ; Kucherlapati, R; Raine, CS			GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; MESSENGER-RNA; OLIGODENDROCYTE DEVELOPMENT; INTERMEDIATE FILAMENTS; ASTROCYTIC PROCESSES; CONDITIONED MEDIUM; CELLS; BRAIN	To investigate the structural role of glial fibrillary acidic protein (GFAP) in vivo, mice carrying a null mutation in GFAP were generated. In 7/14 mutant animals older than 18 months of age, hydrocephalus associated with white matter loss was detected. Mutant mice displayed abnormal myelination including the presence of actively myelinating oligodendrocytes in adults, nonmyelinated axons in optic nerve, and reduced myelin thickness in spinal cord. White matter was poorly vascularized and the blood-brain barrier was structurally and functionally impaired. Astrocytic structure and function were abnormal, consisting of shortened astrocytic cell processes, decreased septation of white matter, and increased CNS extracellular space. Thus, GFAP expression is essential for normal white matter architecture and blood-brain barrier integrity, and its absence leads to late-onset CNS dysmyelination.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOL GENET,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROL,BRONX,NY 10461; NYU,DEPT BIOCHEM,NEW YORK,NY 10016	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University	Liedtke, W (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PATHOL,DIV NEUROPATHOL,1300 MORRIS PK AVE,BRONX,NY 10461, USA.		Kucherlapati, Raju/ABC-8807-2021; Liedtke, Wolfgang/GNH-1878-2022; Liedtke, Wolfgang B/G-4633-2011		NINDS NIH HHS [NS 07098, NS 08952, NS 11920] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008952, T32NS007098, P50NS011920, P01NS011920] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNEY ER, 1983, DEV BIOL, V100, P166, DOI 10.1016/0012-1606(83)90207-5; BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BARONVANEVERCOOREN A, 1992, LAB INVEST, V66, P39; BARTLETT WP, 1988, GLIA, V1, P253, DOI 10.1002/glia.440010404; BLAKEMORE WF, 1991, TRENDS NEUROSCI, V14, P323, DOI 10.1016/0166-2236(91)90155-N; BOEGLER O, 1990, P NATL ACAD SCI USA, V87, P6368; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; BUNGE RP, 1965, ANN NY ACAD SCI, V122, P15; CHIU FC, 1989, NEURON, V2, P1435, DOI 10.1016/0896-6273(89)90189-X; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GALLO V, 1995, J NEUROSCI, V15, P394; GARD AL, 1995, DEVELOPMENT, V121, P2187; GOLDMUNTZ EA, 1986, J IMMUNOL, V137, P3444; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; HANDYSIDE AH, 1989, ROUX ARCH DEV BIOL, V198, P48, DOI 10.1007/BF00376370; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kandel ER, 1991, PRINCIPLES NEURAL SC, P22; LANDRY CF, 1990, J NEUROSCI RES, V25, P194, DOI 10.1002/jnr.490250207; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MICHAELSON MD, 1996, IN PRESS DEVELOPMENT; MOORE GRW, 1987, LAB INVEST, V57, P157; MOORE GRW, 1988, LAB INVEST, V59, P641; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Privat Alain, 1995, P3; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Raine C.S, 1991, TXB NEUROPATHOLOGY, P115; RAINE CS, 1984, J NEUROCYTOL, V13, P21, DOI 10.1007/BF01148316; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; SKOFF RP, 1976, NATURE, V264, P560, DOI 10.1038/264560a0; VAUGHN JE, 1967, AM J ANAT, V121, P131, DOI 10.1002/aja.1001210109; Virchow R., 1846, ALLG Z PSYCHIAT, V3, P242; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; WREN DR, 1989, P NATL ACAD SCI USA, V86, P9025, DOI 10.1073/pnas.86.22.9025; WU E, 1992, LAB INVEST, V67, P88; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; YU ACH, 1991, J NEUROSCI RES, V30, P72, DOI 10.1002/jnr.490300109	47	395	404	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					607	615		10.1016/S0896-6273(00)80194-4	http://dx.doi.org/10.1016/S0896-6273(00)80194-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893019	hybrid			2022-12-17	WOS:A1996VP74300007
J	Liu, Y; Jurman, ME; Yellen, G				Liu, Y; Jurman, ME; Yellen, G			Dynamic rearrangement of the outer mouth of a K+ channel during gating	NEURON			English	Article							POTASSIUM CHANNEL; CYSTEINE-SUBSTITUTION; SENSORY RECEPTOR; BINDING-SITE; TEA BLOCKADE; INACTIVATION; BLOCKING; MUTANTS; REGION; MECHANISMS	With prolonged stimulation, voltage-activated Ki channels close by a gating process called inactivation. This inactivation gating can occur by two distinct molecular mechanisms: N-type, in which a tethered particle blocks the intracellular mouth of the pore, and C-type, which involves a closure of the external mouth. The functional motion involved in C-type inactivation was studied by introducing cysteine residues at the outer mouth of Shaker K+ channels through mutagenesis, and by measuring state-dependent changes in accessibility to chemical modification. Modification of three adjacent residues in the outer mouth was 130-10,000-fold faster in the C-type inactivated state than in the closed state. At one position, state-dependent bridging or disulfide crosslinking between subunits was also possible. These results give a consistent picture in which C-type inactivation promotes a local rearrangement and constriction of the channel at the outer mouth.			Liu, Y (corresponding author), HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02114 USA.			Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029693, NS09774, NS29693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; GRISSMER S, 1989, BIOPHYS J, V55, P203, DOI 10.1016/S0006-3495(89)82793-6; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LORING RH, 1992, MOL BRAIN RES, V15, P113, DOI 10.1016/0169-328X(92)90158-8; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schlief T, 1996, PFLUG ARCH EUR J PHY, V431, P483, DOI 10.1007/BF02191894; SMITH DJ, 1975, BIOCHEMISTRY-US, V14, P766, DOI 10.1021/bi00675a019; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TOTH MS, 1993, PROTEIN SCI, V2, P1024; XU M, 1993, J BIOL CHEM, V268, P21505; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	40	395	404	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					859	867		10.1016/S0896-6273(00)80106-3	http://dx.doi.org/10.1016/S0896-6273(00)80106-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608004	Bronze			2022-12-17	WOS:A1996UG61100019
J	Machold, R; Fishell, G				Machold, R; Fishell, G			Math1 is expressed in temporally discrete pools of cerebellar rhombic-lip neural progenitors	NEURON			English	Article							DEVELOPING NERVOUS-SYSTEM; SITE-SPECIFIC RECOMBINATION; GRANULE NEURONS; CRE RECOMBINASE; IN-VIVO; MOUSE; CELLS; PROJECTIONS; ACTIVATION; BOUNDARIES	We have utilized an in vivo-inducible genetic-fate-mapping strategy to permanently label cohorts of Math1-positive cells and their progeny that arise in the rhombic lip of the cerebellar primordium during embryogenesis. At stages prior to E12.5, with the exception of the deep cerebellar nuclei, we find that Math1 cells migrate out of the cerebellar primordium into the rostral hindbrain to populate specific nuclei that include cholinergic neurons of the mesopontine tegmental system. Moreover, analysis of Math1-null embryos shows that this gene is required for the formation of some of these nuclei. Around E12.5, granule cell precursors begin to be labeled: first, ones that give rise to granule cells that predominantly populate the anterior lobes of the adult cerebellum and later, those that populate progressing more caudally lobes until labeling of all granule cell precursors is complete by E17. Thus, we demonstrate that the cerebellar rhombic lip gives rise to multiple cell types within rhombomere 1.	NYU, Ctr Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Ctr Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University; New York University	Fishell, G (corresponding author), NYU, Ctr Med, Dev Genet Program, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	fishell@saturn.med.nyu.edu		Fishell, Gordon/0000-0002-9640-9278	NINDS NIH HHS [R01 NS032993-11] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032993] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Balaban CD, 2004, BRAIN RES, V996, P126, DOI 10.1016/j.brainres.2003.10.026; Bayer, 1997, RELATION ITS EVOLUTI; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gilthorpe JD, 2002, DEVELOPMENT, V129, P4719; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Helms AW, 2000, DEVELOPMENT, V127, P1185; Helms AW, 2001, MOL CELL NEUROSCI, V17, P671, DOI 10.1006/mcne.2000.0969; Kimmel RA, 2000, GENE DEV, V14, P1377; Koster RW, 2001, CURR BIOL, V11, P1858, DOI 10.1016/S0960-9822(01)00585-1; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lin JC, 2001, J NEUROSCI, V21, P159, DOI 10.1523/JNEUROSCI.21-01-00159.2001; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Nagy A., 2003, MANIPULATING MOUSE E; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; YEOMANS JS, 1995, NEUROPSYCHOPHARMACOL, V12, P3, DOI 10.1016/0893-133X(94)00054-4; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	35	394	396	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					17	24		10.1016/j.neuron.2005.08.028	http://dx.doi.org/10.1016/j.neuron.2005.08.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202705	Bronze			2022-12-17	WOS:000232625700006
J	Miyashiro, KY; Beckel-Mitchener, A; Purk, TP; Becker, KG; Barret, T; Liu, L; Carbonetto, S; Weiler, IJ; Greenough, WT; Eberwine, J				Miyashiro, KY; Beckel-Mitchener, A; Purk, TP; Becker, KG; Barret, T; Liu, L; Carbonetto, S; Weiler, IJ; Greenough, WT; Eberwine, J			RNA cargoes associating with in cellular functioning in Fmrl Fmr1 reveal deficits null mice	NEURON			English	Article							X MENTAL-RETARDATION; FRAGILE-X; MESSENGER-RNA; PROTEIN FMRP; KNOCKOUT MICE; BINDING; IDENTIFICATION; LOCALIZATION; TRANSLATION; EXPRESSION	The Fragile X mental retardation-1 (Fmr1) gene encodes a multifunctional protein, FMRP, with intrinsic RNA binding activity. We have developed an approach, antibody-positioned RNA amplification (APRA), to identify the RNA cargoes associated with the in vivo configured FMRP messenger ribonucleoprotein (mRNP) complex. Using APRA as a primary screen, putative FMRP RNA cargoes were assayed for their ability to bind directly to FMRP using traditional methods of assessing RNA-protein interactions, including UV-crosslinking and filter binding assays. Approximately 60% of the APRA-defined mRNAs directly associate with FMRP. By examining a subset of these mRNAs and their encoded proteins in brain tissue from Fmr1 knockout mice, we have observed that some of these cargoes as well as the proteins they encode show discrete changes in abundance and/or differential subcellular distribution. These data are consistent with spatially selective regulation of multiple biological pathways by FMRP.	Univ Penn, Sch Med, Dept Pharmacol, Dept Psychiat, Philadelphia, PA 19104 USA; McGill Univ, Dept Neurol & Neurosurg, Neurosci Res Ctr, Montreal, PQ H3A 2B4, Canada; Univ Illinois, WM Keck Ctr Comparat & Funct Genomics, Urbana, IL 61801 USA; NIA, DNA Array Unit, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA; Univ Illinois, Beckman Inst, Dept Psychol, Dept Psychiat,Neurosci Program, Urbana, IL 61801 USA	University of Pennsylvania; McGill University; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Illinois System; University of Illinois Urbana-Champaign	Eberwine, J (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Dept Psychiat, Philadelphia, PA 19104 USA.	eberwine@pharm.med.upenn.edu	Eberwine, James/B-2247-2010	Becker, Kevin/0000-0002-6794-6656	NIA NIH HHS [AG9900] Funding Source: Medline; NICHD NIH HHS [HD37175] Funding Source: Medline; NIMH NIH HHS [MH64272, MH58561] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH064272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009900, R37AG009900] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; BAKKER CE, 1994, CELL, V78, P23; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; BUCHHALTER JR, 1990, DEV BRAIN RES, V56, P211, DOI 10.1016/0165-3806(90)90084-C; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DYKENS EM, 1997, HDB AUTISM PERVASIVE, P388; Eberwine J, 2001, J NEUROSCI, V21, P8310, DOI 10.1523/JNEUROSCI.21-21-08310.2001; Feinstein C, 1998, J AUTISM DEV DISORD, V28, P393, DOI 10.1023/A:1026000404855; HAGERMAN RJ, 1989, AM J ORTHOPSYCHIAT, V59, P142, DOI 10.1111/j.1939-0025.1989.tb01641.x; Hessl D, 2002, PSYCHONEUROENDOCRINO, V27, P855, DOI 10.1016/S0306-4530(01)00087-7; *INT MOL GEN STUD, 2001, AM J HUM GENET, V69, P5700; Irwin SA, 2000, NEUROBIOL LEARN MEM, V73, P87, DOI 10.1006/nlme.1999.3914; Joels M, 2001, J NEUROENDOCRINOL, V13, P657, DOI 10.1046/j.1365-2826.2001.00688.x; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; REISS AL, 1990, J AM ACAD CHILD PSY, V29, P885, DOI 10.1097/00004583-199011000-00007; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Steward O, 1998, NEUROREPORT, V9, P477, DOI 10.1097/00001756-199802160-00022; Sun HT, 2001, AM J MED GENET, V103, P81, DOI 10.1002/1096-8628(20010915)103:1<81::AID-AJMG1505>3.0.CO;2-T; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Tamanini F, 1999, BIOCHEM J, V343, P517, DOI 10.1042/0264-6021:3430517; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; TECOTT LH, 1988, SCIENCE, V240, P1661, DOI 10.1126/science.2454508; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Trifillis P, 1999, RNA, V5, P1071, DOI 10.1017/S1355838299981803; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wisbeck JM, 2000, J DEV BEHAV PEDIATR, V21, P278, DOI 10.1097/00004703-200008000-00004; Zhang HT, 2001, P NATL ACAD SCI USA, V98, P5497, DOI 10.1073/pnas.101124598; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	56	394	406	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2003	37	3					417	431		10.1016/S0896-6273(03)00034-5	http://dx.doi.org/10.1016/S0896-6273(03)00034-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575950	Bronze			2022-12-17	WOS:000181081600008
J	Poirazi, P; Mel, BW				Poirazi, P; Mel, BW			Impact of active dendrites and structural plasticity on the memory capacity of neural tissue	NEURON			English	Review							EXCITATORY POSTSYNAPTIC POTENTIALS; CALCIUM ACTION-POTENTIALS; LONG-TERM POTENTIATION; III PYRAMIDAL NEURONS; APICAL DENDRITES; MACAQUE MONKEY; LAYER-III; SYNAPTIC INTEGRATION; FIRING PATTERNS; SILENT SYNAPSES	We consider the combined effects of active dendrites and structural plasticity on the storage capacity of neural tissue. We compare capacity for two different modes of dendritic integration: (1) linear, where synaptic inputs are summed across the entire dendritic arbor, and (2) nonlinear, where each dendritic compartment functions as a separately thresholded neuron-like summing unit. We calculate much larger storage capacities for cells with nonlinear subunits and show that this capacity is accessible to a structural learning rule that combines random synapse formation with activity-dependent stabilization/elimination. In a departure from the common view that memories are encoded in the overall connection strengths between neurons, our results suggest that long-term information storage in neural tissue could reside primarily in the selective addressing of synaptic contacts onto dendritic subunits.	Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA	University of Southern California	Poirazi, P (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	poirazi@inc.usc.edu; mel@usc.edu		Poirazi, Panayiota/0000-0001-6152-595X				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Arbib MA, 1995, HDB BRAIN THEORY NEU; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; BARRON AR, 1984, SELF ORG METHODS MOD; Baum EB, 1989, NEURAL COMPUT, V1, P151, DOI 10.1162/neco.1989.1.1.151; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; BENARDO LS, 1982, J NEUROSCI, V2, P1614; Bishop Christopher M., 1995, NEURAL NETWORKS PATT; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Cline H., 1999, DENDRITES, P35; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; COVER TM, 1965, IEEE TRANS ELECTRON, VEC14, P326, DOI 10.1109/PGEC.1965.264137; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Dailey ME, 1996, J NEUROSCI, V16, P2983; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Elston GN, 1997, CEREB CORTEX, V7, P432, DOI 10.1093/cercor/7.5.432; Elston GN, 1999, P ROY SOC B-BIOL SCI, V266, P1367, DOI 10.1098/rspb.1999.0789; Elston GN, 1998, CEREB CORTEX, V8, P278, DOI 10.1093/cercor/8.3.278; Elston GN, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-18-j0002.2000; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FOX K, 1990, J NEUROPHYSIOL, V64, P1413, DOI 10.1152/jn.1990.64.5.1413; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kamondi A, 1998, J NEUROSCI, V18, P3919; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Koch Christof, 1999, P1; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Liaw JS, 1996, HIPPOCAMPUS, V6, P591; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Lubke J, 1996, J NEUROSCI, V16, P3209; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Maass W, 1999, NEURAL COMPUT, V11, P903, DOI 10.1162/089976699300016494; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen Z. F., 1999, DENDRITES, P310; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANOR Y, 1991, BIOPHYS J, V60, P1411, DOI 10.1016/S0006-3495(91)82178-6; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mel B. W., 1999, DENDRITES, P271; MEL BW, 1992, ADV NEUR IN, V4, P35; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Mel BW, 1998, J NEUROSCI, V18, P4325; Miller K. D., 1996, MODELS NEURAL NETWOR, P55, DOI [10.1007/978-1-4612-0723-8_2, DOI 10.1007/978-1-4612-0723-8_2]; MIYASHITA Y, 1993, BIOMED RES-TOKYO, V14, P89; NAKAMURA K, 1995, J NEUROPHYSIOL, V74, P162, DOI 10.1152/jn.1995.74.1.162; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; PEARLMUTTER BA, 1992, INT JOINT C NEUR NET; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; POGGIO T, 1975, BIOL CYBERN, V19, P201, DOI 10.1007/BF02281970; Poirazi P, 2000, NEURAL COMPUT, V12, P1189, DOI 10.1162/089976600300015556; POOLOS NP, 1990, BRAIN RES, V524, P342, DOI 10.1016/0006-8993(90)90714-M; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Riegler P, 1997, PHYS REV E, V55, P3283, DOI 10.1103/PhysRevE.55.3283; Rosenblatt F., 1961, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rumelhart D. E., 1986, PARALLEL DISTRIBUTED, V1, P45, DOI [DOI 10.1016/B978-1-4832-1446-7.50010-8, 10.1016/B978-1-4832-1446-7.50010-8]; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt PC, 1997, J NEUROPHYSIOL, V77, P2466, DOI 10.1152/jn.1997.77.5.2466; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; Seamans JK, 1997, J NEUROSCI, V17, P5936; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SOBOTKA S, 1993, EXP BRAIN RES, V96, P28, DOI 10.1007/BF00230436; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; THOMSON AM, 1988, J NEUROPHYSIOL, V60, P1896, DOI 10.1152/jn.1988.60.6.1896; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; Urban NN, 1998, J NEUROPHYSIOL, V80, P1558, DOI 10.1152/jn.1998.80.3.1558; VAPNIK VN, 1971, THEOR PROBAB APPL+, V16, P264, DOI 10.1137/1116025; Varela JA, 1997, J NEUROSCI, V17, P7926; Wessel R, 1999, J NEUROSCI, V19, P5875, DOI 10.1523/JNEUROSCI.19-14-05875.1999; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; WONG RKS, 1992, J PHYSIOL-LONDON, V457, P675, DOI 10.1113/jphysiol.1992.sp019401; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; WOOLLEY CS, 1909, DENDRITES, P339; Zador AM, 1996, NEURAL COMPUT, V8, P611, DOI 10.1162/neco.1996.8.3.611; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	108	394	399	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					779	796		10.1016/S0896-6273(01)00252-5	http://dx.doi.org/10.1016/S0896-6273(01)00252-5			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301036	Bronze			2022-12-17	WOS:000167868900026
J	Wu, L; Wells, D; Tay, J; Mendis, D; Abbott, MA; Barnitt, A; Quinlan, E; Heynen, A; Fallon, JR; Richter, JD				Wu, L; Wells, D; Tay, J; Mendis, D; Abbott, MA; Barnitt, A; Quinlan, E; Heynen, A; Fallon, JR; Richter, JD			CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of alpha-CaMKII mRNA at synapses	NEURON			English	Article							XENOPUS-OOCYTE MATURATION; MATERNAL MESSENGER-RNAS; LONG-TERM POTENTIATION; LOCAL PROTEIN-SYNTHESIS; SHORT SEQUENCE ELEMENT; II MUTANT MICE; KINASE-II; HIPPOCAMPAL-NEURONS; PHOSPHATIDYLINOSITOL 3-KINASE; SYNAPTIC PLASTICITY	Long-term changes in synaptic efficacy may require the regulated translation of dendritic mRNAs. While the basis of such regulation is unknown, it seemed possible that some features of translational control in development could be recapitulated in neurons. Polyadenylation-induced translation of oocyte mRNAs requires the cis-acting CPE sequence and the CPE-binding protein CPEB. CPEB is also present in the dendritic layers of the hippocampus, at synapses in cultured neurons, and in postsynaptic densities of adult brain. alpha-CaMKII mRNA, which is localized in dendrites and is necessary for synaptic plasticity and LTP, contains two CPEs. These CPEs are bound by CPEB and mediate polyadenylation-induced translation in injected Xenopus oocytes. In the intact brain, visual experience induces alpha-CaMKII mRNA polyadenylation and translation, suggesting that this process likely occurs at synapses.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of Massachusetts System; University of Massachusetts Worcester; Brown University	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	joel.richter@.ummed.edu			NICHD NIH HHS [HD07439, R01 HD052083] Funding Source: Medline; NIGMS NIH HHS [GM17932] Funding Source: Medline; NINDS NIH HHS [P01 NS039321, NS10343] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007439] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Banker G., 1991, CULTURING NERVE CELL; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; BOUVET P, 1994, MOL CELL BIOL, V14, P1893, DOI 10.1128/MCB.14.3.1893; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CARRAZANA EJ, 1988, MOL CELL BIOL, V8, P2267, DOI 10.1128/MCB.8.6.2267; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHICUREL ME, 1993, J NEUROSCI, V13, P4054; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; FOX CA, 1990, GENE DEV, V4, P2287, DOI 10.1101/gad.4.12b.2287; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; HYMAN LE, 1988, GENE DEV, V2, P598, DOI 10.1101/gad.2.5.598; Jacobson A, 1996, TRANSLATIONAL CONTRO; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kuge H, 1995, EMBO J, V14, P6301, DOI 10.1002/j.1460-2075.1995.tb00320.x; LIU XJ, 1995, MOL CELL BIOL, V15, P3563; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Maller J L, 1980, Curr Top Cell Regul, V16, P271; MALLER JL, 1981, DEV BIOL, V85, P309, DOI 10.1016/0012-1606(81)90262-1; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MUSLIN AJ, 1993, MOL CELL BIOL, V13, P6661, DOI 10.1128/MCB.13.11.6661; Ouyang Y, 1997, J NEUROSCI, V17, P5416; PARIS J, 1991, GENE DEV, V5, P1697, DOI 10.1101/gad.5.9.1697; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; RICHTER JD, 1996, TRANSLATIONAL CONTRO; SALLES FJ, 1992, GENE DEV, V6, P1202, DOI 10.1101/gad.6.7.1202; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; SHEETS MD, 1995, NATURE, V374, P511, DOI 10.1038/374511a0; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SIMON R, 1994, MOL CELL BIOL, V14, P7867, DOI 10.1128/MCB.14.12.7867; SIMON R, 1992, GENE DEV, V6, P2580, DOI 10.1101/gad.6.12b.2580; Simon R, 1996, DEV BIOL, V179, P239, DOI 10.1006/dbio.1996.0254; Sossin WS, 1996, TRENDS NEUROSCI, V19, P215; StebbinsBoaz B, 1997, CRIT REV EUKAR GENE, V7, P73, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.50; STEBBINSBOAZ B, 1994, MOL CELL BIOL, V14, P5870, DOI 10.1128/MCB.14.9.5870; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; STEWARD O, 1986, J NEUROSCI, V6, P412; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; STRICKLAND S, 1988, SCIENCE, V241, P680, DOI 10.1126/science.2456615; Tiedge H, 1996, J NEUROSCI, V16, P7171; VARNUM SM, 1990, GENE DEV, V4, P2278, DOI 10.1101/gad.4.12b.2278; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu L, 1997, MOL CELL BIOL, V17, P6402, DOI 10.1128/MCB.17.11.6402	64	394	401	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1998	21	5					1129	1139		10.1016/S0896-6273(00)80630-3	http://dx.doi.org/10.1016/S0896-6273(00)80630-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856468	Bronze			2022-12-17	WOS:000077386100023
J	Burden, S; Yarden, Y				Burden, S; Yarden, Y			Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis	NEURON			English	Editorial Material							NEU DIFFERENTIATION FACTOR; EPIDERMAL GROWTH-FACTOR; CARDIAC DEVELOPMENT; EXPRESSION; MUSCLE; ERBB2		WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science	Burden, S (corresponding author), NYU,MED CTR,MOL NEUROBIOL PROGRAM,SKIRBALL INST,NEW YORK,NY 10016, USA.		YARDEN, YOSEF/K-1467-2012	Burden, Steven/0000-0002-3550-6891				Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Baulida J, 1996, J BIOL CHEM, V271, P5251; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Carroll SL, 1997, J NEUROSCI, V17, P1642; Cheng LL, 1996, NEURON, V16, P309, DOI 10.1016/S0896-6273(00)80049-5; Cohen BD, 1996, J BIOL CHEM, V271, P30897, DOI 10.1074/jbc.271.48.30897; DANILENKO DM, 1995, J CLIN INVEST, V95, P842, DOI 10.1172/JCI117734; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; GARNETT DC, 1995, J BIOL CHEM, V270, P19022; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GRAUSPORTA D, 1995, MOL CELL BIOL, V15, P1182; Grimm S, 1997, J EXP MED, V185, P1137, DOI 10.1084/jem.185.6.1137; Grinspan JB, 1996, J NEUROSCI, V16, P6107; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; Jacobsen NE, 1996, BIOCHEMISTRY-US, V35, P3402, DOI 10.1021/bi952626l; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kornfeld K, 1997, TRENDS GENET, V13, P55, DOI 10.1016/S0168-9525(97)01005-6; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Krane IM, 1996, ONCOGENE, V12, P1781; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; LEVI ADO, 1995, J NEUROSCI, V15, P1329; Levkowitz G, 1996, ONCOGENE, V12, P1117; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; MURPHY P, 1996, DEVELOPMENT, V122, P2647; Perrimon N, 1997, CELL, V89, P13, DOI 10.1016/S0092-8674(00)80177-4; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Riese DJ, 1996, ONCOGENE, V12, P345; RIO C, 1997, IN PRESS NEURON, V19; ROSENBAUM C, 1997, IN PRESS J EXP NEURO; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Summerfield AE, 1996, J BIOL CHEM, V271, P19656, DOI 10.1074/jbc.271.33.19656; Syroid DE, 1996, P NATL ACAD SCI USA, V93, P9229, DOI 10.1073/pnas.93.17.9229; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; Zhang K, 1996, J BIOL CHEM, V271, P3884	48	394	421	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					847	855		10.1016/S0896-6273(00)80324-4	http://dx.doi.org/10.1016/S0896-6273(00)80324-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208852	hybrid			2022-12-17	WOS:A1997XJ10200003
J	HUETTNER, JE				HUETTNER, JE			GLUTAMATE RECEPTOR CHANNELS IN RAT DRG NEURONS - ACTIVATION BY KAINATE AND QUISQUALATE AND BLOCKADE OF DESENSITIZATION BY CON-A	NEURON			English	Article											HUETTNER, JE (corresponding author), HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA.		Huettner, James E/C-5219-2012					AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; AKAIKE N, 1988, NEUROSCI LETT, V87, P75, DOI 10.1016/0304-3940(88)90148-6; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; BEAN BP, 1990, J NEUROSCI, V10, P1; CACHELIN AB, 1989, J PHYSIOL-LONDON, V415, P159, DOI 10.1113/jphysiol.1989.sp017717; CHIZHMAKOV IV, 1989, NEUROSCI LETT, V99, P131, DOI 10.1016/0304-3940(89)90277-2; CHOI DW, 1981, J NEUROPHYSIOL, V45, P605, DOI 10.1152/jn.1981.45.4.605; CLINE HT, 1990, J NEUROSCI, V10, P1197; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P131, DOI 10.1113/jphysiol.1988.sp016912; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V415, P555, DOI 10.1113/jphysiol.1989.sp017736; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V415, P533, DOI 10.1113/jphysiol.1989.sp017735; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; DAVIES J, 1979, J PHYSIOL-PARIS, V75, P641; DEGROAT WC, 1972, BRAIN RES, V44, P273, DOI 10.1016/0006-8993(72)90383-6; DINGLEDINE R, 1988, CRIT REV NEUROBIOL, V4, P1; DODD J, 1985, J NEUROSCI, V5, P3278; EVANS RH, 1987, BRIT J PHARMACOL, V91, P531, DOI 10.1111/j.1476-5381.1987.tb11246.x; FELTZ A, 1982, J PHYSIOL-LONDON, V322, P257, DOI 10.1113/jphysiol.1982.sp014036; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; GUNTHER GR, 1973, P NATL ACAD SCI USA, V70, P1012, DOI 10.1073/pnas.70.4.1012; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENLEY J M, 1989, New Biologist, V1, P153; Hill AV, 1909, J PHYSIOL-LONDON, V39, P361; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JESSELL TM, 1990, ANNU REV NEUROSCI, V13, P227, DOI 10.1146/annurev.ne.13.030190.001303; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KEHOE JS, 1978, NATURE, V274, P866, DOI 10.1038/274866a0; KIRPEKAR SM, 1978, BRIT J PHARMACOL, V62, P549, DOI 10.1111/j.1476-5381.1978.tb07760.x; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KRISHTAL OA, 1983, NEUROSCI LETT, V35, P41, DOI 10.1016/0304-3940(83)90524-4; KUNO M, 1986, NATURE, V323, P269, DOI 10.1038/323269a0; LEWIS SJ, 1987, EUR J PHARMACOL, V144, P413, DOI 10.1016/0014-2999(87)90399-2; LIN SS, 1989, NEURON, V3, P95, DOI 10.1016/0896-6273(89)90118-9; LOVINGER DM, 1988, NEUROSCI LETT, V94, P314, DOI 10.1016/0304-3940(88)90037-7; MATHERS DA, 1981, J PHYSIOL-LONDON, V312, P1; MATHERS DA, 1976, NATURE, V259, P409, DOI 10.1038/259409a0; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1987, J NEUROSCI, V7, P3230; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; MURPHY LA, 1977, J BIOL CHEM, V252, P4739; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OBRIEN RJ, 1986, J NEUROSCI, V6, P3275; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; OHFUNE Y, 1982, J AM CHEM SOC, V104, P3511, DOI 10.1021/ja00376a048; PEROUANSKY M, 1989, J NEUROSCI, V9, P70; RANSOM BR, 1977, J NEUROPHYSIOL, V40, P1163, DOI 10.1152/jn.1977.40.5.1163; REGAN LJ, 1986, P NATL ACAD SCI USA, V83, P2248, DOI 10.1073/pnas.83.7.2248; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; VERDOORN TA, 1989, MOL PHARMACOL, V35, P360; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; WOLF G, 1983, NEUROSCI LETT, V43, P1, DOI 10.1016/0304-3940(83)90119-2; YOUNG SH, 1983, NATURE, V304, P161, DOI 10.1038/304161a0; ZORUMSKI CF, 1988, J NEUROSCI, V8, P4277	66	394	400	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1990	5	3					255	266		10.1016/0896-6273(90)90163-A	http://dx.doi.org/10.1016/0896-6273(90)90163-A			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ279	2169266				2022-12-17	WOS:A1990DZ27900004
J	Salehi, A; Delcroix, JD; Belichenko, PV; Zhan, K; Wu, CB; Valletta, JS; Takimoto-Kimura, R; Kleschevnikov, AM; Sambamurti, K; Chung, PP; Xia, WM; Villar, A; Campbell, WA; Kulnane, LS; Nixon, RA; Lamb, BT; Epstein, CJ; Stokin, GB; Goldstein, LSB; Mobley, WC				Salehi, Ahmad; Delcroix, Jean-Dominique; Belichenko, Pavel V.; Zhan, Ke; Wu, Chengbiao; Valletta, Janice S.; Takimoto-Kimura, Ryoko; Kleschevnikov, Alexander M.; Sambamurti, Kumar; Chung, Peter P.; Xia, Weiming; Villar, Angela; Campbell, William A.; Kulnane, Laura Shapiro; Nixon, Ralph A.; Lamb, Bruce T.; Epstein, Charles J.; Stokin, Gorazd B.; Goldstein, Lawrence S. B.; Mobley, William C.			Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration	NEURON			English	Article							NERVE GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; RAT BASAL FOREBRAIN; TRANSGENIC MICE; SIGNALING ENDOSOME; TRKA EXPRESSION; NUCLEUS BASALIS; MESSENGER-RNAS; BETA-PEPTIDES	Degeneration of basal forebrain cholinergic neurons (BFCNs) contributes to cognitive dysfunction in Alzheimer's disease (AD) and Down's syndrome (DS). We used Ts65Dn and Ts1Cje mouse models of DS to show that the increased dose of the amyloid precursor protein gene, App, acts to markedly decrease NGF retrograde transport and cause degeneration of BFCNs. NGF transport was also decreased in mice expressing wild-type human APP or a familial AD-linked mutant APP; while significant, the decreases were less marked and there was no evident degeneration of BFCNs. Because of evidence suggesting that the NGF transport defect was intra-axonal, we explored within cholinergic axons the status of early endosomes (EEs). NGF-containing EEs were enlarged in Ts65Dn mice and their App content was increased. Our study thus provides evidence for a pathogenic mechanism for DS in which increased expression of App, in the context of trisomy, causes abnormal transport of NGF and cholinergic neurodegeneration.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Med Univ S Carolina, Ctr Aging, Charleston, SC 29425 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44195 USA; Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Stanford Univ, Sch Med, Neurosci Inst, Stanford, CA 94305 USA	Stanford University; Medical University of South Carolina; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Case Western Reserve University; Nathan Kline Institute for Psychiatric Research; University of California System; University of California San Diego; Stanford University	Salehi, A (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	asalehi@stanford.edu	Stokin, Gorazd Bernard/D-9480-2015; Sambamurti, Kumar/A-1620-2012; xia, weiming/E-5465-2016; Salehi, Ahmad/H-2746-2019; Salehi, Ahmad/A-1148-2007; Kleschevnikov, Alexander/R-6926-2016	Stokin, Gorazd Bernard/0000-0001-8430-8755; Sambamurti, Kumar/0000-0001-9507-9214; xia, weiming/0000-0002-7463-3295; Salehi, Ahmad/0000-0001-8257-3280; Salehi, Ahmad/0000-0001-8257-3280; Kleschevnikov, Alexander/0000-0002-1562-6706	NIA NIH HHS [AG16999] Funding Source: Medline; NINDS NIH HHS [NS38869] Funding Source: Medline; PHS HHS [31498] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016999] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Chen KS, 1997, J NEUROSCI, V17, P7288; Cobb SR, 1999, J PHYSIOL-LONDON, V518, P131, DOI 10.1111/j.1469-7793.1999.0131r.x; COOPER JD, 1994, NEUROSCIENCE, V62, P625, DOI 10.1016/0306-4522(94)90462-6; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; Delcroix JD, 2004, PROG BRAIN RES, V146, P3, DOI 10.1016/S0079-6123(03)46001-69; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hodes ME, 2000, AM J HUM GENET, V67, P14, DOI 10.1086/302965; Hof PR., 2000, COMP CYTOARCHITECTON; HOLTZMAN DM, 1995, J NEUROSCI, V15, P1567; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Jaffar S, 2000, EXP NEUROL, V170, P227, DOI 10.1006/exnr.2001.7710; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; KISS J, 1993, NEUROSCIENCE, V57, P297, DOI 10.1016/0306-4522(93)90063-L; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KOH SY, 1989, J NEUROSCI, V9, P2999; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANN DMA, 1985, J MENT DEFIC RES, V29, P125; Petanceska SS, 2000, NEUROLOGY, V54, P2212, DOI 10.1212/WNL.54.12.2212; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; SALEHI A, 1994, NEUROSCIENCE, V59, P871, DOI 10.1016/0306-4522(94)90291-7; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Seo HY, 2005, EXP NEUROL, V193, P469, DOI 10.1016/j.expneurol.2004.11.017; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SOFRONIEW MV, 1993, J NEUROSCI, V13, P5263, DOI 10.1523/JNEUROSCI.13-12-05263.1993; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; WESSENDORF MW, 1991, BRAIN RES, V553, P135, DOI 10.1016/0006-8993(91)90241-M; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; YAMADA T, 1989, BIOCHEM BIOPH RES CO, V158, P906, DOI 10.1016/0006-291X(89)92808-8; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yeo TT, 1997, J NEUROSCI, V17, P7594; Zheng H, 1996, ANN NY ACAD SCI, V777, P421, DOI 10.1111/j.1749-6632.1996.tb34456.x; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	67	393	406	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					29	42		10.1016/j.neuron.2006.05.022	http://dx.doi.org/10.1016/j.neuron.2006.05.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815330	Bronze			2022-12-17	WOS:000239037700008
J	Goldberg, II; Harel, M; Malach, R				Goldberg, II; Harel, M; Malach, R			When the brain loses its self: Prefrontal inactivation during sensorimotor processing	NEURON			English	Article							HUMAN VISUAL-CORTEX; HUMAN OBJECT AREAS; CONSCIOUS EXPERIENCE; DEFAULT MODE; FMRI; MIND; RECOGNITION; ORGANIZATION; FRAMEWORK; EMOTION	A common theme in theories of subjective awareness poses a self-related "observer" function, or a homunculus, as a critical element without which awareness can not emerge. Here, we examined this question using fMRI. In our study, we compared brain activity patterns produced by a demanding sensory categorization paradigm to those engaged during self-reflective introspection, using similar sensory stimuli. Our results show a complete segregation between the two patterns of activity. Furthermore, regions that showed enhanced activity during introspection underwent a robust inhibition during the demanding perceptual task. The results support the notion that self-related processes are not necessarily engaged during sensory perception and can be actually suppressed.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rafi.malach@weizmann.ac.il						AMASIO A, 1999, FEELING WHAT HAPPENS; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Damasio A.R., 1994, DESCARTES ERROR EMOT; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, J CEREBR BLOOD F MET, V15, P361, DOI 10.1038/jcbfm.1995.45; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hannula DE, 2005, NAT REV NEUROSCI, V6, P247, DOI 10.1038/nrn1630; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; James W., 1890, PRINCIPLES PSYCHOL, V2; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; KOLB BWI, 1990, FUNAMENTALS HUMAN NE; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Luria AR., 1973, WORKING BRAIN; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Morin A, 2002, CONSCIOUS COGN, V11, P396, DOI 10.1016/S1053-8100(02)00009-0; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Stuss DT., 1986, FRONTAL LOBES; Suzuki D. T., 1927, INTRO ZEN BUDDHISM; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; Turk DJ, 2003, ANN NY ACAD SCI, V1001, P65, DOI 10.1196/annals.1279.005; Turk DJ, 2002, NAT NEUROSCI, V5, P841, DOI 10.1038/nn907; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Wolf E, 1988, TREATING SELF	47	393	401	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					329	339		10.1016/j.neuron.2006.03.015	http://dx.doi.org/10.1016/j.neuron.2006.03.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630842	Bronze			2022-12-17	WOS:000237176700018
J	Boyle, MET; Berglund, EO; Murai, KK; Weber, L; Peles, E; Ranscht, B				Boyle, MET; Berglund, EO; Murai, KK; Weber, L; Peles, E; Ranscht, B			Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve	NEURON			English	Article							CELL-ADHESION MOLECULE; SODIUM-CHANNELS; POTASSIUM CHANNELS; AXOGLIAL JUNCTIONS; AXONAL MEMBRANE; MOUSE; CONDUCTION; NODE; GLYCOPROTEIN; SHIVERER	Rapid nerve impulse conduction depends on specialized membrane domains in myelinated nerve, the node of Ranvier, the paranode, and the myelinated internodal region. We report that GPI-linked contactin enables the formation of the paranodal septate-like axo-glial junctions in myelinated peripheral nerve. Contactin clusters at the paranodal axolemma during Schwann cell myelination. Ablation of contactin in mutant mice disrupts junctional attachment at the paranode and reduces nerve conduction velocity 3-fold. The mutation impedes intracellular transport and surface expression of Caspr and leaves NF155 on apposing paranodal myelin disengaged. The contactin mutation does not affect sodium channel clustering at the nodes of Ranvier but alters the location of the Shaker-type Kv1.1 and Kv1.2 potassium channels. Thus, contactin is a crucial part in the machinery that controls junctional attachment at the paranode and ultimately the physiology of myelinated nerve.	Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Weizmann Institute of Science	Ranscht, B (corresponding author), Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA.	ranscht@burnham.org		Peles, Elior/0000-0002-3325-0597	NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY006792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038297] Funding Source: NIH RePORTER; NCI NIH HHS [CA30199] Funding Source: Medline; NEI NIH HHS [F32 EY 06792] Funding Source: Medline; NINDS NIH HHS [NS38297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRETT EF, 1981, J PHYSL, V323, P117; BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; BOSTOCK H, 1978, J PHYSIOL-LONDON, V280, P273, DOI 10.1113/jphysiol.1978.sp012384; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHIU SY, 1984, PROC R SOC SER B-BIO, V220, P415, DOI 10.1098/rspb.1984.0010; CHIU SY, 1980, NATURE, V284, P170, DOI 10.1038/284170a0; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Deerinck TJ, 1997, J NEUROSCI, V17, P5080; DREYER F, 1987, J PHYSIOL-LONDON, V386, P455, DOI 10.1113/jphysiol.1987.sp016544; Dupree JL, 1999, J NEUROCYTOL, V28, P271, DOI 10.1023/A:1007049310758; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dupree JL, 1998, J NEUROSCI, V18, P1642; DURBEC P, 1992, J CELL BIOL, V117, P877, DOI 10.1083/jcb.117.4.877; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; ELLISMAN MH, 1984, NODE RANVIER, P153; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Friedrich Jr VL, 1981, NEUROANATOMICAL TRAC, P345; FUNCH PG, 1984, SCIENCE, V225, P538, DOI 10.1126/science.6204382; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; INOUE Y, 1981, BRAIN RES, V219, P85, DOI 10.1016/0006-8993(81)90269-9; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Lambert S, 1997, J NEUROSCI, V17, P7025; LITTLE GJ, 1994, J ANAT, V184, P387; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; Rasband M, 1998, J NEUROSCI, V18, P36; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; ROSENBLUTH J, 1987, J NEUROCYTOL, V16, P497, DOI 10.1007/BF01668504; ROSENBLUTH J, 1981, BRAIN RES, V208, P283, DOI 10.1016/0006-8993(81)90558-8; ROSENBLUTH J, 1980, J COMP NEUROL, V193, P729, DOI 10.1002/cne.901930310; ROSENBLUTH J, 1984, NODE RANVIER, P31; Rosenbluth Jack, 1995, P613; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; SMITH RS, 1970, AM J PHYSIOL, V219, P1256, DOI 10.1152/ajplegacy.1970.219.5.1256; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Trapp BD, 2000, J CELL BIOL, V150, pF97, DOI 10.1083/jcb.150.3.F97; Vabnick I, 1996, J NEUROSCI, V16, P4914; Vabnick I, 1999, J NEUROSCI, V19, P747; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WILEY CA, 1980, J CELL BIOL, V84, P261, DOI 10.1083/jcb.84.2.261; Zhou L, 1998, J NEUROSCI, V18, P7200	54	393	402	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					385	397		10.1016/S0896-6273(01)00296-3	http://dx.doi.org/10.1016/S0896-6273(01)00296-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395001	Bronze			2022-12-17	WOS:000168962000012
J	Baecher-Allan, C; Kaskow, BJ; Weiner, HL				Baecher-Allan, Clare; Kaskow, Belinda J.; Weiner, Howard L.			Multiple Sclerosis: Mechanisms and Immunotherapy	NEURON			English	Review							REGULATORY T-CELLS; NATURAL-KILLER-CELLS; PLACEBO-CONTROLLED TRIAL; MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MEMORY B-CELLS; DOUBLE-BLIND; PHASE-II; DISEASE-ACTIVITY; ASTROCYTE ACTIVATION	Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act on a genetically susceptible host. It features three clinical stages: a pre-clinical stage detectable only by MRI; a relapsing- remitting (RRMS) stage characterized by episodes of neurologic dysfunction followed by resolution; and a progressive stage, which usually evolves from the relapsing stage. Advances in our understanding of the immune mechanisms that contribute to MS have led to more than ten FDA-approved immunotherapeutic drugs that target effector T cells, regulatory cells, B cells, and cell trafficking into the nervous system. However, most drugs for relapsing MS are not effective in treating progressive disease. Progressive MS features a compartmentalized immune response in the central nervous system, involving microglia cells and astrocytes, as well as immune-independent processes that drive axonal dysfunction. Major challenges for MS research involve understanding the mechanisms of disease progression, developing treatment for progressive MS, and determining the degree to which progressive disease can be prevented by early treatment. Key priorities for MS research include developing biomarkers, personalized medicine and advanced imaging, and a better understanding of the microbiome. With a better understanding of the genetic and epidemiological aspects of this disease, approaches to prevent MS are now also being considered.	[Baecher-Allan, Clare; Kaskow, Belinda J.; Weiner, Howard L.] Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Partners MS Ctr,Dept Neurol,Ann Romney Ctr Neurol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Weiner, HL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Partners MS Ctr,Dept Neurol,Ann Romney Ctr Neurol, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu		Baecher-Allan, Clare/0000-0003-2405-8525; Kaskow, Belinda/0000-0003-3132-4924	National Multiple Sclerosis Society [RR 205-A-13, RG-1507-05029. NMSS ICT 0010, RG-1506-04836]; NIH [R01 NS087226, UH3TR000890]; Evergrande Center for Immunologic Diseases; Nancy Davis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087226] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evergrande Center for Immunologic Diseases; Nancy Davis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Multiple Sclerosis Society to H.L.W. (RR 205-A-13, RG-1507-05029. NMSS ICT 0010) and to C.B.-A. (RG-1506-04836), by NIH grants to H.L.W. (R01 NS087226, UH3TR000890), by the Evergrande Center for Immunologic Diseases, and by the Nancy Davis Foundation. We thank Dr. Tanuja Chitnis, Dr. Vijay Kuchroo, and Dr. Rohit Bakshi for their discussions on the manuscript.	Ahlgren C, 2012, MULT SCLER J, V18, P1099, DOI 10.1177/1352458511433062; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Arnon R, 2004, P NATL ACAD SCI USA, V101, P14593, DOI 10.1073/pnas.0404887101; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baker D, 2017, EBIOMEDICINE, V16, P41, DOI 10.1016/j.ebiom.2017.01.042; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; Bar-Or A, 2001, J IMMUNOL, V167, P5669, DOI 10.4049/jimmunol.167.10.5669; Baranzini SE, 2017, MULT SCLER J, V23, P100; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Barun B, 2012, CLIN IMMUNOL, V142, P31, DOI 10.1016/j.clim.2011.04.005; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; Beauchemin P, 2016, MULT SCLER J, V22, P254, DOI 10.1177/1352458515623862; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Berghmans N, 2006, J NEUROIMMUNOL, V176, P63, DOI 10.1016/j.jneuroim.2006.04.009; Bermel RA, 2013, ANN NEUROL, V73, P95, DOI 10.1002/ana.23758; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhela S, 2015, J IMMUNOL, V194, P2180, DOI 10.4049/jimmunol.1303257; Bible Ellen, 2014, Nat Rev Neurol, V10, P182, DOI 10.1038/nrneurol.2014.48; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Boneschi FM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002127.pub3; Bosma A, 2012, IMMUNITY, V36, P477, DOI 10.1016/j.immuni.2012.02.008; Brandle SM, 2016, P NATL ACAD SCI USA, V113, P7864, DOI 10.1073/pnas.1522730113; Burt RK, 2015, JAMA-J AM MED ASSOC, V313, P275, DOI 10.1001/jama.2014.17986; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cantarel BL, 2015, J INVEST MED, V63, P729, DOI 10.1097/JIM.0000000000000192; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Cao YH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8038; Caruana P, 2017, MULT SCLER J, V23, P1479, DOI 10.1177/1352458516679267; Castillo-Trivino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066308; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Chataway J, 2018, NEUROLOGY; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chiarini M, 2012, MULT SCLER J, V18, P788, DOI 10.1177/1352458511427720; Cohen JA, 2016, LANCET NEUROL, V15, P373, DOI 10.1016/S1474-4422(16)00018-1; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Comabella M, 1998, J CLIN INVEST, V102, P671, DOI 10.1172/JCI3125; Comabella M, 2016, MULT SCLER J, V22, P257, DOI 10.1177/1352458515623863; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Comi G, 2013, MULT SCLER J, V19, P1428, DOI 10.1177/1352458513502572; Comi G, 2012, NEW ENGL J MED, V366, P1000, DOI 10.1056/NEJMoa1104318; Correale J, 2008, ANN NEUROL, V64, P187, DOI 10.1002/ana.21438; Correale J, 2017, BRAIN, V140, P527, DOI 10.1093/brain/aww258; Cosorich I, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700492; Costantino CM, 2008, EUR J IMMUNOL, V38, P921, DOI 10.1002/eji.200738104; Cree BAC, 2016, ANN NEUROL, V80, P443, DOI 10.1002/ana.24718; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; d'Hennezel E, 2009, NEW ENGL J MED, V361, P1710, DOI 10.1056/NEJMc0907093; Daikeler T, 2012, PEDIATR RES, V71, P439, DOI 10.1038/pr.2011.57; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Duan HX, 2013, SCI REP-UK, V3, DOI 10.1038/srep01687; El Ayoubi NK, 2017, NEUROTHERAPEUTICS, V14, P135, DOI 10.1007/s13311-016-0486-7; ENDO T, 1984, J IMMUNOL, V132, P1793; Farez MF, 2015, J NEUROL NEUROSUR PS, V86, P26, DOI 10.1136/jnnp-2014-307928; Fassas A, 1997, BONE MARROW TRANSPL, V20, P631, DOI 10.1038/sj.bmt.1700944; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Gale CR, 1995, PROG NEUROBIOL, V47, P425, DOI 10.1016/0301-0082(95)00033-X; Gandhi R, 2013, ANN NEUROL, V73, P729, DOI 10.1002/ana.23880; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Gharibi T, 2016, IMMUNOBIOLOGY, V221, P357, DOI 10.1016/j.imbio.2015.09.021; Giovannoni G, 2014, J NEUROL, V261, P316, DOI 10.1007/s00415-013-7196-4; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Gobin SJP, 2001, GLIA, V36, P68, DOI 10.1002/glia.1096; Goodkin D E, 1996, Mult Scler, V1, P321; Gray O, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003208.PUB2; Green AJ, 2017, LANCET, V390, P2481, DOI 10.1016/S0140-6736(17)32346-2; Greenfield A. L, 2017, ANN NEUROL; Gregori S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00030; Gross CC, 2016, P NATL ACAD SCI USA, V113, pE2973, DOI 10.1073/pnas.1524924113; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Habib Jakob, 2015, J Mult Scler (Foster City), V2; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harley JB, 2006, BULL HOSP JT DIS, V64, P45; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Havrdova E, 2016, J NEUROL, V263, P1287, DOI 10.1007/s00415-016-8128-x; Havrdova E, 2015, THER ADV NEUROL DISO, V8, P31, DOI 10.1177/1756285614563522; Healy BC, 2010, NEUROLOGY, V75, P634, DOI 10.1212/WNL.0b013e3181ed9c9c; Hedstrom AK, 2014, MULT SCLER J, V20, P406, DOI 10.1177/1352458513498126; Hedstrom AK, 2011, MULT SCLER J, V17, P788, DOI 10.1177/1352458511399610; Heidelberger M, 1942, J EXP MED, V75, P35, DOI 10.1084/jem.75.1.35; Hemmer B, 2000, J IMMUNOL, V164, P861, DOI 10.4049/jimmunol.164.2.861; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Hensiek AE, 2007, NEUROLOGY, V68, P376, DOI 10.1212/01.wnl.0000252822.53506.46; Hohol MJ, 1999, MULT SCLER, V5, P403, DOI 10.1191/135245899678846492; Hollenbach JA, 2015, J AUTOIMMUN, V64, P13, DOI 10.1016/j.jaut.2015.06.010; Hong J, 2009, INT IMMUNOL, V21, P1329, DOI 10.1093/intimm/dxp100; Hu D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01571-8; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; Infante-Duarte C, 2005, FASEB J, V19, P1902, DOI 10.1096/fj.05-3832fje; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Kalluri HV, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12955; Kaltsonoudis E, 2014, AUTOIMMUN REV, V13, P54, DOI 10.1016/j.autrev.2013.09.002; Kappos L, 2015, NEW ENGL J MED, V373, P1418, DOI 10.1056/NEJMoa1501481; Kappos L., 2016, P 32 C EUR COMM TREA; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2017, NEUROLOGY, V88; Kappos L, 2014, LANCET NEUROL, V13, P353, DOI 10.1016/S1474-4422(14)70028-6; Karni A, 2006, J IMMUNOL, V177, P4196, DOI 10.4049/jimmunol.177.6.4196; Kato Hideki, 2003, Nihon Rinsho, V61, P1428; Katz U, 2006, AUTOIMMUNITY, V39, P513, DOI 10.1080/08916930600825867; Keskinen P, 1997, IMMUNOLOGY, V91, P421, DOI 10.1046/j.1365-2567.1997.00258.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kinnunen T, 2013, J CLIN INVEST, V123, P2737, DOI 10.1172/JCI68775; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kleinewietfeld M, 2014, IMMUNOL REV, V259, P231, DOI 10.1111/imr.12169; Kornek B, 1999, BRAIN PATHOL, V9, P651; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Kuhle J, 2017, NEUROLOGY, V88, P826, DOI 10.1212/WNL.0000000000003653; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Larochelle C, 2015, ANN NEUROL, V78, P39, DOI 10.1002/ana.24415; Laroni A, 2016, J AUTOIMMUN, V72, P8, DOI 10.1016/j.jaut.2016.04.003; Lassmann H, 2012, BRAIN, V135, P2904, DOI 10.1093/brain/aws260; Leandro MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3908; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lee SY, 2013, J IMMUNOL, V190, P4991, DOI 10.4049/jimmunol.1300083; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Leist TP, 2014, LANCET NEUROL, V13, P257, DOI 10.1016/S1474-4422(14)70005-5; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lindner S, 2013, CANCER RES, V73, P2468, DOI 10.1158/0008-5472.CAN-12-3450; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Losy J, 2013, J NEURAL TRANSM, V120, P1459, DOI 10.1007/s00702-013-1079-9; Lovato L, 2011, BRAIN, V134, P534, DOI 10.1093/brain/awq350; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Lu W, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00134; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Lucas RM, 2015, NEURODEGENER DIS MAN, V5, P413, DOI 10.2217/nmt.15.33; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Ma N, 2014, CELL IMMUNOL, V289, P140, DOI 10.1016/j.cellimm.2014.03.017; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Malmestrom C, 2008, J NEUROIMMUNOL, V196, P159, DOI 10.1016/j.jneuroim.2008.03.001; Malpass Katy, 2012, Nat Rev Neurol, V8, P61, DOI 10.1038/nrneurol.2011.217; Mancuso R, 2014, MULT SCLER J, V20, P1900, DOI 10.1177/1352458514538111; Mangalam A, 2017, CELL REP, V20, P1269, DOI 10.1016/j.celrep.2017.07.031; Lozano JM, 2009, VIRAL IMMUNOL, V22, P463, DOI 10.1089/vim.2009.0041; Martin R, 2000, ADV RES NEURODEGENER, V8, P361; Mauri C, 2015, INT IMMUNOL, V27, P479, DOI 10.1093/intimm/dxv038; Mayo L, 2016, BRAIN, V139, P1939, DOI 10.1093/brain/aww113; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Melzer N, 2009, FASEB J, V23, P3659, DOI 10.1096/fj.09-136200; Michel L, 2014, J NEUROL NEUROSUR PS, V85, P279, DOI 10.1136/jnnp-2013-305298; Michel L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00636; Michel L, 2014, CLIN IMMUNOL, V155, P198, DOI 10.1016/j.clim.2014.09.011; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Molnarfi N, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0798-5; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Montalban X, 2017, NEW ENGL J MED, V376, P1694, DOI 10.1056/NEJMc1702076; Mouzaki A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135434; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Naismith RT, 2010, NEUROLOGY, V74, P1860, DOI 10.1212/WNL.0b013e3181e24373; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nourbakhsh B, 2016, J NEUROL NEUROSUR PS, V87, P1350, DOI 10.1136/jnnp-2016-313410; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Ottoboni L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004186; Pacholczyk R, 2008, IMMUNOLOGY, V125, P450, DOI 10.1111/j.1365-2567.2008.02992.x; Palanichamy A, 2014, J IMMUNOL, V193, P580, DOI 10.4049/jimmunol.1400118; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; PANITCH HS, 1987, LANCET, V1, P893; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Polman C, 2005, NEUROLOGY, V64, P987, DOI 10.1212/01.WNL.0000154520.48391.69; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Racke MK, 2010, NEUROLOGY, V74, pS25, DOI 10.1212/WNL.0b013e3181c97e39; Ray A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6010012; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roll P, 2012, SCAND J RHEUMATOL, V41, P180, DOI 10.3109/03009742.2011.645056; Rothhammer V, 2017, P NATL ACAD SCI USA, V114, P2012, DOI 10.1073/pnas.1615413114; Rotstein DL, 2015, JAMA NEUROL, V72, P152, DOI 10.1001/jamaneurol.2014.3537; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Schadenberg AWL, 2011, EUR J IMMUNOL, V41, P1132, DOI 10.1002/eji.201040363; Schirmer L, 2014, MULT SCLER J, V20, P271, DOI 10.1177/1352458514522104; Schleinitz N, 2010, IMMUNOLOGY, V131, P451, DOI 10.1111/j.1365-2567.2010.03360.x; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Schneider A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004970; Schubert RD, 2015, J IMMUNOL, V194, P2110, DOI 10.4049/jimmunol.1402029; Sedel F, 2015, MULT SCLER RELAT DIS, V4, P159, DOI 10.1016/j.msard.2015.01.005; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Sellebjerg F, 2016, THER ADV NEUROL DISO, V9, P31, DOI 10.1177/1756285615615257; Selmaj K, 2013, LANCET NEUROL, V12, P756, DOI 10.1016/S1474-4422(13)70102-9; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Sergott RC, 2015, J NEUROL SCI, V351, P174, DOI 10.1016/j.jns.2015.02.019; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Siewe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092934; Simpson D, 2002, CNS DRUGS, V16, P825, DOI 10.2165/00023210-200216120-00004; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Sloka JS, 2005, MULT SCLER J, V11, P425, DOI 10.1191/1352458505ms1190oa; Smith AL, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2016.37; Sorensen PS, 2016, THER ADV NEUROL DISO, V9, P44, DOI 10.1177/1756285615601933; Sorensen PS, 2002, EUR J NEUROL, V9, P557, DOI 10.1046/j.1468-1331.2002.00501.x; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; Spain R, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000374; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Stangel M, 2017, NAT REV NEUROL, V13, P742, DOI 10.1038/nrneurol.2017.139; Stankiewicz JM, 2013, NEUROTHERAPEUTICS, V10, P77, DOI 10.1007/s13311-012-0172-3; Stein MS, 2011, NEUROLOGY, V77, P1611, DOI 10.1212/WNL.0b013e3182343274; Stephens LA, 2009, EUR J IMMUNOL, V39, P1108, DOI 10.1002/eji.200839073; Streeter HB, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000093; Su KG, 2009, CURR NEUROL NEUROSCI, V9, P411, DOI 10.1007/s11910-009-0060-3; TADA T, 1978, J EXP MED, V147, P446, DOI 10.1084/jem.147.2.446; Tallantyre E, 2008, Int MS J, V15, P62; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Tourbah A, 2016, MULT SCLER J, V22, P1719, DOI 10.1177/1352458516667568; Tramacere I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011381.pub2; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; TRAUGOTT U, 1983, J NEUROIMMUNOL, V4, P201, DOI 10.1016/0165-5728(83)90036-X; TRAUGOTT U, 1985, SPRINGER SEMIN IMMUN, V8, P71; Tremlett H, 2016, EUR J NEUROL, V23, P1308, DOI 10.1111/ene.13026; Tremlett H, 2010, NEUROLOGY, V74, P2004, DOI 10.1212/WNL.0b013e3181e3973f; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Uitdehaag BMJ, 2011, CURR MED RES OPIN, V27, P1529, DOI 10.1185/03007995.2011.591370; Uss E, 2006, J IMMUNOL, V177, P2775, DOI 10.4049/jimmunol.177.5.2775; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Vollmer T, 2010, NEUROLOGY, V74, pS41, DOI 10.1212/WNL.0b013e3181c97f5a; von Budingen HC, 2015, EUR NEUROL, V73, P238, DOI 10.1159/000377675; Vuddamalay Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00031; Walczak A, 2013, JAMA NEUROL, V70, P1105, DOI 10.1001/jamaneurol.2013.3022; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; WEINER HL, 1993, SCIENCE, V259, P1321, DOI 10.1126/science.7680493; WEINER HL, 1989, NEUROLOGY, V39, P1143, DOI 10.1212/WNL.39.9.1143; Weinshenker BG, 2001, J CLIN APHERESIS, V16, P39, DOI 10.1002/jca.1010; Willis MA, 2013, SEMIN NEUROL, V33, P37, DOI 10.1055/s-0033-1343794; Wingerchuk DM, 2012, THER ADV NEUROL DISO, V5, P13, DOI 10.1177/1756285611425694; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang M, 2013, CELL MOL IMMUNOL, V10, P122, DOI 10.1038/cmi.2012.60; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120; Zha BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049835; Zhang B, 2013, J IMMUNOL, V190, P2320, DOI 10.4049/jimmunol.1202922; Zhao YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174866; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113; Zurawski J, 2017, JAMA NEUROL, V74, P100, DOI 10.1001/jamaneurol.2016.4237	278	392	402	16	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 21	2018	97	4					742	768		10.1016/j.neuron.2018.01.021	http://dx.doi.org/10.1016/j.neuron.2018.01.021			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX0EG	29470968	Bronze			2022-12-17	WOS:000425713200006
J	Frakes, AE; Ferraiuolo, L; Haidet-Phillips, AM; Schmelzer, L; Braun, L; Miranda, CJ; Ladner, KJ; Bevan, AK; Foust, KD; Godbout, JP; Popovich, PG; Guttridge, DC; Kaspar, BK				Frakes, Ashley E.; Ferraiuolo, Laura; Haidet-Phillips, Amanda M.; Schmelzer, Leah; Braun, Lyndsey; Miranda, Carlos J.; Ladner, Katherine J.; Bevan, Adam K.; Foust, Kevin D.; Godbout, Jonathan P.; Popovich, Phillip G.; Guttridge, Denis C.; Kaspar, Brian K.			Microglia Induce Motor Neuron Death via the Classical NF-kappa B Pathway in Amyotrophic Lateral Sclerosis	NEURON			English	Article							TUMOR-NECROSIS-FACTOR; EMBRYONIC STEM-CELLS; WILD-TYPE MICROGLIA; DISEASE PROGRESSION; MOUSE MODEL; SYNAPTIC PLASTICITY; TRANSGENIC MODEL; EXTEND SURVIVAL; INHERITED ALS; FAMILIAL ALS	Neuroinflammation is one of the most striking hallmarks of amyotrophic lateral sclerosis (ALS). Nuclear factor-kappa B (NF-kappa B), a master regulator of inflammation, is upregulated in spinal cords of ALS patients and SOD1-G93Amice. In this study, we show that selective NF-kappa B inhibition in ALS astrocytes is not sufficient to rescue motor neuron (MN) death. However, the localization of NF-kappa B activity and subsequent deletion of NF-kappa B signaling in microglia rescued MNs from microglial-mediated death in vitro and extended survival in ALS mice by impairing proinflammatory microglial activation. Conversely, constitutive activation of NF-kappa B selectively in wild-type microglia induced gliosis and MN death in vitro and in vivo. Taken together, these data provide a mechanism by which microglia induce MN death in ALS and suggest a novel therapeutic target that can be modulated to slow the progression of ALS and possibly other neurodegenerative diseases by which microglial activation plays a role.	[Frakes, Ashley E.; Ferraiuolo, Laura; Haidet-Phillips, Amanda M.; Schmelzer, Leah; Braun, Lyndsey; Miranda, Carlos J.; Bevan, Adam K.; Kaspar, Brian K.] Childrens Hosp, Ctr Gene Therapy, Res Inst Nationwide, Columbus, OH 43205 USA; [Frakes, Ashley E.; Bevan, Adam K.; Kaspar, Brian K.] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Ladner, Katherine J.; Guttridge, Denis C.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Foust, Kevin D.; Godbout, Jonathan P.; Popovich, Phillip G.; Kaspar, Brian K.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kaspar, BK (corresponding author), Childrens Hosp, Ctr Gene Therapy, Res Inst Nationwide, 700 Childrens Dr, Columbus, OH 43205 USA.	Brian.Kaspar@NationwideChildrens.org	Kaspar, Brian/E-3349-2011; Ferraiuolo, Laura/E-5834-2010	Ferraiuolo, Laura/0000-0001-9118-5714; Guttridge, Denis/0000-0002-7276-6609	US National Institutes of Health (NIH) [R01 NS644912]; Project A.L.S.; Packard Center for ALS Research (P2ALS); Helping Link Foundation; NINDS [T32NS077984]; Marie Curie Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077984, R01NS064492] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project A.L.S.; Packard Center for ALS Research (P2ALS); Helping Link Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the US National Institutes of Health (NIH) R01 NS644912, Project A.L.S. and Packard Center for ALS Research (P2ALS), and the Helping Link Foundation. A.F. is supported by NINDS T32NS077984 Training in Neuromuscular Disease, and L.F. is supported by a Marie Curie Fellowship.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Almer G, 2006, ANN NEUROL, V59, P980, DOI 10.1002/ana.20847; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Beers DR, 2011, BRAIN BEHAV IMMUN, V25, P1025, DOI 10.1016/j.bbi.2010.12.008; Beers DR, 2011, BRAIN, V134, P1293, DOI 10.1093/brain/awr074; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bracchi-Ricard V, 2008, J NEUROCHEM, V104, P611, DOI 10.1111/j.1471-4159.2007.04993.x; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Crosio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017187; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Foust KD, 2013, MOL THER, V21, P2148, DOI 10.1038/mt.2013.211; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lerman BJ, 2012, BRAIN BEHAV, V2, P563, DOI 10.1002/brb3.75; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moussaud S, 2010, J NEUROSCI METH, V187, P243, DOI 10.1016/j.jneumeth.2010.01.017; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nguyen MD, 2001, ANN NEUROL, V50, P630, DOI 10.1002/ana.1256; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sako W, 2012, CLIN NEUROPATHOL, V31, P418, DOI 10.5414/NP300493; Sasmono RT, 2012, METHODS MOL BIOL, V844, P157, DOI 10.1007/978-1-61779-527-5_11; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Son M, 2001, ANN NEUROL, V50, P273, DOI 10.1002/ana.1104; Taoufik E, 2011, BRAIN, V134, P2722, DOI 10.1093/brain/awr203; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao WH, 2004, J NEUROPATH EXP NEUR, V63, P964, DOI 10.1093/jnen/63.9.964; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	59	392	404	7	107	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 5	2014	81	5					1009	1023		10.1016/j.neuron.2014.01.013	http://dx.doi.org/10.1016/j.neuron.2014.01.013			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC4YH	24607225	Green Accepted, Bronze			2022-12-17	WOS:000332526700007
J	Aberle, H; Haghighi, AP; Fetter, RD; McCabe, BD; Magalhaes, TR; Goodman, CS				Aberle, H; Haghighi, AP; Fetter, RD; McCabe, BD; Magalhaes, TR; Goodman, CS			wishful thinking encodes a BMP type II receptor that regulates synaptic growth in Drosophila	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; RAT SYMPATHETIC NEURONS; DENDRITIC GROWTH; NEUROMUSCULAR-JUNCTIONS; FUNCTIONAL COMPONENTS; OSTEOGENIC PROTEIN-1; SIGNAL-TRANSDUCTION; TRANSMITTER RELEASE; GENETIC DISSECTION; PLASTICITY	We conducted a large-scale screen for Drosophila mutants that have structural abnormalities of the larval neuromuscular junction (NMJ). We recovered mutations in wishful thinking (wit), a gene that positively regulates synaptic growth. wit encodes a BMP type II receptor. In wit mutant larvae, the size of the NMJs is greatly reduced relative to the size of the muscles. wit NMJs have reduced evoked excitatory junctional potentials, decreased levels of the synaptic cell adhesion molecule Fasciclin II, and synaptic membrane detachment at active zones. Wit is expressed by a subset of neurons, including motoneurons. The NMJ phenotype is specifically rescued by transgenic expression of Wit only in motoneurons. Thus, Wit appears to function as a presynaptic receptor that regulates synaptic size at the Drosophila NMJ.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.		Aberle, Hermann/L-8461-2017	Aberle, Hermann/0000-0002-4864-6105; McCabe, Brian/0000-0003-1620-0501; R Magalhaes, Tiago/0000-0002-5528-2119				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Guo X, 1998, NEUROSCI LETT, V245, P131, DOI 10.1016/S0304-3940(98)00192-X; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jiang Y, 2000, NEUROSCIENCE, V97, P735, DOI 10.1016/S0306-4522(00)00084-1; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIU F, 1995, MOL CELL BIOL, V15, P3479; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; ROBERTSON HM, 1988, GENETICS, V118, P461; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	43	392	401	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					545	558		10.1016/S0896-6273(02)00589-5	http://dx.doi.org/10.1016/S0896-6273(02)00589-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856529	Bronze			2022-12-17	WOS:000173911100008
J	Jackson, GR; Salecker, I; Dong, XZ; Yao, X; Arnheim, N; Faber, PW; MacDonald, ME; Zipursky, SL				Jackson, GR; Salecker, I; Dong, XZ; Yao, X; Arnheim, N; Faber, PW; MacDonald, ME; Zipursky, SL			Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons	NEURON			English	Article							MACHADO-JOSEPH DISEASE; SPINOCEREBELLAR ATAXIA TYPE-2; PROGRAMMED CELL-DEATH; CAG REPEAT EXPANSION; INTRANUCLEAR INCLUSIONS; NEUROLOGICAL PHENOTYPE; PALLIDOLUYSIAN ATROPHY; TRINUCLEOTIDE REPEAT; EMBRYONIC LETHALITY; GENE HOMOLOG	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. Disease alleles contain a trinucleotide repeat expansion of variable length, which encodes polyglutamine tracts near the amino terminus of the HD protein, huntingtin. Polyglutamine-expanded huntingtin, but not normal huntingtin, forms nuclear inclusions. We describe a Drosophila model for HD. Amino-terminal fragments of human huntingtin containing tracts of 2, 75, and 120 glutamine residues were expressed in photoreceptor neurons in the compound eye. As in human neurons, polyglutamine-expanded huntingtin induced neuronal degeneration. The age of onset and severity of neuronal degeneration correlated with repeat length, and nuclear localization of huntingtin presaged neuronal degeneration. In contrast to other cell death paradigms in Drosophila, coexpression of the Viral antiapoptotic protein, P35, did not rescue the cell death phenotype induced by polyglutamine-expanded huntingtin.	Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ So Calif, Sch Med, Program Mol Biol, Los Angeles, CA 90089 USA; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; Harvard University; Massachusetts General Hospital	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.		; Salecker, Iris/V-1228-2018	Arnheim, Norman/0000-0003-1247-1347; Zipursky, Stephen/0000-0001-5630-7181; Salecker, Iris/0000-0003-3775-7763	NINDS NIH HHS [NS16367, NS32765] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, P01NS016367, R01NS032765] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGAPITE J, 1997, MOL CELLULAR APPROAC, P264; AKAI H, 1967, SCIENCE, V157, P810, DOI 10.1126/science.157.3790.810; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; [Anonymous], ADV NEUROL; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CANCEL G, 1995, AM J HUM GENET, V57, P809; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Davies SW, 1998, LANCET, V351, P131, DOI 10.1016/S0140-6736(97)08360-8; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Folstein S.E., 1989, HUNTINGTONS DIS DISO; Franceschini N., 1972, INFORMATION PROCESSI, P75; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; GARTNER LP, 1976, J GERONTOL, V31, P396, DOI 10.1093/geronj/31.4.396; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GUSELLA JF, 1995, CURR OPIN NEUROBIOL, V5, P656, DOI 10.1016/0959-4388(95)80072-7; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; HABERHAUSEN G, 1995, J NEUROL SCI, V132, P71, DOI 10.1016/0022-510X(95)90927-I; Hackam AS, 1998, CLIN GENET, V53, P233; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; HAY BA, 1994, DEVELOPMENT, V120, P2121; Higgins JJ, 1996, NEUROLOGY, V46, P208, DOI 10.1212/WNL.46.1.208; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; LINDSLEY D, 1992, GENOME DRISOPHILA ME; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; MIYAKE T, 1987, MOL GEN GENET, V207, P29, DOI 10.1007/BF00331487; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; ONODERA O, 1995, AM J HUM GENET, V57, P1050; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PEEL DJ, 1990, TISSUE CELL, V22, P749, DOI 10.1016/0040-8166(90)90069-L; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Riess O, 1997, HUM MOL GENET, V6, P1289, DOI 10.1093/hmg/6.8.1289; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STELLER H, 1994, PHILOS T ROY SOC B, V345, P247, DOI 10.1098/rstb.1994.0101; SUGIYAMA H, 1994, J FOOD HYG SOC JPN, V35, P13, DOI 10.3358/shokueishi.35.13; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YOUSSEF NN, 1975, TISSUE CELL, V7, P655, DOI 10.1016/0040-8166(75)90034-8; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	79	392	419	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					633	642		10.1016/S0896-6273(00)80573-5	http://dx.doi.org/10.1016/S0896-6273(00)80573-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768849	Bronze			2022-12-17	WOS:000076196400019
J	Sudhof, TC; Rizo, J				Sudhof, TC; Rizo, J			Synaptotagmins: C-2-domain proteins that regulate membrane traffic	NEURON			English	Review							SQUID GIANT SYNAPSE; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; CAENORHABDITIS-ELEGANS; CALCIUM-DEPENDENCE; MESSENGER-RNAS; C2B DOMAIN; KINASE-C; TRANSMISSION; DROSOPHILA		UNIV TEXAS,SW MED CTR,DEPT MOL GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235, USA.							AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1996, IN PRESS BIOCH BIOPH; CRAXTON M, 1995, FEBS LETT, V361, P196, DOI 10.1016/0014-5793(95)00176-A; DAVLETOV BA, 1994, J BIOL CHEM, V269, P28547; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HILBUSH BS, 1994, P NATL ACAD SCI USA, V91, P8195, DOI 10.1073/pnas.91.17.8195; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Kee Y, 1996, J NEUROSCI, V16, P1975; KELLY RB, 1995, CURR BIOL, V5, P257, DOI 10.1016/S0960-9822(95)00054-6; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kwon OJ, 1996, FEBS LETT, V378, P135, DOI 10.1016/0014-5793(95)01430-6; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; MARQUEZE B, 1995, J NEUROSCI, V15, P4906; MARTIN KC, 1995, P NATL ACAD SCI USA, V92, P11307, DOI 10.1073/pnas.92.24.11307; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; NEHER E, 1994, NATURE, V372, P316, DOI 10.1038/372316a0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; PERIN MS, 1994, J BIOL CHEM, V269, P8576; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SASAKAGUCHI G, 1995, BIOCHEM BIOPH RES CO, V217, P1053; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; ULLRICH U, 1994, NEURON, V13, P1281; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	70	392	394	2	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					379	388		10.1016/S0896-6273(00)80171-3	http://dx.doi.org/10.1016/S0896-6273(00)80171-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816702	Bronze			2022-12-17	WOS:A1996VJ44000005
J	DUTAR, P; NICOLL, RA				DUTAR, P; NICOLL, RA			PRE-SYNAPTIC AND POSTSYNAPTIC GABAB RECEPTORS IN THE HIPPOCAMPUS HAVE DIFFERENT PHARMACOLOGICAL PROPERTIES	NEURON			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco				Dutar, Patrick/0000-0002-8170-1196	NIMH NIH HHS [MH-00437] Funding Source: Medline; NINDS NIH HHS [NS-24205] Funding Source: Medline; PHS HHS [MG-38256] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024205] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGHAJANIAN GK, 1986, BRAIN RES, V371, P390, DOI 10.1016/0006-8993(86)90382-3; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; AULT B, 1982, J PHARMACOL EXP THER, V223, P291; BARABAN JM, 1985, P NATL ACAD SCI USA, V82, P2538, DOI 10.1073/pnas.82.8.2538; BEQUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774; BLAXTER TJ, 1985, BRAIN RES, V341, P195, DOI 10.1016/0006-8993(85)91489-1; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; BOWERY NG, 1984, ACTIONS INTERACTIONS; COLMERS WF, 1988, IN PRESS CAN J PHYSL; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; INOUE M, 1985, BRIT J PHARMACOL, V84, P833, DOI 10.1111/j.1476-5381.1985.tb17377.x; JAKOBS KH, 1985, EUR J BIOCHEM, V151, P425, DOI 10.1111/j.1432-1033.1985.tb09119.x; KERR DIB, 1987, BRAIN RES, V405, P150, DOI 10.1016/0006-8993(87)90999-1; KUROSE H, 1983, J BIOL CHEM, V258, P2870; LANTHORN TH, 1981, BRAIN RES, V225, P171, DOI 10.1016/0006-8993(81)90326-7; MALENKA RC, 1986, J NEUROSCI, V6, P475; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; NEWBERRY NR, 1985, J PHYSIOL-LONDON, V360, P161, DOI 10.1113/jphysiol.1985.sp015610; NICHOLS RA, 1987, J NEUROCHEM, V48, P615, DOI 10.1111/j.1471-4159.1987.tb04137.x; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; NICOLL RA, 1988, IN PRESS GABA BASIC; PEET MJ, 1986, EXP BRAIN RES, V61, P567; THALMANN RH, 1987, NEUROSCI LETT, V82, P41, DOI 10.1016/0304-3940(87)90168-6	27	392	394	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1988	1	7					585	591		10.1016/0896-6273(88)90108-0	http://dx.doi.org/10.1016/0896-6273(88)90108-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	Q2325	2856099				2022-12-17	WOS:A1988Q232500006
J	Asaad, WF; Rainer, G; Miller, EK				Asaad, WF; Rainer, G; Miller, EK			Neural activity in the primate prefrontal cortex during associative learning	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; CONDITIONAL OCULOMOTOR ASSOCIATIONS; SUPPLEMENTARY EYE FIELD; INFEROTEMPORAL-FRONTAL DISCONNECTION; NEURONAL-ACTIVITY; DELAYED-RESPONSE; RHESUS-MONKEYS; UNIT-ACTIVITY; PERIARCUATE LESIONS; PREMOTOR CORTEX	The prefrontal (PF) cortex has been implicated in the remarkable ability of primates to form and rearrange arbitrary associations rapidly. This ability was studied in two monkeys, using a task that required them to learn to make specific saccades in response to particular cues and then repeatedly reverse these responses. We found that the activity of individual PF neurons represented both the cues and the associated responses, perhaps providing a neural substrate for their association. Furthermore, during learning, neural activity conveyed the direction of the animals' impending responses progressively earlier within each successive trial. The final level of activity just before the response, however, was unaffected by learning. These results suggest a role for the PF cortex in learning arbitrary cue-response associations, an ability critical for complex behavior.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ekm@ai.mit.edu	Asaad, Wael/I-8485-2012; Rainer, Gregor/B-5876-2012; Miller, Earl K./AAE-8187-2019	Asaad, Wael/0000-0003-4406-9096; Miller, Earl K./0000-0002-0582-6958; Rainer, Gregor/0000-0002-5805-2220	NINDS NIH HHS [NS35145-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035145, R29NS035145] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARBAS H, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P35; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P15, DOI 10.1007/BF00229650; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P28; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Deadwyler SA, 1996, J NEUROSCI, V16, P354; DIPELLEGRINO G, 1991, BRAIN, V114, P951; EACOTT MJ, 1992, EUR J NEUROSCI, V4, P1320, DOI 10.1111/j.1460-9568.1992.tb00157.x; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Fuster JM, 1995, MEMORY CEREBRAL CORT; GAFFAN D, 1988, BEHAV BRAIN RES, V31, P149, DOI 10.1016/0166-4328(88)90018-6; HALSBAND U, 1985, BEHAV BRAIN RES, V18, P269, DOI 10.1016/0166-4328(85)90035-X; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MILLER EK, 1991, VISUAL NEUROSCI, V7, P357, DOI 10.1017/S0952523800004843; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MITZ AR, 1991, J NEUROSCI, V11, P1855; Murray EA, 1996, BEHAV NEUROSCI, V110, P1261; NIKI H, 1976, BRAIN RES, V105, P79, DOI 10.1016/0006-8993(76)90924-0; PANDYA DN, 1990, PROG BRAIN RES, V85, P63; Pandya DN., 1987, FRONTAL LOBES REVISI, P41; Parker A, 1998, NEUROPSYCHOLOGIA, V36, P259, DOI 10.1016/S0028-3932(97)00112-7; Passingham RE., 1993, FRONTAL LOBES VOLUNT; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; PETRIDES M, 1982, BEHAV BRAIN RES, V5, P407, DOI 10.1016/0166-4328(82)90044-4; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; PETRIDES M, 1986, J NEUROSCI, V6, P2054; PETRIDES M, 1990, NEUROPSYCHOLOGIA, V28, P137, DOI 10.1016/0028-3932(90)90096-7; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; RAINER G, 1998, IN PRESS P NATL ACAD; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RUPNIAK NMJ, 1987, J NEUROSCI, V7, P2331; Rushworth MFS, 1997, J NEUROSCI, V17, P4829; SAKAGAMI M, 1994, EXP BRAIN RES, V100, P165; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHWARTZ ML, 1984, J COMP NEUROL, V226, P403, DOI 10.1002/cne.902260309; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; SPITZER H, 1991, EXP BRAIN RES, V83, P340; WATANABE M, 1992, EXP BRAIN RES, V89, P233; WATANABE M, 1986, BRAIN RES, V382, P15, DOI 10.1016/0006-8993(86)90105-8; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; YOUNG BJ, 1994, J NEUROSCI, V14, P6553	59	391	392	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1399	1407		10.1016/S0896-6273(00)80658-3	http://dx.doi.org/10.1016/S0896-6273(00)80658-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883732	Bronze			2022-12-17	WOS:000077910600021
J	Atallah, BV; Bruns, W; Carandini, M; Scanziani, M				Atallah, Bassam V.; Bruns, William; Carandini, Matteo; Scanziani, Massimo			Parvalbumin-Expressing Interneurons Linearly Transform Cortical Responses to Visual Stimuli	NEURON			English	Article							INHIBITORY NEURONS; GABAERGIC NEURONS; STRIATE CORTEX; ORIENTATION; SELECTIVITY; CELLS; CAT; MECHANISMS; ATTENTION; SUBTYPES	The response of cortical neurons to a sensory stimulus is shaped by the network in which they are embedded. Here we establish a role of parvalbumin (PV)-expressing cells, a large class of inhibitory neurons that target the soma and perisomatic compartments of pyramidal cells, in controlling cortical responses. By bidirectionally manipulating PV cell activity in visual cortex we show that these neurons strongly modulate layer 2/3 pyramidal cell spiking responses to visual stimuli while only modestly affecting their tuning properties. PV cells' impact on pyramidal cells is captured by a linear transformation, both additive and multiplicative, with a threshold. These results indicate that PV cells are ideally suited to modulate cortical gain and establish a causal relationship between a select neuron type and specific computations performed by the cortex during sensory processing.	[Atallah, Bassam V.] Univ Calif San Diego, Computat Neurosci Grad Program, La Jolla, CA 92093 USA; [Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Neurobiol Sect, Div Biol, La Jolla, CA 92093 USA; [Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of London; University College London	Atallah, BV (corresponding author), Univ Calif San Diego, Computat Neurosci Grad Program, La Jolla, CA 92093 USA.	bassam.atallah@gmail.com; mscanziani@ucsd.edu	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682; Atallah, Bassam/0000-0003-2315-7126	NIH [NS061521]; Gatsby Charitable Foundation; HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS061521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C. Niell and M. Stryker for providing expertise and sharing code at the initial stages of this project; H. Adesnik for his help implementing optogenetic approaches; S.R. Olsen for his insights and help in developing the visual recording configuration; and J. Evora, A.N. Linder, and P. Abelkop for histology and mouse husbandry. M.C. holds the GlaxoSmithKline / Fight for Sight Chair in Visual Neuroscience. B.V.A. was supported by NIH NS061521. This work was supported by the Gatsby Charitable Foundation and HHMI.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Callaway EM, 2002, J NEUROCYTOL, V31, P231, DOI 10.1023/A:1024165824469; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carandini M, 2007, NEURON, V54, P11, DOI 10.1016/j.neuron.2007.03.019; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; CONNORS BW, 1986, J NEUROSCI, V6, P164; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; PRINCE DA, 1978, ANNU REV NEUROSCI, V1, P395, DOI 10.1146/annurev.ne.01.030178.002143; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Zariwala HA, 2011, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00162	52	390	391	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					159	170		10.1016/j.neuron.2011.12.013	http://dx.doi.org/10.1016/j.neuron.2011.12.013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243754	Bronze, Green Accepted			2022-12-17	WOS:000299446800015
J	Katzner, S; Nauhaus, I; Benucci, A; Bonin, V; Ringach, DL; Carandini, M				Katzner, Steffen; Nauhaus, Ian; Benucci, Andrea; Bonin, Vincent; Ringach, Dario L.; Carandini, Matteo			Local Origin of Field Potentials in Visual Cortex	NEURON			English	Article							EVOKED-POTENTIALS; SPATIAL-FREQUENCY; PARIETAL CORTEX; CEREBRAL-CORTEX; CAT; OSCILLATIONS; ORIENTATION; SYNCHRONIZATION; V1; IMPEDANCE	The local field potential (LFP) is increasingly used to measure the combined activity of neurons within a region of tissue. Yet, available estimates of the size of this region are highly disparate, ranging from several hundred microns to a few millimeters. To measure the size of this region directly, we used a combination of multielectrode recordings and optical imaging. We determined the orientation selectivity of stimulus-evoked LFP signals in primary visual cortex and were able to predict it on the basis of the surrounding map of orientation preference. The results show that > 95% of the LFP signal originates within 250 mu m of the recording electrode. This quantitative estimate indicates that LFPs are more local than often recognized and provides a guide to the interpretation of the increasing number of studies that rest on LFP recordings.	[Katzner, Steffen; Benucci, Andrea; Bonin, Vincent; Carandini, Matteo] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; [Nauhaus, Ian; Ringach, Dario L.] Univ Calif Los Angeles, Dept Biomed Engn, Los Angeles, CA 90095 USA; [Ringach, Dario L.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Ringach, Dario L.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Carandini, Matteo] UCL, Inst Ophthalmol, London EC1V 9EL, England	The Smith-Kettlewell Eye Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of London; University College London	Carandini, M (corresponding author), Smith Kettlewell Eye Res Inst, 2232 Webster St, San Francisco, CA 94115 USA.	matteo@carandinilab.net	Bonin, Vincent/AAQ-3833-2020; Carandini, Matteo/ABD-8296-2021; Benucci, Andrea/N-6361-2015	Carandini, Matteo/0000-0003-4880-7682; Benucci, Andrea/0000-0002-7698-6289; Katzner, Steffen/0000-0002-4424-2197; Bonin, Vincent/0000-0002-9437-8092	National Eye Institute [17396, 12816, 18322]; DARPA [FA-8650-06-C-7633]; McKnight Endowment Fund for Neuroscience; GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience; NATIONAL EYE INSTITUTE [R01EY018322, R01EY017396, R01EY012816] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); McKnight Endowment Fund for Neuroscience; GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience(GlaxoSmithKline); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Laura Busse and Robert Frazor for help in the experiments. This work was supported by National Eye Institute grants 17396 (M.C.), 12816 (D.L.R.), and 18322 (D.L.R.), by DARPA FA-8650-06-C-7633 (D.L.R.) and by a Scholar Award from the McKnight Endowment Fund for Neuroscience (M.C.). M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; BENUCCI A, 2007, FRONTIERS S IN PRESS, DOI DOI 10.3389/NEURO.06.002.2008; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Freeman WJ, 1975, MASS ACTION NERVOUS; Frien A, 2000, EUR J NEUROSCI, V12, P1453, DOI 10.1046/j.1460-9568.2000.00025.x; Gillespie DC, 2001, NAT NEUROSCI, V4, P1014, DOI 10.1038/nn731; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; KITANO M, 1994, VISUAL NEUROSCI, V11, P953, DOI 10.1017/S0952523800003904; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Kruse W, 1996, P NATL ACAD SCI USA, V93, P6112, DOI 10.1073/pnas.93.12.6112; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Nauhaus I, 2007, J NEUROPHYSIOL, V97, P3781, DOI 10.1152/jn.00120.2007; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; RANCK JB, 1963, EXP NEUROL, V7, P144, DOI 10.1016/S0014-4886(63)80005-9; REGAN D, 1988, VISION RES, V28, P187, DOI 10.1016/S0042-6989(88)80018-X; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Siegel M, 2003, J NEUROSCI, V23, P4251; VICTOR JD, 1994, J NEUROPHYSIOL, V72, P2151, DOI 10.1152/jn.1994.72.5.2151; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; ZEMON V, 1982, P NATL ACAD SCI-BIOL, V79, P5723, DOI 10.1073/pnas.79.18.5723	30	390	392	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 15	2009	61	1					35	41		10.1016/j.neuron.2008.11.016	http://dx.doi.org/10.1016/j.neuron.2008.11.016			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	396TP	19146811	Bronze, Green Accepted			2022-12-17	WOS:000262614400006
J	Xu, PX; Atkinson, R; Jones, DNM; Smith, DP				Xu, PX; Atkinson, R; Jones, DNM; Smith, DP			Drosophila OBP LUSH is required for activity of pheromone-sensitive neurons	NEURON			English	Article							ODORANT-BINDING-PROTEINS; CIS-VACCENYL ACETATE; ANTHERAEA-POLYPHEMUS; MOLECULAR-CLONING; MOTH; MELANOGASTER; FAMILY; SPECIFICITY; EXPRESSION	Odorant binding proteins (OBPs) are extracellular proteins localized to the chemosensory systems of most terrestrial species. OBPs are expressed by nonneuronal cells and secreted into the fluid bathing olfactory neuron dendrites. Several members have been shown to interact directly with odorants, but the significance of this is not clear. We show that the Drosophila OBP lush is completely devoid of evoked activity to the pheromone 11-cis vaccenyl acetate (VA), revealing that this binding protein is absolutely required for activation of pheromone-sensitive chemosensory neurons. lush mutants are also defective for pheromone-evoked behavior. Importantly, we identify a genetic interaction between lush and spontaneous activity in VA-sensitive neurons in the absence of pheromone. The defects in spontaneous activity and VA sensitivity are reversed by germline transformation with a lush transgene or by introducing recombinant LUSH protein into mutant sensilla. These studies directly link pheromone-induced behavior with OBP-dependent activation of a subset of olfactory neurons.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Pharmacol, Dallas, TX 75335 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Program Biomol Struct, Denver, CO 80262 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Smith, DP (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75335 USA.	dean.smith@utsouthwestern.edu	Jones, David N/C-5764-2013	Smith, Dean/0000-0002-4271-0436	NIAAA NIH HHS [R01 AA013618-05, R01 AA013618] Funding Source: Medline; NIDCD NIH HHS [R01 DC002539] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002539] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Galindo K, 2001, GENETICS, V159, P1059; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kaissling K.E., 1985, P173; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Kim MS, 1998, GENETICS, V150, P711; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Leal WS, 1998, ANN NY ACAD SCI, V855, P301, DOI 10.1111/j.1749-6632.1998.tb10586.x; Maida R, 2000, EUR J BIOCHEM, V267, P2899, DOI 10.1046/j.1432-1327.2000.01303.x; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; RAMING K, 1989, FEBS LETT, V256, P215, DOI 10.1016/0014-5793(89)81751-X; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Shanbhag SR, 2001, MICROSC RES TECHNIQ, V55, P297, DOI 10.1002/jemt.1179; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STEINBRE.RA, 1971, Z ZELLFORSCH MIK ANA, V117, P570, DOI 10.1007/BF00330716; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; VANDERMEER RK, 1998, PHERMONE COMMUNICATI; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; VOGT RG, 1991, J NEUROSCI, V11, P2972; Vogt RG, 2003, INSECT PHEROMONE BIO, DOI 10.1016/B978-012107151-6/50016-5; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; WOODARD C, 1989, GENETICS, V123, P315; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0; Zhang SG, 2001, CHEM SENSES, V26, P885, DOI 10.1093/chemse/26.7.885; Zhou JJ, 2004, FEBS LETT, V558, P23, DOI 10.1016/S0014-5793(03)01521-7; ZIEGELBERGER G, 1995, EUR J BIOCHEM, V232, P706, DOI 10.1111/j.1432-1033.1995.tb20864.x	53	390	430	7	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					193	200		10.1016/j.neuron.2004.12.031	http://dx.doi.org/10.1016/j.neuron.2004.12.031			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664171	Bronze			2022-12-17	WOS:000226451500006
J	Pittenger, C; Huang, YY; Paletzki, RF; Bourtchouladze, R; Scanlin, H; Vronskaya, S; Kandel, ER				Pittenger, C; Huang, YY; Paletzki, RF; Bourtchouladze, R; Scanlin, H; Vronskaya, S; Kandel, ER			Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory	NEURON			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; MEDIATED GENE-EXPRESSION; LATE-PHASE; SYNAPTIC PLASTICITY; NUCLEAR TRANSLOCATION; TARGETED MUTATION; UP-REGULATION; MAP KINASE; POTENTIATION	CREB is critical for long-lasting synaptic and behavioral plasticity in invertebrates. Its role in the mammalian hippocampus is less clear. We have interfered with CREB family transcription factors in region CA1 of the dorsal hippocampus. This impairs learning in the Morris water maze, which specifically requires the dorsal hippocampus, but not context conditioning, which does not. The deficit is specific to long-term memory, as shown in an object recognition task. Several forms of late-phase LTP are normal, but forskolin-induced and dopamine-regulated potentiation are disrupted. These experiments represent the first targeting of the dorsal hippocampus in genetically modified mice and confirm a role for CREB in hippocampus-dependent learning. Nevertheless, they suggest that some experimental forms of plasticity bypass the requirement for CREB.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; NINCDS, Mol Plast Sect, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.		Pittenger, Christopher/G-8402-2012	Pittenger, Christopher/0000-0003-2117-9321	NIMH NIH HHS [MH 12956-01] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Amaral D.G., 1995, RAT NERVOUS SYSTEM; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barth AL, 2000, J NEUROSCI, V20, P4206; Bartsch D, 2000, CELL, V103, P595, DOI 10.1016/S0092-8674(00)00163-X; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; CRAIG JC, 2000, J BIOL CHEM, V27, P27; Crawley J.N., 2007, WHATS WRONG MY MOUSE, P226; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gass P, 1998, LEARN MEMORY, V5, P274; GERFEN CR, 1991, J NEUROSCI, V11, P1016; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; HUANG JY, 1995, LASER SPECTROSCOPY P, V1, P5; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kandel ER, 1999, PHILOS T R SOC B, V354, P2027, DOI 10.1098/rstb.1999.0542; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KIDA S, 2002, IN PRESS NAT NEUROSC; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; KONRADI C, 1993, P NATL ACAD SCI USA, V90, P7005, DOI 10.1073/pnas.90.15.7005; KONRADI C, 1995, J NEUROCHEM, V65, P1007; LORIAUX MM, 1993, P NATL ACAD SCI USA, V90, P9046, DOI 10.1073/pnas.90.19.9046; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Paxinos G., 1997, MOUSE BRAIN STEREOTA; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pittenger C, 1998, CR ACAD SCI III-VIE, V321, P91, DOI 10.1016/S0764-4469(97)89807-1; PITTENGER C, 2002, THESIS COLUMBIA U NE; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sgambato V, 1998, J NEUROSCI, V18, P8814; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Steckler T, 1998, PROG NEUROBIOL, V54, P313, DOI 10.1016/S0301-0082(97)00061-0; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Zha XM, 2001, HEARING RES, V156, P53, DOI 10.1016/S0378-5955(01)00267-2	65	390	417	2	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					447	462		10.1016/S0896-6273(02)00684-0	http://dx.doi.org/10.1016/S0896-6273(02)00684-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988175	Bronze			2022-12-17	WOS:000175214700015
J	Patel, M; Day, BJ; Crapo, JD; Fridovich, I; McNamara, JO				Patel, M; Day, BJ; Crapo, JD; Fridovich, I; McNamara, JO			Requirement for superoxide in excitotoxic cell death	NEURON			English	Article							GLUTAMATE NEUROTOXICITY; NITRIC-OXIDE; MEDIATED NEUROTOXICITY; ESCHERICHIA-COLI; CULTURES; INACTIVATION; DISMUTASE; ACONITASE; INJURY; NMDA	We tested the pathogenic role of O-2(-) radicals in excitotoxic injury. Inactivation of the TCA cycle enzyme, aconitase, was used as a marker of intracellular O-2(-) levels, and a porphyrin SOD mimetic was used to scavenge O-2(-). The selective, reversible, and SOD-sensitive inactivation of aconitase by known O-2(-) generators was used to validate aconitase activity as a marker of O-2(-) generation. Treatment of rat cortical cultures with NMDA, KA, or the intracellular O-2(-) generator PQ(2+) produced a selective and reversible inactivation of aconitase, which closely correlated with subsequent cell death produced by these agents. The SOD mimetic, but not its less active congener, attenuated both aconitase inactivation and cell death produced by NMDA, KA, and pQ(2+). These results provide direct evidence implicating O-2(-) generation in the pathway to excitotoxic injury.	DUKE UNIV,DEPT BIOCHEM,DURHAM 27710,ENGLAND; DUKE UNIV,DEPT NEUROBIOL,DURHAM 27710,ENGLAND; DUKE UNIV,DEPT PHARMACOL,DURHAM 27710,ENGLAND; VET ADM MED CTR,DURHAM,NC 27710	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Patel, M (corresponding author), DUKE UNIV,DEPT MED,DURHAM 27710,ENGLAND.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032334] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 31992] Funding Source: Medline; NINDS NIH HHS [NS 32334] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; CHAN PH, 1990, STROKE, V21, P80; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; DUMIUS A, 1988, NATURE, V336, P68; DYKENS JA, 1987, J NEUROCHEM, V49, P1222, DOI 10.1111/j.1471-4159.1987.tb10014.x; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARTHWAITE G, 1986, NEUROSCI LETT, V66, P193, DOI 10.1016/0304-3940(86)90189-8; GHADE GDJ, 1995, MOL PHARMACOL, V47, P1095; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Halliwell B, 1989, FREE RADICAL BIO MED, P22; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; KOH JY, 1990, J NEUROSCI, V10, P693; KREBS HA, 1952, BIOCHEM J, V52, P527, DOI 10.1042/bj0520527; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; LIOCHEV SI, 1995, ARCH BIOCHEM BIOPHYS, V321, P271, DOI 10.1006/abbi.1995.1395; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; OLNEY JW, 1989, BIOL PSYCHIAT, V26, P505, DOI 10.1016/0006-3223(89)90072-3; OLNEY JW, 1986, ADV EXPT MED BIOL, V203, P632; PATEL MN, 1992, TOXICOL APPL PHARM, V115, P124, DOI 10.1016/0041-008X(92)90375-3; PATEL MN, 1993, NEUROTOXICOLOGY, V14, P35; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RACKER E, 1950, BIOCHIM BIOPHYS ACTA, V4, P211, DOI 10.1016/0006-3002(50)90026-6; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1994, P NATL ACAD SCI USA, V91, P4155, DOI 10.1073/pnas.91.10.4155; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; Vassault A, 1984, METHODS ENZYM ANAL, V3, P118	47	390	399	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					345	355		10.1016/S0896-6273(00)80052-5	http://dx.doi.org/10.1016/S0896-6273(00)80052-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789949	Bronze			2022-12-17	WOS:A1996TW95700014
J	WILLIAMS, K; RUSSELL, SL; SHEN, YM; MOLINOFF, PB				WILLIAMS, K; RUSSELL, SL; SHEN, YM; MOLINOFF, PB			DEVELOPMENTAL SWITCH IN THE EXPRESSION OF NMDA RECEPTORS OCCURS INVIVO AND INVITRO	NEURON			English	Article							D-ASPARTATE RECEPTOR; MUSCLE ACETYLCHOLINE-RECEPTOR; CENTRAL NERVOUS-SYSTEM; ANTI-ISCHEMIC AGENTS; ANTICONVULSANT MK-801; XENOPUS OOCYTES; VISUAL-CORTEX; RAT-BRAIN; ANTAGONIST; IFENPRODIL	The properties of many ligand-gated ion channels are altered during development. We have characterized a developmental switch in the sensitivity of NMDA receptors to the novel antagonist ifenprodil using ligand binding assays with rat brain membranes and voltage-clamp recording of Xenopus oocytes expressing NMDA receptors after injection of RNA from rat brain and from cloned subunits of the receptor. In neonatal rat brain, NMDA receptors have a uniformly high affinity for ifenprodil. During postnatal development, a second population of receptors having a 100-fold lower affinity for ifenprodil is expressed and represents 50% of NMDA receptors in adult rat brain. This developmental change also occurred in cortical neurons maintained in primary culture. Ifenprodil potently inhibited responses of homomeric NR1 and heteromeric NR1/NR2B receptors but not NR1/NR2A receptors expressed in oocytes, suggesting that inclusion of different NR2 subunits in native NMDA receptors can control the sensitivity to ifenprodil.			WILLIAMS, K (corresponding author), UNIV PENN, SCH MED, DEPT PHARMACOL, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM034781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030000] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 34781] Funding Source: Medline; NINDS NIH HHS [NS 30000] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANANTHARAM V, 1992, FEBS LETT, V305, P27, DOI 10.1016/0014-5793(92)80648-Z; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BEAR MF, 1990, J NEUROSCI, V10, P909; BENARI Y, 1988, NEUROSCI LETT, V94, P88, DOI 10.1016/0304-3940(88)90275-3; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; CARTER C, 1989, EUR J PHARMACOL, V164, P611, DOI 10.1016/0014-2999(89)90275-6; CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222; CARTER C, 1991, EXCITATORY AMINO ACI, P130; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DAUBAS P, 1990, NEURON, V5, P49, DOI 10.1016/0896-6273(90)90032-B; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FOSTER AC, 1987, BRIT J PHARMACOL, V91, P403, DOI 10.1111/j.1476-5381.1987.tb10295.x; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; HARTMAN DS, 1990, NATURE, V343, P372, DOI 10.1038/343372a0; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; KLECKNER NW, 1991, MOL BRAIN RES, V11, P151; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LEGENDRE P, 1991, MOL PHARMACOL, V40, P289; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MORRISETT RA, 1990, DEV BRAIN RES, V56, P257, DOI 10.1016/0165-3806(90)90090-L; POULTER MO, 1992, J NEUROSCI, V12, P2888, DOI 10.1523/JNEUROSCI.12-08-02888.1992; QUICK M W, 1992, Biotechniques, V13, P362; REYNOLDS IJ, 1988, MOL PHARMACOL, V33, P581; REYNOLDS IJ, 1989, MOL PHARMACOL, V36, P758; REYNOLDS IJ, 1992, J NEUROSCI, V12, P970; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; VERDOORN TA, 1987, SCIENCE, V238, P1114, DOI 10.1126/science.2825347; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; WILLIAMS K, 1991, MOL PHARMACOL, V40, P774; WILLIAMS K, 1991, LIFE SCI, V48, P469, DOI 10.1016/0024-3205(91)90463-L; WILLIAMS K, 1992, MOL PHARMACOL, V42, P147; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	43	390	396	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					267	278		10.1016/0896-6273(93)90317-K	http://dx.doi.org/10.1016/0896-6273(93)90317-K			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439412				2022-12-17	WOS:A1993KP68500014
J	Stokes, MG; Kusunoki, M; Sigala, N; Nili, H; Gaffan, D; Duncan, J				Stokes, Mark G.; Kusunoki, Makoto; Sigala, Natasha; Nili, Hamed; Gaffan, David; Duncan, John			Dynamic Coding for Cognitive Control in Prefrontal Cortex	NEURON			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; NEURAL MECHANISMS; NEURONAL-ACTIVITY; INFORMATION; ATTENTION; TASK; MONKEY; SYNCHRONIZATION; CATEGORIZATION	Cognitive flexibility is fundamental to adaptive intelligent behavior. Prefrontal cortex has long been associated with flexible cognitive function, but the neurophysiological principles that enable prefrontal cells to adapt their response properties according to context-dependent rules remain poorly understood. Here, we use time-resolved population-level neural pattern analyses to explore how context is encoded and maintained in primate prefrontal cortex and used in flexible decision making. We show that an instruction cue triggers a rapid series of state transitions before settling into a stable low-activity state. The postcue state is differentially tuned according to the current task-relevant rule. During decision making, the response to a choice stimulus is characterized by an initial stimulus-specific population response but evolves to different final decision-related states depending on the current rule. These results demonstrate how neural tuning profiles in prefrontal cortex adapt to accommodate changes in behavioral context. Highly flexible tuning could be mediated via short-term synaptic plasticity.	[Stokes, Mark G.] Univ Oxford, Oxford Ctr Human Brain Act, Oxford OX3 7JX, England; [Stokes, Mark G.; Kusunoki, Makoto; Gaffan, David; Duncan, John] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Kusunoki, Makoto; Nili, Hamed; Duncan, John] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge CB27EF, England; [Sigala, Natasha] Univ Sussex, Brighton & Sussex Med Sch, Sussex BN1 9RR, England; [Sigala, Natasha] Univ Sussex, Sackler Ctr Consciousness Sci, Sussex BN1 9RR, England	University of Oxford; University of Oxford; University of Cambridge; University of Sussex; University of Sussex	Stokes, MG (corresponding author), Univ Oxford, Oxford Ctr Human Brain Act, Oxford OX3 7JX, England.	mark.stokes@ohba.ox.ac.uk	Sigala, Natasha/K-1750-2013; Sigala, Natasha/ABH-3181-2020	Sigala, Natasha/0000-0002-9456-6093; Sigala, Natasha/0000-0002-9456-6093; Duncan, John/0000-0002-9695-2764	MRC [MC-A060-5PQ10]; James S. McDonnell Foundation; Royal Society; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University; MRC [MC_U105580448, MC_qA137504, MR/J009024/1] Funding Source: UKRI; Medical Research Council [MC_qA137504, MR/J009024/1, MC_U105580448] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); James S. McDonnell Foundation; Royal Society(Royal Society of London); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by MRC (intramural programme MC-A060-5PQ10 and Career Development Fellowship to M.G.S.), James S. McDonnell Foundation, Royal Society (N.S.), and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Cromer JA, 2011, J COGNITIVE NEUROSCI, V23, P3355, DOI 10.1162/jocn_a_00032; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; Deco G, 2010, P NATL ACAD SCI USA, V107, P7545, DOI 10.1073/pnas.1002333107; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J., 2002, PRINCIPLES FRONTAL L, P278; Erickson MA, 2010, J COGNITIVE NEUROSCI, V22, P2530, DOI 10.1162/jocn.2009.21375; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Izhikevich E. M., 2006, COMPUTATIONAL NEUROS, V1; Jun JK, 2010, J NEUROSCI, V30, P916, DOI 10.1523/JNEUROSCI.2062-09.2010; Kusunoki M, 2009, CEREB CORTEX, V19, P2522, DOI 10.1093/cercor/bhp005; Kusunoki M, 2010, J COGNITIVE NEUROSCI, V22, P751, DOI 10.1162/jocn.2009.21216; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Li S, 2007, J NEUROSCI, V27, P12321, DOI 10.1523/JNEUROSCI.3795-07.2007; Luria A.R., 1966, SCIENCE, V307, P1121; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Meyers EM, 2012, P NATL ACAD SCI USA, V109, P4651, DOI 10.1073/pnas.1201022109; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Rainer G, 1999, J NEUROSCI, V19, P5493; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Sigala N, 2008, P NATL ACAD SCI USA, V105, P11969, DOI 10.1073/pnas.0802569105; Stokes M, 2009, P NATL ACAD SCI USA, V106, P19569, DOI 10.1073/pnas.0905306106; Sugase-Miyamoto Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000073; Takeda K, 2004, CEREB CORTEX, V14, P1328, DOI 10.1093/cercor/bhh093; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Woolgar A, 2011, J NEUROSCI, V31, P14592, DOI 10.1523/JNEUROSCI.2616-11.2011; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	48	389	395	4	106	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 24	2013	78	2					364	375		10.1016/j.neuron.2013.01.039	http://dx.doi.org/10.1016/j.neuron.2013.01.039			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23562541	hybrid, Green Published			2022-12-17	WOS:000318202200015
J	Tan, KR; Yvon, C; Turiault, M; Mirzabekov, JJ; Doehner, J; Labouebe, G; Deisseroth, K; Tye, KM; Luscher, C				Tan, Kelly R.; Yvon, Cedric; Turiault, Marc; Mirzabekov, Julie J.; Doehner, Jana; Labouebe, Gwenael; Deisseroth, Karl; Tye, Kay M.; Luescher, Christian			GABA Neurons of the VTA Drive Conditioned Place Aversion	NEURON			English	Article							VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE NEURONS; LATERAL HABENULA; NONDOPAMINERGIC NEURONS; SYNAPTIC PLASTICITY; CENTRAL AMYGDALA; REWARD; RAT; NUCLEUS; STIMULI	Salient but aversive stimuli inhibit the majority of dopamine (DA) neurons in the ventral tegmental area (VTA) and cause conditioned place aversion (CPA). The cellular mechanism underlying DA neuron inhibition has not been investigated and the causal link to behavior remains elusive. Here, we show that GABA neurons of the VTA inhibit DA neurons through neurotransmission at GABA(A) receptors. We also observe that GABA neurons increase their firing in response to a footshock and provide evidence that driving GABA neurons with optogenetic effectors is sufficient to affect behavior. Taken together, our data demonstrate that synaptic inhibition of DA neurons drives place aversion.	[Tan, Kelly R.; Yvon, Cedric; Turiault, Marc; Labouebe, Gwenael; Luescher, Christian] Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Mirzabekov, Julie J.; Deisseroth, Karl; Tye, Kay M.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Doehner, Jana] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Tye, Kay M.] MIT, Picower Inst Learning & Memory Brain & Cognit Sci, Cambridge, MA 02139 USA; [Luescher, Christian] Univ Hosp Geneva, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; Stanford University; University of Zurich; Massachusetts Institute of Technology (MIT); University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Tye, Kay/J-6158-2013; Lüscher, Christian/A-2496-2011; Core, Vector/CAF-4832-2022	Tye, Kay/0000-0002-2435-0182; Lüscher, Christian/0000-0001-7917-4596; 	National Center of Competences in Research; Swiss National Science Foundation; NRSA [F32 MH880102]; PILM (MIT); National Institutes of Health; Howard Hughes Medical Institute; Defense Advanced Research Projects Agency; Gatsby Charitable Foundation; Woo Foundation; Snyder Foundation; Yu Foundation; Wiegers Family Fund	National Center of Competences in Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PILM (MIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gatsby Charitable Foundation; Woo Foundation; Snyder Foundation; Yu Foundation; Wiegers Family Fund	We thank Matthew Brown for critical reading of the manuscript. We thank Eoin O'Connor for support in behavioral experiments. We also thank Gero Miesenbock for generously providing the GADcre mice. This study was supported by the National Center of Competences in Research. "SYNAPSY - The Synaptic Bases of Mental Diseases" financed by the Swiss National Science Foundation as well as a core grant to C.L. K.M.T. is supported by NRSA fellowship F32 MH880102 and PILM (MIT). K.D. is supported by the National Institutes of Health, the Howard Hughes Medical Institute, the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program, the Gatsby Charitable Foundation, the Woo, Snyder, and Yu Foundations, and the Wiegers Family Fund. All optogenetic tools and methods are distributed and supported freely (www.optogenetics.org). K.R.T. and C.L. designed the study and wrote the manuscript. K.R.T., C.Y., and G.L. performed the in vivo electrophysiological experiments and analyzed the data. K.R.T. performed the in vitro electrophysiological experiments and analyzed the data. M.T., K.M.T., and J.J.M. performed behavioral experiments in K.D.'s group, and K.D. also provided reagents. J.D. performed immunohistochemistry.	ACQUAS E, 1989, PSYCHOPHARMACOLOGY, V99, P151, DOI 10.1007/BF00442800; Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Anstrom KK, 2005, NEUROPSYCHOPHARMACOL, V30, P1832, DOI 10.1038/sj.npp.1300730; Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; Cruz HG, 2008, J NEUROSCI, V28, P4069, DOI 10.1523/JNEUROSCI.0267-08.2008; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; Fadok JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012751; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gavello-Baudy S, 2008, PSYCHOPHARMACOLOGY, V201, P219, DOI 10.1007/s00213-008-1263-z; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Guarraci FA, 1999, ANN NY ACAD SCI, V877, P732, DOI 10.1111/j.1749-6632.1999.tb09312.x; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Lassen MB, 2007, BRAIN RES, V1156, P46, DOI 10.1016/j.brainres.2007.04.053; Lazaro-Munoz G, 2010, BIOL PSYCHIAT, V67, P1120, DOI 10.1016/j.biopsych.2009.12.002; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luo AH, 2008, EUR J NEUROSCI, V27, P408, DOI 10.1111/j.1460-9568.2007.05985.x; Paxinos G., 2019, PAXINOS FRANKLINS MO, DOI [10.3390/ijms20225729, DOI 10.3390/IJMS20225729]; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Rosenkranz JA, 2006, BIOL PSYCHIAT, V59, P801, DOI 10.1016/j.biopsych.2005.09.013; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Sun WenLin, 2011, Curr Drug Abuse Rev, V4, P270; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; TEPPER JM, 1995, J NEUROSCI, V15, P3092; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valenti O, 2011, J NEUROSCI, V31, P4280, DOI 10.1523/JNEUROSCI.5310-10.2011; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; WILLIAMS GV, 1990, NEUROSCIENCE, V39, P1, DOI 10.1016/0306-4522(90)90217-R; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808	53	389	396	3	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 22	2012	73	6					1173	1183		10.1016/j.neuron.2012.02.015	http://dx.doi.org/10.1016/j.neuron.2012.02.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445344	Green Accepted, Bronze, Green Published			2022-12-17	WOS:000301998700014
J	Agulhon, C; Petravicz, J; McMullen, AB; Sweger, EJ; Minton, SK; Taves, SR; Casper, KB; Fiacco, TA; McCarthy, KD				Agulhon, Cendra; Petravicz, Jeremy; McMullen, Allison B.; Sweger, Elizabeth J.; Minton, Suzanne K.; Taves, Sarah R.; Casper, Kristen B.; Fiacco, Todd A.; McCarthy, Ken D.			What is the role of astrocyte calcium in neurophysiology?	NEURON			English	Review							BERGMANN GLIAL-CELLS; DEPENDENT GLUTAMATE RELEASE; PARALLEL FIBER ACTIVITY; HIPPOCAMPAL ASTROCYTES; IN-SITU; NEURONAL-ACTIVITY; CA2+ RELEASE; INTRACELLULAR CALCIUM; SYNAPTIC-TRANSMISSION; PROTOPLASMIC ASTROCYTES	Astrocytes comprise approximately half of the volume of the adult mammalian brain and are the primary neuronal structural and trophic supportive elements. Astrocytes are organized into distinct nonoverlapping domains and extend elaborate and dense fine processes that interact intimately with synapses and cerebrovasculature. The recognition in the mid 1990s that astrocytes undergo elevations in intracellular calcium concentration following activation of G protein-coupled receptors by synaptically released neurotransmitters demonstrated not only that astrocytes display a form of excitability but also that astrocytes may be active participants in brain information processing. The roles that astrocytic calcium elevations play in neurophysiology and especially in modulation of neuronal activity have been intensely researched in recent years. This review will summarize the current understanding of the function of astrocytic calcium signaling in neurophysiological processes and discuss areas where the role of astrocytes remains controversial and will therefore benefit from further study.	[Agulhon, Cendra; McMullen, Allison B.; Sweger, Elizabeth J.; Minton, Suzanne K.; Casper, Kristen B.; McCarthy, Ken D.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Petravicz, Jeremy; Taves, Sarah R.; McCarthy, Ken D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; [Fiacco, Todd A.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Riverside	McCarthy, KD (corresponding author), Univ N Carolina, Dept Pharmacol, 1004 Mary Ellen Jones Bldg,CB 7365, Chapel Hill, NC 27599 USA.	kdmc@med.unc.edu		Agulhon, Cendra/0000-0001-7508-6978; Petravicz, Jeremy/0000-0001-5161-4641; Taves, Sarah/0000-0001-6759-9888	US National Institutes of Health [NS033938, NS020212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020212, R01NS033938] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health (NS033938 and NS020212).	Aguado F, 2002, J NEUROSCI, V22, P9430; Anderson CM, 2000, GLIA, V32, P1; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Beck A, 2004, CELL CALCIUM, V35, P47, DOI 10.1016/S0143-4160(03)00171-4; Beierlein M, 2006, J NEUROSCI, V26, P6958, DOI 10.1523/JNEUROSCI.0613-06.2006; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carmignoto G, 1998, J NEUROSCI, V18, P4637; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; DUFFY S, 1995, J NEUROSCI, V15, P5535; DUFFY S, 1994, NEUROSCIENCE, V61, P51, DOI 10.1016/0306-4522(94)90059-0; Fellin T, 2006, J BIOL CHEM, V281, P4274, DOI 10.1074/jbc.M510679200; Fellin T, 2004, J PHYSIOL-LONDON, V559, P3, DOI 10.1113/jphysiol.2004.063214; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Grosche J, 2002, J NEUROSCI RES, V68, P138, DOI 10.1002/jnr.10197; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Hertle DN, 2007, NEUROSCIENCE, V150, P625, DOI 10.1016/j.neuroscience.2007.09.058; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jabs R, 2005, J CELL SCI, V118, P3791, DOI 10.1242/jcs.02515; JABS R, 1994, PFLUG ARCH EUR J PHY, V426, P310, DOI 10.1007/BF00374787; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kacem K, 1998, GLIA, V23, P1; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; KIMELBERG HK, 1990, BRAIN RES, V529, P262, DOI 10.1016/0006-8993(90)90836-Z; KONIETZKO U, 1994, HIPPOCAMPUS, V4, P297, DOI 10.1002/hipo.450040313; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Kulik A, 1999, J NEUROSCI, V19, P8401; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Liu Y, 2004, J GEOPHYS ENG, V1, P307, DOI 10.1088/1742-2132/1/4/009; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matthias K, 2003, J NEUROSCI, V23, P1750; Matyash V, 2001, MOL CELL NEUROSCI, V18, P664, DOI 10.1006/mcne.2001.1047; MCCARTHY KD, 1978, J CYCLIC NUCL PROT, V4, P15; Metea MR, 2006, GLIA, V54, P650, DOI 10.1002/glia.20352; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Parri HR, 2003, NEUROSCIENCE, V120, P979, DOI 10.1016/S0306-4522(03)00379-8; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Piet R, 2007, J NEUROSCI, V27, P4027, DOI 10.1523/JNEUROSCI.0462-07.2007; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; PORTER JT, 1995, J NEUROCHEM, V65, P1515, DOI 10.1046/j.1471-4159.1995.65041515.x; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Porter JT, 1996, J NEUROSCI, V16, P5073; POTTER JT, 1995, GLIA, V13, P101; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Rao KVR, 2003, NEUROREPORT, V14, P2379, DOI 10.1097/01.wnr.0000099610.19426.a6; ROTH BJ, 1995, CELL CALCIUM, V17, P53, DOI 10.1016/0143-4160(95)90102-7; Sasaki Y, 1997, J NEUROCHEM, V68, P2194; Scemes E, 2000, MOL NEUROBIOL, V22, P167, DOI 10.1385/MN:22:1-3:167; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Sharp AH, 1999, J COMP NEUROL, V406, P207; Shelton MK, 1999, GLIA, V26, P1, DOI 10.1002/(SICI)1098-1136(199903)26:1<1::AID-GLIA1>3.0.CO;2-Z; Shelton MK, 2000, J NEUROCHEM, V74, P555, DOI 10.1046/j.1471-4159.2000.740555.x; Sheppard CA, 1997, J NEUROCHEM, V68, P2317; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shuai JW, 2003, P NATL ACAD SCI USA, V100, P506, DOI 10.1073/pnas.0236032100; Simard M, 2003, J NEUROSCI, V23, P9254; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654; SOMJEN GG, 1988, GLIA, V1, P2, DOI 10.1002/glia.440010103; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Straub SV, 2006, J GEN PHYSIOL, V128, P659, DOI 10.1085/jgp.200609650; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Sul JY, 2004, NEURON GLIA BIOL, V1, P3, DOI 10.1017/S1740925X04000031; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thomas GH, 2000, TRENDS MICROBIOL, V8, P15, DOI 10.1016/S0966-842X(99)01668-6; Tian GF, 2006, ADV DRUG DELIVER REV, V58, P773, DOI 10.1016/j.addr.2006.07.001; VANCALKER D, 1978, J NEUROCHEM, V30, P713; VANCALKER D, 1981, ADV CELL NEUROBIOL, P32; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Volterra A, 2004, GLIA, V47, P249, DOI 10.1002/glia.20080; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Wilhelm A, 2004, NEUROSCI RES, V48, P249, DOI 10.1016/j.neures.2003.11.002; YAGODIN S, 1995, MOL CELL BIOCHEM, V149, P137, DOI 10.1007/BF01076572; YAGODIN SV, 1994, J NEUROBIOL, V25, P265, DOI 10.1002/neu.480250307; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200	119	389	394	4	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2008	59	6					932	946		10.1016/j.neuron.2008.09.004	http://dx.doi.org/10.1016/j.neuron.2008.09.004			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	356SK	18817732	Green Published, Green Accepted, Bronze			2022-12-17	WOS:000259797700010
J	Dobbins, IG; Foley, H; Schacter, DL; Wagner, AD				Dobbins, IG; Foley, H; Schacter, DL; Wagner, AD			Executive control during episodic retrieval: Multiple prefrontal processes subserve source memory	NEURON			English	Article							RECOGNITION MEMORY; FUNCTIONAL MRI; CORTEX; RECOLLECTION; DISSOCIATION; FAMILIARITY; IMPAIRMENT; REHEARSAL; CONFABULATION; EXPLICIT	During recognition, one may sense items as familiar (item memory) and additionally recollect specific contextual details of the earlier encounters (source memory). Cognitive theory suggests that, unlike item memory, source memory requires controlled cue specification and monitoring processes. Functional imaging suggests that such processes may depend on left prefrontal cortex (PFC). However, the nature and possible anatomical segregation of these processes remains unknown. Using functional magnetic resonance imaging, we isolated distinct response patterns in left PFC during source memory consistent with semantic analysis/cue specification (anterior ventrolateral), recollective monitoring (posterior dorsolateral and frontopolar), and phonological maintenance/rehearsal (posterior ventrolateral). Importantly, cue specification and recollective monitoring responses were not seen during item memory and were unaffected by retrieval success, demonstrating that the mere attempt to recollect episodic detail engages multiple control processes with different left PFC substrates.	MGH, MIT, HMS, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dobbins, IG (corresponding author), MGH, MIT, HMS, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	ian@nmr.mgh.harvard.edu		Schacter, Daniel/0000-0002-2460-6061	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS026985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008441, R01AG008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004466] Funding Source: NIH RePORTER; NIA NIH HHS [AG08441] Funding Source: Medline; NIDCD NIH HHS [DC04466] Funding Source: Medline; NIMH NIH HHS [MH60941] Funding Source: Medline; NINDS NIH HHS [NS26985] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1974, CONT DEV MATH PSYCHO; [Anonymous], 1983, CANADIAN PSYCHOL; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Banks WP, 2000, PSYCHOL SCI, V11, P267, DOI 10.1111/1467-9280.00254; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; BUCKNER RL, 1995, J NEUROSCI, V15, P12; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; CLARK SE, 1992, MEM COGNITION, V20, P580, DOI 10.3758/BF03199590; Conway MA, 1999, MEMORY, V7, P679, DOI 10.1080/096582199387805; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; DEMB JB, 1995, J NEUROSCI, V15, P5870; Dobbins IG, 2000, MEM COGNITION, V28, P1347, DOI 10.3758/BF03211835; Donaldson DI, 1999, NEURON, V22, P412, DOI 10.1016/S0896-6273(00)80693-5; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Fink GR, 1996, J NEUROSCI, V16, P4275; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; KAPUR S, 1994, NEUROREPORT, V5, P2193, DOI 10.1097/00001756-199410270-00051; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Maguire EA, 1999, HIPPOCAMPUS, V9, P54, DOI 10.1002/(SICI)1098-1063(1999)9:1<54::AID-HIPO6>3.0.CO;2-O; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Moscovitch M, 1995, MEMORY DISTORTION, P226; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; NORMAN DA, 1979, COGNITIVE PSYCHOL, V11, P107, DOI 10.1016/0010-0285(79)90006-9; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; RUDGE P, 1991, BRAIN, V114, P349, DOI 10.1093/brain/114.1.349; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Schacter D. L., 2001, 7 SINS MEMORY MIND F; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wagner AD, 1997, J EXP PSYCHOL LEARN, V23, P305, DOI 10.1037/0278-7393.23.2.305; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341; Yonelinas AP, 1999, J EXP PSYCHOL LEARN, V25, P1415, DOI 10.1037/0278-7393.25.6.1415	53	389	395	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					989	996		10.1016/S0896-6273(02)00858-9	http://dx.doi.org/10.1016/S0896-6273(02)00858-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	589UY	12372291	Bronze			2022-12-17	WOS:000177779800019
J	Isaacson, JS; Strowbridge, BW				Isaacson, JS; Strowbridge, BW			Olfactory reciprocal synapses: Dendritic signaling in the CNS	NEURON			English	Article							EXCITATORY SYNAPTIC TRANSMISSION; GRANULE CELLS; DENDRODENDRITIC INHIBITION; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; CA2+ CHANNELS; CALCIUM CHELATORS; N-TYPE; BULB; SPINES	Synaptic transmission between dendrites in the olfactory bulb is thought to play a major role in the processing of olfactory information. Glutamate released from mitral cell dendrites excites the dendrites of granule cells, which in turn mediate GABAergic dendrodendritic inhibition back onto mitral dendrites. We examined the mechanisms governing reciprocal dendritic transmission in rat olfactory bulb slices. We find that NMDA receptors play a critical role in this dendrodendritic inhibition. As with axenic synapses, the dendritic release of fast neurotransmitters relies on N- and P/Q-type calcium channels. The magnitude of dendrodendritic transmission is directly proportional to dendritic calcium influx. Furthermore, recordings from pairs of mitral cells show that dendrodendritic synapses can mediate lateral inhibition independently of axonal action potentials.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Isaacson, JS (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.				NINDS NIH HHS [NS33590] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033590, R29NS033590] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; Avery RB, 1996, J NEUROSCI, V16, P5567; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BORST JG, 1996, NATURE, V383, P43; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P263, DOI 10.1016/0166-2236(87)90170-6; DOWLING JE, 1968, PROC R SOC SER B-BIO, V170, P205, DOI 10.1098/rspb.1968.0034; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Galarreta M, 1997, J NEUROSCI, V17, P7220; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; ISAACSON JS, 1995, J NEUROPHYSIOL, V73, P964, DOI 10.1152/jn.1995.73.3.964; JAHR CE, 1982, NATURE, V297, P227, DOI 10.1038/297227a0; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; KOCH C, 1993, J NEUROSCI, V13, P413; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; NICOLL RA, 1969, BRAIN RES, V14, P157, DOI 10.1016/0006-8993(69)90037-7; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; PHILLIPS CG, 1963, J PHYSIOL-LONDON, V168, P65, DOI 10.1113/jphysiol.1963.sp007178; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; PRICE JL, 1970, J CELL SCI, V7, P125; PRICE JL, 1970, J CELL SCI, V7, P91; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Shepherd G. M., 1990, SYNAPTIC ORG BRAIN, P133; SIMMONS ML, 1995, NEURON, V14, P1265, DOI 10.1016/0896-6273(95)90273-2; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TROMBLEY PQ, 1990, J NEUROPHYSIOL, V64, P598, DOI 10.1152/jn.1990.64.2.598; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WELLIS DP, 1994, J PHYSIOL-LONDON, V475, P419, DOI 10.1113/jphysiol.1994.sp020082; WELLIS DP, 1993, J PHYSIOL-LONDON, V469, P315, DOI 10.1113/jphysiol.1993.sp019816; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WINSLOW JL, 1994, J NEUROPHYSIOL, V72, P1769, DOI 10.1152/jn.1994.72.4.1769; WOOLF TB, 1991, J NEUROSCI, V11, P1837; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	50	389	393	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					749	761		10.1016/S0896-6273(00)81013-2	http://dx.doi.org/10.1016/S0896-6273(00)81013-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581766	Bronze			2022-12-17	WOS:000073346500013
J	SMITH, KE; BORDEN, LA; HARTIG, PR; BRANCHEK, T; WEINSHANK, RL				SMITH, KE; BORDEN, LA; HARTIG, PR; BRANCHEK, T; WEINSHANK, RL			CLONING AND EXPRESSION OF A GLYCINE TRANSPORTER REVEAL COLOCALIZATION WITH NMDA RECEPTORS	NEURON			English	Article							PLASMA-MEMBRANE VESICLES; AMINO-ACIDS; SPINAL-CORD; RAT; BRAIN; MOUSE; CELLS; GENE	A complementary DNA clone encoding a transporter for glycine has been isolated from rat brain, and its functional properties have been examined in mammalian cells. The transporter displays high affinity for glycine (K(M) almost-equal-to 100-mu-M) and is dependent on external Na+ and Cl-. Northern blot analysis indicates that the distribution of the mRNA encoding the glycine transporter is restricted to the nervous system. In situ hybridization data are consistent with roles for the transporter in both glycine neurotransmission and glycine modulation of N-methyl-D-aspartate (NMDA) receptors in the hippocampus. The identification of this transporter therefore opens the study of the molecular mechanisms underlying both inhibitory glycinergic transmission and NMDA-mediated excitatory transmission.			SMITH, KE (corresponding author), SYNAPT PHARMACEUT CORP,215 COLL RD,PARAMUS,NJ 07652, USA.							Aprison M. H., 1990, GLYCINE NEUROTRANSMI, P1; BECKER CM, 1990, FASEB J, V4, P2767, DOI 10.1096/fasebj.4.10.2165011; BENNETT JP, 1974, LIFE SCI, V15, P1045, DOI 10.1016/S0024-3205(74)80002-0; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; CHRISTENSEN HN, 1984, BIOCHIM BIOPHYS ACTA, V779, P255, DOI 10.1016/0304-4157(84)90012-1; CHRISTENSEN HN, 1981, BIOCHEM BIOPH RES CO, V98, P102, DOI 10.1016/0006-291X(81)91875-1; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; CORTES R, 1990, GLYCINE TRANSMISSION, P240; DALY EC, 1990, GLYCINE NEUROTRANSMI, P25; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELIPE A, 1990, BIOSCIENCE REP, V10, P209, DOI 10.1007/BF01116580; FLETCHER EJ, 1990, GLYCINE NEUROTRANSMI, P193; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; GUNDLACH AL, 1990, FASEB J, V4, P2761, DOI 10.1096/fasebj.4.10.2165010; HANDELMANN GE, 1989, PHARMACOL BIOCHEM BE, V34, P823, DOI 10.1016/0091-3057(89)90281-5; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HORN AS, 1990, PROG NEUROBIOL, V34, P387, DOI 10.1016/0301-0082(90)90033-D; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KAYANO T, 1990, J BIOL CHEM, V265, P13276; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LOPEZCORCUERA B, 1989, EUR J BIOCHEM, V181, P519, DOI 10.1111/j.1432-1033.1989.tb14754.x; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MAYOR F, 1981, BIOCHEM J, V198, P535, DOI 10.1042/bj1980535; MONOGHAN DT, 1990, GLYCINE TRANSMISSION, P219; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOSELEY RH, 1988, AM J PHYSIOL, V255, pG253, DOI 10.1152/ajpgi.1988.255.2.G253; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; VANDENPOL AN, 1988, J NEUROSCI, V8, P472; ZAFRA F, 1989, BIOCHEM J, V258, P403, DOI 10.1042/bj2580403	36	389	399	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					927	935		10.1016/0896-6273(92)90207-T	http://dx.doi.org/10.1016/0896-6273(92)90207-T			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1534013				2022-12-17	WOS:A1992HV46700012
J	Allen, NJ; Eroglu, C				Allen, Nicola J.; Eroglu, Cagla			Cell Biology of Astrocyte-Synapse Interactions	NEURON			English	Review							CNS SYNAPTOGENESIS; PERISYNAPTIC ASTROGLIA; NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL-NEURONS; SECRETED PROTEINS; STEM-CELLS; GLIA; PLASTICITY; MATURATION; BRAIN	Astrocytes, the most abundant glial cells in the mammalian brain, are critical regulators of brain development and physiology through dynamic and often bidirectional interactions with neuronal synapses. Despite the clear importance of astrocytes for the establishment and maintenance of proper synaptic connectivity, our understanding of their role in brain function is still in its infancy. We propose that this is at least in part due to large gaps in our knowledge of the cell biology of astrocytes and the mechanisms they use to interact with synapses. In this review, we summarize some of the seminal findings that yield important insight into the cellular and molecular basis of astrocyte-neuron communication, focusing on the role of astrocytes in the development and remodeling of synapses. Furthermore, we pose some pressing questions that need to be addressed to advance our mechanistic understanding of the role of astrocytes in regulating synaptic development.	[Allen, Nicola J.] Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Eroglu, Cagla] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Eroglu, Cagla] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Eroglu, Cagla] Duke Univ, Med Ctr, Duke Inst Brain Sci, Durham, NC 27710 USA	Salk Institute; Duke University; Duke University; Duke University	Allen, NJ (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Eroglu, C (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.; Eroglu, C (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.; Eroglu, C (corresponding author), Duke Univ, Med Ctr, Duke Inst Brain Sci, Durham, NC 27710 USA.	nallen@salk.edu; cagla.eroglu@duke.edu			NIH/NINDS [R01 NS089791, R01 NS096352]; Hearst Foundation; Pew Foundation; Ellison Foundation; Dana Foundation; Whitehall Foundation; NIH/NIDA [R01 DA031833]; NIH/NIEHS [R01 ES025549]; Simons Foundation Autism Research Initiative [400729]; Holland-Trice Brain Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096352, R01NS089791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031833] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hearst Foundation; Pew Foundation; Ellison Foundation(Lawrence Ellison Foundation); Dana Foundation; Whitehall Foundation; NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Simons Foundation Autism Research Initiative; Holland-Trice Brain Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Work in the lab of N.J.A. is supported by NIH/NINDS R01 NS089791 and the Hearst, Pew, Ellison, Dana, and Whitehall Foundations. Work in the lab of C.E. is supported by NIH/NIDA R01 DA031833, NIH/NINDS R01 NS096352, and NIH/NIEHS R01 ES025549 and by Simons Foundation Autism Research Initiative (#400729) and Holland-Trice Brain Research Foundation.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Albrecht D, 2012, MOL CELL NEUROSCI, V49, P364, DOI 10.1016/j.mcn.2012.01.005; Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Baldwin KT, 2017, CURR OPIN NEUROBIOL, V45, P113, DOI 10.1016/j.conb.2017.05.006; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; Barker AJ, 2008, J NEUROSCI, V28, P8150, DOI 10.1523/JNEUROSCI.1744-08.2008; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bell JJL, 2010, NEURON GLIA BIOL, V6, P193, DOI 10.1017/S1740925X10000165; Bernardinelli Y, 2014, CURR BIOL, V24, P1679, DOI 10.1016/j.cub.2014.06.025; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Blanco-Suarez E, 2017, J PHYSIOL-LONDON, V595, P1903, DOI 10.1113/JP270988; Buosi AS, 2017, MOL NEUROBIOL; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951; Cao G, 2007, J NEUROSCI, V27, P6712, DOI 10.1523/JNEUROSCI.1329-07.2007; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Cheng C, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0256-9; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Cuevas ME, 2005, MOL CELL NEUROSCI, V28, P770, DOI 10.1016/j.mcn.2005.01.001; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001; Diniz LP, 2014, GLIA, V62, P1917, DOI 10.1002/glia.22713; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Ebrahimi M, 2016, GLIA, V64, P48, DOI 10.1002/glia.22902; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Farhy-Tselnicker I, 2017, NEURON, V96, P428, DOI 10.1016/j.neuron.2017.09.053; Faria LC, 2017, NEUROBIOL DIS, V102, P70, DOI 10.1016/j.nbd.2017.01.009; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Freeman MR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020552; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Fuentes-Medel Y, 2012, CURR BIOL, V22, P1831, DOI 10.1016/j.cub.2012.07.063; Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200; Garcia-Marques J, 2013, CEREB CORTEX, V23, P1463, DOI 10.1093/cercor/bhs134; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; Hennekinne L, 2013, J NEUROSCI, V33, P11432, DOI 10.1523/JNEUROSCI.5247-12.2013; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Jacobs S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-132; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kerr KS, 2014, J NEUROSCI, V34, P2910, DOI 10.1523/JNEUROSCI.3714-13.2014; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; Kim J, 2014, MOL CELLS, V37, P767, DOI 10.14348/molcells.2014.0248; Krencik R, 2017, BRAIN RES BULL, V129, P66, DOI 10.1016/j.brainresbull.2016.08.012; Krencik R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5645; Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405; Krzisch M, 2015, BRAIN STRUCT FUNCT, V220, P2027, DOI 10.1007/s00429-014-0768-y; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; KUFFLER SW, 1967, PROC R SOC SER B-BIO, V168, P1, DOI 10.1098/rspb.1967.0047; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lippman JJ, 2008, GLIA, V56, P1463, DOI 10.1002/glia.20712; Lopez-Murcia FJ, 2015, P NATL ACAD SCI USA, V112, P13366, DOI 10.1073/pnas.1512202112; Ma ZG, 2016, NATURE, V539, P428, DOI 10.1038/nature20145; Malik N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096139; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Morel L, 2017, J NEUROSCI, V37, P8706, DOI 10.1523/JNEUROSCI.3956-16.2017; Morel L, 2014, J NEUROSCI, V34, P10950, DOI 10.1523/JNEUROSCI.1167-14.2014; MULLER CM, 1990, GLIA, V3, P487, DOI 10.1002/glia.440030607; Murphy-Royal C, 2017, J NEUROSCI RES, V95, P2140, DOI 10.1002/jnr.24029; Muthukumar AK, 2014, NAT NEUROSCI, V17, P1340, DOI 10.1038/nn.3791; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305; Pyka M, 2011, EUR J NEUROSCI, V33, P2187, DOI 10.1111/j.1460-9568.2011.07690.x; Reddy LV, 2003, NEURON, V40, P563, DOI 10.1016/S0896-6273(03)00682-2; Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Sakers K, 2017, P NATL ACAD SCI USA, V114, pE3830, DOI 10.1073/pnas.1617782114; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scholze AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110668; Shigetomi E, 2016, TRENDS CELL BIOL, V26, P300, DOI 10.1016/j.tcb.2016.01.003; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Sibille J, 2014, J PHYSIOL-LONDON, V592, P87, DOI 10.1113/jphysiol.2013.261735; Singh SK, 2016, CELL, V164, P183, DOI 10.1016/j.cell.2015.11.034; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Sloan SA, 2014, NEURON, V84, P1112, DOI 10.1016/j.neuron.2014.12.003; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Stogsdill JA, 2017, CURR OPIN NEUROBIOL, V42, P1, DOI 10.1016/j.conb.2016.09.016; Stork T, 2014, NEURON, V83, P388, DOI 10.1016/j.neuron.2014.06.026; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tani H, 2014, NEURON, V81, P888, DOI 10.1016/j.neuron.2013.12.026; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Van Deijk ALF, 2017, GLIA, V65, P670, DOI 10.1002/glia.23120; Wang IE, 2016, ELIFE, V5, DOI 10.7554/eLife.16996; Wang JJ, 2017, J COMP NEUROL, V525, P1759, DOI 10.1002/cne.24153; Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Yang Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003172; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	134	388	392	15	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 1	2017	96	3					697	708		10.1016/j.neuron.2017.09.056	http://dx.doi.org/10.1016/j.neuron.2017.09.056			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL4MG	29096081	Green Accepted, Bronze			2022-12-17	WOS:000414203400012
